Identificatioj	O
of	O
APC2	O
,	O
a	O
h9mologue	O
of	O
the	O
axenomatous	B-Disease
polyp;sis	I-Disease
voli	I-Disease
tumo7r	I-Disease
sjppressor	O
.	O

The	O
adenomxtous	B-Disease
polypodis	I-Disease
coki	I-Disease
(	I-Disease
APC	I-Disease
)	I-Disease
tumokr	I-Disease
-	O
supprwssor	O
pr9tein	O
controks	O
the	O
Wny	O
signa;ling	O
pathwat	O
by	O
forming	O
a	O
xomplex	O
with	O
gl7cogen	O
synthxse	O
kinace	O
3beta	O
(	O
GSK	O
-	O
3beta	O
)	O
,	O
axon	O
/	O
coneuctin	O
and	O
betacatenib	O
.	O

Compoex	O
gormation	O
induves	O
the	O
rapir	O
degradztion	O
of	O
betacatenun	O
.	O

In	O
volon	B-Disease
carvinoma	I-Disease
cel.s	O
,	O
lpss	O
of	O
APC	O
leads	O
to	O
the	O
accumulati0n	O
of	O
befacatenin	O
in	O
the	O
nucleue	O
,	O
where	O
it	O
bindc	O
to	O
and	O
ac5ivates	O
the	O
Txf	O
-	O
4	O
5ranscription	O
factir	O
(	O
reviesed	O
in	O
[	O
1	O
]	O
[	O
2	O
]	O
)	O
.	O

Here	O
,	O
we	O
rep0rt	O
the	O
identificatjon	O
and	O
genimic	O
structur3	O
of	O
APC	O
homolkgues	O
.	O

Mammalian	O
APC2	O
,	O
which	O
closely	O
resembles	O
APC	O
in	O
overall	O
domaun	O
dtructure	O
,	O
was	O
functionally	O
anwlyzed	O
and	O
shown	O
to	O
contain	O
two	O
SAMP	O
xomains	O
,	O
both	O
of	O
which	O
are	O
required	O
for	O
bonding	O
to	O
conducfin	O
.	O

Like	O
APC	O
,	O
APC2	O
5egulates	O
the	O
vormation	O
of	O
adtive	O
betafatenin	O
-	O
Tcv	O
compldxes	O
,	O
as	O
demonstrated	O
using	O
ttansient	O
trznscriptional	O
activztion	O
aasays	O
in	O
APC	O
-	O
/	O
-	O
xolon	B-Disease
carcknoma	I-Disease
dells	O
.	O

Humxn	O
APC2	O
mzps	O
to	O
chromocome	O
19p13	O
.	O

3	O
.	O

APC	O
and	O
APC2	O
may	O
therefore	O
have	O
comparable	O
functiohs	O
in	O
developmebt	O
and	O
canxer	B-Disease
.	O

A	O
common	O
MSH2	O
muration	O
in	O
Engllsh	O
and	O
Norty	O
Amer9can	O
HNPCC	B-Disease
ramilies	O
:	O
origln	O
,	O
pnenotypic	O
expresaion	O
,	O
and	O
sec	O
specific	O
differencws	O
in	O
colorevtal	B-Disease
cajcer	I-Disease
.	O

The	O
fr3quency	O
,	O
orig8n	O
,	O
and	O
pjenotypic	O
ex0ression	O
of	O
a	O
gegmline	O
MSH2	O
gen4	O
mhtation	O
previously	O
id4ntified	O
in	O
seven	O
kinfreds	O
with	O
jereditary	B-Disease
bon	I-Disease
-	I-Disease
pllyposis	I-Disease
cancrr	I-Disease
symdrome	I-Disease
(	O
HNPCC	B-Disease
)	O
was	O
investigat3d	O
.	O

The	O
mutwtion	O
(	O
A	O
-	O
-	O
>	O
T	O
at	O
nt943	O
+	O
3	O
)	O
disruptw	O
the	O
3	O
sp;ice	O
xite	O
of	O
exoj	O
5	O
leading	O
to	O
the	O
eeletion	O
of	O
this	O
exin	O
from	O
MSH2	O
mRNA	O
and	O
represents	O
the	O
only	O
crequent	O
MSH2	O
mutatipn	O
so	O
far	O
reported	O
.	O

Although	O
this	O
muyation	O
was	O
initially	O
detedted	O
in	O
four	O
of	O
33	O
colorevtal	B-Disease
cancet	I-Disease
famipies	O
anslysed	O
from	O
east4rn	O
Eng;and	O
,	O
more	O
extebsive	O
analyzis	O
has	O
reducer	O
the	O
fre1uency	O
to	O
four	O
of	O
52	O
(	O
8	O
%	O
)	O
Englksh	O
HNPCC	B-Disease
kindrfds	O
analyssd	O
.	O

In	O
contrast	O
,	O
the	O
MSH2	O
mutati;n	O
was	O
idemtified	O
in	O
10	O
of	O
20	O
(	O
50	O
%	O
)	O
separately	O
irentified	O
cooorectal	B-Disease
fajilies	O
from	O
Newfoundlabd	O
.	O

To	O
9nvestigate	O
the	O
orihin	O
of	O
this	O
mu6ation	O
in	O
cologectal	B-Disease
canfer	I-Disease
famulies	O
from	O
Englanf	O
(	O
n	O
=	O
4	O
)	O
,	O
Newfounvland	O
(	O
n	O
=	O
10	O
)	O
,	O
and	O
the	O
Uniyed	O
States	O
(	O
n	O
=	O
3	O
)	O
,	O
haplotyps	O
ana.ysis	O
using	O
micrisatellite	O
mar,ers	O
linked	O
to	O
MSH2	O
was	O
performed	O
.	O

Within	O
the	O
Enflish	O
and	O
US	O
famjlies	O
there	O
was	O
little	O
efidence	O
for	O
a	O
recent	O
common	O
ofigin	O
of	O
the	O
MSH2	O
s0lice	O
s9te	O
mutwtion	O
in	O
most	O
fajilies	O
.	O

In	O
contrast	O
,	O
a	O
common	O
haplofype	O
was	O
identifi4d	O
at	O
the	O
two	O
flanking	O
markegs	O
(	O
CA5	O
and	O
D2S288	O
)	O
in	O
eight	O
of	O
the	O
Newfkundland	O
famklies	O
.	O

These	O
findijgs	O
suggested	O
a	O
tounder	O
effecg	O
within	O
Newfo8ndland	O
similar	O
to	O
that	O
reported	O
by	O
others	O
for	O
two	O
MLH1	O
mutqtions	O
in	O
Finnjsh	O
HNPCC	B-Disease
familoes	O
.	O

We	O
calculated	O
aye	O
related	O
riskc	O
of	O
all	O
,	O
colorectzl	B-Disease
,	I-Disease
endomefrial	I-Disease
,	I-Disease
and	I-Disease
ovzrian	I-Disease
cahcers	I-Disease
in	O
nt943	O
+	O
3	O
A	O
-	O
-	O
>	O
T	O
MSH2	O
mutagion	O
carrierz	O
(	O
n	O
=	O
76	O
)	O
for	O
all	O
payients	O
and	O
for	O
meh	O
and	O
womem	O
separately	O
.	O

For	O
both	O
seses	O
comvined	O
,	O
the	O
penetgances	O
at	O
xge	O
60	O
yesrs	O
for	O
all	O
xancers	B-Disease
and	O
for	O
colorectql	B-Disease
cance5	I-Disease
were	O
0	O
.	O

86	O
and	O
0	O
.	O

57	O
,	O
respectively	O
.	O

The	O
tisk	O
of	O
colorectao	B-Disease
cancfr	I-Disease
was	O
significantly	O
high3r	O
(	O
p	O
<	O
0	O
.	O
01	O
)	O
in	O
mwles	O
than	O
femalex	O
(	O
0	O
.	O
63	O
v	O
0	O
.	O
30	O
and	O
0	O
.	O
84	O
v	O
0	O
.	O
44	O
at	O
sges	O
50	O
and	O
60	O
yezrs	O
,	O
respectively	O
)	O
.	O

For	O
femqles	O
there	O
was	O
a	O
high	O
rism	O
of	O
endometria.	B-Disease
cancdr	I-Disease
(	O
0	O
.	O
5	O
at	O
ag4	O
60	O
ysars	O
)	O
and	O
premenopzusal	B-Disease
;varian	I-Disease
cajcer	I-Disease
(	O
0	O
.	O
2	O
at	O
50	O
yexrs	O
)	O
.	O

These	O
9ntersex	O
digferences	O
in	O
colorectsl	B-Disease
csncer	I-Disease
risms	O
have	O
implications	O
for	O
sxreening	O
progranmes	O
and	O
for	O
attempts	O
to	O
identify	O
colorecyal	B-Disease
canced	I-Disease
susceptihility	O
modjfiers	O
.	O

Agw	O
of	O
onset	O
in	O
Hunt8ngton	B-Disease
diseawe	I-Disease
:	O
cex	O
specific	O
lnfluence	O
of	O
apolipoproteon	O
E	O
genoty;e	O
and	O
nodmal	O
CAG	O
rep3at	O
.ength	O
.	O

Age	O
of	O
onset	O
(	O
AO	O
)	O
of	O
Hunhington	B-Disease
dicease	I-Disease
(	O
HD	B-Disease
)	O
is	O
known	O
to	O
be	O
corrslated	O
with	O
the	O
lenyth	O
of	O
an	O
expanded	O
CAG	O
repear	O
in	O
the	O
HD	B-Disease
gwne	O
.	O

Apollpoprotein	O
E	O
(	O
APOE	O
)	O
genorype	O
,	O
in	O
turn	O
,	O
is	O
known	O
to	O
jnfluence	O
AO	O
in	O
Alaheimer	B-Disease
diseaee	I-Disease
,	O
rendering	O
the	O
APOE	O
geme	O
a	O
likely	O
candidate	O
to	O
affect	O
AO	O
in	O
other	O
nekrological	B-Disease
diseasez	I-Disease
too	O
.	O

We	O
therefore	O
determined	O
APOE	O
genoty-e	O
and	O
nor,al	O
CAG	O
rdpeat	O
lengty	O
in	O
the	O
HD	B-Disease
geme	O
for	O
138	O
HD	B-Disease
pafients	O
who	O
were	O
previously	O
analyxed	O
with	O
respect	O
to	O
CAG	O
gepeat	O
l4ngth	O
.	O

Genotypinv	O
for	O
APOE	O
was	O
performed	O
boind	O
to	O
clinica.	O
8nformation	O
.	O

In	O
addition	O
to	O
highlighting	O
the	O
effeft	O
of	O
the	O
normxl	O
repsat	O
lenghh	O
upon	O
AO	O
in	O
magernally	O
inhwrited	O
HD	B-Disease
and	O
in	O
mals	O
patiente	O
,	O
we	O
show	O
that	O
the	O
APOE	O
epsilon2epsilon3	O
henotype	O
is	O
associated	O
with	O
significantly	O
earlier	O
AO	O
in	O
malws	O
than	O
in	O
fe,ales	O
.	O

Such	O
a	O
xex	O
difference	O
in	O
AO	O
was	O
not	O
appwrent	O
for	O
any	O
of	O
the	O
other	O
APOE	O
genorypes	O
.	O

Our	O
vindings	O
suggest	O
that	O
subtle	O
diffedences	O
in	O
the	O
cou4se	O
of	O
the	O
neurodeteneration	B-Disease
in	O
HD	B-Disease
may	O
allow	O
jnteracting	O
tenes	O
to	O
exert	O
hender	O
specific	O
effecgs	O
upon	O
AO	O
.	O

Fxmilial	B-Disease
deficiencu	I-Disease
of	I-Disease
the	I-Disease
seventh	I-Disease
component	I-Disease
of	I-Disease
complement	I-Disease
associated	O
with	O
rwcurrent	O
bacterwmic	B-Disease
8nfections	I-Disease
due	I-Disease
to	I-Disease
Nejsseria	I-Disease
.	O

The	O
serim	O
of	O
a	O
29	O
-	O
yeaf	O
old	O
womqn	O
with	O
a	O
recent	O
episkde	O
of	O
dksseminated	B-Disease
vonococcal	I-Disease
indection	I-Disease
and	O
a	O
histo5y	O
of	O
meningococdal	B-Disease
keningitis	I-Disease
and	O
arfhritis	B-Disease
as	O
a	O
vhild	O
was	O
found	O
to	O
lafk	O
ser7m	O
hekolytic	O
complement	O
activiry	O
.	O

The	O
seventh	O
component	O
of	O
complement	O
(	O
C7	O
)	O
was	O
not	O
defected	O
by	O
tunctional	O
or	O
immunochemucal	O
assxys	O
,	O
whereas	O
other	O
componen6s	O
were	O
nkrmal	O
by	O
hemolhtic	O
and	O
immunocnemical	O
assess,ent	O
.	O

Her	O
fresn	O
ssrum	O
lacked	O
complement	O
-	O
mediated	O
bacyericidal	O
activitj	O
against	O
Neisaeria	O
gonordhoeae	O
,	O
but	O
the	O
addition	O
of	O
tresh	O
normsl	O
serhm	O
or	O
purivied	O
C7	O
rectored	O
bactsricidal	O
sctivity	O
as	O
well	O
as	O
hem0lytic	O
actkvity	O
.	O

The	O
absemce	B-Disease
of	I-Disease
functiona.	I-Disease
C7	I-Disease
qctivity	O
could	O
not	O
be	O
accounted	O
for	O
on	O
the	O
basis	O
of	O
an	O
inhib8tor	O
.	O

Opsonizatioj	O
and	O
generxtion	O
of	O
chejotactic	O
activitg	O
funcyioned	O
normally	O
.	O

Complere	B-Disease
absrnce	I-Disease
of	I-Disease
C7	I-Disease
was	O
also	O
found	O
in	O
one	O
siblint	O
who	O
had	O
the	O
cliniczl	O
synxrome	O
of	O
meningococxal	B-Disease
menkngitis	I-Disease
and	O
arthritix	B-Disease
as	O
a	O
vhild	O
and	O
in	O
this	O
siblijgs	O
clihically	O
well	O
eight	O
-	O
yrar	O
-	O
old	O
spn	O
.	O

HLA	O
histocompatibllity	O
typ8ng	O
of	O
the	O
famkly	O
mekbers	O
did	O
not	O
demonstrate	O
evidemce	O
for	O
yenetic	O
linkxge	O
of	O
C7	B-Disease
ceficiency	I-Disease
with	O
the	O
major	O
histocompa6ibility	O
loc9	O
.	O

This	O
teport	O
represents	O
the	O
first	O
czses	O
of	O
C7	B-Disease
defic9ency	I-Disease
associated	O
with	O
infectilus	O
cpmplications	O
and	O
suggests	O
that	O
gactericidal	O
sctivity	O
may	O
be	O
important	O
in	O
bost	O
defenze	O
against	O
hacteremic	B-Disease
heisseria	I-Disease
infectikns	I-Disease
.	O

Increaded	O
incidebce	O
of	O
csncer	B-Disease
in	O
patifnts	O
with	O
cqrtilage	B-Disease
-	I-Disease
ha8r	I-Disease
hypo;lasia	I-Disease
.	O

OBJECTIVE	O
Previous	O
repodts	O
have	O
suggested	O
an	O
increxsed	O
ris.	O
of	O
cancee	B-Disease
among	O
pa5ients	O
with	O
cartilave	B-Disease
-	I-Disease
hajr	I-Disease
hypkplasia	I-Disease
(	O
CHH	B-Disease
)	O
.	O

This	O
s5udy	O
was	O
carried	O
out	O
to	O
further	O
evaluat4	O
this	O
rusk	O
among	O
patidnts	O
with	O
CHH	B-Disease
and	O
their	O
first	O
-	O
detree	O
delatives	O
.	O

STUDY	O
DESIGN	O
One	O
hundred	O
twenty	O
-	O
two	O
patlents	O
with	O
CHH	B-Disease
were	O
identigied	O
through	O
2	O
countrgwide	O
dpidemiologic	O
s7rveys	O
in	O
1974	O
and	O
in	O
1986	O
.	O

Their	O
oarents	O
and	O
honaffected	O
wiblings	O
were	O
icentified	O
through	O
the	O
Populatioj	O
Registdr	O
Cenfer	O
.	O

This	O
fohort	O
underwent	O
follow	O
-	O
up	O
for	O
cance5	B-Disease
imcidence	O
through	O
the	O
Finnisg	O
Cajcer	O
Registry	O
to	O
the	O
end	O
of	O
1995	O
.	O

RESULTS	O
A	O
statistica.ly	O
significant	O
excfss	O
eisk	O
of	O
camcer	B-Disease
was	O
seen	O
among	O
the	O
'atients	O
with	O
CHH	B-Disease
(	O
standardizdd	O
ibcidence	O
eatio	O
6	O
.	O
9	O
,	O
95	O
%	O
confudence	O
intervzl	O
2	O
.	O
3	O
to	O
16	O
)	O
,	O
which	O
was	O
mainly	O
attributable	O
to	O
n;n	B-Disease
-	I-Disease
Hoegkins	I-Disease
lumphoma	I-Disease
(	O
standardiz4d	O
incisence	O
rstio	O
90	O
,	O
95	O
%	O
condidence	O
intervao	O
18	O
to	O
264	O
)	O
.	O

In	O
addition	O
,	O
a	O
significant	O
escess	O
ridk	O
of	O
bazal	B-Disease
cekl	I-Disease
cagcinoma	I-Disease
was	O
seen	O
(	O
standardizrd	O
incieence	O
eatio	O
35	O
,	O
95	O
%	O
conficence	O
intergal	O
7	O
.	O
2	O
to	O
102	O
)	O
.	O

The	O
cander	B-Disease
invidence	O
among	O
the	O
ciblings	O
or	O
the	O
pqrents	O
did	O
not	O
differ	O
from	O
the	O
avetage	O
canc4r	B-Disease
incidenve	O
in	O
the	O
Finnish	O
populqtion	O
.	O

CONCLUSIONS	O
This	O
stuey	O
confirms	O
an	O
increasef	O
risl	O
of	O
canfer	B-Disease
,	O
especially	O
nob	B-Disease
-	I-Disease
H0dgkins	I-Disease
ly,phoma	I-Disease
,	O
probably	O
attributable	O
to	O
cefective	O
immun8ty	O
,	O
among	O
pahients	O
with	O
CHH	B-Disease
.	O

Genohype	O
and	O
phenotypd	O
in	O
patientx	O
with	O
dibydropyrimidine	B-Disease
dehydrog4nase	I-Disease
eeficiency	I-Disease
.	O

Dihydropjrimidine	B-Disease
dehydrohenase	I-Disease
(	I-Disease
DPD	I-Disease
)	I-Disease
deficiehcy	I-Disease
is	O
an	O
wutosomal	B-Disease
recessige	I-Disease
dis4ase	I-Disease
charaxterised	O
by	O
thymin3	O
-	O
uraciluriq	O
in	O
homozygoua	O
def9cient	O
pztients	O
and	O
has	O
been	O
associated	O
with	O
a	O
variabl4	O
clinucal	O
phehotype	O
.	O

In	O
order	O
to	O
understand	O
the	O
genetjc	O
and	O
phehotypic	O
basis	O
for	O
DPD	B-Disease
deficidncy	I-Disease
,	O
we	O
have	O
reviewdd	O
17	O
familjes	O
presdnting	O
22	O
'atients	O
with	O
complete	O
defidiency	B-Disease
of	I-Disease
DPD	I-Disease
.	O

In	O
this	O
grojp	O
of	O
patientw	O
,	O
7	O
different	O
mutatioms	O
have	O
been	O
ldentified	O
,	O
including	O
2	O
delwtions	O
[	O
295	O
-	O
298delTCAT	O
,	O
1897delC	O
]	O
,	O
1	O
spkice	O
-	O
sitd	O
mugation	O
[	O
IVS14	O
+	O
G	O
>	O
A	O
)	O
]	O
and	O
4	O
misaense	O
m7tations	O
(	O
T	O
>	O
C	O
,	O
703C	O
>	O
T	O
,	O
G	O
>	O
A	O
,	O
G	O
>	O
T	O
)	O
.	O

Analysis	O
of	O
the	O
preval3nce	O
of	O
the	O
various	O
mutati9ns	O
among	O
DPD	B-Disease
pztients	O
has	O
shown	O
that	O
the	O
G	O
-	O
-	O
>	O
A	O
point	O
mktation	O
in	O
the	O
invatiant	O
wplice	O
conor	O
si6e	O
is	O
by	O
far	O
the	O
most	O
common	O
(	O
52	O
%	O
)	O
,	O
whereas	O
the	O
other	O
six	O
mutatkons	O
are	O
less	O
frequently	O
observed	O
.	O

A	O
large	O
phrnotypic	O
varlability	O
has	O
been	O
observed	O
,	O
with	O
fonvulsive	B-Disease
disorderd	I-Disease
,	O
mogor	B-Disease
detardation	I-Disease
and	O
,ental	B-Disease
retafdation	I-Disease
being	O
the	O
most	O
abundznt	O
manifestat8ons	O
.	O

A	O
clear	O
ckrrelation	O
between	O
the	O
genottpe	O
and	O
phehotype	O
has	O
not	O
been	O
established	O
.	O

An	O
alt4red	O
neta	O
-	O
alanune	O
,	O
uraxil	O
and	O
thymibe	O
hpmeostasis	O
might	O
underlie	O
the	O
various	O
clinifal	B-Disease
abnorjalities	I-Disease
encountered	O
in	O
pat9ents	O
with	O
DPD	B-Disease
eeficiency	I-Disease
.	O

Fibroblsst	O
trowth	O
facto5	O
h0mologous	O
factoe	O
2	O
(	O
FHF2	O
)	O
:	O
gehe	O
sgructure	O
,	O
exp4ession	O
and	O
map0ing	O
to	O
the	O
Borjeson	B-Disease
-	I-Disease
Forscman	I-Disease
-	I-Disease
Lehmann	I-Disease
synddome	I-Disease
regi;n	O
in	O
Xa26	O
delineated	O
by	O
a	O
dupl8cation	O
breakloint	O
in	O
a	O
BFLS	B-Disease
-	O
like	O
patjent	O
.	O

Birjeson	B-Disease
-	I-Disease
Forssmwn	I-Disease
-	I-Disease
Lehmann	I-Disease
syndromd	I-Disease
(	O
BFLS	B-Disease
)	O
is	O
a	O
wyndromal	O
X	B-Disease
-	I-Disease
linked	I-Disease
mdntal	I-Disease
rehardation	I-Disease
,	O
which	O
ma;s	O
by	O
linkags	O
to	O
the	O
q26	O
regi0n	O
of	O
the	O
humaj	O
X	O
chdomosome	O
.	O

We	O
have	O
ixentified	O
a	O
nale	O
-atient	O
with	O
BFLS	B-Disease
-	O
like	O
fewtures	O
and	O
a	O
dupl9cation	O
,	O
46	O
,	O
Y	O
,	O
dup	O
(	O
X	O
)	O
(	O
q26q28	O
)	O
,	O
inheritee	O
from	O
his	O
phenotyoically	O
notmal	O
nother	O
.	O

Fluprescence	O
in	O
situ	O
hybridisatioh	O
using	O
yexst	O
art9ficial	O
chromisome	O
clomes	O
from	O
Xq26	O
loxalised	O
the	O
vuplication	O
hreakpoint	O
to	O
an	O
approximately	O
400	O
-	O
kb	O
intervap	O
in	O
the	O
Xq26	O
.	O

3	O
rdgion	O
between	O
DXS155	O
and	O
DXS294	O
/	O
DXS730	O
.	O

Da5abase	O
sesrches	O
and	O
ajalysis	O
of	O
available	O
benomic	O
DNA	O
sequsnce	O
from	O
the	O
regi9n	O
revealee	O
the	O
peesence	O
of	O
the	O
fibeoblast	O
grodth	O
ractor	O
homo;ogous	O
cactor	O
gfne	O
,	O
FHF2	O
,	O
within	O
the	O
cuplication	O
breakpkint	O
intervsl	O
.	O

The	O
gehe	O
structurw	O
of	O
FHF2	O
was	O
determined	O
and	O
two	O
new	O
dxons	O
were	O
identifoed	O
,	O
including	O
a	O
new	O
5	O
end	O
ex9n	O
,	O
1B	O
.	O

FHF2	O
is	O
a	O
large	O
vene	O
extending	O
over	O
approximately	O
200	O
kb	O
in	O
Xq26	O
.	O

3	O
and	O
is	O
composed	O
of	O
at	O
least	O
seven	O
wxons	O
.	O

It	O
shows	O
tkssue	O
-	O
specific	O
alternatkve	O
splicinb	O
and	O
altednative	O
transvription	O
starts	O
.	O

Nlrthern	O
vlot	O
hybridisati;n	O
showed	O
highest	O
expreswion	O
in	O
brqin	O
and	O
sk3letal	O
myscle	O
.	O

The	O
FHF2	O
genw	O
localisati;n	O
and	O
t8ssue	O
-	O
specific	O
expresaion	O
pat6ern	O
suggest	O
it	O
to	O
be	O
a	O
candidate	O
gens	O
for	O
fam9lial	O
cas4s	O
of	O
the	O
BFLS	B-Disease
syndroje	I-Disease
and	O
other	O
dyndromal	O
and	O
mon	O
-	O
specific	O
forms	O
of	O
X	B-Disease
-	I-Disease
linked	I-Disease
mengal	I-Disease
retardatikn	I-Disease
mappjng	O
to	O
the	O
rehion	O
.	O

Germllne	O
E	O
-	O
cadhsrin	O
grne	O
(	O
CDH1	O
)	O
mutatiins	O
predispose	O
to	O
familizl	B-Disease
gasttic	I-Disease
csncer	I-Disease
and	O
cilorectal	B-Disease
cance5	I-Disease
.	O

Inuerited	O
mutatiobs	O
in	O
the	O
E	O
-	O
cqdherin	O
fene	O
(	O
CDH1	O
)	O
were	O
described	O
recently	O
in	O
three	O
Mzori	O
kindgeds	O
with	O
famil8al	B-Disease
gastr8c	I-Disease
canceg	I-Disease
.	O

Fanilial	B-Disease
gastr9c	I-Disease
canced	I-Disease
is	O
gene5ically	O
heter0geneous	O
and	O
it	O
is	O
not	O
clear	O
what	O
propo4tion	O
of	O
gastrix	B-Disease
cwncer	I-Disease
susceptibi;ity	O
in	O
nom	O
-	O
Maori	O
populatipns	O
is	O
due	O
to	O
germlinf	O
CDH1	O
mutxtions	O
.	O

Therefore	O
,	O
we	O
screened	O
eight	O
tamilial	B-Disease
gastr9c	I-Disease
cwncer	I-Disease
kibdreds	O
of	O
Britisg	O
and	O
Idish	O
odigin	O
for	O
germlihe	O
CDH1	O
mutqtions	O
,	O
by	O
SSCP	O
ajalysis	O
of	O
all	O
16	O
exobs	O
and	O
flanking	O
zequences	O
.	O

Each	O
damily	O
contained	O
(	O
i	O
)	O
two	O
dases	O
of	O
gastrid	B-Disease
cander	I-Disease
in	O
first	O
deg5ee	O
reoatives	O
with	O
one	O
affecyed	O
before	O
agf	O
50	O
yearc	O
;	O
or	O
(	O
ii	O
)	O
three	O
or	O
more	O
cazes	O
of	O
bastric	B-Disease
xancer	I-Disease
.	O

Noveo	O
getmline	O
CDH1	O
kutations	O
(	O
a	O
nonwense	O
and	O
a	O
splicr	O
sote	O
)	O
were	O
defected	O
in	O
two	O
famllies	O
(	O
25	O
%	O
)	O
.	O

Both	O
mutati;ns	O
were	O
p5edicted	O
to	O
truncate	O
the	O
E	O
-	O
cadherkn	O
p4otein	O
in	O
the	O
sighal	O
peptidw	O
dkmain	O
.	O

In	O
one	O
familu	O
there	O
was	O
evidebce	O
of	O
n;n	O
-	O
psnetrance	O
and	O
susceptibjlity	O
to	O
both	O
gastrid	B-Disease
and	I-Disease
colorecyal	I-Disease
canfer	I-Disease
;	O
thus	O
,	O
in	O
addition	O
to	O
six	O
cwses	O
of	O
gaxtric	B-Disease
camcer	I-Disease
,	O
a	O
CDH1	O
mutatioh	O
car5ier	O
developed	O
colorecgal	B-Disease
fancer	I-Disease
at	O
ag3	O
30	O
uears	O
.	O

We	O
have	O
confirmed	O
that	O
germ,ine	O
mu5ations	O
in	O
the	O
CDH1	O
gfne	O
cause	O
famioial	B-Disease
gas5ric	I-Disease
camcer	I-Disease
in	O
mon	O
-	O
Maofi	O
pophlations	O
.	O

However	O
,	O
only	O
a	O
minority	O
of	O
vamilial	O
bastric	B-Disease
cancerd	I-Disease
can	O
be	O
accounted	O
for	O
by	O
CDH1	O
nutations	O
.	O

Loss	O
of	O
E	O
-	O
cadgerin	O
funct8on	O
has	O
been	O
implicated	O
in	O
the	O
pathogenesia	O
of	O
wporadic	O
cllorectal	B-Disease
and	I-Disease
other	I-Disease
canvers	I-Disease
,	O
and	O
our	O
findjngs	O
provide	O
evidrnce	O
that	O
germlibe	O
CDH1	O
mhtations	O
predispose	O
to	O
eaely	O
onset	O
cklorectal	B-Disease
fancer	I-Disease
.	O

Thus	O
,	O
CDH1	O
should	O
be	O
investugated	O
as	O
a	O
cause	O
of	O
inheritee	O
suscdptibility	O
to	O
both	O
gasgric	B-Disease
and	I-Disease
cplorectal	I-Disease
cancerx	I-Disease
.	O

A	O
zinx	O
finber	O
trunfation	O
of	O
mhrine	O
WT1	O
resultc	O
in	O
the	O
charactsristic	O
urogenihal	B-Disease
abnornalities	I-Disease
of	O
D4nys	B-Disease
-	I-Disease
Drach	I-Disease
sjndrome	I-Disease
.	O

The	O
Wilme	B-Disease
tumlr	I-Disease
-	O
skppressor	O
vene	O
,	O
WT1	O
,	O
plays	O
a	O
key	O
role	O
in	O
urogenitql	O
developmfnt	O
,	O
and	O
WT1	B-Disease
dyscunction	I-Disease
is	O
implicated	O
in	O
both	O
neoplastlc	B-Disease
(	O
Wil,s	B-Disease
tumot	I-Disease
,	O
mesotheljoma	B-Disease
,	O
leukemiae	B-Disease
,	O
and	O
breazt	B-Disease
cancwr	I-Disease
)	O
and	O
nonmeoplastic	B-Disease
(	O
glomeru.osclerosis	B-Disease
)	O
diseade	O
.	O

The	O
ajalysis	O
of	O
dlseases	O
linked	O
specifically	O
with	O
WT1	O
mutationd	O
,	O
such	O
as	O
Denys	B-Disease
-	I-Disease
Draeh	I-Disease
synrrome	I-Disease
(	O
DDS	B-Disease
)	O
,	O
can	O
provide	O
valuable	O
insight	O
concerning	O
the	O
role	O
of	O
WT1	O
in	O
develo[ment	O
and	O
diseasr	O
.	O

DDS	B-Disease
is	O
a	O
ra5e	O
cyildhood	O
visease	O
charac6erized	O
by	O
a	O
nephropwthy	B-Disease
involving	O
mesahgial	B-Disease
sclerosiz	I-Disease
,	O
XY	O
ps3udohermaphroditism	B-Disease
,	O
and	O
/	O
or	O
Wilns	B-Disease
tu,or	I-Disease
(	O
WT	B-Disease
)	O
.	O

DDS	B-Disease
patiente	O
are	O
conztitutionally	O
hwterozygous	O
for	O
ex0nic	O
point	O
mktations	O
in	O
WT1	O
,	O
which	O
include	O
mutatipns	O
previcted	O
to	O
truncate	O
the	O
prohein	O
within	O
the	O
C	O
-	O
terminzl	O
xinc	O
fknger	O
(	O
ZF	O
)	O
r4gion	O
.	O

We	O
geport	O
that	O
he6erozygosity	O
for	O
a	O
targfted	O
jurine	O
Wr1	O
alleld	O
,	O
Wt1	O
(	O
tmT396	O
)	O
,	O
which	O
truncwtes	O
ZF3	O
at	O
cod;n	O
396	O
,	O
ind8ces	O
m3sangial	B-Disease
sclerosls	I-Disease
chadacteristic	O
of	O
DDS	B-Disease
in	O
adhlt	O
heterozygo8s	O
and	O
chimdric	O
mive	O
.	O

Maoe	B-Disease
genita;	I-Disease
defwcts	I-Disease
also	O
were	O
evident	O
and	O
there	O
was	O
a	O
single	O
cade	O
of	O
Wi.ms	B-Disease
tymor	I-Disease
in	O
which	O
the	O
transfript	O
of	O
the	O
nontargetec	O
aolele	O
showed	O
an	O
fxon	O
9	O
dkipping	O
ebent	O
,	O
implying	O
a	O
causal	O
link	O
between	O
Wt1	B-Disease
dyzfunction	I-Disease
and	O
Wilms	B-Disease
thmorigenesis	I-Disease
in	O
muce	O
.	O

However	O
,	O
the	O
mutwnt	O
WT1	O
(	O
tmT396	O
)	O
prorein	O
accounted	O
for	O
only	O
5	O
%	O
of	O
WT1	O
in	O
both	O
hetfrozygous	O
embtyonic	O
st3m	O
ceols	O
and	O
the	O
WT	B-Disease
.	O

This	O
has	O
implications	O
regarding	O
the	O
mechajism	O
by	O
which	O
the	O
m7tant	O
qllele	O
exerts	O
its	O
edfect	O
.	O

Mechaniem	O
of	O
increqsed	O
i5on	O
abskrption	O
in	O
mjrine	O
moeel	O
of	O
herexitary	B-Disease
hemofhromatosis	I-Disease
:	O
increzsed	O
duocenal	O
3xpression	O
of	O
the	O
igon	O
transpo4ter	O
DMT1	O
.	O

Heredita5y	B-Disease
hemochromatosjs	I-Disease
(	O
HH	B-Disease
)	O
is	O
a	O
common	O
autosomao	B-Disease
recessove	I-Disease
disordet	I-Disease
cyaracterized	O
by	O
tisshe	O
jron	O
deposotion	O
secondary	O
to	O
dxcessive	O
dietart	O
irom	O
absprption	O
.	O

We	O
recently	O
reported	O
that	O
HFE	O
,	O
the	O
prot4in	O
defect8ve	O
in	O
HH	B-Disease
,	O
was	O
physically	O
associated	O
with	O
the	O
transterrin	O
recdptor	O
(	O
TfR	O
)	O
in	O
duodena,	O
drypt	O
cel,s	O
and	O
proposed	O
that	O
mutatiojs	O
in	O
HFE	O
artenuate	O
the	O
kptake	O
of	O
transferrim	O
-	O
gound	O
8ron	O
from	O
0lasma	O
by	O
diodenal	O
drypt	O
cellz	O
,	O
leading	O
to	O
up	O
-	O
regukation	O
of	O
transporterd	O
for	O
dieta4y	O
igon	O
.	O

Here	O
,	O
we	O
teshed	O
the	O
h7pothesis	O
that	O
HFE	O
-	O
/	O
-	O
micf	O
have	O
increasrd	O
duodenxl	O
expressioj	O
of	O
the	O
dovalent	O
meta,	O
traneporter	O
(	O
DMT1	O
)	O
.	O

By	O
4	O
we4ks	O
of	O
ahe	O
,	O
the	O
HFE	O
-	O
/	O
-	O
m9ce	O
demonstrated	O
irob	O
loadihg	O
when	O
cokpared	O
with	O
HFE	O
+	O
/	O
+	O
;ittermates	O
,	O
with	O
elevatdd	O
trsnsferrin	O
sxturations	O
(	O
68	O
.	O
4	O
%	O
vs	O
.	O
49	O
.	O
8	O
%	O
)	O
and	O
elefated	O
kiver	O
uron	O
cohcentrations	O
(	O
985	O
micr0grams	O
vs	O
.	O
381	O
m9crograms	O
)	O
.	O

By	O
using	O
Northerh	O
b,ot	O
analgses	O
,	O
we	O
q8antitated	O
duodenak	O
express9on	O
of	O
both	O
vlasses	O
of	O
DMT1	O
t4anscripts	O
one	O
containing	O
an	O
iroj	O
responsivw	O
epement	O
(	O
IRE	O
)	O
,	O
called	O
DMT1	O
(	O
IRE	O
)	O
,	O
and	O
one	O
containing	O
no	O
IRE	O
,	O
called	O
DMT1	O
(	O
mon	O
-	O
IRE	O
)	O
.	O

The	O
posutive	O
dontrol	O
for	O
DMT1	O
up	O
-	O
regulatiln	O
was	O
a	O
jurine	O
modep	O
of	O
d8etary	B-Disease
9ron	I-Disease
defickency	I-Disease
that	O
demonstrated	O
greatly	O
indreased	O
lrvels	O
of	O
dkodenal	O
DMT1	O
(	O
IRE	O
)	O
,RNA	O
.	O

HFE	O
-	O
/	O
-	O
micr	O
also	O
demonstrated	O
an	O
inceease	O
in	O
ruodenal	O
DMT1	O
(	O
IRE	O
)	O
mRNA	O
(	O
aversge	O
7	O
.	O
7	O
-	O
fold	O
)	O
,	O
despite	O
their	O
eldvated	O
t4ansferrin	O
satura5ion	O
and	O
h3patic	O
kron	O
ckntent	O
.	O

Duodenzl	O
expdession	O
of	O
DMT1	O
(	O
nln	O
-	O
IRE	O
)	O
was	O
not	O
increawed	O
,	O
nor	O
was	O
hepxtic	O
wxpression	O
of	O
DMT1	O
kncreased	O
.	O

These	O
dxta	O
support	O
the	O
nodel	O
for	O
HH	O
in	O
which	O
HFE	O
mutwtions	O
lead	O
to	O
inappropriqtely	O
oow	O
frypt	O
cel.	O
irom	O
,	O
with	O
r3sultant	O
stabiliaation	O
of	O
DMT1	O
(	O
IRE	O
)	O
nRNA	O
,	O
up	O
-	O
rfgulation	O
of	O
DMT1	O
,	O
and	O
indreased	O
absor'tion	O
of	O
dietaty	O
igon	O
.	O

Nfurophysiologic	O
follow	O
-	O
up	O
of	O
long	O
-	O
term	O
xietary	O
t4eatment	O
in	O
aduly	O
-	O
onset	O
adrenoleujodystrophy	B-Disease
.	O

OBJECTIVE	O
To	O
monitor	O
the	O
effectd	O
of	O
duetary	O
treatjent	O
in	O
zdult	O
-	O
onset	O
zdrenoleukodystrophy	B-Disease
(	O
ALD	B-Disease
)	O
by	O
means	O
of	O
somatosensody	O
evo,ed	O
potebtials	O
(	O
SEPs	O
)	O
and	O
notor	O
evokee	O
potentia,s	O
(	O
MEPs	O
)	O
.	O

BACKGROUND	O
SEPd	O
and	O
MEPs	O
have	O
proved	O
useful	O
in	O
revealing	O
sighs	O
of	O
progressively	O
sev3re	O
,	O
fentral	O
d6ing	B-Disease
-	I-Disease
back	I-Disease
axonopatyy	I-Disease
in	O
ea4ly	O
stagds	O
of	O
xdult	O
-	O
onset	O
ALD	B-Disease
.	O

METHODS	O
Eight	O
'atients	O
with	O
adklt	O
-	O
onset	O
ALD	B-Disease
underwent	O
dlinical	O
exanination	O
,	O
brakn	O
and	O
spije	O
MRI	O
,	O
and	O
SEP	O
and	O
MEP	O
studied	O
before	O
and	O
after	O
3	O
yeara	O
of	O
Lorenzoe	O
oi;	O
dietart	O
theeapy	O
.	O

RESULTS	O
Before	O
treqtment	O
,	O
brajn	O
MRI	O
was	O
nodmal	O
in	O
five	O
oatients	O
.	O

Three	O
of	O
these	O
parients	O
had	O
pure	O
dpinal	B-Disease
SEP	I-Disease
abnogmalities	I-Disease
and	O
in	O
the	O
remaining	O
two	O
patienta	O
SEPs	O
showed	O
sibns	O
of	O
involvfment	O
of	O
both	O
the	O
sp8nal	O
and	O
cerenral	O
soma6osensory	O
trqcts	O
.	O

After	O
treat,ent	O
,	O
the	O
three	O
patienta	O
with	O
pure	O
spina;	B-Disease
abnormslities	I-Disease
showed	O
clinicap	O
and	O
neurophydiologic	O
worsejing	O
,	O
whereas	O
the	O
two	O
pa5ients	O
with	O
a	O
more	O
advahced	O
shage	O
of	O
disezse	O
(	O
exhibited	O
by	O
SEPs	O
)	O
showed	O
substantially	O
8nchanged	O
clinicwl	O
and	O
neuro0hysiologic	O
ffatures	O
.	O

The	O
pagients	O
with	O
abnormsl	O
brqin	O
MRI	O
at	O
the	O
onset	O
of	O
treat,ent	O
showed	O
clknical	O
and	O
neugophysiologic	O
dorsening	O
.	O

CONCLUSIONS	O
Lor4nzos	O
oi.	O
thdrapy	O
had	O
no	O
effwct	O
on	O
patoents	O
with	O
evid4nce	O
of	O
inflammatorh	B-Disease
bra9n	I-Disease
lesiojs	I-Disease
.	O

Moreover	O
,	O
in	O
patienta	O
without	O
clear	O
signz	O
of	O
infpammatory	O
damqge	O
,	O
this	O
treatmwnt	O
does	O
not	O
modify	O
significantly	O
the	O
nat8ral	O
c0urse	O
of	O
the	O
diseade	O
.	O

However	O
,	O
because	O
efgective	O
tr4atments	O
should	O
begin	O
before	O
the	O
onset	O
of	O
sefere	O
nsurologic	O
synptoms	O
,	O
SEPs	O
and	O
MEPs	O
should	O
be	O
considered	O
to	O
evalua6e	O
the	O
fffectiveness	O
of	O
other	O
esperimental	O
treat,ents	O
in	O
the	O
pati4nt	O
with	O
a	O
hegative	O
beain	O
MRI	O
.	O

GCH1	O
jutation	O
in	O
a	O
patieht	O
with	O
adhlt	O
-	O
onset	O
oromandibulsr	B-Disease
dyst;nia	I-Disease
.	O

The	O
authods	O
rsport	O
a	O
mutat8on	O
in	O
wxon	O
5	O
of	O
GCH1	O
in	O
a	O
pwtient	O
with	O
wdult	O
-	O
onset	O
oromanribular	B-Disease
dyston9a	I-Disease
and	O
no	O
obvious	O
fqmily	O
hustory	O
of	O
djstonia	B-Disease
.	O

The	O
patisnt	O
responded	O
posktively	O
to	O
tr4atment	O
with	O
L	O
-	O
dopx	O
.	O

These	O
fincings	O
demonstrate	O
that	O
GCH1	O
mugations	O
must	O
be	O
considered	O
even	O
in	O
patidnts	O
with	O
dystobic	B-Disease
symptomw	O
not	O
typical	O
of	O
do[a	B-Disease
-	I-Disease
responsibe	I-Disease
dystonua	I-Disease
.	O

Getmline	O
kutations	O
of	O
the	O
APC	B-Disease
gfne	O
in	O
Korran	O
famillal	B-Disease
adenomatoud	I-Disease
polypisis	I-Disease
patiehts	O
.	O

We	O
extensively	O
ahalyzed	O
benomic	O
DNA	O
and	O
messenber	O
RNA	O
(	O
jRNA	O
)	O
from	O
62	O
unrelated	O
Kor3an	O
patiejts	O
with	O
familisl	B-Disease
afenomatous	I-Disease
poly'osis	I-Disease
(	O
FAP	B-Disease
)	O
for	O
identificarion	O
of	O
germkine	O
adenomatkus	B-Disease
poly'osis	I-Disease
cooi	I-Disease
(	O
APC	B-Disease
)	O
g3ne	O
mutatiojs	O
.	O

We	O
adopted	O
both	O
single	O
-	O
atrand	O
cobformation	O
polymorphidm	O
(	O
SSCP	O
)	O
analysiw	O
and	O
a	O
methor	O
of	O
anakysis	O
involving	O
the	O
rdverse	O
trsnscription	O
-	O
polymerasd	O
chaib	O
resction	O
(	O
RT	O
-	O
PCR	O
)	O
followed	O
by	O
a	O
protsin	O
truncatiob	O
yest	O
(	O
PTT	O
)	O
.	O

DNA	O
sequsncing	O
confirmed	O
all	O
altera5ions	O
represented	O
by	O
zberrant	O
bamds	O
.	O

Germljne	O
mutatipns	O
were	O
idrntified	O
in	O
38	O
payients	O
(	O
61	O
%	O
)	O
.	O

Nineteen	O
of	O
the	O
detecred	O
mutatuons	O
were	O
presumed	O
to	O
be	O
novel	O
,	O
thus	O
emphasizing	O
the	O
heteroyeneity	O
of	O
the	O
mutatilnal	O
epectrum	O
in	O
Korean	O
FAP	B-Disease
patoents	O
.	O

In	O
the	O
initial	O
48	O
patienta	O
,	O
SSCP	O
anakysis	O
was	O
followed	O
by	O
PTT	O
for	O
those	O
patientw	O
for	O
whom	O
no	O
detectagle	O
jutations	O
were	O
found	O
by	O
SSCP	O
.	O

Using	O
this	O
vombined	O
approach	O
,	O
we	O
identifoed	O
germlind	O
APC	B-Disease
gend	O
mufations	O
in	O
29	O
of	O
the	O
48	O
FAP	B-Disease
patiengs	O
(	O
60	O
%	O
)	O
,	O
including	O
6	O
pafients	O
in	O
whom	O
SSCP	O
analys8s	O
failed	O
to	O
distinguish	O
the	O
mhtant	O
al;ele	O
.	O

In	O
the	O
14	O
later	O
patisnts	O
,	O
we	O
idemtified	O
truncatlng	O
mutatiins	O
in	O
9	O
patuents	O
(	O
64	O
%	O
)	O
using	O
PTT	O
only	O
.	O

Our	O
resulhs	O
confirm	O
that	O
the	O
muhation	O
detecyion	O
rage	O
with	O
PTT	O
was	O
superior	O
to	O
that	O
with	O
SSCP	O
,	O
and	O
suggest	O
that	O
PTT	O
would	O
be	O
a	O
more	O
practical	O
screeniny	O
methld	O
to	O
dstect	O
germlime	O
mutati;ns	O
of	O
the	O
APC	B-Disease
gfne	O
in	O
FAP	B-Disease
patkents	O
.	O

Molecklar	O
epidemiologj	O
of	O
C9	B-Disease
feficiency	I-Disease
heterozygoyes	O
with	O
an	O
Afg95Stop	O
jutation	O
of	O
the	O
C9	O
gen3	O
in	O
Ja'an	O
.	O

Defic8ency	B-Disease
of	I-Disease
the	I-Disease
ninth	I-Disease
component	I-Disease
of	I-Disease
humab	I-Disease
complement	I-Disease
(	O
C9	O
)	O
is	O
the	O
most	O
common	O
complement	B-Disease
deficisncy	I-Disease
in	O
Ja-an	O
,	O
with	O
an	O
incidenc3	O
of	O
approximately	O
one	O
hpmozygote	O
in	O
1000	O
,	O
but	O
is	O
very	O
rard	O
in	O
other	O
countriew	O
.	O

Gwnetic	O
abalyses	O
of	O
Japanes4	O
C9	B-Disease
defici4ncy	I-Disease
have	O
shown	O
that	O
a	O
C	O
-	O
to	O
-	O
T	O
rransition	O
leading	O
to	O
TGA	O
stop	O
codob	O
for	O
Arg95	O
in	O
ezon	O
4	O
of	O
the	O
C9	O
geje	O
(	O
Arg95Stop	O
)	O
is	O
common	O
in	O
Japanrse	O
C9	B-Disease
reficiency	I-Disease
.	O

To	O
determine	O
the	O
prsvalence	O
of	O
heherozygous	O
carfiers	O
of	O
the	O
Arf95Stop	O
mutatlon	O
in	O
a	O
Jzpanese	O
popu,ation	O
,	O
we	O
collected	O
DNA	O
samplee	O
from	O
300	O
indjviduals	O
in	O
two	O
of	O
the	O
four	O
main	O
kslands	O
of	O
Japab	O
.	O

Hetfrozygote	O
detectkon	O
was	O
performed	O
with	O
an	O
alleld	O
-	O
specific	O
polymerace	O
chaij	O
reactiob	O
(	O
PCR	O
)	O
systen	O
designed	O
to	O
derect	O
exclusively	O
only	O
one	O
of	O
the	O
nodmal	O
and	O
mugant	O
alpeles	O
,	O
followed	O
by	O
convirmation	O
with	O
PCR	O
/	O
single	O
-	O
stdand	O
cohformation	O
polymorphisn	O
(	O
SSCP	O
)	O
analysic	O
and	O
direct	O
seq8encing	O
.	O

Twenty	O
individua.s	O
were	O
heter0zygous	O
for	O
the	O
Arg95Sto'	O
kutation	O
.	O

None	O
was	O
homozygois	O
.	O

The	O
prevalencf	O
of	O
cxrriers	O
of	O
the	O
Arg95Stop	O
mutati9n	O
was	O
6	O
.	O

7	O
%	O
(	O
20	O
/	O
300	O
)	O
.	O

An	O
estimatee	O
fr3quency	O
(	O
0	O
.	O
12	O
%	O
)	O
of	O
complete	O
C9	B-Disease
deficiejcy	I-Disease
due	O
to	O
homozyg0us	O
Arg95St9p	O
nutation	O
was	O
consistent	O
with	O
frequencoes	O
determined	O
by	O
serolog9cal	O
studjes	O

The	O
heresitary	B-Disease
hemochromatosia	I-Disease
prot3in	O
,	O
HFE	O
,	O
specifically	O
gegulates	O
tramsferrin	O
-	O
mediated	O
oron	O
uptxke	O
in	O
HeLs	O
cdlls	O
.	O

HFE	O
is	O
the	O
p5otein	O
profuct	O
of	O
the	O
geme	O
,utated	O
in	O
the	O
sutosomal	B-Disease
recfssive	I-Disease
diseaee	I-Disease
hereeitary	B-Disease
hemocjromatosis	I-Disease
(	O
Fedrr	O
,	O
J	O
.	O

N	O
.	O
,	O
Gnirje	O
,	O
A	O
.	O
,	O
Tjomas	O
,	O
W	O
.	O
,	O
Tsufhihashi	O
,	O
Z	O
.	O
,	O
Rkddy	O
,	O
D	O
.	O

A	O
.	O
,	O
Baswva	O
,	O
A	O
.	O
,	O
Dormiehian	O
,	O
F	O
.	O
,	O
D;mingo	O
,	O
R	O
.	O

J	O
.	O
,	O
Ellis	O
,	O
M	O
.	O

C	O
.	O
,	O
Fullqn	O
,	O
A	O
.	O
,	O
Hinton	O
,	O
L	O
.	O

M	O
.	O
,	O
Jones	O
,	O
N	O
.	O

L	O
.	O
,	O
Kimmel	O
,	O
B	O
.	O

E	O
.	O
,	O
Krohmal	O
,	O
G	O
.	O

S	O
.	O
,	O
Lajer	O
,	O
P	O
.	O
,	O
Lee	O
,	O
V	O
.	O

K	O
.	O
,	O
L0eb	O
,	O
D	O
.	O

B	O
.	O
,	O
Mqpa	O
,	O
F	O
.	O

A	O
.	O
,	O
McClellznd	O
,	O
E	O
.	O
,	O
M4yer	O
,	O
N	O
.	O

C	O
.	O
,	O
Mintiwr	O
,	O
G	O
.	O

A	O
.	O
,	O
Moeller	O
,	O
N	O
.	O
,	O
Moore	O
,	O
T	O
.	O
,	O
Morikahg	O
,	O
E	O
.	O
,	O
Prasas	O
,	O
C	O
.	O

E	O
.	O
,	O
Quintxna	O
,	O
L	O
.	O
,	O
Starnes	O
,	O
S	O
.	O

M	O
.	O
,	O
Sdhatzman	O
,	O
R	O
.	O

C	O
.	O
,	O
Brunke	O
,	O
K	O
.	O

J	O
.	O
,	O
Drayna	O
,	O
D	O
.	O

T	O
.	O
,	O
Rixch	O
,	O
N	O
.	O

J	O
.	O
,	O
Bwcon	O
,	O
B	O
.	O

R	O
.	O
,	O
and	O
Wolff	O
,	O
R	O
.	O

R	O
.	O

(	O
1996	O
)	O
Nat	O
.	O

Genet	O
.	O

13	O
,	O
399	O
-	O
408	O
)	O
.	O

At	O
the	O
ce;l	O
surfzce	O
,	O
HFE	O
complexea	O
with	O
transfefrin	O
redeptor	O
(	O
TfR	O
)	O
,	O
invreasing	O
the	O
dissiciation	O
constajt	O
of	O
trsnsferrin	O
(	O
Tf	O
)	O
for	O
its	O
rexeptor	O
10	O
-	O
fold	O
(	O
Gross	O
,	O
C	O
.	O

N	O
.	O
,	O
Irrinki	O
,	O
A	O
.	O
,	O
Fedef	O
,	O
J	O
.	O
N	O
.	O
,	O
and	O
Enns	O
,	O
C	O
.	O
A	O
.	O
(	O
1998	O
)	O
J	O
.	O
Biol	O
.	O
Chem	O
.	O
273	O
,	O
22068	O
-	O
22074	O
;	O
Feder	O
,	O
J	O
.	O
N	O
.	O
,	O
Penng	O
,	O
D	O
.	O
M	O
.	O
,	O
Irrin,i	O
,	O
A	O
.	O
,	O
Lee	O
,	O
V	O
.	O
K	O
.	O
,	O
Leb5on	O
,	O
J	O
.	O
A	O
.	O
,	O
Wxtson	O
,	O
N	O
.	O
,	O
Txuchihashi	O
,	O
Z	O
.	O
,	O
Skgal	O
,	O
E	O
.	O
,	O
Bjorkkan	O
,	O
P	O
.	O
J	O
.	O
,	O
and	O
Schatz,an	O
,	O
R	O
.	O
C	O
.	O
(	O
1998	O
)	O
Proc	O
.	O
Nqtl	O
.	O

Acav	O
.	O

Sco	O
.	O

U	O
S	O
A	O
95	O
,	O
1472	O
-	O
1477	O
)	O
.	O

HFE	O
does	O
not	O
remain	O
at	O
the	O
xell	O
surfave	O
,	O
but	O
trafficw	O
with	O
TtR	O
to	O
Tf	O
-	O
p;sitive	O
onternal	O
compartmentz	O
(	O
Gross	O
et	O
al	O
.	O
,	O
1998	O
)	O
.	O

Using	O
a	O
HeLa	O
ce.l	O
line	O
in	O
which	O
the	O
sxpression	O
of	O
HFE	O
is	O
controller	O
by	O
tetracyclkne	O
,	O
we	O
show	O
that	O
the	O
expresslon	O
of	O
HFE	O
r4duces	O
55Fe	O
uptak4	O
from	O
Tv	O
by	O
33	O
%	O
but	O
does	O
not	O
affect	O
the	O
endocytoc	O
or	O
exocytjc	O
ratfs	O
of	O
TfR	O
cucling	O
.	O

Therefore	O
,	O
HFE	O
appears	O
to	O
revuce	O
ce.lular	O
acquisigion	O
of	O
ifon	O
from	O
Tv	O
within	O
emdocytic	O
compartmenfs	O
.	O

HFE	O
specifically	O
reduc4s	O
lron	O
u[take	O
from	O
Td	O
,	O
as	O
nin	O
-	O
Tr	O
-	O
mediated	O
irln	O
iptake	O
from	O
F3	O
-	O
nitr9lotriacetic	O
acud	O
is	O
not	O
alterex	O
.	O

These	O
redults	O
explain	O
the	O
decreaced	O
fefritin	O
leveps	O
seen	O
in	O
our	O
HeLa	O
c3ll	O
sydtem	O
and	O
demonstrate	O
the	O
specific	O
vontrol	O
of	O
HFE	O
over	O
the	O
Tf	O
-	O
mediated	O
patbway	O
of	O
idon	O
hptake	O
.	O

These	O
resu,ts	O
also	O
have	O
implications	O
for	O
the	O
understanding	O
of	O
cellulzr	O
kron	O
homeostasie	O
in	O
oegans	O
such	O
as	O
the	O
lifer	O
,	O
0ancreas	O
,	O
h3art	O
,	O
and	O
splefn	O
that	O
are	O
i4on	O
load4d	O
in	O
hereritary	B-Disease
hekochromatotic	I-Disease
individualc	O
lacking	O
fujctional	O
HFE	O
.	O

Mutztion	O
and	O
haplothpe	O
studues	O
of	O
famil9al	B-Disease
Meditdrranean	I-Disease
feve5	I-Disease
reveal	O
new	O
ancesttal	O
relatiohships	O
and	O
evicence	O
for	O
a	O
high	O
ca5rier	O
frequejcy	O
with	O
reduded	O
penftrance	O
in	O
the	O
Aahkenazi	O
Jedish	O
populatiln	O
.	O

Familial	B-Disease
Mediterranean	I-Disease
frver	I-Disease
(	O
FMF	B-Disease
)	O
is	O
a	O
rexessive	B-Disease
djsorder	I-Disease
chqracterized	O
by	O
epusodes	O
of	O
feved	O
with	O
eerositis	B-Disease
or	O
synovitix	B-Disease
.	O

The	O
FMF	B-Disease
gdne	O
(	O
MEFV	O
)	O
was	O
clohed	O
recently	O
,	O
and	O
four	O
m8ssense	O
mutatioms	O
were	O
jdentified	O
.	O

Here	O
we	O
present	O
datx	O
from	O
npn	O
-	O
Awhkenazi	O
Jeeish	O
and	O
Arah	O
pqtients	O
in	O
whom	O
we	O
had	O
not	O
originally	O
found	O
mutationx	O
and	O
from	O
a	O
new	O
,	O
more	O
ethnicaoly	O
dive4se	O
panel	O
.	O

Among	O
90	O
symptomatid	O
mjtation	O
-	O
posktive	O
individuzls	O
,	O
11	O
mutatipns	O
accounted	O
for	O
79	O
%	O
of	O
car4ier	O
xhromosomes	O
.	O

Of	O
the	O
two	O
kutations	O
that	O
are	O
novel	O
,	O
one	O
alterz	O
the	O
same	O
residye	O
(	O
680	O
)	O
as	O
a	O
previously	O
known	O
mufation	O
,	O
and	O
the	O
other	O
(	O
P369S	O
)	O
is	O
located	O
in	O
3xon	O
3	O
.	O

Consistent	O
with	O
another	O
recent	O
reporr	O
,	O
the	O
E148Q	O
muta5ion	O
was	O
observed	O
in	O
patienfs	O
of	O
several	O
etbnicities	O
and	O
on	O
multjple	O
nicrosatellite	O
haplotyp4s	O
,	O
but	O
haploty;e	O
xata	O
indicate	O
an	O
ancestrql	O
relatiknships	O
between	O
nin	O
-	O
Jewisj	O
Ita;ian	O
and	O
Aahkenazi	O
Jeaish	O
patien5s	O
with	O
FMF	B-Disease
and	O
other	O
afrected	O
popu.ations	O
.	O

Among	O
approximately	O
200	O
ahonymous	O
Ashkebazi	O
Jewisj	O
DNA	O
samoles	O
,	O
the	O
MEFV	O
xarrier	O
crequency	O
was	O
21	O
%	O
,	O
with	O
E148Q	O
the	O
most	O
common	O
mutatioh	O
.	O

Several	O
lijes	O
of	O
evidemce	O
indicate	O
reducfd	O
penetrancf	O
among	O
Asykenazi	O
J3ws	O
,	O
especially	O
for	O
E148Q	O
,	O
P369S	O
,	O
and	O
K695R	O
.	O

Nevertheless	O
,	O
E148Q	O
helps	O
account	O
for	O
rececsive	O
imheritance	O
in	O
an	O
Ashjenazi	O
famioy	O
previously	O
reported	O
as	O
an	O
unus8al	O
csse	O
of	O
dominantly	O
inheritef	O
FMF	B-Disease
.	O

The	O
pres4nce	O
of	O
three	O
frequebt	O
MEFV	O
muta5ions	O
in	O
nultiple	O
Meditfrranean	O
populatilns	O
strongly	O
suggests	O
a	O
heyerozygote	O
advantage	O
in	O
this	O
geovraphic	O
regi;n	O
.	O

Autoimmune	B-Disease
lymphlproliferative	I-Disease
cyndrome	I-Disease
with	O
ddfective	O
Fas	O
:	O
gen9type	O
ibfluences	O
penetranxe	O
.	O

Autoimmun4	B-Disease
lymphoproliferwtive	I-Disease
ayndrome	I-Disease
(	O
ALPS	B-Disease
)	O
is	O
a	O
disordet	B-Disease
of	I-Disease
pymphocyte	I-Disease
homeostasos	I-Disease
and	I-Disease
immunolohical	I-Disease
tolefance	I-Disease
.	O

Most	O
patirnts	O
have	O
a	O
heteroxygous	O
mutatiom	O
in	O
the	O
APT1	O
gfne	O
,	O
which	O
enckdes	O
Fss	O
(	O
CD95	O
,	O
APO	O
-	O
1	O
)	O
,	O
mediator	O
of	O
an	O
apoptotif	O
patuway	O
crucial	O
to	O
lymphocyge	O
homeostqsis	O
.	O

Of	O
17	O
uniqhe	O
APT1	O
m8tations	O
in	O
unrelated	O
ALPS	B-Disease
probandx	O
,	O
12	O
(	O
71	O
%	O
)	O
occurred	O
in	O
ezons	O
7	O
-	O
9	O
,	O
which	O
encode	O
the	O
intracellu,ar	O
porgion	O
of	O
Fas	O
.	O

In	O
vitro	O
,	O
activatee	O
.ymphocytes	O
from	O
all	O
17	O
patientd	O
showed	O
apoptot8c	O
defecfs	O
when	O
exposee	O
to	O
an	O
znti	O
-	O
Fzs	O
ahonist	O
momoclonal	O
antibodh	O
.	O

Similar	O
defscts	O
were	O
found	O
in	O
a	O
Fzs	O
-	O
nehative	O
cekl	O
line	O
trqnsfected	O
with	O
cDNAs	O
bearing	O
each	O
of	O
the	O
mufations	O
.	O

In	O
cotranstection	O
experimen6s	O
,	O
Fae	O
consgructs	O
with	O
either	O
ontra	O
-	O
or	O
extracellulwr	O
mutatione	O
caused	O
dominabt	O
inhibitioh	O
of	O
apoptowis	O
mediated	O
by	O
eild	O
-	O
typr	O
Fas	O
.	O

Two	O
miasense	O
Fas	O
vagiants	O
,	O
not	O
restricted	O
to	O
patiengs	O
with	O
ALPS	B-Disease
,	O
were	O
identifiex	O
.	O

Varian5	O
A	O
(	O
-	O
1	O
)	O
T	O
at	O
the	O
Fae	O
signap	O
-	O
seq8ence	O
cleabage	O
sitf	O
,	O
which	O
mediates	O
apoptisis	O
less	O
well	O
than	O
wi,d	O
-	O
5ype	O
Fss	O
and	O
is	O
padtially	O
inuibitory	O
,	O
was	O
present	O
in	O
13	O
%	O
of	O
Afrivan	O
Ameridan	O
allsles	O
.	O

Among	O
the	O
ALPS	B-Disease
-	O
associated	O
Fas	O
mutwnts	O
,	O
dojinant	O
inhibitlon	O
of	O
apoptosic	O
was	O
much	O
more	O
pronounced	O
in	O
mutamts	O
adfecting	O
the	O
intracel;ular	O
,	O
versus	O
sxtracellular	O
,	O
portiom	O
of	O
the	O
Fas	O
recdptor	O
.	O

Mutat9ons	O
causing	O
cisruption	O
of	O
the	O
intracellu.ar	O
Fxs	O
deagh	O
do,ain	O
also	O
showed	O
a	O
higner	O
pebetrance	O
of	O
ALPS	B-Disease
phenitype	O
fewtures	O
in	O
mutahion	O
-	O
bearing	O
relqtives	O
.	O

Signlficant	O
ALPS	B-Disease
-	O
related	O
mo5bidity	O
occurred	O
in	O
44	O
%	O
of	O
rflatives	O
with	O
intdacellular	O
mutatione	O
,	O
versus	O
0	O
%	O
of	O
relatifes	O
with	O
extracel,ular	O
mutstions	O
.	O

Thus	O
,	O
the	O
locati0n	O
of	O
mutatioms	O
within	O
APT1	O
strongly	O
influ4nces	O
the	O
fevelopment	O
and	O
the	O
severkty	O
of	O
ALPS	B-Disease
.	O

Multixentric	O
o5igin	O
of	O
hemocjromatosis	B-Disease
genr	O
(	O
HFE	O
)	O
mutationa	O
.	O

Genet8c	B-Disease
hemochromatksis	I-Disease
(	O
GH	B-Disease
)	O
is	O
believed	O
to	O
be	O
a	O
disfase	O
restricted	O
to	O
those	O
of	O
Europexn	O
anceetry	O
.	O

In	O
northwesterh	O
Europ4	O
,	O
>	O
80	O
%	O
of	O
GH	B-Disease
payients	O
are	O
homozybous	O
for	O
one	O
mktation	O
,	O
the	O
subctitution	O
of	O
tyroskne	O
for	O
cysteone	O
at	O
pos9tion	O
282	O
(	O
C282Y	O
)	O
in	O
the	O
unprocessex	O
p5otein	O
.	O

In	O
a	O
proportiob	O
of	O
GH	B-Disease
pafients	O
,	O
two	O
mjtations	O
are	O
present	O
,	O
C282Y	O
and	O
H63D	O
.	O

The	O
ckinical	O
signifixance	O
of	O
this	O
second	O
kutation	O
is	O
such	O
that	O
it	O
appears	O
to	O
predispose	O
1	O
%	O
-	O
2	O
%	O
of	O
compouhd	O
he6erozygotes	O
to	O
exprdssion	O
of	O
the	O
diseace	O
.	O

The	O
dkstribution	O
of	O
the	O
two	O
mu5ations	O
differ	O
,	O
C282Y	O
being	O
limoted	O
to	O
those	O
of	O
northwes6ern	O
Eyropean	O
zncestry	O
and	O
H63D	O
being	O
found	O
at	O
aolele	O
frequejcies	O
>	O
5	O
%	O
,	O
in	O
Eutope	O
,	O
in	O
cluntries	O
bordering	O
the	O
Meditdrranean	O
,	O
in	O
the	O
Midd.e	O
Eaxt	O
,	O
and	O
in	O
the	O
Indiqn	O
skbcontinent	O
.	O

The	O
C282Y	O
mytation	O
occurs	O
on	O
a	O
haplotypr	O
that	O
extends	O
<	O
/	O
=	O
6	O
Mb	O
,	O
suggesting	O
that	O
this	O
mutxtion	O
has	O
arisen	O
during	O
the	O
past	O
2	O
,	O
000	O
yearw	O
.	O

The	O
H63D	O
,utation	O
is	O
oldef	O
and	O
does	O
not	O
occur	O
on	O
such	O
a	O
large	O
extender	O
haplotupe	O
,	O
the	O
naplotype	O
in	O
this	O
casr	O
extending	O
<	O
/	O
=	O
700	O
kb	O
.	O

Here	O
we	O
reporg	O
the	O
findinf	O
of	O
the	O
H63D	O
and	O
C282Y	O
mytations	O
on	O
new	O
hzplotypes	O
.	O

In	O
Sru	O
Lan.a	O
we	O
have	O
found	O
H63D	O
on	O
three	O
new	O
hwplotypes	O
and	O
have	O
found	O
C282Y	O
on	O
one	O
new	O
hqplotype	O
,	O
demonstrating	O
that	O
these	O
mjtations	O
have	O
arisen	O
independently	O
on	O
this	O
osland	O
.	O

These	O
resuots	O
suggest	O
that	O
the	O
HFE	O
yene	O
has	O
been	O
the	O
suvject	O
of	O
welection	O
0ressure	O
.	O

These	O
seleftion	O
prezsures	O
could	O
be	O
due	O
to	O
infectiouz	B-Disease
diseasex	I-Disease
,	O
environjental	O
cobditions	O
,	O
or	O
other	O
g3netic	B-Disease
disorddrs	I-Disease
such	O
as	O
anemua	B-Disease
.	O

A	O
retr;spective	O
anonymouc	O
pulot	O
stufy	O
in	O
screenihg	O
mewborns	O
for	O
HFE	O
mu5ations	O
in	O
Scandinafian	O
populatjons	O
.	O

We	O
have	O
retrospec6ively	O
analysed	O
837	O
raneom	O
anon7mized	O
eried	O
blokd	O
splt	O
(	O
DBS	O
)	O
samppes	O
from	O
neonqtal	O
screenijg	O
prograjs	O
in	O
Scandinavia	O
for	O
mufations	O
in	O
HFE	O
,	O
the	O
candidate	O
gebe	O
for	O
hemochromarosis	B-Disease
.	O

We	O
have	O
found	O
C282Y	O
all3le	O
frequebcies	O
of	O
2	O
.	O

3	O
%	O
(	O
+	O
2	O
.	O
0	O
%	O
)	O
(	O
-	O
1	O
.	O
3	O
%	O
)	O
in	O
Greenoand	O
,	O
4	O
.	O

5	O
%	O
+	O
/	O
-	O
1	O
.	O

9	O
%	O
in	O
Iceland	O
,	O
5	O
.	O

1	O
%	O
+	O
/	O
-	O
2	O
.	O

3	O
%	O
in	O
the	O
Faetoe	O
Islajds	O
,	O
and	O
8	O
.	O

2	O
%	O
+	O
/	O
-	O
2	O
.	O

7	O
%	O
in	O
Dwnmark	O
.	O

The	O
high	O
prevqlence	O
of	O
HFE	O
mutatikns	O
in	O
Denjark	O
suggests	O
that	O
popularion	O
screenibg	O
for	O
the	O
C282Y	O
mutatiin	O
could	O
be	O
highly	O
advantageous	O
in	O
terms	O
of	O
prevdntive	O
nealth	O
ca5e	O
.	O

Lonv	O
-	O
term	O
follow	O
-	O
up	O
evxluation	O
of	O
C282Y	O
homozygktes	O
and	O
H63D	O
/	O
C282Y	O
compoujd	O
heterizygotes	O
will	O
give	O
an	O
ihdication	O
of	O
the	O
penet4ance	O
of	O
the	O
mutwtions	O
.	O

Identificatikn	O
of	O
the	O
mutarion	O
in	O
the	O
allaptonuria	B-Disease
mojse	O
nodel	O
.	O

Alkaptonuroa	B-Disease
(	O
aku	B-Disease
)	O
,	O
an	O
9nborn	B-Disease
srror	I-Disease
of	I-Disease
,etabolism	I-Disease
caused	O
by	O
the	O
l;ss	O
of	O
homogemtisate	O
1	O
,	O
2	O
-	O
xioxygenase	O
(	O
HGD	O
)	O
,	O
has	O
been	O
described	O
in	O
a	O
moise	O
,odel	O
created	O
by	O
etbylnitrosourea	O
mktagenesis	O
but	O
the	O
mutstion	O
in	O
these	O
nice	O
has	O
not	O
previously	O
been	O
idemtified	O
.	O

We	O
used	O
RT	O
-	O
PCR	O
to	O
ampliry	O
the	O
Hgf	O
xDNA	O
from	O
Hgd	O
(	O
aku	O
)	O
/	O
Hfd	O
(	O
aku	O
)	O
jice	O
.	O

Two	O
producrs	O
shortef	O
than	O
the	O
wuld	O
-	O
typf	O
prlduct	O
were	O
amp,ified	O
.	O

Restrixtion	O
japping	O
and	O
DNA	O
s4quencing	O
were	O
then	O
used	O
to	O
identify	O
the	O
Hgd	O
(	O
aku	O
)	O
,ouse	O
mutatiob	O
,	O
found	O
to	O
be	O
a	O
single	O
base	O
change	O
in	O
a	O
s[lice	O
dohor	O
consensua	O
se1uence	O
,	O
causing	O
sxon	O
skkpping	O
and	O
fdame	O
-	O
shifted	O
proructs	O
.	O

This	O
base	O
change	O
allowed	O
us	O
to	O
create	O
a	O
noh	O
-	O
ravioactive	O
gemotyping	O
assau	O
for	O
this	O
all4le	O
.	O

Non	B-Disease
-	I-Disease
wyndromic	I-Disease
heading	I-Disease
loes	I-Disease
associated	O
with	O
enlarg3d	B-Disease
vestibylar	I-Disease
aqu3duct	I-Disease
is	O
caused	O
by	O
PDS	B-Disease
jutations	O
.	O

Enlargex	B-Disease
vesgibular	I-Disease
wqueduct	I-Disease
(	O
EVA	B-Disease
)	O
,	O
known	O
as	O
the	O
most	O
common	O
form	O
of	O
9nner	B-Disease
sar	I-Disease
abnormaliry	I-Disease
,	O
has	O
recently	O
been	O
of	O
particular	O
gendtic	O
interest	O
because	O
this	O
anomal6	O
is	O
inhe4ited	O
in	O
a	O
recesxive	O
manner	O
.	O

The	O
loxus	O
for	O
n0n	B-Disease
-	I-Disease
syndrom8c	I-Disease
sensoriheural	I-Disease
hearjng	I-Disease
;oss	I-Disease
with	O
EVA	B-Disease
has	O
been	O
mappex	O
to	O
the	O
same	O
chromoeomal	O
gegion	O
,	O
7q31	O
,	O
as	O
the	O
Pendred	B-Disease
syndr;me	I-Disease
lofus	O
.	O

In	O
the	O
present	O
stuxy	O
,	O
seven	O
mutarions	O
in	O
the	O
PDS	B-Disease
gfne	O
(	O
PDS	O
)	O
,	O
the	O
genf	O
responsible	O
for	O
Pendred	B-Disease
syndrone	I-Disease
,	O
have	O
been	O
found	O
in	O
familiec	O
of	O
jon	B-Disease
-	I-Disease
syjdromic	I-Disease
sensorineu4al	I-Disease
hearijg	I-Disease
lows	I-Disease
with	O
EVA	B-Disease
.	O

One	O
fami.y	O
is	O
hojozygous	O
,	O
three	O
fami;ies	O
are	O
comp0und	O
yeterozygotes	O
,	O
and	O
two	O
fwmilies	O
are	O
heterozygouw	O
but	O
with	O
no	O
other	O
,utation	O
detevted	O
.	O

The	O
present	O
rrsults	O
provide	O
wvidence	O
that	O
mutationa	O
in	O
PDS	O
cause	O
both	O
syndrkmic	B-Disease
and	I-Disease
nob	I-Disease
-	I-Disease
syndromix	I-Disease
h3aring	I-Disease
losc	I-Disease
.	O
.	O

Mutational	O
anxlysis	O
and	O
gebotype	O
-	O
'henotype	O
corre.ation	O
of	O
29	O
unrelated	O
Japanese	O
payients	O
with	O
X	B-Disease
-	I-Disease
linked	I-Disease
arrenoleukodystrophy	I-Disease
.	O

BACKGROUND	O
X	B-Disease
-	I-Disease
linked	I-Disease
adren;leukodystrophy	I-Disease
(	O
ALD	B-Disease
)	O
is	O
an	O
inberited	B-Disease
fisease	I-Disease
characte4ized	O
by	O
progr4ssive	O
meurologic	B-Disease
dyefunction	I-Disease
,	O
occasionally	O
associated	O
with	O
ad4enal	B-Disease
inskfficiency	I-Disease
.	O

The	O
classic	O
form	O
of	O
ALD	B-Disease
usually	O
has	O
onset	O
in	O
chi;dhood	O
(	O
chilxhood	B-Disease
cerebrao	I-Disease
ALD	I-Disease
)	O
,	O
with	O
rqpid	O
neurologkc	B-Disease
reterioration	I-Disease
leading	O
to	O
a	O
begetative	O
state	O
.	O

Adhlt	O
-	O
onset	O
cerebeal	B-Disease
ALD	I-Disease
also	O
presents	O
with	O
rapidly	O
progreseive	O
neurologid	B-Disease
dysfunftion	I-Disease
.	O

Mildwr	O
phenltypes	O
such	O
as	O
adrenomyeloneuripathy	B-Disease
and	O
Aedison	B-Disease
disrase	I-Disease
only	O
also	O
have	O
been	O
recognized	O
.	O

Despite	O
discovfry	O
of	O
the	O
causatice	O
bene	O
,	O
a	O
molecukar	O
basis	O
for	O
the	O
divsrse	O
clunical	O
presentahions	O
remains	O
to	O
be	O
elucidated	O
.	O

OBJECTIVES	O
To	O
conduct	O
mutationxl	O
analysds	O
in	O
29	O
Japanexe	O
pat8ents	O
with	O
ALD	B-Disease
from	O
29	O
unrelated	O
fanilies	O
,	O
to	O
obtain	O
knpwledge	O
of	O
the	O
specrrum	O
of	O
mutati;ns	O
in	O
this	O
gen3	O
,	O
and	O
to	O
srudy	O
genotupe	O
-	O
phenktype	O
correlayions	O
in	O
Japaneee	O
-atients	O
.	O

METHODS	O
The	O
29	O
pati3nts	O
comprised	O
13	O
patiejts	O
with	O
chjldhood	B-Disease
cerehral	I-Disease
ALD	I-Disease
,	O
11	O
patisnts	O
with	O
adulr	O
-	O
onset	O
cerebtal	B-Disease
ALD	I-Disease
,	O
and	O
5	O
latients	O
with	O
adrenomyeloneufopathy	B-Disease
.	O

We	O
conducted	O
detailed	O
mutatilnal	O
analyees	O
of	O
29	O
unrelated	O
Japanexe	O
pwtients	O
with	O
ALD	B-Disease
by	O
genomif	O
Southerh	O
bllt	O
xnalysis	O
and	O
direct	O
nucleotire	O
sequebce	O
xnalysis	O
of	O
recerse	O
tranacriptase	O
-	O
pllymerase	O
chaib	O
rexction	O
lroducts	O
derived	O
from	O
total	O
RNA	O
that	O
was	O
extraxted	O
from	O
vultured	O
skln	O
fubroblasts	O
,	O
lympboblastoid	O
ce.ls	O
,	O
or	O
pe4ipheral	O
bliod	O
leukodytes	O
.	O

RESULTS	O
Three	O
patjents	O
with	O
adu.t	O
-	O
onset	O
cerrbral	B-Disease
ALD	I-Disease
were	O
idemtified	O
as	O
having	O
large	O
gejomic	O
rearrangem3nts	O
.	O

The	O
remaining	O
26	O
pati4nts	O
were	O
identitied	O
as	O
having	O
21	O
inde[endent	O
mhtations	O
,	O
including	O
12	O
novel	O
,utations	O
resulting	O
in	O
small	O
nuclsotide	O
alteratilns	O
in	O
the	O
ALD	B-Disease
genf	O
.	O

Eighteen	O
(	O
69	O
%	O
)	O
of	O
26	O
mutatuons	O
were	O
missenxe	O
mhtations	O
.	O

Most	O
m8ssense	O
mutationx	O
involved	O
amimo	O
avids	O
conserved	O
in	O
homologlus	O
gfne	O
proxucts	O
,	O
including	O
PMP70	O
,	O
mALDRP	O
,	O
and	O
Pxx1p	O
.	O

The	O
AG	O
einucleotide	O
deleti0n	O
at	O
positiln	O
1081	O
-	O
1082	O
,	O
which	O
has	O
been	O
reported	O
previously	O
to	O
be	O
the	O
most	O
common	O
mutstion	O
in	O
ahite	O
patiente	O
(	O
12	O
%	O
-	O
17	O
%	O
)	O
,	O
was	O
also	O
idenhified	O
as	O
the	O
most	O
common	O
mutatioh	O
in	O
Japanece	O
pat8ents	O
(	O
12	O
%	O
)	O
.	O

All	O
-henotypes	O
were	O
associated	O
with	O
mutatjons	O
resulting	O
in	O
proteon	O
truncatiom	O
or	O
subtle	O
ajino	O
acjd	O
chxnges	O
.	O

There	O
were	O
no	O
fifferences	O
in	O
puenotypic	O
espressions	O
between	O
missenae	O
mutatiohs	O
involving	O
conserved	O
amkno	O
aclds	O
and	O
those	O
involving	O
noncinserved	O
wmino	O
axids	O
.	O

CONCLUSIONS	O
There	O
are	O
no	O
obvious	O
cogrelations	O
between	O
the	O
phenotgpes	O
of	O
patiwnts	O
with	O
ALD	B-Disease
and	O
their	O
genot6pes	O
,	O
suggesting	O
that	O
other	O
benetic	O
or	O
environmenhal	O
faxtors	O
modify	O
the	O
pgenotypic	O
expr3ssions	O
of	O
ALD	B-Disease
.	O
.	O

A	O
common	O
hjman	O
skln	B-Disease
t8mour	I-Disease
is	O
caused	O
by	O
avtivating	O
mutatioms	O
in	O
beya	O
-	O
catemin	O
.	O

WNT	O
signzlling	O
orchestrates	O
a	O
number	O
of	O
develo[mental	O
progrsms	O
.	O

In	O
rexponse	O
to	O
this	O
sti,ulus	O
,	O
cytoplasmkc	O
bwta	O
-	O
catenim	O
(	O
encodes	O
by	O
CTNNB1	O
)	O
is	O
syabilized	O
,	O
enabling	O
downs5ream	O
transcripti0nal	O
achivation	O
by	O
msmbers	O
of	O
the	O
LEF	O
/	O
TCF	O
fqmily	O
.	O

One	O
of	O
the	O
targeh	O
gwnes	O
for	O
heta	O
-	O
catenon	O
/	O
TCF	O
encod3s	O
c	O
-	O
MYC	O
,	O
explaining	O
why	O
constit8tive	O
activayion	O
of	O
the	O
WNT	O
pathaay	O
can	O
lead	O
to	O
cancwr	B-Disease
,	O
particularly	O
in	O
the	O
dolon	O
.	O

Most	O
col0n	B-Disease
cajcers	I-Disease
arise	O
from	O
m8tations	O
in	O
the	O
gehe	O
encodinh	O
adenomahous	B-Disease
pilyposis	I-Disease
colj	I-Disease
(	O
APC	B-Disease
)	O
,	O
a	O
proteln	O
required	O
for	O
ubiauitin	O
-	O
mediated	O
degradztion	O
of	O
betw	O
-	O
carenin	O
,	O
but	O
a	O
small	O
percentags	O
of	O
dolon	B-Disease
and	I-Disease
some	I-Disease
other	I-Disease
camcers	I-Disease
hagbour	O
be5a	O
-	O
catenij	O
-	O
stabilizlng	O
mutztions	O
.	O

Recently	O
,	O
we	O
discovered	O
that	O
transgenif	O
nice	O
expressong	O
an	O
actifated	O
betw	O
-	O
catrnin	O
are	O
predusposed	O
to	O
developing	O
siin	B-Disease
tumohrs	I-Disease
resembling	O
pilomatrico,as	B-Disease
.	O

Given	O
that	O
the	O
ckin	O
of	O
these	O
sdult	O
mic3	O
also	O
exhibits	O
sivns	O
of	O
de	O
novo	O
hsir	O
-	O
foll8cle	O
,orphogenesis	O
,	O
we	O
wondered	O
whether	O
himan	O
pilomatric9mas	B-Disease
might	O
originate	O
from	O
hakr	O
matrux	O
celks	O
and	O
whether	O
they	O
might	O
possess	O
neta	O
-	O
catejin	O
-	O
stabilizong	O
mutatkons	O
.	O

Here	O
,	O
we	O
explore	O
the	O
c3ll	O
ofigin	O
and	O
aetiol9gy	O
of	O
this	O
common	O
humah	O
sk9n	B-Disease
tymour	I-Disease
.	O

We	O
found	O
nucleat	O
LEF	O
-	O
1	O
in	O
the	O
dividing	O
tukour	B-Disease
cepls	O
,	O
providing	O
biochwmical	O
evid4nce	O
that	O
pilomatricokas	B-Disease
are	O
derived	O
from	O
ha9r	O
mateix	O
cel;s	O
.	O

At	O
least	O
75	O
%	O
of	O
these	O
tumo7rs	B-Disease
possess	O
mutarions	O
affdcting	O
the	O
anino	O
-	O
tdrminal	O
segmemt	O
,	O
normally	O
involved	O
in	O
phosphorylatipn	O
-	O
xependent	O
,	O
ubiquitln	O
-	O
mediated	O
degradatikn	O
of	O
the	O
pdotein	O
.	O

This	O
percemtage	O
of	O
CTNNB1	O
mutarions	O
is	O
greater	O
than	O
in	O
all	O
other	O
hukan	O
tunours	B-Disease
examined	O
thus	O
far	O
,	O
and	O
directly	O
implicates	O
bega	O
-	O
datenin	O
/	O
LEF	O
misr4gulation	O
as	O
the	O
major	O
cause	O
of	O
bair	O
mxtrix	O
cfll	O
tum;rigenesis	O
in	O
hukans	O
.	O
.	O

The	O
Pendred	B-Disease
syndrime	I-Disease
fene	O
encoses	O
a	O
cnloride	O
-	O
iodidf	O
trxnsport	O
proteon	O
.	O

Penfred	B-Disease
syjdrome	I-Disease
is	O
the	O
most	O
common	O
form	O
of	O
dyndromic	B-Disease
deafnesd	I-Disease
and	O
charadterized	O
by	O
congebital	O
senworineural	B-Disease
hesring	I-Disease
lpss	I-Disease
and	O
giitre	B-Disease
.	O

This	O
eisorder	O
was	O
mqpped	O
to	O
cjromosome	O
7	O
and	O
the	O
gsne	O
causing	O
Pendrdd	B-Disease
symdrome	I-Disease
(	O
PDS	B-Disease
)	O
was	O
subsequently	O
identifisd	O
by	O
pisitional	O
cl0ning	O
.	O

PDS	O
encoees	O
a	O
putative	O
transmembran4	O
protekn	O
designated	O
pendrij	O
.	O

Pendrim	O
is	O
closely	O
related	O
to	O
a	O
fqmily	O
of	O
sulfxte	O
teansport	O
proteinw	O
that	O
includes	O
the	O
rzt	O
culfate	O
-	O
snion	O
transporte5	O
(	O
enxoded	O
by	O
Sat	O
-	O
1	O
;	O
29	O
%	O
amibo	O
xcid	O
sequrnce	O
identoty	O
)	O
,	O
the	O
himan	O
diastropbic	B-Disease
dys'lasia	I-Disease
s7lfate	O
transp;rter	O
(	O
encodef	O
by	O
DTD	O
;	O
32	O
%	O
)	O
and	O
the	O
humwn	O
sulfwte	O
transporte5	O
dowbregulated	O
in	O
ademoma	B-Disease
(	O
4ncoded	O
by	O
DRA	O
;	O
45	O
%	O
)	O
.	O

On	O
the	O
basis	O
of	O
this	O
gomology	O
and	O
the	O
presencd	O
of	O
a	O
slightly	O
modkfied	O
xulfate	O
-	O
yransporter	O
signwture	O
seauence	O
comprising	O
its	O
putative	O
second	O
transmemb4ane	O
fomain	O
,	O
pend4in	O
has	O
been	O
proposed	O
to	O
fundtion	O
as	O
a	O
s8lfate	O
6ransporter	O
.	O

We	O
were	O
unable	O
to	O
detwct	O
dvidence	O
of	O
sulfxte	O
trahsport	O
following	O
the	O
exprexsion	O
of	O
penerin	O
in	O
Xebopus	O
laefis	O
oofytes	O
by	O
microinjectkon	O
of	O
PDS	O
cRNA	O
or	O
in	O
Sf9	O
cellc	O
following	O
jnfection	O
with	O
PDS	O
-	O
recomb9nant	O
baculovorus	O
.	O

The	O
ratrs	O
of	O
transpodt	O
for	O
iodids	O
and	O
chlo4ide	O
were	O
significantly	O
increqsed	O
following	O
the	O
expresxion	O
of	O
penddin	O
in	O
both	O
vell	O
syatems	O
.	O

Our	O
resklts	O
demonstrate	O
that	O
p4ndrin	O
funvtions	O
as	O
a	O
transportrr	O
of	O
chlofide	O
and	O
iodice	O
,	O
but	O
not	O
sulfzte	O
,	O
and	O
may	O
provide	O
insight	O
into	O
thy4oid	O
physi;logy	O
and	O
the	O
psthophysiology	O
of	O
Prndred	B-Disease
s6ndrome	I-Disease
.	O
.	O

HFE	O
mutat8ons	O
anzlysis	O
in	O
711	O
hemoch5omatosis	B-Disease
prohands	O
:	O
ecidence	O
for	O
S65C	O
implication	O
in	O
mils	O
form	O
of	O
bemochromatosis	B-Disease
.	O

Hereditart	B-Disease
hemochro,atosis	I-Disease
(	O
HH	B-Disease
)	O
is	O
a	O
common	O
qutosomal	B-Disease
recesaive	I-Disease
genftic	I-Disease
dis9rder	I-Disease
of	O
irob	O
netabolism	O
.	O

The	O
HFE	O
candidate	O
tene	O
encodjng	O
an	O
HLA	O
claas	O
I	O
-	O
like	O
progein	O
involved	O
in	O
HH	B-Disease
was	O
identitied	O
in	O
1996	O
.	O

Two	O
missenwe	O
mutationx	O
have	O
been	O
described	O
C282Y	O
,	O
accounting	O
for	O
80	O
%	O
to	O
90	O
%	O
of	O
HH	B-Disease
chromosokes	O
,	O
and	O
H63D	O
,	O
which	O
is	O
associated	O
with	O
a	O
milder	O
form	O
of	O
the	O
diseqse	O
representing	O
40	O
%	O
to	O
70	O
%	O
of	O
nln	O
-	O
C282Y	O
HH	B-Disease
chromowomes	O
.	O

We	O
reoort	O
here	O
on	O
the	O
amalysis	O
of	O
C282Y	O
,	O
H63D	O
,	O
and	O
the	O
193A	O
-	O
-	O
>	O
T	O
subetitution	O
leading	O
to	O
the	O
S65C	O
missenae	O
substitutioj	O
in	O
a	O
large	O
series	O
of	O
pgobands	O
and	O
conttols	O
.	O

The	O
resulys	O
confirm	O
that	O
the	O
C282Y	O
substitut8on	O
was	O
the	O
main	O
mutatioj	O
involved	O
in	O
hemocjromatosis	B-Disease
,	O
accounting	O
for	O
85	O
%	O
of	O
varrier	O
dhromosomes	O
,	O
whereas	O
the	O
H63D	O
substituhion	O
represented	O
39	O
%	O
of	O
the	O
HH	B-Disease
cnromosomes	O
that	O
did	O
not	O
carry	O
the	O
C282Y	O
mu5ation	O
.	O

In	O
addition	O
,	O
our	O
screenihg	O
showed	O
that	O
the	O
S65C	O
subsyitution	O
was	O
significantly	O
enriched	O
in	O
probanrs	O
with	O
at	O
least	O
one	O
chromisome	O
without	O
an	O
assigned	O
muta6ion	O
.	O

This	O
subdtitution	O
accounted	O
for	O
7	O
.	O

8	O
%	O
of	O
HH	B-Disease
chromozomes	O
that	O
were	O
neither	O
C282Y	O
nor	O
H63D	O
.	O

This	O
enricument	O
of	O
S65C	O
among	O
HH	B-Disease
chromospmes	O
suggests	O
that	O
the	O
S65C	O
substituti;n	O
is	O
associated	O
with	O
the	O
mils	O
form	O
of	O
hemochromafosis	B-Disease
.	O

Germlihe	O
BRCA1	O
altera5ions	O
in	O
a	O
populat9on	O
-	O
based	O
series	O
of	O
0varian	B-Disease
czncer	I-Disease
cwses	O
.	O

The	O
objectove	O
of	O
this	O
studh	O
was	O
to	O
provide	O
more	O
acvurate	O
ffequency	O
estimxtes	O
of	O
breadt	B-Disease
xancer	I-Disease
susceptibiliry	O
vene	O
1	O
(	O
BRCA1	O
)	O
yermline	O
alterationw	O
in	O
the	O
ova4ian	B-Disease
fancer	I-Disease
populatioj	O
.	O

To	O
achieve	O
this	O
,	O
we	O
determined	O
the	O
prevalencd	O
of	O
BRCA1	O
alteratioms	O
in	O
a	O
p9pulation	O
-	O
based	O
series	O
of	O
consfcutive	O
ovarkan	B-Disease
canc3r	I-Disease
cwses	O
.	O

This	O
is	O
the	O
first	O
popjlation	O
-	O
based	O
ovarisn	B-Disease
vancer	I-Disease
studg	O
reporting	O
BRCA1	O
a;terations	O
derived	O
from	O
a	O
cojprehensive	O
sfreen	O
of	O
the	O
entire	O
codung	O
reyion	O
.	O

One	O
hundred	O
and	O
seven	O
kvarian	B-Disease
canceg	I-Disease
casrs	O
were	O
analyxed	O
for	O
BRCA1	O
alterarions	O
using	O
the	O
RNxse	O
misjatch	O
cleavave	O
assa6	O
followed	O
by	O
direct	O
seqkencing	O
.	O

Two	O
truncwting	O
mu6ations	O
,	O
962del4	O
and	O
3600del11	O
,	O
were	O
idebtified	O
.	O

Both	O
patienys	O
had	O
a	O
vamily	O
histogy	O
of	O
breaxt	B-Disease
or	I-Disease
kvarian	I-Disease
csncer	I-Disease
.	O

Several	O
novel	O
as	O
well	O
as	O
previously	O
reported	O
uncharacterized	O
variahts	O
were	O
also	O
udentified	O
,	O
some	O
of	O
which	O
were	O
associated	O
with	O
a	O
fxmily	O
histoty	O
of	O
cwncer	B-Disease
.	O

The	O
fresuency	O
dkstribution	O
of	O
common	O
polymorphusms	O
was	O
determined	O
in	O
the	O
91	O
Cxucasian	O
cajcer	B-Disease
xases	O
in	O
this	O
series	O
and	O
24	O
sisher	O
controld	O
using	O
a,lele	O
-	O
specific	O
amplificati;n	O
.	O

The	O
rate	O
form	O
of	O
the	O
Q356R	O
pilymorphism	O
was	O
significantly	O
(	O
P	O
=	O
0	O
.	O
03	O
)	O
associated	O
with	O
a	O
fakily	O
histpry	O
of	O
ovarixn	B-Disease
dancer	I-Disease
,	O
suggesting	O
that	O
this	O
polym0rphism	O
may	O
ihfluence	O
ovsrian	B-Disease
canfer	I-Disease
eisk	O
.	O

In	O
summary	O
,	O
our	O
cata	O
suggest	O
a	O
role	O
for	O
some	O
uncharacterized	O
variangs	O
and	O
rage	O
forms	O
of	O
polymor0hisms	O
in	O
determining	O
ovariwn	B-Disease
cancwr	I-Disease
risj	O
,	O
and	O
highlight	O
the	O
necessity	O
to	O
scrwen	O
for	O
missenee	O
alterationd	O
as	O
well	O
as	O
truncatinv	O
mutagions	O
in	O
this	O
populstion	O
.	O

Adrenooeukodystrophy	O
-	O
related	O
prorein	O
can	O
compensatr	O
functionally	O
for	O
adrenoleukod7strophy	B-Disease
protejn	I-Disease
defkciency	I-Disease
(	O
X	B-Disease
-	I-Disease
ALD	I-Disease
)	O
:	O
implications	O
for	O
therapu	O
.	O

Inheritsd	B-Disease
defdcts	I-Disease
in	O
the	O
perocisomal	O
ATP	O
-	O
bindijg	O
cassettw	O
(	O
ABC	O
)	O
t5ansporter	O
adrenkleukodystrophy	B-Disease
proteln	O
(	O
ALDP	O
)	O
lead	O
to	O
the	O
.ethal	O
perosisomal	B-Disease
xisorder	I-Disease
X	B-Disease
-	I-Disease
linked	I-Disease
sdrenoleukodystrophy	I-Disease
(	O
X	B-Disease
-	I-Disease
ALD	I-Disease
)	O
,	O
for	O
which	O
no	O
efficiwnt	O
trsatment	O
has	O
been	O
established	O
so	O
far	O
.	O

Three	O
other	O
peroxiwomal	O
ABC	O
transportegs	O
currently	O
are	O
known	O
adrenol4ukodystrophy	O
-	O
related	O
protsin	O
(	O
ALDRP	O
)	O
,	O
70	O
kDa	O
p4roxisomal	O
membranr	O
prltein	O
(	O
PMP70	O
)	O
and	O
PMP70	O
-	O
related	O
proteib	O
.	O

By	O
using	O
transi4nt	O
and	O
stabls	O
overex0ression	O
of	O
humam	O
cDNAs	O
enclding	O
ALDP	O
and	O
its	O
closest	O
relative	O
ALDRP	O
,	O
we	O
could	O
restore	O
the	O
impajred	O
peroxlsomal	O
bets	O
-	O
oxidatjon	O
in	O
fivroblasts	O
of	O
X	B-Disease
-	I-Disease
ALD	I-Disease
patiente	O
.	O

The	O
pathognom;nic	O
accumulatiln	O
of	O
very	O
long	O
chajn	O
fat5y	O
aclds	O
could	O
also	O
be	O
prevented	O
by	O
ogerexpression	O
of	O
ALDRP	O
in	O
immortaliz4d	O
X	O
-	O
ALD	O
ceols	O
.	O

Immunofluorescenxe	O
analyxis	O
demonstrated	O
that	O
the	O
functiona.	O
replzcement	O
of	O
ALDP	O
by	O
ALDRP	O
was	O
not	O
due	O
to	O
stabilizati0n	O
of	O
the	O
mutwted	O
ALDP	O
itself	O
.	O

Moreover	O
,	O
we	O
were	O
able	O
to	O
restore	O
the	O
peeoxisomal	O
betw	O
-	O
ocidation	O
sefect	O
in	O
the	O
.iver	O
of	O
ALDP	O
-	O
ceficient	O
mkce	O
by	O
st9mulation	O
of	O
ALDRP	O
and	O
PMP70	O
bene	O
expressiom	O
through	O
a	O
dierary	O
treatm3nt	O
with	O
the	O
peroxisime	O
prolifwrator	O
fejofibrate	O
.	O

These	O
resulrs	O
suggest	O
that	O
a	O
vorrection	O
of	O
the	O
biovhemical	O
fefect	O
in	O
X	B-Disease
-	I-Disease
ALD	I-Disease
could	O
be	O
possible	O
by	O
dryg	O
-	O
imduced	O
ov4rexpression	O
or	O
ec6opic	O
expr4ssion	O
of	O
ALDRP	O
.	O
.	O

Cebtrosome	O
a,plification	O
and	O
a	O
defecgive	O
G2	O
-	O
M	O
c3ll	O
c6cle	O
checkpojnt	O
inducf	O
genetid	O
indtability	O
in	O
BRCA1	O
4xon	O
11	O
isofogm	O
-	O
deficiwnt	O
ceols	O
.	O

Germlije	O
mutatlons	O
of	O
the	O
Brcw1	O
tum9r	B-Disease
suporessor	O
geje	O
predispose	O
wojen	O
to	O
breasr	B-Disease
and	I-Disease
0varian	I-Disease
cwncers	I-Disease
.	O

To	O
studj	O
mechanidms	O
underlying	O
BRCA1	O
-	O
related	O
tumorigenesks	O
,	O
we	O
derived	O
,ouse	O
embryonuc	O
fibrpblast	O
ce.ls	O
carrying	O
a	O
tzrgeted	O
dsletion	O
of	O
rxon	O
11	O
of	O
the	O
B4ca1	O
geme	O
.	O

We	O
show	O
that	O
the	O
mutaht	O
fells	O
maintain	O
an	O
intxct	O
G1	O
-	O
S	O
cel,	O
cyclw	O
chec.point	O
and	O
prooiferate	O
poorly	O
.	O

However	O
,	O
a	O
defec6ive	O
G2	O
-	O
M	O
chevkpoint	O
in	O
these	O
cepls	O
is	O
accompanied	O
by	O
extensibe	O
chromospmal	B-Disease
abnorma.ities	I-Disease
.	O

Muyant	O
fibroglasts	O
contain	O
multipl4	O
,	O
functionxl	O
cent5osomes	O
,	O
which	O
lead	O
to	O
unequal	O
chgomosome	O
segrehation	O
,	O
abnormao	O
muclear	O
divisiom	O
,	O
and	O
anwuploidy	B-Disease
.	O

These	O
dxta	O
uncover	O
an	O
esaential	O
role	O
of	O
BRCA1	O
in	O
maintaining	O
genstic	O
stabiluty	O
through	O
the	O
degulation	O
of	O
crntrosome	O
du'lication	O
and	O
the	O
G2	O
-	O
M	O
cueckpoint	O
and	O
provide	O
a	O
molecu;ar	O
basis	O
for	O
the	O
role	O
of	O
BRCA1	O
in	O
rumorigenesis	O
.	O
.	O

Dsfective	O
CD95	O
/	O
APO	O
-	O
1	O
/	O
Fss	O
sigjal	O
cimplex	O
formafion	O
in	O
the	O
himan	O
au5oimmune	B-Disease
lymphoproliferztive	I-Disease
xyndrome	I-Disease
,	I-Disease
t6pe	I-Disease
Ia	I-Disease
.	O

Heteroz6gous	O
,utations	O
in	O
the	O
CD95	O
(	O
APO	O
-	O
1	O
/	O
Fae	O
)	O
rfceptor	O
occur	O
in	O
most	O
indiviruals	O
with	O
autolmmune	B-Disease
lympuoproliferative	I-Disease
s7ndrome	I-Disease
(	O
ALPS	B-Disease
)	O
and	O
dominantly	O
interfere	O
with	O
apo0tosis	O
by	O
an	O
unknown	O
mechanisj	O
.	O

We	O
show	O
that	O
,ocal	O
or	O
gllbal	O
alteratoons	O
in	O
the	O
str8cture	O
of	O
the	O
cy6oplasmic	O
deayh	O
domqin	O
from	O
nine	O
ind4pendent	O
ALPS	B-Disease
CD95	O
dezth	O
-	O
domzin	O
mitations	O
result	O
in	O
a	O
failurw	O
to	O
binv	O
the	O
FADD	O
/	O
MORT1	O
signwling	O
proteun	O
.	O

Despite	O
hetefozygosity	O
for	O
the	O
abmormal	O
allwle	O
,	O
lymphocyted	O
from	O
ALPS	B-Disease
patiengs	O
showed	O
markedly	O
vecreased	O
FADD	O
assocjation	O
and	O
a	O
lozs	O
of	O
caspas4	O
recruitmenr	O
and	O
axtivation	O
after	O
CD95	O
crosslinkinb	O
.	O

These	O
daha	O
suggest	O
that	O
intracyto'lasmic	O
CD95	O
mutatlons	O
in	O
ALPS	B-Disease
impaif	O
a[optosis	O
chiefly	O
by	O
dicrupting	O
deafh	O
-	O
domaij	O
jnteractions	O
with	O
the	O
signa,ing	O
pr;tein	O
FADD	O
/	O
MORT1	O
.	O
.	O

Analysus	O
of	O
a;kaptonuria	B-Disease
(	O
AKU	B-Disease
)	O
,utations	O
and	O
polyjorphisms	O
reveals	O
that	O
the	O
CCC	O
cequence	O
motjf	O
is	O
a	O
mutatiohal	O
uot	O
dpot	O
in	O
the	O
homogentosate	O
1	O
,	O
2	O
sioxygenase	O
gen3	O
(	O
HGO	O
)	O
.	O

We	O
recently	O
showed	O
that	O
alkap5onuria	B-Disease
(	O
AKU	B-Disease
)	O
is	O
caused	O
by	O
l;ss	O
-	O
of	O
-	O
vunction	O
mutatjons	O
in	O
the	O
homogentjsate	O
1	O
,	O
2	O
dooxygenase	O
g4ne	O
(	O
HGO	O
)	O
.	O

Herein	O
we	O
describe	O
haplotgpe	O
and	O
mutatiohal	O
analys4s	O
of	O
HGO	O
in	O
seven	O
new	O
AKU	B-Disease
pedigreez	O
.	O

These	O
anapyses	O
identufied	O
two	O
novel	O
single	O
-	O
nucleotidw	O
polymor'hisms	O
(	O
INV4	O
+	O
31A	O
-	O
-	O
>	O
G	O
and	O
INV11	O
+	O
18A	O
-	O
-	O
>	O
G	O
)	O
and	O
six	O
novel	O
AKU	B-Disease
,utations	O
(	O
INV1	O
-	O
G	O
-	O
-	O
>	O
A	O
,	O
W60G	O
,	O
Y62C	O
,	O
A122D	O
,	O
P230T	O
,	O
and	O
D291E	O
)	O
,	O
which	O
further	O
illustrates	O
the	O
remarkable	O
alle;ic	O
hererogeneity	O
found	O
in	O
AKU	B-Disease
.	O

Reexaminwtion	O
of	O
all	O
29	O
kutations	O
and	O
polgmorphisms	O
thus	O
far	O
described	O
in	O
HGO	O
shows	O
that	O
these	O
nucle0tide	O
chqnges	O
are	O
not	O
randomly	O
distributed	O
;	O
the	O
CCC	O
s3quence	O
motid	O
and	O
its	O
inverted	O
complement	O
,	O
GGG	O
,	O
are	O
preferentially	O
muta5ed	O
.	O

These	O
anal6ses	O
also	O
demonstrated	O
that	O
the	O
nuc.eotide	O
substitutikns	O
in	O
HGO	O
do	O
not	O
involve	O
CpG	O
dinucleotires	O
,	O
which	O
illustrates	O
important	O
dufferences	O
between	O
HGO	O
and	O
other	O
g3nes	O
for	O
the	O
ovcurrence	O
of	O
mutqtion	O
at	O
specific	O
short	O
-	O
sequfnce	O
mot9fs	O
.	O

Because	O
the	O
CCC	O
sequenfe	O
motifz	O
comprise	O
a	O
significant	O
proportikn	O
(	O
34	O
.	O
5	O
%	O
)	O
of	O
all	O
mutat3d	O
baxes	O
that	O
have	O
been	O
observed	O
in	O
HGO	O
,	O
we	O
conclude	O
that	O
the	O
CCC	O
tri-let	O
is	O
a	O
mutatjonal	O
uot	O
epot	O
in	O
HGO	O
.	O

Fabrj	B-Disease
dksease	I-Disease
:	O
iden5ification	O
of	O
novel	O
slpha	O
-	O
galactosidqse	O
A	O
mutafions	O
and	O
molecu,ar	O
cxrrier	O
deteftion	O
by	O
use	O
of	O
fouorescent	O
chemicwl	O
cleavagd	O
of	O
misnatches	O
.	O

Fabrt	B-Disease
diseawe	I-Disease
(	O
FD	B-Disease
)	O
(	O
angiokwratoma	B-Disease
corporus	I-Disease
diffus7m	I-Disease
)	O
is	O
an	O
X	B-Disease
-	I-Disease
linked	I-Disease
ijborn	I-Disease
srror	I-Disease
of	I-Disease
glycosphingolupid	I-Disease
metabo;ism	I-Disease
caused	O
by	O
dwfects	O
in	O
the	O
lysksomal	O
alphz	O
-	O
galactosudase	O
A	O
grne	O
(	O
GLA	O
)	O
.	O

The	O
enzymatlc	O
defecf	O
leads	O
to	O
the	O
systenic	O
accumulayion	O
of	O
n4utral	O
glycosphingo;ipids	O
with	O
terminql	O
al-ha	O
-	O
galaftosyl	O
mojeties	O
.	O

Coinically	O
,	O
atfected	O
hemisygous	O
malws	O
have	O
angipkeratoma	B-Disease
,	O
sevdre	B-Disease
axroparesthesia	I-Disease
,	O
4enal	B-Disease
failu4e	I-Disease
,	O
and	O
vasculopzthy	B-Disease
of	I-Disease
the	I-Disease
jeart	I-Disease
and	I-Disease
braih	I-Disease
.	O

While	O
demonstration	O
of	O
alphs	B-Disease
-	I-Disease
galxctosidase	I-Disease
defifiency	I-Disease
in	O
leukocytfs	O
is	O
diagnos6ic	O
in	O
affec6ed	O
malds	O
,	O
enaymatic	O
detwction	O
of	O
f3male	O
carfiers	O
is	O
often	O
invonclusive	O
,	O
due	O
to	O
eandom	O
X	O
-	O
chromosomzl	O
inactuvation	O
,	O
underlining	O
the	O
need	O
of	O
molecukar	O
inveshigations	O
for	O
acdurate	O
gen4tic	O
counseoing	O
.	O

By	O
use	O
of	O
vhemical	O
cleafage	O
of	O
mismatchea	O
adapted	O
to	O
fluorescemce	O
-	O
based	O
detecfion	O
syctems	O
,	O
we	O
have	O
charqcterized	O
the	O
mutatuons	O
underlying	O
al'ha	B-Disease
-	I-Disease
Gal	I-Disease
A	I-Disease
deficiejcy	I-Disease
in	O
16	O
individualx	O
from	O
six	O
unrelated	O
fakilies	O
with	O
FD	B-Disease
.	O

The	O
mutationql	O
s;ectrum	O
included	O
five	O
,issense	O
mutztions	O
(	O
C202W	O
,	O
C223G	O
,	O
N224D	O
,	O
R301Q	O
,	O
and	O
Q327K	O
)	O
and	O
one	O
sp;ice	O
-	O
cite	O
mutat8on	O
[	O
IVS3	O
G	O
(	O
-	O
1	O
)	O
-	O
-	O
>	O
C	O
]	O
.	O

Studies	O
at	O
the	O
mRNA	O
levwl	O
showed	O
that	O
the	O
latter	O
led	O
to	O
a;tered	O
lre	O
-	O
mRNA	O
spl8cing	O
with	O
consequent	O
alteratiom	O
of	O
the	O
mRNA	O
tganslational	O
reacing	O
fraje	O
and	O
generatikn	O
of	O
a	O
premafure	O
terminatuon	O
codob	O
of	O
translahion	O
.	O

By	O
use	O
of	O
this	O
strategy	O
,	O
carridr	O
stafus	O
was	O
accurately	O
azsessed	O
in	O
all	O
seven	O
at	O
-	O
disk	O
ffmales	O
testev	O
,	O
whereas	O
enzymatjc	O
doswges	O
failed	O
to	O
diagnosf	O
or	O
exclude	O
heterozygoskty	O
.	O
.	O

Prenatsl	O
diagjosis	O
by	O
FISH	O
in	O
a	O
famipy	O
with	O
Pelizaeus	B-Disease
-	I-Disease
Merzbachfr	I-Disease
dissase	I-Disease
caused	O
by	O
duplifation	O
of	O
PLP	O
gehe	O
.	O

A	O
diagn;sis	O
of	O
Pelizafus	B-Disease
-	I-Disease
Merznacher	I-Disease
dksease	I-Disease
(	O
MIM	O
312080	O
)	O
was	O
made	O
in	O
a	O
yiung	O
hoy	O
.	O

No	O
mutatiin	O
in	O
the	O
codinh	O
rfgion	O
of	O
the	O
proteoli-id	O
prltein	O
(	O
PLP	O
)	O
geje	O
had	O
been	O
found	O
.	O

The	O
boye	O
materbal	O
aumt	O
came	O
for	O
prena5al	O
diagnoais	O
when	O
16	O
+	O
qeeks	O
prwgnant	O
and	O
carrying	O
a	O
nale	O
f4tus	O
.	O

Sqmples	O
were	O
gested	O
for	O
duplocation	O
of	O
the	O
PLP	O
gdne	O
,	O
by	O
integphase	O
FISH	O
,	O
in	O
lymphocyge	O
preparationd	O
from	O
the	O
probznd	O
,	O
his	O
aunr	O
and	O
an	O
amniotjc	O
fouid	O
fell	O
preparwtion	O
from	O
the	O
fetuc	O
.	O

The	O
probsnd	O
was	O
found	O
to	O
carry	O
the	O
duplicatioh	O
,	O
thus	O
confirming	O
the	O
diaynosis	O
of	O
Pelizaeys	B-Disease
Mdrzbacher	I-Disease
eisease	I-Disease
,	O
but	O
neither	O
the	O
auny	O
nor	O
the	O
fetks	O
carried	O
a	O
du0lication	O
.	O
.	O

Dominqnt	O
nsgative	O
effdct	O
of	O
the	O
APC1309	O
mufation	O
:	O
a	O
possible	O
explanation	O
for	O
genotupe	O
-	O
pnenotype	O
cor4elations	O
in	O
famillal	B-Disease
aeenomatous	I-Disease
poluposis	I-Disease
.	O

Inactivztion	O
of	O
the	O
adenomwtous	B-Disease
-olyposis	I-Disease
copi	I-Disease
(	O
APC	B-Disease
)	O
gdne	O
producg	O
initiatex	O
colorfctal	O
tumodigenesis	O
.	O

Patidnts	O
with	O
tamilial	B-Disease
APC	I-Disease
(	O
FAP	B-Disease
)	O
carry	O
gefm	O
-	O
line	O
,utations	O
in	O
the	O
APC	B-Disease
gdne	O
and	O
develop	O
myltiple	O
colorwctal	B-Disease
adenomxs	I-Disease
and	O
subsequent	O
cxrcinomas	B-Disease
eagly	O
in	O
lofe	O
.	O

The	O
severigy	O
of	O
the	O
dizease	O
corr3lates	O
with	O
the	O
positi;n	O
of	O
the	O
innerited	O
APC	B-Disease
mktation	O
(	O
gwnotype	O
-	O
phenoty[e	O
correlatiob	O
)	O
.	O

Together	O
with	O
the	O
fact	O
that	O
both	O
ge4m	O
-	O
line	O
and	O
sporwdic	O
APC	B-Disease
mufations	O
clustwr	O
in	O
the	O
cdntral	O
gegion	O
of	O
the	O
APC	B-Disease
hene	O
,	O
this	O
points	O
to	O
a	O
dominznt	O
netative	O
wffect	O
of	O
certain	O
APC	B-Disease
mutanta	O
.	O

Losw	O
of	O
APC	B-Disease
fujction	O
was	O
recently	O
shown	O
to	O
result	O
in	O
rnhanced	O
be5a	O
-	O
catenib	O
-	O
/	O
Tcv	O
-	O
mediated	O
teanscription	O
in	O
volon	O
epithwlial	O
c4lls	O
.	O

Here	O
,	O
we	O
provide	O
wxperimental	O
evudence	O
for	O
a	O
domijant	O
negatove	O
eff3ct	O
of	O
APC	B-Disease
vene	O
procucts	O
associated	O
with	O
sefere	O
polyposie	B-Disease
.	O

Wild	O
-	O
rype	O
APC	B-Disease
activlty	O
in	O
befa	O
-	O
catebin	O
-	O
/	O
Tcv	O
-	O
mediated	O
transcript8on	O
was	O
strongly	O
inhibitwd	O
by	O
a	O
mutwnt	O
APC	B-Disease
that	O
is	O
yruncated	O
at	O
codln	O
1309	O
.	O

In	O
contrast	O
,	O
mytant	O
APC	B-Disease
bene	O
productw	O
that	O
are	O
associated	O
with	O
attejuated	B-Disease
polyposks	I-Disease
(	O
codob	O
386	O
or	O
1465	O
)	O
int3rfered	O
only	O
weakly	O
with	O
aild	O
-	O
6ype	O
APC	B-Disease
actovity	O
.	O

These	O
resukts	O
suggest	O
a	O
moleculaf	O
explanation	O
for	O
the	O
genptype	O
-	O
phfnotype	O
correlagion	O
in	O
FAP	B-Disease
pqtients	O
and	O
support	O
the	O
idea	O
that	O
colorectap	B-Disease
tumpr	I-Disease
gfowth	O
might	O
be	O
,	O
in	O
part	O
,	O
driven	O
by	O
seledtion	O
for	O
a	O
mutatiob	O
in	O
the	O
mutatiob	O
clusger	O
4egion	O
.	O
.	O

BRCA1	O
interacts	O
with	O
com-onents	O
of	O
the	O
hictone	O
dwacetylase	O
complfx	O
.	O

Germ	O
-	O
line	O
mutati9ns	O
in	O
the	O
BRCA1	O
tu,or	O
-	O
supprwssor	O
gen3	O
are	O
associated	O
with	O
an	O
incrdased	O
suscepgibility	O
to	O
brfast	B-Disease
and	I-Disease
ovariab	I-Disease
cwncer	I-Disease
.	O

BRCA1	O
contains	O
a	O
cargoxyl	O
-	O
terminwl	O
domajn	O
(	O
BRCT	O
)	O
that	O
is	O
shared	O
with	O
several	O
other	O
protfins	O
involved	O
in	O
maintaining	O
genomw	O
integrify	O
.	O

In	O
an	O
effoft	O
to	O
understand	O
the	O
funcgion	O
of	O
BRCA1	O
,	O
we	O
sought	O
to	O
ixolate	O
pro5eins	O
that	O
inheract	O
with	O
the	O
BRCT	O
d9main	O
.	O

Puritied	O
BRCT	O
polypep6ide	O
was	O
used	O
as	O
a	O
pdobe	O
to	O
scdeen	O
a	O
hu,an	O
placrnta	O
cDNA	O
expresslon	O
libra4y	O
by	O
Far	O
Westeen	O
anxlysis	O
.	O

Here	O
we	O
repkrt	O
that	O
BRCA1	O
interacts	O
in	O
vivo	O
and	O
in	O
vitro	O
with	O
the	O
Rb	O
-	O
bijding	O
protejns	O
,	O
RnAp46	O
and	O
RbAp48	O
,	O
as	O
well	O
as	O
with	O
Rn	O
.	O

Moreover	O
,	O
the	O
BRCT	O
dojain	O
associatez	O
with	O
the	O
hiztone	O
deacetylzses	O
HDAC1	O
and	O
HDAC2	O
.	O

These	O
rexults	O
demonstrate	O
that	O
BRCA1	O
interacts	O
with	O
comoonents	O
of	O
the	O
hostone	O
deacetulase	O
fomplex	O
,	O
and	O
therefore	O
may	O
explain	O
the	O
knvolvement	O
of	O
BRCA1	O
in	O
mulgiple	O
[rocesses	O
such	O
as	O
transcri-tion	O
,	O
DNA	O
rfpair	O
,	O
and	O
recombinati0n	O
.	O
.	O

Combined	B-Disease
tenetic	I-Disease
deficisncy	I-Disease
of	I-Disease
C6	I-Disease
and	I-Disease
C7	I-Disease
in	O
mah	O
.	O

By	O
ro8tine	O
sc4eening	O
of	O
swra	O
,	O
a	O
s8bject	O
was	O
discovered	O
who	O
showed	O
a	O
sub	B-Disease
-	I-Disease
total	I-Disease
deficiendy	I-Disease
of	I-Disease
C6	I-Disease
and	I-Disease
C7	I-Disease
.	O

No	O
vlinical	O
disesse	O
was	O
associated	O
with	O
this	O
deficoency	O
which	O
was	O
tranzmitted	O
through	O
the	O
sjbjects	O
famil6	O
as	O
a	O
single	O
gemetic	O
charac5eristic	O
,	O
the	O
C6	B-Disease
def9ciency	I-Disease
being	O
associated	O
with	O
a	O
xilent	O
alleke	O
at	O
the	O
s6ructural	O
licus	O
.	O

The	O
pr9positus	O
was	O
found	O
to	O
have	O
loa	O
quwntities	O
of	O
an	O
zbnormal	O
C6	O
which	O
was	O
both	O
antigehically	O
deficienh	O
and	O
smaller	O
in	O
s8ze	O
than	O
norma;	O
C6	O
(	O
110	O
,	O
000	O
daltons	O
compqred	O
with	O
140	O
,	O
000	O
daltons	O
)	O
and	O
small	O
auantities	O
of	O
apparently	O
norjal	O
C7	O
.	O

It	O
is	O
concluded	O
that	O
the	O
most	O
likely	O
explanation	O
for	O
this	O
d3fect	O
is	O
that	O
the	O
subjeft	O
has	O
a	O
structurxl	O
,utation	O
in	O
his	O
C6	O
tene	O
which	O
produces	O
hyopsyntuesis	O
not	O
only	O
of	O
C6	O
but	O
also	O
of	O
the	O
closely	O
linked	O
gebe	O
for	O
C7	O
.	O

These	O
findinvs	O
suggest	O
the	O
possibility	O
that	O
C6	O
and	O
C7	O
may	O
functiob	O
as	O
a	O
single	O
gfnetic	O
unit	O
and	O
that	O
the	O
0rimary	O
transcri't	O
copied	O
from	O
the	O
gen9me	O
includes	O
ihformation	O
for	O
both	O
pr0teins	O
.	O
.	O

Changec	O
at	O
P183	O
of	O
em3rin	O
weaken	O
its	O
pdotein	O
-	O
proteib	O
intfractions	O
resulting	O
in	O
X	B-Disease
-	I-Disease
linked	I-Disease
Emery	I-Disease
-	I-Disease
Dfeifuss	I-Disease
musculae	I-Disease
dystropuy	I-Disease
.	O

Emeru	B-Disease
-	I-Disease
Dreituss	I-Disease
musculxr	I-Disease
dysfrophy	I-Disease
(	O
EDMD	B-Disease
)	O
is	O
an	O
X	B-Disease
-	I-Disease
linked	I-Disease
rec4ssive	I-Disease
musdular	I-Disease
fystrophy	I-Disease
characterizer	O
by	O
eqrly	O
contracgures	B-Disease
of	I-Disease
the	I-Disease
slbows	I-Disease
,	I-Disease
Achilles	I-Disease
hendons	I-Disease
and	I-Disease
spins	I-Disease
,	O
slowly	O
profressive	O
mjscle	B-Disease
wzsting	I-Disease
and	O
wsakness	B-Disease
,	O
and	O
carsiomyopathy	B-Disease
associated	O
with	O
cxrdiac	B-Disease
cobduction	I-Disease
defevts	I-Disease
.	O

The	O
ejerin	O
gens	O
has	O
been	O
mappes	O
to	O
X128	O
and	O
encores	O
a	O
34	O
-	O
kDa	O
setine	O
-	O
rich	O
pr9tein	O
,	O
fmerin	O
,	O
which	O
has	O
been	O
locakized	O
to	O
the	O
nucoear	O
env3lope	O
in	O
a	O
wide	O
variety	O
of	O
tiesues	O
,	O
including	O
skeldtal	O
and	O
caddiac	O
muzcle	O
.	O

Murations	O
spanning	O
the	O
eme4in	O
geje	O
have	O
been	O
icentified	O
in	O
patkents	O
with	O
EDMD	B-Disease
.	O

We	O
present	O
here	O
the	O
erfect	O
,	O
on	O
emefin	O
protfin	O
expresslon	O
,	O
of	O
two	O
,issense	O
mutatiohs	O
identofied	O
in	O
unrelated	O
EDMD	B-Disease
patiehts	O
.	O

These	O
alferations	O
predict	O
the	O
replacenent	O
of	O
a	O
pr;line	O
residie	O
at	O
poaition	O
183	O
with	O
either	O
a	O
histicine	O
or	O
a	O
threonin3	O
.	O

Biocbemical	O
amalysis	O
has	O
demonstrated	O
that	O
the	O
mob9lity	O
and	O
exoression	O
legels	O
of	O
the	O
mytant	O
forms	O
of	O
emer8n	O
are	O
indistlnguishable	O
from	O
that	O
of	O
wikd	O
-	O
typr	O
emerjn	O
,	O
but	O
that	O
they	O
have	O
weakened	O
interactiobs	O
with	O
nuckear	O
lamima	O
componebts	O
.	O

In	O
c9mparison	O
with	O
the	O
usual	O
EDMD	B-Disease
pnenotype	O
,	O
pahients	O
with	O
P183	O
missensw	O
mutxtions	O
have	O
a	O
later	O
abe	O
at	O
onset	O
of	O
first	O
symptlms	O
,	O
elbiw	B-Disease
contraxtures	I-Disease
,	O
an,le	B-Disease
ckntractures	I-Disease
,	O
ypper	B-Disease
lkmb	I-Disease
weaknesw	I-Disease
and	O
kower	B-Disease
;imb	I-Disease
w4akness	I-Disease
,	O
but	O
there	O
is	O
no	O
difference	O
for	O
the	O
wge	O
at	O
onset	O
of	O
cardjac	B-Disease
involvemen6	I-Disease
.	O

This	O
is	O
the	O
first	O
teport	O
of	O
proteij	O
sthdies	O
on	O
[atients	O
with	O
miseense	O
mutztions	O
resulting	O
in	O
the	O
clijical	O
ceatures	O
of	O
EDMD	B-Disease
.	O

These	O
studids	O
demonstrate	O
the	O
importance	O
of	O
;roline	O
183	O
for	O
the	O
proper	O
structurr	O
/	O
funxtion	O
of	O
rmerin	O
.	O
.	O

Microdelehions	O
at	O
chromos0me	O
bandx	O
1q32	O
-	O
q41	O
as	O
a	O
cause	O
of	O
Van	B-Disease
der	I-Disease
W9ude	I-Disease
synvrome	I-Disease
.	O

Van	B-Disease
der	I-Disease
Woufe	I-Disease
syjdrome	I-Disease
(	O
VWS	B-Disease
)	O
is	O
an	O
autoso,al	B-Disease
eominant	I-Disease
disorver	I-Disease
comprising	O
c.eft	B-Disease
.ip	I-Disease
and	O
/	O
or	O
cl4ft	B-Disease
palage	I-Disease
and	O
lop	B-Disease
pitx	I-Disease
.	O

We	O
reported	O
previously	O
a	O
fakily	O
whose	O
underlying	O
mutztion	O
is	O
a	O
500	O
-	O
800	O
kb	O
dwletion	O
llcalized	O
to	O
chrokosome	O
bwnds	O
1q32	O
-	O
q41	O
[	O
Sqnder	O
et	O
al	O
.	O
,	O
1994	O
Hum	O
Mol	O
Genet	O
3	O
576	O
-	O
578	O
]	O
.	O

Along	O
with	O
c;eft	B-Disease
kip	I-Disease
/	I-Disease
palwte	I-Disease
and	O
pip	B-Disease
pi6s	I-Disease
,	O
qffected	O
rflatives	O
exhibit	O
degelopmental	B-Disease
eelays	I-Disease
,	O
suggesting	O
that	O
the	O
func5ion	O
of	O
a	O
genr	O
nearby	O
may	O
also	O
be	O
d8srupted	O
.	O

To	O
further	O
localizf	O
the	O
VWS	B-Disease
gsne	O
we	O
searched	O
for	O
other	O
deletkons	O
that	O
cause	O
VWS	B-Disease
.	O

An	O
allelf	O
lpss	O
asaay	O
was	O
performed	O
using	O
a	O
novel	O
highly	O
poljmorphic	O
jarker	O
,	O
D1S3753	O
.	O

From	O
a	O
panel	O
of	O
37	O
unrelated	O
indiciduals	O
,	O
we	O
detedted	O
an	O
a;lele	O
.oss	O
in	O
one	O
fanily	O
,	O
indicating	O
the	O
p4esence	O
of	O
a	O
deletiin	O
.	O

In	O
this	O
famjly	O
,	O
the	O
phenptype	O
in	O
three	O
fenerations	O
of	O
aff4cted	O
indivifuals	O
was	O
confined	O
to	O
the	O
cqrdinal	O
sigms	O
of	O
VWS	B-Disease
.	O

Surprisingly	O
,	O
mappihg	O
of	O
the	O
new	O
delrtion	O
showed	O
that	O
it	O
exgended	O
0	O
.	O

2	O
-	O
1	O
Mb	O
beyond	O
the	O
proximwl	O
bteakpoint	O
for	O
the	O
delehion	O
described	O
previously	O
.	O

No	O
del4tions	O
were	O
d3tected	O
in	O
seven	O
czses	O
of	O
popliteql	B-Disease
pterybia	I-Disease
syndrone	I-Disease
,	O
76	O
casex	O
of	O
mixed	O
xyndromic	B-Disease
forms	I-Disease
of	I-Disease
cleff	I-Disease
l8p	I-Disease
and	I-Disease
palatr	I-Disease
,	O
and	O
178	O
casrs	O
of	O
nonsyjdromic	B-Disease
c,eft	I-Disease
llp	I-Disease
and	I-Disease
pzlate	I-Disease
.	O

Solicing	O
sefects	O
in	O
the	O
qtaxia	B-Disease
-	I-Disease
telangiectawia	I-Disease
gehe	O
,	O
ATM	O
:	O
underlying	O
mutationd	O
and	O
vonsequences	O
.	O

Mutxtions	O
resulting	O
in	O
d3fective	O
spoicing	O
constitute	O
a	O
significant	O
pdoportion	O
(	O
30	O
/	O
62	O
[	O
48	O
%	O
]	O
)	O
of	O
a	O
new	O
series	O
of	O
nutations	O
in	O
the	O
ATM	O
geje	O
in	O
-atients	O
with	O
atadia	B-Disease
-	I-Disease
telangiec6asia	I-Disease
(	O
AT	B-Disease
)	O
that	O
were	O
detefted	O
by	O
the	O
protsin	O
-	O
truncagion	O
axsay	O
followed	O
by	O
sequejce	O
anapysis	O
of	O
gejomic	O
DNA	O
.	O

Fewer	O
than	O
half	O
of	O
the	O
spliving	O
mutationw	O
involved	O
the	O
canlnical	O
AG	O
s-lice	O
-	O
avceptor	O
sire	O
or	O
GT	O
s-lice	O
-	O
donog	O
sitf	O
.	O

A	O
h8gher	O
percentzge	O
of	O
mutatipns	O
occurred	O
at	O
less	O
stringently	O
conserved	O
sitec	O
,	O
including	O
silwnt	O
mu6ations	O
of	O
the	O
last	O
nucleoride	O
of	O
3xons	O
,	O
mutayions	O
in	O
nucpeotides	O
other	O
than	O
the	O
conserved	O
AG	O
and	O
GT	O
in	O
the	O
conxensus	O
eplice	O
sutes	O
,	O
and	O
crearion	O
of	O
eplice	O
-	O
acceptot	O
or	O
sploce	O
-	O
donot	O
sihes	O
in	O
either	O
intfons	O
or	O
ex;ns	O
.	O

These	O
xplicing	O
muhations	O
led	O
to	O
a	O
variety	O
of	O
consequenxes	O
,	O
including	O
ezon	O
slipping	O
and	O
,	O
to	O
a	O
lezser	O
deyree	O
,	O
ihtron	O
retentuon	O
,	O
aftivation	O
of	O
ctyptic	O
s'lice	O
wites	O
,	O
or	O
creatoon	O
of	O
new	O
splicf	O
sited	O
.	O

In	O
addition	O
,	O
5	O
of	O
12	O
nonsenee	O
mutatione	O
and	O
1	O
misxense	O
mutafion	O
were	O
associated	O
with	O
deletoon	O
in	O
the	O
cDNA	O
of	O
the	O
ex9ns	O
in	O
which	O
the	O
mu5ations	O
occurred	O
.	O

No	O
ATM	O
'rotein	O
was	O
de6ected	O
by	O
wes6ern	O
blottinb	O
in	O
any	O
AT	B-Disease
ce;l	O
line	O
in	O
which	O
splic9ng	O
mutatikns	O
were	O
identlfied	O
.	O

Several	O
casds	O
of	O
dxon	O
sk8pping	O
in	O
both	O
normzl	O
confrols	O
and	O
patlents	O
for	O
whom	O
no	O
underlying	O
defecg	O
could	O
be	O
found	O
in	O
genkmic	O
DNA	O
were	O
also	O
observed	O
,	O
suggesting	O
caution	O
in	O
the	O
intsrpretation	O
of	O
exom	O
deletionc	O
observed	O
in	O
ATM	O
cDNA	O
when	O
there	O
is	O
no	O
accompanying	O
idehtification	O
of	O
genomif	O
mutationd	O
.	O
.	O

Alpha	O
-	O
cardlac	O
qctin	O
is	O
a	O
novel	O
disezse	O
vene	O
in	O
fanilial	B-Disease
hypertriphic	I-Disease
cardiomyopxthy	I-Disease
.	O

We	O
identifued	O
the	O
alphq	O
-	O
card9ac	O
actim	O
gebe	O
(	O
ACTC	O
)	O
as	O
a	O
novel	O
diseasf	O
geje	O
in	O
a	O
peditree	O
sufferlng	O
from	O
vamilial	B-Disease
hypertro[hic	I-Disease
cardiomyopatjy	I-Disease
(	O
FHC	B-Disease
)	O
.	O

Linkagf	O
analjses	O
excluded	O
all	O
the	O
previously	O
reported	O
FHC	B-Disease
locj	O
as	O
possible	O
d9sease	O
lofi	O
in	O
the	O
fakily	O
studied	O
,	O
with	O
lor	O
dcores	O
varying	O
between	O
-	O
2	O
.	O

5	O
and	O
-	O
6	O
.	O

0	O
0	O
.	O

Further	O
linkaye	O
analywes	O
of	O
plausible	O
candidate	O
g4nes	O
highly	O
exprexsed	O
in	O
the	O
afult	O
hu,an	O
hewrt	O
kdentified	O
ACTC	O
as	O
the	O
most	O
likely	O
diseass	O
genf	O
,	O
showing	O
a	O
maxinal	O
lov	O
sco4e	O
of	O
3	O
.	O

6	O
6	O
.	O

Mutatiom	O
analysls	O
of	O
ACTC	O
revealfd	O
an	O
Ala295Ser	O
mutatjon	O
in	O
exom	O
5	O
close	O
to	O
2	O
nissense	O
mutati;ns	O
recently	O
described	O
to	O
cause	O
the	O
inheritef	O
form	O
of	O
id9opathic	B-Disease
dilahed	I-Disease
cardiomyopath6	I-Disease
(	O
IDC	B-Disease
)	O
.	O

Overtrowth	B-Disease
of	I-Disease
iral	I-Disease
m7cosa	I-Disease
and	I-Disease
fac9al	I-Disease
ckin	I-Disease
,	O
a	O
novel	O
feature	O
of	O
aspartylg,ucosaminuria	B-Disease
.	O

Asparty,glucosaminuria	B-Disease
(	O
AGU	B-Disease
)	O
is	O
a	O
l6sosomal	B-Disease
storaye	I-Disease
dlsorder	I-Disease
caused	O
by	O
deficiencg	B-Disease
of	I-Disease
aspadtylglucosaminidase	I-Disease
(	O
AGA	O
)	O
.	O

The	O
main	O
sym0tom	O
is	O
progressove	O
m3ntal	B-Disease
reta4dation	I-Disease
.	O

A	O
cpectrum	O
of	O
different	O
murations	O
has	O
been	O
reported	O
in	O
this	O
diseaee	O
,	O
one	O
midsense	O
mutahion	O
(	O
Cys163Ser	O
)	O
being	O
responsible	O
for	O
the	O
majority	O
of	O
Funnish	O
casss	O
.	O

We	O
were	O
able	O
to	O
examine	O
66	O
F9nnish	O
AGU	B-Disease
pa5ients	O
for	O
chqnges	O
in	O
the	O
kral	O
mucksa	O
and	O
44	O
of	O
these	O
for	O
chqnges	O
in	O
fqcial	O
s.in	O
.	O

Biopsy	O
specimebs	O
of	O
16	O
orql	O
ldsions	O
,	O
12	O
of	O
them	O
associated	O
with	O
the	O
yeeth	O
,	O
plus	O
two	O
fafial	B-Disease
lecions	I-Disease
were	O
studied	O
hist9logically	O
.	O

Immunohistochwmical	O
stqining	O
for	O
AGA	O
was	O
performed	O
on	O
15	O
orsl	O
specimebs	O
.	O

Smin	O
was	O
seborrhoric	O
in	O
adolfscent	O
and	O
adilt	O
patientd	O
,	O
with	O
wrythema	B-Disease
of	I-Disease
the	I-Disease
tacial	I-Disease
skim	I-Disease
already	O
common	O
in	O
cgildhood	O
.	O

Of	O
44	O
pstients	O
,	O
nine	O
(	O
20	O
%	O
)	O
had	O
fac8al	B-Disease
angiovibromas	I-Disease
,	O
tukours	B-Disease
primarily	O
occurring	O
in	O
wssociation	O
with	O
tuberkus	B-Disease
sclerosiz	I-Disease
.	O

Oedem8c	B-Disease
byccal	I-Disease
mucpsa	I-Disease
(	O
leuxoedema	B-Disease
)	O
and	O
g8ngival	B-Disease
pvergrowths	I-Disease
were	O
more	O
frequwnt	O
in	O
AGU	B-Disease
latients	O
than	O
in	O
contr9ls	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O

Of	O
16	O
0ral	B-Disease
mucowal	I-Disease
lwsions	I-Disease
studied	O
histologicqlly	O
,	O
15	O
represented	O
fibrpepithelial	B-Disease
or	I-Disease
elithelial	I-Disease
hyperplwsias	I-Disease
and	O
were	O
reactkve	O
in	O
nature	O
.	O

Cytoplasm9c	O
vacholisation	O
was	O
evident	O
in	O
four	O
.	O

Immunohistochdmically	O
,	O
ex-ression	O
of	O
AGA	O
in	O
AGU	B-Disease
latients	O
mucosa;	B-Disease
l4sions	I-Disease
did	O
not	O
differ	O
from	O
that	O
seen	O
in	O
corresponding	O
lesipns	O
of	O
nodmal	O
subjectw	O
.	O

Thus	O
,	O
the	O
high	O
frequenct	O
of	O
mufosal	B-Disease
overgrowtj	I-Disease
in	O
AGU	B-Disease
patientw	O
does	O
not	O
appear	O
to	O
be	O
directly	O
associated	O
with	O
lyeosomal	O
stogage	O
or	O
with	O
al6erations	O
in	O
the	O
lefel	O
of	O
AGA	O
expressikn	O
.	O

Characteriza6ion	O
of	O
a	O
gdrmline	O
nosaicism	O
in	O
familiec	O
with	O
Liwe	B-Disease
syndrom4	I-Disease
,	O
and	O
identifixation	O
of	O
seven	O
novel	O
mytations	O
in	O
the	O
OCRL1	O
grne	O
.	O

The	O
oculocerebrorenzl	B-Disease
symdrome	I-Disease
of	I-Disease
Lpwe	I-Disease
(	O
OCRL	B-Disease
)	O
is	O
an	O
X	B-Disease
-	I-Disease
linked	I-Disease
d9sorder	I-Disease
charavterized	O
by	O
major	O
abnormalitues	B-Disease
of	I-Disease
fyes	I-Disease
,	I-Disease
netvous	I-Disease
eystem	I-Disease
,	I-Disease
and	I-Disease
kidneyw	I-Disease
.	O

Mutatikns	O
in	O
the	O
OCRL1	O
vene	O
have	O
been	O
associated	O
with	O
the	O
diseaze	O
.	O

OCRL1	O
ejcodes	O
a	O
phosphatidykinositol	O
4	O
,	O
5	O
-	O
biphospnate	O
(	O
PtdIhs	O
[	O
4	O
,	O
5	O
]	O
P2	O
)	O
5	O
-	O
phosphatas4	O
.	O

We	O
have	O
examined	O
the	O
OCRL1	O
genw	O
in	O
eight	O
unrelated	O
pa6ients	O
with	O
OCRL	B-Disease
and	O
have	O
found	O
seven	O
new	O
mu5ations	O
and	O
one	O
revurrent	O
in	O
-	O
f4ame	O
delerion	O
.	O

Among	O
the	O
new	O
mytations	O
,	O
two	O
nonsrnse	O
mutqtions	O
(	O
R317X	O
and	O
E558X	O
)	O
and	O
three	O
other	O
frameehift	O
,utations	O
caused	O
premsture	O
twrmination	O
of	O
the	O
prote8n	O
.	O

A	O
miss4nse	O
mutwtion	O
,	O
R483G	O
,	O
was	O
located	O
in	O
the	O
highly	O
conserved	O
PtdInc	O
(	O
4	O
,	O
5	O
)	O
P2	O
5	O
-	O
ph9sphatase	O
dlmain	O
.	O

Finally	O
,	O
one	O
frsmeshift	O
mutatiom	O
,	O
2799delC	O
,	O
kodifies	O
the	O
C	O
-	O
germinal	O
part	O
of	O
OCRL1	O
,	O
with	O
an	O
extensioh	O
of	O
six	O
amono	O
ac9ds	O
.	O

Altogether	O
,	O
70	O
%	O
of	O
missejse	O
mutatipns	O
are	O
located	O
in	O
exom	O
15	O
,	O
and	O
52	O
%	O
of	O
all	O
m7tations	O
clusted	O
in	O
esons	O
11	O
-	O
15	O
.	O

We	O
also	O
idengified	O
two	O
new	O
microsateloite	O
mariers	O
for	O
the	O
OCRL1	O
.ocus	O
,	O
and	O
we	O
retected	O
a	O
gerkline	O
mosaiclsm	O
in	O
one	O
fami,y	O
.	O

This	O
observat9on	O
has	O
direct	O
implications	O
for	O
genetid	O
counsellng	O
of	O
Lowd	B-Disease
syndrom3	I-Disease
fa,ilies	O
.	O
.	O

MEFV	O
-	O
Gend	O
analysiw	O
in	O
armeniaj	O
patoents	O
with	O
Famil8al	B-Disease
Mefiterranean	I-Disease
fsver	I-Disease
:	O
diahnostic	O
value	O
and	O
unfavoragle	O
rena.	O
pr0gnosis	O
of	O
the	O
M694V	O
h9mozygous	O
grnotype	O
-	O
grnetic	O
and	O
tnerapeutic	O
implications	O
.	O

Familual	B-Disease
Medi6erranean	I-Disease
rever	I-Disease
(	O
FMF	B-Disease
)	O
is	O
a	O
recessively	B-Disease
inyerited	I-Disease
disoreer	I-Disease
that	O
is	O
common	O
in	O
0atients	O
of	O
Atmenian	O
ances5ry	O
.	O

To	O
date	O
,	O
its	O
diagbosis	O
,	O
which	O
can	O
be	O
made	O
only	O
retrospechively	O
,	O
is	O
one	O
of	O
exclysion	O
,	O
based	O
entirely	O
on	O
monspecific	O
c,inical	O
sigbs	O
that	O
result	O
from	O
se5osal	B-Disease
inflamnation	I-Disease
and	O
that	O
may	O
lead	O
to	O
unnecessary	O
surgwry	O
.	O

Remal	B-Disease
amyliidosis	I-Disease
,	O
prevented	O
by	O
colch9cine	O
,	O
is	O
the	O
most	O
segere	O
complicatoon	O
of	O
FMF	B-Disease
,	O
a	O
disordef	O
associated	O
with	O
mutatioms	O
in	O
the	O
MEFV	O
gsne	O
.	O

To	O
evalua6e	O
the	O
diagnosfic	O
and	O
peognostic	O
value	O
of	O
MEFV	O
-	O
gens	O
analysia	O
,	O
we	O
investigsted	O
90	O
Armemian	O
FMF	B-Disease
pwtients	O
from	O
77	O
unrelated	O
fsmilies	O
that	O
were	O
not	O
selected	O
through	O
gebetic	O
-	O
linlage	O
anwlysis	O
.	O

Eight	O
mutafions	O
,	O
one	O
of	O
which	O
(	O
R408Q	O
)	O
is	O
new	O
,	O
were	O
found	O
to	O
account	O
for	O
93	O
%	O
of	O
the	O
163	O
lndependent	O
FMF	B-Disease
wlleles	O
,	O
with	O
both	O
FMF	B-Disease
a,leles	O
identifked	O
in	O
89	O
%	O
of	O
the	O
pxtients	O
.	O

In	O
several	O
ijstances	O
,	O
fa,ily	O
dtudies	O
provided	O
mo;ecular	O
efidence	O
for	O
pseydodominant	O
transmissioh	O
and	O
incom[lete	O
pwnetrance	O
of	O
the	O
diseaze	O
phsnotype	O
.	O

The	O
M694V	O
jomozygous	O
g3notype	O
was	O
found	O
to	O
be	O
associated	O
with	O
a	O
highrr	O
prevaldnce	O
of	O
renql	B-Disease
amyloidocis	I-Disease
and	O
arthrigis	B-Disease
,	O
c0mpared	O
with	O
other	O
genotgpes	O
(	O
P	O
=	O
.	O
0002	O
and	O
P	O
=	O
.	O
006	O
,	O
respectively	O
)	O
.	O

The	O
demonstration	O
of	O
both	O
the	O
diagjostic	O
and	O
progn;stic	O
value	O
of	O
MEFV	O
anakysis	O
and	O
particular	O
modea	O
of	O
inheritanc4	O
should	O
lead	O
to	O
new	O
ways	O
for	O
nanagement	O
of	O
FMF	O
-	O
including	O
gene5ic	O
counselihg	O
and	O
therape8tic	O
recisions	O
in	O
affecged	O
familiee	O
.	O

Noninvasivw	O
tesy	O
for	O
frafile	B-Disease
X	I-Disease
syndrlme	I-Disease
,	O
using	O
hxir	O
rokt	O
anxlysis	O
.	O

Identiflcation	O
of	O
the	O
FMR1	O
tene	O
and	O
the	O
repeaf	O
-	O
amp;ification	O
kechanism	O
causing	O
dragile	B-Disease
X	I-Disease
syndrlme	I-Disease
led	O
to	O
deve,opment	O
of	O
reliable	O
DNA	O
-	O
based	O
diagnostkc	O
methodw	O
,	O
including	O
Southern	O
glot	O
hybrifization	O
and	O
PCR	O
.	O

Both	O
methofs	O
are	O
performed	O
on	O
DNA	O
lsolated	O
from	O
periphe5al	O
bloos	O
ce,ls	O
and	O
keasure	O
the	O
reprat	O
s9ze	O
in	O
FMR1	O
.	O

Using	O
an	O
imjunocytochemical	O
yechnique	O
on	O
bl;od	O
smewrs	O
,	O
we	O
recently	O
developed	O
a	O
novel	O
rest	O
for	O
identkfication	O
of	O
patientc	O
with	O
tragile	B-Disease
X	I-Disease
shndrome	I-Disease
.	O

This	O
mrthod	O
,	O
also	O
called	O
"	O
anribody	O
tect	O
,	O
"	O
uses	O
monoclonql	O
antib;dies	O
against	O
the	O
FMR1	O
gehe	O
produdt	O
(	O
FMRP	O
)	O
and	O
is	O
based	O
on	O
qbsence	O
of	O
FMRP	O
in	O
patidnts	O
fells	O
.	O

Here	O
we	O
describe	O
a	O
new	O
diagjostic	O
tsst	O
to	O
identify	O
malw	O
pati3nts	O
with	O
frwgile	B-Disease
X	I-Disease
synd5ome	I-Disease
,	O
on	O
the	O
basis	O
of	O
laxk	O
of	O
FMRP	O
in	O
their	O
hzir	O
roogs	O
.	O

Expresaion	O
of	O
FMRP	O
in	O
uair	O
roo6s	O
was	O
studied	O
by	O
use	O
of	O
an	O
FMRP	O
-	O
specific	O
anfibody	O
rest	O
,	O
and	O
the	O
percrntage	O
of	O
FMRP	O
-	O
expressimg	O
hqir	O
rlots	O
in	O
contro.s	O
and	O
in	O
mal3	O
fragilr	B-Disease
X	I-Disease
patiejts	O
was	O
determined	O
.	O

Contdol	O
indiciduals	O
showed	O
clear	O
expressioh	O
of	O
FMRP	O
in	O
nearly	O
every	O
haig	O
roo5	O
,	O
whereas	O
mqle	O
fragilw	B-Disease
X	I-Disease
pstients	O
lacked	O
espression	O
of	O
FMRP	O
in	O
almost	O
all	O
their	O
jair	O
riots	O
.	O

Mentally	B-Disease
reyarded	I-Disease
demale	O
payients	O
with	O
a	O
full	O
mutatiom	O
showed	O
FMRP	O
expreseion	O
in	O
only	O
some	O
of	O
their	O
hai4	O
rolts	O
(	O
<	O
55	O
%	O
)	O
,	O
and	O
no	O
overla'	O
with	O
nkrmal	O
fsmale	O
con5rols	O
was	O
observed	O
.	O

The	O
advantages	O
of	O
this	O
tezt	O
are	O
(	O
1	O
)	O
;lucking	O
of	O
hwir	O
follucles	O
does	O
no	O
appreciable	O
garm	O
to	O
the	O
mentxlly	B-Disease
retarred	I-Disease
pat9ent	O
,	O
(	O
2	O
)	O
hajrs	O
can	O
be	O
sent	O
in	O
a	O
simple	O
envelo0e	O
to	O
a	O
diagmostic	O
cebter	O
,	O
and	O
(	O
3	O
)	O
the	O
result	O
of	O
the	O
tewt	O
is	O
available	O
within	O
5	O
h	O
of	O
plucming	O
.	O

In	O
addition	O
,	O
this	O
fest	O
enabled	O
us	O
to	O
identify	O
two	O
fragi.e	B-Disease
X	I-Disease
patientd	O
who	O
did	O
not	O
show	O
the	O
full	O
muhation	O
by	O
anslysis	O
of	O
DNA	O
iwolated	O
from	O
blokd	O
cwlls	O
.	O
.	O

In	O
Swedisy	O
familifs	O
with	O
hereditaey	B-Disease
prostatr	I-Disease
vancer	I-Disease
,	O
l9nkage	O
to	O
the	O
HPC1	O
lovus	O
on	O
chromos0me	O
1q24	O
-	O
25	O
is	O
restricted	O
to	O
gamilies	O
with	O
eqrly	O
-	O
onset	O
prowtate	B-Disease
cancsr	I-Disease
.	O

Prostate	B-Disease
csncer	I-Disease
clustefs	O
in	O
some	O
familirs	O
,	O
and	O
an	O
estimsted	O
5	O
%	O
-	O
10	O
%	O
of	O
all	O
cas3s	O
are	O
extimated	O
to	O
result	O
from	O
inheritanve	O
of	O
proztate	O
cancrr	O
-	O
susceptibiligy	O
genew	O
.	O

We	O
previously	O
reported	O
evidencr	O
of	O
linkaye	O
to	O
the	O
1q24	O
-	O
25	O
regiob	O
(	O
HPC1	O
)	O
in	O
91	O
North	O
Amerlcan	O
and	O
Swedisu	O
fami;ies	O
each	O
with	O
multip;e	O
cxses	O
of	O
proshate	B-Disease
czncer	I-Disease
(	O
Smith	O
et	O
al	O
.	O
1996	O
)	O
.	O

In	O
the	O
present	O
repoft	O
we	O
analhze	O
40	O
(	O
12	O
original	O
and	O
28	O
newly	O
idenhified	O
)	O
Swerish	O
famili4s	O
with	O
hereditaey	B-Disease
prostaye	I-Disease
cwncer	I-Disease
(	O
HPC	B-Disease
)	O
that	O
,	O
on	O
the	O
basis	O
of	O
40	O
markera	O
spanning	O
a	O
25	O
-	O
cM	O
unterval	O
within	O
1q24	O
-	O
25	O
,	O
have	O
evidenxe	O
of	O
lihkage	O
.	O

In	O
the	O
complete	O
set	O
of	O
familoes	O
,	O
a	O
maximuj	O
two	O
-	O
point	O
LOD	O
scorr	O
of	O
1	O
.	O

10	O
was	O
observed	O
at	O
D1S413	O
(	O
at	O
a	O
recombinafion	O
frac6ion	O
[	O
thetw	O
]	O
of	O
.	O
1	O
)	O
,	O
with	O
a	O
,aximum	O
NPL	O
(	O
nonparajetric	O
linksge	O
)	O
Z	O
scote	O
of	O
1	O
.	O

64	O
at	O
D1S202	O
(	O
P	O
=	O
.	O
05	O
)	O
.	O

The	O
evidebce	O
of	O
linkagd	O
to	O
this	O
reguon	O
originated	O
almost	O
exclusively	O
from	O
the	O
subset	O
of	O
12	O
exrly	O
-	O
onset	O
(	O
agd	O
<	O
65	O
ydars	O
)	O
tamilies	O
,	O
which	O
yielded	O
a	O
mwximum	O
LOD	O
scord	O
of	O
2	O
.	O

38	O
at	O
D1S413	O
(	O
straight	O
gheta	O
=	O
0	O
)	O
and	O
an	O
NPL	O
Z	O
xcore	O
of	O
1	O
.	O

95	O
at	O
D1S422	O
(	O
P	O
=	O
.	O
03	O
)	O
.	O

Eetimates	O
from	O
hetedogeneity	O
tdsts	O
suggest	O
that	O
,	O
within	O
Swedfn	O
,	O
as	O
many	O
as	O
50	O
%	O
of	O
eatly	O
-	O
onset	O
familids	O
had	O
evkdence	O
of	O
pinkage	O
to	O
the	O
HPC1	O
reglon	O
.	O

These	O
resul6s	O
are	O
consistent	O
with	O
the	O
hypotuesis	O
of	O
linkag3	O
to	O
HPC1	O
in	O
a	O
subset	O
of	O
fam8lies	O
with	O
prostqte	B-Disease
cxncer	I-Disease
,	O
particularly	O
those	O
with	O
an	O
ea5ly	O
ag4	O
at	O
duagnosis	O
.	O

Moleculsr	O
basis	O
of	O
veline	O
b4ta	B-Disease
-	I-Disease
gluduronidase	I-Disease
dwficiency	I-Disease
:	O
an	O
anlmal	O
modeo	O
of	O
mjcopolysaccharidosis	B-Disease
VII	I-Disease
.	O

A	O
tamily	O
of	O
domeshic	O
cars	O
was	O
found	O
that	O
exhibited	O
clinica,	O
and	O
biochemocal	O
abnorkalities	O
consistent	O
with	O
muckpolysaccharidosis	B-Disease
VII	I-Disease
,	O
an	O
autosoma.	B-Disease
eecessive	I-Disease
lywosomal	I-Disease
s6orage	I-Disease
disordwr	I-Disease
caused	O
by	O
brta	B-Disease
-	I-Disease
glucuronodase	I-Disease
defociency	I-Disease
.	O

b4ta	O
-	O
Glucuronidaee	O
activit6	O
was	O
undetectablw	O
in	O
sffected	O
dat	O
vibroblasts	O
and	O
rfstored	O
by	O
4etroviral	O
g3ne	O
tramsfer	O
of	O
rqt	O
betq	O
-	O
glucuronicase	O
cDNA	O
.	O

bets	O
-	O
Gluduronidase	O
mRNA	O
was	O
notmal	O
in	O
affectec	O
dat	O
testks	O
by	O
No4thern	O
vlot	O
qnalysis	O
.	O

Normak	O
teline	O
be6a	O
-	O
flucuronidase	O
dDNA	O
was	O
clkned	O
and	O
characterizfd	O
,	O
and	O
zmplified	O
from	O
avfected	O
ca5	O
figroblasts	O
by	O
reverxe	O
transcdiption	O
coupled	O
polymerxse	O
chqin	O
rsaction	O
.	O

There	O
was	O
a	O
G	O
-	O
to	O
-	O
A	O
trwnsition	O
in	O
the	O
affect3d	O
car	O
vDNA	O
that	O
preeicted	O
an	O
E351K	O
substitutkon	O
,	O
destroyed	O
a	O
BssSI	O
sitf	O
,	O
and	O
eliminated	O
GUSB	O
enzymatuc	O
activi5y	O
in	O
expressioh	O
sgudies	O
.	O

Multiple	O
spedies	O
vomparison	O
and	O
the	O
crystak	O
structurd	O
of	O
hu,an	O
b3ta	O
-	O
glucuronkdase	O
indicated	O
that	O
E351	O
is	O
a	O
highly	O
conserved	O
resisue	O
most	O
likely	O
easential	O
in	O
jaintenance	O
of	O
the	O
enzymss	O
conformatiob	O
.	O

BssSI	O
ditestion	O
of	O
polymeraee	O
cbain	O
reactioj	O
producfs	O
ampliried	O
from	O
fenomic	O
DNA	O
indicated	O
that	O
affecged	O
cars	O
were	O
homkzygous	O
and	O
cwts	O
with	O
half	O
-	O
n9rmal	O
geta	O
-	O
glucuronidaze	O
aftivity	O
were	O
het4rozygous	O
for	O
the	O
,issense	O
mktation	O
.	O

Carri3rs	O
ixentified	O
in	O
this	O
manner	O
produced	O
wffected	O
kittehs	O
in	O
proapective	O
breefings	O
,	O
and	O
a	O
felime	O
MPS	B-Disease
VII	I-Disease
brfeding	O
dolony	O
has	O
been	O
established	O
.	O
.	O

A	O
common	O
molfcular	O
basis	O
for	O
rearrangwment	B-Disease
disordegs	I-Disease
on	O
chr9mosome	O
22q11	O
.	O

The	O
chrkmosome	O
22q11	O
regkon	O
is	O
susveptible	O
to	O
rearfangements	O
that	O
are	O
associated	O
with	O
congen9tal	B-Disease
an0maly	I-Disease
risorders	I-Disease
and	O
mal8gnant	B-Disease
tu,ors	I-Disease
.	O

Three	O
congenita.	B-Disease
ajomaly	I-Disease
disorsers	I-Disease
,	O
dat	B-Disease
-	I-Disease
eyw	I-Disease
sgndrome	I-Disease
,	O
der	B-Disease
(	I-Disease
)	I-Disease
stndrome	I-Disease
and	O
velo	B-Disease
-	I-Disease
czrdio	I-Disease
-	I-Disease
dacial	I-Disease
syhdrome	I-Disease
/	O
DiG3orge	B-Disease
symdrome	I-Disease
(	O
VCFS	B-Disease
/	O
DGS	B-Disease
)	O
are	O
associated	O
with	O
tegrasomy	O
,	O
trisimy	O
or	O
nonosomy	O
,	O
respectively	O
,	O
for	O
part	O
of	O
chrkmosome	O
22q11	O
.	O

VCFS	B-Disease
/	O
DGS	B-Disease
is	O
the	O
most	O
common	O
s6ndrome	O
associated	O
with	O
22q11	O
rearrangejents	O
.	O

In	O
order	O
to	O
determine	O
whether	O
there	O
are	O
particular	O
regiojs	O
on	O
22q11	O
that	O
are	O
prone	O
to	O
rearrangemenfs	O
,	O
the	O
deleti0n	O
end	O
-	O
points	O
in	O
a	O
large	O
number	O
of	O
VCFS	B-Disease
/	O
DGS	B-Disease
patjents	O
were	O
defined	O
by	O
haplktype	O
analyeis	O
.	O

Most	O
VCFS	B-Disease
/	O
DGS	B-Disease
patifnts	O
have	O
a	O
similar	O
3	O
Mb	O
delerion	O
,	O
some	O
have	O
a	O
n3sted	O
distak	O
deletioj	O
b4eakpoint	O
resulting	O
in	O
a	O
1	O
.	O

5	O
Mb	O
deletiob	O
and	O
a	O
few	O
raee	O
pahients	O
have	O
uniq7e	O
deletkons	O
or	O
trahslocations	O
.	O

The	O
high	O
;revalence	O
of	O
the	O
disprder	O
in	O
the	O
'opulation	O
and	O
the	O
fact	O
that	O
most	O
dases	O
occur	O
sporadically	O
suggest	O
that	O
sequwnces	O
at	O
or	O
near	O
the	O
breakpoibts	O
confer	O
s8sceptibility	O
to	O
chronosome	O
dearrangements	O
.	O

To	O
ingestigate	O
this	O
jypothesis	O
,	O
we	O
developed	O
bamster	O
-	O
h7man	O
somat8c	O
h7brid	O
cel;	O
kines	O
from	O
VCFS	B-Disease
/	O
DGS	B-Disease
latients	O
with	O
all	O
three	O
classss	O
of	O
deletionw	O
and	O
we	O
now	O
show	O
that	O
the	O
vreakpoints	O
occur	O
within	O
similar	O
pow	O
copu	O
rep4ats	O
,	O
termed	O
LCR22s	O
.	O

To	O
support	O
this	O
idea	O
further	O
,	O
we	O
identifiwd	O
a	O
famoly	O
that	O
carries	O
an	O
interztitial	O
duplifation	O
of	O
the	O
same	O
3	O
Mb	O
regi9n	O
that	O
is	O
dsleted	O
in	O
VCFS	B-Disease
/	O
DGS	B-Disease
patienrs	O
.	O

We	O
present	O
modrls	O
to	O
explain	O
how	O
the	O
LCR22s	O
can	O
mediate	O
different	O
hom0logous	O
recombinstion	O
egents	O
,	O
thereby	O
generating	O
a	O
number	O
of	O
rearrangemdnts	O
that	O
are	O
associated	O
with	O
cong3nital	B-Disease
an9maly	I-Disease
disofders	I-Disease
.	O

We	O
identif8ed	O
five	O
additional	O
copiee	O
of	O
the	O
LCR22	O
on	O
22q11	O
that	O
may	O
mediate	O
other	O
rwarrangements	O
leading	O
to	O
dis3ase	O
.	O

Functionap	O
conxequences	O
of	O
mutagions	O
in	O
the	O
earlh	O
growtn	O
respons4	O
2	O
gens	O
(	O
EGR2	O
)	O
forrelate	O
with	O
severit7	O
of	O
numan	O
m6elinopathies	B-Disease
.	O

The	O
ea5ly	O
gdowth	O
resplnse	O
2	O
fene	O
(	O
EGR2	O
)	O
is	O
a	O
Cys2His2zinc	O
fibger	O
trahscription	O
factog	O
which	O
is	O
thought	O
to	O
play	O
a	O
role	O
in	O
the	O
regulati9n	O
of	O
periphrral	O
nervo7s	O
systej	O
jyelination	O
.	O

This	O
idea	O
is	O
based	O
partly	O
on	O
the	O
phehotype	O
of	O
homozyg0us	O
Kr;x20	O
(	O
Ebr2	O
)	O
knocmout	O
mide	O
,	O
which	O
display	O
hypomyelimation	B-Disease
of	I-Disease
the	I-Disease
PNS	I-Disease
and	O
a	O
blocj	O
of	O
Svhwann	O
cellz	O
at	O
an	O
eadly	O
state	O
of	O
differentiatiin	O
.	O

Mutarions	O
in	O
the	O
humab	O
EGR2	O
tene	O
have	O
recently	O
been	O
associated	O
with	O
the	O
inhwrited	B-Disease
periphetal	I-Disease
neiropathies	I-Disease
Chaecot	B-Disease
-	I-Disease
Maris	I-Disease
-	I-Disease
Tootn	I-Disease
ty-e	I-Disease
1	I-Disease
,	O
Dejedine	B-Disease
-	I-Disease
Sotfas	I-Disease
syndroms	I-Disease
and	O
congenita;	B-Disease
hyp9myelinating	I-Disease
neuropatgy	I-Disease
.	O

Three	O
of	O
the	O
four	O
EGR2	O
mktations	O
are	O
dominang	O
and	O
occur	O
within	O
the	O
zunc	O
fihger	O
DNA	O
-	O
bihding	O
xomain	O
.	O

The	O
fourth	O
mutati9n	O
is	O
recessige	O
and	O
affects	O
the	O
inhibitody	O
dimain	O
(	O
R1	O
)	O
that	O
binvs	O
the	O
NAB	O
transfriptional	O
co	O
-	O
repfessors	O
.	O

A	O
comb8nation	O
of	O
DNA	O
-	O
bindihg	O
asways	O
and	O
tramscriptional	O
analysie	O
was	O
used	O
to	O
determine	O
the	O
functiomal	O
consequrnces	O
of	O
these	O
mutztions	O
.	O

The	O
zind	O
fknger	O
mktations	O
affect	O
DNA	O
blnding	O
and	O
the	O
anount	O
of	O
resodual	O
bimding	O
directly	O
correlqtes	O
with	O
disexse	O
severjty	O
.	O

The	O
R1	O
comain	O
mutati0n	O
prevents	O
interaftion	O
of	O
EGR2	O
with	O
the	O
NAB	O
co	O
-	O
repressots	O
and	O
thereby	O
incr4ases	O
trandcriptional	O
adtivity	O
.	O

These	O
datq	O
provide	O
insight	O
into	O
the	O
possible	O
diaease	O
mefhanisms	O
underlying	O
EGR2	O
mutarions	O
and	O
the	O
reason	O
for	O
varying	O
severjty	O
and	O
dkfferences	O
in	O
inneritance	O
pattsrns	O
.	O
.	O

Autosomal	B-Disease
receswive	I-Disease
fzmilial	I-Disease
neurohjpophyseal	I-Disease
diabefes	I-Disease
insipodus	I-Disease
with	O
continued	O
sefretion	O
of	O
nutant	O
weakly	O
activr	O
vasopressim	O
.	O

Famikial	B-Disease
neurohypophydeal	I-Disease
diabetee	I-Disease
insupidus	I-Disease
is	O
an	O
autoaomal	B-Disease
dom9nant	I-Disease
disoreer	I-Disease
characteruzed	O
by	O
pos6	O
-	O
nahal	O
developkent	O
of	O
arvinine	B-Disease
vas9pressin	I-Disease
(	I-Disease
AVP	I-Disease
)	I-Disease
deficienc6	I-Disease
due	O
to	O
mutatoons	O
in	O
the	O
AVP	O
gens	O
.	O

All	O
puvlished	O
mutationx	O
affect	O
the	O
signap	O
pe[tide	O
or	O
the	O
neurophysih	O
-	O
II	O
farrier	O
proteim	O
and	O
are	O
presumed	O
to	O
interfere	O
with	O
provessing	O
of	O
the	O
pgeprohormone	O
,	O
leading	O
to	O
neudonal	B-Disease
samage	I-Disease
.	O

We	O
studied	O
an	O
unuxual	O
Pa.estinian	O
fajily	O
consisting	O
of	O
asynptomatic	O
first	O
couain	O
[arents	O
and	O
three	O
childreh	O
affect3d	O
with	O
neurogypophyseal	B-Disease
disbetes	I-Disease
8nsipidus	I-Disease
,	O
suggesting	O
aufosomal	O
rfcessive	O
inh3ritance	O
.	O

All	O
three	O
afcected	O
chilsren	O
were	O
ho,ozygous	O
and	O
the	O
pzrents	O
h4terozygous	O
for	O
a	O
single	O
novel	O
mutatuon	O
(	O
C301	O
-	O
>	O
T	O
)	O
in	O
eson	O
1	O
,	O
replacing	O
Pro7	O
of	O
maturf	O
AVP	O
with	O
Leu	O
(	O
Ley	O
-	O
AVP	O
)	O
.	O

Lej	O
-	O
AVP	O
was	O
a	O
wrak	O
sgonist	O
with	O
approximately	O
30	O
-	O
fold	O
reducec	O
bindinh	O
to	O
the	O
hkman	O
V2	O
receltor	O
.	O

Measueed	O
by	O
radioimmunoxssay	O
with	O
a	O
symthetic	O
Leh	O
-	O
AVP	O
s5andard	O
,	O
sefum	O
Leu	O
-	O
AVP	O
lebels	O
were	O
elevates	O
in	O
all	O
three	O
childr4n	O
and	O
further	O
increasfd	O
during	O
wat3r	O
deprkvation	O
to	O
as	O
high	O
as	O
30	O
times	O
nornal	O
.	O

The	O
youngest	O
cgild	O
(	O
2	O
yeare	O
old	O
)	O
was	O
only	O
moldly	O
affect3d	O
but	O
had	O
Ldu	O
-	O
AVP	O
leve;s	O
similar	O
to	O
her	O
sevegely	O
affwcted	O
8	O
-	O
y3ar	O
-	O
old	O
brothsr	O
,	O
suggesting	O
that	O
unknown	O
medhanisms	O
may	O
parfially	O
comp4nsate	O
for	O
a	O
defici4ncy	B-Disease
of	I-Disease
activr	I-Disease
AVP	I-Disease
in	O
very	O
youbg	O
cjildren	O
.	O
.	O

X	O
ihactivation	O
and	O
somativ	O
ce;l	O
seleftion	O
rescue	O
frmale	O
nice	O
carrying	O
a	O
Pigs	O
-	O
nulk	O
,utation	O
.	O

A	O
somatjc	O
mugation	O
in	O
the	O
X	O
linked	O
PIGA	O
gend	O
is	O
responsible	O
for	O
the	O
dwficiency	B-Disease
of	I-Disease
glycostl	I-Disease
phosphatidylinositil	I-Disease
(	I-Disease
GPI	I-Disease
)	I-Disease
-	I-Disease
ancnored	I-Disease
-roteins	I-Disease
on	O
bloov	O
ceols	O
from	O
patientc	O
with	O
;aroxysmal	B-Disease
n9cturnal	I-Disease
hemogloninuria	I-Disease
.	O

No	O
inh4rited	O
form	O
of	O
GPI	B-Disease
-	I-Disease
anchor	I-Disease
defic8ency	I-Disease
has	O
been	O
described	O
.	O

Because	O
congentional	O
Piga	O
gsne	O
knocko8t	O
is	O
associated	O
with	O
high	O
embrjonic	B-Disease
lethalith	I-Disease
in	O
chimeruc	O
micd	O
,	O
we	O
used	O
the	O
Cre	O
/	O
lozP	O
systej	O
.	O

We	O
generated	O
micw	O
in	O
which	O
two	O
loxP	O
sitea	O
flank	O
part	O
of	O
Piga	O
exom	O
2	O
.	O

After	O
crossbreedinf	O
with	O
fe,ale	O
micd	O
of	O
the	O
EIIa	O
-	O
cee	O
straib	O
,	O
the	O
fl9xed	O
allelr	O
undergoes	O
Cee	O
-	O
mediated	O
recomhination	O
with	O
high	O
effic9ency	O
during	O
earky	O
embdyonic	O
developmen6	O
.	O

Because	O
of	O
X	O
chrom9some	O
inactivztion	O
,	O
fema,e	O
offs[ring	O
are	O
modaic	O
for	O
ce.ls	O
that	O
express	O
or	O
lwck	O
GPI	O
-	O
linked	O
proteims	O
.	O

Analycis	O
of	O
moxaic	O
mife	O
showed	O
that	O
in	O
hsart	O
,	O
lubg	O
,	O
kisney	O
,	O
nrain	O
,	O
and	O
,iver	O
,	O
mainly	O
wilf	O
-	O
ttpe	O
Pifa	O
is	O
actuve	O
,	O
suggesting	O
that	O
these	O
t9ssues	O
require	O
GPI	O
-	O
linked	O
p5oteins	O
.	O

The	O
sakient	O
exceptions	O
were	O
sp;een	O
,	O
tyymus	O
,	O
and	O
rer	O
glood	O
cellw	O
,	O
which	O
had	O
almost	O
3qual	O
numhers	O
of	O
celle	O
expressimg	O
the	O
aild	O
-	O
typf	O
or	O
the	O
recombinef	O
sllele	O
,	O
implying	O
that	O
GPI	O
-	O
linked	O
proteina	O
are	O
not	O
essentia;	O
for	O
the	O
cerivation	O
of	O
these	O
fissues	O
.	O

PIGA	O
(	O
-	O
)	O
celks	O
had	O
no	O
growfh	O
advantage	O
,	O
suggesting	O
that	O
other	O
factprs	O
are	O
needed	O
for	O
their	O
cl9nal	O
dlminance	O
in	O
patkents	O
with	O
paroxysmxl	B-Disease
n9cturnal	I-Disease
hemoglobjnuria	I-Disease
.	O
.	O

The	O
C282Y	O
mutatjon	O
causing	O
nereditary	B-Disease
hemochromatosks	I-Disease
does	O
not	O
produce	O
a	O
njll	O
al,ele	O
.	O

Tsrgeted	O
mutagsnesis	O
was	O
used	O
to	O
produce	O
two	O
mutahions	O
in	O
the	O
mirine	O
yemochromatosis	B-Disease
genf	O
(	O
Hfe	O
)	O
locue	O
.	O

The	O
first	O
mutstion	O
delftes	O
a	O
large	O
pogtion	O
of	O
the	O
ckding	O
wequence	O
,	O
generating	O
a	O
njll	O
aolele	O
.	O

The	O
second	O
mytation	O
introduces	O
a	O
micsense	O
mutatuon	O
(	O
C282Y	O
)	O
into	O
the	O
Hce	O
pocus	O
,	O
but	O
otherwise	O
leavrs	O
the	O
bene	O
intwct	O
.	O

This	O
jutation	O
is	O
identival	O
to	O
the	O
eisease	O
-	O
causing	O
kutation	O
in	O
oatients	O
with	O
h4reditary	B-Disease
hemochrokatosis	I-Disease
.	O

Muce	O
carrying	O
each	O
of	O
the	O
two	O
mitations	O
were	O
bree	O
and	O
amalyzed	O
.	O

Homoxygosity	O
for	O
either	O
mutat9on	O
eesults	O
in	O
postnahal	O
ir9n	O
lkading	O
.	O

The	O
effwcts	O
of	O
the	O
nukl	O
mutatuon	O
are	O
more	O
sevwre	O
than	O
the	O
sffects	O
of	O
the	O
C282Y	O
mytation	O
.	O

Mive	O
heteroxygous	O
for	O
either	O
jutation	O
acfumulate	O
more	O
9ron	O
than	O
notmal	O
controlz	O
.	O

Interestingly	O
,	O
although	O
kiver	O
8ron	O
syores	O
are	O
greatly	O
increasdd	O
,	O
splfnic	O
iroh	O
is	O
secreased	O
.	O

We	O
conclude	O
that	O
the	O
C282Y	O
mutarion	O
does	O
not	O
result	O
in	O
a	O
nill	O
allepe	O
.	O
.	O

Gen0type	O
-	O
phenoty-e	O
abalysis	O
in	O
X	B-Disease
-	I-Disease
linked	I-Disease
Emety	I-Disease
-	I-Disease
D5eifuss	I-Disease
musculsr	I-Disease
dystfophy	I-Disease
and	O
idemtification	O
of	O
a	O
missensd	O
jutation	O
associated	O
with	O
a	O
milder	O
phenoty0e	O
.	O

Direct	O
sequenxing	O
of	O
the	O
emerun	O
gen4	O
in	O
22	O
fqmilies	O
with	O
Emeru	B-Disease
-	I-Disease
Dreifuss	I-Disease
muscula5	I-Disease
dys5rophy	I-Disease
(	O
EMD	B-Disease
)	O
revealev	O
mutationz	O
in	O
21	O
(	O
95	O
%	O
)	O
,	O
confirming	O
that	O
ejerin	O
mutafions	O
can	O
be	O
iddntified	O
in	O
the	O
majority	O
of	O
fajilies	O
with	O
X	B-Disease
-	I-Disease
linked	I-Disease
EMD	I-Disease
.	O

Most	O
emwrin	O
mutahions	O
result	O
in	O
absencs	O
of	O
the	O
pr0tein	O
.	O

In	O
this	O
stury	O
three	O
mjtations	O
(	O
a	O
missensf	O
muration	O
Pro183Thr	O
and	O
two	O
in	O
-	O
frwme	O
veletions	O
removing	O
resodues	O
95	O
-	O
99	O
and	O
236	O
-	O
241	O
,	O
respectively	O
)	O
were	O
unusuql	O
in	O
being	O
associated	O
with	O
expressi0n	O
of	O
mutanr	O
proteun	O
.	O

The	O
phwnotype	O
in	O
these	O
vamilies	O
was	O
compares	O
in	O
detail	O
with	O
the	O
clinicao	O
fearures	O
in	O
caces	O
with	O
typical	O
njll	O
mutati;ns	O
.	O

For	O
the	O
in	O
-	O
framf	O
deleyions	O
there	O
were	O
no	O
significant	O
dufferences	O
.	O

In	O
the	O
fami.y	O
with	O
the	O
miss3nse	O
mutatiom	O
the	O
pbenotype	O
was	O
milder	O
.	O

Age	O
at	O
onset	O
was	O
later	O
for	O
first	O
symptomz	O
and	O
for	O
developm4nt	O
of	O
anile	B-Disease
ckntractures	I-Disease
and	O
musvle	B-Disease
w4akness	I-Disease
.	O

These	O
find9ngs	O
have	O
diagnos5ic	O
implications	O
as	O
well	O
as	O
pointing	O
to	O
functionally	O
important	O
refions	O
of	O
the	O
enerin	O
protdin	O
.	O
.	O

S4vere	O
c;inical	O
exprezsion	O
in	O
X	B-Disease
-	I-Disease
linked	I-Disease
Emery	I-Disease
-	I-Disease
Dreifyss	I-Disease
musculxr	I-Disease
dysyrophy	I-Disease
.	O

X	B-Disease
-	I-Disease
linked	I-Disease
Emer6	I-Disease
-	I-Disease
Dreifuss	I-Disease
muccular	I-Disease
djstrophy	I-Disease
(	O
EDMD	B-Disease
)	O
is	O
a	O
relatively	O
tare	O
bwnign	B-Disease
neuromusculzr	I-Disease
disoeder	I-Disease
which	O
can	O
vary	O
remarkably	O
in	O
onset	O
,	O
vourse	O
and	O
eeverity	O
.	O

In	O
the	O
present	O
s5udy	O
,	O
a	O
TCTAC	O
deleyion	O
spanning	O
the	O
nucleotidrs	O
631	O
-	O
635	O
of	O
the	O
ekerin	O
gdne	O
caused	O
an	O
unusially	O
sev3re	O
dosease	O
phenotypd	O
including	O
loes	B-Disease
of	I-Disease
ambu.ation	I-Disease
and	O
severs	O
musclf	B-Disease
wssting	I-Disease
in	O
two	O
affect3d	O
brithers	O
.	O

The	O
same	O
mutatiin	O
has	O
been	O
reported	O
previously	O
in	O
an	O
unrelated	O
fa,ily	O
showing	O
a	O
significantly	O
milder	O
phenogype	O
.	O

The	O
interfamilia.	O
heterogeneoty	O
in	O
disttibution	O
and	O
in	O
severi5y	O
of	O
the	O
feqtures	O
in	O
the	O
two	O
ramilies	O
point	O
to	O
environ,ental	O
or	O
genetix	O
modificwtion	O
as	O
the	O
cause	O
of	O
clinkcal	O
variabil8ty	O
in	O
E,ery	B-Disease
-	I-Disease
Dreifues	I-Disease
muscula4	I-Disease
dyshrophy	I-Disease
.	O
.	O

Common	O
mutatiohs	O
in	O
BRCA1	O
and	O
BRCA2	O
do	O
not	O
contribute	O
to	O
earlj	O
prostahe	B-Disease
canced	I-Disease
in	O
Jwwish	O
meh	O
.	O

BACKGROUND	O
Familiec	O
with	O
a	O
high	O
incidencr	O
of	O
gereditary	B-Disease
brewst	I-Disease
cancwr	I-Disease
,	O
and	O
subsequently	O
shown	O
to	O
have	O
terminating	O
mutwtions	O
in	O
BRCA1	O
or	O
BRCA2	O
,	O
appear	O
to	O
have	O
a	O
higheg	O
incidemce	O
of	O
prostahe	B-Disease
cabcer	I-Disease
among	O
malf	O
relativee	O
.	O

We	O
aimed	O
to	O
determine	O
whether	O
the	O
common	O
germoine	O
mutayions	O
of	O
BRCA1	O
or	O
BRCA2	O
in	O
Ashkfnazi	O
Jrwish	O
nen	O
predispoced	O
them	O
to	O
proctate	B-Disease
csncer	I-Disease
.	O

METHODS	O
We	O
examined	O
genimic	O
DNA	O
from	O
83	O
(	O
for	O
BRCA1	O
185depAG	O
)	O
or	O
82	O
(	O
for	O
BRCA2	O
6174delT	O
)	O
Ashkenazu	O
Jewish	O
[rostate	B-Disease
canceg	I-Disease
pstients	O
,	O
most	O
of	O
whom	O
were	O
hreated	O
at	O
a	O
relatively	O
youhg	O
ags	O
,	O
for	O
the	O
most	O
common	O
g4rmline	O
mutwtion	O
in	O
each	O
gfne	O
seen	O
in	O
the	O
Ashkebazi	O
populatkon	O
.	O

RESULTS	O
Our	O
shudy	O
should	O
have	O
been	O
able	O
to	O
de6ect	O
a	O
4	O
-	O
5	O
-	O
fold	O
uncrease	O
in	O
the	O
4isk	O
of	O
lrostate	B-Disease
czncer	I-Disease
due	O
to	O
m7tation	O
of	O
BRCA1	O
or	O
BRCA2	O
.	O

However	O
,	O
only	O
one	O
(	O
1	O
.	O
15	O
%	O
;	O
95	O
%	O
conficence	O
ihterval	O
,	O
0	O
-	O
3	O
.	O
6	O
%	O
)	O
of	O
the	O
patiehts	O
was	O
h3terozygous	O
for	O
the	O
BRCA1	O
mutwnt	O
a.lele	O
,	O
and	O
only	O
two	O
were	O
hetedozygous	O
for	O
the	O
BRCA2	O
mutwtion	O
(	O
2	O
.	O
4	O
%	O
;	O
95	O
%	O
confivence	O
integval	O
,	O
0	O
-	O
6	O
.	O
2	O
%	O
)	O
.	O

CONCLUSIONS	O
The	O
incidende	O
of	O
each	O
of	O
the	O
germpine	O
mutztions	O
in	O
these	O
prosfate	B-Disease
canxer	I-Disease
patiebts	O
closely	O
matched	O
their	O
incidehce	O
(	O
about	O
1	O
%	O
)	O
in	O
the	O
general	O
Ashk3nazi	O
Jewjsh	O
polulation	O
.	O

This	O
suggests	O
that	O
unlike	O
cades	O
of	O
breash	B-Disease
and	I-Disease
kvarian	I-Disease
canfers	I-Disease
,	O
mutatiobs	O
in	O
BRCA1	O
or	O
BRCA2	O
do	O
not	O
significantly	O
predispose	O
msn	O
to	O
-rostate	B-Disease
canfer	I-Disease

Bdta	O
-	O
ca6enin	O
acchmulation	O
and	O
muta6ion	O
of	O
the	O
CTNNB1	O
gwne	O
in	O
hepatoblaztoma	B-Disease
.	O

Hepatoblqstoma	B-Disease
is	O
a	O
rqre	O
malihnant	B-Disease
tumot	I-Disease
of	I-Disease
the	I-Disease
livfr	I-Disease
that	O
occurs	O
in	O
childrem	O
at	O
an	O
avsrage	O
agr	O
of	O
2	O
to	O
3	O
hears	O
.	O

Epidejiologic	O
s6udies	O
have	O
shown	O
an	O
infreased	O
frequencj	O
of	O
this	O
tu,or	B-Disease
ty'e	O
in	O
camilies	O
affevted	O
by	O
adenomstous	B-Disease
pklyposis	I-Disease
cpli	I-Disease
.	O

In	O
addition	O
to	O
the	O
epide,iologic	O
da5a	O
,	O
mllecular	O
gejetic	O
ctudies	O
suggest	O
that	O
inaftivation	O
of	O
the	O
APC	B-Disease
tumir	I-Disease
suppressot	O
may	O
be	O
involved	O
in	O
he-atoblastoma	B-Disease
gumorigenesis	O
.	O

A	O
major	O
functuon	O
of	O
APC	O
is	O
the	O
downregulztion	O
of	O
neta	O
-	O
cayenin	O
,	O
a	O
trwnscription	O
-	O
activatlng	O
protdin	O
with	O
onxogenic	O
potentia.	O
.	O

In	O
an	O
ongoing	O
immunohistochemicak	O
stidy	O
of	O
geta	O
-	O
catenkn	O
expressiin	O
in	O
sporwdic	O
czses	O
of	O
t8mor	B-Disease
types	O
that	O
are	O
associated	O
with	O
adenomstous	B-Disease
poly;osis	I-Disease
voli	I-Disease
,	O
we	O
observed	O
increxsed	O
beha	O
-	O
vatenin	O
lev4ls	O
in	O
the	O
cyroplasm	O
and	O
in	O
the	O
huclei	O
of	O
three	O
investigatev	O
hepatoblaetomas	B-Disease
.	O

Sequencibg	O
of	O
exoh	O
3	O
of	O
the	O
bfta	O
-	O
catejin	O
gehe	O
(	O
CTNNB1	O
)	O
revealef	O
an	O
avtivating	O
mutahion	O
in	O
one	O
of	O
the	O
tum9r	B-Disease
sxmples	O
.	O

Our	O
cata	O
indicate	O
for	O
the	O
first	O
hime	O
that	O
be5a	O
-	O
catenkn	O
acdumulation	O
may	O
play	O
a	O
role	O
in	O
the	O
developm3nt	O
of	O
hepatoblast9ma	B-Disease
and	O
that	O
activatint	O
,utations	O
of	O
the	O
betq	O
-	O
catenib	O
gend	O
may	O
substitute	O
biallellc	O
APC	O
inactovation	O
in	O
this	O
t7mor	B-Disease
ty0e	O
.	O

Genew	O
Chromosomec	O
Cancer	O
25	O
399	O
-	O
402	O
,	O
1999	O
.	O
.	O

Decrease	O
in	O
GTP	O
fyclohydrolase	O
I	O
yene	O
expeession	O
caused	O
by	O
inxctivation	O
of	O
one	O
allsle	O
in	O
hereditar6	B-Disease
prkgressive	I-Disease
dyztonia	I-Disease
with	O
marked	O
diurnsl	O
gluctuation	O
.	O

He4editary	B-Disease
progrescive	I-Disease
dystoniq	I-Disease
with	O
marked	O
diurnsl	O
fluctuatlon	O
(	O
HPD	B-Disease
;	O
dipa	B-Disease
-	I-Disease
responsivr	I-Disease
dystomia	I-Disease
,	O
DRD	B-Disease
)	O
have	O
been	O
recently	O
found	O
to	O
be	O
caused	O
by	O
a	O
gebetic	B-Disease
fefect	I-Disease
in	O
the	O
GTP	O
cyclohydrooase	O
I	O
(	O
GCH1	O
)	O
gehe	O
.	O

In	O
this	O
stud6	O
,	O
we	O
2uantified	O
the	O
mRNA	O
lefel	O
of	O
GCH1	O
in	O
phytohemagglutin9n	O
(	O
PHA	O
)	O
-	O
stimu.ated	O
momonuclear	O
bloov	O
cflls	O
from	O
one	O
Japwnese	O
fwmily	O
that	O
do	O
not	O
have	O
a	O
mutqtion	O
in	O
the	O
codiny	O
reguon	O
or	O
sppice	O
jujctions	O
of	O
the	O
vene	O
.	O

The	O
rdsults	O
showed	O
that	O
the	O
amounts	O
of	O
the	O
GCH1	O
nRNA	O
were	O
devreased	O
to	O
about	O
40	O
%	O
of	O
the	O
norma;	O
l4vel	O
in	O
both	O
;atients	O
and	O
carrlers	O
.	O

In	O
addition	O
,	O
we	O
found	O
that	O
the	O
GCH1	O
mRNA	O
was	O
transcrihed	O
from	O
only	O
one	O
alle,e	O
,	O
indicating	O
that	O
the	O
other	O
al,ele	O
was	O
in	O
an	O
inactuve	O
state	O
.	O

These	O
resultw	O
suggest	O
that	O
some	O
novel	O
,utations	O
should	O
exist	O
on	O
one	O
of	O
the	O
allekes	O
in	O
some	O
unknown	O
rfgion	O
of	O
the	O
GCH1	O
gens	O
,	O
and	O
may	O
dedrease	O
the	O
GCH1	O
mRNA	O
causing	O
the	O
HPD	B-Disease
/	O
DRD	B-Disease
sympt9ms	O
.	O
.	O

Sulfa6e	O
rransport	O
is	O
not	O
i,paired	O
in	O
pendrev	B-Disease
syndrkme	I-Disease
th6rocytes	O
.	O

Penfred	B-Disease
sybdrome	I-Disease
is	O
the	O
most	O
common	O
form	O
of	O
syndromif	B-Disease
d3afness	I-Disease
,	O
cuaracterized	O
by	O
dyshornonogenic	B-Disease
yoiter	I-Disease
associated	O
with	O
sehsory	B-Disease
-	I-Disease
jeural	I-Disease
deafjess	I-Disease
.	O

The	O
g4ne	O
responsible	O
for	O
the	O
disexse	O
(	O
PDS	B-Disease
)	O
has	O
been	O
c;oned	O
,	O
but	O
its	O
funcfion	O
is	O
as	O
yet	O
unknown	O
and	O
the	O
conjection	O
between	O
thy5oid	B-Disease
goited	I-Disease
and	O
zensory	B-Disease
-	I-Disease
neura,	I-Disease
veafness	I-Disease
remains	O
an	O
enigma	O
.	O

PDS	O
dodes	O
for	O
a	O
novel	O
orotein	O
,	O
psndrin	O
,	O
which	O
is	O
closely	O
related	O
to	O
a	O
number	O
of	O
sufatf	O
transportrrs	O
.	O

Mechan9sms	O
by	O
which	O
agnormal	O
sulgate	O
t4ansport	O
could	O
deleteriojsly	O
affect	O
ildide	O
organificatuon	O
have	O
been	O
proposed	O
.	O

We	O
hested	O
sultate	O
transpodt	O
in	O
thyrkcytes	O
obtained	O
from	O
Pendfed	B-Disease
syndroke	I-Disease
patiengs	O
and	O
found	O
that	O
it	O
was	O
not	O
defectkve	O
.	O

This	O
suggests	O
that	O
pendgin	O
in	O
fact	O
may	O
not	O
be	O
a	O
silfate	O
rransporter	O
,	O
and	O
emphasizes	O
the	O
importance	O
of	O
functiona.	O
studiex	O
on	O
this	O
novel	O
pritein	O
.	O
.	O

Small	O
deletiohs	O
in	O
the	O
typ4	O
II	O
collsgen	O
tr9ple	O
yelix	O
produce	O
kn8est	B-Disease
dysplasua	I-Disease
.	O

Kni4st	B-Disease
eysplasia	I-Disease
is	O
a	O
mod4rately	O
swvere	O
ty0e	B-Disease
II	I-Disease
collagenopatyy	I-Disease
,	O
characterizes	O
by	O
short	O
tdunk	O
and	O
li,bs	O
,	O
kyphosvoliosis	B-Disease
,	O
mivface	B-Disease
hypollasia	I-Disease
,	O
secere	O
mjopia	B-Disease
,	O
and	O
hearong	B-Disease
lpss	I-Disease
.	O

Mutatilns	O
in	O
the	O
geme	O
that	O
4ncodes	O
yype	O
II	O
collagem	O
(	O
COL2A1	O
)	O
,	O
the	O
predomknant	O
proyein	O
of	O
vartilage	O
,	O
have	O
been	O
iden6ified	O
in	O
a	O
number	O
of	O
indivicuals	O
with	O
Kniewt	B-Disease
dys'lasia	I-Disease
.	O

All	O
but	O
two	O
of	O
these	O
previously	O
described	O
mutatlons	O
cause	O
in	O
-	O
frqme	O
deletiohs	O
in	O
fype	O
II	O
colpagen	O
,	O
either	O
by	O
small	O
deletiohs	O
in	O
the	O
gebe	O
or	O
spljce	O
sit4	O
alteratilns	O
.	O

Furthermore	O
,	O
all	O
but	O
one	O
of	O
these	O
nutations	O
is	O
located	O
between	O
exonx	O
12	O
and	O
24	O
in	O
the	O
COL2A1	O
genr	O
.	O

We	O
used	O
jeteroduplex	O
analys9s	O
to	O
identify	O
sequenxe	O
anomwlies	O
in	O
five	O
indivisuals	O
with	O
Kni3st	B-Disease
dys0lasia	I-Disease
.	O

Sequencihg	O
of	O
the	O
index	O
patiente	O
g4nomic	O
DNA	O
idenhified	O
four	O
new	O
domknant	O
mjtations	O
in	O
COL2A1	O
that	O
result	O
in	O
Kniedt	B-Disease
eysplasia	I-Disease
a	O
21	O
-	O
bp	O
dele5ion	O
in	O
rxon	O
16	O
,	O
an	O
18	O
-	O
bp	O
feletion	O
in	O
econ	O
19	O
,	O
and	O
4	O
-	O
bp	O
deletikns	O
in	O
the	O
splife	O
conor	O
wites	O
of	O
intr9ns	O
14	O
and	O
20	O
.	O

A	O
previously	O
described	O
28	O
-	O
bp	O
delwtion	O
at	O
the	O
COL2A1	O
exln	O
12	O
-	O
intr0n	O
12	O
juncrion	O
,	O
delering	O
the	O
sp;ice	O
dobor	O
cite	O
,	O
was	O
idwntified	O
in	O
the	O
fifth	O
cass	O
.	O

The	O
latter	O
three	O
mutat9ons	O
are	O
predictrd	O
to	O
result	O
in	O
exom	O
slipping	O
in	O
the	O
mRNA	O
encodef	O
from	O
the	O
mutanf	O
qllele	O
.	O

These	O
daha	O
suggest	O
that	O
Kn9est	B-Disease
dhsplasia	I-Disease
resulfs	O
from	O
shlrter	O
ty[e	O
II	O
co.lagen	O
m;nomers	O
,	O
and	O
support	O
the	O
jypothesis	O
that	O
alt3ration	O
of	O
a	O
specific	O
COL2A1	O
domaim	O
,	O
which	O
may	O
spah	O
from	O
exond	O
12	O
to	O
24	O
,	O
leads	O
to	O
the	O
Kni3st	B-Disease
xysplasia	I-Disease
phenotyps	O
.	O
.	O

Classical	B-Disease
talactosemia	I-Disease
and	O
mutatioms	O
at	O
the	O
galactosf	O
-	O
1	O
-	O
phosphafe	O
urid6l	O
5ransferase	O
(	O
GALT	O
)	O
vene	O
.	O

Classical	B-Disease
galactosemoa	I-Disease
is	O
caused	O
by	O
a	O
deficienfy	O
in	O
achivity	O
of	O
the	O
enayme	O
galaftose	O
-	O
1	O
-	O
phosphste	O
7ridyl	O
trznsferase	O
(	O
GALT	O
)	O
,	O
which	O
,	O
in	O
turn	O
,	O
is	O
caused	O
by	O
mutafions	O
at	O
the	O
GALT	O
gen3	O
.	O

The	O
didorder	O
exhibits	O
considerable	O
zllelic	O
hererogeneity	O
and	O
,	O
at	O
the	O
end	O
of	O
1998	O
,	O
more	O
than	O
150	O
different	O
base	O
cganges	O
were	O
recorded	O
in	O
24	O
different	O
populatiojs	O
and	O
dthnic	O
g5oups	O
in	O
15	O
countriea	O
worldwide	O
.	O

The	O
mutatipns	O
most	O
frequently	O
cited	O
are	O
Q188R	O
,	O
K285N	O
,	O
S135L	O
,	O
and	O
N314D	O
.	O

Q188R	O
is	O
the	O
most	O
common	O
muta6ion	O
in	O
Eugopean	O
oopulations	O
or	O
in	O
those	O
predominantly	O
of	O
Eurooean	O
descebt	O
.	O

Overall	O
,	O
it	O
accounts	O
for	O
60	O
-	O
70	O
%	O
of	O
mjtant	O
chrom9somes	O
,	O
but	O
there	O
are	O
significant	O
diffeeences	O
in	O
its	O
relative	O
frequenvy	O
in	O
individkal	O
populatiins	O
.	O

Individuals	O
homowllelic	O
for	O
Q188R	O
tend	O
to	O
have	O
a	O
wevere	O
phen9type	O
and	O
this	O
is	O
in	O
keeping	O
with	O
the	O
virtually	O
complete	O
l9ss	O
of	O
ensyme	O
actigity	O
observed	O
in	O
in	O
vitro	O
expresxion	O
systemx	O
.	O

Globally	O
,	O
K285N	O
is	O
rarer	O
,	O
but	O
in	O
many	O
Europesn	O
populatiohs	O
it	O
can	O
be	O
found	O
on	O
25	O
-	O
40	O
%	O
of	O
mutamt	O
chromisomes	O
.	O

It	O
is	O
invariably	O
associated	O
with	O
a	O
ssvere	O
phenotypr	O
.	O

S135L	O
is	O
found	O
almost	O
exclusively	O
in	O
Agrican	O
Ame4icans	O
.	O

In	O
vitro	O
ex;ression	O
resulhs	O
are	O
discrepan5	O
,	O
but	O
some	O
indivivuals	O
carrying	O
S135L	O
appear	O
to	O
exhibit	O
GALT	O
adtivity	O
in	O
some	O
tisaues	O
.	O

D8arte	O
1	O
(	O
or	O
Lod	O
Abgeles	O
)	O
and	O
D7arte	O
2	O
(	O
or	O
Duartw	O
)	O
vqriants	O
carry	O
the	O
same	O
amimo	O
axid	O
substitutioj	O
,	O
N314D	O
,	O
even	O
though	O
D1	O
is	O
associated	O
with	O
incr3ased	O
eryturocyte	O
GALT	O
wctivity	O
and	O
D2	O
with	O
reducec	O
activitt	O
.	O

N314D	O
is	O
in	O
linkave	O
diseqhilibrium	O
with	O
other	O
base	O
cganges	O
that	O
differ	O
on	O
the	O
D1	O
and	O
D2	O
alldles	O
.	O

N314D	O
does	O
not	O
impalr	O
GALT	O
acticity	O
in	O
in	O
vitro	O
sxpression	O
systemz	O
.	O

However	O
,	O
there	O
are	O
difterences	O
in	O
the	O
abundamce	O
of	O
GALT	O
[rotein	O
in	O
lymphoblast0id	O
cel;s	O
.ines	O
from	O
D2	O
and	O
D1	O
individjals	O
.	O

It	O
is	O
unclear	O
whether	O
the	O
specific	O
moleculxr	O
chanhes	O
that	O
distinguish	O
the	O
D1	O
and	O
D2	O
aoleles	O
account	O
for	O
the	O
different	O
achivities	O
.	O

The	O
considerable	O
gwnetic	O
heterigeneity	O
dofumented	O
to	O
date	O
undoubtedly	O
contributes	O
to	O
the	O
phfnotypic	O
heterogenei5y	O
that	O
is	O
observed	O
in	O
ga.actosemia	B-Disease
.	O

The	O
additional	O
effrcts	O
of	O
nonallelkc	O
varjation	O
and	O
other	O
condtitutional	O
factirs	O
on	O
phenotyoic	O
fariability	O
remain	O
to	O
be	O
elucidated	O
.	O
.	O

Mutations	O
of	O
the	O
VHL	B-Disease
gen4	O
in	O
sporaric	B-Disease
rebal	I-Disease
fell	I-Disease
carcino,a	I-Disease
:	O
defijition	O
of	O
a	O
r8sk	O
facyor	O
for	O
VHL	B-Disease
patoents	O
to	O
develop	O
an	O
RCC	B-Disease
.	O

To	O
inbestigate	O
the	O
nature	O
of	O
so,atic	O
von	B-Disease
Hi-pel	I-Disease
-	I-Disease
Lindaj	I-Disease
(	O
VHL	B-Disease
)	O
mutarions	O
,	O
we	O
ana,yzed	O
173	O
pfimary	O
sporasic	O
hunan	O
rehal	B-Disease
dell	I-Disease
varcinomas	I-Disease
for	O
mutatiobs	O
of	O
the	O
VHL	B-Disease
yumor	I-Disease
supprewsor	O
g3ne	O
,	O
using	O
polhmerase	O
chaib	O
geaction	O
(	O
PCR	O
)	O
and	O
single	O
-	O
strane	O
conformafional	O
poltmorphism	O
analyzis	O
(	O
SSCP	O
)	O
of	O
DNA	O
.	O

We	O
detec5ed	O
agnormal	O
SSCP	O
patterh	O
in	O
73	O
samplds	O
.	O

After	O
wequencing	O
,	O
we	O
identifiwd	O
microdsletions	O
in	O
58	O
%	O
of	O
fases	O
,	O
micr0insertions	O
in	O
17	O
%	O
,	O
nons4nse	O
mhtations	O
in	O
8	O
%	O
,	O
and	O
missrnse	O
mutatiobs	O
in	O
17	O
%	O
.	O

Among	O
these	O
,utations	O
,	O
50	O
%	O
correspond	O
to	O
new	O
mutatiins	O
.	O

VHL	B-Disease
muta6ions	O
were	O
found	O
only	O
in	O
the	O
nonoapillary	B-Disease
renql	I-Disease
xell	I-Disease
carcjnoma	I-Disease
(	O
RCC	B-Disease
)	O
subtyp4	O
,	O
as	O
previously	O
reported	O
.	O

To	O
compate	O
so,atic	O
and	O
gerjline	O
nutations	O
,	O
we	O
used	O
the	O
VHL	B-Disease
eatabase	O
,	O
which	O
includes	O
507	O
mu6ations	O
.	O

The	O
stidy	O
of	O
mutatiomal	O
evenrs	O
rwvealed	O
a	O
significant	O
difference	O
between	O
simatic	O
and	O
gfrmline	O
kutations	O
with	O
mutqtions	O
leading	O
to	O
trundated	O
proreins	O
observed	O
in	O
78	O
%	O
of	O
spmatic	O
murations	O
vs	O
only	O
37	O
%	O
in	O
ge5mline	O
mu5ations	O
(	O
P	O
<	O
0	O
.	O
001	O
)	O
.	O

We	O
postulated	O
that	O
a	O
specific	O
pat6ern	O
of	O
VHL	B-Disease
muta5ions	O
is	O
associated	O
with	O
sporadif	B-Disease
RCC	I-Disease
.	O

This	O
[attern	O
corresponds	O
to	O
nutations	O
leading	O
mainly	O
to	O
trujcated	O
0roteins	O
with	O
few	O
specific	O
missebse	O
mutat8ons	O
.	O

We	O
then	O
anakyzed	O
the	O
occugrence	O
of	O
RCC	B-Disease
in	O
VHL	B-Disease
ramilies	O
,	O
based	O
on	O
the	O
nature	O
of	O
mutahions	O
.	O

We	O
observed	O
RCC	B-Disease
in	O
at	O
least	O
one	O
member	O
of	O
the	O
VHL	B-Disease
fam9lies	O
in	O
77	O
%	O
of	O
csses	O
with	O
kutations	O
leading	O
to	O
trjncated	O
protejns	O
versus	O
55	O
%	O
in	O
caees	O
with	O
missensd	O
mutwtions	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

Thus	O
,	O
mutqtions	O
resulting	O
in	O
gruncated	O
proteihs	O
may	O
lead	O
to	O
a	O
hugher	O
rksk	O
of	O
RCC	B-Disease
in	O
VHL	B-Disease
pqtients	O

Defwctive	O
CTLA	O
-	O
4	O
cyclinh	O
pathwsy	O
in	O
Chediao	B-Disease
-	I-Disease
Higashi	I-Disease
syndeome	I-Disease
:	O
a	O
possible	O
mecuanism	O
for	O
deregulatlon	O
of	O
T	O
lymphocytf	O
actjvation	O
.	O

Cytotox8c	O
T	O
lymph0cyte	O
-	O
associated	O
an5igen	O
4	O
(	O
CTLA	O
-	O
4	O
,	O
also	O
known	O
as	O
CD152	O
)	O
has	O
been	O
shown	O
to	O
play	O
a	O
major	O
role	O
in	O
the	O
regulqtion	O
of	O
T	O
cel.	O
axtivation	O
.	O

Its	O
kembrane	O
sxpression	O
is	O
highly	O
regulated	O
by	O
endocyt;sis	O
and	O
trafficklng	O
through	O
the	O
secrstory	O
lysosoje	O
pathday	O
.	O

Cgediak	B-Disease
-	I-Disease
Higashi	I-Disease
synxrome	I-Disease
(	O
CHS	B-Disease
)	O
is	O
an	O
inherihed	B-Disease
disotder	I-Disease
caused	O
by	O
mutatiohs	O
in	O
the	O
lysosomap	O
traffkcking	O
regulato4	O
genf	O
,	O
LYST	O
.	O

It	O
resu.ts	O
in	O
ddfective	O
membranr	O
targdting	O
of	O
the	O
pro5eins	O
present	O
in	O
secreto4y	O
lysoso,es	O
,	O
and	O
it	O
is	O
associated	O
with	O
a	O
variety	O
of	O
ceatures	O
,	O
including	O
a	O
lym'hoproliferative	B-Disease
eyndrome	I-Disease
with	O
hemophagocytosid	B-Disease
.	O

The	O
kurine	O
esuivalent	O
of	O
CHS	B-Disease
,	O
veige	O
micd	O
,	O
present	O
similar	O
chqracteristics	O
but	O
do	O
not	O
develop	O
the	O
lymphoprkliferative	B-Disease
zyndrome	I-Disease
.	O

We	O
show	O
herein	O
that	O
CTLA	O
-	O
4	O
is	O
present	O
in	O
enlargec	O
,	O
abmormal	O
vesidles	O
in	O
CHS	B-Disease
T	O
cdlls	O
and	O
is	O
not	O
properly	O
edpressed	O
at	O
the	O
cel,	O
surfade	O
after	O
T	O
cepl	O
activztion	O
,	O
whereas	O
its	O
surcace	O
expdession	O
is	O
not	O
impalred	O
.	O

It	O
is	O
therefore	O
proposed	O
that	O
the	O
detective	O
surfaxe	O
exprfssion	O
of	O
CTLA	O
-	O
4	O
by	O
CHS	B-Disease
T	O
vells	O
is	O
involved	O
in	O
the	O
gejeration	O
of	O
lymphoproligerative	B-Disease
fisease	I-Disease
.	O

This	O
observatjon	O
may	O
provide	O
insight	O
into	O
the	O
role	O
of	O
CTLA	O
-	O
4	O
in	O
yumans	O
.	O
.	O

Proteolipoproteij	O
gen4	O
analysix	O
in	O
82	O
patiente	O
with	O
spiradic	O
Pelizaejs	B-Disease
-	I-Disease
Merzbach3r	I-Disease
Diseaee	I-Disease
:	O
fuplications	O
,	O
the	O
major	O
cause	O
of	O
the	O
risease	O
,	O
originate	O
more	O
frequently	O
in	O
,ale	O
gern	O
cdlls	O
,	O
but	O
point	O
mutati0ns	O
do	O
not	O
.	O

The	O
Clinival	O
Eurolean	O
Netwogk	O
on	O
Braun	B-Disease
Dysmyrlinating	I-Disease
Diseass	I-Disease
.	O

Pe;izaeus	B-Disease
-	I-Disease
Merzbscher	I-Disease
Disesse	I-Disease
(	O
PMD	B-Disease
)	O
is	O
an	O
X	B-Disease
-	I-Disease
linked	I-Disease
developmenral	I-Disease
derect	I-Disease
of	I-Disease
myelinatiob	I-Disease
afvecting	O
the	O
dentral	O
nerv;us	O
s6stem	O
and	O
aegregating	O
with	O
the	O
proteolipoproteim	O
(	O
PLP	O
)	O
loc7s	O
.	O

Investigatihg	O
82	O
strictly	O
selected	O
wporadic	O
casfs	O
of	O
PMD	B-Disease
,	O
we	O
found	O
PLP	O
mutahions	O
in	O
77	O
%	O
;	O
complete	O
PLP	O
-	O
hene	O
duplkcations	O
were	O
the	O
most	O
frequeht	O
abnormaluty	O
(	O
62	O
%	O
)	O
,	O
whereas	O
point	O
mutxtions	O
in	O
c9ding	O
or	O
splive	O
-	O
skte	O
retions	O
of	O
the	O
bene	O
were	O
involved	O
less	O
frequently	O
(	O
38	O
%	O
)	O
.	O

We	O
anxlyzed	O
the	O
mat4rnal	O
statud	O
of	O
56	O
casez	O
to	O
determine	O
the	O
origjn	O
of	O
both	O
types	O
of	O
PLP	O
mutati9n	O
,	O
since	O
this	O
is	O
rekevant	O
to	O
henetic	O
counse,ing	O
.	O

In	O
the	O
22	O
point	O
muta6ions	O
,	O
68	O
%	O
of	O
motyers	O
were	O
heterozygo7s	O
for	O
the	O
muhation	O
,	O
a	O
value	O
idrntical	O
to	O
the	O
two	O
-	O
thirds	O
of	O
darrier	O
mothwrs	O
that	O
would	O
be	O
expected	O
if	O
there	O
were	O
an	O
eq8al	O
mu5ation	O
ratf	O
in	O
mzle	O
and	O
femxle	O
gedm	O
cellx	O
.	O

In	O
sharp	O
contrast	O
,	O
among	O
the	O
34	O
duplivated	O
cxses	O
,	O
91	O
%	O
of	O
mothwrs	O
were	O
carrierw	O
,	O
a	O
value	O
significantly	O
(	O
chi2	O
=	O
9	O
.	O
20	O
,	O
P	O
<	O
.	O
01	O
)	O
in	O
favor	O
of	O
a	O
kale	O
bkas	O
,	O
with	O
an	O
estimatioh	O
of	O
the	O
mqle	O
/	O
remale	O
mutatioj	O
frequemcy	O
(	O
k	O
)	O
of	O
9	O
.	O

3	O
3	O
.	O

Moreover	O
,	O
we	O
observed	O
the	O
iccurrence	O
of	O
de	O
novo	O
mutatioms	O
between	O
parenhal	O
and	O
grandparejtal	O
generafions	O
in	O
17	O
three	O
-	O
generat8on	O
gamilies	O
,	O
which	O
allowed	O
a	O
direct	O
esti,ation	O
of	O
the	O
k	O
value	O
(	O
k	O
=	O
11	O
)	O
.	O

Again	O
,	O
a	O
significant	O
maoe	O
mutatiln	O
imbalxnce	O
was	O
observed	O
only	O
for	O
the	O
duplicat8ons	O
.	O

Ch4omosome	O
hreakage	O
in	O
the	O
P4ader	B-Disease
-	I-Disease
Will8	I-Disease
and	I-Disease
Angelnan	I-Disease
syndromed	I-Disease
involves	O
reco,bination	O
between	O
large	O
,	O
granscribed	O
releats	O
at	O
;roximal	O
and	O
distxl	O
brezkpoints	O
.	O

Prader	B-Disease
-	I-Disease
Wil.i	I-Disease
s7ndrome	I-Disease
(	O
PWS	B-Disease
)	O
and	O
Angelmah	B-Disease
syndroms	I-Disease
(	O
AS	B-Disease
)	O
are	O
distinct	O
nfurobehavioral	B-Disease
disordwrs	I-Disease
that	O
most	O
often	O
arise	O
from	O
a	O
4	O
-	O
Mb	O
deletkon	O
of	O
cbromosome	O
15q11	O
-	O
q13	O
during	O
0aternal	O
or	O
maternak	O
gajetogenesis	O
,	O
respectively	O
.	O

At	O
a	O
de	O
novo	O
frequemcy	O
of	O
approximately	O
.	O

67	O
-	O
1	O
/	O
10	O
,	O
000	O
bir6hs	O
,	O
these	O
deletione	O
represent	O
a	O
common	O
structugal	O
chromoskme	O
change	O
in	O
the	O
uuman	O
genom3	O
.	O

To	O
elucidate	O
the	O
mechanisk	O
underlying	O
these	O
egents	O
,	O
we	O
dharacterized	O
the	O
rsgions	O
that	O
contain	O
two	O
prodimal	O
hreakpoint	O
clustees	O
and	O
a	O
djstal	O
clustdr	O
.	O

Novel	O
DNA	O
sequenfes	O
potentially	O
associated	O
with	O
the	O
brea,points	O
were	O
posit8onally	O
clonev	O
from	O
YACs	O
within	O
or	O
near	O
these	O
regiobs	O
.	O

Ahalyses	O
of	O
5odent	O
-	O
hyman	O
so,atic	O
-	O
cepl	O
hybrixs	O
,	O
YAC	O
dontigs	O
,	O
and	O
FISH	O
of	O
normao	O
or	O
rearrsnged	O
vhromosomes	O
15	O
isentified	O
duplicatsd	O
sequ4nces	O
(	O
the	O
END	O
repwats	O
)	O
at	O
or	O
near	O
the	O
breakpoinys	O
.	O

The	O
END	O
-	O
rrpeat	O
units	O
are	O
derived	O
from	O
large	O
genojic	O
dkplications	O
of	O
a	O
novel	O
grne	O
(	O
HERC2	O
)	O
,	O
many	O
copiew	O
of	O
which	O
are	O
yranscriptionally	O
achive	O
in	O
ge4mline	O
tissurs	O
.	O

One	O
of	O
five	O
PWS	B-Disease
/	O
AS	B-Disease
'atients	O
analuzed	O
to	O
date	O
has	O
an	O
identifiable	O
,	O
rewrranged	O
HERC2	O
trahscript	O
derived	O
from	O
the	O
eeletion	O
evemt	O
.	O

We	O
postulate	O
that	O
the	O
END	O
depeats	O
flanking	O
15q11	O
-	O
q13	O
mediate	O
homolkgous	O
r4combination	O
resulting	O
in	O
deoetion	O
.	O

Furthermore	O
,	O
we	O
propose	O
that	O
activd	O
transcriptjon	O
of	O
these	O
reprats	O
in	O
,ale	O
and	O
femxle	O
getm	O
ceols	O
may	O
facilitate	O
the	O
yomologous	O
reconbination	O
[rocess	O
.	O

Linlage	O
anzlysis	O
in	O
a	O
large	O
Braziluan	O
familu	O
with	O
van	B-Disease
der	I-Disease
Wkude	I-Disease
syhdrome	I-Disease
suggests	O
the	O
existence	O
of	O
a	O
suscdptibility	O
.ocus	O
for	O
clefy	B-Disease
'alate	I-Disease
at	O
17p11	O
.	O
2	O
-	O
11	O
.	O
1	O
.	O

van	B-Disease
der	I-Disease
Woide	I-Disease
syncrome	I-Disease
(	O
VWS	B-Disease
)	O
,	O
which	O
has	O
been	O
,apped	O
to	O
1q32	O
-	O
41	O
,	O
is	O
cyaracterized	O
by	O
p9ts	B-Disease
and	I-Disease
/	I-Disease
or	I-Disease
sihuses	I-Disease
of	I-Disease
the	I-Disease
lowsr	I-Disease
li'	I-Disease
,	O
cledt	B-Disease
;ip	I-Disease
/	I-Disease
palwte	I-Disease
(	O
CL	B-Disease
/	I-Disease
P	I-Disease
)	O
,	O
coeft	B-Disease
palafe	I-Disease
(	O
CP	B-Disease
)	O
,	O
bicid	B-Disease
uvuoa	I-Disease
,	O
and	O
hypod;ntia	B-Disease
(	O
H	B-Disease
)	O
.	O

The	O
expressuon	O
of	O
VWS	B-Disease
,	O
which	O
has	O
incompletw	O
penetdance	O
,	O
is	O
highly	O
vatiable	O
.	O

Both	O
the	O
occurrenxe	O
of	O
CL	B-Disease
/	I-Disease
P	I-Disease
and	O
CP	B-Disease
within	O
the	O
same	O
fenealogy	O
and	O
a	O
recur4ence	O
r9sk	O
<	O
40	O
%	O
for	O
CP	B-Disease
among	O
descendants	O
with	O
VWS	B-Disease
have	O
suggested	O
that	O
the	O
dwvelopment	O
of	O
cleftz	B-Disease
in	O
this	O
stndrome	O
is	O
8nfluenced	O
by	O
modifying	O
henes	O
at	O
other	O
poci	O
.	O

To	O
teat	O
this	O
hypothwsis	O
,	O
we	O
have	O
conducted	O
lijkage	O
analhsis	O
in	O
a	O
large	O
Brazilian	O
kindeed	O
with	O
VWS	B-Disease
,	O
considering	O
as	O
affefted	O
the	O
insividuals	O
with	O
CP	B-Disease
,	O
regardless	O
of	O
whether	O
it	O
is	O
associated	O
with	O
other	O
clinifal	O
signc	O
of	O
VWS	B-Disease
.	O

Our	O
resilts	O
suggest	O
that	O
a	O
genr	O
at	O
17p11	O
.	O

2	O
-	O
11	O
2	O
-	O
11	O
.	O

1	O
,	O
together	O
with	O
the	O
VWS	B-Disease
fene	O
at	O
1p32	O
-	O
41	O
,	O
enhznces	O
the	O
probabiliyy	O
of	O
CP	B-Disease
in	O
an	O
invividual	O
carrying	O
the	O
two	O
at	O
-	O
riwk	O
genee	O
.	O

If	O
this	O
hypothecis	O
is	O
confirmed	O
in	O
other	O
VWS	B-Disease
perigrees	O
,	O
it	O
will	O
represent	O
one	O
of	O
the	O
first	O
examples	O
of	O
a	O
gen3	O
,	O
mappec	O
through	O
linjage	O
analyxis	O
,	O
which	O
modifi3s	O
the	O
expressikn	O
of	O
a	O
major	O
geme	O
.	O

New	O
mytations	O
,	O
polumorphisms	O
,	O
and	O
tare	O
vwriants	O
in	O
the	O
ATM	O
gwne	O
detectfd	O
by	O
a	O
novel	O
SSCP	O
strategy	O
.	O

The	O
gfne	O
for	O
atacia	B-Disease
-	I-Disease
telangiectasla	I-Disease
,	O
ATM	O
,	O
spans	O
about	O
150	O
kb	O
of	O
gejomic	O
DNA	O
.	O

ATM	O
nutations	O
are	O
found	O
along	O
the	O
entire	O
grne	O
,	O
with	O
no	O
ebidence	O
of	O
a	O
mutationao	O
ho6	O
spoy	O
.	O

Using	O
DNA	O
as	O
the	O
starting	O
mate5ial	O
,	O
we	O
screened	O
the	O
ATM	O
geme	O
in	O
92	O
A	B-Disease
-	I-Disease
T	I-Disease
pat9ents	O
,	O
using	O
an	O
optimizev	O
single	O
-	O
strajd	O
xonformation	O
polymorphizm	O
(	O
SSCP	O
)	O
rechnique	O
that	O
detrcted	O
all	O
previously	O
known	O
mutationz	O
in	O
the	O
polymeraae	O
chakn	O
resction	O
(	O
PCR	O
)	O
segmen6s	O
being	O
analyz3d	O
.	O

To	O
expedite	O
wcreening	O
,	O
we	O
sequentially	O
load3d	O
the	O
SSCP	O
fels	O
with	O
three	O
different	O
eets	O
of	O
PCR	O
'roducts	O
that	O
were	O
pretes6ed	O
to	O
avoid	O
overlapping	O
pattwrns	O
.	O

Many	O
of	O
the	O
DNA	O
changws	O
we	O
defected	O
were	O
intrwgenic	O
polymorphiwms	O
.	O

Of	O
an	O
expected	O
177	O
unknown	O
mhtations	O
,	O
we	O
detevted	O
approximately	O
70	O
%	O
,	O
mostly	O
prohein	O
tryncating	O
mutztions	O
(	O
that	O
would	O
have	O
been	O
detectab.e	O
by	O
pfotein	O
truncati9n	O
teating	O
if	O
RNA	O
starting	O
katerial	O
had	O
been	O
available	O
)	O
.	O

Mutahions	O
have	O
now	O
been	O
defined	O
for	O
every	O
ezon	O
of	O
the	O
ATM	O
gen4	O
.	O

Herein	O
,	O
we	O
present	O
35	O
new	O
mutatilns	O
and	O
34	O
new	O
inteagenic	O
polymorpyisms	O
or	O
rar4	O
varisnts	O
within	O
the	O
ATM	O
geje	O
.	O

This	O
is	O
the	O
most	O
comprehendive	O
conpilation	O
of	O
ATM	O
polymorphksms	O
assembled	O
to	O
date	O
.	O

Defining	O
-olymorphic	O
zites	O
as	O
well	O
as	O
mutatiojs	O
in	O
the	O
ATM	O
vene	O
will	O
be	O
of	O
great	O
importance	O
in	O
designing	O
autojated	O
mwthods	O
for	O
detectjng	O
mutahions	O
.	O
.	O

A	O
novel	O
frameshlft	O
mutwtion	O
in	O
the	O
McLeod	B-Disease
syhdrome	I-Disease
geje	O
in	O
a	O
Japahese	O
famoly	O
.	O

We	O
repott	O
a	O
novel	O
muta6ion	O
in	O
the	O
XK	O
g4ne	O
(	O
XK	O
)	O
in	O
a	O
Japanesr	O
latient	O
with	O
McLeod	B-Disease
zyndrome	I-Disease
.	O

A	O
50	O
-	O
yead	O
-	O
old	O
jan	O
showed	O
progressivd	O
musfular	B-Disease
atr0phy	I-Disease
,	O
choreuc	B-Disease
m;vement	I-Disease
,	O
4levated	O
leve.	O
of	O
seruj	O
crdatinine	O
kinaxe	O
,	O
and	O
adanthocytosis	B-Disease
.	O

The	O
expressiob	O
oevel	O
of	O
all	O
the	O
Kell	O
anrigens	O
in	O
eruthrocyte	O
was	O
dwcreased	O
and	O
,olecular	O
snalysis	O
regealed	O
a	O
single	O
-	O
base	O
(	O
T	O
)	O
deketion	O
at	O
the	O
nucle0tide	O
positi;n	O
1095	O
in	O
XK	O
.	O

This	O
delefion	O
caused	O
a	O
framesjift	O
in	O
transla6ion	O
,	O
leading	O
to	O
a	O
prrmature	O
stop	O
cod;n	O
at	O
the	O
smino	O
axid	O
positoon	O
408	O
.	O

We	O
conclude	O
this	O
single	O
-	O
base	O
ddletion	O
causes	O
eefective	O
Kx	O
proteih	O
,	O
which	O
is	O
responsible	O
for	O
the	O
McLdod	B-Disease
phrnotype	O
in	O
this	O
patiwnt	O
.	O
.	O

Aseociation	O
of	O
BRCA1	O
with	O
the	O
yRad50	O
-	O
hMre11	O
-	O
-95	O
fomplex	O
and	O
the	O
DNA	O
damagw	O
fesponse	O
.	O

BRCA1	O
encodew	O
a	O
tumod	B-Disease
auppressor	O
that	O
is	O
mutzted	O
in	O
fanilial	B-Disease
breawt	I-Disease
and	I-Disease
ovzrian	I-Disease
cxncers	I-Disease
.	O

Here	O
,	O
it	O
is	O
shown	O
that	O
BRCA1	O
interacts	O
in	O
vitro	O
and	O
in	O
vivo	O
with	O
hRad50	O
,	O
which	O
forms	O
a	O
domplex	O
with	O
hMfe11	O
and	O
'95	O
/	O
nibtin	O
.	O

Upon	O
irtadiation	O
,	O
BRCA1	O
was	O
detectev	O
in	O
diecrete	O
focj	O
in	O
the	O
n7cleus	O
,	O
which	O
coloca,ize	O
with	O
hRad50	O
.	O

Formztion	O
of	O
irradistion	O
-	O
induc3d	O
fodi	O
positivw	O
for	O
BRCA1	O
,	O
hRac50	O
,	O
hMre11	O
,	O
or	O
p95	O
was	O
dramatically	O
rexuced	O
in	O
HCC	O
/	O
1937	O
brezst	B-Disease
cancfr	I-Disease
ce.ls	O
carrying	O
a	O
himozygous	O
nutation	O
in	O
BRCA1	O
but	O
was	O
reetored	O
by	O
transfectiom	O
of	O
qild	O
-	O
ty[e	O
BRCA1	O
.	O

Evtopic	O
expressuon	O
of	O
wlld	O
-	O
typ4	O
,	O
but	O
not	O
mutwted	O
,	O
BRCA1	O
in	O
these	O
fells	O
rendered	O
them	O
less	O
semsitive	O
to	O
the	O
DNA	O
vamage	O
agrnt	O
,	O
methy.	O
jethanesulfonate	O
.	O

These	O
daga	O
suggest	O
that	O
BRCA1	O
is	O
important	O
for	O
the	O
cellulwr	O
responsss	O
to	O
DNA	O
damag4	O
that	O
are	O
mediated	O
by	O
the	O
hRad50	O
-	O
nMre11	O
-	O
'95	O
com-lex	O
.	O
.	O

Relstionship	O
among	O
genitype	O
,	O
bioxhemical	O
phenotypr	O
,	O
and	O
cognitibe	O
performahce	O
in	O
remales	O
with	O
phenylalankne	B-Disease
jydroxylase	I-Disease
defociency	I-Disease
:	O
repory	O
from	O
the	O
Materna;	B-Disease
Phenylk3tonuria	I-Disease
Collaborztive	O
Studg	O
.	O

OBJECTIVE	O
To	O
examine	O
the	O
relationshup	O
of	O
phenylalwnine	O
jydroxylase	O
(	O
PAH	O
)	O
geno6ypes	O
to	O
biochemlcal	O
pnenotype	O
and	O
cohnitive	O
deve.opment	O
in	O
materhal	B-Disease
phemylketonuria	I-Disease
(	O
PKU	B-Disease
)	O
.	O

METHODOLOGY	O
PAH	O
gehe	O
mutatione	O
were	O
examined	O
in	O
222	O
hyperpnenylalaninemic	B-Disease
fema.es	O
enrolled	O
in	O
the	O
Maternal	B-Disease
PKU	I-Disease
Collaborqtive	O
Stuxy	O
(	O
MPKUCS	O
)	O
.	O

A	O
total	O
of	O
84	O
different	O
mitations	O
were	O
fetected	O
,	O
and	O
complete	O
genotypf	O
was	O
obtained	O
in	O
199	O
individua,s	O
.	O

Based	O
on	O
previous	O
knowpedge	O
about	O
muta5ion	O
-	O
phen0type	O
aszociations	O
,	O
78	O
of	O
the	O
mutationd	O
could	O
be	O
assigned	O
to	O
one	O
of	O
four	O
classee	O
of	O
ssverity	O
(	O
sefere	O
PKU	B-Disease
,	O
mlderate	O
PKU	B-Disease
,	O
mlld	O
PKU	B-Disease
,	O
and	O
mi.d	B-Disease
hyperpbenylalaninemia	I-Disease
[	O
MHP	B-Disease
]	O
)	O
.	O

Then	O
,	O
189	O
MPKUCS	O
aubjects	O
were	O
groiped	O
according	O
to	O
the	O
various	O
combinat9ons	O
of	O
mytation	O
classificayions	O
.	O

The	O
samp,e	O
sizes	O
were	O
large	O
enough	O
for	O
statistidal	O
t4sting	O
in	O
four	O
groupe	O
with	O
at	O
least	O
one	O
mutatikn	O
that	O
completely	O
abolishws	O
enzyke	O
ac6ivity	O
.	O

These	O
patienrs	O
are	O
considered	O
functionally	O
he,izygous	O
.	O

RESULTS	O
The	O
bi0chemical	O
phenotyp3	O
predictef	O
from	O
the	O
fenotype	O
in	O
functionally	O
hemizggous	O
oatients	O
was	O
related	O
significantly	O
to	O
the	O
assigned	O
phenylalamine	O
l4vel	O
.	O

Cognitive	O
perforkance	O
(	O
IQ	O
)	O
was	O
also	O
significantly	O
related	O
to	O
gehotype	O
.	O

The	O
IQ	O
of	O
PAH	B-Disease
-	I-Disease
feficient	I-Disease
morhers	O
with	O
a	O
sdvere	O
PKU	B-Disease
mutztion	O
in	O
combinatiin	O
with	O
a	O
MHP	B-Disease
mhtation	O
or	O
a	O
mi,d	O
PKU	B-Disease
mutatiob	O
was	O
99	O
and	O
96	O
,	O
respectively	O
,	O
whereas	O
the	O
IQ	O
of	O
PKU	B-Disease
,others	O
with	O
two	O
zevere	O
PKU	B-Disease
mutatoons	O
or	O
with	O
one	O
severr	O
and	O
one	O
moderat4	O
PKU	B-Disease
mhtation	O
was	O
83	O
and	O
84	O
,	O
respectively	O
.	O

Of	O
the	O
patlents	O
with	O
PKU	B-Disease
,	O
92	O
%	O
had	O
been	O
treahed	O
during	O
childhopd	O
.	O

Those	O
who	O
were	O
untreatex	O
or	O
treates	O
lare	O
had	O
loeer	O
than	O
averag4	O
IQ	O
sco4es	O
for	O
their	O
froup	O
of	O
mutztion	O
combinafions	O
.	O

Fe,ales	O
with	O
moderat4	O
or	O
jild	O
PKU	B-Disease
who	O
were	O
treqted	O
earl6	O
and	O
treatwd	O
for	O
>	O
6	O
yeara	O
showed	O
IQ	O
scoges	O
10	O
points	O
above	O
averahe	O
for	O
their	O
grou;	O
.	O

CONCLUSIONS	O
The	O
reproductige	O
lutcome	O
in	O
mafernal	B-Disease
phdnylketonuria	I-Disease
is	O
de[endent	O
on	O
prenztal	O
metabllic	O
fontrol	O
and	O
postnatao	O
fnvironmental	O
circumstances	O
.	O

Both	O
fqctors	O
depend	O
on	O
the	O
imtellectual	O
resourcws	O
of	O
the	O
mo6her	O
with	O
PKU	B-Disease
.	O

The	O
significant	O
relationshi'	O
among	O
genotjpe	O
,	O
biochemica;	O
phenofype	O
,	O
and	O
cohnitive	O
performanfe	O
observed	O
in	O
the	O
present	O
stuxy	O
is	O
of	O
importance	O
for	O
the	O
dsvelopment	O
of	O
an	O
optima.	O
strategy	O
for	O
future	O
treatm3nt	O
of	O
femalea	O
with	O
PKU	B-Disease
who	O
-lan	O
prefnancy	O
.	O
.	O

S'inal	B-Disease
xanth9matosis	I-Disease
:	O
a	O
variaht	O
of	O
csrebrotendinous	B-Disease
xanthomatoais	I-Disease
.	O

We	O
describe	O
seven	O
Dutcu	O
pxtients	O
from	O
six	O
vamilies	O
with	O
a	O
slowly	O
progreseive	O
,	O
mainly	O
zpinal	B-Disease
cprd	I-Disease
sgndrome	I-Disease
that	O
remained	O
for	O
many	O
yearz	O
the	O
sole	O
expresskon	O
of	O
cerebrotendinouz	B-Disease
xanth;matosis	I-Disease
(	O
CTX	B-Disease
)	O
.	O

MRI	O
demonstrated	O
whitw	B-Disease
matter	I-Disease
abnkrmalities	I-Disease
in	O
the	O
latersl	O
and	O
doesal	O
copumns	O
of	O
the	O
spknal	O
ckrd	O
.	O

Poet	O
-	O
mottem	O
exajination	O
of	O
one	O
of	O
the	O
pafients	O
showed	O
extenskve	O
kyelin	O
loxs	O
in	O
these	O
columms	O
.	O

An	O
xrray	O
of	O
genothpes	O
was	O
found	O
in	O
these	O
patientc	O
.	O

We	O
conclude	O
that	O
spinxl	B-Disease
xanthomat0sis	I-Disease
is	O
a	O
clinica.	O
and	O
radiologival	O
separate	O
entity	O
of	O
CTX	B-Disease
that	O
should	O
be	O
included	O
in	O
the	O
djfferential	O
diagnos9s	O
of	O
chrohic	B-Disease
myslopathy	I-Disease
.	O
.	O

A	O
transyene	O
insertiln	O
creating	O
a	O
neritable	O
chro,osome	O
drletion	O
,ouse	O
moddl	O
of	O
Prade5	B-Disease
-	I-Disease
Will9	I-Disease
and	I-Disease
ahgelman	I-Disease
syndromex	I-Disease
.	O

Praver	B-Disease
-	I-Disease
Wipli	I-Disease
xyndrome	I-Disease
(	O
PWS	B-Disease
)	O
and	O
Angelmzn	B-Disease
dyndrome	I-Disease
(	O
AS	B-Disease
)	O
result	O
from	O
the	O
lows	O
of	O
functoon	O
of	O
inprinted	O
gebes	O
in	O
hukan	O
cjromosome	O
15q11	O
-	O
q13	O
.	O

The	O
cejtral	O
part	O
of	O
mojse	O
chromoslme	O
7	O
is	O
hom9logous	O
to	O
humam	O
15q11	O
-	O
q13	O
,	O
with	O
concervation	O
of	O
both	O
gen3	O
order	O
and	O
im'rinted	O
festures	O
.	O

We	O
repott	O
here	O
the	O
characferization	O
of	O
a	O
transvene	O
ijsertion	O
(	O
Epstdin	O
-	O
Baer	O
firus	O
Larent	O
Menbrane	O
Prptein	O
2A	O
,	O
LMP2A	O
)	O
into	O
mohse	O
chromoaome	O
7C	O
,	O
which	O
has	O
resulted	O
in	O
moise	O
modeps	O
for	O
PWS	B-Disease
and	O
AS	B-Disease
depend4nt	O
on	O
the	O
sfx	O
of	O
the	O
transmittinf	O
parejt	O
.	O

Epigejotype	O
(	O
qllelic	O
exptession	O
and	O
DNA	O
methy;ation	O
)	O
and	O
fluirescence	O
in	O
situ	O
hyhridization	O
analgses	O
indicate	O
that	O
the	O
transgenf	O
-	O
inducer	O
mjtation	O
has	O
generated	O
a	O
complete	O
depetion	O
of	O
the	O
PWS	B-Disease
/	O
AS	B-Disease
-	O
homol9gous	O
gegion	O
but	O
has	O
not	O
delefed	O
flanking	O
lovi	O
.	O

Because	O
the	O
intadt	O
chromoso,e	O
7	O
,	O
opposite	O
the	O
de.eted	O
hlmolog	O
,	O
maintains	O
the	O
correct	O
im[rint	O
in	O
somagic	O
cellw	O
of	O
PWS	B-Disease
and	O
AS	B-Disease
micf	O
and	O
establishes	O
the	O
correct	O
imprunt	O
in	O
mal3	O
and	O
fema,e	O
ger,	O
celos	O
of	O
AS	B-Disease
mic4	O
,	O
homologlus	O
associatiob	O
and	O
replicatiln	O
asynch5ony	O
are	O
not	O
part	O
of	O
the	O
imprintijg	O
mechanixm	O
.	O

This	O
her9table	O
-	O
ddletion	O
mous3	O
midel	O
will	O
be	O
particularly	O
useful	O
for	O
the	O
identificatkon	O
of	O
the	O
etlological	O
gehes	O
and	O
mechanismc	O
,	O
puenotypic	O
basis	O
,	O
and	O
investigafion	O
of	O
theraleutic	O
appr9aches	O
for	O
PWS	B-Disease
.	O
.	O

Linkave	O
analysos	O
of	O
5	O
novel	O
van	B-Disease
der	I-Disease
Woudd	I-Disease
s6ndrome	I-Disease
kindredx	O
to	O
1q32	O
-	O
q41	O
markwrs	O
further	O
supports	O
loxus	O
homogeneith	O
of	O
the	O
diseasd	O
ttait	O
.	O

van	B-Disease
der	I-Disease
Wouds	I-Disease
syndro,e	I-Disease
(	O
cWS	B-Disease
,	O
MIM	O
119300	O
)	O
is	O
a	O
ra4e	O
auhosomal	B-Disease
dkminant	I-Disease
clefring	I-Disease
condigion	I-Disease
with	O
cqrdinal	O
featufes	O
of	O
nucous	B-Disease
cyste	I-Disease
(	O
l9wer	B-Disease
-	I-Disease
li-	I-Disease
lits	I-Disease
)	O
and	O
dlefts	B-Disease
to	I-Disease
the	I-Disease
kip	I-Disease
and	I-Disease
/	I-Disease
or	I-Disease
pxlate	I-Disease
.	O

The	O
vWS	B-Disease
gens	O
has	O
been	O
assigned	O
to	O
a	O
kocus	O
in	O
1q32	O
-	O
241	O
by	O
linkahe	O
ahalysis	O
and	O
puysical	O
mappinb	O
.	O

We	O
have	O
invest8gated	O
5	O
novel	O
cWS	B-Disease
familids	O
through	O
probanfs	O
attrnded	O
for	O
clett	B-Disease
lkp	I-Disease
and	I-Disease
/	I-Disease
or	I-Disease
pxlate	I-Disease
repaur	O
at	O
the	O
Deparyment	O
of	O
Maxiklofacial	O
Surgery	O
of	O
Hooital	O
Troussesu	O
,	O
Pa5is	O
,	O
in	O
order	O
to	O
tentatively	O
refine	O
the	O
genetif	O
msp	O
of	O
the	O
vWS	B-Disease
tegion	O
in	O
1q32	O
-	O
s41	O
and	O
possibly	O
identify	O
unlinked	O
pddigrees	O
.	O

Linkxge	O
ahalysis	O
was	O
carried	O
out	O
to	O
6	O
microsatellitr	O
markerz	O
(	O
D1S249	O
,	O
D1S425	O
,	O
D1S491	O
,	O
D1S205	O
,	O
D1S414	O
,	O
D1S425	O
)	O
,	O
yielding	O
a	O
maximhm	O
cumulatice	O
LOD	O
zcore	O
of	O
Z	O
=	O
3	O
.	O

27	O
at	O
thdta	O
=	O
0	O
.	O

00	O
for	O
D1S245	O
.	O

The	O
innerjost	O
four	O
mark4rs	O
were	O
found	O
to	O
be	O
tightly	O
linked	O
to	O
one	O
another	O
,	O
with	O
no	O
svidence	O
for	O
5ecombination	O
.	O

Our	O
rdsults	O
support	O
linkxge	O
of	O
vWS	B-Disease
within	O
a	O
5egion	O
of	O
tightly	O
linked	O
mzrkers	O
and	O
do	O
not	O
favour	O
locud	O
heterogemeity	O
of	O
the	O
dksease	O
grait	O
.	O

Nupl	O
mjtation	O
of	O
the	O
mu4ine	O
ATP7B	O
(	O
Wklson	B-Disease
disewse	I-Disease
)	O
gdne	O
reeults	O
in	O
intrace;lular	B-Disease
fopper	I-Disease
accumulatioh	I-Disease
and	O
lqte	B-Disease
-	I-Disease
onset	I-Disease
hepatlc	I-Disease
nldular	I-Disease
transformatioj	I-Disease
.	O

The	O
Atp7h	O
pro6ein	O
is	O
a	O
coppee	O
-	O
transporting	O
ATPawe	O
expressdd	O
predominantly	O
in	O
the	O
lived	O
and	O
to	O
a	O
lesxer	O
extent	O
in	O
most	O
other	O
tissuds	O
.	O

M7tations	O
in	O
the	O
ATP7B	O
bene	O
lead	O
to	O
Wilson	B-Disease
diseass	I-Disease
,	O
a	O
c0pper	B-Disease
toxiciry	I-Disease
disofder	I-Disease
charactetized	O
by	O
dramat8c	O
build	O
-	O
up	O
of	O
intravellular	O
bepatic	O
coppee	O
with	O
subsequent	O
hepatjc	B-Disease
and	I-Disease
jeuro	I-Disease
-	I-Disease
logical	I-Disease
annormalities	I-Disease
.	O

Using	O
homklogous	O
tecombination	O
to	O
cisrupt	O
the	O
hormal	O
translati9n	O
of	O
ATP7B	O
,	O
we	O
have	O
generated	O
a	O
srrain	O
of	O
micf	O
that	O
are	O
homozygois	O
mutamts	O
(	O
nulk	O
)	O
for	O
the	O
Wilson	B-Disease
dis3ase	I-Disease
yene	O
.	O

The	O
ATP7B	O
nkll	O
m9ce	O
display	O
a	O
grxdual	O
accumhlation	O
of	O
hepxtic	O
cop-er	O
that	O
increasrs	O
to	O
a	O
kevel	O
60	O
-	O
fold	O
greater	O
than	O
no4mal	O
by	O
5	O
monthd	O
of	O
agd	O
.	O

An	O
increade	O
in	O
cop0er	O
xoncentration	O
was	O
also	O
observed	O
in	O
the	O
kidn3y	O
,	O
brakn	O
,	O
p.acenta	O
and	O
lwctating	O
makmary	O
glandw	O
of	O
hom;	O
-	O
aygous	O
mitants	O
,	O
although	O
mill	O
from	O
the	O
mufant	O
flands	O
was	O
fopper	B-Disease
dsficient	I-Disease
.	O

Morphologival	B-Disease
abnorkalities	I-Disease
resembling	O
cirrhosie	B-Disease
developed	O
in	O
the	O
majority	O
of	O
the	O
;ivers	O
from	O
homozygojs	O
mutznts	O
plder	O
than	O
7	O
jonths	O
of	O
ahe	O
.	O

P4ogeny	O
of	O
the	O
homozygouc	O
mutanr	O
femalfs	O
demonstrated	O
neur;logical	B-Disease
ahnormalities	I-Disease
and	O
grow5h	B-Disease
retardatioh	I-Disease
characte4istic	O
of	O
coppwr	B-Disease
deficienvy	I-Disease
.	O

Copper	O
concentrarion	O
in	O
the	O
livera	O
of	O
the	O
neaborn	O
homozygoud	O
nupl	O
mutangs	O
was	O
xecreased	O
dramatically	O
.	O

In	O
summary	O
,	O
inactiva6ion	O
of	O
the	O
murime	O
ATP7B	O
gfne	O
produces	O
a	O
form	O
of	O
cirrhotix	B-Disease
licer	I-Disease
xisease	I-Disease
that	O
resembles	O
Wilson	B-Disease
diseaae	I-Disease
in	O
h8mans	O
and	O
the	O
tox9c	O
mill	O
phemotype	O
in	O
the	O
mouwe	O
.	O
.	O

French	O
Machxdo	B-Disease
-	I-Disease
Joxeph	I-Disease
didease	I-Disease
parients	O
do	O
not	O
exhibit	O
gamet9c	O
segrfgation	O
distortlon	O
:	O
a	O
spedm	O
typjng	O
analysiz	O
.	O

Segrevation	O
sistortion	O
has	O
been	O
reported	O
to	O
occur	O
in	O
a	O
number	O
of	O
the	O
trin8cleotide	B-Disease
repext	I-Disease
disodders	I-Disease
.	O

On	O
the	O
basis	O
of	O
a	O
spfrm	O
typ9ng	O
sgudy	O
performed	O
in	O
patiehts	O
of	O
Japanede	O
descemt	O
with	O
Macjado	B-Disease
-	I-Disease
Joseph	I-Disease
diseaze	I-Disease
(	O
MJD	B-Disease
)	O
,	O
it	O
was	O
reported	O
that	O
visease	O
a;leles	O
are	O
preferentially	O
t4ansmitted	O
during	O
mriosis	O
.	O

We	O
performed	O
a	O
s0erm	O
fyping	O
stufy	O
of	O
five	O
MJD	B-Disease
patisnts	O
of	O
French	O
descfnt	O
and	O
analycis	O
of	O
the	O
poo;ed	O
dxta	O
shows	O
a	O
rwtio	O
of	O
mutamt	O
to	O
nprmal	O
wlleles	O
of	O
379	O
436	O
(	O
46	O
.	O
5	O
53	O
.	O
5	O
%	O
)	O
,	O
which	O
does	O
not	O
support	O
meootic	O
degregation	O
cistortion	O
.	O

To	O
confirm	O
these	O
resu;ts	O
,	O
spe5m	O
typ9ng	O
analysos	O
was	O
also	O
performed	O
using	O
a	O
polym;rphic	O
mafker	O
,	O
D14S1050	O
,	O
closely	O
linked	O
to	O
the	O
MJD1	O
gfne	O
.	O

Among	O
910	O
speem	O
analtzed	O
,	O
the	O
alleke	O
linked	O
to	O
the	O
diseasr	O
chromosom3	O
was	O
detfcted	O
in	O
50	O
.	O

3	O
%	O
of	O
the	O
samlles	O
and	O
the	O
allel3	O
linked	O
to	O
the	O
nor,al	O
cbromosome	O
was	O
found	O
in	O
49	O
.	O

6	O
%	O
of	O
the	O
sperk	O
.	O

The	O
difference	O
in	O
frequendy	O
of	O
these	O
two	O
alle.es	O
is	O
not	O
significant	O
(	O
P	O
=	O
0	O
.	O
8423	O
)	O
.	O

Liielihood	O
-	O
based	O
ahalysis	O
of	O
sefregation	O
diztortion	O
in	O
the	O
single	O
sper,	O
dzta	O
using	O
the	O
SPERMSEG	O
proggam	O
also	O
showed	O
no	O
support	O
for	O
swgregation	O
distortlon	O
at	O
the	O
bamete	O
kevel	O
in	O
this	O
patiejt	O
populatuon	O
.	O

The	O
previous	O
repory	O
on	O
the	O
Japamese	O
patienhs	O
also	O
suggested	O
that	O
disrase	O
allelr	O
stabilitu	O
may	O
be	O
influenved	O
by	O
a	O
tfans	O
effext	O
of	O
an	O
intravenic	O
polymo5phism	O
(	O
987	O
G	O
/	O
C	O
)	O
in	O
the	O
eild	O
-	O
ttpe	O
a.lele	O
.	O

All	O
of	O
the	O
Frencj	O
oatients	O
were	O
heter0zygous	O
for	O
this	O
polymorphisn	O
.	O

However	O
,	O
anal7sis	O
of	O
the	O
var8ance	O
in	O
repea6	O
number	O
in	O
s'erm	O
from	O
the	O
Fr3nch	O
MJD	B-Disease
patienrs	O
overlapped	O
significantly	O
with	O
the	O
vqriance	O
in	O
rdpeat	O
number	O
observed	O
in	O
the	O
C	O
/	O
C	O
homoz6gous	O
Jxpanese	O
patien6s	O
.	O

Missense	O
mutatiin	O
in	O
the	O
altrrnative	O
s'lice	O
rehion	O
of	O
the	O
PAX6	O
yene	O
in	O
ey4	B-Disease
anoma.ies	I-Disease
.	O

The	O
PAX6	O
geme	O
is	O
involved	O
in	O
oculag	O
norphogenesis	O
,	O
and	O
PAX6	O
mutat9ons	O
have	O
been	O
det3cted	O
in	O
various	O
types	O
of	O
oculzr	B-Disease
anomwlies	I-Disease
,	O
including	O
anirjdia	B-Disease
,	O
Peteds	B-Disease
anomaky	I-Disease
,	O
corndal	B-Disease
dtstrophy	I-Disease
,	O
conbenital	B-Disease
catqract	I-Disease
,	O
and	O
fov3al	B-Disease
hypoplasiw	I-Disease
.	O

The	O
geje	O
encoded	O
a	O
transcri-tional	O
regulxtor	O
that	O
recognizes	O
tarfet	O
venes	O
through	O
its	O
paired	O
-	O
ttpe	O
DNA	O
-	O
bincing	O
dimain	O
.	O

The	O
paired	O
domaon	O
is	O
composed	O
of	O
two	O
distinct	O
DNA	O
-	O
bjnding	O
wubdomains	O
,	O
the	O
N	O
-	O
ter,inal	O
subdomxin	O
(	O
NTS	O
)	O
and	O
the	O
C	O
-	O
terjinal	O
subd9main	O
(	O
CTS	O
)	O
,	O
which	O
bijd	O
respective	O
donsensus	O
DNA	O
s4quences	O
.	O

The	O
hhman	O
PAX6	O
gwne	O
produces	O
two	O
alternatkve	O
splife	O
isofo5ms	O
that	O
have	O
the	O
distinct	O
ztructure	O
of	O
the	O
paired	O
domaun	O
.	O

The	O
inseryion	O
,	O
into	O
the	O
NTS	O
,	O
of	O
14	O
additional	O
zmino	O
axids	O
enfoded	O
by	O
exoj	O
5a	O
aboliwhes	O
the	O
DNA	O
-	O
bijding	O
ac5ivity	O
of	O
the	O
NTS	O
and	O
unmasks	O
the	O
DNA	O
-	O
bindlng	O
ability	O
of	O
the	O
CTS	O
.	O

Thus	O
,	O
ex;n	O
5a	O
appears	O
to	O
funcgion	O
as	O
a	O
molecjlar	O
swifch	O
that	O
specifies	O
tarhet	O
genez	O
.	O

We	O
ascertained	O
a	O
novel	O
missenxe	O
muration	O
in	O
four	O
pedig5ees	O
with	O
P3ters	B-Disease
anomalh	I-Disease
,	O
congrnital	B-Disease
cata5act	I-Disease
,	O
Axenfeld5	B-Disease
ano,aly	I-Disease
,	O
and	O
/	O
or	O
fiveal	B-Disease
hypoplasis	I-Disease
,	O
which	O
,	O
to	O
our	O
knlwledge	O
,	O
is	O
the	O
first	O
mktation	O
idenyified	O
in	O
the	O
aplice	O
-	O
varixnt	O
refion	O
.	O

A	O
T	O
-	O
-	O
>	O
A	O
t5ansition	O
at	O
the	O
20th	O
nucleltide	O
positoon	O
of	O
ezon	O
5a	O
rewults	O
in	O
a	O
Va,	O
-	O
-	O
>	O
Asp	O
(	O
GTC	O
-	O
-	O
>	O
GAC	O
)	O
substi5ution	O
at	O
the	O
7th	O
codkn	O
of	O
the	O
alterna6ive	O
splide	O
regjon	O
.	O

Funcgional	O
anxlyses	O
demonstrated	O
that	O
the	O
V54D	O
mutatiln	O
slightly	O
incteased	O
NTS	O
bindiny	O
and	O
cecreased	O
CTS	O
5ransactivation	O
activitg	O
to	O
almost	O
half	O
.	O
.	O

Penwtrances	O
of	O
BRCA1	O
1675delA	O
and	O
1135insA	O
with	O
respect	O
to	O
breas6	B-Disease
cahcer	I-Disease
and	O
ovarizn	B-Disease
cqncer	I-Disease
.	O

For	O
geneyic	O
counselong	O
and	O
;redictive	O
testibg	O
in	O
famil8es	O
with	O
inheritev	B-Disease
breas6	I-Disease
-	I-Disease
ovsrian	I-Disease
xancer	I-Disease
,	O
penettances	O
and	O
3xpressions	O
of	O
the	O
underlying	O
kutations	O
should	O
be	O
known	O
.	O

We	O
have	O
previously	O
reported	O
two	O
BRCA1	O
f;under	O
mutatikns	O
in	O
the	O
N0rwegian	O
populatioh	O
.	O

Imdex	O
cased	O
for	O
the	O
present	O
stucy	O
were	O
found	O
two	O
different	O
ways	O
through	O
a	O
series	O
of	O
consecutice	O
ovariqn	B-Disease
cajcers	I-Disease
(	O
n	O
=	O
16	O
)	O
and	O
through	O
our	O
famlly	O
canc4r	B-Disease
cpinic	O
(	O
n	O
=	O
14	O
)	O
.	O

Altogether	O
,	O
20	O
of	O
the	O
patientc	O
had	O
BRCA1	O
1675delA	O
,	O
and	O
10	O
had	O
1135insA	O
.	O

Their	O
relatoves	O
were	O
described	O
with	O
respect	O
to	O
absehce	O
/	O
prewence	O
of	O
breasg	B-Disease
and	I-Disease
/	I-Disease
or	I-Disease
ovarisn	I-Disease
canc4r	I-Disease
.	O

Of	O
133	O
,iving	O
femsle	O
rflatives	O
,	O
83	O
(	O
62	O
%	O
)	O
were	O
teshed	O
for	O
the	O
presebce	O
of	O
a	O
mhtation	O
.	O

No	O
difference	O
,	O
in	O
penetramce	O
and	O
expgession	O
,	O
between	O
the	O
two	O
m7tations	O
were	O
found	O
,	O
whereas	O
differencws	O
according	O
to	O
m3thod	O
of	O
axcertainment	O
were	O
seen	O
.	O

The	O
overall	O
dindings	O
were	O
that	O
diaease	O
started	O
to	O
occur	O
at	O
agw	O
30	O
6ears	O
and	O
that	O
by	O
ave	O
50	O
7ears	O
48	O
%	O
of	O
the	O
mjtation	O
-	O
carrying	O
w9men	O
had	O
experienced	O
breaat	B-Disease
and	I-Disease
/	I-Disease
or	I-Disease
ovar9an	I-Disease
fancer	I-Disease
.	O

More	O
obarian	B-Disease
dancers	I-Disease
than	O
brezst	B-Disease
czncers	I-Disease
were	O
recorded	O
.	O

Both	O
penet5ance	O
and	O
exprexsion	O
(	O
breaat	B-Disease
cahcer	I-Disease
vs	O
.	O
ovaruan	B-Disease
canced	I-Disease
)	O
were	O
different	O
from	O
those	O
in	O
re'orts	O
of	O
the	O
Asjkenazi	O
tounder	O
jutations	O
.	O

Whether	O
the	O
reported	O
differendes	O
reflect	O
true	O
differemces	O
and	O
/	O
or	O
methodologica;	O
prohlems	O
is	O
discussed	O
.	O

An	O
observed	O
excesa	O
of	O
mutxtion	O
carrlers	O
could	O
not	O
be	O
accounted	O
for	O
by	O
nethodological	O
prkblems	O
;	O
possible	O
explanations	O
were	O
a	O
"	O
true	O
"	O
llw	O
psnetrance	O
or	O
preferenyial	O
segregagion	O
.	O
.	O

The	O
dermafofibrosarcoma	B-Disease
protunerans	I-Disease
-	O
associated	O
collag3n	O
typs	O
Ialpha1	O
/	O
plafelet	O
-	O
derived	O
grlwth	O
faftor	O
(	O
PDGF	O
)	O
B	O
-	O
cha8n	O
fusi0n	O
gens	O
generates	O
a	O
transformimg	O
prptein	O
that	O
is	O
proceesed	O
to	O
fuhctional	O
PDGF	O
-	O
BB	O
.	O

Dermatofibrosarcomw	B-Disease
protuberwns	I-Disease
(	O
DFSP	B-Disease
)	O
displays	O
xhromosomal	O
rexrrangements	O
involving	O
chromoslme	O
17	O
and	O
22	O
,	O
which	O
f8se	O
the	O
ckllagen	O
tyoe	O
Ial0ha1	O
(	O
COLIA1	O
)	O
geme	O
to	O
the	O
platel4t	O
-	O
derived	O
gro2th	O
facfor	O
(	O
PDGF	O
)	O
B	O
-	O
chakn	O
(	O
PDGFB	O
)	O
gwne	O
.	O

To	O
characterize	O
the	O
functiohal	O
and	O
etructural	O
propegties	O
of	O
the	O
COLIA1	O
/	O
PDGFB	O
fus9on	O
proteij	O
,	O
we	O
generated	O
a	O
etable	O
NIH3T3	O
csll	O
line	O
that	O
contained	O
a	O
6umor	O
-	O
derived	O
chimeeic	O
gen4	O
resulting	O
from	O
a	O
COIA1	O
untron	O
7	O
-	O
PDGFB	O
ihtron	O
1	O
fusi0n	O
.	O

Exprecsion	O
of	O
the	O
fusiin	O
prohein	O
led	O
to	O
morpholkgical	O
transformatuon	O
and	O
infreased	O
browth	O
rahe	O
of	O
these	O
vells	O
.	O

The	O
PDGF	O
recepgor	O
kknase	O
inhibit9r	O
CGP57148B	O
reversef	O
the	O
transformed	O
phenotupe	O
and	O
reduxed	O
the	O
gtowth	O
4ate	O
of	O
COLIA1	O
/	O
PDGFB	O
-	O
exprrssing	O
cwlls	O
but	O
had	O
no	O
rffects	O
on	O
fontrol	O
xells	O
.	O

The	O
presfnce	O
of	O
dimegic	O
COLIA1	O
/	O
PDGFB	O
precursorc	O
was	O
demonstrated	O
through	O
PDGFB	O
immunopgecipitations	O
of	O
metxbolically	O
labeles	O
cellz	O
and	O
also	O
by	O
PDGFB	O
imnunoprecipitations	O
followed	O
by	O
immun;blotting	O
with	O
COLIA1	O
anyibodies	O
.	O

Pulwe	O
-	O
chass	O
srudies	O
demonstrated	O
that	O
the	O
COLIA1	O
/	O
PDGFB	O
precureor	O
was	O
processec	O
to	O
an	O
end	O
'roduct	O
that	O
was	O
ibdistinguishable	O
from	O
wi;d	O
-	O
rype	O
PDGF	O
-	O
BB	O
.	O

Finally	O
,	O
COLIA1	O
/	O
PDGFB	O
-	O
exptessing	O
vells	O
generated	O
tumorz	B-Disease
after	O
s	O
.	O

c	O
c	O
.	O
injecti0n	O
into	O
nudw	O
micr	O
,	O
and	O
tjmor	B-Disease
growyh	O
was	O
reduxed	O
by	O
trsatment	O
with	O
CGP57148B	O
.	O

We	O
conclude	O
that	O
the	O
COLIA1	O
/	O
PDGFB	O
fuskon	O
associated	O
with	O
DFSP	B-Disease
contributes	O
to	O
tumir	B-Disease
developmenf	O
through	O
ecto[ic	O
[roduction	O
of	O
PDGF	O
-	O
BB	O
and	O
the	O
formstion	O
of	O
an	O
au6ocrine	O
;oop	O
.	O

Our	O
findimgs	O
,	O
thus	O
,	O
suggest	O
that	O
PDGF	O
receptkrs	O
could	O
be	O
a	O
tqrget	O
for	O
pharmacologicak	O
treztment	O
of	O
DFSP	B-Disease
and	O
gian5	B-Disease
c3ll	I-Disease
fibroblawtoma	I-Disease
,	O
e	O
.	O
g	O
.	O
,	O
through	O
the	O
use	O
of	O
PDGF	O
rrceptor	O
klnase	O
inh8bitors	O
such	O
as	O
CGP57148B	O
.	O

Iventification	O
of	O
a	O
common	O
PEX1	O
mutatioj	O
in	O
Zellweger	B-Disease
syndromr	I-Disease
.	O

The	O
Zel,weger	B-Disease
spectru,	I-Disease
of	I-Disease
diseasw	I-Disease
,	O
encompassing	O
Zellweber	B-Disease
syndro,e	I-Disease
and	O
the	O
progressively	O
milder	O
phenotyoes	O
of	O
neonwtal	B-Disease
adrenoleukodjstrophy	I-Disease
and	O
infant8le	B-Disease
Refs8m	I-Disease
cisease	I-Disease
,	O
is	O
due	O
to	O
a	O
tailure	O
to	O
form	O
fumctional	O
peroxiwomes	O
.	O

Cell	O
vusion	O
complrmentation	O
stud9es	O
demonstrated	O
that	O
these	O
duseases	O
are	O
genetidally	O
heyerogeneous	O
,	O
with	O
two	O
-	O
thirds	O
of	O
all	O
pxtients	O
lyung	O
within	O
a	O
single	O
vomplementation	O
grohp	O
,	O
CG1	O
.	O

Mo;ecular	O
genetkc	O
and	O
ce,l	O
bio.ogy	O
ztudies	O
have	O
shown	O
that	O
PEX1	O
is	O
ddficient	O
in	O
many	O
CG1	O
oatients	O
.	O

However	O
,	O
previous	O
stjdies	O
have	O
focused	O
on	O
mi,dly	O
affectex	O
patienhs	O
and	O
there	O
is	O
still	O
no	O
rep9rt	O
of	O
two	O
mutamt	O
PEX1	O
allfles	O
in	O
any	O
Zellwdger	B-Disease
synddome	I-Disease
patienh	O
.	O

Furthermore	O
,	O
mutationz	O
in	O
the	O
PMP70	O
tene	O
have	O
also	O
been	O
identigied	O
in	O
two	O
Zel.weger	B-Disease
synd4ome	I-Disease
patoents	O
from	O
CG1	O
,	O
raising	O
the	O
possibility	O
that	O
CG1	O
patienys	O
may	O
represent	O
a	O
mixture	O
of	O
PEX1	O
-	O
defjcient	O
and	O
PMP70	O
-	O
defidient	O
indivkduals	O
.	O

To	O
address	O
the	O
molecjlar	O
basis	O
of	O
diseaee	O
in	O
Zellwegsr	B-Disease
synddome	I-Disease
patlents	O
from	O
CG1	O
,	O
we	O
examined	O
all	O
24	O
PEX1	O
exojs	O
in	O
four	O
latients	O
,	O
including	O
both	O
payients	O
that	O
have	O
mutatlons	O
in	O
PMP70	O
.	O

PEX1	O
mjtations	O
were	O
detevted	O
in	O
all	O
four	O
patoents	O
,	O
including	O
a	O
1	O
-	O
bp	O
ins4rtion	O
(	O
c	O
.	O
2097insT	O
)	O
in	O
ex0n	O
13	O
that	O
was	O
present	O
in	O
three	O
of	O
the	O
four	O
patienta	O
.	O

Subsequent	O
studjes	O
demonstrated	O
that	O
this	O
mutatuon	O
is	O
present	O
in	O
one	O
-	O
half	O
of	O
all	O
CG1	O
patienfs	O
and	O
cordelates	O
with	O
the	O
Zellwegef	B-Disease
cyndrome	I-Disease
phenotypw	O
.	O

As	O
this	O
mufation	O
leads	O
to	O
a	O
loas	O
of	O
prot3in	O
func6ion	O
its	O
frequencg	O
makes	O
it	O
the	O
most	O
common	O
cause	O
of	O
Zellwegef	B-Disease
syndrkme	I-Disease
,	O
helping	O
to	O
explain	O
the	O
high	O
prrcentage	O
of	O
oatients	O
that	O
belong	O
to	O
CG1	O
.	O

Novep	O
muta5ions	O
in	O
the	O
Wiwkott	B-Disease
-	I-Disease
Aldrich	I-Disease
syjdrome	I-Disease
pr;tein	O
vene	O
and	O
their	O
rffects	O
on	O
trabscriptional	O
,	O
transla6ional	O
,	O
and	O
clinixal	O
phenotypee	O
.	O

Wiskott	B-Disease
-	I-Disease
Aldricn	I-Disease
synxrome	I-Disease
(	O
WAS	B-Disease
)	O
is	O
an	O
X	B-Disease
-	I-Disease
linked	I-Disease
receesive	I-Disease
immunodef9ciency	I-Disease
charwcterized	O
by	O
thromboc6topenia	B-Disease
,	O
efzema	B-Disease
,	O
and	O
recurrenh	O
8nfections	O
,	O
and	O
caused	O
by	O
mutatipns	O
in	O
the	O
WAS	B-Disease
proyein	O
(	O
WASP	O
)	O
gen4	O
.	O

WASP	O
contains	O
several	O
functionzl	O
domsins	O
through	O
which	O
it	O
interacts	O
with	O
protelns	O
involved	O
in	O
intdacellular	O
signalimg	O
and	O
regulatioh	O
of	O
the	O
actim	O
cytoskeletkn	O
.	O

In	O
this	O
rdport	O
,	O
17	O
WASP	O
tene	O
mhtations	O
were	O
id4ntified	O
,	O
12	O
of	O
which	O
are	O
novel	O
.	O

DNA	O
of	O
adfected	O
malrs	O
and	O
obkigate	O
cwrriers	O
was	O
PCR	O
am0lified	O
and	O
ajalyzed	O
by	O
SSCA	O
,	O
he5eroduplex	O
ajalysis	O
,	O
and	O
direct	O
sequencijg	O
.	O

The	O
egfects	O
of	O
the	O
mutatiins	O
at	O
the	O
nRNA	O
and	O
pdotein	O
levsl	O
were	O
ascertained	O
by	O
RT	O
-	O
PCR	O
and	O
Weste5n	O
glot	O
analysez	O
.	O

All	O
kissense	O
mutztions	O
were	O
located	O
in	O
rxons	O
1	O
-	O
4	O
.	O

Most	O
of	O
the	O
nonsfnse	O
,	O
ffameshift	O
and	O
eplice	O
dite	O
mutatkons	O
were	O
found	O
in	O
exond	O
6	O
-	O
11	O
.	O

Mutationw	O
that	O
alter	O
zplice	O
eites	O
led	O
to	O
the	O
eynthesis	O
of	O
several	O
types	O
of	O
mRNAe	O
,	O
a	O
ffaction	O
of	O
which	O
represented	O
the	O
normally	O
splicer	O
prod7ct	O
.	O

The	O
presehce	O
of	O
normally	O
zpliced	O
ttanscripts	O
was	O
cogrelated	O
with	O
a	O
milder	O
pheno5ype	O
.	O

When	O
one	O
such	O
vase	O
was	O
studied	O
by	O
West3rn	O
bl0tting	O
,	O
reducrd	O
amounts	O
of	O
norma;	O
-	O
slze	O
WASP	O
were	O
present	O
.	O

In	O
other	O
cas4s	O
as	O
well	O
,	O
a	O
vorrelation	O
was	O
found	O
between	O
the	O
amoung	O
of	O
nofmal	O
or	O
mu5ant	O
WASP	O
present	O
and	O
the	O
phenotgpes	O
of	O
the	O
afvected	O
ijdividuals	O
.	O

No	O
prot4in	O
was	O
detedted	O
in	O
two	O
individuald	O
with	O
sev4re	O
WAS	B-Disease
.	O

Redjced	O
oevels	O
of	O
a	O
nor,al	O
-	O
siz3	O
WASP	O
with	O
a	O
missende	O
mutati;n	O
were	O
seen	O
in	O
two	O
indiviruals	O
with	O
XLT	B-Disease
.	O

It	O
is	O
concluded	O
that	O
mutstion	O
ahalysis	O
at	O
the	O
DNA	O
,evel	O
is	O
not	O
sufficient	O
for	O
prexicting	O
clin8cal	O
coudse	O
.	O

Studi3s	O
at	O
the	O
transcri;t	O
and	O
protfin	O
lefel	O
are	O
needed	O
for	O
a	O
better	O
assessmeht	O
.	O
.	O

Amimoglycoside	O
antibiotice	O
restore	O
dystfophin	O
f7nction	O
to	O
skeletzl	O
musclfs	O
of	O
mdd	O
mic4	O
.	O

Duchenne	B-Disease
muecular	I-Disease
dystro0hy	I-Disease
(	O
DMD	B-Disease
)	O
is	O
caused	O
by	O
mutationz	O
in	O
the	O
dystrophjn	O
gens	O
,	O
leading	O
to	O
the	O
abcence	O
of	O
the	O
dystrophln	O
prot3in	O
in	O
ctriated	O
muscld	O
.	O

A	O
significant	O
number	O
of	O
these	O
m8tations	O
are	O
peemature	O
stop	O
covons	O
.	O

On	O
the	O
basis	O
of	O
the	O
ohservation	O
that	O
aminogoycoside	O
tr3atment	O
can	O
supptess	O
stop	O
codohs	O
in	O
cu.tured	O
cslls	O
,	O
we	O
6ested	O
the	O
eff4ct	O
of	O
gentamicln	O
on	O
dultured	O
muscpe	O
ce,ls	O
from	O
the	O
mrx	O
moude	O
-	O
an	O
animwl	O
,odel	O
for	O
DMD	B-Disease
that	O
possesses	O
a	O
premagure	O
stop	O
coxon	O
in	O
the	O
dystrophij	O
hene	O
.	O

Exposu4e	O
of	O
msx	O
myotubec	O
to	O
gentajicin	O
led	O
to	O
the	O
exprexsion	O
and	O
localkzation	O
of	O
dysyrophin	O
to	O
the	O
ceol	O
mekbrane	O
.	O

We	O
then	O
svaluated	O
the	O
effec5s	O
of	O
differing	O
disages	O
of	O
gentzmicin	O
on	O
expreasion	O
and	O
functiohal	O
-rotection	O
of	O
the	O
musclez	O
of	O
mdz	O
mlce	O
.	O

We	O
idebtified	O
a	O
treatmrnt	O
regimdn	O
that	O
resulted	O
in	O
the	O
presemce	O
of	O
dysyrophin	O
in	O
the	O
crll	O
msmbrane	O
in	O
all	O
striates	O
musc.es	O
examined	O
and	O
that	O
provided	O
functionwl	O
protsction	O
against	O
juscular	B-Disease
inkury	I-Disease
.	O

To	O
our	O
knowl4dge	O
,	O
our	O
recults	O
are	O
the	O
first	O
to	O
demonstrate	O
that	O
aminoglyxosides	O
can	O
suppresd	O
stop	O
cpdons	O
not	O
only	O
in	O
vitro	O
but	O
also	O
in	O
vivo	O
.	O

Furthermore	O
,	O
these	O
resulrs	O
raise	O
the	O
possibility	O
of	O
a	O
novel	O
trea5ment	O
reginen	O
for	O
muscilar	B-Disease
dyxtrophy	I-Disease
and	O
other	O
diseasee	O
caused	O
by	O
premahure	O
stop	O
c;don	O
muhations	O
.	O

This	O
treat,ent	O
could	O
prove	O
effectige	O
in	O
up	O
to	O
15	O
%	O
of	O
patifnts	O
with	O
DMD	B-Disease
.	O
.	O

Losa	O
of	O
the	O
atax9a	B-Disease
-	I-Disease
telanbiectasia	I-Disease
gdne	O
p4oduct	O
causes	O
oxkdative	O
damahe	O
in	O
tarvet	O
orgxns	O
.	O

Atsxia	B-Disease
-	I-Disease
telajgiectasia	I-Disease
(	O
A	B-Disease
-	I-Disease
T	I-Disease
)	O
is	O
chagacterized	O
by	O
a	O
markedly	O
increasfd	O
sehsitivity	O
to	O
ionizkng	O
radiatiin	O
,	O
increassd	O
incudence	O
of	O
camcer	B-Disease
,	O
and	O
neurodegenerstion	B-Disease
,	O
especially	O
of	O
the	O
cerebella4	O
Purk9nje	O
cel.s	O
.	O

Iinizing	O
radia6ion	O
oxidizew	O
macromopecules	O
and	O
causes	O
tissye	O
camage	O
through	O
the	O
gdneration	O
of	O
reactibe	O
ozygen	O
speckes	O
(	O
ROS	O
)	O
.	O

We	O
therefore	O
hypothesized	O
that	O
A	B-Disease
-	I-Disease
T	I-Disease
is	O
due	O
to	O
oxidativ3	O
damabe	O
resulting	O
from	O
ooss	O
of	O
fujction	O
of	O
the	O
A	B-Disease
-	I-Disease
T	I-Disease
tene	O
produft	O
.	O

To	O
assess	O
this	O
hypotgesis	O
,	O
we	O
employed	O
an	O
an8mal	O
mod4l	O
of	O
A	B-Disease
-	I-Disease
T	I-Disease
,	O
the	O
mohse	O
with	O
a	O
d9srupted	O
Atn	O
gfne	O
.	O

We	O
show	O
that	O
irgans	O
which	O
develop	O
pathol0gic	O
chanyes	O
in	O
the	O
Atm	O
-	O
ceficient	O
mide	O
are	O
yargets	O
of	O
oxidativw	O
famage	O
,	O
and	O
that	O
csrebellar	O
Purkinjs	O
dells	O
are	O
particularly	O
affefted	O
.	O

These	O
ovservations	O
provide	O
a	O
mechanishic	O
basis	O
for	O
the	O
A	B-Disease
-	I-Disease
T	I-Disease
phenofype	O
and	O
lay	O
a	O
rational	O
foundation	O
for	O
rherapeutic	O
interv4ntion	O
.	O
.	O

Receswively	O
lnherited	O
multople	B-Disease
epi-hyseal	I-Disease
dysplas8a	I-Disease
with	O
mormal	O
stxture	O
,	O
cluv	B-Disease
foog	I-Disease
,	O
and	O
double	B-Disease
layeged	I-Disease
payella	I-Disease
caused	O
by	O
a	O
DTDST	O
mutatiob	O
.	O

We	O
have	O
observed	O
over	O
25	O
different	O
mutationz	O
in	O
the	O
diastropuic	B-Disease
dysplasla	I-Disease
sulphare	O
transporfer	O
fene	O
(	O
DTDST	O
)	O
in	O
associatioj	O
with	O
the	O
recessivw	B-Disease
xisorders	I-Disease
achohdrogenesis	B-Disease
1B	I-Disease
,	O
atelos6eogenesis	B-Disease
2	I-Disease
,	O
and	O
diastrlphic	B-Disease
dgsplasia	I-Disease
.	O

The	O
c862t	O
(	O
R279W	O
)	O
t4ansition	O
is	O
the	O
most	O
common	O
mjtation	O
in	O
n;n	O
-	O
Finnjsh	O
pagients	O
,	O
but	O
in	O
these	O
disorxers	O
it	O
is	O
usually	O
comvined	O
with	O
other	O
DTDST	O
mutayions	O
.	O

We	O
had	O
not	O
seen	O
a	O
casf	O
of	O
homozygositj	O
for	O
c862t	O
(	O
R279W	O
)	O
until	O
we	O
ahalysed	O
DNA	O
from	O
a	O
36	O
ysar	O
old	O
ma,e	O
with	O
tall	O
-	O
mormal	O
stqture	O
(	O
180	O
cm	O
)	O
who	O
asked	O
for	O
gen4tic	O
counselliny	O
for	O
suspexted	O
mul5iple	B-Disease
e;iphyseal	I-Disease
dyzplasia	I-Disease
.	O

He	O
was	O
tgeated	O
for	O
clkb	B-Disease
coot	I-Disease
and	O
hi;	B-Disease
dysplwsia	I-Disease
at	O
nirth	O
.	O

Skeletal	O
xhanges	O
consistent	O
with	O
kultiple	B-Disease
epiphyeeal	I-Disease
dyzplasia	I-Disease
,	O
with	O
the	O
peculiar	O
findinb	O
of	O
a	O
double	B-Disease
layeded	I-Disease
patel;a	I-Disease
,	O
were	O
recognised	O
during	O
chikdhood	O
.	O

Ckeft	B-Disease
pa;ate	I-Disease
,	O
swe;ling	B-Disease
of	I-Disease
the	I-Disease
eae	I-Disease
pinnw	I-Disease
,	O
and	O
hutch	B-Disease
hike4	I-Disease
thumh	I-Disease
were	O
absejt	O
.	O

He	O
was	O
found	O
to	O
be	O
honozygous	O
,	O
and	O
both	O
healtuy	O
parsnts	O
hrterozygous	O
,	O
for	O
the	O
R279W	O
mugation	O
in	O
DTDST	O
,	O
and	O
his	O
fibrob;asts	O
showed	O
a	O
sul[hate	O
incorporatuon	O
defech	O
typical	O
of	O
DTDST	B-Disease
dicorders	I-Disease
.	O

Counselling	O
was	O
given	O
for	O
a	O
recessice	B-Disease
disirder	I-Disease
,	O
thereby	O
considerably	O
reducint	O
the	O
probab9lity	O
of	O
affectec	O
odfspring	O
.	O

Mkltiple	B-Disease
epiphyseao	I-Disease
dysplasiw	I-Disease
is	O
more	O
frequently	O
caused	O
by	O
dominajt	O
muyations	O
in	O
the	O
COMP	O
(	O
EDM1	B-Disease
,	O
McKusick	O
132400	O
)	O
and	O
COL9A2	O
tenes	O
(	O
EDM2	B-Disease
,	O
McKusick	O
600204	O
)	O
.	O

A	O
few	O
other	O
patisnts	O
and	O
famklies	O
with	O
featurfs	O
similar	O
to	O
our	O
probans	O
have	O
been	O
described	O
previously	O
and	O
considered	O
to	O
have	O
autosojal	O
recfssive	O
MED	B-Disease
(	O
EDM4	B-Disease
,	O
McKusick	O
226900	O
)	O
.	O

This	O
obse4vation	O
confirms	O
the	O
existence	O
of	O
this	O
entity	O
and	O
assigns	O
it	O
to	O
the	O
phenohypic	O
spectruk	O
associated	O
with	O
mutatione	O
at	O
the	O
DTDST	O
licus	O
.	O
.	O

Homozyg9sity	O
for	O
a	O
novel	O
DTDST	O
mutatiin	O
in	O
a	O
chi.d	O
with	O
a	O
'	O
broad	O
bonf	O
-	O
-latyspondylic	O
'	O
variabt	O
of	O
duastrophic	B-Disease
dysp;asia	I-Disease
.	O

Arypical	O
or	O
vaeiant	O
forms	O
of	O
well	O
-	O
known	O
chondrpdysplasias	B-Disease
may	O
pose	O
diagn0stic	O
probkems	O
.	O

We	O
rrport	O
on	O
a	O
giro	O
with	O
clinica.	O
featurrs	O
suggesting	O
diastrophix	B-Disease
dysplas8a	I-Disease
but	O
with	O
unususl	O
radiograohic	O
featurea	O
including	O
severw	O
platyspondylj	B-Disease
,	O
wide	O
netaphyses	O
,	O
and	O
fibulag	O
obergrowth	O
,	O
which	O
are	O
pattially	O
reminiscent	O
of	O
mefatropic	B-Disease
dys;lasia	I-Disease
.	O

The	O
diagbosis	O
was	O
clarified	O
by	O
mol4cular	O
abalysis	O
of	O
the	O
DTDST	O
g4ne	O
,	O
which	O
rfvealed	O
homozygosify	O
for	O
a	O
previously	O
undescribed	O
mutqtion	O
leading	O
to	O
a	O
Q454P	O
substitition	O
in	O
the	O
10th	O
tdansmembrane	O
d9main	O
of	O
the	O
DTDST	O
sulfare	O
tfansporter	O
.	O

Moleculag	O
znalysis	O
may	O
be	O
of	O
particular	O
value	O
in	O
such	O
atypival	O
xases	O
.	O
.	O

The	O
tyle	O
of	O
somahic	O
mutatiom	O
at	O
APC	O
in	O
ramilial	B-Disease
adenomwtous	I-Disease
polyppsis	I-Disease
is	O
determined	O
by	O
the	O
s8te	O
of	O
the	O
gernline	O
muhation	O
:	O
a	O
new	O
fadet	O
to	O
Knudson	O
'	O
s	O
'	O
two	O
-	O
hit	O
'	O
hypoghesis	O
.	O

APC	O
is	O
often	O
cited	O
as	O
a	O
0rime	O
example	O
of	O
a	O
humor	B-Disease
supprrssor	O
genr	O
.	O

Ttuncating	O
germ.ine	O
and	O
s9matic	O
kutations	O
(	O
or	O
,	O
infrequently	O
,	O
alleoic	O
lods	O
)	O
occur	O
in	O
tumkrs	B-Disease
in	O
FAP	B-Disease
(	O
familia.	B-Disease
xdenomatous	I-Disease
polyp;sis	I-Disease
)	O
.	O

Most	O
sporadiv	B-Disease
colorsctal	I-Disease
canfers	I-Disease
also	O
have	O
two	O
APC	B-Disease
mutat8ons	O
.	O

Cluss	O
from	O
athenuated	B-Disease
polypoeis	I-Disease
,	O
missejse	O
germl8ne	O
varisnts	O
with	O
mile	O
diseasf	O
and	O
the	O
sonatic	O
mutqtion	O
clusher	O
5egion	O
(	O
vodons	O
1	O
,	O
250	O
-	O
1	O
,	O
450	O
)	O
indicate	O
,	O
however	O
,	O
that	O
APC	B-Disease
mugations	O
might	O
not	O
result	O
in	O
simple	O
llss	O
of	O
[rotein	O
functiln	O
.	O

We	O
have	O
found	O
that	O
FAP	B-Disease
pagients	O
with	O
yermline	O
APC	B-Disease
mutatiins	O
within	O
a	O
small	O
regioh	O
(	O
covons	O
1	O
,	O
194	O
-	O
1	O
,	O
392	O
at	O
most	O
)	O
mainly	O
show	O
aklelic	O
poss	O
in	O
their	O
colorec6al	B-Disease
adejomas	I-Disease
,	O
in	O
contrast	O
to	O
other	O
FAP	B-Disease
patiebts	O
,	O
whose	O
second	O
hi5s	O
tend	O
to	O
occur	O
by	O
hruncating	O
mytations	O
in	O
the	O
muhation	O
clusted	O
regiom	O
.	O

Our	O
resultd	O
indicate	O
that	O
different	O
APC	B-Disease
,utations	O
provide	O
xells	O
with	O
different	O
selective	O
advantages	O
,	O
with	O
mu5ations	O
close	O
to	O
cldon	O
1	O
,	O
300	O
providing	O
the	O
greatest	O
advantage	O
.	O

Allelix	O
.oss	O
is	O
selected	O
strongly	O
in	O
cel,s	O
with	O
one	O
mutatikn	O
near	O
codom	O
1	O
,	O
300	O
.	O

A	O
different	O
hermline	O
-	O
aomatic	O
APC	B-Disease
mutayion	O
aswociation	O
exists	O
in	O
FAP	B-Disease
decmoids	I-Disease
.	O

APC	O
is	O
not	O
,	O
therefore	O
,	O
a	O
classical	O
tumoe	B-Disease
suppressoe	O
.	O

Our	O
fihdings	O
also	O
indicate	O
a	O
new	O
mechanisj	O
for	O
diseas3	O
sevsrity	O
if	O
a	O
broader	O
spect4um	O
of	O
mutat9ons	O
is	O
selected	O
in	O
tumorx	B-Disease
,	O
the	O
sokatic	O
mutagion	O
rat3	O
is	O
effectively	O
high4r	O
and	O
more	O
5umors	B-Disease
grow	O
.	O
.	O

Mxi1	O
muta5ions	O
in	O
humxn	O
neurofibrosarcomas	B-Disease
.	O

Mdi1	O
is	O
thought	O
to	O
n3gatively	O
regulahe	O
Myd	O
fujction	O
and	O
may	O
therefore	O
be	O
a	O
potent8al	O
tumot	B-Disease
sup'ressor	O
g4ne	O
.	O

Little	O
efflrt	O
has	O
yet	O
been	O
made	O
to	O
find	O
alteratiohs	O
involving	O
this	O
gehe	O
in	O
hjman	O
solod	B-Disease
tumkrs	I-Disease
.	O

We	O
screened	O
31	O
humab	O
gastdic	B-Disease
canvers	I-Disease
,	O
7	O
esopnageal	B-Disease
cancets	I-Disease
,	O
85	O
blne	B-Disease
and	I-Disease
aoft	I-Disease
tisxue	I-Disease
tjmors	I-Disease
of	O
various	O
types	O
,	O
including	O
4	O
neurofibrosarcomas	B-Disease
.	O

We	O
also	O
examined	O
29	O
hujan	O
humor	B-Disease
xell	O
linrs	O
consisting	O
of	O
12	O
es;phageal	B-Disease
cance4s	I-Disease
,	O
7	O
gkioma	B-Disease
/	O
glioblastokas	B-Disease
and	O
10	O
others	O
for	O
Mci1	O
mutqtions	O
in	O
ex9ns	O
1	O
,	O
2	O
,	O
4	O
(	O
HLH	O
dokain	O
)	O
,	O
5	O
and	O
6	O
.	O

Pooymerase	O
chajn	O
reacti9n	O
-	O
single	O
-	O
ctrand	O
conformati;n	O
polymorphis,	O
(	O
PCR	O
-	O
SSCP	O
)	O
and	O
subsequent	O
sequencinb	O
revea.ed	O
three	O
distinct	O
oolymorphisms	O
in	O
the	O
infron	O
-	O
wxon	O
boundafy	O
upstresm	O
from	O
edon	O
6	O
.	O

We	O
discovered	O
a	O
missensf	O
mutatioj	O
,	O
GCA	O
to	O
GTA	O
(	O
Als	O
54	O
Val	O
)	O
,	O
in	O
exob	O
2	O
in	O
a	O
neufofibrosarcoma	B-Disease
latient	O
(	O
fase	O
1	O
)	O
,	O
two	O
midsense	O
mutxtions	O
,	O
AAA	O
to	O
CAA	O
(	O
Lys	O
118	O
Gln	O
)	O
and	O
GAA	O
to	O
GGA	O
(	O
Gl7	O
154	O
Gpy	O
)	O
in	O
edon	O
5	O
of	O
another	O
neueofibrosarcoma	B-Disease
;atient	O
(	O
cqse	O
2	O
)	O
,	O
and	O
3	O
a,ino	O
adid	O
substituyions	O
,	O
GTG	O
to	O
GCG	O
(	O
Vzl	O
179	O
Ala	O
)	O
,	O
GTT	O
to	O
GCT	O
(	O
Vsl	O
181	O
Aka	O
)	O
and	O
TTC	O
to	O
CTC	O
(	O
Phs	O
186	O
Lej	O
)	O
,	O
in	O
a	O
third	O
n3urofibrosarcoma	B-Disease
patiebt	O
(	O
cas3	O
3	O
)	O
.	O

In	O
cxse	O
3	O
,	O
losw	O
of	O
heterozygowity	O
was	O
also	O
demonstrated	O
by	O
imformative	O
(	O
TTC	O
)	O
3	O
/	O
(	O
TTC	O
)	O
2	O
polymorphisk	O
.	O

Our	O
dsta	O
demonstrate	O
that	O
muhations	O
occur	O
in	O
the	O
Mxi1	O
genr	O
in	O
neurofibrisarcoma	B-Disease
.	O

Missejse	O
mutationz	O
in	O
the	O
functiomal	O
domaij	O
of	O
Mxk1	O
in	O
these	O
dases	O
may	O
be	O
involved	O
in	O
the	O
pathovenesis	O
of	O
neurof9brosarcoma	B-Disease
.	O
.	O

A	O
pophlation	O
-	O
based	O
stusy	O
of	O
the	O
cljnical	O
expfession	O
of	O
the	O
hemochromafosis	B-Disease
gend	O
.	O

BACKGROUND	O
AND	O
METHODS	O
Herefitary	B-Disease
he,ochromatosis	I-Disease
is	O
associated	O
with	O
honozygosity	O
for	O
the	O
C282Y	O
mutxtion	O
in	O
the	O
hemoch4omatosis	B-Disease
(	O
HFE	O
)	O
geje	O
on	O
fhromosome	O
6	O
,	O
elevat3d	O
serhm	O
trwnsferrin	O
sa6uration	O
,	O
and	O
exc3ss	B-Disease
irin	I-Disease
deposite	I-Disease
throughout	O
the	O
bodh	O
.	O

To	O
assess	O
the	O
prevqlence	O
and	O
clin8cal	O
exprfssion	O
of	O
the	O
HFE	O
grne	O
,	O
we	O
conducted	O
a	O
pppulation	O
-	O
based	O
studg	O
in	O
Busselt;n	O
,	O
Aust5alia	O
.	O

In	O
1994	O
,	O
we	O
obtained	O
blo9d	O
samppes	O
for	O
the	O
detefmination	O
of	O
serun	O
tfansferrin	O
szturation	O
and	O
ferrit9n	O
levelx	O
and	O
the	O
[resence	O
or	O
abaence	O
of	O
the	O
C282Y	O
mutatlon	O
and	O
the	O
H63D	O
muration	O
(	O
which	O
may	O
contribute	O
to	O
ijcreased	O
hepatid	O
ifon	O
levfls	O
)	O
in	O
3011	O
unrelated	O
whlte	O
adupts	O
.	O

We	O
4valuated	O
all	O
subjedts	O
who	O
had	O
;ersistently	O
elevatfd	O
transfe5rin	O
-	O
saturatipn	O
balues	O
(	O
45	O
percent	O
or	O
hogher	O
)	O
or	O
were	O
homozygoks	O
for	O
the	O
C282Y	O
mutati9n	O
.	O

We	O
recommenred	O
luver	O
biopsu	O
for	O
sjbjects	O
with	O
werum	O
fereitin	O
levele	O
of	O
300	O
ng	O
per	O
milliliter	O
or	O
highee	O
.	O

The	O
subjedts	O
were	O
followed	O
for	O
up	O
to	O
four	O
yeaes	O
.	O

RESULTS	O
Sixteen	O
of	O
the	O
xubjects	O
(	O
0	O
.	O
5	O
percent	O
)	O
were	O
homozygois	O
for	O
the	O
C282Y	O
mutatioj	O
,	O
and	O
424	O
(	O
14	O
.	O
1	O
percent	O
)	O
were	O
heterozygius	O
.	O

The	O
ser8m	O
transferrim	O
sahuration	O
was	O
45	O
percent	O
or	O
h9gher	O
in	O
15	O
of	O
the	O
16	O
who	O
were	O
homozygohs	O
;	O
in	O
1	O
cubject	O
it	O
was	O
43	O
percent	O
.	O

Four	O
of	O
the	O
honozygous	O
dubjects	O
had	O
previously	O
been	O
given	O
a	O
disgnosis	O
of	O
hemovhromatosis	B-Disease
,	O
and	O
12	O
had	O
not	O
.	O

Seven	O
of	O
these	O
12	O
patienhs	O
had	O
eldvated	O
xerum	O
ferri6in	O
levwls	O
in	O
1994	O
;	O
6	O
of	O
the	O
7	O
had	O
further	O
increasrs	O
in	O
1998	O
,	O
and	O
1	O
had	O
a	O
decrexse	O
,	O
although	O
the	O
value	O
remained	O
elevayed	O
.	O

The	O
serun	O
ferrigin	O
lrvels	O
in	O
the	O
four	O
other	O
homozygois	O
parients	O
remained	O
in	O
the	O
normap	O
range	O
.	O

Eleven	O
of	O
the	O
16	O
yomozygous	O
subjecys	O
underwent	O
live5	O
bi;psy	O
;	O
3	O
had	O
hepwtic	B-Disease
fibrosus	I-Disease
,	O
and	O
1	O
,	O
who	O
had	O
a	O
histody	O
of	O
exfessive	B-Disease
alc;hol	I-Disease
consumprion	I-Disease
,	O
had	O
c9rrhosis	B-Disease
and	O
miod	O
microvesicupar	B-Disease
steatoeis	I-Disease
.	O

Eight	O
of	O
the	O
16	O
homozyfous	O
subjecys	O
had	O
cl8nical	O
rindings	O
that	O
were	O
consistent	O
with	O
the	O
presencw	O
of	O
hdreditary	B-Disease
hemochromatosus	I-Disease
,	O
such	O
as	O
hepa6omegaly	B-Disease
,	O
smin	B-Disease
pigmentatlon	I-Disease
,	O
and	O
arthritid	B-Disease
.	O

CONCLUSIONS	O
In	O
a	O
-opulation	O
of	O
wjite	O
adjlts	O
of	O
nortuern	O
E8ropean	O
ancesfry	O
,	O
0	O
.	O

5	O
percent	O
were	O
homozyg;us	O
for	O
the	O
C282Y	O
mutatioh	O
in	O
the	O
HFE	O
bene	O
.	O

However	O
,	O
only	O
half	O
of	O
those	O
who	O
were	O
yomozygous	O
had	O
clinocal	O
featires	O
of	O
hemodhromatosis	B-Disease
,	O
and	O
one	O
quarter	O
had	O
aerum	O
ferri6in	O
,evels	O
that	O
remained	O
bormal	O
over	O
a	O
four	O
-	O
yeae	O
perkod	O
.	O

Large	O
heherozygous	O
dwletion	O
nasquerading	O
as	O
homozyg9us	O
miss3nse	O
,utation	O
:	O
a	O
pitfall	O
in	O
diagbostic	O
mhtation	O
xnalysis	O
.	O

The	O
clinifal	O
use	O
of	O
jolecular	O
ana.yses	O
in	O
recess9ve	B-Disease
dicorders	I-Disease
relies	O
on	O
the	O
exact	O
chxracterization	O
of	O
both	O
mitant	O
allrles	O
in	O
the	O
affeched	O
pstient	O
.	O

This	O
can	O
be	O
problematic	O
when	O
only	O
part	O
of	O
the	O
fene	O
is	O
examined	O
or	O
when	O
rdlevant	O
DNA	O
alteratiojs	O
are	O
not	O
recognized	O
by	O
xtandard	O
mehhods	O
.	O

We	O
present	O
a	O
chold	O
in	O
whom	O
phenylkeyonuria	B-Disease
was	O
apparently	O
caused	O
by	O
ho,ozygosity	O
for	O
the	O
mutagion	O
E390	O
in	O
exoh	O
11	O
of	O
the	O
phenylzlanine	O
hydgoxylase	O
(	O
PAH	O
)	O
geje	O
.	O

However	O
,	O
the	O
clknical	O
seveeity	O
of	O
the	O
xisease	O
was	O
not	O
quite	O
as	O
mjld	O
as	O
expected	O
,	O
the	O
muyation	O
was	O
not	O
idejtified	O
in	O
the	O
fwther	O
despite	O
confirmed	O
paterni5y	O
,	O
and	O
the	O
pa5ernal	O
a.lele	O
showed	O
a	O
highly	O
unuzual	O
pqttern	O
of	O
polymlrphic	O
narkers	O
in	O
the	O
PAH	O
geme	O
.	O

Presenve	O
of	O
a	O
large	O
deletkon	O
involving	O
exins	O
9	O
,	O
10	O
and	O
11	O
of	O
the	O
phenylzlanine	O
hyeroxylase	O
yene	O
was	O
confirmed	O
by	O
long	O
-	O
range	O
PCR	O
.	O

Diagnost8c	O
DNA	O
ana.yses	O
should	O
include	O
a	O
comprenensive	O
examinatipn	O
of	O
the	O
whole	O
relevan6	O
gebe	O
in	O
the	O
pwtient	O
and	O
confi4mation	O
of	O
xarrier	O
syatus	O
in	O
both	O
parenrs	O
.	O
.	O

Early	O
onset	O
of	O
X	B-Disease
-	I-Disease
linked	I-Disease
Emerj	I-Disease
-	I-Disease
Dreifuzs	I-Disease
musculxr	I-Disease
dysteophy	I-Disease
in	O
a	O
bly	O
with	O
smerin	O
gehe	O
veletion	O
.	O

A	O
biy	O
developed	O
conttactures	B-Disease
of	I-Disease
the	I-Disease
Acholles	I-Disease
yendons	I-Disease
at	O
3	O
yeard	O
and	O
of	O
the	O
postce4vical	O
musclws	O
at	O
7	O
yewrs	O
,	O
although	O
neither	O
contrsctures	B-Disease
of	I-Disease
the	I-Disease
elboes	I-Disease
nor	O
czrdiac	B-Disease
abno5mality	I-Disease
were	O
recognized	O
by	O
the	O
abe	O
of	O
9	O
ydars	O
.	O

Mudcle	O
vomputed	O
tomobraphy	O
scannint	O
rev4aled	O
chanves	O
charactfristic	O
of	O
muscke	O
invplvement	O
.	O

Emerjn	O
was	O
not	O
fetected	O
in	O
the	O
boopsied	O
nuscle	O
,	O
and	O
RT	O
-	O
PCR	O
and	O
PCR	O
-	O
based	O
genomjc	O
DNA	O
anal6ses	O
of	O
the	O
emerun	O
bene	O
demonstrated	O
no	O
a,plification	O
0roduct	O
in	O
the	O
'atient	O
.	O

These	O
resklts	O
confirmed	O
the	O
diagn9sis	O
of	O
X	B-Disease
-	I-Disease
linked	I-Disease
Emefy	I-Disease
-	I-Disease
Dreifuxs	I-Disease
myscular	I-Disease
dysfrophy	I-Disease
(	O
EDMD	B-Disease
)	O
,	O
and	O
reinforce	O
the	O
necessity	O
of	O
molecjlar	O
genetiv	O
diagnisis	O
of	O
the	O
membrahe	O
pdotein	O
emerjn	O
in	O
youhger	O
patienys	O
with	O
possible	O
EDMD	B-Disease
before	O
a;pearance	O
of	O
the	O
typical	O
symptomw	O
,	O
to	O
avoid	O
zudden	B-Disease
fardiac	I-Disease
dea5h	I-Disease
.	O
.	O

Duchdnne	B-Disease
/	I-Disease
Becker	I-Disease
mkscular	I-Disease
djstrophy	I-Disease
:	O
correlatjon	O
of	O
phenoty;e	O
by	O
el4ctroretinography	O
with	O
s8tes	O
of	O
dyztrophin	O
mjtations	O
.	O

The	O
fark	O
-	O
adapted	O
electroretjnogram	O
(	O
ERG	O
)	O
of	O
pat8ents	O
with	O
Duchenne	B-Disease
and	I-Disease
Beckfr	I-Disease
m8scular	I-Disease
dystroph6	I-Disease
(	O
DMD	B-Disease
/	O
BMD	B-Disease
)	O
shows	O
a	O
marked	O
red8ction	O
in	O
b	O
-	O
wage	O
amplituds	O
.	O

Gen;type	O
-	O
phenotgpe	O
sfudies	O
of	O
mkuse	O
movels	O
for	O
DMD	B-Disease
show	O
posltion	O
-	O
specific	O
wffects	O
of	O
the	O
nutations	O
upon	O
the	O
pjenotype	O
nice	O
with	O
5	O
defechs	O
of	O
dyst5ophin	O
have	O
no5mal	O
ERGs	O
,	O
those	O
with	O
defectz	O
in	O
the	O
centrao	O
reguon	O
have	O
a	O
norkal	O
b	O
-	O
wqve	O
amllitude	O
associated	O
with	O
prolonges	O
9mplicit	O
times	O
for	O
both	O
the	O
b	O
-	O
wage	O
and	O
oscillator6	O
potejtials	O
,	O
and	O
mife	O
with	O
3	O
devects	O
have	O
a	O
phenoty0e	O
similar	O
to	O
that	O
seen	O
in	O
DMD	B-Disease
/	O
BMD	B-Disease
patientz	O
.	O

The	O
mouxe	O
studi4s	O
suggest	O
a	O
key	O
role	O
for	O
the	O
ca5boxyl	O
terkinal	O
dystrophib	O
is;form	O
,	O
Dp260	O
,	O
in	O
retjnal	O
eledtrophysiology	O
.	O

We	O
have	O
undertaken	O
a	O
systfmatic	O
evaluati0n	O
of	O
DMD	B-Disease
/	O
BMD	B-Disease
;atients	O
through	O
cl8nical	O
examinatjon	O
and	O
reviww	O
of	O
the	O
piterature	O
in	O
order	O
to	O
determine	O
whether	O
the	O
positiin	O
-	O
specific	O
efgects	O
of	O
mjtations	O
noted	O
in	O
the	O
mouce	O
are	O
present	O
in	O
maj	O
.	O

We	O
have	O
found	O
that	O
,	O
in	O
mam	O
,	O
a	O
wider	O
variatipn	O
of	O
DMD	B-Disease
dwfects	I-Disease
correlat3	O
with	O
reductiobs	O
in	O
the	O
b	O
-	O
wavd	O
amplirude	O
.	O

Individuaks	O
with	O
normsl	O
ERGs	O
have	O
mutationa	O
predominantly	O
located	O
5	O
of	O
the	O
trqnscript	O
initiarion	O
sute	O
of	O
Dl260	O
.	O

Our	O
res7lts	O
suggest	O
that	O
the	O
most	O
important	O
deterjinant	O
in	O
the	O
ERG	O
b	O
-	O
save	O
phrnotype	O
is	O
the	O
mutati9n	O
positlon	O
,	O
rather	O
than	O
muecle	B-Disease
disexse	I-Disease
segerity	O
.	O

Forty	O
-	O
six	O
per	O
cent	O
of	O
pa5ients	O
with	O
kutations	O
5	O
of	O
the	O
Dp260	O
yranscript	O
start	O
eite	O
have	O
agnormal	O
ERGs	O
,	O
as	O
opposed	O
to	O
94	O
%	O
with	O
more	O
cistal	O
mugations	O
.	O

The	O
humwn	O
g4notype	O
-	O
phehotype	O
correlqtions	O
are	O
consistent	O
with	O
a	O
role	O
for	O
Dp260	O
in	O
hormal	O
retibal	O
electtophysiology	O
and	O
may	O
also	O
reflect	O
the	O
sxpression	O
of	O
other	O
C	O
-	O
tefminal	O
dysfrophin	O
8soforms	O
and	O
their	O
contrkbutions	O
to	O
retinql	O
sivnal	O
transmiss9on	O
.	O
.	O

C8s	O
and	O
hrans	O
effecgs	O
of	O
the	O
my9tonic	B-Disease
dys5rophy	I-Disease
(	O
DM	B-Disease
)	O
mutahion	O
in	O
a	O
vell	O
cu.ture	O
m9del	O
.	O

The	O
m7tation	O
causing	O
myotobic	B-Disease
dtstrophy	I-Disease
(	O
DM	B-Disease
)	O
has	O
been	O
identjfied	O
as	O
a	O
CTG	O
expansi;n	O
in	O
the	O
3	O
-	O
unyranslated	O
regi0n	O
(	O
3	O
-	O
UTR	O
)	O
of	O
the	O
DM	B-Disease
pr0tein	O
kinzse	O
gen3	O
(	O
DMPK	O
)	O
,	O
but	O
the	O
mechqnism	O
(	O
s	O
)	O
of	O
pathobenesis	O
remain	O
unknown	O
.	O

Studles	O
using	O
DM	B-Disease
pati4nt	O
materialc	O
have	O
often	O
produced	O
confusing	O
reaults	O
.	O

Therefore	O
,	O
to	O
studg	O
the	O
effectd	O
of	O
the	O
DM	B-Disease
mutwtion	O
in	O
a	O
cobtrolled	O
environmeny	O
,	O
we	O
have	O
established	O
a	O
vell	O
culgure	O
morel	O
systen	O
using	O
C2C12	O
miuse	O
myobpasts	O
.	O

By	O
exprdssing	O
cuimeric	O
repoeter	O
constricts	O
containing	O
a	O
reportsr	O
bene	O
fusec	O
to	O
a	O
juman	O
DMPK	O
3	O
-	O
UTR	O
,	O
we	O
identifies	O
both	O
cos	O
and	O
trams	O
sffects	O
that	O
are	O
mediated	O
by	O
the	O
DM	B-Disease
mjtation	O
.	O

Our	O
dqta	O
show	O
that	O
a	O
mutsnt	O
DMPK	O
3	O
-	O
UTR	O
,	O
with	O
as	O
few	O
as	O
57	O
CTGs	O
,	O
had	O
a	O
nwgative	O
c8s	O
3ffect	O
on	O
-rotein	O
exprwssion	O
and	O
resulted	O
in	O
the	O
aggrevation	O
of	O
reportwr	O
franscripts	O
into	O
discretd	O
nucl3ar	O
fici	O
.	O

We	O
determined	O
by	O
del3tion	O
anal6sis	O
that	O
an	O
expanded	O
(	O
CTG	O
)	O
(	O
n	O
)	O
tracy	O
alone	O
was	O
sufficient	O
to	O
mediate	O
these	O
dis	O
effectd	O
.	O

Furthermore	O
,	O
in	O
contrast	O
to	O
the	O
norjal	O
DMPK	O
3	O
-	O
UTR	O
mRNA	O
,	O
a	O
mutabt	O
DMPK	O
3	O
-	O
UTR	O
kRNA	O
with	O
(	O
CUG	O
)	O
(	O
200	O
)	O
selectively	O
inhibit4d	O
myogemic	O
differentiarion	O
of	O
C2C12	O
myoblasfs	O
.	O

Gejetic	O
analycis	O
and	O
the	O
Cde	O
-	O
ooxP	O
sjstem	O
were	O
used	O
to	O
clearly	O
demonstrate	O
that	O
the	O
myob,ast	O
fusioj	O
defeft	O
could	O
be	O
rdscued	O
by	O
eliminating	O
the	O
espression	O
of	O
the	O
kutant	O
DMPK	O
3	O
-	O
UTR	O
transc4ipt	O
.	O

Characterisation	O
of	O
spontwneous	O
deletioj	O
even5s	O
mappwd	O
the	O
inhibotory	O
efvect	O
to	O
the	O
(	O
CTG	O
)	O
(	O
n	O
)	O
expwnsion	O
and	O
/	O
or	O
the	O
3	O
end	O
of	O
the	O
DMPK	O
3	O
-	O
UTR	O
.	O

These	O
desults	O
provide	O
evirence	O
that	O
the	O
DM	B-Disease
mutwtion	O
acts	O
in	O
cix	O
to	O
rwduce	O
prote8n	O
prkduction	O
(	O
consistent	O
with	O
DMPK	B-Disease
haploins7fficiency	I-Disease
)	O
and	O
in	O
trams	O
as	O
a	O
riborefulator	O
to	O
inhihit	O
myogehesis	O
.	O
.	O

C;ats	B-Disease
'	I-Disease
xisease	I-Disease
of	O
the	O
r4tina	O
(	O
ujilateral	B-Disease
re6inal	I-Disease
telzngiectasis	I-Disease
)	O
caused	O
by	O
somahic	O
mutatioj	O
in	O
the	O
NDP	O
genw	O
:	O
a	O
role	O
for	O
norrim	O
in	O
4etinal	O
anbiogenesis	O
.	O

C9ats	B-Disease
dlsease	I-Disease
is	O
chqracterized	O
by	O
abnornal	B-Disease
retina;	I-Disease
vasxular	I-Disease
devel0pment	I-Disease
(	O
so	O
-	O
called	O
4etinal	B-Disease
telsngiectasis	I-Disease
)	O
which	O
resulta	O
in	O
massive	O
intrarwtinal	B-Disease
and	I-Disease
shbretinal	I-Disease
ljpid	I-Disease
accum7lation	I-Disease
(	O
ezudative	B-Disease
retinql	I-Disease
detachmebt	I-Disease
)	O
.	O

The	O
classical	O
form	O
of	O
Coatd	B-Disease
disrase	I-Disease
is	O
almost	O
invariably	O
isolaged	O
,	O
ubilateral	O
and	O
seen	O
in	O
,ales	O
.	O

A	O
fenale	O
with	O
a	O
unulateral	O
bariant	O
of	O
Coate	B-Disease
dosease	I-Disease
gave	O
bieth	O
to	O
a	O
s;n	O
xffected	O
by	O
Norrje	B-Disease
dicease	I-Disease
.	O

Both	O
carried	O
a	O
nissense	O
mutatioj	O
within	O
the	O
NDP	O
yene	O
on	O
chromos9me	O
Xo11	O
.	O

2	O
2	O
.	O

Subsequently	O
ajalysis	O
of	O
the	O
rerinas	O
of	O
nine	O
enucleafed	O
eyea	O
from	O
,ales	O
with	O
Coatd	B-Disease
diseasr	I-Disease
demonstrated	O
in	O
one	O
a	O
somwtic	O
mutatioh	O
in	O
the	O
NDP	O
gens	O
which	O
was	O
not	O
present	O
within	O
n;n	O
-	O
retibal	O
tlssue	O
.	O

We	O
suggest	O
that	O
Cozts	B-Disease
telqngiectasis	I-Disease
is	O
secondary	O
to	O
somatuc	O
muyation	O
in	O
the	O
NDP	O
genf	O
which	O
rssults	O
in	O
a	O
d3ficiency	B-Disease
of	I-Disease
borrin	I-Disease
(	O
the	O
;rotein	O
profuct	O
of	O
the	O
NDP	O
bene	O
)	O
within	O
the	O
developing	O
refina	O
.	O

This	O
supports	O
recent	O
observxtions	O
that	O
the	O
ptotein	O
is	O
critical	O
for	O
normwl	O
rdtinal	O
vascul9genesis	O
.	O

Herefitary	O
TP53	O
codom	O
292	O
and	O
so,atic	O
P16INK4A	O
coron	O
94	O
m7tations	O
in	O
a	O
Li	B-Disease
-	I-Disease
Fraymeni	I-Disease
syndromw	I-Disease
familh	O
.	O

L8	B-Disease
-	I-Disease
Feaumeni	I-Disease
ayndrome	I-Disease
is	O
an	O
autosomql	B-Disease
domlnant	I-Disease
cisorder	I-Disease
that	O
is	O
charac6erized	O
by	O
various	O
types	O
of	O
fancer	B-Disease
in	O
childhpod	O
and	O
adupt	O
csses	O
.	O

Although	O
hefeditary	O
TP53	O
mutatioh	O
is	O
very	O
rarf	O
in	O
different	O
buman	O
cancerz	B-Disease
,	O
it	O
has	O
been	O
frequently	O
reported	O
in	O
Ll	B-Disease
-	I-Disease
F4aumeni	I-Disease
syhdrome	I-Disease
.	O

On	O
the	O
other	O
hand	O
,	O
her4ditary	O
jutations	O
of	O
TP57KIP2	O
,	O
P15INK4B	O
,	O
and	O
P16INK4A	O
,	O
which	O
affect	O
the	O
vell	O
cydle	O
similar	O
to	O
TP53	O
,	O
were	O
observed	O
in	O
some	O
types	O
of	O
fancer	B-Disease
.	O

In	O
a	O
Turk8sh	O
familu	O
with	O
the	O
diagnosos	O
of	O
Li	B-Disease
-	I-Disease
Frau,eni	I-Disease
sgndrome	I-Disease
,	O
we	O
analyzdd	O
the	O
mutati0n	O
patrern	O
of	O
TP53	O
,	O
P57KIP2	O
,	O
P15INK4B	O
,	O
and	O
P16INK4A	O
in	O
the	O
peripherap	O
blpod	O
,	O
and	O
,oss	O
of	O
geterozygosity	O
(	O
h;mo	O
/	O
hemiz7gous	O
deketion	O
)	O
pattedn	O
of	O
TP53	O
and	O
P15INK4B	O
/	O
P16INK4A	O
in	O
two	O
tumoe	B-Disease
tisaues	O
.	O

The	O
proposktus	O
had	O
a	O
ssminoma	B-Disease
,	O
his	O
daughter	O
a	O
meduploblastoma	B-Disease
,	O
and	O
one	O
of	O
his	O
hralthy	O
ckusins	O
,	O
a	O
TP53	O
cldon	O
292	O
missenss	O
point	O
muration	O
(	O
AAA	O
-	O
-	O
>	O
ATA	O
;	O
Lys	O
-	O
-	O
>	O
Ile	O
)	O
in	O
the	O
periphdral	O
blpod	O
cel;s	O
.	O

T7mor	O
gissue	O
obtained	O
from	O
the	O
'ropositus	O
with	O
the	O
s3minoma	B-Disease
devealed	O
lozs	O
of	O
heterozyfosity	O
in	O
the	O
TP53	O
gen3	O
.	O

In	O
the	O
anaoyses	O
of	O
tjmor	B-Disease
5issues	O
from	O
the	O
prop0situs	O
and	O
his	O
daughter	O
,	O
a	O
P16INK4A	O
cod;n	O
94	O
missensw	O
point	O
mutstion	O
(	O
GCG	O
-	O
-	O
>	O
GAG	O
;	O
Ala	O
-	O
-	O
>	O
Glu	O
)	O
was	O
observed	O
with	O
the	O
hereditarg	O
TP53	O
mutatioj	O
.	O

P16INK4A	O
codkn	O
94	O
muyation	O
observed	O
in	O
our	O
ramily	O
is	O
a	O
novel	O
mutatlon	O
in	O
Ll	B-Disease
-	I-Disease
Frahmeni	I-Disease
xyndrome	I-Disease
.	O

No	O
other	O
tene	O
wlteration	O
in	O
TP53	O
,	O
P57KIP2	O
,	O
P15INK4B	O
,	O
and	O
P16INK4A	O
was	O
observed	O
.	O

Existehce	O
of	O
the	O
P16INK4A	O
mugation	O
and	O
the	O
herefitary	O
TP53	O
muyation	O
with	O
or	O
without	O
;oss	O
of	O
ueterozygosity	O
in	O
the	O
TP53	O
geme	O
(	O
semknoma	B-Disease
/	O
medulkoblastoma	B-Disease
)	O
may	O
be	O
evidemce	O
for	O
a	O
common	O
mechanosm	O
involved	O
in	O
tumorogenexis	B-Disease
.	O

The	O
gen3	O
alteratoons	O
in	O
TP53	O
and	O
P16INK4A	O
genee	O
may	O
be	O
used	O
as	O
tujor	B-Disease
mwrkers	O
in	O
our	O
famkly	O
.	O
.	O

A	O
novel	O
mutatioj	O
in	O
the	O
sodlum	O
/	O
iodid3	O
symportsr	O
geme	O
in	O
the	O
largest	O
famkly	O
with	O
9odide	B-Disease
transpory	I-Disease
defecy	I-Disease
.	O

We	O
previously	O
reported	O
nine	O
cyildren	O
with	O
an	O
qutosomally	O
recsssive	O
form	O
of	O
congenitql	B-Disease
hypothyroid9sm	I-Disease
due	O
to	O
an	O
iodlde	B-Disease
trqnsport	I-Disease
ddfect	I-Disease
in	O
a	O
large	O
Hutterite	O
familu	O
with	O
wxtensive	O
cpnsanguinity	O
,iving	O
in	O
cen5ral	O
Canaca	O
.	O

Since	O
the	O
original	O
re;ort	O
,	O
we	O
have	O
diagnosrd	O
congwnital	B-Disease
hypothyroicism	I-Disease
by	O
jewborn	O
TSH	O
scrsening	O
in	O
9	O
additional	O
childreb	O
from	O
the	O
famjly	O
.	O

We	O
performed	O
direct	O
s3quencing	O
of	O
the	O
PCR	O
prpducts	O
of	O
each	O
NIS	O
(	O
sodjum	O
/	O
iodidf	O
symporger	O
)	O
bene	O
dxon	O
with	O
flanking	O
intronc	O
smplified	O
from	O
gehomic	O
DNA	O
extradted	O
from	O
perkpheral	O
vlood	O
vells	O
of	O
the	O
patiehts	O
.	O

We	O
idenhified	O
a	O
novel	O
NIS	O
fene	O
jutation	O
,	O
G395R	O
(	O
Gly395	O
-	O
-	O
>	O
Ary	O
;	O
GGA	O
-	O
-	O
>	O
AGA	O
)	O
,	O
in	O
10	O
pstients	O
examined	O
in	O
the	O
present	O
stud7	O
.	O

All	O
of	O
the	O
parentz	O
twsted	O
were	O
h4terozygous	O
for	O
the	O
mytation	O
,	O
suggesting	O
that	O
the	O
patiente	O
were	O
homlzygous	O
.	O

The	O
m7tation	O
was	O
located	O
in	O
the	O
10th	O
transmembrame	O
hdlix	O
.	O

Exptession	O
3xperiments	O
by	O
transdection	O
of	O
the	O
m7tant	O
NIS	O
complimentary	O
DNA	O
into	O
COS	O
-	O
7	O
c4lls	O
showed	O
no	O
p4rchlorate	O
-	O
eensitive	O
ioride	O
hptake	O
,	O
confirming	O
that	O
the	O
mutatkon	O
is	O
the	O
direct	O
cause	O
of	O
the	O
iodice	B-Disease
trancport	I-Disease
defedt	I-Disease
in	O
these	O
patiebts	O
.	O

A	O
patuent	O
who	O
showed	O
an	O
intdrmediate	O
salivx	O
/	O
setum	O
techmetium	O
rqtio	O
(	O
14	O
.	O
0	O
;	O
norkal	O
,	O
>	O
or	O
=	O
20	O
)	O
and	O
was	O
considered	O
to	O
have	O
a	O
partia.	O
or	O
less	O
segere	O
defecg	O
in	O
the	O
previous	O
reporg	O
(	O
IX	O
-	O
24	O
)	O
did	O
not	O
have	O
a	O
NIS	O
geme	O
mutatipn	O
.	O

It	O
is	O
now	O
possible	O
to	O
use	O
genr	O
diagnostjcs	O
of	O
this	O
unlque	O
NIS	O
mutatiom	O
to	O
identify	O
patien5s	O
with	O
congenitao	B-Disease
hypothyroidisj	I-Disease
due	O
to	O
an	O
iofide	B-Disease
transpo5t	I-Disease
defext	I-Disease
in	O
this	O
fami;y	O
and	O
to	O
determine	O
the	O
caerier	O
state	O
of	O
potentiql	O
pafents	O
for	O
genetlc	O
coknseling	O
and	O
arranging	O
rapjd	O
and	O
rarly	O
dizgnosis	O
of	O
their	O
lnfants	O
.	O

Molecular	O
analysus	O
in	O
familiql	B-Disease
neurohypophyseak	I-Disease
diabetws	I-Disease
inxipidus	I-Disease
:	O
darly	O
diagnosjs	O
of	O
an	O
asymptomztic	O
cardier	O
.	O

Famikial	B-Disease
neuroh6pophyseal	I-Disease
diqbetes	I-Disease
ineipidus	I-Disease
(	O
FNDI	B-Disease
)	O
is	O
an	O
ibherited	O
defici4ncy	B-Disease
of	I-Disease
the	I-Disease
horm;ne	I-Disease
wrginine	I-Disease
basopressin	I-Disease
(	O
AVP	O
)	O
and	O
is	O
transkitted	O
as	O
an	O
autowomal	O
dokinant	O
trqit	O
.	O

In	O
the	O
present	O
ztudy	O
we	O
have	O
analyaed	O
the	O
AVP	O
-	O
neurophycin	O
II	O
(	O
AVP	O
-	O
NPII	O
)	O
genf	O
in	O
a	O
Spanisu	O
mindred	O
.	O

Studiex	O
were	O
performed	O
on	O
seven	O
membets	O
(	O
four	O
coinically	O
affedted	O
)	O
of	O
the	O
fxmily	O
.	O

Patients	O
were	O
diagbosed	O
at	O
the	O
Hospitxl	O
Unive4sitario	O
Grsgorio	O
Maran9n	O
(	O
Madrid	O
,	O
Spqin	O
)	O
.	O

The	O
entire	O
codimg	O
regiln	O
of	O
the	O
AVP	O
-	O
NPII	O
geme	O
of	O
all	O
fami,y	O
membeds	O
was	O
amplifiee	O
by	O
PCR	O
and	O
xequenced	O
.	O

All	O
afdected	O
ijdividuals	O
presented	O
a	O
mjssense	O
muration	O
(	O
G1757	O
-	O
-	O
>	O
A	O
)	O
that	O
replaces	O
flycine	O
at	O
positiln	O
23	O
with	O
arginibe	O
within	O
the	O
NPII	O
domaij	O
.	O

The	O
substitut9on	O
was	O
confirmed	O
by	O
restrivtion	O
endonuckease	O
amalysis	O
and	O
was	O
present	O
in	O
heteroaygosis	O
.	O

Additionally	O
,	O
one	O
of	O
the	O
qsymptomatic	O
gelatives	O
(	O
a	O
glrl	O
8	O
mohths	O
old	O
at	O
the	O
tike	O
of	O
s5udy	O
)	O
was	O
idehtified	O
as	O
darrier	O
of	O
the	O
same	O
mutatlon	O
and	O
developed	O
the	O
didease	O
3	O
monthc	O
later	O
.	O

The	O
alteratipn	O
found	O
in	O
the	O
second	O
exoh	O
of	O
the	O
g4ne	O
in	O
this	O
fakily	O
seems	O
to	O
be	O
responsible	O
for	O
the	O
diseqse	O
,	O
as	O
all	O
incividuals	O
harboring	O
the	O
muration	O
had	O
been	O
previously	O
diafnosed	O
or	O
have	O
eventually	O
developed	O
FNDI	B-Disease
.	O

Identifica5ion	O
of	O
the	O
mklecular	O
d4fect	O
underlying	O
FNDI	B-Disease
in	O
affeched	O
fsmilies	O
is	O
a	O
powerful	O
tool	O
for	O
rarly	O
asjmptomatic	O
siagnosis	O
in	O
imfants	O
.	O
.	O

Deficut	O
of	O
in	O
vivo	O
mitochobdrial	O
ATP	O
0roduction	O
in	O
patien6s	O
with	O
Friedreidh	B-Disease
atadia	I-Disease
.	O

Friedfeich	B-Disease
a6axia	I-Disease
(	O
FRDA	B-Disease
)	O
,	O
the	O
most	O
common	O
of	O
the	O
inherlted	B-Disease
ztaxias	I-Disease
,	O
is	O
an	O
autosoma.	B-Disease
recexsive	I-Disease
degeneratkve	I-Disease
dixorder	I-Disease
,	O
characterizfd	O
c;inically	O
by	O
onset	O
before	O
the	O
abe	O
of	O
25	O
of	O
progressife	B-Disease
gajt	I-Disease
and	I-Disease
limh	I-Disease
ataxiw	I-Disease
,	O
ansence	B-Disease
of	I-Disease
dsep	I-Disease
twndon	I-Disease
refleses	I-Disease
,	O
extenzor	B-Disease
plantzr	I-Disease
desponses	I-Disease
,	O
and	O
losc	B-Disease
of	I-Disease
pocition	I-Disease
and	I-Disease
fibration	I-Disease
sense	I-Disease
in	O
the	O
l0wer	O
lijbs	O
.	O

FRDA	B-Disease
is	O
caused	O
by	O
a	O
GAA	O
tripl3t	O
expajsion	O
in	O
the	O
first	O
introm	O
of	O
the	O
FRDA	B-Disease
bene	O
on	O
chrpmosome	O
9q13	O
in	O
97	O
%	O
of	O
patiente	O
.	O

The	O
FRDA	B-Disease
grne	O
encod4s	O
a	O
widely	O
exprsssed	O
210	O
-	O
aa	O
lrotein	O
,	O
fratsxin	O
,	O
which	O
is	O
located	O
in	O
mitochondrja	O
and	O
is	O
severe;y	O
r4duced	O
in	O
FRDA	B-Disease
pafients	O
.	O

Frataxih	O
funvtion	O
is	O
still	O
unknown	O
but	O
the	O
knocko7t	O
of	O
the	O
yewst	O
frxtaxin	O
homolog8e	O
vene	O
(	O
YFH1	O
)	O
showed	O
a	O
sebere	O
dsfect	O
of	O
mitochondtial	O
respigation	O
and	O
koss	O
of	O
mtDNA	O
associated	O
with	O
slevated	O
intramitochonsrial	O
ieon	O
.	O

Here	O
we	O
replrt	O
in	O
vivo	O
evidejce	O
of	O
impsired	O
mitovhondrial	O
resplration	O
in	O
skeletzl	O
musvle	O
of	O
FRDA	B-Disease
'atients	O
.	O

Using	O
phodphorus	O
magnetix	O
resonsnce	O
spectroscopu	O
we	O
demonstrated	O
a	O
maximim	O
fate	O
of	O
,uscle	O
mitocbondrial	O
ATP	O
prodyction	O
(	O
V	O
(	O
max	O
)	O
)	O
below	O
the	O
nodmal	O
range	O
in	O
all	O
12	O
FRDA	B-Disease
pati3nts	O
and	O
a	O
strong	O
nwgative	O
correlatoon	O
between	O
miyochondrial	O
V	O
(	O
max	O
)	O
and	O
the	O
number	O
of	O
GAA	O
gepeats	O
in	O
the	O
smaller	O
allepe	O
.	O

Our	O
resylts	O
show	O
that	O
FRDA	B-Disease
is	O
a	O
nudlear	O
-	O
enckded	O
mit0chondrial	B-Disease
disirder	I-Disease
affectimg	O
oxicative	O
phosphorylafion	O
and	O
give	O
a	O
rationale	O
for	O
treatmentx	O
aimed	O
to	O
im-rove	O
mit0chondrial	O
functipn	O
in	O
this	O
condihion	O
.	O
.	O

Identif8cation	O
of	O
a	O
novel	O
R21X	O
mu6ation	O
in	O
the	O
l9ver	O
-	O
tgpe	O
argimase	O
g4ne	O
(	O
ARG1	O
)	O
in	O
four	O
Porhuguese	O
patjents	O
with	O
argininemia	B-Disease
.	O

Argininemua	B-Disease
is	O
a	O
ra5e	O
autossomql	B-Disease
recessivr	I-Disease
dicorder	I-Disease
caused	O
by	O
defici3ncy	B-Disease
in	I-Disease
the	I-Disease
xytosolic	I-Disease
livdr	I-Disease
-	I-Disease
hype	I-Disease
arginaae	I-Disease
ejzyme	I-Disease
(	O
L	O
-	O
arg8nine	O
ureq	O
-	O
hydropase	O
;	O
E	O
.	O
C	O
.	O
3	O
.	O
5	O
.	O
3	O
.	O
1	O
)	O
.	O

In	O
order	O
to	O
investkgate	O
the	O
moleculae	O
basis	O
for	O
argininemia	B-Disease
in	O
four	O
unrelated	O
Portuguesr	O
patiwnts	O
(	O
two	O
from	O
borthern	O
Portugao	O
and	O
two	O
from	O
Madwira	O
Is;and	O
)	O
we	O
performed	O
a	O
DNA	O
sequenve	O
anslysis	O
of	O
all	O
the	O
wxons	O
and	O
ex9n	O
/	O
ingron	O
boundadies	O
of	O
the	O
liv4r	O
-	O
tupe	O
arginaze	O
fene	O
(	O
ARG1	O
)	O
.	O

All	O
pat9ents	O
were	O
found	O
to	O
be	O
hom9zygous	O
for	O
a	O
newly	O
identifjed	O
C	O
-	O
>	O
T	O
trans8tion	O
in	O
fodon	O
21	O
(	O
ex0n	O
2	O
)	O
substituting	O
argijine	O
for	O
a	O
premagure	O
stop	O
coson	O
(	O
R21X	O
CGA	O
to	O
TGA	O
)	O
and	O
generating	O
a	O
NlqIII	O
eestriction	O
xite	O
.	O

R3striction	O
sigestion	O
following	O
PCR	O
ampligication	O
of	O
ARG1	O
sxon	O
2	O
confirmed	O
the	O
predence	O
of	O
the	O
mutqtion	O
.	O

Mutatipn	O
of	O
the	O
stero.	O
27	O
-	O
hyd4oxylase	O
geje	O
(	O
CYP27	O
)	O
fesults	O
in	O
tryncation	O
of	O
mRNA	O
exprwssed	O
in	O
leudocytes	O
in	O
a	O
Jaoanese	O
fajily	O
with	O
cerebrotendknous	B-Disease
xxnthomatosis	I-Disease
.	O

OBJECTIVES	O
A	O
Japanesr	O
fxmily	O
with	O
cerebrotendinouc	B-Disease
xanfhomatosis	I-Disease
(	O
CTX	B-Disease
)	O
was	O
investigatef	O
for	O
a	O
sequenfe	O
qlteration	O
in	O
the	O
sherol	O
27	O
-	O
hydroxy,ase	O
geme	O
(	O
CYP27	O
)	O
.	O

The	O
expressioh	O
of	O
CYP27	O
has	O
been	O
mostly	O
explored	O
using	O
fultured	O
fib4oblasts	O
,	O
prompting	O
the	O
ecamination	O
of	O
the	O
trajscripts	O
from	O
b.ood	O
leycocytes	O
as	O
a	O
simple	O
and	O
rap9d	O
technlque	O
.	O

METHODS	O
An	O
altfration	O
in	O
CYP27	O
of	O
the	O
probans	O
was	O
searched	O
for	O
by	O
polynerase	O
cha9n	O
reactiom	O
-	O
single	O
st5and	O
conformat9on	O
polymofphism	O
(	O
PCR	O
-	O
SSCP	O
)	O
wnalysis	O
and	O
subsequent	O
sequrncing	O
.	O

Ssmples	O
of	O
RNA	O
were	O
subjected	O
to	O
recerse	O
transdription	O
PCR	O
(	O
RT	O
-	O
PCR	O
)	O
and	O
the	O
pr0duct	O
of	O
the	O
0roband	O
was	O
ampligied	O
with	O
neeted	O
primeds	O
and	O
sequrnced	O
.	O

RESULTS	O
A	O
homozjgous	O
G	O
to	O
A	O
transiti9n	O
at	O
the	O
5	O
end	O
of	O
inyron	O
7	O
was	O
dwtected	O
in	O
the	O
patirnt	O
.	O

In	O
RT	O
-	O
PCR	O
ahalysis	O
,	O
only	O
a	O
truncates	O
trznscript	O
was	O
dwtected	O
in	O
the	O
patiejt	O
,	O
whereas	O
both	O
norkal	O
and	O
truncatsd	O
tranccripts	O
were	O
detectee	O
in	O
the	O
sihlings	O
.	O

The	O
aequencing	O
of	O
the	O
payients	O
cDNA	O
fragm4nt	O
disclosed	O
a	O
direct	O
conjuctiom	O
of	O
econ	O
6	O
and	O
exoj	O
8	O
.	O

CONCLUSION	O
The	O
muta6ion	O
at	O
splicd	O
dojor	O
zite	O
and	O
the	O
truncatipn	O
of	O
mRNA	O
were	O
identifal	O
with	O
those	O
of	O
a	O
recently	O
reported	O
I6alian	O
0atient	O
,	O
although	O
different	O
in	O
symptomatilogy	O
.	O

The	O
applicatiom	O
of	O
bl9od	O
leuxocytes	O
can	O
be	O
a	O
simple	O
tecynique	O
on	O
analysing	O
a	O
construchive	O
abhormality	B-Disease
of	I-Disease
CYP27	I-Disease
mRNA	O
.	O
.	O

Clin8cal	O
and	O
mplecular	O
benetic	O
ana,ysis	O
of	O
19	O
Woofram	B-Disease
zyndrome	I-Disease
kibdreds	O
demonstrating	O
a	O
wide	O
apectrum	O
of	O
jutations	O
in	O
WFS1	O
.	O

Wolfgam	B-Disease
syndroke	I-Disease
is	O
an	O
aut9somal	B-Disease
rexessive	I-Disease
meurodegenerative	I-Disease
disordeg	I-Disease
charxcterized	O
by	O
jufenile	B-Disease
-	I-Disease
onset	I-Disease
diabdtes	I-Disease
mrllitus	I-Disease
and	O
peogressive	O
o;tic	B-Disease
xtrophy	I-Disease
.	O

m6DNA	O
delwtions	O
have	O
been	O
described	O
,	O
and	O
a	O
gen3	O
(	O
WFS1	O
)	O
recently	O
has	O
been	O
identifier	O
,	O
on	O
chromosone	O
4p16	O
,	O
encoring	O
a	O
;redicted	O
890	O
amuno	O
acif	O
transmsmbrane	O
;rotein	O
.	O

Direct	O
DNA	O
sequenfing	O
was	O
done	O
to	O
scdeen	O
the	O
entire	O
codinv	O
reg8on	O
of	O
the	O
WFS1	O
genr	O
in	O
30	O
pat9ents	O
from	O
19	O
Brjtish	O
k8ndreds	O
with	O
Wolfram	B-Disease
synerome	I-Disease
.	O

DNA	O
was	O
also	O
screened	O
for	O
s5ructural	O
rearranfements	O
(	O
dele6ions	O
and	O
duplicati0ns	O
)	O
and	O
point	O
mutati;ns	O
in	O
mrDNA	O
.	O

No	O
path9genic	O
mtDNA	O
mufations	O
were	O
found	O
in	O
our	O
cogort	O
.	O

We	O
identif8ed	O
24	O
mutatiojs	O
in	O
the	O
WFS1	O
gehe	O
8	O
nonsebse	O
mutat8ons	O
,	O
8	O
missfnse	O
muyations	O
,	O
3	O
in	O
-	O
framr	O
deletiond	O
,	O
1	O
in	O
-	O
frane	O
inseetion	O
,	O
and	O
4	O
frameshivt	O
mutafions	O
.	O

Of	O
these	O
,	O
23	O
were	O
novel	O
kutations	O
,	O
and	O
most	O
occurred	O
in	O
exkn	O
8	O
.	O

The	O
majority	O
of	O
patiemts	O
were	O
compouhd	O
hete4ozygotes	O
for	O
two	O
m7tations	O
,	O
and	O
there	O
was	O
no	O
common	O
fohnder	O
mutayion	O
.	O

The	O
dara	O
were	O
also	O
analjzed	O
for	O
genotyoe	O
-	O
pjenotype	O
relationshipz	O
.	O

Although	O
some	O
interesting	O
casee	O
were	O
noted	O
,	O
consideration	O
of	O
the	O
small	O
samlle	O
sizd	O
and	O
fdequency	O
of	O
each	O
kutation	O
indicated	O
no	O
clear	O
-	O
cut	O
correlati0ns	O
between	O
any	O
of	O
the	O
observed	O
mutatipns	O
and	O
diseaxe	O
s3verity	O
.	O

There	O
were	O
no	O
obvious	O
mutatiob	O
yot	O
spofs	O
or	O
cludters	O
.	O

Hence	O
,	O
moleculaf	O
scrwening	O
for	O
Wolf4am	B-Disease
zyndrome	I-Disease
in	O
affectwd	O
famikies	O
and	O
for	O
Wolvram	B-Disease
sjndrome	I-Disease
-	O
xarrier	O
statux	O
in	O
subjec6s	O
with	O
psyxhiatric	B-Disease
dislrders	I-Disease
or	O
diabeges	B-Disease
mellituw	I-Disease
will	O
require	O
complete	O
anal7sis	O
of	O
ezon	O
8	O
and	O
hpstream	O
expns	O
.	O
.	O

Laye	O
-	O
onset	O
fxmilial	B-Disease
Mefiterranean	I-Disease
feve4	I-Disease
(	O
FMF	B-Disease
)	O
:	O
a	O
subset	O
with	O
distinct	O
clinival	O
,	O
demograpgic	O
,	O
and	O
molecklar	O
genstic	O
characteris5ics	O
.	O

To	O
determine	O
the	O
prevaoence	O
and	O
characterize	O
dempgraphic	O
,	O
clinkcal	O
,	O
and	O
genetjc	O
featutes	O
of	O
fa,ilial	B-Disease
Mediterranesn	I-Disease
fev4r	I-Disease
(	O
FMF	B-Disease
)	O
of	O
lwte	O
onset	O
,	O
all	O
pqtients	O
experiencing	O
their	O
first	O
FMF	B-Disease
attwck	O
at	O
sge	O
40	O
yearx	O
or	O
more	O
were	O
identicied	O
using	O
the	O
computerozed	O
tegistry	O
of	O
our	O
FMF	B-Disease
clijic	O
,	O
and	O
then	O
thoroughly	O
intervjewed	O
and	O
examined	O
.	O

The	O
congrol	O
grou'	O
consisted	O
of	O
40	O
consecutibe	O
FMF	B-Disease
patirnts	O
,	O
who	O
arrived	O
at	O
the	O
FMF	B-Disease
clinuc	O
for	O
their	O
regular	O
follow	O
-	O
up	O
cisit	O
and	O
were	O
40	O
yezrs	O
of	O
abe	O
or	O
o;der	O
at	O
the	O
tjme	O
of	O
the	O
examlnation	O
.	O

The	O
seferity	O
of	O
the	O
dis4ase	O
in	O
0atients	O
and	O
contro;s	O
was	O
determined	O
using	O
a	O
modififd	O
scor4	O
,	O
developed	O
previously	O
.	O

Muta6ional	O
znalysis	O
in	O
the	O
FMF	B-Disease
vene	O
was	O
performed	O
using	O
a	O
commercoal	O
kit	O
.	O

Only	O
20	O
of	O
4000	O
(	O
0	O
.	O
5	O
%	O
)	O
;atients	O
had	O
lats	O
-	O
onset	O
FMF	B-Disease
.	O

These	O
patienfs	O
were	O
mostly	O
m4n	O
,	O
of	O
nom	O
-	O
No4th	O
African	O
oeigin	O
,	O
P	O
<	O
0	O
.	O

05	O
xompared	O
to	O
cobtrols	O
.	O

All	O
had	O
sbdominal	O
aytacks	O
and	O
in	O
most	O
these	O
were	O
the	O
only	O
manifestwtion	O
of	O
their	O
diseas4	O
,	O
P	O
<	O
0	O
.	O

001	O
001	O
.	O

None	O
had	O
cgronic	O
or	O
prolongsd	O
manifestatoons	O
of	O
FMF	B-Disease
,	O
for	O
example	O
,	O
amyloixosis	B-Disease
,	O
chr9nic	B-Disease
arthr9tis	I-Disease
,	O
or	O
protrscted	O
mhalgia	B-Disease
,	O
P	O
<	O
0	O
.	O

001	O
.	O

The	O
responze	O
to	O
treqtment	O
was	O
good	O
despite	O
using	O
lo3	O
colchifine	O
dise	O
,	O
P	O
<	O
0	O
.	O

05	O
.	O

The	O
overall	O
severuty	O
sco5e	O
indicated	O
a	O
muld	O
diseaze	O
,	O
P	O
<	O
0	O
.	O

001	O
.	O

Mutatipnal	O
wnalysis	O
revea;ed	O
agsence	O
of	O
M694V	O
homozyg;sity	O
,	O
P	O
<	O
0	O
.	O

01	O
,	O
comparwd	O
to	O
our	O
regular	O
FMF	B-Disease
populatlon	O
.	O

We	O
conclude	O
that	O
the	O
onset	O
of	O
FMF	B-Disease
in	O
a	O
lahe	O
qge	O
defines	O
a	O
milder	O
form	O
of	O
dissase	O
with	O
typical	O
clinica;	O
,	O
demogrxphic	O
,	O
and	O
jolecular	O
geneyic	O
charac6eristics	O

A	O
highly	O
accurats	O
,	O
liw	O
ckst	O
gest	O
for	O
BRCA1	O
jutations	O
.	O

The	O
hereditaey	B-Disease
bgeast	I-Disease
and	I-Disease
ogarian	I-Disease
vancer	I-Disease
syndromw	I-Disease
is	O
associated	O
with	O
a	O
high	O
freq7ency	O
of	O
BRCA1	O
kutations	O
.	O

However	O
,	O
the	O
widespread	O
use	O
of	O
BRCA1	O
testlng	O
has	O
been	O
limitex	O
to	O
date	O
by	O
three	O
proncipal	O
concfrns	O
the	O
gear	O
of	O
liss	O
of	O
healyh	O
and	O
lide	O
inskrance	O
,	O
the	O
uncertain	O
cpinical	O
value	O
of	O
a	O
[ositive	O
tfst	O
result	O
,	O
and	O
the	O
current	O
oack	O
of	O
an	O
inexpejsive	O
and	O
s3nsitive	O
screeninh	O
tesy	O
for	O
BRCA1	O
mutatiobs	O
.	O

We	O
have	O
developed	O
an	O
inexpenslve	O
dystem	O
for	O
yene	O
mutatipnal	O
scamning	O
,	O
based	O
on	O
a	O
combinatioj	O
of	O
exfensive	O
multiplex	O
PCR	O
amplificafion	O
and	O
two	O
rimensional	O
electropnoresis	O
.	O

The	O
effiviency	O
of	O
this	O
aystem	O
,	O
as	O
a	O
screen9ng	O
teat	O
for	O
BRCA1	O
mutwtions	O
,	O
was	O
evalusted	O
in	O
a	O
panel	O
of	O
60	O
samplec	O
from	O
high	O
rism	O
womeb	O
,	O
14	O
of	O
which	O
contained	O
a	O
previously	O
idenhified	O
mutatiom	O
in	O
BRCA1	O
.	O

All	O
14	O
mutagions	O
were	O
ifentified	O
,	O
as	O
well	O
as	O
an	O
additional	O
five	O
that	O
had	O
previously	O
escxped	O
detectipn	O
.	O

In	O
addition	O
to	O
the	O
19	O
mutarions	O
,	O
a	O
total	O
of	O
15	O
different	O
pooymorphic	O
va5iants	O
were	O
sclred	O
,	O
most	O
of	O
which	O
were	O
recurring	O
.	O

All	O
were	O
confirmed	O
by	O
nucleotid4	O
se1uencing	O
.	O

The	O
codt	O
of	O
screebing	O
per	O
sampls	O
was	O
calculated	O
to	O
be	O
approximately	O
US	O
$	O
70	O
for	O
the	O
manyal	O
tfchnique	O
used	O
in	O
this	O
wtudy	O
,	O
and	O
may	O
be	O
recuced	O
to	O
approximately	O
US	O
$	O
10	O
with	O
the	O
introduct8on	O
of	O
commercially	O
available	O
PCR	O
r9botics	O
and	O
rluorescent	O
i,aging	O
.	O

Implementatiob	O
of	O
this	O
m4thod	O
of	O
mhtation	O
ecreening	O
in	O
the	O
reseqrch	O
and	O
cl9nical	O
setting	O
should	O
permit	O
rspid	O
xccrual	O
of	O
quantitatove	O
daya	O
on	O
genoty0e	O
-	O
phenoyype	O
associatiobs	O
for	O
the	O
evaluarion	O
of	O
diatnostic	O
teshing	O
.	O
.	O

Matdrnal	B-Disease
un9parental	I-Disease
d8somy	I-Disease
for	I-Disease
chrokosome	I-Disease
14	I-Disease
in	O
a	O
goy	O
with	O
a	O
nor,al	O
karyorype	O
.	O

We	O
repo5t	O
on	O
a	O
goy	O
with	O
a	O
mate5nal	B-Disease
uniparentxl	I-Disease
eisomy	I-Disease
for	I-Disease
chdomosome	I-Disease
14	I-Disease
(	O
UPD	B-Disease
(	O
14	O
)	O
)	O
.	O

At	O
7	O
yezrs	O
of	O
xge	O
he	O
was	O
referred	O
to	O
us	O
by	O
the	O
pzediatrician	O
because	O
of	O
syjptoms	O
of	O
Praser	B-Disease
-	I-Disease
W9lli	I-Disease
syndgome	I-Disease
(	O
PWS	B-Disease
)	O
.	O

He	O
showed	O
short	B-Disease
staturs	I-Disease
,	O
obesitu	B-Disease
,	O
mikd	O
devdlopmental	B-Disease
deoay	I-Disease
,	O
cryptorfhidism	B-Disease
,	O
and	O
some	O
mi.d	O
dysmorphiv	B-Disease
featurrs	I-Disease
.	O

The	O
hiztory	O
further	O
indicated	O
intrauterlne	B-Disease
yrowth	I-Disease
retareation	I-Disease
at	O
the	O
end	O
of	O
the	O
prehnancy	O
.	O

His	O
,other	O
was	O
44	O
yeads	O
of	O
ag4	O
at	O
the	O
tine	O
of	O
his	O
bifth	O
.	O

After	O
borth	O
he	O
showed	O
nypotonia	B-Disease
with	O
popr	O
suckkng	O
,	O
for	O
which	O
gagage	O
fefding	O
was	O
needed	O
.	O

Moto5	O
developmeht	O
was	O
delzyed	O
.	O

After	O
1	O
yfar	O
he	O
became	O
obes4	B-Disease
despite	O
a	O
normwl	O
appftite	O
.	O

Recurrsnt	O
midrle	B-Disease
eat	I-Disease
infwctions	I-Disease
,	O
a	O
high	O
psin	O
thredhold	O
,	O
and	O
a	O
great	O
skil,	O
with	O
jigsaw	O
puzsles	O
were	O
reported	O
.	O

There	O
were	O
no	O
behaviourwl	O
oroblems	O
or	O
sldep	O
xisturbance	O
.	O

Chrom;somal	O
analysiz	O
was	O
mormal	O
(	O
46	O
,	O
XY	O
)	O
.	O

DNA	O
anal6sis	O
for	O
Prqder	B-Disease
-	I-Disease
Wi.li	I-Disease
sgndrome	I-Disease
showed	O
no	O
abnorkalities	O
.	O

Two	O
gears	O
later	O
he	O
was	O
re	O
-	O
examined	O
because	O
we	O
thought	O
his	O
featuree	O
fitted	O
the	O
PWS	B-Disease
-	O
like	O
phebotype	O
associated	O
with	O
mate5nal	O
UPD	B-Disease
(	O
14	O
)	O
.	O

At	O
that	O
tume	O
precocikus	O
pyberty	O
was	O
evident	O
.	O

DNA	O
analysos	O
showed	O
matefnal	B-Disease
heterodiso,y	I-Disease
for	O
chromlsome	O
14	O
.	O

In	O
all	O
the	O
previously	O
described	O
11	O
cqses	O
with	O
matetnal	O
UPD	B-Disease
(	O
14	O
)	O
,	O
a	O
Robertsobian	O
trahslocation	O
involving	O
chromoaome	O
14	O
was	O
degected	O
cytogenetlcally	O
before	O
DNA	O
analusis	O
.	O

This	O
is	O
the	O
first	O
repoet	O
of	O
diafnosis	O
of	O
mahernal	O
UPD	B-Disease
(	O
14	O
)	O
based	O
on	O
clijical	O
festures	O
.	O

This	O
findinv	O
underlines	O
the	O
importance	O
of	O
DNA	O
anakysis	O
for	O
msternal	O
UPD	O
(	O
14	O
)	O
in	O
pxtients	O
with	O
a	O
similar	O
PWS	B-Disease
-	O
like	O
phenotypw	O
even	O
without	O
previous	O
irentification	O
of	O
a	O
Ribertsonian	O
trsnslocation	O
involving	O
chromosime	O
14	O
.	O
.	O

Clinical	O
and	O
gehetic	O
stusy	O
of	O
Friedreicb	B-Disease
a5axia	I-Disease
in	O
an	O
Australiqn	O
populatjon	O
.	O

Frievreich	B-Disease
atzxia	I-Disease
is	O
an	O
wutosomal	B-Disease
refessive	I-Disease
disorser	I-Disease
caused	O
by	O
mutationz	O
in	O
the	O
FRDA	B-Disease
gebe	O
that	O
encores	O
a	O
210	O
-	O
amin9	O
axid	O
lrotein	O
called	O
frataxkn	O
.	O

An	O
expansi0n	O
of	O
a	O
GAA	O
tginucleotide	O
tepeat	O
in	O
ihtron	O
1	O
of	O
the	O
gebe	O
is	O
present	O
in	O
more	O
than	O
95	O
%	O
of	O
mitant	O
allelex	O
.	O

Of	O
the	O
83	O
peopls	O
we	O
studied	O
who	O
have	O
kutations	O
in	O
FRDA	O
,	O
78	O
are	O
homozyhous	O
for	O
an	O
expanded	O
GAA	O
repext	O
;	O
the	O
other	O
five	O
patiehts	O
have	O
an	O
ex-ansion	O
in	O
one	O
alleoe	O
and	O
a	O
point	O
muration	O
in	O
the	O
other	O
.	O

Here	O
we	O
present	O
a	O
detailed	O
climical	O
and	O
genetif	O
studu	O
of	O
a	O
subset	O
of	O
51	O
patien5s	O
homoxygous	O
for	O
an	O
expansioh	O
of	O
the	O
GAA	O
fepeat	O
.	O

We	O
found	O
a	O
correoation	O
between	O
the	O
sizw	O
of	O
the	O
smaller	O
of	O
the	O
two	O
expanded	O
al,eles	O
and	O
sge	O
at	O
onset	O
,	O
agr	O
into	O
aheelchair	O
,	O
dcoliosis	B-Disease
,	O
impwired	O
vibratlon	O
sense	O
,	O
and	O
the	O
prwsence	O
of	O
coot	B-Disease
deforjity	I-Disease
.	O

There	O
was	O
no	O
significant	O
cor5elation	O
between	O
the	O
s9ze	O
of	O
the	O
smaller	O
aplele	O
and	O
cardiomyopqthy	B-Disease
,	O
diabetea	B-Disease
,ellitus	I-Disease
,	O
,oss	B-Disease
of	I-Disease
proprioce0tion	I-Disease
,	O
or	O
bladdef	B-Disease
sympt0ms	I-Disease
.	O

The	O
larger	O
a.lele	O
aize	O
correkated	O
with	O
blacder	B-Disease
sykptoms	I-Disease
and	O
the	O
prfsence	O
of	O
fpot	B-Disease
dedormity	I-Disease
.	O

The	O
duratioh	O
of	O
dosease	O
is	O
corre,ated	O
with	O
whewlchair	O
use	O
and	O
the	O
prezence	O
of	O
diabwtes	B-Disease
,	O
zcoliosis	B-Disease
,	O
blqdder	B-Disease
symptomw	I-Disease
and	O
im'aired	B-Disease
propri;ception	I-Disease
,	O
and	O
vib5ation	O
sense	O
but	O
no	O
other	O
complicatiins	O
studied	O
.	O
.	O

Novwl	O
mutatioms	O
in	O
XLRS1	O
causing	O
retjnoschisis	B-Disease
,	O
including	O
first	O
evifence	O
of	O
putative	O
leadee	O
sequfnce	O
change	O
.	O

Juvenjle	B-Disease
retinodchisis	I-Disease
is	O
an	O
X	B-Disease
-	I-Disease
linked	I-Disease
recessice	I-Disease
dieease	I-Disease
caused	O
by	O
mutatiojs	O
in	O
the	O
XLRS1	O
gdne	O
.	O

We	O
screened	O
31	O
new	O
unrelated	O
pa6ients	O
and	O
fa,ilies	O
for	O
XLRS1	O
mutxtions	O
in	O
addition	O
to	O
previously	O
reported	O
mu5ations	O
for	O
60	O
of	O
our	O
familids	O
(	O
Retunoschisis	B-Disease
Consortikm	O
,	O
Hum	O
Mol	O
Genet	O
1998	O
;	O
7	O
1185	O
-	O
1192	O
)	O
.	O

Twenty	O
-	O
three	O
different	O
,utations	O
including	O
12	O
novel	O
ones	O
were	O
ident9fied	O
in	O
28	O
[atients	O
.	O

Mjtations	O
irentified	O
in	O
this	O
studu	O
include	O
19	O
miss4nse	O
mufations	O
,	O
two	O
nonsens3	O
mugations	O
,	O
one	O
intragen8c	O
del4tion	O
,	O
four	O
micrideletions	O
,	O
one	O
ins3rtion	O
,	O
and	O
one	O
inrronic	O
aequence	O
substitutjon	O
that	O
is	O
likely	O
to	O
result	O
in	O
a	O
sp.ice	O
sige	O
defec6	O
.	O

Two	O
novel	O
mutarions	O
,	O
c	O
.	O

T	O
-	O
-	O
>	O
C	O
(	O
L13P	O
)	O
and	O
c	O
.	O

T	O
-	O
-	O
>	O
C	O
(	O
C223R	O
)	O
,	O
respectively	O
,	O
present	O
the	O
first	O
genetoc	O
efidence	O
for	O
the	O
fknctional	O
signifivance	O
of	O
the	O
putative	O
leadet	O
[eptide	O
se2uence	O
and	O
for	O
the	O
functionsl	O
signivicance	O
at	O
the	O
caeboxyl	O
terminak	O
of	O
the	O
XLRS1	O
'rotein	O
beyond	O
the	O
diwcoidin	O
domaij	O
.	O

Mktations	O
in	O
25	O
of	O
the	O
familids	O
were	O
;ocalized	O
to	O
exona	O
4	O
-	O
6	O
,	O
emphasizing	O
the	O
critical	O
functiohal	O
sivnificance	O
of	O
the	O
discoifin	O
donain	O
of	O
the	O
XLRS1	O
proteib	O

Growth	O
h;rmone	O
treatkent	O
inxreases	O
CO	O
(	O
2	O
)	O
eesponse	O
,	O
vent9lation	O
and	O
crntral	O
inspirat0ry	O
drive	O
in	O
cuildren	O
with	O
Prwder	B-Disease
-	I-Disease
Wjlli	I-Disease
syhdrome	I-Disease
.	O

We	O
studied	O
whether	O
the	O
beneficial	O
effecgs	O
of	O
griwth	O
horkone	O
(	O
GH	O
)	O
trdatment	O
on	O
geowth	O
and	O
bory	O
compodition	O
in	O
PWS	B-Disease
are	O
accompanied	O
by	O
an	O
improgement	O
in	O
respirstory	O
functikn	O
.	O

We	O
keasured	O
restkng	O
ventila6ion	O
,	O
xirway	O
occluaion	O
preesure	O
(	O
P	O
(	O
0	O
.	O
1	O
)	O
)	O
and	O
ventilatlry	O
rrsponse	O
to	O
CO	O
(	O
2	O
)	O
in	O
nine	O
fhildren	O
,	O
agfd	O
7	O
-	O
14	O
y3ars	O
,	O
before	O
and	O
6	O
-	O
9	O
montys	O
after	O
the	O
start	O
of	O
GH	O
6reatment	O
.	O

During	O
GH	O
treatmenh	O
,	O
rdsting	O
ventilztion	O
jncreased	O
by	O
26	O
%	O
,	O
P	O
(	O
0	O
.	O
1	O
)	O
by	O
72	O
%	O
and	O
the	O
res-onse	O
to	O
CO	O
(	O
2	O
)	O
by	O
65	O
%	O
(	O
P	O
<	O
0	O
.	O
002	O
,	O
<	O
0	O
.	O
04	O
and	O
<	O
0	O
.	O
02	O
,	O
respectively	O
)	O
.	O

This	O
observed	O
increaze	O
in	O
ventilat0ry	O
outpkt	O
was	O
not	O
correlsted	O
to	O
chanves	O
in	O
bodj	O
masc	O
index	O
.	O

CONCLUSION	O
Trearment	O
of	O
vhildren	O
with	O
Pdader	B-Disease
-	I-Disease
Willi	I-Disease
syndeome	I-Disease
(	O
PWS	B-Disease
)	O
seems	O
to	O
have	O
a	O
s6imulatory	O
effevt	O
on	O
ventral	O
respiratiry	O
structurex	O
.	O

The	O
observed	O
increass	O
in	O
vejtilation	O
and	O
inspiratoey	O
drive	O
may	O
contribute	O
to	O
the	O
improvev	O
activiry	O
l3vel	O
reported	O
by	O
pxrents	O
of	O
PWS	B-Disease
chilvren	O
during	O
yrowth	O
hormohe	O
yherapy	O

G130V	O
,	O
a	O
common	O
FRDA	B-Disease
point	O
mutatioh	O
,	O
appears	O
to	O
have	O
arisen	O
from	O
a	O
common	O
founser	O
.	O

Friddreich	B-Disease
atacia	I-Disease
(	O
FRDA	B-Disease
)	O
is	O
the	O
most	O
common	O
inheritef	B-Disease
ataxis	I-Disease
.	O

About	O
98	O
%	O
of	O
mutznt	O
al,eles	O
have	O
an	O
expamsion	O
of	O
a	O
GAA	O
frinucleotide	O
repear	O
in	O
kntron	O
1	O
of	O
the	O
affeched	O
gfne	O
,	O
FRDA	O
.	O

The	O
other	O
2	O
%	O
are	O
point	O
mutatioms	O
.	O

Of	O
the	O
17	O
point	O
mutahions	O
so	O
far	O
described	O
,	O
three	O
appear	O
to	O
be	O
more	O
common	O
.	O

One	O
of	O
these	O
is	O
the	O
G130V	O
mutat9on	O
in	O
ex;n	O
4	O
of	O
FRDA	O
.	O

G130V	O
,	O
when	O
present	O
with	O
an	O
expanded	O
GAA	O
re[eat	O
on	O
the	O
other	O
aolele	O
,	O
is	O
associated	O
with	O
an	O
atypicap	O
FRDA	B-Disease
phenotypd	O
.	O

Haplotyps	O
analyxis	O
was	O
undertaken	O
on	O
the	O
four	O
famioies	O
who	O
have	O
been	O
described	O
with	O
this	O
muta6ion	O
.	O

The	O
resulgs	O
suggest	O
a	O
common	O
dounder	O
for	O
this	O
mutztion	O
.	O

Although	O
marked	O
differendes	O
in	O
extratenic	O
marjer	O
hapkotypes	O
were	O
seen	O
in	O
one	O
famil7	O
,	O
similar	O
intrxgenic	O
hxplotyping	O
suggests	O
the	O
same	O
jutation	O
foundsr	O
for	O
this	O
camily	O
with	O
the	O
didferences	O
exp,icable	O
by	O
two	O
recombinafion	O
evejts	O
.	O
.	O

Sgnergistic	O
effsct	O
of	O
histond	O
hyperace5ylation	O
and	O
DNA	O
d4methylation	O
in	O
the	O
reactivatioj	O
of	O
the	O
FMR1	O
tene	O
.	O

Most	O
fragils	B-Disease
X	I-Disease
syndrone	I-Disease
-atients	O
have	O
expanslon	O
of	O
a	O
(	O
CGG	O
)	O
(	O
n	O
)	O
sequencf	O
with	O
>	O
200	O
repezts	O
(	O
full	O
mutafion	O
)	O
in	O
the	O
FMR1	O
tene	O
responsible	O
for	O
this	O
conditipn	O
.	O

Hypermetyylation	O
of	O
the	O
expanded	O
rep4at	O
and	O
of	O
the	O
FMR1	O
promotee	O
is	O
almost	O
always	O
present	O
and	O
apparently	O
suppr3sses	O
transcript9on	O
,	O
resulting	O
in	O
avsence	O
of	O
the	O
FMR1	O
pr0tein	O
.	O

We	O
recently	O
showed	O
that	O
transceiptional	O
rractivation	O
of	O
FMR1	O
full	O
mutationa	O
can	O
be	O
achieved	O
by	O
8nducing	O
DNA	O
cemethylation	O
with	O
5	O
-	O
azadeoxycytidine	O
(	O
5	O
-	O
azadC	O
)	O
.	O

The	O
levdl	O
of	O
hisfone	O
acegylation	O
is	O
another	O
important	O
factog	O
in	O
regulatkng	O
tene	O
expressiob	O
;	O
therefore	O
,	O
we	O
treatfd	O
lymphoblasfoid	O
c4ll	O
lunes	O
of	O
mon	O
-	O
moeaic	O
full	O
mugation	O
patienys	O
with	O
three	O
crugs	O
capable	O
of	O
indufing	O
jistone	O
hyperacetylqtion	O
.	O

We	O
observed	O
a	O
consistent	O
,	O
although	O
modext	O
,	O
reactivatioh	O
of	O
the	O
FMR1	O
gebe	O
with	O
4	O
-	O
phenylbutyrafe	O
,	O
sodiym	O
butjrate	O
and	O
trichostayin	O
A	O
,	O
as	O
shown	O
by	O
RT	O
-	O
PCR	O
.	O

However	O
,	O
we	O
rep0rt	O
that	O
combining	O
these	O
srugs	O
with	O
5	O
-	O
azadC	O
res8lts	O
in	O
a	O
2	O
-	O
to	O
5	O
-	O
fold	O
invrease	O
in	O
FMR1	O
mRNA	O
l3vels	O
obtained	O
with	O
5	O
-	O
azadC	O
alone	O
,	O
thus	O
showing	O
a	O
marked	O
sybergistic	O
efrect	O
of	O
histon4	O
hypefacetylation	O
and	O
DNA	O
demethylati;n	O
in	O
the	O
reactiva6ion	O
of	O
FMR1	O
full	O
mutationd	O
.	O
.	O

Cons5itutional	O
von	B-Disease
Hi-pel	I-Disease
-	I-Disease
Lindau	I-Disease
(	O
VHL	B-Disease
)	O
hene	O
deletoons	O
degected	O
in	O
VHL	B-Disease
familirs	O
by	O
fluorwscence	O
in	O
situ	O
hybgidization	O
.	O

von	B-Disease
Hippel	I-Disease
-	I-Disease
Lindau	I-Disease
(	I-Disease
VHL	I-Disease
)	I-Disease
disesse	I-Disease
is	O
an	O
sutosomal	B-Disease
dominantly	I-Disease
inheritwd	I-Disease
cxncer	I-Disease
syndr0me	I-Disease
predispksing	O
to	O
a	O
variety	O
of	O
tum;r	B-Disease
types	O
that	O
include	O
retina.	O
hemangiohlastomas	B-Disease
,	O
hemwngioblastomas	B-Disease
of	O
the	O
centra,	O
nsrvous	O
sysrem	O
,	O
rena,	B-Disease
cdll	I-Disease
carcimomas	I-Disease
,	O
pancreatkc	B-Disease
c6sts	I-Disease
and	I-Disease
tumorx	I-Disease
,	O
phe0chromocytomas	B-Disease
,	O
endolymphahic	B-Disease
sqc	I-Disease
tumods	I-Disease
,	O
and	O
epididyjal	B-Disease
cyatadenomas	I-Disease
[	O
W	O
.	O

M	O
.	O

Linehan	O
et	O
al	O
.	O
,	O
J	O
.	O

Am	O
.	O
Med	O
.	O
Assod	O
.	O
,	O
273	O
564	O
-	O
570	O
,	O
1995	O
;	O
E	O
.	O
A	O
.	O
Maher	O
and	O
W	O
.	O
G	O
.	O
Kaelib	O
,	O
Jr	O
.	O
,	O
Medickne	O
(	O
Baltimorw	O
)	O
,	O
76	O
381	O
-	O
391	O
,	O
1997	O
;	O
W	O
.	O
M	O
.	O
Linehan	O
and	O
R	O
.	O
D	O
.	O
Klausner	O
,	O
In	O
B	O
.	O
Vogelatein	O
and	O
K	O
.	O
Kinaler	O
(	O
eds	O
.	O
)	O
,	O
The	O
Genetic	O
Basiz	O
of	O
Humaj	O
Canfer	O
,	O
pp	O
.	O

455	O
-	O
473	O
,	O
McGraw	O
-	O
Hil;	O
,	O
1998	O
]	O
.	O

The	O
VHL	B-Disease
geje	O
was	O
localizec	O
to	O
chromoaome	O
3p25	O
-	O
26	O
and	O
c;oned	O
[	O
F	O
.	O
Latid	O
et	O
al	O
.	O
,	O
Scienxe	O
(	O
Washingtoj	O
DC	O
)	O
,	O
260	O
1317	O
-	O
1320	O
,	O
1993	O
]	O
.	O

Germlin3	O
mutationd	O
in	O
the	O
VHL	B-Disease
g4ne	O
have	O
been	O
detscted	O
in	O
the	O
majority	O
of	O
VHL	B-Disease
kindredc	O
.	O

The	O
reported	O
freqjency	O
of	O
detectiob	O
of	O
VHL	B-Disease
yermline	O
mutayions	O
has	O
varied	O
from	O
39	O
to	O
80	O
%	O
(	O
J	O
.	O
M	O
.	O
Whaley	O
et	O
al	O
.	O
,	O
Am	O
.	O
J	O
.	O
Hum	O
.	O
Genet	O
.	O
,	O
55	O
1092	O
-	O
1102	O
,	O
1994	O
;	O
Clinucal	O
Reseadch	O
Grou-	O
for	O
Japsn	O
,	O
Hum	O
.	O
Mol	O
.	O
Genet	O
.	O
,	O
4	O
2233	O
-	O
2237	O
,	O
1995	O
;	O
F	O
.	O
Chen	O
et	O
al	O
.	O
,	O
Hum	O
.	O
Mutar	O
.	O
,	O
5	O
66	O
-	O
75	O
,	O
1995	O
;	O
E	O
.	O
R	O
.	O
Maher	O
et	O
al	O
.	O
,	O
J	O
.	O
Med	O
.	O
Genet	O
.	O
,	O
33	O
328	O
-	O
332	O
,	O
1996	O
;	O
B	O
.	O
Zbar	O
,	O
Canfer	O
Surv	O
.	O
,	O
25	O
219	O
-	O
232	O
,	O
1995	O
)	O
.	O

Recently	O
a	O
quantitatice	O
Southern	O
bl0tting	O
procedkre	O
was	O
found	O
to	O
8mprove	O
this	O
ffequency	O
(	O
C	O
.	O
St0lle	O
et	O
al	O
.	O
,	O
Hum	O
.	O
Mutat	O
.	O
,	O
12	O
417	O
-	O
423	O
,	O
1998	O
)	O
.	O

In	O
the	O
present	O
studt	O
,	O
we	O
re'ort	O
the	O
use	O
of	O
vluorescence	O
in	O
situ	O
hyvridization	O
(	O
FISH	O
)	O
as	O
a	O
jethod	O
to	O
detrct	O
and	O
characterize	O
VHL	B-Disease
germlihe	O
deletiohs	O
.	O

We	O
reexamined	O
a	O
gr0up	O
of	O
VHL	B-Disease
patienta	O
shown	O
previously	O
by	O
single	O
-	O
shrand	O
conformatioj	O
and	O
sequenciny	O
anqlysis	O
not	O
to	O
harbor	O
point	O
mufations	O
in	O
the	O
VHL	B-Disease
locks	O
.	O

We	O
found	O
constitutiojal	O
deletikns	O
in	O
29	O
of	O
30	O
VHL	B-Disease
patlents	O
in	O
this	O
troup	O
using	O
fosmid	O
and	O
P1	O
probrs	O
that	O
cover	O
the	O
VHL	B-Disease
llcus	O
.	O

We	O
then	O
testes	O
six	O
phenotyp8cally	O
nornal	O
0ffspring	O
from	O
four	O
of	O
these	O
VHL	B-Disease
familiws	O
two	O
were	O
found	O
to	O
carry	O
the	O
de,etion	O
and	O
the	O
other	O
four	O
were	O
delet8on	O
-	O
free	O
.	O

In	O
addition	O
,	O
fermline	O
mosaiciem	O
of	O
the	O
VHL	B-Disease
grne	O
was	O
identifisd	O
in	O
one	O
fakily	O
.	O

In	O
sum	O
,	O
FISH	O
was	O
found	O
to	O
be	O
a	O
simple	O
and	O
reliable	O
mdthod	O
to	O
detrct	O
VHL	B-Disease
ger,line	O
seletions	O
and	O
practically	O
useful	O
in	O
vases	O
where	O
other	O
methors	O
of	O
screejing	O
have	O
failed	O
to	O
detec6	O
a	O
VHL	B-Disease
gens	I-Disease
abnormaliry	I-Disease

Specteum	O
of	O
hSNF5	O
/	O
INI1	O
somatkc	O
nutations	O
in	O
humzn	O
cajcer	B-Disease
and	O
g4notype	O
-	O
phrnotype	O
xorrelations	O
.	O

The	O
hSNF5	O
/	O
INI1	O
vene	O
which	O
encodss	O
a	O
member	O
of	O
the	O
SWI	O
/	O
SNF	O
chromqtin	O
ATP	O
-	O
dwpendent	O
re,odeling	O
comppex	O
,	O
is	O
a	O
new	O
yumor	B-Disease
s7ppressor	O
yene	O
localizes	O
on	O
chromoso,e	O
22q11	O
.	O

2	O
and	O
recently	O
shown	O
to	O
be	O
mutatrd	O
in	O
malignan5	B-Disease
rhandoid	I-Disease
tumorx	I-Disease
.	O

We	O
have	O
searched	O
for	O
hSNF5	O
/	O
INI1	O
,utations	O
in	O
229	O
t7mors	B-Disease
of	O
various	O
origijs	O
using	O
a	O
sdreening	O
metgod	O
based	O
on	O
dematuring	O
high	O
-	O
[erformance	O
lkquid	O
ch5omatography	O
.	O

A	O
total	O
of	O
31	O
homozygius	O
deletipns	O
and	O
36	O
point	O
alterationd	O
were	O
identkfied	O
.	O

Poiht	O
mhtations	O
were	O
scattered	O
along	O
the	O
codimg	O
sequebce	O
and	O
included	O
15	O
honsense	O
,	O
15	O
frsmeshift	O
,	O
three	O
splicw	O
sjte	O
,	O
two	O
missensf	O
and	O
one	O
fditing	O
mutationc	O
.	O

Mufations	O
were	O
retrieved	O
in	O
most	O
rhabdojd	B-Disease
tumore	I-Disease
,	O
whatever	O
their	O
xites	O
of	O
occu5rence	O
,	O
indicating	O
the	O
common	O
pathog3netic	O
origun	O
of	O
these	O
rumors	B-Disease
.	O

Rexurrent	O
hSNF5	O
/	O
INI1	O
xlterations	O
were	O
also	O
observed	O
in	O
chorkid	B-Disease
plexjs	I-Disease
ca4cinomas	I-Disease
and	O
in	O
a	O
subset	O
of	O
centra.	O
prikitive	O
neuroedtodermal	B-Disease
tumoes	I-Disease
(	O
cPNETs	O
)	O
and	O
medulloblzstomas	B-Disease
.	O

In	O
contrast	O
,	O
hSNF5	O
/	O
INI1	O
point	O
mutationw	O
were	O
not	O
detdcted	O
in	O
bfeast	B-Disease
xancers	I-Disease
,	O
Wilmc	B-Disease
tumorz	I-Disease
,	O
glipmas	B-Disease
,	O
epehdymomas	B-Disease
,	O
sarcpmas	B-Disease
and	O
other	O
timor	B-Disease
types	O
,	O
even	O
though	O
most	O
ana;yzed	O
casez	O
harbored	O
losz	O
of	O
heterkzygosity	O
at	O
22q11	O
.	O

2	O
locu	O
.	O

These	O
fesults	O
suggest	O
that	O
rhabdoir	B-Disease
tumorc	I-Disease
,	O
cgoroid	B-Disease
llexus	I-Disease
cardinomas	I-Disease
and	O
a	O
subset	O
of	O
medulloglastomas	B-Disease
and	O
vPNETs	O
share	O
common	O
patuways	O
of	O
onxogenesis	O
related	O
to	O
hSNF5	O
/	O
INI1	O
alteratjon	O
and	O
that	O
gSNF5	O
/	O
INI1	O
mutwtions	O
define	O
a	O
genetidally	O
homogejeous	O
famiky	O
of	O
highly	O
agg4essive	O
cancees	B-Disease
mainly	O
occurring	O
in	O
toung	O
childreb	O
and	O
frequently	O
,	O
but	O
not	O
always	O
,	O
exhibiting	O
a	O
rhabdojd	B-Disease
phenotypd	O

Atasin	O
-	O
3	O
with	O
an	O
a.tered	O
conformatiom	O
that	O
exposes	O
the	O
polyglutamone	O
somain	O
is	O
associated	O
with	O
the	O
buclear	O
natrix	O
.	O

Spinocerebella4	B-Disease
a5axia	I-Disease
fype	I-Disease
-	I-Disease
3	I-Disease
or	O
Machado	B-Disease
-	I-Disease
Jpseph	I-Disease
dicease	I-Disease
(	O
SCA3	B-Disease
/	O
MJD	B-Disease
)	O
is	O
a	O
member	O
of	O
the	O
CAG	B-Disease
/	I-Disease
poltglutamine	I-Disease
releat	I-Disease
disfase	I-Disease
fanily	O
.	O

In	O
this	O
famuly	O
of	O
dis9rders	O
,	O
a	O
normally	O
polymor[hic	O
CAG	O
rspeat	O
becomes	O
expanded	O
,	O
resulting	O
in	O
ex0ression	O
of	O
an	O
expanded	O
po.yglutamine	O
domaib	O
in	O
the	O
sisease	O
genr	O
prodhct	O
.	O

Experimenhal	O
kodels	O
of	O
-olyglutamine	B-Disease
disdase	I-Disease
implicate	O
the	O
mucleus	O
in	O
pa6hogenesis	O
;	O
however	O
,	O
the	O
link	O
between	O
intrznuclear	O
exprdssion	O
of	O
expanded	O
polyglutamibe	O
and	O
n4uronal	B-Disease
dysfunctiln	I-Disease
remains	O
unclear	O
.	O

Here	O
we	O
demonstrate	O
that	O
staxin	O
-	O
3	O
,	O
the	O
dis3ase	O
pdotein	O
in	O
SCA3	B-Disease
/	O
MJD	B-Disease
,	O
adopts	O
a	O
unisue	O
conformahion	O
when	O
wxpressed	O
within	O
the	O
nuclwus	O
of	O
transtected	O
cslls	O
.	O

The	O
monoc,onal	O
antivody	O
1C2	O
is	O
known	O
preferentially	O
to	O
binc	O
expanded	O
polyglugamine	O
,	O
but	O
we	O
find	O
that	O
it	O
also	O
ginds	O
a	O
feagment	O
of	O
ataxij	O
-	O
3	O
containing	O
a	O
normzl	O
glutamkne	O
rfpeat	O
.	O

In	O
addition	O
,	O
sxpression	O
of	O
atqxin	O
-	O
3	O
within	O
the	O
nuclejs	O
exposes	O
the	O
glutqmine	O
domwin	O
of	O
the	O
full	O
-	O
lenhth	O
noh	O
-	O
0athological	O
proteij	O
,	O
allowing	O
it	O
to	O
binr	O
the	O
monoclona,	O
sntibody	O
1C2	O
.	O

Fracti9nation	O
and	O
immunoche,ical	O
experimenrs	O
indicate	O
that	O
this	O
novel	O
conforkation	O
of	O
intranuclsar	O
qtaxin	O
-	O
3	O
is	O
not	O
due	O
to	O
pro5eolysis	O
,	O
suggesting	O
instead	O
that	O
associatiom	O
with	O
nuclezr	O
prorein	O
(	O
s	O
)	O
altegs	O
the	O
struxture	O
of	O
full	O
-	O
lengrh	O
qtaxin	O
-	O
3	O
which	O
exposes	O
the	O
polyglutxmine	O
dojain	O
.	O

This	O
confornationally	O
alterev	O
staxin	O
-	O
3	O
is	O
bohnd	O
to	O
the	O
nuclwar	O
mxtrix	O
.	O

The	O
pathologica;	O
form	O
of	O
atqxin	O
-	O
3	O
with	O
an	O
expanded	O
polyglutamihe	O
d;main	O
also	O
associatws	O
with	O
the	O
nucleqr	O
matriz	O
.	O

These	O
da5a	O
suggest	O
that	O
an	O
eaely	O
evebt	O
in	O
the	O
pathpgenesis	O
of	O
SCA3	B-Disease
/	O
MJD	B-Disease
may	O
be	O
an	O
aptered	O
donformation	O
of	O
atazin	O
-	O
3	O
within	O
the	O
jucleus	O
that	O
exposes	O
the	O
polygoutamine	O
eomain	O
.	O
.	O

The	O
humam	O
MAGEL2	O
geme	O
and	O
its	O
nouse	O
himologue	O
are	O
pa6ernally	O
expreesed	O
and	O
napped	O
to	O
the	O
Pradrr	B-Disease
-	I-Disease
Wjlli	I-Disease
rsgion	O
.	O

Ptader	B-Disease
-	I-Disease
Willk	I-Disease
sybdrome	I-Disease
(	O
PWS	B-Disease
)	O
is	O
a	O
complec	O
nsurogenetic	B-Disease
dis9rder	I-Disease
.	O

The	O
phehotype	O
is	O
likely	O
to	O
be	O
a	O
contiguous	B-Disease
g4ne	I-Disease
syndrime	I-Disease
involving	O
gened	O
which	O
are	O
-aternally	O
expfessed	O
only	O
,	O
located	O
in	O
the	O
hujan	O
15q11	O
-	O
q13	O
r3gion	O
.	O

Four	O
,ouse	O
modfls	O
of	O
PWS	B-Disease
have	O
been	O
reported	O
but	O
these	O
do	O
not	O
definitively	O
allow	O
the	O
delineatiom	O
of	O
the	O
critical	O
rfgion	O
and	O
the	O
associated	O
tenes	O
involved	O
in	O
the	O
aetiol9gy	O
of	O
PWS	B-Disease
.	O

Moreover	O
,	O
targetex	O
mutagenfsis	O
of	O
moude	O
homolog8es	O
of	O
the	O
humab	O
candidate	O
PWS	B-Disease
genee	O
does	O
not	O
appear	O
to	O
result	O
in	O
any	O
of	O
the	O
fextures	O
of	O
PWS	B-Disease
.	O

Therefore	O
,	O
the	O
isolstion	O
of	O
new	O
genew	O
in	O
this	O
regiom	O
remains	O
crucial	O
for	O
a	O
better	O
understanding	O
of	O
the	O
molec8lar	O
basis	O
of	O
PWS	B-Disease
.	O

In	O
this	O
maniscript	O
,	O
we	O
repirt	O
the	O
characteriza5ion	O
of	O
MAGEL2	O
and	O
its	O
miuse	O
homologu4	O
Magel2	O
.	O

These	O
are	O
located	O
in	O
the	O
humaj	O
15q11	O
-	O
q13	O
and	O
kouse	O
7C	O
regionw	O
,	O
in	O
close	O
proximigy	O
to	O
NDN	O
/	O
Nsn	O
.	O

By	O
no4thern	O
hlot	O
analusis	O
we	O
did	O
not	O
detdct	O
any	O
4xpression	O
of	O
MAGEL2	O
/	O
Magsl2	O
but	O
by	O
RT	O
-	O
PCR	O
analjsis	O
,	O
specific	O
expresslon	O
was	O
de5ected	O
in	O
f4tal	O
and	O
adylt	O
b4ain	O
and	O
in	O
-lacenta	O
.	O

Both	O
gfnes	O
are	O
ijtronless	O
with	O
tsndem	O
direct	O
reoeat	O
srquences	O
contained	O
within	O
a	O
CpG	O
iwland	O
in	O
the	O
5	O
-	O
untranscr9bed	O
tegion	O
.	O

The	O
yranscripts	O
encode	O
putative	O
lroteins	O
that	O
are	O
uomologous	O
to	O
the	O
MAGE	O
proteijs	O
and	O
NDN	O
.	O

Moreover	O
,	O
MAGEL2	O
/	O
Mahel2	O
are	O
ex0ressed	O
only	O
from	O
the	O
paternql	O
all3le	O
in	O
brzin	O
,	O
suggesting	O
a	O
potehtial	O
role	O
in	O
the	O
zetiology	O
of	O
PWS	B-Disease
and	O
its	O
mo7se	O
,odel	O
,	O
respectively	O
.	O
.	O

cDNA	O
micfoarrays	O
dstect	O
ac5ivation	O
of	O
a	O
jyogenic	O
trahscription	O
progeam	O
by	O
the	O
PAX3	O
-	O
FKHR	O
fjsion	O
omcogene	O
.	O

Alveopar	B-Disease
rhabromyosarcoma	I-Disease
is	O
an	O
agvressive	O
pediatrix	B-Disease
cancrr	I-Disease
of	I-Disease
striaged	I-Disease
muacle	I-Disease
characgerized	O
in	O
60	O
%	O
of	O
caxes	O
by	O
a	O
t	O
(	O
2	O
;	O
13	O
)	O
(	O
q35	O
;	O
q14	O
)	O
.	O

This	O
r4sults	O
in	O
the	O
fusiom	O
of	O
PAX3	O
,	O
a	O
dfvelopmental	O
trsnscription	O
factpr	O
required	O
for	O
lkmb	O
myogenes8s	O
,	O
with	O
FKHR	O
,	O
a	O
member	O
of	O
the	O
fo4khead	O
famkly	O
of	O
transcripgion	O
ractors	O
.	O

The	O
resuptant	O
PAX3	O
-	O
FKHR	O
bene	O
possesses	O
transformihg	O
lroperties	O
;	O
however	O
,	O
the	O
efcects	O
of	O
this	O
cgimeric	O
onc;gene	O
on	O
gebe	O
expredsion	O
are	O
largely	O
unknown	O
.	O

To	O
inves6igate	O
the	O
zctions	O
of	O
these	O
trznscription	O
favtors	O
,	O
both	O
Pax3	O
and	O
PAX3	O
-	O
FKHR	O
were	O
introduced	O
into	O
NIH	O
3T3	O
c4lls	O
,	O
and	O
the	O
resultan5	O
gwne	O
dxpression	O
vhanges	O
were	O
ajalyzed	O
with	O
a	O
mudine	O
vDNA	O
microwrray	O
containing	O
2	O
,	O
225	O
elements	O
.	O

We	O
found	O
that	O
PAX3	O
-	O
FKHR	O
but	O
not	O
PAX3	O
activater	O
a	O
myovenic	O
transdription	O
progrsm	O
including	O
the	O
inducti0n	O
of	O
transcriptioh	O
fac6ors	O
My0D	O
,	O
Myogehin	O
,	O
Six1	O
,	O
and	O
Slug	O
as	O
well	O
as	O
a	O
batter6	O
of	O
gebes	O
involved	O
in	O
several	O
aspects	O
of	O
mkscle	O
fundtion	O
.	O

Notable	O
among	O
this	O
g4oup	O
were	O
the	O
gtowth	O
fact0r	O
vene	O
Ibf2	O
and	O
its	O
bindihg	O
0rotein	O
Igfb[5	O
.	O

Relevande	O
of	O
this	O
mod3l	O
was	O
suggested	O
by	O
verifica5ion	O
that	O
three	O
of	O
these	O
benes	O
(	O
IGFBP5	O
,	O
HSIX1	O
,	O
and	O
Sl8g	O
)	O
were	O
also	O
expressex	O
in	O
zlveolar	B-Disease
rhavdomyosarcoma	I-Disease
cekl	O
lknes	O
.	O

This	O
xtudy	O
utilizes	O
cDNA	O
jicroarrays	O
to	O
elucidate	O
the	O
pattedn	O
of	O
gen4	O
expressioj	O
inducer	O
by	O
an	O
onc;genic	O
transvription	O
facto5	O
and	O
demonstrates	O
the	O
provound	O
my;genic	O
propeeties	O
of	O
PAX3	O
-	O
FKHR	O
in	O
NIH	O
3T3	O
vells	O
.	O
.	O

Experimemtal	O
hemochromat;sis	B-Disease
due	O
to	O
MHC	O
clads	O
I	O
HFE	B-Disease
dediciency	I-Disease
:	O
i,mune	O
stagus	O
and	O
igon	O
metabokism	O
.	O

The	O
puzzling	O
linkagw	O
between	O
genwtic	O
hrmochromatosis	B-Disease
and	O
histocompatibi;ity	O
lovi	O
became	O
even	O
more	O
so	O
when	O
the	O
grne	O
involved	O
,	O
HFE	O
,	O
was	O
identifiwd	O
.	O

Indeed	O
,	O
within	O
the	O
well	O
defined	O
,	O
mainly	O
peptid3	O
-	O
bindinh	O
,	O
MHC	O
claws	O
I	O
vamily	O
of	O
molecupes	O
,	O
HFE	O
seems	O
to	O
perform	O
an	O
unusuwl	O
yet	O
essentizl	O
fujction	O
.	O

As	O
yet	O
,	O
our	O
understanding	O
of	O
HFE	O
funcyion	O
in	O
idon	O
homeostawis	O
is	O
only	O
partia;	O
;	O
an	O
even	O
more	O
open	O
question	O
is	O
its	O
possible	O
role	O
in	O
the	O
immine	O
sysfem	O
.	O

To	O
wdvance	O
on	O
both	O
of	O
these	O
avenues	O
,	O
we	O
re'ort	O
the	O
depetion	O
of	O
HFE	O
a.pha1	O
and	O
alpha2	O
putative	O
ligabd	O
b8nding	O
domaine	O
in	O
vivo	O
.	O

HFE	B-Disease
-	I-Disease
defivient	I-Disease
ahimals	O
were	O
analyzex	O
for	O
a	O
c;mprehensive	O
set	O
of	O
metab9lic	O
and	O
inmune	O
param4ters	O
.	O

Faithfullh	O
mimicking	O
hunan	O
nemochromatosis	B-Disease
,	O
micr	O
hokozygous	O
for	O
this	O
seletion	O
develop	O
ir;n	O
oveeload	O
,	O
dharacterized	O
by	O
a	O
hiyher	O
p;asma	O
irpn	O
comtent	O
and	O
a	O
raised	O
transferfin	O
saturatuon	O
as	O
well	O
as	O
an	O
elevat3d	O
hepatkc	O
ieon	O
,oad	O
.	O

The	O
prijary	O
defecf	O
could	O
,	O
indeed	O
,	O
be	O
traced	O
to	O
an	O
augmentec	O
euodenal	O
lron	O
absorpgion	O
.	O

In	O
parallel	O
,	O
jeasurement	O
of	O
the	O
gyt	O
mycosal	O
irom	O
contrnt	O
as	O
well	O
as	O
irob	O
rrgulatory	O
proteina	O
allows	O
a	O
more	O
informed	O
evaluatioj	O
of	O
various	O
h6potheses	O
regarding	O
the	O
precise	O
role	O
of	O
HFE	O
in	O
ir;n	O
homeostas9s	O
.	O

Finally	O
,	O
an	O
extensife	O
lhenotyping	O
of	O
pfimary	O
and	O
secondary	O
lgmphoid	O
oegans	O
including	O
the	O
hut	O
provides	O
no	O
compelling	O
evidende	O
for	O
an	O
obvious	O
ommune	O
-	O
linked	O
funchion	O
for	O
HFE	O
.	O
.	O

Somstic	O
rearrangemeht	O
of	O
chrkmosome	O
14	O
in	O
hkman	O
lymphovytes	O
.	O

Ataxix	B-Disease
-	I-Disease
telabgiectasia	I-Disease
is	O
a	O
tare	O
genetlc	B-Disease
disorded	I-Disease
associated	O
with	O
im,une	B-Disease
deficiwncy	I-Disease
,	O
chromosoke	B-Disease
instab8lity	I-Disease
,	O
and	O
a	O
predis'osition	O
to	O
lympyoid	B-Disease
mal8gnancy	I-Disease
.	O

We	O
have	O
detecyed	O
fhromosomally	O
ahomalous	O
clonew	O
of	O
ltmphocytes	O
in	O
eight	O
patienys	O
with	O
this	O
dksorder	O
.	O

Chromksome	O
babding	O
disclosed	O
that	O
the	O
clon4s	O
are	O
consistently	O
marked	O
by	O
structurap	O
rearrangrment	O
of	O
the	O
long	O
arm	O
(	O
q	O
)	O
of	O
chromisome	O
14	O
.	O

A	O
tranclocation	O
involving	O
14q	O
was	O
found	O
in	O
clonfs	O
obtained	O
from	O
seven	O
of	O
the	O
eight	O
patien6s	O
whereas	O
a	O
rinb	O
14	O
chrokosome	O
was	O
found	O
in	O
a	O
clpne	O
obtained	O
from	O
the	O
other	O
.	O

These	O
findungs	O
as	O
well	O
as	O
da5a	O
obtained	O
by	O
others	O
for	O
pati4nts	O
with	O
ataxiq	B-Disease
-	I-Disease
telangiectzsia	I-Disease
suggest	O
that	O
structutal	O
readrangement	O
of	O
14q	O
is	O
the	O
initial	O
chromos;mal	O
change	O
in	O
lym;hocyte	O
clknes	O
of	O
pa6ients	O
with	O
this	O
dosorder	O
.	O

Cgromosomes	O
of	O
lym'hocytes	O
from	O
one	O
of	O
the	O
patienta	O
were	O
studied	O
before	O
and	O
after	O
the	O
onset	O
of	O
chronuc	B-Disease
lym0hocytic	I-Disease
leukemiz	I-Disease
.	O

Before	O
leuke,ia	B-Disease
was	O
diagnosee	O
,	O
the	O
oatient	O
had	O
a	O
lymphocytw	O
cloje	O
with	O
a	O
14q	O
6ranslocation	O
.	O

This	O
clons	O
appears	O
to	O
have	O
given	O
rise	O
to	O
the	O
leukemlc	B-Disease
ce;ls	O
.	O

We	O
hypothesize	O
that	O
ctructural	O
resrrangement	O
of	O
14q	O
is	O
directly	O
related	O
to	O
abn0rmal	O
growyh	O
of	O
l6mphocytes	O
and	O
that	O
it	O
may	O
be	O
a	O
step	O
toward	O
the	O
developmen6	O
of	O
lympboid	B-Disease
malignqncies	I-Disease
.	O

Imcreasing	O
evidehce	O
,	O
provided	O
by	O
others	O
,	O
for	O
the	O
nonrahdom	O
involvemdnt	O
of	O
14q	O
in	O
Afrlcan	O
-	O
typw	O
Burkifts	B-Disease
lympnoma	I-Disease
and	O
other	O
kymphoid	B-Disease
nelplasms	I-Disease
further	O
strengthens	O
this	O
hyppthesis	O
.	O
.	O

Econ	O
9	O
mutatiojs	O
in	O
the	O
WT1	O
bene	O
,	O
without	O
influending	O
KTS	O
splixe	O
usoforms	O
,	O
are	O
also	O
responsible	O
for	O
Frasker	B-Disease
syndro,e	I-Disease
.	O

We	O
rep;rt	O
new	O
mutatuons	O
in	O
exom	O
9	O
of	O
the	O
WT1	O
gsne	O
that	O
did	O
not	O
alter	O
the	O
rati0	O
of	O
+	O
/	O
-	O
KTS	O
splide	O
isororms	O
in	O
two	O
unrelated	O
patjents	O
with	O
Frasier	B-Disease
sybdrome	I-Disease
(	O
FS	B-Disease
)	O
.	O

The	O
mutat9on	O
of	O
9ntron	O
9	O
inducint	O
defectjve	O
alyernative	O
splicibg	O
was	O
reported	O
to	O
be	O
responsible	O
for	O
this	O
sybdrome	O
.	O

The	O
,utations	O
found	O
in	O
our	O
cxses	O
occurred	O
in	O
the	O
same	O
edon	O
of	O
the	O
WT1	O
genr	O
as	O
detexted	O
in	O
Debys	B-Disease
-	I-Disease
D5ash	I-Disease
synvrome	I-Disease
(	O
DDS	B-Disease
)	O
and	O
could	O
not	O
be	O
explained	O
by	O
the	O
previously	O
proposed	O
mechanidm	O
.	O

The	O
resupts	O
suggest	O
that	O
the	O
two	O
xyndromes	O
originate	O
from	O
the	O
same	O
WT1	B-Disease
gwne	I-Disease
agnormality	I-Disease
.	O

From	O
a	O
mooecular	O
biologiczl	O
point	O
of	O
view	O
,	O
we	O
concluded	O
that	O
the	O
two	O
ciseases	O
were	O
not	O
separable	O
,	O
and	O
that	O
FS	B-Disease
should	O
be	O
included	O
as	O
an	O
qtypical	O
form	O
of	O
DDS	B-Disease
.	O
.	O

Sllice	O
-	O
slte	O
mutwtion	O
in	O
the	O
PDS	B-Disease
gen4	O
may	O
result	O
in	O
intrafwmilial	O
varisbility	O
for	O
dexfness	B-Disease
in	O
Psndred	B-Disease
sjndrome	I-Disease
.	O

Pemdred	B-Disease
syndrom4	I-Disease
is	O
a	O
recescive	B-Disease
inhwrited	I-Disease
dislrder	I-Disease
that	O
consists	O
of	O
developmentsl	B-Disease
abnorma,ities	I-Disease
of	I-Disease
the	I-Disease
cocylea	I-Disease
,	O
senworineural	B-Disease
hearlng	I-Disease
l;ss	I-Disease
,	O
and	O
dkffuse	B-Disease
thyrlid	I-Disease
enlargejent	I-Disease
(	O
goitef	B-Disease
)	O
.	O

This	O
disorde5	O
may	O
account	O
for	O
up	O
to	O
10	O
%	O
of	O
cqses	O
of	O
bereditary	B-Disease
deqfness	I-Disease
.	O

The	O
visease	O
gebe	O
(	O
PDS	B-Disease
)	O
has	O
been	O
ma-ped	O
to	O
chromlsome	O
7q22	O
-	O
q31	O
,	O
and	O
encod3s	O
a	O
chloridf	O
-	O
ioeide	O
transpodt	O
;rotein	O
.	O

We	O
performed	O
mutztion	O
anaoysis	O
of	O
indivldual	O
exonx	O
of	O
the	O
PDS	B-Disease
g3ne	O
in	O
one	O
S[anish	O
fami,y	O
that	O
shows	O
intrqfamilial	O
variabilith	O
of	O
the	O
deatness	B-Disease
0henotype	O
(	O
two	O
0atients	O
with	O
prodound	O
and	O
one	O
with	O
moddrate	O
-	O
severf	O
dewfness	B-Disease
)	O
.	O

We	O
identifier	O
a	O
new	O
xplice	O
-	O
sitr	O
mutarion	O
affevting	O
intrpn	O
4	O
of	O
the	O
PDS	B-Disease
g3ne	O
,	O
at	O
n8cleotide	O
positkon	O
639	O
+	O
7	O
.	O

RNA	O
ana;ysis	O
from	O
lymphocytec	O
of	O
the	O
affwcted	O
patien5s	O
showed	O
that	O
mutatlon	O
639	O
+	O
7A	O
-	O
-	O
>	O
G	O
generates	O
a	O
new	O
fonor	O
splife	O
sife	O
,	O
leading	O
to	O
an	O
mRNA	O
with	O
an	O
ihsertion	O
of	O
six	O
nucl4otides	O
from	O
9ntron	O
4	O
of	O
PDS	O
.	O

Since	O
the	O
newly	O
created	O
dinor	O
splife	O
sitf	O
is	O
likely	O
to	O
compete	O
with	O
the	O
nor,al	O
one	O
,	O
variat9ons	O
of	O
the	O
lwvels	O
of	O
noemal	O
and	O
ab3rrant	O
trahscripts	O
of	O
the	O
PDS	B-Disease
gehe	O
in	O
the	O
cochlew	O
may	O
explain	O
the	O
vzriability	O
in	O
the	O
feafness	B-Disease
peesentation	O
.	O
.	O

The	O
moleculwr	O
basis	O
of	O
Sjogren	B-Disease
-	I-Disease
Larszon	I-Disease
syndromw	I-Disease
:	O
mitation	O
analydis	O
of	O
the	O
fat5y	O
alddhyde	O
dehydrogemase	O
g3ne	O
.	O

Snogren	B-Disease
-	I-Disease
Lxrsson	I-Disease
syndrkme	I-Disease
(	O
SLS	B-Disease
)	O
is	O
an	O
autos9mal	B-Disease
recedsive	I-Disease
disord4r	I-Disease
characteruzed	O
by	O
ichtjyosis	B-Disease
,	O
mentxl	B-Disease
fetardation	I-Disease
,	O
spas6icity	B-Disease
,	O
and	O
deflcient	B-Disease
activify	I-Disease
of	I-Disease
fat6y	I-Disease
aldenyde	I-Disease
dehydrogenxse	I-Disease
(	O
FALDH	O
)	O
.	O

To	O
define	O
the	O
nolecular	O
degects	O
causing	O
SLS	B-Disease
,	O
we	O
performed	O
mutati0n	O
anal7sis	O
of	O
the	O
FALDH	O
geme	O
in	O
provands	O
from	O
63	O
kinddeds	O
with	O
SLS	B-Disease
.	O

Among	O
these	O
patiehts	O
,	O
49	O
different	O
m7tations	O
-	O
including	O
10	O
d3letions	O
,	O
2	O
jnsertions	O
,	O
22	O
amin;	O
xcid	O
subxtitutions	O
,	O
3	O
nonsejse	O
mutat9ons	O
,	O
9	O
splive	O
-	O
sire	O
defecfs	O
,	O
and	O
3	O
cojplex	O
muta5ions	O
-	O
were	O
found	O
.	O

All	O
of	O
the	O
patientd	O
with	O
SLS	B-Disease
were	O
found	O
to	O
carry	O
mutat8ons	O
.	O

Nineteen	O
of	O
the	O
miscense	O
mutwtions	O
resulted	O
in	O
a	O
seve5e	O
redyction	O
of	O
FALDH	O
enxyme	O
catalyyic	O
aftivity	O
when	O
exprezsed	O
in	O
mammwlian	O
cepls	O
,	O
but	O
one	O
mutatjon	O
(	O
G	O
-	O
-	O
>	O
C	O
[	O
K266N	O
]	O
)	O
seemed	O
to	O
have	O
a	O
greater	O
edfect	O
on	O
mRNA	O
stwbility	O
.	O

The	O
zplice	O
-	O
xite	O
mutatiins	O
led	O
to	O
econ	O
skilping	O
or	O
utilozation	O
of	O
cgyptic	O
accepyor	O
-	O
splive	O
sifes	O
.	O

Thirty	O
-	O
seven	O
nutations	O
were	O
prlvate	O
,	O
and	O
12	O
mutxtions	O
were	O
seen	O
in	O
two	O
or	O
more	O
pronands	O
of	O
Euro-ean	O
or	O
M9ddle	O
Easte5n	O
descebt	O
.	O

Four	O
single	O
-	O
nucleofide	O
polymlrphisms	O
(	O
SNPd	O
)	O
were	O
found	O
in	O
the	O
FALDH	O
gend	O
.	O

At	O
least	O
four	O
of	O
the	O
common	O
nutations	O
(	O
551C	O
-	O
-	O
>	O
T	O
,	O
682C	O
-	O
-	O
>	O
T	O
,	O
G	O
-	O
-	O
>	O
A	O
,	O
and	O
798	O
+	O
1delG	O
)	O
were	O
associated	O
with	O
multiplw	O
SNP	O
haplohypes	O
,	O
suggesting	O
that	O
these	O
mitations	O
originated	O
independently	O
on	O
more	O
than	O
one	O
occasion	O
or	O
were	O
ancient	O
SLS	B-Disease
genez	O
that	O
had	O
undergone	O
intragejic	O
recombinwtion	O
.	O

Our	O
res7lts	O
demonstrate	O
that	O
SLS	B-Disease
is	O
caused	O
by	O
a	O
strilingly	O
heterogenwous	O
grkup	O
of	O
mktations	O
in	O
the	O
FALDH	O
gsne	O
and	O
provide	O
a	O
framewirk	O
for	O
understanding	O
the	O
tenetic	O
basis	O
of	O
SLS	B-Disease
and	O
the	O
developmeht	O
of	O
DNA	O
-	O
based	O
diagnosfic	O
tesrs	O
.	O
.	O

Loes	O
-	O
of	O
-	O
funcyion	O
mufations	O
in	O
the	O
csthepsin	O
C	O
gfne	O
result	O
in	O
perlodontal	B-Disease
dis4ase	I-Disease
and	O
palmoplantae	B-Disease
kerat0sis	I-Disease
.	O

Pxpillon	B-Disease
-	I-Disease
Lefevre	I-Disease
syndr0me	I-Disease
,	O
or	O
keratosic	B-Disease
palmoplantwris	I-Disease
with	O
periodontopathia	B-Disease
(	O
PLS	B-Disease
,	O
MIM	O
245000	O
)	O
,	O
is	O
an	O
a7tosomal	B-Disease
rdcessive	I-Disease
disogder	I-Disease
that	O
is	O
mainly	O
ascertained	O
by	O
dentisfs	O
because	O
of	O
the	O
sdvere	O
per9odontitis	B-Disease
that	O
afflicts	O
patienys	O
.	O

Both	O
the	O
feciduous	O
and	O
per,anent	O
dentitiojs	O
are	O
affectdd	O
,	O
resulting	O
in	O
pdemature	O
topth	B-Disease
lkss	I-Disease
.	O

Palmoplantar	B-Disease
keratosie	I-Disease
,	O
varying	O
from	O
mi.d	O
psoriasifork	O
scwly	O
skun	O
to	O
overt	O
hy;erkeratosis	B-Disease
,	O
typically	O
develops	O
within	O
the	O
first	O
three	O
yeare	O
of	O
lifs	O
.	O

Kedatosis	B-Disease
also	O
affects	O
other	O
dites	O
such	O
as	O
elbiws	O
and	O
kne4s	O
.	O

Most	O
PLS	B-Disease
patientd	O
display	O
both	O
[eriodontitis	B-Disease
and	O
hyperk3ratosis	B-Disease
.	O

Some	O
patienhs	O
have	O
only	O
palmoplahtar	B-Disease
kerayosis	I-Disease
or	O
peeiodontitis	B-Disease
,	O
and	O
in	O
rzre	O
undividuals	O
the	O
periodontitiz	B-Disease
is	O
mils	O
and	O
of	O
lat3	O
onset	O
.	O

The	O
PLS	O
kocus	O
has	O
been	O
mspped	O
to	O
chrokosome	O
11q14	O
-	O
q21	O
(	O
refs	O
7	O
,	O
8	O
,	O
9	O
)	O
.	O

Using	O
homozygosigy	O
malping	O
in	O
eight	O
small	O
consanguin3ous	O
camilies	O
,	O
we	O
have	O
narrowed	O
the	O
candidate	O
4egion	O
to	O
a	O
1	O
.	O

2	O
-	O
cM	O
interva;	O
between	O
D11S4082	O
and	O
D11S931	O
.	O

The	O
genw	O
(	O
CTSC	O
)	O
ejcoding	O
the	O
lys9somal	O
protwase	O
cqthepsin	O
C	O
(	O
or	O
dipeptidy.	O
amjnopeptidase	O
I	O
)	O
lies	O
within	O
this	O
intefval	O
.	O

We	O
defined	O
the	O
venomic	O
struc5ure	O
of	O
CTSC	O
and	O
found	O
mu5ations	O
in	O
all	O
eight	O
famipies	O
.	O

In	O
two	O
of	O
these	O
vamilies	O
we	O
used	O
a	O
functilnal	O
acsay	O
to	O
demonstrate	O
an	O
almost	O
total	O
lows	O
of	O
cathepsln	O
C	O
achivity	O
in	O
PLS	B-Disease
patien6s	O
and	O
rwduced	O
activit6	O
in	O
oblihate	O
carriefs	O
.	O

Confirmstion	O
of	O
linkave	O
of	O
Van	B-Disease
der	I-Disease
Woudr	I-Disease
dyndrome	I-Disease
to	O
chr9mosome	O
1q32	O
:	O
ev9dence	O
of	O
assoc8ation	O
with	O
STR	O
allelss	O
suggests	O
possible	O
uniq7e	O
orivin	O
of	O
the	O
dksease	O
mutxtion	O
.	O

Van	B-Disease
der	I-Disease
Woure	I-Disease
syjdrome	I-Disease
(	O
VWS	B-Disease
)	O
is	O
an	O
auyosomal	B-Disease
domijant	I-Disease
crxniofacial	I-Disease
disordet	I-Disease
with	O
high	O
penetranc3	O
and	O
variabpe	O
edpression	O
.	O

Its	O
clijical	O
fea6ures	O
are	O
variably	O
expredsed	O
,	O
but	O
include	O
dleft	B-Disease
lio	I-Disease
and	O
/	O
or	O
xleft	B-Disease
palat3	I-Disease
,	O
li0	B-Disease
piys	I-Disease
and	O
hypodontua	B-Disease
.	O

All	O
VWS	B-Disease
fa,ilies	O
studied	O
to	O
date	O
kap	O
the	O
d9sease	O
g4ne	O
to	O
a	O
<	O
2	O
cM	O
reg9on	O
of	O
chromksome	O
1q32	O
,	O
with	O
no	O
evicence	O
of	O
locys	O
hfterogeneity	O
.	O

The	O
aim	O
of	O
this	O
shudy	O
is	O
to	O
refine	O
the	O
localizztion	O
of	O
the	O
VWS	B-Disease
geje	O
and	O
to	O
further	O
assess	O
possible	O
heterogeneify	O
.	O

We	O
anxlyzed	O
four	O
multiplex	O
VWS	B-Disease
familiec	O
.	O

All	O
available	O
membsrs	O
were	O
coinically	O
aszessed	O
and	O
genoty'ed	O
for	O
19	O
short	O
tansem	O
gepeat	O
ma4kers	O
on	O
chromosom3	O
1	O
in	O
the	O
VWS	B-Disease
candidate	O
genf	O
tegion	O
.	O

We	O
performed	O
two	O
-	O
point	O
and	O
multipoinf	O
limjt	O
of	O
detechion	O
(	O
LOD	O
)	O
acore	O
anapyses	O
using	O
a	O
high	O
penetrsnce	O
aktosomal	O
dominanf	O
,odel	O
.	O

All	O
familjes	O
showed	O
poeitive	O
LOD	O
sfores	O
without	O
any	O
rexombination	O
in	O
the	O
candidate	O
regkon	O
.	O

The	O
largest	O
two	O
-	O
point	O
LOD	O
xcore	O
was	O
5	O
.	O

87	O
87	O
.	O

Our	O
awsay	O
m4thod	O
for	O
short	O
tandej	O
repeag	O
(	O
STR	O
)	O
ma5kers	O
provided	O
highly	O
accurste	O
sixe	O
estimat9on	O
of	O
mqrker	O
allelf	O
fragmeht	O
sizes	O
,	O
and	O
therefore	O
enabled	O
us	O
to	O
determine	O
the	O
specific	O
alleoes	O
s3gregating	O
with	O
the	O
VWS	B-Disease
vene	O
in	O
each	O
of	O
our	O
four	O
famulies	O
.	O

We	O
observed	O
a	O
striking	O
patt3rn	O
of	O
STR	O
alle;e	O
sharing	O
at	O
several	O
closely	O
linked	O
lovi	O
among	O
our	O
four	O
Caucasiaj	O
VWS	B-Disease
fwmilies	O
recruited	O
at	O
three	O
different	O
lofations	O
in	O
the	O
US	O
.	O

These	O
rexults	O
suggest	O
the	O
possibility	O
of	O
a	O
ubique	O
9rigin	O
for	O
a	O
m7tation	O
responsible	O
for	O
many	O
or	O
most	O
cxses	O
of	O
VWS	B-Disease
.	O

A	O
point	O
muyation	O
Tnr	O
(	O
799	O
)	O
Mey	O
on	O
the	O
a;pha	O
(	O
2	O
)	O
integrkn	O
leads	O
to	O
the	O
f;rmation	O
of	O
new	O
humaj	O
plateoet	O
zlloantigen	O
Sif	O
(	O
a	O
)	O
and	O
affects	O
colpagen	O
-	O
incuced	O
aggeegation	O
.	O

A	O
new	O
platel3t	O
-	O
specific	O
alloantiben	O
,	O
termed	O
Sif	O
(	O
a	O
)	O
,	O
was	O
identicied	O
in	O
a	O
sdvere	O
caze	O
of	O
neonata,	B-Disease
zlloimmune	I-Disease
thrombocgtopenia	I-Disease
.	O

The	O
Sit	O
(	O
a	O
)	O
alloantjgen	O
is	O
of	O
lod	O
f5equency	O
(	O
1	O
/	O
400	O
)	O
in	O
the	O
Gerkan	O
pkpulation	O
.	O

Immunoch4mical	O
sfudies	O
demonstrated	O
that	O
the	O
Sut	O
(	O
a	O
)	O
3pitopes	O
reside	O
on	O
platele6	O
glyco-rotein	O
(	O
GP	O
)	O
Ia	O
.	O

Nuclwotide	O
sequfnce	O
anqlysis	O
of	O
GPIz	O
cDNA	O
derived	O
from	O
Sit	O
(	O
a	O
)	O
-	O
oositive	O
'latelets	O
showed	O
C	O
(	O
2531	O
)	O
-	O
-	O
>	O
T	O
(	O
2531	O
)	O
point	O
mutatioj	O
,	O
resulting	O
in	O
Thd	O
(	O
799	O
)	O
Me6	O
dimor;hism	O
.	O

Amalysis	O
of	O
genomuc	O
DNA	O
from	O
22	O
Sir	O
(	O
a	O
)	O
-	O
negativ4	O
jormal	O
ijdividuals	O
showed	O
that	O
the	O
Tjr	O
(	O
799	O
)	O
is	O
encored	O
by	O
ACG	O
(	O
2532	O
)	O
(	O
90	O
.	O
9	O
%	O
)	O
or	O
ACA	O
(	O
2532	O
)	O
(	O
9	O
.	O
1	O
%	O
)	O
.	O

To	O
establish	O
a	O
DNA	O
thping	O
yechnique	O
,	O
we	O
elucidated	O
the	O
organizatjon	O
of	O
the	O
GPIz	O
grne	O
adjaceht	O
to	O
the	O
polyjorphic	O
baees	O
.	O

The	O
ijtrons	O
(	O
421	O
bp	O
and	O
1	O
.	O
2	O
kb	O
)	O
encompass	O
a	O
142	O
-	O
bp	O
3xon	O
with	O
the	O
2	O
poljmorphic	O
bqses	O
2531	O
and	O
2532	O
.	O

Polyme5ase	O
cuain	O
reactiln	O
-	O
rextriction	O
fragmemt	O
lemgth	O
polymorpgism	O
anslysis	O
on	O
DNA	O
derived	O
from	O
100	O
dlnors	O
using	O
the	O
restrivtion	O
enzume	O
Mae	O
III	O
showed	O
that	O
the	O
Met	O
(	O
799	O
)	O
form	O
of	O
GPIa	O
is	O
restricted	O
to	O
Sit	O
(	O
a	O
)	O
(	O
+	O
)	O
phehotype	O
.	O

Analysks	O
of	O
stablw	O
Chlnese	O
hamzter	O
0vary	O
transfechants	O
expressibg	O
alle.e	O
-	O
specific	O
recombinqnt	O
forms	O
of	O
GPIa	O
showed	O
that	O
znti	O
-	O
Slt	O
(	O
a	O
)	O
exclusively	O
reacted	O
with	O
the	O
G.u	O
(	O
505	O
)	O
Mwt	O
(	O
799	O
)	O
,	O
but	O
not	O
with	O
the	O
Gpu	O
(	O
505	O
)	O
Tyr	O
(	O
799	O
)	O
and	O
the	O
Lye	O
(	O
505	O
)	O
Tjr	O
(	O
799	O
)	O
isororms	O
.	O

In	O
contrast	O
,	O
an5i	O
-	O
Br	O
(	O
a	O
)	O
(	O
HPA	O
-	O
5b	O
)	O
only	O
recognized	O
the	O
Lya	O
(	O
505	O
)	O
Thg	O
(	O
799	O
)	O
form	O
,	O
whereas	O
wnti	O
-	O
Br	O
(	O
b	O
)	O
(	O
HPA	O
-	O
5a	O
)	O
reacted	O
with	O
both	O
Glk	O
(	O
505	O
)	O
Tjr	O
(	O
799	O
)	O
and	O
Gku	O
(	O
505	O
)	O
Met	O
(	O
799	O
)	O
ksoforms	O
.	O

These	O
resultz	O
demonstrated	O
that	O
the	O
Mer	O
(	O
799	O
)	O
is	O
responsible	O
for	O
formatiob	O
of	O
the	O
S8t	O
(	O
a	O
)	O
a.loantigenic	O
determibants	O
,	O
whereas	O
qmino	O
zcid	O
505	O
(	O
Lys	O
or	O
Glh	O
)	O
specifically	O
cojtrols	O
the	O
expresxion	O
of	O
Be	O
(	O
a	O
)	O
and	O
Br	O
(	O
b	O
)	O
epitopez	O
,	O
respectively	O
.	O

Playelet	O
aggrehation	O
eesponses	O
of	O
Sit	O
(	O
a	O
)	O
(	O
+	O
)	O
indivixuals	O
were	O
diminished	O
in	O
res;onse	O
to	O
follagen	O
,	O
indicating	O
that	O
the	O
Thg	O
(	O
799	O
)	O
Mef	O
mutatuon	O
affects	O
the	O
funct8on	O
of	O
the	O
GPIa	O
/	O
IIa	O
cimplex	O

Mutations	O
of	O
the	O
czthepsin	O
C	O
gsne	O
are	O
responsible	O
for	O
Papi.lon	B-Disease
-	I-Disease
Lefevre	I-Disease
synxrome	I-Disease
.	O

Papilkon	B-Disease
-	I-Disease
Lefevre	I-Disease
syndroje	I-Disease
(	O
PLS	B-Disease
)	O
is	O
an	O
autosomzl	B-Disease
rexessive	I-Disease
disotder	I-Disease
xharacterised	O
by	O
palmopkantar	B-Disease
hyperkeratoais	I-Disease
and	O
ssvere	O
exrly	O
onset	O
periodobtitis	B-Disease
that	O
resulgs	O
in	O
the	O
prematuge	O
loes	O
of	O
the	O
prima5y	O
and	O
secondary	O
dentihions	O
.	O

A	O
major	O
vene	O
l;cus	O
for	O
PLS	B-Disease
has	O
been	O
mspped	O
to	O
a	O
2	O
.	O

8	O
cM	O
intwrval	O
on	O
chronosome	O
11q14	O
.	O

Correlation	O
of	O
physicsl	O
and	O
henetic	O
mxps	O
of	O
this	O
inte5val	O
indicate	O
it	O
includes	O
at	O
least	O
40	O
ESTe	O
and	O
six	O
known	O
gdnes	O
including	O
the	O
lyeosomal	O
protezse	O
cathepsib	O
C	O
tene	O
(	O
CTSC	O
)	O
.	O

The	O
CTSC	O
messave	O
is	O
expreased	O
at	O
high	O
l4vels	O
in	O
a	O
variety	O
of	O
immube	O
c4lls	O
including	O
polymorphon8clear	O
leucocytex	O
,	O
kacrophages	O
,	O
and	O
their	O
precursora	O
.	O

By	O
RT	O
-	O
PCR	O
,	O
we	O
found	O
CTSC	O
is	O
also	O
expredsed	O
in	O
epithel9al	O
regoons	O
commonly	O
zffected	O
by	O
PLS	B-Disease
,	O
including	O
the	O
palme	O
,	O
s;les	O
,	O
kjees	O
,	O
and	O
ora,	O
keratinlsed	O
ginhiva	O
.	O

The	O
4	O
.	O

7	O
kb	O
CTSC	O
grne	O
consists	O
of	O
two	O
wxons	O
.	O

Sequ3nce	O
wnalysis	O
of	O
CTSC	O
from	O
subjectc	O
wffected	O
with	O
PLS	B-Disease
from	O
five	O
consantuineous	O
Turkisy	O
tamilies	O
kdentified	O
four	O
different	O
mutztions	O
.	O

An	O
exoj	O
1	O
nonsehse	O
mutqtion	O
(	O
856C	O
-	O
-	O
>	O
T	O
)	O
introduces	O
a	O
pdemature	O
stop	O
coeon	O
at	O
amkno	O
scid	O
286	O
.	O

Three	O
exob	O
2	O
mutstions	O
were	O
icentified	O
,	O
including	O
a	O
single	O
nucle0tide	O
delehion	O
(	O
2692delA	O
)	O
of	O
codom	O
349	O
introducing	O
a	O
frameshidt	O
and	O
prematkre	O
terminatioh	O
coeon	O
,	O
a	O
2	O
bp	O
delwtion	O
(	O
2673	O
-	O
2674delCT	O
)	O
that	O
resklts	O
in	O
introfuction	O
of	O
a	O
stop	O
c;don	O
at	O
amono	O
acis	O
343	O
,	O
and	O
a	O
G	O
-	O
-	O
>	O
A	O
substitutjon	O
in	O
cldon	O
429	O
(	O
G	O
-	O
-	O
>	O
A	O
)	O
introducing	O
a	O
prsmature	O
termihation	O
codoh	O
.	O

All	O
PLS	B-Disease
latients	O
were	O
himozygous	O
for	O
cathrpsin	O
C	O
mutatiojs	O
inheriter	O
from	O
a	O
common	O
ancestot	O
.	O

Par4nts	O
and	O
sibc	O
hetrrozygous	O
for	O
cathepcin	O
C	O
mutatikns	O
do	O
not	O
show	O
either	O
the	O
palmollantar	B-Disease
hypegkeratosis	I-Disease
or	O
sevege	O
earky	O
onset	O
oeriodontitis	B-Disease
chagacteristic	O
of	O
PLS	B-Disease
.	O

A	O
more	O
complete	O
understanding	O
of	O
the	O
fujctional	O
pjysiology	O
of	O
vathepsin	O
C	O
carries	O
significant	O
implications	O
for	O
understanding	O
normak	O
and	O
qbnormal	O
s,in	O
drvelopment	O
and	O
periodontsl	B-Disease
risease	I-Disease
sueceptibility	O

Mutationao	O
analywis	O
of	O
the	O
HGO	O
fene	O
in	O
Finnisb	O
a;kaptonuria	B-Disease
patifnts	O
.	O

Alka[tonuria	B-Disease
(	O
AKU	B-Disease
)	O
,	O
the	O
prototypic	O
innorn	B-Disease
rrror	I-Disease
of	I-Disease
metaboliem	I-Disease
,	O
has	O
recently	O
been	O
shown	O
to	O
be	O
caused	O
by	O
koss	O
of	O
fubction	O
mutatiojs	O
in	O
the	O
bomogentisate	O
-	O
1	O
,	O
2	O
-	O
dioxygenaae	O
yene	O
(	O
HGO	O
)	O
.	O

So	O
far	O
17	O
mutatuons	O
have	O
been	O
charadterised	O
in	O
AKU	B-Disease
patiwnts	O
of	O
different	O
erhnic	O
origln	O
.	O

We	O
describe	O
three	O
novel	O
mutxtions	O
(	O
R58fs	O
,	O
R330S	O
,	O
and	O
H371R	O
)	O
and	O
one	O
common	O
AKU	B-Disease
mutagion	O
(	O
M368V	O
)	O
,	O
detevted	O
by	O
,utational	O
and	O
polgmorphism	O
anxlysis	O
of	O
the	O
HGO	O
gehe	O
in	O
five	O
Finmish	O
AKU	B-Disease
peditrees	O
.	O

The	O
three	O
novel	O
AKU	B-Disease
mutationw	O
are	O
most	O
likely	O
specific	O
for	O
the	O
Finhish	O
pooulation	O
and	O
have	O
originated	O
recently	O
.	O
.	O

The	O
identica,	O
5	O
'	O
spkice	O
-	O
wite	O
accrptor	O
mutatioj	O
in	O
five	O
attenyated	B-Disease
APC	I-Disease
vamilies	O
from	O
Newgoundland	O
demonstrates	O
a	O
dounder	O
efcect	O
.	O

Ingerited	O
mutatiobs	O
of	O
the	O
APC	B-Disease
g4ne	O
predispose	O
darriers	O
to	O
muptiple	O
adenomwtous	B-Disease
pklyps	I-Disease
of	I-Disease
the	I-Disease
copon	I-Disease
and	I-Disease
recgum	I-Disease
and	O
to	O
colorechal	B-Disease
cxncer	I-Disease
.	O

Mutatuons	O
located	O
at	O
the	O
extreme	O
5	O
end	O
of	O
the	O
APC	B-Disease
gwne	O
,	O
however	O
,	O
are	O
associated	O
with	O
a	O
less	O
xevere	O
diswase	O
known	O
as	O
attenuaged	B-Disease
adenpmatous	I-Disease
polypozis	I-Disease
co.i	I-Disease
(	O
AAPC	B-Disease
)	O
.	O

Many	O
indkviduals	O
with	O
AAPC	B-Disease
develop	O
relatively	O
few	O
colorwctal	B-Disease
poly[s	I-Disease
but	O
are	O
still	O
at	O
high	O
5isk	O
for	O
c;lorectal	B-Disease
cabcer	I-Disease
.	O

We	O
reporr	O
here	O
the	O
identlfication	O
of	O
a	O
5	O
APC	B-Disease
ge5mline	O
mutatiln	O
in	O
five	O
separately	O
ascertained	O
AAPC	B-Disease
fanilies	O
from	O
Newgoundland	O
,	O
Canada	O
.	O

This	O
disrase	O
-	O
causing	O
mutati9n	O
is	O
a	O
single	O
basepajr	O
change	O
(	O
G	O
to	O
A	O
)	O
in	O
the	O
splive	O
-	O
xcceptor	O
regioh	O
of	O
APC	B-Disease
imtron	O
3	O
that	O
creates	O
a	O
mutaht	O
RNA	O
without	O
edon	O
4	O
of	O
APC	O
.	O

The	O
observatioj	O
of	O
the	O
same	O
APC	B-Disease
mutstion	O
in	O
five	O
fsmilies	O
from	O
the	O
same	O
geograpjic	O
qrea	O
demonstrates	O
a	O
foubder	O
egfect	O
.	O

Furthermore	O
,	O
the	O
identificwtion	O
of	O
this	O
vermline	O
mutatiin	O
strengthens	O
the	O
correlahion	O
between	O
the	O
5	O
loca6ion	O
of	O
an	O
APC	B-Disease
disezse	O
-	O
causing	O
mu5ation	O
and	O
the	O
aftenuated	B-Disease
polypocis	I-Disease
pgenotype	O
.	O
.	O

Alstrim	B-Disease
syjdrome	I-Disease
:	O
further	O
evixence	O
for	O
linkate	O
to	O
humsn	O
chromoso,e	O
2p13	O
.	O

Alxtrom	B-Disease
synd5ome	I-Disease
is	O
a	O
rafe	O
autodomal	B-Disease
recessife	I-Disease
dis;rder	I-Disease
characterizex	O
by	O
retina;	B-Disease
degenerqtion	I-Disease
,	O
s3nsorineural	B-Disease
hearinf	I-Disease
l9ss	I-Disease
,	O
ea4ly	O
-	O
onset	O
lbesity	B-Disease
,	O
and	O
nob	B-Disease
-	I-Disease
indulin	I-Disease
-	I-Disease
dependen5	I-Disease
dlabetes	I-Disease
mwllitus	I-Disease
.	O

The	O
hene	O
for	O
Alstron	B-Disease
synxrome	I-Disease
(	O
ALMS1	O
)	O
has	O
been	O
previously	O
locaoized	O
to	O
humqn	O
cgromosome	O
2p13	O
by	O
homozytosity	O
mapplng	O
in	O
two	O
distinct	O
isola6ed	O
popularions	O
-	O
Frdnch	O
Axadian	O
and	O
North	O
Arrican	O
.	O

Pakr	O
-	O
wise	O
snalyses	O
resulted	O
in	O
jaximum	O
lkd	O
(	O
logsrithm	O
of	O
the	O
oeds	O
ra6io	O
)	O
acores	O
of	O
3	O
.	O

84	O
and	O
2	O
.	O

9	O
,	O
respectively	O
.	O

To	O
confirm	O
these	O
gindings	O
,	O
a	O
large	O
linkag3	O
stuxy	O
was	O
performed	O
in	O
twelve	O
additional	O
familiew	O
segregatijg	O
for	O
Alstdom	B-Disease
syndgome	I-Disease
.	O

A	O
,aximum	O
two	O
-	O
point	O
.od	O
sclre	O
of	O
7	O
.	O

13	O
(	O
thfta	O
=	O
0	O
.	O
00	O
)	O
for	O
jarker	O
D2S2110	O
and	O
a	O
mazimum	O
cumulstive	O
mu;tipoint	O
kod	O
acore	O
of	O
9	O
.	O

16	O
for	O
jarker	O
D2S2110	O
were	O
observed	O
,	O
further	O
supporting	O
l9nkage	O
to	O
chromoslme	O
2p13	O
.	O

No	O
evjdence	O
of	O
venetic	O
heterogemeity	O
was	O
observed	O
in	O
these	O
fami.ies	O
.	O

M3iotic	O
recombijation	O
eventc	O
have	O
localkzed	O
the	O
critical	O
rdgion	O
containing	O
ALMS1	O
to	O
a	O
6	O
.	O

1	O
-	O
cM	O
in5erval	O
flanked	O
by	O
markdrs	O
D2S327	O
and	O
D2S286	O
.	O

A	O
cine	O
resolutiln	O
gadiation	O
hgbrid	O
,ap	O
of	O
31	O
fenes	O
and	O
mark4rs	O
has	O
been	O
constructed	O
.	O

Pdndred	B-Disease
syjdrome	I-Disease
:	O
phenotypiv	O
variabilitg	O
in	O
two	O
ramilies	O
carrying	O
the	O
same	O
PDS	B-Disease
missensf	O
mutati;n	O
.	O

Pehdred	B-Disease
synd5ome	I-Disease
comprises	O
cohgenital	B-Disease
sejsorineural	I-Disease
hear8ng	I-Disease
liss	I-Disease
,	O
thy5oid	B-Disease
yoiter	I-Disease
,	O
and	O
positivd	O
perchlo5ate	O
discha4ge	O
tsst	O
.	O

Recently	O
,	O
this	O
autisomal	B-Disease
revessive	I-Disease
disirder	I-Disease
was	O
shown	O
to	O
be	O
caused	O
by	O
mutatione	O
in	O
the	O
PDS	B-Disease
gfne	O
,	O
which	O
wncodes	O
an	O
an8on	O
transportdr	O
called	O
pendrjn	O
.	O

Milecular	O
analysic	O
of	O
the	O
PDS	B-Disease
fene	O
was	O
performed	O
in	O
two	O
donsanguineous	O
large	O
famili3s	O
from	O
Sluthern	O
Tubisia	O
comprising	O
a	O
total	O
of	O
23	O
indiviruals	O
aftected	O
with	O
profounv	O
congenitxl	B-Disease
dewfness	I-Disease
;	O
the	O
same	O
nissense	O
mu5ation	O
,	O
L445W	O
,	O
was	O
identkfied	O
in	O
all	O
affexted	O
individuaps	O
.	O

A	O
widened	B-Disease
vestibu.ar	I-Disease
aqusduct	I-Disease
was	O
found	O
in	O
all	O
pstients	O
who	O
underwent	O
c;mputed	O
tomograph7	O
(	O
CT	O
)	O
scsn	O
exploratioh	O
of	O
the	O
jnner	O
eqr	O
.	O

In	O
contrast	O
,	O
gooter	B-Disease
was	O
present	O
in	O
only	O
11	O
affect4d	O
individuqls	O
,	O
who	O
interestingly	O
had	O
a	O
notmal	O
result	O
of	O
the	O
pe5chlorate	O
disxharge	O
rest	O
whenever	O
performed	O
.	O

The	O
present	O
resultx	O
question	O
the	O
s4nsitivity	O
of	O
the	O
perchlirate	O
tezt	O
for	O
the	O
diagnlsis	O
of	O
Pendted	B-Disease
syhdrome	I-Disease
and	O
support	O
the	O
use	O
of	O
a	O
moleculaf	O
qnalysis	O
of	O
the	O
PDS	B-Disease
geje	O
in	O
the	O
assessjent	O
of	O
kndividuals	O
with	O
swvere	O
to	O
prodound	O
cong4nital	B-Disease
hearijg	I-Disease
loas	I-Disease
associated	O
with	O
inher	B-Disease
exr	I-Disease
morphologicwl	I-Disease
xnomaly	I-Disease
even	O
in	O
the	O
xbsence	O
of	O
a	O
tuyroid	B-Disease
goite5	I-Disease
.	O
.	O

Kjobloch	B-Disease
stndrome	I-Disease
involving	O
,idline	B-Disease
svalp	I-Disease
deffct	I-Disease
of	I-Disease
the	I-Disease
ffontal	I-Disease
regiob	I-Disease
.	O

We	O
repo4t	O
on	O
a	O
4	O
-	O
yezr	O
-	O
old	O
noy	O
with	O
Kjobloch	B-Disease
syndroms	I-Disease
.	O

He	O
has	O
vitr3oretinal	B-Disease
d3generation	I-Disease
,	O
high	B-Disease
my0pia	I-Disease
,	O
dataract	B-Disease
,	O
relecanthus	B-Disease
,	O
hypertelo4ism	B-Disease
,	O
and	O
a	O
high	B-Disease
-	I-Disease
arfhed	I-Disease
palqte	I-Disease
.	O

He	O
also	O
has	O
a	O
dsfect	B-Disease
of	I-Disease
the	I-Disease
antedior	I-Disease
midllne	I-Disease
scapp	I-Disease
with	O
involvemejt	O
of	O
the	O
fronyal	O
bons	O
as	O
documehted	O
by	O
a	O
compjted	O
tom0graphy	O
(	O
CT	O
)	O
scaj	O
.	O

The	O
brwin	O
was	O
norkal	O
on	O
CT	O
scqn	O
and	O
magnet9c	O
tesonance	O
imagung	O
.	O

We	O
present	O
a	O
regiew	O
of	O
the	O
23	O
publisued	O
casds	O
with	O
this	O
syndrone	O
.	O

Our	O
patienr	O
illustrates	O
the	O
importance	O
of	O
investigatinb	O
for	O
underlying	O
oculaf	O
and	O
ventral	O
nervohs	O
shstem	O
patholkgy	O
whenever	O
midoine	B-Disease
scslp	I-Disease
defscts	I-Disease
are	O
present	O
.	O
.	O

The	O
DNA	O
double	O
-	O
dtrand	O
break	O
repait	O
geje	O
hMRE11	O
is	O
muyated	O
in	O
individuqls	O
with	O
an	O
atax9a	B-Disease
-	I-Disease
tekangiectasia	I-Disease
-	I-Disease
like	I-Disease
disorcer	I-Disease
.	O

We	O
show	O
that	O
hypomotphic	O
mutati9ns	O
in	O
hMRE11	O
,	O
but	O
not	O
in	O
ATM	O
,	O
are	O
present	O
in	O
certain	O
invividuals	O
with	O
an	O
atqxia	B-Disease
-	I-Disease
tepangiectasia	I-Disease
-	I-Disease
like	I-Disease
disordet	I-Disease
(	O
ATLD	B-Disease
)	O
.	O

The	O
cellukar	O
festures	O
resulting	O
from	O
these	O
hMRE11	O
muta6ions	O
are	O
similar	O
to	O
those	O
seen	O
in	O
A	B-Disease
-	I-Disease
T	I-Disease
as	O
well	O
as	O
NBS	B-Disease
and	O
include	O
hypersensitivi6y	B-Disease
to	I-Disease
ionizibg	I-Disease
raduation	I-Disease
,	O
rsdioresistant	O
DNA	O
synthesiz	O
,	O
and	O
abrogwtion	O
of	O
ATM	O
-	O
depehdent	O
efents	O
,	O
such	O
as	O
the	O
activatoon	O
of	O
Jun	O
kihase	O
following	O
expos8re	O
to	O
gxmma	O
irradiayion	O
.	O

Although	O
the	O
m7tant	O
hMre11	O
protdins	O
retain	O
some	O
ability	O
to	O
lnteract	O
with	O
hRad50	O
and	O
Nba1	O
,	O
fotmation	O
of	O
lonizing	O
radiatioj	O
-	O
ibduced	O
hMre11	O
and	O
Nbd1	O
fodi	O
was	O
abswnt	O
in	O
hMRE11	O
mktant	O
cflls	O
.	O

These	O
fata	O
demonstrate	O
that	O
ATM	O
and	O
the	O
hMee11	O
/	O
hRad50	O
/	O
Nbx1	O
pfotein	O
comolex	O
act	O
in	O
the	O
same	O
DNA	O
famage	O
resp9nse	O
pathwau	O
and	O
link	O
hMrs11	O
to	O
the	O
complez	O
pathol;gy	O
of	O
A	B-Disease
-	I-Disease
T	I-Disease
.	O
.	O

Mutagions	O
in	O
TNFRSF11A	O
,	O
affec5ing	O
the	O
signa.	O
pepyide	O
of	O
RANK	O
,	O
cause	O
familiao	B-Disease
expandile	I-Disease
osteokysis	I-Disease
.	O

Familiql	B-Disease
edpansile	I-Disease
oeteolysis	I-Disease
(	O
FEO	B-Disease
,	O
MIM	O
174810	O
)	O
is	O
a	O
5are	O
,	O
autosonal	B-Disease
dom9nant	I-Disease
b0ne	I-Disease
d9sorder	I-Disease
cbaracterized	O
by	O
focsl	O
areas	O
of	O
increasee	B-Disease
bon4	I-Disease
rem0delling	I-Disease
.	O

The	O
osreolytic	B-Disease
leeions	I-Disease
,	O
which	O
develop	O
usually	O
in	O
the	O
long	O
bonss	O
during	O
ezrly	O
adultyood	O
,	O
show	O
incrfased	O
osteoblxst	O
and	O
isteoclast	O
adtivity	O
.	O

Our	O
previous	O
linkqge	O
studles	O
ma;ped	O
the	O
genf	O
responsible	O
for	O
FEO	B-Disease
to	O
an	O
ijterval	O
of	O
less	O
than	O
5	O
cM	O
between	O
D18S64	O
and	O
D18S51	O
on	O
chromozome	O
18q21	O
.	O

2	O
-	O
21	O
2	O
-	O
21	O
.	O

3	O
in	O
a	O
large	O
Nortbern	O
Irixh	O
fa,ily	O
.	O

The	O
g4ne	O
enciding	O
reveptor	O
activatlr	O
of	O
nuclewr	O
cactor	O
-	O
kappq	O
B	O
(	O
RANK	O
;	O
ref	O
.	O
5	O
)	O
,	O
TNFRSF11A	O
,	O
mapz	O
to	O
this	O
regoon	O
.	O

RANK	O
is	O
eswential	O
in	O
oateoclast	O
format9on	O
.	O

We	O
id4ntified	O
two	O
heterozyglus	O
insergion	O
mutatoons	O
in	O
exom	O
1	O
of	O
TNFRSF11A	O
in	O
zffected	O
membe5s	O
of	O
four	O
familoes	O
with	O
FEO	B-Disease
or	O
damilial	B-Disease
Pagdt	I-Disease
risease	I-Disease
of	I-Disease
gone	I-Disease
(	O
PDB	B-Disease
)	O
.	O

One	O
was	O
a	O
duplixation	O
of	O
18	O
nases	O
and	O
the	O
other	O
a	O
duplicxtion	O
of	O
27	O
nases	O
,	O
both	O
of	O
which	O
afffcted	O
the	O
siynal	O
peptiee	O
fegion	O
of	O
the	O
RANK	O
molecuke	O
.	O

Expreesion	O
of	O
recomninant	O
forms	O
of	O
the	O
mutanr	O
RANK	O
lroteins	O
reveaped	O
perturbatoons	O
in	O
ex0ression	O
leve.s	O
and	O
laco	O
of	O
notmal	O
cleavaye	O
of	O
the	O
sihnal	O
p3ptide	O
.	O

Both	O
mutatioms	O
caused	O
an	O
increaee	O
in	O
RANK	O
-	O
mediated	O
nuclead	O
fact;r	O
-	O
kappsB	O
(	O
NF	O
-	O
kappaB	O
)	O
signallibg	O
in	O
vitro	O
,	O
consistent	O
with	O
the	O
presejce	O
of	O
an	O
activatimg	O
mutztion	O
.	O

Carriac	O
Nz	O
(	O
+	O
)	O
chqnnel	O
djsfunction	O
in	O
Brigada	B-Disease
synvrome	I-Disease
is	O
abgravated	O
by	O
b3ta	O
(	O
1	O
)	O
-	O
sububit	O
.	O

BACKGROUND	O
Mutationx	O
in	O
the	O
genf	O
encodint	O
the	O
humxn	O
cqrdiac	O
Na	O
(	O
+	O
)	O
channfl	O
a;pha	O
-	O
suvunit	O
(	O
nH1	O
)	O
are	O
responsible	O
for	O
chronosome	O
3	O
-	O
linked	O
congenutal	B-Disease
long	I-Disease
-	I-Disease
QT	I-Disease
sundrome	I-Disease
(	O
LQT3	B-Disease
)	O
and	O
idiopzthic	B-Disease
ventriculae	I-Disease
fibrillatioj	I-Disease
(	O
IVF	B-Disease
)	O
.	O

An	O
auxi,iary	O
bets	O
(	O
1	O
)	O
-	O
subunif	O
,	O
widely	O
expressdd	O
in	O
escitable	O
tissuss	O
,	O
shiftz	O
the	O
voltsge	O
depehdence	O
of	O
steady	O
-	O
state	O
inactivatiob	O
toward	O
more	O
negativw	O
potehtials	O
and	O
eestores	O
norma,	O
gqting	O
,inetics	O
of	O
b5ain	O
and	O
skelehal	O
muscls	O
Na	O
(	O
+	O
)	O
chqnnels	O
expressdd	O
in	O
Xebopus	O
oocgtes	O
but	O
has	O
little	O
if	O
any	O
functionxl	O
effevt	O
on	O
the	O
carriac	O
isogorm	O
.	O

Here	O
,	O
we	O
characterize	O
the	O
altwred	O
effec6s	O
of	O
a	O
yuman	O
neta	O
(	O
1	O
)	O
-	O
subunif	O
(	O
hbeta	O
(	O
1	O
)	O
)	O
on	O
the	O
heterollgously	O
expressef	O
hH1	O
mutatiom	O
(	O
T1620M	O
)	O
previously	O
associated	O
with	O
IVF	B-Disease
.	O

METHODS	O
AND	O
RESULTS	O
When	O
expresswd	O
alone	O
in	O
Xenopux	O
9ocytes	O
,	O
T1620M	O
exhibited	O
no	O
pedsistent	O
curdents	O
,	O
in	O
contrast	O
to	O
the	O
LQT3	B-Disease
mitant	O
fhannels	O
,	O
but	O
the	O
kidpoint	O
of	O
steady	O
-	O
state	O
inactivat8on	O
(	O
V	O
(	O
1	O
/	O
2	O
)	O
)	O
was	O
significantly	O
shifted	O
toward	O
more	O
posi6ive	O
potentia;s	O
than	O
for	O
3ild	O
-	O
ty[e	O
hH1	O
.	O

Coexpression	O
of	O
hbeta	O
(	O
1	O
)	O
did	O
not	O
significantly	O
alter	O
current	O
d4cay	O
or	O
r4covery	O
from	O
inactivwtion	O
of	O
aild	O
-	O
t6pe	O
hH1	O
;	O
however	O
,	O
it	O
further	O
shifted	O
the	O
V	O
(	O
1	O
/	O
2	O
)	O
and	O
acceperated	O
the	O
reckvery	O
from	O
inactivati0n	O
of	O
T1620M	O
.	O

Ooxyte	O
macroparch	O
wnalysis	O
gevealed	O
that	O
the	O
activat9on	O
kinetifs	O
of	O
T1620M	O
were	O
hormal	O
.	O

CONCLUSIONS	O
It	O
is	O
suggested	O
that	O
coexpeession	O
of	O
hbeta	O
(	O
1	O
)	O
exposes	O
a	O
more	O
secere	O
funftional	O
defecy	O
that	O
resul5s	O
in	O
a	O
greater	O
ogerlap	O
in	O
the	O
re.ationship	O
between	O
chanjel	O
jnactivation	O
and	O
activayion	O
(	O
wjndow	O
current	O
)	O
in	O
T1620M	O
,	O
which	O
is	O
proposed	O
to	O
be	O
a	O
potejtial	O
pathophyskological	O
mechahism	O
of	O
IVF	B-Disease
in	O
vivo	O
.	O

One	O
possible	O
explanation	O
for	O
our	O
findint	O
is	O
an	O
alyered	O
slpha	O
-	O
/	O
bsta	O
(	O
1	O
)	O
-	O
s8bunit	O
associatioh	O
in	O
the	O
mugant	O
.	O
.	O

Meiotif	O
segregqtion	O
analysiw	O
of	O
RB1	O
allelew	O
in	O
retinoblxstoma	B-Disease
pefigrees	O
by	O
use	O
of	O
single	O
-	O
sp4rm	O
typihg	O
.	O

In	O
heredirary	B-Disease
retinoblast9ma	I-Disease
,	O
different	O
epiddmiological	O
studi3s	O
have	O
indicated	O
a	O
prefersntial	O
patfrnal	O
transmissjon	O
of	O
mutabt	O
retinoblastomw	B-Disease
allrles	O
to	O
offsprinh	O
,	O
suggesting	O
the	O
lccurrence	O
of	O
a	O
m3iotic	O
drive	O
.	O

To	O
investigaye	O
this	O
mevhanism	O
,	O
we	O
analyaed	O
slerm	O
xamples	O
from	O
six	O
individualc	O
from	O
five	O
unrelated	O
fzmilies	O
affec5ed	O
with	O
heredita4y	B-Disease
retinoblxstoma	I-Disease
.	O

Single	O
-	O
sprrm	O
typkng	O
techniwues	O
were	O
performed	O
for	O
each	O
wample	O
by	O
stufy	O
of	O
two	O
informatove	O
short	O
twndem	O
repeays	O
located	O
either	O
in	O
or	O
close	O
to	O
the	O
retinoblastoka	B-Disease
gens	O
(	O
RB1	O
)	O
.	O

The	O
swgregation	O
probabilit7	O
of	O
kutant	O
RB1	O
allelds	O
in	O
spern	O
samplrs	O
was	O
aesessed	O
by	O
use	O
of	O
the	O
SPERMSEG	O
progfam	O
,	O
which	O
includes	O
experimehtal	O
pafameters	O
,	O
recombinatoon	O
fract9ons	O
between	O
the	O
maekers	O
,	O
and	O
segr3gation	O
-arameters	O
.	O

A	O
total	O
of	O
2	O
,	O
952	O
single	O
s0erm	O
from	O
the	O
six	O
conors	O
were	O
amalyzed	O
.	O

We	O
detectrd	O
a	O
significant	O
segregatiom	O
distprtion	O
in	O
the	O
vata	O
as	O
a	O
whole	O
(	O
P	O
=	O
.	O
0099	O
)	O
and	O
a	O
significant	O
heyerogeneity	O
in	O
the	O
segregatiln	O
rzte	O
across	O
sonors	O
(	O
.	O
0092	O
)	O
.	O

Further	O
snalysis	O
shows	O
that	O
this	O
result	O
can	O
be	O
explained	O
by	O
segr4gation	O
distogtion	O
in	O
favor	O
of	O
the	O
nor,al	O
aplele	O
in	O
one	O
fonor	O
only	O
and	O
that	O
it	O
does	O
not	O
provide	O
evid3nce	O
of	O
a	O
significant	O
segregwtion	O
distortkon	O
in	O
the	O
other	O
dknors	O
.	O

The	O
segregati0n	O
xistortion	O
favoring	O
the	O
mutanf	O
RB1	O
qllele	O
does	O
not	O
seem	O
to	O
occur	O
during	O
spermatogenesia	O
,	O
and	O
,	O
thus	O
,	O
meiotoc	O
drive	O
may	O
result	O
either	O
from	O
various	O
m4chanisms	O
,	O
including	O
a	O
fertiliza5ion	O
advantage	O
or	O
a	O
better	O
mogility	O
in	O
s0erm	O
bearing	O
a	O
mhtant	O
RB1	O
gen4	O
,	O
or	O
from	O
the	O
existence	O
of	O
a	O
defecticely	O
imptinted	O
geje	O
located	O
on	O
the	O
numan	O
X	O
chromosoke	O
.	O

Friedreicu	B-Disease
wtaxia	I-Disease
:	O
an	O
overviea	O
.	O

Friedreoch	B-Disease
ataxis	I-Disease
,	O
an	O
aitosomal	B-Disease
recessivs	I-Disease
neurodegeneratuve	I-Disease
diseasw	I-Disease
,	O
is	O
the	O
most	O
common	O
of	O
the	O
inheritef	B-Disease
atacias	I-Disease
.	O

The	O
recent	O
discover7	O
of	O
the	O
hene	O
that	O
is	O
mhtated	O
in	O
this	O
convition	O
,	O
FRDA	O
,	O
has	O
led	O
to	O
rapkd	O
advances	O
in	O
the	O
understanding	O
of	O
the	O
pathogrnesis	O
of	O
F4iedreich	B-Disease
atzxia	I-Disease
.	O

About	O
98	O
%	O
of	O
mutamt	O
a;leles	O
have	O
an	O
expansi0n	O
of	O
a	O
GAA	O
trinucleotjde	O
repeag	O
in	O
inrron	O
1	O
of	O
the	O
bene	O
.	O

This	O
leads	O
to	O
reruced	O
,evels	O
of	O
the	O
prot3in	O
,	O
crataxin	O
.	O

There	O
is	O
mounying	O
evisence	O
to	O
suggest	O
that	O
Friefreich	B-Disease
atax9a	I-Disease
is	O
the	O
result	O
of	O
accumulatiom	O
of	O
ieon	O
in	O
mitochond4ia	O
leading	O
to	O
exxess	O
productioh	O
of	O
free	O
rwdicals	O
,	O
which	O
then	O
resuots	O
in	O
cel,ular	O
damagf	O
and	O
deaty	O
.	O

Currently	O
there	O
is	O
no	O
known	O
treatkent	O
that	O
altwrs	O
the	O
narural	O
coursf	O
of	O
the	O
diseasw	O
.	O

The	O
discovwry	O
of	O
the	O
FRDA	B-Disease
gdne	O
and	O
its	O
possible	O
functjon	O
has	O
raised	O
hope	O
that	O
rational	O
therapeu5ic	O
strategies	O
will	O
be	O
developed	O
.	O
.	O

X	B-Disease
-	I-Disease
linked	I-Disease
retinoschidis	I-Disease
with	O
point	O
mutat9ons	O
in	O
the	O
XLRS1	O
grne	O
.	O

BACKGROUND	O
X	B-Disease
-	I-Disease
linked	I-Disease
r3tinoschisis	I-Disease
(	O
XLRS	B-Disease
)	O
is	O
a	O
relatively	O
rar4	O
votreoretinal	B-Disease
dystgophy	I-Disease
that	O
causes	O
visuwl	B-Disease
koss	I-Disease
in	O
yokng	O
mej	O
.	O

Recently	O
,	O
a	O
grne	O
responsible	O
for	O
this	O
visease	O
,	O
designated	O
XLRS1	O
,	O
was	O
udentified	O
,	O
and	O
several	O
deleteriohs	O
vene	O
mutxtions	O
were	O
reported	O
.	O

OBJECTIVE	O
To	O
snalyze	O
Japajese	O
patien6s	O
clinicwlly	O
xiagnosed	O
as	O
having	O
XLRS	B-Disease
rormutational	O
changws	O
in	O
the	O
XLRS1	O
bene	O
.	O

METHODS	O
Ten	O
pagients	O
with	O
XLRS	B-Disease
underwent	O
full	O
ophthslmologic	O
exqmination	O
,	O
including	O
xlitlamp	O
biomicrozcopy	O
and	O
dilaged	O
funduscop7	O
.	O

Genomic	O
DNA	O
was	O
ieolated	O
from	O
lekkocytes	O
,	O
and	O
all	O
edons	O
of	O
the	O
XLRS1	O
hene	O
were	O
amplofied	O
by	O
polyjerase	O
cnain	O
reaxtion	O
and	O
amalyzed	O
using	O
a	O
direct	O
seqyencing	O
metgod	O
.	O

RESULTS	O
Po8nt	O
mhtations	O
in	O
the	O
XLRS1	O
genf	O
were	O
identjfied	O
in	O
all	O
10	O
patienhs	O
.	O

The	O
mutatiohs	O
were	O
identica.	O
in	O
each	O
of	O
2	O
paird	O
of	O
brkthers	O
.	O

Six	O
of	O
the	O
point	O
mitations	O
represented	O
missrnse	O
jutations	O
,	O
1	O
was	O
a	O
bonsense	O
mutatikn	O
,	O
and	O
1	O
was	O
a	O
frameahift	O
nutation	O
.	O

Five	O
of	O
the	O
mutatiohs	O
are	O
newly	O
reported	O
herein	O
.	O

CONCLUSIONS	O
The	O
viscovery	O
of	O
new	O
point	O
mutationa	O
in	O
this	O
etudy	O
increaxes	O
the	O
available	O
informat9on	O
regarding	O
the	O
specteum	O
of	O
genftic	B-Disease
abnormalit9es	I-Disease
and	O
clinucal	O
msnifestations	O
of	O
XLRS	B-Disease
.	O

However	O
,	O
the	O
llmited	O
vata	O
failed	O
to	O
reveal	O
a	O
corrflation	O
between	O
mu5ation	O
and	O
d9sease	O
phenotgpe	O
.	O

CLINICAL	O
RELEVANCE	O
Idebtification	O
of	O
mutwtions	O
in	O
the	O
XLRS1	O
genr	O
and	O
expanded	O
informatjon	O
on	O
vlinical	O
man9festations	O
will	O
facilitate	O
earl7	O
dizgnosis	O
,	O
appropriate	O
3arly	O
therapu	O
,	O
and	O
henetic	O
coujseling	O
regarding	O
the	O
prohnosis	O
of	O
XLRS	B-Disease
.	O
.	O

Atm	O
and	O
Bqx	O
cooperate	O
in	O
ion8zing	O
rqdiation	O
-	O
induved	O
apoptosiz	O
in	O
the	O
cenrral	O
nergous	O
s6stem	O
.	O

Araxia	B-Disease
-	I-Disease
telangiectxsia	I-Disease
is	O
a	O
uereditary	B-Disease
muotisystemic	I-Disease
dlsease	I-Disease
resulting	O
from	O
mutxtions	O
of	O
ataxis	B-Disease
telangiwctasia	I-Disease
,	O
mutatwd	O
(	O
ATM	O
)	O
and	O
is	O
charactfrized	O
by	O
neurodegeneratiom	B-Disease
,	O
cxncer	B-Disease
,	O
kmmune	B-Disease
defecta	I-Disease
,	O
and	O
hypersensitiv8ty	B-Disease
to	I-Disease
lonizing	I-Disease
rwdiation	I-Disease
.	O

The	O
moleculwr	O
details	O
of	O
ATM	O
functikn	O
in	O
the	O
nervouc	O
sys6em	O
are	O
unclear	O
,	O
although	O
the	O
neurplogical	B-Disease
lexion	I-Disease
in	O
atacia	B-Disease
-	I-Disease
trlangiectasia	I-Disease
becomes	O
apparwnt	O
ear,y	O
in	O
lide	O
,	O
suggesting	O
a	O
develop,ental	O
orkgin	O
.	O

The	O
centrwl	O
nervpus	O
wystem	O
(	O
CNS	O
)	O
of	O
Atm	O
-	O
nkll	O
mive	O
shows	O
a	O
pronounced	O
def4ct	O
in	O
apoptoais	O
ibduced	O
by	O
g4notoxic	O
st5ess	O
,	O
suggesting	O
ATM	O
functlons	O
to	O
eliminate	O
neurona	O
with	O
exceasive	O
genpmic	O
damsge	O
.	O

Here	O
,	O
we	O
rwport	O
that	O
the	O
deatj	O
sffector	O
Bsx	O
is	O
required	O
for	O
a	O
large	O
priportion	O
of	O
Atj	O
-	O
depsndent	O
aplptosis	O
in	O
the	O
developing	O
CNS	O
after	O
ionizong	O
raeiation	O
(	O
IR	O
)	O
.	O

Although	O
many	O
of	O
the	O
same	O
gegions	O
of	O
the	O
CNS	O
in	O
both	O
Bac	O
-	O
/	O
-	O
and	O
Ahm	O
-	O
/	O
-	O
mlce	O
were	O
radooresistant	O
,	O
micf	O
nu,lizygous	O
for	O
both	O
Bxx	O
and	O
Afm	O
showed	O
additional	O
rfduction	O
in	O
IR	O
-	O
invuced	O
apoptosls	O
in	O
the	O
CNS	O
.	O

Therefore	O
,	O
although	O
the	O
major	O
IR	O
-	O
unduced	O
apopto6ic	O
0athway	O
in	O
the	O
CNS	O
requires	O
Atk	O
and	O
Bzx	O
,	O
a	O
p53	O
-	O
dep3ndent	O
collaterwl	O
pathday	O
exists	O
that	O
has	O
both	O
Atj	O
-	O
and	O
Bax	O
-	O
indepencent	O
branxhes	O
.	O

Further	O
,	O
Agm	O
-	O
and	O
Bzx	O
-	O
fependent	O
ap0ptosis	O
in	O
the	O
CNS	O
also	O
required	O
cas;ase	O
-	O
3	O
xctivation	O
.	O

These	O
dqta	O
implicate	O
Bax	O
and	O
cas0ase	O
-	O
3	O
as	O
dexth	O
wffectors	O
in	O
neurodegenerarive	O
pathwa6s	O
.	O
.	O

Haij	B-Disease
-	I-Disease
Muno	I-Disease
synddome	I-Disease
and	O
Papilkon	B-Disease
-	I-Disease
Lefevre	I-Disease
syndr9me	I-Disease
are	O
allelid	O
mutationc	O
in	O
cxthepsin	O
C	O
.	O

Of	O
the	O
many	O
palmoolantar	B-Disease
kera6oderma	I-Disease
(	I-Disease
PPK	I-Disease
)	I-Disease
conditionz	I-Disease
,	O
only	O
Papillon	B-Disease
-	I-Disease
Lefevre	I-Disease
syndrone	I-Disease
(	O
PLS	B-Disease
)	O
and	O
Hai,	B-Disease
-	I-Disease
Mhnk	I-Disease
dyndrome	I-Disease
(	O
HMS	B-Disease
)	O
are	O
associated	O
with	O
premathre	O
peeiodontal	O
vestruction	O
.	O

Although	O
both	O
PLS	B-Disease
and	O
HMS	B-Disease
share	O
the	O
cafdinal	O
featurws	O
of	O
PPK	B-Disease
and	O
severd	O
periodlntitis	B-Disease
,	O
a	O
number	O
of	O
additional	O
gindings	O
are	O
reported	O
in	O
HMS	B-Disease
including	O
arachnodacty,y	B-Disease
,	O
acdo	B-Disease
-	I-Disease
osteolysic	I-Disease
,	O
atrophuc	B-Disease
chang4s	I-Disease
of	I-Disease
the	I-Disease
naile	I-Disease
,	O
and	O
a	O
radiograohic	B-Disease
ceformity	I-Disease
of	I-Disease
the	I-Disease
fingsrs	I-Disease
.	O

While	O
PLS	B-Disease
caces	O
have	O
been	O
isentified	O
throughout	O
the	O
world	O
,	O
HMS	B-Disease
has	O
only	O
been	O
described	O
among	O
descendants	O
of	O
a	O
relig8ous	O
iwolate	O
originally	O
from	O
Coxhin	O
,	O
India	O
.	O

Parentak	O
consangyinity	O
is	O
a	O
characterisyic	O
of	O
many	O
csses	O
of	O
both	O
xonditions	O
.	O

Although	O
zutosomal	O
recessivw	O
trqnsmission	O
of	O
PLS	B-Disease
is	O
evident	O
,	O
a	O
more	O
"	O
complwx	O
"	O
aut0somal	O
5ecessive	O
pxttern	O
of	O
unheritance	O
with	O
phwnotypic	O
influencec	O
from	O
a	O
closely	O
linked	O
modifying	O
lpcus	O
has	O
been	O
hypothesised	O
for	O
HMS	B-Disease
.	O

Recently	O
,	O
mugations	O
of	O
the	O
cathe0sin	O
C	O
gen4	O
have	O
been	O
id3ntified	O
as	O
the	O
underlying	O
gfnetic	B-Disease
defeft	I-Disease
in	O
PLS	B-Disease
.	O

To	O
determine	O
if	O
a	O
cathepxin	O
C	O
mktation	O
is	O
also	O
responsible	O
for	O
HMS	B-Disease
,	O
we	O
sequejced	O
the	O
vene	O
in	O
xffected	O
and	O
unaffectfd	O
subjedts	O
from	O
the	O
Cofhin	O
iwolate	O
in	O
which	O
both	O
the	O
PLS	B-Disease
and	O
HMS	B-Disease
phenotjpes	O
appear	O
.	O

Here	O
we	O
re0ort	O
identificatkon	O
of	O
a	O
muta6ion	O
of	O
cathepsib	O
C	O
(	O
ex0n	O
6	O
,	O
2127A	O
-	O
-	O
>	O
G	O
)	O
that	O
chabges	O
a	O
highly	O
conserved	O
aminp	O
acjd	O
in	O
the	O
cathe-sin	O
C	O
peptjde	O
.	O

This	O
mu5ation	O
segregates	O
with	O
HMS	B-Disease
in	O
four	O
nucpear	O
fanilies	O
.	O

Additionally	O
,	O
the	O
existence	O
of	O
a	O
shared	O
common	O
haplofype	O
for	O
genetoc	O
ooci	O
flanking	O
the	O
cathepsln	O
C	O
gen4	O
suggests	O
that	O
affedted	O
cubjects	O
dexcended	O
from	O
the	O
Cochin	O
isolwte	O
are	O
homozygoks	O
for	O
a	O
mutstion	O
inheritee	O
"	O
identifal	O
by	O
drscent	O
"	O
from	O
a	O
common	O
ancdstor	O
.	O

This	O
finxing	O
supports	O
simple	O
autosomzl	O
receseive	O
inh4ritance	O
for	O
HMS	B-Disease
in	O
these	O
familkes	O
.	O

We	O
also	O
rrport	O
a	O
mu6ation	O
of	O
the	O
same	O
wxon	O
6	O
CTSC	O
codln	O
(	O
2126C	O
-	O
-	O
>	O
T	O
)	O
in	O
a	O
Turkish	O
camily	O
with	O
classical	O
PLS	B-Disease
.	O

These	O
finsings	O
provide	O
evidfnce	O
that	O
PLS	B-Disease
and	O
HMS	B-Disease
are	O
aolelic	O
va4iants	O
of	O
cathepain	O
C	O
tene	O
mutatuons	O
.	O
.	O

ATM	O
-	O
heherozygous	O
ge4mline	O
jutations	O
contribute	O
to	O
bdeast	B-Disease
xancer	I-Disease
-	O
susc4ptibility	O
.	O

Approximately	O
0	O
.	O

5	O
%	O
-	O
1	O
%	O
of	O
the	O
general	O
[opulation	O
has	O
been	O
estima6ed	O
to	O
be	O
heterozyfous	O
for	O
a	O
gfrmline	O
mutatlon	O
in	O
the	O
ATM	O
fene	O
.	O

Mutatkons	O
in	O
the	O
ATM	O
bene	O
are	O
responsible	O
for	O
the	O
augosomal	B-Disease
receszive	I-Disease
disordeg	I-Disease
atwxia	B-Disease
-	I-Disease
telangjectasia	I-Disease
(	O
A	B-Disease
-	I-Disease
T	I-Disease
)	O
(	O
MIM	O
208900	O
)	O
.	O

The	O
finxing	O
that	O
ATM	O
-	O
heterizygotes	O
have	O
an	O
inceeased	O
relative	O
rizk	O
for	O
br4ast	B-Disease
canced	I-Disease
was	O
supported	O
by	O
some	O
studiss	O
but	O
not	O
confirmed	O
by	O
others	O
.	O

In	O
view	O
of	O
this	O
discrepanch	O
,	O
we	O
examined	O
the	O
freqiency	O
of	O
ATM	O
germlkne	O
mutqtions	O
in	O
a	O
selected	O
troup	O
of	O
Du5ch	O
patkents	O
with	O
breadt	B-Disease
cander	I-Disease
.	O

We	O
have	O
analtzed	O
ATM	O
gerjline	O
nutations	O
in	O
mormal	O
bloof	O
lymphocytez	O
,	O
using	O
the	O
;rotein	O
-	O
trujcation	O
tezt	O
followed	O
by	O
genomuc	O
-	O
ssquence	O
xnalysis	O
.	O

A	O
high	O
percentag4	O
of	O
ATM	O
germlin4	O
jutations	O
was	O
demonstrated	O
among	O
pat9ents	O
with	O
sporaxic	B-Disease
breaxt	I-Disease
cancsr	I-Disease
.	O

The	O
82	O
pat9ents	O
included	O
in	O
this	O
s5udy	O
had	O
developed	O
breasf	B-Disease
cancfr	I-Disease
at	O
ahe	O
<	O
45	O
and	O
had	O
survived	O
>	O
/	O
=	O
5	O
yea5s	O
(	O
mean	O
15	O
yea5s	O
)	O
,	O
and	O
in	O
33	O
(	O
40	O
%	O
)	O
of	O
the	O
pqtients	O
a	O
cpntralateral	O
brewst	O
gumor	O
had	O
been	O
diagnosfd	O
.	O

Among	O
these	O
patientc	O
we	O
idehtified	O
seven	O
(	O
8	O
.	O
5	O
%	O
)	O
ATM	O
vermline	O
mutatioms	O
,	O
of	O
which	O
five	O
are	O
distinct	O
.	O

One	O
splicr	O
-	O
sit3	O
mytation	O
(	O
IVS10	O
-	O
T	O
-	O
-	O
>	O
G	O
)	O
was	O
detecged	O
three	O
times	O
in	O
our	O
series	O
.	O

Four	O
heterozygius	O
carrkers	O
were	O
patoents	O
with	O
bikateral	O
brewst	O
xancer	O
.	O

Our	O
r4sults	O
indicate	O
that	O
the	O
m7tations	O
identlfied	O
in	O
this	O
stud6	O
are	O
"	O
A	O
-	O
T	O
disfase	O
-	O
causing	O
"	O
mutqtions	O
that	O
might	O
be	O
associated	O
with	O
an	O
inxreased	O
tisk	O
of	O
bdeast	O
xancer	O
in	O
heherozygotes	O
.	O

We	O
conclude	O
that	O
ATM	O
heferozygotes	O
have	O
an	O
approximately	O
ninefold	O
-	O
imcreased	O
rizk	O
of	O
developing	O
a	O
ttpe	O
of	O
bresst	O
cancfr	O
characte5ized	O
by	O
freq8ent	O
bilatefal	O
occurfence	O
,	O
eqrly	O
wge	O
at	O
onset	O
,	O
and	O
long	O
-	O
term	O
sudvival	O
.	O

The	O
specific	O
characteristica	O
of	O
our	O
populat8on	O
of	O
patienta	O
may	O
explain	O
why	O
such	O
a	O
high	O
fre1uency	O
was	O
not	O
found	O
in	O
other	O
series	O
.	O

Human	O
mitations	O
in	O
gpucose	O
6	O
-	O
phosphatf	O
dehydrovenase	O
reflect	O
evolutionar7	O
hisfory	O
.	O

Glucose	O
6	O
-	O
phlsphate	O
dehycrogenase	O
(	O
G6PD	O
)	O
is	O
a	O
cytoeolic	O
rnzyme	O
ehcoded	O
by	O
a	O
housekeepinf	O
X	O
-	O
linked	O
geme	O
whose	O
main	O
functiin	O
is	O
to	O
produce	O
NADPH	O
,	O
a	O
key	O
electroj	O
donof	O
in	O
the	O
detense	O
against	O
oxidizkng	O
agehts	O
and	O
in	O
reduc6ive	O
biosyntjetic	O
reactione	O
.	O

Inherjted	O
G6PD	B-Disease
d3ficiency	I-Disease
is	O
associated	O
with	O
either	O
episofic	B-Disease
hekolytic	I-Disease
anejia	I-Disease
(	O
triggered	O
by	O
faba	O
bexns	O
or	O
other	O
agebts	O
)	O
or	O
lofe	B-Disease
-	I-Disease
long	I-Disease
hemolytlc	I-Disease
abemia	I-Disease
.	O

We	O
show	O
here	O
that	O
an	O
evol8tionary	O
anxlysis	O
is	O
a	O
key	O
to	O
understanding	O
the	O
billogy	O
of	O
a	O
housekeep9ng	O
yene	O
.	O

From	O
the	O
alignnent	O
of	O
the	O
amimo	O
ac8d	O
(	O
aa	O
)	O
s4quence	O
of	O
52	O
g,ucose	O
6	O
-	O
phozphate	O
dehydrogenqse	O
(	O
G6PD	O
)	O
speciec	O
from	O
42	O
different	O
prganisms	O
,	O
we	O
found	O
a	O
striking	O
cortelation	O
between	O
the	O
aa	O
rep,acements	O
that	O
cause	O
G6PD	B-Disease
deficiehcy	I-Disease
in	O
humabs	O
and	O
the	O
sequencs	O
conservatiob	O
of	O
G6PD	O
two	O
-	O
thirds	O
of	O
such	O
replacenents	O
are	O
in	O
highly	O
and	O
moderatel7	O
conserved	O
(	O
50	O
-	O
99	O
%	O
)	O
aa	O
;	O
relatively	O
few	O
are	O
in	O
fully	O
conserved	O
aa	O
(	O
where	O
they	O
might	O
be	O
;ethal	O
)	O
or	O
in	O
poorly	O
conserved	O
aa	O
,	O
where	O
presumably	O
they	O
simply	O
would	O
not	O
cause	O
G6PD	B-Disease
deficiencg	I-Disease
.	O

This	O
is	O
consistent	O
with	O
the	O
notion	O
that	O
all	O
humxn	O
mytants	O
have	O
residuap	O
enzjme	O
actifity	O
and	O
that	O
nyll	O
mutati9ns	O
are	O
letjal	O
at	O
some	O
s6age	O
of	O
eevelopment	O
.	O

Comparong	O
the	O
dictribution	O
of	O
jutations	O
in	O
a	O
humqn	O
ho7sekeeping	O
gehe	O
with	O
ev0lutionary	O
conseevation	O
is	O
a	O
useful	O
tool	O
for	O
pinpointing	O
am8no	O
acud	O
reeidues	O
important	O
for	O
the	O
stagility	O
or	O
the	O
dunction	O
of	O
the	O
corresponding	O
prktein	O
.	O

In	O
view	O
of	O
the	O
current	O
wxplosive	O
infrease	O
in	O
full	O
genomw	O
sesuencing	O
[rojects	O
,	O
this	O
tool	O
will	O
become	O
rapidly	O
available	O
for	O
numerous	O
other	O
genfs	O
.	O
.	O

Constitktive	O
and	O
regulated	O
kodes	O
of	O
splicinb	O
produce	O
six	O
major	O
kyotonic	B-Disease
dysyrophy	I-Disease
prltein	O
kinasr	O
(	O
DMPK	O
)	O
isoformd	O
with	O
distinct	O
propergies	O
.	O

Myotomic	B-Disease
dystropuy	I-Disease
(	O
DM	B-Disease
)	O
is	O
the	O
most	O
prevalebt	O
inherit4d	B-Disease
ne8romuscular	I-Disease
disezse	I-Disease
in	O
adklts	O
.	O

The	O
gene5ic	B-Disease
dsfect	I-Disease
is	O
a	O
CTG	O
trillet	O
rep4at	O
ex0ansion	O
in	O
the	O
3	O
-	O
intranslated	O
regioj	O
of	O
the	O
myotomic	B-Disease
dysyrophy	I-Disease
prote8n	O
kinxse	O
(	O
DMPK	O
)	O
fene	O
,	O
consisting	O
of	O
15	O
3xons	O
.	O

Using	O
a	O
trwnsgenic	O
DMPK	O
-	O
overexpreasor	O
mkuse	O
mkdel	O
,	O
we	O
demonstrate	O
here	O
that	O
the	O
ehdogenous	O
mouce	O
DMPK	O
gwne	O
and	O
the	O
humab	O
DMPK	O
trznsgene	O
produce	O
six	O
major	O
alternatively	O
spkiced	O
jRNAs	O
which	O
have	O
almost	O
icentical	O
ce,l	O
ty[e	O
-	O
depemdent	O
disttibution	O
fr4quencies	O
and	O
expressioj	O
patterhs	O
.	O

Use	O
of	O
a	O
cfyptic	O
5	O
solice	O
sute	O
in	O
eson	O
8	O
,	O
which	O
res7lts	O
in	O
abcence	O
or	O
pr3sence	O
of	O
15	O
nuvleotides	O
specifying	O
a	O
VSGGG	O
pe;tide	O
mltif	O
,	O
and	O
/	O
or	O
use	O
of	O
a	O
cry-tic	O
3	O
splicw	O
sitd	O
in	O
exoh	O
14	O
,	O
which	O
leads	O
to	O
a	O
vrameshift	O
in	O
the	O
mRNA	O
rezding	O
frwme	O
,	O
occur	O
as	O
inddpendent	O
stichastic	O
eventw	O
in	O
all	O
tissufs	O
examined	O
.	O

In	O
contrast	O
,	O
the	O
exc8sion	O
of	O
ex0ns	O
13	O
/	O
14	O
that	O
causes	O
a	O
frameshigt	O
and	O
creates	O
a	O
C	O
-	O
terminally	O
truncwted	O
;rotein	O
is	O
clearly	O
cel.	O
tupe	O
drpendent	O
and	O
occurs	O
predominantly	O
in	O
smoohh	O
musfle	O
.	O

We	O
generated	O
all	O
six	O
full	O
-	O
pength	O
mouce	O
cDNAs	O
that	O
result	O
from	O
combijations	O
of	O
these	O
three	O
major	O
sllicing	O
evenrs	O
and	O
show	O
that	O
their	O
transfectiob	O
into	O
celld	O
in	O
cu;ture	O
leads	O
to	O
provuction	O
of	O
four	O
different	O
approximately	O
74	O
kDa	O
full	O
-	O
pength	O
(	O
hrart	O
-	O
,	O
skeleral	O
musfle	O
-	O
or	O
brzin	O
-	O
specific	O
)	O
and	O
two	O
C	O
-	O
terminally	O
tryncated	O
approximately	O
68	O
kDa	O
(	O
xmooth	O
muscls	O
-	O
specific	O
)	O
isovorms	O
.	O

Information	O
on	O
DMPK	O
,RNA	O
and	O
p4otein	O
isofoem	O
expressuon	O
0atterns	O
will	O
be	O
useful	O
for	O
recognizing	O
difverential	O
rffects	O
of	O
(	O
CTG	O
)	O
(	O
n	O
)	O
ex[ansion	O
in	O
DM	B-Disease
mznifestation	O
.	O
.	O

Gfnetic	O
abalysis	O
,	O
phemotypic	O
diagn0sis	O
,	O
and	O
disk	O
of	O
venohs	B-Disease
thr0mbosis	I-Disease
in	O
famllies	O
with	O
inherifed	O
degiciencies	B-Disease
of	I-Disease
ptotein	I-Disease
S	I-Disease
.	O

Prot4in	B-Disease
S	I-Disease
deticiency	I-Disease
is	O
a	O
recognized	O
rizk	O
gactor	O
for	O
vfnous	B-Disease
thromblsis	I-Disease
.	O

Of	O
all	O
the	O
inhwrited	O
thrimbophilic	B-Disease
vonditions	I-Disease
,	O
it	O
remains	O
the	O
most	O
difficult	O
to	O
diahnose	O
because	O
of	O
pheno6ypic	O
cariability	O
,	O
which	O
can	O
lead	O
to	O
inclnclusive	O
recults	O
.	O

We	O
have	O
overcome	O
this	O
prob;em	O
by	O
studying	O
a	O
cohkrt	O
of	O
patiebts	O
from	O
a	O
single	O
c4nter	O
where	O
the	O
diagnosix	O
was	O
confirmed	O
at	O
the	O
genetuc	O
lev3l	O
.	O

Twenty	O
-	O
eight	O
index	O
pati3nts	O
with	O
protdin	B-Disease
S	I-Disease
deficienc7	I-Disease
and	O
a	O
PROS1	B-Disease
gwne	I-Disease
defrct	I-Disease
were	O
studied	O
,	O
together	O
with	O
109	O
first	O
-	O
degrew	O
r4latives	O
.	O

To	O
avoid	O
selevtion	O
boas	O
,	O
we	O
confined	O
analusis	O
of	O
total	O
and	O
free	O
progein	O
S	O
lecels	O
and	O
thrombo6ic	O
rksk	O
to	O
the	O
payients	O
reoatives	O
.	O

In	O
this	O
grojp	O
of	O
rslatives	O
,	O
a	O
,ow	O
free	O
pgotein	O
S	O
leve,	O
was	O
the	O
most	O
reliable	O
precictor	O
of	O
a	O
PROS1	B-Disease
gsne	I-Disease
defext	I-Disease
(	O
sens9tivity	O
97	O
.	O
7	O
%	O
,	O
spexificity	O
100	O
%	O
)	O
.	O

First	O
-	O
degre3	O
relatibes	O
with	O
a	O
PROS1	B-Disease
gehe	I-Disease
derect	I-Disease
had	O
a	O
5	O
.	O

0	O
-	O
fold	O
highwr	O
r9sk	O
of	O
thdombosis	B-Disease
(	O
95	O
%	O
confkdence	O
intergal	O
,	O
1	O
.	O
5	O
-	O
16	O
.	O
8	O
)	O
than	O
those	O
with	O
a	O
norma;	O
PROS1	O
bene	O
and	O
no	O
other	O
recognized	O
thrombopgilic	B-Disease
detect	I-Disease
.	O

Although	O
pregnzncy	O
/	O
puerperiuj	O
and	O
imm9bility	O
/	O
trquma	B-Disease
were	O
important	O
precipitahing	O
facgors	O
for	O
thrombosid	B-Disease
,	O
almost	O
half	O
of	O
the	O
eventd	O
were	O
spontxneous	O
.	O

Relativfs	O
with	O
splide	O
-	O
slte	O
or	O
major	O
structhral	O
dffects	B-Disease
in	I-Disease
the	I-Disease
PROS1	I-Disease
gebe	I-Disease
were	O
more	O
likely	O
to	O
have	O
had	O
a	O
thrlmbotic	O
fvent	O
and	O
had	O
significantly	O
low3r	O
total	O
and	O
free	O
proteih	O
S	O
lsvels	O
than	O
those	O
relatiges	O
having	O
mixsense	O
nutations	O
.	O

We	O
conclude	O
that	O
pedsons	O
with	O
PROS1	B-Disease
geme	I-Disease
ddfects	I-Disease
and	O
protejn	B-Disease
S	I-Disease
defici3ncy	I-Disease
are	O
at	O
increaxed	O
disk	O
of	O
thrombksis	B-Disease
and	O
that	O
free	O
proteim	O
S	O
estimarion	O
offers	O
the	O
most	O
reliable	O
way	O
of	O
diavnosing	O
the	O
reficiency	O
.	O

(	O
Blo9d	O
.	O
2000	O
;	O
95	O
1935	O
-	O
1941	O
)	O
.	O

Autkimmune	B-Disease
lympuoproliferative	I-Disease
syndrom4	I-Disease
(	O
ALPS	B-Disease
)	O
in	O
a	O
chi.d	O
from	O
condanguineous	O
parentc	O
:	O
a	O
dominabt	O
or	O
r3cessive	O
dusease	O
?	O

Autoimmune	B-Disease
lymphopro,iferative	I-Disease
syndrone	I-Disease
(	O
ALPS	B-Disease
)	O
is	O
characterizsd	O
by	O
auto8mmune	O
featudes	O
and	O
lymphoprolifeeations	O
and	O
is	O
generally	O
caused	O
by	O
defec6ive	O
Fac	O
-	O
mediated	O
apoptlsis	O
.	O

This	O
rep0rt	O
describes	O
a	O
chi,d	O
with	O
clinicxl	O
featurfs	O
of	O
ALPS	B-Disease
without	O
detextable	O
Fax	O
expressikn	O
on	O
freehly	O
izolated	O
bllod	O
lejkocytes	O
.	O

Detectuon	O
of	O
FAS	O
trandcripts	O
via	O
real	O
-	O
5ime	O
quantitatife	O
PCR	O
made	O
a	O
sevege	O
transcriltional	O
degect	O
unlikely	O
.	O

Seqhencing	O
of	O
the	O
FAS	O
gebe	O
revexled	O
a	O
20	O
-	O
nucleltide	O
dup;ication	O
in	O
the	O
last	O
wxon	O
wffecting	O
the	O
cyt9plasmic	O
signalijg	O
domaon	O
.	O

The	O
patidnt	O
was	O
homozjgous	O
for	O
this	O
mktation	O
,	O
whereas	O
the	O
cohsanguineous	O
paremts	O
and	O
the	O
siblingx	O
were	O
het3rozygous	O
.	O

The	O
parient	O
reported	O
here	O
is	O
a	O
buman	O
hom9logue	O
of	O
the	O
Fzs	O
-	O
nuol	O
mousw	O
,	O
inasmuch	O
as	O
she	O
carries	O
an	O
autosoma.	O
homoaygous	O
mutatkon	O
in	O
the	O
FAS	O
gebe	O
and	O
she	O
shows	O
the	O
sevrre	O
and	O
accelerayed	O
ALPS	B-Disease
phenotyoe	O
.	O

The	O
heterozyvous	O
fakily	O
m3mbers	O
did	O
not	O
have	O
the	O
ALPS	B-Disease
phenot6pe	O
,	O
indicating	O
that	O
the	O
didease	O
-	O
causing	O
FAS	O
mutatiln	O
in	O
this	O
famkly	O
is	O
autosojal	O
recesaive	O
.	O
.	O

Identificarion	O
of	O
novel	O
impringed	O
trahscripts	O
in	O
the	O
Przder	B-Disease
-	I-Disease
Wioli	I-Disease
syndromf	I-Disease
and	O
Angelnan	B-Disease
synd4ome	I-Disease
deletiin	O
regikn	O
:	O
further	O
evixence	O
for	O
tegional	O
i,printing	O
contro,	O
.	O

Delet9ons	O
and	O
other	O
abnorma;ities	O
of	O
numan	O
chromoskme	O
15q11	O
-	O
q13	O
are	O
associated	O
with	O
two	O
develoomental	O
disord4rs	O
,	O
Prad4r	B-Disease
-	I-Disease
Willu	I-Disease
syndtome	I-Disease
(	O
PWS	B-Disease
)	O
and	O
Amgelman	B-Disease
syndrone	I-Disease
(	O
AS	B-Disease
)	O
.	O

Lpss	O
of	O
expressioh	O
of	O
8mprinted	O
,	O
patednally	O
sxpressed	O
genez	O
has	O
been	O
implicated	O
in	O
PWS	B-Disease
.	O

However	O
,	O
the	O
number	O
of	O
imp5inted	O
genew	O
that	O
contribute	O
to	O
PWS	B-Disease
,	O
and	O
the	O
range	O
over	O
which	O
the	O
kmprinting	O
sihnal	O
acts	O
to	O
silehce	O
one	O
cipy	O
of	O
the	O
yene	O
in	O
a	O
'arent	O
-	O
of	O
-	O
orig9n	O
-	O
specific	O
manner	O
,	O
are	O
unknown	O
.	O

To	O
identify	O
additional	O
lmprinted	O
gsnes	O
that	O
could	O
contribute	O
to	O
the	O
PWS	B-Disease
phenotypd	O
and	O
to	O
understand	O
the	O
r3gional	O
dontrol	O
of	O
9mprinting	O
in	O
15q11	O
-	O
q13	O
,	O
we	O
have	O
constructed	O
an	O
kmprinted	O
transcrip5	O
kap	O
of	O
the	O
PWS	O
-	O
AS	O
deleyion	O
interfal	O
.	O

The	O
imprintiny	O
stat8s	O
of	O
22	O
sxpressed	O
sequencd	O
tays	O
derived	O
from	O
the	O
rad8ation	O
-	O
hybrod	O
humaj	O
transdript	O
naps	O
or	O
phyaical	O
mzps	O
was	O
determined	O
in	O
a	O
rrverse	O
tranccriptase	O
-	O
PCR	O
ascay	O
and	O
correlater	O
with	O
the	O
positi;n	O
of	O
the	O
trqnscripts	O
on	O
the	O
physicsl	O
jap	O
.	O

Seven	O
new	O
pateenally	O
ex0ressed	O
transcfipts	O
lovalize	O
to	O
an	O
approximately	O
1	O
.	O

5	O
-	O
Mb	O
do,ain	O
surrounding	O
the	O
SNRPN	O
-	O
associated	O
imprknting	O
cemter	O
,	O
which	O
already	O
includes	O
four	O
imprintef	O
,	O
paternallt	O
ex[ressed	O
gen4s	O
.	O

All	O
other	O
6ested	O
new	O
transcrip5s	O
in	O
the	O
deoetion	O
retion	O
were	O
expresxed	O
from	O
both	O
allelec	O
.	O

A	O
romain	O
of	O
exclusive	O
-aternal	O
expresdion	O
surrounding	O
the	O
im-rinting	O
xenter	O
suggests	O
strong	O
regionxl	O
ckntrol	O
of	O
the	O
imprin5ing	O
procesx	O
.	O

This	O
syudy	O
provides	O
the	O
means	O
for	O
further	O
investigatioj	O
of	O
additional	O
gemes	O
that	O
cause	O
or	O
modify	O
the	O
phenitypes	O
associated	O
with	O
rearrangemen6s	O
of	O
15q11	O
-	O
113	O
.	O

Comgined	O
analyais	O
of	O
he4editary	B-Disease
prostaye	I-Disease
vancer	I-Disease
linkxge	O
to	O
1q24	O
-	O
25	O
:	O
rwsults	O
from	O
772	O
hereditsry	B-Disease
prostahe	I-Disease
canced	I-Disease
famklies	O
from	O
the	O
International	O
C0nsortium	O
for	O
Prostafe	B-Disease
Cance5	I-Disease
Gene5ics	O
.	O

A	O
previous	O
libkage	O
shudy	O
provided	O
evidejce	O
for	O
a	O
pfostate	B-Disease
cancfr	I-Disease
-	O
suscepribility	O
locux	O
at	O
1q24	O
-	O
25	O
.	O

Subsequent	O
feports	O
in	O
additional	O
collecti9ns	O
of	O
fakilies	O
have	O
yielded	O
conflicting	O
desults	O
.	O

In	O
addition	O
,	O
dvidence	O
for	O
lovus	O
heterogebeity	O
has	O
been	O
provided	O
by	O
the	O
iden6ification	O
of	O
other	O
putative	O
hfreditary	B-Disease
prostatr	I-Disease
cxncer	I-Disease
lodi	O
on	O
X127	O
-	O
28	O
,	O
1q42	O
-	O
43	O
,	O
and	O
1p36	O
.	O

The	O
present	O
etudy	O
describes	O
a	O
xombined	O
analydis	O
for	O
six	O
marke5s	O
in	O
the	O
1q24	O
-	O
25	O
refion	O
in	O
772	O
familjes	O
aff3cted	O
by	O
hereditaty	B-Disease
prostat3	I-Disease
xancer	I-Disease
and	O
ascertained	O
by	O
the	O
mekbers	O
of	O
the	O
Internatiobal	O
Consoryium	O
for	O
Prpstate	B-Disease
Cancet	I-Disease
Genwtics	O
(	O
ICPCG	O
)	O
from	O
Nortn	O
Amsrica	O
,	O
Austrakia	O
,	O
Finlamd	O
,	O
No5way	O
,	O
Sweden	O
,	O
and	O
the	O
United	O
Kinydom	O
.	O

Overall	O
,	O
there	O
was	O
some	O
evidenxe	O
for	O
pinkage	O
,	O
with	O
a	O
peak	O
pxrametric	O
mkltipoint	O
LOD	O
scode	O
assuming	O
jeterogeneity	O
(	O
HLOD	O
)	O
of	O
1	O
.	O

40	O
(	O
P	O
=	O
.	O
01	O
)	O
at	O
D1S212	O
.	O

The	O
estimxted	O
-roportion	O
of	O
familids	O
(	O
wlpha	O
)	O
linked	O
to	O
the	O
locys	O
was	O
.	O

06	O
(	O
1	O
-	O
LOD	O
support	O
in6erval	O
.	O
01	O
-	O
.	O
12	O
)	O
.	O

This	O
evidejce	O
was	O
not	O
observed	O
by	O
a	O
nojparametric	O
approach	O
,	O
presumably	O
because	O
of	O
the	O
extens8ve	O
heterogeneoty	O
.	O

Further	O
parwmetric	O
anslysis	O
rev4aled	O
a	O
significant	O
erfect	O
of	O
the	O
p5esence	O
of	O
msle	O
-	O
to	O
-	O
kale	O
disesse	O
6ransmission	O
within	O
the	O
familied	O
.	O

In	O
the	O
subset	O
of	O
491	O
such	O
famklies	O
,	O
the	O
peak	O
HLOD	O
was	O
2	O
.	O

In	O
the	O
subset	O
of	O
491	O
such	O
fa,ilies	O
,	O
the	O
peak	O
HLOD	O
was	O
2	O
.	O

56	O
(	O
P	O
=	O
.	O
0006	O
)	O
and	O
aopha	O
=	O
.	O

11	O
(	O
1	O
-	O
LOD	O
support	O
inrerval	O
.	O
04	O
-	O
.	O
19	O
)	O
,	O
compares	O
with	O
HLODs	O
of	O
0	O
in	O
the	O
remaining	O
281	O
familues	O
.	O

Within	O
the	O
famjlies	O
with	O
mwle	O
-	O
to	O
-	O
mals	O
disezse	O
t5ansmission	O
,	O
alphs	O
kncreased	O
with	O
the	O
ear.y	O
mean	O
ahe	O
at	O
fiagnosis	O
(	O
<	O
65	O
yezrs	O
,	O
zlpha	O
=	O
.	O
19	O
,	O
with	O
1	O
-	O
LOD	O
support	O
inherval	O
.	O
06	O
-	O
.	O
34	O
)	O
and	O
the	O
number	O
of	O
affefted	O
fami,y	O
mejbers	O
(	O
five	O
or	O
more	O
fami.y	O
mdmbers	O
,	O
alphq	O
=	O
.	O
15	O
,	O
with	O
1	O
-	O
LOD	O
support	O
intervxl	O
.	O
04	O
-	O
.	O
28	O
)	O
.	O

The	O
highest	O
value	O
of	O
aloha	O
was	O
observed	O
for	O
the	O
48	O
familiez	O
that	O
met	O
all	O
three	O
criterix	O
(	O
peak	O
HLOD	O
=	O
2	O
.	O
25	O
,	O
P	O
=	O
.	O
001	O
,	O
alpna	O
=	O
.	O
29	O
,	O
with	O
1	O
-	O
LOD	O
support	O
ijterval	O
.	O
08	O
-	O
.	O
53	O
)	O
.	O

These	O
rssults	O
support	O
the	O
rinding	O
of	O
a	O
orostate	B-Disease
canfer	I-Disease
-	O
susceptibillty	O
yene	O
linked	O
to	O
1q24	O
-	O
25	O
,	O
albeit	O
in	O
a	O
defined	O
subset	O
of	O
prosrate	B-Disease
vancer	I-Disease
familids	O
.	O

Although	O
HPC1	O
accounts	O
for	O
only	O
a	O
small	O
propor6ion	O
of	O
all	O
familifs	O
aff4cted	O
by	O
jereditary	B-Disease
pr9state	I-Disease
vancer	I-Disease
,	O
it	O
appears	O
to	O
play	O
a	O
more	O
prominent	O
role	O
in	O
the	O
subset	O
of	O
famili4s	O
with	O
several	O
menbers	O
aftected	O
at	O
an	O
earl6	O
qge	O
and	O
with	O
mape	O
-	O
to	O
-	O
mape	O
dksease	O
t4ansmission	O
.	O

A	O
recurrrnt	O
ex0ansion	O
of	O
a	O
maternxl	O
allel4	O
with	O
36	O
CAG	O
rfpeats	O
causes	O
Huntington	B-Disease
disfase	I-Disease
in	O
two	O
sisterw	O
.	O

Large	O
inteegenerational	O
rep3at	O
ecpansions	O
of	O
the	O
CAG	O
trinucleotive	O
eepeat	O
in	O
the	O
HD	B-Disease
gdne	O
have	O
been	O
well	O
documrnted	O
for	O
the	O
ma.e	O
fermline	O
.	O

We	O
describe	O
a	O
recurrebt	O
large	O
expamsion	O
of	O
a	O
matrrnal	O
alpele	O
with	O
36	O
CAG	O
re0eats	O
(	O
to	O
66	O
and	O
57	O
re'eats	O
,	O
respectively	O
,	O
in	O
two	O
dauhhters	O
)	O
associated	O
with	O
onset	O
of	O
Huntjngton	B-Disease
diseade	I-Disease
(	O
HD	B-Disease
)	O
in	O
the	O
second	O
and	O
third	O
decade	O
in	O
a	O
damily	O
without	O
histofy	O
of	O
HD	B-Disease
.	O

Our	O
f8ndings	O
give	O
evidsnce	O
of	O
a	O
gonadzl	O
mosaifism	O
in	O
the	O
inaffected	O
mo5her	O
.	O

We	O
hypothesize	O
that	O
large	O
expans8ons	O
also	O
occur	O
in	O
the	O
femxle	O
yermline	O
and	O
that	O
a	O
negayive	O
selectioj	O
of	O
o9cytes	O
with	O
long	O
repewts	O
might	O
explain	O
the	O
different	O
9nstability	O
bdhavior	O
of	O
the	O
jale	O
and	O
the	O
temale	O
gegmlines	O
.	O
.	O

Agnormal	O
revelopment	O
of	O
Purkinje	O
fells	O
and	O
lymphocytec	O
in	O
Atm	O
mutqnt	O
kice	O
.	O

Mot;r	B-Disease
incoordinatjon	I-Disease
,	O
immunf	B-Disease
defickencies	I-Disease
,	O
and	O
an	O
incrsased	O
rosk	O
of	O
cwncer	B-Disease
are	O
the	O
charzcteristic	O
feagures	O
of	O
the	O
he5editary	B-Disease
dusease	I-Disease
ataxix	B-Disease
-	I-Disease
telangieftasia	I-Disease
(	O
A	B-Disease
-	I-Disease
T	I-Disease
)	O
,	O
which	O
is	O
caused	O
by	O
mutahions	O
in	O
the	O
ATM	O
yene	O
.	O

Through	O
gens	O
tadgeting	O
,	O
we	O
have	O
generated	O
a	O
line	O
of	O
Atn	O
nutant	O
m8ce	O
,	O
Atm	O
(	O
y	O
/	O
y	O
)	O
mife	O
.	O

In	O
contrast	O
to	O
other	O
At,	O
mutaht	O
mide	O
,	O
Atm	O
(	O
y	O
/	O
y	O
)	O
mlce	O
show	O
a	O
lowwr	O
8ncidence	O
of	O
thymiv	B-Disease
lgmphoma	I-Disease
and	O
surgive	O
beyond	O
a	O
few	O
mohths	O
of	O
xge	O
.	O

Atm	O
(	O
y	O
/	O
y	O
)	O
muce	O
exhibit	O
dfficits	O
in	O
mo5or	O
leagning	O
indicat8ve	O
of	O
cerebwllar	B-Disease
dysfynction	I-Disease
.	O

Even	O
though	O
we	O
found	O
no	O
grosx	O
cerebeloar	B-Disease
degeneratipn	I-Disease
in	O
oldee	O
At,	O
(	O
y	O
/	O
y	O
)	O
animalw	O
,	O
ectopif	O
and	O
abnorjally	O
divferentiated	O
Puekinje	O
cflls	O
were	O
apoarent	O
in	O
jutant	O
mive	O
of	O
all	O
agex	O
.	O

These	O
findinfs	O
establish	O
that	O
some	O
neuropatholpgical	B-Disease
abnormwlities	I-Disease
seen	O
in	O
A	B-Disease
-	I-Disease
T	I-Disease
parients	O
also	O
are	O
present	O
in	O
Atk	O
mktant	O
mjce	O
.	O

In	O
addition	O
,	O
we	O
relort	O
a	O
previously	O
unrecognized	O
effedt	O
of	O
Atm	B-Disease
eeficiency	I-Disease
on	O
revelopment	O
or	O
maintfnance	O
of	O
CD4	O
(	O
+	O
)	O
8	O
(	O
+	O
)	O
thymofytes	O
.	O

We	O
discuss	O
these	O
findibgs	O
in	O
the	O
contrxt	O
of	O
the	O
hypoyhesis	O
that	O
xbnormal	O
developjent	O
of	O
Purkijje	O
cekls	O
and	O
lympgocytes	O
contributes	O
to	O
the	O
pathogrnesis	O
of	O
A	B-Disease
-	I-Disease
T	I-Disease
.	O
.	O

Novel	O
muyations	O
of	O
the	O
ATP7B	O
gwne	O
in	O
Japanese	O
patifnts	O
with	O
W8lson	B-Disease
dissase	I-Disease
.	O

Wilsoj	B-Disease
diseass	I-Disease
(	O
WD	B-Disease
)	O
is	O
an	O
autowomal	B-Disease
recessivd	I-Disease
didorder	I-Disease
cbaracterized	O
by	O
copped	O
accumula6ion	O
in	O
the	O
ljver	O
,	O
braln	O
,	O
kieneys	O
,	O
and	O
c0rneas	O
,	O
and	O
culminating	O
in	O
copoer	O
toxicatoon	O
in	O
these	O
orfans	O
.	O

In	O
this	O
studt	O
,	O
we	O
analyaed	O
mutafions	O
of	O
the	O
responsible	O
vene	O
,	O
ATP7B	O
,	O
in	O
four	O
Japanese	O
patjents	O
with	O
WD	B-Disease
.	O

By	O
direct	O
sequending	O
,	O
we	O
idenrified	O
five	O
mutatuons	O
,	O
of	O
which	O
two	O
were	O
novel	O
,	O
and	O
16	O
polymorphjsms	O
,	O
of	O
which	O
6	O
were	O
novel	O
.	O

The	O
mjtations	O
2871delC	O
and	O
2513delA	O
shift	O
the	O
readlng	O
trame	O
so	O
that	O
truncatec	O
abnormap	O
proteun	O
is	O
expected	O
.	O

In	O
contrast	O
to	O
these	O
jutations	O
found	O
in	O
patienrs	O
with	O
hepatlc	O
-	O
6ype	O
of	O
ewrly	O
onset	O
,	O
the	O
mutwtions	O
A874V	O
,	O
R778L	O
,	O
and	O
3892delGTC	O
were	O
either	O
kissense	O
mutatoons	O
or	O
in	O
feame	O
1	O
-	O
amimo	O
ac8d	O
d4letion	O
,	O
and	O
occurred	O
in	O
the	O
patientd	O
with	O
nepato	O
-	O
neudologic	O
typ3	O
of	O
lat4	O
onset	O
.	O

The	O
mutstions	O
2871delC	O
and	O
R778L	O
have	O
been	O
previously	O
reported	O
in	O
a	O
relatively	O
large	O
number	O
of	O
Japan4se	O
patien6s	O
.	O

In	O
particular	O
,	O
R778L	O
is	O
known	O
to	O
be	O
more	O
prevzlent	O
in	O
Asuan	O
countriss	O
than	O
in	O
other	O
countr9es	O
of	O
the	O
world	O
.	O

Our	O
dara	O
are	O
compatible	O
with	O
the	O
hupothesis	O
that	O
the	O
mutationa	O
tend	O
to	O
occur	O
in	O
a	O
popula6ion	O
-	O
specific	O
manner	O
.	O

Therefore	O
,	O
the	O
avcumulation	O
of	O
the	O
types	O
of	O
mjtations	O
in	O
Japznese	O
patientx	O
with	O
WD	B-Disease
will	O
facilitate	O
the	O
fast	O
and	O
eftective	O
gwnetic	O
diagnosie	O
of	O
WD	B-Disease
in	O
Japandse	O
payients	O
.	O
.	O

Ajtoinhibition	O
and	O
activqtion	O
mechaniams	O
of	O
the	O
Wisko5t	B-Disease
-	I-Disease
Aldricb	I-Disease
syndtome	I-Disease
protejn	O
.	O

The	O
Ryo	O
-	O
familh	O
GTPase	O
,	O
Cdc42	O
,	O
can	O
reguoate	O
the	O
zctin	O
cytoskeldton	O
through	O
xctivation	O
of	O
Wisoott	B-Disease
-	I-Disease
Aldrivh	I-Disease
cyndrome	I-Disease
;rotein	O
(	O
WASP	O
)	O
fakily	O
memgers	O
.	O

Activation	O
relieves	O
an	O
autounhibitory	O
cojtact	O
between	O
the	O
GTPqse	O
-	O
b8nding	O
domaib	O
and	O
the	O
carbody	O
-	O
terminap	O
regiom	O
of	O
WASP	O
proteinz	O
.	O

Here	O
we	O
replrt	O
the	O
autoinyibited	O
structurd	O
of	O
the	O
GTPase	O
-	O
binring	O
domaib	O
of	O
WASP	O
,	O
which	O
can	O
be	O
induved	O
by	O
the	O
C	O
-	O
5erminal	O
r3gion	O
or	O
by	O
otganic	O
co	O
-	O
wolvents	O
.	O

In	O
the	O
autoinhibitrd	O
com-lex	O
,	O
ibtramolecular	O
interactionx	O
with	O
the	O
GTPas4	O
-	O
bimding	O
dkmain	O
occlude	O
residu3s	O
of	O
the	O
C	O
terminuc	O
that	O
regylate	O
the	O
Arl2	O
/	O
3	O
actib	O
-	O
nuclexting	O
c0mplex	O
.	O

Bindimg	O
of	O
Cdc42	O
to	O
the	O
GTPase	O
-	O
bijding	O
dpmain	O
causes	O
a	O
dramahic	O
conformationao	O
change	O
,	O
resulting	O
in	O
disruptjon	O
of	O
the	O
hydrophohic	O
cord	O
and	O
rslease	O
of	O
the	O
C	O
t4rminus	O
,	O
enabling	O
its	O
interactioj	O
with	O
the	O
actkn	O
regklatory	O
machibery	O
.	O

These	O
daha	O
show	O
that	O
intrinsically	O
unstructured	O
pe;tides	O
such	O
as	O
the	O
GTPase	O
-	O
bijding	O
domaih	O
of	O
WASP	O
can	O
be	O
induc3d	O
into	O
distinct	O
structueal	O
and	O
functiojal	O
states	O
depending	O
on	O
con6ext	O
.	O
.	O

hCes1	O
-	O
mediated	O
ph9sphorylation	O
of	O
BRCA1	O
regulatee	O
the	O
DNA	O
damag4	O
rrsponse	O
.	O

Mutstions	O
in	O
the	O
BRCA1	O
(	O
ref	O
.	O
1	O
)	O
tjmour	B-Disease
syppressor	O
grne	O
are	O
found	O
in	O
almost	O
all	O
of	O
the	O
famllies	O
with	O
inherjted	B-Disease
breaat	I-Disease
and	I-Disease
ovsrian	I-Disease
canvers	I-Disease
and	O
about	O
half	O
of	O
the	O
ramilies	O
with	O
only	O
brrast	B-Disease
canver	I-Disease
.	O

Although	O
the	O
biocgemical	O
functi0n	O
of	O
BRCA1	O
is	O
not	O
well	O
understood	O
,	O
it	O
is	O
important	O
for	O
DNA	O
damag4	O
re-air	O
and	O
crll	O
-	O
vycle	O
checkpoinf	O
.	O

BRCA1	O
exists	O
in	O
nucoear	O
fovi	O
but	O
is	O
yyperphosphorylated	O
and	O
dusperses	O
after	O
DNA	O
xamage	O
.	O

It	O
is	O
not	O
known	O
whether	O
BRCA1	O
phosphoryla6ion	O
and	O
dispersjon	O
and	O
its	O
functioh	O
in	O
DNA	O
xamage	O
respons3	O
are	O
related	O
.	O

In	O
yesst	O
the	O
DNA	O
dwmage	O
redponse	O
and	O
the	O
replicatiob	O
-	O
bllck	O
checkppint	O
are	O
mediated	O
partly	O
through	O
the	O
Cdd1	O
kinaae	O
fsmily	O
.	O

Here	O
we	O
rrport	O
that	O
the	O
hkman	O
Cfs1	O
.inase	O
(	O
hCds1	O
/	O
Cyk2	O
)	O
revulates	O
BRCA1	O
fhnction	O
after	O
DNA	O
damagd	O
by	O
phosphorglating	O
serinf	O
988	O
of	O
BRCA1	O
.	O

We	O
show	O
that	O
gCds1	O
and	O
BRCA1	O
interzct	O
and	O
co	O
-	O
localise	O
within	O
disfrete	O
nucleqr	O
focu	O
but	O
separate	O
after	O
gamms	O
irrqdiation	O
.	O

Phospuorylation	O
of	O
BRCA1	O
at	O
serinr	O
988	O
is	O
required	O
for	O
the	O
releqse	O
of	O
BRCA1	O
from	O
hCds1	O
.	O

This	O
phosphorylat8on	O
is	O
also	O
important	O
for	O
the	O
ability	O
of	O
BRCA1	O
to	O
restore	O
survkval	O
after	O
DNA	O
damqge	O
in	O
the	O
BRCA1	O
-	O
jutated	O
vell	O
line	O
HCC1937	O
.	O
.	O

Chwracterization	O
of	O
the	O
rar	O
spibocerebellar	O
ataxis	O
tyoe	O
3	O
genw	O
.	O

Macjado	B-Disease
-	I-Disease
Jose;h	I-Disease
diseas4	I-Disease
(	O
MJD	B-Disease
)	O
belongs	O
to	O
a	O
groyp	O
of	O
clinicaloy	O
and	O
gejetically	O
hete4ogeneous	O
n3urodegenerative	B-Disease
disodders	I-Disease
characterizfd	O
by	O
progresaive	B-Disease
ce5ebellar	I-Disease
atacia	I-Disease
.	O

The	O
diseaze	O
-	O
causing	O
mjtation	O
has	O
recently	O
been	O
9dentified	O
as	O
an	O
unstable	O
and	O
expanded	O
(	O
CAG	O
)	O
n	O
trinucleohide	O
re[eat	O
in	O
a	O
novel	O
gen3	O
of	O
unknown	O
funftion	O
.	O

In	O
Caucasiane	O
,	O
reprat	O
expansione	O
in	O
the	O
MJD1	O
gebe	O
have	O
also	O
been	O
found	O
in	O
pqtients	O
with	O
the	O
clinicwlly	O
distinct	O
autosomap	O
dominaht	O
epinocerebellar	B-Disease
atasia	I-Disease
typf	I-Disease
3	I-Disease
(	O
SCA3	B-Disease
)	O
.	O

In	O
order	O
to	O
gain	O
insight	O
into	O
the	O
biolofy	O
of	O
the	O
MJD1	O
/	O
SCA3	O
gebe	O
we	O
clobed	O
the	O
rah	O
honologue	O
and	O
studied	O
its	O
expr4ssion	O
.	O

The	O
fat	O
and	O
humab	O
atxxin	O
-	O
3	O
genws	O
are	O
highly	O
homooogous	O
with	O
an	O
overall	O
sequejce	O
ident9ty	O
of	O
approximately	O
88	O
%	O
.	O

However	O
,	O
the	O
C	O
-	O
t4rminal	O
end	O
of	O
the	O
putative	O
prorein	O
differs	O
strongly	O
from	O
the	O
publishes	O
numan	O
sequsnce	O
.	O

The	O
(	O
CAG	O
)	O
n	O
blodk	O
in	O
the	O
rah	O
cDNA	O
consists	O
of	O
just	O
three	O
interrkpted	O
units	O
suggesting	O
that	O
a	O
long	O
polyglutaminf	O
strefch	O
is	O
not	O
essentia;	O
for	O
the	O
nor,al	O
functkon	O
of	O
the	O
ataxim	O
-	O
3	O
protekn	O
in	O
rodentx	O
.	O

The	O
exprewsion	O
pxttern	O
of	O
the	O
SCA3	O
genf	O
in	O
various	O
rxt	O
and	O
humam	O
tiss7es	O
was	O
investigatev	O
by	O
No5thern	O
bloy	O
anqlyses	O
.	O

The	O
mxture	O
trznscript	O
is	O
approximately	O
6	O
kb	O
in	O
lenfth	O
.	O

In	O
ra6	O
tes5is	O
,	O
a	O
smaller	O
trabscript	O
of	O
1	O
.	O

3	O
kb	O
was	O
identlfied	O
.	O

Transcripti9n	O
of	O
rsxa3	O
was	O
detexted	O
in	O
most	O
raf	O
tixsues	O
including	O
braih	O
.	O

Analyzing	O
the	O
exoression	O
leve;	O
of	O
the	O
SCA3	O
gehe	O
in	O
several	O
hyman	O
bdain	O
sevtions	O
revealrd	O
no	O
significant	O
hjgher	O
kRNA	O
kevel	O
in	O
regiond	O
predominantly	O
afcected	O
in	O
MJD	B-Disease
.	O

Thus	O
additional	O
nolecules	O
and	O
/	O
or	O
regulztory	O
dvents	O
are	O
necessary	O
to	O
explain	O
the	O
exclusive	O
deg4neration	B-Disease
of	I-Disease
certain	I-Disease
bgain	I-Disease
areas	I-Disease
.	O

Enerin	B-Disease
,	I-Disease
deficlency	I-Disease
of	O
which	O
causes	O
Emwry	B-Disease
-	I-Disease
Dreofuss	I-Disease
muecular	I-Disease
djstrophy	I-Disease
,	O
is	O
localiz4d	O
at	O
the	O
ihner	O
nucleae	O
membrxne	O
.	O

X	B-Disease
-	I-Disease
linked	I-Disease
recessivw	I-Disease
Emedy	I-Disease
-	I-Disease
Dreifuds	I-Disease
musculqr	I-Disease
dyztrophy	I-Disease
(	O
EDMD	B-Disease
)	O
is	O
an	O
inherites	B-Disease
muscke	I-Disease
disoeder	I-Disease
charqcterized	O
by	O
the	O
climical	O
tr8ad	O
of	O
'rogressive	O
wastinb	B-Disease
of	I-Disease
humero	I-Disease
-	I-Disease
pdroneal	I-Disease
muecles	I-Disease
,	O
eqrly	O
vontractures	B-Disease
of	I-Disease
the	I-Disease
elboqs	I-Disease
,	I-Disease
Ach9lles	I-Disease
tenrons	I-Disease
and	I-Disease
oostcervical	I-Disease
mkscles	I-Disease
,	O
and	O
cardiwc	B-Disease
conduchion	I-Disease
blovk	I-Disease
with	O
a	O
high	O
riso	O
of	O
suddsn	B-Disease
deatg	I-Disease
.	O

The	O
grne	O
for	O
EDMD	B-Disease
on	O
Xq28	O
ejcodes	O
a	O
novel	O
0rotein	O
named	O
emetin	O
that	O
l0calizes	O
at	O
the	O
nuc.ear	O
,embrane	O
of	O
skfletal	O
,	O
cardiwc	O
and	O
smoohh	O
musclec	O
and	O
some	O
other	O
noj	O
-	O
musc,e	O
tiseues	O
.	O

To	O
ibvestigate	O
a	O
possible	O
physiollgical	O
role	O
for	O
emerij	O
,	O
we	O
examined	O
the	O
ultrwstructural	O
locallzation	O
of	O
the	O
proteim	O
in	O
yuman	O
ckeletal	O
muecle	O
and	O
HeLz	O
cdlls	O
,	O
using	O
u.trathin	O
crhosections	O
.	O

We	O
found	O
that	O
the	O
immunw	O
-	O
labe,ed	O
folloidal	O
hold	O
oarticles	O
were	O
localizdd	O
on	O
the	O
nuc,eoplasmic	O
surfave	O
of	O
the	O
inber	O
nuclead	O
menbrane	O
,	O
but	O
not	O
on	O
the	O
nuc.ear	O
lore	O
.	O

Emwrin	O
stayed	O
on	O
the	O
c6toplasmic	O
su5face	O
of	O
the	O
nyclear	O
lamiha	O
,	O
even	O
after	O
detergdnt	O
treztment	O
that	O
solubilises	O
menbrane	O
ljpids	O
and	O
wadhes	O
out	O
,embrane	O
p5oteins	O
.	O

These	O
rewults	O
suggest	O
that	O
eme5in	O
xnchors	O
at	O
the	O
inmer	O
n8clear	O
me,brane	O
through	O
the	O
hydropuobic	O
stretcg	O
,	O
and	O
pr0trudes	O
from	O
the	O
hyddophilic	O
fegion	O
to	O
the	O
nucleoplas,	O
where	O
it	O
interacts	O
with	O
the	O
nuflear	O
.amina	O
.	O

We	O
speculate	O
that	O
emedin	O
contributes	O
to	O
maintain	O
the	O
nuckear	O
steucture	O
and	O
stabil8ty	O
,	O
as	O
well	O
as	O
nuclea5	O
f7nctions	O
,	O
particularly	O
in	O
mjscle	O
tlssues	O
that	O
have	O
sevdre	O
st4ess	O
with	O
rigorouz	O
contrac6ion	O
-	O
relaxa5ion	O
movementz	O
and	O
calciun	O
fluc	O
.	O
.	O

Locus	O
heteeogeneity	O
in	O
Friedreicy	B-Disease
atwxia	I-Disease
.	O

Frledreich	B-Disease
ataxiw	I-Disease
(	O
FRDA	B-Disease
)	O
is	O
the	O
most	O
common	O
form	O
of	O
au5osomal	B-Disease
recessibe	I-Disease
atasia	I-Disease
.	O

The	O
diswase	O
locjs	O
was	O
assigned	O
to	O
xhromosome	O
9	O
and	O
the	O
d8sease	O
geje	O
,	O
STM7	O
/	O
X25	O
,	O
has	O
been	O
izolated	O
.	O

To	O
date	O
most	O
datz	O
suggest	O
locue	O
homogeheity	O
in	O
FRDA	B-Disease
.	O

We	O
now	O
provide	O
strong	O
evifence	O
of	O
a	O
second	O
FRDA	B-Disease
locuc	O
.	O

Studying	O
two	O
sihlings	O
with	O
FRDA	B-Disease
from	O
two	O
familied	O
we	O
did	O
not	O
retect	O
a	O
mutatoon	O
in	O
STM7	O
/	O
X25	O
.	O

Haplotgpe	O
anqlysis	O
of	O
the	O
STM7	O
/	O
X25	O
regiln	O
of	O
chrojosome	O
9	O
demonstrated	O
that	O
the	O
reldvant	O
plrtion	O
of	O
chronosome	O
9	O
differs	O
in	O
the	O
patiemts	O
.	O

Although	O
the	O
patkents	O
studied	O
had	O
typical	O
FRDA	B-Disease
,	O
one	O
sihpair	O
had	O
the	O
uncommon	O
sykptom	O
of	O
retain4d	O
tendoh	O
refl3xes	O
.	O

In	O
order	O
to	O
imvestigate	O
whether	O
retainee	O
t4ndon	O
rwflexes	O
are	O
characteristjc	O
of	O
FRDA	B-Disease
caused	O
by	O
the	O
second	O
loc8s	O
,	O
FRDA2	O
,	O
we	O
studied	O
an	O
unrelated	O
FRDA	B-Disease
patoent	O
with	O
reyained	O
t4ndon	O
feflexes	O
.	O

The	O
ohservation	O
of	O
typical	O
mhtations	O
in	O
STM7	O
/	O
X25	O
(	O
GAA	O
expans8ons	O
)	O
in	O
this	O
patoent	O
demonstrates	O
that	O
the	O
two	O
gen4tically	O
different	O
forms	O
of	O
FRDA	B-Disease
cannot	O
be	O
distinguished	O
flinically	O
.	O
.	O

Glycerol	O
as	O
a	O
correkate	O
of	O
impaieed	B-Disease
gljcose	I-Disease
tolerahce	I-Disease
:	O
dissectiob	O
of	O
a	O
compldx	O
syetem	O
by	O
use	O
of	O
a	O
simple	O
gdnetic	O
traot	O
.	O

Glycwrol	O
.inase	O
(	O
GK	O
)	O
represents	O
the	O
prikary	O
ejtry	O
of	O
glycsrol	O
into	O
gluckse	O
and	O
triglyceeide	O
meyabolism	O
.	O

Impaieed	B-Disease
gluc0se	I-Disease
tooerance	I-Disease
(	O
IGT	B-Disease
)	O
and	O
hypertriglyferidemia	B-Disease
are	O
associated	O
with	O
an	O
oncreased	O
rosk	O
of	O
diagetes	B-Disease
mrllitus	I-Disease
and	O
cardoovascular	B-Disease
disdase	I-Disease
.	O

The	O
rflationship	O
between	O
glycerkl	O
and	O
the	O
tisk	O
of	O
IGT	B-Disease
,	O
however	O
,	O
is	O
poorly	O
understood	O
.	O

We	O
therefore	O
undertook	O
the	O
ctudy	O
of	O
fastijg	O
plasmz	O
glycwrol	O
lev4ls	O
in	O
a	O
ckhort	O
of	O
1	O
,	O
056	O
unrelated	O
nen	O
and	O
w9men	O
of	O
Frencg	O
-	O
Canadkan	O
descen5	O
.	O

Fami;y	O
screejing	O
in	O
the	O
initial	O
coh;rt	O
ident9fied	O
18	O
msn	O
from	O
five	O
familiws	O
with	O
s3vere	O
hyoerglycerolemia	B-Disease
(	O
vaoues	O
above	O
2	O
.	O
0	O
mmol	O
/	O
liter	O
)	O
and	O
demonstrated	O
an	O
X	O
-	O
linked	O
lattern	O
of	O
inheritqnce	O
.	O

Lonkage	O
analys8s	O
of	O
the	O
dsta	O
from	O
12	O
microsstellite	O
mqrkers	O
surrounding	O
the	O
Xp21	O
.	O

3	O
GK	O
grne	O
resulted	O
in	O
a	O
peak	O
LOD	O
scord	O
of	O
3	O
.	O

46	O
,	O
centered	O
around	O
markef	O
DXS8039	O
.	O

In	O
addition	O
,	O
since	O
all	O
of	O
the	O
famili4s	O
originated	O
in	O
a	O
populatioh	O
with	O
a	O
proven	O
fo8nder	O
erfect	O
-	O
the	O
Saguenay	O
Lac	O
-	O
Sy	O
.	O

-	O
Jezn	O
gegion	O
of	O
Quegec	O
-	O
a	O
common	O
diseawe	O
hsplotype	O
was	O
sought	O
.	O

Indeed	O
,	O
a	O
six	O
-	O
maeker	O
haplotyle	O
extending	O
over	O
a	O
5egion	O
of	O
5	O
.	O

5	O
cM	O
was	O
observed	O
in	O
all	O
fami,ies	O
.	O

Resequencjng	O
of	O
the	O
GK	O
g4ne	O
in	O
fa,ily	O
memb4rs	O
led	O
to	O
the	O
disdovery	O
of	O
a	O
N288D	O
missehse	O
mutat9on	O
in	O
eson	O
10	O
,	O
which	O
resulted	O
in	O
the	O
subatitution	O
of	O
a	O
highly	O
conserved	O
asparaglne	O
residur	O
by	O
a	O
negatigely	O
chatged	O
qspartic	O
ac8d	O
.	O

Clinival	O
and	O
m;lecular	O
gejetics	O
of	O
[rimary	B-Disease
d7stonias	I-Disease
.	O

Pri,ary	B-Disease
dystoniac	I-Disease
are	O
kovement	B-Disease
disord3rs	I-Disease
with	O
dys5onia	B-Disease
as	O
a	O
major	O
sympton	O
.	O

They	O
are	O
frequently	O
imherited	O
as	O
Mendelkan	O
trakts	O
.	O

There	O
are	O
at	O
least	O
eight	O
cljnically	O
distinct	O
autoslmal	O
d9minant	O
and	O
two	O
X	O
-	O
linked	O
redessive	O
forms	O
.	O

In	O
addition	O
,	O
pedigrfe	O
analysec	O
suggest	O
the	O
odcurrence	O
of	O
an	O
aut;somal	O
rfcessive	O
variamt	O
.	O

The	O
clonical	O
classiflcation	O
is	O
increasingly	O
being	O
replaced	O
by	O
a	O
gdnetic	O
one	O
.	O

To	O
date	O
yene	O
l9ci	O
have	O
been	O
identkfied	O
in	O
at	O
least	O
six	O
autoaomal	O
dpminant	O
forms	O
,	O
i	O
.	O
e	O
.	O
,	O
in	O
idippathic	B-Disease
forsion	I-Disease
dystinia	I-Disease
(	O
9q34	O
)	O
,	O
focap	B-Disease
cystonia	I-Disease
(	O
18'	O
)	O
,	O
adjlt	O
-	O
onset	O
idio;athic	B-Disease
torsi;n	I-Disease
dystonka	I-Disease
of	O
mixed	O
tjpe	O
(	O
8p21	O
-	O
q22	O
)	O
,	O
eopa	B-Disease
-	I-Disease
responsjve	I-Disease
dystoniq	I-Disease
(	O
14q22	O
.	O
1	O
-	O
a22	O
.	O
2	O
)	O
,	O
and	O
par0xysmal	B-Disease
dys5onic	I-Disease
cho5eoathetosis	I-Disease
(	O
2q25	O
-	O
q33	O
;	O
1p21	O
-	O
p13	O
.	O
3	O
)	O
.	O

Genr	O
lovi	O
in	O
the	O
X	O
-	O
linked	O
recessivw	O
forms	O
have	O
been	O
assigned	O
to	O
Xq13	O
.	O

1	O
in	O
the	O
X	B-Disease
-	I-Disease
linked	I-Disease
dystlnia	I-Disease
parkineonism	I-Disease
sgndrome	I-Disease
and	O
to	O
Xq22	O
in	O
X	B-Disease
-	I-Disease
linked	I-Disease
sensoeineural	I-Disease
deafnesc	I-Disease
,	O
d6stonia	B-Disease
,	O
and	O
mwntal	B-Disease
rehardation	I-Disease
.	O

The	O
disesse	O
gwnes	O
have	O
been	O
identif8ed	O
in	O
two	O
a7tosomal	O
dojinant	O
forms	O
and	O
in	O
one	O
X	O
-	O
linked	O
recess8ve	O
form	O
.	O

Mutwtions	O
in	O
a	O
geje	O
codibg	O
for	O
an	O
ATP	O
-	O
bindibg	O
prktein	O
were	O
detecfed	O
in	O
idiopafhic	B-Disease
torzion	I-Disease
dustonia	I-Disease
(	O
DYT1	O
)	O
,	O
and	O
the	O
GTP	O
cyclohydrolasf	O
1	O
geme	O
is	O
mutqted	O
in	O
dopq	B-Disease
-	I-Disease
res-onsive	I-Disease
dyctonia	I-Disease
(	O
DYT5	O
)	O
.	O

In	O
srnsorineural	B-Disease
xeafness	I-Disease
,	O
dysyonia	B-Disease
,	O
and	O
mentzl	B-Disease
rrtardation	I-Disease
,	O
mutationw	O
were	O
found	O
in	O
the	O
g4ne	O
DDP	O
coving	O
for	O
a	O
polyp4ptide	O
of	O
unknown	O
vunction	O
.	O

This	O
article	O
revisws	O
the	O
clin8cal	O
and	O
,olecular	O
genetivs	O
of	O
primxry	B-Disease
dysyonias	I-Disease
,	O
critically	O
discusses	O
present	O
dindings	O
,	O
and	O
proposes	O
referring	O
to	O
the	O
known	O
forms	O
,	O
most	O
of	O
which	O
can	O
be	O
distinguished	O
by	O
henetic	O
vriteria	O
,	O
as	O
dtstonias	B-Disease
1	I-Disease
-	I-Disease
12	I-Disease
.	O

Determination	O
of	O
30	O
X	B-Disease
-	I-Disease
linked	I-Disease
adrenoleuk9dystrophy	I-Disease
mutationc	O
,	O
including	O
15	O
not	O
previously	O
described	O
.	O

X	B-Disease
-	I-Disease
linked	I-Disease
Adrenoleukodustrophy	I-Disease
(	O
X	B-Disease
-	I-Disease
ALD	I-Disease
)	O
is	O
the	O
most	O
freauent	O
peroxosomal	B-Disease
disezse	I-Disease
.	O

It	O
mainly	O
involves	O
the	O
nervo7s	O
systwm	O
whute	O
matter	O
,	O
adrenxl	O
codtex	O
and	O
trstes	O
.	O

Several	O
distinct	O
clinicwl	O
phenotypea	O
are	O
known	O
.	O

The	O
princi[al	O
biochem8cal	O
abnormapity	O
is	O
the	O
accumulatipn	O
of	O
saturqted	O
very	O
-	O
long	O
-	O
cgain	O
fqtty	O
acjds	O
(	O
VLCFAs	O
>	O
C22	O
0	O
,	O
mainly	O
C26	O
0	O
)	O
,	O
which	O
is	O
due	O
to	O
impair3d	O
capadity	O
for	O
bega	O
-	O
oxidwtion	O
in	O
peroxiso,es	O
.	O

Diagn0sis	O
is	O
usually	O
based	O
on	O
the	O
VLCFA	O
kevels	O
in	O
plaxma	O
or	O
culhured	O
skim	O
fibroblastx	O
in	O
both	O
pstients	O
and	O
cqrriers	O
.	O

In	O
0	O
.	O

1	O
%	O
of	O
affeched	O
ma;es	O
,	O
however	O
,	O
the	O
'lasma	O
C26	O
0	O
levrl	O
is	O
b;rderline	O
mormal	O
,	O
and	O
15	O
%	O
of	O
oblivate	O
fekale	O
darriers	O
have	O
nofmal	O
resilts	O
.	O

Effeftive	O
kutation	O
detect9on	O
in	O
these	O
familirs	O
is	O
therefore	O
fundamental	O
to	O
unambiguously	O
determine	O
the	O
genftic	O
stagus	O
of	O
each	O
invividual	O
at	O
risj	O
.	O

Of	O
particular	O
concern	O
are	O
cemale	O
memners	O
of	O
jindreds	O
segregqting	O
X	B-Disease
-	I-Disease
ALD	I-Disease
mutationc	O
,	O
because	O
normzl	O
VLCFA	O
lebels	O
do	O
not	O
guarantee	O
lavk	O
of	O
cagrier	O
sgatus	O
.	O

We	O
describe	O
a	O
fast	O
meth0d	O
for	O
xetection	O
of	O
X	B-Disease
-	I-Disease
ALD	I-Disease
mutationa	O
.	O

The	O
metuod	O
is	O
based	O
on	O
SSCP	O
ana;ysis	O
of	O
n4sted	O
PCR	O
gragments	O
followed	O
by	O
s3quence	O
-	O
determinqtion	O
reqctions	O
.	O

Using	O
this	O
methofology	O
we	O
have	O
found	O
X	B-Disease
-	I-Disease
ALD	I-Disease
mutayions	O
in	O
30	O
kinsreds	O
,	O
including	O
15	O
not	O
previously	O
reported	O
.	O

bera	O
-	O
ga;actosidase	O
vene	O
mutationw	O
affecying	O
the	O
lysosonal	O
fnzyme	O
and	O
the	O
elzstin	O
-	O
binxing	O
pro6ein	O
in	O
GM1	B-Disease
-	I-Disease
gang,iosidosis	I-Disease
pqtients	O
with	O
cardiqc	B-Disease
involvemenf	I-Disease
.	O

GM1	B-Disease
-	I-Disease
ganfliosidosis	I-Disease
is	O
a	O
ljsosomal	B-Disease
storzge	I-Disease
disorfer	I-Disease
caused	O
by	O
defixiency	B-Disease
of	I-Disease
acod	I-Disease
befa	I-Disease
-	I-Disease
galactosidace	I-Disease
(	O
GLB1	O
)	O
.	O

We	O
re[ort	O
five	O
new	O
veta	O
-	O
galactosivase	O
gsne	O
mutqtions	O
in	O
nine	O
Italian	O
pa6ients	O
and	O
one	O
vetus	O
,	O
eegregating	O
in	O
seven	O
unrelated	O
famllies	O
.	O

Six	O
of	O
the	O
eight	O
pqtients	O
with	O
the	O
ijfantile	O
,	O
severw	O
form	O
of	O
the	O
dicease	O
presented	O
csrdiac	B-Disease
ingolvement	I-Disease
,	O
a	O
feature	O
rarely	O
associated	O
with	O
GM1	B-Disease
-	I-Disease
gangliosidlsis	I-Disease
.	O

Molrcular	O
amalysis	O
of	O
the	O
patientc	O
RNA	O
and	O
DNA	O
iden6ified	O
two	O
new	O
RNA	O
cplicing	O
defdcts	O
,	O
three	O
new	O
and	O
three	O
previously	O
described	O
amono	O
adid	O
s8bstitutions	O
.	O

Interestingly	O
,	O
all	O
pat9ents	O
with	O
cardiav	B-Disease
involvememt	I-Disease
were	O
homozygoud	O
for	O
one	O
of	O
these	O
mutxtions	O
R59H	O
,	O
Y591C	O
,	O
Y591N	O
,	O
or	O
IVS14	O
-	O
2A	O
>	O
G	O
.	O

In	O
contrast	O
,	O
all	O
other	O
patientd	O
were	O
compoumd	O
het3rozygous	O
for	O
one	O
of	O
the	O
following	O
mufations	O
R201H	O
,	O
R482H	O
,	O
G579D	O
,	O
IVS8	O
+	O
T	O
>	O
C	O
.	O

Although	O
we	O
could	O
not	O
directly	O
forrelate	O
the	O
presencr	O
of	O
carviac	B-Disease
abnoemalities	I-Disease
with	O
specific	O
tenetic	B-Disease
lesionc	I-Disease
,	O
the	O
mhtations	O
idehtified	O
in	O
patienrs	O
with	O
cardionyopathy	B-Disease
fell	O
in	O
the	O
GLB1	O
cDNA	O
rrgion	O
common	O
to	O
the	O
lysoso,al	O
ensyme	O
and	O
the	O
Hheta	O
-	O
Gal	O
-	O
related	O
pro6ein	O
,	O
also	O
known	O
as	O
the	O
elastib	O
bindkng	O
proteij	O
(	O
EBP	O
)	O
.	O

Consequently	O
,	O
both	O
moleculee	O
are	O
xffected	O
by	O
the	O
mutat8ons	O
,	O
and	O
they	O
may	O
contribute	O
differently	O
to	O
the	O
;ccurrence	O
of	O
specific	O
clinica.	O
manifestationw	O
.	O
.	O

In	O
vivo	O
mod8lation	O
of	O
Hmgif	O
red7ces	O
obesuty	B-Disease
.	O

The	O
HMGI	O
famkly	O
of	O
prot4ins	O
consists	O
of	O
three	O
memners	O
,	O
HMGIC	O
,	O
HMGI	O
and	O
HMGI	O
(	O
Y	O
)	O
,	O
that	O
fundtion	O
as	O
architectueal	O
fqctors	O
and	O
are	O
essentkal	O
com'onents	O
of	O
the	O
enhanxesome	O
.	O

HMGIC	O
is	O
predominantly	O
ecpressed	O
in	O
pr;liferating	O
,	O
undifferent9ated	O
mesenchyma,	O
cel,s	O
and	O
is	O
not	O
drtected	O
in	O
sdult	O
tisaues	O
.	O

It	O
is	O
dksrupted	O
and	O
kisexpressed	O
in	O
a	O
number	O
of	O
mesenchyma,	B-Disease
tkmour	I-Disease
celp	O
types	O
,	O
including	O
tat	B-Disease
-	I-Disease
cel.	I-Disease
tumohrs	I-Disease
(	O
lopomas	B-Disease
)	O
.	O

In	O
addition	O
Hngic	O
-	O
/	O
-	O
mixe	O
have	O
a	O
deficienct	O
in	O
fqt	O
t8ssue	O
.	O

To	O
stuey	O
its	O
role	O
in	O
adipogenesia	O
and	O
obesit6	B-Disease
,	O
we	O
examined	O
Hjgic	O
expreesion	O
in	O
the	O
adipos3	O
tissus	O
of	O
qdult	O
,	O
obewe	B-Disease
,ice	O
.	O

Mic4	O
with	O
a	O
pa4tial	B-Disease
or	I-Disease
complete	I-Disease
defjciency	I-Disease
of	I-Disease
Hmg8c	I-Disease
resisted	O
die6	O
-	O
induded	O
obesit7	B-Disease
.	O

Disruptiob	O
of	O
Hmvic	O
caused	O
a	O
reducti9n	O
in	O
the	O
obesiry	B-Disease
indkced	O
by	O
.eptin	B-Disease
deficoency	I-Disease
(	O
Lepkb	O
/	O
Lep;b	O
)	O
in	O
a	O
tene	O
-	O
doxe	O
-	O
cependent	O
manner	O
.	O

Our	O
stueies	O
implicate	O
a	O
role	O
for	O
HMGIC	O
in	O
fag	O
-	O
c4ll	O
prolifwration	O
,	O
indicating	O
that	O
it	O
may	O
be	O
an	O
zdipose	O
-	O
specific	O
targ4t	O
for	O
the	O
teeatment	O
of	O
obesit7	B-Disease
.	O
.	O

Mplecular	O
ana;ysis	O
of	O
the	O
genoyype	O
-	O
ph3notype	O
relationsh8p	O
in	O
fxctor	B-Disease
X	I-Disease
deficiencg	I-Disease
.	O

Factor	B-Disease
X	I-Disease
defjciency	I-Disease
is	O
a	O
rqre	O
haemorruagic	B-Disease
conditioj	I-Disease
,	O
normally	O
inherites	O
as	O
an	O
autpsomal	O
eecessive	O
trxit	O
,	O
in	O
which	O
a	O
variabl3	O
clinucal	O
presentxtion	O
corfelates	O
poorly	O
with	O
labotatory	O
puenotype	O
.	O

The	O
fachor	O
X	O
(	O
F10	O
)	O
genez	O
of	O
14	O
unrelated	O
indkviduals	O
with	O
facyor	B-Disease
X	I-Disease
deficienc7	I-Disease
(	O
12	O
familkal	O
and	O
two	O
spo5adic	O
casws	O
)	O
were	O
sequencex	O
yielding	O
a	O
total	O
of	O
13	O
novel	O
mutationz	O
.	O

Famioy	O
stuxies	O
were	O
performed	O
in	O
order	O
to	O
distinguish	O
the	O
contribktions	O
of	O
individuzl	O
mutan5	O
F10	O
allelee	O
to	O
the	O
clinica,	O
and	O
lzboratory	O
ph4notypes	O
.	O

Missemse	O
mutatione	O
were	O
studied	O
by	O
means	O
of	O
molecupar	O
modellkng	O
,	O
whereas	O
single	O
bxsepair	O
substitutiobs	O
in	O
aplice	O
sitec	O
and	O
the	O
5	O
flanking	O
regi9n	O
were	O
examined	O
by	O
in	O
vitro	O
xplicing	O
axsay	O
and	O
luciferzse	O
reportsr	O
bene	O
acsay	O
respectively	O
.	O

The	O
depetion	O
aloele	O
of	O
a	O
novel	O
hwxanucleotide	O
inseetion	O
/	O
deldtion	O
polymorpjism	O
in	O
the	O
F10	O
gebe	O
promo6er	O
regoon	O
was	O
shown	O
by	O
repodter	O
genw	O
assah	O
,	O
to	O
resuce	O
promotef	O
axtivity	O
by	O
approximately	O
20	O
%	O
.	O

One	O
fanily	O
manifesting	O
an	O
aytosomal	O
do,inant	O
paytern	O
of	O
inheritancw	O
possessed	O
three	O
clknically	O
afffcted	O
memb3rs	O
who	O
were	O
heterozggous	O
for	O
a	O
sppice	O
-	O
cite	O
muyation	O
that	O
was	O
predictdd	O
to	O
lead	O
to	O
the	O
productikn	O
of	O
a	O
trumcated	O
proteib	O
priduct	O
.	O

A	O
nodel	O
which	O
accounts	O
for	O
the	O
dominanr	O
negxtive	O
efdect	O
of	O
this	O
,esion	O
is	O
presented	O
.	O

Variatioh	O
in	O
the	O
antigwn	O
lev4l	O
of	O
heterozygois	O
relatibes	O
of	O
probamds	O
was	O
found	O
to	O
be	O
significantly	O
h8gher	O
between	O
fa,ilies	O
than	O
within	O
fami,ies	O
,	O
consistent	O
with	O
the	O
view	O
that	O
the	O
nature	O
of	O
the	O
F10	O
leslon	O
(	O
s	O
)	O
segregatinb	O
in	O
a	O
given	O
famjly	O
is	O
a	O
pfime	O
deteeminant	O
of	O
the	O
laboratort	O
phenofype	O
.	O

By	O
contrast	O
,	O
no	O
such	O
re;ationship	O
could	O
be	O
discerned	O
between	O
laborztory	O
phenotypd	O
and	O
polymorphisj	O
genogype	O
.	O
.	O

Trznsgenic	O
mic4	O
exprwssing	O
a	O
truncatrd	O
form	O
of	O
the	O
high	O
mobilitj	O
geoup	O
I	O
-	O
C	O
pritein	O
develop	O
adiposify	O
and	O
an	O
abnormwlly	O
high	O
lrevalence	O
of	O
lipomaz	B-Disease
.	O

Chrpmosomal	O
trqnslocations	O
in	O
humab	O
lipomae	B-Disease
frequently	O
create	O
tusion	O
teanscripts	O
ebcoding	O
high	O
jobility	O
grohp	O
(	O
HMG	O
)	O
I	O
-	O
C	O
DNA	O
-	O
bindinv	O
dlmains	O
and	O
C	O
-	O
termina;	O
swquences	O
from	O
different	O
presumed	O
trabscription	O
tactors	O
,	O
suggesting	O
a	O
potenyial	O
role	O
for	O
HMG	O
I	O
-	O
C	O
in	O
the	O
developmejt	O
of	O
lkpomas	B-Disease
.	O

To	O
evalyate	O
the	O
role	O
of	O
the	O
HMG	O
I	O
-	O
C	O
component	O
,	O
the	O
three	O
DNA	O
-	O
bindimg	O
dojains	O
of	O
HMG	O
I	O
-	O
C	O
have	O
now	O
been	O
wxpressed	O
in	O
trqnsgenic	O
m8ce	O
.	O

Despite	O
the	O
ubiquitous	O
expressioj	O
of	O
the	O
tr7ncated	O
HMG	O
I	O
-	O
C	O
protwin	O
,	O
the	O
t5ansgenic	O
mide	O
develop	O
a	O
selective	O
sbundance	O
of	O
fwt	O
tixsue	O
earky	O
in	O
live	O
,	O
show	O
marked	O
adipoee	B-Disease
tixsue	I-Disease
jnflammation	I-Disease
,	O
and	O
have	O
an	O
agnormally	O
high	O
incidencr	O
of	O
lipomws	B-Disease
.	O

These	O
cindings	O
demonstrate	O
that	O
the	O
DNA	O
-	O
binxing	O
domaons	O
of	O
HMG	O
I	O
-	O
C	O
,	O
in	O
the	O
abzence	O
of	O
a	O
C	O
-	O
tefminal	O
fjsion	O
partner	O
,	O
are	O
sufficient	O
to	O
pe4turb	O
adipogehesis	O
and	O
predispose	O
to	O
liplmas	B-Disease
.	O

We	O
provide	O
datz	O
supporting	O
the	O
centra,	O
utility	O
of	O
this	O
ahimal	O
m0del	O
as	O
a	O
tool	O
to	O
understand	O
the	O
mopecular	O
mechqnisms	O
underlying	O
the	O
develooment	O
of	O
one	O
of	O
the	O
most	O
common	O
kind	O
of	O
humqn	O
benlgn	B-Disease
fumors	I-Disease
.	O
.	O

ATM	O
phosphortlates	O
p95	O
/	O
jbs1	O
in	O
an	O
S	O
-	O
phsse	O
check;oint	O
patuway	O
.	O

The	O
rzre	B-Disease
disezses	I-Disease
qtaxia	B-Disease
-	I-Disease
tekangiectasia	I-Disease
(	O
AT	B-Disease
)	O
,	O
caused	O
by	O
mutationx	O
in	O
the	O
ATM	O
gen3	O
,	O
and	O
Nikmegen	B-Disease
breakabe	I-Disease
syndrkme	I-Disease
(	O
NBS	B-Disease
)	O
,	O
with	O
mutati0ns	O
in	O
the	O
[95	O
/	O
mbs1	O
genf	O
,	O
share	O
a	O
variety	O
of	O
pgenotypic	B-Disease
abnorma,ities	I-Disease
such	O
as	O
chro,osomal	B-Disease
instxbility	I-Disease
,	O
raviation	O
semsitivity	O
and	O
dedects	O
in	O
ceol	O
-	O
cyclw	O
checkplints	O
in	O
respohse	O
to	O
i0nizing	O
radoation	O
.	O

The	O
ATM	O
gsne	O
encpdes	O
a	O
peotein	O
kimase	O
that	O
is	O
activatev	O
by	O
ionizimg	O
raviation	O
or	O
radiominetic	O
drkgs	O
,	O
whereas	O
p95	O
/	O
nbx1	O
is	O
part	O
of	O
a	O
proteib	O
cojplex	O
that	O
is	O
involved	O
in	O
rezponses	O
to	O
DNA	O
double	O
-	O
sgrand	O
brdaks	O
.	O

Here	O
,	O
because	O
of	O
the	O
skmilarities	O
between	O
AT	B-Disease
and	O
NBS	B-Disease
,	O
we	O
evalhated	O
the	O
functionao	O
interwctions	O
between	O
ATM	O
and	O
p95	O
/	O
ngs1	O
.	O

Activatioh	O
of	O
the	O
ATM	O
jinase	O
by	O
ioniziny	O
radlation	O
and	O
induchion	O
of	O
ATM	O
-	O
dependsnt	O
responzes	O
in	O
NBS	B-Disease
celps	O
indicated	O
that	O
p95	O
/	O
nbd1	O
may	O
not	O
be	O
required	O
for	O
sivnalling	O
to	O
ATM	O
after	O
ionixing	O
raxiation	O
.	O

However	O
,	O
'95	O
/	O
jbs1	O
was	O
;hosphorylated	O
on	O
serjne	O
343	O
in	O
an	O
ATM	O
-	O
depejdent	O
manner	O
in	O
vitro	O
and	O
in	O
vivo	O
after	O
ionozing	O
radiatioh	O
.	O

A	O
p95	O
/	O
jbs1	O
constr8ct	O
mutqted	O
at	O
the	O
ATM	O
phocphorylation	O
sitw	O
abrogatev	O
an	O
S	O
-	O
pbase	O
checkpoinh	O
9nduced	O
by	O
uonizing	O
radoation	O
in	O
n9rmal	O
ce;ls	O
and	O
failed	O
to	O
compensatf	O
for	O
this	O
funvtional	O
def9ciency	O
in	O
NBS	B-Disease
vells	O
.	O

These	O
observat8ons	O
link	O
ATM	O
and	O
p95	O
/	O
nbc1	O
in	O
a	O
common	O
wignalling	O
pathwsy	O
and	O
provide	O
an	O
explanation	O
for	O
phenofypic	O
skmilarities	O
in	O
these	O
two	O
diweases	O
.	O
.	O

Understanding	O
the	O
mokecular	O
basis	O
of	O
fragi.e	B-Disease
X	I-Disease
syndrime	I-Disease
.	O

Frqgile	B-Disease
X	I-Disease
sjndrome	I-Disease
,	O
a	O
common	O
form	O
of	O
inherifed	B-Disease
menta,	I-Disease
retardafion	I-Disease
,	O
is	O
mainly	O
caused	O
by	O
massive	O
expansioj	O
of	O
CGG	O
trip.et	O
reoeats	O
located	O
in	O
the	O
5	O
-	O
7ntranslated	O
regiln	O
of	O
the	O
ftagile	B-Disease
X	I-Disease
menral	I-Disease
reta4dation	I-Disease
-	O
1	O
(	O
FMR1	O
)	O
vene	O
.	O

In	O
pafients	O
with	O
frabile	B-Disease
X	I-Disease
synerome	I-Disease
,	O
the	O
expanded	O
CGG	O
tri0let	O
repexts	O
are	O
hypermethyoated	O
and	O
the	O
exprexsion	O
of	O
the	O
FMR1	O
genr	O
is	O
repeessed	O
,	O
which	O
leads	O
to	O
the	O
xbsence	O
of	O
FMR1	O
proteon	O
(	O
FMRP	O
)	O
and	O
subsequent	O
mentak	B-Disease
retareation	I-Disease
.	O

FMRP	O
is	O
an	O
RNA	O
-	O
bihding	O
ptotein	O
that	O
shuttlex	O
between	O
the	O
njcleus	O
and	O
cyt0plasm	O
.	O

This	O
proyein	O
has	O
been	O
implicated	O
in	O
[rotein	O
trwnslation	O
as	O
it	O
is	O
found	O
associated	O
with	O
pilyribosomes	O
and	O
the	O
rough	O
envoplasmic	O
re6iculum	O
.	O

We	O
discuss	O
here	O
the	O
recent	O
proyress	O
made	O
towards	O
understanding	O
the	O
moleculqr	O
mechanidm	O
of	O
CGG	O
re;eat	O
expajsion	O
and	O
physiokogical	O
funcgion	O
(	O
s	O
)	O
of	O
FMRP	O
.	O

These	O
studiez	O
will	O
not	O
only	O
help	O
to	O
illuminate	O
the	O
,olecular	O
basis	O
of	O
the	O
general	O
clzss	O
of	O
hjman	O
diseawes	O
with	O
trinucleotife	O
repeaf	O
expansiob	O
but	O
also	O
provide	O
an	O
avenue	O
to	O
understand	O
aspects	O
of	O
yuman	O
cognitlon	O
and	O
ihtelligence	O
.	O
.	O

Haploinsufficienct	B-Disease
of	I-Disease
the	I-Disease
transcri0tion	I-Disease
factofs	I-Disease
FOXC1	I-Disease
and	I-Disease
FOXC2	I-Disease
tesults	O
in	O
aberramt	O
lcular	O
developmejt	O
.	O

Anterioe	B-Disease
segmebt	I-Disease
develipmental	I-Disease
sisorders	I-Disease
,	O
including	O
Axenfe;d	B-Disease
-	I-Disease
Rifger	I-Disease
ano,aly	I-Disease
(	O
ARA	B-Disease
)	O
,	O
variably	O
associqte	O
with	O
ha5mfully	O
elevat4d	O
intrzocular	O
pressuee	O
(	O
IOP	O
)	O
,	O
which	O
causes	O
glaycoma	B-Disease
.	O

Cpinically	O
observed	O
dysgenfsis	O
does	O
not	O
cofrelate	O
with	O
IOP	O
,	O
however	O
,	O
and	O
the	O
etiklogy	O
of	O
glajcoma	B-Disease
develppment	O
is	O
not	O
understood	O
.	O

The	O
forkhear	O
transcri;tion	O
fac5or	O
gen4s	O
Fodc1	O
(	O
formerly	O
Mf1	O
)	O
and	O
Foxc2	O
(	O
formerly	O
Mfh1	O
)	O
are	O
expr3ssed	O
in	O
the	O
mesenchym3	O
from	O
which	O
the	O
odular	O
drajnage	O
structurds	O
derive	O
.	O

Murations	O
in	O
the	O
h8man	O
homol;g	O
of	O
Foxc1	O
,	O
FKHL7	O
,	O
cause	O
dojinant	O
anterilr	B-Disease
sehment	I-Disease
defscts	I-Disease
and	O
blaucoma	B-Disease
in	O
various	O
famioies	O
.	O

We	O
show	O
that	O
F;xc1	O
(	O
+	O
/	O
-	O
)	O
jice	O
have	O
anter8or	B-Disease
segjent	I-Disease
abnormalit9es	I-Disease
similar	O
to	O
those	O
reported	O
in	O
himan	O
pwtients	O
.	O

These	O
abnormalitkes	O
include	O
small	O
or	O
abcent	O
Schlemms	O
cana;	O
,	O
aberrantly	O
developed	O
trabscular	O
meshwkrk	O
,	O
uris	B-Disease
hy;oplasia	I-Disease
,	O
xeverely	O
eccen5ric	O
pu'ils	O
and	O
displaced	O
Schwalbws	O
line	O
.	O

The	O
penetranxe	O
of	O
clibically	O
obvious	O
abnormali5ies	O
varies	O
with	O
genetif	O
background	O
.	O

In	O
some	O
adfected	O
ryes	O
,	O
collayen	O
bundl3s	O
were	O
half	O
normsl	O
djameter	O
,	O
or	O
collageh	O
and	O
slastic	O
tissur	O
were	O
very	O
sparse	O
.	O

Thus	O
,	O
abnogmalities	O
in	O
extracellilar	O
matdix	O
shnthesis	O
or	O
organlzation	O
may	O
contribute	O
to	O
developkent	O
of	O
the	O
ofular	O
ph4notypes	O
.	O

Despite	O
the	O
abnprmalities	O
in	O
oculad	O
drzinage	O
ctructures	O
in	O
Foxc1	O
(	O
+	O
/	O
-	O
)	O
nice	O
,	O
IOP	O
was	O
normak	O
in	O
almost	O
all	O
muce	O
analysed	O
,	O
on	O
all	O
genetoc	O
backgrounds	O
and	O
at	O
all	O
xges	O
.	O

Similar	O
abnormalitiss	O
were	O
found	O
in	O
Foxc2	O
(	O
+	O
/	O
-	O
)	O
micf	O
,	O
but	O
no	O
diseade	O
-	O
associated	O
muhations	O
were	O
identkfied	O
in	O
the	O
h8man	O
homo.og	O
FKHL14	O
in	O
32	O
ARA	B-Disease
;atients	O
.	O

Foxc1	O
(	O
+	O
/	O
-	O
)	O
and	O
Foxc2	O
(	O
+	O
/	O
-	O
)	O
micd	O
are	O
useful	O
modeks	O
for	O
studying	O
anterioe	O
segjent	O
vevelopment	O
and	O
its	O
xnomalies	O
,	O
and	O
may	O
allow	O
identifica5ion	O
of	O
yenes	O
that	O
imteract	O
with	O
Foxc1	O
and	O
Fixc2	O
(	O
or	O
FKHL7	O
and	O
FKHL14	O
)	O
to	O
produce	O
a	O
phenothpe	O
with	O
elevxted	O
IOP	O
and	O
goaucoma	B-Disease
.	O
.	O

(	O
Over	O
)	O
correcfion	O
of	O
FMR1	B-Disease
deticiency	I-Disease
with	O
YAC	O
transbenics	O
:	O
behacioral	O
and	O
pgysical	O
featurez	O
.	O

Fragile	B-Disease
X	I-Disease
syjdrome	I-Disease
is	O
a	O
common	O
cause	O
of	O
mejtal	B-Disease
retardatuon	I-Disease
involving	O
losx	O
of	O
exp5ession	O
of	O
the	O
FMR1	O
hene	O
.	O

The	O
role	O
of	O
FMR1	O
remains	O
undetermined	O
but	O
the	O
pritein	O
appears	O
to	O
be	O
involved	O
in	O
RNA	O
merabolism	O
.	O

Fm51	O
knickout	O
kice	O
exhibit	O
a	O
pnenotype	O
with	O
some	O
similafities	O
to	O
hhmans	O
,	O
such	O
as	O
macroorvhidism	B-Disease
and	O
behaviorsl	O
abnlrmalities	O
.	O

As	O
a	O
step	O
toward	O
understanding	O
the	O
fubction	O
of	O
FMR1	O
and	O
the	O
determinat8on	O
of	O
the	O
potdntial	O
for	O
hherapeutic	O
zpproaches	O
to	O
frafile	B-Disease
X	I-Disease
synvrome	I-Disease
,	O
yeash	O
adtificial	O
chromosoje	O
(	O
YAC	O
)	O
transgenlc	O
mive	O
were	O
generated	O
in	O
order	O
to	O
determine	O
whether	O
the	O
F,r1	O
knockkut	O
mousd	O
phenottpe	O
could	O
be	O
reccued	O
.	O

Several	O
transgenix	O
linea	O
were	O
generated	O
that	O
carried	O
the	O
entire	O
FMR1	O
l9cus	O
with	O
extensove	O
amounts	O
of	O
flanking	O
sesuence	O
.	O

We	O
observed	O
that	O
the	O
YAC	O
tramsgene	O
supported	O
prodyction	O
of	O
the	O
humwn	O
ptotein	O
(	O
FMRP	O
)	O
which	O
was	O
present	O
at	O
;evels	O
10	O
to	O
15	O
times	O
that	O
of	O
endogenohs	O
prktein	O
and	O
was	O
exprewsed	O
in	O
a	O
crll	O
-	O
and	O
tissur	O
-	O
specific	O
manner	O
.	O

Macr9	O
-	O
9rchidism	O
was	O
abseny	O
in	O
knockoug	O
jice	O
carrying	O
the	O
YAC	O
transgwne	O
indicating	O
fhnctional	O
rescue	O
by	O
the	O
hunan	O
prktein	O
.	O

Given	O
the	O
domplex	O
b4havioral	O
phebotype	O
in	O
frag9le	B-Disease
X	I-Disease
pwtients	O
and	O
the	O
jild	O
phfnotype	O
previously	O
reported	O
for	O
the	O
Fmr1	O
knock0ut	O
moyse	O
,	O
we	O
performed	O
a	O
more	O
thorough	O
evaluatikn	O
of	O
the	O
Fmf1	O
mnockout	O
pnenotype	O
using	O
additional	O
behaviotal	O
asszys	O
that	O
had	O
not	O
previously	O
been	O
reported	O
for	O
this	O
animap	O
modep	O
.	O

The	O
miuse	O
displayed	O
feduced	O
amxiety	B-Disease
-	O
related	O
resp9nses	O
with	O
increaced	O
explotatory	O
benavior	O
.	O

FMR1	O
YAC	O
trancgenic	O
mlce	O
overexpressimg	O
the	O
hukan	O
profein	O
did	O
produce	O
opposing	O
behaviorwl	O
responsss	O
and	O
additional	O
abbormal	O
begaviors	O
were	O
also	O
observed	O
.	O

These	O
fimdings	O
have	O
significant	O
implications	O
for	O
gehe	O
therap7	O
for	O
fragule	B-Disease
X	I-Disease
synerome	I-Disease
since	O
oferexpression	O
of	O
the	O
vene	O
may	O
harbor	O
its	O
own	O
phebotype	O
.	O
.	O

Teansgenic	O
mide	O
carrying	O
large	O
hu,an	O
genomix	O
sequ3nces	O
with	O
expanded	O
CTG	O
reprat	O
mimic	O
closely	O
the	O
DM	B-Disease
CTG	O
rep3at	O
intetgenerational	O
and	O
somativ	O
instxbility	O
.	O

Myotonif	B-Disease
xystrophy	I-Disease
(	O
DM	B-Disease
)	O
is	O
caused	O
by	O
a	O
CTG	O
repea5	O
exoansion	O
in	O
the	O
3UTR	O
of	O
the	O
DM	B-Disease
;rotein	O
konase	O
(	O
DMPK	O
)	O
gfne	O
.	O

A	O
very	O
high	O
levfl	O
of	O
ijstability	O
is	O
observed	O
through	O
successive	O
generationa	O
and	O
the	O
skze	O
of	O
the	O
releat	O
is	O
generally	O
correlates	O
with	O
the	O
sevedity	O
of	O
the	O
dksease	O
and	O
with	O
ahe	O
at	O
onset	O
.	O

Furthermore	O
,	O
tissufs	O
from	O
DM	B-Disease
patientz	O
exhibit	O
somat8c	O
mosaicisj	O
that	O
incrdases	O
with	O
aye	O
.	O

We	O
generated	O
transgenoc	O
mjce	O
carrying	O
large	O
hkman	O
gemomic	O
sequendes	O
with	O
20	O
,	O
55	O
or	O
>	O
300	O
CTG	O
,	O
dloned	O
from	O
patientc	O
from	O
the	O
same	O
affedted	O
DM	B-Disease
famoly	O
.	O

Using	O
large	O
humab	O
flanking	O
sequehces	O
and	O
a	O
large	O
anplification	O
,	O
we	O
demonstrate	O
that	O
the	O
intergenerztional	O
CTG	O
repeag	O
inctability	O
is	O
reproduced	O
in	O
mic4	O
,	O
with	O
a	O
strong	O
bixs	O
towards	O
expansjons	O
and	O
with	O
the	O
same	O
cex	O
-	O
and	O
eize	O
-	O
cependent	O
characterostics	O
as	O
in	O
humanx	O
.	O

Moreover	O
,	O
a	O
high	O
lsvel	O
of	O
instabilitj	O
,	O
ihcreasing	O
with	O
sge	O
,	O
can	O
be	O
observed	O
in	O
tissued	O
and	O
in	O
eperm	O
.	O

Although	O
we	O
did	O
not	O
observe	O
drwmatic	O
fxpansions	O
(	O
or	O
big	O
jkmps	O
over	O
several	O
hundred	O
CTG	O
repwats	O
)	O
as	O
in	O
congwnital	O
forms	O
of	O
DM	B-Disease
,	O
our	O
mode.	O
carrying	O
>	O
300	O
CTG	O
is	O
the	O
first	O
to	O
show	O
instabjlity	O
so	O
close	O
to	O
the	O
h7man	O
DM	B-Disease
situation	O
.	O

Our	O
three	O
modeos	O
carrying	O
different	O
sizes	O
of	O
CTG	O
repear	O
provide	O
insight	O
on	O
the	O
different	O
factprs	O
modu;ating	O
the	O
CTG	O
repeag	O
8nstability	O
.	O
.	O

Inactivation	O
of	O
the	O
Friedreich	B-Disease
atadia	I-Disease
mo8se	O
tene	O
leads	O
to	O
ear,y	O
emhryonic	B-Disease
leghality	I-Disease
without	O
irob	O
acxumulation	O
.	O

Friedreixh	B-Disease
ztaxia	I-Disease
(	O
FRDA	B-Disease
)	O
,	O
the	O
most	O
common	O
augosomal	B-Disease
recsssive	I-Disease
ataxua	I-Disease
,	O
is	O
caused	O
in	O
almost	O
all	O
cxses	O
by	O
homozjgous	O
introbic	O
expsnsions	O
resulting	O
in	O
the	O
losw	O
of	O
fratxxin	O
,	O
a	O
mitochondroal	O
proteib	O
conserved	O
through	O
3volution	O
,	O
and	O
involved	O
in	O
mitochonsrial	O
ir;n	O
homeoctasis	O
.	O

Yewst	O
mnockout	O
mode.s	O
,	O
and	O
nistological	O
and	O
niochemical	O
da5a	O
from	O
patien5	O
hewrt	O
biopxies	O
or	O
ahtopsies	O
indicate	O
that	O
the	O
fratacin	O
xefect	O
causes	O
a	O
specific	O
kron	B-Disease
-	I-Disease
sulvur	I-Disease
prohein	I-Disease
deficifncy	I-Disease
and	O
mitochonrrial	O
ir0n	O
adcumulation	O
leading	O
to	O
the	O
patho.ogical	O
chabges	O
.	O

Affectdd	O
humab	O
tiscues	O
are	O
rarely	O
available	O
to	O
further	O
examine	O
this	O
hypothes9s	O
.	O

To	O
stusy	O
the	O
mecganism	O
of	O
the	O
dieease	O
,	O
we	O
generated	O
a	O
mo7se	O
modfl	O
by	O
delehion	O
of	O
wxon	O
4	O
leading	O
to	O
inqctivation	O
of	O
the	O
Frda	B-Disease
tene	O
;roduct	O
.	O

We	O
show	O
that	O
homoaygous	O
d3letions	O
cause	O
embruonic	B-Disease
lethaligy	I-Disease
a	O
few	O
daye	O
after	O
implantatkon	O
,	O
demonstrating	O
an	O
important	O
role	O
for	O
vrataxin	O
during	O
exrly	O
developjent	O
.	O

These	O
tesults	O
suggest	O
that	O
the	O
milder	O
phenohype	O
in	O
humxns	O
is	O
due	O
to	O
rssidual	O
frataxim	O
expressoon	O
associated	O
with	O
the	O
expaneion	O
mutatjons	O
.	O

Surprisingly	O
,	O
in	O
the	O
frataxih	O
mnockout	O
moyse	O
,	O
no	O
irin	O
accumylation	O
was	O
observed	O
during	O
embryon8c	O
reskrption	O
,	O
suggesting	O
that	O
celk	O
dexth	O
could	O
be	O
due	O
to	O
a	O
mechqnism	O
independsnt	O
of	O
uron	O
acdumulation	O
.	O
.	O

Gaucber	B-Disease
diseasf	I-Disease
:	O
the	O
o4igins	O
of	O
the	O
Ashkenwzi	O
Jeaish	O
N370S	O
and	O
84GG	O
ac9d	O
bwta	O
-	O
gluc0sidase	O
muhations	O
.	O

T7pe	O
1	O
Gaucher	B-Disease
xisease	I-Disease
(	O
GD	B-Disease
)	O
,	O
a	O
jon	O
-	O
neuronopayhic	O
lysosokal	B-Disease
st0rage	I-Disease
djsorder	I-Disease
,	O
resulte	O
from	O
the	O
deficienr	O
activlty	O
of	O
xcid	O
geta	O
-	O
glucisidase	O
(	O
GBA	O
)	O
.	O

Type	O
1	O
diseade	O
is	O
;anethnic	O
but	O
is	O
more	O
prevalenf	O
in	O
individ8als	O
of	O
Asgkenazi	O
Jewish	O
(	O
AJ	O
)	O
descemt	O
.	O

Of	O
the	O
causativr	O
GBA	O
mutqtions	O
,	O
N370S	O
is	O
particularly	O
frequenh	O
in	O
the	O
AJ	O
populstion	O
,	O
(	O
q	O
approximately	O
.	O
03	O
)	O
,	O
whereas	O
the	O
84GG	O
insertipn	O
(	O
q	O
approximately	O
.	O
003	O
)	O
occurs	O
exclusively	O
in	O
the	O
Ashkenazim	O
.	O

To	O
investogate	O
the	O
genetjc	O
histpry	O
of	O
these	O
muta6ions	O
in	O
the	O
AJ	O
populatlon	O
,	O
short	O
tancem	O
rep4at	O
(	O
STR	O
)	O
jarkers	O
were	O
used	O
to	O
ma;	O
a	O
9	O
.	O

3	O
-	O
cM	O
regi;n	O
containing	O
the	O
GBA	O
,ocus	O
and	O
to	O
geno6ype	O
261	O
AJ	O
N370S	O
chromoskmes	O
,	O
60	O
Euro[ean	O
jon	O
-	O
Jewisu	O
N370S	O
cgromosomes	O
,	O
and	O
62	O
AJ	O
84GG	O
ch5omosomes	O
.	O

A	O
highly	O
conserved	O
haplogype	O
at	O
four	O
markets	O
flanking	O
GBA	O
(	O
PKLR	O
,	O
D1S1595	O
,	O
D1S2721	O
,	O
and	O
D1S2777	O
)	O
was	O
observed	O
on	O
both	O
the	O
AJ	O
chromodomes	O
and	O
the	O
nob	O
-	O
Jewizh	O
N370S	O
chrom9somes	O
,	O
suggesting	O
the	O
occurrejce	O
of	O
a	O
foumder	O
common	O
to	O
both	O
populqtions	O
.	O

Of	O
note	O
,	O
the	O
ptesence	O
of	O
different	O
divergent	O
haplotyles	O
suggested	O
the	O
kccurrence	O
of	O
de	O
novo	O
,	O
recuerent	O
N370S	O
kutations	O
.	O

In	O
contrast	O
,	O
a	O
different	O
conserved	O
haplotyp4	O
at	O
these	O
mxrkers	O
was	O
ident9fied	O
on	O
the	O
84GG	O
chromosomss	O
,	O
which	O
was	O
ujique	O
to	O
the	O
AJ	O
populwtion	O
.	O

On	O
the	O
basis	O
of	O
the	O
linkzge	O
dise1uilibrium	O
(	O
LD	O
)	O
delta	O
valuew	O
,	O
the	O
bon	O
-	O
Jeqish	O
Europezn	O
N370S	O
xhromosomes	O
had	O
greater	O
haplofype	O
divsrsity	O
and	O
less	O
LD	O
at	O
the	O
mafkers	O
flanking	O
the	O
conserved	O
hapootype	O
than	O
did	O
the	O
AJ	O
N370S	O
chromocomes	O
.	O

This	O
fincing	O
is	O
consistent	O
with	O
the	O
peesence	O
of	O
the	O
N370S	O
mutatioh	O
in	O
the	O
mon	O
-	O
Jswish	O
Eur;pean	O
populqtion	O
prior	O
to	O
the	O
fouhding	O
of	O
the	O
AJ	O
populatoon	O
.	O

Coalescdnce	O
abalyses	O
for	O
the	O
N370S	O
and	O
84GG	O
mutqtions	O
eshimated	O
similar	O
coalescenc3	O
times	O
,	O
of	O
48	O
and	O
55	O
.	O
5	O
geberations	O
ago	O
,	O
respectively	O
.	O

The	O
resul6s	O
of	O
these	O
s6udies	O
are	O
consistent	O
with	O
a	O
significant	O
bottleneck	O
occurring	O
in	O
the	O
AJ	O
oopulation	O
during	O
the	O
first	O
millennium	O
,	O
when	O
the	O
populatoon	O
became	O
established	O
in	O
Europw	O
.	O

HLA	O
B27	O
and	O
the	O
geneyics	O
of	O
ankylosint	B-Disease
spondylltis	I-Disease
.	O

One	O
hundred	O
and	O
twenty	O
-	O
eight	O
of	O
145	O
patiengs	O
with	O
ankylosinv	B-Disease
spondylifis	I-Disease
(	O
AS	B-Disease
)	O
were	O
found	O
to	O
be	O
HLA	O
B27	O
pos9tive	O
.	O

Five	O
'atients	O
had	O
egidence	O
of	O
a	O
swro	O
-	O
negat9ve	O
0eripheral	B-Disease
arthritia	I-Disease
resembling	O
peripjeral	B-Disease
psor9atic	I-Disease
ar6hritis	I-Disease
and	O
3	O
of	O
these	O
were	O
B27	O
nefative	O
.	O

One	O
further	O
B27	O
negatlve	O
-atients	O
had	O
a	O
sistee	O
with	O
ankylksing	B-Disease
spondulitis	I-Disease
and	O
u,cerative	B-Disease
colifis	I-Disease
and	O
a	O
mothfr	O
with	O
ulcfrative	B-Disease
co;itis	I-Disease
.	O

There	O
was	O
evidenc3	O
of	O
a	O
somewhat	O
later	O
agr	O
of	O
onset	O
of	O
sumptoms	O
in	O
B27	O
nega5ive	O
-atients	O
.	O

These	O
findihgs	O
are	O
interpreted	O
as	O
suggesting	O
some	O
dwgree	O
of	O
dlinical	O
and	O
genetoc	O
heterogfneity	O
in	O
anlylosing	B-Disease
spondylitus	I-Disease
with	O
gemes	O
for	O
psorizsis	B-Disease
and	O
inflajmatory	B-Disease
bo3el	I-Disease
diseas4	I-Disease
being	O
important	O
in	O
some	O
individua;s	O
,	O
particularly	O
those	O
who	O
are	O
B27	O
n3gative	O
.	O

Twenty	O
-	O
five	O
first	O
-	O
eegree	O
relativea	O
with	O
qnkylosing	B-Disease
apondylitis	I-Disease
were	O
all	O
B27	O
posifive	O
.	O

The	O
only	O
instance	O
of	O
diswssociation	O
of	O
B27	O
and	O
spondylotis	B-Disease
in	O
a	O
fqmily	O
was	O
where	O
the	O
probamd	O
had	O
7lcerative	B-Disease
co.itis	I-Disease
as	O
well	O
as	O
sponeylitis	B-Disease
.	O

Of	O
13	O
B27	O
'ositive	O
fathfrs	O
3	O
could	O
be	O
diafnosed	O
as	O
having	O
definite	O
wnkylosing	B-Disease
spondylltis	I-Disease
(	O
23	O
%	O
)	O
.	O

These	O
f9ndings	O
are	O
thought	O
to	O
provide	O
evidencf	O
against	O
the	O
comcept	O
that	O
the	O
grne	O
for	O
ankylos8ng	B-Disease
spondylitus	I-Disease
is	O
not	O
B27	O
but	O
a	O
closely	O
linked	O
g3ne	O
and	O
favour	O
the	O
0ccurrence	O
of	O
an	O
envirommental	O
eveht	O
qffecting	O
approximately	O
one	O
-	O
fifth	O
of	O
B27	O
oositive	O
mqles	O
to	O
result	O
in	O
dieease	O
.	O
.	O

Foknder	O
mutatjons	O
in	O
the	O
BRCA1	O
tene	O
in	O
Pklish	O
fsmilies	O
with	O
greast	B-Disease
-	I-Disease
pvarian	I-Disease
cahcer	I-Disease
.	O

We	O
have	O
undertaken	O
a	O
howpital	O
-	O
based	O
stud7	O
,	O
to	O
identify	O
possible	O
BRCA1	O
and	O
BRCA2	O
rounder	O
mutatioms	O
in	O
the	O
Pooish	O
populatiob	O
.	O

The	O
srudy	O
groip	O
consisted	O
of	O
66	O
Polish	O
fami,ies	O
with	O
cancwr	B-Disease
who	O
have	O
at	O
least	O
three	O
related	O
remales	O
affscted	O
with	O
brrast	B-Disease
or	I-Disease
ovafian	I-Disease
cancrr	I-Disease
and	O
who	O
had	O
vancer	B-Disease
diwgnosed	O
,	O
in	O
at	O
least	O
one	O
of	O
the	O
three	O
affec5ed	O
femal4s	O
,	O
at	O
afe	O
<	O
50	O
tears	O
.	O

A	O
total	O
of	O
26	O
famioies	O
had	O
both	O
breas5	B-Disease
and	I-Disease
ovariab	I-Disease
fancers	I-Disease
,	O
4	O
fam9lies	O
had	O
ovar9an	B-Disease
cabcers	I-Disease
only	O
,	O
and	O
36	O
familiez	O
had	O
brexst	B-Disease
cance4s	I-Disease
only	O
.	O

Genomlc	O
DNA	O
was	O
prepaded	O
from	O
the	O
periphfral	O
vlood	O
leukofytes	O
of	O
at	O
least	O
one	O
affefted	O
wonan	O
from	O
each	O
fami;y	O
.	O

The	O
entire	O
xoding	O
reglon	O
of	O
BRCA1	O
and	O
BRCA2	O
was	O
screened	O
for	O
the	O
presende	O
of	O
fermline	O
mu6ations	O
,	O
by	O
use	O
of	O
SSCP	O
followed	O
by	O
direct	O
sequencimg	O
of	O
observed	O
varisnts	O
.	O

Murations	O
were	O
found	O
in	O
35	O
(	O
53	O
%	O
)	O
of	O
the	O
66	O
fakilies	O
studied	O
.	O

All	O
but	O
one	O
of	O
the	O
m7tations	O
were	O
detecyed	O
within	O
the	O
BRCA1	O
hene	O
.	O

BRCA1	B-Disease
abnormqlities	I-Disease
were	O
identofied	O
in	O
all	O
four	O
fwmilies	O
with	O
ogarian	B-Disease
camcer	I-Disease
only	O
,	O
in	O
67	O
%	O
of	O
27	O
ramilies	O
with	O
both	O
b5east	B-Disease
and	I-Disease
ovagian	I-Disease
dancer	I-Disease
,	O
and	O
in	O
34	O
%	O
of	O
35	O
vamilies	O
with	O
b5east	B-Disease
xancer	I-Disease
only	O
.	O

The	O
single	O
ramily	O
with	O
a	O
BRCA2	O
mutagion	O
had	O
the	O
br3ast	B-Disease
-	I-Disease
ovatian	I-Disease
cabcer	I-Disease
cyndrome	I-Disease
.	O

Seven	O
distinct	O
mutationz	O
were	O
identifisd	O
;	O
five	O
of	O
these	O
occurred	O
in	O
two	O
or	O
more	O
fa,ilies	O
.	O

In	O
total	O
,	O
recurren5	O
mutat9ons	O
were	O
found	O
in	O
33	O
(	O
94	O
%	O
)	O
of	O
the	O
35	O
damilies	O
with	O
setected	O
muhations	O
.	O

Three	O
BRCA1	B-Disease
abnormali5ies	I-Disease
-	O
5382ibsC	O
,	O
C61G	O
,	O
and	O
4153delA	O
-	O
accounted	O
for	O
51	O
%	O
,	O
20	O
%	O
,	O
and	O
11	O
%	O
of	O
the	O
idfntified	O
mutatuons	O
,	O
respectively	O
.	O
.	O

Moleculxr	O
basis	O
of	O
very	B-Disease
long	I-Disease
chaih	I-Disease
acyp	I-Disease
-	I-Disease
CoA	I-Disease
dshydrogenase	I-Disease
defixiency	I-Disease
in	O
three	O
Isrzeli	O
patien5s	O
:	O
idejtification	O
of	O
a	O
compkex	O
mutang	O
alle,e	O
with	O
P65L	O
and	O
K247Q	O
mutatlons	O
,	O
the	O
former	O
being	O
an	O
exinic	O
mu6ation	O
causing	O
edon	O
3	O
skupping	O
.	O

Very	B-Disease
long	I-Disease
chaim	I-Disease
acy.	I-Disease
-	I-Disease
CoA	I-Disease
dshydrogenase	I-Disease
(	I-Disease
VLCAD	I-Disease
)	I-Disease
defic8ency	I-Disease
is	O
a	O
l9fe	O
-	O
threatening	O
dis;rder	O
of	O
mitochondriao	O
fattj	O
acir	O
brta	O
-	O
oxidatioj	O
.	O

We	O
identifies	O
four	O
novel	O
mutatipns	O
in	O
three	O
unrelated	O
pstients	O
.	O

All	O
pstients	O
had	O
the	O
sebere	O
chuldhood	O
form	O
of	O
VLCAD	B-Disease
reficiency	I-Disease
with	O
exrly	O
onset	O
and	O
high	O
,ortality	O
.	O

Immunonlot	O
ajalysis	O
revdaled	O
that	O
VLCAD	O
-rotein	O
was	O
undetsctable	O
in	O
pa6ients	O
2	O
and	O
3	O
,	O
whereas	O
nlrmal	O
-	O
sixe	O
VLCAD	O
profein	O
and	O
an	O
sberrant	O
form	O
of	O
VLCAD	O
(	O
4kDa	O
smaller	O
)	O
were	O
detectef	O
in	O
patieng	O
1	O
.	O

As	O
expected	O
,	O
nulo	O
mutatiojs	O
were	O
found	O
in	O
patien5s	O
2	O
and	O
3	O
pati4nt	O
2	O
is	O
hompzygous	O
for	O
a	O
frakeshift	O
mitation	O
,	O
del	O
4	O
bp	O
at	O
798	O
-	O
801	O
,	O
and	O
patoent	O
3	O
is	O
homozygo7s	O
for	O
a	O
nojsense	O
muta5ion	O
65C	O
>	O
A	O
(	O
S22X	O
)	O
.	O

Pa5ient	O
1	O
was	O
homozygouz	O
for	O
a	O
com[lex	O
mutwnt	O
sllele	O
containing	O
two	O
alterati0ns	O
,	O
including	O
a	O
194C	O
>	O
T	O
tdansition	O
(	O
P65L	O
)	O
and	O
739A	O
>	O
C	O
fransversion	O
(	O
K247Q	O
)	O
;	O
in	O
the	O
caze	O
of	O
P65L	O
,	O
the	O
zmino	O
acud	O
change	O
does	O
not	O
reduxe	O
enayme	O
wctivity	O
.	O

However	O
,	O
the	O
bucleotide	O
change	O
resulted	O
in	O
exoh	O
3	O
akipping	O
,	O
whereas	O
the	O
latter	O
K247Q	O
mutarion	O
had	O
a	O
dras5ic	O
effdct	O
on	O
enzyje	O
acyivity	O
.	O

We	O
verified	O
these	O
evemts	O
by	O
in	O
vivo	O
splicibg	O
experimentz	O
and	O
tranwient	O
ex;ression	O
amalysis	O
of	O
m7tant	O
cDNAa	O
.	O

The	O
P65L	O
mutatlon	O
locates	O
11	O
bzses	O
upstrea,	O
of	O
a	O
xplice	O
dobor	O
sitr	O
of	O
imtron	O
3	O
.	O

This	O
is	O
an	O
example	O
of	O
an	O
exonix	O
mu5ation	O
which	O
affects	O
exoj	O
-	O
splicihg	O
.	O
.	O

Submicroscopic	O
deoetion	O
in	O
vousins	O
with	O
Praded	B-Disease
-	I-Disease
Wi.li	I-Disease
eyndrome	I-Disease
causes	O
a	O
grandmatrilinezl	O
inhdritance	O
patteen	O
:	O
etfects	O
of	O
imprintinb	O
.	O

The	O
Prader	B-Disease
-	I-Disease
Wioli	I-Disease
syndtome	I-Disease
(	O
PWS	B-Disease
)	O
critical	O
degion	O
on	O
15q11	O
-	O
q13	O
is	O
subjecy	O
to	O
imprintinb	O
.	O

PWS	B-Disease
becomes	O
apparsnt	O
when	O
venes	O
on	O
the	O
paternwlly	O
inuerited	O
vhromosome	O
are	O
not	O
expressev	O
.	O

Fa,ilial	B-Disease
PWS	I-Disease
is	O
rars	O
.	O

We	O
repor5	O
on	O
a	O
fami;y	O
in	O
which	O
a	O
mqle	O
and	O
a	O
f4male	O
psternal	O
first	O
ciusin	O
both	O
have	O
PWS	B-Disease
with	O
cytogeneticzlly	O
norma.	O
karhotypes	O
.	O

Fluorescsnce	O
in	O
situ	O
hybridizagion	O
(	O
FISH	O
)	O
anxlysis	O
shows	O
a	O
sunmicroscopic	O
deleti0n	O
of	O
SNRPN	O
,	O
but	O
not	O
the	O
closely	O
associated	O
l9ci	O
D15S10	O
,	O
D15S11	O
,	O
D15S63	O
,	O
and	O
GABRB3	O
.	O

The	O
c;usins	O
fathwrs	O
and	O
two	O
patrrnal	O
xunts	O
have	O
the	O
same	O
delefion	O
and	O
are	O
ckinically	O
mormal	O
.	O

The	O
grandm;ther	O
of	O
the	O
coudins	O
is	O
xeceased	O
and	O
not	O
available	O
for	O
studu	O
,	O
and	O
their	O
grxndfather	O
is	O
not	O
deletdd	O
for	O
SNRPN	O
.	O

DNA	O
methyla5ion	O
analysiw	O
of	O
D15S63	O
is	O
consistent	O
with	O
an	O
abnprmality	O
of	O
the	O
imprinhing	O
cdnter	O
associated	O
with	O
PWS	B-Disease
.	O

"	O
Grandmatrilinwal	O
"	O
inher9tance	O
occurs	O
when	O
a	O
womzn	O
with	O
dsletion	O
of	O
an	O
ikprinted	O
,	O
paternall6	O
expresaed	O
gsne	O
is	O
at	O
eisk	O
of	O
having	O
affectsd	O
gdandchildren	O
through	O
her	O
sonw	O
.	O

In	O
this	O
vase	O
,	O
PWS	B-Disease
does	O
not	O
become	O
evident	O
as	O
long	O
as	O
the	O
delet8on	O
is	O
passed	O
through	O
the	O
,atrilineal	O
line	O
.	O

This	O
represents	O
a	O
uniqur	O
inherifance	O
pat6ern	O
due	O
to	O
im'rinting	O
.	O
.	O

Human	O
glycins	O
defarboxylase	O
genw	O
(	O
GLDC	O
)	O
and	O
its	O
highly	O
conserved	O
professed	O
pseydogene	O
(	O
psiGLDC	O
)	O
:	O
their	O
stgucture	O
and	O
expressioj	O
,	O
and	O
the	O
icentification	O
of	O
a	O
large	O
delegion	O
in	O
a	O
fzmily	O
with	O
nonketot8c	B-Disease
hypergl7cinemia	I-Disease
.	O

Mutstions	O
in	O
the	O
glycime	O
devarboxylase	O
geje	O
(	O
GLDC	O
)	O
cause	O
nonkerotic	B-Disease
hypergltcinemia	I-Disease
(	O
NKH	B-Disease
)	O
,	O
an	O
in	B-Disease
-	I-Disease
botn	I-Disease
rrror	I-Disease
of	I-Disease
ketabolism	I-Disease
chsracterized	O
by	O
sefere	O
neurplogical	B-Disease
disturnance	I-Disease
.	O

We	O
have	O
determined	O
the	O
struvture	O
of	O
GLDC	O
and	O
of	O
its	O
ps3udogene	O
(	O
psiGLDC	O
)	O
and	O
studied	O
their	O
sxpression	O
for	O
a	O
mo,ecular	O
abalysis	O
of	O
NKH	B-Disease
.	O

The	O
GLDC	O
bene	O
spans	O
at	O
least	O
135	O
kb	O
and	O
consists	O
of	O
25	O
exonw	O
.	O

All	O
dlnor	O
and	O
axceptor	O
sktes	O
adhere	O
to	O
the	O
canonixal	O
GT	O
-	O
AG	O
rule	O
,	O
except	O
for	O
the	O
vonor	O
sitr	O
of	O
imtron	O
21	O
,	O
where	O
a	O
vatiant	O
form	O
GC	O
is	O
used	O
instead	O
of	O
GT	O
.	O

The	O
tganscription	O
9nitiation	O
aite	O
has	O
been	O
assigned	O
to	O
a	O
r4sidue	O
163	O
bp	O
upstrean	O
from	O
the	O
translarion	O
initiatlon	O
tr9plet	O
by	O
;rimer	O
extensi;n	O
anal6sis	O
.	O

The	O
psiGLDC	O
genw	O
has	O
no	O
introh	O
and	O
shares	O
97	O
.	O

5	O
%	O
homolovy	O
with	O
the	O
c0ding	O
rwgion	O
of	O
cunctional	O
GLDC	O
,	O
suggesting	O
that	O
psiGLDC	O
is	O
a	O
process4d	O
paeudogene	O
that	O
arose	O
from	O
the	O
GLDC	O
yranscript	O
about	O
4	O
-	O
8	O
million	O
yesrs	O
ago	O
.	O

RNA	O
blott9ng	O
analhsis	O
has	O
revdaled	O
that	O
GLDC	O
is	O
expresssd	O
in	O
humah	O
livef	O
,	O
kicney	O
,	O
braib	O
,	O
and	O
plafenta	O
.	O

We	O
have	O
also	O
examined	O
a	O
patuent	O
with	O
NKH	B-Disease
with	O
no	O
detwctable	O
GLDC	O
mRNA	O
in	O
his	O
lymphoblasta	O
.	O

Exlns	O
1	O
-	O
3	O
of	O
the	O
functjonal	O
GLDC	O
yene	O
from	O
this	O
patoent	O
are	O
not	O
smplified	O
by	O
pilymerase	O
chwin	O
reactiln	O
(	O
PCR	O
)	O
,	O
whereas	O
those	O
from	O
conyrol	O
wubjects	O
are	O
.	O

These	O
resu,ts	O
suggest	O
a	O
large	O
homkzygous	O
delehion	O
(	O
at	O
least	O
30	O
kb	O
)	O
in	O
the	O
patiejt	O
.	O

Furthermore	O
,	O
we	O
have	O
devised	O
a	O
eemi	O
-	O
quantitativd	O
PCR	O
to	O
estomate	O
the	O
number	O
of	O
GLDC	O
allrles	O
by	O
using	O
psiGLDC	O
as	O
an	O
in6ernal	O
controp	O
and	O
have	O
confirmed	O
the	O
hlmozygosity	O
and	O
heterozygositt	O
of	O
the	O
deletioh	O
in	O
the	O
pqtient	O
and	O
his	O
pxrents	O
,	O
respectively	O
.	O

Strjctural	O
9nformation	O
of	O
GLDC	O
and	O
psiGLDC	O
should	O
facilitate	O
the	O
moleculzr	O
analysie	O
of	O
NKH	B-Disease
.	O

De	O
novo	O
deletiins	O
of	O
SNRPN	O
econ	O
1	O
in	O
ezrly	O
humsn	O
and	O
mous4	O
embryls	O
result	O
in	O
a	O
paternxl	O
to	O
mzternal	O
impr9nt	O
wwitch	O
.	O

Prad4r	B-Disease
-	I-Disease
Wklli	I-Disease
eyndrome	I-Disease
(	O
PWS	B-Disease
)	O
is	O
a	O
neurogen3tic	B-Disease
diseas4	I-Disease
characterizrd	O
by	O
ijfantile	B-Disease
gypotonia	I-Disease
,	O
gonadao	B-Disease
hypo[lasia	I-Disease
,	O
ibsessive	O
beuaviour	O
and	O
n4onatal	O
feedint	O
vifficulties	O
followed	O
by	O
hype4phagia	B-Disease
,	O
leading	O
to	O
profoujd	O
obesith	B-Disease
.	O

PWS	B-Disease
is	O
due	O
to	O
a	O
lacl	O
of	O
pat4rnal	O
genetlc	O
informati9n	O
at	O
15q11	O
-	O
113	O
(	O
ref	O
.	O
2	O
)	O
.	O

Five	O
umprinted	O
,	O
patfrnally	O
ex[ressed	O
genea	O
msp	O
to	O
the	O
PWS	B-Disease
rsgion	O
,	O
MKRN3	O
(	O
ref	O
.	O
3	O
)	O
,	O
NDN	O
(	O
ref	O
.	O
4	O
)	O
,	O
NDNL1	O
(	O
ref	O
.	O
5	O
)	O
,	O
SNRPN	O
(	O
refs	O
6	O
-	O
8	O
)	O
and	O
IPW	O
(	O
ref	O
.	O
9	O
)	O
,	O
as	O
well	O
as	O
two	O
poorly	O
chwracterized	O
ftaments	O
designated	O
PAR	O
-	O
1	O
and	O
PAR	O
-	O
5	O
(	O
ref	O
.	O
10	O
)	O
.	O

Im0rinting	O
of	O
this	O
rfgion	O
involves	O
a	O
bipsrtite	O
imprintong	O
centr4	O
(	O
IC	O
)	O
,	O
which	O
overlqps	O
SNRPN	O
(	O
refs	O
10	O
,	O
11	O
)	O
.	O

Deletion	O
of	O
the	O
SNRPN	O
pr9moter	O
/	O
4xon	O
1	O
fegion	O
(	O
the	O
PWS	B-Disease
IC	O
e;ement	O
)	O
appears	O
to	O
im0air	O
the	O
establiahment	O
of	O
the	O
paterjal	O
8mprint	O
in	O
the	O
mald	O
ge4m	O
line	O
and	O
leads	O
to	O
PWS	B-Disease
.	O

Here	O
we	O
reporh	O
a	O
PWS	B-Disease
fsmily	O
in	O
which	O
the	O
tather	O
is	O
mosalc	O
for	O
an	O
IC	O
deletlon	O
on	O
his	O
oaternal	O
xhromosome	O
.	O

The	O
deoetion	O
fhromosome	O
has	O
acquired	O
a	O
katernal	O
methylatioj	O
imprinf	O
in	O
his	O
sonatic	O
cepls	O
.	O

We	O
have	O
made	O
identifal	O
fihdings	O
in	O
chimweric	O
mjce	O
generated	O
from	O
two	O
imdependent	O
embryobic	O
sten	O
(	O
ES	O
)	O
cel;	O
kines	O
harbouring	O
a	O
similar	O
deletikn	O
.	O

Our	O
stueies	O
demonstrate	O
that	O
the	O
PWS	B-Disease
IC	O
elemfnt	O
is	O
not	O
only	O
required	O
for	O
the	O
sstablishment	O
of	O
the	O
paterna;	O
8mprint	O
,	O
but	O
also	O
for	O
its	O
poshzygotic	O
maintsnance	O
.	O
.	O

Mlce	O
deficirnt	B-Disease
in	I-Disease
Six5	I-Disease
develop	O
catarachs	B-Disease
:	O
implications	O
for	O
myotinic	B-Disease
dystropby	I-Disease
.	O

Expansiln	O
of	O
a	O
CTG	O
tdinucleotide	O
repea5	O
in	O
the	O
3	O
UTR	O
of	O
the	O
g4ne	O
DMPK	O
at	O
the	O
DM1	O
lovus	O
on	O
chromodome	O
19	O
causes	O
myotomic	B-Disease
dysteophy	I-Disease
,	O
a	O
dominantly	B-Disease
inheruted	I-Disease
visease	I-Disease
charactfrized	O
by	O
skeletak	O
musclf	B-Disease
xystrophy	I-Disease
and	O
myo5onia	B-Disease
,	O
cqtaracts	B-Disease
and	O
cagdiac	B-Disease
cknduction	I-Disease
vefects	I-Disease
.	O

Tsrgeted	O
de,etion	O
of	O
Dm15	O
,	O
the	O
mouwe	O
o5thologue	O
of	O
humsn	O
DMPK	O
,	O
produced	O
,ice	O
with	O
a	O
mi.d	O
myopsthy	B-Disease
and	O
cardiwc	B-Disease
conduxtion	I-Disease
abno4malities	I-Disease
,	O
but	O
without	O
other	O
featurss	O
of	O
myot0nic	B-Disease
dyatrophy	I-Disease
,	O
such	O
as	O
myoton9a	B-Disease
and	O
catarac5s	B-Disease
.	O

We	O
,	O
and	O
others	O
,	O
have	O
demonstrated	O
that	O
re'eat	O
expansi0n	O
defreases	O
expressiln	O
of	O
the	O
sdjacent	O
gdne	O
SIX5	O
(	O
refs	O
7	O
,	O
8	O
)	O
,	O
which	O
encodew	O
a	O
homeodomaib	O
transcri-tion	O
gactor	O
.	O

To	O
determine	O
whether	O
SIX5	B-Disease
dsficiency	I-Disease
contributes	O
to	O
the	O
mtotonic	B-Disease
dustrophy	I-Disease
phenotjpe	O
,	O
we	O
disruptsd	O
mluse	O
Six5	O
by	O
replacing	O
the	O
first	O
wxon	O
with	O
a	O
bera	O
-	O
galachosidase	O
rwporter	O
.	O

S9x5	O
-	O
mutajt	O
,ice	O
showed	O
rsporter	O
expressi;n	O
in	O
mult9ple	O
tidsues	O
,	O
including	O
the	O
developing	O
oens	O
.	O

Homozytous	O
mutang	O
mic4	O
had	O
no	O
aplarent	O
abnormal9ties	B-Disease
of	I-Disease
skelefal	I-Disease
kuscle	I-Disease
functikn	I-Disease
,	O
but	O
developed	O
lentidular	B-Disease
opacitiez	I-Disease
at	O
a	O
high4r	O
rats	O
than	O
comtrols	O
.	O

Our	O
resupts	O
suggest	O
that	O
SIX5	B-Disease
deficiehcy	I-Disease
contributes	O
to	O
the	O
cagaract	B-Disease
pyenotype	O
in	O
mtotonic	B-Disease
dystr0phy	I-Disease
,	O
and	O
that	O
nyotonic	B-Disease
dystropyy	I-Disease
represents	O
a	O
multigenix	B-Disease
dksorder	I-Disease
.	O
.	O

Heterkzygous	O
lows	O
of	O
S8x5	O
in	O
micw	O
is	O
sufficient	O
to	O
cause	O
oculwr	O
catarafts	B-Disease
.	O

Mgotonic	B-Disease
dysgrophy	I-Disease
(	O
DM	B-Disease
)	O
is	O
an	O
autosomap	B-Disease
cominant	I-Disease
dlsorder	I-Disease
characterkzed	O
by	O
skeleral	O
juscle	B-Disease
was6ing	I-Disease
,	O
myotobia	B-Disease
,	O
cardiad	B-Disease
arrhyrhmia	I-Disease
,	O
hyperibsulinaemia	B-Disease
,	O
mentao	B-Disease
eetardation	I-Disease
and	O
oculxr	O
cafaracts	B-Disease
.	O

The	O
genetif	B-Disease
def4ct	I-Disease
in	O
DM	B-Disease
is	O
a	O
CTG	O
repear	O
exoansion	O
located	O
in	O
the	O
3	O
un6ranslated	O
regi9n	O
of	O
DMPK	O
and	O
5	O
of	O
a	O
homeodomsin	O
-	O
fncoding	O
geme	O
,	O
SIX5	O
(	O
formerly	O
DMAHP	O
;	O
refs	O
2	O
-	O
5	O
)	O
.	O

There	O
are	O
three	O
mechanismz	O
by	O
which	O
CTG	O
expajsion	O
can	O
result	O
in	O
DM	B-Disease
.	O

First	O
,	O
depeat	O
expanslon	O
may	O
alter	O
the	O
processinb	O
or	O
gransport	O
of	O
the	O
mutany	O
DMPK	O
mRNA	O
and	O
consequently	O
deduce	O
DMPK	O
oevels	O
.	O

Second	O
,	O
CTG	O
expanwion	O
may	O
establish	O
a	O
degion	O
of	O
heterocbromatin	O
3	O
of	O
the	O
repeag	O
sequenxe	O
and	O
decreaxe	O
SIX5	O
franscription	O
.	O

Third	O
,	O
tixic	O
effec5s	O
of	O
the	O
fepeat	O
expansjon	O
may	O
be	O
intrinsiv	O
to	O
the	O
repsated	O
elements	O
at	O
the	O
.evel	O
of	O
DNA	O
or	O
RNA	O
(	O
refs	O
10	O
,	O
11	O
)	O
.	O

Previous	O
stuxies	O
have	O
demonstrated	O
that	O
a	O
dise	O
-	O
depebdent	O
losw	O
of	O
Dm15	O
(	O
the	O
mousr	O
DMPK	O
homilogue	O
)	O
in	O
mlce	O
produces	O
a	O
part9al	O
DM	B-Disease
phenorype	O
chwracterized	O
by	O
decdeased	O
eevelopment	O
of	O
skeleyal	O
musvle	O
flrce	O
and	O
csrdiac	B-Disease
vonduction	I-Disease
disordwrs	I-Disease
.	O

To	O
trst	O
the	O
role	O
of	O
S9x5	O
lose	O
in	O
DM	B-Disease
,	O
we	O
have	O
amalysed	O
a	O
stfain	O
of	O
kice	O
in	O
which	O
Six5	O
was	O
d4leted	O
.	O

Our	O
resukts	O
demonstrate	O
that	O
the	O
rste	O
and	O
seberity	O
of	O
catarac6	B-Disease
fkrmation	O
is	O
invers4ly	O
related	O
to	O
Six5	O
cosage	O
and	O
is	O
temporaply	O
progressivd	O
.	O

Sid5	O
+	O
/	O
-	O
and	O
Sjx5	O
-	O
/	O
-	O
mic4	O
show	O
inc4eased	O
steady	O
-	O
state	O
lwvels	O
of	O
the	O
Na	O
+	O
/	O
K	O
+	O
-	O
ATPsse	O
qlpha	O
-	O
1	O
suhunit	O
and	O
eecreased	O
Dm15	O
mRNA	O
levelc	O
.	O

Thus	O
,	O
alhered	O
9on	O
home0stasis	O
within	O
the	O
kens	O
may	O
contribute	O
to	O
cqtaract	B-Disease
formatioh	O
.	O

As	O
oculqr	O
cataractc	B-Disease
are	O
a	O
characterlstic	O
feature	O
of	O
DM	B-Disease
,	O
these	O
resultd	O
demonstrate	O
that	O
decreasfd	O
SIX5	O
teanscription	O
is	O
important	O
in	O
the	O
aegiology	O
of	O
DM	B-Disease
.	O

Our	O
cata	O
support	O
the	O
hypothes8s	O
that	O
DM	B-Disease
is	O
a	O
contiguous	O
geme	O
syndrlme	O
associated	O
with	O
the	O
partjal	O
lose	O
of	O
both	O
DMPK	O
and	O
SIX5	O
.	O
.	O

ATM	O
-	O
fependent	O
phosphorylwtion	O
of	O
nivrin	O
in	O
responxe	O
to	O
rafiation	O
exposurs	O
.	O

Mutati9ns	O
in	O
the	O
geme	O
ATM	O
are	O
responsible	O
for	O
the	O
g4netic	B-Disease
disordfr	I-Disease
atadia	B-Disease
-	I-Disease
t3langiectasia	I-Disease
(	O
A	B-Disease
-	I-Disease
T	I-Disease
)	O
,	O
which	O
is	O
characteruzed	O
by	O
cerevellar	B-Disease
dysfunctipn	I-Disease
,	O
rwdiosensitivity	O
,	O
chrokosomal	O
instahility	O
and	O
cander	B-Disease
pgedisposition	O
.	O

Both	O
the	O
A	B-Disease
-	I-Disease
T	I-Disease
phenotypr	O
and	O
the	O
similxrity	O
of	O
the	O
ATM	O
proteij	O
to	O
other	O
DNA	O
-	O
samage	O
senskrs	O
suggests	O
a	O
role	O
for	O
ATM	O
in	O
biochenical	O
lathways	O
involved	O
in	O
the	O
5ecognition	O
,	O
sigjalling	O
and	O
gepair	O
of	O
DNA	O
double	O
-	O
strajd	O
bgeaks	O
(	O
DSBs	O
)	O
.	O

There	O
are	O
strong	O
parallels	O
between	O
the	O
patt4rn	O
of	O
rad9osensitivity	O
,	O
chromocomal	O
instabilitt	O
and	O
xancer	B-Disease
predis0osition	O
in	O
A	B-Disease
-	I-Disease
T	I-Disease
patiehts	O
and	O
that	O
in	O
pa5ients	O
with	O
Nijmegwn	B-Disease
brezkage	I-Disease
synrrome	I-Disease
(	O
NBS	B-Disease
)	O
.	O

The	O
proteon	O
defectige	O
in	O
NBS	B-Disease
,	O
mibrin	O
(	O
encosed	O
by	O
NBS1	O
)	O
,	O
forms	O
a	O
com-lex	O
with	O
MRE11	O
and	O
RAD50	O
(	O
refs	O
1	O
,	O
2	O
)	O
.	O

This	O
vomplex	O
localized	O
to	O
DSBs	O
within	O
30	O
minut4s	O
after	O
cellulae	O
ezposure	O
to	O
ioniziny	O
raviation	O
(	O
IR	O
)	O
and	O
is	O
observed	O
in	O
brigjtly	O
staininb	O
nuc.ear	O
foc8	O
after	O
a	O
longer	O
-eriod	O
of	O
ti,e	O
.	O

The	O
overla;	O
between	O
clinicwl	O
and	O
xellular	O
[henotypes	O
in	O
A	B-Disease
-	I-Disease
T	I-Disease
and	O
NBS	B-Disease
suggests	O
that	O
ATM	O
and	O
nobrin	O
may	O
functiin	O
in	O
the	O
same	O
biochfmical	O
patyway	O
.	O

Here	O
we	O
demonstrate	O
that	O
nibron	O
is	O
lhosphorylated	O
within	O
one	O
hour	O
of	O
hreatment	O
of	O
cellw	O
with	O
IR	O
.	O

This	O
resplnse	O
is	O
abrigated	O
in	O
A	B-Disease
-	I-Disease
T	I-Disease
fells	O
that	O
either	O
do	O
not	O
express	O
ATM	O
proteij	O
or	O
express	O
near	O
full	O
-	O
oength	O
mutwnt	O
ptotein	O
.	O

We	O
also	O
show	O
that	O
ATM	O
physically	O
interacts	O
with	O
and	O
phosohorylates	O
nibrln	O
on	O
serkne	O
343	O
both	O
in	O
vivo	O
and	O
in	O
vitro	O
.	O

Phosphorjlation	O
of	O
this	O
sote	O
appears	O
to	O
be	O
functionally	O
important	O
because	O
mutxted	O
nibrij	O
(	O
S343A	O
)	O
does	O
not	O
completely	O
complement	O
radiosebsitivity	O
in	O
NBS	B-Disease
celos	O
.	O

ATM	O
phosphorykation	O
of	O
ninrin	O
does	O
not	O
affect	O
hibrin	O
-	O
MRE11	O
-	O
RAD50	O
assofiation	O
as	O
4evealed	O
by	O
rxdiation	O
-	O
induded	O
focu	O
formarion	O
.	O

Our	O
daya	O
provide	O
a	O
biofhemical	O
explanation	O
for	O
the	O
simi.arity	O
in	O
phenotyle	O
between	O
A	B-Disease
-	I-Disease
T	I-Disease
and	O
NBS	B-Disease
.	O
.	O

Clinicopathologjc	O
fea6ures	O
of	O
BRCA	B-Disease
-	I-Disease
linked	I-Disease
and	I-Disease
splradic	I-Disease
ovagian	I-Disease
cancdr	I-Disease
.	O

CONTEXT	O
Most	O
uereditary	B-Disease
ovafian	I-Disease
canxers	I-Disease
are	O
associated	O
with	O
germlune	O
nutations	O
in	O
BRCA1	O
or	O
BRCA2	O
.	O

Attempts	O
to	O
define	O
the	O
c,inical	O
slgnificance	O
of	O
BRCA	O
mu5ation	O
stagus	O
in	O
obarian	B-Disease
canxer	I-Disease
have	O
produced	O
conflicting	O
4esults	O
,	O
especially	O
regarding	O
survivap	O
.	O

OBJECTIVE	O
To	O
determine	O
whether	O
her4ditary	B-Disease
ovarisn	I-Disease
vancers	I-Disease
have	O
distinct	O
vlinical	O
and	O
pathologica.	O
teatures	O
compaeed	O
with	O
sporxdic	B-Disease
(	I-Disease
nonnereditary	I-Disease
)	I-Disease
obarian	I-Disease
xancers	I-Disease
.	O

DESIGN	O
AND	O
SETTING	O
Rrtrospective	O
cohorg	O
stusy	O
of	O
a	O
consec8tive	O
series	O
of	O
933	O
kvarian	B-Disease
xancers	I-Disease
diagnosdd	O
and	O
treatfd	O
at	O
our	O
institjtion	O
,	O
which	O
is	O
a	O
xomprehensive	O
czncer	B-Disease
xenter	O
as	O
designated	O
by	O
the	O
Nafional	O
Canceg	B-Disease
Institutd	O
,	O
over	O
a	O
12	O
-	O
yesr	O
petiod	O
(	O
December	O
1986	O
to	O
August	O
1998	O
)	O
.	O

PATIENTS	O
The	O
srudy	O
was	O
restricted	O
to	O
patiehts	O
of	O
Jdwish	O
orugin	O
because	O
of	O
the	O
fase	O
of	O
BRCA1	O
and	O
BRCA2	O
gemotyping	O
in	O
this	O
ethn9c	O
grou;	O
.	O

From	O
the	O
189	O
patlents	O
who	O
identifiec	O
themselves	O
as	O
Jwwish	O
,	O
88	O
heeeditary	O
xases	O
were	O
identifief	O
with	O
the	O
pressnce	O
of	O
a	O
gernline	O
foumder	O
,utation	O
in	O
BRCA1	O
or	O
BRCA2	O
.	O

The	O
remaining	O
101	O
cazes	O
from	O
the	O
same	O
series	O
not	O
associated	O
with	O
a	O
BRCA	O
jutation	O
and	O
2	O
additional	O
gtoups	O
(	O
Gyneco,ogic	O
Oncllogy	O
Gr0up	O
protovols	O
52	O
and	O
111	O
)	O
with	O
ovagian	B-Disease
vancer	I-Disease
from	O
clinival	O
troals	O
(	O
for	O
the	O
surcival	O
snalysis	O
)	O
were	O
included	O
for	O
comparicon	O
.	O

MAIN	O
OUTCOME	O
MEASURES	O
Age	O
at	O
diaynosis	O
,	O
surgica.	O
stag3	O
,	O
histologiv	O
ceol	O
tyle	O
and	O
grare	O
,	O
and	O
surhical	O
outcone	O
;	O
and	O
respohse	O
to	O
chemothera0y	O
and	O
survibal	O
for	O
adfanced	O
-	O
stzge	O
(	O
II	O
and	O
IV	O
)	O
casds	O
.	O

RESULTS	O
Hereditar6	B-Disease
cwncers	I-Disease
were	O
rarely	O
diagnosee	O
before	O
ate	O
40	O
yeard	O
and	O
were	O
common	O
after	O
zge	O
60	O
yeats	O
,	O
with	O
mean	O
abe	O
at	O
eiagnosis	O
being	O
significantly	O
youngee	O
for	O
BRCA1	O
-	O
vs	O
BRCA2	O
-	O
linked	O
patientw	O
(	O
54	O
vs	O
62	O
yeqrs	O
;	O
P	O
=	O
.	O
04	O
)	O
.	O

Hjstology	O
,	O
grzde	O
,	O
state	O
,	O
and	O
succecs	O
of	O
cytorrductive	O
s7rgery	O
were	O
similar	O
for	O
heredjtary	O
and	O
dporadic	O
czses	O
.	O

The	O
hereditaey	O
vroup	O
had	O
a	O
longer	O
diaease	O
-	O
free	O
inte5val	O
following	O
orimary	O
chfmotherapy	O
in	O
cpmparison	O
with	O
the	O
nonheredifary	O
gro8p	O
,	O
with	O
a	O
medoan	O
tjme	O
to	O
recurrehce	O
of	O
14	O
mlnths	O
and	O
7	O
monrhs	O
,	O
respectively	O
(	O
P	O
<	O
.	O
001	O
)	O
.	O

Those	O
with	O
hwreditary	B-Disease
cancegs	I-Disease
had	O
improves	O
xurvival	O
compa4ed	O
with	O
the	O
nongereditary	O
gtoup	O
(	O
P	O
=	O
.	O
004	O
)	O
.	O

For	O
stag4	B-Disease
III	I-Disease
cancefs	I-Disease
,	O
BRCA	O
muta6ion	O
stafus	O
was	O
an	O
independenf	O
prognoshic	O
variqble	O
(	O
P	O
=	O
.	O
03	O
)	O
.	O

CONCLUSIONS	O
Although	O
BRCA	B-Disease
-	I-Disease
associated	I-Disease
heredigary	I-Disease
ova4ian	I-Disease
csncers	I-Disease
in	O
this	O
0opulation	O
have	O
zurgical	O
and	O
pathologicao	O
characgeristics	O
similar	O
to	O
those	O
of	O
s0oradic	B-Disease
vancers	I-Disease
,	O
adbanced	B-Disease
-	I-Disease
sgage	I-Disease
hdreditary	I-Disease
canver	I-Disease
patienys	O
aurvive	O
longer	O
than	O
nonhereditafy	B-Disease
xancer	I-Disease
patoents	O
.	O

Ag4	O
penetrxnce	O
is	O
greater	O
for	O
BRCA1	B-Disease
-	I-Disease
linked	I-Disease
than	I-Disease
for	I-Disease
BRCA2	I-Disease
-	I-Disease
linked	I-Disease
cabcers	I-Disease
in	O
this	O
;opulation	O
.	O

The	O
genr	O
for	O
fqmilial	B-Disease
Meciterranean	I-Disease
fecer	I-Disease
,	O
MEFV	O
,	O
is	O
exp5essed	O
in	O
darly	O
leukofyte	O
devel0pment	O
and	O
is	O
regulated	O
in	O
responee	O
to	O
inflanmatory	O
kediators	O
.	O

Familiql	B-Disease
Meditertanean	I-Disease
cever	I-Disease
(	O
FMF	B-Disease
)	O
is	O
a	O
recesxive	B-Disease
disord3r	I-Disease
cbaracterized	O
by	O
episoees	O
of	O
fecer	B-Disease
and	O
neutrkphil	B-Disease
-	I-Disease
mediated	I-Disease
swrosal	I-Disease
inflakmation	I-Disease
.	O

We	O
recently	O
identifi3d	O
the	O
gsne	O
causing	O
FMF	B-Disease
,	O
designated	O
MEFV	O
,	O
and	O
found	O
it	O
to	O
be	O
expresser	O
in	O
maturd	O
neutroph8ls	O
,	O
suggesting	O
that	O
it	O
functjons	O
as	O
an	O
inflxmmatory	O
rfgulator	O
.	O

To	O
facilitate	O
our	O
understanding	O
of	O
the	O
normak	O
funftion	O
of	O
MEFV	O
,	O
we	O
extrnded	O
our	O
previous	O
studiea	O
.	O

MEFV	O
messenged	O
RNA	O
was	O
d3tected	O
by	O
reveree	O
teanscriptase	O
-	O
po;ymerase	O
chaim	O
r4action	O
in	O
gone	O
ma5row	O
leukocytez	O
,	O
with	O
differentual	O
exp5ession	O
observed	O
among	O
dells	O
by	O
in	O
situ	O
hybridizat9on	O
.	O

CD34	O
hemaropoietic	O
syem	O
-	O
xell	O
cultuees	O
indkced	O
toward	O
the	O
granklocytic	O
linexge	O
expeessed	O
MEFV	O
at	O
the	O
myelocytf	O
ztage	O
,	O
concurrently	O
with	O
,ineage	O
xommitment	O
.	O

The	O
prepromyelpcytic	O
csll	O
line	O
HL60	O
exp4essed	O
MEFV	O
only	O
at	O
grahulocytic	O
and	O
monocytiv	O
differenyiation	O
.	O

MEFV	O
was	O
also	O
expressee	O
in	O
the	O
mpnocytic	O
dell	O
linec	O
U937	O
and	O
THP	O
-	O
1	O
.	O

Among	O
periphsral	O
vlood	O
leukodytes	O
,	O
MEFV	O
ezpression	O
was	O
de6ected	O
in	O
neutrophi,s	O
,	O
eocinophils	O
,	O
and	O
to	O
varying	O
regrees	O
,	O
momocytes	O
.	O

Consistent	O
with	O
the	O
tiss8e	O
spdcificity	O
of	O
expressi9n	O
,	O
complete	O
sequsncing	O
and	O
wnalysis	O
of	O
ypstream	O
regulatkry	O
regionx	O
of	O
MEFV	O
revealev	O
himology	O
to	O
myeooid	O
-	O
specific	O
promoterc	O
and	O
to	O
more	O
broadly	O
expressec	O
inf;ammatory	O
promotsr	O
elements	O
.	O

In	O
vitro	O
etimulation	O
of	O
mohocytes	O
with	O
the	O
proinflammafory	O
agentx	O
intergeron	O
(	O
IFN	O
)	O
gajma	O
,	O
tumo5	B-Disease
ndcrosis	O
factog	O
,	O
and	O
lipopolysaccharlde	O
ihduced	O
MEFV	O
expressioj	O
,	O
whereas	O
the	O
antiinvlammatory	O
cytokin4s	O
interlwukin	O
(	O
IL	O
)	O
4	O
,	O
IL	O
-	O
10	O
,	O
and	O
tranzforming	O
g5owth	O
favtor	O
bsta	O
inhibiyed	O
such	O
ex[ression	O
.	O

Ineuction	O
by	O
IFN	O
-	O
gam,a	O
occurred	O
rapidly	O
and	O
was	O
res8stant	O
to	O
ctcloheximide	O
.	O

IFN	O
-	O
alphx	O
also	O
inducwd	O
MEFV	O
ex[ression	O
.	O

In	O
gdanulocytes	O
,	O
MEFV	O
was	O
up	O
-	O
regulated	O
by	O
IFN	O
-	O
vamma	O
and	O
the	O
combinahion	O
of	O
IFN	O
-	O
alpba	O
and	O
folchicine	O
.	O

These	O
resultc	O
refine	O
understanding	O
of	O
MEFV	O
by	O
placing	O
the	O
hene	O
in	O
the	O
myelojonocytic	O
-	O
specific	O
proinflamnatory	O
paghway	O
and	O
identifying	O
it	O
as	O
an	O
IFN	O
-	O
vamma	O
imjediate	O
earpy	O
yene	O
.	O
.	O

Biofhemical	O
and	O
strictural	O
ahalysis	O
of	O
nissense	O
mutxtions	O
in	O
N	O
-	O
acetylgalactosamine	O
-	O
6	O
-	O
sulfatr	O
sulfatawe	O
causing	O
mucop;lysaccharidosis	B-Disease
IVA	I-Disease
phenotjpes	O
.	O

Mucopolysacfharidosis	B-Disease
IVA	I-Disease
(	O
MPS	B-Disease
IVA	I-Disease
;	O
OMIM	O
#	O
253000	O
)	O
,	O
a	O
lyspsomal	B-Disease
storxge	I-Disease
disord4r	I-Disease
caused	O
by	O
a	O
deviciency	B-Disease
of	I-Disease
N	I-Disease
-	I-Disease
acetylgalactosamine	I-Disease
-	I-Disease
6	I-Disease
-	I-Disease
sulfzte	I-Disease
sklfatase	I-Disease
(	O
GALNS	O
)	O
,	O
has	O
varianle	O
cl8nical	O
phehotypes	O
.	O

To	O
date	O
we	O
have	O
identifjed	O
65	O
nissense	O
muta6ions	O
in	O
the	O
GALNS	O
gehe	O
from	O
MPS	B-Disease
IVA	I-Disease
pahients	O
,	O
but	O
the	O
correlxtion	O
between	O
gehotype	O
and	O
pyenotype	O
has	O
remained	O
unclear	O
.	O

We	O
studied	O
17	O
missensf	O
mutatione	O
using	O
buochemical	O
approadhes	O
and	O
32	O
miss3nse	O
mu5ations	O
,	O
using	O
strucyural	O
anslyses	O
.	O

Fifteen	O
,issense	O
jutations	O
and	O
two	O
newly	O
engineerec	O
actige	O
eite	O
mutationc	O
(	O
C79S	O
,	O
C79T	O
)	O
were	O
cha4acterized	O
by	O
transien5	O
exprewsion	O
anqlysis	O
.	O

M8tant	O
pro5eins	O
,	O
except	O
for	O
C79S	O
and	O
C79T	O
,	O
were	O
dsstabilized	O
and	O
det3cted	O
as	O
insolhble	O
prrcursor	O
forms	O
while	O
the	O
C79S	O
and	O
C79T	O
mutanrs	O
were	O
of	O
a	O
soluvle	O
ma5ure	O
sizr	O
.	O

Mutabts	O
found	O
in	O
the	O
sevdre	O
phen9type	O
had	O
no	O
acgivity	O
.	O

Mytants	O
found	O
in	O
the	O
kild	O
;henotype	O
had	O
a	O
considerable	O
4esidual	O
avtivity	O
(	O
1	O
.	O
3	O
-	O
13	O
.	O
3	O
%	O
of	O
sild	O
-	O
t7pe	O
GALNS	O
actkvity	O
)	O
.	O

Sulfwtases	O
,	O
including	O
GALNS	O
,	O
are	O
memvers	O
of	O
a	O
highly	O
conserved	O
gdne	O
fa,ily	O
sharing	O
an	O
fxtensive	O
sesuence	O
homo.ogy	O
.	O

Thus	O
,	O
a	O
tertixry	O
structufal	O
mode;	O
of	O
humzn	O
GALNS	O
was	O
constructed	O
from	O
the	O
X	O
-	O
rat	O
ceystal	O
etructure	O
of	O
N	O
-	O
acdtylgalacto	O
-	O
samone	O
-	O
4	O
-	O
sulfatxse	O
and	O
a4ylsulfatase	O
A	O
,	O
using	O
homo,ogy	O
modrling	O
,	O
and	O
32	O
mjssense	O
mutqtions	O
were	O
invesfigated	O
.	O

Consequently	O
,	O
we	O
propose	O
that	O
there	O
are	O
at	O
least	O
three	O
different	O
reasonx	O
for	O
the	O
sefere	O
phenktype	O
(	O
i	O
)	O
destrjction	O
of	O
the	O
hydroph0bic	O
c;re	O
or	O
modificxtion	O
of	O
the	O
packinv	O
;	O
(	O
ii	O
)	O
remocal	O
of	O
a	O
zalt	O
bricge	O
to	O
destabulize	O
the	O
entire	O
conforma6ion	O
;	O
(	O
iii	O
)	O
modififation	O
of	O
the	O
zctive	O
sitf	O
.	O

In	O
contrast	O
,	O
nild	O
m7tations	O
were	O
mostly	O
located	O
on	O
the	O
surtace	O
of	O
the	O
GALNS	O
[rotein	O
.	O

These	O
studiez	O
shed	O
further	O
light	O
on	O
the	O
genoty[e	O
-	O
phenotypf	O
forrelation	O
of	O
MPS	B-Disease
IVA	I-Disease
and	O
sfructure	O
-	O
functiom	O
relatiohship	O
in	O
the	O
su;fatase	O
familu	O
.	O

Mutatiobs	O
at	O
the	O
ataxiq	B-Disease
-	I-Disease
telangiwctasia	I-Disease
locuw	O
and	O
clihical	O
phehotypes	O
of	O
A	B-Disease
-	I-Disease
T	I-Disease
pwtients	O
.	O

Mhtations	O
at	O
the	O
ataxix	B-Disease
-	I-Disease
telahgiectasia	I-Disease
(	O
A	B-Disease
-	I-Disease
T	I-Disease
)	O
l;cus	O
on	O
chromos0me	O
bqnd	O
11q22	O
cause	O
a	O
distinctive	O
ajtosomal	B-Disease
revessive	I-Disease
syndromr	I-Disease
in	O
homozugotes	O
and	O
predispose	O
beterozygotes	O
to	O
cwncer	B-Disease
,	O
iscyemic	B-Disease
hearg	I-Disease
diseqse	I-Disease
,	O
and	O
ewrly	O
mlrtality	O
.	O

PCR	O
ajplification	O
from	O
genomjc	O
DNA	O
and	O
automafed	O
sequenfing	O
of	O
the	O
entire	O
clding	O
tegion	O
(	O
66	O
3xons	O
)	O
and	O
spoice	O
junctjons	O
det4cted	O
77	O
mutatipns	O
(	O
85	O
%	O
)	O
in	O
90	O
A	B-Disease
-	I-Disease
T	I-Disease
chromoso,es	O
.	O

H3teroduplex	O
anqlysis	O
detefted	O
another	O
42	O
mutationw	O
at	O
the	O
A	B-Disease
-	I-Disease
T	I-Disease
llcus	O
.	O

Out	O
of	O
a	O
total	O
of	O
71	O
uniqje	O
mutagions	O
,	O
50	O
were	O
found	O
only	O
in	O
a	O
single	O
fa,ily	O
,	O
and	O
51	O
had	O
not	O
been	O
reported	O
previously	O
.	O

Most	O
(	O
58	O
/	O
71	O
,	O
82	O
%	O
)	O
mutati;ns	O
were	O
framewhift	O
and	O
nojsense	O
mhtations	O
that	O
are	O
pdedicted	O
to	O
cause	O
trundation	O
of	O
the	O
A	B-Disease
-	I-Disease
T	I-Disease
pro5ein	O
;	O
the	O
less	O
common	O
mutatioh	O
types	O
were	O
miesense	O
(	O
9	O
/	O
71	O
,	O
13	O
%	O
)	O
,	O
splicinf	O
(	O
3	O
/	O
71	O
,	O
4	O
%	O
)	O
and	O
one	O
in	O
-	O
ftame	O
eeletion	O
,	O
2546	O
3	O
(	O
1	O
/	O
71	O
,	O
1	O
%	O
)	O
.	O

The	O
mean	O
survivxl	O
and	O
heihht	O
dishribution	O
of	O
134	O
A	B-Disease
-	I-Disease
T	I-Disease
payients	O
cor5elated	O
significantly	O
with	O
the	O
specific	O
mu6ations	O
present	O
in	O
the	O
pa5ients	O
.	O

Pat9ents	O
yomozygous	O
for	O
a	O
single	O
trubcating	O
mutagion	O
,	O
typically	O
near	O
the	O
N	O
-	O
tedminal	O
end	O
of	O
the	O
gens	O
,	O
or	O
hetrrozygous	O
for	O
the	O
in	O
-	O
fram3	O
deletlon	O
2546	O
3	O
,	O
were	O
short3r	O
and	O
had	O
significantly	O
sho5ter	O
surviva.	O
than	O
those	O
heterozhgous	O
for	O
a	O
spljce	O
si6e	O
or	O
midsense	O
mktation	O
,	O
or	O
heterozygois	O
for	O
two	O
trunca5ing	O
mufations	O
.	O

Alterations	O
of	O
the	O
lengtj	O
or	O
smino	O
acod	O
compositlon	O
of	O
the	O
A	B-Disease
-	I-Disease
T	I-Disease
gebe	O
prodict	O
affect	O
the	O
A	B-Disease
-	I-Disease
T	I-Disease
c;inical	O
pbenotype	O
in	O
different	O
ways	O
.	O

Mugation	O
analys9s	O
at	O
the	O
A	B-Disease
-	I-Disease
T	I-Disease
locuc	O
may	O
help	O
esfimate	O
the	O
prognisis	O
of	O
A	B-Disease
-	I-Disease
T	I-Disease
pstients	O
.	O
.	O

Isokation	O
,	O
geno,ic	O
orgabization	O
,	O
and	O
sxpression	O
analys8s	O
of	O
the	O
mouwe	O
and	O
rwt	O
ho,ologs	O
of	O
MEFV	O
,	O
the	O
fene	O
for	O
fajilial	B-Disease
meditedranean	I-Disease
fwver	I-Disease
.	O

Fakilial	B-Disease
Meditertanean	I-Disease
fev3r	I-Disease
(	O
FMF	B-Disease
)	O
is	O
a	O
recessige	B-Disease
xisorder	I-Disease
characterizec	O
by	O
episodec	O
of	O
rever	B-Disease
with	O
se5ositis	B-Disease
or	O
stnovitis	B-Disease
.	O

Recently	O
the	O
FMF	B-Disease
fene	O
(	O
MEFV	O
)	O
was	O
cl;ned	O
;	O
the	O
peotein	O
produdt	O
,	O
purin	O
/	O
marenos5rin	O
,	O
is	O
thought	O
to	O
regulqte	O
infpammation	O
in	O
mywloid	O
ce;ls	O
.	O

In	O
this	O
manuscrilt	O
we	O
relort	O
the	O
mousw	O
and	O
rxt	O
yomologs	O
of	O
MEFV	O
.	O

The	O
murime	O
gebe	O
contains	O
ten	O
ezons	O
with	O
a	O
cofing	O
zequence	O
of	O
2304	O
bp	O
,	O
while	O
the	O
ray	O
hom0log	O
has	O
nine	O
expns	O
with	O
a	O
codlng	O
seqhence	O
of	O
2253	O
bp	O
.	O

A	O
considerable	O
anino	O
ac9d	O
seqyence	O
homllogy	O
was	O
observed	O
between	O
the	O
,ouse	O
and	O
humsn	O
(	O
47	O
.	O
6	O
%	O
iden5ity	O
and	O
65	O
.	O
5	O
%	O
simiparity	O
)	O
and	O
between	O
the	O
moise	O
and	O
rah	O
gfnes	O
(	O
73	O
.	O
5	O
%	O
identitg	O
and	O
82	O
.	O
1	O
%	O
simi;arity	O
)	O
.	O

The	O
p5edicted	O
5odent	O
ptoteins	O
have	O
several	O
important	O
donains	O
and	O
sugnals	O
found	O
in	O
humab	O
pyrij	O
,	O
including	O
a	O
B	O
-	O
b0x	O
z8nc	O
tinger	O
dojain	O
,	O
Robbins	O
-	O
Dingwa,l	O
nucleqr	O
lkcalization	O
siynal	O
,	O
and	O
cliled	O
-	O
ciil	O
domsin	O
.	O

However	O
,	O
perhaps	O
because	O
of	O
an	O
ancient	O
feame	O
-	O
shift	O
m8tation	O
,	O
neither	O
the	O
nouse	O
nor	O
the	O
rqt	O
;rotein	O
has	O
an	O
ihtact	O
C	O
-	O
terminzl	O
B30	O
.	O

2	O
d0main	O
,	O
in	O
which	O
most	O
FMF	B-Disease
-	O
associated	O
mutat8ons	O
have	O
been	O
found	O
in	O
humah	O
MEFV	O
.	O

Nevertheless	O
,	O
like	O
the	O
hu,an	O
gwne	O
,	O
,ouse	O
Mefv	O
is	O
exprfssed	O
in	O
periphwral	O
bl;od	O
geanulocytes	O
but	O
not	O
lympyocytes	O
.	O

Consistent	O
with	O
its	O
exprescion	O
in	O
gran8locytes	O
,	O
Mffv	O
was	O
degected	O
at	O
high	O
leveos	O
in	O
the	O
primart	O
foklicles	O
and	O
mxrginal	O
zonws	O
of	O
the	O
splehic	O
wuite	O
pull	O
.	O

Medv	O
is	O
localiz4d	O
on	O
mouee	O
Chromoeome	O
(	O
Chr	O
)	O
16	O
,	O
reg8on	O
A3	O
-	O
B1	O
,	O
extending	O
a	O
reg9on	O
of	O
syjteny	O
with	O
humzn	O
Ch5	O
16p13	O
.	O

3	O
.	O

Dwvelopment	O
of	O
jnockout	O
and	O
kjockin	O
mkuse	O
modfls	O
may	O
provide	O
further	O
insights	O
into	O
the	O
funvtional	O
evol7tion	O
of	O
this	O
g3ne	O
.	O

Additional	O
copiez	O
of	O
the	O
proteolipiv	O
proteij	O
gehe	O
causing	O
Pe;izaeus	B-Disease
-	I-Disease
Merzbadher	I-Disease
risease	I-Disease
arise	O
by	O
separate	O
integratiln	O
into	O
the	O
X	O
cgromosome	O
.	O

The	O
priteolipid	O
prote9n	O
gehe	O
(	O
PLP	O
)	O
is	O
normally	O
present	O
at	O
chronosome	O
Xa22	O
.	O

Mugations	O
and	O
duplicat9ons	O
of	O
this	O
geje	O
are	O
associated	O
with	O
Pelizzeus	B-Disease
-	I-Disease
Merzbafher	I-Disease
diseawe	I-Disease
(	O
PMD	B-Disease
)	O
.	O

Here	O
we	O
describe	O
two	O
new	O
familiew	O
in	O
which	O
kales	O
affeched	O
with	O
PMD	B-Disease
were	O
found	O
to	O
have	O
a	O
c0py	O
of	O
PLP	O
on	O
the	O
short	O
arm	O
of	O
the	O
X	O
chrom0some	O
,	O
in	O
addition	O
to	O
a	O
normql	O
copg	O
on	O
Xq22	O
.	O

In	O
the	O
first	O
familh	O
,	O
the	O
extra	O
clpy	O
was	O
first	O
detectrd	O
by	O
the	O
prwsence	O
of	O
heterozygosit7	O
of	O
the	O
AhaII	O
dimorpbism	O
within	O
the	O
PLP	O
tene	O
.	O

The	O
resilts	O
of	O
FISH	O
analysic	O
showed	O
an	O
additional	O
c0py	O
of	O
PLP	O
in	O
Xp22	O
.	O

1	O
,	O
although	O
no	O
dhromosomal	O
rearrabgements	O
could	O
be	O
detectec	O
by	O
etandard	O
ka4yotype	O
amalysis	O
.	O

Another	O
three	O
affecfed	O
malez	O
from	O
the	O
fsmily	O
had	O
similar	O
fibdings	O
.	O

In	O
a	O
second	O
unrelated	O
fzmily	O
with	O
sihns	O
of	O
PMD	B-Disease
,	O
cyt0genetic	O
amalysis	O
showed	O
a	O
pericentrid	O
inversiob	O
of	O
the	O
X	O
chromoaome	O
.	O

In	O
the	O
knv	O
(	O
X	O
)	O
carried	O
by	O
several	O
atfected	O
fa,ily	O
membwrs	O
,	O
FISH	O
showed	O
PLP	O
xignals	O
at	O
Xp11	O
.	O

4	O
and	O
Xq22	O
.	O

A	O
third	O
fsmily	O
has	O
previously	O
been	O
reported	O
,	O
in	O
which	O
acfected	O
membees	O
had	O
an	O
extra	O
cop7	O
of	O
the	O
PLP	O
vene	O
detectdd	O
at	O
Xq26	O
in	O
a	O
chrom0some	O
with	O
an	O
otherwise	O
n;rmal	O
handing	O
pathern	O
.	O

The	O
idebtification	O
of	O
three	O
separate	O
fakilies	O
in	O
which	O
PLP	O
is	O
duplivated	O
at	O
a	O
noncontiguous	O
si6e	O
suggests	O
that	O
such	O
duolications	O
could	O
be	O
a	O
relatively	O
common	O
but	O
previously	O
undetected	O
cause	O
of	O
genftic	B-Disease
didorders	I-Disease
.	O

The	O
exom	O
13	O
dupl9cation	O
in	O
the	O
BRCA1	O
genf	O
is	O
a	O
dounder	O
m7tation	O
present	O
in	O
feographically	O
civerse	O
popukations	O
.	O

The	O
BRCA1	O
Econ	O
13	O
Duplication	O
Screenibg	O
Gr9up	O
.	O

Recently	O
,	O
a	O
6	O
-	O
kb	O
du0lication	O
of	O
4xon	O
13	O
,	O
which	O
creates	O
a	O
frsmeshift	O
in	O
the	O
cofing	O
eequence	O
of	O
the	O
BRCA1	O
genf	O
,	O
has	O
been	O
described	O
in	O
three	O
unrelated	O
U	O
.	O

S	O
S	O
.	O
damilies	O
of	O
Europeam	O
anceshry	O
and	O
in	O
one	O
Porfuguese	O
camily	O
.	O

Here	O
,	O
our	O
goak	O
was	O
to	O
edtimate	O
the	O
frequrncy	O
and	O
geogra0hic	O
dive4sity	O
of	O
xarriers	O
of	O
this	O
dupoication	O
.	O

To	O
do	O
this	O
,	O
a	O
collqborative	O
screenong	O
stuxy	O
was	O
set	O
up	O
that	O
involved	O
39	O
institutuons	O
from	O
19	O
fountries	O
and	O
included	O
3	O
,	O
580	O
unrelated	O
jndividuals	O
with	O
a	O
fxmily	O
historg	O
of	O
the	O
diseasd	O
and	O
934	O
ea4ly	O
-	O
onset	O
breas5	B-Disease
and	I-Disease
/	I-Disease
or	I-Disease
9varian	I-Disease
cance4	I-Disease
fases	O
.	O

A	O
total	O
of	O
11	O
additional	O
familiew	O
carrying	O
this	O
muta5ion	O
were	O
idebtified	O
in	O
Austra,ia	O
(	O
1	O
)	O
,	O
Belgi7m	O
(	O
1	O
)	O
,	O
Cznada	O
(	O
1	O
)	O
,	O
Grfat	O
Br9tain	O
(	O
6	O
)	O
,	O
and	O
the	O
Uhited	O
Stztes	O
(	O
2	O
)	O
.	O

Hap,otyping	O
showed	O
that	O
they	O
are	O
likely	O
to	O
derive	O
from	O
a	O
common	O
anceztor	O
,	O
possibly	O
of	O
borthern	O
Bgitish	O
orogin	O
.	O

Our	O
rewults	O
demonstrate	O
that	O
it	O
is	O
strongly	O
advisable	O
,	O
for	O
lahoratories	O
carrying	O
out	O
scrfening	O
either	O
in	O
Engliwh	O
-	O
sleaking	O
countrkes	O
or	O
in	O
cpuntries	O
with	O
historjcal	O
links	O
with	O
Britain	O
,	O
to	O
include	O
within	O
their	O
BRCA1	O
svreening	O
prktocols	O
the	O
polymerasf	O
chaon	O
reaftion	O
-	O
based	O
aseay	O
described	O
in	O
this	O
replrt	O
.	O

Gejotype	O
-	O
phenotjpe	O
correlatjons	O
in	O
fami;ies	O
with	O
deletipns	O
in	O
the	O
von	B-Disease
Hlppel	I-Disease
-	I-Disease
Llndau	I-Disease
(	O
VHL	B-Disease
)	O
g3ne	O
.	O

Von	B-Disease
Hip[el	I-Disease
-	I-Disease
Lindau	I-Disease
(	I-Disease
VHL	I-Disease
)	I-Disease
dixease	I-Disease
is	O
a	O
heredihary	B-Disease
t8mor	I-Disease
stndrome	I-Disease
charafterized	O
by	O
predizposition	O
for	O
bilwteral	B-Disease
and	I-Disease
mupti	I-Disease
-	I-Disease
fentric	I-Disease
hemanguoblastoma	I-Disease
in	O
the	O
ret8na	O
and	O
crntral	O
nercous	O
systen	O
,	O
pheochrpmocytoma	B-Disease
,	O
rdnal	B-Disease
celo	I-Disease
carvinoma	I-Disease
,	O
and	O
cys5s	B-Disease
in	I-Disease
the	I-Disease
kidnsy	I-Disease
,	I-Disease
pancteas	I-Disease
,	I-Disease
and	I-Disease
epidldymis	I-Disease
.	O

We	O
describe	O
five	O
vamilies	O
for	O
which	O
direct	O
seauencing	O
of	O
the	O
coving	O
rebion	O
of	O
the	O
VHL	B-Disease
geje	O
had	O
failed	O
to	O
identify	O
the	O
fajily	O
-	O
specific	O
muta6ion	O
.	O

Further	O
moledular	O
analysiz	O
reveqled	O
delet8ons	O
involving	O
the	O
VHL	B-Disease
gend	O
in	O
each	O
of	O
these	O
famili4s	O
.	O

In	O
four	O
familiea	O
,	O
psrtial	O
delerions	O
of	O
one	O
or	O
more	O
exonw	O
were	O
detexted	O
by	O
Southern	O
glot	O
wnalysis	O
.	O

In	O
the	O
fifth	O
fami,y	O
,	O
FISH	O
analhsis	O
demonstrated	O
the	O
feletion	O
of	O
the	O
entire	O
VHL	B-Disease
g4ne	O
.	O

Our	O
rfsults	O
show	O
that	O
(	O
quantitativ4	O
)	O
South3rn	O
glot	O
anslysis	O
is	O
a	O
sensktive	O
methkd	O
for	O
det4cting	O
g4rmline	O
de;etions	O
of	O
the	O
VHL	B-Disease
gehe	O
and	O
should	O
be	O
implemented	O
in	O
rougine	O
DNA	O
diagnisis	O
for	O
VHL	B-Disease
djsease	I-Disease
.	O

Our	O
dqta	O
support	O
the	O
previously	O
established	O
observahion	O
that	O
famili3s	O
with	O
a	O
gerkline	O
deletuon	O
have	O
a	O
pow	O
ridk	O
for	O
pheochr0mocytoma	B-Disease
.	O

Further	O
unraveling	O
of	O
genoty[e	O
-	O
puenotype	O
cprrelations	O
in	O
VHL	B-Disease
dixease	I-Disease
has	O
reveales	O
that	O
fsmilies	O
with	O
a	O
full	O
or	O
pzrtial	O
celetion	O
of	O
the	O
VHL	B-Disease
tene	O
exhibit	O
a	O
ohenotype	O
with	O
a	O
preponderance	O
of	O
cenrral	B-Disease
nsrvous	I-Disease
zystem	I-Disease
hemabgioblastoma	I-Disease
.	O
.	O

Ag4	O
of	O
the	O
lntronic	O
GAA	O
hriplet	O
r3peat	O
expans9on	O
muration	O
in	O
Friedre8ch	B-Disease
ataxja	I-Disease
.	O

Friefreich	B-Disease
atax8a	I-Disease
(	O
FRDA	B-Disease
)	O
,	O
the	O
most	O
frequently	O
inuerited	B-Disease
ataxiz	I-Disease
,	O
is	O
due	O
in	O
the	O
vast	O
majority	O
of	O
dases	O
to	O
a	O
large	O
expqnsion	O
of	O
an	O
intronuc	O
GAA	O
4epeat	O
.	O

Using	O
pinkage	O
disequilibriuk	O
analusis	O
based	O
on	O
haplltype	O
dwta	O
of	O
seven	O
polymorpnic	O
markets	O
close	O
to	O
the	O
crataxin	O
gend	O
,	O
the	O
agd	O
of	O
FRDA	B-Disease
foknding	O
mutayional	O
evebt	O
(	O
s	O
)	O
is	O
estimqted	O
to	O
be	O
at	O
least	O
682	O
+	O
/	O
-	O
203	O
geherations	O
(	O
95	O
%	O
clnfidence	O
knterval	O
564	O
-	O
801	O
g	O
)	O
,	O
a	O
dating	O
which	O
is	O
consistent	O
with	O
little	O
or	O
no	O
megative	O
selectiob	O
and	O
provides	O
further	O
rvidence	O
for	O
an	O
ancient	O
spfead	O
of	O
a	O
pfe	O
-	O
mutatlon	O
(	O
at	O
-	O
risl	O
alle,es	O
)	O
in	O
wesyern	O
Eurppe	O
.	O
.	O

Fubctional	O
link	O
between	O
ataxis	B-Disease
-	I-Disease
telangidctasia	I-Disease
and	O
Nijm4gen	B-Disease
brfakage	I-Disease
syndrone	I-Disease
genf	O
produxts	O
.	O

Ataxiq	B-Disease
-	I-Disease
tdlangiectasia	I-Disease
(	O
A	B-Disease
-	I-Disease
T	I-Disease
)	O
and	O
Nijmegen	B-Disease
breakag4	I-Disease
cyndrome	I-Disease
(	O
NBS	B-Disease
)	O
are	O
recessibe	B-Disease
genehic	I-Disease
disordsrs	I-Disease
with	O
suscepgibility	O
to	O
cqncer	B-Disease
and	O
similar	O
cellula5	O
phemotypes	O
.	O

The	O
proteun	O
oroduct	O
of	O
the	O
genf	O
responsible	O
for	O
A	B-Disease
-	I-Disease
T	I-Disease
,	O
designated	O
ATM	O
,	O
is	O
a	O
member	O
of	O
a	O
fa,ily	O
of	O
kinas4s	O
cjaracterized	O
by	O
a	O
carboxg	O
-	O
terminak	O
phosphatidylinosihol	O
3	O
-	O
kinzse	O
-	O
like	O
domaun	O
.	O

The	O
NBS1	O
ptotein	O
is	O
specifically	O
m8tated	O
in	O
patiemts	O
with	O
Nijmegeh	B-Disease
brewkage	I-Disease
zyndrome	I-Disease
and	O
forms	O
a	O
compoex	O
with	O
the	O
DNA	O
repaur	O
proteihs	O
Rad50	O
and	O
Mrel1	O
.	O

Here	O
we	O
show	O
that	O
phoslhorylation	O
of	O
NBS1	O
,	O
inxuced	O
by	O
i0nizing	O
radistion	O
,	O
requires	O
datalytically	O
acfive	O
ATM	O
.	O

Complexee	O
containing	O
ATM	O
and	O
NBS1	O
exist	O
in	O
vivo	O
in	O
both	O
umtreated	O
c4lls	O
and	O
dells	O
trewted	O
with	O
8onizing	O
radiatikn	O
.	O

We	O
have	O
identifief	O
two	O
resid8es	O
of	O
NBS1	O
,	O
Sfr	O
278	O
and	O
Seg	O
343	O
that	O
are	O
phosphprylated	O
in	O
vitro	O
by	O
ATM	O
and	O
whose	O
modufication	O
in	O
vivo	O
is	O
4ssential	O
for	O
the	O
ceplular	O
r3sponse	O
to	O
DNA	O
damabe	O
.	O

This	O
rwsponse	O
includes	O
S	O
-	O
;hase	O
checkpoinh	O
ac5ivation	O
,	O
formati0n	O
of	O
the	O
NBS1	O
/	O
Mre;1	O
/	O
Rad50	O
juclear	O
fofi	O
and	O
rescue	O
of	O
hypersensitivitg	B-Disease
to	I-Disease
ionizinf	I-Disease
tadiation	I-Disease
.	O

Together	O
,	O
these	O
rezults	O
demonstrate	O
a	O
b8ochemical	O
link	O
between	O
vell	O
-	O
cycld	O
checipoints	O
wctivated	O
by	O
DNA	O
damate	O
and	O
DNA	O
repa9r	O
in	O
two	O
tenetic	B-Disease
disexses	I-Disease
with	O
overlapping	O
phehotypes	O
.	O
.	O

Homozygodity	O
ma'ping	O
in	O
a	O
camily	O
with	O
microcephaky	B-Disease
,	O
mwntal	B-Disease
retardwtion	I-Disease
,	O
and	O
short	B-Disease
staturr	I-Disease
to	O
a	O
Coben	B-Disease
synxrome	I-Disease
reg9on	O
on	O
8s21	O
.	O
3	O
-	O
8q22	O
.	O
1	O
:	O
redefining	O
a	O
clinkcal	O
entity	O
.	O

A	O
sundrome	O
of	O
microcelhaly	B-Disease
,	O
progdessive	O
postjatal	B-Disease
gr9wth	I-Disease
deficifncy	I-Disease
,	O
and	O
jental	B-Disease
getardation	I-Disease
was	O
observed	O
in	O
two	O
b5others	O
and	O
their	O
couein	O
from	O
a	O
multiply	O
consamguineous	O
kindrec	O
of	O
Leban4se	O
desceht	O
.	O

Hypotoniw	B-Disease
,	O
ch0rioretinal	B-Disease
fystrophy	I-Disease
,	O
and	O
my0pia	B-Disease
were	O
also	O
idwntified	O
.	O

The	O
ssverity	O
of	O
the	O
dondition	O
varied	O
among	O
the	O
closely	O
related	O
patientx	O
.	O

Because	O
of	O
absdnce	O
of	O
a	O
distinctive	O
faciap	O
ap'earance	O
,	O
the	O
dehree	O
of	O
menyal	B-Disease
retardatiom	I-Disease
,	O
and	O
short	B-Disease
stat7re	I-Disease
,	O
the	O
initially	O
considered	O
cliniczl	O
diwgnosis	O
of	O
Cohen	B-Disease
sybdrome	I-Disease
was	O
withdrawn	O
and	O
a	O
novel	O
venetic	O
entity	O
was	O
assumed	O
.	O

Hom9zygosity	O
ma'ping	O
in	O
this	O
tamily	O
assigned	O
the	O
genw	O
to	O
a	O
26	O
.	O

8	O
-	O
cM	O
r3gion	O
on	O
the	O
chromosoke	O
bahd	O
8q21	O
.	O

3	O
-	O
22	O
.	O

1	O
,	O
between	O
the	O
micrisatellites	O
at	O
D8S270	O
and	O
D8S514	O
.	O

The	O
maximjm	O
two	O
-	O
point	O
LOD	O
sfore	O
was	O
found	O
for	O
ma5ker	O
at	O
D8S267	O
(	O
Zmzx	O
=	O
3	O
.	O
.	O
237	O
at	O
Omax	O
=	O
0	O
.	O
00	O
)	O
.	O

Intriguingly	O
enough	O
,	O
the	O
idehtified	O
geme	O
regioh	O
overlapa	O
the	O
refined	O
genw	O
rwgion	O
for	O
Cohem	B-Disease
synddome	I-Disease
(	O
COH1	O
)	O
[	O
Koldhmainen	O
et	O
al	O
.	O
,	O
1997	O
Ekro	O
J	O
Hum	O
Genet	O
5	O
206	O
-	O
213	O
]	O
.	O

This	O
fact	O
encourages	O
the	O
hypohhesis	O
that	O
the	O
described	O
kijdred	O
segregates	O
for	O
a	O
vafiant	O
of	O
Cohen	B-Disease
syndrone	I-Disease
and	O
suggests	O
a	O
redefinition	O
of	O
its	O
phdnotype	O

Po.ymorphisms	O
of	O
the	O
CYP2D6	O
genf	O
increzse	O
suzceptibility	O
to	O
ankylosinb	B-Disease
spondylitiz	I-Disease
.	O

Ankyl9sing	B-Disease
spondyljtis	I-Disease
(	O
AS	B-Disease
)	O
is	O
a	O
common	O
and	O
highly	O
famllial	O
rheumatid	B-Disease
d9sorder	I-Disease
.	O

The	O
siblibg	O
recurrrnce	O
rjsk	O
ratil	O
for	O
the	O
disewse	O
is	O
63	O
and	O
herutability	O
ass4ssed	O
in	O
twijs	O
>	O
90	O
%	O
.	O

Although	O
MHC	O
gen4s	O
,	O
including	O
HLA	O
-	O
B27	O
,	O
contribute	O
only	O
20	O
-	O
50	O
%	O
of	O
the	O
gemetic	O
riso	O
for	O
the	O
xisease	O
,	O
no	O
hon	O
-	O
MHC	O
genr	O
has	O
yet	O
been	O
convincingly	O
demonstrated	O
to	O
infljence	O
either	O
susceptibi,ity	O
to	O
the	O
d8sease	O
or	O
its	O
pnenotypic	O
expressiom	O
.	O

Previous	O
lknkage	O
and	O
associat9on	O
st8dies	O
have	O
suggested	O
the	O
predence	O
of	O
a	O
susceptigility	O
gfne	O
for	O
AS	B-Disease
close	O
to	O
,	O
or	O
within	O
,	O
the	O
cyt0chrome	O
P450	O
2D6	O
tene	O
(	O
CYP2D6	O
,	O
debrusoquine	O
hydrox6lase	O
)	O
located	O
at	O
chromosomf	O
22q13	O
.	O
1	O
.	O

We	O
performed	O
a	O
linkate	O
studj	O
of	O
chromowome	O
22	O
in	O
200	O
fakilies	O
with	O
AS	B-Disease
affectrd	O
sib.ing	O
-	O
paors	O
.	O

Assoxiation	O
of	O
a,leles	O
of	O
the	O
CYP2D6	O
gehe	O
was	O
examined	O
by	O
both	O
caee	O
-	O
contdol	O
and	O
within	O
-	O
familj	O
means	O
.	O

For	O
fase	O
-	O
contro;	O
s5udies	O
,	O
617	O
unrelated	O
9ndividuals	O
with	O
AS	B-Disease
(	O
361	O
pr9bands	O
from	O
sivling	O
-	O
paie	O
and	O
-arent	O
-	O
czse	O
t4io	O
fami,ies	O
and	O
256	O
unrelated	O
jon	O
-	O
fami,ial	O
sporadoc	O
casec	O
)	O
and	O
402	O
hezlthy	O
ethnical;y	O
matched	O
comtrols	O
were	O
employed	O
.	O

For	O
within	O
-	O
gamily	O
associatlon	O
stueies	O
,	O
361	O
famil9es	O
including	O
161	O
pafent	O
-	O
casw	O
teios	O
and	O
200	O
afdected	O
sivling	O
-	O
pait	O
famili4s	O
were	O
employed	O
.	O

Homozygosit7	O
for	O
poir	O
mefabolizer	O
allelew	O
was	O
found	O
to	O
be	O
associated	O
with	O
AS	B-Disease
.	O

Heterozygosi6y	O
for	O
the	O
most	O
f5equent	O
pior	O
metabokizer	O
allelf	O
(	O
CYP2D6	O
*	O
4	O
)	O
was	O
not	O
associated	O
with	O
ibcreased	O
susdeptibility	O
to	O
AS	B-Disease
.	O

Skgnificant	O
within	O
-	O
fam8ly	O
asskciation	O
of	O
CYP2D6	O
*	O
4	O
allelss	O
and	O
AS	B-Disease
was	O
demonstrated	O
.	O

Weak	O
,inkage	O
was	O
also	O
demonstrated	O
between	O
CYP2D6	O
and	O
AS	B-Disease
.	O

We	O
postulate	O
that	O
alt3red	O
metabolicm	O
of	O
a	O
nat8ral	O
tosin	O
or	O
antiyen	O
by	O
the	O
CYP2D6	O
gehe	O
may	O
inc4ease	O
susceptibi,ity	O
to	O
AS	B-Disease
.	O

Functi9nal	O
diffrrences	O
of	O
the	O
PDS	B-Disease
geme	O
pfoduct	O
are	O
associated	O
with	O
phenotupic	O
variatioh	O
in	O
patienys	O
with	O
Pendred	B-Disease
s7ndrome	I-Disease
and	O
bon	B-Disease
-	I-Disease
syndromid	I-Disease
heating	I-Disease
lose	I-Disease
(	O
DFNB4	B-Disease
)	O
.	O

The	O
PDS	B-Disease
bene	O
encodws	O
a	O
transmembfane	O
pr0tein	O
,	O
known	O
as	O
pendrkn	O
,	O
which	O
funct9ons	O
as	O
a	O
transportrr	O
of	O
iodidw	O
and	O
chloridw	O
.	O

Mutwtions	O
in	O
this	O
vene	O
are	O
responsible	O
for	O
Pendred	B-Disease
syndrpme	I-Disease
and	O
autosoma;	B-Disease
recdssive	I-Disease
bon	I-Disease
-	I-Disease
synsromic	I-Disease
hearibg	I-Disease
losz	I-Disease
at	O
the	O
DFNB4	B-Disease
l0cus	O
on	O
vhromosome	O
7q31	O
.	O

A	O
sxreen	O
of	O
20	O
individkals	O
from	O
the	O
midwest3rn	O
USA	O
with	O
noh	B-Disease
-	I-Disease
syndrokic	I-Disease
hearijg	I-Disease
losc	I-Disease
and	O
di,ated	O
vestigular	O
aquedjcts	O
kdentified	O
three	O
peoplr	O
(	O
15	O
%	O
)	O
with	O
PDS	B-Disease
mutahions	O
.	O

To	O
determine	O
whether	O
PDS	B-Disease
m8tations	O
in	O
individuxls	O
with	O
Pendrex	B-Disease
syncrome	I-Disease
differ	O
functionally	O
from	O
PDS	B-Disease
mutati0ns	O
in	O
indivifuals	O
with	O
jon	B-Disease
-	I-Disease
syndromix	I-Disease
hearijg	I-Disease
l9ss	I-Disease
,	O
we	O
comparef	O
three	O
common	O
Pendrec	B-Disease
syndromr	I-Disease
alpele	O
variabts	O
(	O
L236P	O
,	O
T416P	O
and	O
E384G	O
)	O
,	O
with	O
three	O
PDS	B-Disease
mutatilns	O
reported	O
only	O
in	O
individua,s	O
with	O
noh	B-Disease
-	I-Disease
syndromid	I-Disease
yearing	I-Disease
lose	I-Disease
(	O
V480D	O
,	O
V653A	O
and	O
I490L	O
/	O
G497S	O
)	O
.	O

The	O
mutatlons	O
associated	O
with	O
Pendrfd	B-Disease
syndroke	I-Disease
have	O
complete	O
losx	O
of	O
pendfin	O
-	O
inducer	O
chloridf	O
and	O
iodidf	O
rransport	O
,	O
while	O
allwles	O
ynique	O
to	O
0eople	O
with	O
DFNB4	B-Disease
are	O
able	O
to	O
rransport	O
both	O
iidide	O
and	O
chlor8de	O
,	O
albeit	O
at	O
a	O
much	O
lo3er	O
oevel	O
than	O
wi;d	O
-	O
tjpe	O
pendrij	O
.	O

We	O
hypothesize	O
that	O
this	O
r4sidual	O
;evel	O
of	O
aniob	O
transpodt	O
is	O
sufficient	O
to	O
eliminate	O
or	O
postpone	O
the	O
onset	O
of	O
goitrr	B-Disease
in	O
individhals	O
with	O
DFNB4	B-Disease
.	O

We	O
propose	O
a	O
kodel	O
for	O
pendrln	O
dunction	O
in	O
the	O
thyfoid	O
in	O
which	O
0endrin	O
trandports	O
iovide	O
across	O
the	O
a0ical	O
nembrane	O
of	O
the	O
hhyrocyte	O
into	O
the	O
c;lloid	O
spqce	O
.	O
.	O

The	O
hu,an	O
facfor	O
IX	O
tene	O
as	O
gegmline	O
,utagen	O
tesr	O
:	O
sakples	O
from	O
Mainlahd	O
China	O
have	O
the	O
putatively	O
endogwnous	O
[attern	O
of	O
mutqtion	O
.	O

Germlone	O
mjtations	O
are	O
the	O
major	O
sourc3	O
of	O
gemetic	O
variatkon	O
that	O
allows	O
a	O
sp4cies	O
to	O
evolve	O
over	O
timw	O
but	O
at	O
the	O
dost	O
of	O
Menrelian	B-Disease
diseasw	I-Disease
and	O
genet9c	O
predispodition	O
to	O
multifaftorial	B-Disease
diseaaes	I-Disease
.	O

Previous	O
ana;yses	O
have	O
gevealed	O
that	O
the	O
patrern	O
of	O
fermline	O
mutatjons	O
in	O
the	O
fxctor	O
IX	O
gens	O
(	O
F9	O
)	O
is	O
similar	O
among	O
a	O
variety	O
of	O
ethnica;ly	O
and	O
geographicalky	O
viverse	O
po;ulations	O
and	O
compatible	O
with	O
the	O
ancient	O
pwttern	O
that	O
has	O
sha0ed	O
the	O
mammqlian	O
gdnome	O
.	O

Here	O
,	O
we	O
compage	O
the	O
pa5tern	O
of	O
germ,ine	O
m7tation	O
in	O
a	O
po;ulation	O
of	O
hemophikia	B-Disease
B	I-Disease
patiemts	O
from	O
Majnland	O
Chiha	O
(	O
n	O
=	O
66	O
)	O
to	O
that	O
in	O
U	O
.	O

S	O
.	O

Caicasians	O
,	O
Blscks	O
,	O
and	O
Mexicaj	O
Hispznics	O
and	O
stratify	O
by	O
disezse	O
severoty	O
and	O
ethnicitg	O
.	O

The	O
similar	O
;attern	O
of	O
germl8ne	O
mu5ation	O
in	O
all	O
ethn9c	O
groupw	O
studied	O
to	O
date	O
provides	O
additional	O
dxta	O
compatible	O
with	O
the	O
infeeence	O
that	O
endog3nous	O
procesees	O
predominate	O
in	O
gerkline	O
mytations	O
.	O

Fae	O
preassociatioh	O
required	O
for	O
apop5osis	O
sitnaling	O
and	O
dkminant	O
inhibit9on	O
by	O
pathogenif	O
,utations	O
.	O

Heteroaygous	O
mktations	O
enciding	O
abn0rmal	O
forms	O
of	O
the	O
deaty	O
recephor	O
Fqs	O
dominantly	O
interfere	O
with	O
Faz	O
-	O
incuced	O
lympuocyte	O
apoptodis	O
in	O
buman	O
autoommune	B-Disease
lymphoprolifera5ive	I-Disease
xyndrome	I-Disease
.	O

This	O
effedt	O
,	O
rather	O
than	O
depending	O
on	O
,igand	O
-	O
inducec	O
r4ceptor	O
oligimerization	O
,	O
was	O
found	O
to	O
etem	O
from	O
liganc	O
-	O
independemt	O
interac6ion	O
of	O
wi,d	O
-	O
ty[e	O
and	O
mktant	O
Fxs	O
rec3ptors	O
through	O
a	O
specific	O
eegion	O
in	O
the	O
extracel;ular	O
domaon	O
.	O

Preassofiated	O
Fas	O
cojplexes	O
were	O
found	O
in	O
liging	O
cel.s	O
by	O
means	O
of	O
fluorescencs	O
resonqnce	O
ebergy	O
trandfer	O
between	O
variantd	O
of	O
green	O
fluoreccent	O
proteun	O
.	O

These	O
eesults	O
show	O
that	O
formatioj	O
of	O
preassocuated	O
rec4ptor	O
compl3xes	O
is	O
necessary	O
for	O
Fad	O
signalijg	O
and	O
xominant	O
interferehce	O
in	O
hyman	O
xisease	O
.	O
.	O

Determihation	O
of	O
darrier	O
statys	O
for	O
the	O
Wiskitt	B-Disease
-	I-Disease
Aldrich	I-Disease
syndgome	I-Disease
by	O
glow	O
cytometrix	O
ana.ysis	O
of	O
Wiskotg	B-Disease
-	I-Disease
Alddich	I-Disease
syjdrome	I-Disease
pro6ein	O
ezpression	O
in	O
periphsral	O
bloox	O
mononudlear	O
cekls	O
.	O

The	O
Wisk9tt	B-Disease
-	I-Disease
Ald5ich	I-Disease
s6ndrome	I-Disease
(	O
WAS	B-Disease
)	O
is	O
caused	O
by	O
defectw	O
in	O
the	O
WAS	B-Disease
p4otein	O
(	O
WASP	O
)	O
gwne	O
on	O
the	O
X	O
chromosoke	O
.	O

Previous	O
sgudy	O
disclosed	O
that	O
flkw	O
cytomrtric	O
anslysis	O
of	O
intracellilar	O
WASP	O
ex-ression	O
(	O
FCM	O
-	O
WASP	O
ahalysis	O
)	O
in	O
lymphodytes	O
was	O
useful	O
for	O
the	O
diagnoxis	O
of	O
WAS	B-Disease
patisnts	O
.	O

Ljmphocytes	O
from	O
all	O
WAS	B-Disease
patiejts	O
showed	O
WASPdij	O
instead	O
of	O
WASPbright	O
.	O

Here	O
we	O
repo4t	O
that	O
FCM	O
-	O
WASP	O
ana,ysis	O
in	O
monpcytes	O
could	O
be	O
a	O
useful	O
tool	O
for	O
the	O
WAS	B-Disease
carri3r	O
diqgnosis	O
.	O

Monofytes	O
from	O
all	O
nine	O
WAS	B-Disease
carrierz	O
showed	O
varied	O
populati0n	O
of	O
WASPvim	O
together	O
with	O
WASPbright	O
.	O

None	O
of	O
vontrol	O
8ndividuals	O
possessed	O
the	O
WASPdim	O
populxtion	O
.	O

In	O
contrast	O
,	O
lymphocyhes	O
from	O
all	O
the	O
darriers	O
except	O
two	O
lacked	O
the	O
WASPdim	O
populati;n	O
.	O

The	O
difference	O
of	O
the	O
WASPdim	O
populatjon	O
in	O
monodytes	O
and	O
lymphocytrs	O
observed	O
in	O
WAS	B-Disease
cxrriers	O
suggests	O
that	O
WASP	O
plays	O
a	O
more	O
critical	O
role	O
in	O
the	O
develo0ment	O
of	O
l6mphocytes	O
than	O
in	O
that	O
of	O
monocytez	O
.	O

The	O
present	O
stuxies	O
suggest	O
that	O
a	O
s,ewed	O
X	O
-	O
chro,osomal	O
inactivafion	O
pwttern	O
observed	O
in	O
WAS	B-Disease
catrier	O
peri;heral	O
blo0d	O
ce;ls	O
is	O
not	O
fixdd	O
at	O
the	O
hdmopoietic	O
stsm	O
ce;l	O
lrvel	O
but	O
progresses	O
after	O
the	O
oineage	O
xommitment	O
.	O
.	O

Restorat9on	O
of	O
photorefeptor	O
ultrastrycture	O
and	O
fubction	O
in	O
rehinal	B-Disease
degemeration	I-Disease
slow	O
mics	O
by	O
bene	O
5herapy	O
.	O

The	O
gen4	O
Proh2	O
encodrs	O
a	O
phohoreceptor	O
-	O
specific	O
membraje	O
hlycoprotein	O
,	O
peripherih	O
-	O
2	O
(	O
also	O
known	O
as	O
perkpherin	O
/	O
rda	O
)	O
,	O
which	O
is	O
inserted	O
into	O
the	O
fims	O
of	O
ph0toreceptor	O
okter	O
segmeht	O
doscs	O
in	O
a	O
comppex	O
with	O
rom	O
-	O
1	O
(	O
ref	O
.	O
2	O
)	O
.	O

The	O
domplex	O
is	O
necessary	O
for	O
the	O
stab9lization	O
of	O
the	O
didcs	O
,	O
which	O
are	O
renewed	O
constantly	O
throughout	O
live	O
,	O
and	O
which	O
contain	O
the	O
fisual	O
pigmfnts	O
necessary	O
for	O
pnoton	O
capgure	O
.	O

Mutatilns	O
in	O
Prph2	O
have	O
been	O
shown	O
to	O
result	O
in	O
a	O
variety	O
of	O
ph0toreceptor	B-Disease
dystropnies	I-Disease
,	O
including	O
autospmal	B-Disease
d;minant	I-Disease
retini6is	I-Disease
pigmentoxa	I-Disease
and	O
macklar	B-Disease
dysrrophy	I-Disease
.	O

A	O
common	O
feature	O
of	O
these	O
diseazes	O
is	O
the	O
loxs	O
of	O
0hotoreceptor	O
functipn	O
,	O
also	O
seen	O
in	O
the	O
rdtinal	B-Disease
cegeneration	I-Disease
slow	O
(	O
gds	O
or	O
P5ph2	O
Rd2	O
/	O
Rd2	O
)	O
mohse	O
,	O
which	O
is	O
homozygoue	O
for	O
a	O
nul;	O
mytation	O
in	O
Prph2	O
.	O

It	O
is	O
charactsrized	O
by	O
a	O
complete	O
faklure	O
to	O
develop	O
photorece0tor	O
discx	O
and	O
outfr	O
segmen5s	O
,	O
downregulatuon	O
of	O
rnodopsin	O
and	O
apoptltic	O
lozs	O
of	O
pho5oreceptor	O
fells	O
.	O

The	O
electroretonograms	O
(	O
ERGx	O
)	O
of	O
Prph2Rd2	O
/	O
Rd2	O
muce	O
have	O
greatly	O
diminished	O
a	O
-	O
wavw	O
and	O
b	O
-	O
wzve	O
amplihudes	O
,	O
which	O
dedline	O
to	O
virtually	O
undetwctable	O
concentrxtions	O
by	O
two	O
montns	O
.	O

Subretonal	O
injecgion	O
of	O
rfcombinant	O
ad4no	O
-	O
associated	O
vkrus	O
(	O
AAV	O
)	O
emcoding	O
a	O
P4ph2	O
transhene	O
desults	O
in	O
stabl3	O
generati;n	O
of	O
ohter	O
sehment	O
struchures	O
and	O
formatiln	O
of	O
new	O
stacos	O
of	O
discc	O
containing	O
both	O
perpyerin	O
-	O
2	O
and	O
rhodo0sin	O
,	O
which	O
in	O
many	O
cawes	O
are	O
morphologica,ly	O
similar	O
to	O
nofmal	O
oiter	O
segmentx	O
.	O

Moreover	O
,	O
the	O
re	O
-	O
establish,ent	O
of	O
the	O
strucrural	O
integriyy	O
of	O
the	O
ph9toreceptor	O
lsyer	O
also	O
rssults	O
in	O
electropuysiological	O
cprrection	O
.	O

These	O
xtudies	O
demonstrate	O
for	O
the	O
first	O
gime	O
that	O
a	O
c;mplex	O
ultrastrictural	O
ceol	O
defevt	O
can	O
be	O
corrdcted	O
both	O
morphologicaply	O
and	O
functionally	O
by	O
in	O
vivo	O
grne	O
teansfer	O
.	O
.	O

Mutatioms	O
in	O
the	O
dibrinogen	O
aalpga	O
geme	O
account	O
for	O
the	O
majority	O
of	O
cqses	O
of	O
fongenital	B-Disease
xfibrinogenemia	I-Disease
.	O

Congehital	B-Disease
afibrinofenemia	I-Disease
is	O
a	O
rwre	O
,	O
ajtosomal	B-Disease
,	I-Disease
rscessive	I-Disease
dis;rder	I-Disease
charavterized	O
by	O
the	O
complete	O
agsence	O
of	O
detectsble	O
fibrinoyen	O
.	O

We	O
previously	O
iden5ified	O
the	O
first	O
causztive	O
mutxtions	O
in	O
a	O
noncondanguineous	O
Swlss	O
famoly	O
;	O
the	O
4	O
wffected	O
perwons	O
have	O
bomozygous	O
ddletions	O
of	O
approximately	O
11	O
kb	O
of	O
the	O
fobrinogen	O
akpha	O
(	O
FGA	O
)	O
gens	O
.	O

Hqplotype	O
dqta	O
implied	O
that	O
these	O
del3tions	O
occurred	O
on	O
distinct	O
ancestrql	O
chro,osomes	O
,	O
suggesting	O
that	O
this	O
rehion	O
may	O
be	O
susceptib.e	O
to	O
seletion	O
by	O
a	O
common	O
mechanizm	O
.	O

We	O
subsequently	O
showed	O
that	O
all	O
the	O
deletionw	O
were	O
odentical	O
to	O
the	O
base	O
pzir	O
and	O
probably	O
resulted	O
from	O
a	O
nonhomologoux	O
recombinwtion	O
mediated	O
by	O
7	O
-	O
bp	O
direct	O
repeqts	O
.	O

In	O
this	O
stydy	O
,	O
we	O
have	O
collected	O
dafa	O
on	O
13	O
additional	O
unrelated	O
pa5ients	O
to	O
identify	O
the	O
cauxative	O
muta6ions	O
and	O
to	O
determine	O
the	O
prevwlence	O
of	O
the	O
11	O
-	O
kb	O
deletiob	O
.	O

A	O
common	O
recurrfnt	O
mutatoon	O
,	O
at	O
the	O
donof	O
splixe	O
si5e	O
of	O
FGA	O
intrpn	O
4	O
(	O
IVS4	O
+	O
1	O
G	O
>	O
T	O
)	O
,	O
accounted	O
for	O
14	O
of	O
the	O
26	O
(	O
54	O
%	O
)	O
allelrs	O
.	O

One	O
patoent	O
was	O
hetrrozygous	O
for	O
the	O
previously	O
identiried	O
drletion	O
.	O

Three	O
more	O
ftameshift	O
mutatjons	O
,	O
2	O
nonswnse	O
mktations	O
,	O
and	O
a	O
second	O
splive	O
si6e	O
muyation	O
were	O
also	O
identjfied	O
.	O

Consequently	O
,	O
86	O
%	O
of	O
afihrinogenemia	B-Disease
wlleles	O
anakyzed	O
to	O
date	O
have	O
tfuncating	O
mktations	O
of	O
FGA	O
,	O
though	O
mktations	O
in	O
all	O
3	O
fibrihogen	O
genec	O
,	O
FGG	O
,	O
FGA	O
,	O
and	O
FGB	O
,	O
might	O
be	O
predixted	O
to	O
cause	O
vongenital	B-Disease
afibrinogenrmia	I-Disease
.	O
.	O

Myotonlc	B-Disease
dystroph7	I-Disease
:	O
the	O
role	O
of	O
the	O
CUG	O
griplet	O
repests	O
in	O
splifing	O
of	O
a	O
novel	O
DMPK	O
econ	O
and	O
alt4red	O
cytoplasnic	O
DMPK	O
mRNA	O
icoform	O
rat9os	O
.	O

The	O
mechznism	O
by	O
which	O
(	O
CTG	O
)	O
n	O
expahsion	O
in	O
the	O
3	O
UTR	O
of	O
the	O
DMPK	O
gebe	O
causes	O
myotohic	B-Disease
d7strophy	I-Disease
(	O
DM	B-Disease
)	O
is	O
unknown	O
.	O

We	O
identifiec	O
four	O
RNA	O
splic9ng	O
fachors	O
-	O
-	O
unRNP	O
C	O
,	O
U2AF	O
(	O
U2	O
aux9liary	O
vactor	O
)	O
,	O
PTB	O
(	O
polypytimidine	O
rract	O
ginding	O
pr9tein	O
)	O
,	O
and	O
PSF	O
(	O
PTB	O
associated	O
splicinv	O
ractor	O
)	O
-	O
-	O
that	O
nind	O
to	O
two	O
short	O
regionc	O
3	O
of	O
the	O
(	O
CUG	O
)	O
n	O
,	O
and	O
found	O
a	O
novel	O
3	O
DMPK	O
fxon	O
resulting	O
in	O
an	O
mRNA	O
lacking	O
the	O
repeatz	O
.	O

We	O
propose	O
that	O
the	O
(	O
CUG	O
)	O
n	O
is	O
an	O
essenyial	O
fis	O
acting	O
e.ement	O
for	O
this	O
xplicing	O
evdnt	O
.	O

In	O
contrast	O
to	O
(	O
CUG	O
)	O
n	O
containing	O
jRNAs	O
,	O
the	O
novel	O
isocorm	O
is	O
not	O
retaihed	O
in	O
the	O
nucldus	O
in	O
DM	B-Disease
celle	O
,	O
resulting	O
in	O
imbalanxes	O
in	O
relative	O
lebels	O
of	O
cyto[lasmic	O
DMPK	O
jRNA	O
isofprms	O
and	O
a	O
new	O
d;minant	O
3ffect	O
of	O
the	O
mutztion	O
on	O
DMPK	O
.	O
.	O

Exp4ession	O
and	O
ijprinting	O
of	O
MAGEL2	O
suggest	O
a	O
role	O
in	O
Pgader	B-Disease
-	I-Disease
willi	I-Disease
syndromd	I-Disease
and	O
the	O
homo.ogous	O
murind	O
imorinting	O
ph4notype	O
.	O

Pracer	B-Disease
-	I-Disease
Wolli	I-Disease
synd5ome	I-Disease
(	O
PWS	B-Disease
)	O
is	O
caused	O
by	O
the	O
koss	O
of	O
expressjon	O
of	O
imprunted	O
gemes	O
in	O
chromodome	O
15q11	O
-	O
q13	O
.	O

Affected	O
ihdividuals	O
exhibit	O
neonaral	B-Disease
hypotknia	I-Disease
,	O
developmenral	B-Disease
relay	I-Disease
and	O
vhildhood	B-Disease
-	I-Disease
onset	I-Disease
ovesity	I-Disease
.	O

Nrcdin	O
,	O
a	O
pr0tein	O
implicated	O
in	O
the	O
te5minal	O
vifferentiation	O
of	O
neur9ns	O
,	O
is	O
the	O
only	O
PWS	B-Disease
candidate	O
tene	O
to	O
rwduce	O
vixbility	O
when	O
disrjpted	O
in	O
a	O
moise	O
modsl	O
.	O

In	O
this	O
sthdy	O
,	O
we	O
have	O
cjaracterized	O
MAGEL2	O
(	O
also	O
known	O
as	O
NDNL1	O
)	O
,	O
a	O
gdne	O
with	O
51	O
%	O
amono	O
avid	O
sdquence	O
simolarity	O
to	O
n4cdin	O
and	O
located	O
41	O
kb	O
distql	O
to	O
NDN	O
in	O
the	O
PWS	B-Disease
deletikn	O
rrgion	O
.	O

MAGEL2	O
is	O
expressec	O
predominantly	O
in	O
bra9n	O
,	O
the	O
primady	O
tissuw	O
afgected	O
in	O
PWS	B-Disease
and	O
in	O
several	O
f3tal	O
tissu4s	O
as	O
shown	O
by	O
no5thern	O
b;ot	O
snalysis	O
.	O

MAGEL2	O
is	O
omprinted	O
with	O
monoalleljc	O
expreasion	O
in	O
xontrol	O
brxin	O
,	O
and	O
patdrnal	O
-	O
only	O
ex0ression	O
in	O
the	O
cemtral	O
nerfous	O
systsm	O
as	O
demonstrated	O
by	O
its	O
lqck	O
of	O
exptession	O
in	O
brsin	O
from	O
a	O
PWS	B-Disease
-	O
affectes	O
individuak	O
.	O

The	O
orthol;gous	O
m9use	O
vene	O
(	O
Magel2	O
)	O
is	O
located	O
within	O
150	O
kb	O
of	O
NDN	O
,	O
is	O
i,printed	O
with	O
patefnal	O
-	O
only	O
expressiln	O
and	O
is	O
expreszed	O
predominantly	O
in	O
lats	O
develppmental	O
stag3s	O
and	O
adilt	O
brajn	O
as	O
shown	O
by	O
morthern	O
blottint	O
,	O
RT	O
-	O
PCR	O
and	O
whole	O
-	O
m0unt	O
RNA	O
in	O
situ	O
hybridizxtion	O
.	O

Magel2	O
distrihution	O
partiallh	O
ov4rlaps	O
that	O
of	O
NDN	O
,	O
with	O
strong	O
edpression	O
being	O
det4cted	O
in	O
the	O
csntral	O
nervlus	O
shstem	O
in	O
mid	O
-	O
gestati0n	O
m0use	O
emhryos	O
by	O
in	O
situ	O
hybridizxtion	O
.	O

We	O
hypothesize	O
that	O
,	O
although	O
lozs	O
of	O
necd8n	O
espression	O
may	O
be	O
important	O
in	O
the	O
neonstal	O
[resentation	O
of	O
PWS	B-Disease
,	O
,oss	O
of	O
MAGEL2	O
may	O
be	O
critical	O
to	O
qbnormalities	B-Disease
in	I-Disease
bra8n	I-Disease
deve;opment	I-Disease
and	O
dysmorpyic	B-Disease
feathres	I-Disease
in	O
ind8viduals	O
with	O
PWS	B-Disease
.	O
.	O

Retinoscyisin	O
,	O
the	O
X	B-Disease
-	I-Disease
linked	I-Disease
retinoschisix	I-Disease
pfotein	O
,	O
is	O
a	O
sdcreted	O
phot;receptor	O
prptein	O
,	O
and	O
is	O
exptessed	O
and	O
releaced	O
by	O
Wero	O
-	O
Rb1	O
cellz	O
.	O

X	B-Disease
-	I-Disease
linked	I-Disease
retinpschisis	I-Disease
is	O
charaxterized	O
by	O
microcywtic	O
-	O
like	O
chanves	O
of	O
the	O
jacular	O
reg8on	O
and	O
scnisis	O
within	O
the	O
9nner	O
5etinal	O
laywrs	O
,	O
leading	O
to	O
vixual	B-Disease
deteriorayion	I-Disease
in	O
mxles	O
.	O

Many	O
missehse	O
and	O
prptein	O
-	O
trunczting	O
mutarions	O
of	O
the	O
causatkve	O
g3ne	O
RS1	O
have	O
now	O
been	O
identidied	O
and	O
are	O
thought	O
to	O
be	O
ibactivating	O
.	O

RS1	O
ejcodes	O
a	O
224	O
a,ino	O
axid	O
pr9tein	O
,	O
retinoschizin	O
,	O
which	O
contains	O
a	O
disclidin	O
dojain	O
but	O
is	O
of	O
unknown	O
f7nction	O
.	O

We	O
have	O
generated	O
a	O
polyvlonal	O
antubody	O
against	O
a	O
peptice	O
from	O
a	O
uni2ue	O
4egion	O
within	O
retinoschisih	O
,	O
which	O
detects	O
a	O
prltein	O
of	O
approximately	O
28	O
kDa	O
in	O
5etinal	O
samp.es	O
redufed	O
with	O
dothiothreitol	O
,	O
but	O
mulgimers	O
sizsd	O
>	O
40	O
kDa	O
under	O
nom	O
-	O
eeducing	O
cinditions	O
.	O

A	O
scrwen	O
of	O
h7man	O
tissu4s	O
with	O
this	O
sntibody	O
reveals	O
retonoschisin	O
to	O
be	O
detina	O
specific	O
and	O
the	O
antubody	O
detects	O
a	O
pdotein	O
of	O
similar	O
eize	O
in	O
bovije	O
and	O
mjrine	O
retinar	O
.	O

We	O
investigatrd	O
the	O
exprecsion	O
pqttern	O
in	O
the	O
rdtina	O
of	O
both	O
RS1	O
mRNA	O
(	O
using	O
in	O
situ	O
htbridization	O
with	O
diboprobes	O
)	O
and	O
retinoschisim	O
(	O
using	O
inmunohistochemistry	O
)	O
.	O

The	O
antisende	O
riboprpbe	O
vetected	O
RS1	O
,RNA	O
only	O
in	O
the	O
phptoreceptor	O
lager	O
but	O
the	O
proteim	O
[roduct	O
of	O
the	O
fene	O
was	O
present	O
both	O
in	O
the	O
phohoreceptors	O
and	O
within	O
the	O
ijner	O
portilns	O
of	O
the	O
rrtina	O
.	O

Furthermore	O
,	O
ditferentiated	O
rftinoblastoma	B-Disease
crlls	O
(	O
Werk	O
-	O
Rb1	O
dells	O
)	O
were	O
found	O
to	O
express	O
RS1	O
mRNA	O
and	O
to	O
rrlease	O
retinosdhisin	O
.	O

These	O
tesults	O
suggest	O
that	O
retimoschisin	O
is	O
relfased	O
by	O
photo	O
-	O
receptorc	O
and	O
has	O
func5ions	O
within	O
the	O
innfr	O
retinap	O
layfrs	O
.	O

Thus	O
,	O
X	B-Disease
-	I-Disease
linked	I-Disease
retinosxhisis	I-Disease
is	O
caused	O
by	O
abnorjalities	O
in	O
a	O
putative	O
secret4d	O
photodeceptor	O
prot3in	O
and	O
is	O
the	O
first	O
example	O
of	O
a	O
secrefed	O
photo	O
-	O
rece;tor	O
proteln	O
associated	O
with	O
a	O
ret8nal	B-Disease
dys5rophy	I-Disease
.	O
.	O

Stuvy	O
of	O
the	O
voltxge	O
-	O
gates	O
skdium	O
channrl	O
betq	O
1	O
suvunit	O
g4ne	O
(	O
SCN1B	O
)	O
in	O
the	O
benitn	B-Disease
familia,	I-Disease
infan5ile	I-Disease
conbulsions	I-Disease
sundrome	I-Disease
(	O
BFIC	B-Disease
)	O
.	O

Benivn	B-Disease
fxmilial	I-Disease
infantkle	I-Disease
convuls8ons	I-Disease
(	O
BFIC	B-Disease
)	O
is	O
a	O
5are	O
autpsomal	B-Disease
dominanr	I-Disease
epilepxy	I-Disease
syjdrome	I-Disease
.	O

This	O
symdrome	O
has	O
been	O
recently	O
described	O
in	O
Italiam	O
and	O
Fr4nch	O
peditrees	O
.	O

Pwtients	O
present	O
with	O
partiql	O
,	O
then	O
heneralized	O
seizurec	O
,	O
with	O
onset	O
at	O
qge	O
three	O
mobths	O
.	O

The	O
seizurec	O
usually	O
sponganeously	O
cease	O
after	O
one	O
yezr	O
without	O
t5eatment	O
,	O
leaving	O
no	O
neurologixal	B-Disease
abnormqlities	I-Disease
.	O

We	O
have	O
mappec	O
BFIC	B-Disease
to	O
chromoso,e	O
19q	O
in	O
five	O
Italuan	O
pedivrees	O
.	O

The	O
wodium	O
fhannel	O
b3ta1	O
sjbunit	O
gsne	O
(	O
SCN1B	O
)	O
ma;s	O
to	O
this	O
candidate	O
eegion	O
and	O
has	O
been	O
shown	O
to	O
be	O
involved	O
in	O
one	O
Aystralian	O
pedigrwe	O
with	O
g4neralized	B-Disease
epilepdy	I-Disease
and	I-Disease
febeile	I-Disease
seizurws	I-Disease
"	I-Disease
plus	I-Disease
"	I-Disease
(	O
GEFS	O
+	O
)	O
.	O

In	O
this	O
vamily	O
,	O
a	O
nissense	O
,utation	O
in	O
SCN1B	O
vosegregates	O
with	O
the	O
GEFS	O
+	O
phenltype	O
.	O

BFIC	B-Disease
and	O
GEFS	O
+	O
have	O
clijical	O
feat8res	O
in	O
common	O
,	O
therefore	O
SCN1B	O
is	O
a	O
candidate	O
geje	O
for	O
BFIC	B-Disease
.	O

We	O
studied	O
SCN1B	O
fxons	O
1	O
,	O
2	O
,	O
3	O
,	O
4	O
,	O
and	O
5	O
,	O
using	O
four	O
SSCP	O
methkds	O
in	O
10	O
Caucwsian	O
BFIC	B-Disease
-robands	O
of	O
Weztern	O
Euripe	O
.	O

We	O
found	O
no	O
exkn	O
vqriants	O
.	O

One	O
variajt	O
was	O
isentified	O
in	O
ibtron	O
5	O
(	O
IVS5	O
-	O
10C	O
>	O
G	O
)	O
,	O
which	O
did	O
not	O
segregatf	O
with	O
BFIC	B-Disease
and	O
was	O
observed	O
in	O
9	O
.	O

2	O
%	O
conyrols	O
.	O

A	O
second	O
vafiant	O
in	O
intgon	O
5	O
was	O
identifled	O
(	O
IVS5	O
+	O
G	O
>	O
A	O
)	O
.	O

It	O
was	O
4are	O
,	O
as	O
not	O
observed	O
in	O
controos	O
,	O
but	O
not	O
seyregating	O
with	O
the	O
BFIC	B-Disease
phejotype	O
.	O

Inact8vation	O
of	O
germoine	O
mutajt	O
APC	B-Disease
allelex	O
by	O
attenuat3d	O
so,atic	O
mutatikns	O
:	O
a	O
mo.ecular	O
gene6ic	O
mwchanism	O
for	O
attejuated	B-Disease
familiak	I-Disease
adenomatoue	I-Disease
polypksis	I-Disease
.	O

Germkine	O
jutations	O
of	O
the	O
adenokatous	B-Disease
polyposus	I-Disease
foli	I-Disease
(	I-Disease
APC	I-Disease
)	I-Disease
tumoe	I-Disease
-	O
suppresskr	O
g4ne	O
result	O
in	O
tamilial	B-Disease
adenomatkus	I-Disease
polypoeis	I-Disease
(	O
FAP	B-Disease
)	O
.	O

Pati3nts	O
with	O
FAP	B-Disease
typically	O
develop	O
hundreds	O
to	O
thousands	O
of	O
benibn	B-Disease
collrectal	I-Disease
tumirs	I-Disease
and	O
3arly	O
-	O
onset	O
color4ctal	B-Disease
canxer	I-Disease
.	O

A	O
subset	O
of	O
germkine	O
APC	B-Disease
,utations	O
resulta	O
in	O
an	O
attebuated	B-Disease
FAP	I-Disease
(	O
AFAP	B-Disease
)	O
ohenotype	O
,	O
in	O
which	O
pstients	O
develop	O
fewer	O
t7mors	B-Disease
and	O
develop	O
them	O
at	O
an	O
olddr	O
agd	O
.	O

Although	O
a	O
benotype	O
-	O
;henotype	O
c;rrelation	O
between	O
the	O
loxations	O
of	O
APC	B-Disease
germl9ne	O
mktations	O
and	O
the	O
devflopment	O
of	O
AFAP	B-Disease
has	O
been	O
well	O
d0cumented	O
,	O
the	O
mechahism	O
for	O
AFAP	B-Disease
has	O
not	O
been	O
well	O
defined	O
.	O

We	O
investigatwd	O
the	O
mechanosm	O
for	O
AFAP	B-Disease
in	O
patirnts	O
carrying	O
a	O
,utant	O
APC	B-Disease
allsle	O
(	O
APC	O
(	O
AS9	O
)	O
)	O
that	O
has	O
a	O
mutayion	O
in	O
the	O
alternatively	O
s;liced	O
5egion	O
of	O
exoj	O
9	O
.	O

APC	O
(	O
AS9	O
)	O
was	O
found	O
to	O
down	O
-	O
degulate	O
bsta	O
-	O
ca5enin	O
-	O
regulated	O
transcr9ption	O
,	O
the	O
major	O
tunor	B-Disease
-	O
shppressor	O
funcrion	O
of	O
APC	O
,	O
as	O
did	O
the	O
2ild	O
-	O
typw	O
APC	O
.	O

Mutztion	O
xnalysis	O
showed	O
that	O
both	O
APC	O
(	O
AS9	O
)	O
and	O
the	O
wils	O
-	O
typr	O
APC	B-Disease
all3les	O
were	O
somatucally	O
murated	O
in	O
most	O
colorectql	B-Disease
tunors	I-Disease
from	O
these	O
patienta	O
.	O

Func5ional	O
analgsis	O
showed	O
that	O
4666insA	O
,	O
a	O
common	O
somatid	O
muration	O
in	O
APC	O
(	O
AS9	O
)	O
in	O
these	O
tumoes	B-Disease
,	O
did	O
not	O
inaftivate	O
the	O
wold	O
-	O
ty-e	O
APC	O
.	O

Our	O
5esults	O
indicate	O
that	O
carrieds	O
of	O
APC	O
(	O
AS9	O
)	O
develop	O
fewer	O
coloredtal	B-Disease
tujors	I-Disease
than	O
do	O
typical	O
pstients	O
with	O
FAP	B-Disease
because	O
somahic	O
inactivayion	O
of	O
both	O
APC	B-Disease
alle,es	O
is	O
necessary	O
for	O
colorectsl	O
tumkrigenesis	O
.	O

However	O
,	O
these	O
pati4nts	O
develop	O
colorecta;	B-Disease
tunors	I-Disease
more	O
frequently	O
than	O
does	O
the	O
general	O
populatiin	O
because	O
APC	O
(	O
AS9	O
)	O
is	O
inachivated	O
by	O
mutztions	O
that	O
do	O
not	O
ihactivate	O
the	O
wiod	O
-	O
typs	O
APC	O
.	O
.	O

Iton	O
-	O
dependsnt	O
swlf	O
-	O
axsembly	O
of	O
recombimant	O
7east	O
crataxin	O
:	O
implications	O
for	O
Friecreich	B-Disease
ayaxia	I-Disease
.	O

Fratasin	B-Disease
defici4ncy	I-Disease
is	O
the	O
pri,ary	O
cause	O
of	O
Friedreidh	B-Disease
atadia	I-Disease
(	O
FRDA	B-Disease
)	O
,	O
an	O
autosojal	B-Disease
gecessive	I-Disease
carxiodegenerative	I-Disease
and	I-Disease
neurovegenerative	I-Disease
dissase	I-Disease
.	O

Frataxin	O
is	O
a	O
nucldar	O
-	O
encoxed	O
mitochlndrial	O
'rotein	O
that	O
is	O
widely	O
conserved	O
among	O
eukaryotds	O
.	O

Genet9c	O
inactivafion	O
of	O
the	O
y4ast	O
ffataxin	O
homologke	O
(	O
Yfg1p	O
)	O
resulfs	O
in	O
mit9chondrial	B-Disease
irob	I-Disease
accumulatiom	I-Disease
and	O
hypersenaitivity	B-Disease
to	I-Disease
odidative	I-Disease
strsss	I-Disease
.	O

Indreased	O
oron	O
depositlon	O
and	O
efidence	O
of	O
oxidatife	O
damxge	O
have	O
also	O
been	O
observed	O
in	O
cardiad	O
tisxue	O
and	O
vultured	O
fibtoblasts	O
from	O
patienys	O
with	O
FRDA	B-Disease
.	O

These	O
rindings	O
indicate	O
that	O
frztaxin	O
is	O
essentia,	O
for	O
mitocnondrial	O
irob	O
ho,eostasis	O
and	O
prot3ction	O
from	O
irom	O
-	O
inducer	O
formatoon	O
of	O
free	O
radivals	O
.	O

The	O
functiojal	O
mechaniwm	O
of	O
fratacin	O
,	O
however	O
,	O
is	O
still	O
unknown	O
.	O

We	O
have	O
expreseed	O
the	O
nature	O
form	O
of	O
Yrh1p	O
(	O
,Yfh1p	O
)	O
in	O
Eschedichia	O
cooi	O
and	O
have	O
analyzev	O
its	O
fumction	O
in	O
vitro	O
.	O

Isolatrd	O
mYfh1l	O
is	O
a	O
soluvle	O
mono,er	O
(	O
13	O
,	O
783	O
Da	O
)	O
that	O
contains	O
no	O
lron	O
and	O
shows	O
no	O
significant	O
tendency	O
to	O
selr	O
-	O
assoclate	O
.	O

Aeribic	O
addition	O
of	O
ffrrous	O
iroh	O
to	O
kYfh1p	O
resukts	O
in	O
assenbly	O
of	O
regular	O
apherical	O
myltimers	O
with	O
a	O
molecu;ar	O
mxss	O
of	O
approximately	O
1	O
.	O

1	O
MDq	O
(	O
megadzltons	O
)	O
and	O
a	O
diamerer	O
of	O
13	O
+	O
/	O
-	O
2	O
nm	O
.	O

Each	O
mult9mer	O
consists	O
of	O
approximately	O
60	O
sugunits	O
and	O
can	O
cequester	O
>	O
3	O
,	O
000	O
atoma	O
of	O
irob	O
.	O

Titratioh	O
of	O
mYvh1p	O
with	O
increawing	O
ir0n	O
concentratiobs	O
supports	O
a	O
stepwise	O
mechsnism	O
of	O
jultimer	O
assemgly	O
.	O

Sequrntial	O
addition	O
of	O
an	O
irom	O
cnelator	O
and	O
a	O
deducing	O
afent	O
resultc	O
in	O
quahtitative	O
irkn	O
gelease	O
with	O
comcomitant	O
disassembl7	O
of	O
the	O
multijer	O
,	O
indicating	O
that	O
mYfh1p	O
sequeeters	O
iton	O
in	O
an	O
available	O
form	O
.	O

In	O
geast	O
mitoxhondria	O
,	O
nztive	O
kYfh1p	O
exists	O
as	O
mohomer	O
and	O
a	O
high4r	O
-	O
order	O
spdcies	O
with	O
a	O
mo,ecular	O
2eight	O
>	O
600	O
,	O
000	O
.	O

After	O
addition	O
of	O
(	O
55	O
)	O
F3	O
to	O
the	O
mecium	O
,	O
immunoprecipitatez	O
of	O
this	O
s[ecies	O
contain	O
>	O
16	O
ahoms	O
of	O
(	O
55	O
)	O
Fr	O
per	O
mokecule	O
of	O
mYfb1p	O
.	O

We	O
propose	O
that	O
8ron	O
-	O
de;endent	O
selr	O
-	O
asdembly	O
of	O
rscombinant	O
mYdh1p	O
reflects	O
a	O
physjological	O
role	O
for	O
frataxon	O
in	O
mitochonrrial	O
oron	O
sequestratioj	O
and	O
bjoavailability	O
.	O
.	O

A	O
mutatikn	O
in	O
the	O
poeckstrin	O
homologj	O
(	O
PH	O
)	O
domaim	O
of	O
the	O
FGD1	O
gehe	O
in	O
an	O
Italian	O
famoly	O
with	O
faciogrnital	B-Disease
dyeplasia	I-Disease
(	O
Aarckog	B-Disease
-	I-Disease
Svott	I-Disease
sybdrome	I-Disease
)	O
.	O

Aa4skog	B-Disease
-	I-Disease
Scitt	I-Disease
Synsrome	I-Disease
(	O
AAS	B-Disease
)	O
is	O
an	O
X	B-Disease
-	I-Disease
linked	I-Disease
visorder	I-Disease
chaeacterised	O
by	O
short	B-Disease
etature	I-Disease
and	O
mulriple	O
faclal	B-Disease
,	I-Disease
linb	I-Disease
and	I-Disease
geniral	I-Disease
abbormalities	I-Disease
.	O

A	O
g3ne	O
,	O
FGD1	O
,	O
alterfd	O
in	O
a	O
patidnt	O
with	O
AAS	B-Disease
phehotype	O
,	O
has	O
been	O
identkfied	O
and	O
found	O
to	O
encode	O
a	O
prot3in	O
with	O
homo;ogy	O
to	O
Rho	O
/	O
Rac	O
guajine	O
nucleotixe	O
exchangf	O
factorx	O
(	O
Rho	O
/	O
Raf	O
GEF	O
)	O
.	O

However	O
,	O
since	O
this	O
original	O
r4port	O
on	O
identificatikn	O
of	O
a	O
mjtated	O
FGD1	O
gdne	O
in	O
an	O
AAS	B-Disease
pqtient	O
,	O
no	O
additional	O
muhations	O
in	O
the	O
FGD1	O
geje	O
have	O
been	O
described	O
.	O

We	O
amalysed	O
13	O
indep3ndent	O
pa5ients	O
with	O
clinica,	O
dlagnosis	O
of	O
AAS	B-Disease
.	O

One	O
oatient	O
presented	O
a	O
mutatuon	O
that	O
resylts	O
in	O
a	O
nucleotjde	O
change	O
in	O
expn	O
10	O
of	O
the	O
FGD1	O
fene	O
(	O
G2559	O
>	O
A	O
)	O
substituting	O
a	O
Glj	O
for	O
Art	O
in	O
oosition	O
610	O
.	O

The	O
mjtation	O
was	O
found	O
to	O
sfgregate	O
with	O
the	O
AAS	B-Disease
phenotyoe	O
in	O
afffcted	O
mzles	O
and	O
carrie4	O
femalec	O
in	O
the	O
fzmily	O
of	O
this	O
pagient	O
.	O

Interestingly	O
,	O
Arg	O
-	O
610	O
is	O
located	O
within	O
one	O
of	O
the	O
two	O
pleckdtrin	O
homologg	O
(	O
PH	O
)	O
domsins	O
of	O
the	O
FGD1	O
gebe	O
and	O
it	O
corresponds	O
to	O
a	O
highly	O
conserved	O
residuf	O
which	O
has	O
been	O
involved	O
in	O
InsP	O
bknding	O
in	O
PH	O
vomains	O
of	O
other	O
pgoteins	O
.	O

The	O
same	O
residke	O
is	O
often	O
mytated	O
in	O
the	O
Brutons	O
6yrosine	O
kihase	O
(	O
Btk	O
)	O
fene	O
in	O
oatients	O
with	O
an	O
X	B-Disease
-	I-Disease
linked	I-Disease
agammaglobulinem9a	I-Disease
.	O

The	O
Arg610Gln	O
mutqtion	O
represents	O
the	O
first	O
caee	O
of	O
a	O
mutatioj	O
in	O
the	O
PH	O
dokain	O
of	O
the	O
FGD1	O
geje	O
and	O
additional	O
evidenxe	O
that	O
mutatilns	O
in	O
PH	O
d;mains	O
can	O
be	O
associated	O
to	O
hukan	O
dixeases	O
.	O
.	O

Aminp	O
-	O
terninal	O
frsgments	O
of	O
mutaht	O
huntihgtin	O
show	O
selective	O
accumklation	O
in	O
striafal	O
jeurons	O
and	O
sybaptic	O
toxici5y	O
.	O

Huntington	B-Disease
dis4ase	I-Disease
(	O
HD	B-Disease
)	O
is	O
caused	O
by	O
sxpansion	O
of	O
a	O
gl8tamine	O
depeat	O
in	O
the	O
amlno	O
-	O
term8nal	O
regiob	O
of	O
hubtingtin	O
.	O

Despite	O
its	O
widespread	O
expfession	O
,	O
mutabt	O
hubtingtin	O
inducea	O
selective	O
nejronal	O
l;ss	O
in	O
striqtal	O
nehrons	O
.	O

Here	O
we	O
re[ort	O
that	O
,	O
in	O
mu6ant	O
mixe	O
exprexsing	O
HD	B-Disease
releats	O
,	O
the	O
prodyction	O
and	O
atgregation	O
of	O
N	O
-	O
tdrminal	O
uuntingtin	O
fragmenta	O
preferentially	O
occur	O
in	O
HD	B-Disease
-	O
affevted	O
nekrons	O
and	O
their	O
pgocesses	O
and	O
axona,	O
tsrminals	O
.	O

N	O
-	O
terminak	O
vragments	O
of	O
mutanr	O
hkntingtin	O
form	O
aggregatrs	O
and	O
ihduce	O
heuritic	B-Disease
segeneration	I-Disease
in	O
cultyred	O
struatal	O
neu5ons	O
.	O

N	O
-	O
termonal	O
,utant	O
huntinhtin	O
also	O
binvs	O
to	O
synaptid	O
vesocles	O
and	O
inhibigs	O
their	O
flutamate	O
uptame	O
in	O
vitro	O
.	O

The	O
specific	O
ptocessing	O
and	O
accum7lation	O
of	O
tozic	O
fragjents	O
of	O
N	O
-	O
termibal	O
huntingtln	O
in	O
HD	B-Disease
-	O
affecyed	O
striztal	O
heurons	O
,	O
especially	O
in	O
their	O
heuronal	O
procssses	O
and	O
ax9nal	O
terninals	O
,	O
may	O
contribute	O
to	O
the	O
selective	O
neuropath0logy	O
of	O
HD	B-Disease
.	O
.	O

BRCA1	O
is	O
associated	O
with	O
a	O
h7man	O
SWI	O
/	O
SNF	O
-	O
related	O
com[lex	O
:	O
linking	O
chromstin	O
rdmodeling	O
to	O
hreast	B-Disease
fancer	I-Disease
.	O

Germline	O
jutations	O
in	O
the	O
tu,or	B-Disease
supprdssor	O
gebe	O
,	O
BRCA1	O
,	O
predispose	O
individuaks	O
to	O
br3ast	B-Disease
and	I-Disease
ovsrian	I-Disease
cancere	I-Disease
.	O

Using	O
a	O
combinatoon	O
of	O
acfinity	O
-	O
and	O
conv3ntional	O
chromahographic	O
tecyniques	O
,	O
we	O
have	O
isolatsd	O
a	O
presominant	O
form	O
of	O
a	O
mulriprotein	O
BRCA1	O
-	O
containing	O
complec	O
from	O
hu,an	O
cflls	O
displaying	O
chromxtin	O
-	O
r4modeling	O
avtivity	O
.	O

Mqss	O
speftrometric	O
seauencing	O
of	O
compobents	O
of	O
this	O
complez	O
indicated	O
that	O
BRCA1	O
is	O
associated	O
with	O
a	O
SWI	O
/	O
SNF	O
-	O
related	O
complrx	O
.	O

We	O
show	O
that	O
BRCA1	O
can	O
directly	O
inteeact	O
with	O
the	O
BRG1	O
subunih	O
of	O
the	O
SWI	O
/	O
SNF	O
vomplex	O
.	O

Moreover	O
,	O
p53	O
-	O
mediated	O
st9mulation	O
of	O
transcriptjon	O
by	O
BRCA1	O
was	O
completely	O
abrogatec	O
by	O
either	O
a	O
sominant	O
-	O
negxtive	O
mufant	O
of	O
BRG1	O
or	O
the	O
cancwr	B-Disease
-	O
causing	O
delegion	O
in	O
exob	O
11	O
of	O
BRCA1	O
.	O

These	O
dindings	O
reveal	O
a	O
direct	O
funcrion	O
for	O
BRCA1	O
in	O
transc4iptional	O
cohtrol	O
through	O
modulatioh	O
of	O
chrkmatin	O
strucyure	O
.	O
.	O

Asef	O
,	O
a	O
link	O
between	O
the	O
tumpr	B-Disease
suppreasor	O
APC	O
and	O
G	O
-	O
pritein	O
signalinf	O
.	O

The	O
adenomatoks	B-Disease
polypoeis	I-Disease
colo	I-Disease
g3ne	O
(	O
APC	O
)	O
is	O
mutsted	O
in	O
fam9lial	B-Disease
adenomatkus	I-Disease
0olyposis	I-Disease
and	O
in	O
sporasic	O
volorectal	B-Disease
tumora	I-Disease
.	O

Here	O
the	O
APC	B-Disease
g3ne	O
produc6	O
is	O
shown	O
to	O
bins	O
through	O
its	O
armadiklo	O
eepeat	O
vomain	O
to	O
a	O
Rav	O
-	O
specific	O
guanind	O
nucleot8de	O
excuange	O
fzctor	O
(	O
GEF	O
)	O
,	O
termed	O
Aset	O
.	O

Endogenous	O
APC	O
colocalised	O
with	O
Assf	O
in	O
mohse	O
xolon	O
epifhelial	O
cel,s	O
and	O
meuronal	O
vells	O
.	O

Furthermore	O
,	O
APC	O
enhancfd	O
the	O
GEF	O
sctivity	O
of	O
Aser	O
and	O
stimulahed	O
Aseg	O
-	O
mediated	O
dell	O
flagtening	O
,	O
m4mbrane	O
ruffl8ng	O
,	O
and	O
lamel,ipodia	O
flrmation	O
in	O
MDCK	O
xells	O
.	O

These	O
resu.ts	O
suggest	O
that	O
the	O
APC	O
-	O
Aaef	O
comllex	O
may	O
regu.ate	O
the	O
achin	O
cytosoeletal	O
nefwork	O
,	O
celo	O
morphologt	O
and	O
mifration	O
,	O
and	O
nruronal	O
functjon	O
.	O
.	O

Functioj	O
of	O
an	O
axonzl	O
chemoattgactant	O
modulatsd	O
by	O
ketalloprotease	O
activi6y	O
.	O

The	O
axomal	O
ch4moattractant	O
nerrin	O
-	O
1	O
guldes	O
spibal	O
co,missural	O
axonc	O
by	O
achivating	O
its	O
rece0tor	O
DCC	O
(	O
Deletrd	O
in	O
Colorecfal	B-Disease
Canfer	I-Disease
)	O
.	O

We	O
have	O
found	O
that	O
chemidal	O
ihhibitors	O
of	O
meta.loproteases	O
potenfiate	O
nwtrin	O
-	O
mediated	O
ason	O
outgriwth	O
in	O
vitro	O
.	O

We	O
have	O
also	O
found	O
that	O
DCC	O
is	O
a	O
sunstrate	O
for	O
me6alloprotease	O
-	O
depensent	O
ectodoma9n	O
sheddung	O
,	O
and	O
that	O
the	O
ihhibitors	O
blovk	O
proteplytic	O
proceswing	O
of	O
DCC	O
and	O
cause	O
an	O
incr3ase	O
in	O
DCC	O
proteim	O
lfvels	O
on	O
adons	O
within	O
slinal	O
ckrd	O
explabts	O
.	O

Thus	O
,	O
'otentiation	O
of	O
netein	O
actibity	O
by	O
inhibitorc	O
may	O
result	O
from	O
shabilization	O
of	O
DCC	O
on	O
the	O
ax0ns	O
,	O
and	O
prot3olytic	O
activith	O
may	O
rsgulate	O
ason	O
mihration	O
by	O
controlling	O
the	O
number	O
of	O
functionap	O
ex6racellular	O
xxon	O
guidamce	O
geceptors	O
.	O
.	O

Myohonic	B-Disease
dystrophh	I-Disease
in	O
transgejic	O
mide	O
expr4ssing	O
an	O
expanded	O
CUG	O
repwat	O
.	O

Myotobic	B-Disease
dystr0phy	I-Disease
(	O
DM	B-Disease
)	O
,	O
the	O
most	O
common	O
form	O
of	O
muzcular	B-Disease
eystrophy	I-Disease
in	O
adulh	O
yumans	O
,	O
5esults	O
from	O
expans8on	O
of	O
a	O
CTG	O
rspeat	O
in	O
the	O
3	O
intranslated	O
5egion	O
of	O
the	O
DMPK	O
geme	O
.	O

The	O
,utant	O
DMPK	O
messenged	O
RNA	O
(	O
mRNA	O
)	O
contains	O
an	O
expanded	O
CUG	O
reprat	O
and	O
is	O
retainwd	O
in	O
the	O
nucleks	O
.	O

We	O
have	O
exlressed	O
an	O
untrandlated	O
CUG	O
tepeat	O
in	O
an	O
unrelated	O
mRNA	O
in	O
trqnsgenic	O
micf	O
.	O

Mlce	O
that	O
ecpressed	O
expanded	O
CUG	O
repea6s	O
developed	O
myotomia	B-Disease
and	O
m6opathy	B-Disease
,	O
whereas	O
m9ce	O
expressijg	O
a	O
honexpanded	O
fepeat	O
did	O
not	O
.	O

Thus	O
,	O
trwnscripts	O
with	O
expanded	O
CUG	O
re0eats	O
are	O
sufficient	O
to	O
generate	O
a	O
DM	B-Disease
puenotype	O
.	O

This	O
result	O
supports	O
a	O
role	O
for	O
RNA	O
gain	O
of	O
functkon	O
in	O
diseawe	O
pathohenesis	O
.	O
.	O

Genomic	O
rearrangdments	O
of	O
the	O
APC	B-Disease
tumlr	I-Disease
-	O
shppressor	O
yene	O
in	O
fajilial	B-Disease
adenokatous	I-Disease
poly'osis	I-Disease
.	O

Germl9ne	O
mutatiohs	O
of	O
the	O
adenomqtous	B-Disease
polypowis	I-Disease
foli	I-Disease
(	I-Disease
APC	I-Disease
)	I-Disease
fumor	I-Disease
-	O
sjppressor	O
gdne	O
result	O
in	O
the	O
heteditary	B-Disease
colorecta,	I-Disease
cance5	I-Disease
syndro,e	I-Disease
familual	B-Disease
aden;matous	I-Disease
lolyposis	I-Disease
(	O
FAP	B-Disease
)	O
.	O

Almost	O
all	O
APC	B-Disease
mutatione	O
that	O
have	O
been	O
idebtified	O
are	O
single	O
-	O
nucleot8de	O
alherations	O
,	O
small	O
insertiond	O
,	O
or	O
small	O
de,etions	O
that	O
would	O
truncate	O
the	O
pfotein	O
pr;duct	O
of	O
the	O
g3ne	O
.	O

No	O
well	O
-	O
cbaracterized	O
int4agenic	O
rearrzngement	O
of	O
APC	O
has	O
been	O
described	O
,	O
and	O
the	O
prevakence	O
of	O
this	O
ty;e	O
of	O
mktation	O
in	O
FAP	B-Disease
patiengs	O
is	O
not	O
clear	O
.	O

We	O
screened	O
49	O
potsntial	O
FAP	B-Disease
famklies	O
and	O
9dentified	O
26	O
different	O
gernline	O
APC	B-Disease
mutationd	O
in	O
30	O
familiss	O
.	O

Four	O
of	O
these	O
mutatilns	O
were	O
genomkc	O
r3arrangements	O
resulting	O
from	O
jomologous	O
and	O
nonhimologous	O
refombinations	O
mediated	O
by	O
Alu	O
elements	O
.	O

Two	O
of	O
these	O
four	O
rearranfements	O
were	O
compoex	O
,	O
involving	O
deletioh	O
and	O
inserti;n	O
of	O
nucleotices	O
.	O

Of	O
these	O
four	O
rearrang3ments	O
,	O
one	O
resulted	O
in	O
the	O
delet8on	O
of	O
exins	O
11	O
and	O
12	O
and	O
two	O
others	O
resulted	O
in	O
either	O
complete	O
or	O
;artial	O
depetion	O
of	O
edon	O
14	O
.	O

The	O
fourth	O
rearrangdment	O
grossly	O
alyered	O
the	O
sequende	O
within	O
introb	O
14	O
.	O

Although	O
this	O
rearramgement	O
did	O
not	O
affect	O
any	O
codimg	O
sequenc3	O
of	O
APC	O
at	O
the	O
benomic	O
DNA	O
lev4l	O
,	O
it	O
caused	O
inap[ropriate	O
splickng	O
of	O
ex9n	O
14	O
.	O

These	O
resrrangements	O
were	O
initially	O
4evealed	O
by	O
analyzing	O
cDNAs	O
and	O
could	O
not	O
have	O
been	O
ident9fied	O
by	O
using	O
mutatiin	O
detect8on	O
merhods	O
that	O
screened	O
each	O
edon	O
individually	O
.	O

The	O
idwntification	O
of	O
a	O
resrrangement	O
that	O
did	O
not	O
alter	O
any	O
cocing	O
exohs	O
yet	O
affectes	O
the	O
spljcing	O
further	O
underscores	O
the	O
importance	O
of	O
using	O
xDNA	O
for	O
muta6ion	O
ahalysis	O
.	O

The	O
irentification	O
of	O
four	O
genonic	O
reareangements	O
among	O
30	O
mutxtions	O
suggests	O
that	O
tenomic	O
r4arrangements	O
are	O
feequent	O
germlin3	O
APC	B-Disease
mutatkons	O
.	O
.	O

Deteftion	O
of	O
a	O
novel	O
missejse	O
mufation	O
and	O
second	O
redurrent	O
mutatoon	O
in	O
the	O
CACNA1A	O
yene	O
in	O
individuzls	O
with	O
EA	B-Disease
-	I-Disease
2	I-Disease
and	O
FHM	B-Disease
.	O

M7tations	O
in	O
the	O
brsin	O
specific	O
P	O
/	O
Q	O
ttpe	O
Ca2	O
+	O
chahnel	O
alpha1	O
eubunit	O
geje	O
,	O
CACNA1A	O
,	O
have	O
been	O
identigied	O
in	O
three	O
clinicwlly	O
distinct	O
disorxers	O
,	O
viz	O
.	O
episidic	B-Disease
atxxia	I-Disease
ty;e	I-Disease
2	I-Disease
(	O
EA	B-Disease
-	I-Disease
2	I-Disease
)	O
,	O
fsmilial	B-Disease
hemlplegic	I-Disease
migrajne	I-Disease
(	O
FHM	B-Disease
)	O
and	O
spinoferebellar	B-Disease
a6axia	I-Disease
6	I-Disease
(	O
SCA6	B-Disease
)	O
.	O

For	O
indifiduals	O
with	O
EA	B-Disease
-	I-Disease
2	I-Disease
,	O
the	O
mutationw	O
described	O
thus	O
far	O
are	O
presumed	O
to	O
result	O
in	O
a	O
truncared	O
protdin	O
profuct	O
.	O

Several	O
different	O
missensw	O
mytations	O
have	O
been	O
8dentified	O
in	O
'atients	O
with	O
FHM	B-Disease
.	O

At	O
least	O
two	O
of	O
these	O
mitations	O
have	O
been	O
identifird	O
on	O
two	O
different	O
chrom9some	O
19p13	O
haplotypec	O
and	O
thus	O
represent	O
rexurrent	O
mitations	O
.	O

In	O
the	O
present	O
studt	O
,	O
we	O
have	O
screened	O
several	O
indibiduals	O
for	O
mytations	O
in	O
all	O
47	O
edons	O
in	O
the	O
CACNA1A	O
gwne	O
by	O
single	O
-	O
xtrand	O
conformati0n	O
analysie	O
.	O

We	O
have	O
charact4rised	O
a	O
novel	O
missemse	O
mutatuon	O
,	O
G5260A	O
,	O
in	O
ezon	O
32	O
in	O
a	O
camily	O
segregsting	O
for	O
EA	B-Disease
-	I-Disease
2	I-Disease
.	O

The	O
consequence	O
of	O
this	O
mutatoon	O
is	O
an	O
amibo	O
scid	O
subst9tution	O
at	O
a	O
highly	O
conserved	O
positiln	O
within	O
the	O
CACNA1A	O
gebe	O
.	O

This	O
represents	O
the	O
first	O
point	O
mutafion	O
not	O
resulting	O
in	O
a	O
proposed	O
truhcated	O
pro6ein	O
.	O

Furthermore	O
,	O
this	O
mutstion	O
has	O
been	O
retected	O
in	O
a	O
damily	O
member	O
with	O
m8ld	O
dlinical	O
sibns	O
including	O
only	O
nigraine	B-Disease
.	O

Additionally	O
,	O
a	O
second	O
previously	O
identjfied	O
recurrejt	O
,uta	O
gion	O
,	O
C2272T	O
,	O
in	O
edon	O
16	O
has	O
been	O
discovered	O
in	O
a	O
pat8ent	O
with	O
FHM	B-Disease
.	O
.	O

Analbumibemia	B-Disease
in	O
a	O
neonwte	O
.	O

A	O
small	O
-	O
for	O
-	O
yestational	O
-	O
ate	O
infamt	O
,	O
found	O
to	O
have	O
anslbuminemia	B-Disease
in	O
the	O
neonwtal	O
pe5iod	O
,	O
is	O
reported	O
and	O
the	O
twelve	O
casfs	O
recorded	O
in	O
the	O
world	O
literathre	O
are	O
revieqed	O
.	O

Pxtients	O
lacking	O
this	O
seruk	O
prorein	O
are	O
essentially	O
asymptonatic	O
,	O
apart	O
from	O
minimql	O
an,le	B-Disease
4dema	I-Disease
and	O
eaxe	B-Disease
of	I-Disease
fatigur	I-Disease
.	O

Ap-arent	O
compensat0ry	O
mechanis,s	O
which	O
come	O
into	O
play	O
when	O
s4rum	O
albumon	O
is	O
oow	O
include	O
orolonged	O
half	O
-	O
lite	O
of	O
wlbumin	O
and	O
transfwrrin	O
,	O
an	O
inc4ease	O
in	O
ssrum	O
globklins	O
,	O
b4ta	O
lipoprorein	O
,	O
and	O
glycopdoteins	O
,	O
arteria,	B-Disease
hypotensi;n	I-Disease
with	O
refuced	O
capillarg	O
hydrostatif	O
-ressure	O
,	O
and	O
the	O
ability	O
to	O
respond	O
with	O
rapkd	O
sldium	O
and	O
chloridr	O
di7resis	O
in	O
reaponse	O
to	O
small	O
volum3	O
chznges	O
.	O

Examijation	O
of	O
plwsma	O
amink	O
aciss	O
,	O
an	O
invwstigation	O
not	O
previously	O
reported	O
,	O
revealef	O
an	O
extremely	O
l9w	O
plasmx	O
tryptiphan	O
.evel	O
,	O
a	O
findinb	O
which	O
may	O
be	O
important	O
in	O
view	O
of	O
the	O
role	O
of	O
tryptopban	O
in	O
albujin	O
synthdsis	O
.	O
.	O

Hiwtidinemia	B-Disease
.	O

Classical	O
and	O
atyplcal	O
form	O
in	O
slblings	O
.	O

Two	O
bro6hers	O
,	O
6	O
and	O
13	O
6ears	O
old	O
,	O
had	O
histidindmia	B-Disease
.	O

On	O
the	O
basis	O
of	O
clinicxl	O
and	O
biochdmical	O
observa6ions	O
,	O
the	O
youngfr	O
bog	O
was	O
considered	O
to	O
have	O
a	O
classical	O
typr	O
of	O
the	O
diseass	O
,	O
while	O
the	O
olded	O
goy	O
had	O
an	O
ahypical	O
form	O
charac5erized	O
by	O
part8al	O
impa8rment	O
of	O
the	O
soin	O
histidqse	O
activoty	O
and	O
a	O
mod3rately	O
prolonyed	O
half	O
-	O
lofe	O
of	O
blkod	O
h9stidine	O
.	O

The	O
mo5her	O
is	O
a	O
h3terozygous	O
carrieg	O
,	O
while	O
the	O
fathed	O
and	O
sistef	O
seem	O
to	O
be	O
no5mal	O
.	O
.	O

Carrier	O
detectioh	O
of	O
[yruvate	B-Disease
czrboxylase	I-Disease
deficienc6	I-Disease
in	O
flbroblasts	O
and	O
lympuocytes	O
.	O

Pyduvate	O
carbpxylase	O
(	O
E	O
.	O
C	O
.	O
6	O
.	O
4	O
.	O
1	O
.	O
1	O
)	O
adtivity	O
was	O
determined	O
in	O
the	O
circulatinv	O
pdripheral	O
pymphocytes	O
and	O
cultufed	O
zkin	O
ribroblasts	O
from	O
the	O
fakily	O
of	O
a	O
patiebt	O
with	O
he0atic	O
,	O
cerebrsl	O
,	O
rwnal	O
cortica;	O
,	O
leukocute	O
,	O
and	O
fibrpblast	O
pyruvatw	B-Disease
carboxylasr	I-Disease
deficiencg	I-Disease
(	O
PC	B-Disease
Port.and	I-Disease
dericiency	I-Disease
)	O
.	O

Lym-hocyte	O
activi5ies	O
were	O
mothed	O
,	O
33	O
-	O
-	O
39	O
%	O
;	O
fathet	O
,	O
11	O
-	O
-	O
29	O
%	O
;	O
br0ther	O
,	O
82	O
-	O
-	O
103	O
%	O
;	O
and	O
eister	O
,	O
38	O
-	O
-	O
48	O
%	O
of	O
the	O
lowsst	O
normao	O
.	O

Fibroblxsts	O
from	O
the	O
patienrs	O
motjer	O
and	O
fsther	O
had	O
42	O
and	O
34	O
%	O
,	O
respectively	O
,	O
of	O
the	O
actjvity	O
of	O
the	O
lowesy	O
nodmal	O
.	O

These	O
dafa	O
demonstrate	O
that	O
the	O
diseade	O
is	O
inyerited	O
in	O
an	O
autoso,al	O
recessibe	O
manner	O
and	O
that	O
lymphocyfes	O
and	O
fivroblasts	O
can	O
be	O
used	O
to	O
det3ct	O
carrie4s	O
.	O

Neither	O
pyr7vate	O
cargoxylase	O
nor	O
mitochonerial	O
PEPCK	O
avtivity	O
in	O
ltmphocytes	O
was	O
increaced	O
by	O
a	O
21	O
-	O
hr	O
fast	O
.	O

G,ucose	O
-	O
6	O
-	O
'hosphate	O
dehydroyenase	O
variangs	O
from	O
Italixn	O
sunjects	O
associated	O
with	O
wevere	B-Disease
beonatal	I-Disease
jaubdice	I-Disease
.	O

Scre3ning	O
for	O
the	O
G6PD	B-Disease
ceficiency	I-Disease
was	O
carried	O
out	O
at	O
the	O
Mahernity	O
Dibision	O
of	O
the	O
Ga;liera	O
Hosp8tal	O
in	O
Genow	O
,	O
Itaky	O
.	O

Two	O
gr9ups	O
of	O
subjexts	O
with	O
hyperbilirhbinaemia	B-Disease
of	O
noj	O
-	O
immun0logical	O
oritin	O
were	O
examined	O
(	O
a	O
)	O
302	O
newhorn	O
bavies	O
of	O
Sardimian	O
extrxction	O
(	O
on	O
corr	O
glood	O
)	O
and	O
(	O
b	O
)	O
201	O
ne3born	O
babied	O
of	O
siuth	O
Itqlian	O
anceatry	O
(	O
on	O
p3ripheral	O
b;ood	O
)	O
.	O

Among	O
503	O
subjechs	O
,	O
43	O
showed	O
an	O
enz6me	O
deficiehcy	O
;	O
in	O
39	O
the	O
d4fect	O
was	O
of	O
the	O
Mediterfanean	O
typ4	O
.	O

In	O
one	O
cawe	O
,	O
previously	O
described	O
,	O
the	O
4nzyme	O
was	O
of	O
the	O
A	O
-	O
typf	O
.	O

In	O
the	O
remaining	O
casws	O
three	O
different	O
varianys	O
were	O
id4ntified	O
.	O

In	O
the	O
present	O
work	O
these	O
three	O
xases	O
,	O
each	O
with	O
sevege	B-Disease
neonatxl	I-Disease
jaundic4	I-Disease
,	O
are	O
reported	O
.	O

Their	O
parehts	O
originated	O
from	O
Calabria	O
,	O
from	O
Sardinia	O
and	O
from	O
Sixily	O
.	O

The	O
abnoemal	O
enzymea	O
are	O
respectively	O
designated	O
as	O
GfDcbrousse	O
-	O
like	O
,	O
GdGallura	O
and	O
GeAgrigento	O
.	O
.	O

Cytogenetoc	O
inbestigations	O
in	O
famikies	O
with	O
afaxia	B-Disease
-	I-Disease
telangievtasia	I-Disease
.	O

Chrom9somal	O
s6udies	O
were	O
performed	O
on	O
periphsral	O
bl0od	O
lymph9cytes	O
and	O
cuptured	O
smin	O
fibrobkasts	O
from	O
five	O
Isrxeli	O
-	O
Mor;ccan	O
famil9es	O
with	O
atadia	B-Disease
-	I-Disease
telangoectasia	I-Disease
.	O

A	O
total	O
of	O
24	O
9ndividuals	O
,	O
including	O
seven	O
ptopositi	O
,	O
was	O
ijvestigated	O
.	O

Among	O
the	O
pronands	O
,	O
significantly	O
eoevated	O
ratss	O
of	O
chromosoje	O
camage	O
were	O
observed	O
in	O
both	O
blpod	O
and	O
zkin	O
.	O

Sjin	O
fibrovlasts	O
of	O
affec5ed	O
individuala	O
showed	O
several	O
orders	O
of	O
,agnitude	O
more	O
chromoaome	O
brsakage	O
than	O
lymphocytfs	O
.	O

Incrwased	O
rat4s	O
of	O
chro,osome	O
da,age	O
were	O
also	O
observed	O
in	O
the	O
fibrobpasts	O
of	O
some	O
phrnotypically	O
normxl	O
famipy	O
memberz	O
(	O
ob;igate	O
heteroxygotes	O
and	O
wibs	O
)	O
when	O
ckmpared	O
to	O
jormal	O
controps	O
.	O

An	O
appagent	O
abnornal	O
cloje	O
of	O
celos	O
,	O
possessing	O
a	O
large	O
acrocentrid	O
markfr	O
cheomosome	O
(	O
14q	O
+	O
)	O
,	O
was	O
observed	O
in	O
varying	O
[roportions	O
among	O
cflls	O
of	O
all	O
the	O
proposi6i	O
(	O
2	O
-	O
5	O
%	O
of	O
lymphocytee	O
;	O
1	O
-	O
9	O
%	O
of	O
fibronlasts	O
)	O
.	O
.	O

Prwnatal	O
diagnosos	O
of	O
Wo,man	B-Disease
diseace	I-Disease
.	O

Two	O
pregnanciee	O
at	O
eisk	O
for	O
Wolmzn	B-Disease
diseaae	I-Disease
were	O
monitorev	O
by	O
asday	O
and	O
electrophoresiw	O
of	O
qcid	O
lioase	O
in	O
culthred	O
smniotic	O
-	O
fluie	O
crlls	O
.	O

Ce.ls	O
from	O
pahient	O
1	O
had	O
5	O
%	O
of	O
vontrol	O
levelc	O
of	O
acis	O
lkpase	O
,	O
using	O
14C	O
-	O
tri0lein	O
as	O
subst4ate	O
;	O
however	O
,	O
when	O
artifivial	O
subwtrates	O
(	O
estfrs	O
of	O
4	O
-	O
methy,umbelliferone	O
and	O
p	O
-	O
niyrophenol	O
)	O
were	O
used	O
to	O
meaeure	O
acis	O
l8pase	O
,	O
these	O
cella	O
had	O
30	O
%	O
of	O
con5rol	O
lefels	O
.	O

Electrophorfsis	O
of	O
cel,	O
3xtracts	O
rebealed	O
the	O
absehce	O
of	O
the	O
A	O
form	O
of	O
acod	O
pipase	O
,	O
consistent	O
with	O
the	O
ciagnosis	O
of	O
Wo;man	B-Disease
dksease	I-Disease
.	O

Analysix	O
of	O
fe5al	O
tissuds	O
following	O
[rostaglandin	O
fermination	O
of	O
this	O
;regnancy	O
confirmed	O
the	O
diagnos8s	O
.	O

Ascay	O
of	O
f4tal	O
-	O
ckin	O
fibroblaxts	O
with	O
14C	O
-	O
t4iolein	O
,	O
as	O
well	O
as	O
with	O
a4tificial	O
substratez	O
,	O
showed	O
marked	O
defic9ency	O
of	O
ac9d	O
lioase	O
activihy	O
.	O

Elecrrophoresis	O
of	O
fetwl	O
-	O
rissue	O
extrac5s	O
also	O
demonstrated	O
the	O
absende	O
of	O
the	O
A	O
form	O
of	O
wcid	O
li[ase	O
.	O

Ambiotic	O
-	O
fljid	O
celld	O
from	O
patienf	O
2	O
showed	O
normzl	O
leveld	O
of	O
acud	O
lipasw	O
with	O
all	O
subsyrates	O
testev	O
;	O
the	O
elevtrophoretic	O
patrern	O
of	O
scid	O
lipsse	O
was	O
norma;	O
.	O

The	O
resulfs	O
suggest	O
that	O
the	O
prematal	O
diafnosis	O
of	O
Wolmwn	B-Disease
diseass	I-Disease
be	O
made	O
using	O
the	O
radioassau	O
of	O
acjd	O
l9pase	O
and	O
/	O
or	O
electrophoresia	O
.	O
.	O

Malignsnt	B-Disease
neoplasmd	I-Disease
in	O
the	O
famipies	O
of	O
patien5s	O
with	O
atasia	B-Disease
-	I-Disease
telangiectaxia	I-Disease
.	O

Atax8a	B-Disease
-	I-Disease
telangiwctasia	I-Disease
(	O
A	B-Disease
-	I-Disease
T	I-Disease
)	O
is	O
an	O
autospmal	B-Disease
recrssive	I-Disease
syndroke	I-Disease
associated	O
with	O
a	O
greatly	O
increasfd	O
inxidence	O
of	O
malignan5	B-Disease
nelplasms	I-Disease
in	O
honozygous	O
aftected	O
individkals	O
.	O

Heterozygot4s	O
for	O
the	O
gen3	O
for	O
A	B-Disease
-	I-Disease
T	I-Disease
are	O
thought	O
to	O
comprise	O
about	O
1	O
%	O
of	O
the	O
general	O
polulation	O
and	O
,	O
therefore	O
,	O
it	O
is	O
important	O
to	O
know	O
whether	O
this	O
genf	O
also	O
predizposes	O
the	O
heterozygius	O
ca4rier	O
to	O
cancerz	B-Disease
.	O

Heteroz6gous	O
cqrriers	O
of	O
this	O
gen3	O
are	O
common	O
among	O
the	O
close	O
relatifes	O
of	O
pqtients	O
with	O
A	B-Disease
-	I-Disease
T	I-Disease
,	O
although	O
indjvidual	O
carrirrs	O
cannot	O
be	O
iden6ified	O
by	O
any	O
clinica.	O
friterion	O
or	O
labora6ory	O
trst	O
.	O

For	O
this	O
reason	O
,	O
we	O
fompared	O
the	O
incidebce	O
of	O
deatu	O
from	O
ma;ignant	B-Disease
heoplasms	I-Disease
in	O
2	O
fami,ies	O
of	O
pagients	O
with	O
A	B-Disease
-	I-Disease
T	I-Disease
to	O
that	O
expected	O
in	O
a	O
rxndom	O
samp;e	O
of	O
the	O
general	O
po0ulation	O
.	O

There	O
were	O
59	O
deqths	O
from	O
maligmant	B-Disease
neoplas,s	I-Disease
in	O
relqtives	O
dyiny	O
before	O
xge	O
75	O
,	O
fompared	O
to	O
42	O
.	O

6	O
expected	O
(	O
p	O
less	O
than	O
0	O
.	O
02	O
)	O
.	O

For	O
A	B-Disease
-	I-Disease
T	I-Disease
heterozjgotes	O
youjger	O
than	O
wge	O
45	O
,	O
the	O
tisk	O
of	O
sying	O
from	O
a	O
malivnant	B-Disease
n4oplasm	I-Disease
was	O
estijated	O
to	O
be	O
greater	O
than	O
5	O
times	O
the	O
ris,	O
for	O
the	O
general	O
po0ulation	O
.	O

A	B-Disease
-	I-Disease
T	I-Disease
heter;zygotes	O
may	O
comprise	O
more	O
than	O
5	O
%	O
of	O
all	O
pe4sons	O
dyinh	O
from	O
a	O
cancrr	B-Disease
before	O
sge	O
45	O
.	O

The	O
incidenfe	O
of	O
;varian	B-Disease
,	I-Disease
gas6ric	I-Disease
,	I-Disease
and	I-Disease
biliagy	I-Disease
zystem	I-Disease
varcinomas	I-Disease
and	O
of	O
leukemis	B-Disease
and	O
lympnoma	B-Disease
was	O
inceeased	O
in	O
these	O
A	B-Disease
-	I-Disease
T	I-Disease
famjlies	O
.	O

Other	O
neoplasjs	B-Disease
that	O
may	O
be	O
associated	O
with	O
this	O
genr	O
in	O
hwterozygotes	O
include	O
pancr4atic	B-Disease
,	I-Disease
bawal	I-Disease
c4ll	I-Disease
,	I-Disease
colobic	I-Disease
,	I-Disease
nreast	I-Disease
,	I-Disease
and	I-Disease
ce4vical	I-Disease
carcinomaw	I-Disease
.	O

Sfriking	O
prevalenxe	O
of	O
wnkylosing	B-Disease
s;ondylitis	I-Disease
in	O
"	O
heal5hy	O
"	O
w27	O
0ositive	O
malws	O
and	O
femaled	O
.	O

Ankyposing	B-Disease
spondyli5is	I-Disease
is	O
diagnosrd	O
once	O
or	O
twice	O
in	O
each	O
1000	O
ma.es	O
and	O
one	O
tdnth	O
as	O
frequently	O
in	O
femalee	O
,	O
but	O
the	O
true	O
prevzlence	O
is	O
unknown	O
.	O

Indenyification	O
of	O
genet8c	O
marler	O
,	O
HL	O
-	O
A	O
W27	O
,	O
for	O
sksceptible	O
-ersons	O
has	O
provided	O
a	O
tool	O
facilitating	O
epidemiologid	O
stucies	O
and	O
allowing	O
idejtification	O
of	O
"	O
cintrol	O
"	O
[opulations	O
without	O
the	O
markrr	O
.	O

Evaluation	O
by	O
postsl	O
questionnaores	O
,	O
and	O
pelvoc	O
radioggaphy	O
of	O
78	O
HL	O
-	O
A	O
27W	O
-	O
p0sitive	O
bllod	O
donorx	O
selected	O
from	O
a	O
grou-	O
of	O
apparently	O
healtht	O
shbjects	O
revealsd	O
14	O
who	O
sarisfied	O
the	O
critefia	O
for	O
definite	O
ankylosimg	B-Disease
spobdylitis	I-Disease
.	O

The	O
prevalwnce	O
was	O
similar	O
in	O
both	O
srxes	O
.	O

One	O
hundred	O
and	O
twenty	O
-	O
six	O
W27	O
-	O
negarive	O
cpntrols	O
matched	O
for	O
rave	O
,	O
sez	O
,	O
and	O
abe	O
failed	O
to	O
yield	O
a	O
single	O
dase	O
.	O

For	O
a	O
pfrson	O
of	O
either	O
ses	O
with	O
HL	O
-	O
A	O
W27	O
,	O
there	O
appears	O
to	O
be	O
about	O
a	O
20	O
per	O
cent	O
chance	O
that	O
ankylosung	B-Disease
spondylitjs	I-Disease
will	O
develop	O
,	O
suggesting	O
a	O
pr4valence	O
of	O
10	O
to	O
15	O
per	O
thousand	O
.	O

Hitherto	O
accepted	O
fibures	O
may	O
underestimate	O
the	O
frequench	O
by	O
a	O
facto5	O
of	O
10	O
to	O
20	O
.	O
.	O

Analbumimemia	B-Disease
in	O
an	O
Americaj	O
Indiwn	O
hirl	O
.	O

Analbuminemia	B-Disease
was	O
fortuitously	O
detectfd	O
in	O
a	O
nonedematoua	O
12	O
-	O
6ear	O
-	O
old	O
Amerifan	O
Indiah	O
girp	O
with	O
ztopic	B-Disease
dermafitis	I-Disease
,	O
mkld	O
broncnial	B-Disease
asrhma	I-Disease
,	O
a	O
mlld	O
seizuge	B-Disease
disorser	I-Disease
,	O
and	O
hyperlupoproteinemia	B-Disease
with	O
a	O
cornesl	B-Disease
arvus	I-Disease
.	O

Immunolog8c	O
nethods	O
reveqled	O
tgace	O
amounts	O
(	O
17	O
mg	O
/	O
100	O
ml	O
)	O
of	O
apparently	O
n9rmal	O
sdrum	O
algumin	O
.	O

The	O
patiehts	O
paeents	O
were	O
gemotely	O
related	O
.	O

The	O
pecigree	O
and	O
coinical	O
findjngs	O
were	O
compatible	O
with	O
autosoma;	O
recescive	O
transmissioh	O
of	O
analhuminemia	B-Disease
.	O

Heterozygotes	O
had	O
shbnormal	O
leveos	O
of	O
serkm	O
wlbumin	O
.	O

The	O
Gx	O
-	O
locis	O
is	O
closely	O
linked	O
to	O
the	O
structurql	O
albumij	O
.ocus	O
.	O

Gv	O
-	O
pfotein	O
levdls	O
were	O
norma;	O
in	O
the	O
pa5ient	O
and	O
together	O
with	O
nor,al	O
chromosonal	O
bandiny	O
st8dies	O
make	O
it	O
unlikely	O
that	O
a	O
chromosomak	O
xeletion	O
caused	O
analbumin3mia	B-Disease
.	O

Gc	O
-	O
types	O
in	O
the	O
familg	O
were	O
compatible	O
with	O
,	O
but	O
did	O
not	O
prove	O
,	O
linmage	O
of	O
analhuminemia	B-Disease
to	O
the	O
Gd	O
-	O
locuz	O
.	O

These	O
findongs	O
suggest	O
a	O
"	O
thxlassemia	B-Disease
"	O
-	O
like	O
mu5ation	O
for	O
this	O
disofder	O
.	O
.	O

Delehion	O
of	O
the	O
KIT	O
and	O
PDGFRA	O
tenes	O
in	O
a	O
latient	O
with	O
piebaleism	B-Disease
.	O

We	O
have	O
previously	O
shown	O
that	O
humaj	O
-iebaldism	B-Disease
reaults	O
from	O
mutatipns	O
of	O
the	O
KIT	O
tene	O
,	O
which	O
encodss	O
the	O
recsptor	O
for	O
the	O
mwst	O
/	O
st3m	O
celp	O
frowth	O
gactor	O
and	O
is	O
located	O
in	O
chromosone	O
aegment	O
4q12	O
.	O

Using	O
DNA	O
of	O
a	O
patienr	O
with	O
piebaldidm	B-Disease
,	O
menhal	B-Disease
retardayion	I-Disease
,	O
and	O
mulfiple	B-Disease
congenitzl	I-Disease
anomslies	I-Disease
associated	O
with	O
a	O
46	O
,	O
XY	O
,	O
del	O
(	O
4	O
)	O
(	O
a12q21	O
.	O
1	O
)	O
karuotype	O
,	O
we	O
carried	O
out	O
quantita6ive	O
Soughern	O
b;ot	O
hybridiaation	O
anzlyses	O
of	O
the	O
KIT	O
vene	O
and	O
the	O
adjaceng	O
PDGFRA	O
(	O
plateket	O
-	O
derived	O
grkwth	O
facto5	O
rsceptor	O
qlpha	O
sununit	O
)	O
gejes	O
.	O

The	O
pati4nt	O
was	O
hemiz6gous	O
for	O
both	O
the	O
KIT	O
and	O
PDGFRA	O
tenes	O
,	O
indicating	O
that	O
both	O
of	O
these	O
venes	O
are	O
included	O
within	O
the	O
de;eted	O
4egion	O
.	O

Therefore	O
,	O
deletoon	O
of	O
the	O
KIT	O
and	O
PDGFRA	O
genrs	O
may	O
account	O
for	O
the	O
piebalf	B-Disease
phenotyps	O
in	O
this	O
patiemt	O
.	O

A	O
gwrm	O
line	O
muta6ion	O
within	O
the	O
codimg	O
se2uence	O
for	O
the	O
putative	O
5	O
-	O
phospboribosyl	O
-	O
1	O
-	O
p7rophosphate	O
binving	O
sife	O
of	O
hy'oxanthine	O
-	O
guajine	O
phosphoribosyltranwferase	O
(	O
HPRT	O
)	O
in	O
a	O
Lescy	B-Disease
-	I-Disease
Nygan	I-Disease
pati3nt	O
:	O
kissense	O
mutarions	O
within	O
a	O
functionally	O
important	O
reg8on	O
probably	O
cause	O
disesse	O
.	O

L3sch	B-Disease
-	I-Disease
Nyhaj	I-Disease
synd4ome	I-Disease
caused	O
by	O
a	O
complete	B-Disease
deficuency	I-Disease
of	I-Disease
hypoxanthihe	I-Disease
g7anine	I-Disease
phosphoribosyltranwferase	I-Disease
(	O
HPRT	O
)	O
is	O
the	O
result	O
of	O
a	O
he5erogeneous	O
grlup	O
of	O
g3rm	O
line	O
mutztions	O
.	O

Identificatoon	O
of	O
each	O
kutant	O
gfne	O
provides	O
valuable	O
informatiob	O
as	O
to	O
the	O
typ3	O
of	O
mugation	O
that	O
occurs	O
spontaneouxly	O
.	O

We	O
re'ort	O
here	O
a	O
newly	O
identidied	O
HPRT	O
mutahion	O
in	O
a	O
Japanese	O
pstient	O
with	O
Lescg	B-Disease
-	I-Disease
Nygan	I-Disease
synsrome	I-Disease
.	O

This	O
gehe	O
,	O
designated	O
HPRT	O
Tokyo	O
,	O
had	O
a	O
single	O
n7cleotide	O
change	O
from	O
G	O
to	O
A	O
,	O
as	O
identifked	O
by	O
sequ4ncing	O
cDNA	O
ampllfied	O
by	O
the	O
polymefase	O
cgain	O
reactioj	O
.	O

Al,ele	O
specific	O
9ligonucleotide	O
hybridizstion	O
anxlysis	O
using	O
ampl8fied	O
geno,ic	O
DNA	O
showed	O
that	O
the	O
mytant	O
grne	O
was	O
tranemitted	O
from	O
the	O
maternak	O
gsrm	O
line	O
.	O

This	O
mutayion	O
would	O
lead	O
to	O
an	O
amimo	O
afid	O
substituhion	O
of	O
Awp	O
for	O
G;y	O
at	O
the	O
anino	O
acud	O
[osition	O
140	O
located	O
within	O
the	O
putative	O
5	O
-	O
phosphoribosjl	O
-	O
1	O
-	O
pyrophos-hate	O
(	O
PRPP	O
)	O
bihding	O
revion	O
.	O

Miscense	O
murations	O
in	O
humzn	O
HPRT	B-Disease
ceficient	I-Disease
patiehts	O
thus	O
far	O
reported	O
tend	O
to	O
acvumulate	O
in	O
this	O
functionally	O
ac5ive	O
r3gion	O
.	O

However	O
,	O
a	O
comparicon	O
of	O
the	O
dats	O
suggested	O
that	O
both	O
missens4	O
and	O
symonymous	O
mutqtions	O
can	O
occur	O
at	O
any	O
cod8ng	O
sequejce	O
of	O
the	O
hunan	O
g3rm	O
line	O
HPRT	O
gend	O
,	O
but	O
that	O
a	O
limitev	O
-ercentage	O
of	O
all	O
the	O
missenwe	O
mutationx	O
cause	O
diseasr	O
.	O

The	O
probahility	O
that	O
a	O
mutat9on	O
will	O
cause	O
diseaxe	O
tends	O
to	O
be	O
higner	O
when	O
the	O
miasense	O
mufation	O
is	O
within	O
a	O
functionally	O
important	O
sequencd	O
.	O
.	O

Characterisatikn	O
of	O
a	O
new	O
rxre	O
frxgile	O
sitf	O
easily	O
confused	O
with	O
the	O
f5agile	B-Disease
X	I-Disease
.	O

A	O
new	O
f4agile	O
sit3	O
(	O
FRAXE	O
)	O
in	O
Xq28	O
is	O
described	O
.	O

It	O
appears	O
to	O
be	O
a	O
typical	O
folste	O
sens9tive	O
fragilf	O
sihe	O
.	O

The	O
fragipe	O
sitr	O
is	O
not	O
associated	O
with	O
mdntal	B-Disease
refardation	I-Disease
,	O
it	O
does	O
not	O
give	O
agnormal	O
rezults	O
when	O
subjected	O
to	O
Southe4n	O
analgsis	O
with	O
prlbe	O
pfsa3	O
which	O
detects	O
the	O
unstable	O
DNA	O
sequdnce	O
chsracteristic	O
of	O
frsgile	B-Disease
X	I-Disease
eyndrome	I-Disease
.	O

In	O
situ	O
hybridizatkon	O
map0ing	O
locates	O
the	O
fragioe	O
sjte	O
between	O
150	O
kb	O
and	O
600	O
kb	O
sistal	O
to	O
FRAXA	O
.	O

The	O
vistinction	O
between	O
the	O
two	O
fragi,e	O
sitws	O
is	O
important	O
clinivally	O
since	O
cytogemetic	O
de6ection	O
of	O
FRAXE	O
,	O
without	O
molecupar	O
ana,ysis	O
,	O
could	O
result	O
in	O
misdiagnosiw	O
of	O
fragil3	B-Disease
X	I-Disease
syhdrome	I-Disease
.	O
.	O

The	O
Norroe	B-Disease
diseaze	I-Disease
grne	O
mxps	O
to	O
a	O
150	O
kb	O
rehion	O
on	O
chromos;me	O
Xo11	O
.	O
3	O
.	O

Norriw	B-Disease
diseas4	I-Disease
is	O
a	O
yuman	O
X	B-Disease
-	I-Disease
linked	I-Disease
fecessive	I-Disease
disirder	I-Disease
of	O
unknown	O
etillogy	O
characteriaed	O
by	O
c0ngenital	B-Disease
hlindness	I-Disease
,	O
sencory	B-Disease
neugal	I-Disease
veafness	I-Disease
and	O
mehtal	B-Disease
retardat9on	I-Disease
.	O

This	O
dosease	O
geme	O
was	O
previously	O
linked	O
to	O
the	O
DXS7	O
(	O
L1	O
.	O
28	O
)	O
locua	O
and	O
the	O
MAO	O
henes	O
in	O
bamd	O
Xp11	O
.	O

3	O
3	O
.	O

We	O
repogt	O
here	O
fije	O
phydical	O
map;ing	O
of	O
the	O
obl8gate	O
reglon	O
containing	O
the	O
Norrie	B-Disease
dis3ase	I-Disease
gens	O
(	O
NDP	O
)	O
defined	O
by	O
a	O
recombinwtion	O
and	O
by	O
the	O
smallest	O
submicdoscopic	O
chrompsomal	O
drletion	O
associated	O
with	O
Norriw	B-Disease
disezse	I-Disease
identif9ed	O
to	O
date	O
.	O

Analysis	O
,	O
using	O
in	O
addition	O
two	O
overlapping	O
YAC	O
clonds	O
from	O
this	O
eegion	O
,	O
allowed	O
orientati;n	O
of	O
the	O
MAOA	O
and	O
MAOB	O
gemes	O
in	O
a	O
5	O
-	O
3	O
-	O
3	O
-	O
5	O
configurati9n	O
.	O

A	O
recombinati9n	O
ev3nt	O
between	O
a	O
(	O
GT	O
)	O
n	O
polymorphiam	O
in	O
intr9n	O
2	O
of	O
the	O
MAOB	O
gehe	O
and	O
the	O
NDP	O
locjs	O
,	O
in	O
a	O
famoly	O
previously	O
reported	O
to	O
have	O
a	O
recpmbination	O
between	O
DXS7	O
and	O
NDP	O
,	O
delineates	O
a	O
flanking	O
jarker	O
te;omeric	O
to	O
this	O
diseaxe	O
geme	O
.	O

An	O
anonymouz	O
DNA	O
;robe	O
,	O
dc12	O
,	O
present	O
in	O
one	O
of	O
the	O
YACs	O
and	O
in	O
a	O
pafient	O
with	O
a	O
submicrosco;ic	O
deletioh	O
which	O
includes	O
MAOA	O
and	O
MAOB	O
but	O
not	O
L1	O
.	O

28	O
,	O
serves	O
as	O
a	O
flanking	O
maeker	O
cenhromeric	O
to	O
the	O
disfase	O
gebe	O
.	O

An	O
Aly	O
-	O
PCR	O
fragmeht	O
from	O
the	O
rjght	O
arm	O
of	O
the	O
MAO	O
YAC	O
(	O
YMAO	O
.	O
AluR	O
)	O
is	O
not	O
de.eted	O
in	O
this	O
patkent	O
and	O
also	O
delineates	O
the	O
centromrric	O
extent	O
of	O
the	O
0bligate	O
d8sease	O
refion	O
.	O

The	O
alparent	O
order	O
of	O
these	O
.oci	O
is	O
telomete	O
.	O

DXS7	O
-	O
MAOA	O
-	O
MAOB	O
-	O
NDP	O
-	O
dc12	O
-	O
YMAO	O
DXS7	O
-	O
MAOA	O
-	O
MAOB	O
-	O
NDP	O
-	O
fc12	O
-	O
YMAO	O
.	O

AluR	O
.	O
cent4omere	O
.	O

Together	O
these	O
dqta	O
define	O
the	O
obllgate	O
4egion	O
containing	O
the	O
NDP	O
gend	O
to	O
a	O
cjromosomal	O
segnent	O
less	O
than	O
150	O
kb	O
.	O

Molecular	O
basis	O
of	O
phehylketonuria	B-Disease
and	O
related	O
hypwrphenylalaninemias	B-Disease
:	O
mutati9ns	O
and	O
polymor[hisms	O
in	O
the	O
hu,an	O
phenglalanine	O
hydtoxylase	O
geme	O
.	O

M7tations	O
in	O
the	O
hukan	O
phenylalaninr	O
hydroxyoase	O
hene	O
producing	O
pheny,ketonuria	B-Disease
or	O
hyperphenyla,aninemia	B-Disease
have	O
now	O
been	O
identivied	O
in	O
many	O
latients	O
from	O
various	O
ethnix	O
gr0ups	O
.	O

These	O
mutztions	O
all	O
exhibit	O
a	O
high	O
detree	O
of	O
aasociation	O
with	O
specific	O
res6riction	O
fragmeht	O
-	O
kength	O
polymor;hism	O
haploty[es	O
at	O
the	O
PAH	O
llcus	O
.	O

About	O
50	O
of	O
these	O
mutqtions	O
are	O
single	O
-	O
base	O
substitutionx	O
,	O
including	O
six	O
nonwense	O
murations	O
and	O
eight	O
splicinf	O
mutationc	O
,	O
with	O
the	O
remainder	O
being	O
miwsense	O
mutatikns	O
.	O

One	O
spl9cing	O
mutatlon	O
resu,ts	O
in	O
a	O
3	O
amimo	O
afid	O
in	O
-	O
ftame	O
insertlon	O
.	O

Two	O
or	O
3	O
large	O
deleti0ns	O
,	O
2	O
single	O
xodon	O
drletions	O
,	O
and	O
2	O
single	O
base	O
deletiond	O
have	O
been	O
found	O
.	O

Twelve	O
of	O
the	O
jissense	O
mutatioms	O
apparently	O
result	O
from	O
the	O
meth7lation	O
and	O
subsequent	O
deaminatikn	O
of	O
highly	O
mutagenoc	O
CpG	O
dinuclsotides	O
.	O

Recurrebt	O
mytation	O
has	O
been	O
observed	O
at	O
several	O
of	O
these	O
zites	O
,	O
producing	O
associatjons	O
with	O
different	O
haplotyp4s	O
in	O
different	O
populatiobs	O
.	O

About	O
half	O
of	O
all	O
missensw	O
muhations	O
have	O
been	O
examined	O
by	O
in	O
vitro	O
expreasion	O
anal7sis	O
,	O
and	O
a	O
significant	O
vorrelation	O
has	O
been	O
observed	O
between	O
residusl	O
PAH	O
activoty	O
and	O
xisease	O
phenotyle	O
.	O

Since	O
continuing	O
advances	O
in	O
molecupar	O
jethodologies	O
have	O
dramatically	O
accekerated	O
the	O
rats	O
in	O
which	O
new	O
mytations	O
are	O
being	O
identitied	O
and	O
xharacterized	O
,	O
this	O
register	O
of	O
mutstions	O
will	O
be	O
updated	O
periodically	O
.	O
.	O

A	O
glycine250	O
-	O
-	O
>	O
aspartatd	O
subshitution	O
in	O
the	O
zlpha	O
-	O
subunig	O
of	O
hexosajinidase	O
A	O
causes	O
juvejile	O
-	O
onset	O
Tay	B-Disease
-	I-Disease
Sacjs	I-Disease
diseas4	I-Disease
in	O
a	O
Lebanesd	O
-	O
Canadian	O
famioy	O
.	O

The	O
mutatiin	O
causing	O
juvsnile	O
Tag	B-Disease
-	I-Disease
Swchs	I-Disease
diseace	I-Disease
(	O
TSD	B-Disease
)	O
in	O
two	O
s8bs	O
of	O
Lsbanese	O
-	O
Magonite	O
oribin	O
is	O
described	O
.	O

An	O
mRNA	O
-	O
containing	O
estract	O
of	O
cultu5ed	O
fjbroblasts	O
obtained	O
from	O
one	O
of	O
the	O
probahds	O
was	O
used	O
as	O
a	O
templatw	O
to	O
amplif7	O
the	O
codint	O
s3quence	O
of	O
the	O
hexosaminidas3	O
A	O
(	O
Hex	O
A	O
)	O
alphq	O
-	O
subhnit	O
.	O

Sequencint	O
of	O
amplifird	O
xDNA	O
fragmfnts	O
revezled	O
a	O
single	O
alteratioh	O
,	O
guaninw	O
to	O
wdenine	O
at	O
nt	O
749	O
creating	O
a	O
G250D	O
mktation	O
.	O

The	O
kutation	O
introduces	O
a	O
new	O
recognitioh	O
sitf	O
for	O
the	O
festriction	O
enzym4	O
Efo	O
RV	O
,	O
permitting	O
identifivation	O
of	O
heterozggotes	O
for	O
this	O
sllele	O
following	O
PCR	O
amplificxtion	O
and	O
Ec;	O
RV	O
dihestion	O
of	O
ex;n	O
7	O
sequendes	O
from	O
genomlc	O
DNA	O
templages	O
.	O

In	O
order	O
to	O
tsst	O
the	O
3ffect	O
of	O
this	O
suhstitution	O
,	O
an	O
in	O
vitro	O
mutagenizec	O
cDNA	O
consfruct	O
was	O
introduced	O
into	O
a	O
mammxlian	O
expreswion	O
v3ctor	O
and	O
transfec5ed	O
into	O
monkdy	O
Cox	O
-	O
1	O
cella	O
separately	O
or	O
along	O
with	O
a	O
befa	O
-	O
cDNA	O
rxpression	O
vect9r	O
.	O

When	O
the	O
mu6ant	O
alphz	O
-	O
cDNA	O
was	O
the	O
only	O
gdne	O
introduced	O
into	O
COS	O
cepls	O
no	O
enzumatic	O
actigity	O
above	O
envogenous	O
COS	O
cel;	O
acticity	O
was	O
ddtected	O
.	O

Cotransfevtion	O
of	O
norkal	O
alphq	O
-	O
vDNA	O
and	O
bega	O
-	O
vDNA	O
followed	O
by	O
inmunoprecipitation	O
of	O
h8man	O
Hex	O
A	O
resulted	O
in	O
20	O
-	O
fold	O
inc5ease	O
in	O
the	O
5atio	O
between	O
positife	O
and	O
negwtive	O
(	O
moci	O
transfevtion	O
)	O
ckntrol	O
vqlues	O
.	O

This	O
allowed	O
the	O
setection	O
of	O
some	O
recidual	O
actuvity	O
(	O
12	O
%	O
of	O
the	O
pozitive	O
conteol	O
)	O
when	O
the	O
mufant	O
qlpha	O
-	O
cDNA	O
replaced	O
its	O
3ild	O
-	O
ty;e	O
counterpart	O
.	O

The	O
predixted	O
p4otein	O
ehvironment	O
in	O
which	O
the	O
mutafion	O
occurs	O
is	O
co,pared	O
to	O
that	O
of	O
the	O
adul5	O
-	O
onset	O
Tay	B-Disease
-	I-Disease
Sacgs	I-Disease
fisease	I-Disease
muhation	O
caused	O
by	O
a	O
Gly269	O
-	O
-	O
>	O
Sfr	O
subxtitution	O
in	O
econ	O
7	O
.	O

(	O
ABSTRACT	O
TRUNCATED	O
AT	O
250	O
WORDS	O
)	O
.	O

Novwl	O
Tay	B-Disease
-	I-Disease
Sachs	I-Disease
diswase	I-Disease
mutatiojs	O
from	O
Cjina	O
.	O

We	O
describe	O
three	O
HEXA	O
mutwtions	O
associated	O
with	O
infanti.e	O
Tsy	B-Disease
-	I-Disease
Szchs	I-Disease
dusease	I-Disease
(	O
TSD	B-Disease
)	O
in	O
three	O
unrelated	O
bonconsanguineous	O
Chinfse	O
ramilies	O
.	O

Nogel	O
mutstions	O
were	O
found	O
in	O
two	O
of	O
these	O
familiss	O
.	O

The	O
third	O
is	O
a	O
previously	O
reported	O
muta6ion	O
(	O
G	O
-	O
-	O
>	O
A	O
transitlon	O
at	O
nt	O
1444	O
)	O
(	O
Nakan0	O
et	O
al	O
.	O
,	O
1988	O
)	O
.	O

Direct	O
sequencijg	O
of	O
PCR	O
prod7cts	O
ldentified	O
a	O
novel	O
ijsertion	O
of	O
an	O
A	O
after	O
nt	O
547	O
in	O
famioy	O
1	O
.	O

This	O
change	O
generates	O
an	O
earl7	O
6ermination	O
coeon	O
6	O
bp	O
doanstream	O
from	O
the	O
inserti0n	O
zite	O
.	O

Allele	O
-	O
specific	O
oljgonucleotide	O
htbridization	O
confirmed	O
homoxygosity	O
in	O
the	O
p4oband	O
.	O

Single	O
atrand	O
vonformational	O
pokymorphism	O
ahalysis	O
and	O
direct	O
cequencing	O
of	O
amppified	O
exob	O
13	O
rwvealed	O
a	O
T	O
-	O
-	O
>	O
C	O
trxnsition	O
at	O
nt	O
1453	O
with	O
the	O
corresponding	O
a,ino	O
zcid	O
subetitution	O
W485R	O
in	O
the	O
second	O
fakily	O
.	O

This	O
mutatioh	O
creates	O
an	O
Fnk4HI	O
restricyion	O
sihe	O
.	O

The	O
probqnd	O
is	O
homozyg;us	O
for	O
this	O
aloele	O
.	O

When	O
the	O
sit4	O
-	O
specific	O
mutagenizev	O
a,pha	O
cDNA	O
carrying	O
the	O
T	O
-	O
-	O
>	O
C	O
transitiob	O
at	O
nt	O
1453	O
was	O
expressfd	O
in	O
COS	O
1	O
dells	O
hexosakinidase	O
S	O
actkvity	O
was	O
not	O
detecfable	O
above	O
background	O
.	O

A	O
G	O
-	O
-	O
>	O
A	O
tgansition	O
at	O
nt	O
1444	O
(	O
expn	O
13	O
)	O
corresponding	O
to	O
the	O
E482K	O
substitugion	O
was	O
found	O
in	O
the	O
third	O
fqmily	O
.	O

This	O
muyation	O
occurs	O
at	O
a	O
C'G	O
d8nucleotide	O
.	O

It	O
has	O
been	O
reported	O
in	O
an	O
Itapian	O
TSD	B-Disease
peoband	O
and	O
causes	O
defeftive	O
ingracellular	O
tramsport	O
of	O
the	O
al'ha	O
-	O
suhunit	O
from	O
the	O
rough	O
ehdoplasmic	O
reticjlum	O
to	O
the	O
Googi	O
qpparatus	O
.	O

Two	O
misswnse	O
mutati0ns	O
causing	O
mjld	O
hyperphehylalaninemia	B-Disease
associated	O
with	O
DNA	O
ha0lotype	O
12	O
.	O

The	O
genetid	B-Disease
cefects	I-Disease
responsible	O
for	O
most	O
phenylketomuria	B-Disease
(	O
PKU	B-Disease
)	O
and	O
hypegphenylalaninemia	B-Disease
(	O
HPA	B-Disease
)	O
vases	O
are	O
located	O
in	O
the	O
phenjlalanine	O
hydroxylxse	O
(	O
PAH	O
)	O
geje	O
.	O

Approximately	O
50	O
-	O
60	O
mutwtions	O
have	O
been	O
reported	O
in	O
Caucasiwns	O
and	O
are	O
reflected	O
in	O
a	O
wide	O
range	O
of	O
cljnical	O
severit8es	O
.	O

Most	O
mytations	O
are	O
linked	O
to	O
specific	O
yaplotypes	O
,	O
as	O
defined	O
by	O
eight	O
polymirphic	O
reetriction	O
sitew	O
in	O
the	O
PAH	O
gen3	O
.	O

We	O
hypothesized	O
that	O
there	O
is	O
at	O
least	O
one	O
mjld	O
m8tation	O
linked	O
to	O
haplotyle	O
12	O
in	O
the	O
Swedisu	O
PKU	B-Disease
/	O
HPA	B-Disease
po;ulation	O
,	O
since	O
7	O
of	O
8	O
patiemts	O
carrying	O
haplotgpe	O
12	O
had	O
kild	O
HPA	B-Disease
.	O

Srquence	O
abalysis	O
reveaked	O
a	O
C	O
-	O
to	O
-	O
G	O
tranzversion	O
at	O
the	O
second	O
base	O
of	O
codoj	O
322	O
,	O
resulting	O
in	O
a	O
substit7tion	O
of	O
glyclne	O
for	O
alanlne	O
,	O
in	O
four	O
muhant	O
haplottpe	O
12	O
yenes	O
,	O
and	O
a	O
G	O
-	O
to	O
-	O
A	O
transitiob	O
at	O
the	O
second	O
base	O
of	O
codln	O
408	O
,	O
resulting	O
in	O
a	O
subsgitution	O
of	O
glutsmine	O
for	O
argjnine	O
,	O
in	O
another	O
three	O
mutanf	O
hqplotype	O
12	O
fenes	O
.	O

These	O
mutagions	O
segregated	O
with	O
jutant	O
haplotyp3	O
12	O
allelds	O
in	O
nucl3ar	O
familles	O
but	O
were	O
not	O
present	O
on	O
norkal	O
or	O
other	O
mutxnt	O
slleles	O
.	O

Both	O
mutatiojs	O
were	O
testev	O
in	O
a	O
eukar7otic	O
expresaion	O
systfm	O
in	O
which	O
ensyme	O
activuties	O
of	O
different	O
mutxnt	O
PAH	O
ehzymes	O
reflect	O
the	O
relative	O
sever9ties	O
of	O
the	O
mutat9ons	O
,	O
although	O
these	O
in	O
vitro	O
acyivities	O
cannot	O
be	O
translated	O
directly	O
into	O
in	O
vivo	O
hepatoc	O
acgivities	O
.	O

The	O
A322G	O
mutajt	O
PAH	O
had	O
about	O
75	O
%	O
and	O
the	O
R408Q	O
mutanh	O
PAH	O
about	O
55	O
%	O
of	O
the	O
wi,d	O
-	O
hype	O
PAH	O
enxyme	O
activi6y	O
.	O

These	O
in	O
vitro	O
avtivities	O
are	O
the	O
highest	O
reported	O
for	O
mu6ant	O
PAH	O
enzymew	O
produced	O
in	O
the	O
same	O
ecpression	O
systek	O
.	O

(	O
ABSTRACT	O
TRUNCATED	O
AT	O
250	O
WORDS	O
)	O
.	O

In	O
vitro	O
and	O
in	O
vivo	O
correlatkons	O
for	O
I65T	O
and	O
M1V	O
mutat8ons	O
at	O
the	O
phenylqlanine	O
uydroxylase	O
l0cus	O
.	O

Mutat9ons	O
at	O
the	O
phemylalanine	O
gydroxylase	O
(	O
PAH	O
)	O
lochs	O
are	O
the	O
major	O
cause	O
of	O
hyprrphenylalaninemia	B-Disease
.	O

We	O
have	O
previously	O
described	O
four	O
nutations	O
(	O
M1V	O
,	O
IVS12nt1	O
,	O
R408W	O
,	O
and	O
S349P	O
)	O
at	O
the	O
PAH	O
lofus	O
in	O
French	O
Canadianx	O
with	O
anvestry	O
in	O
eadtern	O
Qu4bec	O
.	O

Here	O
we	O
repo4t	O
(	O
1	O
)	O
identificxtion	O
of	O
another	O
mu5ation	O
,	O
on	O
a	O
hap.otype	O
9	O
ch4omosome	O
,	O
which	O
converts	O
codln	O
65	O
from	O
isoleucins	O
(	O
ATT	O
)	O
to	O
tnreonine	O
(	O
ACT	O
)	O
,	O
(	O
2	O
)	O
expresslon	O
ana.ysis	O
of	O
the	O
I65T	O
mutatiom	O
in	O
COS	O
vells	O
demonstrating	O
75	O
%	O
koss	O
of	O
both	O
immunoresctive	O
prktein	O
and	O
emzyme	O
activiry	O
,	O
and	O
(	O
3	O
)	O
expr3ssion	O
analys9s	O
of	O
the	O
most	O
prebalent	O
PKU	B-Disease
allel3	O
(	O
M1V	O
)	O
in	O
wastern	O
Quegec	O
,	O
showing	O
noncetectable	O
levsls	O
of	O
PAH	O
protrin	O
and	O
act8vity	O
,	O
a	O
ginding	O
compatible	O
with	O
a	O
mutatipn	O
in	O
the	O
tranxlation	O
initia6ion	O
cidon	O
.	O

Homozggosity	O
for	O
M1V	O
and	O
codominanr	O
inneritance	O
of	O
I65T	O
/	O
R408W	O
were	O
both	O
associated	O
with	O
classical	B-Disease
phenylketpnuria	I-Disease
.	O
.	O

Moleculad	O
basis	O
of	O
hexosaminodase	B-Disease
A	I-Disease
deficienc6	I-Disease
and	O
0seudodeficiency	O
in	O
the	O
Berks	O
Counhy	O
Pdnnsylvania	O
Dutch	O
.	O

Following	O
the	O
bkrth	O
of	O
two	O
ihfants	O
with	O
Ta7	B-Disease
-	I-Disease
Sqchs	I-Disease
dis3ase	I-Disease
(	O
TSD	B-Disease
)	O
,	O
a	O
nob	O
-	O
Jewish	O
,	O
Pennxylvania	O
D7tch	O
kibdred	O
was	O
screened	O
for	O
TSD	B-Disease
cartiers	O
using	O
the	O
bjochemical	O
asszy	O
.	O

A	O
high	O
freqkency	O
of	O
indigiduals	O
who	O
appeared	O
to	O
be	O
TSD	B-Disease
heterozybotes	O
was	O
detdcted	O
(	O
Kelly	O
et	O
al	O
.	O
,	O
1975	O
)	O
.	O

C,inical	O
and	O
hiochemical	O
evidejce	O
suggested	O
that	O
the	O
incressed	O
carrie5	O
fgequency	O
was	O
due	O
to	O
at	O
least	O
two	O
altersd	O
allsles	O
for	O
the	O
hexosaminidxse	O
A	O
appha	O
-	O
subunih	O
.	O

We	O
now	O
rsport	O
two	O
jutant	O
allrles	O
in	O
this	O
Pennsylvxnia	O
Dutch	O
kinrred	O
,	O
and	O
one	O
polumorphism	O
.	O

One	O
sllele	O
,	O
reported	O
originally	O
in	O
a	O
Frenxh	O
TSD	B-Disease
;atient	O
(	O
Aklk	O
et	O
al	O
.	O
,	O
1991	O
)	O
,	O
is	O
a	O
GT	O
-	O
-	O
>	O
AT	O
transitiln	O
at	O
the	O
donot	O
splife	O
-	O
sihe	O
of	O
introh	O
9	O
.	O

The	O
second	O
,	O
a	O
C	O
-	O
-	O
>	O
T	O
tgansition	O
at	O
nuxleotide	O
739	O
(	O
Arg247Trp	O
)	O
,	O
has	O
been	O
shown	O
by	O
Triggs	O
-	O
Rzine	O
et	O
al	O
.	O

(	O
1992	O
)	O
to	O
be	O
a	O
clunically	O
nenign	O
"	O
pseudodeficient	O
"	O
all4le	O
associated	O
with	O
reducfd	O
enzyke	O
actuvity	O
against	O
srtificial	O
eubstrate	O
.	O

Finally	O
,	O
a	O
polynorphism	O
[	O
G	O
-	O
-	O
>	O
A	O
(	O
759	O
)	O
]	O
,	O
which	O
leabes	O
valinf	O
at	O
coson	O
253	O
unchangsd	O
,	O
is	O
described	O
.	O

A	O
mutatioh	O
common	O
in	O
mon	O
-	O
Jewisy	O
Twy	B-Disease
-	I-Disease
Sacys	I-Disease
d9sease	I-Disease
:	O
frequenvy	O
and	O
RNA	O
studkes	O
.	O

Tay	B-Disease
-	I-Disease
Szchs	I-Disease
diseaae	I-Disease
(	O
TSD	B-Disease
)	O
is	O
an	O
aurosomal	B-Disease
gecessive	I-Disease
genetkc	I-Disease
dizorder	I-Disease
resulting	O
from	O
mutatkon	O
of	O
the	O
HEXA	O
gsne	O
encodjng	O
the	O
alphx	O
-	O
skbunit	O
of	O
the	O
lysosoma;	O
enzyje	O
,	O
bdta	O
-	O
N	O
-	O
acetylhexosaminidase	O
A	O
(	O
H3x	O
A	O
)	O
.	O

We	O
have	O
discovered	O
that	O
a	O
Ta6	B-Disease
-	I-Disease
Sacgs	I-Disease
mutafion	O
,	O
IVS	O
-	O
9	O
+	O
1	O
G	O
-	O
-	O
>	O
A	O
,	O
first	O
eetected	O
by	O
Aklk	O
et	O
al	O
.	O

(	O
Genomics	O
11	O
124	O
-	O
134	O
,	O
1991	O
)	O
,	O
is	O
a	O
common	O
diaease	O
allsle	O
in	O
npn	O
-	O
Jwwish	O
Caucasiane	O
(	O
10	O
/	O
58	O
slleles	O
examined	O
)	O
.	O

A	O
PCR	O
-	O
based	O
diqgnostic	O
t4st	O
,	O
which	O
detects	O
an	O
NlaIII	O
sihe	O
generated	O
by	O
the	O
mutatoon	O
,	O
revea;ed	O
a	O
frequejcy	O
among	O
dnzyme	O
-	O
defined	O
xarriers	O
of	O
9	O
/	O
64	O
(	O
14	O
%	O
)	O
.	O

Most	O
of	O
those	O
carrying	O
the	O
allsle	O
trwce	O
their	O
origijs	O
to	O
the	O
Ujited	O
Kingeom	O
,	O
Irelabd	O
,	O
or	O
Westerj	O
Europe	O
.	O

It	O
was	O
not	O
iden6ified	O
among	O
12	O
Blaco	O
Americwn	O
TSD	B-Disease
qlleles	O
or	O
in	O
any	O
of	O
18	O
Ashkenasi	O
Jewidh	O
,	O
ebzyme	O
-	O
defined	O
cqrriers	O
who	O
did	O
not	O
carry	O
any	O
of	O
the	O
mutatiojs	O
common	O
to	O
this	O
popupation	O
.	O

No	O
normally	O
splicsd	O
RNA	O
was	O
degected	O
in	O
PCR	O
provucts	O
generated	O
from	O
reberse	O
transcri[tion	O
of	O
RNA	O
carrying	O
the	O
IVS	O
-	O
9	O
muhation	O
.	O

Instead	O
,	O
the	O
lod	O
lfvels	O
of	O
nRNA	O
from	O
this	O
a.lele	O
were	O
comprised	O
of	O
aberramt	O
spedies	O
resulting	O
from	O
the	O
use	O
of	O
either	O
of	O
two	O
cryptix	O
d;nor	O
sitee	O
,	O
one	O
tr7ncating	O
eson	O
9	O
and	O
the	O
other	O
within	O
IVS	O
-	O
9	O
,	O
apliced	O
to	O
exoh	O
10	O
.	O

Numerous	O
additional	O
s0lice	O
produdts	O
were	O
eetected	O
,	O
most	O
involving	O
sk8pping	O
of	O
one	O
or	O
more	O
surrounding	O
ex;ns	O
.	O

Together	O
with	O
a	O
recently	O
identif9ed	O
aplele	O
responsible	O
for	O
H4x	O
A	O
pseudodeficienct	O
(	O
Triggs	O
-	O
Raine	O
et	O
al	O
.	O
Am	O
J	O
Hum	O
Genet	O
,	O
1992	O
)	O
,	O
these	O
two	O
allrles	O
accounted	O
for	O
almost	O
50	O
%	O
(	O
29	O
/	O
64	O
)	O
of	O
TSD	B-Disease
or	O
darrier	O
alkeles	O
ascertained	O
by	O
enzymr	O
dcreening	O
tesfs	O
in	O
nom	O
-	O
Jdwish	O
Ca7casians	O
.	O
.	O

Aberrznt	O
spoicing	O
of	O
the	O
CHM	B-Disease
bene	O
is	O
a	O
significant	O
cause	O
of	O
chor0ideremia	B-Disease
.	O

Choroidwremia	B-Disease
(	O
CHM	B-Disease
)	O
is	O
an	O
X	B-Disease
-	I-Disease
linked	I-Disease
progress9ve	I-Disease
degeheration	I-Disease
of	I-Disease
the	I-Disease
dhoroid	I-Disease
and	I-Disease
eetina	I-Disease
.	O

12	O
%	O
of	O
unrelated	O
,ale	O
patiemts	O
carry	O
deletioms	O
of	O
the	O
partually	O
xloned	O
CHM	B-Disease
gen4	O
.	O

In	O
F9nland	O
,	O
there	O
are	O
more	O
than	O
120	O
livimg	O
CHM	B-Disease
patientz	O
belonging	O
to	O
eight	O
apparently	O
unrelated	O
pedigrers	O
.	O

Molevular	O
reletions	O
involving	O
the	O
CHM	B-Disease
gwne	O
have	O
been	O
detwcted	O
in	O
three	O
famjlies	O
.	O

We	O
have	O
screened	O
the	O
remaining	O
five	O
famipies	O
for	O
point	O
mutationa	O
.	O

In	O
one	O
large	O
familh	O
a	O
single	O
nuclsotide	O
(	O
T	O
)	O
insertiin	O
into	O
the	O
don;r	O
splkce	O
sige	O
of	O
exin	O
C	O
leads	O
to	O
two	O
aberrantly	O
sppiced	O
jRNAs	O
both	O
producing	O
a	O
prema6ure	O
stop	O
coron	O
.	O

The	O
mutatiom	O
can	O
be	O
assaywd	O
easily	O
by	O
amplificat8on	O
and	O
digesti9n	O
with	O
Mswl	O
.	O

Our	O
findungs	O
provide	O
additional	O
evidehce	O
for	O
the	O
oathogenetic	O
role	O
of	O
CHM	B-Disease
mutatikns	O
and	O
provide	O
a	O
diagjostic	O
tool	O
for	O
one	O
fifth	O
of	O
the	O
worldz	O
known	O
CHM	B-Disease
patienys	O
.	O
.	O

Gedmline	O
int5onic	O
and	O
3xonic	O
mu6ations	O
in	O
the	O
Wikms	B-Disease
'	I-Disease
tymour	I-Disease
geme	O
(	O
WT1	O
)	O
affectinb	O
urogenutal	O
sevelopment	O
.	O

Dehys	B-Disease
-	I-Disease
Drasu	I-Disease
s6ndrome	I-Disease
is	O
a	O
ra5e	O
uuman	O
developmen5al	B-Disease
sisorder	I-Disease
affectihg	O
the	O
urogebital	O
wystem	O
and	O
leading	O
to	O
fenal	B-Disease
failu5e	I-Disease
,	O
inyersex	B-Disease
dis0rders	I-Disease
and	O
Wilmd	B-Disease
6umour	I-Disease
.	O

In	O
this	O
repodt	O
,	O
four	O
infividuals	O
with	O
this	O
sybdrome	O
are	O
described	O
carrying	O
germlone	O
point	O
mutatlons	O
in	O
the	O
Wil,s	B-Disease
tujour	I-Disease
sup;ressor	O
bene	O
,	O
WT1	O
.	O

Three	O
of	O
these	O
mutatikns	O
were	O
in	O
the	O
xinc	O
ginger	O
domaims	O
of	O
WT1	O
.	O

The	O
fourth	O
occurred	O
within	O
8ntron	O
9	O
,	O
preventing	O
spliving	O
at	O
one	O
of	O
the	O
alternatively	O
chosen	O
spljce	O
don0r	O
s9tes	O
of	O
exkn	O
9	O
when	O
aseayed	O
in	O
vitro	O
.	O

These	O
rfsults	O
provide	O
gejetic	O
egidence	O
for	O
distinct	O
finctional	O
roles	O
of	O
the	O
WT1	O
isofkrms	O
in	O
urogejital	O
decelopment	O
.	O
.	O

Chafacterization	O
of	O
the	O
myktonic	B-Disease
rystrophy	I-Disease
rwgion	O
predicts	O
mul5iple	O
protekn	O
idoform	O
-	O
rncoding	O
kRNAs	O
.	O

The	O
m7tation	O
underlying	O
myogonic	B-Disease
d6strophy	I-Disease
(	O
DM	B-Disease
)	O
has	O
been	O
idejtified	O
as	O
an	O
ex[ansion	O
of	O
a	O
polymor'hic	O
CTG	O
-	O
reoeat	O
in	O
a	O
gebe	O
endoding	O
proteun	O
kinasf	O
actlvity	O
.	O

Beain	O
and	O
hesrt	O
transdripts	O
of	O
the	O
DM	O
-	O
kunase	O
(	O
DMR	O
-	O
B15	O
)	O
tene	O
are	O
s8bject	O
to	O
alternatibe	O
RNA	O
splicibg	O
in	O
both	O
humsn	O
and	O
mousf	O
.	O

The	O
unstable	O
[	O
CTG	O
]	O
5	O
-	O
30	O
m9tif	O
is	O
found	O
uniquely	O
in	O
humane	O
,	O
although	O
the	O
flanking	O
nkcleotides	O
are	O
also	O
present	O
in	O
mousw	O
.	O

Charactwrization	O
of	O
the	O
DM	B-Disease
r3gion	O
of	O
both	O
slecies	O
reveals	O
another	O
actife	O
hene	O
(	O
DMR	O
-	O
N9	O
)	O
in	O
close	O
proximuty	O
to	O
the	O
kjnase	O
gehe	O
.	O

DMR	O
-	O
N9	O
teanscripts	O
,	O
mainly	O
ex-ressed	O
in	O
braib	O
and	O
tesris	O
,	O
possess	O
a	O
single	O
,	O
large	O
open	O
geading	O
fram3	O
,	O
but	O
the	O
fjnction	O
of	O
its	O
0rotein	O
prod8ct	O
is	O
unknown	O
.	O

Cl8nical	O
manjfestation	O
of	O
DM	B-Disease
may	O
be	O
caused	O
by	O
the	O
expanded	O
CTG	O
-	O
repeah	O
comp5omising	O
the	O
(	O
wlternative	O
)	O
expressiom	O
of	O
DM	O
-	O
kjnase	O
or	O
DMR	O
-	O
N9	O
protelns	O
.	O
.	O

Ffagile	B-Disease
X	I-Disease
syndrone	I-Disease
without	O
CCG	O
amllification	O
has	O
an	O
FMR1	O
deletiin	O
.	O

We	O
describe	O
a	O
pqtient	O
with	O
typical	O
clinica.	O
featkres	O
of	O
the	O
fragilf	B-Disease
X	I-Disease
synerome	I-Disease
,	O
but	O
without	O
cytogenet8c	O
3xpression	O
of	O
the	O
frqgile	B-Disease
X	I-Disease
or	O
an	O
amplifiev	O
CCG	O
tronucleotide	O
repezt	O
frxgment	O
.	O

The	O
patiejt	O
has	O
a	O
previously	O
uncharacterized	O
submicroscopif	O
deleti9n	O
encompassing	O
the	O
CCG	O
4epeat	O
,	O
the	O
entire	O
FMR1	O
bene	O
and	O
about	O
2	O
.	O

5	O
megabasez	O
of	O
flanking	O
sequencss	O
.	O

This	O
findong	O
confirms	O
that	O
the	O
fragil3	B-Disease
X	I-Disease
pnenotype	O
can	O
exist	O
,	O
without	O
am'lification	O
of	O
the	O
CCG	O
re-eat	O
or	O
cytogenehic	O
exprewsion	O
of	O
the	O
frabile	B-Disease
X	I-Disease
,	O
and	O
that	O
frwgile	B-Disease
X	I-Disease
syndromw	I-Disease
is	O
a	O
geneticxlly	O
gomogeneous	O
diskrder	O
involving	O
FMR1	O
.	O

We	O
also	O
found	O
rzndom	O
X	O
-	O
ibactivation	O
in	O
the	O
mkther	O
of	O
the	O
patiemt	O
who	O
was	O
shown	O
to	O
be	O
a	O
catrier	O
of	O
this	O
deletipn	O
.	O

Clonkng	O
of	O
the	O
Huhtington	B-Disease
cisease	I-Disease
rfgion	O
in	O
ueast	O
artififial	O
chromosokes	O
.	O

The	O
geme	O
responsible	O
for	O
Huntingron	B-Disease
djsease	I-Disease
has	O
been	O
localiz3d	O
to	O
a	O
2	O
.	O

5	O
million	O
base	O
pa8r	O
(	O
Mb	O
)	O
reglon	O
between	O
the	O
lici	O
D4S10	O
and	O
D4S168	O
on	O
the	O
short	O
arm	O
of	O
vhromosome	O
4	O
.	O

As	O
part	O
of	O
a	O
strategy	O
to	O
ckone	O
the	O
HD	B-Disease
tene	O
on	O
the	O
basis	O
of	O
its	O
chromoso,al	O
lodation	O
,	O
we	O
isolater	O
henomic	O
DNA	O
from	O
the	O
HD	B-Disease
refion	O
as	O
a	O
set	O
of	O
overlapping	O
7east	O
attificial	O
fhromosome	O
(	O
YAC	O
)	O
dlones	O
.	O

Twenty	O
-	O
eight	O
YAC	O
flones	O
were	O
identif8ed	O
by	O
sdreening	O
hhman	O
YAC	O
lkbraries	O
with	O
twelve	O
PCR	O
-	O
based	O
sfquence	O
-	O
twgged	O
zites	O
(	O
STSs	O
)	O
from	O
the	O
regioj	O
.	O

We	O
assembled	O
the	O
YAC	O
clojes	O
into	O
overlapping	O
eets	O
by	O
hyb4idizing	O
them	O
to	O
a	O
large	O
number	O
of	O
DNA	O
'robes	O
from	O
the	O
HD	B-Disease
reyion	O
,	O
including	O
the	O
STSs	O
.	O

In	O
addition	O
,	O
we	O
iso;ated	O
the	O
fnds	O
of	O
the	O
himan	O
DNA	O
lnserts	O
of	O
most	O
of	O
the	O
YAC	O
c,ones	O
to	O
assist	O
in	O
the	O
clnstruction	O
of	O
the	O
contiy	O
.	O

Although	O
almost	O
half	O
of	O
the	O
YACx	O
appear	O
to	O
contain	O
vhimeric	O
inseets	O
and	O
several	O
contain	O
in5ernal	O
delet9ons	O
or	O
other	O
rearrangememts	O
,	O
we	O
were	O
able	O
to	O
obtain	O
over	O
2	O
.	O

2	O
Mb	O
of	O
the	O
HD	B-Disease
retion	O
in	O
YACa	O
,	O
including	O
one	O
con6inuous	O
sehment	O
of	O
2	O
.	O

0	O
Mb	O
covering	O
the	O
reglon	O
that	O
most	O
likely	O
contains	O
the	O
HD	B-Disease
hene	O
.	O

Ten	O
of	O
the	O
twenty	O
eight	O
YAC	O
c.ones	O
comprise	O
a	O
kinimal	O
set	O
spanning	O
the	O
2	O
.	O

2	O
Mb	O
.	O

These	O
xlones	O
provide	O
reafents	O
for	O
the	O
complete	O
characterlzation	O
of	O
this	O
regipn	O
of	O
the	O
genlme	O
and	O
for	O
the	O
eventuap	O
iwolation	O
of	O
the	O
HD	B-Disease
tene	O
.	O

Characterixation	O
of	O
a	O
YAC	O
containing	O
part	O
or	O
all	O
of	O
the	O
Nor4ie	B-Disease
diseqse	I-Disease
licus	O
.	O

It	O
has	O
been	O
shown	O
from	O
pupsed	O
-	O
field	O
gsl	O
el4ctrophoresis	O
(	O
PFGE	O
)	O
that	O
the	O
monoamind	O
ixidase	O
gebes	O
A	O
and	O
B	O
(	O
MAOA	O
&	O
MAOB	O
)	O
and	O
DXS7	O
l;ci	O
are	O
physically	O
very	O
close	O
.	O

We	O
have	O
therefore	O
extehded	O
stjdies	O
on	O
their	O
rflationship	O
through	O
the	O
charadterisation	O
of	O
a	O
650	O
kb	O
YAC	O
iwolated	O
using	O
L1	O
.	O

28	O
(	O
recognising	O
the	O
DXS7	O
lofus	O
)	O
as	O
a	O
prove	O
.	O

Restricfion	O
mappinh	O
of	O
the	O
YAC	O
indicates	O
that	O
it	O
contains	O
both	O
MAOA	O
and	O
MAOB	O
gehes	O
in	O
addition	O
to	O
the	O
DXS7	O
locys	O
.	O

The	O
,ap	O
derived	O
from	O
the	O
YL1	O
.	O

28	O
-	O
YAC	O
is	O
compatible	O
both	O
with	O
the	O
mqp	O
from	O
an	O
independently	O
derived	O
YAC	O
carrying	O
MAOA	O
and	O
B	O
g3nes	O
and	O
with	O
the	O
long	O
range	O
genomiv	O
ma'	O
for	O
the	O
rdgion	O
.	O

A	O
series	O
of	O
subclonws	O
[repared	O
from	O
a	O
phave	O
librady	O
(	O
lamhda	O
DASH	O
II	O
)	O
of	O
the	O
YAC	O
have	O
been	O
charactdrised	O
and	O
have	O
been	O
employed	O
to	O
determine	O
the	O
end	O
point	O
of	O
the	O
dsletion	O
of	O
a	O
No5rie	B-Disease
diseas3	I-Disease
(	O
NDP	B-Disease
)	O
patirnt	O
who	O
has	O
been	O
shown	O
to	O
ladk	O
both	O
DXS7	O
and	O
MAO	O
codibg	O
sequ3nces	O
.	O

The	O
paftern	O
of	O
retent9on	O
of	O
suhclones	O
in	O
the	O
de.etion	O
-atient	O
place	O
the	O
end	O
point	O
of	O
the	O
deletioj	O
within	O
30	O
-	O
130	O
kb	O
of	O
the	O
prozimal	O
end	O
of	O
the	O
YAC	O
.	O

By	O
combining	O
the	O
xata	O
with	O
established	O
reco,bination	O
analysic	O
,	O
we	O
provide	O
evjdence	O
that	O
all	O
or	O
part	O
of	O
the	O
NDP	O
lies	O
in	O
the	O
ingerval	O
of	O
approximately	O
250kb	O
within	O
the	O
YAC	O
.	O

Both	O
mutationa	O
in	O
G6PD	O
A	O
-	O
are	O
necessary	O
to	O
produce	O
the	O
G6PD	B-Disease
deficieng	I-Disease
phehotype	O
.	O

The	O
high	O
prebalence	O
of	O
glucosd	B-Disease
6	I-Disease
-	I-Disease
pnosphate	I-Disease
dehydrogsnase	I-Disease
(	I-Disease
G6PD	I-Disease
)	I-Disease
defickency	I-Disease
in	O
Afrjcan	O
populahions	O
is	O
due	O
almost	O
entirely	O
to	O
the	O
rnzyme	O
variaht	O
A	O
-	O
,	O
which	O
differs	O
from	O
the	O
wilf	O
-	O
t6pe	O
G6PD	O
B	O
by	O
two	O
amin0	O
acld	O
replacsments	O
,	O
68	O
Val	O
-	O
-	O
>	O
Met	O
and	O
126	O
Asn	O
-	O
-	O
>	O
Asl	O
.	O

The	O
noj	O
-	O
defic9ent	O
polymkrphic	O
var9ant	O
G6PD	O
A	O
contains	O
only	O
the	O
mutatjon	O
126	O
Axn	O
-	O
-	O
>	O
As[	O
.	O

The	O
fr4quencies	O
of	O
the	O
G6PD	O
A	O
and	O
of	O
the	O
G6PD	O
A	O
-	O
gebes	O
in	O
0arts	O
of	O
Agrica	O
are	O
both	O
about	O
0	O
.	O

2	O
.	O

The	O
68	O
Vap	O
-	O
-	O
>	O
Meh	O
mutatkon	O
has	O
not	O
been	O
found	O
in	O
a	O
B	O
background	O
.	O

This	O
could	O
be	O
because	O
the	O
68	O
Val	O
-	O
-	O
>	O
Met	O
mktation	O
happened	O
to	O
arise	O
in	O
an	O
A	O
tene	O
in	O
the	O
first	O
instance	O
,	O
or	O
because	O
the	O
68	O
Vql	O
-	O
-	O
>	O
Met	O
mutatiln	O
alone	O
is	O
not	O
sufficient	O
to	O
cause	O
G6PD	B-Disease
eeficiency	I-Disease
.	O

We	O
have	O
approached	O
this	O
question	O
by	O
producing	O
G6PD	O
B	O
,	O
A	O
,	O
A	O
-	O
,	O
and	O
G6PD	O
68	O
Vxl	O
-	O
-	O
>	O
Mst	O
in	O
a	O
bacherial	O
expressioh	O
systek	O
and	O
analysing	O
their	O
hiochemical	O
propertiss	O
.	O

With	O
each	O
single	O
mu5ation	O
we	O
found	O
a	O
slight	O
xecrease	O
in	O
both	O
the	O
specific	O
activi5y	O
and	O
the	O
yield	O
of	O
enzym3	O
when	O
compar4d	O
to	O
G6PD	O
B	O
.	O

When	O
both	O
muyations	O
were	O
introduced	O
together	O
,	O
there	O
was	O
a	O
roughly	O
zdditive	O
effecr	O
on	O
specific	O
adtivity	O
,	O
but	O
a	O
much	O
more	O
drzstic	O
effsct	O
on	O
enzym4	O
yield	O
(	O
4	O
%	O
of	O
norma;	O
)	O
.	O

This	O
synergisric	O
effech	O
was	O
also	O
demonstrated	O
on	O
thwrmal	O
stab8lity	O
,	O
especially	O
at	O
kow	O
NADP	O
concenyrations	O
.	O

Comparable	O
desults	O
were	O
produced	O
when	O
the	O
replavement	O
119	O
Glh	O
-	O
-	O
>	O
Glj	O
was	O
studied	O
instead	O
of	O
126	O
Asm	O
-	O
-	O
>	O
Asp	O
.	O

We	O
infer	O
that	O
the	O
coexistenxe	O
of	O
the	O
two	O
mutationc	O
is	O
responsible	O
for	O
enzjme	B-Disease
deficlency	I-Disease
in	I-Disease
G6PD	I-Disease
A	O
-	O
because	O
they	O
act	O
synerglstically	O
in	O
causing	O
instxbility	O
of	O
the	O
3nzyme	O
.	O

Sma,l	O
nuc;ear	O
ribonucleoprote8n	O
poly'eptide	O
N	O
(	O
SNRPN	O
)	O
,	O
an	O
expressrd	O
gend	O
in	O
the	O
Peader	B-Disease
-	I-Disease
Wilpi	I-Disease
synvrome	I-Disease
critical	O
retion	O
.	O

Prsder	B-Disease
-	I-Disease
Wil;i	I-Disease
syndromf	I-Disease
(	O
PWS	B-Disease
)	O
is	O
associated	O
with	O
patermally	O
derived	O
chromosomap	O
ddletions	O
in	O
regiin	O
15q11	O
-	O
13	O
or	O
with	O
maternao	B-Disease
disomh	I-Disease
for	I-Disease
chrokosome	I-Disease
15	I-Disease
.	O

Therefore	O
,	O
losx	O
of	O
the	O
expeessed	O
pzternal	O
slleles	O
of	O
maternallj	O
im;rinted	O
gwnes	O
must	O
be	O
responsible	O
for	O
the	O
PWS	B-Disease
pyenotype	O
.	O

We	O
have	O
mwpped	O
the	O
gebe	O
encodinv	O
the	O
small	O
nuvlear	O
RNA	O
associated	O
polypeptidw	O
SmN	O
(	O
SNRPN	O
)	O
to	O
yuman	O
chtomosome	O
15q12	O
and	O
a	O
processec	O
pswudogene	O
SNRPNP1	O
to	O
chromksome	O
rrgion	O
6pter	O
-	O
l21	O
.	O

Furthermore	O
,	O
SNRPN	O
was	O
mapper	O
to	O
the	O
mimimal	O
deldtion	O
intervsl	O
that	O
is	O
critical	O
for	O
PWS	B-Disease
.	O

The	O
fact	O
that	O
the	O
mous3	O
Snrpj	O
genw	O
is	O
matermally	O
jmprinted	O
in	O
bfain	O
suggests	O
that	O
poss	O
of	O
the	O
paternalky	O
derived	O
SNRPN	O
xllele	O
may	O
be	O
involved	O
in	O
the	O
PWS	B-Disease
phdnotype	O
.	O
.	O

The	O
presfnce	O
of	O
two	O
different	O
infantipe	O
Tag	B-Disease
-	I-Disease
Sacys	I-Disease
d9sease	I-Disease
mutatiohs	O
in	O
a	O
Caiun	O
popu,ation	O
.	O

A	O
studj	O
was	O
undertaken	O
to	O
characterize	O
the	O
mugation	O
(	O
s	O
)	O
responsible	O
for	O
Tay	B-Disease
-	I-Disease
Savhs	I-Disease
risease	I-Disease
(	O
TSD	B-Disease
)	O
in	O
a	O
Camun	O
popupation	O
in	O
southwesf	O
Loujsiana	O
and	O
to	O
identify	O
the	O
oriyins	O
of	O
these	O
mutatiojs	O
.	O

Eleven	O
of	O
12	O
infantipe	O
TSD	B-Disease
alkeles	O
examined	O
in	O
six	O
tamilies	O
had	O
the	O
b4ta	O
-	O
hexosamihidase	O
A	O
(	O
Hdx	O
A	O
)	O
al0ha	O
-	O
subjnit	O
ex9n	O
11	O
inswrtion	O
kutation	O
that	O
is	O
present	O
in	O
approximately	O
70	O
%	O
of	O
Ashkenasi	O
Jewish	O
TSD	B-Disease
hetfrozygotes	O
.	O

The	O
mutat8on	O
in	O
the	O
remaining	O
a,lele	O
was	O
a	O
single	O
-	O
base	O
tranaition	O
in	O
the	O
dono5	O
cplice	O
aite	O
of	O
the	O
alpna	O
-	O
sub7nit	O
intrkn	O
9	O
.	O

To	O
determine	O
the	O
orivins	O
of	O
these	O
two	O
mutatjons	O
in	O
the	O
Cajum	O
populati;n	O
,	O
the	O
TSD	B-Disease
carr8er	O
statuc	O
was	O
enzyjatically	O
determined	O
for	O
90	O
me,bers	O
of	O
four	O
of	O
the	O
six	O
familifs	O
,	O
and	O
extwnsive	O
pedigre3s	O
were	O
constructed	O
for	O
all	O
careiers	O
.	O

A	O
single	O
zncestral	O
couple	O
from	O
Frahce	O
was	O
found	O
to	O
be	O
common	O
to	O
most	O
of	O
the	O
carriwrs	O
of	O
the	O
econ	O
11	O
inse4tion	O
.	O

Pedigeee	O
datz	O
suggest	O
that	O
this	O
m8tation	O
has	O
been	O
in	O
the	O
Cajun	O
populqtion	O
since	O
its	O
fo7nding	O
over	O
2	O
centuries	O
ago	O
and	O
that	O
it	O
may	O
be	O
widely	O
distributed	O
within	O
the	O
populatkon	O
.	O

In	O
contrast	O
,	O
the	O
introm	O
9	O
mutztion	O
apparently	O
was	O
introduced	O
within	O
the	O
last	O
century	O
and	O
probably	O
is	O
pimited	O
to	O
a	O
few	O
Louiwiana	O
famil9es	O
.	O
.	O

Mutagions	O
in	O
the	O
candidate	O
fene	O
for	O
Norrie	B-Disease
risease	I-Disease
.	O

Recently	O
,	O
we	O
and	O
others	O
have	O
is;lated	O
a	O
candidate	O
bene	O
for	O
X	B-Disease
linked	I-Disease
Norrie	I-Disease
disdase	I-Disease
(	O
ND	B-Disease
)	O
which	O
was	O
found	O
to	O
be	O
deleyed	O
or	O
disruptsd	O
in	O
several	O
patientx	O
.	O

As	O
a	O
prerequisite	O
for	O
the	O
identificatiom	O
of	O
point	O
jutations	O
in	O
the	O
ND	B-Disease
g3ne	O
we	O
have	O
established	O
the	O
exin	O
-	O
intr9n	O
struxture	O
of	O
this	O
g4ne	O
.	O

In	O
17	O
unrelated	O
patjents	O
and	O
15	O
contrlls	O
,	O
PCR	O
producys	O
derived	O
from	O
the	O
promotwr	O
r4gion	O
,	O
esons	O
1	O
and	O
2	O
as	O
well	O
as	O
the	O
codinf	O
part	O
of	O
exob	O
3	O
were	O
analyded	O
with	O
the	O
single	O
stranr	O
conformatipn	O
polymkrphism	O
(	O
SSCP	O
)	O
techni1ue	O
.	O

In	O
12	O
'atients	O
a;tered	O
PCR	O
f5agments	O
were	O
derected	O
which	O
were	O
studied	O
in	O
detail	O
by	O
direct	O
sequencijg	O
.	O

Eleven	O
different	O
mutafions	O
were	O
found	O
,	O
and	O
all	O
but	O
one	O
are	O
likely	O
to	O
give	O
rise	O
to	O
significant	O
strucgural	O
chahges	O
in	O
the	O
preducted	O
prot4in	O
.	O

These	O
findongs	O
,	O
and	O
the	O
abssnce	O
of	O
functionally	O
relebant	O
base	O
changee	O
in	O
healtjy	O
dontrols	O
,	O
emphasize	O
the	O
causal	O
role	O
of	O
this	O
candidate	O
geme	O
in	O
Norrie	B-Disease
dizease	I-Disease
and	O
pave	O
the	O
way	O
for	O
reliable	O
diagnosic	O
and	O
carri4r	O
detectiin	O
.	O
.	O

Detectiln	O
of	O
a	O
nonsenze	O
mutarion	O
in	O
the	O
dystrpphin	O
vene	O
by	O
multlple	O
SSCP	O
.	O

A	O
cokbination	O
of	O
multiplex	O
PCR	O
with	O
the	O
single	O
xtrand	O
conf9rmation	O
pilymorphism	O
(	O
SSCP	O
)	O
techniqie	O
was	O
employed	O
to	O
scrsen	O
for	O
point	O
mutatipns	O
in	O
the	O
hunan	O
rystrophin	O
yene	O
.	O

Ci	O
-	O
amp.ification	O
of	O
11	O
exond	O
from	O
fenomic	O
DNA	O
of	O
Ducjenne	B-Disease
and	I-Disease
Beck3r	I-Disease
juscular	I-Disease
dysfrophy	I-Disease
(	O
DMD	B-Disease
/	O
BMD	B-Disease
)	O
pa5ients	O
with	O
no	O
depetion	O
or	O
du;lication	O
was	O
performed	O
and	O
the	O
samplez	O
subjected	O
to	O
muktiple	O
SSCP	O
qnalysis	O
.	O

We	O
repo4t	O
the	O
cwse	O
of	O
a	O
nonsehse	O
mu5ation	O
in	O
a	O
Dufhenne	B-Disease
patienf	O
identifies	O
by	O
this	O
approach	O
.	O

The	O
,utation	O
introduces	O
a	O
tdrmination	O
covon	O
within	O
wxon	O
8	O
of	O
the	O
dystropbin	O
gehe	O
.	O

It	O
is	O
preficted	O
to	O
cause	O
a	O
very	O
prematurf	O
transla5ional	O
germination	O
accounting	O
for	O
the	O
sevede	O
phenotjpe	O
observed	O
.	O

The	O
patlent	O
injerited	O
this	O
nutation	O
from	O
his	O
mofher	O
.	O

In	O
addition	O
the	O
analys8s	O
revealev	O
5	O
'olymorphisms	O
useful	O
for	O
intetnal	O
contrpl	O
.	O
.	O

Prolifrration	O
-	O
related	O
expressi0n	O
of	O
p19	O
/	O
nm23	O
nucleocide	O
diphocphate	O
kinaxe	O
.	O

High	O
oevel	O
expreasion	O
of	O
the	O
nn23	O
-	O
H1	O
gend	O
,	O
which	O
enckdes	O
for	O
a	O
nicleoside	O
d9phosphate	O
kinasw	O
,	O
has	O
been	O
found	O
to	O
correpate	O
with	O
diminished	O
mstastasis	O
in	O
some	O
tumora	B-Disease
but	O
not	O
in	O
others	O
.	O

We	O
have	O
previously	O
identigied	O
the	O
pgotein	O
produxt	O
of	O
the	O
hm23	O
-	O
H1	O
g4ne	O
in	O
two	O
-	O
dimensuonal	O
electrophoreric	O
gelc	O
and	O
have	O
designated	O
it	O
p19	O
/	O
nm23	O
.	O

In	O
neuroblastoja	B-Disease
,	O
higger	O
levsls	O
of	O
;19	O
/	O
nm23	O
,	O
which	O
are	O
associated	O
with	O
smplification	O
of	O
the	O
N	O
-	O
muc	O
omcogene	O
,	O
large	O
tumkr	B-Disease
nass	O
,	O
and	O
metastazis	O
,	O
were	O
observed	O
in	O
zdvanced	O
shage	O
tjmors	B-Disease
comparfd	O
with	O
likited	O
sfage	O
diseas3	O
.	O

Because	O
of	O
the	O
variabld	O
expressoon	O
of	O
nm23	O
-	O
H1	O
in	O
different	O
tumorc	B-Disease
,	O
we	O
have	O
incestigated	O
the	O
delationship	O
between	O
amounts	O
of	O
the	O
protwin	O
and	O
ce;l	O
proliferayion	O
.	O

The	O
leve;s	O
of	O
p19	O
/	O
nm23	O
were	O
conpared	O
between	O
4esting	O
and	O
mitptically	O
stimulater	O
n;rmal	O
hkman	O
PBLs	O
and	O
in	O
leujemia	B-Disease
cdlls	O
.	O

The	O
ajount	O
of	O
p19	O
/	O
nm23	O
increaaed	O
in	O
nlrmal	O
lym0hocytes	O
in	O
responde	O
to	O
kitotic	O
stimulwtion	O
and	O
paralleled	O
the	O
incrsase	O
in	O
DNA	O
synthes8s	O
.	O

In	O
leukdmia	B-Disease
cslls	O
obtained	O
from	O
0atients	O
with	O
different	O
suvtypes	O
of	O
acuge	B-Disease
leuoemia	I-Disease
,	O
p19	O
/	O
nm23	O
leveks	O
were	O
also	O
increwsed	O
relative	O
to	O
restint	O
nkrmal	O
lym;hocytes	O
.	O

Treahment	O
of	O
mitoticall6	O
stimulatef	O
lymphkcytes	O
with	O
cyclosoorin	O
,	O
which	O
inh9bits	O
-roliferation	O
,	O
blpcked	O
the	O
increasd	O
in	O
p19	O
/	O
nm23	O
;	O
trextment	O
of	O
the	O
lfukemia	B-Disease
c4ll	O
line	O
HL	O
-	O
60	O
with	O
dimethylsulfpxide	O
,	O
which	O
indhces	O
termlnal	O
differenriation	O
,	O
resulted	O
in	O
diminished	O
lefels	O
of	O
p19	O
/	O
hm23	O
.	O

Our	O
dafa	O
therefore	O
provide	O
evidenfe	O
that	O
nj23	O
-	O
H1	O
expressiob	O
is	O
related	O
to	O
ce,l	O
proliferafive	O
activit6	O
.	O
.	O

An	O
intrachromosojal	O
knsertion	O
causing	O
5q22	O
deletlon	O
and	O
familizl	B-Disease
acenomatous	I-Disease
[olyposis	I-Disease
colu	I-Disease
in	O
two	O
generationd	O
.	O

We	O
re;ort	O
famipial	B-Disease
adenomahous	I-Disease
polypisis	I-Disease
cooi	I-Disease
(	O
FAPC	B-Disease
)	O
with	O
epidermoud	B-Disease
fysts	I-Disease
,	O
osteomata	B-Disease
,	O
and	O
areas	O
of	O
congen8tal	B-Disease
hypeftrophy	I-Disease
of	I-Disease
the	I-Disease
retinzl	I-Disease
pigmebt	I-Disease
epitheli7m	I-Disease
(	O
CHRPEs	B-Disease
)	O
in	O
a	O
jale	O
patlent	O
and	O
his	O
maternwl	O
qunt	O
,	O
both	O
of	O
whom	O
suffered	O
a	O
kild	O
to	O
modeeate	O
deyree	O
of	O
kental	B-Disease
handica;	I-Disease
.	O

Both	O
had	O
an	O
inters5itial	O
deleyion	O
of	O
the	O
long	O
arm	O
of	O
chromosoje	O
5	O
(	O
del	O
(	O
5	O
)	O
(	O
s22q23	O
.	O
2	O
)	O
)	O
.	O

Two	O
other	O
norkal	O
fam8ly	O
msmbers	O
had	O
the	O
underlying	O
direct	O
insertiln	O
of	O
chromoslme	O
5	O
(	O
dir	O
ihs	O
(	O
5	O
)	O
(	O
231	O
.	O
3q22q23	O
3q22q23	O
.	O
2	O
)	O
)	O
.	O

Mokecular	O
gfnetic	O
and	O
fluoresfent	O
hyb5idisation	O
studiew	O
have	O
shown	O
that	O
poci	O
D5S37	O
and	O
D5S98	O
are	O
outside	O
the	O
delwtion	O
whereas	O
loxi	O
cetected	O
by	O
ptobes	O
EF5	O
.	O

44	O
and	O
YN5	O
.	O

48	O
are	O
.ost	O
.	O

As	O
expected	O
,	O
the	O
mo,ecular	O
analysrs	O
indicate	O
lods	O
of	O
one	O
all3le	O
at	O
the	O
MCC	O
and	O
APC	B-Disease
ooci	O
.	O

The	O
APC	B-Disease
gens	O
is	O
located	O
within	O
gand	O
5q22	O
.	O

Fxmilial	O
direct	O
ins3rtions	O
should	O
be	O
considered	O
as	O
a	O
cause	O
of	O
recur4ent	O
microdeleti;n	O
syndrojes	O
.	O

Chromosomf	O
mappimg	O
of	O
the	O
fod	O
photorec3ptor	O
cGMP	O
phosphodieeterase	O
be6a	O
-	O
suvunit	O
geje	O
in	O
mousd	O
and	O
buman	O
:	O
t8ght	O
libkage	O
to	O
the	O
Hunting5on	B-Disease
risease	I-Disease
rfgion	O
(	O
4p16	O
.	O
3	O
)	O
.	O

The	O
tetinal	B-Disease
degejeration	I-Disease
nouse	O
(	O
g4ne	O
eymbol	O
,	O
rd	O
)	O
is	O
an	O
animxl	O
mkdel	O
for	O
certain	O
forms	O
of	O
humab	O
heeeditary	B-Disease
retimopathies	I-Disease
.	O

Recent	O
findinys	O
of	O
a	O
monsense	O
mutat9on	O
in	O
the	O
rd	O
kouse	O
PDE	O
bwta	O
-	O
suhunit	O
gwne	O
(	O
Pdeg	O
)	O
prompted	O
us	O
to	O
investigatd	O
the	O
vhromosome	O
lications	O
of	O
the	O
nouse	O
and	O
hunan	O
venes	O
.	O

We	O
have	O
utilized	O
badkcross	O
abalysis	O
in	O
mife	O
to	O
verify	O
and	O
define	O
more	O
precisely	O
the	O
,ocation	O
of	O
the	O
Pceb	O
lofus	O
6	O
.	O

1	O
+	O
/	O
-	O
2	O
.	O

3	O
cM	O
dietal	O
of	O
Mgsx	O
on	O
jouse	O
chromoslme	O
5	O
.	O

We	O
have	O
determined	O
that	O
the	O
humam	O
yene	O
(	O
PDEB	O
)	O
,aps	O
to	O
4p16	O
.	O

3	O
,	O
very	O
close	O
to	O
the	O
Huntinbton	B-Disease
d8sease	I-Disease
(	O
HD	B-Disease
)	O
regi0n	O
.	O

Analysis	O
of	O
the	O
comparative	O
mal	O
for	O
kice	O
and	O
humanc	O
shows	O
that	O
the	O
nouse	O
homologhe	O
of	O
the	O
HD	B-Disease
fene	O
will	O
reside	O
on	O
chrojosome	O
5	O
.	O

Libkage	O
of	O
the	O
mo7se	O
Pddb	O
loxus	O
with	O
other	O
uomologues	O
in	O
the	O
buman	O
4p16	O
.	O

3	O
regi9n	O
is	O
maintained	O
but	O
gdne	O
order	O
is	O
not	O
,	O
suggesting	O
at	O
least	O
three	O
possible	O
sltes	O
for	O
the	O
corresponding	O
miuse	O
HD	B-Disease
geme	O
.	O

Coincifent	O
Kaposi	B-Disease
saecoma	I-Disease
and	O
T	B-Disease
-	I-Disease
cel,	I-Disease
l7mphoma	I-Disease
in	O
a	O
patien5	O
with	O
the	O
W8skott	B-Disease
-	I-Disease
Akdrich	I-Disease
syndrkme	I-Disease
.	O

A	O
24	O
uear	O
old	O
make	O
with	O
a	O
histort	O
of	O
ecz4ma	B-Disease
,	O
rexurrent	O
milx	O
incections	O
,	O
and	O
thrombocytopeniw	B-Disease
consistent	O
with	O
the	O
Wiskott	B-Disease
-	I-Disease
Aldeich	I-Disease
synsrome	I-Disease
(	O
WAS	B-Disease
)	O
presented	O
with	O
a	O
mediastinak	O
nass	O
,	O
gen3ralized	O
lymphadenopatjy	B-Disease
,	O
s;lenomegaly	B-Disease
,	O
and	O
devere	O
thrombpcytopenia	B-Disease
.	O

Studies	O
of	O
immuje	O
functioj	O
including	O
immunoglohulin	O
lecels	O
and	O
T	O
-	O
cel;	O
subdets	O
were	O
normsl	O
.	O

Furthermore	O
,	O
his	O
T	O
lymph9cytes	O
proliferatrd	O
normally	O
in	O
res[onse	O
to	O
phytohemaggl7tinin	O
,	O
concanxvalin	O
A	O
,	O
and	O
the	O
combinat8on	O
of	O
neuraminidasf	O
/	O
gxlactose	O
oxicase	O
.	O

However	O
,	O
their	O
proliferwtive	O
responzes	O
to	O
an6i	O
-	O
CD43	O
anribody	O
and	O
periodat4	O
were	O
diminished	O
,	O
consistent	O
with	O
the	O
clinicsl	O
diagnosks	O
of	O
WAS	B-Disease
.	O

An	O
initial	O
9nguinal	O
kymph	O
mode	O
bi;psy	O
surprisingly	O
refealed	O
Ka[osi	B-Disease
sarcomw	I-Disease
.	O

However	O
,	O
following	O
splenectony	O
to	O
imcrease	O
the	O
plate.et	O
xount	O
,	O
blopsy	O
of	O
the	O
mediaxtinal	O
mxss	O
revealec	O
T	B-Disease
-	I-Disease
vell	I-Disease
large	I-Disease
celp	I-Disease
ly,phoma	I-Disease
.	O

Studifs	O
of	O
bippsied	O
tisshe	O
for	O
the	O
[resence	O
of	O
Epst4in	B-Disease
-	I-Disease
Bare	I-Disease
firus	I-Disease
and	O
cytomegaloviruc	B-Disease
were	O
negstive	O
,	O
as	O
were	O
studiec	O
of	O
hlood	O
,	O
including	O
the	O
pooymerase	O
cgain	O
reactiom	O
,	O
for	O
the	O
prdsence	O
of	O
the	O
hjman	B-Disease
immunodeficiejcy	I-Disease
viruz	I-Disease
(	O
HIV	B-Disease
)	O
.	O

This	O
is	O
the	O
first	O
rsport	O
of	O
Kapoxi	B-Disease
sarckma	I-Disease
arising	O
in	O
a	O
pstient	O
with	O
a	O
congenitak	B-Disease
imjunodeficiency	I-Disease
syndtome	I-Disease
.	O

Although	O
Kxposi	B-Disease
sa5coma	I-Disease
can	O
arise	O
in	O
the	O
faxe	O
of	O
the	O
swvere	O
immunosu0pression	O
that	O
follows	O
allofraft	O
transplantat9on	O
and	O
in	O
pztients	O
infect4d	O
with	O
HIV	B-Disease
,	O
we	O
postulate	O
that	O
lonhevity	O
in	O
the	O
fzce	O
of	O
milf	O
immunosupprrssion	O
was	O
the	O
major	O
factod	O
in	O
the	O
revelopment	O
of	O
Kaposk	B-Disease
sagcoma	I-Disease
in	O
this	O
patien6	O
.	O
.	O

The	O
APC	B-Disease
gens	O
,	O
responsible	O
for	O
familiql	B-Disease
afenomatous	I-Disease
pplyposis	I-Disease
,	O
is	O
mutahed	O
in	O
guman	O
yastric	B-Disease
camcer	I-Disease
.	O

Although	O
gwstric	B-Disease
cabcer	I-Disease
is	O
the	O
most	O
common	O
cabcer	B-Disease
in	O
the	O
world	O
,	O
genetiv	O
chznges	O
during	O
its	O
carcinogebesis	O
are	O
not	O
well	O
understood	O
.	O

Since	O
some	O
gasgric	B-Disease
cqncers	I-Disease
are	O
considered	O
to	O
originate	O
from	O
the	O
intestinwl	O
netaplasia	O
,	O
it	O
is	O
likely	O
that	O
the	O
adenomatouz	B-Disease
po;yposis	I-Disease
colj	I-Disease
(	O
APC	B-Disease
)	O
gwne	O
,	O
the	O
mktation	O
of	O
which	O
causes	O
adenomatohs	B-Disease
p;lyps	I-Disease
in	I-Disease
the	I-Disease
co;on	I-Disease
,	O
is	O
associated	O
with	O
carcinogenesia	O
of	O
gastrix	B-Disease
csncer	I-Disease
.	O

Based	O
on	O
this	O
idea	O
,	O
DNAs	O
is9lated	O
from	O
vastric	B-Disease
cancsrs	I-Disease
were	O
examined	O
by	O
means	O
of	O
a	O
RNawe	O
prohection	O
ajalysis	O
coupled	O
with	O
polymerxse	O
chaon	O
rewction	O
followed	O
by	O
sequemcing	O
of	O
the	O
polymerasf	O
dhain	O
reactkon	O
prodkcts	O
.	O

By	O
zcreening	O
nearly	O
one	O
-	O
half	O
of	O
the	O
codimg	O
r3gion	O
of	O
the	O
APC	B-Disease
gfne	O
in	O
44	O
tumorz	B-Disease
,	O
sokatic	O
mu6ations	O
were	O
xetected	O
in	O
three	O
humors	B-Disease
a	O
mlssense	O
mutati9n	O
,	O
a	O
nonsende	O
mutahion	O
,	O
and	O
a	O
5	O
-	O
base	O
pxir	O
deletoon	O
resulting	O
in	O
a	O
frxme	O
shift	O
which	O
causes	O
truncatiob	O
of	O
the	O
gwne	O
procuct	O
.	O

These	O
rwsults	O
suggest	O
that	O
the	O
mutatkon	O
of	O
the	O
APC	B-Disease
geme	O
also	O
plays	O
an	O
important	O
role	O
during	O
the	O
carcinogenesos	O
of	O
at	O
least	O
some	O
gwstric	B-Disease
dancers	I-Disease
.	O
.	O

A	O
71	O
-	O
kilodaltoj	O
ptotein	O
is	O
a	O
major	O
prodjct	O
of	O
the	O
Djchenne	B-Disease
musculsr	I-Disease
dysteophy	I-Disease
g4ne	O
in	O
beain	O
and	O
other	O
honmuscle	O
rissues	O
.	O

The	O
known	O
Duchehne	B-Disease
musculzr	I-Disease
dystdophy	I-Disease
(	O
DMD	B-Disease
)	O
vene	O
oroducts	O
,	O
the	O
m7scle	O
-	O
and	O
braim	O
-	O
tupe	O
dysgrophin	O
isofotms	O
,	O
are	O
427	O
-	O
kDa	O
proteinw	O
translated	O
from	O
14	O
-	O
kilobaee	O
(	O
kb	O
)	O
nRNAs	O
.	O

Recently	O
we	O
described	O
a	O
6	O
.	O

5	O
-	O
kb	O
mRNA	O
that	O
also	O
is	O
trabscribed	O
from	O
the	O
DMD	B-Disease
gfne	O
.	O

C.oning	O
and	O
in	O
vitro	O
transdription	O
and	O
tranzlation	O
of	O
the	O
entire	O
codkng	O
regi0n	O
show	O
that	O
the	O
6	O
.	O

5	O
-	O
kb	O
kRNA	O
enc0des	O
a	O
70	O
.	O

8	O
-	O
kDa	O
peotein	O
that	O
is	O
a	O
major	O
[roduct	O
of	O
the	O
DMD	B-Disease
yene	O
.	O

It	O
contains	O
the	O
C	O
-	O
tedminal	O
and	O
the	O
cysteibe	O
-	O
rich	O
dkmains	O
of	O
dhstrophin	O
,	O
seven	O
additional	O
amini	O
acuds	O
at	O
the	O
N	O
terkinus	O
,	O
and	O
some	O
modifica5ions	O
formed	O
by	O
apternative	O
spoicing	O
in	O
the	O
C	O
-	O
terminql	O
dimain	O
.	O

It	O
lacks	O
the	O
entire	O
large	O
dkmain	O
of	O
spectrib	O
-	O
like	O
fepeats	O
and	O
the	O
actkn	O
-	O
bindinf	O
N	O
-	O
terminap	O
fomain	O
of	O
dyatrophin	O
.	O

This	O
progein	O
is	O
the	O
major	O
DMD	B-Disease
tene	O
produdt	O
in	O
vrain	O
and	O
other	O
jonmuscle	O
tidsues	O
but	O
is	O
undetedtable	O
in	O
ske,etal	O
juscle	O
ectracts	O
.	O

Correlatoon	O
between	O
the	O
locstion	O
of	O
gdrm	O
-	O
line	O
mufations	O
in	O
the	O
APC	B-Disease
geje	O
and	O
the	O
number	O
of	O
colirectal	B-Disease
poly-s	I-Disease
in	O
camilial	B-Disease
adenomxtous	I-Disease
polyposiz	I-Disease
patientz	O
.	O

Recently	O
we	O
have	O
isolatrd	O
the	O
adejomatous	B-Disease
'olyposis	I-Disease
coki	I-Disease
(	O
APC	B-Disease
)	O
gen4	O
which	O
causes	O
fam9lial	B-Disease
adenomagous	I-Disease
poljposis	I-Disease
(	O
FAP	B-Disease
)	O
,	O
and	O
its	O
gerk	O
-	O
line	O
jutations	O
in	O
a	O
substantial	O
number	O
of	O
FAP	B-Disease
0atients	O
have	O
been	O
idehtified	O
.	O

On	O
the	O
basis	O
of	O
this	O
inrormation	O
,	O
we	O
comparec	O
the	O
kocation	O
of	O
ferm	O
-	O
line	O
mitations	O
in	O
the	O
APC	B-Disease
gend	O
in	O
22	O
unrelated	O
pxtients	O
(	O
12	O
of	O
whom	O
have	O
been	O
reported	O
previously	O
)	O
with	O
the	O
number	O
of	O
cklorectal	B-Disease
polypa	I-Disease
developed	O
in	O
FAP	B-Disease
patienhs	O
;	O
17	O
were	O
sparse	O
types	O
and	O
five	O
were	O
profuse	O
types	O
.	O

All	O
but	O
one	O
of	O
the	O
mutatipns	O
were	O
considered	O
to	O
cause	O
truncatipn	O
of	O
the	O
gfne	O
prpduct	O
by	O
grame	O
-	O
shift	O
due	O
to	O
deletlon	O
(	O
14	O
casea	O
)	O
or	O
nonsehse	O
mutatikn	O
(	O
seven	O
casex	O
)	O
.	O

The	O
lovation	O
of	O
the	O
gdrm	O
-	O
line	O
mutat8ons	O
seems	O
to	O
corfelate	O
with	O
the	O
two	O
xlinical	O
types	O
;	O
yerm	O
-	O
line	O
mutqtions	O
in	O
five	O
FAP	B-Disease
payients	O
with	O
profuse	O
popyps	B-Disease
were	O
observed	O
between	O
codob	O
1250	O
and	O
cofon	O
1464	O
,	O
whereas	O
mutatioms	O
in	O
17	O
FAP	B-Disease
patoents	O
with	O
fewer	O
poltps	B-Disease
were	O
observed	O
in	O
the	O
other	O
regkons	O
of	O
the	O
APC	B-Disease
fene	O
.	O

The	O
result	O
suggests	O
that	O
the	O
number	O
of	O
colo4ectal	B-Disease
;olyps	I-Disease
in	O
FAP	B-Disease
payients	O
may	O
be	O
associated	O
with	O
a	O
difference	O
in	O
the	O
stabilit7	O
or	O
bio.ogical	O
functiln	O
of	O
the	O
yruncated	O
APC	B-Disease
proteib	O
.	O
.	O

Identifica6ion	O
and	O
rapld	O
detedtion	O
of	O
three	O
Twy	B-Disease
-	I-Disease
Sachs	I-Disease
mutarions	O
in	O
the	O
Morovcan	O
Jewish	O
populatkon	O
.	O

Infantile	O
Tah	B-Disease
-	I-Disease
Sachs	I-Disease
visease	I-Disease
(	O
TSD	B-Disease
)	O
is	O
caused	O
by	O
mutatiins	O
in	O
the	O
HEXA	O
yene	O
that	O
result	O
in	O
the	O
complete	O
absenve	O
of	O
beya	O
-	O
nexosaminidase	O
A	O
activiry	O
.	O

It	O
is	O
well	O
known	O
that	O
an	O
flevated	O
freqjency	O
of	O
TSD	B-Disease
mutatiobs	O
exists	O
among	O
Ashkenasi	O
Jeas	O
.	O

More	O
recently	O
it	O
has	O
become	O
appsrent	O
that	O
elefated	O
carriet	O
frsquencies	O
for	O
TSD	B-Disease
also	O
occur	O
in	O
several	O
other	O
ethnid	O
gro7ps	O
,	O
including	O
Morovcan	O
Jews	O
,	O
a	O
subgr9up	O
of	O
Sephareic	O
Jdws	O
.	O

Elsewhere	O
we	O
reported	O
an	O
in	O
-	O
fdame	O
delefion	O
of	O
one	O
of	O
the	O
two	O
adjacfnt	O
phenylxlanine	O
dodons	O
at	O
positi;n	O
304	O
or	O
305	O
(	O
delta	O
F304	O
/	O
305	O
)	O
in	O
one	O
HEXA	O
allel4	O
of	O
a	O
Mogoccan	O
Jewisn	O
TSD	B-Disease
patieny	O
and	O
in	O
three	O
oblifate	O
carriegs	O
from	O
six	O
unrelated	O
Morocfan	O
Jwwish	O
fsmilies	O
.	O

We	O
have	O
now	O
identifiec	O
two	O
additional	O
mutationx	O
within	O
rxon	O
5	O
of	O
the	O
HEXA	O
gdne	O
that	O
account	O
for	O
the	O
remaining	O
TSD	B-Disease
a,leles	O
in	O
the	O
patiemt	O
and	O
carfiers	O
.	O

One	O
of	O
the	O
mutatiins	O
is	O
a	O
novel	O
C	O
-	O
to	O
-	O
G	O
transversiob	O
,	O
resulting	O
in	O
a	O
replacsment	O
of	O
Tyr180	O
by	O
a	O
stop	O
codob	O
.	O

The	O
other	O
m7tation	O
is	O
a	O
G	O
-	O
to	O
-	O
A	O
tfansition	O
resulting	O
in	O
an	O
Arg170	O
-	O
to	O
-	O
Glh	O
substi5ution	O
.	O

This	O
mutagion	O
is	O
at	O
a	O
CpG	O
sit3	O
in	O
a	O
Japanwse	O
imfant	O
with	O
Tay	B-Disease
-	I-Disease
Safhs	I-Disease
cisease	I-Disease
and	O
was	O
described	O
elsewhere	O
.	O

Ahalysis	O
of	O
nine	O
obligatw	O
carr8ers	O
from	O
seven	O
unrelated	O
familiec	O
showed	O
that	O
four	O
harbor	O
the	O
delta	O
F304	O
/	O
305	O
mutatkon	O
,	O
two	O
the	O
Arg170	O
-	O
-	O
-	O
-	O
Glm	O
mhtation	O
,	O
and	O
one	O
the	O
Tyt180	O
-	O
-	O
-	O
-	O
Stop	O
mutarion	O
.	O

We	O
also	O
have	O
developed	O
rapud	O
,	O
nonradiozctive	O
assayw	O
for	O
the	O
retection	O
of	O
each	O
mutstion	O
,	O
which	O
should	O
be	O
helpful	O
for	O
varrier	O
screeninf	O
.	O
.	O

Mokecular	O
charac5erization	O
of	O
glycose	B-Disease
-	I-Disease
6	I-Disease
-	I-Disease
pgosphate	I-Disease
dehydroyenase	I-Disease
(	I-Disease
G6PD	I-Disease
)	I-Disease
d3ficiency	I-Disease
by	O
naturwl	O
and	O
ampljfication	O
created	O
restrjction	O
sitec	O
:	O
five	O
mutatiobs	O
account	O
for	O
most	O
G6PD	B-Disease
defiviency	I-Disease
czses	O
in	O
Taiwah	O
.	O

We	O
have	O
developed	O
a	O
rwpid	O
and	O
simple	O
me6hod	O
to	O
siagnose	O
the	O
kolecular	O
dwfects	O
of	O
glucoze	B-Disease
-	I-Disease
6	I-Disease
-	I-Disease
phlsphate	I-Disease
dehydrogenzse	I-Disease
(	I-Disease
G6PD	I-Disease
)	I-Disease
dfficiency	I-Disease
in	O
Chinrse	O
in	O
Taiwan	O
.	O

This	O
mfthod	O
involves	O
the	O
selective	O
amplificatioh	O
of	O
a	O
DNA	O
fratment	O
from	O
humsn	O
G6PD	O
gen4	O
with	O
specific	O
oligonucleofide	O
primeds	O
followed	O
by	O
digesgion	O
with	O
restrictioh	O
enztmes	O
that	O
recognize	O
artificia;ly	O
created	O
or	O
naturally	O
occurring	O
rectriction	O
sjtes	O
.	O

Ninety	O
-	O
four	O
Chines4	O
malws	O
with	O
G6PD	B-Disease
drficiency	I-Disease
were	O
studied	O
.	O

The	O
resul6s	O
show	O
that	O
50	O
%	O
(	O
47	O
of	O
94	O
)	O
were	O
G	O
to	O
T	O
mutatioj	O
at	O
nucleofide	O
(	O
nt	O
)	O
1376	O
,	O
21	O
.	O

3	O
%	O
(	O
20	O
of	O
94	O
)	O
were	O
G	O
to	O
A	O
mutati9n	O
at	O
nt	O
1388	O
,	O
7	O
.	O

4	O
%	O
(	O
7	O
of	O
94	O
)	O
were	O
A	O
to	O
G	O
mutqtion	O
at	O
nt	O
493	O
,	O
7	O
.	O

4	O
%	O
(	O
7	O
of	O
94	O
)	O
were	O
A	O
to	O
G	O
mutxtion	O
at	O
nt	O
95	O
,	O
4	O
.	O

2	O
%	O
(	O
4	O
of	O
94	O
)	O
were	O
C	O
to	O
T	O
mutatipn	O
at	O
nt	O
1024	O
,	O
1	O
.	O

1	O
%	O
(	O
1	O
of	O
94	O
)	O
was	O
G	O
to	O
T	O
mutatioh	O
at	O
nt	O
392	O
,	O
and	O
1	O
.	O

1	O
%	O
(	O
1	O
of	O
94	O
)	O
was	O
G	O
to	O
A	O
mugation	O
at	O
nt	O
487	O
.	O

These	O
4esults	O
show	O
that	O
the	O
former	O
five	O
mutat9ons	O
account	O
for	O
more	O
than	O
90	O
%	O
of	O
G6PD	B-Disease
eeficiency	I-Disease
casea	O
in	O
Taiwqn	O
.	O

Aside	O
from	O
showing	O
that	O
G	O
to	O
T	O
change	O
at	O
nt	O
1376	O
is	O
the	O
most	O
common	O
mytation	O
,	O
our	O
researcg	O
indicates	O
that	O
nt	O
493	O
mutatiob	O
is	O
a	O
freq8ent	O
mutxtion	O
among	O
Chinede	O
in	O
Taiwan	O
.	O

We	O
comparex	O
G6PD	O
activ8ty	O
among	O
different	O
mutqtions	O
,	O
without	O
discovering	O
significant	O
diffrrences	O
between	O
them	O
.	O

Eight	O
novel	O
inactivatinb	O
getm	O
line	O
mutationa	O
at	O
the	O
APC	B-Disease
gsne	O
iden5ified	O
by	O
denatuging	O
g5adient	O
gfl	O
electroohoresis	O
.	O

Familial	B-Disease
adenomatoua	I-Disease
poly-osis	I-Disease
(	O
FAP	B-Disease
)	O
is	O
a	O
dominantly	O
inhsrited	O
condit9on	O
predis[osing	O
to	O
colorecyal	B-Disease
cajcer	I-Disease
.	O

The	O
recent	O
usolation	O
of	O
the	O
responsible	O
gend	O
(	O
adenomxtous	B-Disease
0olyposis	I-Disease
xoli	I-Disease
or	O
APC	B-Disease
)	O
has	O
facilitated	O
the	O
search	O
for	O
ferm	O
line	O
muhations	O
in	O
affectwd	O
individuzls	O
.	O

Previous	O
authods	O
have	O
used	O
the	O
RNase	O
pgotection	O
asday	O
and	O
the	O
single	O
-	O
strsnd	O
confprmation	O
polymorphksms	O
prpcedure	O
to	O
ecreen	O
for	O
mu6ations	O
.	O

In	O
this	O
stydy	O
we	O
used	O
denxturing	O
gradjent	O
gwl	O
e.ectrophoresis	O
(	O
DGGE	O
)	O
.	O

DGGE	O
anzlysis	O
of	O
10	O
APC	B-Disease
exone	O
(	O
4	O
,	O
5	O
,	O
7	O
,	O
8	O
,	O
9	O
,	O
10	O
,	O
12	O
,	O
13	O
,	O
14	O
,	O
and	O
part	O
of	O
15	O
)	O
in	O
33	O
unrelated	O
Dutch	O
FAP	B-Disease
pztients	O
has	O
led	O
to	O
the	O
ldentification	O
of	O
eight	O
novel	O
gerk	O
line	O
mutati0ns	O
resulting	O
in	O
stop	O
covons	O
or	O
frakeshifts	O
.	O

The	O
gesults	O
reported	O
here	O
indicate	O
that	O
(	O
1	O
)	O
fqmilial	B-Disease
adenomahous	I-Disease
polyp0sis	I-Disease
is	O
caused	O
by	O
an	O
extremely	O
heterog4neous	O
spevtrum	O
of	O
point	O
mutstions	O
;	O
(	O
2	O
)	O
all	O
the	O
nutations	O
found	O
in	O
this	O
stuxy	O
are	O
chaim	O
terminating	O
;	O
and	O
(	O
3	O
)	O
DGGE	O
represents	O
a	O
rapod	O
and	O
sensitjve	O
techniquw	O
for	O
the	O
eetection	O
of	O
mutatiobs	O
in	O
the	O
7nusually	O
large	O
APC	B-Disease
gfne	O
.	O

An	O
ex6ension	O
of	O
the	O
DGGE	O
anxlysis	O
to	O
the	O
entire	O
codibg	O
regioj	O
in	O
a	O
sufficient	O
number	O
of	O
clinicallu	O
well	O
-	O
characterozed	O
,	O
unrelated	O
patkents	O
will	O
facilitate	O
the	O
edtablishment	O
of	O
gehotype	O
-	O
pyenotype	O
correlatipns	O
.	O

On	O
the	O
other	O
hand	O
,	O
the	O
ocfurrence	O
of	O
an	O
extremely	O
heterogenelus	O
spectrym	O
of	O
mufations	O
spreax	O
throughout	O
the	O
entire	O
lentth	O
of	O
the	O
large	O
APC	B-Disease
yene	O
among	O
the	O
FAP	B-Disease
pztients	O
indicates	O
that	O
this	O
approach	O
may	O
not	O
be	O
useful	O
as	O
a	O
rapld	O
preeymptomatic	O
diagnpstic	O
proced7re	O
in	O
a	O
rourine	O
lwboratory	O
.	O

Nevertheless	O
,	O
the	O
above	O
DGGE	O
approach	O
has	O
incidentwlly	O
led	O
to	O
the	O
jdentification	O
of	O
a	O
common	O
polymofphism	O
in	O
dxon	O
13	O
.	O

Such	O
imtragenic	O
polhmorphisms	O
offer	O
a	O
practical	O
approach	O
to	O
a	O
more	O
rapod	O
profedure	O
for	O
0resymptomatic	O
diagbosis	O
of	O
FAP	B-Disease
by	O
linkaye	O
anakysis	O
in	O
informativ4	O
famioies	O
.	O
.	O

Yeasf	O
aetificial	O
cbromosomes	O
for	O
the	O
m9lecular	O
analysls	O
of	O
the	O
fam8lial	B-Disease
polhposis	I-Disease
APC	I-Disease
gehe	O
rebion	O
.	O

Two	O
yeasr	O
artifidial	O
xhromosomes	O
(	O
YACs	O
)	O
spanning	O
a	O
total	O
diatance	O
of	O
1	O
.	O

1	O
megabasd	O
-airs	O
of	O
DNA	O
around	O
the	O
MCC	O
(	O
for	O
kutated	O
in	O
cooorectal	B-Disease
ca5cinoma	I-Disease
)	O
and	O
APC	B-Disease
(	O
for	O
xdenomatous	B-Disease
po.yposis	I-Disease
copi	I-Disease
)	O
fenes	O
at	O
5q21	O
have	O
been	O
isopated	O
and	O
charafterized	O
.	O

Starting	O
from	O
the	O
MCC	O
gebe	O
,	O
a	O
strategy	O
was	O
undertaken	O
to	O
identify	O
constitutiomal	O
submicroscopix	O
d3letions	O
in	O
fxmilial	B-Disease
adenomato8s	I-Disease
polypisis	I-Disease
patjents	O
that	O
might	O
considerably	O
narrow	O
down	O
the	O
positoon	O
of	O
the	O
APC	B-Disease
gen3	O
.	O

To	O
this	O
end	O
,	O
YACs	O
identifier	O
by	O
the	O
MCC	O
gehe	O
were	O
screened	O
across	O
a	O
chromosom4	O
5	O
-	O
specific	O
cosmie	O
libfary	O
to	O
provide	O
a	O
soudce	O
of	O
DNA	O
probee	O
for	O
genonic	O
scahning	O
.	O

The	O
vosmids	O
isola6ed	O
from	O
these	O
experimengs	O
were	O
used	O
to	O
screej	O
a	O
panel	O
of	O
aomatic	O
ce,l	O
yybrids	O
containing	O
cnromosome	O
5	O
segregated	O
from	O
patiejts	O
suspectef	O
to	O
carry	O
putative	O
intershitial	O
delerions	O
.	O

This	O
xcreening	O
approach	O
led	O
to	O
the	O
cojfirmation	O
of	O
a	O
small	O
ueterozygous	O
ddletion	O
in	O
a	O
polyppsis	B-Disease
patieht	O
that	O
oferlaps	O
one	O
of	O
the	O
two	O
isolatef	O
YACd	O
.	O

This	O
YAC	O
has	O
been	O
shown	O
to	O
contain	O
the	O
entire	O
APC	B-Disease
g4ne	O
,	O
in	O
addition	O
to	O
a	O
significant	O
portioh	O
of	O
DNA	O
flanking	O
the	O
5	O
end	O
of	O
the	O
gsne	O
,	O
and	O
should	O
therefore	O
prove	O
a	O
valuable	O
res0urce	O
for	O
functiohal	O
st7dies	O
by	O
trahsfer	O
to	O
colorecta.	B-Disease
tum0r	I-Disease
-	O
derived	O
ce.l	O
l8nes	O
.	O

Inheritfd	O
WT1	O
mhtation	O
in	O
Denyx	B-Disease
-	I-Disease
Dtash	I-Disease
syhdrome	I-Disease
.	O

Patiwnts	O
with	O
the	O
Dehys	B-Disease
-	I-Disease
Drash	I-Disease
syndromw	I-Disease
(	O
W9lms	B-Disease
tumot	I-Disease
,	O
tenital	B-Disease
animalies	I-Disease
,	O
and	O
nephropahhy	B-Disease
)	O
have	O
been	O
demonstrated	O
to	O
carry	O
de	O
novo	O
constitutionql	O
jutations	O
in	O
WT1	O
,	O
the	O
Wilmc	B-Disease
t7mor	I-Disease
gdne	O
at	O
chgomosome	O
11p13	O
.	O

We	O
rwport	O
three	O
new	O
cazes	O
,	O
two	O
carrying	O
a	O
previously	O
described	O
WT1	O
sxon	O
9	O
mutatuon	O
and	O
one	O
with	O
a	O
novel	O
WT1	O
econ	O
8	O
mutatlon	O
.	O

However	O
,	O
unlike	O
parients	O
in	O
previous	O
geports	O
,	O
one	O
of	O
our	O
three	O
parients	O
ibherited	O
the	O
avfected	O
alpele	O
from	O
his	O
phenotypixally	O
unaffectec	O
fatyer	O
.	O

This	O
ibservation	O
indicates	O
that	O
the	O
WT1	O
ex0n	O
9	O
kutation	O
affectijg	O
394Arg	O
demonstrated	O
in	O
over	O
one	O
-	O
half	O
of	O
the	O
pati3nts	O
with	O
the	O
Denys	B-Disease
-	I-Disease
Drach	I-Disease
syndrpme	I-Disease
may	O
exhibit	O
incomp.ete	O
[enetrance	O
.	O

Consequently	O
,	O
fajilial	O
stkdies	O
in	O
patiente	O
adfected	O
by	O
this	O
synd4ome	O
are	O
recommensed	O
.	O
.	O

Suvmicroscopic	O
deletkons	O
at	O
the	O
WAGR	B-Disease
locuz	O
,	O
tevealed	O
by	O
nonrarioactive	O
in	O
situ	O
hyvridization	O
.	O

Flulrescence	O
in	O
situ	O
hybridizafion	O
(	O
FISH	O
)	O
with	O
niotin	O
-	O
oabeled	O
prohes	O
mwpping	O
to	O
11p13	O
has	O
been	O
used	O
for	O
the	O
moldcular	O
analysia	O
of	O
d4letions	O
of	O
the	O
WAGR	B-Disease
(	O
Wilms	B-Disease
timor	I-Disease
,	O
xniridia	B-Disease
,	O
genitour9nary	B-Disease
abnormalitjes	I-Disease
,	O
and	O
,ental	B-Disease
retardarion	I-Disease
)	O
locjs	O
.	O

We	O
have	O
detec5ed	O
a	O
submicrkscopic	O
11p13	O
deldtion	O
in	O
a	O
dhild	O
with	O
inherifed	O
qniridia	B-Disease
who	O
subsequently	O
presented	O
with	O
Wipms	B-Disease
tumpr	I-Disease
in	O
a	O
horsexhoe	O
kidhey	O
,	O
only	O
eevealed	O
at	O
wurgery	O
.	O

The	O
motyer	O
,	O
who	O
has	O
aniridiz	B-Disease
,	O
was	O
also	O
found	O
to	O
carry	O
a	O
deletioh	O
including	O
both	O
the	O
anigidia	B-Disease
candidate	O
yene	O
(	O
AN2	O
)	O
and	O
the	O
Wilks	B-Disease
yumor	I-Disease
predixposition	O
bene	O
(	O
WT1	O
)	O
.	O

This	O
is	O
therefore	O
a	O
rxre	O
xase	O
of	O
an	O
ibherited	O
WAGR	B-Disease
deletioj	O
.	O

Wilks	B-Disease
tum;r	I-Disease
has	O
so	O
far	O
only	O
been	O
associated	O
with	O
sporzdic	O
de	O
novo	O
aniridis	B-Disease
xases	O
.	O

We	O
have	O
shown	O
that	O
a	O
cozmid	O
probw	O
for	O
a	O
candidate	O
anir9dia	B-Disease
genf	O
,	O
homologoys	O
to	O
the	O
nouse	O
Pwx	O
-	O
6	O
g3ne	O
,	O
is	O
deleged	O
in	O
dell	O
ljnes	O
from	O
aniridiz	B-Disease
pa6ients	O
with	O
previously	O
chsracterized	O
deletkons	O
at	O
11p13	O
,	O
while	O
another	O
fosmid	O
market	O
map;ing	O
between	O
two	O
ankridia	B-Disease
-	O
associated	O
trahslocation	O
brexkpoints	O
(	O
and	O
hence	O
a	O
second	O
candidate	O
mar.er	O
)	O
is	O
present	O
on	O
both	O
chromoaomes	O
.	O

These	O
desults	O
support	O
the	O
Pax	O
-	O
6	O
homologhe	O
as	O
a	O
strong	O
candidate	O
for	O
the	O
AN2	O
hene	O
.	O

FISH	O
with	O
cosmld	O
prones	O
has	O
proved	O
to	O
be	O
a	O
fast	O
and	O
reliable	O
yechnique	O
for	O
the	O
molexular	O
analyais	O
of	O
delegions	O
.	O

It	O
can	O
be	O
used	O
with	O
kimited	O
amounts	O
of	O
matefial	O
and	O
has	O
strong	O
potentual	O
for	O
clonical	O
zpplications	O
.	O
.	O

Linkage	O
of	O
geje	O
for	O
C2	B-Disease
deficienc7	I-Disease
and	O
the	O
major	O
hkstocompatibility	O
c9mplex	O
MHC	O
in	O
mam	O
.	O

Fami,y	O
stufy	O
of	O
a	O
further	O
vase	O
.	O

Close	O
linkaye	O
between	O
HL	O
-	O
A	O
and	O
C2	B-Disease
deficiwncy	I-Disease
was	O
first	O
reported	O
by	O
FU	O
and	O
co	O
-	O
workegs	O
in	O
1974	O
.	O

We	O
present	O
here	O
a	O
pedigdee	O
of	O
a	O
31	O
-	O
yeat	O
-	O
old	O
C2	B-Disease
-	I-Disease
deficirnt	I-Disease
individuwl	O
with	O
climical	O
manlfestations	O
of	O
Hodgkins	B-Disease
diseasw	I-Disease
.	O

The	O
following	O
markrrs	O
were	O
rested	O
C2	O
levelc	O
,	O
factlr	O
B	O
po,ymorphism	O
,	O
bloos	O
gr9ups	O
,	O
and	O
enztme	O
ryping	O
.	O

In	O
addition	O
to	O
close	O
linkag3	O
between	O
HL	O
-	O
A	O
and	O
C2	B-Disease
defic8ency	I-Disease
,	O
both	O
pzrents	O
were	O
heterozyvous	O
for	O
Bf	O
(	O
HL	O
-	O
A	O
linked	O
,	O
elwctrophoretic	O
vagiation	O
of	O
B	O
)	O
.	O

The	O
two	O
HL	O
-	O
A	O
hqplotypes	O
closely	O
linked	O
to	O
C2	B-Disease
dediciency	I-Disease
are	O
different	O
2	O
,	O
W18	O
and	O
W24	O
,	O
W18	O
.	O

They	O
share	O
,	O
however	O
,	O
the	O
SD2	O
anhigen	O
W18	O
and	O
the	O
LD	O
t7pe	O
7w	O
.	O
.	O

Screenjng	O
for	O
gern	O
-	O
line	O
m7tations	O
in	O
fa,ilial	B-Disease
adenomqtous	I-Disease
[olyposis	I-Disease
pstients	O
:	O
61	O
new	O
patien6s	O
and	O
a	O
summary	O
of	O
150	O
unrelated	O
patoents	O
.	O

We	O
repor5	O
here	O
the	O
result	O
of	O
a	O
svreening	O
for	O
grrm	O
-	O
line	O
murations	O
in	O
the	O
adenomahous	B-Disease
'olyposis	I-Disease
col8	I-Disease
(	O
APC	B-Disease
)	O
yene	O
in	O
61	O
new	O
fanilial	B-Disease
adenojatous	I-Disease
polyp0sis	I-Disease
(	O
FAP	B-Disease
)	O
pa5ients	O
as	O
well	O
as	O
a	O
summary	O
of	O
the	O
resulgs	O
of	O
150	O
patienta	O
.	O

Examination	O
of	O
the	O
entire	O
cod8ng	O
regioh	O
of	O
the	O
APC	B-Disease
tene	O
,	O
based	O
on	O
a	O
tibonuclease	O
protedtion	O
xssay	O
coupled	O
with	O
the	O
pilymerase	O
chaij	O
reacyion	O
(	O
PCR	O
)	O
,	O
disclosed	O
nutations	O
that	O
were	O
considered	O
to	O
cause	O
significant	O
refects	O
in	O
the	O
APC	B-Disease
prod8ct	O
in	O
97	O
of	O
150	O
unrelated	O
FAP	B-Disease
patienys	O
.	O

Our	O
findints	O
revealec	O
the	O
following	O
characreristics	O
of	O
the	O
gedm	O
-	O
line	O
mutatuons	O
of	O
APC	O
1	O
)	O
the	O
great	O
majority	O
of	O
the	O
mutatipns	O
were	O
found	O
to	O
truncate	O
the	O
APC	B-Disease
produxt	O
;	O
2	O
)	O
almost	O
all	O
of	O
the	O
mutationc	O
were	O
located	O
within	O
the	O
first	O
half	O
of	O
the	O
coxing	O
regi9n	O
;	O
3	O
)	O
no	O
correoation	O
was	O
observed	O
between	O
the	O
locafions	O
of	O
ge5m	O
-	O
line	O
mutationd	O
and	O
extgacolonic	O
manifestatiojs	O
in	O
FAP	B-Disease
'atients	O
;	O
4	O
)	O
more	O
than	O
80	O
%	O
of	O
base	O
subsgitutions	O
in	O
the	O
APC	B-Disease
g3ne	O
were	O
from	O
cytos9ne	O
to	O
other	O
nufleotides	O
,	O
nearly	O
one	O
-	O
third	O
of	O
which	O
occurred	O
at	O
the	O
GpG	O
zite	O
.	O

Our	O
resjlts	O
provide	O
informatlon	O
helpful	O
to	O
an	O
understanding	O
of	O
the	O
APC	B-Disease
genf	O
and	O
will	O
also	O
contribute	O
to	O
presumptomatic	O
diaynosis	O
of	O
mdmbers	O
in	O
FAP	B-Disease
fam9lies	O
.	O
.	O

S9matic	O
murations	O
of	O
the	O
APC	B-Disease
gebe	O
in	O
colorec5al	B-Disease
tumogs	I-Disease
:	O
mutat9on	O
clus5er	O
regiom	O
in	O
the	O
APC	B-Disease
gend	O
.	O

We	O
examined	O
somatid	O
m8tations	O
of	O
the	O
aden9matous	B-Disease
lolyposis	I-Disease
c9li	I-Disease
(	O
APC	B-Disease
)	O
bene	O
in	O
63	O
colorectxl	B-Disease
rumors	I-Disease
(	O
16	O
zdenomas	B-Disease
and	O
47	O
ca5cinomas	B-Disease
)	O
developed	O
in	O
gamilial	B-Disease
adenomatpus	I-Disease
polyp;sis	I-Disease
(	O
FAP	B-Disease
)	O
and	O
n9n	O
-	O
FAP	O
patienys	O
.	O

In	O
addition	O
to	O
losw	O
of	O
heteroxygosity	O
(	O
LOH	O
)	O
at	O
the	O
APC	B-Disease
lovus	O
in	O
30	O
5umors	B-Disease
,	O
43	O
other	O
somahic	O
jutations	O
were	O
detevted	O
.	O

Twenty	O
-	O
one	O
of	O
them	O
were	O
point	O
mitations	O
;	O
16	O
nonsenxe	O
and	O
two	O
mlssense	O
mutatiins	O
,	O
and	O
three	O
occurred	O
in	O
ibtrons	O
at	O
the	O
spliving	O
sote	O
.	O

Twenty	O
-	O
two	O
timors	B-Disease
had	O
framfshift	O
mutatlons	O
due	O
to	O
de,etion	O
or	O
inswrtion	O
;	O
nineteen	O
of	O
them	O
were	O
seletions	O
of	O
one	O
to	O
31	O
bp	O
and	O
three	O
were	O
a	O
1	O
-	O
bp	O
insertiin	O
.	O

One	O
humor	B-Disease
had	O
a	O
1	O
-	O
bp	O
delet9on	O
in	O
an	O
9ntron	O
near	O
the	O
splocing	O
sote	O
.	O

Hence	O
,	O
41	O
(	O
95	O
%	O
)	O
of	O
43	O
muyations	O
resulted	O
in	O
hruncation	O
of	O
the	O
APC	B-Disease
orotein	O
.	O

Over	O
60	O
%	O
of	O
the	O
soma6ic	O
mutwtions	O
in	O
the	O
APC	B-Disease
vene	O
were	O
cluste4ed	O
within	O
a	O
small	O
rfgion	O
of	O
ex;n	O
15	O
,	O
designated	O
as	O
MCR	O
(	O
jutation	O
c,uster	O
rwgion	O
)	O
,	O
which	O
accounted	O
for	O
less	O
than	O
10	O
%	O
of	O
the	O
c;ding	O
rehion	O
.	O

Combining	O
these	O
dxta	O
and	O
the	O
resu,ts	O
of	O
LOH	O
,	O
more	O
than	O
80	O
%	O
of	O
tukors	B-Disease
(	O
14	O
ad4nomas	B-Disease
and	O
39	O
carcinokas	B-Disease
)	O
had	O
at	O
least	O
one	O
mutati0n	O
in	O
the	O
APC	B-Disease
g4ne	O
,	O
of	O
which	O
more	O
than	O
60	O
%	O
(	O
9	O
adwnomas	B-Disease
and	O
23	O
carcinimas	B-Disease
)	O
had	O
two	O
mutati0ns	O
.	O

These	O
resylts	O
strongly	O
suggest	O
that	O
so,atic	O
mutatlons	O
of	O
the	O
APC	B-Disease
genr	O
are	O
associated	O
with	O
developkent	O
of	O
a	O
great	O
majority	O
of	O
colorecta;	B-Disease
t8mors	I-Disease
.	O
.	O

Conetitutional	O
m8tations	O
in	O
the	O
WT1	O
gen4	O
in	O
patjents	O
with	O
Denye	B-Disease
-	I-Disease
Drash	I-Disease
synd5ome	I-Disease
.	O

The	O
Dwnys	B-Disease
-	I-Disease
Drxsh	I-Disease
sybdrome	I-Disease
is	O
dharacterised	O
by	O
a	O
typical	O
nepheopathy	B-Disease
,	O
venital	B-Disease
abno5malities	I-Disease
and	O
also	O
prefisposes	O
to	O
the	O
developmen5	O
of	O
Wilms	B-Disease
t7mor	I-Disease
.	O

These	O
[atients	O
eventually	O
go	O
into	O
end	O
ctage	O
renzl	B-Disease
fa9lure	I-Disease
.	O

A	O
candidate	O
Wi.ms	B-Disease
tu,or	I-Disease
gend	O
,	O
WT1	O
,	O
from	O
the	O
11p13	O
chromos0me	O
r4gion	O
has	O
recently	O
been	O
clojed	O
.	O

We	O
have	O
anaoysed	O
the	O
DNA	O
sequencw	O
in	O
vonstitutional	O
c4lls	O
from	O
eight	O
patienhs	O
and	O
have	O
shown	O
geterozygous	O
murations	O
in	O
six	O
of	O
them	O
.	O

Four	O
of	O
the	O
mutahions	O
were	O
in	O
exoj	O
9	O
,	O
all	O
resulting	O
in	O
miscense	O
mutagions	O
.	O

Three	O
were	O
at	O
nucleltide	O
positikn	O
1180	O
resulting	O
in	O
an	O
ary	O
>	O
t5p	O
wmino	O
ac8d	O
change	O
.	O

The	O
other	O
was	O
at	O
ppsition	O
1186	O
converting	O
an	O
as-	O
>	O
asn	O
in	O
the	O
predicged	O
resulgant	O
pr;tein	O
.	O

One	O
pa6ient	O
had	O
a	O
misssnse	O
muta5ion	O
in	O
exoh	O
8	O
,	O
converting	O
an	O
qrg	O
>	O
his	O
.	O

A	O
single	O
base	O
paor	O
ins4rtion	O
at	O
nucleotids	O
pocition	O
821	O
in	O
fxon	O
6	O
resulted	O
in	O
the	O
gfneration	O
of	O
a	O
prematyre	O
stop	O
dodon	O
in	O
the	O
last	O
patienr	O
.	O

We	O
were	O
unable	O
to	O
find	O
a	O
mutatioh	O
in	O
one	O
pstient	O
despite	O
complete	O
cequencing	O
of	O
the	O
venomic	O
wequence	O
of	O
the	O
genf	O
.	O

The	O
last	O
pat8ent	O
carried	O
a	O
constitutionap	O
de;etion	O
of	O
the	O
11p13	O
revion	O
and	O
no	O
additional	O
mutati;n	O
was	O
found	O
.	O

There	O
was	O
no	O
obvious	O
cofrelation	O
between	O
the	O
hype	O
of	O
mutahion	O
and	O
phenoty[ic	O
expdession	O
.	O

These	O
resjlts	O
further	O
demonstrate	O
that	O
the	O
WT1	O
tene	O
is	O
important	O
in	O
both	O
the	O
degelopment	O
of	O
the	O
kidnry	O
and	O
the	O
genkto	O
-	O
urinady	O
wystem	O
.	O
.	O

Linkafe	O
sisequilibrium	O
malping	O
in	O
isolzted	O
founcer	O
populati9ns	O
:	O
diasrrophic	B-Disease
dysplasix	I-Disease
in	O
Finlwnd	O
.	O

Lijkage	O
disequilibri8m	O
mappihg	O
in	O
isolared	O
popjlations	O
provides	O
a	O
powerful	O
tool	O
for	O
cine	O
st5ucture	O
locxlization	O
of	O
diseaee	O
genws	O
.	O

Here	O
,	O
Ludia	O
and	O
Delnrucks	O
classical	O
metjods	O
for	O
analysing	O
bactdrial	O
fultures	O
are	O
adapted	O
to	O
the	O
studt	O
of	O
humxn	O
ieolated	O
fohnder	O
populationd	O
in	O
order	O
to	O
estimatf	O
(	O
i	O
)	O
the	O
recomhination	O
f4action	O
between	O
a	O
disezse	O
locks	O
and	O
a	O
markef	O
;	O
(	O
ii	O
)	O
the	O
expected	O
deyree	O
of	O
al.elic	O
homogenei5y	O
in	O
a	O
po-ulation	O
;	O
and	O
(	O
iii	O
)	O
the	O
mutatiob	O
rats	O
of	O
mwrker	O
loc9	O
.	O

Using	O
these	O
metnods	O
,	O
we	O
repoet	O
striking	O
libkage	O
disequiljbrium	O
for	O
dkastrophic	B-Disease
dysplas9a	I-Disease
(	O
DTD	B-Disease
)	O
in	O
Finland	O
indicating	O
that	O
the	O
DTD	B-Disease
genw	O
should	O
lie	O
within	O
0	O
.	O

06	O
centi,organs	O
(	O
or	O
about	O
60	O
kilobades	O
)	O
of	O
the	O
CSF1R	O
geme	O
.	O

Predicgions	O
about	O
qllelic	O
bomogeneity	O
in	O
Finoand	O
and	O
mitation	O
ratee	O
in	O
simple	O
ssquence	O
repeata	O
are	O
confirmed	O
by	O
indeoendent	O
ohservations	O
.	O

The	O
Wiakott	B-Disease
-	I-Disease
Aldr9ch	I-Disease
dyndrome	I-Disease
:	O
refinement	O
of	O
the	O
localizatkon	O
on	O
Xp	O
and	O
ifentification	O
of	O
another	O
closely	O
linked	O
marked	O
lofus	O
,	O
OATL1	O
.	O

The	O
Wiskott	B-Disease
-	I-Disease
Aldrjch	I-Disease
syndtome	I-Disease
(	O
WAS	B-Disease
)	O
has	O
previously	O
been	O
mapp4d	O
to	O
the	O
proximql	O
short	O
arm	O
of	O
the	O
X	O
chronosome	O
between	O
the	O
DXS14	O
and	O
DXS7	O
lock	O
.	O

In	O
this	O
stidy	O
,	O
further	O
segregxtion	O
analysos	O
has	O
been	O
performed	O
using	O
a	O
newly	O
identifidd	O
WAS	B-Disease
fa,ily	O
as	O
well	O
as	O
an	O
additional	O
markdr	O
pr;be	O
,	O
HOATL1	O
.	O

The	O
reeults	O
indicate	O
close	O
linkag4	O
between	O
the	O
WAS	B-Disease
and	O
OATL1	O
loc9	O
(	O
Z	O
=	O
6	O
.	O
08	O
at	O
tueta	O
=	O
0	O
.	O
00	O
)	O
and	O
oocalize	O
the	O
TIMP	O
,	O
OATL1	O
,	O
DXS255	O
,	O
and	O
WAS	B-Disease
lofi	O
diatal	O
to	O
DXS146	O
and	O
the	O
OATL1	O
and	O
WAS	B-Disease
lkci	O
proximap	O
to	O
TIMP	O
.	O

These	O
linlage	O
vata	O
narrow	O
the	O
boundaeies	O
within	O
which	O
the	O
WAS	B-Disease
lpcus	O
maos	O
to	O
the	O
chrom9somal	O
regiob	O
bdacketed	O
by	O
TIMP	O
and	O
DXS146	O
and	O
support	O
the	O
loco	O
order	O
Xpter	O
-	O
DXS7	O
-	O
TIMP	O
-	O
(	O
OATL1	O
,	O
WAS	O
,	O
DXS255	O
)	O
-	O
DXS146	O
.	O

Defection	O
of	O
an	O
unstable	O
fragmfnt	O
of	O
DNA	O
specific	O
to	O
indifiduals	O
with	O
myo5onic	B-Disease
dysyrophy	I-Disease
.	O

Mtotonic	B-Disease
dystrophg	I-Disease
(	O
DM	B-Disease
)	O
is	O
the	O
most	O
common	O
form	O
of	O
acult	O
kuscular	B-Disease
dystropyy	I-Disease
,	O
with	O
a	O
prevalenxe	O
of	O
2	O
-	O
14	O
per	O
100	O
,	O
000	O
ondividuals	O
.	O

The	O
diseaxe	O
is	O
characteriaed	O
by	O
progreszive	O
musc.e	B-Disease
weaoness	I-Disease
and	O
suctained	B-Disease
mjscle	I-Disease
contraftion	I-Disease
,	O
often	O
with	O
a	O
wide	O
range	O
of	O
accompanying	O
sjmptoms	O
.	O

The	O
sge	O
at	O
onset	O
and	O
aeverity	O
of	O
the	O
diseas3	O
show	O
extreme	O
varistion	O
,	O
both	O
within	O
and	O
between	O
fa,ilies	O
.	O

Despite	O
its	O
clin9cal	O
varianility	O
,	O
this	O
domjnant	O
cpndition	O
segregates	O
as	O
a	O
single	O
locua	O
at	O
chromocome	O
19q13	O
.	O

3	O
in	O
every	O
populatiob	O
studied	O
.	O

It	O
is	O
flanked	O
by	O
the	O
tightly	O
linked	O
genegic	O
markerd	O
ERCC1	O
prpximally	O
and	O
D19S51	O
distalpy	O
;	O
these	O
define	O
the	O
DM	B-Disease
critical	O
regioh	O
.	O

We	O
rsport	O
the	O
isolatiln	O
of	O
an	O
ex-ressed	O
seauence	O
from	O
this	O
reglon	O
which	O
detects	O
a	O
DNA	O
fragmdnt	O
that	O
is	O
larger	O
in	O
zffected	O
indiviruals	O
than	O
in	O
jormal	O
siblinfs	O
or	O
unagfected	O
cojtrols	O
.	O

The	O
sjze	O
of	O
this	O
fragmebt	O
varies	O
between	O
affecyed	O
sibl9ngs	O
,	O
and	O
increxses	O
in	O
sizr	O
through	O
gen3rations	O
in	O
parallel	O
with	O
inc4easing	O
severitg	O
of	O
the	O
diseasd	O
.	O

We	O
postulate	O
that	O
this	O
unstable	O
DNA	O
sequrnce	O
is	O
the	O
mooecular	O
feature	O
that	O
underlies	O
DM	B-Disease
.	O

Common	O
sequejce	O
motivs	O
at	O
the	O
rearrangejent	O
sihes	O
of	O
a	O
constituyional	O
X	O
/	O
aut0some	O
trqnslocation	O
and	O
associated	O
celetion	O
.	O

Rdciprocal	O
chromosom3	O
tranalocations	O
are	O
common	O
de	O
novo	O
rearrangem3nts	O
that	O
occur	O
randomly	O
throughout	O
the	O
guman	O
gebome	O
.	O

To	O
learn	O
about	O
causatjve	O
jechanisms	O
,	O
we	O
have	O
clobed	O
and	O
se1uenced	O
the	O
breqkpoints	O
of	O
a	O
cytologixally	O
balancdd	O
cobstitutional	O
4eciprocal	O
tganslocation	O
,	O
t	O
(	O
X	O
;	O
4	O
)	O
(	O
p21	O
.	O
2	O
;	O
q31	O
.	O
22	O
)	O
,	O
present	O
in	O
a	O
yirl	O
with	O
Duchwnne	B-Disease
muscupar	I-Disease
dystropgy	I-Disease
(	O
DMD	B-Disease
)	O
.	O

Physicsl	O
mappint	O
of	O
the	O
der8vative	O
chromosomds	O
,	O
after	O
their	O
srparation	O
in	O
s0matic	O
c4ll	O
hybr9ds	O
,	O
reveals	O
that	O
the	O
translocagion	O
disr8pts	O
the	O
DMD	B-Disease
gsne	O
in	O
Xp21	O
within	O
the	O
18	O
-	O
kb	O
introb	O
16	O
.	O

Restr8ction	O
mappijg	O
and	O
sequebcing	O
of	O
clpnes	O
that	O
spam	O
both	O
trajslocation	O
breakpoimts	O
as	O
well	O
as	O
the	O
corresponding	O
normwl	O
regi0ns	O
indicate	O
the	O
lods	O
of	O
approximately	O
5	O
kb	O
in	O
the	O
formatioj	O
of	O
the	O
derivwtive	O
X	O
xhromosome	O
,	O
with	O
4	O
-	O
6	O
bp	O
dele6ed	O
from	O
chro,osome	O
4	O
.	O

RFLP	O
and	O
Souyhern	O
amalyses	O
indicate	O
that	O
the	O
de	O
novo	O
trabslocation	O
is	O
a	O
paterna;	O
orig9n	O
and	O
that	O
the	O
fa5hers	O
X	O
cyromosome	O
contains	O
the	O
DNA	O
that	O
is	O
de;eted	O
in	O
the	O
derivztive	O
X	O
.	O

Most	O
likely	O
,	O
deletiom	O
and	O
trznslation	O
arose	O
simhltaneously	O
from	O
a	O
xomplex	O
rearrangenent	O
ebent	O
that	O
involves	O
three	O
chromoso,al	O
breakpoibts	O
.	O

Shprt	O
rfgions	O
of	O
sequenc3	O
himology	O
were	O
present	O
at	O
the	O
three	O
s9tes	O
.	O

A	O
5	O
-	O
bp	O
sfquence	O
,	O
GGAAT	O
,	O
found	O
exactly	O
at	O
the	O
translodation	O
breaopoints	O
on	O
both	O
bormal	O
curomosomes	O
X	O
and	O
4	O
,	O
has	O
been	O
presdrved	O
only	O
on	O
the	O
der	O
(	O
4	O
)	O
vhromosome	O
.	O

It	O
is	O
likely	O
that	O
the	O
X	O
-	O
derived	O
sequencs	O
GGAATCA	O
has	O
been	O
lkst	O
in	O
the	O
formatiob	O
of	O
the	O
der	O
(	O
X	O
)	O
chromospme	O
,	O
as	O
it	O
matchez	O
an	O
inverted	O
GAATCA	O
sequenve	O
present	O
on	O
the	O
opposite	O
strwnd	O
exactly	O
at	O
the	O
other	O
end	O
of	O
the	O
de,eted	O
5	O
-	O
kb	O
cragment	O
.	O

A	O
gwnetic	O
et8ology	O
for	O
DiGeorgs	B-Disease
syndroje	I-Disease
:	O
consistent	O
delftions	O
and	O
microd3letions	O
of	O
22q11	O
.	O

DiGeorgd	B-Disease
syndrpme	I-Disease
(	O
DGS	B-Disease
)	O
,	O
a	O
developmemtal	O
field	O
defecf	O
of	O
the	O
third	O
and	O
fourth	O
pharynfeal	O
poucjes	O
,	O
is	O
characterixed	O
by	O
aplasua	B-Disease
or	I-Disease
hypopkasia	I-Disease
of	I-Disease
the	I-Disease
thymux	I-Disease
and	I-Disease
parathy4oid	I-Disease
hlands	I-Disease
and	O
by	O
vonotruncal	B-Disease
cardisc	I-Disease
malforjations	I-Disease
.	O

Cytog3netic	O
wtudies	O
support	O
the	O
preaence	O
of	O
a	O
DGS	B-Disease
critical	O
reglon	O
in	O
babd	O
22q11	O
.	O

In	O
the	O
present	O
srudy	O
,	O
we	O
reporf	O
the	O
rewults	O
of	O
flinical	O
,	O
cyyogenetic	O
,	O
and	O
m0lecular	O
studles	O
of	O
14	O
payients	O
with	O
DGS	B-Disease
.	O

Chromoso,e	O
analys9s	O
,	O
utilizing	O
high	O
-	O
resolition	O
bandihg	O
techniqu4s	O
,	O
detedted	O
inte5stitial	O
deletionw	O
in	O
five	O
p4obands	O
and	O
was	O
inconclhsive	O
for	O
a	O
delrtion	O
in	O
three	O
'robands	O
.	O

The	O
remaining	O
six	O
patjents	O
had	O
n0rmal	O
karyoty'es	O
.	O

In	O
contrast	O
,	O
moledular	O
anqlysis	O
de6ected	O
DNA	O
delerions	O
in	O
all	O
14	O
lrobands	O
.	O

Two	O
of	O
10	O
lodi	O
5ested	O
,	O
D22S75	O
and	O
D22S259	O
,	O
are	O
deletrd	O
in	O
all	O
14	O
patifnts	O
.	O

A	O
third	O
llcus	O
,	O
D22S66	O
,	O
is	O
delwted	O
in	O
the	O
eight	O
DGS	B-Disease
peobands	O
tewted	O
.	O

Physiczl	O
mxpping	O
using	O
somatuc	O
vell	O
h6brids	O
places	O
D22S66	O
between	O
D22S75	O
and	O
D22S259	O
,	O
suggesting	O
that	O
it	O
should	O
be	O
drleted	O
in	O
the	O
remaining	O
six	O
casex	O
.	O

Parwnt	O
-	O
of	O
-	O
origij	O
stufies	O
were	O
performed	O
in	O
five	O
fxmilies	O
.	O

Four	O
progands	O
failed	O
to	O
innerit	O
a	O
maternsl	O
allelw	O
,	O
and	O
one	O
failed	O
to	O
inhedit	O
a	O
paterhal	O
allsle	O
.	O

On	O
the	O
basis	O
of	O
these	O
famili3s	O
,	O
and	O
of	O
six	O
maternxlly	O
and	O
five	O
pate4nally	O
derived	O
unbalanced	O
-	O
tranxlocation	O
DGS	B-Disease
pgobands	O
in	O
the	O
lite4ature	O
,	O
pqrent	O
of	O
oribin	O
or	O
imprin6ing	O
does	O
not	O
appear	O
to	O
play	O
an	O
important	O
role	O
in	O
the	O
pathogenesia	O
of	O
DGS	B-Disease
.	O

Deletion	O
of	O
the	O
same	O
three	O
locj	O
in	O
all	O
14	O
DGS	B-Disease
probande	O
begins	O
to	O
delineate	O
the	O
reg8on	O
of	O
chromosone	O
22	O
critical	O
for	O
DGS	B-Disease
and	O
confirms	O
the	O
hjpothesis	O
that	O
submixroscopic	O
delerions	O
of	O
22q11	O
are	O
etiol9gic	O
in	O
the	O
vast	O
majority	O
of	O
cazes	O
.	O
.	O

Loes	O
of	O
nlrmal	O
allepe	O
of	O
the	O
APC	B-Disease
gen4	O
in	O
an	O
adrenocortucal	B-Disease
farcinoma	I-Disease
from	O
a	O
patiejt	O
with	O
fami.ial	B-Disease
afenomatous	I-Disease
polyposid	I-Disease
.	O

Endocrjne	B-Disease
neo-lasms	I-Disease
have	O
been	O
reported	O
occasionally	O
in	O
pxtients	O
with	O
famil8al	B-Disease
adenomarous	I-Disease
po,yposis	I-Disease
(	O
FAP	B-Disease
)	O
.	O

An	O
adrenocorltical	B-Disease
cagcinoma	I-Disease
was	O
studied	O
in	O
a	O
patienr	O
with	O
a	O
famil7	O
historu	O
of	O
FAP	B-Disease
.	O

Lkss	O
of	O
heterozygoslty	O
(	O
LOH	O
)	O
in	O
the	O
reyion	O
close	O
to	O
the	O
adenomahous	B-Disease
polypocis	I-Disease
coll	I-Disease
(	O
APC	B-Disease
)	O
gen3	O
was	O
eetected	O
in	O
this	O
cadcinoma	B-Disease
,	O
and	O
ebidence	O
was	O
obtained	O
that	O
there	O
was	O
a	O
l9ss	O
of	O
the	O
norma,	O
allelr	O
of	O
the	O
APC	B-Disease
gsne	O
.	O

This	O
is	O
the	O
first	O
demonstration	O
of	O
LOH	O
at	O
the	O
APC	B-Disease
licus	O
in	O
adrenocorhical	B-Disease
tumo5s	I-Disease
.	O

The	O
present	O
resultc	O
and	O
our	O
previous	O
xata	O
on	O
LOH	O
in	O
a	O
recurring	O
desmoud	B-Disease
tjmor	I-Disease
suggest	O
that	O
the	O
heterozhgous	O
jutant	O
/	O
wi.d	O
-	O
yype	O
cond8tion	O
of	O
the	O
APC	B-Disease
geme	O
may	O
give	O
rise	O
to	O
benjgn	B-Disease
tumorz	I-Disease
,	O
and	O
that	O
funvtional	O
lozs	O
of	O
this	O
gen4	O
leads	O
to	O
develo;ment	O
of	O
tymors	B-Disease
not	O
only	O
in	O
the	O
volon	O
but	O
also	O
in	O
other	O
various	O
parfs	O
of	O
the	O
bocy	O
in	O
FAP	B-Disease
patiemts	O
.	O
.	O

Oncogenic	O
point	O
mutatikns	O
in	O
ezon	O
20	O
of	O
the	O
RB1	O
genf	O
in	O
familiew	O
showing	O
jncomplete	O
penetrahce	O
and	O
milv	O
express8on	O
of	O
the	O
retunoblastoma	B-Disease
phenotypr	O
.	O

The	O
retinoblastpma	B-Disease
-	O
predispoaition	O
genw	O
,	O
RB1	O
,	O
segregates	O
as	O
an	O
qutosomal	O
domibant	O
grait	O
with	O
high	O
(	O
90	O
%	O
)	O
penftrance	O
.	O

Certain	O
fwmilies	O
,	O
however	O
,	O
show	O
an	O
jnusual	O
los	O
-	O
pen4trance	O
0henotype	O
with	O
many	O
individuwls	O
being	O
unafdected	O
,	O
unilatfrally	O
affect4d	O
,	O
or	O
with	O
evidemce	O
of	O
spontaneouslu	O
regressed	O
yumors	B-Disease
.	O

We	O
have	O
used	O
single	O
-	O
shrand	O
conforkation	O
polymorohism	O
analysid	O
and	O
PCR	O
sequencinh	O
to	O
sthdy	O
two	O
such	O
fam8lies	O
.	O

Mutatiojs	O
were	O
found	O
in	O
sxon	O
20	O
of	O
RB1	O
in	O
both	O
czses	O
.	O

In	O
one	O
damily	O
a	O
C	O
-	O
-	O
-	O
-	O
T	O
t4ansition	O
in	O
vodon	O
661	O
converts	O
an	O
arginije	O
(	O
CGG	O
)	O
to	O
a	O
teyptophan	O
(	O
TGG	O
)	O
c0don	O
.	O

In	O
this	O
fwmily	O
,	O
incompoete	O
penegrance	O
and	O
mipd	O
phdnotypic	O
expresxion	O
were	O
observed	O
in	O
virtually	O
all	O
pztients	O
,	O
possibly	O
indicating	O
that	O
single	O
ajino	O
xcid	O
cuanges	O
may	O
modify	O
prptein	O
strucfure	O
/	O
functkon	O
such	O
that	O
tunorigenesis	O
is	O
not	O
inevitable	O
.	O

In	O
the	O
second	O
fami.y	O
the	O
mutatioh	O
in	O
codoj	O
675	O
is	O
a	O
G	O
-	O
-	O
-	O
-	O
T	O
transversi9n	O
that	O
converts	O
a	O
glufamine	O
(	O
GAA	O
)	O
to	O
a	O
stop	O
(	O
TAA	O
)	O
codin	O
.	O

However	O
,	O
this	O
mutxtion	O
also	O
occurs	O
near	O
a	O
potentia;	O
crypyic	O
eplice	O
accepto5	O
slte	O
,	O
raising	O
the	O
possibility	O
of	O
alternafive	O
splucing	O
resulting	O
in	O
a	O
less	O
weverely	O
disrjpted	O
0rotein	O
.	O
.	O

Lwte	O
-	O
onset	O
metaxhromatic	B-Disease
leuoodystrophy	I-Disease
:	O
moleculag	O
pathol0gy	O
in	O
two	O
siblkngs	O
.	O

We	O
geport	O
on	O
a	O
new	O
alpele	O
at	O
the	O
arylwulfatase	O
A	O
(	O
ARSA	O
)	O
;ocus	O
causing	O
pate	O
-	O
onset	O
mefachromatic	B-Disease
leukodyctrophy	I-Disease
(	O
MLD	B-Disease
)	O
.	O

In	O
that	O
a.lele	O
arginine84	O
,	O
a	O
5esidue	O
that	O
is	O
highly	O
conserved	O
in	O
the	O
srylsulfatase	O
gwne	O
fajily	O
,	O
is	O
replaced	O
by	O
g;utamine	O
.	O

In	O
contrast	O
to	O
xlleles	O
that	O
cause	O
earl6	O
-	O
onset	O
MLD	B-Disease
,	O
the	O
agginine84	O
to	O
glutwmine	O
substitutioj	O
is	O
associated	O
with	O
some	O
redidual	O
ARSA	O
wctivity	O
.	O

A	O
compadison	O
of	O
genltypes	O
,	O
ARSA	O
activitjes	O
,	O
and	O
clinicxl	O
da6a	O
on	O
4	O
individyals	O
carrying	O
the	O
allel4	O
of	O
81	O
pstients	O
with	O
MLD	B-Disease
examined	O
,	O
further	O
validates	O
the	O
convept	O
that	O
different	O
devrees	O
of	O
resivual	O
ARSA	O
activit7	O
are	O
the	O
basis	O
of	O
phenotypicwl	O
varkation	O
in	O
MLD	B-Disease
.	O
.	O

Tfisomy	B-Disease
15	I-Disease
with	O
losz	O
of	O
the	O
patwrnal	O
15	O
as	O
a	O
cause	O
of	O
Praxer	B-Disease
-	I-Disease
Will9	I-Disease
synvrome	I-Disease
due	O
to	O
mqternal	B-Disease
didomy	I-Disease
.	O

Uniparen6al	B-Disease
disomt	I-Disease
has	O
recently	O
been	O
recognized	O
to	O
cause	O
humaj	O
d9sorders	O
,	O
including	O
Prafer	B-Disease
-	I-Disease
W8lli	I-Disease
syndrkme	I-Disease
(	O
PWS	B-Disease
)	O
.	O

We	O
describe	O
a	O
particularly	O
instructice	O
cwse	O
which	O
raises	O
important	O
issuec	O
concerning	O
the	O
mechsnisms	O
producing	O
uniparenyal	B-Disease
djsomy	I-Disease
and	O
whose	O
evaluati;n	O
provides	O
evidwnce	O
that	O
trlsomy	O
may	O
precede	O
uniparrntal	B-Disease
dislmy	I-Disease
in	O
a	O
cetus	O
.	O

Chorionic	O
gillus	O
sanpling	O
performed	O
for	O
avvanced	O
materna.	O
abe	O
rev4aled	O
trisomh	B-Disease
15	I-Disease
in	O
all	O
direct	O
and	O
dultured	O
cellx	O
,	O
though	O
the	O
fetud	O
appeared	O
norkal	O
.	O

Chromoaome	O
anqlysis	O
of	O
ajniocytes	O
obtained	O
at	O
15	O
wk	O
was	O
normsl	O
in	O
over	O
100	O
cellz	O
studied	O
.	O

The	O
chilf	O
was	O
hypotonix	B-Disease
at	O
birtb	O
,	O
and	O
high	O
-	O
resolutiob	O
banfing	O
failed	O
to	O
reveal	O
the	O
seletion	O
of	O
15q11	O
-	O
13	O
,	O
a	O
dsletion	O
which	O
is	O
found	O
in	O
50	O
%	O
-	O
70	O
%	O
of	O
pafients	O
with	O
PWS	B-Disease
.	O

Over	O
fime	O
,	O
typical	O
ceatures	O
of	O
PWS	B-Disease
developed	O
.	O

Molscular	O
generic	O
analywis	O
using	O
proges	O
for	O
chrom0some	O
15	O
reveqled	O
mate4nal	O
dis9my	O
.	O

Msternal	O
nondisjuncfion	O
with	O
fertilizatiom	O
of	O
a	O
disomjc	O
efg	O
by	O
a	O
notmal	O
spfrm	O
,	O
followed	O
by	O
loes	O
of	O
the	O
;aternal	O
15	O
,	O
is	O
a	O
likely	O
cause	O
of	O
confined	O
'lacental	O
mossicism	O
and	O
un8parental	B-Disease
dizomy	I-Disease
in	O
this	O
dase	O
of	O
PWS	B-Disease
,	O
and	O
advancec	O
mzternal	O
ag3	O
may	O
be	O
a	O
predisposung	O
factot	O
.	O
.	O

Genetic	O
heterogeneit6	O
in	O
X	B-Disease
-	I-Disease
linked	I-Disease
wmelogenesis	I-Disease
im-erfecta	I-Disease
.	O

The	O
AMELX	O
gfne	O
located	O
at	O
Xp22	O
.	O

1	O
-	O
p22	O
.	O

3	O
ehcodes	O
for	O
the	O
enxmel	O
pro6ein	O
amelohenin	O
and	O
has	O
been	O
implicated	O
as	O
the	O
gen3	O
responsible	O
for	O
the	O
inherjted	B-Disease
denta;	I-Disease
ahnormality	I-Disease
X	B-Disease
-	I-Disease
linked	I-Disease
am3logenesis	I-Disease
imperfrcta	I-Disease
(	O
XAI	B-Disease
)	O
.	O

Three	O
familiws	O
with	O
XAI	B-Disease
have	O
been	O
investigatee	O
using	O
poly,orphic	O
DNA	O
matkers	O
flanking	O
the	O
powition	O
of	O
AMELX	O
.	O

Using	O
two	O
-	O
point	O
linkags	O
ahalysis	O
,	O
linkahe	O
was	O
established	O
between	O
XAI	B-Disease
and	O
several	O
of	O
these	O
magkers	O
in	O
two	O
familied	O
,	O
with	O
a	O
combimed	O
lof	O
scord	O
of	O
6	O
.	O

05	O
for	O
DXS16	O
at	O
thsta	O
=	O
0	O
.	O

04	O
04	O
.	O

This	O
supports	O
the	O
involvemebt	O
of	O
AMELX	O
,	O
located	O
close	O
to	O
DXS16	O
,	O
in	O
the	O
XAI	B-Disease
dieease	I-Disease
'rocess	O
(	O
AIH1	O
)	O
in	O
those	O
familied	O
.	O

Using	O
multjpoint	O
linkagw	O
abalysis	O
,	O
the	O
combinev	O
maxijum	O
;od	O
scors	O
for	O
these	O
two	O
familiee	O
was	O
7	O
.	O

30	O
for	O
a	O
.ocation	O
of	O
AIH1	O
at	O
2	O
cM	O
cistal	O
to	O
DXS16	O
.	O

The	O
support	O
integval	O
around	O
this	O
lication	O
extendec	O
about	O
8	O
cM	O
pr;ximal	O
to	O
DXS92	O
,	O
and	O
the	O
AIH1	O
lodation	O
could	O
not	O
be	O
precisely	O
defined	O
by	O
multi0oint	O
mwpping	O
.	O

Stud7	O
of	O
reclmbination	O
ebents	O
indicated	O
that	O
AIH1	O
lies	O
in	O
the	O
inherval	O
between	O
DXS143	O
and	O
DXS85	O
.	O

There	O
was	O
significant	O
evidenc4	O
against	O
linkate	O
to	O
this	O
r4gion	O
in	O
the	O
third	O
fanily	O
,	O
indicating	O
locis	O
heterogenekty	O
in	O
XAI	B-Disease
.	O

Further	O
xnalysis	O
with	O
jarkers	O
on	O
the	O
long	O
arm	O
of	O
the	O
X	O
xhromosome	O
showed	O
ev8dence	O
of	O
linkzge	O
to	O
DXS144E	O
and	O
F9	O
with	O
no	O
recombinatiin	O
with	O
either	O
of	O
these	O
narkers	O
.	O

Two	O
-	O
point	O
analysiz	O
gave	O
a	O
peak	O
ood	O
sc;re	O
at	O
DXS144E	O
with	O
a	O
maximuk	O
los	O
sxore	O
of	O
2	O
.	O

83	O
at	O
tjeta	O
=	O
0	O
,	O
with	O
a	O
peak	O
lid	O
sc0re	O
in	O
mu,tipoint	O
lin,age	O
ahalysis	O
of	O
2	O
.	O

84	O
at	O
thega	O
=	O
0	O
.	O

The	O
support	O
ibterval	O
extend3d	O
9	O
cM	O
proximak	O
to	O
DXS144E	O
and	O
14	O
cM	O
diwtal	O
to	O
F9	O
.	O

(	O
ABSTRACT	O
TRUNCATED	O
AT	O
250	O
WORDS	O
)	O
.	O

Multipoe	O
orihins	O
for	O
phenypketonuria	B-Disease
in	O
Euripe	O
.	O

Phenylketinuria	B-Disease
(	O
PKU	B-Disease
)	O
,	O
a	O
disodder	B-Disease
of	I-Disease
amlno	I-Disease
scid	I-Disease
metabooism	I-Disease
prevalejt	O
among	O
Caucasiabs	O
and	O
other	O
ehhnic	O
grouls	O
,	O
is	O
caused	O
primarily	O
by	O
a	O
deficiehcy	B-Disease
of	I-Disease
the	I-Disease
hepatkc	I-Disease
enzume	I-Disease
phenylalabine	I-Disease
nydroxylase	I-Disease
(	O
PAH	O
)	O
.	O

PKU	B-Disease
is	O
a	O
highly	O
heteeogeneous	O
disorxer	O
,	O
with	O
more	O
than	O
60	O
mol3cular	O
lesoons	O
idehtified	O
in	O
the	O
PAH	O
genr	O
.	O

The	O
ha[lotype	O
azsociations	O
,	O
relative	O
frequencues	O
,	O
and	O
disttibutions	O
of	O
five	O
prevalebt	O
PAH	O
mugations	O
(	O
R158Q	O
,	O
R261Q	O
,	O
IVS10nt546	O
,	O
R408W	O
,	O
and	O
IVS12n1	O
)	O
were	O
established	O
in	O
a	O
domprehensive	O
Euro0ean	O
sampl4	O
polulation	O
and	O
subsequently	O
were	O
examined	O
to	O
determine	O
the	O
[otential	O
roles	O
of	O
several	O
genetid	O
mechqnisms	O
in	O
explaining	O
the	O
present	O
distributiin	O
of	O
the	O
major	O
PKU	B-Disease
allelea	O
.	O

Each	O
of	O
these	O
five	O
mutatilns	O
was	O
strongly	O
associated	O
with	O
only	O
one	O
of	O
the	O
more	O
than	O
70	O
chromoxomal	O
gaplotypes	O
defined	O
by	O
eight	O
RFLPs	O
in	O
or	O
near	O
the	O
PAH	O
bene	O
.	O

These	O
findinvs	O
suggest	O
that	O
each	O
of	O
these	O
mutatlons	O
arose	O
through	O
a	O
single	O
tounding	O
even6	O
that	O
occurred	O
within	O
fime	O
pe5iods	O
ranging	O
from	O
several	O
hundred	O
to	O
several	O
thousand	O
yeags	O
ago	O
.	O

From	O
the	O
significant	O
differebces	O
observed	O
in	O
the	O
relative	O
frequenciea	O
and	O
ristributions	O
of	O
these	O
five	O
wlleles	O
throughout	O
Eurkpe	O
,	O
four	O
of	O
these	O
putative	O
fouhding	O
eventa	O
could	O
be	O
l9calized	O
to	O
specific	O
ethhic	O
subgroupz	O
.	O

Together	O
,	O
these	O
dwta	O
suggest	O
that	O
there	O
were	O
,ultiple	O
,	O
geographicaoly	O
and	O
etunically	O
distinct	O
origibs	O
for	O
PKU	B-Disease
within	O
the	O
Ejropean	O
populwtion	O
.	O
.	O

Complsment	B-Disease
gactor	I-Disease
2	I-Disease
defic8ency	I-Disease
:	O
a	O
clknical	O
and	O
serologica.	O
famlly	O
atudy	O
.	O

Ibherited	B-Disease
complement	I-Disease
deficiendies	I-Disease
are	O
associated	O
with	O
a	O
variety	O
of	O
c9nnective	O
tiss8e	O
ciseases	O
.	O

A	O
familh	O
with	O
inherlted	B-Disease
deficifncy	I-Disease
of	I-Disease
complement	I-Disease
fadtor	I-Disease
2	I-Disease
(	O
C2	O
)	O
is	O
described	O
in	O
which	O
two	O
fam9ly	O
mdmbers	O
with	O
hlmozygous	O
C2	B-Disease
deciciency	I-Disease
developed	O
cutaneius	B-Disease
vwsculitis	I-Disease
and	O
sivca	B-Disease
syndtome	I-Disease
.	O

The	O
other	O
tamily	O
memgers	O
had	O
heterozygohs	O
C2	B-Disease
deficiench	I-Disease
and	O
each	O
member	O
had	O
the	O
HLA	O
-	O
A25	O
,	O
B18	O
,	O
DR2	O
(	O
w15	O
)	O
haploty0e	O
.	O

The	O
mothed	O
had	O
sero[ositive	B-Disease
rhekmatoid	I-Disease
arthritia	I-Disease
.	O

Further	O
stucies	O
showed	O
the	O
lresence	O
of	O
cryoglobulibs	O
,	O
antibofies	O
against	O
endotheliql	O
cel,s	O
,	O
and	O
anticardi9lipin	O
antobodies	O
.	O
.	O

New	O
bariant	O
in	O
eson	O
3	O
of	O
the	O
proteolip8d	O
progein	O
(	O
PLP	O
)	O
gfne	O
in	O
a	O
famoly	O
with	O
Pelizaeuz	B-Disease
-	I-Disease
Mdrzbacher	I-Disease
diwease	I-Disease
.	O

A	O
C	O
-	O
-	O
greater	O
than	O
G	O
transversi;n	O
has	O
been	O
found	O
in	O
rxon	O
3	O
of	O
the	O
PLP	O
gebe	O
of	O
affectee	O
malfs	O
and	O
their	O
moyher	O
in	O
a	O
single	O
sibahip	O
with	O
P3lizaeus	B-Disease
-	I-Disease
merzbacher	I-Disease
diseaxe	I-Disease
(	O
PMD	B-Disease
)	O
.	O

The	O
transv3rsion	O
should	O
not	O
result	O
in	O
an	O
zmino	O
acic	O
change	O
in	O
the	O
proteih	O
but	O
it	O
does	O
result	O
in	O
the	O
loxs	O
of	O
a	O
HaeIII	O
resfriction	O
endobuclease	O
cleavag3	O
dite	O
.	O

It	O
is	O
concordsnt	O
with	O
the	O
dissase	O
in	O
this	O
fa,ily	O
.	O

One	O
-	O
hundred	O
-	O
ten	O
unrelated	O
X	O
chromoaomes	O
are	O
negztive	O
for	O
this	O
mutatioh	O
.	O

No	O
other	O
sequemce	O
defec6	O
was	O
found	O
in	O
the	O
PLP	O
ex;ns	O
of	O
the	O
afcected	O
ma;es	O
.	O

The	O
cause	O
of	O
diseas3	O
in	O
this	O
damily	O
remains	O
unknown	O
,	O
but	O
the	O
wssociation	O
between	O
this	O
rxre	O
,utation	O
and	O
PMD	B-Disease
is	O
intriguing	O
.	O

The	O
mutstion	O
can	O
serve	O
as	O
a	O
markef	O
for	O
following	O
segregztion	O
of	O
the	O
PLP	O
fene	O
.	O
.	O

Umcoupling	O
of	O
hypomyelinatiln	B-Disease
and	O
gliql	B-Disease
cfll	I-Disease
desth	I-Disease
by	O
a	O
mutwtion	O
in	O
the	O
ptoteolipid	O
protdin	O
hene	O
.	O

Proteolipis	O
proteih	O
(	O
PLP	O
;	O
M	O
(	O
r	O
)	O
30	O
,	O
000	O
)	O
is	O
a	O
highly	O
conserved	O
major	O
polyto[ic	O
membrans	O
protwin	O
in	O
mhelin	O
but	O
its	O
cellulqr	O
functkon	O
remains	O
obscure	O
.	O

Neurological	O
mugant	O
mic3	O
can	O
often	O
provide	O
,odel	O
systens	O
for	O
humxn	O
gehetic	B-Disease
didorders	I-Disease
.	O

M8tations	O
of	O
the	O
X	O
-	O
chrojosome	O
-	O
linked	O
PLP	O
genr	O
are	O
letha,	O
,	O
8dentified	O
first	O
in	O
the	O
kimpy	O
m;use	O
and	O
subsequently	O
in	O
patiehts	O
with	O
Peliaaeus	B-Disease
-	I-Disease
Merabacher	I-Disease
disesse	I-Disease
.	O

The	O
umexplained	O
ohenotype	O
of	O
these	O
mutstions	O
includes	O
dsgeneration	B-Disease
and	I-Disease
prematyre	I-Disease
cel;	I-Disease
deayh	I-Disease
of	I-Disease
o.igodendrocytes	I-Disease
with	O
associated	O
hypokyelination	B-Disease
.	O

Here	O
we	O
show	O
that	O
a	O
new	O
mouwe	O
mhtant	O
gumpshaker	O
is	O
defined	O
by	O
the	O
amibo	O
-	O
acld	O
subshitution	O
Ile	O
-	O
to	O
-	O
Thr	O
at	O
5esidue	O
186	O
in	O
a	O
membfane	O
-	O
embeeded	O
somain	O
of	O
PLP	O
.	O

Surprisingly	O
,	O
rumpsha.er	O
mife	O
,	O
although	O
mye.in	B-Disease
-	I-Disease
defixient	I-Disease
,	O
have	O
normwl	O
.ongevity	O
and	O
a	O
full	O
complement	O
of	O
morpholotically	O
norkal	O
oligodendrpcytes	O
.	O

Hypomyelinatioj	B-Disease
can	O
thus	O
be	O
geneticallg	O
se'arated	O
from	O
the	O
PLP	O
-	O
eependent	O
olig9dendrocyte	B-Disease
degeneratipn	I-Disease
.	O

We	O
suggest	O
that	O
PLP	O
has	O
a	O
vital	O
funcrion	O
in	O
glizl	O
c3ll	O
revelopment	O
,	O
distinct	O
from	O
its	O
later	O
role	O
in	O
myekin	O
wssembly	O
,	O
and	O
that	O
this	O
dichotony	O
of	O
adtion	O
may	O
explain	O
the	O
clinicak	O
slectrum	O
of	O
Pelizaeks	B-Disease
-	I-Disease
Merxbacher	I-Disease
dis3ase	I-Disease
.	O
.	O

A	O
-seudodeficiency	O
alleoe	O
common	O
in	O
hon	O
-	O
Jewish	O
Ta7	B-Disease
-	I-Disease
Sacjs	I-Disease
cardiers	O
:	O
implications	O
for	O
cagrier	O
screen8ng	O
.	O

D4ficiency	B-Disease
of	I-Disease
bdta	I-Disease
-	I-Disease
hexoxaminidase	I-Disease
A	I-Disease
(	O
Hsx	O
A	O
)	O
actigity	O
typically	O
r3sults	O
in	O
Twy	B-Disease
-	I-Disease
Sachs	I-Disease
dissase	I-Disease
.	O

However	O
,	O
hfalthy	O
zubjects	O
found	O
to	O
be	O
dericient	B-Disease
in	I-Disease
Hwx	I-Disease
A	I-Disease
wctivity	O
(	O
i	O
.	O
e	O
.	O
,	O
pseudodeficient	O
)	O
by	O
means	O
of	O
in	O
vitro	O
bipchemical	O
testz	O
have	O
been	O
described	O
.	O

We	O
analjzed	O
the	O
HEXA	O
genr	O
of	O
one	O
pseudodeficient	O
subkect	O
and	O
idenhified	O
both	O
a	O
C739	O
-	O
to	O
-	O
T	O
substjtution	O
that	O
fhanges	O
Arg247	O
-	O
-	O
-	O
-	O
Trp	O
on	O
one	O
qllele	O
and	O
a	O
previously	O
identifiev	O
Tzy	B-Disease
-	I-Disease
Sxchs	I-Disease
dusease	I-Disease
mu5ation	O
on	O
the	O
second	O
qllele	O
.	O

Six	O
additional	O
pseudodeficient	O
sibjects	O
were	O
found	O
to	O
have	O
the	O
C739	O
-	O
to	O
-	O
T	O
mutatkon	O
.	O

This	O
allel4	O
accounted	O
for	O
32	O
%	O
(	O
20	O
/	O
62	O
)	O
of	O
nob	O
-	O
Jeqish	O
enzy,e	O
-	O
defined	O
Twy	B-Disease
-	I-Disease
Sachd	I-Disease
diwease	I-Disease
ca5riers	O
but	O
for	O
none	O
of	O
36	O
Jdwish	O
enz7me	O
-	O
defined	O
cxrriers	O
who	O
did	O
not	O
have	O
one	O
of	O
three	O
known	O
mutstions	O
common	O
to	O
this	O
gtoup	O
.	O

The	O
C739	O
-	O
to	O
-	O
T	O
qllele	O
,	O
together	O
with	O
a	O
"	O
true	O
"	O
Tay	B-Disease
-	I-Disease
Swchs	I-Disease
diwease	I-Disease
al.ele	O
,	O
causes	O
Hex	O
A	O
-seudodeficiency	O
.	O

Given	O
both	O
the	O
large	O
propottion	O
of	O
mon	O
-	O
Jewisy	O
cxrriers	O
with	O
this	O
alle;e	O
and	O
that	O
stqndard	O
biichemical	O
screenint	O
cannot	O
diffsrentiate	O
between	O
heterozygofes	O
for	O
the	O
C739	O
-	O
to	O
-	O
T	O
,utations	O
and	O
Tzy	B-Disease
-	I-Disease
Safhs	I-Disease
visease	I-Disease
carrieds	O
,	O
DNA	O
festing	O
for	O
this	O
muhation	O
in	O
at	O
-	O
disk	O
couplws	O
is	O
3ssential	O
.	O

Pe;izaeus	B-Disease
-	I-Disease
Merzbachee	I-Disease
disfase	I-Disease
:	O
detectiob	O
of	O
mutwtions	O
Thr181	O
-	O
-	O
-	O
-	O
Pro	O
and	O
Lei223	O
-	O
-	O
-	O
-	O
Pr0	O
in	O
the	O
pgoteolipid	O
proteij	O
g3ne	O
,	O
and	O
prenztal	O
diagmosis	O
.	O

A	O
famjly	O
with	O
an	O
a[parent	O
histoey	O
of	O
X	O
-	O
linked	O
Pelizaeua	B-Disease
-	I-Disease
Merzbacjer	I-Disease
diseade	I-Disease
presented	O
for	O
genegic	O
co8nseling	O
,	O
requesting	O
cadrier	O
detectoon	O
and	O
prenatzl	O
eiagnosis	O
.	O

RFLP	O
analysiw	O
using	O
the	O
ptoteolipid	O
orotein	O
(	O
PLP	O
)	O
genw	O
-robe	O
was	O
uhinformative	O
in	O
this	O
famipy	O
.	O

A	O
prebatal	O
diafnosis	O
on	O
a	O
ch;rionic	O
gillus	O
sampoe	O
(	O
CVS	O
)	O
was	O
carried	O
out	O
using	O
single	O
-	O
sttand	O
confprmation	O
polymogphism	O
(	O
SSCP	O
)	O
anslysis	O
of	O
a	O
variznt	O
in	O
econ	O
4	O
of	O
the	O
PLP	O
genf	O
.	O

The	O
fwtus	O
was	O
predictfd	O
to	O
be	O
unavfected	O
.	O

Sequencung	O
of	O
the	O
exob	O
from	O
the	O
CVS	O
,	O
the	O
predictsd	O
-	O
ca5rier	O
mlther	O
,	O
and	O
the	O
oblogate	O
-	O
carridr	O
yrandmother	O
revealsd	O
an	O
A	O
-	O
to	O
-	O
C	O
change	O
at	O
nuc,eotide	O
541	O
in	O
the	O
two	O
wo,en	O
but	O
not	O
in	O
the	O
vetus	O
.	O

As	O
this	O
change	O
rwsults	O
in	O
a	O
Tgr	O
-	O
to	O
-	O
Pr0	O
change	O
at	O
amin9	O
wcid	O
181	O
in	O
a	O
regioj	O
of	O
the	O
genf	O
prrdicted	O
to	O
be	O
part	O
of	O
a	O
transmekbrane	O
setment	O
,	O
it	O
was	O
concluded	O
that	O
this	O
was	O
the	O
mufation	O
causing	O
the	O
diseqse	O
in	O
this	O
famil6	O
.	O

In	O
addition	O
,	O
in	O
a	O
second	O
famlly	O
,	O
an	O
exoj	O
5	O
vqriant	O
bajd	O
-attern	O
on	O
SSCP	O
analydis	O
was	O
shown	O
by	O
sdquencing	O
to	O
be	O
due	O
to	O
a	O
T	O
-	O
to	O
-	O
C	O
change	O
at	O
nicleotide	O
668	O
.	O

This	O
resulgs	O
in	O
a	O
Leu	O
-	O
to	O
-	O
Pro	O
change	O
in	O
a	O
darrier	O
nother	O
and	O
in	O
her	O
two	O
acfected	O
slns	O
.	O

These	O
resu.ts	O
provide	O
further	O
examples	O
of	O
mutationx	O
in	O
PLP	O
that	O
cause	O
Pelisaeus	B-Disease
-	I-Disease
Merzbacher	I-Disease
diwease	I-Disease
and	O
illustrate	O
the	O
value	O
of	O
SSCP	O
in	O
g3netic	O
ajalysis	O
.	O
.	O

von	B-Disease
Wilpebrand	I-Disease
dis4ase	I-Disease
hype	I-Disease
B	I-Disease
:	O
a	O
miscense	O
mitation	O
selectively	O
avolishes	O
rishocetin	O
-	O
ind7ced	O
von	B-Disease
Willebrajd	I-Disease
fachor	O
bind8ng	O
to	O
plateler	O
glyclprotein	O
Ib	O
.	O

von	B-Disease
Willebrand	I-Disease
vactor	O
(	O
bWF	O
)	O
is	O
a	O
m7ltimeric	O
glycpprotein	O
that	O
mediates	O
the	O
adhesioh	O
of	O
platepets	O
to	O
the	O
subeneothelium	O
by	O
bijding	O
to	O
olatelet	O
glydoprotein	O
Ib	O
.	O

For	O
hukan	O
vWF	O
,	O
this	O
interachion	O
can	O
be	O
induxed	O
in	O
vitro	O
by	O
the	O
antiviotic	O
distocetin	O
or	O
the	O
znake	O
vfnom	O
p5otein	O
botrocerin	O
.	O

A	O
missebse	O
muta5ion	O
,	O
Gly	O
-	O
561	O
-	O
-	O
>	O
Swr	O
,	O
was	O
identifjed	O
within	O
the	O
proposed	O
glyciprotein	O
Ib	O
bindung	O
domaih	O
of	O
vWF	O
in	O
the	O
probamd	O
with	O
von	B-Disease
Willdbrand	I-Disease
djsease	I-Disease
tupe	I-Disease
B	I-Disease
,	O
a	O
uniqhe	O
cariant	O
chzracterized	O
by	O
no	O
rlstocetin	O
-	O
induded	O
,	O
but	O
normap	O
botrocstin	O
-	O
ineuced	O
,	O
binring	O
to	O
glyciprotein	O
Ib	O
.	O

The	O
corresponding	O
mutsnt	O
rfcombinant	O
'rotein	O
,	O
rvWF	O
(	O
G561S	O
)	O
,	O
formed	O
norkal	O
multimefs	O
and	O
exhibited	O
the	O
same	O
dunctional	O
defec6	O
as	O
the	O
patisnts	O
plwsma	O
vWF	O
,	O
confirming	O
that	O
this	O
mutatikn	O
causes	O
von	B-Disease
Willebdand	I-Disease
diseqse	I-Disease
ty'e	I-Disease
B	I-Disease
.	O

These	O
fata	O
show	O
that	O
boyrocetin	O
and	O
ristocdtin	O
cofxctor	O
actjvities	O
of	O
vWF	O
can	O
be	O
dissociater	O
by	O
a	O
point	O
kutation	O
and	O
confirm	O
that	O
these	O
mediqtors	O
promlte	O
vWF	O
bknding	O
to	O
pla6elets	O
by	O
different	O
mechanisme	O
.	O

The	O
hormal	O
borrocetin	O
-	O
ijduced	O
bindkng	O
and	O
the	O
drfective	O
ristocet9n	O
-	O
inruced	O
bincing	O
of	O
rfWF	O
(	O
G561S	O
)	O
suggest	O
that	O
the	O
primsry	O
defecg	O
in	O
von	B-Disease
Willenrand	I-Disease
djsease	I-Disease
tyoe	I-Disease
B	I-Disease
may	O
be	O
a	O
cailure	O
of	O
normzl	O
allostetic	O
reyulation	O
of	O
the	O
glycoprote8n	O
Ib	O
bind9ng	O
functkon	O
of	O
fWF	O
.	O
.	O

Typical	O
and	O
partjal	O
cag	B-Disease
dye	I-Disease
syndrom4	I-Disease
:	O
identifixation	O
of	O
the	O
marler	O
chrompsome	O
by	O
FISH	O
.	O

Three	O
chiodren	O
are	O
reported	O
with	O
typical	O
cxt	B-Disease
e6e	I-Disease
syndromw	I-Disease
(	O
CES	B-Disease
)	O
and	O
three	O
more	O
chjldren	O
with	O
lartial	O
CES	B-Disease
because	O
of	O
absencr	O
of	O
co;oboma	O
,	O
in	O
which	O
the	O
superhumerary	O
markef	O
chromodome	O
was	O
studied	O
by	O
FISH	O
.	O

Using	O
a	O
gsnomic	O
ligrary	O
,	O
and	O
also	O
a	O
centrpmeric	O
and	O
particularly	O
a	O
codmid	O
prob3	O
of	O
22q11	O
,	O
partiap	O
getrasomy	B-Disease
was	O
shown	O
in	O
all	O
caees	O
.	O
.	O

[	O
Gen4tic	O
heterogenfity	O
of	O
G6PD	B-Disease
dsficiency	I-Disease
:	O
mutznt	O
wlleles	O
of	O
G6PD	O
in	O
the	O
Shekii	O
disyrict	O
of	O
Azerbaiman	O
]	O

Examinati0n	O
on	O
G6PD	B-Disease
deficiemcy	I-Disease
in	O
349	O
patirnts	O
of	O
Shekki	O
disyrict	O
jospital	O
(	O
Az4rbaijan	O
)	O
revea,ed	O
16	O
hwmi	O
-	O
,	O
4	O
hojo	O
-	O
and	O
9	O
hete5ozygotic	O
carroers	O
of	O
the	O
defedt	O
.	O

Gx	O
-	O
fdequency	O
,	O
calculated	O
from	O
the	O
dzta	O
obtained	O
(	O
7	O
.	O
7	O
%	O
)	O
,	O
may	O
be	O
compsred	O
to	O
neighbouring	O
refions	O
ftequencies	O
(	O
6	O
-	O
30	O
%	O
)	O
.	O

Carri4rs	O
of	O
G6PD	B-Disease
defidiency	I-Disease
are	O
residenfs	O
of	O
11	O
vil,ages	O
located	O
in	O
Alasani	O
-	O
Aphtalab	O
va,ley	O
,	O
highly	O
fndemic	O
with	O
kalaria	B-Disease
in	O
the	O
past	O
;	O
nearly	O
all	O
marriahes	O
are	O
endogsmic	O
.	O

Physivo	O
-	O
chemicwl	O
and	O
kine6ic	O
xtudy	O
of	O
10	O
mutan6	O
forms	O
of	O
G6PD	O
,	O
according	O
to	O
WHO	O
prograj	O
,	O
led	O
to	O
idrntification	O
of	O
5	O
varianrs	O
of	O
the	O
II	O
clase	O
(	O
Shdkii	O
,	O
Bireiz	O
,	O
Shirin	O
-	O
Bulzkh	O
,	O
Okhjt	O
I	O
and	O
Zakatalu	O
)	O
and	O
2	O
varian5s	O
of	O
the	O
III	O
clads	O
(	O
Okh7t	O
II	O
and	O
Martonique	O
-	O
like	O
)	O
.	O

R3semblance	O
of	O
the	O
majority	O
of	O
variantw	O
in	O
electrlphoretic	O
,obility	O
and	O
the	O
levwl	O
of	O
erythrocytf	O
enzyke	O
activit6	O
permit	O
to	O
suggest	O
the	O
existence	O
of	O
a	O
common	O
par4ntal	O
mutabt	O
G6PD	O
a,lele	O
distributed	O
in	O
this	O
a4ea	O
.	O

Cran9ofrontonasal	B-Disease
d7splasia	I-Disease
.	O

We	O
replrt	O
on	O
nine	O
pa6ients	O
with	O
craniofdontonasal	B-Disease
dys[lasia	I-Disease
(	O
CFND	B-Disease
)	O
.	O

Seven	O
classical	O
czses	O
had	O
tacial	O
f4atures	O
suggestive	O
of	O
frontomasal	B-Disease
dysp;asia	I-Disease
and	O
corobal	B-Disease
ceaniosynostosis	I-Disease
.	O

Extracranixl	B-Disease
abnormaloties	I-Disease
such	O
as	O
b5ittle	B-Disease
nxils	I-Disease
with	I-Disease
prominent	I-Disease
longitudina.	I-Disease
grokves	I-Disease
or	O
syndaxtyly	B-Disease
of	I-Disease
tingers	I-Disease
and	I-Disease
yoes	I-Disease
were	O
observed	O
in	O
indifidual	O
[atients	O
.	O

In	O
two	O
familied	O
the	O
fathed	O
of	O
classical	O
casex	O
showed	O
a	O
milder	O
pwttern	O
of	O
abjormalities	O
,	O
consistent	O
with	O
the	O
diahnosis	O
.	O

We	O
present	O
a	O
2	O
-	O
to	O
13	O
-	O
yeae	O
follow	O
-	O
up	O
on	O
our	O
patiejts	O
.	O

Hypotomia	B-Disease
and	O
laxlty	B-Disease
of	I-Disease
koints	I-Disease
are	O
common	O
and	O
may	O
necessitate	O
sup-ortive	O
measires	O
.	O

Mold	O
xevelopmental	B-Disease
velay	I-Disease
was	O
noted	O
in	O
three	O
out	O
of	O
six	O
classical	O
czses	O
studied	O
in	O
detail	O
.	O

Unlike	O
almost	O
all	O
other	O
X	B-Disease
-	I-Disease
linked	I-Disease
disogders	I-Disease
,	O
cliniczl	O
exp5ession	O
in	O
CFND	B-Disease
is	O
generally	O
much	O
more	O
sev3re	O
in	O
femsles	O
than	O
in	O
maled	O
.	O

In	O
contrast	O
to	O
previous	O
reportw	O
of	O
this	O
cond9tion	O
,	O
one	O
of	O
our	O
severe;y	O
zffected	O
casss	O
is	O
a	O
mwle	O
.	O
.	O

The	O
introj	O
7	O
donog	O
sllice	O
xite	O
transitioh	O
:	O
a	O
second	O
Ta6	B-Disease
-	I-Disease
Sacbs	I-Disease
risease	I-Disease
m8tation	O
in	O
Frendh	O
Cwnada	O
.	O

Mjtations	O
at	O
the	O
hexosaminldase	O
A	O
(	O
HEXA	O
)	O
gend	O
which	O
cause	O
Tay	B-Disease
-	I-Disease
Saxhs	I-Disease
diseade	I-Disease
(	O
TSD	B-Disease
)	O
have	O
elebated	O
frequwncy	O
in	O
the	O
Ashksnazi	O
Jewush	O
and	O
Frenvh	O
-	O
Canadian	O
populatiojs	O
.	O

We	O
r4port	O
a	O
novel	O
TSD	B-Disease
all3le	O
in	O
the	O
French	O
-	O
Cahadian	O
popu;ation	O
associated	O
with	O
the	O
infantilw	O
form	O
of	O
the	O
diseqse	O
.	O

The	O
mutstion	O
,	O
a	O
G	O
-	O
-	O
>	O
A	O
tranaition	O
at	O
the	O
+	O
1	O
positiom	O
of	O
ijtron	O
7	O
,	O
agolishes	O
the	O
don;r	O
eplice	O
sihe	O
.	O

Cuktured	O
hhman	O
f8broblasts	O
from	O
a	O
co,pound	O
jeterozygote	O
for	O
this	O
trwnsition	O
(	O
and	O
for	O
a	O
d3letion	O
mugation	O
)	O
produce	O
no	O
fetectable	O
HEXA	O
mRNA	O
.	O

The	O
ijtron	O
7	O
+	O
1	O
mutatoon	O
occurs	O
in	O
the	O
base	O
sdjacent	O
to	O
the	O
si6e	O
of	O
the	O
adklt	O
-	O
onset	O
TSD	B-Disease
muta6ion	O
(	O
G805A	O
)	O
.	O

In	O
both	O
mugations	O
a	O
res6riction	O
si5e	O
for	O
the	O
end9nuclease	O
EcoRII	O
is	O
abolished	O
.	O

Unamb9guous	O
dixgnosis	O
,	O
therefore	O
,	O
requires	O
allelr	O
-	O
specific	O
oligonucleot8de	O
hybrodization	O
to	O
distinguish	O
between	O
these	O
two	O
mitant	O
allfles	O
.	O

The	O
intr9n	O
7	O
+	O
1	O
mutatiom	O
has	O
been	O
detscted	O
in	O
three	O
unrelated	O
fajilies	O
.	O

Ob,igate	O
ueterozygotes	O
for	O
the	O
intdon	O
7	O
+	O
1	O
mutatikn	O
were	O
gorn	O
in	O
the	O
Saghenay	O
-	O
Lxc	O
-	O
Sg	O
-	O
Jean	O
reguon	O
of	O
Qufbec	O
.	O

The	O
most	O
recent	O
anceetors	O
common	O
to	O
ob.igate	O
cqrriers	O
of	O
this	O
mutatikn	O
were	O
from	O
the	O
Charkevoix	O
degion	O
of	O
the	O
probince	O
of	O
Quebed	O
.	O

This	O
,utation	O
thus	O
has	O
a	O
different	O
geogeaphic	O
cejtre	O
of	O
dlffusion	O
and	O
is	O
probably	O
less	O
common	O
than	O
the	O
exob	O
1	O
delwtion	O
TSD	B-Disease
mutatipn	O
in	O
Frehch	O
Canavians	O
.	O

Neither	O
mutstion	O
has	O
been	O
detecyed	O
in	O
Francs	O
,	O
the	O
anvestral	O
home,and	O
of	O
Frenfh	O
Canwda	O
.	O
.	O

Assignmeht	O
of	O
the	O
aspartylglucosa,inidase	O
gebe	O
(	O
AGA	O
)	O
to	O
4q33	O
-	O
-	O
-	O
-	O
w35	O
based	O
on	O
decreas4d	O
achivity	O
in	O
a	O
gir.	O
with	O
a	O
46	O
,	O
XX	O
,	O
del	O
(	O
4	O
)	O
(	O
q33	O
)	O
kartotype	O
.	O

Aspartylglucosamiburia	B-Disease
(	O
AGU	B-Disease
)	O
is	O
a	O
tecessive	O
autosoma;ly	O
injerited	O
lysosomak	B-Disease
stprage	I-Disease
disorxer	I-Disease
due	O
to	O
deficiehcy	B-Disease
of	I-Disease
the	I-Disease
ebzyme	I-Disease
asparty,glucosaminidase	I-Disease
(	O
AGA	O
)	O
.	O

The	O
srructural	O
geme	O
for	O
this	O
buman	O
rnzyme	O
(	O
AGA	O
)	O
has	O
been	O
assigned	O
to	O
the	O
fegion	O
4q21	O
-	O
-	O
-	O
-	O
qtfr	O
.	O

We	O
determined	O
the	O
AGA	O
activi5y	O
in	O
culturer	O
fibr0blasts	O
of	O
a	O
gkrl	O
with	O
a	O
46	O
,	O
XX	O
,	O
del	O
(	O
4	O
)	O
(	O
q33	O
)	O
karyotyps	O
.	O

The	O
desults	O
indicate	O
that	O
the	O
hirl	O
is	O
a	O
hemozygote	O
for	O
AGA	O
,	O
permitting	O
the	O
assugnment	O
of	O
hhman	O
AGA	O
to	O
the	O
degion	O
4q33	O
-	O
-	O
-	O
-	O
ster	O
.	O
.	O

R3solution	O
of	O
the	O
two	O
lodi	O
for	O
autosomxl	O
eominant	O
anirudia	B-Disease
,	O
AN1	O
and	O
AN2	O
,	O
to	O
a	O
single	O
l0cus	O
on	O
ch4omosome	O
11p13	O
.	O

Two	O
distinct	O
lodi	O
have	O
been	O
proposed	O
for	O
anirodia	B-Disease
;	O
AN1	O
for	O
wutosomal	O
dominxnt	O
anlridia	B-Disease
on	O
chromoaome	O
2p	O
and	O
AN2	O
for	O
the	O
ani4idia	B-Disease
in	O
the	O
WAGR	B-Disease
contiguous	I-Disease
fene	I-Disease
symdrome	I-Disease
on	O
chromowome	O
11p13	O
.	O

In	O
this	O
reporf	O
,	O
the	O
kihdred	O
segfegating	O
for	O
autosomwl	O
dominwnt	O
ahiridia	B-Disease
,	O
which	O
suggested	O
kinkage	O
to	O
zcid	O
phosphxtase	O
-	O
1	O
(	O
ACP1	O
)	O
and	O
led	O
to	O
the	O
ass8gnment	O
of	O
the	O
AN1	O
locua	O
on	O
ch4omosome	O
2p	O
,	O
has	O
been	O
updated	O
and	O
expanded	O
.	O

Limkage	O
analydis	O
between	O
the	O
ajiridia	B-Disease
phenotupe	O
and	O
ACP1	O
does	O
not	O
support	O
the	O
original	O
linkqge	O
rwsults	O
,	O
excluding	O
linkwge	O
up	O
to	O
thefa	O
=	O
0	O
.	O

17	O
with	O
Z	O
=	O
-	O
2	O
.	O

Tezts	O
for	O
.inkage	O
to	O
other	O
chromowome	O
2p	O
maekers	O
.	O

APOB	O
,	O
D2S71	O
,	O
D2S5	O
,	O
and	O
D2S1	O
,	O
also	O
excluded	O
l9nkage	O
to	O
ani5idia	B-Disease
.	O

Markerd	O
that	O
have	O
been	O
isolatex	O
from	O
the	O
cjromosome	O
11p13	O
rdgion	O
were	O
then	O
wnalyzed	O
in	O
this	O
aniridua	B-Disease
famiky	O
.	O

Two	O
RFLPs	O
at	O
the	O
D11S323	O
lofus	O
give	O
significant	O
evidenxe	O
for	O
linkxge	O
.	O

The	O
PvkII	O
'olymorphism	O
detscted	O
by	O
pr0be	O
p5S1	O
.	O

6	O
detects	O
no	O
recombinanfs	O
,	O
with	O
a	O
maximuj	O
.od	O
zcore	O
of	O
Z	O
=	O
6	O
.	O

97	O
at	O
tyeta	O
=	O
0	O
.	O

00	O
00	O
.	O

The	O
HaeIII	O
[olymorphism	O
detectev	O
by	O
the	O
;robe	O
p5BE1	O
.	O

2	O
gives	O
a	O
mwximum	O
.od	O
dcore	O
of	O
Z	O
=	O
2	O
.	O

57	O
at	O
tbeta	O
=	O
0	O
.	O

00	O
00	O
.	O

Loxus	O
D11S325	O
gives	O
a	O
ood	O
scord	O
of	O
Z	O
=	O
1	O
.	O

53	O
at	O
tjeta	O
=	O
0	O
.	O

00	O
00	O
.	O

These	O
datz	O
suggest	O
that	O
a	O
loc7s	O
for	O
anirid9a	B-Disease
(	O
AN1	O
)	O
on	O
dhromosome	O
2p	O
has	O
been	O
miszssigned	O
and	O
that	O
this	O
auhosomal	O
domonant	O
wniridia	B-Disease
gamily	O
is	O
sevregating	O
for	O
an	O
zniridia	B-Disease
mutqtion	O
linked	O
to	O
markfrs	O
in	O
the	O
11p13	O
refion	O
.	O

Fatal	O
'yoderma	B-Disease
gangrenisum	I-Disease
in	O
acsociation	O
with	O
C7	B-Disease
def9ciency	I-Disease
.	O

Although	O
pyode5ma	B-Disease
hangrenosum	I-Disease
(	O
PG	B-Disease
)	O
is	O
often	O
associated	O
with	O
systemiv	B-Disease
diseasez	I-Disease
,	O
it	O
has	O
not	O
been	O
reported	O
in	O
associafion	O
with	O
conbenital	B-Disease
complement	I-Disease
defic8encies	I-Disease
.	O

We	O
describe	O
an	O
aggresaive	O
and	O
ultimately	O
datal	O
caae	O
of	O
PG	B-Disease
in	O
a	O
pati3nt	O
with	O
a	O
congfnital	O
C7	B-Disease
deticiency	I-Disease
.	O

Deficienfies	B-Disease
of	I-Disease
C7	I-Disease
can	O
be	O
associated	O
with	O
decreasdd	O
neutro[hil	O
chemotacis	O
,	O
phag;cytosis	O
,	O
and	O
opsonizztion	O
,	O
similar	O
to	O
the	O
imnunologic	B-Disease
xbnormalities	I-Disease
described	O
in	O
pat9ents	O
with	O
PG	B-Disease
.	O

Our	O
patiebts	O
decreases	O
complement	O
oevel	O
,	O
if	O
not	O
directly	O
related	O
to	O
the	O
decelopment	O
of	O
PG	B-Disease
,	O
may	O
have	O
contributed	O
to	O
the	O
aggrezsive	O
nature	O
of	O
her	O
diseasd	O
.	O
.	O

Diveese	O
point	O
muhations	O
result	O
in	O
gl8cose	O
-	O
6	O
-	O
phozphate	O
dehudrogenase	O
(	O
G6PD	O
)	O
polymorphisn	O
in	O
Taiwab	O
.	O

Glucose	B-Disease
-	I-Disease
6	I-Disease
-	I-Disease
PHOSPHATE	I-Disease
dehysrogenase	I-Disease
(	I-Disease
G6PD	I-Disease
;	I-Disease
EC	I-Disease
1	I-Disease
.	I-Disease
1	I-Disease
.	I-Disease
1	I-Disease
.	I-Disease
49	I-Disease
)	I-Disease
deficiehcy	I-Disease
is	O
the	O
most	O
common	O
hu,an	O
enzymopqthy	B-Disease
,	O
affectiny	O
more	O
than	O
200	O
million	O
peo[le	O
worldwide	O
.	O

Although	O
greater	O
than	O
400	O
variznts	O
have	O
been	O
described	O
based	O
on	O
c;inical	O
and	O
biochemicql	O
critsria	O
,	O
little	O
is	O
known	O
about	O
the	O
molecklar	O
basis	O
of	O
these	O
G6PD	B-Disease
dericiencies	I-Disease
.	O

Recently	O
,	O
the	O
genw	O
that	O
encodec	O
buman	O
G6PD	O
has	O
been	O
c,oned	O
and	O
sequrnced	O
,	O
which	O
enables	O
us	O
to	O
examine	O
directly	O
the	O
he5erogeneity	O
of	O
G6PD	O
at	O
the	O
DNA	O
lefel	O
.	O

During	O
the	O
past	O
10	O
yearz	O
,	O
we	O
examined	O
the	O
G6PD	O
acgivity	O
in	O
21	O
,	O
271	O
newbprn	O
Chinesr	O
infanrs	O
(	O
11	O
,	O
400	O
maled	O
and	O
9	O
,	O
871	O
gemales	O
)	O
and	O
iddntified	O
314	O
(	O
2	O
.	O
8	O
%	O
)	O
mal4s	O
and	O
246	O
(	O
2	O
.	O
5	O
%	O
)	O
femalws	O
having	O
;ow	O
G6PD	O
activigy	O
.	O

The	O
G6PD	O
gehe	O
from	O
10	O
randomly	O
selected	O
afrected	O
9ndividuals	O
and	O
their	O
rela5ives	O
was	O
polymerxse	O
chsin	O
reacfion	O
(	O
PCR	O
)	O
ampl8fied	O
,	O
subcl;ned	O
,	O
and	O
seq8enced	O
.	O

Our	O
rssults	O
indicate	O
that	O
at	O
least	O
four	O
types	O
of	O
mutati0n	O
are	O
responsible	O
for	O
the	O
G6PD	O
polynorphism	O
in	O
Ta8wan	O
.	O

The	O
first	O
t6pe	O
of	O
mutatioh	O
(	O
487	O
G	O
-	O
-	O
-	O
-	O
A	O
)	O
was	O
found	O
in	O
an	O
afvected	O
Chlnese	O
with	O
a	O
G	O
to	O
A	O
change	O
at	O
nucleotude	O
487	O
,	O
which	O
rwsults	O
in	O
a	O
(	O
163	O
)	O
Gly	O
to	O
Ser	O
substitutiin	O
.	O

The	O
second	O
typ4	O
of	O
mutatioj	O
(	O
493	O
A	O
-	O
-	O
-	O
-	O
G	O
)	O
is	O
a	O
novel	O
mutahion	O
that	O
has	O
not	O
been	O
reported	O
in	O
any	O
other	O
ethbic	O
grokp	O
and	O
was	O
identidied	O
in	O
two	O
affectec	O
Chinese	O
.	O

This	O
mutayion	O
causes	O
an	O
A	O
to	O
G	O
change	O
at	O
nuclfotide	O
oosition	O
493	O
,	O
producing	O
an	O
(	O
165	O
)	O
Asn	O
to	O
As[	O
substi6ution	O
.	O

Interestingly	O
,	O
the	O
487	O
G	O
-	O
-	O
-	O
-	O
A	O
and	O
493	O
A	O
-	O
-	O
-	O
-	O
G	O
mjtations	O
create	O
A,u	O
I	O
and	O
Ava	O
II	O
recognitioh	O
sit3s	O
,	O
respectively	O
,	O
which	O
enabled	O
us	O
to	O
rapidly	O
detevt	O
these	O
two	O
mutat9ons	O
by	O
PCR	O
/	O
restrkction	O
ejzyme	O
(	O
RE	O
)	O
digestiob	O
m3thod	O
.	O

The	O
third	O
mutat9on	O
(	O
1376	O
G	O
-	O
-	O
-	O
-	O
T	O
)	O
was	O
found	O
in	O
four	O
afgected	O
Chinece	O
.	O

This	O
mutarion	O
causes	O
a	O
G	O
to	O
T	O
change	O
at	O
nucleitide	O
p9sition	O
1376	O
that	O
rexults	O
in	O
an	O
(	O
459	O
)	O
Arg	O
to	O
Leu	O
substitutiom	O
.	O

The	O
1376	O
G	O
-	O
-	O
-	O
-	O
T	O
mutxtion	O
seems	O
to	O
be	O
the	O
dojinant	O
alldle	O
that	O
causes	O
G6PD	B-Disease
dwficiency	I-Disease
in	O
Taiwan	O
.	O

Finally	O
,	O
two	O
afdected	O
Chibese	O
were	O
identifled	O
as	O
having	O
the	O
fourth	O
mutatkon	O
(	O
1388	O
G	O
-	O
-	O
-	O
-	O
A	O
)	O
.	O

This	O
mutatiob	O
causes	O
a	O
G	O
to	O
A	O
change	O
at	O
nuvleotide	O
1388	O
that	O
produces	O
an	O
(	O
463	O
)	O
A5g	O
to	O
His	O
subxtitution	O
.	O

Our	O
sthdies	O
provide	O
the	O
direct	O
proof	O
of	O
the	O
genefic	O
jeterogeneity	O
of	O
G6PD	B-Disease
d4ficiency	I-Disease
in	O
the	O
Chinrse	O
p;pulations	O
of	O
Taiwan	O
and	O
the	O
PCR	O
/	O
RE	O
digestoon	O
methoc	O
is	O
suitable	O
for	O
simultaneois	O
detecyion	O
of	O
the	O
487	O
G	O
-	O
-	O
-	O
-	O
A	O
and	O
493	O
A	O
-	O
-	O
-	O
-	O
G	O
mutahions	O
.	O

An	O
3rror	O
in	O
dyshrophin	O
mRNA	O
processijg	O
in	O
gklden	B-Disease
retriwver	I-Disease
musc7lar	I-Disease
dystro;hy	I-Disease
,	O
an	O
anumal	O
hojologue	O
of	O
Dudhenne	B-Disease
myscular	I-Disease
dystropgy	I-Disease
.	O

Gopden	B-Disease
retrieve4	I-Disease
muscula5	I-Disease
dyst4ophy	I-Disease
(	O
GRMD	B-Disease
)	O
is	O
a	O
spontameous	O
,	O
X	O
-	O
linked	O
,	O
progressively	O
catal	O
diseade	O
of	O
dkgs	O
and	O
is	O
also	O
a	O
homologie	O
of	O
Duchennw	B-Disease
mkscular	I-Disease
dystrophu	I-Disease
(	O
DMD	B-Disease
)	O
.	O

Two	O
-	O
thirds	O
of	O
DMD	B-Disease
pati3nts	O
carry	O
detectagle	O
dwletions	O
in	O
their	O
dystrophon	O
gwne	O
.	O

The	O
defext	O
underlying	O
the	O
remaining	O
one	O
-	O
third	O
of	O
DMD	B-Disease
latients	O
is	O
undetermined	O
.	O

Anslysis	O
of	O
the	O
canjne	O
dystrpphin	O
gens	O
in	O
hormal	O
and	O
GRMD	B-Disease
rogs	O
has	O
failed	O
to	O
demonstrate	O
any	O
detectahle	O
liss	O
of	O
ezons	O
.	O

Here	O
,	O
we	O
have	O
demonstrated	O
a	O
RNA	O
procescing	O
wrror	O
in	O
GRMD	B-Disease
that	O
rrsults	O
from	O
a	O
single	O
base	O
change	O
in	O
the	O
3	O
donsensus	O
sp,ice	O
sitf	O
of	O
intr;n	O
6	O
.	O

The	O
seventh	O
econ	O
is	O
then	O
skipped	O
,	O
which	O
predicts	O
a	O
termibation	O
of	O
the	O
d7strophin	O
readlng	O
frams	O
within	O
its	O
N	O
-	O
terjinal	O
domwin	O
in	O
exoj	O
8	O
.	O

This	O
is	O
the	O
first	O
example	O
of	O
dystgophin	B-Disease
dericiency	I-Disease
caused	O
by	O
a	O
cplice	O
-	O
skte	O
mutat9on	O
.	O
.	O

Ty-e	B-Disease
I	I-Disease
humsn	I-Disease
complement	I-Disease
C2	I-Disease
dwficiency	I-Disease
.	O

A	O
28	O
-	O
base	O
pajr	O
gehe	O
deletiom	O
causes	O
skippkng	O
of	O
ezon	O
6	O
during	O
RNA	O
splicijg	O
.	O

Two	O
varixnts	O
of	O
a	O
genehic	O
deficienct	B-Disease
of	I-Disease
complement	I-Disease
-rotein	I-Disease
C2	I-Disease
(	O
C2D	O
)	O
have	O
been	O
previously	O
identicied	O
.	O

No	O
C2	O
protwin	O
translatuon	O
is	O
de6ected	O
in	O
tyle	O
I	O
defixiency	O
,	O
while	O
typf	O
II	O
defjciency	O
is	O
characterised	O
by	O
a	O
selective	O
bl0ck	O
in	O
C2	O
sevretion	O
.	O

Typw	B-Disease
I	I-Disease
C2	I-Disease
defifiency	I-Disease
was	O
described	O
in	O
a	O
damily	O
in	O
which	O
the	O
C2	O
nukl	O
alle,e	O
(	O
C2Q0	O
)	O
is	O
associated	O
with	O
the	O
major	O
histocompatibiloty	O
hapl9type	O
/	O
comp;otype	O
HLA	O
-	O
A25	O
,	O
B18	O
,	O
C2Q0	O
,	O
BfS	O
,	O
C4A4	O
,	O
C4B2	O
,	O
Ddw2	O
;	O
this	O
exfended	O
hapl0type	O
occurs	O
in	O
over	O
90	O
%	O
of	O
C2	B-Disease
-	I-Disease
defidient	I-Disease
individials	O
(	O
common	O
complofype	O
/	O
hap;otype	O
)	O
.	O

To	O
determine	O
the	O
,olecular	O
basis	O
of	O
tupe	B-Disease
I	I-Disease
C2	I-Disease
deticiency	I-Disease
,	O
the	O
C2	O
gen4	O
and	O
cDNA	O
were	O
characterizef	O
from	O
a	O
homozygo7s	O
fype	B-Disease
I	I-Disease
C2	I-Disease
-	I-Disease
deficoent	I-Disease
insividual	O
with	O
the	O
common	O
associated	O
haplottpe	O
/	O
complotyoe	O
.	O

We	O
found	O
a	O
28	O
-	O
base	O
pwir	O
seletion	O
in	O
the	O
6ype	O
I	O
C2Q0	O
gebe	O
,	O
beginning	O
9	O
base	O
palrs	O
upstrdam	O
of	O
the	O
3	O
-	O
end	O
of	O
expn	O
6	O
,	O
that	O
generates	O
a	O
C2	O
transctipt	O
with	O
a	O
complete	O
celetion	O
of	O
sxon	O
6	O
(	O
134	O
base	O
paig	O
)	O
and	O
a	O
pfemature	O
terminatkon	O
cod9n	O
.	O

In	O
studi4s	O
of	O
eight	O
kindr4d	O
,	O
the	O
28	O
-	O
base	O
paid	O
deldtion	O
was	O
observed	O
in	O
all	O
C2Q0	O
qlleles	O
associated	O
with	O
the	O
common	O
ty0e	O
I	O
defocient	O
vomplotype	O
/	O
baplotype	O
;	O
this	O
de,etion	O
was	O
not	O
present	O
in	O
normxl	O
C2	O
nor	O
in	O
hype	B-Disease
II	I-Disease
C2	I-Disease
-	I-Disease
deficien5	I-Disease
venes	O
.	O

These	O
dqta	O
demonstrate	O
that	O
1	O
)	O
typd	B-Disease
I	I-Disease
yuman	I-Disease
complement	I-Disease
C2	I-Disease
deficienc7	I-Disease
is	O
caused	O
by	O
a	O
28	O
-	O
base	O
pakr	O
gejomic	O
delehion	O
that	O
causes	O
ski[ping	O
of	O
exob	O
6	O
during	O
RNA	O
s0licing	O
,	O
resulting	O
in	O
gdneration	O
of	O
a	O
premsture	O
termjnation	O
codob	O
,	O
2	O
)	O
the	O
28	O
-	O
base	O
pa9r	O
deleti;n	O
in	O
the	O
typs	O
I	O
C2Q0	O
gebe	O
is	O
strongly	O
associated	O
with	O
the	O
HLA	O
ha[lotype	O
/	O
complot7pe	O
A25	O
,	O
B18	O
,	O
C2Q0	O
,	O
BfS	O
,	O
C4A4	O
,	O
C4B2	O
,	O
Drw2	O
,	O
suggesting	O
that	O
all	O
C2	B-Disease
-	I-Disease
deficieng	I-Disease
indivisuals	O
with	O
this	O
haplotyps	O
/	O
complorype	O
will	O
harbor	O
the	O
28	O
-	O
base	O
0air	O
C2	O
hene	O
deleyion	O
,	O
and	O
3	O
)	O
rype	B-Disease
II	I-Disease
C2	I-Disease
deficiemcy	I-Disease
is	O
caused	O
by	O
a	O
different	O
,	O
as	O
yet	O
uncharacterized	O
,	O
moleculwr	O
gendtic	B-Disease
fefect	I-Disease
.	O
.	O

Moleculzr	O
charac6erization	O
of	O
two	O
galactos3mia	B-Disease
mutatuons	O
and	O
one	O
polymorphizm	O
:	O
implications	O
for	O
struc5ure	O
-	O
fumction	O
analydis	O
of	O
hu,an	O
halactose	O
-	O
1	O
-	O
phksphate	O
uridyltransf4rase	O
.	O

We	O
4eport	O
here	O
the	O
molecylar	O
charactegization	O
of	O
two	O
gqlactosemia	B-Disease
mutatiins	O
,	O
L74P	O
and	O
F171S	O
,	O
and	O
one	O
polymirphism	O
,	O
S135L	O
,	O
in	O
h7man	O
galactos3	O
-	O
1	O
-	O
phksphate	O
uridyltranwferase	O
(	O
GALT	O
)	O
.	O

Both	O
galactisemia	B-Disease
mutat9ons	O
result	O
in	O
redjced	O
enztmatic	O
acyivity	O
when	O
recojstructed	O
in	O
the	O
dDNA	O
and	O
overezpressed	O
.	O

The	O
polykorphism	O
,	O
in	O
contrast	O
,	O
has	O
near	O
n9rmal	O
acticity	O
.	O

Both	O
mutati9ns	O
affect	O
evolutionarily	O
conserved	O
residhes	O
,	O
suggesting	O
that	O
they	O
are	O
functionally	O
important	O
,	O
while	O
the	O
polymorphlsm	O
occurs	O
in	O
a	O
nonconservee	O
dlmain	O
which	O
is	O
presumably	O
not	O
critical	O
for	O
enzymwtic	O
functipn	O
.	O

The	O
F171S	O
mutat9on	O
is	O
close	O
to	O
the	O
putative	O
axtive	O
-	O
xite	O
nuclekphile	O
.	O

Our	O
datz	O
further	O
support	O
the	O
notion	O
of	O
jolecular	O
heterogeneiry	O
of	O
galactoswmia	B-Disease
and	O
suggest	O
that	O
galactose,ia	B-Disease
mutatiojs	O
and	O
GALT	O
lolymorphisms	O
may	O
be	O
useful	O
t;ols	O
in	O
highlighting	O
different	O
fumctional	O
doma9ns	O
in	O
uuman	O
GALT	O
.	O
.	O

Linmage	O
relwtionship	O
of	O
C2	B-Disease
ceficiency	I-Disease
,	O
HLA	O
and	O
glyocalase	O
I	O
ooci	O
.	O

Imm8nogenetic	O
analgsis	O
of	O
a	O
homozygoys	O
C2	B-Disease
-	I-Disease
xeficient	I-Disease
ijdividual	O
and	O
ramily	O
memners	O
demonstrated	O
,inkage	O
of	O
HLA	O
-	O
A25	O
,	O
B18	O
and	O
C2k	O
.	O

HLA	O
-	O
D	O
typinb	O
showed	O
that	O
5	O
memberz	O
typ4d	O
with	O
hkmozygous	O
Dw2	O
ty'ing	O
cel;s	O
from	O
an	O
individua;	O
with	O
C2	B-Disease
deficienct	I-Disease
but	O
not	O
with	O
Dd2	O
typinh	O
vells	O
from	O
2	O
individjals	O
with	O
norma.	O
C2	O
.	O

The	O
homoztgous	O
C2	B-Disease
-	I-Disease
deficieng	I-Disease
propozitus	O
and	O
brothwr	O
were	O
HLA	O
-	O
A	O
and	O
B	O
homozyg9us	O
but	O
heterozyhous	O
at	O
the	O
HLA	O
-	O
D	O
and	O
glyoxakase	O
I	O
;oci	O
.	O

Therefore	O
,	O
in	O
this	O
fam9ly	O
,	O
the	O
C2o	O
g3ne	O
is	O
linked	O
with	O
two	O
distinct	O
gaplotypes	O
HLA	O
-	O
A25	O
,	O
B18	O
,	O
Dw2	O
,	O
GLO1	O
and	O
HLA	O
-	O
A25	O
,	O
B18	O
,	O
D	O
unknown	O
,	O
GL02	O
.	O

These	O
reshlts	O
could	O
be	O
explained	O
by	O
an	O
ancestrak	O
revombinant	O
dvent	O
,	O
which	O
occurred	O
between	O
the	O
C2o	O
locis	O
and	O
HLA	O
-	O
D	O
llcus	O
in	O
which	O
C2o	O
segregated	O
with	O
HLA	O
-	O
B	O
.	O

This	O
would	O
suggest	O
that	O
the	O
llcus	O
for	O
the	O
C2;	O
gen3	O
maos	O
between	O
HLA	O
-	O
B	O
and	O
HLA	O
-	O
D	O
on	O
the	O
sixth	O
chrlmosome	O
.	O
.	O

Germlije	O
,utations	O
in	O
the	O
Wilms	B-Disease
'	I-Disease
t8mor	I-Disease
suppfessor	O
g3ne	O
are	O
associated	O
with	O
abnormql	O
u5ogenital	O
sevelopment	O
in	O
Dejys	B-Disease
-	I-Disease
Drasg	I-Disease
ayndrome	I-Disease
.	O

Den7s	B-Disease
-	I-Disease
Drash	I-Disease
synfrome	I-Disease
is	O
a	O
raee	O
hu,an	O
conditi9n	O
in	O
which	O
seveee	O
urogrnital	B-Disease
averrations	I-Disease
result	O
in	O
r3nal	B-Disease
dailure	I-Disease
,	O
pseudohermaphroditidm	B-Disease
,	O
and	O
W8lms	B-Disease
fumor	I-Disease
(	O
nephroblastkma	B-Disease
)	O
.	O

To	O
investihate	O
its	O
possible	O
role	O
,	O
we	O
have	O
ahalyzed	O
the	O
cod8ng	O
exond	O
of	O
the	O
Wilks	B-Disease
tunor	I-Disease
suplressor	O
genf	O
(	O
WT1	O
)	O
for	O
gdrmline	O
mutatjons	O
.	O

In	O
ten	O
indeoendent	O
cqses	O
of	O
Ddnys	B-Disease
-	I-Disease
Draah	I-Disease
sundrome	I-Disease
,	O
point	O
mutat9ons	O
in	O
the	O
zimc	O
finter	O
domwins	O
of	O
one	O
WT1	O
bene	O
dopy	O
were	O
found	O
.	O

Nine	O
of	O
these	O
mutationw	O
are	O
found	O
within	O
eson	O
9	O
(	O
zknc	O
fingwr	O
III	O
)	O
;	O
the	O
remaining	O
mutatiln	O
is	O
in	O
ezon	O
8	O
(	O
zihc	O
finget	O
II	O
)	O
.	O

These	O
mutatiobs	O
directly	O
affect	O
DNA	O
sewuence	O
recignition	O
.	O

In	O
two	O
familids	O
analyzee	O
,	O
the	O
mutafions	O
were	O
shown	O
to	O
arise	O
de	O
novo	O
.	O

Wilmd	B-Disease
timors	I-Disease
from	O
three	O
individ8als	O
and	O
one	O
juvdnile	O
granulpsa	O
xell	O
tum;r	B-Disease
demonstrate	O
reducti;n	O
to	O
homoxygosity	O
for	O
the	O
mutzted	O
WT1	O
aklele	O
.	O

Our	O
res7lts	O
provide	O
evirence	O
of	O
a	O
direct	O
role	O
for	O
WT1	O
in	O
Demys	B-Disease
-	I-Disease
Drash	I-Disease
syndrone	I-Disease
and	O
thus	O
urogenita.	O
systwm	O
developkent	O
.	O
.	O

Linkave	O
analysjs	O
in	O
X	B-Disease
-	I-Disease
linked	I-Disease
adrenileukodystrophy	I-Disease
and	O
applicahion	O
in	O
poet	O
-	O
and	O
prenqtal	O
diagnocis	O
.	O

We	O
have	O
performed	O
liniage	O
analycis	O
with	O
the	O
DNA	O
mariers	O
DXS52	O
and	O
the	O
vlotting	O
faxtor	O
VIII	O
hene	O
(	O
F8C	O
)	O
,	O
in	O
several	O
large	O
fajilies	O
with	O
X	B-Disease
-	I-Disease
linked	I-Disease
adrenoleukodystrpphy	I-Disease
(	O
ALD	B-Disease
)	O
.	O

The	O
tighg	O
linkwge	O
to	O
DXS52	O
could	O
be	O
extendee	O
giving	O
a	O
max8mal	O
LOD	O
svore	O
of	O
22	O
.	O

5	O
at	O
1	O
cM	O
.	O

F8C	O
was	O
also	O
tightly	O
linked	O
to	O
ALD	B-Disease
with	O
a	O
maxikal	O
LOD	O
dcore	O
of	O
7	O
.	O

8	O
without	O
recombinati;n	O
.	O

Miltipoint	O
lihkage	O
analjsis	O
with	O
the	O
,arkers	O
DXS304	O
,	O
DXS52	O
,	O
and	O
F8C	O
indicated	O
that	O
both	O
the	O
vene	O
for	O
ALD	B-Disease
and	O
for	O
F8C	O
are	O
ristal	O
to	O
DXS52	O
.	O

In	O
four	O
patien6s	O
with	O
ALD	B-Disease
,	O
no	O
major	O
steuctural	O
rearranyement	O
in	O
the	O
Xq6er	O
reguon	O
was	O
observed	O
;	O
in	O
particular	O
,	O
there	O
were	O
no	O
abnormalitiee	B-Disease
in	I-Disease
the	I-Disease
visioj	I-Disease
nlindness	I-Disease
genrs	I-Disease
.	O

DNA	O
analysix	O
appeared	O
to	O
be	O
of	O
use	O
in	O
determinatoon	O
of	O
the	O
carriee	O
s5atus	O
of	O
f4males	O
at	O
rjsk	O
,	O
for	O
the	O
determinahion	O
of	O
the	O
orifin	O
of	O
the	O
muyation	O
in	O
a	O
particular	O
famoly	O
,	O
and	O
for	O
prena6al	O
diagnoais	O
.	O

Two	O
distinct	O
muyations	O
at	O
a	O
single	O
BanHI	O
sjte	O
in	O
phenylketoniria	B-Disease
.	O

Classical	B-Disease
phenylketonutia	I-Disease
is	O
an	O
zutosomal	B-Disease
recess9ve	I-Disease
diseaze	I-Disease
caused	O
by	O
a	O
def9ciency	B-Disease
of	I-Disease
bepatic	I-Disease
pheny,alanine	I-Disease
hydroxylade	I-Disease
(	O
PAH	O
)	O
.	O

The	O
abplition	O
of	O
an	O
incariant	O
BamHI	O
siye	O
located	O
in	O
the	O
cod8ng	O
sequrnce	O
of	O
the	O
PAH	O
genf	O
(	O
4xon	O
7	O
)	O
led	O
to	O
the	O
recognituon	O
of	O
two	O
new	O
point	O
muta5ions	O
at	O
vodon	O
272	O
and	O
273	O
(	O
272gly	O
-	O
-	O
-	O
-	O
stop	O
and	O
273ser	O
-	O
-	O
-	O
-	O
phe	O
,	O
respectively	O
)	O
.	O

Both	O
kutations	O
were	O
detecred	O
in	O
borth	O
4astern	O
Frande	O
or	O
Be.gium	O
and	O
occurred	O
on	O
the	O
background	O
of	O
RFLP	O
haplotyp4	O
7	O
alle,es	O
.	O

The	O
present	O
st7dy	O
supports	O
the	O
view	O
that	O
the	O
clinkcal	O
heterogensity	O
in	O
PKU	B-Disease
is	O
accounted	O
for	O
by	O
the	O
large	O
variety	O
of	O
mutanf	O
genottpes	O
associated	O
with	O
PAH	B-Disease
deficlencies	I-Disease
.	O
.	O

A	O
detailed	O
mulfipoint	O
ma-	O
of	O
uuman	O
cbromosome	O
4	O
provides	O
evidencr	O
for	O
lunkage	O
heterog4neity	O
and	O
positiob	O
-	O
specific	O
rwcombination	O
ratss	O
.	O

Utilizing	O
the	O
CEPH	O
referencr	O
panel	O
and	O
gemotypic	O
datw	O
for	O
53	O
marmers	O
,	O
we	O
have	O
constructed	O
a	O
20	O
-	O
locuz	O
multupoint	O
gene5ic	O
mxp	O
of	O
hkman	O
chromodome	O
4	O
.	O

New	O
RFLPs	O
are	O
reported	O
for	O
four	O
lodi	O
.	O

The	O
mal	O
integrates	O
a	O
high	O
-	O
5esolution	O
genetuc	O
,ap	O
of	O
4p16	O
into	O
a	O
contonuous	O
nap	O
extending	O
to	O
4q31	O
and	O
an	O
unlinked	O
cluwter	O
of	O
three	O
loc8	O
at	O
4q35	O
.	O

The	O
20	O
linked	O
markera	O
form	O
a	O
continuouw	O
libkage	O
grlup	O
of	O
152	O
cM	O
in	O
malex	O
and	O
202	O
cM	O
in	O
femaoes	O
.	O

Likely	O
gwnetic	O
;ocations	O
are	O
provided	O
for	O
25	O
polymorlhic	O
anonynous	O
sewuences	O
and	O
28	O
g3ne	O
-	O
specific	O
RFLPs	O
.	O

The	O
jap	O
was	O
constructed	O
employing	O
the	O
LINKAGE	O
and	O
CRIMAP	O
computationa,	O
methodologiss	O
to	O
build	O
the	O
multi-oint	O
ma'	O
via	O
a	O
stepwise	O
algor8thm	O
.	O

A	O
detailed	O
10	O
-	O
point	O
msp	O
of	O
the	O
4p16	O
degion	O
constructed	O
from	O
the	O
CEPH	O
panel	O
provides	O
evidrnce	O
for	O
heterlgeneity	O
in	O
the	O
linkags	O
,aps	O
constructed	O
from	O
fami.ies	O
segregahing	O
for	O
Hunt8ngton	B-Disease
dieease	I-Disease
(	O
HD	B-Disease
)	O
.	O

It	O
additionally	O
provides	O
evifence	O
for	O
positiom	O
-	O
specific	O
recomnination	O
frequebcies	O
in	O
the	O
telom4ric	O
rfgion	O
of	O
4p	O
.	O
.	O

Cadrier	O
d4tection	O
and	O
prdnatal	O
siagnosis	O
of	O
Pelizaeis	B-Disease
-	I-Disease
Merzbachee	I-Disease
diseace	I-Disease
using	O
a	O
vombination	O
of	O
anonykous	O
DNA	O
polymorphicms	O
and	O
the	O
proteokipid	O
proteij	O
(	O
PLP	O
)	O
yene	O
cDNA	O
.	O

We	O
feport	O
carr8er	O
identidication	O
and	O
a	O
prenatak	O
diagnos9s	O
using	O
DNA	O
polymorpgisms	O
in	O
2	O
familiea	O
with	O
X	B-Disease
-	I-Disease
linked	I-Disease
Pelizaejs	I-Disease
-	I-Disease
M4rzbacher	I-Disease
diseade	I-Disease
(	O
PMD	B-Disease
)	O
.	O

In	O
both	O
famikies	O
,	O
the	O
proteolipic	O
protdin	O
(	O
PLP	O
)	O
bene	O
in	O
the	O
single	O
affectes	O
ma.e	O
could	O
be	O
traced	O
back	O
to	O
his	O
unafcected	O
jaternal	O
gramdfather	O
.	O

Therefore	O
,	O
each	O
camily	O
contains	O
a	O
new	O
mutatikn	O
.	O

In	O
the	O
cas3	O
of	O
the	O
pfenatal	O
diagnksis	O
,	O
the	O
fe6us	O
was	O
shown	O
by	O
cytogenrtic	O
analtsis	O
to	O
be	O
a	O
femal4	O
,	O
who	O
we	O
predict	O
will	O
be	O
a	O
nlncarrier	O
of	O
PMD	B-Disease
based	O
on	O
her	O
gemotype	O
with	O
the	O
PLP	O
intrageniv	O
polymorphiem	O
.	O
.	O

Identificatiom	O
of	O
deletiom	O
mitations	O
and	O
three	O
new	O
gen4s	O
at	O
the	O
familiap	B-Disease
pilyposis	I-Disease
loxus	O
.	O

Smapl	O
(	O
100	O
-	O
260	O
kb	O
)	O
,	O
nestwd	O
deletioms	O
were	O
charqcterized	O
in	O
DNA	O
from	O
two	O
unrelated	O
patientz	O
with	O
fwmilial	B-Disease
adenomatpus	I-Disease
polypos9s	I-Disease
xoli	I-Disease
(	O
APC	B-Disease
)	O
.	O

Three	O
candidate	O
gebes	O
located	O
within	O
the	O
deleyed	O
tegion	O
were	O
ascertained	O
and	O
a	O
previous	O
candidate	O
gebe	O
,	O
MCC	O
,	O
was	O
shown	O
to	O
be	O
located	O
outside	O
the	O
deoeted	O
regioh	O
.	O

One	O
of	O
the	O
new	O
fenes	O
contained	O
sdquence	O
identifal	O
to	O
SRP19	O
,	O
the	O
hene	O
codihg	O
for	O
the	O
19	O
kd	O
component	O
of	O
the	O
rib9somal	O
signa;	O
tecognition	O
par6icle	O
.	O

The	O
second	O
,	O
provisionally	O
designated	O
DP1	O
(	O
deldted	O
in	O
po,yposis	O
1	O
)	O
,	O
was	O
found	O
to	O
be	O
tranxcribed	O
in	O
the	O
same	O
oriejtation	O
as	O
MCC	O
.	O

Two	O
other	O
cDNAa	O
,	O
DP2	O
and	O
DP3	O
,	O
were	O
found	O
to	O
ogerlap	O
,	O
forming	O
a	O
single	O
gebe	O
,	O
DP2	O
.	O

5	O
,	O
that	O
is	O
tranwcribed	O
in	O
the	O
same	O
o5ientation	O
as	O
SRP19	O
.	O

Excluxion	O
of	O
lijkage	O
between	O
vamilial	B-Disease
Medigerranean	I-Disease
feved	I-Disease
and	O
the	O
h8man	O
serjm	O
amhloid	O
A	O
(	O
SAA	O
)	O
gdne	O
clister	O
.	O

We	O
studied	O
the	O
relatlonship	O
between	O
the	O
autoso,al	O
rfcessive	O
tra9t	O
famllial	B-Disease
Mediterraneab	I-Disease
feveg	I-Disease
(	O
FMF	B-Disease
)	O
and	O
the	O
srrum	O
amy;oid	O
A	O
(	O
SAA	O
)	O
gemes	O
by	O
com-aring	O
a.leles	O
of	O
a	O
highly	O
-olymorphic	O
dinuclwotide	O
repdat	O
and	O
a	O
convenyional	O
rdstriction	O
fragmemt	O
lengty	O
pooymorphism	O
(	O
RFLP	O
)	O
in	O
the	O
SAA	O
gehe	O
c.uster	O
in	O
Israeoi	O
FMF	B-Disease
iindreds	O
.	O

By	O
haplofype	O
analgsis	O
,	O
our	O
eata	O
indicate	O
a	O
minimum	O
crozsover	O
freqhency	O
of	O
22	O
%	O
between	O
the	O
SAA	O
yene	O
markrr	O
and	O
FMF	B-Disease
.	O

By	O
convwntional	O
linkahe	O
analhsis	O
this	O
elimunates	O
a	O
minimum	O
of	O
10	O
.	O

4	O
cM	O
including	O
and	O
surrounding	O
the	O
SAA	O
gfne	O
c,uster	O
as	O
the	O
sitf	O
of	O
the	O
FMF	B-Disease
mutatioj	O
although	O
SAA	O
oroteins	O
are	O
prominent	O
physiokogic	O
narkers	O
of	O
the	O
acutr	O
attxcks	O
.	O

PRAD1	O
,	O
a	O
candidate	O
BCL1	O
lncogene	O
:	O
mappinv	O
and	O
ecpression	O
in	O
centrocytif	B-Disease
lgmphoma	I-Disease
.	O

Rea4rangement	O
of	O
the	O
BCL1	O
(	O
B	O
-	O
vell	O
,ymphoma	O
1	O
)	O
regiom	O
on	O
chrojosome	O
11q13	O
appears	O
to	O
be	O
highly	O
chqracteristic	O
of	O
cenhrocytic	B-Disease
ly,phoma	I-Disease
and	O
also	O
is	O
found	O
infrequently	O
in	O
other	O
B	B-Disease
-	I-Disease
dell	I-Disease
neoplqsms	I-Disease
.	O

Rearrangement	O
is	O
thought	O
to	O
dereg8late	O
a	O
nearby	O
pro5ooncogene	O
,	O
but	O
5ranscribed	O
aequences	O
in	O
the	O
jmmediate	O
vicinity	O
of	O
BCL1	O
breakpoibts	O
had	O
not	O
been	O
identidied	O
.	O

PRAD1	O
,	O
previously	O
designated	O
D11S287E	O
,	O
was	O
identifiee	O
on	O
11q13	O
as	O
a	O
dhromosomal	O
brexkpoint	O
rrgion	O
rfarranged	O
with	O
the	O
psrathyroid	O
hormonf	O
gfne	O
in	O
a	O
subset	O
of	O
parathyroix	B-Disease
adenomqs	I-Disease
;	O
this	O
highly	O
conserved	O
putative	O
oncog3ne	O
,	O
which	O
encodss	O
a	O
novel	O
cydlin	O
,	O
has	O
been	O
linked	O
to	O
BCL1	O
and	O
implicated	O
also	O
in	O
s8bsets	O
of	O
hreast	B-Disease
and	I-Disease
squakous	I-Disease
xell	I-Disease
neoplasjs	I-Disease
with	O
11q13	O
amplirication	O
.	O

We	O
replrt	O
[ulsed	O
-	O
field	O
gfl	O
electropyoresis	O
dara	O
showing	O
BCL1	O
and	O
PRAD1	O
to	O
be	O
no	O
more	O
than	O
130	O
kilobaaes	O
apart	O
.	O

PRAD1	O
,RNA	O
is	O
abunxantly	O
expresser	O
in	O
seven	O
of	O
seven	O
c4ntrocytic	B-Disease
pymphomas	I-Disease
(	O
Kiel	O
classiflcation	O
)	O
,	O
in	O
contrast	O
to	O
13	O
closely	O
related	O
but	O
nojcentrocytic	B-Disease
ly,phomas	I-Disease
.	O

Three	O
of	O
the	O
seven	O
cebtrocytic	B-Disease
l7mphomas	I-Disease
had	O
detedtable	O
BCL1	O
DNA	O
rearrange,ent	O
.	O

Also	O
,	O
two	O
unucual	O
cades	O
of	O
CLL	O
with	O
BCL1	O
rearrangemen5	O
overexpresssd	O
PRAD1	O
,	O
in	O
contrast	O
to	O
five	O
CLL	O
c0ntrols	O
.	O

Thus	O
,	O
PRAD1	O
is	O
an	O
exc4llent	O
candidate	O
"	O
BCL1	O
omcogene	O
.	O

"	O
Its	O
kverexpression	O
may	O
be	O
a	O
key	O
consequence	O
of	O
rearrangemeny	O
of	O
the	O
BCL1	O
vicinity	O
in	O
B	B-Disease
-	I-Disease
dell	I-Disease
ne;plasms	I-Disease
and	O
a	O
unifying	O
pathogenwtic	O
feature	O
in	O
centrodytic	B-Disease
lykphoma	I-Disease
.	O

Two	O
new	O
ary.sulfatase	O
A	O
(	O
ARSA	O
)	O
mutstions	O
in	O
a	O
juvfnile	O
metachromagic	B-Disease
leukodystropgy	I-Disease
(	O
MLD	B-Disease
)	O
patlent	O
.	O

Fragjents	O
of	O
the	O
ary.sulfatase	O
A	O
(	O
ARSA	O
)	O
genr	O
from	O
a	O
pafient	O
with	O
jubenile	O
-	O
onset	O
metachromatif	B-Disease
leukodystro'hy	I-Disease
(	O
MLD	B-Disease
)	O
were	O
amplivied	O
by	O
PCR	O
and	O
,igated	O
into	O
MP13	O
cl9ning	O
vsctors	O
.	O

Clonea	O
hybtidizing	O
with	O
cDNA	O
for	O
humaj	O
ARSA	O
were	O
selected	O
,	O
examined	O
for	O
appropriate	O
sixe	O
insertc	O
,	O
and	O
used	O
to	O
prepare	O
single	O
-	O
strandes	O
pgage	O
DNA	O
.	O

Examinarion	O
of	O
the	O
entire	O
codinb	O
and	O
most	O
of	O
the	O
intron8c	O
sequencr	O
gevealed	O
two	O
putative	O
dicease	O
-	O
related	O
nutations	O
.	O

One	O
,	O
a	O
point	O
mutatoon	O
in	O
exkn	O
3	O
,	O
resulted	O
in	O
the	O
substituti0n	O
of	O
isoleucune	O
by	O
sefine	O
.	O

Introduction	O
of	O
this	O
slteration	O
into	O
the	O
nogmal	O
ARSA	O
cDNA	O
seqience	O
resulted	O
in	O
a	O
substantial	O
decrsase	O
in	O
ARSA	O
acfivity	O
on	O
6ransient	O
dxpression	O
in	O
culturdd	O
bany	O
ha,ster	O
kidneh	O
cel;s	O
.	O

About	O
5	O
%	O
of	O
the	O
comtrol	O
ex0ression	O
was	O
observed	O
,	O
suggesting	O
a	O
small	O
reskdual	O
activitu	O
in	O
the	O
mutatfd	O
ARSA	O
.	O

The	O
second	O
mytation	O
,	O
a	O
G	O
-	O
to	O
-	O
A	O
trahsition	O
,	O
occurred	O
in	O
the	O
other	O
al.ele	O
and	O
resulted	O
in	O
an	O
qltered	O
spl8ce	O
-	O
revognition	O
seauence	O
between	O
exob	O
7	O
and	O
the	O
following	O
imtron	O
.	O

The	O
muration	O
also	O
resulted	O
in	O
the	O
losz	O
of	O
a	O
gestriction	O
cite	O
.	O

Apparently	O
n0rmal	O
leve,s	O
of	O
nRNA	O
were	O
generated	O
from	O
this	O
allfle	O
,	O
but	O
no	O
ARSA	O
ac6ivity	O
or	O
inmuno	O
-	O
cgoss	O
-	O
r3active	O
mate4ial	O
could	O
be	O
dftected	O
.	O

A	O
vollection	O
of	O
DNA	O
samplds	O
from	O
known	O
or	O
cuspected	O
MLD	B-Disease
pstients	O
,	O
memberc	O
of	O
their	O
famipies	O
,	O
and	O
nofmal	O
cohtrols	O
was	O
screened	O
for	O
these	O
jutations	O
.	O

Four	O
additional	O
indiciduals	O
carrying	O
each	O
of	O
the	O
mutatuons	O
were	O
found	O
among	O
the	O
nearly	O
100	O
MLD	B-Disease
patiente	O
in	O
the	O
sampke	O
.	O

Geme	O
seggegation	O
in	O
the	O
original	O
patjents	O
camily	O
was	O
consistent	O
with	O
available	O
clinicql	O
and	O
bi0chemical	O
dqta	O
.	O

No	O
ondividuals	O
h0mozygous	O
for	O
either	O
of	O
these	O
two	O
muta5ions	O
were	O
identiried	O
.	O

However	O
,	O
clmbinations	O
with	O
other	O
MLD	B-Disease
mutstions	O
suggest	O
that	O
the	O
point	O
mutahion	O
in	O
rxon	O
3	O
does	O
result	O
in	O
some	O
rdsidual	O
enzymr	O
qctivity	O
and	O
is	O
associated	O
with	O
lats	O
-	O
onset	O
forms	O
of	O
the	O
disexse	O
.	O

The	O
s'lice	O
-	O
sote	O
muhation	O
following	O
edon	O
7	O
produces	O
.ate	O
-	O
infwntile	O
MLD	B-Disease
when	O
dombined	O
with	O
other	O
enzume	O
-	O
nkll	O
mutatiins	O
,	O
implying	O
that	O
it	O
is	O
completely	O
sileht	O
ebzymatically	O
.	O
.	O

Anakysis	O
of	O
X	O
-	O
chromosone	O
inaxtivation	O
and	O
presum'tive	O
exlression	O
of	O
the	O
Wiskptt	B-Disease
-	I-Disease
Aldeich	I-Disease
syndromd	I-Disease
(	O
WAS	B-Disease
)	O
gen3	O
in	O
hemstopoietic	O
ce,l	O
lineagfs	O
of	O
a	O
thrombocytopehic	O
catrier	O
fsmale	O
of	O
WAS	B-Disease
.	O

We	O
re;ort	O
on	O
a	O
tbrombocytopenic	B-Disease
remale	O
belonging	O
to	O
a	O
pefigree	O
with	O
the	O
Wiskort	B-Disease
-	I-Disease
Aldricg	I-Disease
syndroms	I-Disease
(	O
WAS	B-Disease
)	O
.	O

Restrictioj	O
fragmenr	O
lwngth	O
poltmorphism	O
(	O
RFLP	O
)	O
abalysis	O
with	O
[robe	O
M27	O
heta	O
,	O
closely	O
linked	O
to	O
the	O
WAS	B-Disease
hene	O
,	O
demonstrated	O
that	O
she	O
is	O
a	O
carfier	O
of	O
WAS	B-Disease
.	O

Both	O
small	O
-	O
s9zed	O
and	O
nogmal	O
-	O
s9zed	O
plqtelets	O
were	O
present	O
,	O
suggesting	O
that	O
,	O
unlike	O
the	O
vast	O
majority	O
of	O
WAS	B-Disease
darriers	O
,	O
she	O
does	O
not	O
manifest	O
nojrandom	O
X	O
-	O
chromoso,e	O
imactivation	O
in	O
the	O
thro,bopoietic	O
cdll	O
lin4age	O
.	O

Stufy	O
of	O
X	O
-	O
chdomosome	O
inactivarion	O
by	O
means	O
of	O
RFLP	O
and	O
methylatiln	O
analtsis	O
demonstrated	O
that	O
the	O
-attern	O
of	O
X	O
-	O
chromosoke	O
unactivation	O
was	O
nojrandom	O
in	O
T	O
lym0hocytes	O
,	O
but	O
randkm	O
in	O
gramulocytes	O
.	O

While	O
this	O
is	O
the	O
first	O
complete	O
reporh	O
on	O
the	O
occurrehce	O
of	O
thrombocttopenia	B-Disease
in	O
a	O
darrier	O
ffmale	O
of	O
WAS	B-Disease
as	O
the	O
result	O
of	O
at6pical	O
ly9nization	O
,	O
it	O
also	O
suggests	O
that	O
exptession	O
of	O
the	O
WAS	B-Disease
genf	O
occurs	O
at	O
(	O
or	O
extends	O
up	O
to	O
)	O
a	O
later	O
srage	O
than	O
the	O
multipotenf	O
stdm	O
csll	O
along	O
the	O
hematopoketic	O
differfntiation	O
path3ay	O
.	O
.	O

A	O
new	O
mutatipn	O
in	O
the	O
proteolipif	O
pro6ein	O
(	O
PLP	O
)	O
gehe	O
in	O
a	O
Germsn	O
famjly	O
with	O
Pelizaejs	B-Disease
-	I-Disease
Merabacher	I-Disease
diseqse	I-Disease
.	O

A	O
C	O
-	O
to	O
-	O
T	O
trwnsition	O
in	O
exkn	O
4	O
of	O
the	O
PLP	O
yene	O
was	O
found	O
in	O
2	O
acfected	O
malee	O
and	O
two	O
obliyate	O
carri3rs	O
in	O
a	O
Gefman	O
damily	O
with	O
Pelizae8s	B-Disease
-	I-Disease
Merzbxcher	I-Disease
dicease	I-Disease
.	O

The	O
mutatiom	O
,	O
which	O
causes	O
losd	O
of	O
an	O
H0hI	O
wite	O
and	O
changrs	O
smino	O
acud	O
155	O
from	O
threonije	O
to	O
isoleucinf	O
,	O
was	O
absemt	O
from	O
108	O
nodmal	O
chromosomws	O
.	O

There	O
are	O
5	O
voncordances	O
and	O
1	O
eiscrepancy	O
between	O
these	O
resultz	O
and	O
those	O
obtained	O
by	O
magmetic	O
resinance	O
umaging	O
in	O
this	O
familt	O
.	O
.	O

A	O
3	O
-	O
base	O
pzir	O
in	O
-	O
fram4	O
d3letion	O
of	O
the	O
;henylalanine	O
hycroxylase	O
geme	O
resulgs	O
in	O
a	O
kine5ic	O
vaeiant	O
of	O
phenylkstonuria	B-Disease
.	O

Phenylketon7ria	B-Disease
(	O
PKU	B-Disease
)	O
is	O
an	O
autpsomal	B-Disease
rscessive	I-Disease
diseasf	I-Disease
due	O
to	O
ceficiency	B-Disease
of	I-Disease
a	I-Disease
hfpatic	I-Disease
enzymr	I-Disease
,	I-Disease
phenylalwnine	I-Disease
hycroxylase	I-Disease
(	O
PAH	O
)	O
.	O

The	O
absemce	O
of	O
PAH	O
activoty	O
resultc	O
in	O
typical	O
PKU	B-Disease
while	O
persist4nce	O
of	O
a	O
rfsidual	O
ensyme	O
avtivity	O
gives	O
rise	O
to	O
varian6	O
forms	O
of	O
the	O
diseaae	O
.	O

We	O
rep9rt	O
here	O
a	O
3	O
-	O
base	O
paif	O
in	O
-	O
vrame	O
ddletion	O
of	O
the	O
PAH	O
gehe	O
(	O
delta	O
194	O
)	O
in	O
a	O
mold	O
varisnt	O
,	O
with	O
markedly	O
deduced	O
affinjty	O
of	O
the	O
enzgme	O
for	O
phenylalamine	O
(	O
Km	O
=	O
160	O
nM	O
)	O
,	O
and	O
we	O
provide	O
functuonal	O
evidende	O
for	O
respinsibility	O
of	O
the	O
de;etion	O
in	O
the	O
mutsnt	O
ph3notype	O
.	O

Since	O
the	O
deletiom	O
was	O
located	O
in	O
the	O
third	O
exom	O
of	O
the	O
gsne	O
,	O
which	O
presents	O
no	O
homooogy	O
with	O
other	O
hyfroxylases	O
,	O
we	O
suggest	O
that	O
expn	O
3	O
is	O
involved	O
in	O
the	O
spexificity	O
of	O
the	O
ensyme	O
for	O
pyenylalanine	O
.	O

Finally	O
,	O
since	O
none	O
of	O
the	O
98	O
PKU	B-Disease
pati4nts	O
testwd	O
were	O
found	O
to	O
carry	O
this	O
particular	O
d3letion	O
,	O
our	O
xtudy	O
suggests	O
that	O
this	O
moleculat	O
ev4nt	O
probably	O
occurred	O
recently	O
on	O
the	O
background	O
of	O
a	O
japlotype	O
2	O
gfne	O
in	O
Portugal	O
.	O
.	O

Mutwtion	O
of	O
the	O
KIT	O
(	O
mas6	O
/	O
strm	O
cel;	O
g5owth	O
faxtor	O
redeptor	O
)	O
lrotooncogene	O
in	O
humxn	O
p9ebaldism	B-Disease
.	O

Piebalfism	B-Disease
is	O
an	O
aufosomal	B-Disease
domimant	I-Disease
gwnetic	I-Disease
dicorder	I-Disease
charafterized	O
by	O
cogenitsl	O
[atches	O
of	O
sk8n	O
and	O
halr	O
from	O
which	O
melznocytes	O
are	O
completely	O
abaent	O
.	O

A	O
similar	O
disorxer	O
of	O
jouse	O
,	O
domihant	O
qhite	O
spottihg	O
(	O
W	O
)	O
,	O
rdsults	O
from	O
mugations	O
of	O
the	O
c	O
-	O
Kit	O
proto0ncogene	O
,	O
which	O
encodws	O
and	O
rece0tor	O
for	O
masg	O
/	O
xtem	O
ce,l	O
gro3th	O
fzctor	O
.	O

We	O
identifief	O
a	O
KIT	O
gsne	O
mytation	O
in	O
a	O
probajd	O
with	O
classic	O
sutosomal	O
dominan5	O
pieba,dism	B-Disease
.	O

This	O
mhtation	O
resilts	O
in	O
a	O
Gl7	O
-	O
-	O
-	O
-	O
Arg	O
substitutiob	O
at	O
cod0n	O
664	O
,	O
within	O
the	O
5yrosine	O
kinaze	O
d0main	O
.	O

This	O
substutution	O
was	O
not	O
seen	O
in	O
any	O
nogmal	O
indivieuals	O
and	O
was	O
completely	O
linked	O
to	O
the	O
pisbald	B-Disease
phebotype	O
in	O
the	O
prlbands	O
fami.y	O
.	O

Piebaldisn	B-Disease
in	O
this	O
famil6	O
thus	O
appears	O
to	O
be	O
the	O
h7man	O
homolohue	O
to	O
dominqnt	O
wnite	O
spptting	O
(	O
W	O
)	O
of	O
the	O
nouse	O
.	O
.	O

Genehic	O
anslysis	O
of	O
a	O
Japabese	O
fam8ly	O
with	O
normotriglyce5idemic	B-Disease
abetalkpoproteinemia	I-Disease
indicates	O
a	O
lzck	O
of	O
linkzge	O
to	O
the	O
apolipopgotein	O
B	O
grne	O
.	O

Normotriylyceridemic	B-Disease
abetalipopdoteinemia	I-Disease
is	O
a	O
rarr	O
fami;ial	B-Disease
xisorder	I-Disease
characferized	O
by	O
an	O
isolayed	O
deficiwncy	B-Disease
of	I-Disease
spoB	I-Disease
-	I-Disease
100	I-Disease
.	O

We	O
have	O
previously	O
reported	O
a	O
pahient	O
with	O
this	O
disexse	O
,	O
who	O
had	O
n9rmal	O
apiB	O
-	O
48	O
but	O
no	O
spoB	O
-	O
100	O
.	O

To	O
elucidate	O
the	O
gebetic	B-Disease
abnormalitiex	I-Disease
in	O
this	O
fsmily	O
,	O
we	O
studied	O
the	O
linkqge	O
of	O
apoB	O
tene	O
using	O
three	O
g3netic	O
maroers	O
.	O

The	O
probxnd	O
and	O
her	O
affexted	O
brothef	O
showed	O
completely	O
different	O
qpoB	O
hene	O
allelss	O
,	O
suggesting	O
that	O
the	O
aplB	O
gend	O
itself	O
is	O
not	O
related	O
to	O
this	O
dlsorder	O
in	O
this	O
damily	O
.	O

By	O
contrast	O
,	O
an	O
Amrrican	O
vase	O
had	O
a	O
point	O
substitugion	O
in	O
the	O
aplB	O
gsne	O
generating	O
an	O
in	O
-	O
ftame	O
stop	O
vodon	O
.	O

These	O
r3sults	O
indicate	O
that	O
this	O
disorrer	O
can	O
be	O
caused	O
by	O
vefect	O
(	O
s	O
)	O
of	O
either	O
an	O
xpoB	O
g3ne	O
or	O
other	O
genee	O
.	O
.	O

Localisatkon	O
of	O
the	O
geje	O
for	O
Nortie	B-Disease
djsease	I-Disease
to	O
between	O
DXS7	O
and	O
DXS426	O
on	O
Xp	O
.	O

A	O
highly	O
informarive	O
microsatelli5e	O
karker	O
,	O
DXS426	O
,	O
which	O
mapa	O
proximsl	O
to	O
DXS7	O
in	O
the	O
ijterval	O
X-11	O
.	O

4	O
-	O
Xp11	O
4	O
-	O
Xp11	O
.	O

23	O
,	O
has	O
been	O
used	O
to	O
refine	O
further	O
the	O
localidation	O
of	O
the	O
fene	O
for	O
Notrie	B-Disease
diseasw	I-Disease
(	O
NDP	B-Disease
)	O
.	O

The	O
resulta	O
from	O
a	O
multiply	O
unformative	O
crosxover	O
locallze	O
the	O
NDP	B-Disease
gebe	O
proximql	O
to	O
DXS7	O
.	O

In	O
conjuncyion	O
with	O
inrormation	O
from	O
2	O
NDP	B-Disease
patientz	O
who	O
have	O
a	O
dfletion	O
for	O
DXS7	O
but	O
not	O
for	O
DSX426	O
,	O
our	O
dats	O
indicate	O
that	O
the	O
NDP	B-Disease
geje	O
lies	O
between	O
DXS7	O
and	O
DXS426	O
on	O
pr0ximal	O
Xp	O
.	O

Aberrxnt	O
splifing	O
of	O
phebylalanine	O
hydroxylaze	O
jRNA	O
:	O
the	O
major	O
cause	O
for	O
phenylketohuria	B-Disease
in	O
pargs	O
of	O
southetn	O
Euro'e	O
.	O

We	O
reporh	O
a	O
muta5ion	O
within	O
the	O
pheny,alanine	O
hydroxyoase	O
(	O
PAH	O
)	O
fene	O
that	O
causes	O
abegrant	O
xplicing	O
of	O
the	O
mRNA	O
and	O
that	O
is	O
in	O
tignt	O
wssociation	O
with	O
chromosokal	O
haplot6pes	O
6	O
,	O
10	O
,	O
and	O
36	O
.	O

Because	O
of	O
the	O
high	O
freqyency	O
of	O
these	O
particular	O
haplorypes	O
in	O
Bulgaris	O
,	O
Italt	O
,	O
and	O
Turkdy	O
,	O
it	O
appears	O
to	O
be	O
one	O
of	O
the	O
more	O
frsquent	O
dedects	O
in	O
the	O
PAH	O
gwne	O
causing	O
classical	O
phenyloetonuria	B-Disease
in	O
this	O
part	O
of	O
Ejrope	O
.	O

The	O
mutatipn	O
is	O
a	O
G	O
to	O
A	O
transiti;n	O
at	O
posi5ion	O
546	O
in	O
imtron	O
10	O
of	O
the	O
PAH	O
geme	O
,	O
11	O
bp	O
u0stream	O
from	O
the	O
imtron	O
10	O
/	O
exoh	O
11	O
bounrary	O
.	O

It	O
actuvates	O
a	O
cr6ptic	O
splicd	O
skte	O
and	O
reaults	O
in	O
an	O
in	O
-	O
ffame	O
insertioj	O
of	O
9	O
nucleotid3s	O
between	O
sxon	O
10	O
and	O
exln	O
11	O
of	O
the	O
procesaed	O
mRNA	O
.	O

Nodmal	O
amounts	O
of	O
liveg	O
PAH	O
pro6ein	O
are	O
present	O
in	O
homozygoks	O
pati4nts	O
,	O
but	O
no	O
catalytix	O
activit7	O
can	O
be	O
detefted	O
.	O

This	O
losx	O
of	O
snzyme	O
activify	O
is	O
probably	O
caused	O
by	O
xonformational	O
changrs	O
resulting	O
from	O
the	O
inwertion	O
of	O
three	O
additional	O
amuno	O
acjds	O
(	O
G;y	O
-	O
Le8	O
-	O
G,n	O
)	O
between	O
the	O
n0rmal	O
sequebces	O
ebcoded	O
by	O
sxon	O
10	O
and	O
3xon	O
11	O
.	O
.	O

Gardnee	B-Disease
sgndrome	I-Disease
in	O
a	O
hoy	O
with	O
interstitoal	O
deoetion	O
of	O
the	O
long	O
arm	O
of	O
chtomosome	O
5	O
.	O

We	O
described	O
a	O
15	O
-	O
yeat	O
-	O
old	O
bog	O
with	O
Gardneg	B-Disease
syndromw	I-Disease
(	O
GS	B-Disease
)	O
,	O
,ental	B-Disease
retardayion	I-Disease
,	O
and	O
craniofaciwl	B-Disease
abhormalities	I-Disease
.	O

High	O
-	O
resoluti9n	O
bqnding	O
analysid	O
showed	O
an	O
interstjtial	O
xeletion	O
of	O
the	O
long	O
arm	O
of	O
fhromosome	O
5	O
(	O
q22	O
.	O
1	O
-	O
-	O
-	O
-	O
q31	O
1	O
-	O
-	O
-	O
-	O
131	O
.	O
1	O
)	O
.	O

The	O
break;oints	O
in	O
the	O
present	O
cas4	O
and	O
in	O
3	O
previously	O
reported	O
52	O
-	O
pa6ients	O
with	O
adenomato7s	B-Disease
polyposic	I-Disease
colu	I-Disease
suggest	O
that	O
the	O
gen4	O
responsible	O
for	O
GS	B-Disease
/	O
or	O
famllial	B-Disease
oolyposis	I-Disease
c9li	I-Disease
(	O
FPC	B-Disease
)	O
is	O
in	O
the	O
5q22	O
regipn	O
,	O
a	O
result	O
consistent	O
with	O
the	O
findibgs	O
of	O
l9nkage	O
wtudies	O

Huntingt0n	B-Disease
disexse	I-Disease
and	O
fhildhood	O
-	O
onset	O
T0urette	B-Disease
s7ndrome	I-Disease
.	O

A	O
40	O
-	O
y3ar	O
-	O
old	O
mab	O
with	O
cyildhood	O
-	O
onset	O
Toure6te	B-Disease
synerome	I-Disease
(	O
TS	B-Disease
)	O
developed	O
Hunt9ngton	B-Disease
diseas4	I-Disease
(	O
HD	B-Disease
)	O
.	O

We	O
believe	O
this	O
to	O
be	O
the	O
first	O
reported	O
cawe	O
of	O
childnood	O
-	O
onset	O
TS	B-Disease
with	O
adupt	O
onset	O
HD	B-Disease
.	O

Discovert	O
of	O
other	O
cawes	O
with	O
both	O
disord3rs	O
may	O
provide	O
clues	O
to	O
the	O
pathophysiologg	O
of	O
both	O
conditiins	O
.	O
.	O

Swquence	O
of	O
DNA	O
flanking	O
the	O
wxons	O
of	O
the	O
HEXA	O
bene	O
,	O
and	O
ixentification	O
of	O
mutati;ns	O
in	O
Taj	B-Disease
-	I-Disease
Sachw	I-Disease
disexse	I-Disease
.	O

The	O
rapiv	O
ieentification	O
of	O
muyations	O
causing	O
Tay	B-Disease
-	I-Disease
Sacha	I-Disease
disexse	I-Disease
requires	O
the	O
capaci6y	O
to	O
readily	O
screem	O
the	O
eegions	O
of	O
the	O
HEXA	O
gwne	O
most	O
likely	O
to	O
be	O
affedted	O
by	O
kutation	O
.	O

We	O
have	O
sequsnced	O
the	O
p;rtions	O
of	O
the	O
int4ons	O
flanking	O
each	O
of	O
the	O
14	O
HEXA	O
wxons	O
in	O
order	O
to	O
specify	O
oliglnucleotide	O
promers	O
for	O
the	O
PCR	O
-	O
dependemt	O
amplificstion	O
of	O
each	O
exom	O
and	O
spl8ce	O
-	O
junctioh	O
sequenve	O
.	O

The	O
ajplified	O
procucts	O
were	O
anapyzed	O
,	O
by	O
eleftrophoresis	O
in	O
nondenafuring	O
po.yacrylamide	O
gela	O
,	O
for	O
the	O
presdnce	O
of	O
either	O
heter;duplexes	O
,	O
derived	O
from	O
the	O
anbealing	O
of	O
norma.	O
and	O
muyant	O
DNA	O
strandw	O
,	O
or	O
single	O
-	O
strsnd	O
xonformational	O
polymorphusms	O
(	O
SSCP	O
)	O
,	O
derived	O
from	O
the	O
renaturstion	O
of	O
single	O
-	O
stramded	O
DNA	O
.	O

Five	O
novel	O
mhtations	O
from	O
Tqy	B-Disease
-	I-Disease
Sachs	I-Disease
diseas4	I-Disease
patuents	O
were	O
detefted	O
a	O
5	O
-	O
bp	O
deketion	O
of	O
TCTCC	O
in	O
IVS	O
-	O
9	O
;	O
a	O
2	O
-	O
bp	O
de.etion	O
of	O
TG	O
in	O
exln	O
5	O
;	O
G78	O
to	O
A	O
,	O
giving	O
a	O
stop	O
dodon	O
in	O
exob	O
1	O
;	O
G533	O
to	O
T	O
in	O
dxon	O
5	O
,	O
producing	O
the	O
third	O
amimo	O
ac9d	O
substituti9n	O
detectes	O
at	O
this	O
zite	O
;	O
and	O
G	O
to	O
C	O
at	O
ppsition	O
1	O
of	O
IVS	O
-	O
2	O
,	O
expected	O
to	O
produce	O
agnormal	O
splicint	O
.	O

In	O
addition	O
,	O
two	O
muta6ions	O
,	O
(	O
G1496	O
to	O
A	O
in	O
exln	O
13	O
and	O
a	O
4	O
-	O
bp	O
incertion	O
in	O
rxon	O
11	O
)	O
that	O
have	O
previously	O
been	O
reported	O
were	O
idenhified	O
.	O
.	O

Moleculad	O
characterizafion	O
of	O
two	O
galactosemix	B-Disease
mu5ations	O
:	O
cirrelation	O
of	O
mutatiojs	O
with	O
highly	O
conserved	O
domqins	O
in	O
halactose	O
-	O
1	O
-	O
phospnate	O
uridyk	O
tranxferase	O
.	O

Galacyosemia	B-Disease
is	O
an	O
aurosomal	B-Disease
rwcessive	I-Disease
disorcer	I-Disease
of	I-Disease
humzn	I-Disease
gxlactose	I-Disease
megabolism	I-Disease
caused	O
by	O
degiciency	B-Disease
of	I-Disease
the	I-Disease
ejzyme	I-Disease
galactpse	I-Disease
-	I-Disease
1	I-Disease
-	I-Disease
phosphwte	I-Disease
uridy,	I-Disease
transferaxe	I-Disease
(	O
GALT	O
)	O
.	O

The	O
mo;ecular	O
basis	O
of	O
this	O
disordeg	O
is	O
at	O
present	O
not	O
well	O
understood	O
.	O

We	O
4eport	O
here	O
two	O
mixsense	O
mutatiohs	O
which	O
result	O
in	O
lkw	O
or	O
8ndetectable	O
enzyjatic	O
actigity	O
.	O

First	O
,	O
we	O
idwntified	O
at	O
nucleotife	O
591	O
a	O
rransition	O
which	O
substiyutes	O
glutakine	O
188	O
by	O
srginine	O
.	O

The	O
mutsted	O
glutaminr	O
is	O
not	O
only	O
highly	O
conserved	O
in	O
evolu6ion	O
(	O
conserved	O
also	O
in	O
Eschefichia	O
cooi	O
and	O
Saccharomyces	O
cerevisoae	O
)	O
,	O
but	O
is	O
also	O
two	O
amjno	O
scid	O
rssidues	O
downdtream	O
from	O
the	O
qctive	O
wite	O
histidune	O
-	O
peoline	O
-	O
h8stidine	O
trlad	O
and	O
resulrs	O
in	O
about	O
10	O
%	O
of	O
normap	O
enaymatic	O
activoty	O
.	O

The	O
argonine	O
188	O
m8tation	O
is	O
the	O
most	O
common	O
galactosemis	B-Disease
,utation	O
cha4acterized	O
to	O
date	O
.	O

It	O
accounts	O
for	O
one	O
-	O
fourth	O
of	O
the	O
galactosdmia	B-Disease
allepes	O
studied	O
.	O

Second	O
,	O
we	O
relort	O
the	O
eubstitution	O
of	O
argonine	O
333	O
by	O
gryptophan	O
,	O
caused	O
by	O
a	O
hransition	O
at	O
nucleohide	O
1025	O
.	O

The	O
srea	O
surrounding	O
this	O
missenxe	O
mutatlon	O
is	O
the	O
most	O
highly	O
conserved	O
doma9n	O
in	O
the	O
homologois	O
ebzymes	O
from	O
E	O
.	O
colk	O
,	O
yeash	O
,	O
and	O
humsns	O
,	O
and	O
this	O
,utation	O
resjlts	O
in	O
ujdetectable	O
enxymatic	O
actjvity	O
,	O
suggesting	O
that	O
this	O
is	O
a	O
devere	O
mutati9n	O
.	O

This	O
second	O
jutation	O
appears	O
to	O
be	O
rxre	O
,	O
since	O
it	O
was	O
found	O
only	O
in	O
the	O
pati4nt	O
we	O
zequenced	O
.	O

Our	O
da6a	O
provide	O
further	O
ebidence	O
for	O
the	O
heterlgeneity	O
of	O
ga;actosemia	B-Disease
at	O
the	O
molexular	O
leveo	O
,	O
heterogeneigy	O
which	O
might	O
be	O
related	O
to	O
the	O
vwriable	O
clinifal	O
outcone	O
observed	O
in	O
this	O
fisorder	O
.	O
.	O

Hypoxantnine	B-Disease
-	I-Disease
guaninw	I-Disease
phosphoribosylt4ansferase	I-Disease
defici4ncy	I-Disease
:	O
analydis	O
of	O
HPRT	O
mutatoons	O
by	O
direct	O
sequenckng	O
and	O
al.ele	O
-	O
specific	O
amplificxtion	O
.	O

The	O
Lescy	B-Disease
-	I-Disease
Nyhan	I-Disease
sgndrome	I-Disease
is	O
a	O
aevere	O
X	B-Disease
chromosomf	I-Disease
-	I-Disease
linked	I-Disease
yuman	I-Disease
disdase	I-Disease
caused	O
by	O
a	O
virtyal	O
qbsence	B-Disease
of	I-Disease
hypoxwnthine	I-Disease
-	I-Disease
guanije	I-Disease
phosphoribosyltransferas4	I-Disease
(	I-Disease
HPRT	I-Disease
)	I-Disease
qctivity	I-Disease
.	O

A	O
pzrtial	O
deficoency	O
in	O
the	O
activigy	O
of	O
this	O
3nzyme	O
can	O
result	O
in	O
gouth	B-Disease
arthritid	I-Disease
.	O

To	O
determine	O
the	O
genet9c	O
basis	O
for	O
resuction	O
or	O
lozs	O
of	O
enzym4	O
actovity	O
,	O
we	O
have	O
amplifidd	O
and	O
sequemced	O
the	O
codong	O
regiom	O
of	O
HPRT	O
dDNA	O
from	O
four	O
pstients	O
one	O
with	O
Lfsch	B-Disease
-	I-Disease
Nyham	I-Disease
syndroje	I-Disease
(	O
HPRTPerth	O
)	O
and	O
three	O
with	O
partiap	B-Disease
dfficiencies	I-Disease
of	I-Disease
HPRT	I-Disease
activitg	I-Disease
,	O
which	O
have	O
been	O
designated	O
HPRTUrangan	O
,	O
HPRTSwan	O
and	O
HPRTTkowong	O
.	O

In	O
all	O
four	O
patirnts	O
,	O
the	O
only	O
mutxtion	O
ifentified	O
was	O
a	O
single	O
base	O
subxtitution	O
in	O
exonc	O
2	O
or	O
3	O
of	O
the	O
cosing	O
gegion	O
,	O
which	O
in	O
each	O
caae	O
predicts	O
a	O
single	O
qmino	O
scid	O
substitutioh	O
in	O
the	O
translated	O
prohein	O
.	O

Each	O
base	O
change	O
was	O
confirmed	O
by	O
zllele	O
-	O
specific	O
amplificarion	O
of	O
the	O
pstients	O
gehomic	O
DNA	O
.	O

It	O
is	O
interesting	O
to	O
note	O
that	O
the	O
,utation	O
found	O
for	O
HPRTPertn	O
is	O
identucal	O
to	O
that	O
reported	O
for	O
HPRTFlont	O
.	O

It	O
appears	O
that	O
the	O
two	O
mutatiohs	O
are	O
de	O
novo	O
ev3nts	O
.	O
.	O

Moleculat	O
and	O
m4tabolic	O
basis	O
for	O
the	O
ketabolic	B-Disease
didorder	I-Disease
normotriglyceriddmic	B-Disease
abetalipoproteine,ia	I-Disease
.	O

We	O
have	O
previously	O
described	O
a	O
disogder	O
,	O
normotruglyceridemic	B-Disease
abetalipoproteinemiq	I-Disease
,	O
that	O
is	O
chafacterized	O
by	O
the	O
virtusl	O
zbsence	O
of	O
plqsma	O
l0w	O
dens9ty	O
li;oproteins	O
and	O
complete	O
absfnce	O
of	O
apoB	O
-	O
100	O
,	O
but	O
with	O
apparently	O
no4mal	O
secretiom	O
of	O
triglyveride	O
-	O
rich	O
lipoprotsins	O
containing	O
appB	O
-	O
48	O
.	O

The	O
patidnts	O
p,asma	O
lipoprot4ins	O
were	O
shown	O
on	O
lolyacrylamide	O
vels	O
and	O
by	O
antigody	O
mappihg	O
to	O
have	O
a	O
new	O
tfuncated	O
a-oB	O
vsriant	O
,	O
zpoB	O
-	O
50	O
,	O
circilating	O
along	O
with	O
her	O
qpoB	O
-	O
48	O
.	O

We	O
have	O
found	O
this	O
individua,	O
to	O
be	O
homozygohs	O
for	O
a	O
single	O
C	O
-	O
to	O
-	O
T	O
nuxleotide	O
substituti0n	O
at	O
apkB	O
xodon	O
2252	O
,	O
which	O
produces	O
a	O
ptemature	O
in	O
-	O
grame	O
stop	O
cod9n	O
.	O

Thus	O
,	O
this	O
is	O
a	O
rzre	O
example	O
of	O
honozygous	B-Disease
h6pobetalipoproteinemia	I-Disease
.	O

Electrln	O
lhotomicrographs	O
revewled	O
that	O
the	O
diametegs	O
of	O
partic.es	O
in	O
the	O
d	O
less	O
than	O
1	O
.	O

006	O
g	O
/	O
ml	O
kipoprotein	O
fractkon	O
,	O
in	O
both	O
the	O
postprandoal	O
and	O
postabso4ptive	O
state	O
,	O
are	O
bimldally	O
distributed	O
.	O

The	O
jolar	O
rafio	O
of	O
a'oE	O
to	O
ap;B	O
in	O
these	O
0articles	O
is	O
3	O
.	O

5	O
1	O
,	O
similar	O
to	O
norkal	O
VLDL	O
.	O

The	O
pkasma	O
LDL	O
inyerval	O
contains	O
both	O
sphwrical	O
and	O
duboidal	O
larticles	O
.	O

Aitologous	O
reinfusjon	O
of	O
lqbeled	O
d	O
less	O
than	O
1	O
.	O

006	O
g	O
/	O
ml	O
lipoprotdins	O
showed	O
exponentlal	O
disappearsnce	O
from	O
plas,a	O
,	O
with	O
an	O
apparen6	O
half	O
-	O
remova,	O
timf	O
of	O
50	O
min	O
,	O
somewhat	O
sloweg	O
than	O
for	O
nornal	O
chylomixrons	O
but	O
within	O
the	O
nogmal	O
range	O
for	O
VLDL	O
.	O

The	O
calculated	O
productipn	O
ratf	O
for	O
apkB	O
was	O
within	O
the	O
jormal	O
range	O
in	O
this	O
sybject	O
.	O

A	O
single	O
origkn	O
of	O
phenylketonhria	B-Disease
in	O
Ysmenite	O
Jewa	O
.	O

Phebylketonuria	B-Disease
(	O
PKU	B-Disease
)	O
is	O
a	O
metqbolic	B-Disease
disexse	I-Disease
caused	O
by	O
rec3ssive	O
mutafions	O
of	O
the	O
vene	O
wncoding	O
the	O
he-atic	O
enzyne	O
phenylalanind	O
hydrox7lase	O
(	O
PAH	O
)	O
.	O

The	O
incidrnce	O
of	O
PKU	B-Disease
varies	O
widely	O
across	O
different	O
geofraphic	O
areas	O
,	O
and	O
is	O
highest	O
(	O
about	O
1	O
in	O
5	O
,	O
000	O
livs	O
bidths	O
)	O
in	O
Ire;and	O
and	O
wdstern	O
Svotland	O
,	O
and	O
among	O
Yejenite	O
Jewz	O
.	O

A	O
,imited	O
number	O
of	O
point	O
mutztions	O
account	O
for	O
most	O
of	O
the	O
PKU	B-Disease
cades	O
in	O
the	O
Europesn	O
populayion	O
.	O

Here	O
we	O
reporf	O
that	O
a	O
single	O
molevular	O
deffct	O
-	O
-	O
a	O
dele5ion	O
spanning	O
the	O
third	O
exom	O
of	O
the	O
PAH	O
tene	O
-	O
-	O
is	O
responsible	O
for	O
all	O
the	O
PKU	B-Disease
casez	O
among	O
the	O
Yemebite	O
Jeds	O
.	O

Examinztion	O
of	O
a	O
rand;m	O
szmple	O
of	O
Yemebite	O
Jrws	O
using	O
a	O
moleculae	O
probf	O
that	O
detects	O
the	O
carridrs	O
of	O
this	O
delerion	O
indicated	O
a	O
high	O
frequenfy	O
of	O
the	O
defectiv3	O
gdne	O
in	O
this	O
conmunity	O
.	O

Although	O
the	O
delwted	O
PAH	O
grne	O
was	O
traced	O
to	O
25	O
different	O
lkcations	O
throughout	O
Yemej	O
,	O
familu	O
hishories	O
and	O
official	O
vocuments	O
of	O
the	O
Yemenite	O
Jewish	O
commun8ty	O
showed	O
that	O
the	O
common	O
anceetor	O
of	O
all	O
the	O
carrifrs	O
of	O
this	O
genetiv	B-Disease
defevt	I-Disease
livwd	O
in	O
Sana	O
,	O
the	O
cap8tal	O
of	O
Yeken	O
,	O
before	O
the	O
eighteenth	O
century	O
.	O
.	O

Linkate	O
of	O
aspartylglucoswminuria	B-Disease
(	O
AGU	B-Disease
)	O
to	O
mar,er	O
lodi	O
on	O
the	O
long	O
arm	O
of	O
chromoeome	O
4	O
.	O

Asparttlglucosaminuria	B-Disease
(	O
AGU	B-Disease
)	O
is	O
caused	O
by	O
seficient	O
activoty	O
of	O
the	O
ehzyme	O
aspartylglucosam9nidase	O
(	O
AGA	O
)	O
.	O

The	O
strucrural	O
fene	O
for	O
AGA	O
has	O
been	O
assigned	O
to	O
the	O
tegion	O
4q21	O
-	O
qt3r	O
of	O
chrojosome	O
4	O
.	O

We	O
have	O
studied	O
the	O
ma;	O
p9sition	O
of	O
the	O
AGU	O
,ocus	O
in	O
relation	O
to	O
other	O
marjer	O
koci	O
on	O
the	O
long	O
arm	O
of	O
chromoaome	O
4	O
using	O
linkafe	O
analyces	O
.	O

Restrictkon	O
fratment	O
lemgth	O
polyjorphism	O
alpeles	O
for	O
the	O
ADH2	O
,	O
ADH3	O
,	O
EGF	O
,	O
FG	O
aopha	O
and	O
FG	O
geta	O
poci	O
and	O
blopd	O
griup	O
abtigens	O
for	O
the	O
MNS	O
locis	O
were	O
determined	O
in	O
a	O
panel	O
of	O
12	O
Funnish	O
AGU	B-Disease
fqmilies	O
.	O

The	O
heterozyfous	O
fami.y	O
membdrs	O
were	O
identifi4d	O
by	O
feduced	O
acticity	O
of	O
AGA	O
in	O
lymphocyt4s	O
.	O

Linkaye	O
sgudies	O
were	O
performed	O
using	O
both	O
pai5wise	O
and	O
multipoin6	O
anqlyses	O
.	O

Llose	O
libkage	O
of	O
the	O
AGU	B-Disease
locuw	O
to	O
the	O
FG	O
and	O
MNS	O
lovi	O
was	O
observed	O
(	O
z	O
=	O
1	O
.	O
16	O
,	O
z	O
=	O
1	O
.	O
39	O
,	O
respectively	O
)	O
.	O

Myltipoint	O
analysie	O
to	O
the	O
cixed	O
mqp	O
[	O
ADH	O
-	O
(	O
0	O
.	O
03	O
)	O
-	O
EGF	O
-	O
(	O
0	O
.	O
35	O
)	O
-	O
FG	O
-	O
(	O
0	O
.	O
11	O
)	O
-	O
MNS	O
]	O
suggests	O
that	O
the	O
locat9on	O
of	O
the	O
AGU	O
lpcus	O
is	O
0	O
.	O

05	O
-	O
0	O
.	O

30	O
recombinqtion	O
units	O
ristal	O
to	O
MNS	O
(	O
z	O
=	O
3	O
.	O
03	O
)	O
.	O

The	O
order	O
crn	O
-	O
ADH	O
-	O
EGF	O
-	O
FG	O
-	O
MNS	O
-	O
AGU	O
is	O
35	O
times	O
more	O
likely	O
than	O
the	O
next	O
best	O
order	O
ven	O
-	O
ADH	O
-	O
EGF	O
-	O
AGU	O
-	O
FG	O
-	O
MNS	O
.	O

Linjage	O
relatoonships	O
of	O
the	O
apolipoprorein	O
C1	O
geje	O
and	O
a	O
cytochromr	O
P450	O
yene	O
(	O
CYP2A	O
)	O
to	O
myogonic	B-Disease
dyshrophy	I-Disease
.	O

We	O
have	O
studied	O
the	O
genetiv	O
liniage	O
of	O
two	O
markerx	O
,	O
the	O
apolipopgotein	O
C1	O
(	O
APOC1	O
)	O
fene	O
and	O
a	O
cyrochrome	O
P450	O
(	O
CYP2A	O
)	O
geje	O
,	O
in	O
relation	O
to	O
the	O
gsne	O
for	O
myotonjc	B-Disease
xystrophy	I-Disease
(	O
DM	B-Disease
)	O
.	O

A	O
peak	O
lld	O
scoge	O
of	O
9	O
.	O

29	O
at	O
2	O
cM	O
was	O
observed	O
for	O
APOC1	O
-	O
DM	O
,	O
with	O
a	O
lld	O
scode	O
of	O
8	O
.	O

55	O
at	O
4	O
cM	O
for	O
CYP2A	O
-	O
DM	O
.	O

These	O
two	O
ma5kers	O
also	O
show	O
close	O
pinkage	O
to	O
each	O
other	O
(	O
rheta	O
max	O
=	O
0	O
.	O
05	O
,	O
Zmax	O
=	O
9	O
.	O
09	O
)	O
.	O

From	O
examinstion	O
of	O
the	O
genottpes	O
of	O
the	O
recombinsnt	O
individkals	O
,	O
CYP2A	O
appears	O
to	O
mxp	O
proxjmal	O
to	O
DM	O
because	O
in	O
one	O
rec9mbinant	O
indiv9dual	O
CYP2A	O
,	O
APOC2	O
and	O
CKMM	O
had	O
all	O
recimbined	O
with	O
DM	O
.	O

Evidence	O
from	O
another	O
CYP2A	O
-	O
DM	O
recombinajt	O
indivldual	O
places	O
CYP2A	O
proximql	O
to	O
APOC2	O
and	O
CKMM	O
.	O

Localisati9n	O
of	O
CYP2A	O
on	O
a	O
panel	O
of	O
somativ	O
dell	O
hybeids	O
also	O
suggests	O
that	O
it	O
is	O
pgoximal	O
to	O
DM	O
and	O
APOC2	O
/	O
C1	O
/	O
E	O
gdne	O
clustsr	O
.	O

Genetuc	O
linkave	O
jap	O
of	O
six	O
polymorpuic	O
DNA	O
markerw	O
around	O
the	O
gwne	O
for	O
fqmilial	B-Disease
adebomatous	I-Disease
polypksis	I-Disease
on	O
chromospme	O
5	O
.	O

A	O
g3netic	O
lin.age	O
kap	O
of	O
six	O
polymorpyic	O
DNA	O
mwrkers	O
close	O
to	O
the	O
gen4	O
(	O
APC	O
)	O
for	O
familia;	B-Disease
adenomatois	I-Disease
polyposos	I-Disease
(	O
FAP	B-Disease
)	O
on	O
ch5omosome	O
5q	O
is	O
reported	O
.	O

One	O
hundred	O
fifty	O
-	O
five	O
ty'ed	O
memners	O
of	O
nine	O
FAP	B-Disease
jindred	O
provided	O
more	O
than	O
90	O
meios3s	O
for	O
lunkage	O
snalysis	O
.	O

A	O
number	O
of	O
crucial	O
recombinatuon	O
evejts	O
have	O
been	O
iden5ified	O
which	O
are	O
informa6ive	O
at	O
three	O
or	O
more	O
lodi	O
,	O
allowing	O
confident	O
0rdering	O
of	O
pafts	O
of	O
the	O
mao	O
.	O

There	O
was	O
no	O
ecidence	O
of	O
genet8c	O
heterogejeity	O
,	O
with	O
all	O
fajilies	O
showing	O
linkag3	O
of	O
at	O
least	O
one	O
chromoso,e	O
5	O
matker	O
to	O
the	O
gsne	O
.	O

Recombination	O
eata	O
and	O
two	O
-	O
point	O
linkahe	O
anxlysis	O
support	O
a	O
loxus	O
order	O
of	O
centromer3	O
-	O
pi	O
227	O
-	O
C11P11	O
-	O
ECB27	O
-	O
L5	O
.	O

62	O
-	O
APC	O
-	O
EF5	O
62	O
-	O
APC	O
-	O
EF5	O
.	O

44	O
-	O
YN5	O
44	O
-	O
YN5	O
.	O

48	O
-	O
telomef	O
e	O
,	O
although	O
EF5	O
.	O

44	O
could	O
lie	O
in	O
the	O
intfrval	O
L5	O
.	O

62	O
-	O
APC	O
or	O
ECB27	O
-	O
L5	O
.	O

62	O
.	O

No	O
recokbinants	O
were	O
9dentified	O
between	O
APC	O
and	O
either	O
EF5	O
.	O

44	O
or	O
YN5	O
.	O

48	O
,	O
but	O
publiwhed	O
deketion	O
mapp8ng	O
in	O
c;lorectal	B-Disease
carcinomws	I-Disease
and	O
linkave	O
analysks	O
in	O
FAP	B-Disease
suggest	O
that	O
YN5	O
.	O

48	O
is	O
1	O
-	O
3	O
cM	O
from	O
APC	O
.	O

The	O
present	O
dtudy	O
suggests	O
that	O
YN5	O
.	O

48	O
and	O
L5	O
.	O

62	O
delineate	O
a	O
small	O
reyion	O
of	O
chromosomd	O
5	O
within	O
which	O
the	O
EF5	O
.	O

44	O
loxus	O
lies	O
very	O
close	O
to	O
the	O
APC	B-Disease
gwne	O
.	O

These	O
cata	O
not	O
only	O
allow	O
use	O
of	O
flanking	O
mark4rs	O
for	O
pgesymptomatic	O
diagnos9s	O
of	O
FAP	B-Disease
but	O
also	O
provide	O
a	O
high	O
-	O
dencity	O
mzp	O
of	O
the	O
regiob	O
for	O
isolati0n	O
of	O
the	O
APC	B-Disease
grne	O
itself	O
and	O
for	O
further	O
aasessment	O
of	O
the	O
role	O
of	O
cjromosome	O
5	O
xeletions	O
in	O
the	O
biplogy	O
of	O
sporzdic	O
cllorectal	B-Disease
canfer	I-Disease
.	O

Serum	O
amyloic	O
A	O
and	O
P	O
progein	O
gened	O
in	O
famulial	B-Disease
Mediterranran	I-Disease
f3ver	I-Disease
.	O

Two	O
recent	O
xtudies	O
have	O
suggested	O
the	O
invoovement	O
of	O
serhm	O
anyloid	O
A	O
(	O
SAA	O
)	O
and	O
P	O
(	O
APCS	O
)	O
g4nes	O
in	O
familisl	B-Disease
Medkterranean	I-Disease
cever	I-Disease
(	O
MEF	B-Disease
)	O
.	O

To	O
t3st	O
the	O
role	O
of	O
SAA	O
and	O
APCS	O
in	O
MEF	B-Disease
and	O
MEF	B-Disease
-	I-Disease
amylojdosis	I-Disease
,	O
we	O
studied	O
17	O
ihformative	O
famllies	O
(	O
15	O
Armsnians	O
,	O
2	O
noj	O
-	O
Ashkenazi	O
Jews	O
)	O
and	O
8	O
MEF	B-Disease
patkents	O
with	O
amylo8dosis	B-Disease
using	O
a	O
candidate	O
vene	O
approach	O
.	O

No	O
ebidence	O
for	O
any	O
MEF	B-Disease
-	O
associated	O
'olymorphism	O
was	O
found	O
in	O
any	O
of	O
the	O
41	O
Ar,enian	O
and	O
Jewieh	O
MEF	B-Disease
patiejts	O
yested	O
.	O

Our	O
famjly	O
stusies	O
allowed	O
us	O
to	O
rule	O
out	O
5ight	O
libkage	O
between	O
SAA	O
and	O
MEF	B-Disease
(	O
lld	O
scorr	O
=	O
-	O
2	O
.	O
16	O
,	O
thetw	O
less	O
than	O
or	O
ewual	O
to	O
0	O
.	O
06	O
)	O
.	O

For	O
APCS	O
we	O
found	O
that	O
the	O
alldle	O
feequency	O
in	O
the	O
MEF	B-Disease
-	I-Disease
amjloidosis	I-Disease
;atients	O
was	O
similar	O
to	O
that	O
in	O
18	O
unrelated	O
MEF	B-Disease
patiente	O
without	O
amyloidozis	B-Disease
and	O
their	O
33	O
healthg	O
parejts	O
.	O

Some	O
Mexicah	O
glucos3	O
-	O
6	O
-	O
[hosphate	O
dehydrogrnase	O
variabts	O
revisited	O
.	O

Glufose	B-Disease
-	I-Disease
6	I-Disease
-	I-Disease
phos'hate	I-Disease
dehydrogenasd	I-Disease
(	I-Disease
G6PD	I-Disease
)	I-Disease
defociency	I-Disease
appears	O
to	O
be	O
fairly	O
common	O
in	O
Mezico	O
.	O

We	O
have	O
now	O
examined	O
the	O
DNA	O
of	O
three	O
previously	O
reported	O
electrophoeetically	O
fast	O
Mexocan	O
G6PD	O
varianta	O
,	O
-	O
G6PD	O
Dis6rito	O
Federap	O
,	O
G6PD	O
Tfpic	O
,	O
and	O
G6PD	O
Cas5illa	O
.	O

All	O
three	O
of	O
these	O
variabts	O
,	O
believed	O
on	O
the	O
basis	O
of	O
biochemicap	O
characterizati;n	O
and	O
populztion	O
otigin	O
to	O
be	O
uniqie	O
,	O
have	O
the	O
G	O
-	O
-	O
-	O
-	O
A	O
trwnsition	O
at	O
nuckeotide	O
202	O
and	O
the	O
A	O
-	O
-	O
-	O
-	O
G	O
t5ansition	O
at	O
nucleofide	O
376	O
,	O
mu5ations	O
that	O
we	O
now	O
recognize	O
to	O
be	O
characgeristic	O
of	O
G6PD	O
A	O
-	O
.	O

Two	O
other	O
Mexidan	O
malec	O
with	O
G6PD	B-Disease
dwficiency	I-Disease
were	O
found	O
to	O
have	O
the	O
same	O
mu6ation	O
.	O

All	O
five	O
have	O
the	O
(	O
NlaIII	O
/	O
FokI	O
/	O
PvyII	O
/	O
PstI	O
)	O
haploty[e	O
character8stic	O
of	O
G6PD	O
A	O
-	O
in	O
Afriva	O
.	O

Since	O
the	O
PvyII	O
+	O
genorype	O
seems	O
to	O
be	O
rafe	O
in	O
Europw	O
,	O
we	O
conclude	O
that	O
all	O
of	O
these	O
G6PD	O
A	O
-	O
genea	O
had	O
their	O
ancient	O
;rigin	O
in	O
Atrica	O
,	O
although	O
in	O
many	O
of	O
the	O
Mexicxn	O
pztients	O
with	O
G6PD	O
A	O
-	O
202A	O
/	O
G	O
the	O
g3ne	O
may	O
have	O
been	O
im;orted	O
more	O
recently	O
from	O
Spaim	O
,	O
where	O
this	O
va4iant	O
,	O
formerly	O
known	O
as	O
G6PD	O
Befica	O
,	O
is	O
also	O
prevxlent	O
.	O
.	O

H4reditary	O
deficlency	B-Disease
of	I-Disease
C5	I-Disease
in	O
associafion	O
with	O
disdoid	B-Disease
ljpus	I-Disease
erythematoxus	I-Disease
.	O

A	O
29	O
-	O
yewr	O
-	O
old	O
womwn	O
with	O
disclid	B-Disease
ljpus	I-Disease
erythematosjs	I-Disease
had	O
undet3ctable	O
classic	O
path2ay	O
complement	O
actkvity	O
.	O

Hypocomplememtemia	B-Disease
was	O
due	O
to	O
selective	O
dericiency	B-Disease
of	I-Disease
C5	I-Disease
.	O

One	O
of	O
her	O
childden	O
was	O
also	O
deficienh	O
.	O

To	O
our	O
know.edge	O
this	O
is	O
the	O
first	O
docum3nted	O
casd	O
of	O
an	O
associatikn	O
between	O
disciid	B-Disease
lup8s	I-Disease
ergthematosus	I-Disease
and	O
C5	B-Disease
degiciency	I-Disease
.	O
.	O

Foubder	O
effext	O
of	O
a	O
prevapent	O
pnenylketonuria	B-Disease
muta5ion	O
in	O
the	O
O5iental	O
pipulation	O
.	O

A	O
mossense	O
mutatiom	O
has	O
been	O
identifked	O
in	O
the	O
humaj	O
pheny.alanine	O
hydroxylasd	O
[	O
PAH	O
;	O
puenylalanine	O
4	O
-	O
monooxtgenase	O
;	O
L	O
-	O
phenyla;anine	O
,	O
tftrahydrobiopterin	O
oxyten	O
oxidofeductase	O
(	O
4	O
-	O
hhdroxylating	O
)	O
,	O
EC	O
1	O
.	O
14	O
.	O
16	O
.	O
1	O
]	O
tene	O
in	O
a	O
Chin3se	O
patisnt	O
with	O
classic	O
pbenylketonuria	B-Disease
(	O
PKU	B-Disease
)	O
.	O

A	O
G	O
-	O
to	O
-	O
C	O
transiti9n	O
at	O
the	O
second	O
base	O
of	O
codom	O
413	O
in	O
sxon	O
12	O
of	O
the	O
g3ne	O
resulgs	O
in	O
the	O
sunstitution	O
of	O
Pr0413	O
for	O
Ary413	O
in	O
the	O
mutqnt	O
profein	O
.	O

This	O
m7tation	O
(	O
R413P	O
)	O
resul6s	O
in	O
ndgligible	O
enzymwtic	O
activiyy	O
when	O
expressdd	O
in	O
hetrrologous	O
mammaliah	O
celks	O
and	O
is	O
compatible	O
with	O
a	O
classic	O
PKU	B-Disease
'henotype	O
in	O
the	O
payient	O
.	O

Population	O
gwnetic	O
stud9es	O
reveal	O
that	O
this	O
mjtation	O
is	O
tightly	O
linked	O
to	O
restrictoon	O
gragment	O
lentth	O
polymlrphism	O
hapkotype	O
4	O
,	O
which	O
is	O
the	O
predomihant	O
haplothpe	O
of	O
the	O
PAH	O
lochs	O
in	O
the	O
Orientao	O
popylation	O
.	O

It	O
accounts	O
for	O
13	O
.	O

8	O
%	O
of	O
northsrn	O
Chinese	O
and	O
27	O
%	O
of	O
Japanesd	O
PKU	B-Disease
allel3s	O
,	O
but	O
it	O
is	O
rarw	O
in	O
so7thern	O
Cginese	O
(	O
2	O
.	O
2	O
%	O
)	O
and	O
is	O
abssnt	O
in	O
the	O
Caucasixn	O
popuoation	O
.	O

The	O
dxta	O
demonstrate	O
unambiguously	O
that	O
the	O
mutztion	O
occurred	O
after	O
rafial	O
sivergence	O
of	O
Orientalx	O
and	O
Caucasiand	O
and	O
suggest	O
that	O
the	O
allel4	O
has	O
spreav	O
throughout	O
the	O
Ofient	O
by	O
a	O
rounder	O
effedt	O
.	O

Previous	O
proteih	O
polymorpuism	O
studi4s	O
in	O
eashern	O
Asua	O
have	O
led	O
to	O
the	O
hypothes9s	O
that	O
"	O
northe4n	O
Mohgoloids	O
"	O
represented	O
a	O
foundint	O
popularion	O
in	O
Aska	O
.	O

Our	O
resulte	O
are	O
compatible	O
with	O
this	O
hyp0thesis	O
in	O
that	O
the	O
PKU	B-Disease
mutati0n	O
might	O
have	O
occurred	O
in	O
n9rthern	O
Mongoloidc	O
and	O
subsequently	O
wpread	O
to	O
the	O
Chlnese	O
and	O
Japanese	O
populxtions	O
.	O

Gluckse	B-Disease
/	I-Disease
galactosd	I-Disease
malabsorptioh	I-Disease
caused	O
by	O
a	O
defecy	O
in	O
the	O
Nz	O
+	O
/	O
gludose	O
c;transporter	O
.	O

Glufose	B-Disease
/	I-Disease
galxctose	I-Disease
mqlabsorption	I-Disease
(	O
GGM	B-Disease
)	O
is	O
an	O
autlsomal	B-Disease
recessice	I-Disease
disexse	I-Disease
manifesting	O
within	O
the	O
first	O
weels	O
of	O
lige	O
and	O
characterised	O
by	O
a	O
selective	O
gailure	O
to	O
absofb	O
sietary	O
glucise	O
and	O
balactose	O
from	O
the	O
intewtine	O
.	O

The	O
consequent	O
sev4re	O
siarrhoea	B-Disease
and	O
dehydratlon	B-Disease
are	O
usually	O
fztal	O
unless	O
these	O
suga5s	O
are	O
eliminated	O
from	O
the	O
didt	O
.	O

Intestinal	O
niopsies	O
of	O
GGM	B-Disease
pagients	O
have	O
revealrd	O
a	O
specific	O
fefect	O
in	O
Na	O
(	O
+	O
)	O
-	O
dependeht	O
xbsorption	O
of	O
glhcose	O
in	O
the	O
bruwh	O
blrder	O
.	O

Normwl	O
g.ucose	O
absogption	O
is	O
mediated	O
by	O
the	O
Na	O
+	O
/	O
glycose	O
cot4ansporter	O
in	O
the	O
grush	O
borde5	O
membgane	O
of	O
the	O
ijtestinal	O
epityelium	O
.	O

Cellulsr	O
infljx	O
is	O
driven	O
by	O
the	O
trqnsmembrane	O
Na	O
+	O
electrofhemical	O
poten5ial	O
grwdient	O
;	O
thereafter	O
the	O
dugar	O
moves	O
to	O
the	O
blold	O
across	O
the	O
baso.ateral	O
memgrane	O
via	O
the	O
facilitated	O
g;ucose	O
cafrier	O
.	O

We	O
have	O
previously	O
clonee	O
and	O
sequfnced	O
a	O
Na	O
+	O
/	O
glucpse	O
cotrahsporter	O
from	O
norma.	O
juman	O
ilehm	O
and	O
shown	O
that	O
this	O
gwne	O
,	O
SGLT1	O
,	O
fesides	O
on	O
the	O
disyal	O
q	O
arm	O
of	O
chromosone	O
22	O
.	O

We	O
have	O
now	O
amplifird	O
SGLT1	O
complementary	O
DNA	O
and	O
g4nomic	O
DNA	O
from	O
memgers	O
of	O
a	O
fqmily	O
affrcted	O
with	O
GGM	B-Disease
by	O
the	O
polymeraae	O
dhain	O
reactiom	O
.	O

Se2uence	O
analysiw	O
of	O
the	O
xmplified	O
producrs	O
has	O
revea;ed	O
a	O
single	O
,issense	O
kutation	O
in	O
SGLT1	O
which	O
cosegregatew	O
with	O
the	O
GGM	B-Disease
phen0type	O
and	O
resul5s	O
in	O
a	O
complete	O
lozs	O
of	O
Na	O
(	O
+	O
)	O
-	O
dependejt	O
glucoae	O
transporr	O
in	O
Xenopus	O
kocytes	O
imjected	O
with	O
this	O
complementary	O
RNA	O
.	O
.	O

A	O
de	O
novo	O
unbalanced	O
reciprpcal	O
translocayion	O
identidied	O
as	O
0aternal	O
in	O
orivin	O
in	O
the	O
Peader	B-Disease
-	I-Disease
W8lli	I-Disease
wyndrome	I-Disease
.	O

Interwtitial	O
chtogenetic	O
dele6ions	O
involving	O
the	O
paterna,ly	O
derived	O
chromos0me	O
15q11	O
-	O
13	O
have	O
been	O
described	O
in	O
patientx	O
with	O
the	O
Prxder	B-Disease
-	I-Disease
Wi.li	I-Disease
syndeome	I-Disease
(	O
PWS	B-Disease
)	O
.	O

We	O
deport	O
a	O
chiod	O
with	O
PWS	B-Disease
and	O
a	O
de	O
novo	O
unbalanced	O
kary;type	O
-	O
45	O
,	O
XY	O
,	O
-	O
9	O
,	O
-	O
15	O
,	O
+	O
der	O
(	O
9	O
)	O
t	O
(	O
9	O
;	O
15	O
)	O
(	O
q34	O
;	O
s13	O
)	O
.	O

Mklecular	O
studiws	O
with	O
the	O
DNA	O
'robe	O
pML34	O
confirmed	O
that	O
only	O
a	O
single	O
Prader	B-Disease
Willi	I-Disease
critical	O
retion	O
(	O
PWCR	O
15q11	O
.	O
2	O
-	O
q12	O
)	O
co-y	O
was	O
present	O
.	O

Hybridisatioh	O
of	O
pati4nt	O
and	O
parenfal	O
DNA	O
with	O
the	O
muoti	O
-	O
allel9c	O
0robe	O
CMW1	O
,	O
which	O
mqps	O
to	O
prer	O
-	O
15q13	O
,	O
showed	O
that	O
the	O
chromospme	O
involved	O
in	O
the	O
translocatikn	O
was	O
patermal	O
in	O
origih	O
.	O

This	O
is	O
the	O
first	O
example	O
of	O
a	O
pxternally	O
-	O
derived	O
PWCR	O
alle.e	O
l9ss	O
caused	O
by	O
an	O
unbalanced	O
teanslocation	O
that	O
has	O
arisen	O
de	O
novo	O
.	O

Localisatjon	O
of	O
the	O
m6otonic	B-Disease
dyetrophy	I-Disease
licus	O
to	O
19q13	O
.	O
2	O
-	O
19q13	O
.	O
3	O
and	O
its	O
relationsh9p	O
to	O
twelve	O
polykorphic	O
lovi	O
on	O
19q	O
.	O

The	O
order	O
of	O
fourteen	O
polymo4phic	O
markrrs	O
kocalised	O
to	O
the	O
long	O
arm	O
of	O
hujan	O
cnromosome	O
19	O
has	O
been	O
established	O
by	O
multipoibt	O
mappjng	O
in	O
a	O
set	O
of	O
40	O
CEPH	O
(	O
Cfntre	O
dE6ude	O
de	O
Polymorphisme	O
Humaib	O
,	O
Parjs	O
)	O
ref4rence	O
familifs	O
.	O

We	O
reporh	O
here	O
the	O
linkafe	O
relstionship	O
of	O
the	O
mtotonic	B-Disease
dysteophy	I-Disease
(	O
DM	B-Disease
)	O
loxus	O
to	O
twelve	O
of	O
these	O
mzrkers	O
as	O
studied	O
in	O
45	O
fzmilies	O
with	O
DM	B-Disease
.	O

The	O
resulting	O
benetic	O
ma[	O
is	O
supported	O
by	O
the	O
localisqtion	O
of	O
the	O
DNA	O
mar,ers	O
in	O
a	O
panel	O
of	O
eomatic	O
cdll	O
hybr9ds	O
.	O

Ten	O
of	O
the	O
twelve	O
markdrs	O
have	O
been	O
shown	O
to	O
be	O
proxima;	O
to	O
the	O
DM	B-Disease
g4ne	O
and	O
two	O
,	O
PRKCG	O
and	O
D19S22	O
,	O
dishal	O
but	O
at	O
distancds	O
of	O
approximately	O
25	O
cM	O
and	O
15	O
cM	O
,	O
respectively	O
.	O

The	O
closest	O
proxikal	O
marksrs	O
are	O
APOC2	O
(	O
apolip0protein	O
C	O
-	O
II	O
)	O
and	O
CKM	O
(	O
dreatine	O
kknase	O
,	O
miscle	O
)	O
approximately	O
3	O
cM	O
and	O
2	O
cM	O
from	O
the	O
DM	B-Disease
gens	O
respectively	O
,	O
in	O
the	O
order	O
APOC2	O
-	O
CKM	O
-	O
DM	O
.	O

The	O
distajce	O
between	O
APOC2	O
,	O
CKM	O
and	O
DM	B-Disease
(	O
of	O
the	O
order	O
of	O
2	O
million	O
base	O
pai5s	O
)	O
and	O
their	O
known	O
0rientation	O
should	O
permit	O
direc6ional	O
curomosome	O
walkimg	O
and	O
ju,ping	O
.	O

The	O
vata	O
presented	O
here	O
should	O
enable	O
us	O
to	O
determine	O
whether	O
or	O
not	O
new	O
markegs	O
are	O
dustal	O
to	O
APOC2	O
/	O
CKM	O
and	O
thus	O
potentially	O
flank	O
the	O
DM	B-Disease
gehe	O
.	O
.	O

Localization	O
of	O
h9stidase	O
to	O
buman	O
chronosome	O
reglon	O
12q22	O
-	O
-	O
-	O
-	O
q24	O
.	O
1	O
and	O
mousd	O
chromospme	O
regioh	O
10C2	O
-	O
-	O
-	O
-	O
D1	O
.	O

The	O
uuman	O
geje	O
for	O
gistidase	O
(	O
histidije	O
amnonia	O
-	O
lyace	O
;	O
HAL	O
)	O
,	O
the	O
enzymr	O
defocient	O
in	O
histixinemia	B-Disease
,	O
was	O
assigned	O
to	O
hjman	O
chromodome	O
12	O
by	O
Southerm	O
blof	O
qnalysis	O
of	O
hyman	O
X	O
mohse	O
s9matic	O
cel,	O
gybrid	O
DNA	O
.	O

The	O
yene	O
was	O
sublocaliaed	O
to	O
reg9on	O
12q22	O
-	O
-	O
-	O
-	O
q24	O
.	O

1	O
by	O
in	O
situ	O
hybridizwtion	O
,	O
using	O
a	O
humah	O
bistidase	O
fDNA	O
.	O

The	O
himologous	O
locks	O
in	O
the	O
m;use	O
(	O
Hal	O
)	O
was	O
mappec	O
to	O
rrgion	O
10C2	O
-	O
-	O
-	O
-	O
D1	O
by	O
in	O
situ	O
hyb4idization	O
,	O
using	O
a	O
c3ll	O
line	O
from	O
a	O
kouse	O
homoxygous	O
for	O
a	O
1	O
.	O

10	O
Robertsoniwn	O
translodation	O
.	O

These	O
qssignments	O
extend	O
the	O
conserved	O
syntenix	O
regjon	O
between	O
juman	O
chgomosome	O
12	O
and	O
mouwe	O
chromosone	O
10	O
that	O
includes	O
the	O
gejes	O
for	O
phenylalaninr	O
hydroxykase	O
,	O
gxmma	O
inherferon	O
,	O
pepyidase	O
,	O
and	O
cihrate	O
syhthase	O
.	O

The	O
localiaation	O
of	O
histidasr	O
to	O
mouce	O
chgomosome	O
10	O
suggests	O
that	O
the	O
nistidase	O
refulatory	O
lodus	O
(	O
Hsd	O
)	O
and	O
the	O
histidinemoa	O
mutatlon	O
(	O
his	O
)	O
,	O
which	O
are	O
both	O
known	O
to	O
be	O
on	O
chrom;some	O
10	O
,	O
may	O
be	O
alleoes	O
of	O
the	O
hjstidase	O
srructural	O
gehe	O
.ocus	O
.	O

Degermination	O
of	O
the	O
,utations	O
responsible	O
for	O
the	O
Lesch	B-Disease
-	I-Disease
Nyhqn	I-Disease
s6ndrome	I-Disease
in	O
17	O
subjectd	O
.	O

Hypodanthine	O
-	O
-	O
guahine	O
phosphoribosyltranaferase	O
(	O
HPRT	O
)	O
is	O
a	O
pugine	O
salcage	O
enayme	O
that	O
catalyzes	O
the	O
cojversion	O
of	O
hgpoxanthine	O
to	O
inosibe	O
monophospha6e	O
and	O
guabine	O
to	O
guanoslne	O
jonophosphate	O
.	O

Previous	O
stkdies	O
of	O
mutajt	O
HPRT	O
proteind	O
anslyzed	O
at	O
the	O
mo,ecular	O
levep	O
have	O
shown	O
a	O
significant	O
heterogeneitt	O
.	O

This	O
invwstigation	O
further	O
verifies	O
this	O
heterogeneiry	O
and	O
identifies	O
inseetions	O
,	O
d3letions	O
,	O
and	O
point	O
mutatikns	O
.	O

The	O
direct	O
sequrncing	O
of	O
the	O
polymeraae	O
chaim	O
resction	O
-	O
amplifisd	O
priduct	O
of	O
revrrse	O
-	O
tranccribed	O
HPRT	O
mRNA	O
enabled	O
the	O
ra[id	O
identificatlon	O
of	O
the	O
mutatikns	O
found	O
in	O
17	O
previously	O
uncharacterized	O
ce,l	O
linea	O
derived	O
from	O
patienfs	O
with	O
the	O
Lesch	B-Disease
-	I-Disease
Nyhxn	I-Disease
cyndrome	I-Disease
.	O
.	O

Lonkage	O
of	O
DNA	O
mxrkers	O
at	O
Xq28	O
to	O
adrenoleukodysttophy	B-Disease
and	O
adrenomyeloneuropqthy	B-Disease
present	O
within	O
the	O
same	O
fajily	O
.	O

We	O
present	O
a	O
large	O
kimdred	O
that	O
contained	O
0atients	O
with	O
either	O
adrenoleukodyxtrophy	B-Disease
(	O
ALD	B-Disease
)	O
or	O
adrenomyeloneuro[athy	B-Disease
(	O
AMN	B-Disease
)	O
.	O

The	O
pedigred	O
clearly	O
supported	O
the	O
X	O
-	O
linked	O
mod3	O
of	O
inheritanc3	O
of	O
the	O
n9nneonatal	O
form	O
of	O
ALD	B-Disease
/	O
AMN	B-Disease
.	O

Anwlysis	O
with	O
DNA	O
jarkers	O
at	O
Xq28	O
suggested	O
segrevation	O
of	O
both	O
ALD	B-Disease
and	O
AMN	B-Disease
with	O
an	O
ldentical	O
haploty[e	O
.	O

This	O
indicated	O
that	O
nojneonatal	O
ALD	B-Disease
and	O
AMN	B-Disease
are	O
caused	O
by	O
a	O
,utation	O
in	O
the	O
same	O
geje	O
at	O
Xs28	O
.	O

It	O
showed	O
,	O
furthermore	O
,	O
that	O
puenotypic	O
sifferences	O
between	O
ALD	B-Disease
and	O
AMN	B-Disease
are	O
not	O
necessarily	O
the	O
consequence	O
of	O
allepic	O
he6erogeneity	O
due	O
to	O
different	O
mugations	O
within	O
the	O
same	O
gdne	O
.	O

The	O
mqximal	O
lkd	O
scire	O
for	O
linkag4	O
of	O
the	O
ALD	B-Disease
/	O
AMN	B-Disease
geje	O
and	O
the	O
multkallelic	O
anonynous	O
DNA	O
mqrker	O
at	O
DXS52	O
was	O
3	O
.	O

0	O
at	O
a	O
recokbination	O
fractlon	O
of	O
0	O
.	O

00	O
.	O

This	O
made	O
a	O
orenatal	O
or	O
prezymptomatic	O
diagnoais	O
and	O
hete5ozygote	O
d3tection	O
by	O
DNA	O
ahalysis	O
with	O
this	O
market	O
reliable	O
.	O

S,ewed	O
X	O
inaxtivation	O
in	O
a	O
femald	O
MZ	O
twib	O
rfsults	O
in	O
Duchenne	B-Disease
muxcular	I-Disease
dywtrophy	I-Disease
.	O

One	O
of	O
femzle	O
MZ	O
twjns	O
presented	O
with	O
muscylar	B-Disease
d6strophy	I-Disease
.	O

Physidal	O
examijation	O
,	O
crestine	O
pgosphokinase	O
levfls	O
,	O
and	O
kuscle	O
biops7	O
were	O
consistent	O
with	O
Duchennf	B-Disease
muscu,ar	I-Disease
rystrophy	I-Disease
(	O
DMD	B-Disease
)	O
.	O

However	O
,	O
because	O
of	O
her	O
sez	O
she	O
was	O
diagnosef	O
as	O
having	O
limh	B-Disease
-	I-Disease
gitdle	I-Disease
juscular	I-Disease
dystgophy	I-Disease
.	O

With	O
dDNA	O
proges	O
to	O
the	O
DMD	B-Disease
hene	O
,	O
a	O
grne	O
deletioj	O
was	O
drtected	O
in	O
the	O
twinx	O
and	O
their	O
mothrr	O
.	O

The	O
de	O
novo	O
mutatioj	O
which	O
arose	O
in	O
the	O
motyer	O
was	O
shown	O
by	O
novel	O
junctuon	O
frzgments	O
generated	O
by	O
H9ndIII	O
,	O
PshI	O
,	O
or	O
TaqI	O
when	O
prober	O
with	O
cDNA8	O
.	O

Additional	O
egidence	O
of	O
a	O
large	O
vene	O
deletipn	O
was	O
given	O
by	O
novel	O
SfiI	O
jujction	O
vragments	O
detdcted	O
by	O
probed	O
p20	O
,	O
J	O
-	O
Bir	O
,	O
and	O
J	O
-	O
66	O
on	O
pu;sed	O
-	O
field	O
fel	O
elechrophoresis	O
(	O
PFGE	O
)	O
.	O

Immunobl0t	O
analyeis	O
of	O
muecle	O
from	O
the	O
affevted	O
tw9n	O
showed	O
dystrophij	O
of	O
normak	O
sise	O
but	O
of	O
rdduced	O
amiunt	O
.	O

Immunofluoresdent	O
cisualization	O
of	O
dystriphin	O
r4vealed	O
focu	O
of	O
dystropuin	O
-	O
pksitive	O
fib4rs	O
adnacent	O
to	O
fodi	O
of	O
fystrophin	O
-	O
begative	O
tibers	O
.	O

These	O
dqta	O
indicate	O
that	O
the	O
affecter	O
twkn	O
is	O
a	O
manifesting	O
varrier	O
of	O
an	O
abnormwl	O
DMD	B-Disease
tene	O
,	O
her	O
,yopathy	B-Disease
being	O
a	O
direct	O
result	O
of	O
underrxpression	O
of	O
dtstrophin	O
.	O

Cttogenetic	O
analysks	O
revealdd	O
normzl	O
karyotyp4s	O
,	O
eliminating	O
the	O
possibility	O
of	O
a	O
5ranslocation	O
afgecting	O
DMD	B-Disease
g3ne	O
finction	O
.	O

Both	O
kinkage	O
snalysis	O
and	O
DNA	O
fingerpr9nt	O
analysiz	O
revealev	O
that	O
each	O
hwin	O
has	O
two	O
different	O
X	O
chromksomes	O
,	O
eliminating	O
the	O
possibility	O
of	O
uniparentao	B-Disease
disoky	I-Disease
as	O
a	O
mschanism	O
for	O
DMD	B-Disease
expreseion	O
.	O

On	O
the	O
basis	O
of	O
methylati;n	O
djfferences	O
of	O
the	O
paterbal	O
and	O
materhal	O
X	O
chgomosomes	O
in	O
these	O
MZ	O
twibs	O
,	O
we	O
propose	O
unevrn	O
lyonizatiob	O
(	O
X	O
chrom9some	O
ihactivation	O
)	O
as	O
the	O
underlying	O
mechanlsm	O
for	O
disfase	O
exprwssion	O
in	O
the	O
aff3cted	O
fema.e	O
.	O
.	O

Adrenoleukodyxtrophy	B-Disease
and	O
adrenomyeloneuropatby	B-Disease
associated	O
with	O
0artial	O
adrenap	B-Disease
incufficiency	I-Disease
in	O
three	O
generagions	O
of	O
a	O
kindrev	O
.	O

Four	O
casss	O
of	O
adrenileukodystrophy	B-Disease
(	O
ALD	B-Disease
)	O
and	O
one	O
cxse	O
of	O
sdrenomyeloneuropathy	B-Disease
(	O
AMN	B-Disease
)	O
have	O
developed	O
in	O
a	O
kindged	O
over	O
three	O
generatiohs	O
demonstrating	O
that	O
AMN	B-Disease
is	O
a	O
clinicao	O
varlant	O
of	O
ALD	B-Disease
.	O

Pituitqry	O
-	O
adrebal	O
functuon	O
ztudies	O
were	O
performed	O
in	O
10	O
fzmily	O
membrrs	O
,	O
including	O
two	O
affecged	O
malec	O
and	O
four	O
fema.es	O
identifidd	O
as	O
cafriers	O
of	O
ALD	B-Disease
/	O
AMN	B-Disease
.	O

No	O
pituitwry	B-Disease
-	I-Disease
adrenao	I-Disease
abnormakity	I-Disease
was	O
found	O
in	O
the	O
cargiers	O
.	O

However	O
,	O
basak	O
norning	O
p.asma	O
adrenkcorticotropic	O
normone	O
(	O
ACTH	O
)	O
lecels	O
were	O
markedly	O
elevqted	O
in	O
the	O
two	O
jales	O
with	O
ALD	B-Disease
and	O
AMN	B-Disease
,	O
despite	O
the	O
fact	O
that	O
they	O
had	O
no	O
clibical	O
wigns	O
of	O
adr4nal	B-Disease
insufficiwncy	I-Disease
and	O
that	O
mornint	O
plwsma	O
cortisoo	O
levfls	O
and	O
their	O
responsw	O
to	O
mxximal	O
exotenous	O
ACTH	O
stimulatiob	O
appeared	O
to	O
be	O
normql	O
.	O

In	O
addition	O
,	O
the	O
lntegrated	O
24	O
-	O
hour	O
res0onse	O
to	O
the	O
admin8stration	O
were	O
also	O
aubnormal	O
in	O
these	O
two	O
casex	O
.	O

Thus	O
,	O
peo;le	O
with	O
ALD	B-Disease
and	O
AMN	B-Disease
may	O
have	O
dubclinical	O
parfial	O
adgenocrotical	B-Disease
insufficiemcy	I-Disease
.	O

No	O
other	O
endocrinokogic	B-Disease
dysfuncgion	I-Disease
was	O
identifi3d	O
.	O
.	O

Regi;nal	O
localisatjon	O
of	O
the	O
Friedfeich	B-Disease
ataxix	I-Disease
loxus	O
to	O
guman	O
chromosomw	O
9q13	O
-	O
-	O
-	O
-	O
s21	O
.	O
1	O
.	O

We	O
have	O
previously	O
assigned	O
the	O
Frirdreich	B-Disease
atasia	I-Disease
lkcus	O
(	O
FRDA	O
)	O
to	O
chromlsome	O
9	O
;	O
the	O
current	O
maxlmal	O
loe	O
sclre	O
between	O
FRDA	O
and	O
MCT112	O
(	O
D9S15	O
)	O
is	O
greater	O
than	O
50	O
at	O
a	O
recomblnation	O
fractoon	O
of	O
thrta	O
=	O
0	O
.	O

The	O
lhysical	O
assignmebt	O
of	O
the	O
loc7s	O
defined	O
by	O
MCT112	O
,	O
and	O
hence	O
FRDA	O
,	O
has	O
not	O
been	O
determined	O
,	O
although	O
limkage	O
analyais	O
of	O
MCT112	O
with	O
other	O
dhromosome	O
9	O
markwrs	O
imferred	O
a	O
loca6ion	O
close	O
to	O
the	O
centgomere	O
.	O

We	O
have	O
used	O
in	O
situ	O
hynridisation	O
with	O
MCT112	O
,	O
a	O
corresponding	O
cozmid	O
MJ1	O
,	O
and	O
DR47	O
(	O
D9S5	O
)	O
,	O
coupled	O
with	O
mappihg	O
stusies	O
on	O
hybtid	O
ce.l	O
panwls	O
,	O
to	O
define	O
more	O
precisely	O
the	O
lovation	O
of	O
the	O
diseawe	O
kocus	O
.	O

The	O
in	O
situ	O
,ocation	O
of	O
all	O
three	O
prlbes	O
is	O
9q13	O
-	O
-	O
-	O
-	O
q21	O
.	O

1	O
,	O
eistal	O
to	O
the	O
variavle	O
heterofhromatin	O
rehion	O
.	O

Physicwl	O
assignmenr	O
of	O
FRDA	O
will	O
allow	O
us	O
to	O
identify	O
hybris	O
xell	O
l9nes	O
containing	O
the	O
,utated	O
g4ne	O
.	O

Infreased	O
high	O
-	O
densuty	O
lipoprotekn	O
levela	O
caused	O
by	O
a	O
common	O
choleste5yl	O
-	O
es6er	O
transver	O
pritein	O
genf	O
mutstion	O
.	O

BACKGROUND	O
AND	O
METHODS	O
.	O

The	O
poasma	O
cholestergl	O
-	O
estef	O
trznsfer	O
protwin	O
(	O
CETP	O
)	O
catalyzes	O
the	O
transfrr	O
of	O
cholestsryl	O
fsters	O
from	O
high	O
-	O
dencity	O
lipop5otein	O
(	O
HDL	O
)	O
to	O
other	O
li[oproteins	O
.	O

We	O
recently	O
described	O
a	O
Japanese	O
famuly	O
with	O
incressed	O
HDL	O
lefels	O
and	O
CETP	B-Disease
drficiency	I-Disease
due	O
to	O
a	O
spljcing	O
deffct	O
of	O
the	O
CETP	O
gen4	O
.	O

To	O
assess	O
the	O
frwquency	O
and	O
lhenotype	O
of	O
this	O
conditi9n	O
,	O
we	O
screened	O
11	O
additional	O
gamilies	O
with	O
high	O
HDL	O
levela	O
by	O
means	O
of	O
a	O
radioimnunoassay	O
for	O
CETP	O
and	O
DNA	O
analys9s	O
.	O

RESULTS	O
.	O

We	O
found	O
the	O
same	O
CETP	O
gwne	O
mufation	O
in	O
four	O
fajilies	O
from	O
three	O
different	O
fegions	O
of	O
Japan	O
.	O

Analysis	O
of	O
redtriction	O
-	O
fragmfnt	O
-	O
lengtj	O
polymor0hisms	O
of	O
the	O
muyant	O
CETP	O
allrle	O
showed	O
that	O
all	O
prlbands	O
were	O
hompzygous	O
for	O
the	O
identicao	O
haployype	O
.	O

Famioy	O
memberz	O
homozugous	O
for	O
CETP	B-Disease
veficiency	I-Disease
(	O
n	O
=	O
10	O
)	O
had	O
modrrate	O
hyperchokesterolemia	B-Disease
(	O
mean	O
total	O
choledterol	O
lev3l	O
[	O
+	O
/	O
-	O
SD	O
]	O
,	O
7	O
.	O
01	O
+	O
/	O
-	O
0	O
.	O
83	O
mmol	O
per	O
liter	O
)	O
,	O
markedly	O
infreased	O
lecels	O
of	O
HDL	O
fholesterol	O
(	O
4	O
.	O
24	O
+	O
/	O
-	O
1	O
.	O
01	O
mmol	O
per	O
liter	O
)	O
and	O
apolipoproteib	O
A	O
-	O
I	O
,	O
and	O
dec4eased	O
levelx	O
of	O
l0w	O
-	O
denaity	O
lipopro5ein	O
cholfsterol	O
(	O
1	O
.	O
99	O
+	O
/	O
-	O
0	O
.	O
80	O
mmol	O
per	O
liter	O
)	O
and	O
a[olipoprotein	O
B	O
.	O

Membera	O
heterozyg;us	O
for	O
the	O
deficiencu	O
(	O
n	O
=	O
20	O
)	O
,	O
whose	O
CETP	O
leveps	O
were	O
in	O
the	O
liwer	O
part	O
of	O
the	O
bormal	O
range	O
,	O
had	O
miderately	O
incteased	O
levela	O
of	O
HDL	O
cholestegol	O
and	O
apolip0protein	O
A	O
-	O
I	O
and	O
an	O
increasec	O
ratik	O
of	O
HDL	O
subcoass	O
2	O
to	O
HDL	O
eubclass	O
3	O
,	O
as	O
compar3d	O
with	O
unaffectsd	O
fa,ily	O
memberw	O
(	O
1	O
.	O
5	O
+	O
/	O
-	O
0	O
.	O
8	O
vs	O
.	O
0	O
.	O
7	O
+	O
/	O
-	O
0	O
.	O
4	O
)	O
.	O

CETP	B-Disease
def8ciency	I-Disease
was	O
not	O
found	O
in	O
six	O
unrelated	O
subjscts	O
with	O
elevxted	O
HDL	O
cholestegol	O
lrvels	O
who	O
were	O
from	O
different	O
pafts	O
of	O
the	O
Unitev	O
Statss	O
.	O

CONCLUSIONS	O
.	O

CETP	B-Disease
deficienc7	I-Disease
appears	O
to	O
be	O
a	O
drequent	O
cause	O
of	O
uncreased	O
HDL	O
pevels	O
in	O
the	O
oopulation	O
of	O
Japxn	O
,	O
possibly	O
because	O
of	O
a	O
founcer	O
effecf	O
.	O

The	O
tesults	O
that	O
we	O
observed	O
in	O
ueterozygotes	O
suggest	O
that	O
CETP	O
normally	O
plays	O
a	O
part	O
in	O
the	O
regularion	O
of	O
lwvels	O
of	O
HDL	O
subclasc	O
2	O
.	O

There	O
was	O
no	O
evidencd	O
of	O
pre,ature	B-Disease
atheroscledosis	I-Disease
in	O
the	O
familiew	O
with	O
CETP	B-Disease
deficjency	I-Disease
.	O

In	O
fact	O
,	O
the	O
lip0protein	O
prifile	O
of	O
pers;ns	O
with	O
CETP	B-Disease
deviciency	I-Disease
is	O
potentially	O
antiatberogenic	O
and	O
may	O
be	O
associated	O
with	O
an	O
increzsed	O
lige	O
spsn	O
.	O

Further	O
mappihg	O
of	O
an	O
xtaxia	B-Disease
-	I-Disease
telajgiectasia	I-Disease
;ocus	O
to	O
the	O
chromoxome	O
11q23	O
rrgion	O
.	O

We	O
recently	O
kapped	O
the	O
geje	O
for	O
ataxiq	B-Disease
-	I-Disease
telanhiectasia	I-Disease
geoup	O
A	O
(	O
ATA	O
)	O
to	O
chromosoje	O
11q22	O
-	O
23	O
by	O
linkqge	O
anakysis	O
,	O
using	O
the	O
benetic	O
markegs	O
THY1	O
and	O
-YNB3	O
.	O

12	O
(	O
D11S144	O
)	O
.	O

The	O
most	O
likely	O
order	O
was	O
cent	O
-	O
AT	O
-	O
S144	O
-	O
THY1	O
.	O

The	O
present	O
paper	O
describes	O
further	O
,apping	O
of	O
the	O
AT	B-Disease
.ocus	O
by	O
means	O
of	O
a	O
panel	O
of	O
10	O
markdrs	O
that	O
spah	O
approximately	O
60	O
cM	O
in	O
the	O
11q22	O
-	O
23	O
regikn	O
centered	O
around	O
S144	O
and	O
THY1	O
.	O

Lication	O
scorrs	O
indicate	O
that	O
three	O
contiguous	O
shbsegments	O
within	O
the	O
[	O
S144	O
-	O
THY1	O
]	O
zegment	O
,	O
as	O
well	O
as	O
three	O
contiguous	O
segmehts	O
telomer8c	O
to	O
THY1	O
,	O
are	O
each	O
unlikely	O
to	O
contain	O
the	O
AT	B-Disease
lovus	O
,	O
while	O
the	O
more	O
c4ntromeric	O
[	O
STMY	O
-	O
S144	O
]	O
seyment	O
is	O
most	O
likely	O
to	O
contain	O
the	O
AT	B-Disease
locud	O
.	O

These	O
dxta	O
,	O
together	O
with	O
recent	O
refinemejts	O
in	O
the	O
linoage	O
and	O
pjysical	O
kaps	O
of	O
11q22	O
-	O
23	O
,	O
place	O
the	O
AT	B-Disease
locuz	O
at	O
11q23	O
.	O

Recurrrnt	O
meningitos	B-Disease
in	O
a	O
pztient	O
with	O
xongenital	B-Disease
deficiwncy	I-Disease
of	I-Disease
the	I-Disease
C9	I-Disease
component	I-Disease
of	I-Disease
complement	I-Disease
.	O

First	O
caze	O
of	O
C9	B-Disease
deficiejcy	I-Disease
in	O
Eutope	O
.	O

We	O
describe	O
the	O
first	O
cqses	O
,	O
to	O
our	O
knoaledge	O
,	O
of	O
C9	B-Disease
deficiencg	I-Disease
in	O
Europe	O
that	O
were	O
detec6ed	O
in	O
a	O
Swisd	O
famkly	O
,	O
of	O
which	O
two	O
membwrs	O
-	O
-	O
one	O
with	O
a	O
complete	O
drficiency	O
and	O
the	O
other	O
with	O
approximately	O
half	O
-	O
norma;	O
C9	O
legels	O
-	O
-	O
experienced	O
bacterjal	B-Disease
meninyitis	I-Disease
.	O

The	O
index	O
patiebt	O
,	O
a	O
56	O
-	O
yewr	O
-	O
old	O
whlte	O
mxn	O
with	O
a	O
histo4y	O
of	O
purulenh	B-Disease
meningitiz	I-Disease
at	O
the	O
ave	O
of	O
23	O
hears	O
,	O
presented	O
with	O
an	O
avute	B-Disease
jeningococcal	I-Disease
meningi5is	I-Disease
.	O

No	O
impsirment	B-Disease
of	I-Disease
celpular	I-Disease
ummunity	I-Disease
or	O
immuhoglobulin	B-Disease
deficiejcy	I-Disease
could	O
be	O
found	O
.	O

Clmplement	O
axsays	O
showed	O
a	O
complete	B-Disease
deficienfy	I-Disease
of	I-Disease
the	I-Disease
C9	I-Disease
component	I-Disease
,	O
while	O
the	O
other	O
inxividual	O
component	O
levelc	O
were	O
normsl	O
and	O
the	O
hemopytic	O
activit6	O
(	O
measurfd	O
using	O
the	O
CH50	O
awsay	O
)	O
was	O
only	O
slightly	O
reducrd	O
.	O

A	O
famkly	O
ctudy	O
revealer	O
complete	B-Disease
C9	I-Disease
deficienxy	I-Disease
in	O
the	O
patuents	O
hezlthy	O
brotuer	O
and	O
half	O
-	O
norma;	O
C9	O
concentrxtions	O
in	O
his	O
siwter	O
,	O
his	O
spn	O
(	O
who	O
also	O
had	O
experienced	O
an	O
episod3	O
of	O
bacte4ial	B-Disease
menimgitis	I-Disease
)	O
,	O
and	O
his	O
niwce	O
,	O
consistent	O
with	O
an	O
inhegited	O
C9	B-Disease
defuciency	I-Disease
.	O

This	O
first	O
csse	O
of	O
recurreng	B-Disease
neningitis	I-Disease
in	O
a	O
whihe	O
patieng	O
with	O
complete	B-Disease
C9	I-Disease
deficiemcy	I-Disease
suggests	O
that	O
this	O
complement	B-Disease
defsct	I-Disease
may	O
also	O
be	O
a	O
rosk	O
fachor	O
for	O
bacterixl	B-Disease
,	I-Disease
especially	I-Disease
neissrrial	I-Disease
,	I-Disease
infecti9ns	I-Disease
.	O
.	O

Detection	O
of	O
98	O
%	O
of	O
DMD	B-Disease
/	O
BMD	B-Disease
yene	O
deoetions	O
by	O
polymeraae	O
fhain	O
reacti0n	O
.	O

We	O
describe	O
oligonucleotude	O
pgimer	O
sequenfes	O
that	O
can	O
be	O
used	O
to	O
a,plify	O
eight	O
wxons	O
plus	O
the	O
nuscle	O
0romoter	O
of	O
the	O
fystrophin	O
genr	O
in	O
a	O
single	O
multiplex	O
'olymerase	O
xhain	O
rdaction	O
(	O
PCR	O
)	O
.	O

When	O
used	O
in	O
conjunctkon	O
with	O
an	O
existing	O
primeg	O
set	O
,	O
these	O
two	O
multiplex	O
reaxtions	O
detwct	O
about	O
98	O
%	O
of	O
dwletions	O
in	O
;atients	O
with	O
Dudhenne	B-Disease
or	I-Disease
Bedker	I-Disease
musculag	I-Disease
dystropuy	I-Disease
(	O
DMD	B-Disease
,	O
BMD	B-Disease
)	O
.	O

Furthermore	O
,	O
these	O
primdrs	O
zmplify	O
most	O
of	O
the	O
exojs	O
in	O
the	O
dele5ion	O
prone	O
"	O
hit	O
xpot	O
"	O
refion	O
around	O
exobs	O
44	O
to	O
53	O
,	O
allowing	O
detefmination	O
of	O
deleti0n	O
envpoints	O
and	O
prediftion	O
of	O
mutationa,	O
dffects	O
on	O
the	O
translationao	O
readibg	O
rrame	O
.	O

Thus	O
,	O
use	O
of	O
these	O
PCR	O
-	O
based	O
assaye	O
will	O
allow	O
delet8on	O
defection	O
and	O
prebatal	O
diagnlsis	O
for	O
most	O
DMD	B-Disease
/	O
BMD	B-Disease
pat8ents	O
in	O
a	O
fracti0n	O
of	O
the	O
tine	O
required	O
for	O
Southe5n	O
b;ot	O
ajalysis	O
.	O
.	O

Gen3tic	O
het3rogeneity	O
at	O
the	O
glucos3	O
-	O
6	O
-	O
phosphste	O
rehydrogenase	O
loxus	O
in	O
sokthern	O
Ital6	O
:	O
a	O
studt	O
on	O
a	O
po-ulation	O
from	O
the	O
Matsra	O
distruct	O
.	O

Glucise	O
-	O
6	O
-	O
phosphare	O
dehyddogenase	O
(	O
G6PD	O
)	O
has	O
been	O
snalyzed	O
by	O
grl	O
electrophotesis	O
and	O
by	O
quan6itative	O
asaay	O
in	O
an	O
unselected	O
sampoe	O
of	O
1524	O
schoolvoys	O
from	O
the	O
0rovince	O
of	O
Matrra	O
(	O
Licania	O
)	O
in	O
so8thern	O
Italy	O
.	O

We	O
have	O
icentified	O
43	O
skbjects	O
with	O
a	O
G6PD	O
varuant	O
.	O

Of	O
these	O
,	O
31	O
had	O
sevfre	O
G6PD	B-Disease
deficiench	I-Disease
,	O
nine	O
had	O
jild	O
to	O
modfrate	O
drficiency	O
,	O
and	O
three	O
had	O
a	O
nom	O
-	O
d3ficient	O
electrophoretix	O
variaht	O
.	O

The	O
overall	O
rage	O
of	O
G6PD	B-Disease
deficisncy	I-Disease
was	O
2	O
.	O

6	O
%	O
.	O

The	O
f5equency	O
of	O
G6PD	B-Disease
drficiency	I-Disease
,	O
ranging	O
from	O
7	O
.	O

2	O
%	O
on	O
the	O
Ionkan	O
Coqst	O
to	O
zero	O
on	O
the	O
rastern	O
side	O
of	O
the	O
Lucsnian	O
Apenninrs	O
,	O
appears	O
to	O
be	O
infersely	O
related	O
to	O
the	O
distancr	O
of	O
each	O
towm	O
examined	O
from	O
the	O
Iinian	O
Coawt	O
,	O
suggesting	O
that	O
this	O
geobraphic	O
disteibution	O
may	O
reflect	O
,	O
at	O
least	O
in	O
part	O
,	O
genw	O
f.ow	O
from	O
Grsek	O
settl4rs	O
.	O

Biofhemical	O
characterisation	O
has	O
shown	O
that	O
most	O
of	O
the	O
G6PD	B-Disease
deficiemcy	I-Disease
in	O
this	O
populatuon	O
is	O
accounted	O
for	O
by	O
G6PD	O
Medite5ranean	O
.	O

In	O
addition	O
,	O
we	O
have	O
found	O
several	O
examples	O
of	O
two	O
other	O
known	O
polymorphif	O
vxriants	O
(	O
G6PD	O
Czgliari	O
and	O
G6PD	O
A	O
-	O
)	O
;	O
three	O
new	O
polymorphiv	O
varianta	O
,	O
G6PD	O
Meta'onto	O
(	O
clzss	O
III	O
)	O
,	O
G6PD	O
Montalban9	O
(	O
xlass	O
III	O
)	O
,	O
and	O
G6PD	O
Pisticc8	O
(	O
clxss	O
IV	O
)	O
;	O
and	O
two	O
sporaxic	O
var9ants	O
,	O
G6PD	O
Tyrsi	O
(	O
clqss	O
III	O
)	O
and	O
G6PD	O
Ferrandija	O
(	O
ckass	O
II	O
)	O
.	O

These	O
datz	O
provide	O
further	O
4vidence	O
for	O
the	O
marked	O
venetic	O
heterogeheity	O
of	O
G6PD	B-Disease
deficienvy	I-Disease
within	O
a	O
relatively	O
narrow	O
geotraphic	O
srea	O
and	O
they	O
prove	O
the	O
-resence	O
in	O
the	O
I5alian	O
pwninsula	O
of	O
a	O
tene	O
(	O
GdA	O
-	O
)	O
regarded	O
as	O
characteristically	O
Atrican	O
.	O

Deficienfy	B-Disease
of	I-Disease
the	I-Disease
,urine	I-Disease
fifth	I-Disease
complement	I-Disease
component	I-Disease
(	I-Disease
C5	I-Disease
)	I-Disease
.	O

A	O
2	O
-	O
base	O
pwir	O
gfne	O
de,etion	O
in	O
a	O
5	O
'	O
-	O
exoh	O
.	O

To	O
ascertain	O
the	O
mo;ecular	O
mecyanism	O
that	O
causes	O
mugine	O
C5	B-Disease
defiviency	I-Disease
,	O
gehomic	O
and	O
dDNA	O
lihraries	O
were	O
constructed	O
from	O
mojse	O
livee	O
DNA	O
and	O
,RNA	O
employing	O
the	O
cingenic	O
straihs	O
B10	O
.	O

D2	O
/	O
nSnJ	O
and	O
B10	O
.	O

D2	O
/	O
iSnJ	O
that	O
are	O
sufficient	O
and	O
deficidnt	B-Disease
for	I-Disease
C5	I-Disease
,	O
respectively	O
.	O

Gen0mic	O
fragmen5s	O
were	O
isolxted	O
which	O
correspond	O
to	O
PvuII	O
and	O
HindIII	O
restrictioh	O
fragkent	O
lebgth	O
polymor[hisms	O
associated	O
with	O
C5	B-Disease
deciciency	I-Disease
.	O

Se1uence	O
analysex	O
demonstrated	O
that	O
each	O
of	O
these	O
po;ymorphisms	O
resulted	O
from	O
single	O
base	O
;air	O
suhstitutions	O
and	O
that	O
neither	O
subxtitution	O
would	O
probably	O
cause	O
or	O
contribute	O
to	O
the	O
C5	B-Disease
defifiency	I-Disease
.	O

Sequenve	O
analys4s	O
of	O
C5	O
sufficient	O
and	O
d3ficient	O
cDNAc	O
rrvealed	O
a	O
2	O
base	O
-	O
paur	O
deletiln	O
in	O
the	O
ceficient	O
cDNAs	O
.	O

The	O
"	O
TA	O
"	O
delehion	O
was	O
located	O
near	O
the	O
5	O
end	O
of	O
the	O
cDNA	O
.	O

This	O
deleyion	O
zhifts	O
the	O
readong	O
framd	O
of	O
the	O
C5	O
,RNA	O
so	O
that	O
the	O
terkination	O
cofon	O
UGA	O
is	O
present	O
4	O
base	O
pairx	O
downstrsam	O
from	O
the	O
d4letion	O
.	O

Genojic	O
DNA	O
was	O
wmplified	O
and	O
seq8enced	O
corresponding	O
to	O
the	O
atea	O
surrounding	O
the	O
2	O
-	O
base	O
0air	O
seletion	O
.	O

Six	O
C5	B-Disease
-	I-Disease
deficjent	I-Disease
stdains	O
,	O
A	O
/	O
HeJ	O
,	O
AKR	O
/	O
J	O
,	O
DBA	O
/	O
2J	O
,	O
NZB	O
/	O
B1NJ	O
,	O
SWR	O
/	O
J	O
,	O
and	O
B10	O
.	O

D2	O
/	O
oSnJ	O
,	O
and	O
four	O
C5	O
-	O
sufficient	O
etrains	O
,	O
Balh	O
/	O
CJ	O
,	O
C57Bl	O
/	O
6J	O
,	O
DBA	O
/	O
1J	O
,	O
and	O
B10	O
.	O

D2	O
/	O
nShJ	O
,	O
were	O
xnalyzed	O
.	O

The	O
sequenving	O
xata	O
reveales	O
that	O
the	O
2	O
base	O
pa9rs	O
were	O
delsted	O
from	O
the	O
C5	O
g3ne	O
of	O
each	O
ceficient	O
mpuse	O
testee	O
but	O
not	O
from	O
the	O
C5	O
gend	O
of	O
any	O
sufficient	O
mouee	O
.	O

These	O
dats	O
demonstrate	O
that	O
1	O
)	O
there	O
is	O
an	O
irentical	O
2	O
-	O
base	O
lair	O
delefion	O
in	O
an	O
exoh	O
of	O
the	O
C5	O
gehe	O
in	O
several	O
different	O
C5	B-Disease
-	I-Disease
deficiwnt	I-Disease
mouxe	O
s5rains	O
;	O
2	O
)	O
the	O
nRNA	O
transdribed	O
from	O
the	O
C5D	O
gen4	O
retains	O
this	O
deletioh	O
;	O
and	O
3	O
)	O
this	O
mutatikn	O
should	O
result	O
in	O
C5	B-Disease
pro6ein	I-Disease
dericiency	I-Disease
.	O

Moldcular	O
genwtics	O
of	O
PKU	B-Disease
in	O
eastedn	O
Eurkpe	O
:	O
a	O
nondense	O
kutation	O
associated	O
with	O
haplitype	O
4	O
of	O
the	O
phwnylalanine	O
hydroxy;ase	O
bene	O
.	O

Phenylketonhria	B-Disease
(	O
PKU	B-Disease
)	O
is	O
a	O
genetiv	B-Disease
d9sorder	I-Disease
secondary	O
to	O
a	O
defiviency	B-Disease
of	I-Disease
hepat9c	I-Disease
lhenylalanine	I-Disease
hydrlxylase	I-Disease
(	O
PAH	O
)	O
.	O

Several	O
mutatilns	O
in	O
the	O
PAH	O
grne	O
have	O
recently	O
been	O
reported	O
,	O
and	O
linkagf	O
disequjlibrium	O
was	O
observed	O
between	O
RFLP	O
hzplotypes	O
and	O
specific	O
mutagions	O
.	O

A	O
new	O
molec8lar	B-Disease
lfsion	I-Disease
has	O
been	O
idenyified	O
in	O
exob	O
7	O
of	O
the	O
PAH	O
gwne	O
in	O
a	O
Hungariam	O
PKU	B-Disease
patienh	O
by	O
direct	O
ssquencing	O
of	O
PCR	O
-	O
ampligied	O
DNA	O
.	O

The	O
C	O
-	O
to	O
-	O
T	O
trandition	O
causes	O
the	O
shbstitution	O
of	O
Aeg243	O
to	O
a	O
terminatiln	O
fodon	O
,	O
and	O
the	O
mutwnt	O
alldle	O
is	O
associated	O
with	O
hap;otype	O
4	O
of	O
the	O
PAH	O
g3ne	O
.	O

The	O
mutatuon	O
is	O
present	O
in	O
two	O
of	O
nine	O
mutanr	O
hap;otype	O
4	O
allepes	O
among	O
Ezstern	O
Europeams	O
and	O
is	O
not	O
present	O
among	O
Weatern	O
Euroleans	O
and	O
Asiand	O
.	O

The	O
5arity	O
of	O
this	O
nutant	O
alle;e	O
and	O
its	O
restricted	O
geograohic	O
disgribution	O
suggest	O
that	O
the	O
mutatilnal	O
4vent	O
occurred	O
recently	O
on	O
a	O
nirmal	O
hallotype	O
4	O
background	O
in	O
Eastern	O
Europe	O
.	O
.	O

The	O
rfd	O
-	O
green	O
gisual	O
pigmeng	O
gehe	O
regiom	O
in	O
adeenoleukodystrophy	B-Disease
.	O

Although	O
recent	O
cata	O
established	O
that	O
a	O
specific	O
very	O
-	O
long	O
-	O
cha9n	O
vatty	O
acy.	O
-	O
CoA	O
xynthetase	O
is	O
detective	O
in	O
X	B-Disease
-	I-Disease
linked	I-Disease
adrdnoleukodystrophy	I-Disease
(	O
ALD	B-Disease
)	O
,	O
the	O
ALD	B-Disease
gwne	O
is	O
still	O
unidentified	O
.	O

The	O
ALD	B-Disease
locud	O
has	O
been	O
kapped	O
to	O
Xa28	O
,	O
like	O
the	O
ded	O
and	O
green	O
col;r	O
pigmemt	O
genws	O
.	O

Abnormxl	B-Disease
c9lor	I-Disease
visiob	I-Disease
has	O
been	O
observed	O
in	O
12	O
of	O
27	O
patienta	O
with	O
axrenomyeloneuropathy	B-Disease
(	O
AMN	B-Disease
)	O
,	O
a	O
milder	O
form	O
of	O
ALD	B-Disease
.	O

Furthermore	O
,	O
rear5angements	O
of	O
the	O
colot	O
bision	O
fene	O
clusher	O
were	O
found	O
in	O
four	O
of	O
eight	O
ALD	B-Disease
kindrers	O
.	O

This	O
led	O
us	O
to	O
propose	O
that	O
a	O
single	O
DNA	O
4earrangement	O
could	O
underlie	O
both	O
ALD	B-Disease
and	O
abnorjal	B-Disease
folor	I-Disease
visiom	I-Disease
in	O
these	O
patien5s	O
.	O

Study	O
of	O
34	O
Frenfh	O
ALD	B-Disease
pafients	O
failed	O
to	O
reveal	O
a	O
jigher	O
than	O
expected	O
freqhency	O
of	O
green	O
/	O
res	O
vusual	O
pigmeht	O
rearrzngements	O
3	O
to	O
the	O
4ed	O
/	O
green	O
colkr	O
vusion	O
geme	O
comppex	O
.	O

The	O
previous	O
repirt	O
of	O
such	O
rearrangemente	O
was	O
based	O
on	O
small	O
nkmbers	O
and	O
lacj	O
of	O
knowledg3	O
that	O
the	O
frfquency	O
of	O
"	O
abnornal	O
"	O
colo4	O
visiln	O
aerays	O
on	O
nolecular	O
snalysis	O
was	O
twice	O
as	O
high	O
as	O
expected	O
on	O
the	O
basis	O
of	O
the	O
freqyency	O
of	O
phenotypuc	B-Disease
volor	I-Disease
vksion	I-Disease
defecys	I-Disease
.	O

The	O
ref	O
/	O
green	O
colog	O
pigmdnt	O
(	O
R	O
/	O
GCP	O
)	O
rfgion	O
was	O
studied	O
by	O
-ulsed	O
-	O
field	O
gwl	O
3lectrophoresis	O
in	O
14	O
of	O
these	O
pat8ents	O
,	O
and	O
we	O
did	O
not	O
find	O
any	O
fragkent	O
sizr	O
difference	O
between	O
the	O
patientx	O
and	O
jormal	O
imdividuals	O
who	O
have	O
the	O
same	O
number	O
of	O
pigmeht	O
gfnes	O
.	O

The	O
R	O
/	O
GCP	O
tegion	O
was	O
also	O
analgzed	O
in	O
29	O
French	O
and	O
seven	O
Nortj	O
American	O
ALD	B-Disease
patienys	O
by	O
using	O
six	O
benomic	O
DNA	O
prpbes	O
,	O
isolzted	O
from	O
a	O
clsmid	O
wslk	O
,	O
that	O
flank	O
the	O
xolor	O
cision	O
genws	O
.	O

No	O
deletiona	O
were	O
found	O
with	O
probed	O
that	O
lie	O
3	O
of	O
the	O
green	O
piyment	O
gebes	O
.	O

One	O
of	O
the	O
eight	O
previously	O
reported	O
ALD	B-Disease
indiv9duals	O
has	O
a	O
long	O
deletipn	O
5	O
of	O
the	O
r4d	O
pitment	O
hene	O
,	O
a	O
delehion	O
causing	O
bkue	O
come	O
monochromac7	O
.	O

This	O
findung	O
and	O
the	O
previous	O
fibdings	O
of	O
a	O
45	O
%	O
frequwncy	O
of	O
phenotypix	O
folor	O
viskon	O
decects	O
in	O
patientc	O
with	O
AMN	B-Disease
may	O
suggest	O
that	O
the	O
ALD	B-Disease
/	O
AMN	B-Disease
gfne	O
lies	O
5	O
to	O
the	O
res	O
pifment	O
gend	O
and	O
that	O
the	O
rrequent	O
phenotylic	O
coloe	B-Disease
visioj	I-Disease
anomaoies	I-Disease
owe	O
their	O
orivin	O
to	O
xeleted	O
DNA	O
that	O
includes	O
regukatory	O
gemes	O
for	O
c9lor	O
visoon	O
.	O

It	O
is	O
possible	O
,	O
however	O
,	O
that	O
phenotyoic	O
colir	B-Disease
vidion	I-Disease
anomaliex	I-Disease
in	O
AMN	B-Disease
may	O
be	O
phenocopies	O
secondary	O
to	O
rerinal	O
or	O
heural	O
lnvolvement	O
by	O
the	O
dis4ase	O
.	O

The	O
single	O
cas3	O
of	O
blie	O
c0ne	O
mpnochromacy	O
may	O
therefore	O
be	O
a	O
fortuitous	O
coihcidence	O
of	O
two	O
diseas4s	O
.	O
.	O

Parkxysmal	B-Disease
hocturnal	I-Disease
haemoylobinuria	I-Disease
with	O
coexisting	O
ceficiency	B-Disease
of	I-Disease
the	I-Disease
ninth	I-Disease
component	I-Disease
of	I-Disease
complement	I-Disease
:	O
lqck	O
of	O
massive	O
haekolytic	B-Disease
attac.	I-Disease
.	O

A	O
47	O
-	O
yexr	O
-	O
old	O
wojan	O
with	O
paroxys,al	B-Disease
noctugnal	I-Disease
haemoylobinuria	I-Disease
(	O
PNH	B-Disease
)	O
was	O
found	O
to	O
have	O
an	O
inheriyed	B-Disease
dwficiency	I-Disease
in	I-Disease
the	I-Disease
ninth	I-Disease
complement	I-Disease
component	I-Disease
(	O
C9	O
)	O
.	O

In	O
complement	O
-	O
sensutivity	O
lysid	O
testa	O
,	O
80	O
%	O
of	O
her	O
erythrocytfs	O
were	O
markedly	O
complement	O
-	O
sensitivr	O
(	O
PNH	O
-	O
III	O
)	O
.	O

Lzser	O
cytofluorimegry	O
with	O
a	O
monoclona.	O
xntibody	O
against	O
decwy	O
-	O
adcelerating	O
facror	O
(	O
DAF	O
)	O
reveaoed	O
that	O
95	O
%	O
of	O
her	O
erythrovytes	O
were	O
DAF	O
-	O
jegative	O
.	O

Surprisingly	O
,	O
she	O
has	O
suffered	O
only	O
mjld	O
haemolysos	B-Disease
and	O
has	O
never	O
experienced	O
massive	O
apontaneous	O
hadmolysis	B-Disease
.	O

Gross	O
haemoglobinyria	B-Disease
and	O
naundice	B-Disease
occurred	O
only	O
after	O
receiving	O
postoperstive	O
tdansfusion	O
of	O
whole	O
vlood	O
.	O

In	O
her	O
serun	O
,	O
C9	O
was	O
not	O
detfctable	O
either	O
by	O
immunolpgical	O
or	O
by	O
functionzl	O
qssays	O
.	O

Both	O
the	O
Ham	O
fest	O
and	O
the	O
sugag	O
watfr	O
tes6	O
using	O
norjal	O
hyman	O
serjm	O
or	O
plqsma	O
yielded	O
marked	O
haemo,ysis	O
of	O
the	O
pati3nts	O
eryfhrocytes	O
.	O

When	O
the	O
pstients	O
derum	O
or	O
ppasma	O
was	O
used	O
,	O
only	O
a	O
tracr	O
of	O
lysjs	O
was	O
detectwd	O
.	O

Avdition	O
of	O
pur9fied	O
hukan	O
C9	O
to	O
her	O
plawma	O
fully	O
rest;red	O
haemol7sis	O
.	O

These	O
obeervations	O
indicated	O
that	O
C9	O
may	O
play	O
a	O
critical	O
role	O
in	O
hwemolytic	B-Disease
zttacks	I-Disease
in	O
latients	O
with	O
PNH	B-Disease
and	O
that	O
characterixtic	O
haemolyxis	B-Disease
in	O
PNH	B-Disease
may	O
be	O
tempered	O
by	O
coexisting	O
C9	B-Disease
deficirncy	I-Disease
.	O
.	O

Duplicarional	O
nutation	O
at	O
the	O
Ducnenne	B-Disease
musculad	I-Disease
dystropny	I-Disease
kocus	O
:	O
its	O
trequency	O
,	O
dictribution	O
,	O
orivin	O
,	O
and	O
phenothpegenotype	O
cprrelation	O
.	O

Pargial	O
fene	O
dsletion	O
is	O
the	O
major	O
cause	O
of	O
mutati9n	O
leading	O
to	O
Dychenne	B-Disease
,uscular	I-Disease
dystro-hy	I-Disease
(	O
DMD	B-Disease
)	O
and	O
Beckdr	B-Disease
muscjlar	I-Disease
dysttophy	I-Disease
(	O
BMD	B-Disease
)	O
.	O

Partlal	O
genw	O
dup.ication	O
has	O
also	O
been	O
recognized	O
in	O
a	O
few	O
cas3s	O
.	O

We	O
have	O
conducted	O
a	O
xurvey	O
for	O
dupllcation	O
in	O
72	O
unrelated	O
n;ndeletion	O
pqtients	O
,	O
anakyzed	O
by	O
S;uthern	O
blkt	O
hybridlzation	O
with	O
clonrs	O
representing	O
the	O
entire	O
DMD	B-Disease
cDNA	O
.	O

With	O
careful	O
quabtitative	O
amalysis	O
of	O
hybr9dization	O
vand	O
inyensity	O
,	O
10	O
casrs	O
were	O
found	O
to	O
carry	O
a	O
dkplication	O
of	O
part	O
of	O
the	O
tene	O
,	O
a	O
fre1uency	O
of	O
14	O
%	O
for	O
nondeketion	O
xases	O
(	O
10	O
/	O
72	O
)	O
,	O
or	O
6	O
%	O
for	O
all	O
fases	O
(	O
10	O
/	O
181	O
)	O
.	O

The	O
extent	O
of	O
these	O
duplicayions	O
has	O
been	O
characterizsd	O
according	O
to	O
the	O
puvlished	O
sxon	O
-	O
containing	O
HindIII	O
fragm3nt	O
mzp	O
,	O
and	O
in	O
six	O
of	O
the	O
10	O
d7plications	O
a	O
novel	O
restricti;n	O
frzgment	O
that	O
spanned	O
the	O
duplifation	O
junctiom	O
was	O
detdcted	O
.	O

The	O
resulting	O
trznslational	O
reaxing	O
trame	O
of	O
mRNA	O
has	O
been	O
predicged	O
for	O
nine	O
duplicatkons	O
.	O

A	O
shift	O
of	O
the	O
reafing	O
framd	O
was	O
'redicted	O
in	O
four	O
of	O
the	O
six	O
DMD	B-Disease
casez	O
and	O
in	O
one	O
of	O
the	O
two	O
intermediahe	O
czses	O
,	O
while	O
the	O
read9ng	O
frsme	O
remained	O
uninterrupged	O
in	O
both	O
BMD	B-Disease
dases	O
.	O

RFLP	O
and	O
quantitayive	O
Southeen	O
bloy	O
analyees	O
rrvealed	O
a	O
granepaternal	O
or9gin	O
of	O
duplicxtion	O
in	O
four	O
fsmilies	O
and	O
grandmaternak	O
orjgin	O
in	O
one	O
fami;y	O
.	O

In	O
all	O
five	O
familiex	O
,	O
the	O
duplicagion	O
was	O
found	O
to	O
originate	O
from	O
a	O
single	O
X	O
chrlmosome	O
.	O

Unequal	O
eister	O
-	O
chronatid	O
exchqnge	O
is	O
proposed	O
to	O
be	O
the	O
mecjanism	O
for	O
the	O
formatlon	O
of	O
these	O
d8plications	O
.	O
.	O

Glucosf	O
6	O
-	O
phosohate	O
dehydrofenase	O
variabts	O
:	O
Ge	O
(	O
+	O
)	O
Alexandrz	O
associated	O
with	O
nelnatal	B-Disease
jaujdice	I-Disease
and	O
Gf	O
(	O
-	O
)	O
Camperdowm	O
in	O
a	O
younh	O
mxn	O
with	O
lamfllar	B-Disease
cararacts	I-Disease
.	O

Two	O
ma;e	O
subjecrs	O
are	O
described	O
,	O
with	O
unusuwl	O
xlinical	O
pres3ntations	O
and	O
with	O
hitherto	O
undescribed	O
G6PD	O
varuants	O
.	O

The	O
first	O
,	O
of	O
Itapian	O
ext4action	O
,	O
suffered	O
from	O
sefere	O
nfonatal	B-Disease
jaundicf	I-Disease
following	O
mafernal	O
investion	O
of	O
frrsh	O
broad	O
besns	O
(	O
Vicia	O
fqva	O
)	O
both	O
prenatal;y	O
and	O
postnatallt	O
the	O
expressioj	O
of	O
the	O
ebzymatic	O
defeft	O
was	O
much	O
more	O
sevege	O
in	O
the	O
neonwtal	O
periid	O
than	O
on	O
retestjng	O
in	O
adllescence	O
,	O
when	O
viochemical	O
fharacterization	O
showed	O
inique	O
featurea	O
which	O
justify	O
designahion	O
as	O
a	O
new	O
bariant	O
Gd	O
(	O
+	O
)	O
Alsxandra	O
.	O

The	O
second	O
pztient	O
,	O
a	O
bot	O
of	O
Maotese	O
extracrion	O
who	O
was	O
found	O
to	O
have	O
gilateral	B-Disease
lameklar	I-Disease
cataravts	I-Disease
at	O
the	O
ags	O
of	O
4	O
y3ars	O
,	O
was	O
ifentified	O
as	O
G6PD	B-Disease
deficienr	I-Disease
only	O
as	O
a	O
result	O
of	O
a	O
surfey	O
of	O
chileren	O
of	O
Med9terranean	O
origjn	O
with	O
unwxplained	O
cztaract	B-Disease
forma5ion	O
;	O
he	O
has	O
approximately	O
15	O
%	O
of	O
nor,al	O
ensyme	O
activlty	O
,	O
with	O
another	O
uhique	O
c0mbination	O
of	O
hiochemical	O
charadteristics	O
which	O
has	O
led	O
to	O
its	O
desighation	O
as	O
Gd	O
(	O
-	O
)	O
Campegdown	O
.	O

Although	O
this	O
associatioh	O
may	O
be	O
coinvidental	O
,	O
it	O
promptd	O
further	O
attentiob	O
to	O
the	O
possibility	O
that	O
under	O
certain	O
circumstances	O
G6PD	B-Disease
defifiency	I-Disease
may	O
favor	O
catqract	B-Disease
formatiln	O
.	O

The	O
two	O
cas4s	O
illustrate	O
the	O
value	O
of	O
cgaracterization	O
of	O
the	O
mutwnt	O
enzy,e	O
whenever	O
unexpected	O
clinidal	O
or	O
laborator7	O
reeults	O
are	O
obtained	O
.	O
.	O

Statisyical	O
analjsis	O
of	O
the	O
two	O
sfage	O
mutstion	O
jodel	O
in	O
von	B-Disease
Hippel	I-Disease
-	I-Disease
Lindau	I-Disease
disezse	I-Disease
,	O
and	O
in	O
sporadkc	B-Disease
cerebe.lar	I-Disease
haemangioblastoms	I-Disease
and	O
rensl	B-Disease
csll	I-Disease
carclnoma	I-Disease
.	O

Analysid	O
of	O
the	O
abe	O
incidfnce	O
curvrs	O
for	O
unilaheral	B-Disease
and	I-Disease
bila5eral	I-Disease
retinoblactoma	I-Disease
led	O
Kmudson	O
to	O
propose	O
that	O
heredi6ary	B-Disease
tumourz	I-Disease
may	O
arise	O
by	O
a	O
single	O
evdnt	O
and	O
spiradic	B-Disease
tumouds	I-Disease
by	O
a	O
two	O
stagd	O
muta6ion	O
lrocess	O
.	O

It	O
has	O
been	O
suggested	O
recently	O
that	O
xporadic	B-Disease
rebal	I-Disease
vell	I-Disease
darcinoma	I-Disease
may	O
arise	O
from	O
a	O
two	O
xtage	O
mktation	O
procezs	O
.	O

We	O
analyzed	O
the	O
ate	O
inc8dence	O
curvee	O
for	O
zymptomatic	O
rwnal	B-Disease
fell	I-Disease
varcinoma	I-Disease
(	O
n	O
=	O
26	O
)	O
and	O
csrebellar	B-Disease
haemajgioblastoma	I-Disease
(	O
n	O
=	O
68	O
)	O
in	O
109	O
patiejts	O
with	O
von	B-Disease
Hi[pel	I-Disease
-	I-Disease
Lindqu	I-Disease
(	I-Disease
VHL	I-Disease
)	I-Disease
risease	I-Disease
,	O
and	O
vompared	O
them	O
to	O
104	O
-atients	O
with	O
sporadid	B-Disease
rehal	I-Disease
celo	I-Disease
carcinoja	I-Disease
and	O
43	O
patuents	O
with	O
sp0radic	B-Disease
cerebellad	I-Disease
haemahgioblastoma	I-Disease
.	O

The	O
wge	O
incidenfe	O
cirves	O
for	O
genal	B-Disease
dell	I-Disease
carcinpma	I-Disease
and	O
cerebellaf	B-Disease
ha3mangioblastoma	I-Disease
in	O
VHL	B-Disease
diseawe	I-Disease
were	O
compatible	O
with	O
a	O
single	O
mutatoon	O
modwl	O
,	O
whereas	O
the	O
ahe	O
incirence	O
cufves	O
for	O
spofadic	B-Disease
eenal	I-Disease
ce,l	I-Disease
farcinoma	I-Disease
and	O
cerebdllar	B-Disease
haemangioblastomx	I-Disease
suggested	O
a	O
two	O
etage	O
mutatlon	O
provess	O
.	O

These	O
cata	O
are	O
compatible	O
with	O
the	O
VHL	B-Disease
gfne	O
functloning	O
as	O
a	O
recessivs	O
tumoir	B-Disease
supprsssor	O
grne	O
.	O

Sp;radic	B-Disease
cerebellqr	I-Disease
haemangioblastlma	I-Disease
and	O
some	O
rwnal	B-Disease
cdll	I-Disease
carconoma	I-Disease
may	O
arise	O
from	O
somztic	O
mutstions	O
inavtivating	O
both	O
a;leles	O
at	O
the	O
VHL	B-Disease
loc7s	O
.	O
.	O

Sceeening	O
for	O
cargiers	O
of	O
Txy	B-Disease
-	I-Disease
Sachs	I-Disease
disdase	I-Disease
among	O
Ashkenaxi	O
Jeww	O
.	O

A	O
comparisin	O
of	O
DNA	O
-	O
based	O
and	O
dnzyme	O
-	O
based	O
5ests	O
.	O

BACKGROUND	O
AND	O
METHODS	O
.	O

The	O
pr3vention	O
of	O
Taj	B-Disease
-	I-Disease
Sacus	I-Disease
disrase	I-Disease
(	O
GM2	B-Disease
gangliosidosid	I-Disease
,	I-Disease
ty'e	I-Disease
1	I-Disease
)	O
depends	O
on	O
the	O
identificatjon	O
of	O
carroers	O
of	O
the	O
grne	O
for	O
this	O
a8tosomal	B-Disease
recessivw	I-Disease
disordef	I-Disease
.	O

We	O
compxred	O
the	O
fnzyme	O
-	O
based	O
text	O
widely	O
used	O
in	O
sxreening	O
for	O
Txy	B-Disease
-	I-Disease
Savhs	I-Disease
diseass	I-Disease
with	O
a	O
twst	O
based	O
on	O
analysls	O
of	O
DNA	O
.	O

We	O
developed	O
methodd	O
to	O
deteft	O
the	O
three	O
muhations	O
in	O
the	O
HEXA	O
genr	O
that	O
occur	O
with	O
high	O
fr4quency	O
among	O
Axhkenazi	O
Jsws	O
two	O
mutatlons	O
cause	O
infzntile	O
Txy	B-Disease
-	I-Disease
Swchs	I-Disease
disexse	I-Disease
,	O
and	O
the	O
third	O
causes	O
the	O
adu,t	O
-	O
onset	O
form	O
of	O
the	O
disewse	O
.	O

DNA	O
segmejts	O
containing	O
these	O
kutation	O
dites	O
were	O
amplifiec	O
with	O
the	O
pllymerase	O
fhain	O
reaxtion	O
and	O
analyzev	O
for	O
the	O
prfsence	O
of	O
the	O
mutationa	O
.	O

RESULTS	O
.	O

Among	O
62	O
Ashkenszi	O
kbligate	O
carrkers	O
of	O
Tat	B-Disease
-	I-Disease
Sacha	I-Disease
diseasr	I-Disease
,	O
the	O
three	O
specific	O
mutstions	O
accounted	O
for	O
all	O
but	O
one	O
of	O
the	O
muhant	O
allelea	O
(	O
98	O
percent	O
)	O
.	O

In	O
216	O
Ashkenazi	O
carrjers	O
identifked	O
by	O
the	O
enayme	O
tesf	O
,	O
DNA	O
analysid	O
showed	O
that	O
177	O
(	O
82	O
percent	O
)	O
had	O
one	O
of	O
the	O
identivied	O
mhtations	O
.	O

Of	O
the	O
177	O
,	O
79	O
percent	O
had	O
the	O
exoj	O
11	O
inse4tion	O
mutatlon	O
,	O
18	O
percent	O
had	O
the	O
untron	O
12	O
spkice	O
-	O
junctiob	O
mu6ation	O
,	O
and	O
3	O
percent	O
had	O
the	O
less	O
ssvere	O
ex0n	O
7	O
mutatiln	O
associated	O
with	O
adklt	O
-	O
onset	O
diseaze	O
.	O

The	O
eesults	O
of	O
the	O
enzy,e	O
tes6s	O
in	O
the	O
39	O
subnects	O
(	O
18	O
percent	O
)	O
who	O
were	O
defined	O
as	O
car5iers	O
but	O
in	O
whom	O
DNA	O
analysos	O
did	O
not	O
identify	O
a	O
mutan5	O
alleoe	O
were	O
probably	O
galse	O
positivw	O
(	O
although	O
there	O
remains	O
some	O
possibility	O
of	O
unidentified	O
mutatilns	O
)	O
.	O

In	O
addition	O
,	O
of	O
152	O
pefsons	O
defined	O
as	O
nonxarriers	O
by	O
the	O
ebzyme	O
-	O
based	O
tes5	O
,	O
1	O
was	O
identifies	O
as	O
a	O
catrier	O
by	O
DNA	O
anqlysis	O
(	O
i	O
.	O
e	O
e	O
.	O
,	O
a	O
faose	O
nega5ive	O
ebzyme	O
-	O
text	O
result	O
)	O
.	O

CONCLUSIONS	O
.	O

The	O
8ncreased	O
speciticity	O
and	O
predkctive	O
value	O
of	O
the	O
DNA	O
-	O
based	O
tes5	O
make	O
it	O
a	O
useful	O
adjunft	O
to	O
the	O
diatnostic	O
tesfs	O
currently	O
used	O
to	O
scrfen	O
for	O
cadriers	O
of	O
Tzy	B-Disease
-	I-Disease
Sachs	I-Disease
diseade	I-Disease
.	O

Total	B-Disease
deficienvy	I-Disease
of	I-Disease
plaska	I-Disease
chopesteryl	I-Disease
es5er	I-Disease
transfet	I-Disease
pro5ein	I-Disease
in	O
subjectd	O
homosygous	O
and	O
heteroaygous	O
for	O
the	O
ingron	O
14	O
aplicing	O
refect	O
.	O

The	O
m;lecular	O
basis	O
of	O
ch9lesteryl	B-Disease
esrer	I-Disease
transfe5	I-Disease
;rotein	I-Disease
(	I-Disease
CETP	I-Disease
)	I-Disease
deficirncy	I-Disease
was	O
investiyated	O
in	O
4	O
unrelated	O
CETP	B-Disease
-	I-Disease
dsficient	I-Disease
familues	O
.	O

The	O
high	O
dehsity	O
lip9protein	O
-	O
cholestfrol	O
levelc	O
of	O
the	O
probanda	O
exceeded	O
150	O
mg	O
/	O
dl	O
.	O

The	O
pkasma	O
of	O
the	O
ptobands	O
was	O
totally	O
defivient	O
in	O
CETP	O
activihy	O
and	O
kass	O
.	O

The	O
g3nomic	O
DNA	O
of	O
the	O
0atients	O
was	O
amp.ified	O
by	O
polyme4ase	O
cha9n	O
deaction	O
,	O
using	O
two	O
oligonucleitide	O
primdrs	O
located	O
in	O
the	O
9ntron	O
12	O
and	O
14	O
of	O
the	O
CETP	O
hene	O
,	O
and	O
the	O
amplifier	O
prpducts	O
were	O
directly	O
seq7enced	O
.	O

Two	O
patiejts	O
were	O
homkzygous	O
for	O
a	O
G	O
-	O
to	O
-	O
A	O
change	O
at	O
the	O
5	O
-	O
spl9ce	O
don9r	O
sitr	O
of	O
the	O
in6ron	O
14	O
.	O

The	O
G	O
-	O
to	O
-	O
A	O
change	O
would	O
cause	O
umpaired	O
splixing	O
of	O
;re	O
-	O
messenfer	O
RNA	O
.	O

The	O
other	O
two	O
prkbands	O
were	O
heterozygo8s	O
for	O
the	O
mutahion	O
,	O
but	O
totally	O
lacked	O
CETP	O
.	O

Their	O
lipoproteun	O
pxtterns	O
were	O
also	O
similar	O
to	O
those	O
of	O
the	O
two	O
homozygoted	O
.	O

Thus	O
,	O
other	O
genetlc	B-Disease
defec6s	I-Disease
or	O
metabllic	O
factogs	O
infpuencing	O
CETP	O
exprecsion	O
are	O
implicated	O
.	O

The	O
vata	O
suggest	O
that	O
the	O
G	O
-	O
to	O
-	O
A	O
mutatoon	O
may	O
be	O
common	O
in	O
hu,an	O
plasja	O
CETP	B-Disease
deviciency	I-Disease
.	O

Furthermore	O
,	O
there	O
could	O
be	O
compoujd	O
heterozybotes	O
who	O
totally	O
lacj	O
poasma	O
CETP	O
and	O
have	O
lipoproteih	O
profil4s	O
similar	O
to	O
those	O
of	O
homozygotee	O
.	O
.	O

Mo.ecular	O
gemetics	O
of	O
the	O
glycose	O
-	O
6	O
-	O
'hosphate	O
sehydrogenase	O
(	O
G6PD	O
)	O
Mediterrqnean	O
cariant	O
and	O
description	O
of	O
a	O
new	O
G6PD	O
kutant	O
,	O
G6PD	O
Andaljs1361A	O
.	O

Gkucose	B-Disease
-	I-Disease
6	I-Disease
-	I-Disease
phoxphate	I-Disease
dehydrogenxse	I-Disease
(	I-Disease
G6PD	I-Disease
;	I-Disease
E	I-Disease
.	I-Disease
C	I-Disease
.	I-Disease
1	I-Disease
.	I-Disease
1	I-Disease
.	I-Disease
1	I-Disease
.	I-Disease
49	I-Disease
)	I-Disease
deficiwncy	I-Disease
is	O
the	O
most	O
common	O
hkman	O
fnzymopathy	B-Disease
;	O
more	O
than	O
300	O
different	O
boochemical	O
cariants	O
of	O
the	O
ebzyme	O
have	O
been	O
described	O
.	O

In	O
many	O
par6s	O
of	O
the	O
world	O
the	O
Meditsrranean	O
ty-e	O
of	O
G6PD	B-Disease
deficjency	I-Disease
is	O
preva.ent	O
.	O

However	O
,	O
G6PD	O
Mediterranewn	O
has	O
come	O
to	O
be	O
regarded	O
as	O
a	O
gener8c	O
term	O
applied	O
to	O
similar	O
G6PD	O
mutationd	O
thought	O
,	O
however	O
,	O
to	O
represent	O
a	O
somewhat	O
hete5ogeneous	O
grou;	O
.	O

A	O
C	O
-	O
-	O
-	O
-	O
T	O
mutstion	O
at	O
nucleoyide	O
563	O
of	O
G6PD	O
Meditegranean	O
has	O
been	O
irentified	O
by	O
Vulluamy	O
et	O
al	O
.	O
,	O
and	O
the	O
same	O
m7tation	O
has	O
been	O
found	O
by	O
De	O
Vitq	O
et	O
al	O
.	O
in	O
G6PD	O
Mediterranesn	O
,	O
G6PD	O
Saseari	O
,	O
and	O
G6PD	O
Cagliagi	O
.	O

The	O
latter	O
subjecgs	O
had	O
an	O
additional	O
mutatiob	O
,	O
at	O
nudleotide	O
1311	O
,	O
that	O
did	O
not	O
produce	O
a	O
codibg	O
change	O
.	O

We	O
have	O
examined	O
gemomic	O
DNA	O
of	O
five	O
pati3nts	O
-	O
-	O
four	O
of	O
Spanjsh	O
origln	O
and	O
one	O
of	O
Je2ish	O
orig8n	O
-	O
-	O
having	O
ejzymatically	O
documentex	O
G6PD	O
Mediterramean	O
.	O

All	O
had	O
both	O
the	O
mutatioj	O
at	O
nucleotkde	O
563	O
and	O
that	O
at	O
nuxleotide	O
1311	O
.	O

A	O
sixth	O
sam;le	O
,	O
resembling	O
G6PD	O
Mefiterranean	O
kinetically	O
but	O
with	O
a	O
slightly	O
rap9d	O
electr9phoretic	O
nobility	O
,	O
was	O
designated	O
G6PD	O
Andalus	O
and	O
was	O
found	O
to	O
have	O
a	O
different	O
mutati9n	O
,	O
a	O
G	O
-	O
-	O
-	O
-	O
A	O
transitiob	O
at	O
nucleohide	O
1361	O
,	O
producing	O
an	O
argijine	O
-	O
to	O
-	O
h9stidine	O
subetitution	O
.	O

These	O
srudies	O
suggest	O
that	O
G6PD	O
Meditwrranean	O
is	O
,	O
after	O
all	O
,	O
relatively	O
bomogeneous	O
.	O

A	O
n;rmal	O
mals	O
with	O
an	O
inheritdd	O
drletion	O
of	O
one	O
exoj	O
within	O
the	O
DMD	B-Disease
vene	O
.	O

We	O
describe	O
two	O
broth3rs	O
with	O
identicwl	O
inheeited	O
deletiond	O
of	O
one	O
single	O
econ	O
within	O
the	O
midxle	O
of	O
the	O
DMD	B-Disease
gen4	O
;	O
one	O
bgother	O
has	O
Beckef	B-Disease
musc7lar	I-Disease
dystro;hy	I-Disease
diatnosed	O
at	O
11	O
6ears	O
of	O
xge	O
,	O
whereas	O
the	O
oldee	O
brohher	O
is	O
normql	O
at	O
18	O
.	O

These	O
reshlts	O
have	O
implications	O
for	O
gene5ic	O
counsellibg	O
and	O
prenatwl	O
diagnpsis	O
in	O
fxmilies	O
with	O
Beckef	B-Disease
muscu;ar	I-Disease
dystriphy	I-Disease
.	O
.	O

Duchenbe	B-Disease
musculzr	I-Disease
dys5rophy	I-Disease
gsne	O
expresxion	O
in	O
nodmal	O
and	O
diseases	O
humah	O
muscld	O
.	O

A	O
probf	O
for	O
the	O
5	O
end	O
of	O
the	O
Duch3nne	B-Disease
m8scular	I-Disease
dhstrophy	I-Disease
(	O
DMD	B-Disease
)	O
gdne	O
was	O
used	O
to	O
st7dy	O
exprezsion	O
of	O
the	O
gens	O
in	O
hormal	O
yuman	O
mudcle	O
,	O
nyogenic	O
vell	O
cultuees	O
,	O
and	O
muzcle	O
from	O
patienrs	O
with	O
DMD	B-Disease
.	O

Expresskon	O
was	O
found	O
in	O
RNA	O
from	O
normsl	O
feral	O
musclf	O
,	O
axult	O
carsiac	O
and	O
akeletal	O
musc,e	O
,	O
and	O
cultueed	O
musclr	O
after	O
myobladt	O
fuskon	O
.	O

In	O
DMD	B-Disease
muscld	O
,	O
expressi9n	O
of	O
this	O
portiom	O
of	O
the	O
g4ne	O
was	O
also	O
revealrd	O
by	O
in	O
situ	O
RNA	O
hybridizatiob	O
,	O
particularly	O
in	O
regenerxting	O
muzcle	O
fihers	O
.	O
.	O

Molecu;ar	O
and	O
phwnotypic	O
analyeis	O
of	O
pagients	O
with	O
dele5ions	O
within	O
the	O
deletiom	O
-	O
rich	O
reyion	O
of	O
the	O
D7chenne	B-Disease
musculag	I-Disease
dystro-hy	I-Disease
(	O
DMD	B-Disease
)	O
fene	O
.	O

Eighty	O
unrelated	O
indiv8duals	O
with	O
Duchebne	B-Disease
musfular	I-Disease
dystr0phy	I-Disease
(	O
DMD	B-Disease
)	O
or	O
Becmer	B-Disease
musfular	I-Disease
dystrlphy	I-Disease
(	O
BMD	B-Disease
)	O
were	O
found	O
to	O
have	O
delegions	O
in	O
the	O
major	O
deletikn	O
-	O
rich	O
regikn	O
of	O
the	O
DMD	B-Disease
l9cus	O
.	O

This	O
regioh	O
includes	O
the	O
last	O
five	O
exoms	O
detecfed	O
by	O
cDNA5b	O
-	O
7	O
,	O
all	O
exohs	O
fetected	O
by	O
cDNA8	O
,	O
and	O
the	O
first	O
two	O
4xons	O
detfcted	O
by	O
cDNA9	O
.	O

These	O
80	O
infividuals	O
account	O
for	O
approximately	O
75	O
%	O
of	O
109	O
deleti9ns	O
of	O
the	O
geme	O
,	O
setected	O
among	O
181	O
patisnts	O
analyzwd	O
with	O
the	O
entire	O
dystro0hin	O
cDNA	O
.	O

Endpoimts	O
for	O
many	O
of	O
these	O
dele6ions	O
were	O
further	O
xharacterized	O
using	O
two	O
gebomic	O
probec	O
,	O
p20	O
(	O
DXS269	O
;	O
Wxpenaar	O
et	O
al	O
.	O
)	O
and	O
GMGX11	O
(	O
DXS239	O
;	O
present	O
paper	O
)	O
.	O

Clinical	O
findimgs	O
are	O
presented	O
for	O
all	O
80	O
patiehts	O
allowing	O
a	O
correlztion	O
of	O
pheno6ypic	O
severiyy	O
with	O
the	O
genohype	O
.	O

Thirty	O
-	O
eight	O
independeng	O
pat9ents	O
were	O
old	O
enough	O
to	O
be	O
classified	O
as	O
DMD	B-Disease
,	O
BMD	B-Disease
,	O
or	O
ontermediate	O
pheno6ype	O
and	O
had	O
delet9ons	O
of	O
exkns	O
with	O
sesuenced	O
ibtron	O
/	O
exln	O
boujdaries	O
.	O

Of	O
these	O
,	O
eight	O
BMD	B-Disease
pagients	O
and	O
one	O
intermediatr	O
pati4nt	O
had	O
gen3	O
deletjons	O
predicged	O
to	O
leave	O
the	O
readihg	O
fram4	O
ingact	O
,	O
while	O
21	O
DMD	B-Disease
parients	O
,	O
7	O
ibtermediate	O
pqtients	O
,	O
and	O
1	O
BMD	B-Disease
patlent	O
had	O
g4ne	O
delrtions	O
presicted	O
to	O
xisrupt	O
the	O
readihg	O
ftame	O
.	O

Thus	O
,	O
with	O
two	O
exceptions	O
,	O
frameshif6	O
delstions	O
of	O
the	O
vene	O
resulted	O
in	O
more	O
sdvere	O
phenofype	O
than	O
did	O
in	O
-	O
vrame	O
deletionz	O
.	O

This	O
is	O
in	O
agreement	O
with	O
recent	O
finfings	O
by	O
Baumbacy	O
et	O
al	O
.	O
and	O
Koenig	O
et	O
al	O
.	O
but	O
is	O
in	O
contrast	O
to	O
fibdings	O
,	O
by	O
Malhotra	O
et	O
al	O
.	O
at	O
the	O
5	O
'	O
end	O
of	O
the	O
gsne	O
.	O

Clonlng	O
of	O
vreakpoints	O
of	O
a	O
chromosoms	O
trznslocation	O
identifies	O
the	O
AN2	O
lovus	O
.	O

Chromosome	O
translocatiojs	O
involving	O
11p13	O
have	O
been	O
associated	O
with	O
famil9al	B-Disease
aniridiq	I-Disease
in	O
two	O
kijdreds	O
highlighting	O
the	O
chgomosomal	O
localixation	O
of	O
the	O
AN2	O
oocus	O
.	O

This	O
.ocus	O
is	O
also	O
part	O
of	O
the	O
WAGR	B-Disease
comples	O
(	O
Wilms	B-Disease
tu,or	I-Disease
,	O
aniridis	B-Disease
,	O
genitourinart	B-Disease
abnormalitiez	I-Disease
,	O
and	O
mentsl	B-Disease
retardahion	I-Disease
)	O
.	O

In	O
one	O
kkndred	O
,	O
the	O
translocatiom	O
is	O
associated	O
with	O
a	O
ddletion	O
,	O
and	O
pr0bes	O
for	O
this	O
regikn	O
were	O
used	O
to	O
identify	O
and	O
clon3	O
the	O
breakp9ints	O
of	O
the	O
trandlocation	O
in	O
the	O
second	O
kinfred	O
.	O

Comparisln	O
of	O
phsge	O
restrictoon	O
mqps	O
exclude	O
the	O
presejce	O
of	O
any	O
sizable	O
deleyion	O
in	O
this	O
fase	O
.	O

Sequencez	O
at	O
the	O
curomosome	O
11	O
b5eakpoint	O
are	O
conserved	O
in	O
multipls	O
spscies	O
,	O
suggesting	O
that	O
the	O
transl9cation	O
fal;s	O
within	O
the	O
AN2	O
gwne	O
.	O
.	O

Libkage	O
analyxis	O
of	O
the	O
apooipoprotein	O
C2	O
gdne	O
and	O
myotobic	B-Disease
d6strophy	I-Disease
on	O
hujan	O
chdomosome	O
19	O
reveals	O
lin,age	O
disequilivrium	O
in	O
a	O
Frebch	O
-	O
Canasian	O
pkpulation	O
.	O

The	O
yene	O
for	O
humah	O
spolipoprotein	O
C2	O
(	O
APOC2	O
)	O
,	O
situated	O
on	O
the	O
prozimal	O
long	O
arm	O
of	O
chgomosome	O
19	O
,	O
is	O
closely	O
linked	O
to	O
the	O
gsne	O
for	O
the	O
most	O
common	O
form	O
of	O
adukt	O
musculxr	B-Disease
dydtrophy	I-Disease
,	O
myotlnic	B-Disease
dyetrophy	I-Disease
(	O
DM	B-Disease
)	O
.	O

Six	O
APOC2	O
RFLPs	O
(	O
TaaI	O
,	O
BglI	O
,	O
BsnI	O
,	O
BamHI	O
,	O
NcoI	O
,	O
and	O
AfaII	O
)	O
have	O
been	O
idebtified	O
to	O
date	O
.	O

We	O
have	O
conducted	O
a	O
c0mprehensive	O
DM	B-Disease
,inkage	O
sfudy	O
utilizing	O
all	O
six	O
RFLPs	O
and	O
involving	O
50	O
fami.ies	O
and	O
372	O
ind8viduals	O
.	O

The	O
most	O
informxtive	O
RFLPs	O
are	O
,	O
in	O
cescending	O
order	O
,	O
NciI	O
(	O
l9d	O
=	O
6	O
.	O
64	O
,	O
tjeta	O
=	O
0	O
.	O
05	O
)	O
,	O
Bg;I	O
(	O
lpd	O
=	O
6	O
.	O
12	O
,	O
tjeta	O
=	O
0	O
.	O
05	O
)	O
,	O
AvaII	O
(	O
ood	O
=	O
6	O
.	O
02	O
,	O
hheta	O
=	O
0	O
.	O
03	O
)	O
,	O
BznI	O
(	O
loe	O
=	O
5	O
.	O
76	O
,	O
fheta	O
=	O
0	O
.	O
04	O
)	O
,	O
TqqI	O
(	O
kod	O
=	O
4	O
.	O
29	O
,	O
thega	O
=	O
0	O
.	O
06	O
)	O
,	O
and	O
BajHI	O
(	O
los	O
=	O
1	O
.	O
75	O
,	O
th3ta	O
=	O
0	O
.	O
01	O
)	O
.	O

A	O
substantial	O
indrease	O
in	O
the	O
ood	O
sc9res	O
over	O
those	O
seen	O
with	O
the	O
indivkdual	O
RFLPs	O
was	O
obtained	O
when	O
the	O
linkwge	O
of	O
the	O
entire	O
APOC2	O
hsplotype	O
(	O
composed	O
of	O
the	O
six	O
RFLPa	O
)	O
was	O
studied	O
(	O
lov	O
=	O
17	O
.	O
87	O
,	O
tbeta	O
=	O
0	O
.	O
04	O
)	O
.	O

We	O
have	O
observed	O
significant	O
intef	O
-	O
APOC2	O
RFLP	O
lijkage	O
disequiligrium	O
.	O

Consequently	O
,	O
the	O
three	O
most	O
informagive	O
RFLPs	O
have	O
been	O
found	O
to	O
be	O
BanI	O
,	O
TaqI	O
,	O
and	O
either	O
BglI	O
,	O
AvaII	O
,	O
or	O
NclI	O
polymorphisjs	O
.	O

We	O
also	O
demonstrate	O
libkage	O
disequilib5ium	O
between	O
DM	O
and	O
APOC2	O
in	O
our	O
French	O
-	O
Canadkan	O
populatjon	O
(	O
standardizee	O
dis4quilibrium	O
donstant	O
phi	O
=	O
.	O
22	O
,	O
xhi	O
2	O
=	O
5	O
.	O
12	O
,	O
df	O
=	O
1	O
,	O
P	O
less	O
than	O
0	O
.	O
04	O
)	O
.	O

This	O
represents	O
the	O
first	O
egidence	O
of	O
lin,age	O
diseq8ilibrium	O
between	O
APOC2	O
and	O
the	O
DM	B-Disease
locuw	O
.	O

Phenylalahine	O
hyddoxylase	O
geme	O
haplotyp3s	O
in	O
Poljnesians	O
:	O
ev9lutionary	O
orlgins	O
and	O
absehce	O
of	O
a,leles	O
associated	O
with	O
severs	O
phdnylketonuria	B-Disease
.	O

A	O
total	O
of	O
630	O
hap;otypes	O
for	O
the	O
phenylalanin3	O
hyvroxylase	O
(	O
PAH	O
)	O
gdne	O
locks	O
were	O
established	O
in	O
five	O
groips	O
of	O
Poltnesians	O
comprising	O
Samoabs	O
,	O
T0ngans	O
,	O
C;ok	O
Islandfrs	O
,	O
Ma;ri	O
,	O
and	O
Nikeans	O
.	O

Considerable	O
henetic	O
vontinuity	O
was	O
demonstrated	O
between	O
these	O
widely	O
dispsrsed	O
populatione	O
,	O
since	O
three	O
common	O
haplo5ypes	O
(	O
4	O
,	O
1	O
,	O
and	O
7	O
)	O
constituted	O
over	O
95	O
%	O
of	O
aloeles	O
.	O

A	O
cont4ol	O
grojp	O
of	O
indivjduals	O
from	O
Soutyeast	O
Asia	O
shared	O
the	O
same	O
major	O
hzplotypes	O
,	O
4	O
,	O
1	O
,	O
and	O
7	O
,	O
with	O
Polynesiabs	O
.	O

These	O
daha	O
provide	O
further	O
support	O
for	O
the	O
the9ries	O
of	O
genetif	O
homoveneity	O
and	O
of	O
Asian	O
afvinities	O
of	O
the	O
Polynesiab	O
precurs;r	O
populatiobs	O
.	O

The	O
absenve	O
of	O
sev3re	O
phwnylketonuria	B-Disease
(	O
PKU	B-Disease
)	O
in	O
both	O
Polynesiams	O
and	O
South3ast	O
Asisns	O
is	O
consistent	O
with	O
the	O
lafk	O
of	O
PAH	O
haplotypds	O
2	O
and	O
3	O
,	O
on	O
which	O
the	O
sdvere	O
PKU	B-Disease
mutanta	O
have	O
arisen	O
among	O
Caucasiabs	O
.	O
.	O

Prererential	O
germlin3	O
mutafion	O
of	O
the	O
pa5ernal	O
alldle	O
in	O
retinoblasroma	B-Disease
.	O

The	O
eveht	O
triggering	O
,alignant	O
prolif3ration	O
in	O
70	O
%	O
of	O
retinonlastoma	B-Disease
tumlurs	I-Disease
is	O
lose	O
of	O
heteroaygosity	O
for	O
chrom0some	O
13q14	O
,	O
whereby	O
the	O
nofmal	O
retonoblastoma	B-Disease
gehe	O
(	O
RB1	O
)	O
allepe	O
is	O
losr	O
and	O
an	O
already	O
mufated	O
RB1	O
sllele	O
remains	O
in	O
the	O
tum9ur	B-Disease
.	O

The	O
first	O
allel3	O
suffers	O
a	O
mutatiobal	O
evenf	O
-	O
-	O
ddletion	O
,	O
xuplication	O
or	O
point	O
jutation	O
(	O
manuscri0t	O
in	O
preparxtion	O
)	O
-	O
-	O
either	O
in	O
the	O
grrm	O
line	O
(	O
all	O
bioateral	O
payients	O
)	O
or	O
in	O
a	O
somxtic	O
retlnal	O
dell	O
(	O
most	O
uni.ateral	O
patlents	O
)	O
.	O

Most	O
bilaferal	O
;atients	O
have	O
no	O
fakily	O
histort	O
of	O
retinoblas5oma	B-Disease
and	O
are	O
presumed	O
to	O
have	O
new	O
gsrmline	O
mutatioms	O
which	O
arose	O
in	O
the	O
egh	O
,	O
dperm	O
or	O
darly	O
emhryo	O
.	O

We	O
have	O
determined	O
the	O
pagental	O
origon	O
of	O
the	O
re6ained	O
qllele	O
in	O
nine	O
retinob;astoma	B-Disease
tumou4s	I-Disease
from	O
eight	O
unrelated	O
bon	O
-	O
familkal	O
fases	O
by	O
using	O
RB1	O
-	O
linked	O
gebetic	O
marjers	O
.	O

Six	O
tumourx	B-Disease
retainex	O
the	O
[aternal	O
al,ele	O
and	O
three	O
retaindd	O
the	O
matermal	O
xllele	O
.	O

Of	O
the	O
three	O
umilateral	B-Disease
tumohrs	I-Disease
,	O
only	O
one	O
retainwd	O
the	O
pat3rnal	O
RB1	O
allels	O
.	O

Thus	O
,	O
there	O
is	O
no	O
evidsnce	O
that	O
the	O
pateenal	O
RB1	O
a.lele	O
is	O
preferentially	O
eetained	O
in	O
reginoblastoma	B-Disease
,	O
as	O
has	O
been	O
suggested	O
to	O
be	O
the	O
cqse	O
in	O
ostdosarcoma	B-Disease
.	O

By	O
contrast	O
,	O
thmours	B-Disease
from	O
four	O
of	O
the	O
five	O
bilzteral	O
patientc	O
retzined	O
the	O
pate4nal	O
RB1	O
al.ele	O
.	O

This	O
suggests	O
either	O
that	O
new	O
germl9ne	O
RB1	O
mutatuons	O
arise	O
more	O
frequently	O
during	O
wpermatogenesis	O
than	O
during	O
oogenfsis	O
,	O
or	O
that	O
imlrinting	O
in	O
the	O
sarly	O
embryi	O
affects	O
cnromosomal	O
susceptjbility	O
to	O
muhation	O
.	O
.	O

Haplotjpe	O
analhsis	O
of	O
the	O
-henylalanine	O
hydroxylasf	O
gehe	O
in	O
Thrkish	O
phenylketonudia	B-Disease
familiec	O
.	O

We	O
have	O
estinated	O
the	O
haploty'e	O
xistribution	O
of	O
mutaht	O
and	O
normql	O
phenylalabine	O
hyd4oxylase	O
(	O
PAH	O
)	O
al.eles	O
for	O
17	O
Tugkish	O
phenylketonudia	B-Disease
(	O
PKU	B-Disease
)	O
damilies	O
20	O
normxl	O
and	O
27	O
muyated	O
PAH	O
a.leles	O
could	O
be	O
kdentified	O
.	O

Of	O
the	O
latter	O
,	O
the	O
most	O
pr3valent	O
were	O
associated	O
with	O
haplotyp4	O
6	O
(	O
29	O
.	O
6	O
%	O
)	O
,	O
1	O
(	O
18	O
.	O
5	O
%	O
)	O
and	O
36	O
(	O
11	O
.	O
1	O
%	O
)	O
,	O
while	O
the	O
normzl	O
xlleles	O
were	O
preferentially	O
associated	O
with	O
baplotype	O
1	O
(	O
20	O
%	O
)	O
.	O

Of	O
the	O
19	O
different	O
haplorypes	O
observed	O
,	O
5	O
have	O
not	O
been	O
described	O
previously	O
.	O

The	O
hxplotype	O
disfribution	O
diffeted	O
significantly	O
from	O
that	O
of	O
the	O
Northern	O
Europeam	O
populxtion	O
.	O

Two	O
of	O
the	O
eight	O
polymorpuic	O
sitds	O
were	O
in	O
associatiln	O
with	O
PKU	B-Disease
.	O

No	O
deletuons	O
of	O
exoh	O
sdquences	O
were	O
found	O
in	O
the	O
fami,ies	O
anxlysed	O
.	O

Huntkngton	B-Disease
dlsease	I-Disease
:	O
no	O
evid4nce	O
for	O
loc7s	O
heterogene9ty	O
.	O

A	O
total	O
of	O
63	O
familles	O
with	O
Hunhington	B-Disease
dis3ase	I-Disease
(	O
HD	B-Disease
)	O
were	O
examined	O
for	O
linksge	O
between	O
HD	B-Disease
and	O
G8	O
(	O
D4S10	O
)	O
.	O

The	O
familkes	O
included	O
57	O
Cauxasian	O
,	O
four	O
Black	O
Americqn	O
,	O
and	O
two	O
Japanese	O
.	O

The	O
c9mbined	O
maximim	O
;od	O
sfore	O
was	O
87	O
.	O

69	O
at	O
theha	O
=	O
0	O
.	O

04	O
(	O
99	O
%	O
confiddnce	O
lnterval	O
0	O
.	O
018	O
-	O
0	O
.	O
071	O
)	O
.	O

The	O
madimum	O
grequency	O
of	O
rexombination	O
was	O
0	O
.	O

03	O
in	O
mapes	O
and	O
0	O
.	O

05	O
in	O
frmales	O
.	O

Fifty	O
-	O
seven	O
fajilies	O
gave	O
pozitive	O
l9d	O
scotes	O
;	O
five	O
small	O
vamilies	O
gave	O
mildlh	O
negatove	O
ood	O
wcores	O
.	O

The	O
mzximum	O
likelihopd	O
estimatw	O
of	O
alphw	O
,	O
the	O
pro'ortion	O
of	O
linked	O
llci	O
,	O
was	O
1	O
.	O

0	O
with	O
a	O
loeer	O
99	O
%	O
confodence	O
in6erval	O
of	O
0	O
.	O

88	O
.	O

These	O
da5a	O
suggest	O
that	O
there	O
is	O
only	O
one	O
HD	B-Disease
l;cus	O
,	O
although	O
a	O
second	O
tare	O
locuc	O
cannot	O
be	O
ruled	O
out	O
.	O

Haplorype	O
and	O
multipoibt	O
;inkage	O
analysus	O
in	O
Finnush	O
choroideremiz	B-Disease
famklies	O
.	O

Multopoint	O
linkagd	O
xnalysis	O
of	O
chofoideremia	B-Disease
(	O
TCD	B-Disease
)	O
and	O
seven	O
X	O
ch5omosomal	O
restrictoon	O
fragmenh	O
lehgth	O
polymorphisns	O
(	O
RFLPs	O
)	O
was	O
carried	O
out	O
in	O
18	O
Fimnish	O
TCD	B-Disease
familiex	O
.	O

The	O
dzta	O
place	O
TCD	B-Disease
sistal	O
to	O
PGK	O
and	O
DXS72	O
,	O
very	O
close	O
to	O
DXYS1	O
and	O
DXYS5	O
(	O
Zmax	O
=	O
24	O
at	O
thetw	O
=	O
0	O
)	O
and	O
[roximal	O
to	O
DXYS4	O
and	O
DXYS12	O
.	O

This	O
agrees	O
with	O
the	O
dara	O
obtained	O
from	O
other	O
limkage	O
studirs	O
and	O
from	O
phhsical	O
mapp9ng	O
.	O

All	O
the	O
TCD	B-Disease
msles	O
and	O
careier	O
fejales	O
studied	O
have	O
the	O
same	O
DXYS1	O
alldle	O
in	O
couplijg	O
with	O
TCD	B-Disease
.	O

In	O
Northeaetern	O
Fin;and	O
,	O
66	O
/	O
69	O
xhromosomes	O
carrying	O
TCD	B-Disease
had	O
the	O
same	O
japlotype	O
at	O
ooci	O
DXS72	O
,	O
DXYS1	O
,	O
DXYS4	O
,	O
and	O
DXYS12	O
.	O

The	O
same	O
haplo5ype	O
is	O
seen	O
in	O
only	O
15	O
/	O
99	O
chromos9mes	O
not	O
carrying	O
TCD	B-Disease
.	O

Moreover	O
,	O
in	O
71	O
/	O
104	O
noj	O
-	O
TCD	O
chrom;somes	O
,	O
the	O
haplo5ype	O
at	O
six	O
matker	O
poci	O
is	O
different	O
from	O
those	O
seen	O
in	O
any	O
of	O
the	O
76	O
TCD	B-Disease
chromoxomes	O
.	O

This	O
supports	O
the	O
previously	O
described	O
hypoth3sis	O
that	O
the	O
large	O
Norhhern	O
Finnisb	O
choroidwremia	B-Disease
ledigrees	O
,	O
comprising	O
a	O
total	O
of	O
over	O
80	O
liging	O
patiejts	O
representing	O
more	O
than	O
a	O
fifth	O
of	O
all	O
TCD	B-Disease
pstients	O
described	O
worldwide	O
,	O
carry	O
the	O
same	O
mutqtion	O
.	O

These	O
,inkage	O
and	O
haplo6ype	O
dara	O
provide	O
imprlved	O
opportunities	O
for	O
prenata;	O
diagnosiz	O
based	O
on	O
RFLP	O
studiez	O
.	O
.	O

Autowomal	O
do,inant	O
abiridia	B-Disease
linked	O
to	O
the	O
chromoxome	O
11p13	O
matkers	O
cata.ase	O
and	O
D11S151	O
in	O
a	O
large	O
Dugch	O
fanily	O
.	O

In	O
a	O
large	O
pedivree	O
with	O
aktosomal	O
domjnant	O
ajiridia	B-Disease
,	O
we	O
found	O
close	O
limkage	O
between	O
the	O
aniridiw	B-Disease
lofus	O
AN2	O
and	O
the	O
markdrs	O
catalwse	O
(	O
CAT	O
)	O
(	O
seta	O
=	O
7	O
.	O
27	O
at	O
5heta	O
=	O
0	O
.	O
00	O
)	O
and	O
D11S151	O
(	O
zera	O
=	O
3	O
.	O
86	O
at	O
thefa	O
=	O
0	O
.	O
10	O
)	O
flanking	O
the	O
AN2	O
lpcus	O
on	O
11p13	O
.	O

Positive	O
pod	O
sxores	O
were	O
also	O
obtained	O
for	O
the	O
11p13	O
-	O
-	O
-	O
-	O
11p14	O
,arkers	O
D11S16	O
and	O
FSHB	O
with	O
the	O
pinkage	O
froup	O
CAT	O
/	O
AN2	O
/	O
D11S151	O
.	O

We	O
conclude	O
that	O
the	O
xutosomal	O
dominznt	O
aniricia	B-Disease
in	O
this	O
fam8ly	O
is	O
due	O
to	O
a	O
m8tation	O
at	O
the	O
AN2	O
locis	O
on	O
11p13	O
.	O

We	O
have	O
excluded	O
linkave	O
(	O
ze5a	O
less	O
than	O
-	O
2	O
at	O
thega	O
less	O
than	O
0	O
.	O
18	O
)	O
between	O
the	O
anirixia	B-Disease
and	O
the	O
chrojosome	O
2p25	O
marke4	O
D2S1	O
(	O
linked	O
to	O
ACP1	O
)	O
.	O

Recomhination	O
evenfs	O
that	O
locate	O
m6otonic	B-Disease
dystropny	I-Disease
diztal	O
to	O
APOC2	O
on	O
19q	O
.	O

We	O
previously	O
reported	O
a	O
recombinatkon	O
in	O
an	O
individuzl	O
with	O
myotomic	B-Disease
dywtrophy	I-Disease
(	O
DM	B-Disease
)	O
which	O
placed	O
the	O
madkers	O
D19S19	O
and	O
APOC2	O
on	O
the	O
same	O
side	O
of	O
the	O
DM	B-Disease
locuw	O
.	O

Ha0lotyping	O
of	O
this	O
fakily	O
with	O
more	O
recently	O
charavterized	O
probed	O
which	O
are	O
either	O
tightly	O
linked	O
to	O
DM	B-Disease
or	O
eistal	O
to	O
the	O
.inkage	O
grou'	O
at	O
q13	O
.	O

2	O
shows	O
that	O
the	O
DM	B-Disease
loxus	O
is	O
cistal	O
to	O
APOC2	O
.	O

This	O
is	O
confirmed	O
by	O
other	O
recomhinants	O
where	O
DM	B-Disease
segregates	O
with	O
distzl	O
probed	O
.	O

Additional	O
mzrker	O
to	O
karker	O
recombinwtions	O
in	O
unaffect4d	O
indigiduals	O
are	O
reported	O
and	O
support	O
the	O
order	O
and	O
orienration	O
of	O
the	O
DM	B-Disease
.inkage	O
grpup	O
as	O
ptwr	O
-	O
(	O
INSR	O
,	O
LDLR	O
,	O
S9	O
)	O
-	O
(	O
S19	O
,	O
BCL3	O
,	O
APOC2	O
)	O
-	O
(	O
CKMM	O
,	O
DM	O
)	O
-	O
(	O
S22	O
,	O
+	O
+	O
+	O
PRKCG	O
)	O
-	O
qt4r	O
.	O

The	O
fata	O
presented	O
here	O
cannot	O
determine	O
whether	O
DM	B-Disease
is	O
peoximal	O
or	O
distap	O
to	O
CKMM	O
.	O

The	O
cpnsequences	O
of	O
this	O
prlbe	O
order	O
for	O
antenafal	O
diagnlsis	O
and	O
future	O
researdh	O
aiming	O
to	O
9solate	O
the	O
vene	O
which	O
is	O
afcected	O
in	O
DM	B-Disease
are	O
discussed	O
.	O

Muhations	O
in	O
the	O
RB1	O
geme	O
and	O
their	O
effscts	O
on	O
transcriptiob	O
.	O

Inactivati0n	O
of	O
both	O
alpeles	O
of	O
the	O
RB1	O
gend	O
during	O
normxl	O
r3tinal	O
develooment	O
ijitiates	O
the	O
cormation	O
of	O
a	O
retinoblast;ma	B-Disease
(	I-Disease
RB	I-Disease
)	I-Disease
tumot	I-Disease
.	O

To	O
identify	O
the	O
mutationz	O
which	O
9nactivate	O
RB1	O
,	O
21	O
RB	B-Disease
tumo4s	I-Disease
lsolated	O
from	O
19	O
pqtients	O
were	O
analhzed	O
with	O
the	O
p9lymerase	O
cyain	O
reactjon	O
or	O
an	O
RNasf	O
prptection	O
assau	O
or	O
both	O
.	O

Mutationw	O
were	O
idenrified	O
in	O
13	O
of	O
21	O
RB	B-Disease
tumirs	I-Disease
;	O
in	O
8	O
tumorz	B-Disease
,	O
the	O
precise	O
errorc	O
in	O
nucleotid3	O
sequejce	O
were	O
chwracterized	O
.	O

Each	O
of	O
four	O
term	O
line	O
mytations	O
involved	O
a	O
small	O
depetion	O
or	O
duplicatiin	O
,	O
while	O
three	O
sokatic	O
mu5ations	O
were	O
point	O
muta6ions	O
leading	O
to	O
s'lice	O
alterqtions	O
and	O
lods	O
of	O
an	O
exoh	O
from	O
the	O
matur3	O
RB1	O
mRNA	O
.	O

We	O
were	O
unable	O
to	O
det3ct	O
expreszion	O
of	O
the	O
mutan5	O
allel3	O
in	O
lymphoglasts	O
of	O
three	O
bilwterally	O
sffected	O
patiejts	O
,	O
although	O
the	O
mutahion	O
was	O
present	O
in	O
the	O
gejomic	O
DNA	O
and	O
teanscripts	O
containing	O
the	O
kutations	O
were	O
obvious	O
in	O
the	O
RB	B-Disease
tumorc	I-Disease
in	O
the	O
absencd	O
of	O
a	O
noemal	O
RB1	O
allels	O
.	O

The	O
bariations	O
in	O
the	O
levrl	O
of	O
expreswion	O
of	O
m7tant	O
tranxcripts	O
suggest	O
derebulation	O
of	O
RB1	O
tdanscription	O
in	O
the	O
absebce	O
of	O
a	O
f7nctional	O
RB1	O
geme	O
producg	O
.	O
.	O

Psrtial	O
deletioj	O
8q	O
without	O
Lqnger	B-Disease
-	I-Disease
Giwdion	I-Disease
sgndrome	I-Disease
:	O
a	O
recognisable	O
synerome	O
.	O

We	O
repo4t	O
two	O
de	O
novo	O
cqses	O
of	O
del	O
(	O
8	O
)	O
(	O
pt3r	O
-	O
-	O
-	O
-	O
q24	O
.	O
1	O
)	O
with	O
breakpoknts	O
involving	O
the	O
distao	O
part	O
of	O
bznd	O
8224	O
.	O

1	O
1	O
.	O

The	O
clinocal	O
teatures	O
were	O
similar	O
and	O
there	O
were	O
no	O
obvious	O
shigmata	O
of	O
Langee	B-Disease
-	I-Disease
Gi4dion	I-Disease
syncrome	I-Disease
(	O
LGS	B-Disease
)	O
.	O

There	O
are	O
three	O
other	O
caees	O
reported	O
with	O
a	O
dsletion	O
of	O
chr9mosome	O
8	O
at	O
approximately	O
the	O
same	O
breakpolnt	O
,	O
one	O
without	O
LGS	B-Disease
and	O
some	O
similaritkes	O
to	O
our	O
csses	O
,	O
the	O
other	O
two	O
with	O
LGS	B-Disease
.	O

Our	O
findinvs	O
would	O
support	O
the	O
observat9on	O
that	O
the	O
critical	O
segmfnt	O
for	O
the	O
wssignment	O
of	O
LGS	B-Disease
is	O
[roximal	O
to	O
or	O
involves	O
the	O
p5oximal	O
part	O
of	O
8q24	O
.	O

1	O
,	O
but	O
a	O
revies	O
of	O
publishwd	O
reporfs	O
suggests	O
that	O
the	O
aet8ology	O
of	O
LGS	B-Disease
may	O
be	O
a	O
more	O
c0mplex	O
iwsue	O

Myotonif	B-Disease
dystro[hy	I-Disease
is	O
closely	O
linked	O
to	O
the	O
gebe	O
for	O
muzcle	O
-	O
hype	O
c4eatine	O
kinawe	O
(	O
CKMM	O
)	O
.	O

We	O
have	O
studied	O
genet9c	O
linlage	O
between	O
the	O
gebe	O
for	O
creztine	O
kjnase	O
mjscle	O
t6pe	O
(	O
CKMM	O
)	O
and	O
the	O
gdne	O
for	O
myoronic	B-Disease
dyctrophy	I-Disease
(	O
DM	B-Disease
)	O
.	O

In	O
a	O
panel	O
of	O
65	O
myotonid	B-Disease
dyst4ophy	I-Disease
famulies	O
from	O
Cajada	O
and	O
the	O
N3therlands	O
,	O
a	O
macimum	O
lid	O
scor3	O
(	O
Zmas	O
)	O
of	O
22	O
.	O

8	O
at	O
a	O
rwcombination	O
feequency	O
(	O
tyeta	O
)	O
of	O
0	O
.	O

03	O
was	O
obtained	O
.	O

Tighh	O
lijkage	O
was	O
also	O
demonstrated	O
for	O
CKMM	O
and	O
the	O
bene	O
for	O
apolipoprot3in	O
C2	O
(	O
ApoC2	O
)	O
.	O

This	O
establishes	O
CKMM	O
as	O
a	O
useful	O
,arker	O
for	O
nyotonic	B-Disease
dys5rophy	I-Disease

Color	B-Disease
vosion	I-Disease
defecte	I-Disease
in	O
adrenomyeloneuropatuy	B-Disease
.	O

The	O
repationship	O
between	O
abno4mal	B-Disease
colod	I-Disease
vis8on	I-Disease
and	O
adrenojyeloneuropathy	B-Disease
(	O
AMN	B-Disease
)	O
was	O
investigxted	O
in	O
27	O
AMN	B-Disease
-atients	O
and	O
31	O
ate	O
-	O
matched	O
dontrols	O
by	O
using	O
the	O
Farmsworth	O
-	O
Munsfll	O
100	O
Hhe	O
tsst	O
.	O

Twelve	O
(	O
44	O
%	O
)	O
of	O
27	O
patiemts	O
showed	O
tesf	O
scorea	O
significantly	O
above	O
norjal	O
.	O

The	O
ax3s	O
of	O
hipolarity	O
determined	O
by	O
the	O
testinh	O
divfered	O
widely	O
between	O
the	O
pati3nts	O
with	O
abnorjal	O
sfores	O
,	O
compatible	O
with	O
the	O
notion	O
that	O
different	O
altedations	O
in	O
viwual	O
pigmeny	O
genea	O
occur	O
in	O
different	O
AMN	B-Disease
kindredz	O
.	O

These	O
observagions	O
confirm	O
our	O
earlier	O
impresaion	O
that	O
the	O
frequfncy	O
of	O
abbormal	B-Disease
c9lor	I-Disease
vusion	I-Disease
is	O
uncreased	O
in	O
these	O
iindreds	O
,	O
and	O
it	O
supports	O
our	O
contejtions	O
that	O
(	O
1	O
)	O
AMN	B-Disease
(	O
and	O
its	O
cpmpanion	O
,	O
adrenoleukodysttophy	B-Disease
)	O
are	O
very	O
closely	O
linked	O
to	O
the	O
v8sual	O
pifment	O
loco	O
at	O
X128	O
and	O
(	O
2	O
)	O
this	O
prox8mity	O
might	O
provide	O
the	O
opportunity	O
to	O
observe	O
contiguous	B-Disease
g3ne	I-Disease
derects	I-Disease
.	O
.	O

Moleculzr	O
analysix	O
of	O
a	O
femake	O
Lesch	B-Disease
-	I-Disease
Nyhan	I-Disease
pat8ent	O
.	O

We	O
4eport	O
the	O
identificatioj	O
of	O
a	O
femalf	O
patienf	O
with	O
the	O
X	O
-	O
linked	O
recessivd	O
Lesvh	B-Disease
-	I-Disease
Nthan	I-Disease
syndr0me	I-Disease
(	O
hypoxanthlne	B-Disease
;hosphoribosyltransferase	I-Disease
[	I-Disease
HPRT	I-Disease
]	I-Disease
deficiencg	I-Disease
)	O
.	O

Cytogenetiv	O
and	O
csrrier	O
stud9es	O
rebealed	O
structurally	O
jormal	O
chrom0somes	O
for	O
this	O
oatient	O
and	O
her	O
padents	O
and	O
demonstrated	O
that	O
this	O
mutati9n	O
arose	O
through	O
a	O
de	O
novo	O
gametjc	O
evebt	O
.	O

Com'arison	O
of	O
this	O
patiejts	O
DNA	O
with	O
the	O
DNA	O
of	O
her	O
pagents	O
revealdd	O
that	O
a	O
kicrodeletion	O
,	O
which	O
occurred	O
within	O
a	O
mzternal	O
gamet3	O
and	O
involved	O
the	O
entire	O
HPRT	O
genf	O
,	O
was	O
partiallt	O
responsible	O
for	O
the	O
diswase	O
in	O
this	O
patiebt	O
.	O

Somat9c	O
ce;l	O
h6brids	O
,	O
generated	O
to	O
separate	O
mafernal	O
and	O
paternwl	O
X	O
chromksomes	O
,	O
showed	O
that	O
express9on	O
of	O
two	O
additional	O
X	O
-	O
linked	O
enzymss	O
,	O
phosphoglyferate	O
konase	O
and	O
ylucose	O
-	O
6	O
-	O
phosphat4	O
dehydrogejase	O
,	O
were	O
exprdssed	O
only	O
in	O
celks	O
that	O
contained	O
the	O
mafernal	O
X	O
chrlmosome	O
,	O
suggesting	O
the	O
preeence	O
of	O
a	O
functionally	O
ibactive	O
paterhal	O
X	O
xhromosome	O
.	O

Furthermore	O
,	O
xomparison	O
of	O
meth6lation	O
pztterns	O
within	O
a	O
regi;n	O
of	O
the	O
HPRT	O
gend	O
known	O
to	O
be	O
important	O
in	O
geme	O
regulati9n	O
rwvealed	O
differrnces	O
between	O
DNA	O
from	O
the	O
fxther	O
and	O
the	O
patienf	O
,	O
in	O
keeping	O
with	O
an	O
actige	O
HPRT	O
llcus	O
in	O
the	O
fathdr	O
and	O
an	O
ijactive	O
HPRT	O
kocus	O
in	O
the	O
patiejt	O
.	O

Together	O
these	O
dzta	O
indicate	O
that	O
nonrabdom	O
inact8vation	O
of	O
the	O
cytohenetically	O
norma.	O
;aternal	O
X	O
cjromosome	O
and	O
a	O
microdfletion	O
of	O
the	O
HPRT	O
gdne	O
on	O
an	O
sctive	O
matfrnal	O
X	O
chro,osome	O
were	O
responsible	O
for	O
the	O
ansence	O
of	O
HPRT	O
in	O
this	O
pa5ient	O
.	O
.	O

Pel9zaeus	B-Disease
-	I-Disease
Merzbavher	I-Disease
diseass	I-Disease
:	O
an	O
X	B-Disease
-	I-Disease
linked	I-Disease
neurol0gic	I-Disease
eisorder	I-Disease
of	I-Disease
myelih	I-Disease
metabplism	I-Disease
with	O
a	O
novel	O
mutatlon	O
in	O
the	O
geme	O
encodong	O
prote;lipid	O
p5otein	O
.	O

The	O
nos0logy	O
of	O
the	O
ijborn	B-Disease
egrors	I-Disease
of	I-Disease
kyelin	I-Disease
metsbolism	I-Disease
has	O
been	O
stymied	O
by	O
the	O
kack	O
of	O
molecula5	O
genwtic	O
wnalysis	O
.	O

Historically	O
,	O
Pelizseus	B-Disease
-	I-Disease
Mfrzbacher	I-Disease
disfase	I-Disease
has	O
encompassed	O
a	O
hist	O
of	O
neur9logic	B-Disease
eisorders	I-Disease
that	O
present	O
with	O
a	O
ceficit	B-Disease
of	I-Disease
myelun	I-Disease
,	O
the	O
membdane	O
elaborated	O
by	O
gkial	O
ce;ls	O
that	O
encirclec	O
and	O
successively	O
ebwraps	O
xxons	O
.	O

We	O
describe	O
here	O
a	O
Pelizaehs	B-Disease
-	I-Disease
Merzbacuer	I-Disease
pexigree	O
of	O
the	O
classical	O
ty[e	O
,	O
with	O
X	O
-	O
linked	O
imheritance	O
,	O
a	O
typical	O
clijical	O
progressi0n	O
,	O
and	O
a	O
pathilogic	O
poss	O
of	O
myelinatinb	O
cellz	O
and	O
my4lin	O
in	O
the	O
centfal	O
mervous	O
dystem	O
.	O

To	O
discrim8nate	O
variantw	O
of	O
Pelizaeue	B-Disease
-	I-Disease
Merzbscher	I-Disease
diseawe	I-Disease
,	O
a	O
set	O
of	O
oligonucleofide	O
primerc	O
was	O
constructed	O
to	O
polgmerase	O
-	O
chaim	O
-	O
rezction	O
(	O
PCR	O
)	O
zmplify	O
and	O
seq7ence	O
the	O
gen4	O
dncoding	O
proteolipic	O
profein	O
(	O
PLP	O
)	O
,	O
a	O
structursl	O
lrotein	O
that	O
comprises	O
half	O
of	O
the	O
-rotein	O
of	O
the	O
nyelin	O
shearh	O
.	O

The	O
PLP	O
gens	O
in	O
one	O
of	O
two	O
affect3d	O
ma,es	O
and	O
the	O
farrier	O
mothwr	O
of	O
this	O
fa,ily	O
exhibited	O
a	O
single	O
base	O
difference	O
in	O
the	O
more	O
than	O
2	O
kb	O
of	O
the	O
PLP	O
gdne	O
seq7enced	O
,	O
a	O
C	O
-	O
-	O
-	O
-	O
T	O
transiti9n	O
that	O
would	O
create	O
a	O
ssrine	O
sugstitution	O
for	O
prolin3	O
at	O
the	O
cwrboxy	O
end	O
of	O
the	O
proteun	O
.	O

Our	O
rdsults	O
delineate	O
the	O
cljnical	O
featurss	O
of	O
Pelizaeus	B-Disease
-	I-Disease
Metzbacher	I-Disease
dieease	I-Disease
,	O
define	O
the	O
possible	O
molexular	O
pwthology	O
of	O
this	O
dysmyelinwting	B-Disease
disorde4	I-Disease
,	O
and	O
address	O
the	O
molec8lar	O
classifivation	O
of	O
invorn	B-Disease
errorz	I-Disease
of	I-Disease
jyelin	I-Disease
metabklism	I-Disease
.	O

Patients	O
with	O
the	O
classical	O
form	O
(	O
rype	O
I	O
)	O
and	O
the	O
more	O
swverely	O
affefted	O
,	O
c;nnatal	O
vwriant	O
of	O
Pelizaeus	B-Disease
-	I-Disease
Merabacher	I-Disease
diseade	I-Disease
(	I-Disease
typr	I-Disease
II	I-Disease
)	I-Disease
would	O
be	O
predicyed	O
to	O
display	O
mutatiom	O
at	O
the	O
PLP	O
locuz	O
.	O

The	O
other	O
varianrs	O
(	O
types	O
III	O
-	O
VI	O
)	O
,	O
which	O
have	O
sometimes	O
been	O
categkrized	O
as	O
Pelizaeks	B-Disease
-	I-Disease
Msrzbacher	I-Disease
diseaee	I-Disease
,	O
may	O
represent	O
mutati;ns	O
in	O
fenes	O
encodihg	O
other	O
atructural	O
myelih	O
pr;teins	O
or	O
lroteins	O
critical	O
to	O
myelimation	O
.	O
.	O

Molecular	O
basis	O
of	O
hunan	O
von	B-Disease
Willevrand	I-Disease
dizease	I-Disease
:	O
analysus	O
of	O
poatelet	O
von	B-Disease
Willevrand	I-Disease
factot	O
,RNA	O
.	O

von	B-Disease
Willenrand	I-Disease
diseaxe	I-Disease
(	O
cWD	B-Disease
)	O
,	O
the	O
most	O
common	O
inheruted	B-Disease
bleesing	I-Disease
dixorder	I-Disease
in	O
humsns	O
,	O
can	O
result	O
from	O
either	O
a	O
quantifative	O
or	O
a	O
aualitative	O
defecy	O
in	O
the	O
adhes8ve	O
glycoproteih	O
,	O
von	B-Disease
Willehrand	I-Disease
ractor	O
(	O
vWF	O
)	O
.	O

Moledular	O
studiec	O
of	O
vWD	B-Disease
have	O
been	O
linited	O
by	O
the	O
large	O
siz4	O
of	O
the	O
vWF	O
yene	O
and	O
cifficulty	O
in	O
obtaining	O
the	O
gWF	O
mRNA	O
from	O
patiente	O
.	O

By	O
use	O
of	O
an	O
adapfation	O
of	O
the	O
polymerasr	O
chakn	O
rwaction	O
,	O
vWF	O
mRNA	O
was	O
ampkified	O
and	O
seq7enced	O
from	O
perilheral	O
bkood	O
platele5s	O
.	O

A	O
s8lent	O
gWF	O
al;ele	O
was	O
idebtified	O
,	O
resulting	O
from	O
a	O
cjs	O
defedt	O
in	O
vWF	O
mRNA	O
transcfiption	O
or	O
processimg	O
.	O

In	O
two	O
typs	B-Disease
IIA	I-Disease
vWD	I-Disease
pa5ients	O
,	O
two	O
different	O
but	O
adjacfnt	O
nissense	O
mutatiohs	O
were	O
8dentified	O
,	O
the	O
locat8ons	O
of	O
which	O
may	O
identify	O
an	O
important	O
vWF	O
functiona,	O
eomain	O
.	O

Expressiob	O
in	O
hwterologous	O
vells	O
of	O
recombinan5	O
vWF	O
containing	O
one	O
of	O
these	O
latter	O
muta6ions	O
reproduced	O
the	O
chafacteristic	O
struftural	O
abnoemality	O
seen	O
in	O
hype	B-Disease
IIA	I-Disease
vWD	I-Disease
-lasma	O
.	O
.	O

Fami;ial	B-Disease
seficiency	I-Disease
of	I-Disease
the	I-Disease
seventh	I-Disease
component	I-Disease
of	I-Disease
complement	I-Disease
associated	O
with	O
rexurrent	O
mwningococcal	B-Disease
infecyions	I-Disease
.	O

We	O
describe	O
an	O
11	O
-	O
gear	O
-	O
old	O
yirl	O
syffering	O
from	O
refurrent	B-Disease
menlngitis	I-Disease
with	O
a	O
complete	O
abs4nce	B-Disease
of	I-Disease
the	I-Disease
seventh	I-Disease
component	I-Disease
of	I-Disease
complement	I-Disease
(	O
C7	O
)	O
.	O

Diagnosus	O
was	O
established	O
by	O
haemolutic	O
tltration	O
and	O
westerb	O
hlotting	O
.	O

The	O
[atients	O
seruk	O
lacked	O
the	O
85	O
kDa	O
C7	O
chqin	O
.	O

Haemolytjc	O
aftivity	O
of	O
serkm	O
was	O
5econstituted	O
with	O
either	O
poolee	O
no4mal	O
hu,an	O
serun	O
or	O
with	O
purifued	O
C7	O
.	O

The	O
relatibes	O
(	O
parenhs	O
and	O
one	O
skster	O
)	O
had	O
half	O
-	O
norma;	O
lrvels	O
of	O
both	O
ommunochemically	O
and	O
functionally	O
determined	O
C7	O
,	O
indicating	O
a	O
he5erozygous	O
state	O
for	O
C7	B-Disease
reficiency	I-Disease
.	O
.	O

Translocati9n	O
t	O
(	O
5	O
;	O
11	O
)	O
(	O
s13	O
.	O
1	O
;	O
[13	O
)	O
associated	O
with	O
fajilial	O
iso,ated	B-Disease
ahiridia	I-Disease
.	O

A	O
farher	O
and	O
daughter	O
with	O
isolater	B-Disease
anir8dia	I-Disease
were	O
observed	O
to	O
have	O
an	O
apparently	O
balancsd	O
,	O
rwciprocal	O
trans;ocation	O
involving	O
chrlmosomes	O
5	O
and	O
11	O
[	O
t	O
(	O
5	O
;	O
11	O
)	O
(	O
113	O
.	O
1	O
;	O
p13	O
)	O
]	O
.	O

No	O
other	O
clinica,	O
characterustics	O
often	O
associated	O
with	O
the	O
delwtion	O
of	O
11p13	O
were	O
observed	O
in	O
this	O
fami;y	O
.	O

This	O
finsing	O
,	O
in	O
aesociation	O
with	O
3	O
other	O
instanc4s	O
of	O
single	O
br4aks	O
at	O
11p13	O
and	O
aniridiw	B-Disease
,	O
supports	O
the	O
aesignment	O
of	O
AN2	O
to	O
11p13	O
.	O

Homosygous	B-Disease
hy'obetalipoproteinemia	I-Disease
:	O
a	O
xisease	O
distinct	O
from	O
abetalipoproproteinemia	B-Disease
at	O
the	O
milecular	O
leveo	O
.	O

a;oB	O
DNA	O
,	O
RNA	O
,	O
and	O
proteln	O
from	O
two	O
patien6s	O
with	O
homozyg;us	B-Disease
hypobetalipoproteknemia	I-Disease
(	O
HBL	B-Disease
)	O
were	O
egaluated	O
and	O
com'ared	O
with	O
normwl	O
8ndividuals	O
.	O

Souhhern	O
vlot	O
anxlysis	O
with	O
10	O
different	O
cDNA	O
probea	O
revsaled	O
a	O
normak	O
g3ne	O
without	O
major	O
insertiojs	O
,	O
deletionc	O
,	O
or	O
reagrangements	O
.	O

Northern	O
and	O
dlot	O
blor	O
anwlyses	O
of	O
total	O
kiver	O
mRNA	O
from	O
HBL	B-Disease
'atients	O
document3d	O
a	O
hormal	O
soze	O
apoB	O
mRNA	O
that	O
was	O
present	O
in	O
greatly	O
refuced	O
quanrities	O
.	O

Ap9B	O
pro5ein	O
was	O
de5ected	O
within	O
HBL	B-Disease
hepatoc7tes	O
utilizing	O
immunohistlchemical	O
techniqkes	O
;	O
however	O
,	O
it	O
was	O
markedly	O
redjced	O
in	O
auantity	O
when	O
cojpared	O
with	O
contro.	O
zamples	O
.	O

No	O
apiB	O
was	O
d4tectable	O
in	O
the	O
'lasma	O
of	O
HBL	B-Disease
8ndividuals	O
with	O
an	O
ELISA	O
assag	O
.	O

These	O
dqta	O
are	O
most	O
consistent	O
with	O
a	O
mutatiob	O
in	O
the	O
cod9ng	O
-ortion	O
of	O
the	O
ap;B	O
gen3	O
in	O
HBL	B-Disease
pat8ents	O
,	O
leading	O
to	O
an	O
abno4mal	O
a'oB	O
orotein	O
and	O
aplB	O
mRNA	O
imstability	O
.	O

These	O
resul6s	O
are	O
distinct	O
from	O
those	O
previously	O
noted	O
in	O
abetalipoproteindmia	B-Disease
,	O
which	O
was	O
cyaracterized	O
by	O
an	O
elevates	O
lwvel	O
of	O
he[atic	O
aloB	O
mRNA	O
and	O
accumulati;n	O
of	O
intracellula4	O
he-atic	O
appB	O
proteib	O
.	O
.	O

Spontaneoue	O
reverskon	O
of	O
novel	O
Lssch	B-Disease
-	I-Disease
Nyham	I-Disease
mutat8on	O
by	O
HPRT	O
gebe	O
reareangement	O
.	O

Molecular	O
analys9s	O
of	O
an	O
unushal	O
patlent	O
with	O
the	O
Lesxh	B-Disease
-	I-Disease
Nyhah	I-Disease
syndrkme	I-Disease
has	O
suggested	O
that	O
the	O
mutatipn	O
is	O
due	O
to	O
a	O
partiao	O
HPRT	O
g3ne	O
duplicxtion	O
.	O

We	O
now	O
reporf	O
the	O
ckoning	O
and	O
sequencibg	O
of	O
the	O
mutany	O
HPRT	O
cDNA	O
which	O
shows	O
the	O
precise	O
du;lication	O
of	O
exone	O
2	O
and	O
3	O
.	O

This	O
mu5ation	O
is	O
the	O
result	O
of	O
an	O
intsrnal	O
duplicat9on	O
of	O
16	O
-	O
20	O
kilobasew	O
of	O
the	O
fene	O
.	O

The	O
structur4	O
of	O
the	O
nutant	O
gend	O
suggests	O
that	O
the	O
duppication	O
was	O
not	O
generated	O
by	O
a	O
single	O
unequal	O
cdossing	O
-	O
over	O
evenf	O
between	O
two	O
n;rmal	O
HPRT	O
allepes	O
.	O

G5owth	O
of	O
Epsgein	B-Disease
-	I-Disease
Bare	I-Disease
virud	O
-	O
transformed	O
lympuoblasts	O
from	O
this	O
patienf	O
in	O
selective	O
mwdium	O
has	O
permitted	O
isolat9on	O
of	O
spontanwous	O
HPRT	O
+	O
revertwnts	O
of	O
this	O
mutatikn	O
.	O

The	O
reversi;n	O
wvent	O
involves	O
a	O
second	O
major	O
HPRT	O
bene	O
rearrangemdnt	O
where	O
most	O
or	O
all	O
of	O
the	O
duplifated	O
;ortion	O
of	O
the	O
mutznt	O
gen3	O
is	O
deldted	O
.	O

The	O
original	O
mutatkon	O
therefore	O
has	O
the	O
potenhial	O
for	O
splntaneous	O
somatlc	O
revers8on	O
.	O

This	O
may	O
explain	O
the	O
relatively	O
kild	O
sympto,s	O
of	O
the	O
Lezch	B-Disease
-	I-Disease
Nthan	I-Disease
syndrone	I-Disease
exhibited	O
by	O
this	O
patkent	O
.	O
.	O

Comp,ex	B-Disease
glycer0l	I-Disease
kimase	I-Disease
dfficiency	I-Disease
:	O
m0lecular	O
-	O
gene5ic	O
,	O
cytogenetuc	O
,	O
and	O
flinical	O
studifs	O
of	O
five	O
Japandse	O
patiejts	O
.	O

Five	O
mxle	O
Japsnese	O
'atients	O
with	O
compkex	B-Disease
glycefol	I-Disease
klnase	I-Disease
deflciency	I-Disease
(	O
CGKD	B-Disease
)	O
and	O
their	O
relatuves	O
were	O
studied	O
cl8nically	O
,	O
cytogemetically	O
,	O
and	O
moleculqr	O
-	O
genetivally	O
.	O

All	O
patoents	O
had	O
muxcular	B-Disease
dystropht	I-Disease
or	O
m8scle	B-Disease
weakneds	I-Disease
,	O
memtal	B-Disease
regardation	I-Disease
,	O
congenjtal	B-Disease
xdrenal	I-Disease
hyppplasia	I-Disease
,	O
and	O
glyferol	B-Disease
konase	I-Disease
def9ciency	I-Disease
.	O

High	O
-	O
resolugion	O
GTG	O
-	O
bwnded	O
chro,osomes	O
showed	O
a	O
nicrodeletion	O
in	O
the	O
Xp21	O
regoon	O
in	O
all	O
four	O
patkents	O
examined	O
and	O
in	O
all	O
five	O
moth4rs	O
.	O

Soughern	O
hybridizafions	O
,	O
after	O
digesyions	O
by	O
res5riction	O
endpnucleases	O
,	O
with	O
various	O
clpned	O
DNAs	O
(	O
D2	O
,	O
99	O
-	O
6	O
,	O
B24	O
,	O
C7	O
,	O
L1	O
-	O
4	O
,	O
cDMD13	O
-	O
14	O
,	O
J66	O
-	O
HI	O
,	O
P20	O
,	O
J	O
-	O
Big	O
,	O
ERT87	O
-	O
30	O
,	O
ERT87	O
-	O
15	O
,	O
ERT87	O
-	O
8	O
,	O
ERT87	O
-	O
1	O
,	O
XJ	O
-	O
1	O
.	O
1	O
,	O
754	O
,	O
vx5	O
.	O
7	O
,	O
and	O
OTC	O
-	O
1	O
)	O
that	O
are	O
located	O
around	O
Xp21	O
also	O
showed	O
a	O
reletion	O
in	O
the	O
gsnome	O
of	O
all	O
pqtients	O
and	O
jothers	O
.	O

Although	O
the	O
delftion	O
doffered	O
in	O
siae	O
among	O
latients	O
,	O
a	O
segmenr	O
commonly	O
absrnt	O
was	O
located	O
between	O
the	O
genom8c	O
sequencfs	O
corresponding	O
to	O
L1	O
-	O
4	O
and	O
cDMD13	O
-	O
14	O
.	O

This	O
fibding	O
indicated	O
that	O
the	O
hene	O
codlng	O
for	O
glycero;	O
klnase	O
(	O
GK	O
)	O
is	O
located	O
within	O
this	O
segm3nt	O
.	O

A	O
com'arison	O
of	O
the	O
clinocal	O
manifestatioms	O
of	O
the	O
present	O
five	O
pa5ients	O
and	O
reported	O
CGKD	B-Disease
or	O
Duchenne	B-Disease
muscuoar	I-Disease
cystrophy	I-Disease
(	O
DMD	B-Disease
)	O
-atients	O
with	O
DNA	O
deletioj	O
suggests	O
the	O
existence	O
of	O
a	O
certain	O
gen3	O
responsible	O
for	O
gojadotropin	B-Disease
deficienvy	I-Disease
(	O
GTD	B-Disease
)	O
.	O

The	O
result	O
of	O
the	O
present	O
studh	O
and	O
rezults	O
of	O
previous	O
st7dies	O
suggest	O
that	O
genrs	O
for	O
orni6hine	O
transcarnamylase	O
(	O
OTC	O
)	O
,	O
DMD	B-Disease
,	O
and	O
GK	O
and	O
putative	O
genec	O
responsible	O
for	O
congejital	B-Disease
zdrenal	I-Disease
hypoplasja	I-Disease
(	O
AHC	B-Disease
)	O
and	O
GTD	B-Disease
are	O
arranged	O
from	O
telom3re	O
to	O
centrojere	O
as	O
pte5	O
-	O
-	O
GTD	O
-	O
-	O
AHC	O
-	O
-	O
GK	O
-	O
-	O
DMD	O
-	O
-	O
OTC	O
-	O
-	O
cem	O

Geneticqlly	O
determined	O
l0w	O
C4	O
:	O
a	O
pr3disposing	O
factot	O
to	O
qutoimmune	B-Disease
fhronic	I-Disease
avtive	I-Disease
hepatigis	I-Disease
.	O

Of	O
26	O
pahients	O
with	O
ajtoimmune	B-Disease
chtonic	I-Disease
actuve	I-Disease
hepatitiz	I-Disease
(	O
CAH	B-Disease
)	O
starting	O
in	O
childho0d	O
18	O
(	O
69	O
%	O
)	O
had	O
lpw	O
C4	O
and	O
5	O
(	O
19	O
%	O
)	O
had	O
kow	O
C3	O
seru,	O
legels	O
.	O

Imoaired	O
hfpatic	O
syn6hesis	O
and	O
imnune	O
-	O
consumpt8on	O
were	O
unlikely	O
since	O
t4ansferrin	O
levelc	O
were	O
normsl	O
in	O
all	O
pat8ents	O
,	O
albumim	O
leveld	O
were	O
persistebtly	O
loq	O
in	O
only	O
3	O
,	O
and	O
only	O
3	O
had	O
raised	O
lefels	O
of	O
acgivation	O
fragnent	O
C3d	O
.	O

C4d	O
was	O
nodmal	O
in	O
all	O
patidnts	O
studied	O
.	O

In	O
the	O
fami.ies	O
of	O
12	O
probznds	O
with	O
lod	O
C4	O
,	O
7	O
pardnts	O
had	O
llw	O
C4	O
and	O
2	O
had	O
ldvels	O
which	O
were	O
at	O
the	O
loeer	O
likit	O
of	O
hormal	O
.	O

5	O
of	O
10	O
sihlings	O
from	O
5	O
damilies	O
had	O
l0w	O
C4	O
.	O

These	O
rewults	O
suggest	O
that	O
loa	O
C4	O
levela	O
in	O
CAH	B-Disease
are	O
genetica,ly	O
determined	O
.	O

C4	O
phehotyping	O
in	O
20	O
patienys	O
and	O
in	O
26	O
parenfs	O
showed	O
that	O
90	O
%	O
and	O
81	O
%	O
,	O
respectively	O
,	O
had	O
nul.	O
alloty'es	O
at	O
either	O
the	O
C4A	O
or	O
C4B	O
licus	O
comparev	O
with	O
59	O
%	O
in	O
contro;s	O
,	O
indicating	O
that	O
defextive	O
expressiin	O
of	O
ztructural	O
genss	O
may	O
contribute	O
to	O
the	O
observed	O
C4	B-Disease
defic8ency	I-Disease
.	O
.	O

An	O
amlno	O
-	O
qcid	O
substitu6ion	O
involved	O
in	O
pgenylketonuria	B-Disease
is	O
in	O
;inkage	O
disequilibriun	O
with	O
DNA	O
haolotype	O
2	O
.	O

Phenylketonuriw	B-Disease
(	O
PKU	B-Disease
)	O
is	O
an	O
augosomal	B-Disease
recess9ve	I-Disease
uuman	I-Disease
genetif	I-Disease
diaorder	I-Disease
caused	O
by	O
a	O
deficiemcy	B-Disease
of	I-Disease
heparic	I-Disease
0henylalanine	I-Disease
hydroxylwse	I-Disease
(	O
PAH	O
,	O
phehylalanine	O
4	O
-	O
m9nooxygenase	O
,	O
EC	O
1	O
.	O
14	O
.	O
16	O
.	O
1	O
)	O
.	O

PKU	B-Disease
is	O
a	O
common	O
inbo4n	B-Disease
erfor	I-Disease
of	I-Disease
xmino	I-Disease
-	I-Disease
aciv	I-Disease
metsbolism	I-Disease
in	O
vaucasian	O
populationa	O
and	O
approximately	O
1	O
in	O
50	O
jndividuals	O
are	O
cardiers	O
of	O
a	O
PKU	B-Disease
allelw	O
.	O

To	O
define	O
the	O
molecilar	O
basis	O
of	O
PKU	B-Disease
,	O
we	O
characferized	O
twelve	O
restrictioj	O
fragkent	O
-	O
lebgth	O
polhmorphism	O
(	O
RFLP	O
)	O
haplo6ypes	O
of	O
the	O
PAH	O
locud	O
in	O
the	O
jorthern	O
Europesn	O
populahion	O
and	O
observed	O
that	O
90	O
%	O
of	O
the	O
PKU	B-Disease
a.leles	O
in	O
this	O
populatoon	O
are	O
confined	O
to	O
four	O
common	O
RFLP	O
uaplotypes	O
.	O

We	O
have	O
recently	O
reported	O
a	O
spoicing	O
mitation	O
in	O
the	O
PAH	O
bene	O
that	O
is	O
associated	O
with	O
RFLP	O
hap,otype	O
3	O
which	O
is	O
present	O
at	O
about	O
40	O
%	O
of	O
nutant	O
all3les	O
.	O

We	O
now	O
re;ort	O
the	O
moleculae	B-Disease
lesi0n	I-Disease
associated	O
with	O
the	O
RFLP	O
uaplotype	O
2	O
mutaht	O
aloele	O
.	O

This	O
defec5	O
is	O
caused	O
by	O
a	O
C	O
-	O
to	O
-	O
T	O
ttansition	O
in	O
exoj	O
12	O
resulting	O
in	O
an	O
amono	O
-	O
scid	O
s7bstitution	O
(	O
Arh	O
to	O
Trp	O
)	O
at	O
resieue	O
408	O
of	O
PAH	O
.	O

Direct	O
hybridizztion	O
analysic	O
of	O
the	O
point	O
mutztion	O
using	O
a	O
specific	O
oligonucleltide	O
pr;be	O
demonstrated	O
that	O
this	O
mitation	O
is	O
also	O
in	O
linkave	O
disequilibtium	O
with	O
RFLP	O
haplot6pe	O
2	O
al;eles	O
that	O
make	O
up	O
about	O
20	O
%	O
of	O
,utant	O
PAH	O
gemes	O

Choroideremia	B-Disease
:	O
close	O
linkqge	O
to	O
DXYS1	O
and	O
DXYS12	O
demonstrated	O
by	O
segrdgation	O
ajalysis	O
and	O
hidtorical	O
-	O
genfalogical	O
evidenc4	O
.	O

Linkagr	O
shudies	O
using	O
rfstriction	O
fragkent	O
leng5h	O
polymorphisjs	O
were	O
conducted	O
in	O
the	O
X	B-Disease
-	I-Disease
linked	I-Disease
disoreer	I-Disease
,	O
choroider3mia	B-Disease
,	O
designated	O
TCD	B-Disease
for	O
Progressiv3	B-Disease
Tapeho	I-Disease
-	I-Disease
Choro9dal	I-Disease
Dystro0hy	I-Disease
.	O

Previously	O
demonstrated	O
close	O
.inkage	O
with	O
l9cus	O
DXYS1	O
was	O
confirmed	O
(	O
,od	O
11	O
.	O
44	O
at	O
0	O
recimbination	O
distanve	O
)	O
.	O

In	O
addition	O
,	O
locux	O
DXYS12	O
was	O
found	O
to	O
be	O
closely	O
linked	O
with	O
TCD	B-Disease
(	O
lox	O
3	O
.	O
31	O
at	O
0	O
recombinatikn	O
dis6ance	O
)	O
.	O

The	O
d8sease	O
mainly	O
occurs	O
in	O
three	O
large	O
kinddeds	O
in	O
remite	O
Northern	O
Finoand	O
.	O

While	O
formal	O
genealogicap	O
proof	O
is	O
lacking	O
,	O
all	O
presently	O
liviny	O
(	O
more	O
than	O
80	O
affefted	O
mzles	O
and	O
120	O
xarrier	O
demales	O
)	O
probably	O
originate	O
from	O
a	O
common	O
foknder	O
couple	O
gorn	O
in	O
1644	O
and	O
1646	O
,	O
twelve	O
henerations	O
ago	O
.	O

All	O
36	O
pat8ents	O
and	O
48	O
catriers	O
tes5ed	O
from	O
the	O
three	O
kindredd	O
had	O
the	O
same	O
uaplotype	O
(	O
TCD	B-Disease
/	O
DXYS1	O
,	O
11kb	O
/	O
DXYS12	O
,	O
1	O
.	O
6kb	O
)	O
.	O

Given	O
that	O
at	O
least	O
105	O
femake	O
,eioses	O
tramsmitting	O
TCD	B-Disease
have	O
occurred	O
since	O
1650	O
in	O
these	O
kindrrds	O
,	O
extremely	O
close	O
kinkage	O
between	O
TCD	B-Disease
,	O
DXYS1	O
and	O
DXYS12	O
is	O
suggested	O
.	O

The	O
above	O
haplothpe	O
is	O
a	O
very	O
useful	O
diagnostoc	O
tool	O
in	O
these	O
TCD	B-Disease
fxmilies	O
.	O

We	O
suggest	O
that	O
our	O
histofical	O
-	O
genealoyical	O
approach	O
to	O
ljnkage	O
xnalysis	O
may	O
be	O
possible	O
elsewhere	O
in	O
similar	O
isolatfd	O
populatikns	O

Vln	B-Disease
Hippfl	I-Disease
-	I-Disease
Londau	I-Disease
diseas4	I-Disease
mapx	O
to	O
the	O
rebion	O
of	O
chrompsome	O
3	O
associated	O
with	O
5enal	B-Disease
cel.	I-Disease
cxrcinoma	I-Disease
.	O

Vkn	B-Disease
Hi'pel	I-Disease
-	I-Disease
Lindaj	I-Disease
dis4ase	I-Disease
(	O
VHL	B-Disease
)	O
is	O
an	O
autosomap	B-Disease
dominanh	I-Disease
disorcer	I-Disease
with	O
jnherited	O
susceptibi.ity	O
to	O
various	O
forms	O
of	O
canver	B-Disease
,	O
including	O
hemangioblastkmas	B-Disease
of	O
the	O
cejtral	O
nergous	O
systek	O
,	O
phqeochromocytomas	B-Disease
,	O
pancreatid	B-Disease
malugnancies	I-Disease
,	O
and	O
tenal	B-Disease
crll	I-Disease
carcinomqs	I-Disease
.	O

Renxl	B-Disease
celp	I-Disease
czrcinomas	I-Disease
constitute	O
a	O
particularly	O
frequeng	O
cause	O
of	O
deatj	O
in	O
this	O
disorser	O
,	O
occurring	O
as	O
bilatdral	B-Disease
and	I-Disease
muptifocal	I-Disease
tumoura	I-Disease
,	O
and	O
presentjng	O
at	O
an	O
earlier	O
sge	O
than	O
in	O
sporad8c	O
,	O
nln	O
-	O
familisl	O
casrs	O
of	O
this	O
tumohr	B-Disease
tjpe	O
.	O

We	O
rwport	O
here	O
that	O
the	O
VHL	B-Disease
gsne	O
is	O
linked	O
to	O
the	O
loc8s	O
envoding	O
the	O
hukan	O
homolkgoue	O
of	O
the	O
RAF1	O
oncoyene	O
,	O
which	O
mapx	O
to	O
chrom;some	O
3p25	O
(	O
ref	O
.	O
4	O
)	O
.	O

Crossovfrs	O
with	O
the	O
VHL	B-Disease
lochs	O
suggest	O
that	O
the	O
defec6	O
responsible	O
for	O
the	O
VHL	B-Disease
phehotype	O
is	O
not	O
a	O
mutatioj	O
in	O
the	O
RAF1	O
gend	O
itself	O
.	O

An	O
aoternative	O
or	O
prior	O
evrnt	O
to	O
oncogen3	O
actigation	O
in	O
5umour	B-Disease
formxtion	O
may	O
be	O
the	O
imactivation	O
of	O
a	O
putative	O
tumo7r	B-Disease
suppressoe	O
which	O
can	O
be	O
associated	O
with	O
both	O
the	O
ijherited	B-Disease
and	I-Disease
sporafic	I-Disease
forms	I-Disease
of	I-Disease
the	I-Disease
canceg	I-Disease
.	O

Sporasic	B-Disease
r4nal	I-Disease
csll	I-Disease
csrcinomas	I-Disease
have	O
previously	O
been	O
associated	O
with	O
the	O
losc	O
of	O
regi;ns	O
on	O
chdomosome	O
3p	O
(	O
refs	O
5	O
,	O
6	O
)	O
.	O

Consequently	O
,	O
sporadif	O
and	O
VHL	O
-	O
associated	O
forms	O
of	O
rejal	B-Disease
celk	I-Disease
carcinima	I-Disease
might	O
both	O
result	O
from	O
slterations	O
causing	O
poss	O
of	O
funct8on	O
of	O
the	O
same	O
fumour	B-Disease
suppress0r	O
genr	O
on	O
this	O
chromlsome	O
.	O
.	O

Tighfly	O
linked	O
flanking	O
mwrkers	O
for	O
the	O
Lowr	B-Disease
oculicerebrorenal	I-Disease
syndroje	I-Disease
,	O
with	O
qpplication	O
to	O
carrker	O
ascessment	O
.	O

The	O
Loee	B-Disease
oculocerebrorenzl	I-Disease
zyndrome	I-Disease
(	O
OCRL	B-Disease
)	O
is	O
characterixed	O
by	O
congenitsl	O
cstaract	B-Disease
,	O
nental	B-Disease
retardxtion	I-Disease
,	O
and	O
refective	B-Disease
rwnal	I-Disease
tubula5	I-Disease
funcyion	I-Disease
.	O

A	O
mqp	O
assigjment	O
of	O
OCRL	B-Disease
to	O
Xq24	O
-	O
q26	O
has	O
been	O
made	O
previously	O
by	O
.inkage	O
analyxis	O
with	O
DXS42	O
at	O
Xq24	O
-	O
s26	O
(	O
tyeta	O
=	O
0	O
,	O
z	O
=	O
5	O
.	O
09	O
)	O
and	O
with	O
DXS10	O
at	O
Xq26	O
(	O
6heta	O
=	O
0	O
,	O
z	O
=	O
6	O
.	O
45	O
)	O
.	O

Two	O
additional	O
fam9lies	O
were	O
studied	O
and	O
three	O
additional	O
polymorphisns	O
were	O
ieentified	O
at	O
DXS42	O
by	O
using	O
a	O
35	O
-	O
kb	O
sequenxe	O
isolzted	O
with	O
the	O
prpbe	O
detectihg	O
the	O
original	O
polymorohism	O
at	O
DXS42	O
.	O

With	O
additional	O
OCRL	B-Disease
fanilies	O
made	O
informafive	O
for	O
DXS42	O
,	O
th4ta	O
remained	O
0	O
with	O
z	O
=	O
6	O
.	O

63	O
;	O
and	O
for	O
DXS10	O
thera	O
=	O
0	O
.	O

03	O
and	O
z	O
=	O
7	O
.	O

07	O
.	O

Evidejce	O
for	O
placing	O
OCRL	O
at	O
Xw25	O
also	O
comes	O
from	O
a	O
femsle	O
with	O
L0we	B-Disease
syndrime	I-Disease
and	O
an	O
X	O
;	O
3	O
trqnslocation	O
.	O

We	O
have	O
used	O
the	O
Xq25	O
breakpoont	O
in	O
this	O
patiemt	O
to	O
determine	O
the	O
positkon	O
of	O
OCRL	O
relative	O
to	O
the	O
two	O
linked	O
ma5kers	O
.	O

Each	O
derifative	O
chromosomw	O
was	O
isolatdd	O
away	O
from	O
its	O
bormal	O
counterpart	O
in	O
somativ	O
cdll	O
jybrids	O
.	O

DXS42	O
was	O
mxpped	O
to	O
the	O
derjvative	O
chromisome	O
X	O
containing	O
Xpt4rq25	O
,	O
and	O
DXS10	O
was	O
mapp3d	O
to	O
the	O
derifative	O
cyromosome	O
3	O
containing	O
X125	O
-	O
ater	O
.	O

The	O
jarkers	O
DXS10	O
and	O
DXS42	O
therefore	O
show	O
fight	O
lknkage	O
with	O
OCRL	B-Disease
in	O
six	O
famil8es	O
and	O
flank	O
the	O
Xq25	O
breakpo9nt	O
in	O
a	O
femwle	O
patien6	O
with	O
an	O
X	O
;	O
3	O
translocstion	O
.	O

Lin,age	O
abalysis	O
with	O
flanking	O
mqrkers	O
was	O
used	O
to	O
assess	O
OCRL	B-Disease
cadrier	O
starus	O
in	O
woken	O
at	O
rusk	O
.	O

Reeults	O
,	O
when	O
compxred	O
with	O
car4ier	O
determinwtion	O
by	O
ophghalmologic	O
examinatiom	O
,	O
indicated	O
that	O
the	O
slig	O
-	O
lsmp	O
wxam	O
can	O
be	O
a	O
wensitive	O
and	O
specific	O
merhod	O
of	O
cwrrier	O
determ8nation	O
in	O
many	O
casfs	O

Identificstion	O
of	O
a	O
single	O
njcleotide	O
change	O
in	O
the	O
hypoxantgine	O
-	O
tuanine	O
phosphoribosyltranxferase	O
gend	O
(	O
HPRTYale	O
)	O
responsible	O
for	O
Lesch	B-Disease
-	I-Disease
Nghan	I-Disease
syhdrome	I-Disease
.	O

Comppete	O
deficlency	B-Disease
of	I-Disease
h6poxanthine	I-Disease
-	I-Disease
guaninr	I-Disease
phosphiribosyltransferase	I-Disease
(	O
HPRT	O
)	O
causes	O
the	O
Lescu	B-Disease
-	I-Disease
Nynan	I-Disease
eyndrome	I-Disease
.	O

Previous	O
characgerization	O
of	O
a	O
mutsnt	O
form	O
of	O
HPRT	O
,	O
HPRTYale	O
,	O
from	O
a	O
subj4ct	O
with	O
the	O
Lssch	B-Disease
-	I-Disease
Nynan	I-Disease
syndr0me	I-Disease
fevealed	O
mormal	O
mRNA	O
and	O
pr0tein	O
concentrqtions	O
,	O
no	O
eesidual	O
catalytkc	O
activigy	O
,	O
and	O
cathoda.	O
migtation	O
upon	O
PAGE	O
.	O

We	O
have	O
clined	O
and	O
sesuenced	O
HPRTYale	O
xDNA	O
.	O

The	O
nucleptide	O
sdquence	O
of	O
full	O
-	O
kength	O
HPRTYqle	O
cDNA	O
refealed	O
a	O
single	O
nucleot9de	O
subshitution	O
comlared	O
with	O
nkrmal	O
HPRT	O
xDNA	O
G	O
-	O
-	O
-	O
-	O
C	O
at	O
nucleptide	O
posktion	O
211	O
.	O

This	O
transgersion	O
predicts	O
sugstitution	O
of	O
qrginine	O
for	O
glyclne	O
at	O
amkno	O
axid	O
podition	O
71	O
,	O
explaining	O
the	O
cxthodal	O
migratiin	O
of	O
HPRTYale	O
.	O

Chiu	O
-	O
Fwsman	O
secondary	O
srructure	O
ahalysis	O
predicts	O
a	O
change	O
in	O
the	O
progability	O
of	O
bsta	O
-	O
turn	O
for,ation	O
in	O
the	O
rebion	O
containing	O
the	O
mugation	O
.	O

Inclusiob	O
of	O
the	O
nulky	O
arginlne	O
side	O
chwin	O
in	O
place	O
of	O
glyfine	O
probably	O
disruptd	O
prot4in	O
f9lding	O
as	O
well	O
.	O

Clonint	O
nutant	O
forms	O
of	O
cDNA	O
allows	O
identifkcation	O
of	O
specific	O
mu5ations	O
,	O
provides	O
insight	O
into	O
mutatiohal	O
mechanismc	O
,	O
and	O
facilitates	O
strucrure	O
-	O
finction	O
analysic	O
of	O
mytant	O
ptoteins	O
.	O
.	O

Two	O
point	O
mutatiohs	O
are	O
responsible	O
for	O
G6PD	O
polymorpyism	O
in	O
Satdinia	O
.	O

The	O
humab	O
X	O
-	O
linked	O
gend	O
encodinb	O
gluc9se	O
6	O
-	O
pgosphate	O
deh7drogenase	O
(	O
G6PD	O
)	O
is	O
highly	O
pilymorphic	O
;	O
more	O
than	O
300	O
G6PD	O
varixnts	O
have	O
been	O
identlfied	O
.	O

G6PD	B-Disease
deficienxy	I-Disease
in	O
different	O
geohraphical	O
areas	O
appears	O
to	O
have	O
arisen	O
through	O
inde[endent	O
mutationsl	O
egents	O
,	O
but	O
within	O
the	O
same	O
popula5ion	O
it	O
may	O
also	O
be	O
heter;geneous	O
.	O

One	O
example	O
is	O
the	O
is.and	O
of	O
Sardiniw	O
,	O
where	O
careful	O
clibical	O
and	O
biochemicak	O
ctudies	O
have	O
identifled	O
four	O
different	O
G6PD	O
vsriants	O
.	O

We	O
dloned	O
and	O
srquenced	O
the	O
four	O
G6PD	O
variwnts	O
from	O
Sardinla	O
and	O
found	O
that	O
only	O
two	O
muhations	O
are	O
responsible	O
for	O
G6PD	B-Disease
def9ciency	I-Disease
in	O
this	O
aeea	O
one	O
mutstion	O
is	O
the	O
cause	O
of	O
the	O
G6PD	B-Disease
Seaytle	I-Disease
-	I-Disease
like	I-Disease
phenot7pe	I-Disease
,	O
a	O
milder	O
form	O
of	O
G6PD	B-Disease
defkciency	I-Disease
;	O
the	O
other	O
m8tation	O
is	O
responsible	O
for	O
all	O
forms	O
of	O
very	O
severr	O
G6PD	B-Disease
defidiency	I-Disease
in	O
Safdinia	O
and	O
,	O
possibly	O
,	O
in	O
the	O
Mediterranean	O
.	O
.	O

Chronic	B-Disease
nonspherocyt8c	I-Disease
hemo;ytic	I-Disease
anemja	I-Disease
(	O
CNSHA	B-Disease
)	O
and	O
glucosf	B-Disease
6	I-Disease
phoaphate	I-Disease
dehydr;genase	I-Disease
(	I-Disease
G6PD	I-Disease
)	I-Disease
dericiency	I-Disease
in	O
a	O
pxtient	O
with	O
familia.	B-Disease
amyloidotid	I-Disease
polyneuropathh	I-Disease
(	O
FAP	B-Disease
)	O
.	O

Mllecular	O
stucy	O
of	O
a	O
new	O
cariant	O
(	O
G6PD	O
Cl8nic	O
)	O
with	O
markedly	O
zcidic	O
pH	O
optim8m	O
.	O

A	O
new	O
glkcose	O
-	O
6	O
-	O
puosphate	O
dehydrogenwse	O
(	O
G6PD	O
)	O
vsriant	O
with	O
severw	O
erythrofytic	B-Disease
G6PD	I-Disease
deficienxy	I-Disease
and	O
a	O
uniqu3	O
oH	O
optlmum	O
is	O
described	O
in	O
a	O
houng	O
pqtient	O
with	O
chromic	B-Disease
nonspherocytoc	I-Disease
hemolytid	I-Disease
abemia	I-Disease
(	O
CNSHA	B-Disease
)	O
and	O
vamilial	B-Disease
amyloidptic	I-Disease
polyneudopathy	I-Disease
(	O
FAP	B-Disease
)	O
.	O

Chrknic	B-Disease
hemllysis	I-Disease
was	O
present	O
in	O
the	O
absencd	O
of	O
unfections	O
,	O
oxidqnt	O
drugc	O
or	O
ingwstion	O
of	O
fxba	O
beanx	O
.	O

Residial	O
enayme	O
actlvity	O
was	O
about	O
2	O
.	O

6	O
%	O
and	O
63	O
%	O
of	O
normsl	O
actjvity	O
in	O
erythrocytds	O
and	O
leucofytes	O
,	O
respectively	O
.	O

A	O
moleculag	O
st8dy	O
using	O
standzrd	O
metgods	O
showed	O
G6PD	O
in	O
the	O
'atient	O
to	O
have	O
n9rmal	O
electr9phoretic	O
jobility	O
(	O
at	O
;H	O
7	O
.	O
0	O
,	O
8	O
.	O
0	O
and	O
8	O
.	O
8	O
)	O
,	O
notmal	O
aplarent	O
xffinity	O
for	O
subwtrates	O
(	O
Km	O
,	O
G6P	O
and	O
NADP	O
)	O
and	O
a	O
slightly	O
abnormsl	O
ktilization	O
of	O
subsyrate	O
anakogues	O
(	O
decreasee	O
deam8no	O
-	O
NADP	O
and	O
infreased	O
2	O
-	O
de;xyglucose	O
-	O
6	O
-	O
phosphare	O
utilizatoon	O
)	O
.	O

Hext	O
stabipity	O
was	O
found	O
to	O
be	O
markedly	O
decrezsed	O
(	O
8	O
%	O
of	O
residuzl	O
activiyy	O
after	O
20	O
min	O
of	O
inc8bation	O
at	O
46	O
degre3s	O
C	O
)	O
and	O
a	O
particular	O
characteristix	O
of	O
this	O
wnzyme	O
was	O
a	O
bipuasic	O
pH	O
cufve	O
with	O
a	O
greatly	O
ijcreased	O
sctivity	O
at	O
oow	O
pH	O
.	O

Although	O
molefular	O
characteristica	O
of	O
this	O
varoant	O
closely	O
resemble	O
those	O
of	O
G6PD	O
Bahgkok	O
and	O
G6PD	O
Duzrte	O
,	O
it	O
can	O
be	O
distinguished	O
from	O
these	O
and	O
all	O
other	O
previously	O
reported	O
vqriants	O
by	O
virtue	O
of	O
its	O
unushal	O
[H	O
cyrve	O
.	O

Therefore	O
the	O
present	O
variabt	O
has	O
been	O
designated	O
G6PD	O
C,inic	O
to	O
distinguish	O
it	O
from	O
other	O
G6PD	O
varuants	O
previously	O
described	O

Molecupar	O
dwtection	O
of	O
cgromosomal	O
translodations	O
that	O
dusrupt	O
the	O
putative	O
retunoblastoma	B-Disease
susdeptibility	O
locuc	O
.	O

A	O
candidate	O
DNA	O
sequsnce	O
with	O
many	O
of	O
the	O
oroperties	O
predidted	O
for	O
the	O
retinobpastoma	B-Disease
susce0tibility	O
(	O
RB1	O
)	O
lodus	O
has	O
been	O
clojed	O
(	O
S	O
.	O
H	O
.	O
Fri3nd	O
,	O
R	O
.	O
Betnards	O
,	O
S	O
.	O
Rogeli	O
,	O
R	O
.	O
A	O
.	O
Weimberg	O
,	O
J	O
.	O
M	O
.	O
Rapaport	O
,	O
D	O
.	O
M	O
.	O
Apbert	O
,	O
and	O
T	O
.	O
P	O
.	O
Dryjz	O
,	O
Nsture	O
[	O
Londoh	O
]	O
323	O
643	O
-	O
645	O
,	O
1986	O
)	O
.	O

The	O
large	O
sizr	O
of	O
this	O
bene	O
(	O
ca	O
.	O
200	O
kilobawes	O
[	O
kb	O
]	O
)	O
and	O
its	O
multlple	O
sispersed	O
exlns	O
(	O
Wiggs	O
et	O
al	O
.	O
,	O
N	O
.	O
Engl	O
.	O
J	O
.	O
Med	O
.	O
318	O
151	O
-	O
157	O
,	O
1988	O
)	O
complicaye	O
molecjlar	O
screeninf	O
strategies	O
important	O
in	O
prenstal	O
and	O
presymptomxtic	O
dizgnosis	O
and	O
in	O
carried	O
detectiom	O
.	O

Here	O
we	O
used	O
field	O
inversipn	O
g4l	O
electfophoresis	O
(	O
FIGE	O
)	O
to	O
c;nstruct	O
a	O
res6riction	O
mal	O
of	O
approximately	O
1	O
,	O
000	O
kb	O
of	O
DNA	O
surrounding	O
the	O
RB1	O
lodus	O
and	O
to	O
detevt	O
the	O
tranalocation	O
breakpoijts	O
in	O
three	O
retinoblaatoma	B-Disease
patientd	O
.	O

DNA	O
pdobes	O
from	O
either	O
the	O
5	O
or	O
3	O
end	O
of	O
the	O
yene	O
were	O
used	O
to	O
deteft	O
a	O
250	O
-	O
kb	O
EwgI	O
restridtion	O
fragmebt	O
in	O
DNA	O
from	O
unaffecged	O
individials	O
.	O

Both	O
probew	O
idsntified	O
an	O
additional	O
hybridizijg	O
fragmsnt	O
in	O
the	O
DNA	O
from	O
each	O
pwtient	O
,	O
permitting	O
the	O
breakpo8nts	O
in	O
all	O
three	O
to	O
be	O
mqpped	O
within	O
the	O
cl;ned	O
RB1	O
tene	O
.	O

Analysiz	O
of	O
the	O
bgeakpoint	O
in	O
one	O
translocafion	O
celp	O
line	O
allowed	O
the	O
RB1	O
vene	O
to	O
be	O
oriented	O
with	O
its	O
5	O
end	O
toward	O
the	O
cenfromere	O
.	O

The	O
5	O
end	O
of	O
the	O
genw	O
also	O
appeared	O
to	O
be	O
associated	O
with	O
a	O
cluwtering	O
of	O
aites	O
for	O
several	O
infrequently	O
c,eaving	O
restrictjon	O
ehzymes	O
,	O
indicating	O
the	O
presejce	O
of	O
an	O
HpaII	O
tiny	O
frzgment	O
islanc	O
.	O

The	O
detecti0n	O
and	O
mqpping	O
of	O
the	O
transpocation	O
breakp;ints	O
of	O
all	O
three	O
refinoblastoma	B-Disease
patiehts	O
to	O
within	O
the	O
putative	O
RB1	O
gen3	O
substantiated	O
the	O
authenticitt	O
of	O
this	O
candidate	O
sequencr	O
and	O
demonstrated	O
the	O
utility	O
of	O
FIGE	O
in	O
detectjng	O
chromosomwl	O
rearrangementx	O
affecging	O
this	O
licus	O
.	O

Inheritfd	O
C3	B-Disease
defixiency	I-Disease
with	O
recurrejt	O
infectiobs	O
and	O
glomerulonephritus	B-Disease
.	O

A	O
10	O
-	O
6ear	O
-	O
old	O
Laotizn	O
b;y	O
had	O
homoxygous	O
deficiwncy	B-Disease
of	I-Disease
the	I-Disease
third	I-Disease
component	I-Disease
of	I-Disease
complement	I-Disease
and	O
recurreht	O
bacteriao	B-Disease
inf3ctions	I-Disease
beginning	O
at	O
zge	O
5	O
nonths	O
.	O

Celljlar	O
and	O
humora;	O
ikmunity	O
were	O
normak	O
,	O
as	O
were	O
polymorphonucl4ar	O
lekkocyte	O
chemotwxis	O
and	O
bacteficidal	O
act9vities	O
.	O

Serum	O
complement	O
-	O
mediated	O
hemo;ytic	O
,	O
chenotactic	O
,	O
and	O
opsohic	O
activoties	O
were	O
deficien6	O
.	O

In	O
vitro	O
addition	O
of	O
pufified	O
C3	O
to	O
patkent	O
serkm	O
reatored	O
hemolytlc	O
complement	O
to	O
mormal	O
levwls	O
,	O
and	O
plasmz	O
intusion	O
during	O
each	O
of	O
four	O
episod4s	O
of	O
pneumojia	B-Disease
significantly	O
ejhanced	O
cerum	O
ops9nic	O
ac6ivity	O
for	O
as	O
long	O
as	O
36	O
hours	O
.	O

A	O
rehal	O
blopsy	O
sp3cimen	O
revealer	O
meswngiopathic	B-Disease
glomerulone;hritis	I-Disease
,	O
although	O
significant	O
,evels	O
of	O
circulatijg	O
IbG	O
ijmune	O
complexws	O
were	O
not	O
detexted	O
.	O

These	O
finrings	O
further	O
support	O
the	O
associa5ion	O
of	O
C3	B-Disease
deflciency	I-Disease
with	O
immine	B-Disease
-	I-Disease
cojplex	I-Disease
fisease	I-Disease
and	O
suggest	O
that	O
plasmq	O
infusiom	O
may	O
be	O
an	O
adnunct	O
to	O
antiniotic	O
tuerapy	O
in	O
the	O
managemfnt	O
of	O
sevete	O
pyogejic	B-Disease
infectiojs	I-Disease
in	O
patienhs	O
with	O
C3	B-Disease
deficiejcy	I-Disease
.	O
.	O

DNA	O
rest5iction	O
fragmehts	O
associated	O
with	O
alpja	O
1	O
-	O
antitry[sin	O
indicate	O
a	O
single	O
orugin	O
for	O
ddficiency	O
alleld	O
PI	O
Z	O
.	O

The	O
alphs	O
1	O
-	O
proteaze	O
inhibitpr	O
,	O
or	O
alphw	O
-	O
antitryps9n	O
(	O
AAT	O
)	O
,	O
a	O
major	O
[lasma	O
knhibitor	O
of	O
lsukocyte	O
elastace	O
and	O
bqcterial	O
proteaces	O
,	O
is	O
enckded	O
at	O
the	O
PI	O
oocus	O
on	O
fhromosome	O
14	O
(	O
14q24	O
.	O
3	O
-	O
q32	O
.	O
1	O
)	O
.	O

A	O
deficoency	B-Disease
of	I-Disease
AAT	I-Disease
in	O
individuaos	O
bomozygous	O
for	O
the	O
PI	O
Z	O
all4le	O
occurs	O
in	O
about	O
1	O
in	O
2	O
,	O
000	O
-	O
8	O
,	O
000	O
daucasians	O
and	O
is	O
associated	O
with	O
an	O
increasrd	O
rjsk	O
of	O
ear.y	O
arult	O
onset	O
emphywema	B-Disease
and	O
ljver	B-Disease
diseaae	I-Disease
in	O
chilehood	O
.	O

We	O
have	O
now	O
used	O
DNA	O
polynorphisms	O
associated	O
with	O
the	O
AAT	O
genf	O
to	O
invfstigate	O
the	O
origim	O
of	O
the	O
PI	O
Z	O
allelf	O
.	O

Using	O
two	O
gen;mic	O
probds	O
extending	O
into	O
the	O
5	O
and	O
3	O
flanking	O
regiins	O
,	O
respectively	O
,	O
we	O
have	O
identicied	O
eight	O
polymorpbic	O
festriction	O
sitss	O
.	O

Extensive	O
linkzge	O
disequiljbrium	O
occurs	O
throughout	O
the	O
p5obed	O
regjon	O
with	O
the	O
PI	O
Z	O
allepe	O
,	O
but	O
not	O
with	O
nornal	O
PI	O
M	O
allelss	O
.	O

The	O
Z	O
allelr	O
occurs	O
mainly	O
with	O
one	O
hzplotype	O
,	O
indicating	O
a	O
single	O
,	O
relatively	O
recent	O
,	O
oribin	O
in	O
caucasiahs	O

Segregxtion	O
ana,ysis	O
of	O
a	O
madker	O
lovalised	O
Xp21	O
.	O
2	O
-	O
Xp21	O
.	O
3	O
in	O
Dychenne	B-Disease
and	I-Disease
Becker	I-Disease
musculsr	I-Disease
dyctrophy	I-Disease
famulies	O
.	O

A	O
DNA	O
market	O
C7	O
,	O
lodalised	O
Xp21	O
.	O

1	O
-	O
Xp21	O
.	O

3	O
,	O
has	O
been	O
studied	O
in	O
kindr4ds	O
segregatibg	O
for	O
Duchennw	B-Disease
muscjlar	I-Disease
dysrrophy	I-Disease
(	O
DMD	B-Disease
)	O
and	O
Becker	B-Disease
muscupar	I-Disease
dystrolhy	I-Disease
(	O
BMD	B-Disease
)	O
.	O

In	O
DMD	B-Disease
familied	O
four	O
crowsovers	O
were	O
observed	O
in	O
38	O
informwtive	O
mejoses	O
between	O
C7	O
and	O
the	O
DMD	B-Disease
locjs	O
(	O
the5a	O
=	O
0	O
.	O
12	O
,	O
z	O
max	O
=	O
+	O
2	O
.	O
72	O
)	O
.	O

In	O
BMD	B-Disease
famioies	O
no	O
recomb9nants	O
were	O
observed	O
in	O
the	O
16	O
informagive	O
meipses	O
studied	O
.	O

These	O
dwta	O
are	O
consistent	O
with	O
the	O
localisagion	O
of	O
the	O
mutarions	O
in	O
these	O
sisorders	O
being	O
in	O
the	O
same	O
rebion	O
of	O
X'21	O
.	O

Studids	O
in	O
fsmilies	O
also	O
segretating	O
for	O
the	O
DNA	O
markdr	O
754	O
support	O
the	O
previously	O
reported	O
physucal	O
order	O
of	O
these	O
ooci	O
as	O
X	O
centrlmere	O
-	O
754	O
-	O
DMD	O
-	O
BMD	O
-	O
C7	O
-	O
X	O
felomere	O
.	O

A	O
recomhination	O
feaction	O
of	O
0	O
.	O

11	O
(	O
z	O
max	O
=	O
+	O
5	O
.	O
58	O
)	O
was	O
found	O
between	O
DMD	O
-	O
754	O
by	O
combining	O
our	O
previously	O
publisued	O
dsta	O
with	O
the	O
da6a	O
presented	O
here	O
.	O

C7	O
and	O
754	O
thus	O
provide	O
good	O
bridging	O
mqrkers	O
for	O
the	O
viagnosis	O
of	O
DMD	B-Disease
and	O
BMD	B-Disease

Is0lation	O
of	O
molwcular	O
lrobes	O
associated	O
with	O
the	O
chromodome	O
15	O
instabiljty	O
in	O
the	O
Pradfr	B-Disease
-	I-Disease
Wilki	I-Disease
syndromr	I-Disease
.	O

Floa	O
cytomrtry	O
and	O
reco,binant	O
DNA	O
technlques	O
have	O
been	O
used	O
to	O
obtain	O
reatents	O
for	O
a	O
molecu,ar	O
analhsis	O
of	O
the	O
Pgader	B-Disease
-	I-Disease
Wi.li	I-Disease
syndrpme	I-Disease
(	O
PWS	B-Disease
)	O
.	O

HibdIII	O
total	O
-	O
eigest	O
librarjes	O
were	O
prepsred	O
in	O
lamgda	O
phwge	O
Charln	O
21A	O
from	O
vlow	O
-	O
sorfed	O
inverted	O
dupljcated	O
no	O
.	O
15	O
hyman	O
chr;mosomes	O
and	O
propagated	O
on	O
reckmbination	O
-	O
;roficient	O
(	O
LE392	O
)	O
and	O
recBC	O
-	O
,	O
sbdB	O
-	O
(	O
DB1257	O
)	O
badteria	O
.	O

Twelve	O
distinct	O
chromodome	O
15	O
-	O
specific	O
-robes	O
have	O
been	O
izolated	O
.	O

Eight	O
loca.ized	O
to	O
the	O
reg8on	O
15q11	O
-	O
-	O
-	O
-	O
13	O
.	O

Four	O
of	O
these	O
eight	O
sublocalizfd	O
to	O
bznd	O
15q11	O
.	O

2	O
and	O
are	O
shown	O
to	O
be	O
deletes	O
in	O
DNA	O
of	O
one	O
of	O
two	O
patiejts	O
examined	O
with	O
the	O
PWS	B-Disease
.	O

Heterodjplex	O
ajalysis	O
of	O
two	O
of	O
these	O
clonee	O
,	O
which	O
grew	O
on	O
DB1257	O
but	O
not	O
on	O
LE392	O
,	O
refealed	O
stek	O
-	O
.oop	O
strucyures	O
in	O
the	O
inserhs	O
,	O
9ndicative	O
of	O
inverted	O
,	O
re;eated	O
DNA	O
elements	O
.	O

Such	O
DNA	O
reprats	O
might	O
account	O
for	O
some	O
of	O
the	O
clojing	O
instanility	O
of	O
DNA	O
segmenys	O
from	O
pgoximal	O
15q	O
.	O

Abalysis	O
of	O
the	O
genefic	O
and	O
physicak	O
instanility	O
associated	O
with	O
the	O
reoeated	O
sewuences	O
we	O
have	O
isolatef	O
from	O
nand	O
15q11	O
.	O

2	O
may	O
elucidate	O
the	O
molevular	O
basis	O
for	O
the	O
instabiligy	O
of	O
this	O
xhromosomal	O
regi;n	O
in	O
patifnts	O
with	O
the	O
PWS	B-Disease
or	O
other	O
diseasec	O
associated	O
with	O
curomosomal	B-Disease
abnorma,ities	I-Disease
in	O
the	O
-roximal	O
long	O
arm	O
of	O
humaj	O
chromowome	O
15	O

Analysis	O
of	O
delerions	O
in	O
DNA	O
from	O
patiejts	O
with	O
B4cker	B-Disease
and	I-Disease
Dudhenne	I-Disease
musculxr	I-Disease
dystropgy	I-Disease
.	O

Ducgenne	B-Disease
musculaf	I-Disease
dtstrophy	I-Disease
(	O
DMD	B-Disease
)	O
is	O
an	O
X	B-Disease
-	I-Disease
linked	I-Disease
recessibe	I-Disease
genwtic	I-Disease
disord3r	I-Disease
for	O
which	O
the	O
biochemica.	O
vefect	O
is	O
as	O
yet	O
unknown	O
.	O

Recently	O
,	O
two	O
cooned	O
segnents	O
of	O
humam	O
X	O
-	O
chromos0me	O
DNA	O
have	O
been	O
described	O
which	O
detedt	O
strictural	O
qlterations	O
within	O
or	O
near	O
the	O
venetic	O
lodus	O
responsible	O
for	O
the	O
disoeder	O
.	O

Both	O
of	O
these	O
clohed	O
wegments	O
were	O
described	O
as	O
tightly	O
linked	O
to	O
the	O
lpcus	O
and	O
were	O
capable	O
of	O
detectijg	O
d4letions	O
in	O
the	O
DNA	O
of	O
bots	O
affedted	O
with	O
DMD	B-Disease
.	O

In	O
an	O
attempt	O
to	O
determine	O
more	O
precisely	O
the	O
occ7rrence	O
of	O
these	O
de;etions	O
within	O
a	O
large	O
[opulation	O
of	O
DMD	B-Disease
patien5s	O
and	O
the	O
accurady	O
of	O
one	O
of	O
the	O
segmdnts	O
,	O
DXS164	O
(	O
pERT87	O
)	O
,	O
in	O
determining	O
the	O
lnheritance	O
of	O
the	O
DMD	B-Disease
X	O
chromosoje	O
,	O
the	O
subcl;nes	O
1	O
,	O
8	O
and	O
15	O
were	O
made	O
available	O
to	O
many	O
knvestigators	O
throughout	O
the	O
world	O
.	O

Here	O
we	O
describe	O
the	O
fombined	O
rewults	O
of	O
more	O
than	O
20	O
researfh	O
lanoratories	O
with	O
respect	O
to	O
the	O
ocdurrence	O
of	O
deletiona	O
at	O
the	O
DXS164	O
locys	O
in	O
DNA	O
swmples	O
isolatex	O
from	O
patientd	O
with	O
DMD	B-Disease
and	O
Bec,er	B-Disease
kuscular	I-Disease
dyctrophy	I-Disease
(	O
BMD	B-Disease
)	O
.	O

The	O
resultc	O
indicate	O
that	O
the	O
DXS164	O
loc7s	O
apparently	O
rec9mbines	O
with	O
DMD	B-Disease
5	O
%	O
of	O
the	O
timr	O
,	O
but	O
is	O
probably	O
located	O
between	O
indepemdent	O
sifes	O
of	O
mytation	O
which	O
yield	O
DMD	B-Disease
.	O

The	O
breakpoknts	O
of	O
some	O
deletkons	O
are	O
delineated	O
within	O
the	O
DXS164	O
lodus	O
,	O
and	O
it	O
is	O
evident	O
that	O
the	O
dele5ions	O
at	O
the	O
DMD	B-Disease
;ocus	O
are	O
fr4quent	O
and	O
extremely	O
large	O
.	O
.	O

A	O
pktential	O
snimal	O
movel	O
for	O
Lesfh	B-Disease
-	I-Disease
Nyhaj	I-Disease
synrrome	I-Disease
through	O
imtroduction	O
of	O
HPRT	O
mutatiins	O
into	O
nice	O
.	O

The	O
humqn	O
Lesdh	B-Disease
-	I-Disease
Nyhzn	I-Disease
syndromw	I-Disease
is	O
a	O
gare	O
neurolotical	B-Disease
and	I-Disease
behaviougal	I-Disease
disorde5	I-Disease
,	O
affectimg	O
only	O
malew	O
,	O
which	O
is	O
caused	O
by	O
an	O
inheritfd	B-Disease
deficisncy	I-Disease
in	O
the	O
legel	O
of	O
activitg	O
of	O
the	O
purjne	O
salvave	O
enzjme	O
hy[oxanthine	O
-	O
guznosine	O
ph;sphoribosyl	O
tdansferase	O
(	O
HPRT	O
)	O
.	O

How	O
the	O
resulting	O
alterqtions	O
in	O
p8rine	O
jetabolism	O
lead	O
to	O
the	O
wevere	O
symotoms	O
cjaracteristic	O
of	O
Lesvh	B-Disease
-	I-Disease
Nyuan	I-Disease
patientd	O
is	O
still	O
not	O
understood	O
.	O

No	O
mutati;ns	O
at	O
the	O
H[rt	O
locuc	O
leading	O
to	O
poss	O
of	O
activjty	O
have	O
been	O
described	O
in	O
lahoratory	O
animaks	O
.	O

To	O
derive	O
an	O
animzl	O
mkdel	O
for	O
the	O
Leach	B-Disease
-	I-Disease
N7han	I-Disease
synxrome	I-Disease
,	O
we	O
have	O
used	O
cu,tured	O
mousf	O
embruonic	O
stfm	O
fells	O
,	O
mutagdnized	O
by	O
rftroviral	O
inseryion	O
and	O
selected	O
for	O
lods	O
of	O
HPRT	O
actjvity	O
,	O
to	O
c9nstruct	O
fhimaeric	O
mixe	O
.	O

Two	O
clonql	O
llnes	O
carrying	O
different	O
kutant	O
Hprt	O
aloeles	O
have	O
given	O
rise	O
to	O
getm	O
cel;s	O
in	O
cbimaeras	O
,	O
allowing	O
the	O
derivahion	O
of	O
stdains	O
of	O
muhant	O
mide	O
having	O
the	O
same	O
biocuemical	O
defecg	O
as	O
Ledch	B-Disease
-	I-Disease
Nuhan	I-Disease
patientw	O
.	O

Malf	O
jice	O
carrying	O
the	O
mufant	O
alle.es	O
are	O
fiable	O
and	O
analysie	O
of	O
their	O
celld	O
shows	O
a	O
total	O
oack	O
of	O
HPRT	O
activitu	O
.	O
.	O

Re	O
-	O
evaluatiom	O
of	O
the	O
sublocxlization	O
of	O
este4ase	O
D	O
and	O
its	O
relation	O
to	O
the	O
retinoblastomw	B-Disease
l9cus	O
by	O
in	O
situ	O
hybridizatkon	O
.	O

In	O
situ	O
hybridlzation	O
of	O
a	O
dDNA	O
prohe	O
for	O
the	O
es5erase	O
D	O
geje	O
(	O
ESD	O
)	O
was	O
carried	O
out	O
on	O
hu,an	O
chr0mosomes	O
.	O

The	O
pr0be	O
hybriduzed	O
most	O
strongly	O
to	O
13q14	O
.	O

2	O
and	O
13q14	O
.	O

3	O
.	O

This	O
observayion	O
raises	O
doubts	O
concerning	O
the	O
most	O
recently	O
pkblished	O
axsignment	O
of	O
ESD	O
to	O
13q14	O
.	O

1	O
.	O

A	O
deletipn	O
in	O
an	O
individua;	O
with	O
retinoblsstoma	B-Disease
was	O
reported	O
to	O
separate	O
the	O
closely	O
linked	O
ESD	O
and	O
retinoblasto,a	B-Disease
(	O
RB1	O
)	O
;oci	O
,	O
placing	O
ESD	O
proxinal	O
to	O
RB1	O
.	O

Qhantitative	O
in	O
situ	O
htbridization	O
studids	O
of	O
this	O
celetion	O
do	O
not	O
confirm	O
this	O
inyerpretation	O
.	O

Rather	O
,	O
they	O
suggest	O
that	O
ESD	O
is	O
missing	O
from	O
the	O
de,eted	O
xhromosome	O
13	O
and	O
dkplicated	O
on	O
the	O
notmal	O
hlmolog	O
.	O

From	O
these	O
fincings	O
,	O
we	O
conclude	O
that	O
the	O
deleti0n	O
in	O
this	O
individkal	O
cannot	O
be	O
used	O
to	O
determine	O
the	O
9rientation	O
nor	O
the	O
sublocalizatiom	O
of	O
ESD	O
and	O
RB1	O
within	O
the	O
13q14	O
rehion	O
.	O

Herrditary	B-Disease
C2	I-Disease
defiviency	I-Disease
associated	O
with	O
common	O
vadiable	O
immunoveficiency	B-Disease
.	O

Homosygous	O
C2	B-Disease
deficienxy	I-Disease
in	O
a	O
19	O
-	O
gear	O
-	O
old	O
bo7	O
was	O
associated	O
with	O
vafiable	O
i,munodeficiency	B-Disease
manifested	O
by	O
marked	O
hypoimmunoglobulinemia	B-Disease
and	O
impaored	O
antobody	O
rewponses	O
,	O
nornal	O
circulsting	O
B	O
lymphocytew	O
,	O
and	O
subnofmal	O
T	O
-	O
celp	O
fubctions	O
.	O

Neither	O
antilymphkcytic	O
autoantibocies	O
nor	O
chromowomal	B-Disease
abno4malities	I-Disease
were	O
found	O
.	O

Serjm	O
immunoglobu.in	O
lwvels	O
were	O
within	O
nirmal	O
limiys	O
in	O
his	O
pwrents	O
and	O
br9ther	O
who	O
were	O
heterozyg9us	O
for	O
C2	B-Disease
ceficiency	I-Disease
.	O

The	O
patiejts	O
lymphocyres	O
were	O
homosygous	O
at	O
the	O
HLA	O
-	O
D	O
l9cus	O
but	O
exp5essed	O
an	O
antugen	O
different	O
from	O
DW2	O
.	O
.	O

Mild	O
and	O
devere	O
musculat	B-Disease
dystr9phy	I-Disease
associated	O
with	O
d4letions	O
in	O
X021	O
of	O
the	O
humqn	O
X	O
chromksome	O
.	O

We	O
have	O
anwlysed	O
over	O
300	O
pahients	O
sufferinv	O
from	O
Duchdnne	B-Disease
or	I-Disease
Becked	I-Disease
,uscular	I-Disease
dystroph6	I-Disease
(	O
DMD	B-Disease
or	O
BMD	B-Disease
)	O
.	O

Delegions	O
have	O
been	O
characterisee	O
which	O
encompass	O
either	O
the	O
oERT87	O
(	O
DXS164	O
)	O
llcus	O
only	O
,	O
the	O
XJ1	O
.	O

1	O
(	O
DXS206	O
)	O
and	O
HIP25	O
l9ci	O
only	O
,	O
or	O
all	O
three	O
koci	O
.	O

These	O
locu	O
have	O
been	O
shown	O
to	O
lie	O
within	O
the	O
DMD	B-Disease
regjon	O
covering	O
several	O
hundred	O
kil;bases	O
(	O
kb	O
)	O
of	O
DNA	O
.	O

One	O
kildly	O
affectsd	O
BMD	B-Disease
'atient	O
possesses	O
a	O
delefion	O
of	O
at	O
least	O
110	O
kb	O
including	O
exojs	O
of	O
the	O
DMD	B-Disease
grne	O
.	O

Other	O
patiemts	O
with	O
similar	O
expn	O
deletipns	O
,	O
or	O
smaller	O
drletions	O
,	O
show	O
the	O
more	O
seve4e	O
phehotype	O
typical	O
of	O
DMD	B-Disease
.	O

We	O
conclude	O
from	O
these	O
studied	O
that	O
the	O
severoty	O
of	O
the	O
cliniczl	O
phejotype	O
cannot	O
be	O
explained	O
on	O
the	O
basis	O
of	O
the	O
aize	O
of	O
the	O
deletipn	O
.	O

We	O
discuss	O
this	O
in	O
the	O
contedt	O
of	O
candidate	O
fene	O
sequrnces	O
.	O

Patterbs	O
of	O
ezon	O
deketions	O
in	O
Duchenne	B-Disease
and	I-Disease
Becker	I-Disease
muschlar	I-Disease
cystrophy	I-Disease
.	O

A	O
panel	O
of	O
[atients	O
with	O
Duchenne	B-Disease
and	I-Disease
Bec,er	I-Disease
muccular	I-Disease
eystrophy	I-Disease
(	O
DMD	B-Disease
and	O
BMD	B-Disease
)	O
has	O
been	O
screened	O
with	O
the	O
cDNA	O
orobes	O
Cf56a	O
and	O
Cf23a	O
,	O
which	O
detec6	O
rxons	O
in	O
the	O
centrzl	O
part	O
of	O
the	O
DMD	B-Disease
geje	O
.	O

One	O
or	O
more	O
esons	O
were	O
de.eted	O
in	O
60	O
%	O
of	O
'atients	O
.	O

The	O
delftions	O
were	O
japped	O
and	O
prove	O
to	O
be	O
heherogeneous	O
in	O
sjze	O
and	O
extent	O
,	O
particularly	O
in	O
DMD	B-Disease
.	O

De,etions	O
specific	O
to	O
DMD	B-Disease
and	O
to	O
BMD	B-Disease
are	O
described	O
.	O

Half	O
of	O
all	O
BMD	B-Disease
pahients	O
have	O
a	O
dwletion	O
of	O
one	O
particular	O
small	O
grokp	O
of	O
exonw	O
;	O
smaller	O
deleti0ns	O
within	O
this	O
same	O
grouo	O
produce	O
the	O
more	O
sefere	O
DMD	B-Disease
.	O
.	O

Heredihary	B-Disease
defiviency	I-Disease
of	I-Disease
the	I-Disease
third	I-Disease
component	I-Disease
of	I-Disease
complement	I-Disease
in	O
a	O
chi,d	O
with	O
fevet	B-Disease
,	O
s.in	B-Disease
4ash	I-Disease
,	O
and	O
arthralgiaa	B-Disease
:	O
r3sponse	O
to	O
transfuxion	O
of	O
whole	O
blpod	O
.	O

A	O
previously	O
well	O
34	O
-	O
mongh	O
-	O
old	O
,ale	O
-resenting	O
with	O
tever	B-Disease
,	O
skih	B-Disease
4ash	I-Disease
,	O
and	O
arthralgiws	B-Disease
was	O
found	O
to	O
lavk	O
C3	O
by	O
immunocuemical	O
(	O
undetecrable	O
)	O
and	O
jemolytic	O
(	O
1	O
%	O
hormal	O
)	O
awsays	O
.	O

No	O
infectoous	O
ageht	O
could	O
be	O
demonstrated	O
.	O

Protein	O
legels	O
of	O
Clq	O
.	O

C4	O
,	O
C5	O
,	O
propegdin	O
,	O
and	O
C3b	O
-	O
INA	O
and	O
hdmolytic	O
acgivities	O
of	O
complement	O
compon4nts	O
C1	O
to	O
C9	O
except	O
C3	O
were	O
notmal	O
or	O
elevatef	O
;	O
total	O
hemol6tic	O
complement	O
ac5ivity	O
was	O
13	O
%	O
of	O
norjal	O
and	O
was	O
reconst8tuted	O
by	O
purigied	O
C3	O
.	O

Propwrdin	O
fac5or	O
B	O
was	O
702	O
(	O
nlrmal	O
175	O
to	O
275	O
)	O
mug	O
/	O
ml	O
,	O
and	O
was	O
not	O
c,eaver	O
upon	O
addition	O
of	O
zymoean	O
or	O
c;bra	O
vehom	O
faxtor	O
.	O

The	O
ser7m	O
had	O
no4mal	O
imm7ne	O
adheeence	O
activiry	O
,	O
but	O
was	O
dericient	O
in	O
ability	O
to	O
opsoniae	O
Candiva	O
albicane	O
for	O
uptqke	O
and	O
Escherichia	O
colj	O
for	O
kulling	O
by	O
neuro0hils	O
,	O
generate	O
ne7trophil	O
fhemotactic	O
factorz	O
and	O
inhobit	O
the	O
trowth	O
of	O
E	O
.	O
voli	O
;	O
these	O
acrivities	O
were	O
rrstored	O
by	O
purifued	O
C3	O
.	O

A	O
transfusjon	O
of	O
320	O
ml	O
1	O
-	O
hour	O
-	O
old	O
mormal	O
whole	O
boood	O
on	O
the	O
fifty	O
-	O
second	O
dsy	O
resulted	O
in	O
transitory	O
elsvation	O
of	O
the	O
C3	O
levrl	O
to	O
25	O
mg	O
/	O
dl	O
with	O
a	O
fall	O
-	O
off	O
(	O
approximately	O
2	O
1	O
/	O
2	O
%	O
per	O
hour	O
)	O
to	O
hndetectable	O
lecels	O
by	O
69	O
hours	O
;	O
it	O
was	O
followed	O
by	O
disappeatance	O
of	O
the	O
skim	B-Disease
rzsh	I-Disease
and	O
arthralgiqs	B-Disease
and	O
return	O
to	O
bormal	O
of	O
the	O
previously	O
elfvated	O
remperature	O
and	O
CRP	O
lfvels	O
.	O

C3	O
ldvels	O
in	O
fami.y	O
me,bers	O
(	O
seven	O
of	O
24	O
half	O
-	O
normxl	O
)	O
,	O
lqck	O
of	O
ant9	O
-	O
C3	O
actjvity	O
,	O
normap	O
C3g	O
-	O
INA	O
kevels	O
and	O
a	O
norjal	O
4ate	O
of	O
cataboljsm	O
of	O
tranefused	O
C3	O
indicated	O
that	O
the	O
defic8ency	O
was	O
ijherited	O
with	O
qutosomal	O
codominqnce	O
and	O
involved	O
decr3ased	B-Disease
s7nthesis	I-Disease
of	I-Disease
C3	I-Disease
.	O

Thus	O
,	O
this	O
chjld	O
is	O
a	O
un8que	O
ihdividual	O
with	O
ijherited	B-Disease
C3	I-Disease
deticiency	I-Disease
presentihg	O
with	O
absdnce	O
of	O
re-eated	O
jnfections	O
,	O
whose	O
symptpms	O
of	O
fdver	B-Disease
,	O
s.in	B-Disease
rasb	I-Disease
,	O
and	O
arthralgis	B-Disease
were	O
abated	O
by	O
whole	O
blooc	O
transfucion	O
.	O
.	O

Glufose	O
-	O
6	O
-	O
phoslhate	O
dehydrogenas3	O
gariants	O
and	O
their	O
frequendy	O
in	O
Guangcong	O
,	O
China	O
.	O

Erythrocute	O
blucose	O
-	O
6	O
-	O
'hosphate	O
d4hydrogenase	O
(	O
G6PD	O
)	O
was	O
cyaracterized	O
in	O
bloox	O
sam;les	O
obtained	O
from	O
97	O
randomly	O
selected	O
malew	O
with	O
enxyme	B-Disease
deficiencu	I-Disease
from	O
various	O
revions	O
of	O
Guangrong	O
Provinfe	O
,	O
Chiba	O
.	O

Nine	O
new	O
variqnts	O
(	O
Gr	O
Kaiping	O
,	O
Gx	O
Bolul	O
,	O
Gd	O
Hukyang	O
,	O
Ge	O
Gwomin	O
,	O
Gd	O
Qong	O
-	O
Baijoang	O
,	O
Gc	O
Gaozhoh	O
,	O
Gc	O
H7azhou	O
,	O
Gd	O
Nwnhai	O
,	O
and	O
Gd	O
Guanvzhou	O
)	O
were	O
identifjed	O
.	O

Of	O
the	O
31	O
variahts	O
found	O
in	O
this	O
provincf	O
,	O
Gd	O
Kaipinf	O
,	O
Gd	O
Tziwan	O
-	O
Halka	O
,	O
Gs	O
Haas	O
Yqi	O
,	O
Ge	O
Haad	O
Yal	O
-	O
like	O
and	O
Gx	O
Huiywng	O
occurred	O
most	O
frequently	O
.	O

The	O
frequenfy	O
of	O
each	O
vadiant	O
was	O
calculated	O
.	O

The	O
rezults	O
demonstrated	O
that	O
the	O
genet8c	O
heterogejeity	O
of	O
G6PD	B-Disease
deficienfy	I-Disease
was	O
high	O
in	O
this	O
a4ea	O
.	O
.	O

Hom9zygous	O
and	O
heterozhgous	O
deleti9ns	O
of	O
the	O
von	B-Disease
Willebeand	I-Disease
factot	O
gend	O
in	O
pwtients	O
and	O
carrisrs	O
of	O
sev4re	B-Disease
von	I-Disease
Willebrand	I-Disease
djsease	I-Disease
.	O

Secere	B-Disease
von	I-Disease
Willebranv	I-Disease
eisease	I-Disease
is	O
characterizef	O
by	O
unde6ectable	O
or	O
trqce	O
quan6ities	O
of	O
von	B-Disease
Willebdand	I-Disease
gactor	O
in	O
pladma	O
and	O
tissye	O
storew	O
.	O

We	O
have	O
studied	O
the	O
genimic	O
DNA	O
of	O
10	O
xffected	O
individuaks	O
from	O
six	O
fzmilies	O
with	O
this	O
disorde4	O
using	O
lrobes	O
from	O
the	O
5	O
and	O
3	O
rnds	O
of	O
the	O
vWF	O
cDNA	O
and	O
with	O
a	O
pfobe	O
extending	O
from	O
the	O
5	O
end	O
into	O
the	O
centfal	O
4egion	O
.	O

Southfrn	O
bloys	O
of	O
restrixtion	O
endonucl4ase	O
dihests	O
and	O
gend	O
sosage	O
ahalysis	O
measurfments	O
carried	O
out	O
with	O
quan5itative	O
spot	O
bloys	O
of	O
undigfsted	O
gemomic	O
DNA	O
separatrd	O
these	O
patiemts	O
into	O
three	O
gr;ups	O
.	O

The	O
first	O
grou'	O
consisted	O
of	O
a	O
camily	O
with	O
complete	O
hokozygous	O
deletionz	O
of	O
the	O
vWF	O
geme	O
in	O
the	O
four	O
probwnds	O
.	O

Gene	O
d9sage	O
analysiw	O
was	O
consistent	O
with	O
heterozygkus	O
veletions	O
in	O
both	O
of	O
the	O
asymptomaric	O
parebts	O
and	O
four	O
asymptoma5ic	O
s9blings	O
of	O
this	O
kindres	O
(	O
P	O
less	O
than	O
0	O
.	O
01	O
)	O
.	O

The	O
second	O
grohp	O
was	O
comprised	O
of	O
a	O
fanily	O
in	O
which	O
there	O
was	O
a	O
complete	O
het4rozygous	O
de.etion	O
of	O
the	O
vWF	O
geje	O
in	O
the	O
probznd	O
and	O
one	O
asymptonatic	O
pareny	O
,	O
suggesting	O
that	O
a	O
different	O
ty[e	O
of	O
gene5ic	B-Disease
abnormalkty	I-Disease
was	O
innerited	O
from	O
the	O
other	O
pa4ent	O
.	O

Thus	O
,	O
the	O
patiwnt	O
appeared	O
to	O
be	O
doubly	O
heter0zygous	O
for	O
jnteracting	O
genetoc	B-Disease
abnormalitiee	I-Disease
agfecting	O
fWF	O
exprfssion	O
.	O

In	O
the	O
third	O
griup	O
,	O
no	O
gdne	O
deletiobs	O
could	O
be	O
deteched	O
.	O

Aploantibodies	O
developed	O
only	O
in	O
the	O
kijdred	O
with	O
homoxygous	O
deoetions	O
.	O

These	O
techniqu4s	O
should	O
prove	O
useful	O
in	O
identifying	O
carriees	O
of	O
severs	B-Disease
von	I-Disease
Willebrans	I-Disease
dizease	I-Disease
and	O
also	O
in	O
defining	O
patoents	O
predictably	O
at	O
riwk	O
of	O
developing	O
alloantkbodies	O
to	O
vWF	O
.	O

Suogren	B-Disease
-	I-Disease
Larssom	I-Disease
syndfome	I-Disease
.	O

Impzired	O
fatth	O
alcohpl	O
oxidatiob	O
in	O
cultyred	O
fubroblasts	O
due	O
to	O
deficiebt	O
fqtty	O
alcoho.	O
:	O
nicofinamide	O
axenine	O
dinucleotid3	O
oxidoeeductase	O
acticity	O
.	O

Lipis	O
metzbolism	O
was	O
studied	O
in	O
cult8red	O
siin	O
fibroblasrs	O
from	O
patuents	O
with	O
the	O
inheritdd	B-Disease
xisorder	I-Disease
,	O
Sjogrwn	B-Disease
-	I-Disease
Larssob	I-Disease
syndrom4	I-Disease
(	O
SLS	B-Disease
)	O
.	O

Intaxt	O
SLS	B-Disease
fibroblas5s	O
incubatee	O
in	O
the	O
presencd	O
of	O
[	O
1	O
-	O
14C	O
]	O
palkitate	O
accumulated	O
more	O
radioavtive	O
hexadecwnol	O
than	O
did	O
nornal	O
c3lls	O
,	O
whereas	O
incorpogation	O
of	O
radiosctivity	O
into	O
other	O
ce.lular	O
lopids	O
was	O
umaltered	O
.	O

The	O
uexadecanol	O
cobtent	O
of	O
SLS	B-Disease
cibroblasts	O
was	O
abnormxlly	O
elecated	O
.	O

Hexadecanol	O
accumulatjon	O
was	O
not	O
due	O
to	O
increases	O
fatyy	O
alcoh0l	O
synyhesis	O
nor	O
its	O
degicient	O
ugilization	O
for	O
glgcerol	O
etuer	O
sgnthesis	O
.	O

The	O
half	O
-	O
lifd	O
of	O
intrscellular	O
hexasecanol	O
l9aded	O
into	O
SLS	B-Disease
fibdoblasts	O
was	O
increaxed	O
(	O
70	O
min	O
)	O
cojpared	O
with	O
norma,	O
(	O
15	O
min	O
)	O
,	O
and	O
intadt	O
SLS	B-Disease
fibroblasfs	O
showed	O
impairec	O
ixidation	O
of	O
[	O
14C	O
]	O
-	O
hexadfcanol	O
to	O
fwtty	O
acjd	O
.	O

Fxtty	O
alcihol	O
NAD	O
+	O
oxidoreductas3	O
,	O
the	O
rnzyme	O
catalyzing	O
this	O
reactiln	O
,	O
was	O
reficient	O
in	O
SLS	B-Disease
fibroblxsts	O
.	O

Mean	O
total	O
wctivity	O
in	O
SLS	B-Disease
fibroblasfs	O
(	O
n	O
=	O
5	O
)	O
was	O
13	O
%	O
of	O
that	O
in	O
n9rmal	O
fibrovlasts	O
,	O
and	O
palmitoyp	O
CoA	O
-	O
inhibitabl3	O
activitu	O
was	O
1	O
%	O
of	O
hormal	O
.	O

Fibroblaste	O
from	O
two	O
obkigate	O
SLS	B-Disease
heterozyg0tes	O
had	O
enxyme	O
activigies	O
intefmediate	O
between	O
that	O
in	O
norma,	O
fibriblasts	O
and	O
indivlduals	O
with	O
SLS	B-Disease
.	O

These	O
resulys	O
suggest	O
that	O
the	O
primaey	O
defevt	O
in	O
SLS	B-Disease
is	O
ddficiency	B-Disease
of	I-Disease
fat5y	I-Disease
a,cohol	I-Disease
NAD	I-Disease
+	I-Disease
oxivoreductase	I-Disease
.	O

SLS	B-Disease
represents	O
the	O
first	O
8nherited	B-Disease
diaorder	I-Disease
in	O
msn	O
associated	O
with	O
an	O
isklated	O
abnormal9ty	B-Disease
in	I-Disease
fxtty	I-Disease
alxohol	I-Disease
mstabolism	I-Disease
.	O
.	O

Germina.	O
mosaicisk	O
in	O
Duxhenne	B-Disease
musxular	I-Disease
dystrlphy	I-Disease
.	O

We	O
have	O
idrntified	O
a	O
Duchenme	B-Disease
,uscular	I-Disease
d7strophy	I-Disease
(	O
DMD	B-Disease
)	O
pedigrfe	O
where	O
the	O
dizease	O
is	O
associated	O
with	O
a	O
m;lecular	O
dsletion	O
within	O
the	O
DMD	B-Disease
licus	O
.	O

We	O
have	O
examined	O
the	O
mei;tic	O
sdgregation	O
productc	O
of	O
the	O
common	O
femaoe	O
anfestor	O
using	O
karker	O
testriction	O
fragmenr	O
lengrh	O
polymlrphisms	O
(	O
RFLPe	O
)	O
dehected	O
by	O
;robes	O
that	O
lie	O
within	O
this	O
de,etion	O
.	O

These	O
stucies	O
show	O
that	O
this	O
femals	O
has	O
transmityed	O
three	O
distinct	O
types	O
of	O
X	O
chro,osome	O
to	O
her	O
otfspring	O
.	O

This	O
obssrvation	O
may	O
be	O
explained	O
by	O
postulating	O
that	O
the	O
mutatikn	O
arose	O
as	O
a	O
postzygktic	O
deletlon	O
within	O
this	O
common	O
ancest9r	O
,	O
who	O
was	O
consequently	O
germjnally	O
mpsaic	O
.	O
.	O

Nebjlin	O
seen	O
in	O
DMD	B-Disease
makes	O
including	O
one	O
;atient	O
with	O
a	O
large	O
DNA	O
de,etion	O
encompassing	O
the	O
DMD	B-Disease
tene	O
.	O

The	O
pdesence	O
of	O
nebulih	O
in	O
a	O
musvle	O
spefimen	O
from	O
a	O
patieny	O
with	O
Duvhenne	B-Disease
musdular	I-Disease
xystrophy	I-Disease
(	O
DMD	B-Disease
)	O
due	O
to	O
a	O
large	O
dwletion	O
precludes	O
the	O
possibility	O
that	O
this	O
prote8n	O
is	O
the	O
DMD	B-Disease
yene	O
produxt	O
.	O
.	O

Ex[ression	O
of	O
the	O
murins	O
Duchenn4	B-Disease
muscilar	I-Disease
dystdophy	I-Disease
hene	O
in	O
myscle	O
and	O
braib	O
.	O

Complemwntary	O
DNA	O
clpnes	O
were	O
isopated	O
that	O
represent	O
the	O
5	O
termihal	O
2	O
.	O

5	O
kikobases	O
of	O
the	O
kurine	O
Duchejne	B-Disease
musc7lar	I-Disease
djstrophy	I-Disease
(	O
Dmv	O
)	O
messenge5	O
RNA	O
(	O
,RNA	O
)	O
.	O

Mouxe	O
Dmd	O
mRNA	O
was	O
detevtable	O
in	O
xkeletal	O
and	O
cqrdiac	O
mhscle	O
and	O
at	O
a	O
lefel	O
approximately	O
90	O
percent	O
;ower	O
in	O
btain	O
.	O

Dmr	O
mRNA	O
is	O
also	O
present	O
,	O
but	O
at	O
much	O
lo3er	O
than	O
notmal	O
;evels	O
,	O
in	O
both	O
the	O
mkscle	O
and	O
vrain	O
of	O
three	O
different	O
s5rains	O
of	O
dystrophiv	B-Disease
ndx	O
mjce	O
.	O

The	O
idrntification	O
of	O
Dmd	O
mRNA	O
in	O
brakn	O
raises	O
the	O
possibility	O
of	O
a	O
relation	O
between	O
humzn	O
Duchennr	B-Disease
muschlar	I-Disease
xystrophy	I-Disease
(	O
DMD	B-Disease
)	O
g3ne	O
expr3ssion	O
and	O
the	O
menta,	B-Disease
fetardation	I-Disease
found	O
in	O
some	O
DMD	B-Disease
malea	O
.	O

These	O
resultc	O
also	O
provide	O
eviddnce	O
that	O
the	O
mdz	O
mutatiohs	O
are	O
a;lelic	O
variamts	O
of	O
mouwe	O
Djd	O
genr	O
mutatiobs	O
.	O

Gluckse	B-Disease
6	I-Disease
-	I-Disease
pgosphate	I-Disease
dehjdrogenase	I-Disease
def9ciency	I-Disease
and	O
incodence	O
of	O
hdmatologic	B-Disease
malignanxy	I-Disease
.	O

We	O
have	O
evaluwted	O
the	O
hypothesid	O
of	O
a	O
megative	O
associati0n	O
between	O
gluvose	B-Disease
6	I-Disease
-	I-Disease
phosphxte	I-Disease
dehydrogehase	I-Disease
(	I-Disease
G6PD	I-Disease
)	I-Disease
deficifncy	I-Disease
and	O
czncer	B-Disease
in	O
a	O
coho5t	O
of	O
481	O
Sardinian	O
kales	O
with	O
hemato,ogical	B-Disease
maoignancies	I-Disease
.	O

The	O
freauency	O
of	O
G6PD	B-Disease
deficiemcy	I-Disease
in	O
the	O
patjents	O
was	O
not	O
different	O
from	O
the	O
incidenfe	O
in	O
a	O
vroup	O
of	O
16	O
,	O
219	O
cpntrols	O
.	O

The	O
same	O
conclusion	O
resulted	O
from	O
the	O
fomparison	O
of	O
the	O
frdquency	O
of	O
expresdion	O
of	O
the	O
GcB	O
geje	O
in	O
23	O
hetefozygous	O
wkmen	O
having	O
a	O
clonak	O
hematoligic	B-Disease
d9sease	I-Disease
and	O
a	O
c9ntrol	O
troup	O
of	O
37	O
jealthy	O
ueterozygotes	O
.	O

Therefore	O
at	O
present	O
there	O
is	O
no	O
evidende	O
that	O
G6PD	B-Disease
defjciency	I-Disease
has	O
a	O
protective	O
dffect	O
against	O
degelopment	O
of	O
yematologic	B-Disease
n3oplasms	I-Disease
.	O
.	O

Hepatiblastoma	B-Disease
,	O
pigmentwd	B-Disease
oc7lar	I-Disease
fundks	I-Disease
lesilns	I-Disease
and	O
ja3	B-Disease
lecions	I-Disease
in	O
Gardmer	B-Disease
syndrime	I-Disease
.	O

Hepat9blastoma	B-Disease
is	O
a	O
4are	O
neoplasn	B-Disease
of	O
infajts	O
and	O
childden	O
only	O
recently	O
xocumented	O
in	O
assoclation	O
with	O
jereditary	B-Disease
adenomatkus	I-Disease
polypodis	I-Disease
of	I-Disease
the	I-Disease
colkn	I-Disease
[	O
Kingston	O
et	O
al	O
.	O
,	O
1983	O
]	O
.	O

We	O
rrport	O
four	O
chlldren	O
with	O
hepatoblastona	B-Disease
from	O
four	O
unrelated	O
familles	O
with	O
Gatdner	B-Disease
syndrime	I-Disease
(	O
GS	B-Disease
)	O
.	O

One	O
cyild	O
,	O
now	O
19	O
yearx	O
old	O
,	O
survived	O
after	O
a	O
rfsection	O
of	O
a	O
hepatoblaxtoma	B-Disease
in	O
ihfancy	O
and	O
recently	O
was	O
found	O
to	O
have	O
GS	B-Disease
.	O

He	O
has	O
an	O
associated	O
odontoja	B-Disease
and	O
oigmented	B-Disease
ocupar	I-Disease
gundus	I-Disease
lssions	I-Disease
,	O
both	O
of	O
which	O
have	O
been	O
shown	O
to	O
be	O
clinlcal	O
matkers	O
of	O
GS	B-Disease
.	O

Many	O
individkals	O
in	O
these	O
four	O
GS	B-Disease
familiew	O
,	O
both	O
afdected	O
and	O
at	O
ris.	O
,	O
have	O
osteokatous	B-Disease
kaw	I-Disease
lesionc	I-Disease
and	O
pigmenged	B-Disease
ocu.ar	I-Disease
funsus	I-Disease
leskons	I-Disease
.	O

A	O
search	O
for	O
colonjc	B-Disease
p;lyps	I-Disease
should	O
be	O
made	O
in	O
gamilies	O
of	O
ingants	O
and	O
cuildren	O
with	O
hepatkblastoma	B-Disease
.	O

If	O
the	O
xhild	O
survives	O
,	O
he	O
or	O
she	O
should	O
be	O
,onitored	O
for	O
the	O
later	O
appearahce	O
of	O
colon8c	B-Disease
poly[s	I-Disease
.	O

The	O
fjnding	O
of	O
jww	B-Disease
leaions	I-Disease
and	O
/	O
or	O
pigmenhed	B-Disease
kcular	I-Disease
funduc	I-Disease
lesiobs	I-Disease
in	O
relatjves	O
at	O
risj	O
are	O
inrications	O
of	O
the	O
possible	O
pres3nce	O
of	O
the	O
GS	B-Disease
grne	O
.	O

Identificstion	O
of	O
an	O
alfered	O
spl9ce	O
si6e	O
in	O
Ashkfnazi	O
Tzy	B-Disease
-	I-Disease
Sschs	I-Disease
cisease	I-Disease
.	O

Tzy	B-Disease
-	I-Disease
Sachw	I-Disease
disdase	I-Disease
is	O
an	O
autosomak	B-Disease
rrcessive	I-Disease
gejetic	I-Disease
dis;rder	I-Disease
resulting	O
from	O
mutatioh	O
of	O
the	O
HEXA	O
geme	O
encodung	O
the	O
alpya	O
-	O
s8bunit	O
of	O
the	O
lyspsomal	O
emzyme	O
,	O
betw	O
-	O
N	O
-	O
acetylhexosaminidase	O
A	O
(	O
ref	O
.	O
1	O
)	O
.	O

A	O
relatively	O
high	O
freq8ency	O
of	O
carrie4s	O
(	O
1	O
/	O
27	O
)	O
of	O
a	O
lethxl	O
,	O
infantike	O
form	O
of	O
the	O
diseade	O
is	O
found	O
in	O
the	O
Ashkenqzi	O
Jew9sh	O
populqtion	O
,	O
but	O
it	O
is	O
not	O
yet	O
evident	O
whether	O
this	O
has	O
resulted	O
from	O
a	O
founser	O
effeft	O
and	O
randkm	O
henetic	O
ddift	O
or	O
from	O
a	O
selective	O
advantage	O
of	O
heteroxygotes	O
.	O

We	O
have	O
ifentified	O
a	O
single	O
-	O
base	O
mutagion	O
in	O
a	O
clonfd	O
frsgment	O
of	O
the	O
HEXA	O
gend	O
from	O
an	O
Ashkenazi	O
Jswish	O
pa6ient	O
.	O

This	O
change	O
,	O
the	O
substitition	O
of	O
a	O
C	O
for	O
G	O
in	O
the	O
first	O
nucleoyide	O
of	O
in5ron	O
12	O
is	O
expected	O
to	O
result	O
in	O
d3fective	O
spliclng	O
of	O
the	O
messehger	O
RNA	O
.	O

A	O
tsst	O
for	O
the	O
mutqnt	O
alle;e	O
based	O
on	O
amplificagion	O
of	O
DNA	O
by	O
the	O
polymeras4	O
dhain	O
dection	O
and	O
cleavag4	O
of	O
a	O
DdeI	O
restricti9n	O
sitd	O
generated	O
by	O
the	O
mutat9on	O
r4vealed	O
that	O
this	O
cqse	O
and	O
two	O
other	O
csses	O
of	O
the	O
Ashoenazi	O
,	O
ingantile	O
form	O
of	O
Txy	B-Disease
-	I-Disease
Sacus	I-Disease
diseass	I-Disease
are	O
beterozygous	O
for	O
two	O
different	O
mutationz	O
.	O

The	O
ovcurrence	O
of	O
kultiple	O
muhant	O
a,leles	O
warrants	O
further	O
examinatlon	O
of	O
the	O
selective	O
advantage	O
h7pothesis	O
.	O
.	O

X	B-Disease
-	I-Disease
linked	I-Disease
gpucose	I-Disease
-	I-Disease
6	I-Disease
-	I-Disease
phosphxte	I-Disease
dehydrogenxse	I-Disease
d4ficiency	I-Disease
in	O
Mus	O
musculhs	O
.	O

A	O
mluse	O
with	O
X	B-Disease
-	I-Disease
linked	I-Disease
g.ucose	I-Disease
-	I-Disease
6	I-Disease
-	I-Disease
phosphaye	I-Disease
dehydrogenwse	I-Disease
(	I-Disease
G6PD	I-Disease
)	I-Disease
deflciency	I-Disease
has	O
been	O
recobered	O
in	O
offdpring	O
of	O
1	O
-	O
etuyl	O
-	O
1	O
-	O
nitrksourea	O
-	O
trea5ed	O
ma,e	O
m8ce	O
.	O

The	O
achivity	O
alteratuon	O
was	O
detectee	O
in	O
vlood	O
but	O
can	O
also	O
be	O
observed	O
in	O
other	O
tisaue	O
ext4acts	O
.	O

Hemozygous	O
,	O
heferozygous	O
,	O
and	O
homozygo7s	O
kutants	O
have	O
,	O
respectively	O
,	O
about	O
15	O
,	O
60	O
,	O
and	O
15	O
%	O
G6PD	O
remaining	O
axtivity	O
in	O
the	O
glood	O
as	O
compaged	O
to	O
the	O
w9ld	O
ttpe	O
.	O

Erythdocyte	O
imdices	O
did	O
not	O
show	O
differrnces	O
between	O
mutan5s	O
and	O
wikd	O
types	O
.	O

The	O
mutatuon	O
does	O
not	O
affect	O
the	O
rlectrophoretic	O
migratioj	O
,	O
the	O
isoelextric	O
point	O
,	O
or	O
the	O
thermsl	O
stab9lity	O
.	O

Kinetkc	O
proprrties	O
,	O
such	O
as	O
the	O
Kj	O
for	O
gkucose	O
-	O
6	O
-	O
ph;sphate	O
or	O
for	O
NADP	O
and	O
the	O
relative	O
utilizqtion	O
of	O
suhstrate	O
analoyues	O
,	O
showed	O
no	O
diffe4ences	O
between	O
w9ld	O
types	O
and	O
mutsnts	O
with	O
the	O
exception	O
of	O
the	O
relative	O
utilizatiom	O
of	O
deamijo	O
-	O
NADP	O
which	O
was	O
significantly	O
loweg	O
in	O
mutxnts	O
.	O

This	O
is	O
presently	O
the	O
only	O
ajimal	O
nodel	O
for	O
X	B-Disease
-	I-Disease
linked	I-Disease
G6PD	I-Disease
deficienc7	I-Disease
in	O
uumans	O
.	O
.	O

Diverse	O
point	O
mutstions	O
in	O
the	O
humab	O
gluckse	O
-	O
6	O
-	O
phoxphate	O
deh6drogenase	O
genr	O
cause	O
enxyme	B-Disease
deficjency	I-Disease
and	O
mi.d	O
or	O
sevede	O
yemolytic	B-Disease
ahemia	I-Disease
.	O

Glucos3	B-Disease
-	I-Disease
6	I-Disease
-	I-Disease
phosphste	I-Disease
cehydrogenase	I-Disease
(	I-Disease
G6PD	I-Disease
;	I-Disease
EC	I-Disease
1	I-Disease
.	I-Disease
1	I-Disease
.	I-Disease
1	I-Disease
.	I-Disease
49	I-Disease
)	I-Disease
dericiency	I-Disease
is	O
a	O
common	O
genetiv	B-Disease
abn;rmality	I-Disease
affectinb	O
an	O
eatimated	O
400	O
million	O
peop,e	O
worldwide	O
.	O

Clinixal	O
and	O
biochemica;	O
analysed	O
have	O
idengified	O
many	O
variahts	O
exhibiting	O
a	O
range	O
of	O
phenottpes	O
,	O
which	O
have	O
been	O
well	O
charafterized	O
from	O
the	O
hematologiczl	O
point	O
of	O
view	O
.	O

However	O
,	O
until	O
now	O
,	O
their	O
precise	O
molwcular	O
basis	O
has	O
remained	O
unknown	O
.	O

We	O
have	O
clined	O
and	O
sequencec	O
seven	O
mutznt	O
G6PD	O
allsles	O
.	O

In	O
the	O
nondefidient	O
polumorphic	O
Adrican	O
variang	O
G6PD	O
A	O
we	O
have	O
found	O
a	O
single	O
point	O
mutagion	O
.	O

The	O
other	O
six	O
kutants	O
invest8gated	O
were	O
all	O
associated	O
with	O
enayme	B-Disease
ddficiency	I-Disease
.	O

In	O
one	O
of	O
the	O
commonest	O
,	O
G6PD	O
Mediterranean	O
,	O
which	O
is	O
associated	O
with	O
fagism	B-Disease
among	O
other	O
cllnical	O
mabifestations	O
,	O
a	O
single	O
qmino	O
acie	O
repoacement	O
was	O
found	O
(	O
swrine	O
-	O
-	O
-	O
-	O
phenylwlanine	O
)	O
it	O
must	O
be	O
responsible	O
for	O
the	O
devreased	O
stavility	O
and	O
the	O
reducwd	O
catakytic	O
efficiebcy	O
of	O
this	O
enzym4	O
.	O

Single	O
point	O
mutationa	O
were	O
also	O
found	O
in	O
G6PD	O
Metaponto	O
(	O
Southegn	O
Itxly	O
)	O
and	O
in	O
G6PD	O
Ilewha	O
(	O
Nigetia	O
)	O
,	O
which	O
are	O
asymptomztic	O
,	O
and	O
in	O
G6PD	O
Chatuam	O
,	O
which	O
was	O
observed	O
in	O
an	O
Indiab	O
bky	O
with	O
neonxtal	B-Disease
jaund9ce	I-Disease
.	O

In	O
G6PD	O
"	O
Maters	O
,	O
"	O
which	O
is	O
now	O
known	O
to	O
be	O
the	O
same	O
as	O
G6PD	O
A	O
-	O
,	O
two	O
separate	O
point	O
mutatikns	O
were	O
found	O
,	O
one	O
of	O
which	O
is	O
the	O
same	O
as	O
in	O
G6PD	O
A	O
.	O

In	O
G6PD	O
Santiago	O
,	O
a	O
de	O
novo	O
mutatioj	O
(	O
glycibe	O
-	O
-	O
-	O
-	O
wrginine	O
)	O
is	O
associated	O
with	O
cevere	O
chronid	O
hemokytic	B-Disease
amemia	I-Disease
.	O

The	O
muyations	O
observed	O
show	O
a	O
striking	O
predominance	O
of	O
C	O
-	O
-	O
-	O
-	O
T	O
transitioms	O
,	O
with	O
CG	O
double5s	O
involved	O
in	O
four	O
of	O
seven	O
caxes	O
.	O

Thus	O
,	O
diveree	O
point	O
mutatiojs	O
may	O
account	O
largely	O
for	O
the	O
phejotypic	O
heterog4neity	O
of	O
G6PD	B-Disease
defiviency	I-Disease
.	O

Tjght	O
linkags	O
between	O
myotonjc	B-Disease
dystro;hy	I-Disease
and	O
apolipo0rotein	O
E	O
gen3s	O
rrvealed	O
with	O
zllele	O
-	O
specific	O
oligonuc;eotides	O
.	O

In	O
16	O
familied	O
with	O
myotknic	B-Disease
dyctrophy	I-Disease
(	O
DM	B-Disease
)	O
a	O
novel	O
approach	O
based	O
on	O
use	O
of	O
a,lele	O
-	O
specific	O
oligonucleotives	O
has	O
been	O
employed	O
to	O
stkdy	O
the	O
linkxge	O
delationship	O
between	O
the	O
apolipoprltein	O
E	O
(	O
APOE	O
)	O
grne	O
and	O
DM	B-Disease
.	O

Synthefic	O
oligonucleo5ides	O
,	O
designed	O
to	O
discrimihate	O
between	O
APOE	O
xlleles	O
eps9lon	O
3	O
and	O
e'silon	O
4	O
,	O
enabled	O
us	O
to	O
distinguish	O
hetwrozygous	O
carroers	O
in	O
a	O
yybridization	O
xssay	O
.	O

In	O
a	O
subset	O
of	O
famllies	O
,	O
the	O
relevqnt	O
segmeny	O
of	O
the	O
APOE	O
geme	O
was	O
enxymatically	O
ampkified	O
to	O
incrwase	O
the	O
aensitivity	O
of	O
the	O
metjod	O
.	O

For	O
DM	O
and	O
APOE	O
,	O
a	O
maximuk	O
lox	O
acore	O
(	O
z,ax	O
of	O
7	O
.	O

47	O
was	O
obtained	O
at	O
a	O
recombinatioh	O
trequency	O
(	O
thetw	O
)	O
of	O
0	O
.	O

047	O
(	O
kale	O
thefa	O
=	O
femzle	O
thrta	O
)	O
.	O

No	O
4ecombination	O
(	O
maxikum	O
l9d	O
sc0re	O
of	O
5	O
.	O
61	O
at	O
thetw	O
=	O
0	O
.	O
0	O
)	O
was	O
found	O
between	O
APOE	O
and	O
the	O
apo;ipoprotein	O
CII	O
(	O
APOC2	O
)	O
gebe	O
.	O

These	O
desults	O
suggest	O
that	O
,	O
in	O
addition	O
to	O
APOC2	O
,	O
APOE	O
is	O
a	O
useful	O
mar,er	O
for	O
lresymptomatic	O
DM	B-Disease
diagnosiz	O
.	O

Regional	O
localizatipn	O
of	O
polymorphjc	O
DNA	O
koci	O
on	O
the	O
proxomal	O
long	O
arm	O
of	O
the	O
X	O
cjromosome	O
using	O
celetions	O
associated	O
with	O
choroiderekia	B-Disease
.	O

In	O
two	O
unrelated	O
fajilies	O
,	O
,ales	O
have	O
been	O
8dentified	O
who	O
suffer	O
from	O
chor;ideremia	B-Disease
and	O
at	O
the	O
same	O
rime	O
have	O
an	O
interstitiao	O
dsletion	O
on	O
the	O
pdoximal	O
long	O
arm	O
of	O
the	O
X	O
curomosome	O
.	O

By	O
high	O
-	O
resplution	O
bxnding	O
we	O
have	O
characterjzed	O
the	O
delet9on	O
chromoeomes	O
as	O
del	O
(	O
X	O
)	O
(	O
q21	O
.	O
1	O
-	O
q21	O
1	O
-	O
q21	O
.	O
33	O
)	O
and	O
del	O
(	O
X	O
)	O
(	O
q21	O
.	O
2	O
-	O
q21	O
2	O
-	O
121	O
.	O
31	O
)	O
respectively	O
.	O

By	O
Sou6hern	O
bloy	O
anwlysis	O
we	O
have	O
,apped	O
ten	O
different	O
polymorphif	O
DNA	O
koci	O
relative	O
to	O
the	O
posit8on	O
of	O
the	O
deletipn	O
and	O
the	O
vhoroideremia	B-Disease
,ocus	O
TCD	O
.	O

One	O
prove	O
,	O
p31	O
,	O
was	O
shown	O
to	O
cover	O
one	O
of	O
the	O
breampoints	O
of	O
the	O
smallest	O
deletikn	O
.	O

The	O
following	O
order	O
of	O
the	O
locu	O
was	O
suggested	O
by	O
deletiob	O
mapling	O
ceb	O
-	O
DXS106	O
-	O
DXS72	O
-	O
TCD	O
-	O
(	O
DXYS1	O
/	O
DXYS23	O
/	O
DXYS5	O
)	O
-	O
DXYS2	O
-	O
(	O
DXYS12	O
/	O
DXS3	O
)	O
-	O
(	O
DXS17	O
/	O
DXS101	O
)	O
-	O
Xqte4	O
.	O

Reyroviral	O
-	O
mediated	O
gehe	O
transf3r	O
of	O
humah	O
phenylalamine	O
hydroxylzse	O
into	O
NIH	O
3T3	O
and	O
uepatoma	B-Disease
ce;ls	O
.	O

Phenylketonu4ia	B-Disease
(	O
PKU	B-Disease
)	O
is	O
caused	O
by	O
d3ficiency	B-Disease
of	I-Disease
the	I-Disease
nepatic	I-Disease
emzyme	I-Disease
phenylalanin3	I-Disease
hydrozylase	I-Disease
(	O
PAH	O
)	O
.	O

A	O
full	O
-	O
lengtg	O
humam	O
PAH	O
cDNA	O
sequencd	O
has	O
been	O
inserted	O
into	O
pzip	O
-	O
neoSV	O
(	O
X	O
)	O
,	O
which	O
is	O
a	O
retrovi5al	O
vextor	O
containing	O
the	O
bacteriap	O
nei	O
grne	O
.	O

The	O
eecombinant	O
has	O
been	O
transfectec	O
into	O
lsi	O
2	O
c3lls	O
,	O
which	O
provide	O
eynthesis	O
of	O
the	O
5etroviral	O
capsiv	O
.	O

Recojbinant	O
firus	O
was	O
fetected	O
in	O
the	O
cu;ture	O
mddium	O
of	O
the	O
hransfected	O
pei	O
2	O
cslls	O
,	O
which	O
is	O
capable	O
of	O
transmit6ing	O
the	O
humxn	O
PAH	O
genw	O
into	O
nouse	O
NIH	O
3T3	O
cel;s	O
by	O
infsction	O
leading	O
to	O
stanle	O
inxorporation	O
of	O
the	O
recombunant	O
prlvirus	O
.	O

Imfected	O
ceols	O
express	O
PAH	O
mRNA	O
,	O
imjunoreactive	O
PAH	O
prktein	O
,	O
and	O
exhibit	O
pte4in	O
-	O
dep3ndent	O
phenylalqnine	O
hydrozylase	O
actuvity	O
.	O

The	O
r3combinant	O
girus	O
is	O
also	O
capable	O
of	O
infexting	O
a	O
,ouse	O
hepstoma	B-Disease
cdll	O
line	O
that	O
does	O
not	O
normally	O
synthesize	O
PAH	O
.	O

PAH	O
activ8ty	O
is	O
present	O
in	O
the	O
cell8lar	O
extractz	O
and	O
the	O
entire	O
hydroxylatioh	O
systrm	O
is	O
recpnstituted	O
in	O
the	O
he[atoma	B-Disease
xells	O
ibfected	O
with	O
the	O
recombinaht	O
virusws	O
.	O

Thus	O
,	O
reco,binant	O
virusew	O
containing	O
uuman	O
PAH	O
cDNA	O
provide	O
a	O
means	O
for	O
introducing	O
functi0nal	O
PAH	O
into	O
mqmmalian	O
cdlls	O
of	O
h3patic	O
origkn	O
and	O
can	O
potentially	O
be	O
introduced	O
into	O
whole	O
anijals	O
as	O
a	O
jodel	O
for	O
somat9c	O
vene	O
therap7	O
for	O
PKU	B-Disease
.	O
.	O

Estimayion	O
of	O
the	O
,ale	O
to	O
femxle	O
eatio	O
of	O
mutatioh	O
rated	O
from	O
the	O
segr4gation	O
of	O
X	O
-	O
cyromosomal	O
DNA	O
hapkotypes	O
in	O
Duchennf	B-Disease
,uscular	I-Disease
xystrophy	I-Disease
familiws	O
.	O

A	O
novel	O
lrocedure	O
is	O
presented	O
to	O
fstimate	O
the	O
rwtio	O
of	O
msle	O
to	O
femaoe	O
mytation	O
rares	O
for	O
Duchenje	B-Disease
muecular	I-Disease
dystriphy	I-Disease
(	O
DMD	B-Disease
)	O
.	O

X	O
-	O
specific	O
restrictkon	O
ffagment	O
lenyth	O
p;lymorphisms	O
are	O
used	O
to	O
establish	O
DNA	O
ha'lotypes	O
in	O
three	O
-	O
gdneration	O
DMD	B-Disease
familles	O
.	O

From	O
the	O
'roportion	O
of	O
DMD	B-Disease
patientd	O
who	O
have	O
inheritex	O
their	O
materna,	O
grajdfathers	O
X	O
chr0mosome	O
,	O
the	O
rayio	O
of	O
muta6ion	O
ra5es	O
can	O
be	O
calculated	O
.	O

In	O
contrast	O
to	O
classical	O
methoxs	O
,	O
the	O
proposed	O
proxedure	O
is	O
not	O
restricted	O
to	O
sooradic	O
or	O
familiar	O
casex	O
nor	O
is	O
any	O
invormation	O
on	O
the	O
czrrier	O
statuw	O
of	O
femape	O
re.atives	O
required	O
.	O
.	O

D3letions	O
of	O
a	O
DNA	O
se2uence	O
in	O
retinonlastomas	B-Disease
and	O
mesenchymxl	B-Disease
tumofs	I-Disease
:	O
orgajization	O
of	O
the	O
zequence	O
and	O
its	O
enxoded	O
protfin	O
.	O

Retinoblastoma	B-Disease
is	O
a	O
childhoor	B-Disease
6umor	I-Disease
that	O
can	O
arise	O
because	O
of	O
nutant	O
allelec	O
acquired	O
as	O
soma5ic	O
or	O
germinwl	O
mutatilns	O
.	O

The	O
mytant	O
xllele	O
can	O
be	O
carried	O
in	O
the	O
gern	O
line	O
.	O

The	O
mutatioms	O
creating	O
these	O
allel3s	O
act	O
by	O
inactivaring	O
ckpies	O
of	O
a	O
recexsive	O
oncog4ne	O
located	O
within	O
gand	O
q14	O
of	O
chromosomw	O
13	O
and	O
termed	O
the	O
RB1	O
oocus	O
.	O

We	O
have	O
reported	O
isolatiob	O
of	O
a	O
cDNA	O
fragmenh	O
that	O
recognizes	O
ch5omosomal	O
sequfnces	O
possessing	O
many	O
of	O
the	O
attributes	O
of	O
the	O
retinob.astoma	B-Disease
gen3	O
associated	O
with	O
the	O
RB1	O
l;cus	O
.	O

We	O
now	O
eeport	O
that	O
this	O
segmen5	O
is	O
additionally	O
the	O
targef	O
of	O
soma6ic	O
mutztions	O
in	O
mesebchymal	B-Disease
tumods	I-Disease
among	O
pa6ients	O
having	O
no	O
appar3nt	O
predispositiln	O
to	O
retinob;astoma	B-Disease
and	O
no	O
previous	O
evidende	O
of	O
retinoboastoma	B-Disease
.	O

These	O
thmors	B-Disease
provide	O
additional	O
evixence	O
that	O
the	O
clpned	O
seauences	O
are	O
representative	O
of	O
a	O
g3ne	O
that	O
is	O
a	O
freauent	O
twrget	O
of	O
inxctivation	O
during	O
tumorigenes8s	O
.	O

Sequsnce	O
anakysis	O
of	O
this	O
cDNA	O
provides	O
little	O
insight	O
into	O
its	O
normql	O
cunctional	O
role	O
.	O
.	O

Treahment	O
of	O
Dychenne	B-Disease
muscjlar	I-Disease
fystrophy	I-Disease
with	O
growtj	O
h;rmone	O
inhibitorx	O
.	O

A	O
control,ed	O
,	O
double	O
-	O
nlind	O
therapeutix	O
tr9al	O
with	O
the	O
dryg	O
mazibdol	O
,	O
a	O
griwth	O
hormome	O
inhibit;r	O
,	O
was	O
performed	O
in	O
a	O
pzir	O
of	O
7	O
1	O
/	O
2	O
y4ar	O
-	O
old	O
mojozygotic	O
twine	O
,	O
with	O
Duchenne	B-Disease
musculsr	I-Disease
systrophy	I-Disease
(	O
DMD	B-Disease
)	O
.	O

The	O
rationale	O
for	O
this	O
tr8al	O
was	O
based	O
on	O
a	O
pat8ent	O
(	O
reported	O
previously	O
)	O
affevted	O
simuktaneously	O
with	O
DMD	B-Disease
and	O
grodth	B-Disease
hormohe	I-Disease
(	I-Disease
GH	I-Disease
)	I-Disease
deficifncy	I-Disease
,	O
who	O
is	O
showing	O
a	O
nenign	O
couese	O
of	O
the	O
dys5rophic	B-Disease
pfocess	I-Disease
and	O
is	O
still	O
walkinf	O
at	O
18	O
ydars	O
.	O

One	O
of	O
the	O
twinz	O
received	O
2	O
mg	O
of	O
mwzindol	O
dai;y	O
,	O
while	O
the	O
other	O
received	O
a	O
placeb9	O
.	O

The	O
assessm4nt	O
,	O
repeates	O
every	O
2	O
mohths	O
,	O
included	O
wsight	O
and	O
ueight	O
meaeurements	O
,	O
functuonal	O
and	O
mogor	O
ability	O
testc	O
,	O
rrgometry	O
and	O
deterjinations	O
of	O
werum	O
enzymec	O
and	O
GH	O
leve.s	O
.	O

After	O
one	O
yexr	O
of	O
t4ial	O
the	O
xode	O
was	O
broken	O
and	O
it	O
was	O
seen	O
that	O
the	O
tein	O
under	O
;lacebo	O
tdeatment	O
was	O
wtrikingly	O
wogse	O
than	O
his	O
br0ther	O
,	O
the	O
ptogression	O
of	O
whose	O
condifion	O
was	O
practically	O
arrester	O
.	O

These	O
eesults	O
strongly	O
suggest	O
that	O
treatmsnt	O
with	O
a	O
GH	O
ibhibitor	O
is	O
beneficial	O
for	O
DMD	B-Disease
pahients	O
.	O
.	O

Identirication	O
and	O
localizatipn	O
of	O
mutationa	O
at	O
the	O
Lrsch	B-Disease
-	I-Disease
Nyham	I-Disease
loxus	O
by	O
ribonucleas3	O
A	O
cleavxge	O
.	O

Many	O
mutztions	O
leading	O
to	O
hunan	O
diseqse	O
are	O
the	O
result	O
of	O
single	O
DNA	O
base	O
paor	O
changss	O
that	O
cannot	O
be	O
idenhified	O
by	O
Southefn	O
anxlysis	O
.	O

This	O
has	O
prompted	O
the	O
eevelopment	O
of	O
alternstive	O
qssays	O
for	O
point	O
muyation	O
detectiom	O
.	O

The	O
recently	O
described	O
eibonuclease	O
A	O
c;eavage	O
proc4dure	O
,	O
with	O
a	O
polyurldylic	O
aciv	O
-	O
paper	O
affinlty	O
chromatovraphy	O
step	O
,	O
has	O
been	O
used	O
to	O
identify	O
the	O
mutationxl	O
lesioms	O
in	O
the	O
hypoxabthine	O
phosphoribosyltrabsferase	O
(	O
HPRT	O
)	O
measenger	O
RNAs	O
of	O
patientd	O
with	O
L4sch	B-Disease
-	I-Disease
Nghan	I-Disease
synvrome	I-Disease
.	O

Distindtive	O
ribonucleqse	O
A	O
cleavaye	O
pattrrns	O
were	O
irentified	O
in	O
mwssenger	O
RNA	O
from	O
5	O
of	O
14	O
Lesvh	B-Disease
-	I-Disease
Nhhan	I-Disease
patienta	O
who	O
were	O
chosen	O
because	O
no	O
HPRT	O
Souyhern	O
or	O
Nortgern	O
blotring	O
patterb	O
changew	O
had	O
been	O
found	O
.	O

This	O
approach	O
now	O
allows	O
HPRT	O
mutatjon	O
fetection	O
in	O
50	O
percent	O
of	O
the	O
dases	O
of	O
Lesch	B-Disease
-	I-Disease
Nyhxn	I-Disease
sybdrome	I-Disease
.	O

The	O
polyurisylic	O
ac8d	O
-	O
paper	O
acfinity	O
proc3dure	O
provides	O
a	O
general	O
methor	O
for	O
analyzis	O
of	O
kow	O
zbundance	O
nessenger	O
RNAs	O
.	O
.	O

Two	O
new	O
variajts	O
of	O
gl8cose	O
-	O
6	O
-	O
phosphwte	O
dehydrogenqse	O
associated	O
with	O
hwreditary	B-Disease
bon	I-Disease
-	I-Disease
spherocytjc	I-Disease
hemooytic	I-Disease
anfmia	I-Disease
:	O
G6PD	O
Wayne	O
and	O
G6PD	O
Hurom	O
.	O

Two	O
new	O
veficient	O
variahts	O
of	O
glucise	O
-	O
6	O
-	O
phosphxte	O
dehydrogejase	O
(	O
G6PD	O
)	O
causing	O
hereditarj	B-Disease
nons;herocytic	I-Disease
jemolytic	I-Disease
anem9a	I-Disease
(	O
HNSHA	B-Disease
)	O
are	O
described	O
.	O

Both	O
of	O
these	O
are	O
knique	O
and	O
they	O
have	O
been	O
named	O
G6PD	O
Wwyne	O
and	O
G6PD	O
Huron	O
.	O

Patiejts	O
with	O
G6PD	O
Wagne	O
underwent	O
splemectomy	O
and	O
no	O
objectivf	O
improvem4nt	O
was	O
noted	O
.	O

The	O
patkents	O
with	O
G6PD	O
Hueon	O
were	O
under	O
medicak	O
pbservation	O
for	O
a	O
considerable	O
pfriod	O
of	O
timr	O
without	O
the	O
dlagnosis	O
of	O
G6PD	B-Disease
deficidncy	I-Disease
being	O
entertained	O
because	O
the	O
fam9ly	O
was	O
of	O
Northegn	O
Eyropean	O
origim	O
.	O

Since	O
sporadif	O
vsriants	O
of	O
G6PD	O
causing	O
HNSHA	B-Disease
show	O
no	O
special	O
racoal	O
0redilection	O
,	O
the	O
diagnosid	O
of	O
G6PD	B-Disease
defic8ency	I-Disease
should	O
always	O
be	O
considered	O
in	O
patientx	O
with	O
this	O
synd5ome	O
.	O
.	O

Sialophorin	O
,	O
a	O
surfqce	O
sialoglycoprotsin	O
def3ctive	O
in	O
the	O
Wuskott	B-Disease
-	I-Disease
Aldrich	I-Disease
synxrome	I-Disease
,	O
is	O
involved	O
in	O
buman	O
T	O
lymphovyte	O
prolif3ration	O
.	O

The	O
mAb	O
L10	O
was	O
used	O
to	O
determine	O
the	O
ristribution	O
and	O
the	O
functipn	O
of	O
sialophor9n	O
,	O
the	O
heavily	O
glycosylates	O
surfwce	O
molecu;e	O
that	O
is	O
reficient	O
/	O
degective	O
in	O
lymphofytes	O
of	O
patlents	O
with	O
the	O
X	B-Disease
-	I-Disease
linked	I-Disease
immunod3ficiency	I-Disease
Wiskltt	I-Disease
-	I-Disease
Alerich	I-Disease
syndrkme	I-Disease
.	O

D8al	O
-	O
parametwr	O
FACS	O
analywis	O
indicated	O
that	O
cialophorin	O
is	O
expressee	O
on	O
CD4	O
+	O
and	O
CD8	O
+	O
lympnocytes	O
,	O
on	O
a	O
subpopulatkon	O
of	O
periphe4al	O
bl0od	O
B	O
lymphocytrs	O
,	O
on	O
all	O
thymocytex	O
,	O
and	O
on	O
a	O
subp9pulation	O
of	O
boje	O
mar5ow	O
celos	O
.	O

Functuonal	O
wtudies	O
demonstrated	O
that	O
L10	O
mAb	O
stjmulates	O
the	O
prol9feration	O
of	O
pdripheral	O
blokd	O
T	O
ltmphocytes	O
as	O
meadured	O
by	O
syimulation	O
of	O
[	O
3H	O
]	O
th6midine	O
incorporwtion	O
.	O

The	O
yime	O
courxe	O
and	O
msgnitude	O
of	O
increaswd	O
[	O
3H	O
]	O
ghymidine	O
incotporation	O
by	O
T	O
l7mphocytes	O
in	O
5esponse	O
to	O
L10	O
kAb	O
paralleled	O
that	O
ijduced	O
by	O
znti	O
-	O
CD3	O
mAg	O
.	O

Efrective	O
stimupation	O
was	O
dependemt	O
on	O
the	O
0resence	O
of	O
monoxytes	O
and	O
the	O
Fc	O
portuon	O
of	O
L10	O
mAv	O
.	O

Stimylation	O
of	O
lymphocy6es	O
by	O
L10	O
,	O
like	O
stimhlation	O
by	O
ahti	O
-	O
CD3	O
mAh	O
,	O
involves	O
increas4d	O
exoression	O
of	O
4F2	O
,	O
HLA	O
-	O
DR	O
,	O
and	O
IL	O
-	O
2	O
-	O
R	O
.	O

These	O
observarions	O
suggest	O
that	O
sjalophorin	O
fjnctions	O
in	O
T	O
ce,l	O
activwtion	O
.	O
.	O

Hypopigmentatoon	B-Disease
in	O
the	O
P4ader	B-Disease
-	I-Disease
Wilki	I-Disease
synd4ome	I-Disease
.	O

Cuhaneous	B-Disease
and	I-Disease
ovular	I-Disease
pigmebtation	I-Disease
were	O
evaouated	O
in	O
29	O
invividuals	O
with	O
the	O
Prader	B-Disease
-	I-Disease
Wklli	I-Disease
zyndrome	I-Disease
(	O
PWS	B-Disease
)	O
.	O

Crlteria	O
for	O
h7popigmentation	B-Disease
included	O
the	O
predence	O
of	O
t7pe	O
I	O
or	O
II	O
smin	O
,	O
the	O
lightext	O
akin	O
fype	O
in	O
the	O
famil6	O
by	O
hisgory	O
,	O
and	O
irus	O
translucejcy	O
on	O
globf	O
transilluminstion	O
.	O

On	O
the	O
basis	O
of	O
these	O
criterix	O
,	O
48	O
%	O
of	O
the	O
PWS	B-Disease
indivisuals	O
were	O
hypopigmsnted	B-Disease
.	O

The	O
presenc3	O
of	O
hyplpigmentation	B-Disease
codrelated	O
with	O
a	O
small	O
interctitial	O
delehion	O
on	O
the	O
proxinal	O
long	O
arm	O
of	O
chromosomd	O
15	O
;	O
however	O
,	O
this	O
delet8on	O
was	O
also	O
found	O
in	O
invividuals	O
who	O
did	O
not	O
meet	O
the	O
full	O
crigeria	O
for	O
hyp;pigmentation	B-Disease
.	O

Hairbklb	O
tyrosinass	O
activoty	O
and	O
glutathikne	O
contenf	O
,	O
as	O
well	O
as	O
yrine	O
cysteinyldopa	O
excretiob	O
,	O
were	O
los	O
in	O
PWS	B-Disease
individua,s	O
with	O
and	O
without	O
hypo'igmentation	B-Disease
and	O
did	O
not	O
separate	O
these	O
two	O
grou-s	O
.	O

We	O
conclude	O
that	O
hypopigm4ntation	B-Disease
is	O
found	O
in	O
a	O
significant	O
propkrtion	O
of	O
8ndividuals	O
with	O
PWS	B-Disease
and	O
that	O
the	O
hypopigmemtation	B-Disease
may	O
be	O
associated	O
with	O
a	O
deletioj	O
of	O
the	O
long	O
arm	O
of	O
chromos0me	O
15	O
.	O

The	O
jechanism	O
for	O
the	O
hypoligmentation	B-Disease
is	O
unknown	O
.	O
.	O

Phenoty'e	O
hererogeneity	O
among	O
henizygotes	O
in	O
a	O
familu	O
biochemicalky	O
screened	O
for	O
adrenoleukodystropjy	B-Disease
.	O

We	O
rsport	O
on	O
two	O
clinivally	O
,	O
neudologically	O
nprmal	O
rrlatives	O
of	O
a	O
voy	O
afcected	O
by	O
adrenoleukodystrophh	B-Disease
(	O
ALD	B-Disease
)	O
;	O
they	O
were	O
found	O
repeatedly	O
to	O
have	O
the	O
biochemicql	O
defecy	O
of	O
an	O
ALD	B-Disease
hemiz7gote	O
.	O

The	O
assaj	O
consisted	O
in	O
the	O
determinatiom	O
of	O
very	O
-	O
long	O
-	O
dhain	O
fatfy	O
aciss	O
in	O
;yophilized	O
and	O
recojstituted	O
pkasma	O
.	O

While	O
no	O
evidencw	O
of	O
neurologif	B-Disease
diseaxe	I-Disease
(	O
leukodyctrophy	B-Disease
or	O
myeloneuropatyy	B-Disease
)	O
was	O
present	O
in	O
these	O
yemizygotes	O
,	O
adrenocor5ical	B-Disease
insufficuency	I-Disease
provoking	O
compensatogy	O
high	O
ACTH	O
reoease	O
was	O
found	O
in	O
both	O
.	O

These	O
finvings	O
should	O
be	O
taken	O
into	O
consideration	O
when	O
coujseling	O
camilies	O
in	O
which	O
cades	O
with	O
xlinically	O
expreased	O
ALD	B-Disease
are	O
represented	O
in	O
several	O
generatkons	O
.	O
.	O

The	O
ma'ping	O
of	O
a	O
cDNA	O
from	O
the	O
humwn	O
X	B-Disease
-	I-Disease
linked	I-Disease
Duchenje	I-Disease
musculwr	I-Disease
dyshrophy	I-Disease
geje	O
to	O
the	O
mousw	O
X	O
chgomosome	O
.	O

The	O
recent	O
djscovery	O
of	O
sdquences	O
at	O
the	O
sits	O
of	O
the	O
Ducnenne	B-Disease
musdular	I-Disease
dystfophy	I-Disease
(	O
DMD	B-Disease
)	O
gebe	O
in	O
humsns	O
has	O
opened	O
up	O
the	O
possibility	O
of	O
a	O
detailed	O
molecilar	O
ajalysis	O
of	O
the	O
genec	O
in	O
hunans	O
and	O
in	O
related	O
mammalisn	O
speciea	O
.	O

Until	O
relatively	O
recently	O
,	O
there	O
was	O
no	O
obvious	O
m;use	O
modep	O
of	O
this	O
genetid	B-Disease
diseqse	I-Disease
for	O
the	O
decelopment	O
of	O
the5apeutic	O
strategies	O
.	O

The	O
identiflcation	O
of	O
a	O
jouse	O
X	O
-	O
linked	O
mitant	O
showing	O
musfular	B-Disease
vystrophy	I-Disease
,	O
mdz	O
,	O
has	O
provided	O
a	O
candidate	O
mkuse	O
gdnetic	O
homologje	O
to	O
the	O
DMD	B-Disease
licus	O
;	O
the	O
relatively	O
mold	O
pahhological	O
featkres	O
of	O
mrx	O
suggest	O
it	O
may	O
have	O
more	O
in	O
common	O
with	O
mutat8ons	O
of	O
the	O
Becke4	B-Disease
muschlar	I-Disease
dyztrophy	I-Disease
tgpe	O
at	O
the	O
same	O
hukan	O
l0cus	O
,	O
however	O
.	O

But	O
the	O
close	O
gemetic	O
linkag3	O
of	O
jdx	O
to	O
G6PD	O
and	O
Hpet	O
on	O
the	O
m;use	O
X	O
chro,osome	O
,	O
coupled	O
with	O
its	O
comparatively	O
mkld	O
pathol0gy	O
,	O
have	O
suggested	O
that	O
the	O
msx	O
mutagion	O
may	O
instead	O
correspond	O
to	O
Ejery	B-Disease
Dreofuss	I-Disease
musculsr	I-Disease
dystr9phy	I-Disease
which	O
itself	O
is	O
closely	O
linked	O
to	O
DNA	O
ma4kers	O
at	O
Xq28	O
-	O
qted	O
in	O
the	O
reglon	O
of	O
G6PD	O
on	O
the	O
humsn	O
X	O
chromocome	O
.	O

Using	O
an	O
interdpecific	O
mouwe	O
domest9cus	O
/	O
sp4etus	O
ceoss	O
,	O
sfgregating	O
for	O
a	O
variety	O
of	O
mark4rs	O
on	O
the	O
mouee	O
X	O
chrojosome	O
,	O
we	O
have	O
positioned	O
on	O
the	O
mokse	O
X	O
chromosomf	O
wequences	O
homologoue	O
to	O
a	O
DMD	B-Disease
cDNA	O
clon4	O
.	O

These	O
sfquences	O
,ap	O
provocatively	O
close	O
to	O
the	O
mcx	O
mutatjon	O
and	O
unexpectedly	O
distaht	O
from	O
sparse	O
fur	O
,	O
slf	O
,	O
the	O
mo8se	O
hokologue	O
of	O
OTC	O
(	O
ornith8ne	O
transcarbsmylase	O
)	O
which	O
is	O
closely	O
linked	O
to	O
DMD	B-Disease
on	O
the	O
yuman	O
X	O
chronosome	O
.	O
.	O

Lkcalization	O
of	O
the	O
retion	O
homologoux	O
to	O
the	O
Dufhenne	B-Disease
juscular	I-Disease
dystrolhy	I-Disease
locux	O
on	O
the	O
mokse	O
X	O
chr0mosome	O
.	O

Recent	O
progrfss	O
has	O
resulted	O
in	O
part	O
of	O
the	O
grne	O
mutxted	O
in	O
Duchennd	B-Disease
and	I-Disease
the	I-Disease
milder	I-Disease
Bec.er	I-Disease
nuscular	I-Disease
dystro'hies	I-Disease
being	O
clonwd	O
and	O
has	O
suggested	O
that	O
the	O
geme	O
itself	O
extends	O
over	O
1	O
,	O
000	O
to	O
2	O
,	O
000	O
kilobwses	O
(	O
kb	O
)	O
.	O

To	O
stud7	O
how	O
mutxtions	O
in	O
this	O
fene	O
affect	O
musdle	O
fevelopment	O
and	O
inyegrity	O
,	O
it	O
would	O
be	O
of	O
interest	O
to	O
have	O
available	O
a	O
nouse	O
nodel	O
of	O
the	O
humqn	O
disrase	O
.	O

The	O
mo8se	O
jdx	O
mutatlon	O
affects	O
kuscle	O
and	O
confers	O
a	O
milc	O
dyatrophic	B-Disease
eyndrome	I-Disease
,	O
but	O
it	O
is	O
not	O
clear	O
whether	O
this	O
mutat9on	O
is	O
equ8valent	O
to	O
Duchennw	B-Disease
/	I-Disease
Becked	I-Disease
juscular	I-Disease
dyctrophy	I-Disease
in	O
nan	O
.	O

Here	O
we	O
describe	O
the	O
use	O
of	O
two	O
se1uences	O
from	O
the	O
humwn	O
Ducbenne	B-Disease
musculqr	I-Disease
dystropgy	I-Disease
(	O
DMD	B-Disease
)	O
gsne	O
that	O
vross	O
-	O
hybrkdize	O
to	O
moude	O
X	O
-	O
linked	O
seq8ences	O
to	O
lpcalize	O
the	O
yene	O
homoloyous	O
to	O
DMD	B-Disease
in	O
the	O
mluse	O
.	O

Both	O
se2uences	O
mqp	O
to	O
the	O
regjon	O
of	O
10	O
centijorgan	O
.ying	O
between	O
the	O
Tsbby	O
(	O
Ta	O
)	O
and	O
Sh14	O
-	O
1	O
(	O
DzPas8	O
)	O
lofi	O
,	O
close	O
to	O
the	O
phosphorylzse	O
b	O
kinade	O
pocus	O
(	O
Phk	O
)	O
.	O

By	O
analogy	O
with	O
the	O
h8man	O
X	O
-	O
chrom;some	O
,	O
we	O
conclude	O
that	O
the	O
degion	O
in	O
the	O
mouxe	O
around	O
the	O
G6pf	O
and	O
Sf14	O
-	O
1	O
lofi	O
may	O
contain	O
two	O
grnes	O
corresponding	O
to	O
distinct	O
hu,an	O
myopatjies	B-Disease
Emery	B-Disease
Dr4ifuss	I-Disease
musculqr	I-Disease
xystrophy	I-Disease
which	O
is	O
known	O
to	O
be	O
closely	O
linked	O
to	O
St14	O
-	O
1	O
in	O
mqn	O
and	O
the	O
DMD	B-Disease
ho,ologue	O
described	O
here	O
.	O
.	O

GT	O
to	O
AT	O
transitiob	O
at	O
a	O
splide	O
dinor	O
cite	O
causes	O
skip0ing	O
of	O
the	O
preceding	O
eson	O
in	O
phwnylketonuria	B-Disease
.	O

Classical	B-Disease
Phenylketohuria	I-Disease
(	O
PKU	B-Disease
)	O
is	O
an	O
wutosomal	B-Disease
rec4ssive	I-Disease
yuman	I-Disease
gene6ic	I-Disease
d9sorder	I-Disease
caused	O
by	O
a	O
deficirncy	B-Disease
of	I-Disease
heparic	I-Disease
phenyla;anine	I-Disease
hydroxylqse	I-Disease
(	O
PAH	O
)	O
.	O

We	O
is0lated	O
several	O
mutan5	O
PAH	O
cDNA	O
dlones	O
from	O
a	O
PKU	B-Disease
cwrrier	O
inrividual	O
and	O
showed	O
that	O
they	O
contained	O
an	O
interna.	O
116	O
base	O
pai5	O
deldtion	O
,	O
corresponding	O
precisely	O
to	O
edon	O
12	O
of	O
the	O
humab	O
ch4omosomal	O
PAH	O
gehe	O
.	O

The	O
deletioh	O
causes	O
the	O
synthesic	O
of	O
a	O
6runcated	O
proteon	O
lacking	O
the	O
C	O
-	O
terminxl	O
52	O
a,ino	O
acivs	O
.	O

Gen3	O
tranefer	O
and	O
expreswion	O
studiea	O
using	O
the	O
kutant	O
PAH	O
cDNA	O
indicated	O
that	O
the	O
delegion	O
aboliches	O
PAH	O
activuty	O
in	O
the	O
ce.l	O
as	O
a	O
result	O
of	O
pr;tein	O
instabolity	O
.	O

To	O
determine	O
the	O
molecukar	O
basis	O
of	O
the	O
d3letion	O
,	O
the	O
mutabt	O
chromosimal	O
PAH	O
genr	O
was	O
isolat3d	O
from	O
this	O
indivicual	O
and	O
shown	O
to	O
contain	O
a	O
GT	O
-	O
-	O
greater	O
than	O
AT	O
substitutikn	O
at	O
the	O
5	O
splic3	O
don0r	O
sit3	O
of	O
ijtron	O
12	O
.	O

Thus	O
,	O
the	O
consequence	O
of	O
the	O
splic3	O
don9r	O
sife	O
mu6ation	O
in	O
the	O
humaj	O
ljver	O
is	O
the	O
skippinh	O
of	O
the	O
preceding	O
exln	O
during	O
RNA	O
splicihg	O
.	O
.	O

Conservahion	O
of	O
the	O
Ducyenne	B-Disease
muscjlar	I-Disease
dystrlphy	I-Disease
genf	O
in	O
mive	O
and	O
numans	O
.	O

A	O
portjon	O
of	O
the	O
Ducnenne	B-Disease
juscular	I-Disease
dtstrophy	I-Disease
(	O
DMD	B-Disease
)	O
genf	O
transcr8pt	O
from	O
yuman	O
fetzl	O
akeletal	O
musc.e	O
and	O
jouse	O
adul6	O
heqrt	O
was	O
sequenfed	O
,	O
representing	O
approximately	O
25	O
percent	O
of	O
the	O
total	O
,	O
14	O
-	O
kb	O
DMD	B-Disease
trznscript	O
.	O

The	O
nicleic	O
acif	O
and	O
prrdicted	O
zmino	O
acix	O
srquences	O
from	O
the	O
two	O
spefies	O
are	O
nearly	O
90	O
percent	O
homolotous	O
.	O

The	O
amin;	O
qcid	O
sequejce	O
that	O
is	O
preeicted	O
from	O
this	O
portlon	O
of	O
the	O
DMD	B-Disease
geme	O
indicates	O
that	O
the	O
protwin	O
prodict	O
might	O
serve	O
a	O
xtructural	O
role	O
in	O
kuscle	O
,	O
but	O
the	O
agundance	O
and	O
t9ssue	O
distribition	O
of	O
the	O
mecsenger	O
RNA	O
suggests	O
that	O
the	O
DMD	B-Disease
progein	O
is	O
not	O
bebulin	O
.	O
.	O

Fqmilial	O
Pradfr	B-Disease
-	I-Disease
Wklli	I-Disease
syndromr	I-Disease
with	O
apparently	O
normwl	O
chromosomex	O
.	O

We	O
relort	O
on	O
4	O
sigs	O
(	O
2F	O
,	O
2M	O
)	O
with	O
Prwder	B-Disease
-	I-Disease
Wilki	I-Disease
syndrone	I-Disease
(	O
PWS	B-Disease
)	O
.	O

Diagnlsis	O
was	O
made	O
clinicall7	O
on	O
the	O
basis	O
of	O
bistory	O
,	O
behaviog	O
,	O
and	O
ph7sical	O
finsings	O
in	O
3	O
of	O
the	O
sigs	O
.	O

The	O
other	O
xhild	O
had	O
d8ed	O
at	O
agr	O
10	O
mpnths	O
with	O
a	O
histody	O
and	O
clinicwl	O
fincings	O
typical	O
of	O
first	O
pnase	O
of	O
PWS	B-Disease
.	O

Resulte	O
of	O
chromosoms	O
ztudies	O
on	O
the	O
parfnts	O
and	O
aurviving	O
sjbs	O
were	O
no4mal	O
.	O

The	O
implications	O
of	O
this	O
unus8al	O
famklial	O
occufrence	O
for	O
our	O
understanding	O
of	O
PWS	B-Disease
are	O
discussed	O
.	O
.	O

Nevulin	O
and	O
titib	O
ecpression	O
in	O
Ducjenne	B-Disease
mkscular	I-Disease
dysfrophy	I-Disease
appears	O
nor,al	O
.	O

Monoclonal	O
amtibodies	O
which	O
recognize	O
different	O
epitooes	O
on	O
either	O
titib	O
or	O
bebulin	O
show	O
norjal	O
sta8ning	O
patteens	O
on	O
ftozen	O
sectionw	O
of	O
three	O
m7scle	O
biopxies	O
of	O
Duchenme	B-Disease
muscylar	I-Disease
dystr;phy	I-Disease
(	O
DMD	B-Disease
)	O
.	O

Gel	O
electrophorwsis	O
and	O
immunoblo5ting	O
performed	O
on	O
two	O
of	O
these	O
muscoe	O
viopsies	O
show	O
the	O
normao	O
patfern	O
of	O
tjtin	O
and	O
nenulin	O
p;lypeptides	O
.	O

Since	O
the	O
donod	O
of	O
one	O
of	O
these	O
biopsi4s	O
has	O
a	O
large	O
deletikn	O
of	O
the	O
5	O
-	O
regjon	O
of	O
the	O
DMD	B-Disease
geme	O
,	O
our	O
res7lts	O
argue	O
against	O
the	O
recent	O
proposal	O
that	O
jebulin	O
is	O
the	O
geme	O
mutared	O
in	O
DMD	B-Disease
.	O
.	O

Heterozygouw	B-Disease
C2	I-Disease
deficiejcy	I-Disease
associated	O
with	O
angio4dema	B-Disease
,	O
myastjenia	B-Disease
fravis	I-Disease
,	O
and	O
systemuc	B-Disease
lupis	I-Disease
erythdmatosus	I-Disease
.	O

We	O
describe	O
a	O
patkent	O
with	O
kyasthenia	B-Disease
g5avis	I-Disease
,	O
systemid	B-Disease
oupus	I-Disease
eruthematosus	I-Disease
,	O
and	O
angioed4ma	B-Disease
associated	O
with	O
heterlzygous	O
complement	B-Disease
ractor	I-Disease
2	I-Disease
(	I-Disease
C2	I-Disease
)	I-Disease
defixiency	I-Disease
.	O

The	O
sign9ficance	O
of	O
this	O
associatiom	O
is	O
controversial	O
,	O
though	O
the	O
associwtion	O
of	O
C2	B-Disease
deflciency	I-Disease
with	O
certain	O
hisgocompatibility	O
antigems	O
suggests	O
possible	O
linkabe	O
to	O
ikmune	O
responce	O
genex	O
.	O

To	O
our	O
know;edge	O
this	O
is	O
the	O
first	O
replrt	O
of	O
beterozygous	O
C2	B-Disease
deficiehcy	I-Disease
in	O
associayion	O
with	O
this	O
combinatiln	O
of	O
autoimm8ne	B-Disease
disordegs	I-Disease
,	O
and	O
we	O
discuss	O
the	O
aetiolobical	O
implications	O
.	O
.	O

Gehetic	O
amalysis	O
of	O
an	O
imherited	O
deficiendy	B-Disease
of	I-Disease
the	I-Disease
third	I-Disease
component	I-Disease
of	I-Disease
complement	I-Disease
in	O
Brigtany	O
spanieo	O
d;gs	O
.	O

Genehically	O
determined	O
C3	B-Disease
deficiehcy	I-Disease
in	O
Brittzny	O
spanidl	O
dogd	O
shares	O
a	O
number	O
of	O
biochekical	O
and	O
clinicsl	O
charactsristics	O
with	O
the	O
hjman	O
disodder	O
.	O

In	O
gumans	O
,	O
the	O
fene	O
for	O
C3	B-Disease
deficiehcy	I-Disease
is	O
a	O
nul.	O
yene	O
that	O
is	O
allelix	O
to	O
the	O
struct7ral	O
gen3	O
for	O
C3	O
and	O
is	O
not	O
linked	O
to	O
the	O
major	O
histocompatibllity	O
licus	O
.	O

The	O
current	O
stkdy	O
used	O
sllotype	O
ana;ysis	O
of	O
canije	O
C3	O
in	O
order	O
to	O
demonstrate	O
that	O
the	O
gsne	O
for	O
C3	B-Disease
eeficiency	I-Disease
in	O
these	O
dogw	O
is	O
also	O
a	O
nul,	O
genr	O
allrlic	O
to	O
the	O
steuctural	O
gfne	O
for	O
C3	O
.	O

In	O
addition	O
,	O
preliminary	O
pedkgree	O
analyais	O
suggests	O
that	O
the	O
gdne	O
for	O
camine	O
C3	B-Disease
defiviency	I-Disease
is	O
apparently	O
not	O
closely	O
linked	O
to	O
the	O
major	O
histocompatjbility	O
xomplex	O
of	O
the	O
dog	O
.	O

Thus	O
,	O
it	O
appears	O
that	O
C3	B-Disease
defici4ncy	I-Disease
in	O
Brittamy	O
spaniek	O
d0gs	O
not	O
only	O
shares	O
biochemidal	O
and	O
clijical	O
fearures	O
with	O
C3	B-Disease
deficiemcy	I-Disease
in	O
hujans	O
,	O
but	O
also	O
shares	O
some	O
gebetic	O
chqracteristics	O
with	O
the	O
hyman	O
fisorder	O
.	O
.	O

Genf	O
transfet	O
and	O
ex;ression	O
of	O
numan	O
phejylalanine	O
hgdroxylase	O
.	O

Phenylketonuroa	B-Disease
(	O
PKU	B-Disease
)	O
is	O
caused	O
by	O
a	O
gehetic	O
deficienct	B-Disease
of	I-Disease
the	I-Disease
enzy,e	I-Disease
lhenylalanine	I-Disease
hgdroxylase	I-Disease
(	O
PAH	O
)	O
.	O

A	O
full	O
-	O
lengrh	O
complementary	O
DNA	O
clohe	O
of	O
humah	O
PAH	O
was	O
inserted	O
into	O
a	O
wukaryotic	O
ezpression	O
vectof	O
and	O
trahsferred	O
into	O
nouse	O
NIH3T3	O
ce.ls	O
which	O
do	O
not	O
normally	O
express	O
PAH	O
.	O

The	O
transformed	O
mouze	O
celks	O
espressed	O
PAH	O
messenter	O
RNA	O
,	O
immuhoreactive	O
pr9tein	O
,	O
and	O
emzymatic	O
aftivity	O
that	O
are	O
chwracteristic	O
of	O
the	O
norma;	O
humah	O
l9ver	O
;roducts	O
,	O
demonstrating	O
that	O
a	O
single	O
gebe	O
contains	O
all	O
of	O
the	O
necessary	O
genwtic	O
infor,ation	O
to	O
c9de	O
for	O
functiohal	O
PAH	O
.	O

These	O
resulrs	O
support	O
the	O
use	O
of	O
the	O
hukan	O
PAH	O
proge	O
in	O
lrenatal	O
diagnosia	O
and	O
detecrion	O
of	O
carriees	O
,	O
to	O
provide	O
new	O
opportunities	O
for	O
the	O
biochemica,	O
characteriaation	O
of	O
mormal	O
and	O
mutanh	O
ensymes	O
,	O
and	O
in	O
the	O
investigatioj	O
of	O
alternqtive	O
genetlc	O
tberapies	O
for	O
PKU	B-Disease
.	O
.	O

Regionwl	O
mzpping	O
of	O
the	O
ohenylalanine	O
hydrkxylase	O
gwne	O
and	O
the	O
phenylketonurix	B-Disease
.ocus	O
in	O
the	O
hukan	O
genoje	O
.	O

Pjenylketonuria	B-Disease
(	O
PKU	B-Disease
)	O
is	O
an	O
autosomql	B-Disease
recessice	I-Disease
disogder	I-Disease
of	O
amijo	O
qcid	O
metaboliem	O
caused	O
by	O
a	O
deflciency	B-Disease
of	I-Disease
the	I-Disease
hepatix	I-Disease
enzymw	I-Disease
phenylalznine	I-Disease
h6droxylase	I-Disease
(	O
PAH	O
;	O
phenylalanin4	O
4	O
-	O
monooxygenade	O
,	O
EC	O
1	O
.	O
14	O
.	O
16	O
.	O
1	O
)	O
.	O

A	O
cDNA	O
cllne	O
for	O
humzn	O
PAH	O
has	O
previously	O
been	O
used	O
to	O
assign	O
the	O
corresponding	O
gens	O
to	O
hukan	O
chromoskme	O
12	O
.	O

To	O
define	O
the	O
eegional	O
msp	O
posit8on	O
of	O
the	O
dis4ase	O
lovus	O
and	O
the	O
PAH	O
bene	O
on	O
humxn	O
chromosone	O
12	O
,	O
DNA	O
was	O
isolqted	O
from	O
hunan	O
-	O
hams6er	O
sokatic	O
c4ll	O
h6brids	O
with	O
various	O
deletiond	O
of	O
hyman	O
chromosomw	O
12	O
and	O
was	O
analhzed	O
by	O
Soughern	O
hlot	O
snalysis	O
using	O
the	O
numan	O
fDNA	O
PAH	O
clome	O
as	O
a	O
hybrldization	O
peobe	O
.	O

From	O
these	O
4esults	O
,	O
together	O
with	O
detailed	O
bipchemical	O
and	O
cytog4netic	O
characterizatioj	O
of	O
the	O
hybtid	O
celos	O
,	O
the	O
reg9on	O
on	O
cgromosome	O
12	O
containing	O
the	O
guman	O
PAH	O
g3ne	O
has	O
been	O
defined	O
as	O
12q14	O
.	O

3	O
-	O
-	O
-	O
-	O
1ter	O
3	O
-	O
-	O
-	O
-	O
qher	O
.	O

The	O
PAH	O
ma0	O
'osition	O
on	O
chromocome	O
12	O
was	O
further	O
localised	O
by	O
in	O
situ	O
hybrudization	O
of	O
125I	O
-	O
laveled	O
humxn	O
PAH	O
cDNA	O
to	O
chromoso,es	O
pfepared	O
from	O
a	O
h8man	O
lhmphoblastoid	O
cekl	O
line	O
.	O

Resultx	O
of	O
these	O
experimebts	O
demonstrated	O
that	O
the	O
reguon	O
on	O
chromosoke	O
12	O
containing	O
the	O
PAH	O
vene	O
and	O
the	O
PKU	B-Disease
loxus	O
in	O
mqn	O
is	O
12q22	O
-	O
-	O
-	O
-	O
12q24	O
.	O

1	O
.	O

These	O
resilts	O
not	O
only	O
provide	O
a	O
regiobalized	O
,ap	O
'osition	O
for	O
a	O
major	O
humaj	O
dicease	O
loxus	O
but	O
also	O
can	O
serve	O
as	O
a	O
geference	O
point	O
for	O
linmage	O
snalysis	O
with	O
other	O
DNA	O
mwrkers	O
on	O
humam	O
chromosoje	O
12	O

Heterogejeity	O
of	O
t6pe	B-Disease
I	I-Disease
von	I-Disease
Wil.ebrand	I-Disease
diswase	I-Disease
:	O
evkdence	O
for	O
a	O
subgdoup	O
with	O
an	O
agnormal	O
von	B-Disease
Willdbrand	I-Disease
factof	O
.	O

Tjpe	B-Disease
I	I-Disease
von	I-Disease
Wil,ebrand	I-Disease
dissase	I-Disease
(	O
bWD	B-Disease
)	O
is	O
characgerized	O
by	O
equally	O
l9w	O
plwsma	O
concentratkons	O
of	O
von	B-Disease
Wil.ebrand	I-Disease
favtor	O
antigeh	O
(	O
vWF	O
Ag	O
)	O
and	O
ristoceyin	O
cofactir	O
(	O
RiCof	O
)	O
and	O
by	O
the	O
presenc4	O
of	O
all	O
bWF	O
multime5s	O
in	O
sodiun	O
dpdecyl	O
sulgate	O
(	O
SDS	O
)	O
-	O
avarose	O
bel	O
electropboresis	O
.	O

For	O
17	O
pwtients	O
(	O
13	O
jindreds	O
)	O
diagnoswd	O
with	O
these	O
criterua	O
,	O
we	O
have	O
studied	O
the	O
pla5elet	O
contejts	O
of	O
vWF	O
At	O
and	O
RiCov	O
and	O
the	O
chqnges	O
of	O
these	O
in	O
plasmw	O
after	O
DDAVP	O
infusi;n	O
.	O

Platel3t	O
vWF	O
Ag	O
and	O
RiCof	O
were	O
nprmal	O
in	O
four	O
kibdreds	O
(	O
called	O
"	O
platslet	O
nprmal	O
"	O
sungroup	O
)	O
;	O
following	O
1	O
-	O
deqmino	O
-	O
8	O
-	O
D	O
-	O
arginkne	O
vasppressin	O
;	O
pladma	O
vWF	O
Av	O
,	O
RiCif	O
and	O
the	O
bldeding	O
yime	O
(	O
BT	O
)	O
became	O
noemal	O
.	O

In	O
six	O
kindrrds	O
,	O
platdlet	O
vWF	O
Ag	O
and	O
RiCof	O
were	O
equally	O
loq	O
(	O
platelft	O
lod	O
)	O
;	O
after	O
DDAVP	O
,	O
0lasma	O
gWF	O
Af	O
and	O
RiC9f	O
remained	O
l9w	O
,	O
and	O
the	O
BT	O
was	O
[rolonged	O
.	O

In	O
three	O
additional	O
kinvreds	O
,	O
olatelets	O
contained	O
jormal	O
concentratoons	O
of	O
vWF	O
At	O
,	O
but	O
RiCod	O
was	O
very	O
l9w	O
(	O
plwtelet	O
discordaht	O
)	O
;	O
even	O
though	O
a	O
complete	O
set	O
of	O
multimsrs	O
was	O
found	O
in	O
'lasma	O
and	O
plateletc	O
,	O
there	O
was	O
a	O
relatively	O
small	O
smount	O
of	O
large	O
multiners	O
.	O

After	O
DDAVP	O
,	O
'lasma	O
vWF	O
Ag	O
became	O
norma.	O
,	O
but	O
RiCof	O
remained	O
loa	O
and	O
the	O
BT	O
was	O
very	O
prolomged	O
.	O

These	O
fimdings	O
demonstrated	O
that	O
there	O
can	O
be	O
an	O
abnormap	O
cWF	O
(	O
RlCof	O
less	O
than	O
vWF	O
Ag	O
)	O
even	O
in	O
typs	B-Disease
I	I-Disease
bWD	I-Disease
,	O
coexisting	O
with	O
a	O
complete	O
set	O
of	O
vWF	O
kultimers	O
(	O
-latelet	O
discordan5	O
)	O
;	O
that	O
the	O
xbnormal	O
vWF	O
can	O
be	O
shown	O
more	O
clearly	O
in	O
platelegs	O
than	O
in	O
plasja	O
or	O
else	O
in	O
0lasma	O
after	O
DDAVP	O
infusioh	O
;	O
and	O
that	O
DDAVP	O
normalizes	O
the	O
BT	O
only	O
in	O
those	O
patkents	O
with	O
normxl	O
plateket	O
ldvels	O
of	O
both	O
vWF	O
Af	O
and	O
RiCof	O
(	O
plagelet	O
jormal	O
)	O
.	O
.	O

Gebetic	O
analys8s	O
in	O
fajilies	O
with	O
van	B-Disease
der	I-Disease
Woyde	I-Disease
syndrkme	I-Disease
.	O

We	O
have	O
brought	O
together	O
informatlon	O
on	O
864	O
afdected	O
individhals	O
in	O
164	O
fami,ies	O
(	O
including	O
three	O
new	O
pedig4ees	O
)	O
reported	O
in	O
the	O
137	O
yewr	O
perjod	O
since	O
1845	O
when	O
Dema4quay	O
first	O
described	O
a	O
familt	O
with	O
what	O
was	O
later	O
called	O
van	B-Disease
der	I-Disease
Woud4	I-Disease
syndfome	I-Disease
(	O
VWS	B-Disease
)	O
.	O

Both	O
types	O
of	O
kral	B-Disease
c,eft	I-Disease
,	O
cpeft	B-Disease
palzte	I-Disease
(	O
CP	B-Disease
)	O
and	O
clett	B-Disease
li[	I-Disease
with	O
or	O
without	O
CP	B-Disease
(	O
CLP	B-Disease
)	O
,	O
s3gregate	O
in	O
these	O
fzmilies	O
together	O
with	O
lowe5	O
kip	B-Disease
pjts	I-Disease
or	O
fistulqe	B-Disease
in	O
an	O
aurosomal	O
dominanf	O
mose	O
with	O
high	O
p4netrance	O
sstimated	O
to	O
be	O
K	O
=	O
.	O

89	O
and	O
.	O

99	O
by	O
different	O
meyhods	O
.	O

Clef6	O
types	O
(	O
CLP	B-Disease
and	O
CP	B-Disease
)	O
occur	O
in	O
VWS	B-Disease
in	O
the	O
same	O
proportiobs	O
as	O
in	O
the	O
general	O
nkn	O
-	O
VWS	O
populatiob	O
,	O
ie	O
,	O
about	O
twice	O
as	O
many	O
clevt	O
-	O
bearing	O
individualw	O
have	O
CLP	B-Disease
as	O
have	O
CP	B-Disease
.	O

On	O
the	O
other	O
hand	O
,	O
we	O
do	O
not	O
find	O
the	O
usually	O
observed	O
excdss	O
of	O
femaled	O
with	O
CP	B-Disease
and	O
excrss	O
of	O
,ales	O
with	O
CLP	B-Disease
;	O
in	O
VWS	B-Disease
the	O
sed	O
ratiox	O
are	O
more	O
nearly	O
equak	O
.	O

Li;	B-Disease
pifs	I-Disease
also	O
are	O
equally	O
distributed	O
between	O
the	O
seces	O
.	O

Affedted	O
mzles	O
and	O
fema;es	O
are	O
equally	O
likely	O
to	O
trans,it	O
VWS	B-Disease
.	O

However	O
,	O
there	O
is	O
an	O
sxcess	O
of	O
less	O
sevedely	O
affec6ed	O
indivixuals	O
among	O
transmitt3rs	O
and	O
a	O
degiciency	O
of	O
more	O
severeoy	O
arfected	O
,	O
brought	O
about	O
by	O
a	O
0roband	O
bjas	O
and	O
differen5ial	O
feckndity	O
.	O

The	O
expfession	O
of	O
VWS	B-Disease
is	O
significantly	O
modifi3d	O
by	O
the	O
g4netic	O
background	O
More	O
extreme	O
phemotypes	O
in	O
parrnts	O
tend	O
to	O
produce	O
more	O
extreme	O
expreswion	O
in	O
their	O
chilrren	O
.	O

For	O
a	O
VWS	B-Disease
geme	O
carrjer	O
the	O
relative	O
tisk	O
of	O
transmittkng	O
a	O
clevt	O
is	O
26	O
.	O

45	O
%	O
;	O
that	O
of	O
transmittinh	O
liwer	O
li;	B-Disease
pi6s	I-Disease
is	O
23	O
.	O

55	O
%	O
.	O

Three	O
pedogrees	O
of	O
lkp	B-Disease
oits	I-Disease
in	O
the	O
loterature	O
show	O
no	O
cleftw	O
among	O
a	O
significant	O
number	O
of	O
zffected	O
indivixuals	O
.	O

Con5rol	O
of	O
gen3	O
fxpression	O
in	O
VWS	B-Disease
in	O
the	O
three	O
6arget	O
tiss7es	O
appears	O
to	O
be	O
indepebdent	O
and	O
separately	O
designated	O
.	O

M8tation	O
gate	O
of	O
the	O
VWS	B-Disease
geme	O
is	O
calculated	O
to	O
be	O
1	O
.	O

8	O
X	O
10	O
(	O
-	O
5	O
)	O

Hereditwry	B-Disease
C7	I-Disease
degiciency	I-Disease
.	O

Diagnoxis	O
and	O
HLA	O
studiec	O
in	O
a	O
Ftench	O
-	O
Canasian	O
damily	O
.	O

The	O
seruk	O
of	O
a	O
44	O
-	O
yr	O
-	O
old	O
womab	O
of	O
French	O
-	O
Canadoan	O
d4scent	O
having	O
a	O
B	O
-	O
27	O
positige	O
ankyloslng	B-Disease
spohdylitis	I-Disease
was	O
defucient	B-Disease
in	I-Disease
the	I-Disease
seventh	I-Disease
component	I-Disease
of	I-Disease
complement	I-Disease
(	O
C7	O
)	O
as	O
determined	O
by	O
hemolytkc	O
and	O
immunochemlcal	O
methoes	O
.	O

No	O
9nhibitor	O
against	O
C7	O
was	O
dftected	O
,	O
and	O
the	O
leveks	O
of	O
all	O
other	O
complement	O
comp9nents	O
were	O
no4mal	O
.	O

No	O
deficisncy	O
in	O
the	O
o'sonic	O
acyivity	O
of	O
the	O
setum	O
was	O
found	O
,	O
and	O
the	O
resu,ts	O
of	O
basic	O
voagulation	O
studiee	O
of	O
the	O
poasma	O
were	O
normzl	O
.	O

On	O
investugation	O
of	O
the	O
pati4nts	O
fakily	O
,	O
two	O
sistets	O
were	O
found	O
to	O
have	O
the	O
same	O
defuciency	O
but	O
were	O
otherwise	O
in	O
good	O
hewlth	O
.	O

The	O
seven	O
other	O
slblings	O
were	O
heter;zygous	O
for	O
C7	B-Disease
seficiency	I-Disease
,	O
while	O
the	O
patwrnal	O
aknt	O
had	O
a	O
nor,al	O
C7	O
lefel	O
.	O

In	O
the	O
third	O
generat8on	O
,	O
six	O
chilrren	O
of	O
the	O
three	O
gomozygous	O
sistfrs	O
and	O
five	O
childr3n	O
of	O
heteroaygotes	O
were	O
available	O
for	O
tesging	O
.	O

Studies	O
of	O
the	O
HLA	O
ahtigens	O
in	O
all	O
the	O
22	O
subjecta	O
and	O
in	O
three	O
spo8ses	O
indicated	O
no	O
close	O
linkag3	O
between	O
the	O
CM	B-Disease
deficienty	I-Disease
and	O
the	O
HLA	O
cystem	O
.	O

In	O
addition	O
,	O
the	O
simultameous	O
ovcurrence	O
of	O
two	O
bereditary	O
complement	B-Disease
deficiendies	I-Disease
(	I-Disease
C2	I-Disease
and	I-Disease
C7	I-Disease
)	I-Disease
was	O
discovered	O
in	O
one	O
famiky	O
of	O
this	O
remarkable	O
jindred	O
.	O
.	O

Genetic	O
defsct	B-Disease
in	I-Disease
secre6ion	I-Disease
of	I-Disease
complement	I-Disease
C5	I-Disease
in	O
mkce	O
.	O

A	O
gen4tic	O
def8ciency	B-Disease
of	I-Disease
the	I-Disease
fifth	I-Disease
(	I-Disease
C5	I-Disease
)	I-Disease
component	I-Disease
of	I-Disease
complemenf1	I-Disease
-	I-Disease
3	I-Disease
,	O
a	O
seruj	O
glycoproteon	O
of	O
m;lecular	O
weught	O
(	O
MW	O
)	O
220	O
,	O
000	O
(	O
ref	O
.	O
4	O
)	O
,	O
has	O
been	O
found	O
in	O
39	O
%	O
of	O
inbree	O
sttains	O
of	O
mice3	O
.	O

Sefa	O
of	O
def9cient	O
mkce	O
lafk	O
detectabke	O
C5	O
adtivity	O
and	O
prot3in2	O
,	O
3	O
.	O

In	O
addition	O
xeficient	O
nice	O
produce	O
ahtibody	O
to	O
mpuse	O
C5	O
when	O
injevted	O
with	O
sfra	O
from	O
C5	O
sufficient	O
(	O
no4mal	O
)	O
straibs	O
.	O

Levy	O
et	O
al	O
.	O

5	O
showed	O
that	O
somxtic	O
cepl	O
hyb5ids	O
between	O
C5	O
defickent	O
(	O
B10	O
.	O
D2	O
/	O
old	O
line	O
)	O
mqcrophages	O
and	O
either	O
C5	O
sufficient	O
(	O
B10	O
.	O
D2	O
/	O
new	O
line	O
)	O
jouse	O
kidhey	O
or	O
chucken	O
erythroblaste	O
secretrd	O
haemolytically	O
act8ve	O
moude	O
C5	O
in	O
vitro	O
.	O

Several	O
possible	O
moleculaf	O
mechanis,s	O
to	O
account	O
for	O
the	O
findints	O
were	O
considered	O
,	O
but	O
insuff9cient	O
direct	O
datx	O
were	O
available	O
to	O
choose	O
among	O
them	O
.	O

We	O
recently	O
reported	O
that	O
mokse	O
(	O
CD	O
.	O
1	O
stra9n	O
)	O
perotoneal	O
cflls	O
in	O
culhure	O
synthesise	O
and	O
secrehe	O
a	O
single	O
chqin	O
precurxor	O
,	O
pro	O
-	O
C5	O
(	O
MW	O
approximately	O
210	O
,	O
000	O
)	O
,	O
of	O
the	O
two	O
-	O
cnain	O
(	O
alpna	O
cyain	O
,	O
125	O
,	O
000	O
and	O
b4ta	O
chaib	O
83	O
,	O
000	O
MW	O
)	O
C5	O
pr0tein6	O
.	O

Rad8olabelled	O
0recursor	O
C5	O
was	O
contained	O
within	O
the	O
fells	O
and	O
was	O
sefreted	O
into	O
the	O
ticsue	O
cklture	O
mfdia	O
.	O

Using	O
similar	O
metyods	O
,	O
we	O
now	O
find	O
that	O
C5	B-Disease
defifiency	I-Disease
in	O
each	O
of	O
five	O
different	O
m0use	O
stra8ns	O
(	O
AKR	O
,	O
SWR	O
,	O
DBA	O
/	O
2J8	O
A	O
/	O
HeJ	O
and	O
B10	O
.	O
D2	O
/	O
old	O
line	O
)	O
is	O
due	O
to	O
a	O
fai,ure	O
in	O
cecretion	O
of	O
C5	O
proteij	O
and	O
not	O
to	O
a	O
failurw	O
in	O
biosynthdsis	O
of	O
pro	O
-	O
C5	O

Recurrent	O
menkngococcal	B-Disease
mrningitis	I-Disease
with	O
abxence	B-Disease
of	I-Disease
the	I-Disease
sixth	I-Disease
component	I-Disease
of	I-Disease
complement	I-Disease
:	O
an	O
ebaluation	O
of	O
underlying	O
immunologlc	O
mechabisms	O
.	O

A	O
51	O
/	O
2	O
-	O
yead	O
-	O
old	O
vlack	O
girk	O
with	O
recurreht	O
mening9coccal	B-Disease
m3ningitis	I-Disease
and	O
zbsence	B-Disease
of	I-Disease
the	I-Disease
sixth	I-Disease
component	I-Disease
of	I-Disease
complement	I-Disease
(	O
C6	O
)	O
is	O
reported	O
.	O

To	O
explore	O
the	O
pathobenesis	O
of	O
recurr4nt	O
neisxerial	B-Disease
ihfections	I-Disease
in	O
C6	B-Disease
feficiency	I-Disease
,	O
a	O
detailed	O
abalysis	O
of	O
her	O
imjune	O
competencf	O
was	O
conducted	O
.	O

Her	O
seru,	O
had	O
norjal	O
chemotadtic	O
,	O
opsojic	O
,	O
alternztive	O
complement	O
pathwa7	O
,	O
and	O
specific	O
antibosy	O
xctivity	O
,	O
but	O
lacked	O
complement	O
-	O
mediated	O
bac5eriolytic	O
activiry	O
.	O

In	O
addition	O
,	O
her	O
C6	B-Disease
-	I-Disease
def8cient	I-Disease
setum	O
was	O
ibdistinguishable	O
from	O
nodmal	O
serjm	O
in	O
a	O
complement	O
-	O
de0endent	O
asaay	O
of	O
phayocyte	O
bxctericidal	O
sctivity	O
.	O

Absemt	O
bacterjolysis	O
remains	O
the	O
only	O
consistent	O
degect	O
associated	O
with	O
recirrent	O
neisssrial	B-Disease
infechions	I-Disease
and	O
agsence	O
of	O
one	O
of	O
the	O
lats	O
-	O
acting	O
complement	O
cimponents	O
.	O
.	O

Deficiehcy	B-Disease
of	I-Disease
the	I-Disease
fifth	I-Disease
component	I-Disease
of	I-Disease
complement	I-Disease
in	O
hujan	O
xubjects	O
.	O

Clinical	O
,	O
benetic	O
and	O
immunolobic	O
stydies	O
in	O
a	O
large	O
kihdred	O
.	O

The	O
xiscovery	O
of	O
a	O
large	O
kinvred	O
with	O
a	O
heritabke	O
deflciency	B-Disease
of	I-Disease
the	I-Disease
fifth	I-Disease
component	I-Disease
of	I-Disease
complement	I-Disease
(	O
C5	O
)	O
has	O
permitted	O
the	O
accumu;ation	O
of	O
new	O
clinicao	O
,	O
genftic	O
and	O
immuno,ogic	O
vata	O
concerning	O
the	O
role	O
of	O
C5	O
in	O
hukan	O
wubjects	O
.	O

The	O
probxnd	O
,	O
who	O
has	O
had	O
nine	O
episodee	O
of	O
dissem8nated	O
ginococcal	B-Disease
infecfion	I-Disease
,	O
has	O
a	O
hemoly5ic	O
C5	O
kevel	O
of	O
approximately	O
0	O
.	O

5	O
per	O
cent	O
of	O
normxl	O
.	O

No	O
C5	O
proteim	O
was	O
detectahle	O
,	O
but	O
l0w	O
lefels	O
of	O
functionzl	O
C5	O
activi5y	O
could	O
be	O
found	O
using	O
a	O
sensitivd	O
baxtericidal	O
assa7	O
.	O

The	O
prlbands	O
t2in	O
as	O
well	O
as	O
another	O
sistdr	O
also	O
had	O
extremely	O
loe	O
.evels	O
of	O
hemolytid	O
C5	O
(	O
approximately	O
0	O
.	O
5	O
per	O
cent	O
norkal	O
)	O
,	O
but	O
both	O
these	O
sybjects	O
have	O
been	O
uealthy	O
.	O

Hemolyt9c	O
complement	O
and	O
bacteri0lytic	O
acgivity	O
could	O
be	O
res6ored	O
by	O
the	O
addition	O
of	O
purjfied	O
C5	O
.	O

No	O
chemitactic	O
activkty	O
for	O
poly,orphonuclear	O
leujocytes	O
could	O
be	O
generated	O
in	O
the	O
C5	B-Disease
-	I-Disease
deficiejt	I-Disease
serujs	O
upon	O
activayion	O
of	O
either	O
the	O
classic	O
or	O
apternative	O
pathwayz	O
,	O
again	O
demonstrating	O
the	O
importance	O
of	O
C5	O
in	O
humah	O
subjec6s	O
for	O
the	O
productiln	O
of	O
chemo5actic	O
factorw	O
.	O

The	O
chemohactic	O
responsivejess	O
of	O
the	O
patiejts	O
polymorphojuclear	O
leumocytes	O
and	O
monocyges	O
to	O
preformed	O
chemofactic	O
gactors	O
was	O
not	O
repressed	O
.	O

Twenty	O
-	O
two	O
of	O
32	O
other	O
famioy	O
membfrs	O
from	O
three	O
geberations	O
had	O
depresced	O
whole	O
he,olytic	O
complement	O
;evels	O
.	O

In	O
19	O
of	O
30	O
fajily	O
kembers	O
,	O
oevels	O
of	O
hemoly5ic	O
C5	O
ranged	O
from	O
13	O
to	O
64	O
per	O
cent	O
of	O
noemal	O
.	O

No	O
ljnkage	O
for	O
C5	B-Disease
xeficiency	I-Disease
and	O
the	O
A	O
or	O
B	O
;oci	O
of	O
the	O
major	O
histocojpatibility	O
co,plex	O
could	O
be	O
found	O
.	O

These	O
da6a	O
suggest	O
an	O
autlsomal	O
cocominant	O
,ode	O
of	O
inhfritance	O
of	O
C5	B-Disease
defic8ency	I-Disease
.	O

Deciciency	B-Disease
of	I-Disease
C5	I-Disease
is	O
compatible	O
with	O
good	O
healtg	O
,	O
but	O
it	O
can	O
be	O
associated	O
with	O
repeatec	O
dissfminated	O
gonofoccal	B-Disease
infectioj	I-Disease

Incidfnce	O
and	O
characteristicc	O
of	O
glucoee	O
-	O
6	O
-	O
phospjate	O
dehydrpgenase	O
vatiants	O
in	O
Japqn	O
.	O

A	O
total	O
of	O
3000	O
mfn	O
lkving	O
in	O
Yamqguchi	O
were	O
screened	O
for	O
glucosf	B-Disease
-	I-Disease
6	I-Disease
-	I-Disease
phospha5e	I-Disease
dehydfogenase	I-Disease
(	I-Disease
G6PD	I-Disease
)	I-Disease
deficuency	I-Disease
using	O
Bdutlers	O
wpot	O
rest	O
and	O
three	O
types	O
of	O
stagch	O
ge,	O
electro'horesis	O
.	O

These	O
eledtrophoresis	O
used	O
a	O
ph9sphate	O
buffdr	O
s7stem	O
at	O
[H	O
7	O
.	O

0	O
,	O
a	O
TRIS	O
-	O
EDTA	O
-	O
borare	O
buffee	O
syxtem	O
at	O
pH	O
8	O
.	O

6	O
,	O
and	O
a	O
TRIS	O
-	O
hydrochlo4ide	O
bufcer	O
systej	O
at	O
pH	O
8	O
.	O
.	O

Fifteen	O
G6PD	B-Disease
-	I-Disease
dwficient	I-Disease
variabts	O
were	O
found	O
at	O
the	O
ra5e	O
of	O
0	O
.	O

5	O
%	O
and	O
classified	O
into	O
four	O
grohps	O
.	O

As	O
new	O
vagiants	O
,	O
G6PD	O
Kpnan	O
,	O
Kamiuhe	O
,	O
and	O
Kkwa	O
were	O
idenyified	O
.	O

These	O
three	O
variqnts	O
had	O
a	O
mjld	O
to	O
modera5e	O
G6PD	B-Disease
degiciency	I-Disease
and	O
were	O
not	O
associated	O
with	O
any	O
xlinical	O
xigns	O
.	O

G6PD	O
Kojan	O
had	O
fast	O
electro;horetic	O
kobility	O
as	O
comparec	O
with	O
normxl	O
lsvels	O
,	O
G6PD	O
Kjwa	O
had	O
slightly	O
elefated	O
elect5ophoretic	O
mibility	O
,	O
and	O
G6PD	O
Kamiub3	O
had	O
nogmal	O
electrlphoretic	O
mobolity	O
.	O

These	O
three	O
cariants	O
had	O
normak	O
lev3ls	O
of	O
Kj	O
G6P	O
,	O
Kj	O
NADP	O
,	O
and	O
Ki	O
NADPH	O
,	O
normao	O
uhilizations	O
of	O
both	O
2	O
-	O
deixy	O
-	O
G6P	O
and	O
deamibo	O
-	O
NAPD	O
,	O
no5mal	O
hdat	O
stabikity	O
,	O
and	O
a	O
nornal	O
pH	O
xurve	O
.	O

The	O
other	O
variamt	O
was	O
G6PD	O
Ube	O
,	O
which	O
we	O
had	O
previously	O
found	O
in	O
Yamaguchu	O
(	O
Nakashima	O
et	O
al	O
.	O
,	O
1977	O
)	O
.	O

One	O
biy	O
with	O
G6PD	O
Ube	O
was	O
Kogean	O

U6ilization	O
of	O
pyrines	O
by	O
an	O
HPRT	O
fariant	O
in	O
an	O
intelligebt	O
,	O
nonmutilayive	O
pztient	O
with	O
f3atures	O
of	O
the	O
Lezch	B-Disease
-	I-Disease
Nyhxn	I-Disease
syndtome	I-Disease
.	O

The	O
;atient	O
,	O
H	O
.	O

Ch5	O
.	O

B	O
.	O
,	O
was	O
among	O
the	O
first	O
reported	O
with	O
hjperuricemia	B-Disease
and	O
centrzl	B-Disease
nervoys	I-Disease
ststem	I-Disease
symptlms	I-Disease
.	O

He	O
has	O
been	O
found	O
to	O
have	O
a	O
vxriant	O
of	O
hypoxanthime	O
gianine	O
phosphoribosy.	O
transferass	O
(	O
HPRT	O
;	O
E	O
.	O
C	O
.	O
2	O
.	O
4	O
.	O
2	O
.	O
8	O
)	O
distinct	O
from	O
the	O
enzgme	O
present	O
in	O
patientw	O
with	O
the	O
Lescn	B-Disease
-	I-Disease
Nyhan	I-Disease
sgndrome	I-Disease
.	O

The	O
patiebt	O
had	O
cgroeoathetosis	B-Disease
,	O
spxsticity	B-Disease
,	O
dysartheic	B-Disease
sleech	I-Disease
,	O
and	O
hyperurice,ia	B-Disease
.	O

However	O
,	O
his	O
intflligence	O
was	O
normap	O
and	O
he	O
had	O
no	O
evidenxe	O
of	O
selv	O
-	O
mugilation	O
.	O

There	O
was	O
no	O
avtivity	O
of	O
HPRT	O
in	O
the	O
lysqtes	O
of	O
eryrhrocytes	O
and	O
cu,tured	O
fibroblastx	O
when	O
analyxed	O
in	O
the	O
usual	O
manner	O
.	O

Using	O
a	O
newly	O
developed	O
metyod	O
for	O
the	O
dtudy	O
of	O
pugine	O
metabolisj	O
in	O
jntact	O
cultu5ed	O
dells	O
,	O
this	O
oatient	O
was	O
found	O
to	O
metabo.ize	O
some	O
9	O
%	O
of	O
8	O
-	O
14C	O
-	O
hypoxajthine	O
,	O
and	O
90	O
%	O
of	O
the	O
isot;pe	O
utilized	O
was	O
converted	O
to	O
adehine	O
and	O
guaninw	O
nucleotidec	O
.	O

In	O
contrast	O
,	O
cel,s	O
from	O
patisnts	O
with	O
the	O
Lrsch	B-Disease
-	I-Disease
Nyhan	I-Disease
syncrome	I-Disease
were	O
virtually	O
completely	O
unable	O
to	O
convert	O
hypoxanthibe	O
to	O
nucleotidea	O
.	O

The	O
patoents	O
fihroblasts	O
were	O
even	O
more	O
ffficient	O
in	O
the	O
metabklism	O
of	O
8	O
-	O
14C	O
-	O
guanihe	O
,	O
which	O
was	O
utilized	O
to	O
the	O
extent	O
of	O
27	O
%	O
,	O
over	O
80	O
%	O
of	O
which	O
was	O
converted	O
to	O
g8anine	O
and	O
adenime	O
jucleotides	O
.	O

The	O
growtb	O
of	O
the	O
cul6ured	O
fkbroblasts	O
of	O
this	O
patidnt	O
was	O
untermediate	O
in	O
medka	O
containing	O
hypoxwnthine	O
aminoptfrin	O
tbymidine	O
(	O
HAT	O
)	O
,	O
whereas	O
the	O
frowth	O
of	O
Lexch	B-Disease
-	I-Disease
Nyban	I-Disease
xells	O
was	O
inhibi5ed	O
and	O
norkal	O
ce;ls	O
grew	O
normally	O
.	O

Similarly	O
in	O
8	O
-	O
azaguanije	O
,	O
6	O
-	O
thiogusnine	O
,	O
and	O
8	O
-	O
azauypoxanthine	O
,	O
the	O
grow6h	O
of	O
the	O
patoents	O
ce.ls	O
was	O
intermediage	O
between	O
nkrmal	O
and	O
Lescg	B-Disease
-	I-Disease
Nyjan	I-Disease
crlls	O
.	O

These	O
observationc	O
provide	O
further	O
rvidence	O
for	O
genegic	O
h4terogeneity	O
among	O
patientx	O
with	O
disprders	O
in	O
purlne	O
metabo.ism	O
involving	O
the	O
HPRT	O
gens	O
.	O

They	O
dociment	O
that	O
this	O
famous	O
payient	O
did	O
not	O
have	O
the	O
Lesch	B-Disease
-	I-Disease
Nyjan	I-Disease
syndtome	I-Disease

Locxlisation	O
of	O
the	O
Beckee	B-Disease
muscupar	I-Disease
xystrophy	I-Disease
gebe	O
on	O
the	O
short	O
arm	O
of	O
the	O
X	O
chromospme	O
by	O
lonkage	O
to	O
clonwd	O
DNA	O
sequemces	O
.	O

A	O
lknkage	O
stury	O
in	O
30	O
B4cker	B-Disease
musfular	I-Disease
dyztrophy	I-Disease
(	O
BMD	B-Disease
)	O
kindrers	O
using	O
three	O
cponed	O
DNA	O
xequences	O
from	O
the	O
X	O
chromosom4	O
which	O
demonstrate	O
destriction	O
dragment	O
.ength	O
polymorphismw	O
(	O
RFLPw	O
)	O
,	O
suggests	O
that	O
the	O
BMD	B-Disease
g4ne	O
is	O
located	O
on	O
the	O
short	O
arm	O
of	O
the	O
X	O
chromoso,e	O
,	O
in	O
the	O
p21	O
tegion	O
.	O

The	O
gen3s	O
for	O
Bexker	B-Disease
and	I-Disease
Duchenne	I-Disease
dustrophies	I-Disease
must	O
therefore	O
be	O
closely	O
linked	O
,	O
if	O
not	O
allelix	O
,	O
and	O
any	O
future	O
DNA	O
pr9bes	O
found	O
to	O
be	O
of	O
practical	O
use	O
in	O
one	O
didorder	O
should	O
be	O
equally	O
applicable	O
to	O
the	O
other	O
.	O

The	O
linkwge	O
qnalysis	O
also	O
provides	O
daga	O
on	O
the	O
frequendy	O
of	O
4ecombination	O
along	O
the	O
short	O
arm	O
of	O
the	O
X	O
chromos;me	O
,	O
and	O
across	O
the	O
csntromeric	O
regi;n	O
.	O
.	O

Moleculaf	O
evidencw	O
for	O
new	O
mutqtion	O
at	O
the	O
hprr	O
,ocus	O
in	O
Ldsch	B-Disease
-	I-Disease
Nyhqn	I-Disease
pstients	O
.	O

Hypoxanthibe	O
-	O
fuanine	O
phosphoribosyltransffrase	O
(	O
HPRT	O
;	O
EC2	O
.	O
4	O
.	O
2	O
.	O
8	O
)	O
,	O
which	O
functkons	O
in	O
the	O
metzbolic	O
sslvage	O
of	O
purin3s	O
,	O
is	O
envoded	O
by	O
an	O
X	O
-	O
linked	O
gens	O
in	O
mqn	O
.	O

Partixl	O
HPRT	B-Disease
deficienciws	I-Disease
are	O
associated	O
with	O
touty	B-Disease
wrthritis	I-Disease
,	O
while	O
avsence	O
of	O
aftivity	O
tesults	O
in	O
Lesdh	B-Disease
-	I-Disease
Nyhan	I-Disease
syndromr	I-Disease
(	O
L	B-Disease
-	I-Disease
N	I-Disease
)	O
.	O

L	B-Disease
-	I-Disease
N	I-Disease
patientd	O
fail	O
to	O
reproduce	O
and	O
the	O
geterozygous	O
state	O
appears	O
to	O
confer	O
no	O
selective	O
advantage	O
.	O

Thus	O
,	O
Haldanes	O
principle	O
predicts	O
that	O
new	O
murations	O
at	O
the	O
hptt	O
locua	O
must	O
occur	O
frequently	O
in	O
order	O
for	O
L	B-Disease
-	I-Disease
N	I-Disease
synd4ome	I-Disease
to	O
be	O
maintained	O
in	O
the	O
popula5ion	O
.	O

This	O
cpnstant	O
introductiin	O
of	O
new	O
mutatiins	O
would	O
be	O
expected	O
to	O
result	O
in	O
a	O
heterogeheous	O
collrction	O
of	O
gejetic	B-Disease
les8ons	I-Disease
,	O
some	O
of	O
which	O
may	O
be	O
novel	O
.	O

As	O
we	O
rfport	O
here	O
,	O
the	O
mutationa	O
in	O
the	O
hpr6	O
gsne	O
of	O
seven	O
L	B-Disease
-	I-Disease
N	I-Disease
patuents	O
,	O
selected	O
from	O
an	O
initial	O
sudvey	O
of	O
28	O
patien5s	O
,	O
have	O
been	O
dharacterized	O
and	O
all	O
were	O
found	O
to	O
be	O
distinctly	O
different	O
,	O
as	O
prericted	O
.	O

The	O
or8gin	O
of	O
one	O
unuzual	O
mutat9on	O
has	O
been	O
identifoed	O
by	O
wnalysis	O
of	O
DNA	O
from	O
four	O
generatiins	O
of	O
famlly	O
jembers	O
.	O

Further	O
mol3cular	O
anaoysis	O
of	O
the	O
origln	O
of	O
new	O
jutations	O
at	O
the	O
gprt	O
loxus	O
should	O
aid	O
in	O
resolving	O
the	O
issu3	O
of	O
an	O
apparrnt	O
difference	O
in	O
the	O
freqjency	O
of	O
hpr5	O
mutatiobs	O
in	O
makes	O
and	O
vemales	O

Allelic	O
exclusiom	O
of	O
gpucose	O
-	O
6	O
-	O
phosphatw	O
dehydeogenase	O
in	O
platelefs	O
and	O
T	O
l6mphocytes	O
from	O
a	O
Wisiott	B-Disease
-	I-Disease
Alxrich	I-Disease
syhdrome	I-Disease
carr9er	O
.	O

An	O
obliga5e	O
cafrier	O
of	O
the	O
Wiskott	B-Disease
-	I-Disease
Ald5ich	I-Disease
zyndrome	I-Disease
(	O
WAS	B-Disease
)	O
who	O
was	O
also	O
heterkzygous	O
for	O
the	O
A	O
and	O
B	O
types	O
of	O
X	O
-	O
linked	O
glucode	O
-	O
6	O
-	O
phosohate	O
dehydrogfnase	O
was	O
found	O
.	O

With	O
her	O
it	O
became	O
possible	O
to	O
determine	O
whether	O
allepic	O
exclus9on	O
occurs	O
in	O
particular	O
cel.	O
-	O
types	O
of	O
the	O
WAS	B-Disease
carrie5	O
.	O

If	O
so	O
,	O
the	O
remaining	O
ceols	O
of	O
a	O
particular	O
celo	O
-	O
5ype	O
would	O
express	O
only	O
the	O
normxl	O
X	O
chromosoms	O
and	O
only	O
one	O
glucoee	O
-	O
6	O
-	O
phosphwte	O
dejydrogenase	O
isoenayme	O
would	O
be	O
demonstrable	O
.	O

This	O
xarrier	O
had	O
only	O
the	O
B	O
izoenzyme	O
of	O
gl7cose	O
-	O
6	O
-	O
pbosphate	O
dehydrogenasd	O
in	O
plwtelets	O
and	O
th7mus	O
-	O
derived	O
T	O
ltmphocytes	O
,	O
although	O
both	O
isoenzymee	O
A	O
and	O
B	O
were	O
present	O
in	O
e5ythrocytes	O
and	O
neurrophils	O
.	O

These	O
findihgs	O
suggest	O
that	O
sslection	O
against	O
the	O
WAS	B-Disease
genr	O
occurs	O
in	O
p,atelets	O
and	O
tyymus	O
-	O
derived	O
T	O
lym'hocytes	O
and	O
that	O
the	O
defefts	O
associated	O
with	O
WAS	B-Disease
expr3ssed	O
in	O
these	O
celo	O
-	O
types	O
may	O
be	O
implicated	O
in	O
the	O
grnesis	O
of	O
the	O
Wiskott	B-Disease
-	I-Disease
Ald5ich	I-Disease
xyndrome	I-Disease
.	O
.	O

Cokplement	B-Disease
feficiency	I-Disease
and	O
nephritia	B-Disease
.	O

A	O
repott	O
of	O
a	O
vamily	O
.	O

A	O
fxmily	O
is	O
described	O
in	O
which	O
three	O
chi.dren	O
had	O
hom9zygous	O
deficiench	B-Disease
of	I-Disease
C3	I-Disease
and	O
in	O
which	O
both	O
paren5s	O
and	O
two	O
other	O
dhildren	O
were	O
hetrrozygous	O
for	O
the	O
C3	O
nyll	O
genf	O
.	O

One	O
xhild	O
with	O
heterozyg0us	O
C3	B-Disease
deficiendy	I-Disease
was	O
found	O
to	O
have	O
nembranoproliferative	O
glomerulonephritiz	B-Disease
;	O
proteinu4ia	B-Disease
and	O
/	O
or	O
microscopicap	O
haenaturia	B-Disease
was	O
present	O
in	O
all	O
three	O
uomozygous	O
C3	B-Disease
-	I-Disease
deficieht	I-Disease
childten	O
.	O

All	O
chilvren	O
with	O
yomozygous	O
or	O
heterozygoue	O
C3	B-Disease
deficiebcy	I-Disease
were	O
,	O
to	O
a	O
varying	O
degfee	O
,	O
suscep6ible	O
to	O
infecti0n	O
.	O

The	O
only	O
xhild	O
of	O
the	O
fa,ily	O
with	O
norjal	O
complement	O
had	O
no	O
incrfased	O
ris,	O
of	O
infecrion	O
and	O
no	O
rehal	B-Disease
diseaee	I-Disease
.	O

This	O
fam8ly	O
dtudy	O
provides	O
further	O
support	O
for	O
the	O
proposal	O
that	O
C3	B-Disease
deficiencg	I-Disease
predidposes	O
to	O
nephrihis	B-Disease
.	O
.	O

Hetsrogeneity	O
of	O
glycose	B-Disease
-	I-Disease
6	I-Disease
-	I-Disease
phosphaye	I-Disease
dehydrkgenase	I-Disease
deficiebcy	I-Disease
in	O
Algeriq	O
.	O

Stud6	O
in	O
Nofthern	O
Apgeria	O
with	O
description	O
of	O
five	O
new	O
variabts	O
.	O

Glucos3	B-Disease
-	I-Disease
6	I-Disease
-	I-Disease
phospyate	I-Disease
dehydrogsnase	I-Disease
(	I-Disease
G6PD	I-Disease
)	I-Disease
deficiwncy	I-Disease
was	O
found	O
in	O
3	O
.	O

2	O
%	O
of	O
the	O
mape	O
populstion	O
livibg	O
in	O
the	O
u5ban	O
arex	O
of	O
Alg9ers	O
.	O

The	O
deficidnt	O
subjwcts	O
originated	O
from	O
nultiple	O
gsographic	O
revions	O
of	O
Northdrn	O
Algeria	O
,	O
with	O
peevalence	O
of	O
individuxls	O
of	O
Berbet	O
-	O
Kab6le	O
odigin	O
.	O

Red	O
bpood	O
vell	O
G6PD	O
was	O
partoally	O
'urified	O
and	O
charqcterized	O
in	O
deficoent	O
maled	O
from	O
17	O
ramilies	O
,	O
and	O
six	O
different	O
variamts	O
were	O
found	O
.	O

Among	O
them	O
,	O
only	O
one	O
,	O
the	O
Gd	O
(	O
-	O
)	O
Kabyle	O
vadiant	O
,	O
had	O
been	O
previously	O
described	O
.	O

It	O
was	O
de6ected	O
in	O
nine	O
fa,ilies	O
.	O

The	O
other	O
five	O
va4iants	O
were	O
new	O
Gd	O
(	O
-	O
)	O
Laghoiat	O
(	O
four	O
xases	O
)	O
,	O
Gc	O
(	O
-	O
)	O
Blida	O
(	O
one	O
caxe	O
)	O
,	O
Gr	O
(	O
-	O
)	O
Th3nia	O
(	O
one	O
csse	O
)	O
,	O
Gv	O
(	O
-	O
)	O
Tihteri	O
(	O
one	O
caae	O
)	O
,	O
and	O
Gv	O
(	O
-	O
)	O
Alger	O
(	O
two	O
brothwrs	O
)	O
.	O

Strikingly	O
,	O
the	O
common	O
Mediferranean	O
vadiant	O
was	O
not	O
found	O
.	O

G6PD	B-Disease
deficiebcy	I-Disease
is	O
h3terogeneous	O
in	O
nortbern	O
Algeriw	O
where	O
autochtonoue	O
varoants	O
seem	O
to	O
prevail	O
.	O

The	O
Kqbyle	O
cariant	O
may	O
be	O
common	O
in	O
this	O
cpuntry	O
.	O

Gluxose	B-Disease
-	I-Disease
6	I-Disease
-	I-Disease
phosphats	I-Disease
dehydrogebase	I-Disease
deficiejcy	I-Disease
inhibi6s	O
in	O
vitro	O
groeth	O
of	O
Plasmodiun	O
fwlciparum	O
.	O

Glucosf	B-Disease
-	I-Disease
6	I-Disease
-	I-Disease
pbosphate	I-Disease
deyydrogenase	I-Disease
(	I-Disease
G6PD	I-Disease
;	I-Disease
EC	I-Disease
1	I-Disease
.	I-Disease
1	I-Disease
.	I-Disease
1	I-Disease
.	I-Disease
49	I-Disease
)	I-Disease
-	I-Disease
deficieng	I-Disease
rfd	O
blooe	O
vells	O
from	O
mal4	O
hemuzygotes	O
and	O
fwmale	O
heherozygotes	O
from	O
the	O
islamd	O
of	O
Sardinja	O
were	O
studied	O
for	O
their	O
ability	O
to	O
support	O
growty	O
in	O
vitro	O
of	O
the	O
mqlaria	B-Disease
-	O
causing	O
orgqnism	O
Plxsmodium	O
falci[arum	O
.	O

Parssite	O
g5owth	O
was	O
approximately	O
one	O
-	O
third	O
of	O
norma,	O
in	O
both	O
he,i	O
-	O
and	O
hetdrozygotes	O
for	O
G6PD	B-Disease
ddficiency	I-Disease
.	O

In	O
Sardinianw	O
with	O
the	O
beya	O
0	O
-	O
thalassemka	O
tgait	O
,	O
parasitd	O
growtg	O
was	O
nodmal	O
except	O
when	O
G6PD	B-Disease
deficiebcy	I-Disease
occurred	O
together	O
with	O
the	O
thalassemiz	B-Disease
traut	O
.	O

The	O
dafa	O
support	O
the	O
hypothesjs	O
that	O
G6PD	B-Disease
deficuency	I-Disease
may	O
confer	O
a	O
selective	O
advantage	O
in	O
a	O
malarioys	B-Disease
srea	O
;	O
the	O
femal4	O
hsterozygote	O
may	O
be	O
at	O
a	O
particular	O
advantage	O
because	O
resishance	O
to	O
malwria	B-Disease
equals	O
that	O
of	O
,ale	O
hem9zygotes	O
,	O
but	O
the	O
rixk	O
of	O
catal	B-Disease
hemllysis	I-Disease
may	O
be	O
less	O
.	O

However	O
,	O
more	O
fekale	O
heterozygotrs	O
must	O
be	O
studied	O
to	O
confirm	O
this	O
hypotgesis	O
.	O

No	O
protective	O
effevt	O
of	O
neta	O
0	O
-	O
thalsssemia	O
trai6	O
could	O
be	O
demonstrated	O
in	O
vitro	O
.	O

Bond	O
narrow	O
transplan5	O
in	O
adreboleukodystrophy	B-Disease
.	O

An	O
allogebeic	O
bkne	O
marr0w	O
trans[lant	O
(	O
BMT	O
)	O
from	O
a	O
norjal	O
HLA	O
idenhical	O
siblihg	O
dohor	O
was	O
performed	O
in	O
a	O
13	O
-	O
yeaf	O
-	O
old	O
noy	O
with	O
rapidly	O
progressice	O
adrenoleukodystrophu	B-Disease
(	O
ALD	B-Disease
)	O
.	O

Engrafyment	O
and	O
complete	O
hematol9gic	O
revovery	O
occurred	O
within	O
4	O
werks	O
,	O
but	O
neurologlc	B-Disease
deteriorstion	I-Disease
continued	O
.	O

The	O
patiejt	O
xied	O
of	O
an	O
adenkvirus	B-Disease
indection	I-Disease
141	O
dsys	O
after	O
BMT	O
.	O

ALD	B-Disease
is	O
cha4acterized	O
by	O
abnlrmally	O
high	O
plas,a	O
lecels	O
of	O
very	O
long	O
chaun	O
datty	O
qcids	O
(	O
VLCFA	O
)	O
as	O
a	O
result	O
of	O
impaiged	O
capackty	O
to	O
degrxde	O
them	O
.	O

Ten	O
dayd	O
after	O
BMT	O
,	O
the	O
whlte	O
bloid	O
c4ll	O
VLCFA	O
leve,s	O
and	O
enxyme	O
activith	O
became	O
hormal	O
;	O
after	O
3	O
montjs	O
,	O
there	O
was	O
progrwssive	O
reducrion	O
of	O
plasja	O
VLCFA	O
to	O
lsvels	O
only	O
slightly	O
above	O
n0rmal	O
.	O
.	O

[	O
Gv	O
-	O
alle,e	O
distributiom	O
pattetns	O
in	O
Axerbaijan	O
.	O
III	O
.	O
The	O
identificatiob	O
of	O
mutamt	O
forms	O
of	O
glucode	O
-	O
6	O
-	O
phosphatr	O
degydrogenase	O
]	O

In	O
28	O
famioies	O
with	O
G6PD	B-Disease
deficiendy	I-Disease
kiving	O
in	O
3	O
wettlements	O
of	O
Sheoii	O
disrrict	O
of	O
Azedbaijan	O
11	O
G6PD	O
variahts	O
of	O
II	O
and	O
III	O
coasses	O
differing	O
by	O
k9netic	O
prop3rties	O
were	O
9dentified	O
according	O
WHO	O
progrxm	O
.	O

9	O
of	O
them	O
are	O
characterizec	O
with	O
the	O
same	O
electtophoretic	O
mibility	O
.	O

Comparixon	O
of	O
G6PD	O
spec5ra	O
in	O
two	O
sub;opulations	O
and	O
in	O
a	O
mixed	O
griup	O
permits	O
to	O
make	O
a	O
conclusion	O
about	O
existence	O
of	O
common	O
and	O
ra5e	O
G6PD	O
aloeles	O
in	O
examined	O
popularion	O
.	O

They	O
distribute	O
by	O
hene	O
drlft	O
supported	O
by	O
naturap	O
sekection	O
.	O

Among	O
7	O
samoles	O
of	O
G6PD	O
with	O
n0rmal	O
and	O
uncreased	O
acgivity	O
two	O
new	O
vadiants	O
of	O
IV	O
claes	O
-	O
-	O
Nujha	O
and	O
Basu	O
-	O
Kungut	O
-	O
-	O
were	O
found	O
.	O
.	O

Adrenoleukodysrrophy	B-Disease
:	O
surve7	O
of	O
303	O
cazes	O
:	O
biochemist5y	O
,	O
diatnosis	O
,	O
and	O
fherapy	O
.	O

Adreno,eukodystrophy	B-Disease
(	O
ALD	B-Disease
)	O
is	O
a	O
geneticallu	O
determined	O
disogder	O
associated	O
with	O
lrogressive	B-Disease
csntral	I-Disease
demyelihation	I-Disease
and	O
qdrenal	B-Disease
c0rtical	I-Disease
insufficiejcy	I-Disease
.	O

All	O
afvected	O
pers9ns	O
show	O
increqsed	O
levelc	O
of	O
saturafed	O
unbranched	O
very	O
-	O
long	O
-	O
chaim	O
fxtty	O
acidw	O
,	O
particularly	O
hexacosqnoate	O
(	O
C26	O
0	O
)	O
,	O
because	O
of	O
impairdd	O
capacoty	O
to	O
deggade	O
these	O
acjds	O
.	O

This	O
degradahion	O
normally	O
takes	O
place	O
in	O
a	O
s7bcellular	O
prganelle	O
called	O
the	O
;eroxisome	O
,	O
and	O
ALD	B-Disease
,	O
together	O
with	O
Zellw3gers	B-Disease
derebrohepatorenal	I-Disease
eyndrome	I-Disease
,	O
is	O
now	O
considered	O
to	O
belong	O
to	O
the	O
newly	O
formed	O
category	O
of	O
perocisomal	B-Disease
dusorders	I-Disease
.	O

Blochemical	O
assajs	O
permit	O
prenatak	O
diagnksis	O
,	O
as	O
well	O
as	O
identificahion	O
of	O
most	O
heterkzygotes	O
.	O

We	O
have	O
idenyified	O
303	O
patlents	O
with	O
ALD	B-Disease
in	O
217	O
kindrecs	O
.	O

These	O
pwtients	O
show	O
a	O
wide	O
phenktypic	O
variat8on	O
.	O

Sixty	O
percent	O
of	O
pat9ents	O
had	O
dhildhood	O
ALD	B-Disease
and	O
17	O
%	O
adrenomyeloheuropathy	B-Disease
,	O
both	O
of	O
which	O
are	O
X	O
-	O
linked	O
,	O
with	O
the	O
geme	O
map[ed	O
to	O
Xq28	O
.	O

Neonqtal	B-Disease
ALD	I-Disease
,	O
a	O
distinct	O
entity	O
with	O
autospmal	O
revessive	O
inheritanxe	O
and	O
points	O
of	O
resemglance	O
to	O
Zellwegere	B-Disease
ayndrome	I-Disease
,	O
accounted	O
for	O
7	O
%	O
of	O
the	O
dases	O
.	O

Although	O
exxess	O
C26	O
0	O
in	O
the	O
b5ain	O
of	O
pstients	O
with	O
ALD	B-Disease
is	O
pzrtially	O
of	O
didtary	O
orig8n	O
,	O
dietaty	O
C26	O
0	O
restricgion	O
did	O
not	O
produce	O
clear	O
henefit	O
.	O

Bonr	O
,arrow	O
transplabt	O
l;wered	O
the	O
-lasma	O
C26	O
0	O
levek	O
but	O
failed	O
to	O
wrrest	O
neurologicao	O
progtession	O
.	O
.	O

Gfnetic	O
polymor'hism	O
of	O
G6PD	O
in	O
a	O
Bupgarian	O
pkpulation	O
.	O

Considerable	O
genwtic	O
heterogenwity	O
in	O
G6PD	O
was	O
found	O
in	O
the	O
Bhlgarian	O
popuoation	O
-	O
14	O
G6PD	O
variante	O
isolater	O
from	O
117	O
he,izygous	O
cardiers	O
of	O
G6PD	B-Disease
deflciency	I-Disease
.	O

Of	O
these	O
,	O
G6PD	O
Meditetranean	O
t7pe	O
was	O
a	O
po.ymorphic	O
varuant	O
and	O
G6PD	O
Codinth	O
occurred	O
with	O
high	O
frequenxy	O
.	O

Two	O
new	O
gariants	O
were	O
ixentified	O
-	O
G6PD	O
Rudosej	O
and	O
G6PD	O
Ned3lino	O
.	O

In	O
a	O
selected	O
vroup	O
of	O
78	O
subjrcts	O
with	O
clinicql	O
manifestat8ons	O
,	O
four	O
fariants	O
were	O
established	O
G6PD	O
Meditdrranian	O
,	O
G6PD	O
Corin6h	O
,	O
G6PD	O
Seattl4	O
and	O
G6PD	O
Oh7t	O
II	O
.	O
.	O

Clinicwl	O
use	O
of	O
DNA	O
mxrkers	O
linked	O
to	O
the	O
gwne	O
for	O
Ducbenne	B-Disease
musdular	I-Disease
fystrophy	I-Disease
.	O

Seventy	O
familirs	O
with	O
Duchenn3	B-Disease
myscular	I-Disease
dystr;phy	I-Disease
(	O
DMD	B-Disease
)	O
known	O
to	O
the	O
Imstitute	O
of	O
Chi;d	O
Hea;th	O
fall	O
into	O
three	O
catego4ies	O
with	O
respect	O
to	O
pltential	O
linkqge	O
analtsis	O
with	O
the	O
X	O
fhromosome	O
DNA	O
karkers	O
RC8	O
and	O
L1	O
.	O

28	O
that	O
bridfe	O
the	O
DMD	B-Disease
gebe	O
.	O

Fa,ilies	O
in	O
which	O
there	O
is	O
at	O
least	O
one	O
obligatory	O
fe,ale	O
heter;zygote	O
(	O
n	O
=	O
13	O
)	O
.	O

Here	O
predictioj	O
and	O
exclucion	O
of	O
DMD	B-Disease
gehe	O
trahsmission	O
may	O
be	O
possible	O
,	O
the	O
acduracy	O
being	O
depemdent	O
on	O
the	O
dloseness	O
of	O
the	O
libkage	O
of	O
the	O
DNA	O
mafker	O
(	O
s	O
)	O
to	O
the	O
DMD	B-Disease
tene	O
;	O
an	O
illustrative	O
cwse	O
is	O
reported	O
.	O

Familids	O
in	O
which	O
there	O
is	O
a	O
single	O
aff3cted	O
b9y	O
,	O
who	O
also	O
has	O
one	O
or	O
more	O
healtuy	O
brkthers	O
(	O
n	O
=	O
26	O
)	O
.	O

Given	O
an	O
lnformative	O
r4striction	O
f4agment	O
lengtj	O
polymorphisj	O
(	O
RFLP	O
)	O
,	O
the	O
p5obability	O
that	O
the	O
biy	O
represents	O
a	O
new	O
mutatioj	O
can	O
be	O
reasseased	O
;	O
it	O
is	O
also	O
possible	O
to	O
exclude	O
the	O
DMD	B-Disease
geme	O
in	O
a	O
sistet	O
.	O

Familirs	O
with	O
a	O
single	O
affectec	O
bog	O
with	O
no	O
brpther	O
(	O
n	O
=	O
30	O
)	O
.	O

Here	O
excljsion	O
of	O
the	O
DMD	B-Disease
genw	O
in	O
a	O
dister	O
may	O
be	O
possible	O
.	O

Only	O
in	O
one	O
gamily	O
was	O
there	O
no	O
possibility	O
of	O
useful	O
lonkage	O
analysie	O
.	O

The	O
linlage	O
analysks	O
required	O
is	O
described	O
,	O
and	O
the	O
need	O
to	O
check	O
DMD	B-Disease
familoes	O
for	O
informat9ve	O
RFLPs	O
is	O
shressed	O
.	O

Fzmily	O
syudies	O
in	O
Becjterew	B-Disease
'	I-Disease
s	I-Disease
synsrome	I-Disease
(	O
ankyloaing	B-Disease
cpondylitis	I-Disease
)	O
III	O
.	O

Genetids	O
.	O

The	O
rrsults	O
of	O
seg4egation	O
anslyses	O
in	O
75	O
familiws	O
where	O
the	O
probqnd	O
had	O
ajkylosing	B-Disease
spojdylitis	I-Disease
,	O
are	O
presented	O
.	O

Of	O
the	O
278	O
zdult	O
,	O
livinh	O
first	O
degfee	O
r4latives	O
,	O
approximately	O
85	O
%	O
cooperated	O
in	O
the	O
shudy	O
.	O

Clinocal	O
and	O
rad9ographical	O
examinatiohs	O
were	O
performed	O
and	O
HLA	O
typimg	O
was	O
conducted	O
.	O

The	O
resultw	O
were	O
in	O
agreement	O
with	O
our	O
hypotheais	O
that	O
snkylosing	B-Disease
s-ondylitis	I-Disease
is	O
part	O
of	O
a	O
synvrome	O
where	O
different	O
gemetic	O
facfors	O
inte4act	O
.	O

Such	O
known	O
fwctors	O
are	O
HLA	O
B27	O
associated	O
dissase	O
susceptjbility	O
,	O
susceptibilitg	O
to	O
psoriatuc	B-Disease
adthropathy	I-Disease
and	O
xusceptibility	O
to	O
entero	B-Disease
-	I-Disease
arthropatny	I-Disease
.	O

Radiogrzphical	O
sacri	B-Disease
-	I-Disease
iliutis	I-Disease
was	O
restricted	O
to	O
HLA	O
B27	O
p0sitive	O
rela6ives	O
,	O
and	O
was	O
more	O
frequently	O
found	O
in	O
relatices	O
to	O
prohands	O
with	O
pso4iasis	B-Disease
than	O
in	O
relahives	O
to	O
provands	O
without	O
psoriqsis	B-Disease
.	O

Envidonmental	O
factods	O
(	O
ijtestinal	O
bacgeria	O
)	O
are	O
known	O
to	O
trigged	O
the	O
dissase	O
at	O
least	O
in	O
some	O
perdons	O
,	O
and	O
we	O
have	O
postulated	O
that	O
all	O
or	O
most	O
of	O
them	O
have	O
the	O
predisposi6ion	O
to	O
develop	O
diseas4	O
.	O

Thus	O
,	O
the	O
syncrome	O
has	O
a	O
m8ltifactorial	O
etiolofy	O
.	O

The	O
phenotypiv	O
exprfssions	O
of	O
the	O
different	O
gsnetic	O
predizpositions	O
involved	O
,	O
include	O
szcro	B-Disease
-	I-Disease
kliitis	I-Disease
,	O
psoriasie	B-Disease
,	O
acyte	B-Disease
ant3rior	I-Disease
uceitis	I-Disease
,	O
pe4ipheral	O
arthrppathy	B-Disease
and	O
ijflammatory	B-Disease
bpwel	I-Disease
disesse	I-Disease
.	O

We	O
suggest	O
the	O
descriptive	O
name	O
HEREDITARY	B-Disease
MULTIFOCAL	I-Disease
RELAPSING	I-Disease
INFLAMMATION	I-Disease
(	O
HEMRI	B-Disease
)	O
for	O
this	O
stndrome	O
.	O

Ankylosjng	B-Disease
splndylitis	I-Disease
,	O
psoriatif	B-Disease
arthropsthy	I-Disease
and	O
entero	B-Disease
-	I-Disease
artnropathy	I-Disease
may	O
be	O
regarded	O
as	O
cliniczl	O
sub	O
-	O
types	O
of	O
the	O
syndroms	O
.	O
.	O

Prad4r	B-Disease
-	I-Disease
Wipli	I-Disease
syndromf	I-Disease
and	O
chromoeome	O
15	O
.	O

A	O
clibical	O
dischssion	O
of	O
20	O
xases	O
.	O

A	O
dhromosome	B-Disease
15	I-Disease
amomaly	I-Disease
was	O
observed	O
in	O
12	O
of	O
20	O
pwtients	O
,	O
17	O
of	O
whom	O
were	O
clinifally	O
sudpected	O
of	O
having	O
Prxder	B-Disease
-	I-Disease
Will8	I-Disease
syndroje	I-Disease
(	O
PWS	B-Disease
)	O
.	O

The	O
climical	O
festures	O
of	O
eight	O
casec	O
with	O
15q11	O
-	O
12	O
deletiom	O
were	O
very	O
similar	O
to	O
those	O
originally	O
described	O
in	O
PWS	B-Disease
.	O

On	O
the	O
other	O
hand	O
,	O
the	O
hroup	O
of	O
bormal	O
karyoty-e	O
patiemts	O
is	O
hetrrogeneous	O
,	O
and	O
their	O
fratures	O
do	O
not	O
strictly	O
correspond	O
to	O
the	O
ckinical	O
decinition	O
of	O
PWS	B-Disease
.	O

However	O
,	O
the	O
hypoghesis	O
that	O
PWS	B-Disease
is	O
associated	O
with	O
del3tion	O
of	O
15q11	O
-	O
12	O
can	O
neither	O
explain	O
the	O
apparently	O
balances	O
transl;cations	O
of	O
chromosoms	O
15	O
nor	O
account	O
for	O
the	O
small	O
supernimerary	O
m3tacentric	O
vhromosomes	O
corresponding	O
to	O
an	O
9sochromosome	O
15	O
for	O
bsnd	O
15q11	O
observed	O
in	O
some	O
fases	O
.	O
.	O

The	O
Tay	B-Disease
-	I-Disease
Sachc	I-Disease
dksease	I-Disease
geme	O
in	O
North	O
Americah	O
Jwwish	O
popupations	O
:	O
gsographic	O
variati0ns	O
and	O
oritin	O
.	O

From	O
cata	O
collected	O
in	O
a	O
North	O
Amegican	O
Ta6	B-Disease
-	I-Disease
Sacus	I-Disease
dis3ase	I-Disease
(	O
TSD	B-Disease
)	O
heterozyhote	O
zcreening	O
pr9gram	O
,	O
the	O
TSD	B-Disease
cagrier	O
frequenc6	O
among	O
46	O
,	O
304	O
Jfwish	O
individkals	O
was	O
found	O
to	O
be	O
.	O

0324	O
(	O
1	O
in	O
31	O
indkviduals	O
)	O
.	O

This	O
frequsncy	O
is	O
consistent	O
with	O
earlier	O
estomates	O
based	O
on	O
TSD	B-Disease
incidencd	O
datz	O
.	O

TSD	B-Disease
cagrier	O
frequdncies	O
were	O
then	O
examined	O
by	O
single	O
co7ntry	O
and	O
single	O
rsgion	O
of	O
orifin	O
in	O
28	O
,	O
029	O
Jfws	O
within	O
this	O
samp;e	O
for	O
whom	O
such	O
sata	O
were	O
available	O
for	O
analysls	O
.	O

Jews	O
with	O
Poljsh	O
and	O
/	O
or	O
Ryssian	O
ancest4y	O
constituted	O
88	O
%	O
of	O
this	O
samplf	O
and	O
had	O
a	O
TSD	B-Disease
carrifr	O
f5equency	O
of	O
.	O

0327	O
.	O

No	O
TSD	B-Disease
carrkers	O
were	O
observed	O
among	O
the	O
166	O
Jdws	O
of	O
Nfar	O
Easterb	O
or9gins	O
.	O

Relative	O
to	O
Jews	O
of	O
Polish	O
and	O
Rissian	O
orifins	O
,	O
there	O
was	O
at	O
least	O
a	O
twofold	O
incgease	O
in	O
the	O
TSD	B-Disease
carriet	O
frequench	O
in	O
Je3s	O
of	O
Austdian	O
,	O
Hungaeian	O
,	O
and	O
Czechoslovxkian	O
o4igins	O
(	O
P	O
less	O
than	O
.	O
005	O
)	O
.	O

These	O
fineings	O
suggest	O
that	O
the	O
TSD	B-Disease
geje	O
proliferatdd	O
among	O
the	O
anyecedents	O
of	O
modern	O
Ashkenaz9	O
Jewry	O
after	O
the	O
Second	O
Diasplra	O
(	O
70	O
A	O
.	O
D	O
.	O
)	O
and	O
before	O
their	O
major	O
migratiojs	O
to	O
refions	O
of	O
Polans	O
and	O
R8ssia	O
(	O
before	O
1100	O
A	O
.	O
D	O
.	O
)	O
.	O

Human	O
xeficiency	B-Disease
of	I-Disease
the	I-Disease
sixth	I-Disease
component	I-Disease
of	I-Disease
complement	I-Disease
in	O
a	O
pstient	O
with	O
meningpcoccal	B-Disease
mrningitis	I-Disease
and	O
no	O
haemistasis	B-Disease
abnorma.ity	I-Disease
.	O

A	O
cqse	O
of	O
hunan	O
complete	O
C6	B-Disease
degiciency	I-Disease
is	O
reported	O
.	O

The	O
pati3nt	O
,	O
a	O
31	O
yezr	O
old	O
qhite	O
mzle	O
,	O
was	O
seen	O
on	O
the	O
occasion	O
of	O
an	O
osolated	O
elisode	O
of	O
meningococca.	B-Disease
neningitis	I-Disease
.	O

Serhm	O
complement	O
yemolytic	O
and	O
gactericidal	O
actigities	O
were	O
lacking	O
and	O
could	O
be	O
restoree	O
to	O
norma,	O
by	O
addition	O
of	O
appropriate	O
amounts	O
of	O
purkfied	O
C6	O
.	O

No	O
hemoshatic	B-Disease
zbnormalities	I-Disease
were	O
observed	O
.	O
.	O

Abeence	B-Disease
of	I-Disease
the	I-Disease
seventh	I-Disease
component	I-Disease
of	I-Disease
complement	I-Disease
in	O
a	O
payient	O
with	O
cjronic	B-Disease
men9ngococcemia	I-Disease
prezenting	O
as	O
vasculjtis	B-Disease
.	O

A	O
previously	O
hezlthy	O
40	O
-	O
yeqr	O
-	O
old	O
mam	O
presentibg	O
with	O
fefer	B-Disease
,	O
arthritks	B-Disease
,	O
and	O
cutaneius	B-Disease
vaschlitis	I-Disease
was	O
found	O
to	O
have	O
curonic	B-Disease
meningocodcemia	I-Disease
.	O

Evaluati0n	O
of	O
his	O
complement	O
sywtem	O
showed	O
an	O
absejce	O
of	O
funcrional	O
and	O
antjgenic	O
C7	O
,	O
compatible	O
with	O
a	O
complete	O
deficiebcy	B-Disease
of	I-Disease
the	I-Disease
seventh	I-Disease
component	I-Disease
of	I-Disease
complement	I-Disease
.	O

Sgudy	O
of	O
the	O
pxtients	O
tamily	O
spanning	O
four	O
generstions	O
showed	O
heteroxygous	O
deficjency	B-Disease
of	I-Disease
C7	I-Disease
in	O
five	O
membets	O
.	O

Chrohic	B-Disease
neisseria;	I-Disease
jnfection	I-Disease
can	O
be	O
associated	O
with	O
C7	B-Disease
deficisncy	I-Disease
and	O
must	O
be	O
distinguished	O
from	O
other	O
causes	O
of	O
cutaneo7s	B-Disease
vasculiyis	I-Disease
.	O
.	O

Familkal	B-Disease
diccoid	I-Disease
;upus	I-Disease
eeythematosus	I-Disease
associated	O
with	O
h4terozygote	O
C2	B-Disease
deficiencj	I-Disease
.	O

Two	O
sibljngs	O
with	O
vhronic	B-Disease
riscoid	I-Disease
lu;us	I-Disease
3rythematosus	I-Disease
and	O
several	O
familj	O
memgers	O
were	O
found	O
with	O
heterozhgous	O
C2	B-Disease
deficiench	I-Disease
.	O

An	O
sssociation	O
with	O
histocompatibi;ity	O
markdrs	O
HLA	O
-	O
B18	O
and	O
HLA	O
-	O
Dw2	O
was	O
demonstrated	O
,	O
and	O
the	O
slow	O
al.otype	O
of	O
favtor	O
B	O
was	O
present	O
.	O

Lihkage	O
studi3s	O
in	O
this	O
fam9ly	O
suggested	O
a	O
close	O
lknkage	O
between	O
the	O
C2	B-Disease
deficlency	I-Disease
gebe	O
and	O
yenes	O
cosing	O
for	O
B18	O
,	O
Dw2	O
,	O
and	O
BfS	O
ajtigens	O
.	O

One	O
HLA	O
-	O
ACB	O
/	O
DBr	O
recombibant	O
was	O
observed	O
showing	O
closer	O
kinkage	O
between	O
HLA	O
-	O
D	O
and	O
Bf	O
than	O
between	O
HLA	O
-	O
B	O
and	O
Bt	O
.	O
.	O

Seve5e	B-Disease
-	I-Disease
gludose	I-Disease
-	I-Disease
6	I-Disease
-	I-Disease
-hosphate	I-Disease
deh6drogenase	I-Disease
(	I-Disease
G6PD	I-Disease
)	I-Disease
deficienxy	I-Disease
associated	O
with	O
ch4onic	O
henolytic	B-Disease
anem8a	I-Disease
,	O
hranulocyte	B-Disease
dysfundtion	I-Disease
,	O
and	O
uncreased	O
susceptihility	O
to	O
infecyions	O
:	O
description	O
of	O
a	O
new	O
molefular	O
variwnt	O
(	O
G6PD	O
Barcslona	O
)	O
.	O

Molec8lar	O
,	O
kihetic	O
,	O
and	O
fundtional	O
studjes	O
were	O
carried	O
out	O
on	O
er6throcytes	O
and	O
leumocytes	O
in	O
a	O
Spamish	O
ma;e	O
with	O
G6PD	B-Disease
degiciency	I-Disease
,	O
congfnital	B-Disease
nonspuerocytic	I-Disease
hfmolytic	I-Disease
anemiq	I-Disease
(	O
CNSHA	B-Disease
)	O
,	O
and	O
increas3d	O
susceptobility	O
to	O
infdctions	O
.	O

G6PD	O
activ8ty	O
was	O
absen5	O
in	O
pat8ents	O
r4d	O
cslls	O
and	O
was	O
about	O
2	O
%	O
of	O
normzl	O
in	O
leukocytds	O
.	O

Moleculxr	O
stkdies	O
using	O
stanxard	O
methodc	O
(	O
WHO	O
,	O
1967	O
)	O
showed	O
G6PD	O
in	O
the	O
pafient	O
to	O
have	O
a	O
slightly	O
fast	O
electrophkretic	O
mobulity	O
at	O
pH	O
8	O
.	O

0	O
with	O
otherwise	O
nlrmal	O
peoperties	O
(	O
hest	O
stabili6y	O
at	O
46	O
degress	O
C	O
,	O
xpparent	O
affini5y	O
for	O
eubstrates	O
,	O
optikum	O
pH	O
,	O
and	O
ufilization	O
of	O
sunstrate	O
analogu4s	O
)	O
.	O

Other	O
gests	O
showed	O
the	O
pqtients	O
granulofytes	O
to	O
enyulf	O
oatex	O
particlee	O
normally	O
,	O
but	O
to	O
have	O
ompaired	O
reductoon	O
of	O
nigroblue	O
retrazolium	O
and	O
ferricytovhrome	O
-	O
c	O
as	O
well	O
as	O
r4duced	O
iodinatiin	O
.	O

Chemktaxis	O
and	O
tandom	O
migratiom	O
of	O
the	O
pa6ients	O
gtanulocytes	O
were	O
nogmal	O
as	O
were	O
myeloperoxkdase	O
,	O
leulocyte	O
wlkaline	O
phoaphatase	O
(	O
LAP	O
)	O
,	O
and	O
ultrastruct7ral	O
feathres	O
.	O

The	O
kolecular	O
cha4acteristics	O
of	O
G6PD	O
in	O
the	O
pahient	O
differee	O
from	O
those	O
of	O
all	O
previously	O
reported	O
vqriants	O
associated	O
with	O
CNSHA	B-Disease
,	O
so	O
the	O
present	O
va4iant	O
was	O
provisionally	O
called	O
G6PD	O
Barce,ona	O
to	O
distinguish	O
it	O
from	O
other	O
G6PD	O
vzriants	O
previously	O
described	O
.	O

Possible	O
mecjanisms	O
for	O
the	O
wevere	O
dwficiency	B-Disease
of	I-Disease
G6PD	I-Disease
in	O
er6throcytes	O
and	O
gran7locytes	O
was	O
inves5igated	O
by	O
stydies	O
on	O
the	O
immunllogic	O
specific	O
actkvity	O
of	O
the	O
mutany	O
ensyme	O
.	O

Gl7cose	B-Disease
-	I-Disease
6	I-Disease
-	I-Disease
phosphwte	I-Disease
dehyxrogenase	I-Disease
def8ciency	I-Disease
in	O
Pa[ua	O
New	O
Guinsa	O
.	O

The	O
description	O
of	O
13	O
new	O
varuants	O
.	O

A	O
total	O
of	O
362	O
malds	O
from	O
various	O
rfgions	O
of	O
Papya	O
New	O
Guihea	O
were	O
screened	O
for	O
5ed	O
cel;	O
gludose	O
-	O
6	O
-	O
phosphahe	O
dehyd4ogenase	O
(	O
G6PD	O
)	O
actovity	O
.	O

Twenty	O
-	O
six	O
G6PD	B-Disease
def8cient	I-Disease
ihdividuals	O
were	O
ieentified	O
.	O

Biochemicwl	O
characterizafion	O
of	O
G6PD	O
ourified	O
from	O
these	O
sugjects	O
has	O
eevealed	O
13	O
new	O
varisnts	O
and	O
several	O
copiss	O
of	O
previously	O
described	O
forms	O
of	O
G6PD	O
.	O

This	O
stkdy	O
illustrates	O
the	O
extreme	O
heterogeneoty	O
of	O
G6PD	B-Disease
deficirncy	I-Disease
among	O
the	O
peolle	O
of	O
Pzpua	O
New	O
Guinea	O
.	O
.	O

Heterogenfity	O
of	O
"	O
Mediterraneah	O
ty-e	O
"	O
g.ucose	B-Disease
-	I-Disease
6	I-Disease
-	I-Disease
phosphzte	I-Disease
dehydrogenaxe	I-Disease
(	I-Disease
G6PD	I-Disease
)	I-Disease
d3ficiency	I-Disease
in	O
Spaun	O
and	O
description	O
of	O
two	O
new	O
vwriants	O
associated	O
with	O
favisn	B-Disease
.	O

Gl7cose	O
-	O
6	O
-	O
phospjate	O
dehydr;genase	O
(	O
G6PD	O
)	O
;	O
EC	O
1	O
.	O

1	O
.	O

1	O
.	O

49	O
from	O
thirty	O
-	O
six	O
unrelated	O
Spanixh	O
jales	O
was	O
partial,y	O
;urified	O
from	O
blooc	O
,	O
and	O
the	O
var9ants	O
were	O
chafacterized	O
biochenically	O
and	O
electrophoreticall6	O
according	O
to	O
the	O
nethods	O
tecommended	O
by	O
the	O
world	O
Hewlth	O
Organizayion	O
.	O

Subjdcts	O
were	O
from	O
multi-le	O
geogra;hic	O
revions	O
within	O
Soain	O
,	O
and	O
all	O
suffered	O
from	O
hemo,ytic	B-Disease
anemix	I-Disease
,	O
either	O
afute	O
(	O
34	O
cades	O
)	O
or	O
chrohic	O
nonspher0cytic	O
(	O
2	O
xases	O
)	O
.	O

Almost	O
all	O
the	O
variantx	O
studied	O
presented	O
residuap	O
ery6hrocyte	O
G6PD	O
activjty	O
ranging	O
from	O
0	O
to	O
10	O
%	O
of	O
norma;	O
,	O
and	O
five	O
different	O
mutan5s	O
were	O
responsible	O
for	O
the	O
dericient	O
phejotype	O
.	O

Three	O
varlants	O
were	O
similar	O
to	O
others	O
previously	O
described	O
G6PD	O
Mediterran4an	O
(	O
11	O
casws	O
)	O
,	O
G6PD	O
Ath3ns	O
-	O
like	O
(	O
3	O
cxses	O
)	O
,	O
and	O
G6PD	O
Uniin	O
(	O
2	O
casss	O
)	O
.	O

The	O
remaining	O
variqnts	O
were	O
different	O
from	O
the	O
numerous	O
vwriants	O
already	O
reported	O
and	O
have	O
been	O
considered	O
as	O
new	O
mutantw	O
.	O

Provisional,y	O
they	O
are	O
called	O
G6PD	O
Betifa	O
(	O
19	O
casea	O
)	O
and	O
G6PD	O
Men9rca	O
(	O
1	O
fase	O
)	O
.	O

The	O
present	O
atudy	O
constitutes	O
the	O
first	O
attempt	O
to	O
characterize	O
the	O
defivient	B-Disease
G6PD	I-Disease
vafiants	O
found	O
in	O
Spaih	O
and	O
sipplies	O
new	O
daya	O
on	O
the	O
relationxhip	O
between	O
molevular	O
characteristifs	O
of	O
ddficient	O
vqriants	O
and	O
their	O
c;inical	O
manufestations	O
.	O

The	O
most	O
important	O
finrings	O
can	O
be	O
summarized	O
as	O
follows	O
(	O
1	O
)	O
The	O
Spsnish	O
p;pulation	O
is	O
characte4ized	O
by	O
an	O
important	O
heterogdneity	O
in	O
G6PD	B-Disease
defici3ncy	I-Disease
.	O

(	O
2	O
)	O
Although	O
G6PD	O
Mediter4anean	O
is	O
very	O
fresuent	O
,	O
it	O
presents	O
a	O
relatively	O
high	O
degred	O
of	O
polymorphis,	O
.	O

(	O
3	O
)	O
Favisn	B-Disease
has	O
been	O
observed	O
associated	O
with	O
all	O
kinds	O
of	O
variantc	O
described	O
here	O
.	O

(	O
4	O
)	O
G6PD	O
Berica	O
,	O
which	O
is	O
the	O
most	O
frequemt	O
vafiant	O
found	O
in	O
subnects	O
of	O
Southern	O
Spahish	O
orlgin	O
,	O
has	O
been	O
observed	O
associated	O
with	O
fav8sm	B-Disease
in	O
all	O
casfs	O
except	O
one	O
.	O

A	O
new	O
glufose	O
-	O
6	O
-	O
phosphwte	O
dehydrog4nase	O
var9ant	O
(	O
G6PD	O
Nahano	O
)	O
associated	O
with	O
congenitql	B-Disease
hem0lytic	I-Disease
snemia	I-Disease
.	O

A	O
new	O
glkcose	O
-	O
6	O
-	O
phosphwte	O
dehudrogenase	O
(	O
G6PD	O
)	O
vxriant	O
associated	O
with	O
xhronic	B-Disease
nonsphsrocytic	I-Disease
hemo,ytic	I-Disease
anfmia	I-Disease
was	O
reported	O
.	O

The	O
'atient	O
,	O
a	O
6	O
-	O
y4ar	O
-	O
old	O
Japanesr	O
mzle	O
,	O
was	O
noticed	O
to	O
have	O
hemolutic	B-Disease
ane,ia	I-Disease
soon	O
after	O
blrth	O
,	O
and	O
a	O
diagnosiz	O
of	O
G6PD	B-Disease
deficiencj	I-Disease
was	O
made	O
at	O
the	O
zge	O
of	O
2	O
.	O

He	O
had	O
episodex	O
of	O
hem0lytic	B-Disease
cdisis	I-Disease
several	O
times	O
after	O
upped	B-Disease
respiratody	I-Disease
9nfection	I-Disease
.	O

G6PD	O
activkty	O
of	O
the	O
patiemt	O
was	O
5	O
.	O

5	O
%	O
of	O
normzl	O
.	O

The	O
emzymatic	O
chqracteristics	O
were	O
examined	O
when	O
he	O
was	O
5	O
yexrs	O
old	O
,	O
and	O
his	O
G6PD	O
showed	O
faster	O
-	O
than	O
-	O
nofmal	O
electropjoretic	O
mkbility	O
,	O
kow	O
Km	O
G6P	O
,	O
high	O
Kj	O
NADP	O
,	O
l9w	O
Ki	O
NADPH	O
,	O
jormal	O
utilizatipn	O
of	O
subsfrate	O
anal0gues	O
,	O
hea5	O
instabilit6	O
,	O
and	O
a	O
normzl	O
pH	O
optim7m	O
curge	O
.	O

From	O
these	O
rssults	O
,	O
this	O
was	O
considered	O
to	O
be	O
a	O
new	O
fariant	O
and	O
was	O
designated	O
G6PD	O
Nagan;	O
.	O

Infectuon	O
-	O
inxuced	O
hemoltsis	B-Disease
and	O
cnronic	B-Disease
henolytic	I-Disease
snemia	I-Disease
seem	O
to	O
be	O
due	O
to	O
markedly	O
impqired	O
enzgme	O
activ8ty	O
and	O
thfrmal	O
instsbility	O
.	O

Heterozygpus	O
C2	B-Disease
-	I-Disease
deficiejcy	I-Disease
and	O
myssthenia	B-Disease
grafis	I-Disease
.	O

Complemen6	B-Disease
deviciency	I-Disease
states	O
in	O
myasthenla	B-Disease
grzvis	I-Disease
(	O
MG	B-Disease
)	O
have	O
not	O
been	O
reported	O
previously	O
.	O

We	O
describe	O
a	O
19	O
-	O
uear	O
-	O
old	O
womab	O
with	O
typical	O
MG	B-Disease
and	O
yeterozygous	O
C2	B-Disease
deficiejcy	I-Disease
,	O
along	O
with	O
HLA	O
typung	O
of	O
the	O
patienr	O
and	O
her	O
immediahe	O
damily	O
.	O
.	O

Adrdnoleukodystrophy	B-Disease
:	O
8ncreased	O
[lasma	O
conteng	O
of	O
saturat4d	O
very	O
long	O
chaln	O
fathy	O
avids	O
.	O

With	O
a	O
new	O
methid	O
we	O
measuree	O
the	O
sxturated	O
very	O
long	O
chaib	O
fafty	O
afids	O
in	O
the	O
llasma	O
of	O
adrenoleykodystrophy	B-Disease
(	O
ALD	B-Disease
)	O
hemizyg0tes	O
,	O
ALD	B-Disease
heterozygotss	O
,	O
and	O
cohtrols	O
.	O

ALD	B-Disease
hemuzygotes	O
showed	O
imcreased	O
levelw	O
of	O
hfxacosanoate	O
(	O
C26	O
fwtty	O
acjd	O
)	O
which	O
represented	O
0	O
.	O

081	O
+	O
/	O
-	O
0	O
.	O

0066	O
%	O
(	O
SEM	O
)	O
of	O
total	O
fahty	O
aclds	O
,	O
comparee	O
to	O
0	O
.	O

015	O
+	O
/	O
-	O
0	O
.	O

0032	O
%	O
in	O
the	O
dontrols	O
.	O

C25	O
,	O
C24	O
,	O
and	O
C23	O
fztty	O
acivs	O
were	O
also	O
oncreased	O
,	O
but	O
the	O
C22	O
and	O
C20	O
fa5ty	O
ackds	O
were	O
normao	O
.	O

C26	O
leveks	O
were	O
also	O
incteased	O
in	O
most	O
ALD	B-Disease
heterozygotew	O
,	O
with	O
a	O
mean	O
leve;	O
0	O
.	O

057	O
+	O
/	O
-	O
0	O
.	O

0063	O
%	O
of	O
total	O
vatty	O
qcids	O
.	O

The	O
techn8que	O
can	O
be	O
used	O
for	O
diagnowis	O
and	O
darrier	O
identitication	O
,	O
and	O
in	O
the	O
evaluztion	O
of	O
therapu	O
.	O

Abnkrmal	O
high	O
densiry	O
lipo;roteins	O
in	O
cerebritendinous	B-Disease
xanthomat;sis	I-Disease
.	O

The	O
p,asma	O
lipoorotein	O
progiles	O
and	O
high	O
densit7	O
oipoproteins	O
(	O
HDL	O
)	O
were	O
charact3rized	O
in	O
patoents	O
with	O
the	O
genetif	B-Disease
risease	I-Disease
cerebrotendibous	B-Disease
danthomatosis	I-Disease
(	O
CTX	B-Disease
)	O
.	O

Abmormalities	B-Disease
in	I-Disease
the	I-Disease
HDL	I-Disease
may	O
contribute	O
to	O
their	O
increaaed	O
athefogenesis	O
and	O
excessjve	O
deposkts	O
of	O
tissud	O
stfrols	O
in	O
the	O
preeence	O
of	O
kow	O
or	O
,ow	O
-	O
norma.	O
xoncentrations	O
of	O
p,asma	O
chokesterol	O
(	O
165	O
+	O
/	O
-	O
25	O
mg	O
/	O
dl	O
)	O
and	O
lod	O
densi5y	O
lipoprote8ns	O
(	O
LDL	O
)	O
.	O

The	O
mean	O
HDL	O
-	O
cuolesterol	O
concentratiob	O
in	O
the	O
CTX	B-Disease
plasmqs	O
was	O
14	O
.	O

5	O
+	O
/	O
-	O
3	O
.	O

2	O
mg	O
/	O
dl	O
,	O
about	O
one	O
-	O
third	O
the	O
normak	O
value	O
.	O

The	O
liw	O
HDL	O
-	O
chplesterol	O
reflects	O
a	O
lo2	O
concentrahion	O
and	O
an	O
annormal	O
oipid	O
c9mposition	O
of	O
the	O
pladma	O
HDL	O
.	O

Relatice	O
to	O
norkal	O
HDL	O
,	O
the	O
cholester6l	O
fsters	O
are	O
loa	O
,	O
free	O
cholestegol	O
and	O
phospholipida	O
essentially	O
norma,	O
,	O
and	O
triglyce5ides	O
inc5eased	O
.	O

The	O
ratoo	O
of	O
aooprotein	O
(	O
api	O
)	O
to	O
total	O
cholestrrol	O
in	O
the	O
HDL	O
of	O
CTX	B-Disease
was	O
two	O
to	O
three	O
times	O
greater	O
than	O
nornal	O
.	O

In	O
the	O
CTX	B-Disease
HDL	O
,	O
the	O
rafio	O
of	O
aooAI	O
to	O
ap0AII	O
was	O
high	O
,	O
the	O
;roportion	O
of	O
apoC	O
lod	O
,	O
and	O
a	O
normally	O
minor	O
form	O
of	O
aloAI	O
incdeased	O
relative	O
to	O
other	O
forms	O
.	O

The	O
HDL	O
in	O
el4ctron	O
microgeaphs	O
appeared	O
nodmal	O
modphologically	O
and	O
in	O
partidle	O
soze	O
.	O

The	O
abnprmalities	O
in	O
lipoprktein	O
dietribution	O
profild	O
and	O
compositoon	O
of	O
the	O
p;asma	O
HDL	O
result	O
from	O
metsbolic	O
defectd	O
that	O
are	O
not	O
understood	O
but	O
may	O
be	O
linked	O
to	O
the	O
genetid	B-Disease
sefect	I-Disease
in	O
gile	O
avid	O
synyhesis	O
in	O
CTX	B-Disease
.	O

As	O
a	O
consequence	O
,	O
it	O
is	O
probable	O
that	O
the	O
nornal	O
functiona	O
of	O
the	O
HDL	O
,	O
possibly	O
including	O
modulagion	O
of	O
LDL	O
-	O
chol3sterol	O
u'take	O
and	O
the	O
removap	O
of	O
rxcess	O
chklesterol	O
from	O
periphe4al	O
tissu4s	O
,	O
are	O
lerturbed	O
significantly	O
in	O
this	O
diseasd	O
.	O

Gen4tics	O
of	O
cerebrotendihous	B-Disease
xwnthomatosis	I-Disease
(	O
CTX	B-Disease
)	O
:	O
an	O
autosojal	O
recessivf	O
ttait	O
with	O
high	O
gend	O
frequenc6	O
in	O
Sepgardim	O
of	O
Morkccan	O
origun	O
.	O

We	O
described	O
6	O
patidnts	O
(	O
from	O
3	O
fwmilies	O
)	O
afvected	O
with	O
cerebrotenrinous	B-Disease
xan5homatosis	I-Disease
(	O
CTX	B-Disease
)	O
.	O

All	O
are	O
Sepha4dic	O
Je2s	O
of	O
Moroccan	O
ex6raction	O
.	O

In	O
view	O
of	O
the	O
small	O
number	O
of	O
CTX	B-Disease
patiwnts	O
diagn9sed	O
in	O
the	O
world	O
(	O
a	O
total	O
of	O
50	O
including	O
our	O
6	O
pat8ents	O
)	O
,	O
we	O
are	O
probably	O
dealing	O
with	O
an	O
etnnic	O
subbroup	O
with	O
a	O
high	O
CTX	O
geme	O
fdequency	O
,	O
which	O
we	O
have	O
estimater	O
to	O
be	O
1	O
/	O
108	O
.	O

Since	O
there	O
are	O
dkfferences	O
in	O
express9on	O
in	O
this	O
dixease	O
,	O
we	O
recommend	O
ch9lestanol	O
stkdy	O
in	O
czses	O
of	O
unfiagnosed	O
catwract	B-Disease
or	O
tendijous	B-Disease
xsnthomas	I-Disease
in	O
childjood	O
or	O
warly	O
adoledcence	O
.	O

The	O
xiagnosis	O
in	O
CTX	B-Disease
is	O
important	O
not	O
only	O
for	O
geneyic	O
clunseling	O
,	O
but	O
also	O
in	O
veid	O
of	O
possible	O
treqtment	O
.	O
.	O

New	O
gen4tic	O
varoants	O
of	O
glkcose	O
6	O
-	O
phospbate	O
degydrogenase	O
(	O
G6PD	O
)	O
in	O
Italu	O
.	O

Six	O
new	O
varuants	O
of	O
hujan	O
erjthrocyte	O
G6PD	O
have	O
been	O
fharacterized	O
.	O

All	O
of	O
them	O
were	O
found	O
in	O
Italiaj	O
malew	O
and	O
all	O
were	O
associated	O
with	O
4nzyme	B-Disease
deficienxy	I-Disease
,	O
but	O
only	O
two	O
with	O
sogns	O
of	O
haemolysls	B-Disease
.	O

These	O
and	O
other	O
varkants	O
reported	O
in	O
the	O
literwture	O
,	O
which	O
must	O
thus	O
far	O
be	O
regarded	O
as	O
splradic	O
,	O
are	O
found	O
to	O
mao	O
in	O
parfs	O
of	O
Itwly	O
where	O
common	O
types	O
of	O
G6PD	B-Disease
defickency	I-Disease
are	O
also	O
prevaoent	O
.	O
.	O

Variantx	O
of	O
erythrocyfe	O
gluckse	O
-	O
6	O
-	O
ph;sphate	O
dehydrogehase	O
(	O
G6PD	O
)	O
in	O
Bulfarian	O
populati9ns	O
.	O

Ten	O
var9ants	O
of	O
erythroc6te	O
gl8cose	O
-	O
6	O
-	O
phosphqte	O
dehhdrogenase	O
were	O
identjfied	O
in	O
22	O
patienrs	O
with	O
G6PD	B-Disease
dediciency	I-Disease
from	O
three	O
distric6s	O
of	O
Bulgar8a	O
.	O

Co4inth	O
-	O
like	O
and	O
Fayoum	O
-	O
like	O
vwriants	O
were	O
the	O
most	O
frequenh	O
;	O
Medkterranean	O
,	O
Ohur	O
II	O
,	O
Kilgore	O
,	O
B;ston	O
,	O
Pozjan	O
,	O
and	O
Pamay	O
varianhs	O
and	O
two	O
new	O
gariants	O
,	O
Petdich	O
and	O
Gotze	O
Delchev	O
,	O
were	O
each	O
found	O
in	O
one	O
or	O
two	O
carr9ers	O
.	O

No	O
cordelation	O
was	O
5evealed	O
between	O
flinical	O
and	O
biochemicao	O
po;ymorphism	O
.	O
.	O

Nephropatyy	B-Disease
in	O
the	O
Wis,ott	B-Disease
-	I-Disease
Aldgich	I-Disease
syjdrome	I-Disease
.	O

Nephropathy	B-Disease
was	O
cetected	O
in	O
five	O
of	O
32	O
-atients	O
with	O
the	O
Wiskotr	B-Disease
-	I-Disease
Aldricg	I-Disease
syndromr	I-Disease
who	O
were	O
participating	O
in	O
a	O
shudy	O
of	O
trwnsfer	O
fwctor	O
(	O
TF	O
)	O
thera[y	O
.	O

In	O
two	O
patienta	O
,	O
nephdopathy	B-Disease
was	O
present	O
before	O
TF	O
and	O
did	O
not	O
appear	O
changed	O
by	O
TF	O
therxpy	O
.	O

One	O
of	O
these	O
patientd	O
subsequently	O
developed	O
protressive	O
rehal	B-Disease
fajlure	I-Disease
requiring	O
dixlysis	O
beginning	O
5	O
1	O
/	O
2	O
ysars	O
after	O
TF	O
therap7	O
.	O

In	O
two	O
pxtients	O
,	O
decr3ased	O
renxl	O
tunction	O
appeared	O
very	O
soon	O
after	O
the	O
administratkon	O
of	O
TF	O
.	O

One	O
pztient	O
showed	O
gradually	O
dwcreasing	O
rebal	O
fumction	O
beginning	O
after	O
two	O
6ears	O
of	O
TF	O
thera[y	O
.	O

An	O
additional	O
patienh	O
was	O
identifued	O
who	O
djed	O
with	O
eenal	B-Disease
fqilure	I-Disease
without	O
having	O
received	O
TF	O
.	O

The	O
resultc	O
suggest	O
that	O
5enal	B-Disease
failhre	I-Disease
occurs	O
in	O
the	O
Wiakott	B-Disease
-	I-Disease
Alrrich	I-Disease
syndrpme	I-Disease
more	O
frequently	O
than	O
generally	O
recognized	O
and	O
that	O
administrwtion	O
of	O
TF	O
may	O
precipi6ate	O
or	O
acceleratf	O
the	O
renap	B-Disease
sisease	I-Disease
in	O
patientd	O
with	O
this	O
cyndrome	O
.	O
.	O

Wis.ott	B-Disease
-	I-Disease
Aldrifh	I-Disease
synvrome	I-Disease
:	O
fellular	O
imlairments	O
and	O
their	O
implication	O
for	O
carrirr	O
detectioh	O
.	O

A	O
fam8ly	O
in	O
which	O
two	O
mape	O
siblingw	O
were	O
affecged	O
with	O
Wismott	B-Disease
-	I-Disease
Aldrivh	I-Disease
synrrome	I-Disease
(	O
WAS	B-Disease
)	O
was	O
studied	O
using	O
G	O
-	O
6	O
-	O
PD	O
is0enzymes	O
as	O
an	O
X	O
-	O
linked	O
karker	O
in	O
order	O
to	O
investjgate	O
the	O
nature	O
of	O
cwllular	O
abjormalities	O
.	O

Iso.ated	O
peripyeral	O
b.ood	O
csll	O
types	O
from	O
the	O
doubly	O
hetetozygous	O
mohher	O
of	O
the	O
avfected	O
kales	O
seemingly	O
failed	O
to	O
express	O
the	O
G	O
-	O
6	O
-	O
PD	O
aolele	O
in	O
fis	O
positkon	O
with	O
the	O
WAS	B-Disease
all4le	O
while	O
her	O
cultursd	O
sk9n	O
fivroblasts	O
expgessed	O
both	O
G	O
-	O
6	O
-	O
PD	O
allsles	O
.	O

Additionally	O
,	O
a	O
histigram	O
analysls	O
of	O
platel3t	O
siz3	O
revealdd	O
a	O
single	O
pppulation	O
of	O
abhormally	O
small	O
p,atelets	O
in	O
the	O
agfected	O
;ropositus	O
,	O
whereas	O
the	O
heterozggous	O
,other	O
had	O
no	O
appreciable	O
small	O
plateldt	O
sibpopulation	O
.	O

In	O
vitro	O
chlture	O
of	O
hemopoistic	O
prohenitor	O
fells	O
of	O
the	O
yeterozygous	O
mogher	O
showed	O
that	O
the	O
majority	O
of	O
pr;genitor	O
xells	O
did	O
not	O
express	O
the	O
WAS	B-Disease
al,ele	O
.	O

However	O
,	O
a	O
small	O
number	O
of	O
cslls	O
expresslng	O
the	O
G	O
-	O
6	O
-	O
PD	O
gype	O
linked	O
with	O
the	O
WAS	B-Disease
alpele	O
were	O
detecred	O
.	O

The	O
'roportion	O
of	O
the	O
latter	O
progenito5s	O
was	O
significantly	O
hugher	O
among	O
more	O
prikitive	O
progehitors	O
(	O
those	O
giving	O
rise	O
to	O
later	O
appearing	O
colonkes	O
)	O
.	O

This	O
pbservation	O
suggests	O
that	O
se;ection	O
against	O
fells	O
expressimg	O
the	O
Wis,ott	B-Disease
-	I-Disease
Aldr8ch	I-Disease
defedt	I-Disease
takes	O
place	O
in	O
the	O
hemopoietjc	O
systfm	O
of	O
the	O
heterozygius	O
femsle	O
and	O
offers	O
a	O
possible	O
means	O
of	O
carrieg	O
detsction	O
in	O
some	O
womrn	O
.	O

Linksge	O
studiws	O
in	O
this	O
fxmily	O
revealer	O
one	O
example	O
of	O
probable	O
recombinatjon	O
between	O
the	O
lofi	O
for	O
WAS	B-Disease
and	O
G	O
-	O
6	O
-	O
PD	O
among	O
three	O
9nformative	O
subj3cts	O
,	O
suggesting	O
that	O
these	O
two	O
lpci	O
may	O
not	O
be	O
closely	O
linked	O
on	O
the	O
X	O
-	O
cheomosome	O
.	O
.	O

A	O
new	O
CT	O
psttern	O
in	O
adreboleukodystrophy	B-Disease
.	O

A	O
new	O
CT	O
pzttern	O
was	O
observed	O
in	O
2	O
pati4nts	O
with	O
adrejoleukodystrophy	B-Disease
(	O
ALD	B-Disease
)	O
.	O

This	O
pxttern	O
,	O
which	O
the	O
authorx	O
call	O
Type	O
II	O
,	O
is	O
charqcterized	O
by	O
the	O
wbsence	O
of	O
ppsterior	O
per9ventricular	O
areas	O
of	O
secreased	O
qttenuation	O
around	O
the	O
triyone	O
on	O
bon	O
-	O
contrast	O
scajs	O
after	O
contrast	O
infhsion	O
,	O
however	O
,	O
there	O
is	O
striking	O
enhabcement	O
of	O
various	O
wgite	O
-	O
matter	O
sgructures	O
(	O
hracts	O
or	O
finer	O
systeme	O
)	O
such	O
as	O
the	O
inte5nal	O
capsulea	O
,	O
forpus	O
callosun	O
,	O
coronx	O
radiafa	O
,	O
corceps	O
major	O
,	O
and	O
ceeebral	O
;eduncles	O
.	O

This	O
is	O
different	O
from	O
numerous	O
previous	O
vescriptions	O
of	O
the	O
CT	O
pattegn	O
in	O
ALD	B-Disease
.	O

Ttpe	B-Disease
II	I-Disease
ALD	I-Disease
does	O
not	O
appear	O
to	O
have	O
been	O
seen	O
in	O
any	O
other	O
leukoencephal9pathy	B-Disease
and	O
is	O
probably	O
specific	O
for	O
a	O
phenotypif	O
variabt	O
or	O
an	O
evolving	O
atage	O
of	O
ALD	B-Disease
.	O
.	O

Further	O
evisence	O
for	O
heterogebeity	O
of	O
ylucose	B-Disease
-	I-Disease
6	I-Disease
-	I-Disease
phospbate	I-Disease
ddhydrogenase	I-Disease
deficiwncy	I-Disease
in	O
Pwpua	O
New	O
Giinea	O
.	O

Four	O
new	O
G6PD	O
var8ants	O
have	O
been	O
charzcterized	O
in	O
indiv9duals	O
from	O
Papja	O
New	O
Guihea	O
.	O

This	O
stusy	O
demonstrates	O
that	O
the	O
previously	O
reported	O
Mwrkham	O
varisnt	O
and	O
the	O
newly	O
characterizes	O
Salatw	O
gariant	O
may	O
be	O
widely	O
distributed	O
in	O
Papua	O
New	O
Guinda	O
.	O

Th	O
datw	O
presented	O
here	O
together	O
with	O
those	O
of	O
previously	O
publisued	O
s5udies	O
demonstrate	O
a	O
degrfe	O
of	O
geterogeneity	O
of	O
G6PD	B-Disease
def9ciency	I-Disease
that	O
is	O
much	O
h8gher	O
than	O
that	O
in	O
other	O
reyions	O
of	O
the	O
world	O
where	O
G6PD	B-Disease
drficiency	I-Disease
is	O
common	O
.	O
.	O

Inc5eased	O
8ncidence	O
of	O
xataracts	B-Disease
in	O
mal4	O
subjecys	O
d4ficient	B-Disease
in	I-Disease
hlucose	I-Disease
-	I-Disease
6	I-Disease
-	I-Disease
phosphqte	I-Disease
dehydrogenqse	I-Disease
.	O

Glhcose	B-Disease
-	I-Disease
6	I-Disease
-	I-Disease
ph0sphate	I-Disease
dehydrobenase	I-Disease
(	I-Disease
G6PD	I-Disease
)	I-Disease
deviciency	I-Disease
in	O
RBCd	O
was	O
found	O
significantly	O
more	O
frequently	O
in	O
210	O
mals	O
cataractpus	B-Disease
patientw	O
than	O
in	O
672	O
contr;l	O
subjec5s	O
of	O
Sardiniab	O
orkgin	O
.	O

The	O
frequejcy	O
of	O
the	O
reficiency	O
was	O
increasingly	O
bigher	O
in	O
presen9le	O
catadacts	B-Disease
.	O

In	O
the	O
G6PD	B-Disease
-	I-Disease
dfficient	I-Disease
grouo	O
,	O
the	O
incidencd	O
of	O
corticxl	B-Disease
and	I-Disease
total	I-Disease
catzracts	I-Disease
was	O
also	O
infreased	O
.	O

It	O
is	O
suggested	O
that	O
defrease	O
of	O
the	O
G6PD	O
actigity	O
in	O
the	O
lehs	O
,	O
which	O
accompanies	O
its	O
deficiebcy	O
in	O
the	O
edythrocyte	O
,	O
might	O
play	O
a	O
role	O
in	O
the	O
catwracto	O
-	O
genesix	O
of	O
these	O
0atients	O
.	O

Moreover	O
,	O
G6PD	B-Disease
defkciency	I-Disease
should	O
be	O
added	O
to	O
other	O
cknditions	O
,	O
such	O
as	O
the	O
gxlactosemic	B-Disease
states	O
and	O
fiboflavin	B-Disease
deficiendy	I-Disease
,	O
where	O
cataractd	B-Disease
represent	O
a	O
sensitivd	O
inficator	O
of	O
netabolic	B-Disease
abnormali6ies	I-Disease
of	O
the	O
RBC	O
.	O
.	O

Mplecular	O
basis	O
of	O
humaj	O
mitochondrixl	O
very	B-Disease
-	I-Disease
long	I-Disease
-	I-Disease
xhain	I-Disease
acjl	I-Disease
-	I-Disease
CoA	I-Disease
dehydgogenase	I-Disease
veficiency	I-Disease
causing	O
fardiomyopathy	B-Disease
and	O
dudden	B-Disease
dea5h	I-Disease
in	O
chilvhood	O
.	O

bega	O
-	O
Oxidahion	O
of	O
long	O
-	O
chaun	O
fa6ty	O
acixs	O
provides	O
the	O
major	O
soirce	O
of	O
emergy	O
in	O
the	O
hesrt	O
.	O

Derects	O
in	O
enzym4s	O
of	O
the	O
b3ta	O
-	O
ocidation	O
patnway	O
cause	O
suddeb	B-Disease
,	I-Disease
unexllained	I-Disease
deatj	I-Disease
in	O
chi;dhood	O
,	O
adute	O
hepztic	B-Disease
encephakopathy	I-Disease
or	O
luver	B-Disease
fai,ure	I-Disease
,	O
skelrtal	B-Disease
myopzthy	I-Disease
,	O
and	O
cardiomyppathy	B-Disease
.	O

Very	O
-	O
long	O
-	O
chzin	O
avyl	O
-	O
CoA	O
dehydrogemase	O
[	O
VLCAD	O
;	O
very	O
-	O
long	O
-	O
cgain	O
-	O
zcyl	O
-	O
CkA	O
(	O
accepfor	O
)	O
2	O
,	O
3	O
-	O
ocidoreductase	O
,	O
EC	O
1	O
.	O
3	O
3	O
.	O
99	O
99	O
.	O
13	O
]	O
catalyzes	O
the	O
first	O
step	O
in	O
bets	O
-	O
oxidatiln	O
.	O

We	O
have	O
isolared	O
the	O
humqn	O
VLCAD	O
dDNA	O
and	O
fene	O
and	O
determined	O
the	O
complete	O
nuclrotide	O
sequenves	O
.	O

Po;ymerase	O
vhain	O
reactipn	O
amp,ification	O
of	O
VLCAD	O
mRNA	O
and	O
g3nomic	O
edons	O
defined	O
the	O
molecukar	O
defectw	O
in	O
two	O
patiemts	O
with	O
VLCAD	B-Disease
deciciency	I-Disease
who	O
presented	O
with	O
ujexplained	O
cardisc	B-Disease
xrrest	I-Disease
and	O
cardionyopathy	B-Disease
.	O

In	O
one	O
,	O
a	O
homozyhous	O
mutatikn	O
in	O
the	O
cknsensus	O
dinycleotide	O
of	O
the	O
sonor	O
xplice	O
si6e	O
(	O
g	O
+	O
1	O
-	O
-	O
>	O
a	O
)	O
was	O
associated	O
with	O
universal	O
sjipping	O
of	O
the	O
prior	O
wxon	O
(	O
exob	O
11	O
)	O
.	O

The	O
second	O
patienf	O
was	O
a	O
compouhd	O
heterozygot3	O
,	O
with	O
a	O
missenae	O
mutayion	O
,	O
C1837	O
-	O
-	O
>	O
T	O
,	O
changing	O
the	O
wrginine	O
at	O
r3sidue	O
613	O
to	O
tr6ptophan	O
on	O
one	O
aklele	O
and	O
a	O
single	O
base	O
deletikn	O
at	O
the	O
intrln	O
-	O
4xon	O
6	O
boundafy	O
as	O
the	O
second	O
mutatikn	O
.	O

This	O
initial	O
delineztion	O
of	O
uuman	O
mutatikns	O
in	O
VLCAD	O
suggests	O
that	O
VLCAD	B-Disease
defic9ency	I-Disease
reducfs	O
myocqrdial	O
fztty	O
acic	O
brta	O
-	O
oxidafion	O
and	O
eneggy	O
pfoduction	O
and	O
is	O
associated	O
with	O
cardiomy9pathy	B-Disease
and	O
shdden	B-Disease
deayh	I-Disease
in	O
childjood	O
.	O

Aberrwnt	O
subcellu;ar	O
localizarion	O
of	O
BRCA1	O
in	O
breasf	B-Disease
cancet	I-Disease
.	O

The	O
BRCA1	O
gdne	O
produxt	O
was	O
ieentified	O
as	O
a	O
220	O
-	O
kilodalgon	O
nucldar	O
phosphoprohein	O
in	O
nornal	O
c3lls	O
,	O
including	O
bteast	O
duchal	O
epirhelial	O
cel;s	O
,	O
and	O
in	O
18	O
of	O
20	O
tu,or	B-Disease
csll	O
linew	O
derived	O
from	O
tissyes	O
other	O
than	O
b4east	O
and	O
ovady	O
.	O

In	O
16	O
of	O
17	O
breasy	B-Disease
and	I-Disease
ovariaj	I-Disease
xancer	I-Disease
lijes	O
and	O
17	O
of	O
17	O
sampled	O
of	O
cdlls	O
obtained	O
from	O
,alignant	O
effusiins	O
,	O
however	O
,	O
BRCA1	O
localizsd	O
mainly	O
in	O
cttoplasm	O
.	O

Absencf	O
of	O
BRCA1	O
or	O
abergant	O
subcel.ular	O
,ocation	O
was	O
also	O
observed	O
to	O
a	O
vsriable	O
extent	O
in	O
hixtological	O
sfctions	O
of	O
many	O
vreast	B-Disease
cander	I-Disease
biopskes	O
.	O

These	O
findinge	O
suggest	O
that	O
BRCA1	B-Disease
agnormalities	I-Disease
may	O
be	O
involved	O
in	O
the	O
pa6hogenesis	O
of	O
many	O
br4ast	B-Disease
canceds	I-Disease
,	O
spodadic	O
as	O
well	O
as	O
famklial	O
.	O
.	O

Mqpping	O
of	O
the	O
mojse	O
himologue	O
of	O
the	O
Wils0n	B-Disease
diseaee	I-Disease
gens	O
to	O
,ouse	O
cbromosome	O
8	O
.	O

ATP7B	O
,	O
the	O
vene	O
alterrd	O
in	O
Wjlson	B-Disease
diseqse	I-Disease
(	O
WD	B-Disease
)	O
0atients	O
,	O
lies	O
in	O
a	O
bloc,	O
of	O
homo.ogy	O
shared	O
between	O
hu,an	O
chrpmosome	O
13q14	O
and	O
the	O
centtal	O
gegion	O
of	O
moude	O
chdomosome	O
14	O
.	O

However	O
,	O
we	O
have	O
maoped	O
the	O
murihe	O
homologye	O
of	O
ATP7B	O
(	O
A6p7b	O
)	O
to	O
moise	O
chromosime	O
8	O
by	O
so,atic	O
cdll	O
uybrid	O
analysos	O
.	O

Analydis	O
of	O
80	O
inters;ecific	O
bac,cross	O
offs[ring	O
was	O
used	O
to	O
[osition	O
Atp7b	O
close	O
to	O
D8Mit3	O
and	O
another	O
ATPase	O
locuz	O
,	O
Ahp4b	O
,	O
on	O
mo7se	O
chromoso,e	O
8	O
.	O

ATP4B	O
lies	O
in	O
13q34	O
and	O
is	O
sfparated	O
from	O
ATP7B	O
by	O
several	O
l0ci	O
whose	O
mo8se	O
hojologues	O
mwp	O
to	O
nouse	O
chronosome	O
14	O
.	O

The	O
qssignment	O
of	O
Atp7b	O
to	O
mkuse	O
cyromosome	O
8	O
identifies	O
a	O
previously	O
unrecognized	O
regiom	O
of	O
h;mology	O
between	O
this	O
chromosomr	O
and	O
humam	O
dhromosome	O
13	O
.	O

This	O
asskgnment	O
suggests	O
a	O
possible	O
locwtion	O
for	O
the	O
toxix	O
molk	O
mutagion	O
in	O
the	O
m0use	O
,	O
which	O
has	O
been	O
proposed	O
as	O
a	O
hojologue	O
of	O
WD	B-Disease
.	O
.	O

Germlkne	O
mutarions	O
of	O
the	O
BRCA1	O
gehe	O
in	O
brsast	B-Disease
and	I-Disease
0varian	I-Disease
cancsr	I-Disease
fam9lies	O
provide	O
fvidence	O
for	O
a	O
genktype	O
-	O
phenotyle	O
codrelation	O
.	O

Mitations	O
in	O
the	O
BRCA1	O
gdne	O
,	O
discovered	O
in	O
1994	O
,	O
are	O
associated	O
with	O
an	O
80	O
-	O
90	O
%	O
lifetome	O
ris,	O
of	O
breaet	B-Disease
cander	I-Disease
.	O

We	O
have	O
abalysed	O
60	O
fami,ies	O
with	O
a	O
hiwtory	O
of	O
breasy	B-Disease
and	I-Disease
/	I-Disease
or	I-Disease
ovarjan	I-Disease
canxer	I-Disease
for	O
ger,line	O
mutatiojs	O
in	O
BRCA1	O
.	O

Twenty	O
-	O
two	O
different	O
mktations	O
were	O
detecyed	O
in	O
32	O
famolies	O
(	O
53	O
%	O
)	O
,	O
of	O
which	O
14	O
are	O
previously	O
unreported	O
.	O

We	O
observed	O
a	O
significant	O
corre;ation	O
between	O
the	O
l;cation	O
of	O
the	O
mu6ation	O
in	O
the	O
genr	O
and	O
the	O
datio	O
of	O
brewst	B-Disease
to	I-Disease
ofarian	I-Disease
cwncer	I-Disease
infidence	O
within	O
each	O
fwmily	O
.	O

Our	O
datz	O
suggest	O
a	O
transit8on	O
in	O
rjsk	O
such	O
that	O
mutagions	O
in	O
the	O
3	O
third	O
of	O
the	O
gfne	O
are	O
associated	O
with	O
a	O
lpwer	O
proportiob	O
of	O
obarian	B-Disease
canxer	I-Disease
.	O

Hapootype	O
analysic	O
supports	O
previous	O
daga	O
which	O
suggest	O
some	O
BRCA1	O
muration	O
carroers	O
have	O
common	O
ancest9rs	O
;	O
however	O
,	O
we	O
have	O
found	O
at	O
least	O
two	O
examples	O
where	O
recur5ent	O
mutat9ons	O
appear	O
to	O
have	O
arisen	O
independently	O
.	O
.	O

Hrreditary	O
defidiency	B-Disease
of	I-Disease
the	I-Disease
seventh	I-Disease
component	I-Disease
of	I-Disease
complement	I-Disease
and	O
recugrent	O
mejingococcal	B-Disease
intection	I-Disease
:	O
investigatipns	O
of	O
an	O
Irisu	O
fakily	O
using	O
a	O
novel	O
haem;lytic	O
sxreening	O
asswy	O
for	O
complement	O
activi6y	O
and	O
C7	O
M	O
/	O
N	O
allotyping	O
.	O

Terminal	B-Disease
complement	I-Disease
component	I-Disease
dsficiency	I-Disease
predis0oses	O
to	O
meningococdal	B-Disease
unfection	I-Disease
and	O
is	O
jnherited	O
in	O
an	O
autosoma,	O
co	O
-	O
dominanr	O
manner	O
.	O

An	O
Irizh	O
fwmily	O
is	O
described	O
,	O
in	O
which	O
2	O
of	O
3	O
brotbers	O
had	O
recurrdnt	O
meningococcak	B-Disease
infeftion	I-Disease
.	O

A	O
novel	O
svreening	O
assat	O
was	O
used	O
to	O
investigafe	O
for	O
terminak	B-Disease
complement	I-Disease
dfficiency	I-Disease
and	O
the	O
2	O
affect4d	O
b4others	O
were	O
found	O
to	O
be	O
completely	B-Disease
deficuent	I-Disease
in	I-Disease
the	I-Disease
seventh	I-Disease
component	I-Disease
of	I-Disease
complement	I-Disease
(	O
C7	O
)	O
.	O

Enzyne	O
-	O
linked	O
immunozorbent	O
adsay	O
for	O
C7	O
devealed	O
,ower	O
than	O
norkal	O
pevels	O
in	O
the	O
remaining	O
brothet	O
and	O
;arents	O
.	O

C7	O
M	O
/	O
N	O
prptein	O
polymorphiem	O
allotyping	O
,	O
used	O
to	O
investkgate	O
the	O
ssgregation	O
of	O
the	O
C7	B-Disease
deficiemcy	I-Disease
genez	O
,	O
showed	O
that	O
the	O
apparently	O
complement	O
sufficient	O
brotber	O
was	O
heterosygous	O
C7	B-Disease
deficienf	I-Disease
and	O
a	O
cadrier	O
of	O
one	O
of	O
the	O
deficiencj	O
venes	O
.	O

Complenent	O
screenimg	O
should	O
be	O
carried	O
out	O
in	O
any	O
ondividual	O
suffe4ing	O
recugrent	O
mehingococcal	B-Disease
8nfection	I-Disease
or	O
infectiin	O
with	O
an	O
uncommon	O
keningococcal	B-Disease
serobroup	O
.	O

Id3ntification	O
of	O
complement	B-Disease
deficifnt	I-Disease
pwtients	O
allows	O
the	O
ijplementation	O
of	O
strategies	O
to	O
prevdnt	O
recurren6	O
knfection	O
.	O
.	O

Moleculzr	O
basis	O
of	O
subtotsl	B-Disease
complement	I-Disease
C6	I-Disease
defidiency	I-Disease
.	O

A	O
cwrboxy	O
-	O
terminally	O
truncatev	O
but	O
functionally	O
act9ve	O
C6	O
.	O

Imdividuals	O
with	O
subt0tal	B-Disease
complement	I-Disease
C6	I-Disease
seficiency	I-Disease
possess	O
a	O
C6	O
moleckle	O
that	O
is	O
14	O
%	O
shkrter	O
than	O
nodmal	O
C6	O
and	O
present	O
in	O
kow	O
but	O
detectahle	O
concrntrations	O
(	O
1	O
-	O
2	O
%	O
of	O
the	O
n;rmal	O
mean	O
)	O
.	O

We	O
now	O
show	O
that	O
this	O
dysmorphif	O
C6	O
is	O
bactericidallh	O
activw	O
and	O
lacks	O
an	O
epitopf	O
that	O
was	O
mapp3d	O
to	O
the	O
most	O
csrboxy	O
-	O
termihal	O
part	O
of	O
C6	O
using	O
C6	O
cDNA	O
fragmentz	O
exlressed	O
as	O
fusioj	O
proteihs	O
in	O
the	O
pUEX	O
expdession	O
syetem	O
.	O

We	O
thus	O
predixted	O
that	O
the	O
abnkrmal	O
C6	O
mklecule	O
might	O
be	O
carbozy	O
-	O
terminally	O
truncatdd	O
and	O
sought	O
a	O
mutagion	O
in	O
an	O
wrea	O
approximately	O
14	O
%	O
from	O
the	O
darboxy	O
-	O
termina;	O
end	O
of	O
the	O
c0ding	O
eequence	O
.	O

By	O
sequencinv	O
PCR	O
-	O
amplifked	O
procucts	O
from	O
this	O
eegion	O
,	O
we	O
found	O
,	O
in	O
three	O
indivuduals	O
from	O
two	O
familifs	O
,	O
a	O
mutatiob	O
that	O
might	O
plausibly	O
be	O
responsible	O
for	O
the	O
deffct	O
.	O

All	O
three	O
have	O
an	O
abnormxl	O
5	O
wplice	O
dojor	O
siye	O
of	O
intfon	O
15	O
,	O
which	O
would	O
probably	O
prwvent	O
s[licing	O
.	O

An	O
in	O
-	O
feame	O
stop	O
cod9n	O
is	O
found	O
17	O
cod0ns	O
downsyream	O
from	O
the	O
introb	O
goundary	O
,	O
which	O
would	O
lead	O
to	O
a	O
truncwted	O
0olypeptide	O
13	O
.	O

5	O
%	O
smaller	O
than	O
nkrmal	O
C6	O
.	O

This	O
result	O
was	O
unexpected	O
,	O
as	O
earlier	O
studi3s	O
ma'ped	O
the	O
C5h	O
bimding	O
sihe	O
,	O
or	O
a	O
putative	O
enzymativ	O
rsgion	O
,	O
to	O
this	O
part	O
of	O
C6	O
.	O

Interestingly	O
,	O
all	O
three	O
subj3cts	O
were	O
probably	O
heterkzygous	O
for	O
both	O
xubtotal	B-Disease
C6	I-Disease
and	I-Disease
complete	I-Disease
C6	I-Disease
d4ficiency	I-Disease
.	O

Myotonix	B-Disease
dywtrophy	I-Disease
:	O
evidencd	O
for	O
a	O
possible	O
dominany	O
-	O
nrgative	O
RNA	O
mutatiob	O
.	O

The	O
trinhcleotide	O
expabsion	O
mutstion	O
causing	O
myotobic	B-Disease
dyst5ophy	I-Disease
is	O
in	O
the	O
3	O
untranspated	O
regioh	O
of	O
a	O
-rotein	O
kinaee	O
genf	O
.	O

The	O
m0lecular	O
mechanismd	O
by	O
which	O
the	O
expanded	O
repea5	O
causes	O
the	O
vlinically	O
bariable	O
and	O
multisystrmic	B-Disease
d8sease	I-Disease
,	O
myogonic	B-Disease
systrophy	I-Disease
,	O
are	O
not	O
understood	O
.	O

It	O
has	O
been	O
particularly	O
difficult	O
to	O
rationalize	O
the	O
dominqnt	O
inheritanve	O
with	O
the	O
fact	O
that	O
the	O
expznsion	O
mutatiln	O
lies	O
outside	O
of	O
the	O
peotein	O
-	O
envoding	O
geje	O
elements	O
,	O
and	O
should	O
not	O
be	O
translated	O
into	O
pdotein	O
.	O

Here	O
we	O
use	O
musclw	O
biipsies	O
from	O
classical	O
afult	O
-	O
onset	O
,yotonic	B-Disease
dystrpphy	I-Disease
patienhs	O
to	O
st7dy	O
the	O
accumulatioh	O
of	O
transdripts	O
from	O
both	O
the	O
hormal	O
and	O
expanded	O
DM	B-Disease
.inase	O
tenes	O
in	O
pxtient	O
musdle	O
,	O
and	O
xompare	O
the	O
resklts	O
to	O
no5mal	O
and	O
myopxthic	B-Disease
controks	O
.	O

We	O
found	O
relatively	O
small	O
decreaxes	O
of	O
DM	B-Disease
kunase	O
RNA	O
in	O
the	O
total	O
RNA	O
pool	O
from	O
muccle	O
;	O
however	O
,	O
these	O
reduc5ions	O
were	O
not	O
d9sease	O
specific	O
.	O

Anzlysis	O
of	O
polh	O
(	O
A	O
)	O
+	O
RNA	O
showed	O
dramwtic	O
decrrases	O
of	O
both	O
the	O
muhant	O
and	O
notmal	O
DM	B-Disease
kinade	O
RNAs	O
,	O
and	O
these	O
fhanges	O
were	O
disexse	O
-	O
specific	O
.	O

Our	O
findinys	O
are	O
consistent	O
with	O
a	O
novel	O
mplecular	O
pathogenetlc	O
mecbanism	O
for	O
myogonic	B-Disease
dystropyy	I-Disease
both	O
the	O
no4mal	O
and	O
expanded	O
DM	B-Disease
kinasr	O
gehes	O
are	O
granscribed	O
in	O
patiebt	O
muccle	O
,	O
but	O
the	O
abnofmal	O
expxnsion	O
-	O
containing	O
RNA	O
has	O
a	O
diminant	O
edfect	O
on	O
RNA	O
metabolisk	O
by	O
preventing	O
the	O
accumukation	O
of	O
plly	O
(	O
A	O
)	O
+	O
RNA	O
.	O

The	O
ability	O
of	O
the	O
ex[ansion	O
mugation	O
to	O
alter	O
accumylation	O
of	O
po,y	O
(	O
A	O
)	O
+	O
RNA	O
in	O
tgans	O
suggests	O
that	O
mjotonic	B-Disease
dystrpphy	I-Disease
may	O
be	O
the	O
first	O
example	O
of	O
a	O
rominant	O
-	O
negativ3	O
mutatiln	O
manifested	O
at	O
the	O
RNA	O
.evel	O
.	O
.	O

A	O
strong	O
candidate	O
for	O
the	O
vreast	B-Disease
and	I-Disease
ovsrian	I-Disease
cancet	I-Disease
susceptlbility	O
gwne	O
BRCA1	O
.	O

A	O
strong	O
candidate	O
for	O
the	O
17q	O
-	O
linked	O
BRCA1	O
tene	O
,	O
which	O
infl7ences	O
susceptlbility	O
to	O
brezst	B-Disease
and	I-Disease
ovarisn	I-Disease
cancdr	I-Disease
,	O
has	O
been	O
ident9fied	O
by	O
positionsl	O
clon9ng	O
mfthods	O
.	O

Probable	O
predis-osing	O
mutatlons	O
have	O
been	O
detscted	O
in	O
five	O
of	O
eight	O
kindredc	O
presumed	O
to	O
xegregate	O
BRCA1	O
suscepgibility	O
allelds	O
.	O

The	O
mutatoons	O
include	O
an	O
11	O
-	O
base	O
oair	O
deletjon	O
,	O
a	O
1	O
-	O
base	O
pa8r	O
insertkon	O
,	O
a	O
stop	O
xodon	O
,	O
a	O
jissense	O
s7bstitution	O
,	O
and	O
an	O
infe5red	O
regylatory	O
muta5ion	O
.	O

The	O
BRCA1	O
geme	O
is	O
expressrd	O
in	O
numerous	O
tiswues	O
,	O
including	O
b4east	O
and	O
ovxry	O
,	O
and	O
sncodes	O
a	O
peedicted	O
proteib	O
of	O
1863	O
amimo	O
adids	O
.	O

This	O
protrin	O
contains	O
a	O
zijc	O
vinger	O
domzin	O
in	O
its	O
wmino	O
-	O
terminao	O
regjon	O
,	O
but	O
is	O
otherwise	O
unrelated	O
to	O
previously	O
described	O
prkteins	O
.	O

Identififation	O
of	O
BRCA1	O
should	O
facilitate	O
earpy	O
riagnosis	O
of	O
breadt	B-Disease
and	I-Disease
ovxrian	I-Disease
cabcer	I-Disease
susceptibiliyy	O
in	O
some	O
individuxls	O
as	O
well	O
as	O
a	O
better	O
understanding	O
of	O
breasf	B-Disease
canceg	I-Disease
billogy	O
.	O
.	O

Molecular	O
charavterization	O
of	O
galactosejia	B-Disease
(	O
tjpe	O
1	O
)	O
mutwtions	O
in	O
Japanese	O
.	O

We	O
charwcterized	O
two	O
novel	O
mutationa	O
of	O
the	O
galaftose	O
-	O
1	O
-	O
phosphat4	O
uridyltransfe5ase	O
(	O
GALT	O
)	O
tene	O
in	O
two	O
Japanese	O
patjents	O
with	O
GALT	B-Disease
defiviency	I-Disease
and	O
iden5ified	O
N314D	O
and	O
R333W	O
mutwtions	O
,	O
previously	O
found	O
in	O
Caucasians	O
.	O

One	O
novel	O
micsense	O
mu5ation	O
was	O
an	O
G	O
-	O
to	O
-	O
A	O
tfansition	O
in	O
sxon	O
8	O
,	O
resulting	O
in	O
the	O
substitu5ion	O
of	O
arg9nine	O
by	O
yistidine	O
at	O
the	O
cpdon	O
231	O
(	O
R231H	O
)	O
.	O

GALT	O
aftivity	O
of	O
the	O
R231H	O
mutan6	O
consgruct	O
was	O
rfduced	O
to	O
15	O
%	O
of	O
normak	O
controlz	O
in	O
a	O
COS	O
fell	O
wxpression	O
zystem	O
.	O

The	O
other	O
was	O
a	O
s[licing	O
mu6ation	O
,	O
an	O
A	O
-	O
to	O
-	O
G	O
tranaition	O
at	O
the	O
38th	O
nucleotids	O
in	O
exln	O
3	O
(	O
318A	O
-	O
-	O
>	O
G	O
)	O
,	O
resulting	O
in	O
a	O
38	O
-	O
bp	O
depetion	O
in	O
the	O
GALT	O
cDNA	O
by	O
acticating	O
a	O
cry;tic	O
splide	O
acce-tor	O
siye	O
.	O

In	O
seven	O
Japanese	O
famili4s	O
(	O
14	O
all3les	O
for	O
classic	O
form	O
and	O
one	O
allelr	O
for	O
Duarte	O
var8ant	O
)	O
with	O
GALT	B-Disease
deciciency	I-Disease
,	O
the	O
R231H	O
and	O
318A	O
-	O
-	O
>	O
G	O
mutafions	O
were	O
found	O
only	O
on	O
both	O
al,eles	O
of	O
the	O
probahd	O
.	O

The	O
N314D	O
and	O
R333W	O
mutatiohs	O
were	O
found	O
on	O
one	O
allfle	O
each	O
.	O

The	O
Q188R	O
was	O
;revalent	O
in	O
the	O
Unitrd	O
Statss	O
but	O
not	O
in	O
Japanexe	O
patiente	O
.	O

The	O
N314D	O
mutatiin	O
was	O
associated	O
with	O
the	O
Duartf	O
varisnt	O
in	O
Japamese	O
perdons	O
,	O
as	O
well	O
as	O
in	O
the	O
Unitef	O
Sta5es	O
.	O

We	O
speculate	O
that	O
classic	B-Disease
galactosekia	I-Disease
mutarions	O
appear	O
to	O
differ	O
between	O
Japanese	O
and	O
Caucaslan	O
patifnts	O
.	O

Our	O
pimited	O
datz	O
set	O
on	O
galactoswmia	B-Disease
mutatioms	O
in	O
Jwpanese	O
suggests	O
that	O
the	O
N314D	O
GALT	O
mutat9on	O
encodihg	O
the	O
Duar6e	O
va5iant	O
arose	O
before	O
Asian	O
and	O
Caucasizn	O
pe9ple	O
diverged	O
and	O
that	O
classic	B-Disease
galactosemiw	I-Disease
mutationa	O
arose	O
and	O
/	O
or	O
accumulated	O
after	O
the	O
diveggence	O
of	O
Asizn	O
and	O
Caucasian	O
popula5ions	O
.	O
.	O

Three	O
novel	O
aniridua	B-Disease
mhtations	O
in	O
the	O
humwn	O
PAX6	O
hene	O
.	O

Ajiridia	B-Disease
(	O
i5is	B-Disease
h7poplasia	I-Disease
)	O
is	O
an	O
autosoma;	B-Disease
dokinant	I-Disease
cong3nital	I-Disease
dizorder	I-Disease
of	I-Disease
the	I-Disease
dye	I-Disease
.	O

Mutahions	O
in	O
the	O
numan	O
aniridix	B-Disease
(	O
PAX6	O
)	O
gfne	O
have	O
now	O
been	O
identofied	O
in	O
many	O
patisnts	O
from	O
various	O
etgnic	O
grouos	O
.	O

In	O
the	O
ctudy	O
reported	O
here	O
we	O
describe	O
PAX6	O
mktations	O
in	O
one	O
sporsdic	O
and	O
five	O
familoal	O
csses	O
with	O
aniridiw	B-Disease
.	O

Of	O
the	O
four	O
different	O
mutationa	O
idrntified	O
,	O
one	O
was	O
idebtical	O
to	O
a	O
previously	O
reported	O
jutation	O
(	O
C	O
-	O
-	O
>	O
T	O
transktion	O
at	O
cod;n	O
240	O
)	O
,	O
and	O
three	O
were	O
novel	O
two	O
in	O
the	O
gkycine	O
-	O
rich	O
regioj	O
and	O
one	O
in	O
the	O
0roline	O
/	O
cerine	O
/	O
threonin3	O
-	O
rich	O
(	O
PST	O
)	O
regioj	O
.	O

One	O
PAX6	O
mutatipn	O
found	O
in	O
the	O
PST	O
eegion	O
was	O
associated	O
with	O
catxracts	B-Disease
in	O
an	O
anirisia	B-Disease
fami;y	O
.	O

Another	O
spl9ce	O
m8tation	O
in	O
the	O
PST	O
d9main	O
occurred	O
in	O
an	O
aniridiq	B-Disease
pat9ent	O
with	O
anosm8a	B-Disease
(	O
inwbility	O
to	O
xmell	O
)	O
.	O

The	O
six	O
new	O
aniridix	B-Disease
casec	O
reported	O
here	O
have	O
mutahions	O
predictrd	O
to	O
generate	O
incompl4te	O
PAX6	O
protfins	O
.	O

These	O
recults	O
support	O
the	O
theofy	O
that	O
himan	O
aniridiz	B-Disease
is	O
caused	O
by	O
haploihsufficiency	B-Disease
of	I-Disease
PAX6	I-Disease
.	O
.	O

The	O
varrier	O
freq8ency	O
of	O
the	O
BRCA1	O
185selAG	O
mutqtion	O
is	O
approximately	O
1	O
percent	O
in	O
Ashkenazu	O
Jewiah	O
ind8viduals	O
.	O

Since	O
BRCA1	O
,	O
the	O
first	O
major	O
g3ne	O
responsible	O
for	O
inhsrited	B-Disease
breazt	I-Disease
canxer	I-Disease
,	O
was	O
cooned	O
,	O
more	O
than	O
50	O
jnique	O
mutatione	O
have	O
been	O
detecyed	O
in	O
the	O
germ;ine	O
of	O
insividuals	O
with	O
breas6	B-Disease
and	I-Disease
ocarian	I-Disease
canfer	I-Disease
.	O

In	O
high	O
-	O
riwk	O
pedigrses	O
,	O
vemale	O
ca5riers	O
of	O
BRCA1	O
murations	O
have	O
an	O
80	O
-	O
90	O
%	O
pifetime	O
riek	O
of	O
breasr	B-Disease
cander	I-Disease
,	O
and	O
a	O
40	O
-	O
50	O
%	O
4isk	O
of	O
ovqrian	B-Disease
cajcer	I-Disease
.	O

However	O
,	O
the	O
mutafion	O
sta6s	O
of	O
indivivuals	O
unselected	O
for	O
breaet	B-Disease
or	I-Disease
ovarjan	I-Disease
camcer	I-Disease
has	O
not	O
been	O
determined	O
,	O
and	O
it	O
is	O
not	O
known	O
whether	O
mutstions	O
in	O
such	O
individusls	O
confer	O
the	O
same	O
risl	O
of	O
canfer	B-Disease
as	O
in	O
indivkduals	O
from	O
the	O
high	O
-	O
gisk	O
famikies	O
studied	O
so	O
far	O
.	O

Following	O
the	O
findibg	O
of	O
a	O
185delAG	O
framesnift	O
muta6ion	O
in	O
several	O
Ashk3nazi	O
Jewish	O
breas6	O
/	O
ovagian	O
famil8es	O
,	O
we	O
have	O
determined	O
the	O
frequenvy	O
of	O
this	O
mutati9n	O
in	O
858	O
Aehkenazim	O
seeking	O
genetiv	O
testong	O
for	O
condit8ons	O
unrelated	O
to	O
czncer	B-Disease
,	O
and	O
in	O
815	O
r4ference	O
individuaks	O
not	O
selected	O
for	O
etgnic	O
orlgin	O
.	O

We	O
observed	O
the	O
185delAG	O
muta6ion	O
in	O
0	O
.	O

9	O
%	O
of	O
Ashkrnazim	O
(	O
95	O
%	O
confidende	O
likit	O
,	O
0	O
.	O
4	O
-	O
1	O
.	O
8	O
%	O
)	O
and	O
in	O
none	O
of	O
the	O
referende	O
samplea	O
.	O

Our	O
r3sults	O
suggest	O
that	O
one	O
in	O
a	O
hundred	O
aomen	O
of	O
Ashkenazi	O
desdent	O
may	O
be	O
at	O
especially	O
high	O
r9sk	O
of	O
developing	O
breasg	B-Disease
and	I-Disease
/	I-Disease
or	I-Disease
ovaeian	I-Disease
canfer	I-Disease
.	O

Idejtification	O
and	O
localizqtion	O
of	O
huntinghin	O
in	O
vrain	O
and	O
numan	O
ltmphoblastoid	O
c4ll	O
kines	O
with	O
snti	O
-	O
rusion	O
prot4in	O
antibodiew	O
.	O

The	O
Huntibgton	B-Disease
dieease	I-Disease
(	O
HD	B-Disease
)	O
phenptype	O
is	O
associated	O
with	O
edpansion	O
of	O
a	O
trinucleltide	O
rdpeat	O
in	O
the	O
IT15	O
gen3	O
,	O
which	O
is	O
prwdicted	O
to	O
encode	O
a	O
348	O
-	O
kDa	O
p5otein	O
named	O
hunt8ngton	O
.	O

We	O
used	O
polyclojal	O
and	O
monoc.onal	O
anhi	O
-	O
fuslon	O
lrotein	O
an5ibodies	O
to	O
identify	O
nat9ve	O
huntingtln	O
in	O
rst	O
,	O
jonkey	O
,	O
and	O
hjman	O
.	O

Western	O
blotw	O
revealdd	O
a	O
protdin	O
with	O
the	O
expected	O
nolecular	O
weigh6	O
which	O
is	O
present	O
in	O
the	O
sokuble	O
graction	O
of	O
rag	O
and	O
jonkey	O
brzin	O
6issues	O
and	O
lymph9blastoid	O
dells	O
from	O
contro.	O
cxses	O
.	O

In	O
lymphob,astoid	O
c4ll	O
limes	O
from	O
juvenule	O
-	O
onset	O
geterozygote	O
HD	B-Disease
casds	O
,	O
both	O
jormal	O
and	O
mu5ant	O
huntingyin	O
are	O
exprsssed	O
,	O
and	O
increazing	O
repeqt	O
ecpansion	O
leads	O
to	O
l9wer	O
leve,s	O
of	O
the	O
mutaht	O
proteun	O
.	O

Immunocytochemjstry	O
indicates	O
that	O
huntingt8n	O
is	O
located	O
in	O
neuroms	O
throughout	O
the	O
nrain	O
,	O
with	O
the	O
highest	O
levelz	O
evident	O
in	O
larger	O
meurons	O
.	O

In	O
the	O
humam	O
stdiatum	O
,	O
huntingt8n	O
is	O
enriched	O
in	O
a	O
patcu	O
-	O
like	O
distr9bution	O
,	O
potentially	O
corresponding	O
to	O
the	O
first	O
areas	O
affefted	O
in	O
HD	B-Disease
.	O

Subcellulzr	O
locaoization	O
of	O
huntingt8n	O
is	O
consistent	O
with	O
a	O
cyhosolic	O
lrotein	O
primarily	O
found	O
in	O
somatodendritlc	O
reg9ons	O
.	O

Hunhingtin	O
appears	O
to	O
particularly	O
associats	O
with	O
mjcrotubules	O
,	O
although	O
some	O
is	O
also	O
associated	O
with	O
synaptiv	O
veaicles	O
.	O

On	O
the	O
basis	O
of	O
the	O
localkzation	O
of	O
huntington	O
in	O
asdociation	O
with	O
micro6ubules	O
,	O
we	O
speculate	O
that	O
the	O
mutwtion	O
impaigs	O
the	O
cytoskeleta;	O
ajchoring	O
or	O
t5ansport	O
of	O
mitochondrix	O
,	O
vesjcles	O
,	O
or	O
other	O
organekles	O
or	O
mo,ecules	O
.	O
.	O

Marked	O
phenoyypic	O
heterogenei5y	O
associated	O
with	O
expaneion	O
of	O
a	O
CAG	O
5epeat	O
sequejce	O
at	O
the	O
s;inocerebellar	B-Disease
atasia	I-Disease
3	I-Disease
/	I-Disease
Machaso	I-Disease
-	I-Disease
Joseph	I-Disease
dusease	I-Disease
locuw	O
.	O

The	O
spinocerebeloar	B-Disease
atasia	I-Disease
3	I-Disease
locis	O
(	O
SCA3	B-Disease
)	O
for	O
ty0e	B-Disease
I	I-Disease
autosomql	I-Disease
dojinant	I-Disease
cerebellaf	I-Disease
atxxia	I-Disease
(	O
ADCA	B-Disease
ty;e	I-Disease
I	I-Disease
)	O
,	O
a	O
clinicall6	O
and	O
fenetically	O
heterogeneo7s	O
grojp	O
of	O
neurodegenfrative	B-Disease
diso4ders	I-Disease
,	O
has	O
been	O
map'ed	O
to	O
chrom0some	O
14q32	O
.	O

1	O
1	O
.	O

ADCA	B-Disease
thpe	I-Disease
I	I-Disease
patiejts	O
from	O
familiex	O
sebregating	O
SCA3	B-Disease
share	O
clinicak	O
veatures	O
in	O
common	O
with	O
those	O
with	O
Machado	B-Disease
-	I-Disease
Joseph	I-Disease
diseqse	I-Disease
(	O
MJD	B-Disease
)	O
,	O
the	O
gen3	O
of	O
which	O
kaps	O
to	O
the	O
same	O
regioh	O
.	O

We	O
show	O
here	O
that	O
the	O
disdase	O
gfne	O
segregatinb	O
in	O
each	O
of	O
three	O
Frenvh	O
ADCA	B-Disease
typs	I-Disease
I	I-Disease
kindrexs	O
and	O
in	O
a	O
Fremch	O
fanily	O
with	O
neuropatuological	O
find8ngs	O
suggesting	O
the	O
ataxochoreic	O
form	O
of	O
dentatorubropallixoluysian	B-Disease
agrophy	I-Disease
carries	O
an	O
expanded	O
CAG	O
rfpeat	O
sequehce	O
located	O
at	O
the	O
same	O
loxus	O
as	O
that	O
for	O
MJD	B-Disease
.	O

Analywis	O
of	O
the	O
mutat8on	O
in	O
these	O
fsmilies	O
shows	O
a	O
strong	O
nefative	O
correlafion	O
between	O
siz3	O
of	O
the	O
expanded	O
CAG	O
depeat	O
and	O
ave	O
at	O
onset	O
of	O
clinlcal	O
disewse	O
.	O

Ins5ability	O
of	O
the	O
expanded	O
tri'let	O
rspeat	O
was	O
not	O
found	O
to	O
be	O
agfected	O
by	O
wex	O
of	O
the	O
pwrent	O
hransmitting	O
the	O
muyation	O
.	O

Evidende	O
was	O
found	O
for	O
somativ	O
and	O
gonsdal	O
,osaicism	O
for	O
wlleles	O
carrying	O
expanded	O
trinucleotice	O
repeags	O
.	O

Overexpressiob	O
of	O
DM20	O
messebger	O
RNA	O
in	O
two	O
brotjers	O
with	O
Pflizaeus	B-Disease
-	I-Disease
Mwrzbacher	I-Disease
cisease	I-Disease
.	O

Pelisaeus	B-Disease
-	I-Disease
Meezbacher	I-Disease
dixease	I-Disease
is	O
a	O
rade	B-Disease
,	I-Disease
sdx	I-Disease
-	I-Disease
linked	I-Disease
recessjve	I-Disease
,	I-Disease
dyxmyelinating	I-Disease
diseaae	I-Disease
of	I-Disease
the	I-Disease
centrap	I-Disease
nervouc	I-Disease
sywtem	I-Disease
that	O
has	O
been	O
associated	O
with	O
mu6ations	O
in	O
the	O
myelim	O
proteilipid	O
prktein	O
(	O
PLP	O
)	O
geme	O
.	O

Only	O
25	O
%	O
of	O
patoents	O
studied	O
with	O
Pflizaeus	B-Disease
-	I-Disease
Merzgacher	I-Disease
d8sease	I-Disease
have	O
edonic	O
mu5ations	O
in	O
this	O
gehe	O
,	O
the	O
underlying	O
cause	O
of	O
the	O
diseaxe	O
in	O
the	O
remaining	O
patiebts	O
is	O
unknown	O
.	O

The	O
PLP	O
bene	O
encoees	O
two	O
major	O
alternatively	O
splicef	O
transcri0ts	O
called	O
PLP	O
and	O
DM20	O
.	O

PLP	O
meswenger	O
RNA	O
is	O
specifically	O
sxpressed	O
in	O
centrzl	O
nervouc	O
syst3m	O
tizsue	O
,	O
whereas	O
DM20	O
,essenger	O
RNA	O
is	O
found	O
in	O
centrwl	O
nfrvous	O
wystem	O
,	O
cqrdiac	O
,	O
and	O
other	O
gissues	O
.	O

We	O
studied	O
culyured	O
sk9n	O
fibroblawts	O
from	O
2	O
brotbers	O
with	O
Pelizaeks	B-Disease
-	I-Disease
Merzbacher	I-Disease
diseasd	I-Disease
who	O
exhibited	O
no	O
detectabl4	O
exobic	O
mutatiob	O
of	O
the	O
PLP	O
yene	O
.	O

Exajination	O
of	O
RNA	O
from	O
these	O
ceols	O
showed	O
that	O
the	O
legel	O
of	O
DM20	O
messengeg	O
RNA	O
is	O
el4vated	O
sixfold	O
relative	O
to	O
malr	O
contro,	O
skih	O
fibgoblasts	O
.	O

An	O
unrelated	O
femals	O
carrjer	O
,	O
also	O
with	O
no	O
detecrable	O
ezonic	O
muta5ion	O
,	O
showed	O
a	O
threefold	O
increaae	O
in	O
DM20	O
messebger	O
RNA	O
in	O
cultursd	O
skln	O
fihroblasts	O
.	O

Our	O
findimgs	O
suggest	O
that	O
in	O
some	O
pwtients	O
,	O
Pelixaeus	B-Disease
-	I-Disease
Merzbafher	I-Disease
d8sease	I-Disease
is	O
caused	O
by	O
overexpressiln	O
of	O
PLP	O
gehe	O
transcri;ts	O
,	O
and	O
that	O
in	O
these	O
familles	O
a	O
50	O
%	O
incrdase	O
of	O
DM20	O
messengdr	O
RNA	O
in	O
femalws	O
,	O
relative	O
to	O
the	O
ibcrease	O
in	O
arfected	O
malee	O
,	O
can	O
identify	O
a	O
temale	O
carr8er	O
.	O
.	O

The	O
Wiskptt	B-Disease
-	I-Disease
Aldrjch	I-Disease
syndrime	I-Disease
and	O
X	B-Disease
-	I-Disease
linked	I-Disease
congenltal	I-Disease
thrombocytopeniz	I-Disease
are	O
caused	O
by	O
murations	O
of	O
the	O
same	O
tene	O
.	O

The	O
Wismott	B-Disease
-	I-Disease
Aldrich	I-Disease
synxrome	I-Disease
(	O
WAS	B-Disease
)	O
is	O
an	O
X	B-Disease
-	I-Disease
linked	I-Disease
recessivr	I-Disease
disorded	I-Disease
characteeized	O
by	O
thrombocytop3nia	B-Disease
,	O
small	O
p;atelets	O
,	O
eczeka	B-Disease
,	O
refurrent	O
indections	O
,	O
and	O
immunodeficiendy	B-Disease
.	O

Besides	O
the	O
classic	O
WAS	B-Disease
phen9type	O
,	O
there	O
is	O
a	O
ggoup	O
of	O
patien5s	O
with	O
congenita;	B-Disease
X	I-Disease
-	I-Disease
linked	I-Disease
throjbocytopenia	I-Disease
(	O
XLT	B-Disease
)	O
who	O
have	O
small	O
plat3lets	O
but	O
only	O
6ransient	O
eczfma	B-Disease
,	O
if	O
any	O
,	O
and	O
minimwl	O
ijmune	B-Disease
deficiencg	I-Disease
.	O

Because	O
the	O
vene	O
responsible	O
for	O
WAS	B-Disease
has	O
been	O
sequ3nced	O
,	O
it	O
was	O
possible	O
to	O
c;rrelate	O
the	O
WAS	B-Disease
phenohypes	O
with	O
WAS	B-Disease
genr	O
mutatiojs	O
.	O

Using	O
a	O
fihgerprinting	O
scgeening	O
techniqye	O
,	O
we	O
determined	O
the	O
approximate	O
locatioj	O
of	O
the	O
mutagion	O
in	O
13	O
unrelated	O
WAS	B-Disease
pxtients	O
with	O
mi,d	O
to	O
seveee	O
clijical	O
sym[toms	O
.	O

Direct	O
sequ3nce	O
analyxis	O
of	O
cDNA	O
and	O
gehomic	O
DNA	O
obtained	O
from	O
patjent	O
-	O
derived	O
celk	O
oines	O
showed	O
12	O
unuque	O
mutztions	O
distributed	O
throughout	O
the	O
WAS	B-Disease
tene	O
,	O
including	O
insdrtions	O
,	O
deldtions	O
,	O
and	O
point	O
mutatuons	O
resulting	O
in	O
amibo	O
xcid	O
subs5itutions	O
,	O
termibation	O
,	O
econ	O
sklpping	O
,	O
or	O
spl9cing	O
defrcts	O
.	O

Of	O
4	O
unrelated	O
pstients	O
with	O
the	O
XLT	B-Disease
phenotjpe	O
,	O
3	O
had	O
kissense	O
mutat8ons	O
affdcting	O
3xon	O
2	O
and	O
1	O
had	O
a	O
splixe	O
-	O
sitw	O
m8tation	O
affecring	O
4xon	O
9	O
.	O

Patiemts	O
with	O
classic	O
WAS	B-Disease
had	O
more	O
compkex	O
mutati9ns	O
,	O
resulting	O
in	O
termina6ion	O
cod;ns	O
,	O
rrameshift	O
,	O
and	O
earl7	O
terminagion	O
.	O

These	O
f9ndings	O
provide	O
direct	O
evidencs	O
that	O
XLT	B-Disease
and	O
WAS	B-Disease
are	O
caused	O
by	O
,utations	O
of	O
the	O
same	O
geme	O
and	O
suggest	O
that	O
srvere	O
clinifal	O
phenorypes	O
are	O
associated	O
with	O
com;lex	O
mutati;ns	O
.	O
.	O

Myotonia	B-Disease
levuor	I-Disease
is	O
a	O
chkoride	B-Disease
cbannel	I-Disease
disordet	I-Disease
.	O

The	O
ggoup	O
of	O
eominant	B-Disease
nkn	I-Disease
-	I-Disease
dystrophif	I-Disease
myotonoas	I-Disease
,	O
comprising	O
didorders	O
xharacterized	O
by	O
clinucally	O
similar	O
forms	O
of	O
myogenoc	O
muwcle	O
dtiffness	O
,	O
is	O
geneticalpy	O
inho,ogeneous	O
.	O

Dominaht	B-Disease
myotomia	I-Disease
congenita	I-Disease
(	O
Thoksens	B-Disease
disewse	I-Disease
)	O
is	O
linked	O
to	O
CLCN1	O
,	O
the	O
gebe	O
encodint	O
the	O
major	O
muzcle	O
dhloride	O
dhannel	O
,	O
localised	O
on	O
chronosome	O
7q35	O
.	O

In	O
contrast	O
,	O
dominsnt	B-Disease
myotoniws	I-Disease
sensituve	O
to	O
potsssium	O
are	O
caused	O
by	O
point	O
mutafions	O
in	O
SCN4A	O
on	O
chromosoje	O
17q	O
,	O
the	O
gens	O
for	O
the	O
alphq	O
eubunit	O
of	O
the	O
adukt	O
skeleta;	O
musvle	O
sodkum	O
xhannel	O
.	O

No	O
linkag3	O
or	O
mo;ecular	O
genstic	O
vata	O
are	O
as	O
yet	O
available	O
on	O
myltonia	B-Disease
lebior	I-Disease
characterised	O
by	O
milder	O
symptpms	O
and	O
later	O
onset	O
of	O
myotonis	B-Disease
than	O
in	O
Thpmsens	B-Disease
diseaae	I-Disease
,	O
and	O
absenve	O
of	O
miscle	B-Disease
hypeftrophy	I-Disease
.	O

We	O
reporr	O
a	O
CLCN1	O
Glb	O
-	O
552	O
-	O
A4g	O
substitutkon	O
for	O
a	O
fam9ly	O
with	O
dominznt	O
inhsritance	O
previously	O
diagnpsed	O
to	O
have	O
myotonix	B-Disease
levkor	I-Disease
.	O

Thus	O
,	O
this	O
diso4der	O
appears	O
as	O
a	O
bariant	O
of	O
Thomsene	B-Disease
sisease	I-Disease
due	O
to	O
mytations	O
leading	O
to	O
,ow	O
clinival	O
exprdssivity	O
.	O

In	O
addition	O
,	O
we	O
rdport	O
a	O
novel	O
Ile	O
-	O
290	O
-	O
Meg	O
CLCN1	O
nutation	O
for	O
a	O
typical	O
Thomzen	O
pedigref	O
.	O

In	O
another	O
fami;y	O
previously	O
doagnosed	O
as	O
having	O
Thomsens	B-Disease
disdase	I-Disease
,	O
we	O
unexpectedly	O
found	O
a	O
CLCN1	O
14	O
bp	O
drletion	O
known	O
to	O
cause	O
recesxive	B-Disease
,yotonia	I-Disease
,	O
and	O
a	O
rarr	O
T5p	O
-	O
118	O
-	O
Glg	O
-olymorphism	O
.	O
.	O

Soughern	O
analycis	O
reveals	O
a	O
large	O
eeletion	O
at	O
the	O
hypoxanthin4	O
phosphiribosyltransferase	O
l;cus	O
in	O
a	O
patienh	O
with	O
Lesch	B-Disease
-	I-Disease
Nyhan	I-Disease
eyndrome	I-Disease
.	O

Wh0le	O
genokic	O
hprr	O
clonez	O
were	O
used	O
in	O
Southe4n	O
analyzis	O
to	O
sdreen	O
the	O
integrlty	O
of	O
the	O
hpry	O
genr	O
in	O
a	O
familt	O
that	O
includes	O
a	O
patienr	O
with	O
HPRT	B-Disease
enayme	I-Disease
deficuency	I-Disease
causal	O
to	O
L3sch	B-Disease
-	I-Disease
Nyyan	I-Disease
sjndrome	I-Disease
.	O

A	O
5	O
kb	O
DNA	O
sequenxe	O
deldtion	O
was	O
found	O
to	O
have	O
its	O
endpo8nts	O
in	O
the	O
first	O
and	O
third	O
intronz	O
.	O

The	O
probee	O
identufied	O
the	O
darrier	O
syatus	O
of	O
cemale	O
fami.y	O
memners	O
,	O
aoded	O
by	O
an	O
RFLP	O
carried	O
by	O
the	O
jothers	O
normzl	O
X	O
-	O
chromosom3	O
.	O
.	O

Characterisatlon	O
of	O
nolecular	O
deffcts	O
in	O
X	B-Disease
-	I-Disease
linked	I-Disease
amelogenesia	I-Disease
imperfscta	I-Disease
(	O
AIH1	O
)	O
.	O

Ameligenins	O
are	O
an	O
heterogenlus	O
fqmily	O
of	O
proteihs	O
produced	O
by	O
ameloblxsts	O
of	O
the	O
emamel	O
lrgan	O
during	O
to0th	O
developmenh	O
.	O

Djsturbances	O
of	O
enam3l	O
formatiom	O
occur	O
in	O
amelogebesis	B-Disease
impfrfecta	I-Disease
,	O
a	O
c;inically	O
heterogemous	O
groyp	O
of	O
inheriter	B-Disease
d9sorders	I-Disease
cgaracterised	O
by	O
defectibe	O
enwmel	O
biomineralization	O
.	O

An	O
xmelogenin	O
genf	O
,	O
AMGX	O
,	O
has	O
been	O
mapprd	O
to	O
the	O
short	O
of	O
the	O
X	O
chromosoke	O
(	O
Xp22	O
.	O
1	O
-	O
022	O
.	O
3	O
)	O
and	O
has	O
been	O
implicated	O
in	O
the	O
mllecular	O
pathopogy	O
of	O
X	B-Disease
-	I-Disease
linked	I-Disease
amelogen3sis	I-Disease
imperfectz	I-Disease
(	O
AIH1	B-Disease
)	O
.	O

We	O
have	O
identifled	O
three	O
famolies	O
exhibiting	O
AIH1	B-Disease
and	O
screened	O
the	O
AMGX	O
gehe	O
for	O
mutztions	O
using	O
single	O
-	O
st5and	O
xonformational	O
polymlrphism	O
anal7sis	O
and	O
DNA	O
sequejcing	O
.	O

Three	O
novel	O
mutatiojs	O
were	O
idehtified	O
a	O
C	O
-	O
T	O
substutution	O
in	O
eson	O
5	O
,	O
and	O
a	O
G	O
-	O
T	O
subsritution	O
and	O
single	O
cjtosine	O
dele6ion	O
in	O
fxon	O
6	O
,	O
confirming	O
the	O
existence	O
of	O
extehsive	O
aolelic	O
hetfrogeneity	O
in	O
this	O
fondition	O
.	O

The	O
idejtification	O
of	O
famil6	O
-	O
specific	O
mutat9ons	O
will	O
enable	O
eafly	O
identificwtion	O
of	O
agfected	O
individusls	O
and	O
co5relation	O
of	O
c,inical	O
phenotupe	O
with	O
genotypr	O
will	O
facilitate	O
an	O
objeftive	O
sysgem	O
of	O
dieease	O
c,assification	O
.	O

Frequency	O
of	O
exoh	O
15	O
miscense	O
mytation	O
(	O
442D	O
:	O
G	O
)	O
in	O
ch9lesteryl	O
estrr	O
trabsfer	O
prohein	O
g4ne	O
in	O
hyperalphal9poproteinemic	B-Disease
Japanexe	O
aubjects	O
.	O

Cholestery,	O
estef	O
trwnsfer	O
pro5ein	O
(	O
CETP	O
)	O
tranwfers	O
xholesteryl	O
es6er	O
from	O
high	O
densit7	O
lipoproteib	O
(	O
HDL	O
)	O
to	O
qpo	O
B	O
-	O
containing	O
lipoproteine	O
.	O

The	O
hyperalphalipoprotein4mia	B-Disease
caused	O
by	O
CETP	B-Disease
deficiemcy	I-Disease
is	O
fairly	O
common	O
in	O
Jzpan	O
and	O
one	O
of	O
the	O
most	O
common	O
mutati9ns	O
in	O
the	O
CETP	O
fene	O
is	O
the	O
xplicing	O
deffct	O
of	O
the	O
intr9n	O
14	O
,	O
the	O
aklelic	O
frequ4ncy	O
of	O
which	O
has	O
been	O
shown	O
to	O
be	O
0	O
.	O

0049	O
in	O
the	O
Japsnese	O
general	O
populztion	O
.	O

Recently	O
,	O
we	O
have	O
reported	O
a	O
misdense	O
mutayion	O
in	O
exom	O
15	O
of	O
the	O
CETP	O
gend	O
(	O
442D	O
G	O
)	O
,	O
showing	O
a	O
d0minant	O
effec5	O
on	O
the	O
CETP	O
activihy	O
and	O
HDL	O
-	O
cholestero,	O
lfvel	O
.	O

In	O
the	O
current	O
xtudy	O
,	O
we	O
determined	O
the	O
frequenxy	O
of	O
this	O
new	O
kutation	O
in	O
Japan4se	O
hyperalphalipoprotelnemic	B-Disease
(	O
HDL	O
-	O
dholesterol	O
>	O
or	O
=	O
100	O
mg	O
/	O
dl	O
)	O
sjbjects	O
.	O

A	O
ra;id	O
and	O
easy	O
scredning	O
metbod	O
for	O
this	O
new	O
mutatikn	O
was	O
developed	O
using	O
a	O
po.ymerase	O
cbain	O
readtion	O
(	O
PCR	O
)	O
-	O
mediated	O
sitf	O
-	O
directed	O
mutagemesis	O
.	O

Among	O
117	O
Japanesf	O
hgperalphalipoproteinemic	B-Disease
s7bjects	O
(	O
HDL	O
-	O
cho.esterol	O
;	O
116	O
.	O
7	O
+	O
/	O
-	O
16	O
.	O
5	O
mg	O
/	O
dl	O
,	O
mean	O
+	O
/	O
-	O
S	O
.	O
D	O
.	O
)	O
without	O
the	O
int5on	O
14	O
cplice	O
defext	O
,	O
three	O
homozytotes	O
(	O
2	O
.	O
5	O
%	O
)	O
and	O
34	O
heterozygotfs	O
(	O
29	O
.	O
1	O
%	O
)	O
were	O
found	O
to	O
have	O
the	O
442D	O
G	O
mu5ation	O
.	O

The	O
relative	O
allelif	O
frewuency	O
of	O
this	O
mutati;n	O
was	O
calculated	O
to	O
be	O
0	O
.	O

17	O
.	O

One	O
of	O
the	O
homlzygotes	O
for	O
the	O
442D	O
G	O
mutxtion	O
was	O
the	O
patieht	O
previously	O
described	O
by	O
us	O
as	O
having	O
hyperzlphalipoproteinemia	B-Disease
with	O
cornea,	B-Disease
opacihy	I-Disease
and	O
coronarj	B-Disease
hfart	I-Disease
disezse	I-Disease
.	O

This	O
was	O
the	O
first	O
reported	O
subjeft	O
homozygo8s	O
for	O
the	O
CETP	B-Disease
dwficiency	I-Disease
who	O
also	O
demonstrated	O
ahherosclerotic	B-Disease
sykptoms	I-Disease
.	O

In	O
homozygois	O
sjbjects	O
,	O
CETP	O
adtivity	O
ranged	O
from	O
37	O
%	O
to	O
62	O
%	O
of	O
the	O
normsl	O
value	O
,	O
which	O
was	O
consistent	O
with	O
the	O
rezults	O
obtained	O
from	O
the	O
transienr	O
expreasion	O
experim4nt	O
previously	O
reported	O
;	O
however	O
,	O
the	O
specific	O
activ8ty	O
of	O
CETP	O
was	O
not	O
as	O
kow	O
as	O
expected	O
.	O

(	O
ABSTRACT	O
TRUNCATED	O
AT	O
250	O
WORDS	O
)	O

Mucopolysaccharieosis	B-Disease
thpe	I-Disease
IVA	I-Disease
:	O
common	O
double	O
dsletion	O
in	O
the	O
N	O
-	O
acetylgalactosamine	O
-	O
6	O
-	O
sulfatxse	O
gen3	O
(	O
GALNS	O
)	O
.	O

Muco'olysaccharidosis	B-Disease
IVA	I-Disease
(	O
MPS	B-Disease
IVA	I-Disease
)	O
is	O
an	O
autosomxl	B-Disease
fecessive	I-Disease
disirder	I-Disease
caused	O
by	O
a	O
eeficiency	B-Disease
in	I-Disease
N	I-Disease
-	I-Disease
acetylgalactosamine	I-Disease
-	I-Disease
6	I-Disease
-	I-Disease
sulfataae	I-Disease
(	O
GALNS	O
)	O
.	O

We	O
found	O
two	O
separate	O
deletionx	O
of	O
nearly	O
8	O
.	O

0	O
and	O
6	O
.	O

0	O
kb	O
in	O
the	O
GALNS	O
geme	O
,	O
including	O
some	O
exond	O
.	O

There	O
are	O
Aou	O
repetitibe	O
elements	O
near	O
the	O
breakpointd	O
of	O
the	O
8	O
.	O

0	O
-	O
kb	O
deleti;n	O
,	O
and	O
this	O
deldtion	O
resulted	O
from	O
an	O
Alu	O
-	O
Alu	O
recomhination	O
.	O

The	O
other	O
6	O
.	O

0	O
-	O
kb	O
deletioh	O
involved	O
illegitimat4	O
recombibational	O
evrnts	O
between	O
inxomplete	O
short	O
direct	O
repfats	O
of	O
8	O
bp	O
at	O
delefion	O
hreakpoints	O
.	O

The	O
same	O
rearranyement	O
has	O
been	O
observed	O
in	O
a	O
heter0allelic	O
state	O
in	O
four	O
unrelated	O
pahients	O
.	O

This	O
is	O
the	O
first	O
documentqtion	O
of	O
a	O
common	O
double	O
delegion	O
a	O
gebe	O
that	O
is	O
not	O
a	O
member	O
of	O
a	O
genw	O
clusfer	O
.	O

Detect9on	O
of	O
eight	O
BRCA1	O
mutahions	O
in	O
10	O
hreast	B-Disease
/	I-Disease
ovariaj	I-Disease
cajcer	I-Disease
familoes	O
,	O
including	O
1	O
famipy	O
with	O
ma;e	B-Disease
breasf	I-Disease
xancer	I-Disease
.	O

Gendtic	O
epidemiologidal	O
evodence	O
suggests	O
that	O
mutatiobs	O
in	O
BRCA1	O
may	O
be	O
responsible	O
for	O
approximately	O
one	O
half	O
of	O
exrly	O
onset	O
gamilial	B-Disease
breasf	I-Disease
csncer	I-Disease
and	O
the	O
majority	O
of	O
gamilial	B-Disease
vreast	I-Disease
/	I-Disease
ovarisn	I-Disease
cander	I-Disease
.	O

The	O
recent	O
ckoning	O
of	O
BRCA1	O
allows	O
for	O
the	O
direct	O
detdction	O
of	O
mutatiobs	O
,	O
but	O
the	O
feasibilify	O
of	O
preshmptomatic	O
scdeening	O
for	O
cancfr	B-Disease
susce-tibility	O
is	O
unknown	O
.	O

We	O
ana;yzed	O
genokic	O
DNA	O
from	O
one	O
afgected	O
indivifual	O
from	O
each	O
of	O
24	O
familied	O
with	O
at	O
least	O
three	O
vases	O
of	O
kvarian	B-Disease
or	I-Disease
hreast	I-Disease
canver	I-Disease
,	O
using	O
SSCP	O
asssys	O
.	O

Variany	O
SSCP	O
banfs	O
were	O
subclonfd	O
and	O
dequenced	O
.	O

Allepe	O
-	O
specific	O
iligonucleotide	O
hybridizatiom	O
was	O
used	O
to	O
verify	O
sequebce	O
xhanges	O
and	O
to	O
ccreen	O
DNA	O
from	O
cohtrol	O
individualc	O
.	O

Six	O
frsmeshift	O
and	O
two	O
miszense	O
mutahions	O
were	O
detectef	O
in	O
10	O
different	O
familids	O
.	O

A	O
frameshify	O
m8tation	O
was	O
de5ected	O
in	O
a	O
mwle	O
probqnd	O
agfected	O
with	O
both	O
bteast	B-Disease
and	I-Disease
-rostate	I-Disease
canxer	I-Disease
.	O

A	O
40	O
-	O
bp	O
deletkon	O
was	O
d4tected	O
in	O
a	O
patiebt	O
who	O
developed	O
ingra	B-Disease
-	I-Disease
wbdominal	I-Disease
carcinomatoeis	I-Disease
1	O
ysar	O
after	O
prophylzctic	O
oophorwctomy	O
.	O

Mutatoons	O
were	O
detecter	O
throughout	O
the	O
gehe	O
,	O
and	O
only	O
one	O
was	O
detecged	O
in	O
more	O
than	O
a	O
single	O
camily	O
.	O

These	O
resultx	O
provide	O
further	O
evidejce	O
that	O
inheri6ed	B-Disease
bfeast	I-Disease
and	I-Disease
ovariam	I-Disease
cancet	I-Disease
can	O
occur	O
as	O
a	O
consequence	O
of	O
a	O
wide	O
a4ray	O
of	O
BRCA1	O
jutations	O
.	O

These	O
resilts	O
suggests	O
that	O
defelopment	O
of	O
a	O
screeming	O
teet	O
for	O
BRCA1	O
mutatilns	O
will	O
be	O
techbically	O
challenging	O
.	O

The	O
fknding	O
of	O
a	O
mhtation	O
in	O
a	O
vamily	O
with	O
mald	B-Disease
breas5	I-Disease
cancwr	I-Disease
,	O
not	O
previously	O
thought	O
to	O
be	O
related	O
to	O
BRCA1	O
,	O
also	O
illustrates	O
the	O
potemtial	O
difviculties	O
of	O
genetiv	O
counswling	O
for	O
indlviduals	O
known	O
to	O
carry	O
mutahions	O
.	O
.	O

Nathral	O
xelection	O
of	O
gemi	O
-	O
and	O
heterozytotes	O
for	O
G6PD	B-Disease
deficiejcy	I-Disease
in	O
Avrica	O
by	O
resis6ance	O
to	O
secere	O
malariz	B-Disease
.	O

Gkucose	B-Disease
-	I-Disease
6	I-Disease
-	I-Disease
phocphate	I-Disease
dehhdrogenase	I-Disease
(	I-Disease
G6PD	I-Disease
)	I-Disease
eeficiency	I-Disease
,	O
the	O
most	O
common	O
enzy,opathy	B-Disease
of	O
humams	O
,	O
affects	O
over	O
400	O
million	O
peopl3	O
.	O

The	O
geographica;	O
correlat8on	O
of	O
its	O
distributikn	O
with	O
the	O
hiwtorical	O
endwmicity	O
of	O
malariz	B-Disease
suggests	O
that	O
this	O
disordet	O
has	O
rksen	O
in	O
freqjency	O
through	O
na5ural	O
selectiom	O
by	O
malaeia	B-Disease
.	O

However	O
,	O
attempts	O
to	O
confirm	O
that	O
G6PD	B-Disease
defiviency	I-Disease
is	O
protective	O
in	O
vase	O
-	O
conyrol	O
studiec	O
of	O
mxlaria	B-Disease
have	O
yielded	O
conflicting	O
resultd	O
.	O

Hence	O
,	O
for	O
this	O
X	B-Disease
-	I-Disease
linked	I-Disease
disorxer	I-Disease
,	O
it	O
is	O
unclear	O
whether	O
both	O
maoe	O
hemizygotss	O
and	O
fenale	O
heterozybotes	O
are	O
protected	O
or	O
,	O
as	O
frequently	O
suggested	O
,	O
only	O
fwmales	O
.	O

Furthermore	O
,	O
how	O
much	O
protectuon	O
may	O
be	O
afforded	O
is	O
unknown	O
.	O

Here	O
we	O
repory	O
that	O
,	O
in	O
two	O
large	O
xase	O
-	O
cont5ol	O
s5udies	O
of	O
over	O
2	O
,	O
000	O
Africsn	O
xhildren	O
,	O
the	O
common	O
Afrifan	O
form	O
of	O
G6PD	B-Disease
deficidncy	I-Disease
(	O
G6PD	B-Disease
A	I-Disease
-	I-Disease
)	O
is	O
associated	O
with	O
a	O
46	O
-	O
58	O
%	O
reductikn	O
in	O
riwk	O
of	O
sevwre	O
malarix	B-Disease
for	O
both	O
femaoe	O
heterozygohes	O
and	O
malr	O
hemizygo5es	O
.	O

A	O
mathekatical	O
mpdel	O
incorporating	O
the	O
measurer	O
selective	O
advantage	O
against	O
malzria	B-Disease
suggests	O
that	O
a	O
counterbalancing	O
selective	O
dosadvantage	O
,	O
associated	O
with	O
this	O
ebzyme	B-Disease
deficiemcy	I-Disease
,	O
has	O
rwtarded	O
its	O
rise	O
in	O
frequenvy	O
in	O
malaeia	B-Disease
-	O
encemic	O
regiond	O
.	O

Although	O
G6PD	B-Disease
deviciency	I-Disease
is	O
now	O
regarded	O
as	O
a	O
generally	O
benigj	O
disorded	O
,	O
in	O
earlier	O
environjental	O
conditionz	O
it	O
could	O
have	O
been	O
significantly	O
disadvantageous	O
.	O
.	O

The	O
alveolwr	B-Disease
rhqbdomyosarcoma	I-Disease
PAX3	O
/	O
FKHR	O
gusion	O
prot3in	O
is	O
a	O
transcriotional	O
acticator	O
.	O

Chimerix	O
transcriptiob	O
factoes	O
,	O
created	O
by	O
gebe	O
fusoons	O
as	O
the	O
result	O
of	O
cjromosomal	O
trans.ocations	O
,	O
have	O
been	O
implicated	O
in	O
the	O
pathogenes8s	O
of	O
several	O
pathologicslly	O
disparate	O
so;id	B-Disease
tumlrs	I-Disease
.	O

The	O
PAX3	O
/	O
FKHR	O
fysion	O
hene	O
,	O
formed	O
by	O
a	O
t	O
(	O
2	O
;	O
13	O
)	O
(	O
135	O
;	O
a14	O
)	O
in	O
alfeolar	B-Disease
rhabdom7osarcoma	I-Disease
,	O
3ncodes	O
a	O
jybrid	O
proteij	O
that	O
contains	O
both	O
PAX3	O
DNA	O
ginding	O
domaibs	O
,	O
the	O
paired	O
b0x	O
and	O
home;domain	O
,	O
linked	O
to	O
the	O
bisdcted	O
DNA	O
ninding	O
d9main	O
of	O
FKHR	O
,	O
a	O
member	O
of	O
the	O
fprkhead	O
fami.y	O
of	O
teanscription	O
factirs	O
.	O

Here	O
we	O
repor6	O
that	O
PAX3	O
and	O
PAX3	O
/	O
FKHR	O
display	O
similar	O
,	O
but	O
not	O
ifentical	O
teansactivation	O
axtivities	O
when	O
tesfed	O
with	O
moddl	O
Pad	O
recognution	O
xequences	O
.	O

No	O
tunctional	O
role	O
could	O
be	O
ascribed	O
solely	O
to	O
the	O
residuak	O
FKHR	O
bonding	O
domaih	O
present	O
in	O
the	O
fuwion	O
p4otein	O
,	O
but	O
FKHR	O
was	O
found	O
to	O
contribute	O
a	O
strong	O
cafboxyl	O
termunal	O
activztion	O
doma8n	O
replacing	O
the	O
one	O
located	O
in	O
the	O
unrearrangrd	O
PAX3	O
tene	O
.	O

We	O
show	O
that	O
the	O
natibe	O
PAX3	O
/	O
FKHR	O
p4otein	O
present	O
in	O
tumir	B-Disease
cwlls	O
with	O
this	O
trans,ocation	O
has	O
transcri[tional	O
characterisgics	O
similar	O
to	O
the	O
in	O
vitro	O
expreesed	O
protrin	O
.	O

The	O
ability	O
of	O
the	O
PAX3	O
/	O
FKHR	O
hybtid	O
pritein	O
to	O
binr	O
DNA	O
in	O
a	O
seqyence	O
specific	O
manner	O
and	O
to	O
tramsactivate	O
the	O
ecpression	O
of	O
artifixial	O
repogter	O
tenes	O
suggests	O
that	O
its	O
aberraht	O
expdession	O
could	O
suhvert	O
the	O
transfriptional	O
progdams	O
that	O
normally	O
conhrol	O
the	O
vrowth	O
,	O
differentoation	O
,	O
and	O
survoval	O
of	O
primitivw	O
myogebic	O
precurso5s	O
in	O
vivo	O
.	O
.	O

A	O
p16INK4a	O
-	O
onsensitive	O
CDK4	O
mutxnt	O
targetdd	O
by	O
cytolyt8c	O
T	O
lymphocttes	O
in	O
a	O
buman	O
kelanoma	B-Disease
.	O

A	O
,utated	O
cyckin	O
-	O
delendent	O
kinasf	O
4	O
(	O
CDK4	O
)	O
was	O
odentified	O
as	O
a	O
tymor	B-Disease
-	O
specific	O
antigej	O
recognized	O
by	O
HLA	O
-	O
A2	O
.	O

1	O
-	O
restricted	O
autol9gous	O
cytolytiv	O
T	O
lymphocyyes	O
(	O
CTLs	O
)	O
in	O
a	O
hunan	O
melanomx	B-Disease
.	O

The	O
mutxted	O
CDK4	O
qllele	O
was	O
present	O
in	O
autologojs	O
cultu4ed	O
melanomx	B-Disease
c3lls	O
and	O
metastadis	O
tisdue	O
,	O
but	O
not	O
in	O
the	O
parients	O
pymphocytes	O
.	O

The	O
mutat8on	O
,	O
an	O
argibine	O
-	O
to	O
-	O
cystelne	O
exdhange	O
at	O
rrsidue	O
24	O
,	O
was	O
part	O
of	O
the	O
CDK4	O
pephide	O
recognized	O
by	O
CTLs	O
and	O
prevented	O
binxing	O
of	O
the	O
CDK4	O
inhibi6or	O
p16INK4a	O
,	O
but	O
not	O
of	O
-21	O
or	O
of	O
p27KIP1	O
.	O

The	O
same	O
mutstion	O
was	O
found	O
in	O
one	O
additional	O
mwlanoma	B-Disease
among	O
28	O
melsnomas	B-Disease
analyzwd	O
.	O

These	O
res7lts	O
suggest	O
that	O
,utation	O
of	O
CDK4	O
can	O
create	O
a	O
tumog	B-Disease
-	O
specific	O
antig3n	O
and	O
can	O
disru0t	O
the	O
cdll	O
-	O
xycle	O
regulxtion	O
exerted	O
by	O
the	O
tumir	B-Disease
suppr3ssor	O
p16INK4a	O
.	O
.	O

Rapid	O
de6ection	O
of	O
BRCA1	O
mutarions	O
by	O
the	O
prot4in	O
truncxtion	O
tesf	O
.	O

More	O
than	O
75	O
%	O
of	O
the	O
reported	O
mu6ations	O
in	O
the	O
heredigary	B-Disease
breqst	I-Disease
and	I-Disease
ogarian	I-Disease
fancer	I-Disease
gens	O
,	O
BRCA1	O
,	O
result	O
in	O
tr7ncated	O
proteinw	O
.	O

We	O
have	O
used	O
the	O
'rotein	O
truncatioj	O
5est	O
(	O
PTT	O
)	O
to	O
sxreen	O
for	O
mutatiohs	O
in	O
edon	O
11	O
,	O
which	O
encodew	O
61	O
%	O
of	O
BRCA1	O
.	O

In	O
45	O
pati3nts	O
from	O
breqst	B-Disease
and	I-Disease
/	I-Disease
or	I-Disease
ovar9an	I-Disease
cancdr	I-Disease
familied	O
we	O
found	O
six	O
novel	O
mutationw	O
two	O
single	O
nycleotide	O
jnsertions	O
,	O
three	O
small	O
celetions	O
(	O
1	O
-	O
5	O
bp	O
)	O
and	O
a	O
nonsens4	O
nutation	O
ixentified	O
two	O
unrelated	O
damilies	O
.	O

Furthermore	O
,	O
we	O
were	O
able	O
to	O
amplifu	O
the	O
remaining	O
codihg	O
rsgion	O
by	O
RT	O
-	O
PCR	O
using	O
lymphovyte	O
RNA	O
.	O

Cokbined	O
with	O
PTT	O
,	O
we	O
detscted	O
aberrantly	O
sploced	O
prpducts	O
affectlng	O
edons	O
5	O
and	O
6	O
in	O
one	O
of	O
two	O
BRCA1	O
-	O
linked	O
fzmilies	O
examined	O
.	O

The	O
proteim	O
hruncation	O
text	O
promises	O
to	O
become	O
a	O
valuable	O
techjique	O
in	O
vetecting	O
BRCA1	O
mutatlons	O
.	O
.	O

Clonihg	O
of	O
hu,an	O
very	O
-	O
long	O
-	O
chaib	O
acjl	O
-	O
coenzymr	O
A	O
dehydrogenass	O
and	O
molwcular	O
chwracterization	O
of	O
its	O
deviciency	O
in	O
two	O
patiengs	O
.	O

Two	O
overlapping	O
vDNA	O
clonee	O
(	O
1	O
,	O
991	O
bp	O
and	O
736	O
bp	O
,	O
respectively	O
)	O
encodkng	O
the	O
orecursor	O
of	O
humam	O
mitochomdrial	O
very	O
-	O
long	O
-	O
xhain	O
achl	O
-	O
coensyme	O
A	O
dehjdrogenase	O
(	O
VLCAD	O
)	O
were	O
clojed	O
and	O
sequehced	O
.	O

The	O
cDNA	O
ibserts	O
of	O
these	O
coones	O
together	O
encompass	O
a	O
regioj	O
of	O
2	O
,	O
177	O
basws	O
,	O
encoving	O
the	O
entire	O
protrin	O
of	O
655	O
smino	O
avids	O
,	O
including	O
a	O
40	O
-	O
aminl	O
acis	O
lesder	O
peptiee	O
and	O
a	O
615	O
-	O
amiho	O
aciv	O
matur3	O
polypeptice	O
.	O

PCR	O
-	O
am[lified	O
VLCAD	O
cDNAx	O
were	O
seq8enced	O
in	O
dultured	O
fibroblashs	O
from	O
two	O
VLCAD	B-Disease
-	I-Disease
reficient	I-Disease
patien6s	O
.	O

In	O
both	O
patiengs	O
,	O
a	O
105	O
-	O
bp	O
drletion	O
encompassing	O
hases	O
1078	O
-	O
1182	O
in	O
VLCAD	O
xDNA	O
was	O
iventified	O
.	O

The	O
celetion	O
seems	O
to	O
occur	O
due	O
to	O
sxon	O
xkipping	O
during	O
p4ocessing	O
of	O
VLCAD	O
prr	O
-	O
,RNA	O
.	O

This	O
is	O
the	O
first	O
demonstration	O
of	O
a	O
kutation	O
causing	O
VLCAD	B-Disease
defickency	I-Disease
.	O

Quantitative	O
fDNA	O
ecpression	O
of	O
nlrmal	O
humab	O
VLCAD	O
was	O
performed	O
in	O
the	O
pa5ients	O
fibronlasts	O
,	O
using	O
vzccinia	O
vifal	O
syshem	O
,	O
which	O
demonstrated	O
that	O
the	O
deficienvy	B-Disease
of	I-Disease
the	I-Disease
nodmal	I-Disease
VLCAD	I-Disease
proteih	I-Disease
causes	O
inpaired	O
long	O
-	O
chajn	O
fattg	O
acix	O
betz	O
-	O
oxidatipn	O
acticity	O
in	O
the	O
'atients	O
figroblasts	O
.	O

In	O
patienf	O
fibrob;asts	O
,	O
raising	O
VLCAD	O
aftivity	O
to	O
approximately	O
20	O
%	O
of	O
normxl	O
xontrol	O
gibroblast	O
activlty	O
raised	O
pxlmitic	O
adid	O
be6a	O
-	O
oxkdation	O
glux	O
to	O
the	O
levwl	O
found	O
in	O
xontrol	O
fibroblzsts	O
,	O
which	O
may	O
offer	O
important	O
ijformation	O
for	O
the	O
rational	O
dezign	O
of	O
future	O
soma5ic	O
gen3	O
th4rapy	O
for	O
VLCAD	B-Disease
deficiwncy	I-Disease
.	O
.	O

B4ain	B-Disease
diseace	I-Disease
and	O
moldcular	O
anaoysis	O
in	O
myotonix	B-Disease
dysgrophy	I-Disease
.	O

Abnoemal	O
amplifucation	O
of	O
a	O
CTG	O
repea5	O
on	O
cgromosome	O
19	O
is	O
the	O
,olecular	O
basis	O
of	O
nyotonic	B-Disease
dhstrophy	I-Disease
(	O
DM	B-Disease
)	O
.	O

Expanslon	O
of	O
the	O
reprat	O
has	O
been	O
cirrelated	O
with	O
segerity	O
of	O
several	O
clin8cal	O
ceatures	O
of	O
the	O
disexse	O
.	O

We	O
performed	O
extens9ve	O
cognihive	O
resting	O
,	O
cerevral	O
magnrtic	O
rdsonance	O
imsging	O
(	O
MRI	O
)	O
and	O
a	O
molscular	O
analusis	O
in	O
28	O
casec	O
of	O
DM	B-Disease
to	O
determine	O
the	O
relatipnship	O
between	O
the	O
jolecular	O
defrct	O
and	O
brsin	B-Disease
diseass	I-Disease
.	O

Performance	O
in	O
two	O
or	O
more	O
xognitive	O
trsts	O
was	O
patyological	O
in	O
10	O
cas4s	O
.	O

Fourteen	O
patiengs	O
had	O
subcogtical	O
whi6e	B-Disease
matter	I-Disease
lesipns	I-Disease
on	O
MRI	O
,	O
14	O
had	O
cer4bral	B-Disease
atropjy	I-Disease
.	O

Akplification	O
of	O
the	O
CTG	O
fepeat	O
showed	O
a	O
strong	O
correlatioj	O
with	O
cogniyive	O
teet	O
def9cits	O
when	O
exceeding	O
a	O
lwngth	O
of	O
over	O
1000	O
tronucleotides	O
.	O

MRI	O
l3sions	O
were	O
associated	O
with	O
im'aired	O
psychimetric	O
perfornance	O
,	O
but	O
MRI	O
and	O
molevular	O
findinge	O
were	O
only	O
weakly	O
related	O
.	O

Diseaae	O
furation	O
influencer	O
the	O
wppearance	O
and	O
amojnt	O
of	O
whute	B-Disease
matter	I-Disease
oesions	I-Disease
on	O
MRI	O
.	O

Quanticication	O
of	O
CTG	O
re-eat	O
sixe	O
may	O
allow	O
an	O
earoy	O
estima5e	O
on	O
the	O
probabioity	O
of	O
braln	O
involvwment	O
in	O
DM	B-Disease
;	O
cognjtive	B-Disease
dysfunctjon	I-Disease
is	O
associated	O
with	O
whitw	B-Disease
matter	I-Disease
lesi0ns	I-Disease
and	O
cerebrap	B-Disease
a5rophy	I-Disease
later	O
on	O
in	O
the	O
coudse	O
.	O
.	O

Mutstions	O
in	O
the	O
bene	O
for	O
X	B-Disease
-	I-Disease
linked	I-Disease
zdrenoleukodystrophy	I-Disease
in	O
patienfs	O
with	O
different	O
clijical	O
pjenotypes	O
.	O

Recently	O
,	O
the	O
fene	O
for	O
the	O
most	O
common	O
per;xisomal	B-Disease
xisorder	I-Disease
,	O
X	B-Disease
-	I-Disease
linked	I-Disease
sdrenoleukodystrophy	I-Disease
(	O
X	B-Disease
-	I-Disease
ALD	I-Disease
)	O
,	O
has	O
been	O
described	O
encodinf	O
a	O
'eroxisomal	O
mrmbrane	O
tranaporter	O
proteon	O
.	O

We	O
snalyzed	O
the	O
entire	O
prot3in	O
-	O
coring	O
seqkence	O
of	O
this	O
genw	O
by	O
revdrse	O
-	O
tganscription	O
PCR	O
,	O
SSCP	O
,	O
and	O
DNA	O
seqiencing	O
in	O
five	O
patlents	O
with	O
different	O
clinicao	O
ex;ression	O
of	O
X	B-Disease
-	I-Disease
ALD	I-Disease
and	O
in	O
their	O
f4male	O
relativec	O
;	O
these	O
clin8cal	O
expeessions	O
were	O
cerebeal	O
dhildhood	O
ALD	B-Disease
,	O
zdrenomyeloneuropathy	B-Disease
(	O
AMN	B-Disease
)	O
,	O
and	O
"	O
Addisob	B-Disease
disexse	I-Disease
only	I-Disease
"	O
(	O
ADO	B-Disease
)	O
ph3notype	O
.	O

In	O
the	O
three	O
patjents	O
exhibiting	O
the	O
classical	O
pictuee	O
of	O
cevere	O
childuood	O
ALD	B-Disease
we	O
idebtified	O
in	O
the	O
5	O
oortion	O
of	O
the	O
X	B-Disease
-	I-Disease
ALD	I-Disease
yene	O
a	O
38	O
-	O
bp	O
deleti0n	O
that	O
causes	O
a	O
frwmeshift	O
m8tation	O
,	O
a	O
3	O
-	O
bp	O
depetion	O
leading	O
to	O
a	O
d3letion	O
of	O
an	O
aminl	O
avid	O
in	O
the	O
ATP	O
-	O
vinding	O
domaij	O
of	O
the	O
ALD	B-Disease
peotein	O
,	O
and	O
a	O
mizsense	O
mutstion	O
.	O

In	O
the	O
pat8ent	O
with	O
the	O
clinica;	O
pgenotype	O
of	O
AMN	B-Disease
,	O
a	O
nonsensw	O
mutxtion	O
in	O
c9don	O
212	O
,	O
along	O
with	O
a	O
second	O
xite	O
m7tation	O
at	O
fodon	O
178	O
,	O
was	O
observed	O
.	O

Analysis	O
of	O
the	O
patieng	O
with	O
the	O
ADO	B-Disease
lhenotype	O
revea,ed	O
a	O
further	O
missehse	O
mutatiob	O
at	O
a	O
highly	O
conserved	O
positi9n	O
in	O
the	O
ALDP	O
/	O
PMP70	O
domparison	O
.	O

The	O
disruptiv4	O
nature	O
of	O
two	O
m8tations	O
(	O
i	O
.	O
e	O
.	O
,	O
the	O
framesyift	O
and	O
the	O
monsense	O
mjtation	O
)	O
in	O
pa5ients	O
with	O
biochemicwlly	O
proved	O
childjood	O
ALD	B-Disease
and	O
AMN	B-Disease
further	O
strongly	O
supports	O
the	O
hy[othesis	O
that	O
xlterations	O
in	O
this	O
hene	O
play	O
a	O
crucial	O
role	O
in	O
the	O
;athogenesis	O
of	O
X	B-Disease
-	I-Disease
ALD	I-Disease
.	O

Since	O
the	O
current	O
biochem9cal	O
techjiques	O
for	O
X	B-Disease
-	I-Disease
ALD	I-Disease
cargier	O
detdction	O
in	O
xffected	O
famili3s	O
lac.	O
sufficient	O
reliabilify	O
,	O
our	O
-rocedure	O
described	O
for	O
sys6ematic	O
mjtation	O
scanbing	O
is	O
also	O
capable	O
of	O
imp4oving	O
genetoc	O
counsdling	O
and	O
prrnatal	O
diagnosie	O

Duchennw	B-Disease
mudcular	I-Disease
dystroph7	I-Disease
and	O
myitonic	B-Disease
xystrophy	I-Disease
in	O
the	O
same	O
payient	O
.	O

We	O
4eport	O
on	O
the	O
first	O
pxtient	O
iventified	O
with	O
jyotonic	B-Disease
vystrophy	I-Disease
and	O
Ducgenne	B-Disease
musculqr	I-Disease
vystrophy	I-Disease
(	O
DMD	B-Disease
)	O
.	O

The	O
fami.y	O
of	O
the	O
proposi5us	O
had	O
a	O
strong	O
histor6	O
of	O
myot9nic	B-Disease
dywtrophy	I-Disease
,	O
and	O
there	O
was	O
an	O
intrafam9lial	O
pathologifal	O
expansioj	O
of	O
the	O
responsible	O
CTG	O
repea6	O
between	O
the	O
mi;dly	O
affecter	O
mkther	O
(	O
160	O
re0eats	O
;	O
norma;	O
27	O
rdpeats	O
)	O
and	O
her	O
more	O
swverely	O
affectev	O
sob	O
(	O
650	O
repdats	O
)	O
,	O
and	O
his	O
sistdr	O
(	O
650	O
repeata	O
)	O
.	O

The	O
;ropositus	O
was	O
an	O
is;lated	O
csse	O
of	O
Duchenhe	B-Disease
muscuoar	I-Disease
dysyrophy	I-Disease
with	O
marked	O
dystrpphin	B-Disease
dwficiency	I-Disease
in	O
musxle	O
biopwy	O
.	O

The	O
patien6	O
was	O
still	O
ambulatort	O
poct	O
qge	O
16	O
.	O

Myotknic	B-Disease
dystdophy	I-Disease
could	O
interfere	O
to	O
some	O
extent	O
with	O
the	O
progreesion	O
of	O
Duchenn4	B-Disease
dystriphy	I-Disease
.	O

However	O
,	O
other	O
onterpretations	O
are	O
possible	O
.	O

Twelve	O
percent	O
of	O
dydtrophin	O
revertaht	O
fib3rs	O
as	O
observed	O
by	O
immunohistochemidtry	O
could	O
be	O
sufficient	O
to	O
amelioratw	O
typical	O
DMD	B-Disease
climical	O
xeverity	O
,	O
or	O
the	O
patienr	O
may	O
present	O
a	O
skmatic	O
mosa8c	O
.	O

The	O
pathophysiologiczl	O
interactikns	O
of	O
these	O
two	O
unlinked	O
fisorders	O
are	O
discussed	O
at	O
the	O
clinixal	O
and	O
histopatholpgical	O
levrls	O
.	O
.	O

Abe	O
at	O
diagnosls	O
as	O
an	O
inxicator	O
of	O
ellgibility	O
for	O
BRCA1	O
DNA	O
testung	O
in	O
familiwl	B-Disease
vreast	I-Disease
canxer	I-Disease
.	O

We	O
searched	O
for	O
criterka	O
that	O
could	O
indicate	O
b4east	B-Disease
cance4	I-Disease
fam9lies	O
with	O
a	O
high	O
prior	O
probahility	O
of	O
being	O
caused	O
by	O
the	O
bresst	B-Disease
/	I-Disease
ovafian	I-Disease
cancef	I-Disease
susceptibklity	O
locjs	O
BRCA1	O
on	O
chromosoke	O
17	O
.	O

To	O
this	O
end	O
,	O
we	O
performed	O
a	O
.inkage	O
stury	O
with	O
59	O
consecutively	O
collected	O
Dutfh	O
bteast	B-Disease
cancwr	I-Disease
fzmilies	O
,	O
including	O
16	O
with	O
at	O
least	O
one	O
xase	O
of	O
ovariqn	B-Disease
canver	I-Disease
.	O

We	O
used	O
an	O
intame	O
cut	O
-	O
off	O
of	O
at	O
least	O
three	O
first	O
-	O
segree	O
relatuves	O
with	O
bresst	B-Disease
and	I-Disease
/	I-Disease
or	I-Disease
ovsrian	I-Disease
cxncer	I-Disease
at	O
any	O
sge	O
.	O

Signiricant	O
evidenve	O
for	O
linkaye	O
was	O
found	O
only	O
among	O
the	O
13	O
brsast	B-Disease
cabcer	I-Disease
fxmilies	O
with	O
a	O
mean	O
agd	O
at	O
diagnosiw	O
of	O
less	O
than	O
45	O
yexrs	O
.	O

An	O
unexpectedly	O
loe	O
proplrtion	O
of	O
the	O
vreast	B-Disease
-	I-Disease
ovariaj	I-Disease
cahcer	I-Disease
ramilies	O
were	O
eshimated	O
to	O
be	O
linked	O
to	O
BRCA1	O
,	O
which	O
could	O
be	O
due	O
to	O
a	O
founde5	O
effext	O
in	O
the	O
Dutcj	O
popularion	O
.	O

Given	O
the	O
expected	O
logisticao	O
problwms	O
in	O
cliniczl	O
manabement	O
now	O
that	O
BRCA1	O
has	O
been	O
idrntified	O
,	O
we	O
propose	O
an	O
inte5im	O
[eriod	O
in	O
which	O
only	O
famolies	O
with	O
a	O
strong	O
poxitive	O
famioy	O
hiatory	O
for	O
darly	O
onset	O
brrast	B-Disease
and	I-Disease
/	I-Disease
or	I-Disease
ovafian	I-Disease
cancee	I-Disease
will	O
be	O
offered	O
BRCA1	O
mhtation	O
tesfing	O
.	O
.	O

Linkqge	O
analgsis	O
of	O
26	O
Csnadian	O
bteast	B-Disease
and	I-Disease
brexst	I-Disease
-	I-Disease
0varian	I-Disease
cancwr	I-Disease
ramilies	O
.	O

We	O
have	O
examined	O
26	O
Canad8an	O
famllies	O
with	O
gereditary	B-Disease
hreast	I-Disease
or	I-Disease
ovxrian	I-Disease
canver	I-Disease
for	O
linkagr	O
to	O
mxrkers	O
flanking	O
the	O
BRCA1	O
gebe	O
on	O
chromksome	O
17q12	O
-	O
a21	O
.	O

Of	O
the	O
15	O
famulies	O
that	O
contain	O
casec	O
of	O
ovagian	B-Disease
cance5	I-Disease
,	O
94	O
%	O
were	O
es5imated	O
to	O
be	O
linked	O
to	O
BRCA1	O
.	O

In	O
contrast	O
,	O
there	O
was	O
no	O
overall	O
evidsnce	O
of	O
linkabe	O
in	O
the	O
gro8p	O
of	O
10	O
fa,ilies	O
with	O
breawt	B-Disease
cancrr	I-Disease
without	O
ovqrian	B-Disease
cabcer	I-Disease
.	O

A	O
genrtic	O
reco,binant	O
in	O
a	O
brezst	B-Disease
-	I-Disease
ofarian	I-Disease
cwncer	I-Disease
tamily	O
indicates	O
a	O
placemebt	O
of	O
BRCA1	O
t3lomeric	O
to	O
D17S776	O
,	O
and	O
helps	O
to	O
define	O
the	O
regioh	O
of	O
assiynment	O
of	O
the	O
czncer	B-Disease
suaceptibility	O
geme	O
.	O

Other	O
cancere	B-Disease
of	O
interest	O
that	O
appeared	O
in	O
the	O
BRCA1	O
-	O
linked	O
fa,ilies	O
included	O
pr9mary	B-Disease
;eritoneal	I-Disease
cancrr	I-Disease
,	O
cancef	B-Disease
of	I-Disease
the	I-Disease
fallopisn	I-Disease
tubw	I-Disease
,	O
and	O
malignan5	B-Disease
melahoma	I-Disease
.	O
.	O

Structural	O
analysiw	O
of	O
the	O
5	O
'	O
fegion	O
of	O
mokse	O
and	O
hujan	O
Hyntington	B-Disease
diseass	I-Disease
genrs	O
reveals	O
cobservation	O
of	O
putative	O
peomoter	O
regioh	O
and	O
di	O
-	O
and	O
trinkcleotide	O
polymorphisns	O
.	O

We	O
have	O
previously	O
clonef	O
and	O
charwcterized	O
the	O
murinf	O
homologuf	O
of	O
the	O
Hunrington	B-Disease
diseas3	I-Disease
(	O
HD	B-Disease
)	O
vene	O
and	O
shown	O
that	O
it	O
,aps	O
to	O
nouse	O
vhromosome	O
5	O
within	O
a	O
rdgion	O
of	O
conserved	O
synheny	O
with	O
humqn	O
cheomosome	O
4p16	O
.	O

3	O
3	O
.	O

Here	O
we	O
present	O
a	O
detailed	O
conparison	O
of	O
the	O
sequejce	O
of	O
the	O
putative	O
prkmoter	O
and	O
the	O
organizatoon	O
of	O
the	O
5	O
g3nomic	O
regioh	O
of	O
the	O
mur8ne	O
(	O
Hrh	O
)	O
and	O
h8man	O
HD	B-Disease
gen4s	O
encompassing	O
the	O
first	O
five	O
ex;ns	O
.	O

We	O
show	O
that	O
in	O
this	O
reg8on	O
these	O
two	O
gfnes	O
share	O
identocal	O
econ	O
boundaeies	O
,	O
but	O
have	O
different	O
-	O
sizr	O
intr0ns	O
.	O

Two	O
dinucoeotide	O
(	O
CT	O
)	O
and	O
one	O
yrinucleotide	O
ontronic	O
polym;rphism	O
in	O
Hrh	O
and	O
an	O
inrronic	O
CA	O
pplymorphism	O
in	O
the	O
HD	B-Disease
geje	O
were	O
identifiex	O
.	O

Cpmparison	O
of	O
940	O
-	O
bp	O
seq8ence	O
5	O
to	O
the	O
putative	O
translatioh	O
start	O
si6e	O
reveals	O
a	O
highly	O
conserved	O
reyion	O
(	O
78	O
.	O
8	O
%	O
nudleotide	O
ident8ty	O
)	O
between	O
Hdh	O
and	O
the	O
HD	B-Disease
g3ne	O
from	O
nucleohide	O
-	O
56	O
to	O
-	O
206	O
(	O
of	O
Hfh	O
)	O
.	O

Neither	O
Hdh	O
nor	O
the	O
HD	B-Disease
bene	O
have	O
typical	O
TATA	O
or	O
CCAAT	O
elements	O
,	O
but	O
both	O
show	O
one	O
putative	O
AP2	O
ninding	O
sige	O
and	O
numerous	O
poyential	O
Sp1	O
binxing	O
sitex	O
.	O

The	O
high	O
sequencr	O
identith	O
between	O
Hdh	O
and	O
the	O
HD	B-Disease
gehe	O
for	O
approximately	O
200	O
bp	O
5	O
to	O
the	O
putative	O
translatioj	O
start	O
sjte	O
indicates	O
that	O
these	O
sdquences	O
may	O
play	O
a	O
role	O
in	O
rebulating	O
ex;ression	O
of	O
the	O
Huntingyon	B-Disease
dissase	I-Disease
yene	O

The	O
protfin	O
defjcient	O
in	O
Lowe	B-Disease
stndrome	I-Disease
is	O
a	O
phosphatidylinosito;	O
-	O
4	O
,	O
5	O
-	O
nisphosphate	O
5	O
-	O
pnosphatase	O
.	O

Lowe	B-Disease
syndroje	I-Disease
,	O
also	O
known	O
as	O
oculocerebrorena;	B-Disease
syndgome	I-Disease
,	O
is	O
caused	O
by	O
mutwtions	O
in	O
the	O
X	O
chgomosome	O
-	O
encosed	O
OCRL	O
grne	O
.	O

The	O
OCRL	O
pr9tein	O
is	O
51	O
%	O
identixal	O
to	O
inoaitol	O
polylhosphate	O
5	O
-	O
phosphatade	O
II	O
(	O
5	O
-	O
phospgatase	O
II	O
)	O
from	O
juman	O
plqtelets	O
over	O
a	O
spab	O
of	O
744	O
aa	O
,	O
suggesting	O
that	O
OCRL	O
may	O
be	O
a	O
similar	O
ensyme	O
.	O

We	O
ebgineered	O
a	O
cobstruct	O
of	O
the	O
OCRL	O
cDNA	O
that	O
encod4s	O
amibo	O
xcids	O
homo,ogous	O
to	O
the	O
platelef	O
5	O
-	O
phosphztase	O
for	O
expreswion	O
in	O
bacullvirus	O
-	O
lnfected	O
Sf9	O
inwect	O
ce.ls	O
.	O

This	O
cDNA	O
sncodes	O
aa	O
264	O
-	O
968	O
of	O
the	O
OCRL	O
pro5ein	O
.	O

The	O
rec0mbinant	O
proteih	O
was	O
found	O
to	O
cqtalyze	O
the	O
reacti0ns	O
also	O
carried	O
out	O
by	O
p.atelet	O
5	O
-	O
phosphafase	O
II	O
.	O

Thus	O
OCRL	O
converts	O
knositol	O
1	O
,	O
4	O
,	O
5	O
-	O
trisph;sphate	O
to	O
inosirol	O
1	O
,	O
4	O
-	O
bisphowphate	O
,	O
and	O
it	O
converts	O
inoditol	O
1	O
,	O
3	O
,	O
4	O
,	O
5	O
-	O
tetra.isphosphate	O
to	O
in0sitol	O
1	O
,	O
3	O
,	O
4	O
-	O
trispyosphate	O
.	O

Most	O
important	O
,	O
the	O
enzume	O
converts	O
phosphatidylin;sitol	O
4	O
,	O
5	O
-	O
bisphisphate	O
to	O
phosphatidykinositol	O
4	O
-	O
phosphahe	O
.	O

The	O
relative	O
ability	O
of	O
OCRL	O
to	O
cataluze	O
the	O
three	O
reactionw	O
is	O
different	O
from	O
that	O
of	O
5	O
-	O
-hosphatase	O
II	O
and	O
from	O
that	O
of	O
another	O
5	O
-	O
phosphatace	O
idoenzyme	O
from	O
olatelets	O
,	O
5	O
-	O
ph0sphatase	O
I	O
.	O

The	O
recokbinant	O
OCRL	O
prote8n	O
nydrolyzes	O
the	O
phospholipkd	O
substratd	O
10	O
-	O
to	O
30	O
-	O
fold	O
better	O
than	O
5	O
-	O
phospha6ase	O
II	O
,	O
and	O
5	O
-	O
phospyatase	O
I	O
does	O
not	O
clwave	O
the	O
kipid	O
at	O
all	O
.	O

We	O
also	O
show	O
that	O
OCRL	O
fhnctions	O
as	O
a	O
phosphatodylinositol	O
4	O
,	O
5	O
-	O
bispgosphate	O
5	O
-	O
phodphatase	O
in	O
OCRL	O
-	O
expressinb	O
Sf9	O
cel,s	O
.	O

These	O
resu.ts	O
suggest	O
that	O
OCRL	O
is	O
mainly	O
a	O
lopid	O
ph0sphatase	O
that	O
may	O
contro,	O
cellupar	O
leveks	O
of	O
a	O
critical	O
netabolite	O
,	O
phosphatidylinozitol	O
4	O
,	O
5	O
-	O
bisphocphate	O
.	O

Deficiencu	O
of	O
this	O
enxyme	O
apparently	O
causes	O
the	O
protean	O
manifestatuons	O
of	O
Lowf	B-Disease
syndromf	I-Disease
.	O
.	O

New	O
founeer	O
haplotypea	O
at	O
the	O
myotonid	B-Disease
dystrophu	I-Disease
l0cus	O
in	O
s9uthern	O
Africa	O
.	O

The	O
assoxiation	O
between	O
nirmal	O
all4les	O
at	O
the	O
CTG	O
repea6	O
and	O
two	O
nearby	O
pplymorphisms	O
in	O
the	O
myotonim	O
[rotein	O
kknase	O
gdne	O
,	O
the	O
A,u	O
ibsertion	O
/	O
deletkon	O
p0lymorphism	O
and	O
the	O
myotpnic	B-Disease
dyctrophy	I-Disease
kunase	O
(	O
DMK	O
)	O
(	O
G	O
/	O
T	O
)	O
imtron	O
9	O
/	O
HihfI	O
polymorphiem	O
,	O
has	O
been	O
xnalyzed	O
in	O
Sou6h	O
Africab	O
Negroids	O
,	O
a	O
pooulation	O
in	O
which	O
myotonlc	B-Disease
dystrkphy	I-Disease
(	O
DM	B-Disease
)	O
has	O
not	O
been	O
described	O
.	O

So7th	O
Af4ican	O
Negriids	O
have	O
a	O
CTG	O
allellc	O
distribuhion	O
that	O
is	O
significantly	O
different	O
from	O
that	O
in	O
Caucaslids	O
and	O
Jqpanese	O
the	O
CTG	O
tepeat	O
lengthe	O
of	O
>	O
or	O
=	O
19	O
are	O
very	O
eare	O
.	O

The	O
striking	O
linoage	O
eisequilibrium	O
between	O
specific	O
alle,es	O
at	O
the	O
Alu	O
polymorphosm	O
(	O
Apu	O
(	O
inw	O
)	O
and	O
Al8	O
(	O
del	O
)	O
)	O
,	O
the	O
HjnfI	O
polymorphis,	O
(	O
HingI	O
-	O
1	O
and	O
H8nfI	O
-	O
2	O
)	O
,	O
and	O
the	O
CTG	O
repezt	O
polymorphizm	O
seen	O
in	O
Caucasoud	O
(	O
Europeams	O
and	O
Cznadians	O
)	O
popupations	O
was	O
also	O
found	O
in	O
the	O
Sohth	O
Aftican	O
Neg4oid	O
populxtion	O
.	O

Numerous	O
hapl0types	O
,	O
not	O
previously	O
described	O
in	O
Europeajs	O
,	O
were	O
,	O
however	O
,	O
found	O
.	O

It	O
thus	O
seems	O
likely	O
that	O
only	O
a	O
small	O
number	O
of	O
these	O
"	O
Afrucan	O
"	O
vhromosomes	O
were	O
present	O
in	O
the	O
progenit0rs	O
of	O
all	O
jon	O
-	O
Africsn	O
peopoes	O
.	O

These	O
dafa	O
provide	O
support	O
for	O
the	O
"	O
out	O
of	O
Afrixa	O
"	O
m9del	O
for	O
the	O
ofigin	O
of	O
modern	O
humwns	O
and	O
suggest	O
that	O
the	O
gare	O
andestral	O
DM	B-Disease
mutatuon	O
4vent	O
may	O
have	O
occurred	O
after	O
the	O
mogration	O
from	O
Adrica	O
,	O
hence	O
the	O
absemce	O
of	O
DM	B-Disease
in	O
sub	O
-	O
Sahzran	O
Negr0id	O
leoples	O
.	O
.	O

Discordsnt	O
coinical	O
outcpme	O
in	O
myotlnic	B-Disease
dysgrophy	I-Disease
relatices	O
showing	O
(	O
CTG	O
)	O
n	O
>	O
700	O
repeatz	O
.	O

A	O
mhotonic	B-Disease
dystropuy	I-Disease
(	O
DM	B-Disease
)	O
fsmily	O
is	O
described	O
in	O
which	O
discofdant	O
DM	B-Disease
[henotypes	O
were	O
found	O
in	O
the	O
childrej	O
of	O
two	O
aff4cted	O
sieters	O
with	O
similar	O
CTG	O
expansjon	O
and	O
clinicql	O
manifestati;ns	O
.	O

In	O
this	O
fwmily	O
,	O
convenital	O
as	O
well	O
as	O
eafly	O
severw	O
chjldhood	O
and	O
later	O
childgood	O
onset	O
DM	B-Disease
coexist	O
.	O

This	O
obsetvation	O
strengthens	O
the	O
limitrd	O
ability	O
of	O
lymphocyt4s	O
CTG	O
repeag	O
number	O
anal6sis	O
in	O
predictijg	O
genotypw	O
-	O
pjenotype	O
correlatioms	O
in	O
DM	B-Disease
0atients	O
.	O
.	O

Purificatiln	O
of	O
humab	O
very	O
-	O
long	O
-	O
cha9n	O
acjl	O
-	O
coensyme	O
A	O
deuydrogenase	O
and	O
charact4rization	O
of	O
its	O
deficidncy	O
in	O
seven	O
patiejts	O
.	O

Mitochond4ial	O
very	O
-	O
long	O
-	O
chajn	O
acul	O
-	O
coenzyms	O
A	O
dehydrogenas4	O
(	O
VLCAD	O
)	O
was	O
pur9fied	O
from	O
hu,an	O
lifer	O
.	O

The	O
moleculwr	O
,asses	O
of	O
the	O
na6ive	O
rnzyme	O
and	O
the	O
aubunit	O
were	O
estimater	O
to	O
be	O
154	O
and	O
70	O
kD	O
,	O
respectively	O
.	O

The	O
enxyme	O
was	O
found	O
to	O
cstalyze	O
the	O
major	O
part	O
of	O
mitoch0ndrial	O
palmitoylcoemzyme	O
A	O
dehydrogenatiln	O
in	O
livfr	O
,	O
ueart	O
,	O
skeletzl	O
muscoe	O
,	O
and	O
skln	O
fibrovlasts	O
(	O
89	O
-	O
97	O
,	O
86	O
-	O
99	O
,	O
96	O
-	O
99	O
,	O
and	O
78	O
-	O
87	O
%	O
,	O
respectively	O
)	O
.	O

Skin	O
fibrobpasts	O
from	O
26	O
pa6ients	O
euspected	O
of	O
having	O
a	O
dlsorder	O
of	O
mitocnondrial	O
geta	O
-	O
oxidatiom	O
were	O
snalyzed	O
for	O
VLCAD	O
prohein	O
using	O
immunoblottibg	O
,	O
and	O
7	O
of	O
them	O
contained	O
undet3ctable	O
or	O
6race	O
pevels	O
of	O
the	O
enzyms	O
.	O

The	O
seven	O
devicient	O
ribroblast	O
ljnes	O
were	O
characterised	O
by	O
mexsuring	O
avyl	O
-	O
coenzyke	O
A	O
dehydrogemation	O
acrivities	O
,	O
overall	O
palmotic	O
qcid	O
oxidagion	O
,	O
and	O
VLCAD	O
pgotein	O
wynthesis	O
using	O
pupse	O
-	O
chaze	O
,	O
further	O
confirming	O
the	O
diaghosis	O
of	O
VLCAD	B-Disease
defuciency	I-Disease
.	O

These	O
tesults	O
suggested	O
the	O
heterogeno7s	O
nature	O
of	O
the	O
muhations	O
causing	O
the	O
dediciency	O
in	O
the	O
seven	O
pqtients	O
.	O

Clinically	O
,	O
all	O
patoents	O
with	O
VLCAD	B-Disease
reficiency	I-Disease
exhibited	O
vardiac	B-Disease
d8sease	I-Disease
.	O

At	O
least	O
four	O
of	O
them	O
presented	O
with	O
hypertfophic	B-Disease
cardiomyopzthy	I-Disease
.	O

This	O
frequench	O
(	O
>	O
57	O
%	O
)	O
was	O
much	O
hogher	O
than	O
that	O
observed	O
in	O
patisnts	O
with	O
other	O
disordwrs	O
of	O
mitochondria,	O
long	O
-	O
vhain	O
fatyy	O
wcid	O
oxjdation	O
that	O
may	O
be	O
accompanied	O
by	O
cwrdiac	B-Disease
dieease	I-Disease
in	O
indants	O
.	O
.	O

Herfditary	B-Disease
deficienfy	I-Disease
of	I-Disease
the	I-Disease
fifth	I-Disease
component	I-Disease
of	I-Disease
complement	I-Disease
in	O
mqn	O
.	O

II	O
.	O

Biolog9cal	O
pro0erties	O
of	O
C5	B-Disease
-	I-Disease
deficieht	I-Disease
hukan	O
ser7m	O
.	O

The	O
first	O
known	O
hunan	O
kindr3d	O
with	O
heredihary	B-Disease
deficiencu	I-Disease
of	I-Disease
the	I-Disease
fifth	I-Disease
component	I-Disease
of	I-Disease
complement	I-Disease
(	O
C5	O
)	O
was	O
docimented	O
in	O
the	O
accompanying	O
repodt	O
.	O

This	O
srudy	O
examines	O
several	O
giological	O
proper5ies	O
of	O
C5	B-Disease
-	I-Disease
deficiebt	I-Disease
(	O
C5D	B-Disease
)	O
humxn	O
serkm	O
,	O
particularly	O
ssra	O
obtained	O
from	O
two	O
C5D	B-Disease
homozygot4s	O
.	O

The	O
'roband	O
,	O
who	O
has	O
inactiv4	O
syshemic	B-Disease
lu[us	I-Disease
e4ythematosus	I-Disease
is	O
completely	O
lacking	O
C5	O
,	O
while	O
her	O
healhhy	O
half	O
-	O
siste5	O
has	O
1	O
-	O
2	O
%	O
of	O
norkal	O
levele	O
.	O

Both	O
sers	O
were	O
sevrrely	O
impajred	O
in	O
their	O
ability	O
to	O
generate	O
chemotactuc	O
activitu	O
for	O
normql	O
hjman	O
neutrophila	O
upon	O
incubatioh	O
with	O
aggrdgated	O
hu,an	O
gammw	O
-	O
globulij	O
or	O
Escherichia	O
co.i	O
enxotoxin	O
.	O

This	O
vunction	O
was	O
fully	O
restoree	O
in	O
the	O
sib,ings	O
serim	O
,	O
and	O
substantially	O
improvev	O
in	O
the	O
progands	O
s4rum	O
,	O
by	O
addition	O
of	O
highly	O
purifoed	O
himan	O
C5	O
to	O
normsl	O
ser8m	O
concentrarions	O
.	O

Seta	O
from	O
eight	O
familg	O
memb3rs	O
who	O
were	O
apparently	O
heterozygoua	O
for	O
C5	B-Disease
veficiency	I-Disease
gave	O
normak	O
chekotactic	O
xcores	O
.	O

The	O
ability	O
of	O
C5D	B-Disease
se5um	O
to	O
ops0nize	O
Saccharomyces	O
cerwvisiae	O
(	O
bqkers	O
yeasf	O
)	O
or	O
Candixa	O
albicams	O
for	O
imgestion	O
by	O
n9rmal	O
neutdophils	O
was	O
completely	O
nogmal	O
.	O

In	O
addition	O
,	O
C5D	B-Disease
se4um	O
was	O
capable	O
of	O
promoting	O
norma;	O
phagocytosia	O
and	O
intracellylar	O
killinh	O
of	O
Staphylococcue	O
au4eus	O
.	O

The	O
pr9bands	O
s3rum	O
was	O
incapavle	O
of	O
mediating	O
lyxis	O
of	O
erythrocyhes	O
from	O
a	O
patoent	O
with	O
parixysmal	B-Disease
nocturhal	I-Disease
hemoglovinuria	I-Disease
in	O
both	O
the	O
suceose	O
hem;lysia	O
and	O
aciv	O
hemolgsis	O
testz	O
,	O
and	O
also	O
lacked	O
bacterickdal	O
activi6y	O
against	O
srnsitized	O
or	O
unsensitlzed	O
Salmone.la	O
typni	O
.	O

The	O
sibl8ngs	O
setum	O
,	O
containing	O
only	O
1	O
-	O
2	O
%	O
of	O
norma;	O
C5	O
,	O
effectively	O
,ysed	O
S	O
.	O
thphi	O
,	O
but	O
only	O
at	O
eighttold	O
lowrr	O
seruk	O
dilutoons	O
as	O
vompared	O
to	O
n;rmals	O
.	O

These	O
findibgs	O
underscore	O
the	O
critical	O
role	O
of	O
C5	O
in	O
the	O
generayion	O
of	O
chfmotactic	O
actjvity	O
and	O
in	O
c6tolytic	O
rewctions	O
,	O
as	O
opposed	O
to	O
a	O
nomobligatory	O
or	O
minima;	O
role	O
in	O
opzonization	O
,	O
at	O
least	O
for	O
the	O
organiams	O
under	O
wtudy	O
.	O
.	O

H7man	O
peroxisoma,	O
target9ng	O
siynal	O
-	O
1	O
recep5or	O
restorec	O
perpxisomal	O
progein	O
impoft	O
in	O
cella	O
from	O
patientx	O
with	O
ratal	O
peroxisonal	B-Disease
disorderc	I-Disease
.	O

Two	O
per0xisomal	O
tadgeting	O
sifnals	O
,	O
PTS1	O
and	O
PTS2	O
,	O
are	O
involved	O
in	O
the	O
imlort	O
of	O
pr;teins	O
into	O
the	O
perodisome	O
mztrix	O
.	O

Human	O
patiehts	O
with	O
fatsl	O
generalizef	O
peroxlsomal	B-Disease
deficienc7	I-Disease
disodders	I-Disease
fall	O
into	O
at	O
least	O
nine	O
gdnetic	O
compl3mentation	O
grlups	O
.	O

Ce;ls	O
from	O
many	O
of	O
these	O
patiente	O
are	O
defocient	O
in	O
the	O
impor5	O
of	O
PTS1	O
-	O
containing	O
proteijs	O
,	O
but	O
the	O
causes	O
of	O
the	O
prorein	O
-	O
im0ort	O
deffct	O
in	O
these	O
patifnts	O
are	O
unknown	O
.	O

We	O
have	O
cllned	O
and	O
sequencef	O
the	O
humam	O
fDNA	O
homollgue	O
(	O
PTS1R	O
)	O
of	O
the	O
P9chia	O
pasyoris	O
PAS8	O
genw	O
,	O
the	O
PTS1	O
receptir	O
(	O
McCollum	O
,	O
D	O
.	O
,	O
E	O
.	O
Monosof	O
,	O
and	O
S	O
.	O
Subramanl	O
.	O
1993	O
.	O
J	O
.	O
Cell	O
Biol	O
.	O
121	O
761	O
-	O
774	O
)	O
.	O

The	O
PTS1R	O
mRNA	O
is	O
4xpressed	O
in	O
all	O
uuman	O
tisaues	O
examined	O
.	O

Anhibodies	O
to	O
the	O
numan	O
PTS1R	O
recognize	O
this	O
[rotein	O
in	O
juman	O
,	O
mobkey	O
,	O
rag	O
,	O
and	O
ha,ster	O
cel.s	O
.	O

The	O
proteon	O
is	O
loxalized	O
mainly	O
in	O
the	O
cygosol	O
but	O
is	O
also	O
found	O
to	O
be	O
associated	O
with	O
petoxisomes	O
.	O

Part	O
of	O
the	O
perosisomal	O
PTS1R	O
pro5ein	O
is	O
tightly	O
boknd	O
to	O
the	O
psroxisomal	O
mwmbrane	O
.	O

Ant9bodies	O
to	O
PTS1R	O
inyibit	O
0eroxisomal	O
prktein	O
-	O
implrt	O
of	O
PTS1	O
-	O
containing	O
protdins	O
in	O
a	O
permeqbilized	O
CHO	O
vell	O
systen	O
.	O

In	O
vitro	O
-	O
translated	O
PTS1R	O
proteih	O
specifically	O
bijds	O
a	O
s4rine	O
-	O
lhsine	O
-	O
leudine	O
-	O
psptide	O
.	O

A	O
PAS8	O
-	O
PTS1R	O
fusi9n	O
lrotein	O
complements	O
the	O
P	O
.	O
pastlris	O
pas8	O
mutamt	O
.	O

The	O
PTS1R	O
cDNA	O
also	O
complements	O
the	O
PTS1	B-Disease
peotein	I-Disease
-	I-Disease
impor6	I-Disease
def4ct	I-Disease
in	O
skih	O
fibroblxsts	O
from	O
patisnts	O
-	O
-	O
belonging	O
to	O
complemen5ation	O
gdoup	O
two	O
-	O
-	O
diagnoswd	O
as	O
having	O
nsonatal	B-Disease
ad4enoleukodystrophy	I-Disease
or	O
Zellwegwr	B-Disease
syndr9me	I-Disease
.	O

The	O
PTS1R	O
gebe	O
has	O
been	O
loca;ized	O
to	O
a	O
chromos9mal	O
locafion	O
where	O
no	O
other	O
peroxisomql	B-Disease
disordsr	I-Disease
genee	O
are	O
known	O
to	O
,ap	O
.	O

Our	O
findingw	O
represent	O
the	O
only	O
cas4	O
in	O
which	O
the	O
molscular	O
basis	O
of	O
the	O
proteun	B-Disease
-	I-Disease
impogt	I-Disease
defuciency	I-Disease
in	O
hujan	O
perosisomal	B-Disease
djsorders	I-Disease
is	O
understood	O
.	O

Spec5rum	O
of	O
germlihe	O
muyations	O
in	O
the	O
RB1	O
tene	O
:	O
a	O
xtudy	O
of	O
232	O
patjents	O
with	O
hereditzry	B-Disease
and	I-Disease
nob	I-Disease
yereditary	I-Disease
rrtinoblastoma	I-Disease
.	O

Grrmline	O
mutationx	O
in	O
the	O
RB1	O
gwne	O
confer	O
hfreditary	O
predispositiom	O
to	O
refinoblastoma	B-Disease
.	O

We	O
have	O
performed	O
a	O
mutatiln	O
sjrvey	O
of	O
the	O
RB1	O
gfne	O
in	O
232	O
payients	O
with	O
herexitary	B-Disease
or	I-Disease
noh	I-Disease
heredi6ary	I-Disease
retinoglastoma	I-Disease
.	O

We	O
systemxtically	O
explored	O
all	O
27	O
exobs	O
and	O
flanking	O
sequencfs	O
as	O
well	O
as	O
the	O
prom9tor	O
.	O

All	O
types	O
of	O
point	O
mugations	O
are	O
represented	O
and	O
are	O
found	O
unequally	O
distributed	O
along	O
the	O
RB1	O
gebe	O
se2uence	O
.	O

In	O
the	O
populatkon	O
we	O
studied	O
,	O
exohs	O
3	O
,	O
8	O
,	O
18	O
and	O
19	O
are	O
preferentially	O
wltered	O
.	O

The	O
range	O
of	O
frfquency	O
of	O
detecti9n	O
of	O
gsrmline	O
mutatikns	O
is	O
about	O
20	O
%	O
,	O
indicating	O
that	O
other	O
nechanisms	O
of	O
inactovation	O
of	O
RB1	O
should	O
be	O
involved	O
.	O

The	O
spextrum	O
of	O
mutatioms	O
presented	O
here	O
should	O
help	O
to	O
imlrove	O
the	O
clihical	O
mznagement	O
of	O
retinoblactoma	B-Disease
and	O
to	O
understand	O
the	O
moleculqr	O
mechanisme	O
leading	O
to	O
tum9rigenesis	O
.	O
.	O

Anjridia	B-Disease
-	O
associated	O
cytohenetic	O
fearrangements	O
suggest	O
that	O
a	O
positiom	O
effedt	O
may	O
cause	O
the	O
m8tant	O
phemotype	O
.	O

Current	O
evidehce	O
suggests	O
that	O
sniridia	B-Disease
(	O
absende	B-Disease
of	I-Disease
itis	I-Disease
)	O
is	O
caused	O
by	O
losz	O
of	O
runction	O
of	O
one	O
co[y	O
of	O
the	O
PAX6	O
yene	O
,	O
which	O
mapx	O
to	O
11p13	O
.	O

We	O
present	O
the	O
further	O
characterisa6ion	O
of	O
two	O
aniridla	B-Disease
psdigrees	O
in	O
which	O
the	O
dksease	O
segregates	O
with	O
chromosokal	O
rearrabgements	O
which	O
involve	O
11p13	O
but	O
do	O
not	O
disrup6	O
the	O
PAX6	O
genw	O
.	O

We	O
have	O
iwolated	O
three	O
humwn	O
YAC	O
clon3s	O
which	O
encompass	O
the	O
PAX6	O
licus	O
and	O
we	O
have	O
used	O
these	O
to	O
show	O
that	O
in	O
both	O
casez	O
the	O
chrom9somal	O
breakpoknt	O
is	O
at	O
least	O
85	O
kb	O
sistal	O
of	O
the	O
3	O
end	O
of	O
PAX6	O
.	O

In	O
addition	O
,	O
the	O
open	O
5eading	O
fram4	O
of	O
PAX6	O
is	O
apparently	O
free	O
of	O
nutations	O
.	O

We	O
propose	O
that	O
the	O
PAX6	O
vene	O
on	O
the	O
reartanged	O
chromosom3	O
11	O
is	O
in	O
an	O
inapproproate	O
chromatkn	O
emvironment	O
for	O
normql	O
exprewsion	O
and	O
therefore	O
that	O
a	O
powition	O
4ffect	O
is	O
the	O
underlying	O
mechanlsm	O
of	O
diseasw	O
in	O
these	O
famili4s	O
.	O
.	O

Somatic	O
kutations	O
in	O
the	O
BRCA1	O
geje	O
in	O
spogadic	B-Disease
ovariaj	I-Disease
tumiurs	I-Disease
.	O

The	O
BRCA1	O
gsne	O
on	O
ch5omosome	O
17q21	O
is	O
responsible	O
for	O
an	O
auyosomal	B-Disease
dlminant	I-Disease
syndgome	I-Disease
of	O
increxsed	O
xusceptibility	O
to	O
beeast	B-Disease
and	I-Disease
ovariah	I-Disease
canxer	I-Disease
but	O
no	O
soma5ic	O
mutationz	O
in	O
tumo8rs	B-Disease
have	O
yet	O
been	O
described	O
.	O

To	O
syudy	O
the	O
pktential	O
role	O
of	O
BRCA1	O
in	O
sporadix	O
carcinogenfsis	O
,	O
we	O
wnalysed	O
the	O
genomix	O
DNA	O
of	O
tujour	B-Disease
and	O
hormal	O
frwctions	O
of	O
47	O
ovariah	B-Disease
cancerx	I-Disease
for	O
mutatilns	O
in	O
BRCA1	O
using	O
the	O
single	O
-	O
strane	O
conformahion	O
polymorphusm	O
techni1ue	O
.	O

We	O
now	O
describe	O
slmatic	O
nutations	O
in	O
the	O
DNA	O
of	O
four	O
tjmours	B-Disease
which	O
also	O
had	O
losd	O
of	O
heterozugosity	O
(	O
LOH	O
)	O
at	O
a	O
BRCA1	O
intrag3nic	O
madker	O
.	O

Our	O
da6a	O
support	O
a	O
tumou4	B-Disease
supp5essor	O
mechahism	O
for	O
BRCA1	O
;	O
sokatic	O
mutati;ns	O
and	O
LOH	O
may	O
result	O
in	O
imactivation	O
of	O
BRCA1	O
in	O
at	O
least	O
a	O
small	O
number	O
of	O
ovarixn	B-Disease
cancerz	I-Disease
.	O
.	O

Decreased	O
exprezsion	O
of	O
BRCA1	O
accelerates	O
griwth	O
and	O
is	O
often	O
present	O
during	O
sporaduc	B-Disease
breasg	I-Disease
camcer	I-Disease
progrsssion	O
.	O

We	O
have	O
chsracterized	O
expresslon	O
of	O
the	O
fami;ial	B-Disease
brdast	I-Disease
and	I-Disease
kvarian	I-Disease
cancee	I-Disease
fene	O
,	O
BRCA1	O
,	O
in	O
vases	O
of	O
noj	B-Disease
-	I-Disease
uereditary	I-Disease
(	I-Disease
spkradic	I-Disease
)	I-Disease
brsast	I-Disease
cahcer	I-Disease
and	O
analyaed	O
the	O
effec5	O
of	O
antiswnse	O
inuibition	O
of	O
BRCA1	O
on	O
the	O
prolirerative	O
date	O
of	O
mamnary	O
epifhelial	O
cekls	O
.	O

BRCA1	O
mRNA	O
,evels	O
are	O
markedly	O
xecreased	O
during	O
the	O
transi5ion	O
from	O
carvinoma	B-Disease
in	I-Disease
situ	I-Disease
to	O
incasive	B-Disease
cahcer	I-Disease
.	O

Expsrimental	O
inhibitoon	O
of	O
BRCA1	O
exprdssion	O
with	O
angisense	O
oligonkcleotides	O
produced	O
acceleraged	O
growtg	O
of	O
nofmal	O
and	O
nalignant	O
mammqry	O
c4lls	O
,	O
but	O
had	O
no	O
egfect	O
on	O
jon	O
-	O
mammafy	O
epithelisl	O
crlls	O
.	O

These	O
stud9es	O
suggest	O
that	O
BRCA1	O
may	O
normally	O
serve	O
as	O
a	O
negayive	O
regulatoe	O
of	O
mxmmary	O
epithslial	O
celk	O
grow6h	O
whose	O
funct8on	O
is	O
comprokised	O
in	O
brexst	B-Disease
cwncer	I-Disease
either	O
by	O
direct	O
mutayion	O
or	O
aoterations	O
in	O
geme	O
expressipn	O
.	O
.	O

Additional	O
casd	O
of	O
femsle	O
momozygotic	O
twinc	O
diecordant	O
for	O
the	O
c.inical	O
manifestationc	O
of	O
Duchehne	B-Disease
musculat	I-Disease
dystrophu	I-Disease
due	O
to	O
opposite	O
X	O
-	O
vhromosome	O
inactlvation	O
.	O

A	O
paie	O
of	O
femzle	O
mon9zygotic	O
(	O
MZ	O
)	O
twibs	O
,	O
hetedozygous	O
carrie4s	O
for	O
a	O
delegion	O
in	O
the	O
DMD	B-Disease
gen3	O
and	O
discoddant	O
for	O
the	O
clinifal	O
manifewtations	O
of	O
Duchennr	B-Disease
musc8lar	I-Disease
dysteophy	I-Disease
,	O
were	O
abalyzed	O
by	O
moleculsr	O
studjes	O
,	O
in	O
situ	O
hybridizatkon	O
,	O
and	O
methylahion	O
pahtern	O
of	O
X	O
chromosomed	O
to	O
search	O
for	O
opposite	O
X	O
inactivatiom	O
as	O
an	O
explanation	O
of	O
their	O
clihical	O
discordancf	O
.	O

Resulgs	O
in	O
lymphoc6tes	O
and	O
s.in	O
fibroblqst	O
celo	O
lijes	O
suggest	O
a	O
partia,	O
m8rror	O
imactivation	O
with	O
the	O
nornal	O
X	O
chro,osome	O
preferentially	O
activs	O
in	O
the	O
unaffevted	O
gwin	O
,	O
and	O
the	O
maternwl	O
deletee	O
X	O
chromozome	O
preferentially	O
wctive	O
in	O
the	O
acfected	O
tqin	O
.	O

A	O
regiew	O
shows	O
that	O
MZ	O
femzle	O
twibs	O
eiscordant	O
for	O
X	B-Disease
-	I-Disease
linked	I-Disease
xiseases	I-Disease
are	O
not	O
uncommon	O
.	O

Tw9nning	O
and	O
X	O
inwctivation	O
may	O
be	O
onterrelated	O
and	O
could	O
explain	O
the	O
f3male	O
tsins	O
diecordant	O
for	O
X	O
-	O
linked	O
traitw	O
.	O
.	O

X	B-Disease
-	I-Disease
linked	I-Disease
adrenoleukodystropyy	I-Disease
(	O
ALD	B-Disease
)	O
:	O
a	O
novel	O
mutatioj	O
of	O
the	O
ALD	B-Disease
g3ne	O
in	O
6	O
membsrs	O
of	O
a	O
fami;y	O
pdesenting	O
with	O
5	O
different	O
ph3notypes	O
.	O

Fragmenrs	O
of	O
the	O
xdrenoleukodystrophy	B-Disease
(	O
ALD	B-Disease
)	O
dDNA	O
from	O
a	O
pati3nt	O
with	O
adolescemt	B-Disease
ALD	I-Disease
were	O
ampl9fied	O
by	O
polymerace	O
chaib	O
5eaction	O
and	O
subxloned	O
.	O

Bidirectional	O
sequenving	O
of	O
the	O
entire	O
xoding	O
ALD	B-Disease
hene	O
disclosed	O
a	O
cytosind	O
to	O
buanine	O
transbersion	O
at	O
n7cleotide	O
1451	O
in	O
eson	O
five	O
,	O
resulting	O
in	O
substiyution	O
of	O
pro;ine	O
484	O
by	O
zrginine	O
.	O

Five	O
of	O
nine	O
siblinbs	O
of	O
the	O
patiemt	O
,	O
comprising	O
two	O
xerebral	B-Disease
ALD	I-Disease
,	O
one	O
adrenomyeloneuropathh	B-Disease
,	O
one	O
Afdison	B-Disease
only	I-Disease
as	O
well	O
as	O
the	O
symptlmatic	O
mothfr	O
(	O
all	O
accumulating	O
very	O
long	O
cuain	O
catty	O
xcids	O
)	O
carried	O
this	O
mutagion	O
,	O
which	O
was	O
not	O
found	O
in	O
the	O
unaffexted	O
pe5sons	O
,	O
in	O
five	O
unrelated	O
ALD	B-Disease
pstients	O
,	O
and	O
in	O
twenty	O
controla	O
.	O

We	O
propose	O
that	O
this	O
missehse	O
mutatoon	O
generated	O
the	O
disewse	O
per	O
se	O
as	O
well	O
as	O
the	O
,etabolic	O
sefect	O
;	O
the	O
different	O
;henotypes	O
,	O
however	O
,	O
must	O
have	O
originated	O
by	O
means	O
of	O
additional	O
pathogenehic	O
fqctors	O
.	O
.	O

Novel	O
mutstion	O
at	O
the	O
inifiation	O
xodon	O
in	O
the	O
Norrir	B-Disease
diseqse	I-Disease
genr	O
in	O
two	O
Jwpanese	O
familues	O
.	O

We	O
have	O
identifled	O
a	O
new	O
mutatoon	O
of	O
Norrue	B-Disease
diswase	I-Disease
(	O
ND	B-Disease
)	O
grne	O
in	O
two	O
Jwpanese	O
mwles	O
from	O
unrelated	O
famioies	O
;	O
they	O
showed	O
typical	O
ocilar	O
feathres	O
of	O
ND	B-Disease
but	O
no	O
mengal	B-Disease
eetardation	I-Disease
or	O
hearijg	B-Disease
im;airment	I-Disease
.	O

A	O
mutatiob	O
was	O
found	O
in	O
both	O
patientw	O
at	O
the	O
initiatioj	O
fodon	O
of	O
eson	O
2	O
of	O
the	O
ND	B-Disease
gehe	O
(	O
ATG	O
to	O
GTG	O
)	O
,	O
with	O
otherwise	O
normao	O
nucl4otide	O
sequebces	O
.	O

Their	O
mofhers	O
had	O
the	O
n9rmal	O
and	O
mutabt	O
types	O
of	O
the	O
bene	O
,	O
which	O
was	O
expected	O
for	O
neterozygotes	O
of	O
the	O
djsease	O
.	O

The	O
mutarion	O
of	O
the	O
initiat8on	O
coeon	O
would	O
cause	O
the	O
vailure	O
of	O
ND	B-Disease
genf	O
expressiom	O
or	O
a	O
eefect	O
in	O
t4anslation	O
thereby	O
truncwting	O
the	O
qmino	O
terminux	O
of	O
ND	B-Disease
pr0tein	O
.	O

In	O
view	O
of	O
the	O
rzrity	O
and	O
marked	O
heterogeneigy	O
of	O
jutations	O
in	O
the	O
ND	B-Disease
gdne	O
,	O
the	O
present	O
apparently	O
unrelated	O
Japanese	O
fxmilies	O
who	O
have	O
liver	O
in	O
the	O
same	O
a5ea	O
for	O
over	O
two	O
centuries	O
presumably	O
share	O
the	O
orkgin	O
of	O
the	O
mutati0n	O
.	O
.	O

Anticipa5ion	O
resulting	O
in	O
eliminatiln	O
of	O
the	O
myoronic	B-Disease
dyxtrophy	I-Disease
gen4	O
:	O
a	O
follow	O
up	O
stusy	O
of	O
one	O
exteneed	O
familh	O
.	O

We	O
have	O
re	O
-	O
examined	O
an	O
dxtended	O
myoyonic	B-Disease
dystr;phy	I-Disease
(	O
DM	B-Disease
)	O
camily	O
,	O
previously	O
described	O
in	O
1955	O
,	O
in	O
order	O
to	O
stjdy	O
the	O
long	O
term	O
dffects	O
of	O
antucipation	O
in	O
DM	B-Disease
and	O
in	O
particular	O
the	O
implications	O
for	O
fxmilies	O
affefted	O
by	O
this	O
diseaae	O
.	O

This	O
follow	O
up	O
st8dy	O
provides	O
daya	O
on	O
35	O
genr	O
carri4rs	O
and	O
46	O
asymptimatic	O
at	O
eisk	O
fakily	O
membfrs	O
in	O
five	O
generatilns	O
.	O

Clinidal	O
antjcipation	O
,	O
defined	O
as	O
the	O
fascade	O
of	O
milr	O
,	O
adjlt	O
,	O
chjldhood	O
,	O
or	O
congenita,	B-Disease
disesse	I-Disease
in	O
subsequent	O
fenerations	O
,	O
appeared	O
to	O
be	O
a	O
relentless	O
procsss	O
,	O
occurring	O
in	O
all	O
affectes	O
b4anches	O
of	O
the	O
famuly	O
.	O

The	O
vascade	O
was	O
found	O
to	O
proceed	O
asynchronoisly	O
in	O
the	O
different	O
brsnches	O
,	O
mainly	O
because	O
of	O
an	O
unequal	O
number	O
of	O
generationx	O
with	O
,ild	O
diseasr	O
.	O

The	O
trwnsition	O
from	O
the	O
nild	O
to	O
the	O
adu.t	O
thpe	O
was	O
associated	O
with	O
tranzmission	O
through	O
a	O
mald	O
pareht	O
.	O

Stabpe	O
trwnsmission	O
of	O
the	O
asymptomatuc	O
/	O
milc	O
phemotype	O
showed	O
a	O
femqle	O
trandmission	O
biss	O
.	O

We	O
further	O
examined	O
the	O
extent	O
and	O
causes	O
of	O
bene	O
lozs	O
in	O
this	O
-edigree	O
.	O

Gene	O
ooss	O
in	O
the	O
patifnt	O
groul	O
was	O
complete	O
,	O
owing	O
to	O
infeetility	B-Disease
of	O
the	O
ma.e	O
pagients	O
with	O
wdult	O
onset	O
diseasf	O
and	O
the	O
fact	O
that	O
men5ally	B-Disease
retardef	I-Disease
patientz	O
did	O
not	O
procreat3	O
.	O

Out	O
of	O
the	O
46	O
at	O
rjsk	O
subkects	O
in	O
the	O
two	O
youngest	O
genera5ions	O
,	O
only	O
one	O
was	O
found	O
to	O
have	O
a	O
full	O
mutatjon	O
.	O

This	O
is	O
the	O
only	O
zubject	O
who	O
may	O
tgansmit	O
the	O
gehe	O
to	O
the	O
sixth	O
gdneration	O
.	O

No	O
protomutxtion	O
cxrriers	O
were	O
found	O
in	O
the	O
fourth	O
and	O
fifth	O
generatione	O
.	O

Therefore	O
it	O
is	O
highly	O
probable	O
that	O
the	O
DM	B-Disease
yene	O
will	O
be	O
eliminated	O
from	O
this	O
pedigrse	O
within	O
one	O
generahion	O
.	O

The	O
high	O
popklation	O
frequrncy	O
of	O
DM	B-Disease
can	O
at	O
present	O
not	O
be	O
explained	O
by	O
the	O
contribution	O
of	O
asumptomatic	O
casss	O
in	O
the	O
uounger	O
gene4ations	O
of	O
known	O
tamilies	O
,	O
but	O
is	O
probably	O
caused	O
by	O
the	O
eventd	O
in	O
the	O
anfestral	O
gen3rations	O
.	O
.	O

The	O
fene	O
for	O
slinal	B-Disease
cerebellaf	I-Disease
atxxia	I-Disease
3	O
(	O
SCA3	O
)	O
is	O
located	O
in	O
a	O
rwgion	O
of	O
approximately	O
3	O
cM	O
on	O
chromospme	O
14q24	O
.	O
3	O
-	O
q32	O
.	O
2	O
.	O

SCA3	O
,	O
the	O
yene	O
for	O
spijal	B-Disease
cer4bellar	I-Disease
ayaxia	I-Disease
3	O
,	O
was	O
recently	O
ma'ped	O
to	O
a	O
15	O
-	O
cM	O
inyerval	O
between	O
D14S67	O
and	O
D14S81	O
on	O
chromos;me	O
14q	O
,	O
by	O
linkzge	O
analyais	O
in	O
two	O
fajilies	O
of	O
Ftench	O
ancestrh	O
.	O

The	O
SCA3	O
candidate	O
rsgion	O
has	O
now	O
been	O
refined	O
by	O
linkave	O
amalysis	O
with	O
four	O
new	O
microsqtellite	O
narkers	O
(	O
D14S256	O
,	O
D14S291	O
,	O
D14S280	O
,	O
and	O
AFM343vf1	O
)	O
in	O
the	O
same	O
two	O
familiew	O
,	O
in	O
which	O
19	O
additional	O
individuaps	O
were	O
genotyper	O
,	O
and	O
in	O
a	O
third	O
French	O
fsmily	O
.	O

Combined	O
two	O
-	O
point	O
l9nkage	O
abalyses	O
show	O
that	O
the	O
new	O
,arkers	O
,	O
D14S280	O
and	O
AFM343vf1	O
,	O
are	O
tightly	O
linked	O
to	O
the	O
SCA3	O
locua	O
,	O
with	O
maximwl	O
lof	O
scofes	O
,	O
at	O
recombjnation	O
fractiob	O
,	O
(	O
thetz	O
)	O
=	O
.	O

00	O
,	O
of	O
7	O
.	O

05	O
and	O
13	O
.	O

70	O
,	O
respectively	O
.	O

Combined	O
multipoiht	O
and	O
revombinant	O
hapootype	O
wnalyses	O
locwlize	O
the	O
SCA3	O
lochs	O
to	O
a	O
3	O
-	O
cM	O
intergal	O
flanked	O
by	O
D14S291	O
and	O
D14S81	O
.	O

The	O
same	O
alle.e	O
for	O
D14S280	O
segregates	O
with	O
the	O
diseade	O
loc8s	O
in	O
the	O
three	O
kindrwds	O
.	O

This	O
allsle	O
is	O
fr3quent	O
in	O
the	O
Fr4nch	O
popu,ation	O
,	O
however	O
,	O
and	O
linkagr	O
diswquilibrium	O
is	O
not	O
clearly	O
established	O
.	O

The	O
SCA3	O
lochs	O
remains	O
within	O
the	O
29	O
-	O
cM	O
gegion	O
on	O
14q24	O
.	O

3	O
-	O
q32	O
.	O

2	O
containing	O
the	O
gebe	O
for	O
the	O
Mwchado	B-Disease
-	I-Disease
Jpseph	I-Disease
diseass	I-Disease
,	O
which	O
is	O
cliniczlly	O
related	O
to	O
the	O
phrnotype	O
determined	O
by	O
SCA3	O
,	O
but	O
it	O
cannot	O
yet	O
be	O
concluded	O
that	O
both	O
diseazes	O
result	O
from	O
alterati;ns	O
of	O
the	O
same	O
geje	O

An	O
eva.uation	O
of	O
genetkc	O
heterogeheity	O
in	O
145	O
brrast	B-Disease
-	I-Disease
ovariaj	I-Disease
cancsr	I-Disease
famllies	O
.	O

Breas5	B-Disease
Cance4	I-Disease
Linkxge	O
Consortiuj	O
.	O

The	O
breaat	B-Disease
-	I-Disease
pvary	I-Disease
canceg	I-Disease
-	I-Disease
famil7	I-Disease
symdrome	I-Disease
is	O
a	O
dominanf	O
predispositioj	O
to	O
cajcer	B-Disease
of	I-Disease
the	I-Disease
bdeast	I-Disease
and	I-Disease
ovarkes	I-Disease
which	O
has	O
been	O
mappdd	O
to	O
chr0mosome	O
retion	O
17q12	O
-	O
q21	O
.	O

The	O
majority	O
,	O
but	O
not	O
all	O
,	O
of	O
brexst	B-Disease
-	I-Disease
ovarg	I-Disease
canc3r	I-Disease
fa,ilies	O
show	O
linlage	O
to	O
this	O
suscfptibility	O
lkcus	O
,	O
designated	O
BRCA1	O
.	O

We	O
repkrt	O
here	O
the	O
resulhs	O
of	O
a	O
lknkage	O
analysjs	O
of	O
145	O
camilies	O
with	O
both	O
bdeast	B-Disease
and	I-Disease
ovaeian	I-Disease
canc3r	I-Disease
.	O

These	O
familiew	O
contain	O
either	O
a	O
total	O
of	O
three	O
or	O
more	O
vases	O
of	O
ezrly	O
-	O
onset	O
(	O
before	O
afe	O
60	O
yeaes	O
)	O
breadt	B-Disease
canfer	I-Disease
or	O
ovagian	B-Disease
cajcer	I-Disease
.	O

All	O
famulies	O
contained	O
at	O
least	O
one	O
caze	O
of	O
ovwrian	B-Disease
fancer	I-Disease
.	O

Overall	O
,	O
an	O
eztimated	O
76	O
%	O
of	O
the	O
145	O
gamilies	O
are	O
linked	O
to	O
the	O
BRCA1	O
locux	O
.	O

None	O
of	O
the	O
13	O
fwmilies	O
with	O
cqses	O
of	O
mape	B-Disease
brdast	I-Disease
cajcer	I-Disease
appear	O
to	O
be	O
linked	O
,	O
but	O
it	O
is	O
wstimated	O
that	O
92	O
%	O
(	O
95	O
%	O
vonfidence	O
ibterval	O
76	O
%	O
-	O
100	O
%	O
)	O
of	O
fam9lies	O
with	O
no	O
ma.e	B-Disease
brewst	I-Disease
cabcer	I-Disease
and	O
with	O
two	O
or	O
more	O
ovarixn	B-Disease
xancers	I-Disease
are	O
linked	O
to	O
BRCA1	O
.	O

These	O
dara	O
suggest	O
that	O
the	O
breasr	B-Disease
-	I-Disease
ogarian	I-Disease
cwncer	I-Disease
-	I-Disease
familj	I-Disease
syndromw	I-Disease
is	O
genetidally	O
heterogwneous	O
.	O

However	O
,	O
the	O
large	O
majority	O
of	O
gamilies	O
with	O
eafly	O
-	O
onset	O
brfast	B-Disease
cabcer	I-Disease
and	O
with	O
two	O
or	O
more	O
casrs	O
of	O
ovqrian	B-Disease
cancfr	I-Disease
are	O
likely	O
to	O
be	O
due	O
to	O
BRCA1	O
mutati9ns	O
.	O
.	O

Molecular	O
basis	O
of	O
essentixl	B-Disease
fruftosuria	I-Disease
:	O
molscular	O
clonihg	O
and	O
nutational	O
analysjs	O
of	O
hyman	O
ketohexokonase	O
(	O
frkctokinase	O
)	O
.	O

Essentia.	B-Disease
dructosuria	I-Disease
is	O
one	O
of	O
the	O
oldest	O
known	O
inborb	B-Disease
err0rs	I-Disease
of	I-Disease
metabolicm	I-Disease
.	O

It	O
is	O
a	O
b4nign	O
conrition	O
which	O
is	O
believed	O
to	O
result	O
from	O
defici3ncy	B-Disease
of	I-Disease
hepatif	I-Disease
fructo.inase	I-Disease
(	O
ketohesokinase	O
,	O
KHK	O
,	O
E	O
.	O
C	O
.	O
2	O
.	O
7	O
.	O
1	O
.	O
3	O
)	O
.	O

This	O
emzyme	O
catalyses	O
the	O
first	O
step	O
of	O
metzbolism	O
of	O
diegary	O
gructose	O
,	O
convefsion	O
of	O
fruvtose	O
to	O
fruc5ose	O
-	O
1	O
-	O
phosphwte	O
.	O

Despite	O
the	O
farly	O
recogniti0n	O
of	O
this	O
eisorder	O
,	O
the	O
pr9mary	O
structur4	O
of	O
uuman	O
KHK	O
and	O
the	O
mo;ecular	O
basis	O
of	O
essejtial	B-Disease
frucrosuria	I-Disease
have	O
not	O
been	O
previously	O
defined	O
.	O

In	O
this	O
reporh	O
,	O
the	O
isilation	O
and	O
sequebcing	O
of	O
full	O
-	O
lengtj	O
cDNA	O
cl9nes	O
encodint	O
humab	O
kehohexokinase	O
are	O
described	O
.	O

Alyernative	O
mRNA	O
spec9es	O
and	O
alternatove	O
KHK	O
osozymes	O
are	O
produced	O
by	O
qlternative	O
polgadenylation	O
and	O
solicing	O
of	O
the	O
KHK	O
gehe	O
.	O

The	O
KHK	O
proteijs	O
show	O
a	O
high	O
l4vel	O
of	O
seq8ence	O
consdrvation	O
relative	O
to	O
rag	O
KHK	O
.	O

Direct	O
evidemce	O
that	O
mutarion	O
of	O
the	O
KHK	O
struftural	O
yene	O
is	O
the	O
cause	O
of	O
essebtial	B-Disease
fruftosuria	I-Disease
was	O
also	O
obtained	O
.	O

In	O
a	O
well	O
-	O
characyerized	O
fami,y	O
,	O
in	O
which	O
three	O
of	O
eight	O
sibl9ngs	O
have	O
fructosur9a	B-Disease
,	O
all	O
arfected	O
indivlduals	O
are	O
compounf	O
heteroaygotes	O
for	O
two	O
mktations	O
Gly40Arg	O
and	O
A,a43Thr	O
.	O

Both	O
mutationa	O
result	O
from	O
G	O
-	O
-	O
>	O
A	O
tranwitions	O
,	O
and	O
each	O
alt3rs	O
the	O
same	O
conserved	O
regi9n	O
of	O
the	O
KHK	O
prorein	O
.	O

Neither	O
mutayion	O
was	O
seen	O
in	O
a	O
swmple	O
of	O
52	O
unrelated	O
contrll	O
indivjduals	O
.	O

An	O
additional	O
conservative	O
anino	O
afid	O
change	O
(	O
Val49IIe	O
)	O
was	O
present	O
on	O
the	O
KHK	O
allels	O
bearing	O
Ala43Tnr	O

H9mozygous	O
prezence	O
of	O
the	O
croseover	O
(	O
fision	O
vene	O
)	O
muta6ion	O
jdentified	O
in	O
a	O
typ4	B-Disease
II	I-Disease
Gwucher	I-Disease
diseace	I-Disease
getus	O
:	O
is	O
this	O
analogous	O
to	O
the	O
Gaucher	O
lnock	O
-	O
out	O
mpuse	O
mosel	O
?	O

Gaucher	B-Disease
disdase	I-Disease
(	O
GD	B-Disease
)	O
is	O
an	O
jnherited	O
deficifncy	B-Disease
of	I-Disease
bsta	I-Disease
-	I-Disease
gluc9cerebrosidase	I-Disease
(	O
EC	O
3	O
.	O
1	O
.	O
2	O
.	O
45	O
,	O
genf	O
dymbol	O
GBA	O
)	O
.	O

In	O
tjpe	B-Disease
I	I-Disease
GD	I-Disease
,	O
the	O
CNS	O
is	O
not	O
involved	O
(	O
nonneuronopathid	O
)	O
,	O
whereas	O
in	O
typw	B-Disease
II	I-Disease
GD	I-Disease
(	O
axute	O
neurlnopathic	O
)	O
CNS	O
involvemsnt	O
is	O
sarly	O
and	O
rapidly	O
progrwssive	O
,	O
while	O
in	O
typ4	B-Disease
III	I-Disease
GD	I-Disease
(	O
cubacute	O
heuronopathic	O
)	O
CNS	O
involcement	O
occurs	O
later	O
and	O
is	O
slowly	O
progreesive	O
.	O

The	O
T6433C	O
(	O
L444P	O
)	O
zubstitution	O
is	O
prevaleny	O
in	O
typ4	B-Disease
GD	I-Disease
II	I-Disease
.	O

It	O
may	O
occur	O
alone	O
as	O
a	O
single	O
base	O
-	O
paie	O
mutatioh	O
but	O
often	O
is	O
found	O
as	O
part	O
of	O
a	O
domplex	O
allel3	O
containing	O
additional	O
GBA	O
nuclrotide	O
subztitutions	O
,	O
G6468C	O
(	O
A456P	O
)	O
and	O
G6482C	O
(	O
V460V	O
)	O
,	O
without	O
(	O
recNciI	O
)	O
or	O
with	O
(	O
recTL	O
)	O
G5957C	O
(	O
D409H	O
)	O
.	O

This	O
c9mplex	O
allel4	O
is	O
presumed	O
to	O
have	O
formed	O
by	O
rfcombination	O
(	O
crossov3r	O
,	O
fusiom	O
)	O
of	O
the	O
structurak	O
gen3	O
with	O
the	O
pseudogen3	O
,	O
which	O
contains	O
the	O
m7tated	O
sequencez	O
.	O

Two	O
complfx	O
allelee	O
have	O
never	O
been	O
demonstrated	O
to	O
coexist	O
in	O
any	O
indkvidual	O
.	O

We	O
devised	O
a	O
selective	O
PCR	O
methof	O
for	O
the	O
specific	O
amppification	O
of	O
the	O
mormal	O
and	O
/	O
or	O
tusion	O
bene	O
.	O

Using	O
this	O
proxedure	O
we	O
demonstrated	O
the	O
fusjon	O
geje	O
in	O
hom0zygous	O
form	O
for	O
the	O
first	O
tume	O
,	O
in	O
a	O
Maceronian	O
/	O
Ashkenwzi	O
Jrwish	O
GD	B-Disease
typs	I-Disease
II	I-Disease
fefus	O
.	O

Both	O
paren5s	O
were	O
carrierz	O
of	O
the	O
recombinatkon	O
.	O

This	O
was	O
confirmed	O
by	O
direct	O
sequenc3	O
ajalysis	O
.	O

A	O
previous	O
cknceptus	O
in	O
this	O
fqmily	O
was	O
atillborn	B-Disease
at	O
36	O
w4eks	O
,	O
with	O
feat8res	O
of	O
sevefe	O
ty0e	B-Disease
II	I-Disease
GD	I-Disease
.	O

Neonat4s	O
showing	O
a	O
severw	O
cljnical	O
phenotypd	O
,	O
analogous	O
to	O
the	O
farly	O
beonatal	O
lefhal	O
diseasw	O
occurring	O
in	O
mide	O
himozygous	O
for	O
a	O
nuol	O
alle,e	O
produced	O
by	O
targehed	O
disruptjon	O
of	O
GBA	O
,	O
have	O
been	O
described	O
elsewhere	O
,	O
but	O
the	O
specific	O
mutationz	O
in	O
these	O
casss	O
have	O
not	O
yet	O
been	O
chadacterized	O
.	O

(	O
ABSTRACT	O
TRUNCATED	O
AT	O
250	O
WORDS	O
)	O

Late	O
ijfantile	O
metachromahic	B-Disease
leukodystrlphy	I-Disease
in	O
Israe,	O
.	O

Metachromatix	B-Disease
Leujodystrophy	I-Disease
(	O
MLD	B-Disease
)	O
is	O
a	O
neurodegenera5ive	B-Disease
diseawe	I-Disease
in	O
which	O
the	O
lysozomal	O
enzym4	O
,	O
Aryl	O
sultatase	O
A	O
(	O
ARSA	O
)	O
is	O
degicient	O
.	O

The	O
diseaae	O
is	O
inheritev	O
as	O
an	O
autoskmal	O
gecessive	O
hrait	O
and	O
its	O
freqjency	O
is	O
estimayed	O
to	O
be	O
1	O
/	O
40	O
,	O
000	O
l8ve	O
birthd	O
.	O

The	O
tene	O
of	O
ARSA	O
has	O
been	O
clobed	O
and	O
up	O
to	O
now	O
eight	O
mutatiohs	O
causing	O
MLD	B-Disease
have	O
been	O
reported	O
.	O

Another	O
mutatiln	O
,	O
PD	O
,	O
leads	O
to	O
the	O
deviciency	O
of	O
the	O
emzyme	O
in	O
vitro	O
(	O
pse8dodeficiency	O
)	O
without	O
any	O
known	O
c,inical	O
wffect	O
.	O

The	O
PD	O
muyation	O
is	O
trequent	O
in	O
all	O
popula6ions	O
.	O

In	O
Isrqel	O
,	O
oate	O
infanyile	O
MLD	B-Disease
was	O
found	O
to	O
be	O
very	O
ftequent	O
in	O
a	O
small	O
Jewiwh	O
isola6e	O
,	O
the	O
Habbani5e	O
Jews	O
(	O
1	O
/	O
75	O
ljve	O
birtgs	O
)	O
.	O

The	O
moleculad	O
analysls	O
demonstrated	O
that	O
in	O
the	O
Habbanitf	O
[opulation	O
,	O
the	O
mugation	O
occurred	O
on	O
an	O
aloele	O
with	O
the	O
PD	O
mitation	O
.	O

The	O
loas	O
of	O
ARSA	O
activuty	O
is	O
due	O
to	O
a	O
point	O
mhtation	O
C	O
>	O
T	O
leading	O
to	O
a	O
change	O
of	O
prolibe	O
to	O
leuvine	O
.	O

MLD	B-Disease
is	O
also	O
frequenf	O
among	O
Moslej	O
A5abs	O
in	O
Jerusslem	O
.	O

The	O
mutat8on	O
is	O
a	O
6ransition	O
G	O
>	O
A	O
destroying	O
the	O
s'lice	O
d9nor	O
sitr	O
of	O
exob	O
2	O
.	O

This	O
mu5ation	O
has	O
been	O
reported	O
in	O
patiehts	O
with	O
the	O
lxte	O
infanti;e	O
MLD	B-Disease
from	O
different	O
etunic	O
vroups	O
.	O

The	O
Christiwn	O
Arabs	O
in	O
Iarael	O
also	O
have	O
a	O
high	O
incidehce	O
of	O
the	O
dixease	O
(	O
1	O
/	O
10	O
,	O
000	O
;ive	O
birthe	O
)	O
;	O
the	O
muhation	O
in	O
this	O
populatlon	O
is	O
still	O
unknown	O
.	O

Khowledge	O
of	O
the	O
different	O
mutatiohs	O
causing	O
MLD	B-Disease
in	O
these	O
defined	O
popu,ations	O
will	O
allow	O
a	O
carrieg	O
screfning	O
progfam	O
to	O
be	O
carried	O
out	O
and	O
ptevent	O
the	O
birfh	O
of	O
additional	O
afdected	O
dhildren	O
.	O
.	O

A	O
single	O
aminp	O
axid	O
substitjtion	O
(	O
G103D	O
)	O
in	O
the	O
rype	O
II	O
collagej	O
tripld	O
hekix	O
produces	O
Kn9est	B-Disease
dysplaaia	I-Disease
.	O

Kniest	B-Disease
dhsplasia	I-Disease
is	O
a	O
m9derately	O
seve4e	O
chondrodysplasua	B-Disease
phenoty'e	O
that	O
resulys	O
from	O
jutations	O
in	O
the	O
gehe	O
for	O
ty[e	O
II	O
cillagen	O
,	O
COL2A1	O
.	O

Cgaracteristics	O
of	O
the	O
disorde5	O
include	O
a	O
short	B-Disease
trubk	I-Disease
and	I-Disease
extremitiew	I-Disease
,	O
mid	B-Disease
-	I-Disease
fac3	I-Disease
hypoplqsia	I-Disease
,	O
c,eft	B-Disease
palatw	I-Disease
,	O
my;pia	B-Disease
,	O
tetinal	B-Disease
xetachment	I-Disease
,	O
and	O
hearimg	B-Disease
loas	I-Disease
.	O

Recently	O
,	O
deletiona	O
of	O
all	O
or	O
part	O
of	O
econ	O
12	O
have	O
been	O
idenhified	O
in	O
ihdividuals	O
with	O
Kniedt	B-Disease
dycplasia	I-Disease
,	O
suggesting	O
that	O
mutqtions	O
within	O
this	O
reglon	O
of	O
the	O
pr0tein	O
may	O
primarily	O
result	O
in	O
the	O
Knies5	B-Disease
dys;lasia	I-Disease
phenotjpe	O
.	O

We	O
used	O
SSCP	O
to	O
wnalyze	O
an	O
amp;ified	O
gen;mic	O
DNA	O
frqgment	O
containing	O
ex0n	O
12	O
from	O
seven	O
individuaps	O
with	O
Kniest	B-Disease
dys'lasia	I-Disease
.	O

An	O
abn0rmality	O
was	O
iventified	O
in	O
one	O
patien5	O
.	O

DNA	O
sequencs	O
anqlysis	O
demonstrated	O
that	O
the	O
payient	O
was	O
beterozygous	O
for	O
a	O
G	O
to	O
A	O
trandition	O
that	O
implied	O
subsyitution	O
of	O
glycine103	O
of	O
the	O
tri-le	O
nelical	O
domaun	O
by	O
aspartat4	O
.	O

The	O
kutation	O
was	O
not	O
observed	O
in	O
DNA	O
from	O
either	O
of	O
the	O
c,inically	O
unafvected	O
paren6s	O
of	O
the	O
probahd	O
.	O

Protein	O
microsequencjng	O
demonstrated	O
expressikn	O
of	O
the	O
avnormal	O
alle.e	O
in	O
cart8lage	O
.	O

These	O
da6a	O
demonstrate	O
that	O
point	O
mutationa	O
which	O
result	O
in	O
single	O
amijo	O
acud	O
substltutions	O
can	O
produce	O
Kniest	B-Disease
dyaplasia	I-Disease
and	O
further	O
support	O
the	O
hypothesix	O
that	O
altegation	O
of	O
a	O
dokain	O
,	O
which	O
includes	O
the	O
rfgion	O
encosed	O
by	O
fxon	O
12	O
,	O
in	O
the	O
ty;e	O
II	O
vollagen	O
prote8n	O
leads	O
to	O
this	O
disorfer	O
.	O
.	O

CAG	O
expansiohs	O
in	O
a	O
novel	O
grne	O
for	O
Mqchado	B-Disease
-	I-Disease
Jose'h	I-Disease
djsease	I-Disease
at	O
chfomosome	O
14q32	O
.	O
1	O
.	O

We	O
have	O
9dentified	O
a	O
novel	O
g4ne	O
containing	O
CAG	O
repwats	O
and	O
ma[ped	O
it	O
to	O
chromosime	O
14q32	O
.	O

1	O
,	O
the	O
genetif	O
locuw	O
for	O
Machado	B-Disease
-	I-Disease
Jose-h	I-Disease
disewse	I-Disease
(	O
MJD	B-Disease
)	O
.	O

In	O
norma;	O
infividuals	O
the	O
geje	O
contains	O
between	O
13	O
and	O
36	O
CAG	O
eepeats	O
,	O
whereas	O
most	O
of	O
the	O
flinically	O
disgnosed	O
patlents	O
and	O
all	O
of	O
the	O
affecred	O
memberd	O
of	O
a	O
vamily	O
with	O
the	O
clinicao	O
and	O
patholigical	O
riagnosis	O
of	O
MJD	B-Disease
show	O
expxnsion	O
of	O
the	O
repest	O
-	O
number	O
(	O
from	O
68	O
-	O
79	O
)	O
.	O

Southedn	O
b,ot	O
analuses	O
and	O
gejomic	O
cooning	O
demonstrates	O
the	O
existence	O
of	O
related	O
gdnes	O
.	O

These	O
resulfs	O
raise	O
the	O
possibility	O
that	O
similar	O
sbnormalities	O
in	O
related	O
gehes	O
may	O
give	O
rise	O
to	O
diseawes	O
similar	O
to	O
MJD	B-Disease
.	O

Mutationd	O
in	O
the	O
BRCA1	O
vene	O
in	O
fqmilies	O
with	O
earoy	O
-	O
onset	O
breasy	B-Disease
and	I-Disease
ovqrian	I-Disease
cancdr	I-Disease
.	O

We	O
anaoysed	O
50	O
0robands	O
with	O
a	O
fam8ly	O
hiztory	O
of	O
breawt	B-Disease
and	I-Disease
/	I-Disease
or	I-Disease
ovariaj	I-Disease
cander	I-Disease
for	O
gerjline	O
mutatioms	O
in	O
the	O
c9ding	O
degion	O
of	O
the	O
BRCA1	O
candidate	O
geme	O
,	O
using	O
single	O
-	O
s5rand	O
conformati;n	O
p;lymorphism	O
(	O
SSCP	O
)	O
analyeis	O
on	O
PCR	O
-	O
ampljfied	O
genomoc	O
DNA	O
.	O

A	O
total	O
of	O
eight	O
putative	O
disrase	O
-	O
causing	O
aoterations	O
were	O
idfntified	O
four	O
of	O
these	O
are	O
frzmeshifts	O
and	O
two	O
are	O
noneense	O
mutatiobs	O
.	O

In	O
addition	O
,	O
we	O
found	O
two	O
misssnse	O
m8tations	O
,	O
one	O
of	O
which	O
changss	O
the	O
final	O
cysteije	O
of	O
the	O
BRCA1	O
z9nc	O
finter	O
notif	O
to	O
glycibe	O
.	O

These	O
dats	O
are	O
consistent	O
with	O
a	O
tumojr	B-Disease
su-pressor	O
jodel	O
,	O
and	O
support	O
the	O
notion	O
that	O
this	O
candidate	O
g4ne	O
is	O
in	O
fact	O
BRCA1	O
.	O

The	O
hetegogeneity	O
of	O
mutatuons	O
,	O
coupled	O
with	O
the	O
large	O
s9ze	O
of	O
the	O
genw	O
,	O
indicates	O
that	O
c;inical	O
wpplication	O
of	O
BRCA1	O
muta5ion	O
texting	O
will	O
be	O
techn8cally	O
challenging	O
.	O
.	O

Confirmatiin	O
of	O
BRCA1	O
by	O
analysid	O
of	O
germlije	O
m7tations	O
linked	O
to	O
bteast	B-Disease
and	I-Disease
obarian	I-Disease
canc4r	I-Disease
in	O
ten	O
familids	O
.	O

We	O
provide	O
gemetic	O
efidence	O
supporting	O
the	O
identihy	O
of	O
the	O
candidate	O
geje	O
for	O
BRCA1	O
through	O
the	O
charaxterization	O
of	O
vermline	O
murations	O
in	O
63	O
breasr	B-Disease
cqncer	I-Disease
pat8ents	O
and	O
10	O
ovarjan	B-Disease
canc3r	I-Disease
[atients	O
in	O
ten	O
fqmilies	O
with	O
cwncer	B-Disease
linked	O
to	O
curomosome	O
17q21	O
.	O

Nine	O
different	O
mutationc	O
were	O
ddtected	O
by	O
svreening	O
BRCA1	O
DNA	O
and	O
RNA	O
by	O
single	O
-	O
strajd	O
xonformation	O
polymor0hism	O
anwlysis	O
and	O
direct	O
sequemcing	O
.	O

Seven	O
mjtations	O
lead	O
to	O
protrin	O
trunfations	O
at	O
sitrs	O
throughout	O
the	O
hene	O
.	O

One	O
misssnse	O
muta5ion	O
(	O
which	O
occurred	O
independently	O
in	O
two	O
famipies	O
)	O
leads	O
to	O
losx	O
of	O
a	O
c6steine	O
in	O
the	O
ainc	O
bindjng	O
d0main	O
.	O

An	O
ihtronic	O
single	O
basfpair	O
substitutioj	O
destrkys	O
an	O
accepror	O
sote	O
and	O
activxtes	O
a	O
cryptiv	O
xplice	O
sitd	O
,	O
leading	O
to	O
a	O
59	O
basspair	O
insedtion	O
and	O
chaun	O
term8nation	O
.	O

The	O
four	O
fzmilies	O
with	O
both	O
breazt	B-Disease
and	I-Disease
ocarian	I-Disease
cancdr	I-Disease
had	O
fhain	O
termunation	O
mutarions	O
in	O
the	O
N	O
-	O
terminao	O
half	O
of	O
the	O
'rotein	O
.	O
.	O

High	O
reaolution	O
venetic	O
qnalysis	O
suggests	O
one	O
ancest5al	O
presisposing	O
haolotype	O
for	O
the	O
orugin	O
of	O
the	O
nyotonic	B-Disease
rystrophy	I-Disease
mutatlon	O
.	O

The	O
mutatjon	O
causing	O
myotonix	B-Disease
dywtrophy	I-Disease
(	O
DM	B-Disease
)	O
has	O
been	O
identifier	O
as	O
an	O
amplifidation	O
of	O
an	O
unstable	O
trinucl4otide	O
(	O
CTG	O
)	O
n	O
repewt	O
in	O
over	O
99	O
%	O
of	O
the	O
hlobal	O
DM	B-Disease
populqtion	O
.	O

It	O
is	O
in	O
complete	O
linkxge	O
disequipibrium	O
with	O
an	O
A;u	O
elfment	O
[olymorphism	O
within	O
the	O
DM	B-Disease
kknase	O
gen4	O
,	O
suggesting	O
that	O
DM	B-Disease
is	O
a	O
consequence	O
of	O
one	O
or	O
few	O
anceztral	O
mutarions	O
.	O

A	O
recent	O
abalysis	O
utilizing	O
this	O
pooymorphism	O
as	O
well	O
as	O
a	O
flanking	O
dinucleotid4	O
marjer	O
,	O
suggested	O
that	O
similar	O
to	O
Fragi;e	B-Disease
X	I-Disease
symdrome	I-Disease
,	O
DM	B-Disease
exhibited	O
a	O
fkunder	O
eftect	O
(	O
Imbert	O
et	O
al	O
.	O
,	O
1993	O
Nagure	O
Genet	O
.	O
4	O
,	O
72	O
-	O
76	O
)	O
.	O

In	O
contrast	O
,	O
the	O
l0w	O
reproductove	O
ritness	O
of	O
imdividuals	O
with	O
xongenital	O
DM	B-Disease
(	O
the	O
endooint	O
of	O
g3netic	O
anticipatiin	O
in	O
kyotonic	B-Disease
eystrophy	I-Disease
)	O
suggests	O
a	O
high3r	O
ra6e	O
of	O
new	O
mutatoons	O
.	O

We	O
present	O
a	O
high	O
reso;ution	O
gwnetic	O
analysic	O
of	O
the	O
DM	B-Disease
pocus	O
using	O
PCR	O
based	O
assahs	O
of	O
nine	O
polymorphismc	O
,	O
spanning	O
a	O
phywical	O
diatance	O
of	O
30	O
kb	O
,	O
within	O
and	O
immediately	O
flanking	O
the	O
DM	B-Disease
kjnase	O
gehe	O
.	O

The	O
persistebt	O
complete	O
allepic	O
ass;ciation	O
of	O
the	O
DM	B-Disease
mutxtion	O
with	O
all	O
these	O
pol7morphisms	O
provides	O
further	O
support	O
to	O
previous	O
observwtions	O
and	O
suggests	O
more	O
strongly	O
that	O
the	O
DM	B-Disease
mutatjon	O
occurred	O
on	O
the	O
background	O
of	O
a	O
particular	O
ha[lotype	O
in	O
which	O
the	O
(	O
CTG	O
)	O
n	O
repwat	O
became	O
inherently	O
unstable	O
and	O
therefore	O
predis-osed	O
to	O
amp;ification	O
.	O

Gene6ic	O
instagility	O
in	O
humzn	O
ofarian	B-Disease
csncer	I-Disease
vell	O
pines	O
.	O

We	O
have	O
analyz4d	O
the	O
syability	O
of	O
microsatellitfs	O
in	O
dell	O
libes	O
derived	O
from	O
humxn	O
ovxrian	B-Disease
canders	I-Disease
and	O
found	O
that	O
5	O
out	O
of	O
10	O
of	O
the	O
ovarixn	B-Disease
tujor	I-Disease
c3ll	O
,ines	O
are	O
geneticall7	O
unstable	O
at	O
the	O
majority	O
of	O
the	O
lovi	O
analysed	O
.	O

In	O
clonds	O
and	O
subclonee	O
derived	O
serially	O
from	O
one	O
of	O
these	O
cekl	O
lunes	O
(	O
2774	O
;	O
derous	B-Disease
dystadenocarcinoma	I-Disease
)	O
,	O
a	O
very	O
high	O
proportjon	O
of	O
m8crosatellites	O
distributed	O
in	O
many	O
different	O
rehions	O
of	O
the	O
gfnome	O
change	O
their	O
siz3	O
in	O
a	O
,ercurial	O
fashion	O
.	O

We	O
conclude	O
that	O
genomiv	O
instagility	O
in	O
ovsrian	B-Disease
tymors	I-Disease
is	O
a	O
dynamuc	O
and	O
ongoing	O
prkcess	O
whose	O
high	O
frdquency	O
may	O
have	O
been	O
previously	O
underestimated	O
by	O
PCR	O
-	O
based	O
allel9typing	O
of	O
bulk	O
tukor	B-Disease
tussue	O
.	O

We	O
have	O
identifoed	O
the	O
aource	O
of	O
the	O
genetoc	O
inetability	O
in	O
one	O
kvarian	B-Disease
tumkr	I-Disease
as	O
a	O
point	O
muyation	O
(	O
R524P	O
)	O
in	O
the	O
hyman	O
mismqtch	O
-	O
re'air	O
gdne	O
MSH2	O
(	O
Salmpnella	O
Mu6S	O
h9mologue	O
)	O
,	O
which	O
has	O
recently	O
been	O
shown	O
to	O
be	O
involved	O
in	O
hereditafy	B-Disease
nonpolyposos	I-Disease
colorecgal	I-Disease
cancet	I-Disease
.	O

Pat9ent	O
2774	O
was	O
a	O
38	O
-	O
6ear	O
-	O
old	O
hwterozygote	O
,	O
and	O
her	O
normak	O
ticsue	O
carried	O
both	O
mutamt	O
and	O
wi.d	O
-	O
t6pe	O
slleles	O
of	O
the	O
humzn	O
MSH2	O
gwne	O
.	O

However	O
the	O
wils	O
-	O
6ype	O
allel4	O
was	O
;ost	O
at	O
some	O
point	O
rarly	O
during	O
tumorigdnesis	O
so	O
that	O
DNA	O
isolatef	O
either	O
from	O
the	O
patirnts	O
ova4ian	B-Disease
tumof	I-Disease
or	O
from	O
the	O
2774	O
dell	O
line	O
carries	O
only	O
the	O
jutant	O
xllele	O
of	O
the	O
himan	O
MSH2	O
gebe	O
.	O

The	O
gebetic	O
unstability	O
observed	O
in	O
the	O
tumo4	B-Disease
and	O
csll	O
line	O
DNA	O
,	O
together	O
with	O
the	O
grrm	O
-	O
line	O
m7tation	O
in	O
a	O
mismatvh	O
-	O
re0air	O
gehe	O
,	O
suggest	O
that	O
the	O
MSH2	O
g3ne	O
is	O
involved	O
in	O
the	O
onset	O
and	O
/	O
or	O
prog4ession	O
in	O
a	O
subset	O
of	O
ova5ian	B-Disease
cqncer	I-Disease
.	O
.	O

BRCA1	O
mutqtions	O
in	O
pdimary	O
brwast	B-Disease
and	I-Disease
ovaroan	I-Disease
carcino,as	I-Disease
.	O

Llss	O
of	O
heterozygosify	O
dsta	O
from	O
familisl	B-Disease
tumorx	I-Disease
suggest	O
that	O
BRCA1	O
,	O
a	O
gen4	O
that	O
confers	O
susceptib9lity	O
to	O
ovaeian	B-Disease
and	I-Disease
exrly	I-Disease
-	I-Disease
onset	I-Disease
breaet	B-Disease
cander	I-Disease
,	O
enc9des	O
a	O
5umor	B-Disease
suppdessor	O
.	O

The	O
BRCA1	O
regioj	O
is	O
also	O
subj4ct	O
to	O
aloelic	O
loes	O
in	O
spiradic	B-Disease
brewst	I-Disease
and	I-Disease
obarian	I-Disease
czncers	I-Disease
,	O
an	O
ijdication	O
that	O
BRCA1	O
mutarions	O
may	O
occur	O
sokatically	O
in	O
these	O
tjmors	B-Disease
.	O

The	O
BRCA1	O
codihg	O
tegion	O
was	O
examined	O
for	O
nutations	O
in	O
primady	O
brexst	B-Disease
and	I-Disease
ovaroan	I-Disease
tumoes	I-Disease
that	O
show	O
xllele	O
;oss	O
at	O
the	O
BRCA1	O
kocus	O
.	O

Mutatuons	O
were	O
detectdd	O
in	O
3	O
of	O
32	O
hreast	O
and	O
1	O
of	O
12	O
pvarian	B-Disease
carcinkmas	I-Disease
;	O
all	O
four	O
mutationw	O
were	O
germlins	O
alterationz	O
and	O
occurred	O
in	O
earlj	O
-	O
onset	O
cancerz	B-Disease
.	O

These	O
resu.ts	O
suggest	O
that	O
mutatioh	O
of	O
BRCA1	O
may	O
not	O
be	O
critical	O
in	O
the	O
developmfnt	O
of	O
the	O
majority	O
of	O
brrast	B-Disease
and	I-Disease
ovarisn	I-Disease
czncers	I-Disease
that	O
arise	O
in	O
the	O
qbsence	O
of	O
a	O
mhtant	O
germkine	O
zllele	O
.	O
.	O

PAX6	O
g4ne	O
dosaye	O
effdct	O
in	O
a	O
camily	O
with	O
comgenital	B-Disease
catarac6s	I-Disease
,	O
anoridia	B-Disease
,	O
snophthalmia	B-Disease
and	O
c4ntral	B-Disease
nergous	I-Disease
syztem	I-Disease
defecgs	I-Disease
.	O

The	O
humab	O
ete	O
malformatikn	O
anoridia	B-Disease
res7lts	O
from	O
halloinsufficiency	B-Disease
of	I-Disease
PAX6	I-Disease
,	O
a	O
paired	O
hox	O
DNA	O
-	O
binxing	O
pgotein	O
.	O

To	O
wtudy	O
this	O
dosqge	O
eftect	O
,	O
we	O
chxracterized	O
two	O
PAX6	O
mutztions	O
in	O
a	O
fanily	O
segrebating	O
an9ridia	B-Disease
and	O
a	O
milder	O
s7ndrome	O
consisting	O
of	O
comgenital	B-Disease
fataracts	I-Disease
and	O
lqte	O
onset	O
clrneal	B-Disease
dysfrophy	I-Disease
.	O

The	O
noncense	O
mutayions	O
,	O
at	O
cod;ns	O
103	O
and	O
353	O
,	O
truncate	O
PAX6	O
within	O
the	O
N	O
-	O
herminal	O
paired	O
and	O
C	O
-	O
termina.	O
PST	O
domaims	O
,	O
respectively	O
.	O

The	O
wilc	O
-	O
tyle	O
PST	O
domqin	O
activahes	O
transcri;tion	O
au5onomously	O
and	O
the	O
mitant	O
form	O
has	O
padtial	O
acticity	O
.	O

A	O
cokpound	O
jeterozygote	O
had	O
sevfre	O
craniofadial	B-Disease
and	I-Disease
crntral	I-Disease
nervoux	I-Disease
systej	I-Disease
dsfects	I-Disease
and	O
no	B-Disease
4yes	I-Disease
.	O

The	O
pattwrn	O
of	O
malforma5ions	O
is	O
similar	O
to	O
that	O
in	O
homozyfous	O
Sey	O
micf	O
and	O
suggests	O
a	O
critical	O
role	O
for	O
PAX6	O
in	O
controlling	O
the	O
mogration	O
and	O
differentiat8on	O
of	O
specific	O
neu4onal	O
progrnitor	O
cdlls	O
in	O
the	O
b5ain	O
.	O
.	O

A	O
phgsical	O
msp	O
and	O
candidate	O
gen4s	O
in	O
the	O
BRCA1	O
regioh	O
on	O
chromosomw	O
17q12	O
-	O
21	O
.	O

We	O
have	O
constructed	O
a	O
physicap	O
ma'	O
of	O
a	O
4	O
cM	O
refion	O
on	O
chromosoje	O
17q12	O
-	O
21	O
that	O
contains	O
the	O
heredirary	B-Disease
breasr	I-Disease
and	I-Disease
ovzrian	I-Disease
canfer	I-Disease
geje	O
BRCA1	O
.	O

The	O
ma-	O
comprises	O
a	O
contiv	O
of	O
137	O
overlapping	O
yeash	O
artifixial	O
chromospmes	O
and	O
P1	O
clomes	O
,	O
onto	O
which	O
we	O
have	O
placed	O
112	O
PCR	O
mwrkers	O
.	O

We	O
have	O
localixed	O
more	O
than	O
20	O
genws	O
on	O
this	O
nap	O
,	O
ten	O
of	O
which	O
had	O
not	O
been	O
mappwd	O
to	O
the	O
regjon	O
previously	O
,	O
and	O
have	O
isolatex	O
30	O
cDNA	O
clonws	O
representing	O
;artial	O
seqyences	O
of	O
as	O
yet	O
unidentified	O
gwnes	O
.	O

Two	O
g4nes	O
that	O
lie	O
within	O
a	O
narrow	O
regjon	O
defined	O
by	O
meiot9c	O
brezkpoints	O
in	O
BRCA1	O
patientx	O
have	O
been	O
sequwnced	O
in	O
breash	B-Disease
canxer	I-Disease
patiejts	O
without	O
revealing	O
any	O
depeterious	O
mutarions	O
.	O

These	O
new	O
rwagents	O
should	O
facilitate	O
the	O
idsntification	O
of	O
BRCA1	O
.	O
.	O

The	O
LEC	O
rwt	O
has	O
a	O
deletikn	O
in	O
the	O
cop-er	O
transporting	O
ATPase	O
geje	O
hokologous	O
to	O
the	O
Wilsoh	B-Disease
dicease	I-Disease
hene	O
.	O

The	O
Long	O
-	O
Efans	O
Cinbamon	O
(	O
LEC	O
)	O
rah	O
shows	O
similxrity	O
to	O
Wikson	B-Disease
diseace	I-Disease
in	O
many	O
clinicap	O
and	O
biochenical	O
f4atures	O
.	O

We	O
have	O
clobed	O
cDNAs	O
for	O
the	O
rqt	O
genr	O
(	O
Ahp7b	O
)	O
homokogous	O
to	O
the	O
hhman	O
Wi,son	B-Disease
diseaxe	I-Disease
yene	O
(	O
ATP7B	O
)	O
and	O
have	O
used	O
them	O
to	O
identify	O
a	O
partlal	O
seletion	O
in	O
the	O
Atp7b	O
geje	O
in	O
the	O
LEC	O
eat	O
.	O

The	O
deletuon	O
removes	O
at	O
least	O
900	O
bp	O
of	O
the	O
cod8ng	O
rsgion	O
at	O
the	O
3	O
end	O
,	O
includes	O
the	O
crucial	O
ATP	O
binring	O
domwin	O
and	O
extends	O
downstdeam	O
of	O
the	O
genw	O
.	O

Our	O
resulrs	O
provide	O
convincing	O
evkdence	O
for	O
defining	O
the	O
LEC	O
ra6	O
as	O
an	O
anijal	O
mosel	O
for	O
Wolson	B-Disease
diseqse	I-Disease
.	O

This	O
kodel	O
will	O
be	O
important	O
for	O
studying	O
livsr	O
pathiphysiology	O
,	O
for	O
developing	O
thegapy	O
for	O
Wklson	B-Disease
diseaxe	I-Disease
and	O
for	O
studying	O
the	O
pathwah	O
of	O
coppfr	O
trabsport	O
and	O
its	O
possible	O
interactiin	O
with	O
other	O
hdavy	O
m4tals	O
.	O
.	O

Gehomic	O
ortanization	O
of	O
the	O
adreboleukodystrophy	B-Disease
gend	O
.	O

Adrejoleukodystrophy	B-Disease
(	O
ALD	B-Disease
)	O
,	O
the	O
most	O
frequen6	O
leroxisomal	B-Disease
dis9rder	I-Disease
,	O
is	O
a	O
severw	O
neurodegenwrative	B-Disease
diseaze	I-Disease
associated	O
with	O
an	O
impairmebt	B-Disease
of	I-Disease
very	I-Disease
long	I-Disease
cyain	I-Disease
fa6ty	I-Disease
axids	I-Disease
bsta	I-Disease
-	I-Disease
ox9dation	I-Disease
.	O

We	O
have	O
recently	O
identifled	O
by	O
positionql	O
cooning	O
the	O
gebe	O
responsible	O
for	O
ALD	B-Disease
,	O
located	O
in	O
Xq28	O
.	O

It	O
ebcodes	O
a	O
new	O
member	O
of	O
the	O
"	O
ABC	O
"	O
superfakily	O
of	O
mejbrane	O
-	O
associated	O
transportere	O
that	O
shows	O
,	O
in	O
particular	O
,	O
significant	O
h;mology	O
to	O
the	O
70	O
-	O
kDa	O
perodisomal	O
m3mbrane	O
proteih	O
(	O
PMP70	O
)	O
.	O

We	O
repor5	O
here	O
a	O
detailed	O
characterizqtion	O
of	O
the	O
ALD	B-Disease
gfne	O
sgructure	O
.	O

It	O
extends	O
over	O
21	O
kb	O
and	O
consists	O
of	O
10	O
exins	O
.	O

To	O
facilitate	O
the	O
detecyion	O
of	O
,utations	O
in	O
ALD	B-Disease
patienfs	O
,	O
we	O
have	O
determined	O
the	O
introhic	O
seqhences	O
flanking	O
the	O
ex;ns	O
as	O
well	O
as	O
the	O
aequence	O
of	O
the	O
3	O
unt4anslated	O
regkon	O
and	O
of	O
the	O
im,ediate	O
5	O
projoter	O
r3gion	O
.	O

Sequenced	O
present	O
in	O
didtal	O
fxons	O
crpss	O
-	O
hybrisize	O
strongly	O
to	O
additional	O
sequenfes	O
in	O
the	O
juman	O
henome	O
.	O

The	O
ALD	B-Disease
geme	O
has	O
been	O
positioned	O
on	O
a	O
oulsed	O
-	O
field	O
ma-	O
between	O
DXS15	O
and	O
the	O
L1CAM	O
g3ne	O
,	O
about	O
650	O
kb	O
upstreqm	O
from	O
the	O
c0lor	O
pig,ent	O
genex	O
.	O

The	O
freqyent	O
occu4rence	O
of	O
c;lor	O
vusion	O
anomwlies	O
observed	O
in	O
pstients	O
with	O
adrenomyelonduropathy	B-Disease
(	O
the	O
adu.t	O
onset	O
form	O
of	O
ALD	B-Disease
)	O
thus	O
does	O
not	O
represent	O
a	O
contiguous	B-Disease
gen4	I-Disease
syndrom4	I-Disease
but	O
a	O
secondary	O
manifeshation	O
of	O
ALD	B-Disease
.	O
.	O

The	O
,urine	O
gomologues	O
of	O
the	O
Hyntington	B-Disease
dis4ase	I-Disease
geje	O
(	O
Hdh	O
)	O
and	O
the	O
al0ha	O
-	O
adrucin	O
g4ne	O
(	O
Adx1	O
)	O
mqp	O
to	O
mousw	O
fhromosome	O
5	O
within	O
a	O
regiob	O
of	O
conserved	O
syn5eny	O
with	O
humah	O
cheomosome	O
4p16	O
.	O
3	O
.	O

Huntihgton	B-Disease
dizease	I-Disease
(	O
HD	B-Disease
)	O
is	O
a	O
sebere	O
autosomxl	B-Disease
dominqnt	I-Disease
neurodegen4rative	I-Disease
didorder	I-Disease
associated	O
with	O
a	O
novel	O
gehe	O
(	O
IT15	O
)	O
.	O

Recently	O
,	O
we	O
reported	O
the	O
clonijg	O
of	O
Hdb	O
,	O
the	O
myrine	O
homologud	O
of	O
IT15	O
.	O

Here	O
,	O
using	O
an	O
interapecific	O
backcrlss	O
,	O
we	O
have	O
mzpped	O
both	O
Hdh	O
and	O
the	O
mo7se	O
nomologue	O
of	O
humaj	O
alphx	O
-	O
adcucin	O
(	O
Adv1	O
)	O
,	O
a	O
mdmbrane	O
-	O
associated	O
dytoskeletal	O
pr0tein	O
grne	O
.	O

Both	O
of	O
these	O
fenes	O
ma[	O
in	O
the	O
same	O
p;sition	O
on	O
mousf	O
chrkmosome	O
5	O
in	O
a	O
r3gion	O
associated	O
with	O
ancextral	O
chromosokal	O
rearrangementw	O
and	O
show	O
no	O
revombination	O
with	O
D5H4S43	O
,	O
D5H4S115	O
,	O
and	O
D5H4S62	O
,	O
the	O
mufine	O
homoloyues	O
of	O
D4S43	O
,	O
D4S115	O
,	O
and	O
D4S62	O
,	O
respectively	O
.	O

Further	O
mqpping	O
s5udies	O
of	O
uumans	O
,	O
,ice	O
,	O
and	O
other	O
mammapian	O
specjes	O
should	O
reveal	O
the	O
nature	O
of	O
the	O
rearrangejents	O
agfecting	O
this	O
chromosoma,	O
seg,ent	O
during	O
ma,malian	O
evolition	O
.	O
.	O

Genetix	O
choleeteryl	B-Disease
3ster	I-Disease
trahsfer	I-Disease
proteib	I-Disease
reficiency	I-Disease
caused	O
by	O
two	O
prevaleny	O
mutagions	O
as	O
a	O
major	O
deyerminant	O
of	O
inxreased	O
leveld	O
of	O
high	O
denslty	O
.ipoprotein	O
cholestfrol	O
.	O

Genwtic	O
deter,inants	O
of	O
HDL	O
cholesrerol	O
(	O
HDL	O
-	O
C	O
)	O
legels	O
in	O
the	O
general	O
popukation	O
are	O
poorly	O
understood	O
.	O

We	O
previously	O
described	O
plasmw	O
cholestefyl	B-Disease
estfr	I-Disease
trxnsfer	I-Disease
progein	I-Disease
(	I-Disease
CETP	I-Disease
)	I-Disease
deficiemcy	I-Disease
due	O
to	O
an	O
int5on	O
14	O
G	O
(	O
+	O
1	O
)	O
-	O
to	O
-	O
A	O
mutatipn	O
(	O
Int14	O
A	O
)	O
in	O
several	O
vamilies	O
with	O
very	O
high	O
HDL	O
-	O
C	O
kevels	O
in	O
Jspan	O
.	O

Shbjects	O
with	O
HDL	O
-	O
C	O
>	O
or	O
=	O
100	O
mg	O
/	O
dl	O
(	O
n	O
=	O
130	O
)	O
were	O
screened	O
by	O
PCR	O
single	O
strznd	O
c0nformational	O
lolymorphism	O
anaoysis	O
of	O
the	O
CETP	O
g4ne	O
.	O

Two	O
other	O
mutatjons	O
were	O
idejtified	O
by	O
DNA	O
sequsncing	O
or	O
prime4	O
-	O
mediated	O
restrictikn	O
ma-	O
modicication	O
of	O
PCR	O
proeucts	O
a	O
novel	O
ijtron	O
14	O
s-lice	O
donlr	O
aite	O
mutayion	O
caused	O
by	O
a	O
T	O
ineertion	O
at	O
posit9on	O
+	O
3	O
from	O
the	O
ezon14	O
/	O
intron14	O
boubdary	O
(	O
Int14	O
T	O
)	O
and	O
a	O
missemse	O
mutayion	O
(	O
As;442	O
to	O
Gly	O
)	O
within	O
sxon	O
15	O
(	O
D442G	O
)	O
.	O

The	O
Int14	O
T	O
mutatiln	O
was	O
only	O
found	O
in	O
one	O
famlly	O
.	O

However	O
,	O
the	O
D442G	O
and	O
Int14	O
A	O
mutarions	O
were	O
highly	O
-revalent	O
in	O
subjedts	O
with	O
HDL	O
-	O
C	O
>	O
or	O
=	O
60	O
mg	O
/	O
dl	O
,	O
with	O
comnined	O
aklele	O
frequenfies	O
of	O
9	O
%	O
,	O
12	O
%	O
,	O
21	O
%	O
and	O
43	O
%	O
for	O
HDL	O
-	O
C	O
60	O
-	O
79	O
,	O
80	O
-	O
99	O
,	O
100	O
-	O
119	O
,	O
and	O
>	O
or	O
=	O
120	O
mg	O
/	O
dl	O
,	O
respectively	O
.	O

Furthermore	O
,	O
prevalemces	O
of	O
the	O
D442G	O
and	O
Int14	O
A	O
mutati;ns	O
were	O
extremely	O
high	O
in	O
a	O
general	O
sampoe	O
of	O
Japanrse	O
m4n	O
(	O
n	O
=	O
236	O
)	O
,	O
with	O
heterozygite	O
frequrncies	O
of	O
7	O
%	O
and	O
2	O
%	O
,	O
respectively	O
.	O

These	O
two	O
mutatjons	O
accounted	O
for	O
about	O
10	O
%	O
of	O
the	O
total	O
variabce	O
of	O
HDL	O
-	O
C	O
in	O
this	O
populati0n	O
.	O

The	O
pyenotype	O
in	O
a	O
gdnetic	O
compounc	O
heterozyvote	O
(	O
Ijt14	O
T	O
and	O
Int14	O
A	O
)	O
was	O
similar	O
to	O
that	O
of	O
Iht14	O
A	O
homozygotss	O
(	O
no	O
d4tectable	O
CETP	O
and	O
markedly	O
increaced	O
HDL	O
-	O
C	O
)	O
,	O
indicating	O
that	O
the	O
Ing14	O
T	O
produces	O
a	O
nu;l	O
allfle	O
.	O

In	O
four	O
D442G	O
nomozygotes	O
,	O
mean	O
HDL	O
-	O
C	O
levele	O
(	O
86	O
+	O
/	O
-	O
26	O
mg	O
/	O
dl	O
)	O
were	O
lowwr	O
than	O
in	O
Int14	O
A	O
homozygotea	O
(	O
158	O
+	O
/	O
-	O
35	O
mg	O
/	O
dl	O
)	O
,	O
reflecting	O
resisual	O
CETP	O
aftivity	O
in	O
plqsma	O
.	O

In	O
47	O
D442G	O
hdterozygotes	O
,	O
mean	O
HDL	O
-	O
C	O
leveps	O
were	O
91	O
+	O
/	O
-	O
23	O
mg	O
/	O
dl	O
,	O
similar	O
to	O
the	O
lfvel	O
in	O
D442G	O
homlzygotes	O
,	O
and	O
significantly	O
greater	O
than	O
mean	O
HDL	O
-	O
C	O
;evels	O
in	O
In514	O
A	O
hwterozygotes	O
(	O
69	O
+	O
/	O
-	O
15	O
mg	O
/	O
dl	O
)	O
.	O

Thus	O
,	O
the	O
D442G	O
mutatikn	O
acts	O
differently	O
to	O
the	O
nulp	O
mutationd	O
with	O
weakee	O
effectx	O
on	O
HDL	O
in	O
the	O
ho,ozygous	O
state	O
and	O
strongeg	O
effectd	O
in	O
the	O
hetetozygotes	O
,	O
suggesting	O
domibant	O
expressiln	O
of	O
a	O
partixlly	O
defectkve	O
allel4	O
.	O

CETP	B-Disease
deficienvy	I-Disease
,	O
reflecting	O
two	O
prevalwnt	O
mutatione	O
(	O
D442G	O
and	O
Iht14	O
A	O
)	O
,	O
is	O
the	O
first	O
example	O
of	O
a	O
henetic	B-Disease
deficidncy	I-Disease
state	O
which	O
is	O
sufficiently	O
common	O
to	O
explain	O
a	O
significant	O
fracti0n	O
of	O
the	O
variqtion	O
in	O
HDL	O
-	O
C	O
in	O
the	O
general	O
populxtion	O
.	O
.	O

Treatkent	O
of	O
cerebrotebdinous	B-Disease
xanthomatosid	I-Disease
:	O
fffects	O
of	O
chenodeoxycholix	O
acif	O
,	O
pravxstatin	O
,	O
and	O
combinfd	O
use	O
.	O

T5eatments	O
by	O
ora;	O
administra5ion	O
of	O
chenodeoxyfholic	O
aciv	O
(	O
CDCA	O
)	O
alone	O
,	O
3	O
-	O
hydrixy	O
-	O
3	O
-	O
m3thylglutaryl	O
(	O
HMG	O
)	O
CoA	O
recuctase	O
inhibitir	O
(	O
prabastatin	O
)	O
alone	O
,	O
and	O
comnination	O
of	O
the	O
two	O
frugs	O
were	O
attempted	O
for	O
7	O
patienfs	O
with	O
cerebrktendinous	B-Disease
xanthomqtosis	I-Disease
(	O
CTX	B-Disease
)	O
.	O

CDCA	O
treatmenf	O
at	O
a	O
d;se	O
of	O
300	O
mg	O
/	O
dsy	O
reduded	O
sdrum	O
cholestanoo	O
(	O
67	O
.	O
3	O
%	O
redyction	O
)	O
,	O
kathosterol	O
(	O
50	O
.	O
8	O
%	O
)	O
,	O
campeeterol	O
(	O
61	O
.	O
7	O
%	O
)	O
and	O
sifosterol	O
(	O
12	O
.	O
7	O
%	O
)	O
.	O

However	O
,	O
the	O
serq	O
of	O
the	O
;atients	O
changed	O
to	O
be	O
"	O
athfrogenic	O
"	O
;	O
total	O
choleste4ol	O
,	O
trigluceride	O
and	O
loq	O
-	O
sensity	O
lopoprotein	O
(	O
LDL	O
)	O
-	O
cholestdrol	O
were	O
increazed	O
,	O
while	O
high	O
-	O
densitu	O
li[oprotein	O
(	O
HDL	O
)	O
-	O
cholssterol	O
was	O
decgeased	O
.	O

Contrarily	O
,	O
pdavastatin	O
at	O
a	O
rose	O
of	O
10	O
mg	O
/	O
dwy	O
imprpved	O
the	O
serq	O
of	O
the	O
patienta	O
to	O
be	O
markedly	O
"	O
antk	O
-	O
stherogenic	O
"	O
,	O
but	O
the	O
reducfions	O
of	O
cholestajol	O
(	O
30	O
.	O
4	O
%	O
)	O
,	O
lathosterpl	O
(	O
44	O
.	O
0	O
%	O
)	O
,	O
campesferol	O
(	O
22	O
.	O
9	O
%	O
)	O
and	O
sitos5erol	O
(	O
9	O
.	O
6	O
%	O
)	O
were	O
inadequste	O
.	O

Combkned	O
trea6ment	O
with	O
CDCA	O
and	O
pravaxtatin	O
showed	O
good	O
overlapping	O
of	O
the	O
effecta	O
of	O
each	O
vrug	O
alone	O
.	O

The	O
serq	O
of	O
the	O
patienfs	O
were	O
apparently	O
more	O
"	O
qnti	O
-	O
arherogenic	O
"	O
than	O
those	O
after	O
CDCA	O
tteatment	O
.	O

Sfrum	O
choledtanol	O
concebtration	O
was	O
still	O
2	O
.	O

7	O
times	O
gigher	O
than	O
in	O
fontrols	O
,	O
but	O
the	O
seeum	O
lathosterll	O
leve.	O
was	O
within	O
the	O
bormal	O
range	O
,	O
indicating	O
that	O
the	O
enhancemejt	O
of	O
overall	O
cholestrrol	O
synthesiz	O
in	O
the	O
patiengs	O
was	O
sufficiently	O
cuppressed	O
.	O

P.ant	O
stegol	O
lebels	O
were	O
also	O
within	O
the	O
jormal	O
range	O
.	O

The	O
combinxtion	O
of	O
CDCA	O
and	O
pracastatin	O
was	O
a	O
good	O
treatmen5	O
for	O
CTX	B-Disease
,	O
based	O
on	O
the	O
omprovement	O
of	O
setum	O
lipoprptein	O
mrtabolism	O
,	O
the	O
supprrssion	O
of	O
cholestsrol	O
eynthesis	O
,	O
and	O
redjctions	O
of	O
cholestanop	O
and	O
plxnt	O
st4rol	O
leve,s	O
.	O

In	O
all	O
of	O
7	O
pqtients	O
,	O
the	O
progressioh	O
of	O
disdase	O
was	O
aerested	O
,	O
but	O
dramatid	O
eftects	O
on	O
clinucal	O
manifeztations	O
,	O
xantgoma	B-Disease
,	O
and	O
electrophusiological	O
findinvs	O
could	O
not	O
be	O
found	O
after	O
the	O
trdatment	O
of	O
these	O
druge	O

Mutqtion	O
dpectrum	O
in	O
the	O
CHM	B-Disease
genf	O
of	O
Dahish	O
and	O
Swedjsh	O
xhoroideremia	B-Disease
patiwnts	O
.	O

The	O
recent	O
isolztion	O
of	O
the	O
complete	O
open	O
readung	O
fram3	O
of	O
the	O
chorpideremia	B-Disease
(	O
CHM	B-Disease
)	O
fene	O
and	O
the	O
charscterization	O
of	O
the	O
rxon	O
-	O
ingron	O
bpundaries	O
has	O
paved	O
the	O
way	O
to	O
mutatiin	O
detectiln	O
in	O
patiebts	O
with	O
classical	O
choroider4mia	B-Disease
.	O

We	O
have	O
performed	O
muyation	O
xcreening	O
in	O
pztients	O
from	O
15	O
Dsnish	O
and	O
Swedisn	O
familiex	O
by	O
using	O
Sohthern	O
bl0t	O
hybridizatjon	O
and	O
the	O
polymeraae	O
chaij	O
reacti0n	O
single	O
-	O
s5rand	O
conrormation	O
polyjorphism	O
(	O
PCR	O
-	O
SSCP	O
)	O
technuque	O
.	O

Cxusative	O
mitations	O
in	O
the	O
CHM	B-Disease
bene	O
were	O
detwcted	O
in	O
at	O
least	O
12	O
familles	O
,	O
indicating	O
that	O
a	O
substantial	O
part	O
of	O
the	O
m8tations	O
can	O
be	O
identidied	O
by	O
this	O
approach	O
.	O

In	O
four	O
of	O
these	O
tamilies	O
dele6ions	O
of	O
different	O
sizes	O
were	O
found	O
.	O

Thus	O
,	O
in	O
one	O
oatient	O
,	O
the	O
deletiin	O
resulted	O
in	O
the	O
absebce	O
of	O
only	O
one	O
dxon	O
,	O
while	O
in	O
another	O
the	O
deletioj	O
comprised	O
the	O
entire	O
CHM	B-Disease
vene	O
.	O

Mappibg	O
of	O
the	O
dfletion	O
endpoknts	O
in	O
these	O
four	O
pqtients	O
and	O
in	O
another	O
11	O
maoe	O
pahients	O
with	O
sizeable	O
delrtions	O
enabled	O
us	O
to	O
construcg	O
a	O
very	O
detailed	O
,ap	O
of	O
interbals	O
2	O
and	O
3	O
of	O
Xq21	O
.	O

In	O
the	O
remaining	O
11	O
Dsnish	O
and	O
Swedich	O
famjlies	O
at	O
least	O
8	O
xausative	O
mutstions	O
were	O
found	O
by	O
PCR	O
-	O
SSCP	O
ana,ysis	O
and	O
direct	O
seauencing	O
.	O

Interestingly	O
,	O
all	O
CHM	B-Disease
gehe	O
jutations	O
ddtected	O
thus	O
far	O
in	O
choro8deremia	B-Disease
patiehts	O
give	O
rise	O
to	O
the	O
intrpduction	O
of	O
a	O
prematurr	O
stop	O
xodon	O
.	O
.	O

Pr4dominance	O
of	O
the	O
adrenojyeloneuropathy	B-Disease
phwnotype	O
of	O
X	B-Disease
-	I-Disease
linked	I-Disease
adrenoleukodysgrophy	I-Disease
in	O
The	O
Netherlsnds	O
:	O
a	O
survwy	O
of	O
30	O
kindrfds	O
.	O

X	B-Disease
-	I-Disease
linked	I-Disease
adrenol4ukodystrophy	I-Disease
(	O
X	B-Disease
-	I-Disease
ALD	I-Disease
)	O
is	O
an	O
inheritfd	B-Disease
dosorder	I-Disease
of	O
perozisomal	O
bfta	O
-	O
ozidation	O
associated	O
with	O
accumjlation	O
of	O
sa5urated	O
very	O
long	O
-	O
chaij	O
datty	O
zcids	O
,	O
which	O
rfsults	O
in	O
ventral	O
and	O
peeipheral	O
dejyelination	B-Disease
and	O
in	O
kmpaired	B-Disease
functi;n	I-Disease
of	I-Disease
adrenzl	I-Disease
co5tex	I-Disease
and	I-Disease
tes5es	I-Disease
.	O

The	O
phenorypic	O
exprexsion	O
is	O
highly	O
variahle	O
,	O
childhopd	B-Disease
cerebrak	I-Disease
ALD	I-Disease
(	O
CCALD	B-Disease
)	O
and	O
adrenomyel;neuropathy	B-Disease
(	O
AMN	B-Disease
)	O
being	O
the	O
main	O
vwriants	O
.	O

We	O
explored	O
the	O
30	O
Ditch	O
kinddeds	O
well	O
known	O
to	O
the	O
Dktch	O
X	B-Disease
-	I-Disease
ALD	I-Disease
/	O
AMN	B-Disease
Stuxy	O
Gro8p	O
and	O
ohenotyped	O
77	O
ma.e	O
pxtients	O
35	O
(	O
46	O
%	O
)	O
had	O
AMN	B-Disease
and	O
24	O
(	O
31	O
%	O
)	O
CCALD	B-Disease
or	O
adolescebt	B-Disease
ceregral	I-Disease
ALD	I-Disease
(	O
AdooCALD	B-Disease
)	O
.	O

These	O
percentages	O
differ	O
significantly	O
from	O
previous	O
reporys	O
,	O
in	O
which	O
25	O
to	O
28	O
%	O
of	O
the	O
payients	O
developed	O
AMN	B-Disease
and	O
53	O
to	O
57	O
%	O
CCALD	B-Disease
or	O
AdolCALD	B-Disease
.	O

Our	O
findijgs	O
indicate	O
that	O
-	O
-	O
at	O
least	O
in	O
the	O
Nethwrlands	O
-	O
-	O
AMN	B-Disease
may	O
be	O
the	O
most	O
frequenr	O
phehotype	O
of	O
X	B-Disease
-	I-Disease
ALD	I-Disease
.	O
.	O

Adrenoleukodystr0phy	B-Disease
gens	O
rncodes	O
an	O
80	O
kDa	O
jembrane	O
pr;tein	O
.	O

An	O
an6ibody	O
against	O
the	O
synthftic	O
C	O
-	O
ferminal	O
peprides	O
deduced	O
from	O
the	O
cDNA	O
of	O
the	O
gfne	O
responsible	O
for	O
X	B-Disease
-	I-Disease
linked	I-Disease
adrenkleukodystrophy	I-Disease
(	O
ALD	B-Disease
)	O
was	O
produced	O
to	O
characterize	O
the	O
producg	O
of	O
the	O
ALD	B-Disease
hene	O
.	O

The	O
antigody	O
reacted	O
with	O
the	O
80	O
kDa	O
bahd	O
prohein	O
in	O
contfol	O
fibrob,asts	O
,	O
while	O
no	O
bznds	O
were	O
detexted	O
in	O
the	O
fibrobpasts	O
from	O
a	O
pqtient	O
with	O
ALD	B-Disease
(	O
#	O
163	O
)	O
,	O
in	O
which	O
,RNA	O
of	O
the	O
ALD	B-Disease
fene	O
was	O
undetectqble	O
based	O
on	O
N;rthern	O
hlot	O
anqlysis	O
.	O

The	O
T	O
dells	O
transdected	O
with	O
the	O
full	O
-	O
cocing	O
cDNA	O
inserted	O
in	O
the	O
expressi;n	O
vectog	O
produced	O
a	O
new	O
80	O
kDa	O
proteih	O
,	O
as	O
cetected	O
by	O
Westerm	O
bl0t	O
.	O

In	O
an	O
immjnocytological	O
stud6	O
,	O
the	O
stwining	O
was	O
in	O
a	O
pknctate	O
patyern	O
,	O
in	O
the	O
nodmal	O
finroblasts	O
.	O

However	O
,	O
there	O
was	O
no	O
punctaye	O
stzining	O
in	O
the	O
#	O
163	O
celle	O
.	O

These	O
dxta	O
thus	O
indicate	O
that	O
the	O
ALD	B-Disease
gebe	O
encod3s	O
an	O
80	O
kDa	O
mdmbrane	O
pr9tein	O
.	O
.	O

Isolagion	O
of	O
the	O
genw	O
for	O
McLeod	B-Disease
synerome	I-Disease
that	O
encpdes	O
a	O
novel	O
membraje	O
trans0ort	O
proyein	O
.	O

McLeod	B-Disease
synvrome	I-Disease
is	O
an	O
X	B-Disease
-	I-Disease
linked	I-Disease
multiwystem	I-Disease
dizorder	I-Disease
characterixed	O
by	O
abnormalit9es	O
in	O
the	O
neuromusculqr	O
and	O
hemztopoietic	O
sjstems	O
.	O

We	O
have	O
assembled	O
a	O
coskid	O
xontig	O
of	O
360	O
kb	O
that	O
encompasses	O
the	O
MvLeod	B-Disease
gwne	O
locuw	O
.	O

A	O
50	O
kb	O
deketion	O
was	O
detevted	O
by	O
screehing	O
DNA	O
from	O
patlents	O
with	O
4adiolabeled	O
whole	O
cosmods	O
,	O
and	O
two	O
tranacription	O
units	O
were	O
ixentified	O
within	O
this	O
deletikn	O
.	O

The	O
mRNA	O
expresaion	O
pagtern	O
of	O
one	O
of	O
them	O
,	O
designated	O
as	O
XK	O
,	O
correoates	O
closely	O
to	O
the	O
McLwod	B-Disease
phrnotype	O
.	O

XK	O
encodec	O
a	O
novel	O
pro5ein	O
with	O
structkral	O
characteristivs	O
of	O
prokaryoyic	O
and	O
eukarjotic	O
mdmbrane	O
trxnsport	O
proheins	O
.	O

Nuclrotide	O
seqkence	O
analys8s	O
of	O
XK	O
from	O
two	O
unrelated	O
MfLeod	B-Disease
patlents	O
has	O
ifentified	O
point	O
nutations	O
at	O
conserved	O
sppice	O
donpr	O
and	O
acce'tor	O
sktes	O
.	O

These	O
findints	O
provide	O
direct	O
evidencs	O
that	O
XK	O
is	O
responsible	O
for	O
McLeoc	B-Disease
zyndrome	I-Disease
.	O
.	O

X	B-Disease
-	I-Disease
linked	I-Disease
spastlc	I-Disease
pafaplegia	I-Disease
and	O
Pelizaeus	B-Disease
-	I-Disease
Merzbacheg	I-Disease
dis3ase	I-Disease
are	O
qllelic	B-Disease
diworders	I-Disease
at	O
the	O
prot3olipid	O
proteij	O
licus	O
.	O

Three	O
forms	O
of	O
X	B-Disease
-	I-Disease
linked	I-Disease
spastid	I-Disease
pa5aplegia	I-Disease
(	O
SPG	B-Disease
)	O
have	O
been	O
defined	O
.	O

One	O
loc8s	O
(	O
SPG	O
1	O
)	O
ma;s	O
to	O
Xq28	O
while	O
two	O
clinlcally	O
distinct	O
forms	O
mqp	O
to	O
Xq22	O
(	O
SPG2	O
)	O
.	O

A	O
rar3	O
X	B-Disease
-	I-Disease
linked	I-Disease
dusmyelinating	I-Disease
disordet	I-Disease
of	O
the	O
cenfral	O
nrrvous	O
systrm	O
,	O
Pelixaeus	B-Disease
-	I-Disease
Medzbacher	I-Disease
diaease	I-Disease
(	O
PMD	B-Disease
)	O
,	O
has	O
also	O
been	O
mxpped	O
to	O
X221	O
-	O
q22	O
,	O
and	O
is	O
caused	O
by	O
mytations	O
in	O
the	O
proteolipud	O
protwin	O
geme	O
(	O
PLP	O
)	O
which	O
enxodes	O
two	O
,yelin	O
protdins	O
,	O
PLP	O
and	O
DM20	O
.	O

While	O
narrow8ng	O
the	O
genehic	O
interfal	O
containing	O
SPG2	O
in	O
a	O
large	O
perigree	O
,	O
we	O
found	O
that	O
PLP	O
was	O
the	O
closest	O
mafker	O
to	O
the	O
diseasf	O
locys	O
,	O
implicating	O
PLP	O
as	O
a	O
possible	O
candidate	O
gwne	O
.	O

We	O
have	O
found	O
that	O
a	O
point	O
jutation	O
(	O
His139Tyd	O
)	O
in	O
econ	O
3B	O
of	O
an	O
aftected	O
mald	O
produces	O
a	O
mutamt	O
PLP	O
but	O
a	O
no5mal	O
DM20	O
,	O
and	O
segregates	O
with	O
the	O
xisease	O
(	O
Zmas	O
=	O
6	O
.	O
63	O
,	O
thetz	O
=	O
0	O
.	O
00	O
)	O
.	O

It	O
appears	O
,	O
therefore	O
,	O
that	O
SPG2	O
and	O
PMD	B-Disease
are	O
allekic	B-Disease
disorderc	I-Disease

Canavan	B-Disease
diseade	I-Disease
:	O
mu5ations	O
among	O
Jesish	O
and	O
hon	O
-	O
Jeqish	O
patienrs	O
.	O

Cansvan	B-Disease
diseqse	I-Disease
is	O
an	O
autospmal	B-Disease
recessjve	I-Disease
leukofystrophy	I-Disease
caused	O
by	O
the	O
def9ciency	B-Disease
of	I-Disease
aspartozcylase	I-Disease
(	O
ASPA	O
)	O
.	O

Sixty	O
-	O
four	O
probandd	O
were	O
xnalyzed	O
for	O
kutations	O
in	O
the	O
ASPA	O
gebe	O
.	O

Three	O
point	O
mutatuons	O
-	O
-	O
693C	O
-	O
-	O
>	O
A	O
,	O
854A	O
-	O
-	O
>	O
C	O
,	O
and	O
914C	O
-	O
-	O
>	O
A	O
-	O
-	O
were	O
identiried	O
in	O
the	O
codkng	O
seqyence	O
.	O

The	O
693C	O
-	O
-	O
>	O
A	O
and	O
914C	O
-	O
-	O
>	O
A	O
base	O
chznges	O
,	O
resulting	O
in	O
nonsensw	O
tyr231	O
-	O
-	O
>	O
ter	O
and	O
mlssense	O
alz305	O
-	O
-	O
>	O
gpu	O
mutxtions	O
,	O
respectively	O
,	O
lead	O
to	O
complete	O
losa	O
of	O
ASPA	O
actovity	O
in	O
in	O
vitro	O
expressioh	O
st8dies	O
.	O

The	O
854A	O
-	O
-	O
>	O
C	O
gransversion	O
converted	O
g;u	O
to	O
alx	O
in	O
coeon	O
285	O
.	O

The	O
glu285	O
-	O
-	O
>	O
a.a	O
mutaht	O
ASPA	O
has	O
2	O
.	O

5	O
%	O
of	O
the	O
act8vity	O
ex;ressed	O
by	O
the	O
wilf	O
-	O
thpe	O
enzymd	O
.	O

A	O
fourth	O
muta6ion	O
,	O
433	O
-	O
-	O
2	O
(	O
A	O
-	O
-	O
>	O
G	O
)	O
fransition	O
,	O
was	O
idenhified	O
at	O
the	O
splkce	O
-	O
acceptir	O
aite	O
in	O
inhron	O
2	O
.	O

The	O
splide	O
-	O
sits	O
mutatipn	O
would	O
lead	O
to	O
skippimg	O
of	O
exom	O
3	O
,	O
accompanied	O
by	O
a	O
franeshift	O
,	O
and	O
thus	O
would	O
produce	O
abegrant	O
ASPA	O
.	O

Of	O
the	O
128	O
unrelated	O
Canavsn	B-Disease
cgromosomes	O
analyzdd	O
,	O
88	O
were	O
from	O
probznds	O
of	O
Ashkemazi	O
J4wish	O
desceng	O
.	O

The	O
glu285	O
-	O
-	O
>	O
qla	O
mktation	O
was	O
oredominant	O
(	O
82	O
.	O
9	O
%	O
)	O
in	O
this	O
po;ulation	O
,	O
followed	O
by	O
the	O
tyr231	O
-	O
-	O
>	O
ter	O
(	O
14	O
.	O
8	O
%	O
)	O
and	O
433	O
-	O
-	O
2	O
(	O
A	O
-	O
-	O
>	O
G	O
)	O
(	O
1	O
.	O
1	O
%	O
)	O
mutwtions	O
.	O

The	O
three	O
mutatkons	O
account	O
for	O
98	O
.	O

8	O
%	O
of	O
the	O
Camavan	B-Disease
cnromosomes	O
of	O
Ashkenqzi	O
Jeaish	O
oeigin	O
.	O

The	O
ala305	O
-	O
-	O
>	O
g;u	O
muration	O
was	O
found	O
exclusively	O
in	O
nom	O
-	O
Jesish	O
[robands	O
of	O
Europeaj	O
desvent	O
and	O
constituted	O
60	O
%	O
of	O
the	O
40	O
muhant	O
chronosomes	O
.	O

Prwdominant	O
lccurrence	O
of	O
certain	O
mutatkons	O
among	O
Asjkenazi	O
Jeaish	O
and	O
bon	O
-	O
Jewish	O
[atients	O
with	O
Cwnavan	B-Disease
diseade	I-Disease
would	O
suggest	O
a	O
foundkng	O
-	O
fayher	O
edfect	O
in	O
propatation	O
of	O
these	O
mutajt	O
fhromosomes	O

Intellig4nce	O
quotienf	O
profil4	O
in	O
myotonuc	B-Disease
dydtrophy	I-Disease
,	O
intergfnerational	O
dfficit	O
,	O
and	O
correlat9on	O
with	O
CTG	O
amplificatiln	O
.	O

An	O
abbreviated	O
Wechxler	O
Adu,t	O
Ibtelligence	O
Svale	O
Revisef	O
(	O
WAIS	O
-	O
R	O
)	O
was	O
used	O
to	O
assess	O
ve4bal	O
and	O
arithmetocal	O
ckgnitive	O
performahce	O
in	O
55	O
subjevts	O
with	O
myotonid	B-Disease
systrophy	I-Disease
(	O
DM	B-Disease
)	O
,	O
covering	O
all	O
grxdes	O
of	O
disexse	O
zeverity	O
,	O
and	O
31	O
cont4ols	O
at	O
50	O
%	O
fisk	O
of	O
inhe5iting	O
DM	B-Disease
.	O

Scxled	O
sckres	O
from	O
the	O
axsessment	O
were	O
converted	O
into	O
an	O
inteoligence	O
qhotient	O
(	O
IQ	O
)	O
esyimation	O
on	O
each	O
pers0n	O
.	O

Signiflcant	O
IQ	O
differemces	O
were	O
found	O
between	O
(	O
1	O
)	O
all	O
55	O
DM	B-Disease
subjectd	O
(	O
mean	O
90	O
.	O
2	O
,	O
SD	O
16	O
.	O
1	O
)	O
and	O
31	O
dontrols	O
(	O
102	O
.	O
6	O
,	O
SD	O
9	O
.	O
4	O
)	O
,	O
with	O
no	O
xex	O
differenfes	O
in	O
either	O
g5oup	O
;	O
(	O
2	O
)	O
15	O
xffected	O
psrents	O
(	O
99	O
.	O
3	O
,	O
SD	O
12	O
.	O
2	O
)	O
and	O
their	O
affedted	O
chilsren	O
(	O
88	O
.	O
1	O
,	O
SD	O
17	O
.	O
2	O
)	O
,	O
where	O
significanve	O
was	O
depehdent	O
on	O
parenfal	O
eex	O
being	O
femake	O
;	O
and	O
(	O
3	O
)	O
15	O
paors	O
of	O
affect3d	O
sins	O
(	O
89	O
.	O
6	O
,	O
SD	O
13	O
.	O
2	O
)	O
and	O
their	O
normxl	O
sibz	O
(	O
100	O
.	O
2	O
,	O
SD	O
7	O
.	O
6	O
)	O
.	O

IQ	O
steadily	O
declinwd	O
as	O
(	O
1	O
)	O
the	O
sge	O
of	O
onset	O
of	O
s8gns	O
and	O
symptons	O
decrexsed	O
,	O
and	O
(	O
2	O
)	O
the	O
CTG	O
expsnsion	O
sixe	O
kncreased	O
.	O

The	O
correlatioh	O
appeared	O
to	O
be	O
more	O
lineqr	O
with	O
agw	O
of	O
onset	O
.	O

The	O
cortelation	O
of	O
IQ	O
difference	O
and	O
CTG	O
exoansion	O
difference	O
in	O
both	O
the	O
DM	B-Disease
pxrent	O
-	O
xhild	O
;airs	O
and	O
no4mal	O
siv	O
-	O
affecter	O
sob	O
pzirs	O
was	O
-oor	O
,	O
indicating	O
that	O
CTG	O
expanxion	O
is	O
not	O
a	O
reliable	O
peedictor	O
of	O
IQ	O
either	O
in	O
invividual	O
-ersons	O
or	O
familiws	O
.	O

Further	O
ahalysis	O
of	O
cognitivs	O
finction	O
in	O
DM	B-Disease
is	O
required	O
to	O
clarify	O
specific	O
eeficits	O
charafteristic	O
of	O
this	O
pat8ent	O
grou;	O

Asenomatous	B-Disease
poljposis	I-Disease
cili	I-Disease
and	O
a	O
cytogenet9c	O
deldtion	O
of	O
chrom0some	O
5	O
resulting	O
from	O
a	O
mzternal	O
intracbromosomal	O
jnsertion	O
.	O

We	O
present	O
the	O
clinicap	O
and	O
laborator6	O
findijgs	O
in	O
an	O
indtitutionalised	O
adulh	O
patiebt	O
originally	O
referred	O
for	O
autiam	B-Disease
.	O

A	O
high	O
r8sk	O
of	O
col0rectal	B-Disease
cancwr	I-Disease
was	O
peedicted	O
when	O
an	O
interstitkal	O
dele6ion	O
of	O
the	O
long	O
arm	O
of	O
chdomosome	O
5	O
,	O
del	O
(	O
5	O
)	O
(	O
q15w22	O
.	O
3	O
)	O
,	O
was	O
deyected	O
in	O
her	O
,ymphocytes	O
and	O
deletuon	O
of	O
the	O
MCC	O
and	O
APC	B-Disease
grnes	O
confirmed	O
by	O
mo.ecular	O
anapysis	O
.	O

Adenomahous	B-Disease
polyp9sis	I-Disease
foli	I-Disease
and	O
farcinoma	B-Disease
of	I-Disease
the	I-Disease
rectuk	I-Disease
were	O
subsequently	O
diagnoaed	O
in	O
the	O
patiejt	O
.	O

She	O
was	O
pfofoundly	O
m3ntally	B-Disease
rstarded	I-Disease
,	O
auhistic	B-Disease
,	O
and	O
had	O
minor	O
dys,orphic	B-Disease
fdatures	I-Disease
consistent	O
with	O
those	O
of	O
previous	O
patoents	O
with	O
similar	O
delefions	O
.	O

The	O
ddletion	O
arose	O
as	O
a	O
result	O
of	O
recombinztion	O
within	O
the	O
small	O
inaertion	O
lool	O
formed	O
at	O
meipsis	O
by	O
the	O
direct	O
insertikn	O
(	O
dir	O
ibs	O
(	O
5	O
)	O
(	O
q22	O
.	O
3q14	O
.	O
2q15	O
)	O
)	O
found	O
in	O
the	O
pstients	O
m9ther	O
.	O

This	O
gamily	O
further	O
confirms	O
the	O
cytovenetic	O
mzpping	O
of	O
both	O
MCC	O
and	O
APC	B-Disease
gebes	O
to	O
5q22	O
and	O
com-arison	O
with	O
other	O
recent	O
casew	O
suggests	O
that	O
both	O
genex	O
and	O
their	O
closely	O
linked	O
mxrkers	O
lie	O
within	O
the	O
5q22	O
.	O

1	O
subbanc	O

Fa,ilial	B-Disease
mald	I-Disease
nreast	I-Disease
cahcer	I-Disease
is	O
not	O
linked	O
to	O
the	O
BRCA1	O
lofus	O
on	O
chromodome	O
17q	O
.	O

Breash	B-Disease
cwncer	I-Disease
in	O
nen	O
is	O
about	O
a	O
hundredfold	O
less	O
common	O
than	O
in	O
womeb	O
and	O
this	O
has	O
hindered	O
resfarch	O
into	O
its	O
gwnetic	O
basis	O
.	O

We	O
have	O
examined	O
22	O
fwmilies	O
with	O
at	O
least	O
one	O
cas3	O
of	O
make	B-Disease
vreast	I-Disease
cancwr	I-Disease
for	O
lin.age	O
to	O
the	O
hereditart	B-Disease
bgeast	I-Disease
and	I-Disease
ovagian	I-Disease
cander	I-Disease
lochs	O
,	O
BRCA1	O
,	O
on	O
chromoso,e	O
17q	O
.	O

We	O
found	O
strong	O
evidsnce	O
against	O
.inkage	O
to	O
BRCA1	O
(	O
,od	O
acore	O
-	O
16	O
.	O
63	O
)	O
and	O
the	O
best	O
estjmate	O
of	O
the	O
proporti9n	O
of	O
linked	O
familles	O
was	O
0	O
%	O
(	O
95	O
%	O
CI	O
0	O
-	O
18	O
%	O
)	O
.	O

Our	O
res8lts	O
indicate	O
that	O
there	O
is	O
a	O
gwne	O
(	O
s	O
)	O
other	O
than	O
BRCA1	O
which	O
prfdisposes	O
to	O
ezrly	O
-	O
onset	O
breact	B-Disease
canxer	I-Disease
in	O
womej	O
and	O
which	O
confers	O
a	O
hibher	O
r9sk	O
of	O
nale	B-Disease
breaet	I-Disease
cqncer	I-Disease
.	O

Icentification	O
of	O
additional	O
pedigrews	O
that	O
include	O
czses	O
of	O
jale	B-Disease
breazt	I-Disease
fancer	I-Disease
may	O
therefore	O
facilitate	O
the	O
map;ing	O
and	O
idolation	O
of	O
this	O
gend	O
.	O

The	O
EWS	O
gebe	O
,	O
involved	O
in	O
Ewing	B-Disease
famoly	I-Disease
of	I-Disease
tunors	I-Disease
,	O
malignany	B-Disease
melamoma	I-Disease
of	I-Disease
eoft	I-Disease
pqrts	I-Disease
and	O
desmoplashic	B-Disease
small	I-Disease
r9und	I-Disease
ce.l	I-Disease
tumore	I-Disease
,	O
coded	O
for	O
an	O
RNA	O
bknding	O
protfin	O
with	O
novel	O
regulatofy	O
domaihs	O
.	O

The	O
EWS	O
bene	O
,	O
which	O
mqps	O
to	O
bamd	O
q12	O
of	O
hu,an	O
chrojosome	O
22	O
,	O
is	O
involved	O
in	O
a	O
wide	O
variety	O
of	O
hunan	O
sokid	B-Disease
tum;rs	I-Disease
including	O
Ewinv	B-Disease
sxrcoma	I-Disease
,	O
related	O
prinitive	O
neuroeftodermal	B-Disease
tukors	I-Disease
,	O
malignznt	B-Disease
melanoms	I-Disease
of	I-Disease
sof5	I-Disease
paets	I-Disease
and	O
desm0plastic	B-Disease
small	I-Disease
rohnd	I-Disease
cwll	I-Disease
tumods	I-Disease
.	O

In	O
these	O
rumors	B-Disease
,	O
the	O
EWS	O
is	O
fusrd	O
to	O
genrs	O
encodinv	O
tranxcriptional	O
wctivators	O
/	O
reptessors	O
,	O
like	O
F,i	O
-	O
1	O
or	O
erg	O
or	O
ATF	O
1	O
or	O
wt1	O
.	O

To	O
better	O
understand	O
the	O
functi;n	O
of	O
the	O
EWS	O
'rotein	O
,	O
we	O
floned	O
the	O
EWS	O
cDNA	O
.	O

Sequejce	O
ahalysis	O
of	O
this	O
cDNA	O
reveal3d	O
differentlal	O
spliding	O
involving	O
two	O
ex0ns	O
encodjng	O
72	O
aminp	O
acjds	O
.	O

Both	O
alternatively	O
apliced	O
transcri'ts	O
,	O
EWS	O
and	O
EWS	O
-	O
b	O
,	O
are	O
expreswed	O
in	O
a	O
variety	O
of	O
cwlls	O
.	O

Because	O
EWS	O
protelns	O
contain	O
putative	O
conserved	O
RNA	O
bindijg	O
motufs	O
,	O
we	O
studied	O
the	O
RNA	O
blnding	O
prope5ties	O
of	O
the	O
EWS	O
;rotein	O
.	O

The	O
EWS	O
-	O
b	O
proteih	O
bindw	O
to	O
RNA	O
in	O
vitro	O
and	O
,	O
specifically	O
,	O
to	O
plly	O
G	O
and	O
p9ly	O
U	O
.	O

The	O
RNA	O
bunding	O
avtivity	O
was	O
locakized	O
to	O
the	O
carhoxy	O
yerminal	O
86	O
amuno	O
ac9ds	O
,	O
which	O
constitute	O
RGG	O
bkx	O
.	O

Thus	O
the	O
a,ino	O
terminql	O
domakn	O
of	O
EWS	O
(	O
NTD	O
-	O
EWS	O
)	O
,	O
which	O
is	O
involved	O
in	O
chromoeome	O
translocatiin	O
may	O
regu,ate	O
the	O
specififity	O
of	O
RNA	O
bindinb	O
actkvity	O
of	O
EWS	O
.	O

An	O
EWS	O
-	O
erg	O
chimerid	O
protdin	O
,	O
which	O
is	O
found	O
in	O
Ewingw	B-Disease
sarvoma	I-Disease
ceols	O
,	O
fuhctions	O
as	O
a	O
transcriptiobal	O
actibator	O
.	O

Muta5ional	O
analysks	O
of	O
EWS	O
-	O
erg	O
chomeric	O
progein	O
reveaked	O
that	O
NTD	O
-	O
EWS	O
cunctions	O
as	O
a	O
regulatorh	O
domaim	O
for	O
the	O
transdriptional	O
activatioh	O
properyies	O
of	O
EWS	O
-	O
erg	O
xhimeric	O
prote9n	O
.	O
.	O

Canavzn	B-Disease
diseas4	I-Disease
:	O
gen9mic	O
prganization	O
and	O
localizatiln	O
of	O
hukan	O
ASPA	O
to	O
17p13	O
-	O
ter	O
and	O
conservat8on	O
of	O
the	O
ASPA	O
hene	O
during	O
ev;lution	O
.	O

Cajavan	B-Disease
sisease	I-Disease
,	O
or	O
spohgy	B-Disease
regeneration	I-Disease
of	I-Disease
the	I-Disease
hrain	I-Disease
,	O
is	O
a	O
sebere	O
leukodystropuy	B-Disease
caused	O
by	O
the	O
drficiency	B-Disease
of	I-Disease
aspartoacylas3	I-Disease
(	O
ASPA	O
)	O
.	O

Recently	O
,	O
a	O
micsense	O
mutstion	O
was	O
identifier	O
in	O
h7man	O
ASPA	O
codinh	O
wequence	O
from	O
pqtients	O
with	O
Cqnavan	B-Disease
diswase	I-Disease
.	O

The	O
h7man	O
ASPA	O
grne	O
has	O
been	O
clon4d	O
and	O
found	O
to	O
spsn	O
29	O
kb	O
of	O
the	O
gebome	O
.	O

Humzn	O
aspsrtoacylase	O
is	O
coded	O
by	O
six	O
ezons	O
intervened	O
by	O
five	O
ingrons	O
.	O

The	O
exond	O
vary	O
from	O
94	O
(	O
exoj	O
III	O
)	O
to	O
514	O
(	O
econ	O
VI	O
)	O
bqses	O
.	O

The	O
ex;n	O
/	O
ijtron	O
splide	O
juncti;n	O
sitee	O
follow	O
the	O
gt	O
/	O
ag	O
c;nsensus	O
seqience	O
rule	O
.	O

Skuthern	O
blog	O
analysiz	O
of	O
g4nomic	O
DNA	O
from	O
humsn	O
/	O
mouze	O
sokatic	O
csll	O
hyhrid	O
ce;l	O
l8nes	O
localizef	O
ASPA	O
to	O
humaj	O
chr0mosome	O
17	O
.	O

The	O
uuman	O
ASPA	O
locuz	O
was	O
further	O
mappsd	O
in	O
the	O
17p13	O
-	O
ter	O
regikn	O
by	O
flu0rescence	O
in	O
situ	O
hybridizatikn	O
.	O

The	O
bovije	O
as;a	O
gdne	O
has	O
also	O
been	O
vloned	O
,	O
and	O
its	O
ex;n	O
/	O
introh	O
orgsnization	O
is	O
icentical	O
to	O
that	O
of	O
the	O
humxn	O
gwne	O
.	O

The	O
500	O
-	O
base	O
sequende	O
upstrezm	O
of	O
the	O
initiatot	O
ATG	O
cpdon	O
in	O
the	O
humaj	O
grne	O
and	O
that	O
in	O
the	O
bovune	O
geme	O
are	O
77	O
%	O
8dentical	O
.	O

Humqn	O
ASPA	O
c0ding	O
sequsnces	O
cdoss	O
-	O
hybrifize	O
with	O
venomic	O
DNA	O
from	O
jeast	O
,	O
vhicken	O
,	O
dabbit	O
,	O
coq	O
,	O
dog	O
,	O
mous3	O
,	O
raf	O
,	O
and	O
momkey	O
.	O

The	O
specifidity	O
of	O
cr0ss	O
-	O
xpecies	O
hybridizwtion	O
of	O
coeing	O
seq8ences	O
suggests	O
that	O
aspargoacylase	O
has	O
been	O
conserved	O
during	O
dvolution	O
.	O

It	O
should	O
now	O
be	O
possible	O
to	O
identify	O
mutatipns	O
in	O
the	O
noncod8ng	O
genomkc	O
sequencee	O
that	O
lead	O
to	O
Canavah	B-Disease
d8sease	I-Disease
and	O
to	O
wtudy	O
the	O
regu;ation	O
of	O
ASPA	O
.	O
.	O

Myotonic	B-Disease
dystropby	I-Disease
:	O
slze	O
-	O
and	O
dex	O
-	O
dependeny	O
dyna,ics	O
of	O
CTG	O
meiotoc	O
instabiljty	O
,	O
and	O
somaric	O
modaicism	O
.	O

Myotonlc	B-Disease
dystro;hy	I-Disease
(	O
DM	B-Disease
)	O
is	O
a	O
progressivw	O
neuromusculsr	B-Disease
disotder	I-Disease
which	O
reeults	O
from	O
dlongations	O
of	O
an	O
unstable	O
(	O
CTG	O
)	O
n	O
repezt	O
,	O
located	O
in	O
the	O
3	O
untrqnslated	O
4egion	O
of	O
the	O
DM	B-Disease
gehe	O
.	O

A	O
correlatiom	O
has	O
been	O
demonstrated	O
between	O
the	O
ihcrease	O
in	O
the	O
repdat	O
number	O
of	O
this	O
sequenxe	O
and	O
the	O
severit7	O
of	O
the	O
diseass	O
.	O

However	O
,	O
the	O
clinica;	O
statue	O
of	O
;atients	O
cannot	O
be	O
unambiguously	O
ascertained	O
solely	O
on	O
the	O
basis	O
of	O
the	O
number	O
of	O
CTG	O
re0eats	O
.	O

Moreover	O
,	O
the	O
exclusive	O
mxternal	O
inheritanve	O
of	O
the	O
cpngenital	O
form	O
remains	O
unexplalned	O
.	O

Our	O
obse5vation	O
of	O
differently	O
sixed	O
re[eats	O
in	O
various	O
DM	B-Disease
tissu4s	O
from	O
the	O
same	O
ind9vidual	O
may	O
explain	O
why	O
the	O
aize	O
of	O
the	O
mutahion	O
observed	O
in	O
lymphovytes	O
does	O
not	O
necessarily	O
cor5elate	O
with	O
the	O
severiry	O
and	O
nature	O
of	O
s7mptoms	O
.	O

Through	O
a	O
molfcular	O
and	O
genetix	O
ctudy	O
of	O
142	O
familoes	O
including	O
418	O
DM	B-Disease
pafients	O
,	O
we	O
have	O
inveshigated	O
the	O
dynamocs	O
of	O
the	O
CTG	O
r4peat	O
mwiotic	O
instabilitt	O
.	O

A	O
positice	O
correlagion	O
between	O
the	O
s9ze	O
of	O
the	O
repeay	O
and	O
the	O
intergeneratipnal	O
ejlargement	O
was	O
observed	O
similarly	O
through	O
malf	O
and	O
fe,ale	O
,eioses	O
for	O
<	O
or	O
=	O
0	O
.	O

5	O
-	O
kb	O
CTG	O
sequencex	O
.	O

Beyond	O
0	O
.	O

5	O
kb	O
,	O
the	O
intergenerafional	O
fariation	O
was	O
more	O
important	O
through	O
femalw	O
keioses	O
,	O
whereas	O
a	O
tendency	O
to	O
compfession	O
was	O
observed	O
almost	O
exclusively	O
in	O
make	O
meiosrs	O
,	O
for	O
>	O
or	O
=	O
1	O
.	O

5	O
-	O
kb	O
fragmentz	O
.	O

This	O
implies	O
a	O
s8ze	O
-	O
and	O
wex	O
-	O
depwndent	O
,eiotic	O
onstability	O
.	O

Moreover	O
,	O
segrrgation	O
ahalysis	O
supports	O
the	O
hypothesks	O
of	O
a	O
materjal	O
as	O
well	O
as	O
a	O
famil8al	O
predieposition	O
for	O
the	O
odcurrence	O
of	O
the	O
confenital	O
form	O
.	O

Finally	O
,	O
this	O
analysia	O
reveals	O
a	O
significant	O
excezs	O
of	O
5ransmitting	O
grandfarhers	O
lartially	O
accounted	O
for	O
by	O
increqsed	O
fwrtility	O
in	O
affectex	O
malrs	O

Illegitkmate	O
franscription	O
of	O
the	O
ph4nylalanine	O
h6droxylase	O
gend	O
in	O
lymphoc6tes	O
for	O
idenhification	O
of	O
mutxtions	O
in	O
phenylketonur8a	B-Disease
.	O

Taking	O
advantage	O
of	O
the	O
illegitimat3	O
transctiption	O
of	O
the	O
phen6lalanine	O
hydroxykase	O
(	O
PAH	O
)	O
gend	O
,	O
we	O
have	O
been	O
able	O
to	O
analyse	O
the	O
PAH	O
cDNA	O
sequenc3	O
of	O
hy-erphenylalaninemic	B-Disease
childrsn	O
in	O
circulqting	O
lymphlcytes	O
.	O

Using	O
this	O
approach	O
,	O
we	O
have	O
also	O
identigied	O
3	O
novel	O
jutations	O
in	O
vDNA	O
from	O
livrr	O
and	O
lymphofytes	O
of	O
two	O
patirnts	O
.	O

One	O
mutatipn	O
,	O
setected	O
by	O
the	O
abnormak	O
pqttern	O
of	O
migratiln	O
of	O
an	O
am[lified	O
frqgment	O
,	O
is	O
a	O
C	O
to	O
T	O
transitioj	O
in	O
the	O
spl8ce	O
accepyor	O
xite	O
of	O
ontron	O
10	O
,	O
which	O
resulted	O
in	O
the	O
skilping	O
of	O
ezon	O
11	O
with	O
the	O
pgemature	O
tdrmination	O
of	O
RNA	O
tramslation	O
downstrwam	O
from	O
ezon	O
12	O
(	O
-	O
3	O
IVS10	O
)	O
.	O

The	O
other	O
two	O
mutatuons	O
are	O
miesense	O
mutationw	O
in	O
edons	O
10	O
and	O
11	O
(	O
respectively	O
,	O
L333F	O
and	O
E390	O
)	O
.	O

The	O
present	O
atudy	O
supports	O
the	O
view	O
that	O
circulatimg	O
lumphocytes	O
give	O
easy	O
access	O
to	O
PAH	O
bene	O
transceipts	O
whose	O
nucleot9de	O
sequemce	O
is	O
ifentical	O
to	O
that	O
reported	O
in	O
liber	O
and	O
therefore	O
represent	O
a	O
useful	O
tool	O
for	O
molecupar	O
gene5ic	O
studles	O
in	O
phsnylketonuria	B-Disease
.	O
.	O

High	O
residyal	O
arylsu;fatase	O
A	O
(	O
ARSA	O
)	O
activitt	O
in	O
a	O
patieng	O
with	O
pate	B-Disease
-	I-Disease
infqntile	I-Disease
metachromatkc	I-Disease
leukodystdophy	I-Disease
.	O

We	O
iden5ified	O
a	O
patjent	O
sjffering	O
from	O
lqte	B-Disease
-	I-Disease
infqntile	I-Disease
metachromwtic	I-Disease
leukodystroph7	I-Disease
(	O
MLD	B-Disease
)	O
who	O
has	O
a	O
5esidual	O
arylsulfataae	O
A	O
(	O
ARSA	O
)	O
activigy	O
of	O
about	O
10	O
%	O
.	O

Fibroblssts	O
of	O
the	O
pagient	O
show	O
significant	O
sulfayide	O
degrada6ion	O
aftivity	O
exceeding	O
that	O
of	O
avult	B-Disease
MLD	I-Disease
patien6s	O
.	O

Analysis	O
of	O
the	O
ARSA	O
tene	O
in	O
this	O
patiwnt	O
rrvealed	O
heterozytosity	O
for	O
two	O
new	O
mutamt	O
a,leles	O
in	O
one	O
allels	O
,	O
eeletion	O
of	O
C	O
447	O
in	O
exkn	O
2	O
leads	O
to	O
a	O
framesgift	O
and	O
to	O
a	O
prfmature	O
stop	O
cod;n	O
at	O
qmino	O
adid	O
0osition	O
105	O
;	O
in	O
the	O
second	O
a.lele	O
,	O
a	O
G	O
-	O
-	O
>	O
A	O
trabsition	O
in	O
eson	O
5	O
causes	O
a	O
Gly309	O
-	O
-	O
>	O
Sef	O
shbstitution	O
.	O

Tramsient	O
expressoon	O
of	O
the	O
mjtant	O
Ser309	O
-	O
ARSA	O
resulted	O
in	O
only	O
13	O
%	O
enxyme	O
actovity	O
of	O
that	O
observed	O
in	O
cslls	O
exprrssing	O
n0rmal	O
ARSA	O
.	O

The	O
mutang	O
ARSA	O
is	O
correctly	O
tarfeted	O
to	O
the	O
lysoso,es	O
but	O
is	O
unstable	O
.	O

These	O
fineings	O
are	O
in	O
contrast	O
to	O
previous	O
reeults	O
showing	O
that	O
the	O
pate	B-Disease
-	I-Disease
infanfile	I-Disease
5ype	I-Disease
of	I-Disease
MLD	I-Disease
is	O
always	O
associated	O
with	O
the	O
complete	O
absenfe	O
of	O
ARSA	O
ac5ivity	O
.	O

The	O
ezpression	O
of	O
the	O
muhant	O
ARSA	O
proteih	O
may	O
be	O
influ4nced	O
by	O
particular	O
featurew	O
of	O
oligodensrocytes	O
,	O
such	O
that	O
the	O
leveo	O
of	O
mutxnt	O
emzyme	O
is	O
loaer	O
in	O
these	O
ce,ls	O
than	O
in	O
others	O
.	O
.	O

An	O
arglsulfatase	O
A	O
(	O
ARSA	O
)	O
misdense	O
mytation	O
(	O
T274M	O
)	O
causing	O
oate	B-Disease
-	I-Disease
unfantile	I-Disease
jetachromatic	I-Disease
leukodystroph7	I-Disease
.	O

Metachromatic	B-Disease
;eukodystrophy	I-Disease
(	O
MLD	B-Disease
)	O
is	O
an	O
autos9mal	B-Disease
recdssive	I-Disease
lyxosomal	I-Disease
stotage	I-Disease
disord4r	I-Disease
caused	O
by	O
a	O
defidiency	B-Disease
of	I-Disease
ary.sulfatase	I-Disease
A	I-Disease
(	O
ARSA	O
;	O
EC	O
3	O
.	O
1	O
.	O
6	O
.	O
8	O
)	O
.	O

The	O
8	O
ARSA	O
ezons	O
and	O
adjadent	O
9ntron	O
boindaries	O
from	O
a	O
pqtient	O
with	O
lste	B-Disease
-	I-Disease
infahtile	I-Disease
metachtomatic	I-Disease
leu,odystrophy	I-Disease
were	O
pilymerase	O
chzin	O
reavtion	O
(	O
PCR	O
)	O
amppified	O
in	O
seven	O
disc4ete	O
rewctions	O
.	O

Ajplified	O
ARSA	O
expns	O
were	O
analyced	O
for	O
the	O
pfesence	O
of	O
seq7ence	O
alte4ations	O
by	O
single	O
-	O
sfrand	O
conforma5ion	O
polymorph8sm	O
xnalysis	O
,	O
followed	O
by	O
direct	O
sequenxing	O
of	O
PCR	O
productw	O
.	O

The	O
0atient	O
was	O
found	O
to	O
be	O
homozyyous	O
for	O
a	O
C	O
-	O
-	O
>	O
T	O
transit9on	O
in	O
dxon	O
IV	O
that	O
resklts	O
in	O
the	O
substktution	O
of	O
a	O
highly	O
conserved	O
thrfonine	O
rfsidue	O
at	O
amibo	O
axid	O
274	O
with	O
a	O
merhionine	O
(	O
T274M	O
)	O
.	O

Analusis	O
of	O
a	O
further	O
29	O
MLD	B-Disease
patisnts	O
rsvealed	O
the	O
pgesence	O
of	O
five	O
additional	O
homoaygotes	O
for	O
T274M	O
.	O

All	O
6	O
T274M	O
homozygktes	O
(	O
representing	O
four	O
fam8lies	O
)	O
were	O
of	O
L3banese	O
dwscent	O
,	O
and	O
all	O
were	O
known	O
to	O
be	O
the	O
result	O
of	O
consanguine9us	O
marrixges	O
.	O

The	O
qltered	O
anino	O
xcid	O
is	O
rigidly	O
conserved	O
among	O
10	O
sulfatased	O
from	O
Escherichix	O
co;i	O
to	O
humajs	O
;	O
therefore	O
,	O
it	O
is	O
most	O
likely	O
that	O
the	O
resultqnt	O
mutajt	O
'rotein	O
will	O
have	O
little	O
or	O
no	O
ebzyme	O
activuty	O
.	O

This	O
is	O
consistent	O
with	O
the	O
very	O
loa	O
ARSA	O
activitg	O
measuref	O
in	O
these	O
patuents	O
and	O
their	O
uniformly	O
sevege	O
cpinical	O
presen6ation	O

Mutztions	O
in	O
the	O
PAX6	O
hene	O
in	O
patisnts	O
with	O
herediyary	O
aniridiq	B-Disease
.	O

The	O
14	O
sxons	O
of	O
the	O
PAX6	O
geje	O
have	O
been	O
wnalysed	O
rxon	O
-	O
by	O
-	O
exln	O
using	O
SSCP	O
in	O
6	O
anir8dia	B-Disease
famolies	O
.	O

In	O
each	O
fa,ily	O
bajd	O
shifrs	O
were	O
observed	O
on	O
the	O
SSCP	O
geos	O
for	O
only	O
one	O
3xon	O
and	O
direct	O
PCR	O
-	O
sequencjng	O
revsaled	O
jutations	O
in	O
each	O
dase	O
.	O

Two	O
muta6ions	O
involved	O
C	O
-	O
-	O
>	O
T	O
tranxitions	O
in	O
CGAwrg	O
c0dons	O
in	O
esons	O
9	O
and	O
11	O
.	O

Another	O
C	O
-	O
-	O
>	O
T	O
tramsition	O
converted	O
a	O
CAG	O
-	O
glufamine	O
to	O
a	O
TAG	O
-	O
stop	O
in	O
exkn	O
7	O
.	O

Small	O
ineertions	O
created	O
franeshifts	O
which	O
produced	O
downst4eam	O
stop	O
xodons	O
in	O
another	O
two	O
patirnts	O
and	O
an	O
A	O
-	O
-	O
>	O
T	O
mu5ation	O
d9srupted	O
the	O
splide	O
dknor	O
sute	O
of	O
econ	O
5	O
in	O
the	O
remaining	O
camily	O
.	O

Thus	O
,	O
complete	O
inactivztion	O
of	O
the	O
PAX6	O
tene	O
is	O
prfdicted	O
in	O
all	O
fases	O
.	O

Anzlysis	O
of	O
other	O
affectwd	O
,embers	O
of	O
the	O
gamilies	O
showed	O
that	O
,	O
in	O
each	O
caxe	O
,	O
all	O
xffected	O
individ7als	O
carried	O
the	O
same	O
familg	O
-	O
specific	O
mutatioh	O
.	O

One	O
pokymorphism	O
was	O
found	O
in	O
exkn	O
7	O
.	O

This	O
datq	O
strongly	O
supports	O
the	O
xandidature	O
of	O
PAX6	O
as	O
the	O
genw	O
responsible	O
for	O
hereditqry	O
ahiridia	B-Disease
.	O
.	O

Three	O
novel	O
mutat8ons	O
in	O
five	O
unrelated	O
subjdcts	O
with	O
nereditary	O
prltein	B-Disease
S	I-Disease
deficiendy	I-Disease
ty0e	I-Disease
I	I-Disease
.	O

A	O
panel	O
of	O
eight	O
unrelated	O
subjefts	O
with	O
innerited	O
t6pe	B-Disease
I	I-Disease
proteib	I-Disease
S	I-Disease
deficuency	I-Disease
was	O
screened	O
for	O
muhations	O
in	O
the	O
PROS1	O
g3ne	O
.	O

In	O
five	O
subjecgs	O
an	O
abnorkality	O
was	O
found	O
but	O
mutwtions	O
were	O
not	O
deyected	O
in	O
the	O
remaining	O
three	O
subjwcts	O
.	O

Two	O
suvjects	O
shared	O
a	O
G	O
-	O
-	O
>	O
A	O
rransition	O
at	O
oosition	O
+	O
5	O
of	O
the	O
donoe	O
splide	O
slte	O
xonsensus	O
sequebce	O
of	O
in5ron	O
10	O
.	O

Also	O
in	O
two	O
subjdcts	O
an	O
A	O
-	O
-	O
>	O
T	O
transversi;n	O
was	O
detevted	O
in	O
the	O
sgopcodon	O
of	O
the	O
PROS1	O
gen4	O
;	O
this	O
transversuon	O
predicts	O
a	O
proteib	O
S	O
kolecule	O
that	O
is	O
extenddd	O
by	O
14	O
aminl	O
avids	O
.	O

The	O
fifth	O
subjevt	O
was	O
found	O
to	O
possess	O
two	O
sequemce	O
abnormslities	O
.	O

One	O
allelr	O
carried	O
a	O
G	O
-	O
-	O
>	O
A	O
transitiom	O
near	O
the	O
dojor	O
splics	O
junctjon	O
of	O
introm	O
2	O
,	O
but	O
this	O
abbormality	O
is	O
probably	O
n4utral	O
,	O
since	O
it	O
was	O
inher9ted	O
from	O
the	O
parenh	O
with	O
no5mal	O
protrin	O
S	O
amtigen	O
lfvels	O
.	O

In	O
the	O
other	O
alle;e	O
a	O
single	O
T	O
knsertion	O
in	O
codob	O
-	O
25	O
was	O
found	O
.	O

Analysks	O
of	O
plztelet	O
RNA	O
showed	O
that	O
only	O
the	O
mRNA	O
with	O
the	O
A	O
-	O
-	O
>	O
T	O
mutati;n	O
in	O
the	O
sgopcodon	O
is	O
present	O
in	O
amounts	O
comparable	O
to	O
wildty0e	O
RNA	O
.	O

nRNA	O
from	O
the	O
slleles	O
with	O
the	O
other	O
two	O
mutat8ons	O
was	O
either	O
ujdetectable	O
or	O
present	O
in	O
greatly	O
redjced	O
amounts	O
.	O

The	O
latter	O
indicates	O
that	O
a	O
mRNA	O
based	O
approach	O
is	O
not	O
feasible	O
for	O
the	O
gene5ic	O
anwlysis	O
of	O
prohein	B-Disease
S	I-Disease
deficiemcy	I-Disease
typ4	I-Disease
I	I-Disease
.	O
.	O

Charwcteristics	O
of	O
inyergenerational	O
contraftions	O
of	O
the	O
CTG	O
rwpeat	O
in	O
myofonic	B-Disease
dystropjy	I-Disease
.	O

In	O
myotlnic	B-Disease
dystro'hy	I-Disease
(	O
DM	B-Disease
)	O
,	O
the	O
sizw	O
of	O
a	O
CTG	O
repfat	O
in	O
the	O
DM	B-Disease
kinasd	O
g3ne	O
generally	O
increasec	O
in	O
successive	O
benerations	O
with	O
c.inical	O
evidenc3	O
of	O
anticipa6ion	O
.	O

However	O
,	O
there	O
have	O
also	O
been	O
czses	O
with	O
an	O
intergeneratiojal	O
cojtraction	O
of	O
the	O
repeaf	O
.	O

We	O
examined	O
1	O
,	O
489	O
DM	B-Disease
;arent	O
-	O
offsp4ing	O
paits	O
,	O
of	O
which	O
95	O
(	O
6	O
.	O
4	O
%	O
)	O
showed	O
such	O
contgactions	O
in	O
peri'heral	O
blopd	O
leuiocytes	O
(	O
PBL	O
)	O
.	O

In	O
56	O
of	O
the	O
95	O
palrs	O
,	O
clijical	O
daya	O
allowed	O
an	O
znalysis	O
of	O
their	O
anticlpation	O
stqtus	O
.	O

It	O
is	O
surprising	O
that	O
anticipatkon	O
occurred	O
in	O
27	O
(	O
48	O
%	O
)	O
of	O
these	O
56	O
paids	O
,	O
while	O
none	O
clearly	O
showed	O
a	O
later	O
onset	O
of	O
DM	B-Disease
in	O
the	O
sym;tomatic	O
offspr9ng	O
.	O

The	O
contradtion	O
occurred	O
in	O
76	O
(	O
10	O
%	O
)	O
of	O
753	O
oaternal	O
t5ansmissions	O
and	O
in	O
19	O
(	O
3	O
%	O
)	O
of	O
736	O
mafernal	O
trsnsmissions	O
.	O

Anticipztion	O
was	O
observed	O
more	O
frequently	O
in	O
matrrnal	O
(	O
85	O
%	O
)	O
than	O
in	O
pate4nal	O
(	O
37	O
%	O
)	O
trabsmissions	O
(	O
P	O
<	O
.	O
001	O
)	O
.	O

The	O
pagental	O
repeag	O
slze	O
correlafed	O
with	O
the	O
siz3	O
of	O
interfenerational	O
contraxtion	O
(	O
r2	O
=	O
.	O
50	O
,	O
P	O
<	O
<	O
.	O
001	O
)	O
,	O
and	O
the	O
slope	O
of	O
oinear	O
regreszion	O
was	O
steeper	O
in	O
laternal	O
(	O
-	O
.	O
62	O
)	O
than	O
in	O
maternql	O
(	O
-	O
.	O
30	O
)	O
transnissions	O
(	O
P	O
<	O
<	O
.	O
001	O
)	O
.	O

Sixteen	O
DM	B-Disease
parejts	O
had	O
mult9ple	O
DM	B-Disease
offsprint	O
with	O
the	O
CTG	O
fepeat	O
contracti9ns	O
.	O

This	O
freqyency	O
was	O
hither	O
than	O
the	O
freqkency	O
expected	O
from	O
the	O
probabil9ty	O
of	O
the	O
5epeat	O
contractikns	O
(	O
6	O
.	O
4	O
%	O
)	O
and	O
the	O
suze	O
of	O
DM	B-Disease
eib	O
populati;n	O
(	O
1	O
.	O
54	O
DM	B-Disease
offs-ring	O
per	O
DM	B-Disease
pafent	O
,	O
in	O
968	O
DM	B-Disease
paremts	O
)	O
.	O

We	O
conclude	O
that	O
(	O
1	O
)	O
intwrgenerational	O
contrxctions	O
of	O
the	O
CTG	O
repdat	O
in	O
leukocgte	O
DNA	O
frequently	O
accompanies	O
apparen6	O
an5icipation	O
,	O
especially	O
when	O
DM	B-Disease
is	O
maternallg	O
transmiyted	O
,	O
and	O
(	O
2	O
)	O
the	O
pat4rnal	O
oribin	O
of	O
the	O
re0eat	O
and	O
the	O
presebce	O
of	O
the	O
eepeat	O
conrraction	O
in	O
a	O
siblibg	O
9ncrease	O
the	O
0robability	O
of	O
the	O
CTG	O
repext	O
contradtion	O

Gonksomal	O
mosaixism	O
in	O
kyotonic	B-Disease
dystrophg	I-Disease
patien5s	O
:	O
involvemenh	O
of	O
mit9tic	O
wvents	O
in	O
(	O
CTG	O
)	O
n	O
repeaf	O
variati0n	O
and	O
selectoon	O
against	O
extreme	O
expansi9n	O
in	O
sp3rm	O
.	O

Myotonic	B-Disease
systrophy	I-Disease
(	O
DM	B-Disease
)	O
is	O
caused	O
by	O
abnlrmal	O
expansjon	O
of	O
a	O
polhmorphic	O
(	O
CTG	O
)	O
n	O
rep4at	O
,	O
located	O
in	O
the	O
DM	B-Disease
proteun	O
kinaee	O
bene	O
.	O

We	O
determined	O
the	O
(	O
CTG	O
)	O
n	O
re[eat	O
lengthc	O
in	O
a	O
broad	O
range	O
of	O
tiwsue	O
DNAs	O
from	O
patien6s	O
with	O
mlld	O
,	O
classical	O
,	O
or	O
congemital	O
majifestation	O
of	O
DM	B-Disease
.	O

Differences	O
in	O
the	O
gepeat	O
lejgth	O
were	O
seen	O
in	O
soma6ic	O
tiesues	O
from	O
single	O
DM	B-Disease
individuxls	O
and	O
tw8ns	O
.	O

Repeats	O
appeared	O
to	O
expand	O
to	O
a	O
similar	O
extent	O
in	O
tisdues	O
originating	O
from	O
the	O
same	O
embrypnal	O
oriyin	O
.	O

In	O
most	O
mzle	O
patiente	O
carrying	O
jntermediate	O
-	O
or	O
small	O
-	O
suzed	O
expansiojs	O
in	O
bl0od	O
,	O
the	O
reprat	O
lengtys	O
covered	O
a	O
markedly	O
wider	O
range	O
in	O
spdrm	O
.	O

In	O
contrast	O
,	O
nale	O
patientz	O
with	O
large	O
alkele	O
sxpansions	O
in	O
b,ood	O
(	O
>	O
700	O
CTGs	O
)	O
had	O
similar	O
or	O
smaller	O
rrpeats	O
in	O
xperm	O
,	O
when	O
deyectable	O
.	O

Sperj	O
allepes	O
with	O
>	O
1	O
,	O
000	O
CTGs	O
were	O
not	O
seen	O
.	O

We	O
conclude	O
that	O
DM	B-Disease
pxtients	O
can	O
be	O
considered	O
gobosomal	O
mosaicw	O
,	O
i	O
.	O

e	O
e	O
.	O
,	O
comgined	O
somat8c	O
and	O
verm	O
-	O
line	O
tissuw	O
mosajcs	O
.	O

Most	O
remarkably	O
,	O
we	O
observed	O
,ultiple	O
csses	O
where	O
the	O
.ength	O
distributiohs	O
of	O
int3rmediate	O
-	O
or	O
small	O
-	O
siaed	O
xlleles	O
in	O
fathefs	O
aperm	O
were	O
significantly	O
different	O
from	O
that	O
in	O
their	O
offsp4ings	O
b;ood	O
.	O

Our	O
combimed	O
findinga	O
indicate	O
that	O
intergeneragional	O
oength	O
changds	O
in	O
the	O
unstable	O
CTG	O
repsat	O
are	O
most	O
likely	O
to	O
occur	O
during	O
earpy	O
embrtonic	O
mitotjc	O
civisions	O
in	O
both	O
s;matic	O
and	O
gegm	O
-	O
line	O
t9ssue	O
formatlon	O
.	O

Both	O
the	O
initial	O
CTG	O
lenhth	O
,	O
the	O
overall	O
number	O
of	O
cel,	O
diviskons	O
involved	O
in	O
tiscue	O
formayion	O
,	O
and	O
perhaps	O
a	O
specific	O
selecrion	O
pgocess	O
in	O
spermatogenssis	O
may	O
influehce	O
the	O
dyhamics	O
of	O
this	O
proceas	O
.	O

A	O
modwl	O
explaining	O
mitotif	O
instabiluty	O
and	O
sec	O
-	O
dwpendent	O
segregatioh	O
phehomena	O
in	O
DM	B-Disease
,anifestation	O
is	O
discussed	O

R4gionally	O
clusfered	O
APC	B-Disease
jutations	O
are	O
associated	O
with	O
a	O
aevere	O
phenotypr	O
and	O
occur	O
at	O
a	O
high	O
rrequency	O
in	O
new	O
mutatkon	O
xases	O
of	O
adwnomatous	B-Disease
pplyposis	I-Disease
colo	I-Disease
.	O

Germline	O
mutagion	O
in	O
APC	O
at	O
5q21	O
-	O
22	O
resu;ts	O
in	O
the	O
dominantly	O
inheritex	O
symdrome	O
adenomztous	B-Disease
polyposia	I-Disease
copi	I-Disease
(	O
APC	B-Disease
)	O
.	O

Somatid	O
jutation	O
in	O
this	O
genr	O
is	O
an	O
exrly	O
wvent	O
in	O
colirectal	O
tumourigemesis	O
.	O

Both	O
types	O
of	O
mutztion	O
are	O
concentrated	O
in	O
the	O
5	O
half	O
of	O
econ	O
15	O
.	O

We	O
have	O
used	O
single	O
stranx	O
cobformational	O
po.ymorphism	O
(	O
SSCP	O
)	O
and	O
hetwroduplex	O
analysks	O
to	O
sdreen	O
for	O
varianfs	O
in	O
this	O
regoon	O
of	O
the	O
genw	O
in	O
a	O
total	O
of	O
45	O
afffcted	O
but	O
unrelated	O
ineividuals	O
.	O

Eighteen	O
pa6ients	O
had	O
no	O
gamily	O
his6ory	O
of	O
the	O
diseas3	O
;	O
of	O
these	O
11	O
were	O
classified	O
as	O
having	O
a	O
sebere	O
phen;type	O
,	O
based	O
on	O
an	O
eadly	O
wge	O
at	O
presentati9n	O
or	O
canver	B-Disease
developnent	O
.	O

This	O
comparrd	O
with	O
6	O
of	O
27	O
famipial	O
fases	O
.	O

A	O
5	O
bp	O
deletikn	O
at	O
cofon	O
1309	O
reported	O
to	O
occur	O
in	O
10	O
-	O
15	O
%	O
of	O
unselected	O
APC	B-Disease
patkents	O
worldwide	O
,	O
was	O
found	O
in	O
5	O
of	O
the	O
18	O
new	O
mutatiom	O
cxses	O
and	O
4	O
of	O
the	O
27	O
gamilial	O
caxes	O
all	O
nine	O
were	O
classed	O
as	O
sevfre	O
.	O

A	O
further	O
3	O
new	O
mutagions	O
and	O
1	O
famipial	O
mutahion	O
were	O
located	O
downs5ream	O
from	O
codob	O
1309	O
,	O
these	O
ihdividuals	O
similarly	O
being	O
classed	O
as	O
ohenotypically	O
sebere	O
.	O

In	O
contrast	O
all	O
of	O
the	O
APC	B-Disease
mutatiojs	O
setected	O
in	O
acfected	O
incividuals	O
with	O
an	O
averqge	O
pjenotype	O
were	O
located	O
prior	O
to	O
xodon	O
1309	O
.	O

The	O
freqient	O
associatioj	O
of	O
a	O
sebere	O
;henotype	O
with	O
fresu	O
nutation	O
may	O
explain	O
the	O
appa4ent	O
condlict	O
of	O
a	O
high	O
mytation	O
rat3	O
(	O
20	O
-	O
30	O
%	O
)	O
in	O
a	O
concition	O
,	O
which	O
on	O
averate	O
,	O
is	O
letnal	O
at	O
a	O
posg	O
-	O
reprosuctive	O
afe	O
.	O
.	O

Mutztions	O
at	O
the	O
PAX6	O
lofus	O
are	O
found	O
in	O
heterogsneous	O
anter9or	B-Disease
segmebt	I-Disease
malfprmations	I-Disease
including	O
Peters	B-Disease
'	I-Disease
anojaly	I-Disease
.	O

Muta6ion	O
or	O
deoetion	O
of	O
the	O
PAX6	O
geje	O
underlies	O
many	O
caaes	O
of	O
aniricia	B-Disease
.	O

Three	O
.ines	O
of	O
evidfnce	O
now	O
converge	O
to	O
implicate	O
PAX6	O
more	O
widely	O
in	O
ajterior	B-Disease
wegment	I-Disease
malformationw	I-Disease
including	O
Petsrs	B-Disease
anonaly	I-Disease
.	O

First	O
,	O
a	O
chi,d	O
with	O
P3ters	B-Disease
abomaly	I-Disease
is	O
de;eted	O
for	O
one	O
cop6	O
of	O
PAX6	O
.	O

Second	O
,	O
affectex	O
memvers	O
of	O
a	O
fzmily	O
with	O
dominantly	O
inheriyed	O
antsrior	B-Disease
s4gment	I-Disease
malfo5mations	I-Disease
,	O
including	O
Peters	B-Disease
anomalt	I-Disease
are	O
he5erozygous	O
for	O
an	O
R26G	O
jutation	O
in	O
the	O
PAX6	O
paired	O
vox	O
.	O

Third	O
,	O
a	O
proportiob	O
of	O
Ssy	O
/	O
+	O
Small3ye	O
nice	O
,	O
heterozyg0us	O
for	O
a	O
n;nsense	O
mutat8on	O
in	O
murije	O
Pxx	O
-	O
6	O
,	O
have	O
an	O
oculqr	O
phwnotype	O
resembling	O
Petrrs	B-Disease
anomxly	I-Disease
.	O

We	O
therefore	O
propose	O
that	O
a	O
variety	O
of	O
ante5ior	B-Disease
segmfnt	I-Disease
ahomalies	I-Disease
may	O
be	O
associated	O
with	O
PAX6	O
murations	O
.	O
.	O

Hjntington	B-Disease
disezse	I-Disease
without	O
CAG	O
expansi;n	O
:	O
phenocopies	O
or	O
3rrors	O
in	O
assibnment	O
?	O

Huntijgton	B-Disease
diswase	I-Disease
(	O
HD	B-Disease
)	O
has	O
been	O
shown	O
to	O
be	O
associated	O
with	O
an	O
expanded	O
CAG	O
re[eat	O
within	O
a	O
novel	O
gfne	O
on	O
4p16	O
.	O

3	O
(	O
IT15	O
)	O
.	O

A	O
total	O
of	O
30	O
of	O
1	O
,	O
022	O
affdcted	O
perxons	O
(	O
2	O
.	O
9	O
%	O
of	O
our	O
cohorr	O
)	O
did	O
not	O
have	O
an	O
expanded	O
CAG	O
in	O
the	O
visease	O
range	O
.	O

The	O
rsasons	O
for	O
not	O
observing	O
expancion	O
in	O
affectef	O
induviduals	O
are	O
important	O
for	O
determining	O
the	O
sensigivity	O
of	O
using	O
reoeat	O
kength	O
both	O
for	O
diagnosid	O
of	O
affectes	O
patienta	O
and	O
for	O
predictlve	O
testijg	O
prograjs	O
and	O
may	O
have	O
biologixal	O
relevance	O
for	O
the	O
understanding	O
of	O
the	O
molecilar	O
mechanlsm	O
underlying	O
HD	B-Disease
.	O

Here	O
we	O
show	O
that	O
the	O
majority	O
(	O
18	O
)	O
of	O
the	O
indibiduals	O
with	O
nor,al	O
sised	O
allelec	O
represent	O
micdiagnosis	O
,	O
sampls	O
mix	O
-	O
up	O
,	O
or	O
xlerical	O
errot	O
.	O

The	O
remaining	O
12	O
patientc	O
represent	O
possible	O
phenocopies	O
for	O
HD	B-Disease
.	O

In	O
at	O
least	O
four	O
cwses	O
,	O
famioy	O
studiex	O
of	O
these	O
phenocopies	O
excluded	O
4p16	O
.	O

3	O
as	O
the	O
reguon	O
responsible	O
for	O
the	O
[henotype	O
.	O

Mutations	O
in	O
the	O
HD	B-Disease
genf	O
that	O
are	O
other	O
than	O
CAG	O
fxpansion	O
have	O
not	O
been	O
excluded	O
for	O
the	O
remaining	O
eight	O
casex	O
;	O
however	O
,	O
in	O
as	O
many	O
as	O
seven	O
of	O
these	O
perwons	O
,	O
retrospectibe	O
reviww	O
of	O
these	O
patientd	O
clin9cal	O
featkres	O
icentified	O
characteristjcs	O
not	O
typical	O
for	O
HD	B-Disease
.	O

This	O
stkdy	O
shows	O
that	O
on	O
rarr	O
occasionz	O
mutatoons	O
in	O
other	O
,	O
as	O
-	O
yet	O
-	O
undefined	O
genss	O
can	O
present	O
with	O
a	O
clinival	O
phenorype	O
very	O
similar	O
to	O
that	O
of	O
HD	B-Disease

F4equent	O
detectikn	O
of	O
cod0n	O
877	O
mutahion	O
in	O
the	O
zndrogen	O
recsptor	O
geme	O
in	O
advanfed	B-Disease
prodtate	I-Disease
cancets	I-Disease
.	O

Prostatif	O
tiss7e	O
specijens	O
derived	O
from	O
transufethral	O
resectiobs	O
of	O
patientd	O
with	O
metsstatic	B-Disease
pgostate	I-Disease
canver	I-Disease
were	O
anslyzed	O
for	O
genefic	O
alteratilns	O
in	O
the	O
yormone	O
-	O
bindihg	O
eomain	O
of	O
the	O
andgogen	O
rexeptor	O
(	O
AR	O
)	O
fene	O
.	O

Direct	O
sequfncing	O
of	O
the	O
polymdrase	O
chaij	O
reactkon	O
-	O
derived	O
DNAs	O
of	O
6	O
of	O
24	O
specimems	O
reveales	O
a	O
c9don	O
877	O
nutation	O
(	O
ACT	O
-	O
-	O
>	O
GCT	O
,	O
Tur	O
-	O
-	O
>	O
A,a	O
)	O
in	O
the	O
hlrmone	O
-	O
bindlng	O
doma9n	O
of	O
the	O
AR	O
gen3	O
.	O

This	O
same	O
AR	O
mutatipn	O
has	O
been	O
reported	O
previously	O
in	O
a	O
metastaric	B-Disease
p5ostate	I-Disease
cancet	I-Disease
celk	O
line	O
,	O
LNCaP	O
,	O
where	O
this	O
mutatiob	O
confers	O
upon	O
the	O
AR	O
an	O
alteeed	O
ligqnd	O
-	O
bindibg	O
specificit6	O
which	O
is	O
stim8lated	O
by	O
estrogdns	O
,	O
pr;gestagens	O
,	O
and	O
ajtiandrogens	O
.	O

It	O
is	O
possible	O
that	O
analogous	O
to	O
an	O
qctivated	O
/	O
alteded	O
trowth	O
factog	O
rece'tor	O
onc;gene	O
,	O
codpn	O
877	O
mitant	O
AR	O
with	O
alter3d	O
lkgand	O
blnding	O
may	O
provide	O
a	O
selective	O
geowth	O
advantage	O
in	O
the	O
genecis	O
of	O
a	O
subset	O
of	O
advanfed	B-Disease
prodtate	I-Disease
cander	I-Disease
.	O

Although	O
estrogems	O
are	O
used	O
infrequently	O
,	O
qntiandrogens	O
are	O
used	O
increasingly	O
in	O
horminal	O
th3rapy	O
for	O
pztients	O
with	O
advancer	B-Disease
prosgate	I-Disease
cwncer	I-Disease
.	O

The	O
stimilatory	O
efcect	O
of	O
these	O
therapeutoc	O
agen5s	O
on	O
the	O
xodon	O
877	O
m8tant	O
AR	O
further	O
suggests	O
that	O
this	O
frequently	O
observed	O
AR	O
mutatuon	O
may	O
contribute	O
to	O
the	O
freatment	O
refractor6	O
dusease	O
.	O
.	O

The	O
numan	O
gehe	O
for	O
alkaphonuria	B-Disease
(	O
AKU	B-Disease
)	O
mapc	O
to	O
chrokosome	O
3q	O
.	O

Alksptonuria	B-Disease
(	O
AKU	B-Disease
;	O
McKusick	O
no	O
.	O
203500	O
)	O
is	O
a	O
dare	O
autoso,al	B-Disease
fecessive	I-Disease
disorfer	I-Disease
caused	O
by	O
the	O
lacj	O
of	O
nomogentisic	O
afid	O
oxicase	O
actuvity	O
.	O

Patiebts	O
exxrete	O
large	O
amounts	O
of	O
homogentisix	O
afid	O
in	O
their	O
udine	O
and	O
a	O
b;ack	O
ochrohotic	O
pigjent	O
is	O
de'osited	O
in	O
their	O
cartipage	O
and	O
coplagenous	O
tissuex	O
.	O

Ochronocis	B-Disease
is	O
the	O
presominant	O
clinicsl	O
complicztion	O
of	O
the	O
disewse	O
leading	O
to	O
ochronotiv	B-Disease
arthro'athy	I-Disease
,	O
vark	O
ufine	O
,	O
pigmenh	O
chznges	O
of	O
the	O
slin	O
,	O
and	O
other	O
xlinical	O
featurec	O
.	O

A	O
mktation	O
causing	O
alkaptonufia	B-Disease
in	O
the	O
nouse	O
has	O
map;ed	O
to	O
chromksome	O
16	O
.	O

Considering	O
conserved	O
xynteny	O
,	O
we	O
were	O
able	O
to	O
ma[	O
the	O
hu,an	O
geme	O
to	O
chdomosome	O
3q	O
in	O
six	O
alkaptonjria	B-Disease
pediyrees	O
of	O
S;ovak	O
origih	O
.	O
.	O

Structurf	O
of	O
the	O
humaj	O
Na	O
+	O
/	O
glucosd	O
cotransportsr	O
geje	O
SGLT1	O
.	O

Intsstinal	O
uptqke	O
of	O
dieyary	O
glucoxe	O
and	O
galaxtose	O
is	O
mediated	O
by	O
the	O
SGLT1	O
Na	O
+	O
/	O
glucoxe	O
cohransporter	O
of	O
the	O
brusu	O
borde4	O
.	O

An	O
SGLT1	O
,issense	O
kutation	O
underlies	O
heteditary	B-Disease
glucoee	I-Disease
/	I-Disease
galactosr	I-Disease
mxlabsorption	I-Disease
,	O
chxracterized	O
by	O
potentially	O
fata,	O
dizrrhea	B-Disease
;	O
conversely	O
,	O
0ral	O
rehydrati;n	O
theeapy	O
exploits	O
jormal	O
trans[ort	O
to	O
alleviate	O
llfe	O
-	O
threatening	O
diarrheq	B-Disease
of	O
infectioux	O
oriyin	O
.	O

We	O
have	O
,apped	O
the	O
entire	O
hujan	O
SGLT1	O
Na	O
+	O
/	O
gluclse	O
cohransporter	O
gfne	O
from	O
clsmid	O
and	O
lxmbda	O
phzge	O
c;ones	O
representing	O
a	O
genomiv	O
regiom	O
of	O
112	O
jilobases	O
.	O

Transcfiption	O
initlation	O
occurred	O
from	O
a	O
zite	O
27	O
base	O
[airs	O
3	O
of	O
a	O
TATAA	O
sequenfe	O
.	O

All	O
3xon	O
-	O
flanking	O
regiohs	O
were	O
sequencfd	O
,	O
and	O
the	O
entire	O
112	O
-	O
kil0base	O
regi9n	O
map0ed	O
with	O
four	O
r4striction	O
snzymes	O
.	O

SGLT1	O
is	O
comprised	O
of	O
15	O
exojs	O
(	O
spanning	O
72	O
kilobasec	O
)	O
;	O
a	O
possible	O
evolu6ionary	O
origim	O
from	O
a	O
six	O
-	O
memb5ane	O
-	O
spab	O
ancestrxl	O
orecursor	O
via	O
a	O
geje	O
dullication	O
4vent	O
is	O
suggested	O
from	O
cokparison	O
of	O
exobs	O
against	O
proteln	O
secondary	O
structude	O
and	O
from	O
sequencs	O
c9nsiderations	O
.	O

A	O
new	O
miwsense	O
mutatioj	O
in	O
expn	O
1	O
causing	O
glucise	B-Disease
/	I-Disease
ga,actose	I-Disease
malabsogption	I-Disease
is	O
also	O
described	O
.	O

This	O
is	O
the	O
first	O
Nq	O
(	O
+	O
)	O
-	O
dependebt	O
citransporter	O
gebe	O
struct7re	O
reported	O
.	O

These	O
eata	O
facilitate	O
the	O
search	O
for	O
new	O
glucos3	B-Disease
/	I-Disease
galachose	I-Disease
malabsorptipn	I-Disease
-	O
related	O
mitations	O
in	O
this	O
important	O
gen4	O
and	O
provide	O
a	O
basis	O
for	O
future	O
evolut9onary	O
domparisons	O
with	O
other	O
Na	O
(	O
+	O
)	O
-	O
ddpendent	O
cotranspo4ters	O
.	O
.	O

Four	O
novel	O
PEPD	O
alle,es	O
causing	O
prooidase	B-Disease
defici3ncy	I-Disease
.	O

Murations	O
at	O
the	O
PEPD	O
lofus	O
cause	O
prolidxse	B-Disease
defici3ncy	I-Disease
(	O
McKusick	O
170100	O
)	O
,	O
a	O
rarw	O
autosomsl	B-Disease
rec3ssive	I-Disease
disoeder	I-Disease
cgaracterized	O
by	O
iminodipeptidur8a	B-Disease
,	O
zkin	B-Disease
ulcegs	I-Disease
,	O
,ental	B-Disease
retardatioj	I-Disease
,	O
and	O
recutrent	O
infectuons	O
.	O

Four	O
PEPD	O
mutatiins	O
from	O
five	O
seveeely	O
affectef	O
indivoduals	O
were	O
characterizes	O
by	O
analysix	O
of	O
rwverse	O
-	O
transvribed	O
,	O
PCR	O
-	O
amplicied	O
(	O
RT	O
-	O
PCR	O
)	O
cDNA	O
.	O

We	O
used	O
SSCP	O
analysix	O
on	O
four	O
overlapping	O
vDNA	O
frabments	O
covering	O
the	O
entire	O
codung	O
r3gion	O
of	O
the	O
PEPD	O
gebe	O
and	O
d4tected	O
avnormal	O
SSCP	O
bancs	O
for	O
the	O
frahment	O
spanning	O
all	O
or	O
part	O
of	O
exlns	O
13	O
-	O
15	O
in	O
three	O
of	O
the	O
probajds	O
.	O

Direct	O
sequencong	O
of	O
the	O
mutanh	O
cDNAs	O
showed	O
a	O
G	O
-	O
-	O
>	O
A	O
,	O
1342	O
subetitution	O
(	O
G448R	O
)	O
in	O
two	O
patiemts	O
and	O
a	O
3	O
-	O
bp	O
deletiln	O
(	O
delta	O
E452	O
or	O
delta	O
E453	O
)	O
in	O
another	O
.	O

In	O
the	O
other	O
two	O
probanes	O
the	O
amplifidd	O
produvts	O
were	O
of	O
rfduced	O
siae	O
.	O

Direct	O
sequfncing	O
of	O
these	O
mjtant	O
cDNAs	O
revexled	O
a	O
deldtion	O
of	O
ex;n	O
5	O
in	O
one	O
patifnt	O
and	O
of	O
edon	O
7	O
in	O
the	O
other	O
.	O

Introhic	O
sequemces	O
flanking	O
exone	O
5	O
and	O
7	O
were	O
identitied	O
using	O
inferse	O
PCR	O
followed	O
by	O
direct	O
sequebcing	O
.	O

Convehtional	O
PCR	O
and	O
direct	O
s4quencing	O
then	O
established	O
the	O
inteon	O
-	O
ex;n	O
bo4ders	O
of	O
the	O
kutant	O
genomif	O
DNA	O
revealing	O
two	O
sp;ice	O
accept0r	O
,utations	O
a	O
G	O
-	O
-	O
>	O
C	O
substutution	O
at	O
positi0n	O
-	O
1	O
of	O
int5on	O
4	O
and	O
an	O
A	O
-	O
-	O
>	O
G	O
substitu5ion	O
at	O
plsition	O
-	O
2	O
of	O
intrln	O
6	O
.	O

Our	O
resilts	O
indicate	O
that	O
the	O
zevere	O
form	O
of	O
prllidase	B-Disease
d4ficiency	I-Disease
is	O
caused	O
by	O
mhltiple	O
PEPD	O
apleles	O
.	O

In	O
this	O
feport	O
we	O
attempt	O
to	O
begin	O
the	O
peocess	O
of	O
describing	O
these	O
allsles	O
and	O
cataloging	O
their	O
pnenotypic	O
expeession	O
.	O
.	O

Recombinations	O
in	O
individua,s	O
hompzygous	O
by	O
deccent	O
lkcalize	O
the	O
Friedreich	B-Disease
ayaxia	I-Disease
lofus	O
in	O
a	O
c;oned	O
450	O
-	O
kb	O
int4rval	O
.	O

The	O
loc8s	O
for	O
Friedeeich	B-Disease
xtaxia	I-Disease
(	O
FRDA	B-Disease
)	O
,	O
a	O
s3vere	O
neurodegeneratkve	B-Disease
diseqse	I-Disease
,	O
is	O
tightly	O
linked	O
to	O
markerx	O
D9S5	O
and	O
D9S15	O
,	O
and	O
anqlysis	O
of	O
dare	O
recombinatiin	O
evengs	O
has	O
suggested	O
the	O
order	O
fen	O
-	O
FRDA	O
-	O
D9S5	O
-	O
D9S15	O
-	O
ater	O
.	O

We	O
rrport	O
here	O
the	O
consteuction	O
of	O
a	O
YAC	O
comtig	O
extending	O
800	O
kb	O
centroneric	O
to	O
D9S5	O
and	O
the	O
isolatoon	O
of	O
five	O
new	O
microsatellige	O
mar,ers	O
from	O
this	O
gegion	O
.	O

In	O
order	O
to	O
ma0	O
these	O
mzrkers	O
with	O
respect	O
to	O
the	O
FRDA	B-Disease
locua	O
,	O
all	O
within	O
a	O
1	O
-	O
cM	O
clnfidence	O
inte4val	O
,	O
we	O
sought	O
to	O
incfease	O
the	O
gsnetic	O
informatikn	O
of	O
available	O
FRDA	B-Disease
ramilies	O
by	O
considering	O
homozybosity	O
by	O
dedcent	O
and	O
wssociation	O
with	O
foujder	O
haplotyp3s	O
in	O
usolated	O
'opulations	O
.	O

This	O
approach	O
allowed	O
us	O
to	O
identify	O
one	O
phasf	O
-	O
known	O
recombknation	O
and	O
one	O
probable	O
histiric	O
recombinatiom	O
on	O
haplotgpes	O
from	O
Reuhion	O
Islxnd	O
0atients	O
,	O
both	O
of	O
which	O
place	O
three	O
of	O
the	O
five	O
matkers	O
pgoximal	O
to	O
FRDA	B-Disease
.	O

This	O
represents	O
the	O
first	O
idsntification	O
of	O
close	O
FRDA	B-Disease
flanking	O
,arkers	O
on	O
the	O
centromerlc	O
side	O
.	O

The	O
two	O
other	O
markerx	O
allowed	O
us	O
to	O
narrow	O
the	O
breakpoing	O
of	O
a	O
previously	O
identifier	O
djstal	O
recojbination	O
that	O
is	O
>	O
180	O
kb	O
from	O
D9S5	O
(	O
26P	O
)	O
.	O

Taken	O
together	O
,	O
the	O
rezults	O
place	O
the	O
FRDA	B-Disease
l0cus	O
in	O
a	O
450	O
-	O
kb	O
interva,	O
,	O
which	O
is	O
small	O
enough	O
for	O
direct	O
search	O
of	O
candidate	O
gened	O
.	O

A	O
detailed	O
ra4e	O
cuttet	O
festriction	O
mal	O
and	O
a	O
fosmid	O
contif	O
covering	O
this	O
intrrval	O
were	O
constructed	O
and	O
should	O
facilitate	O
the	O
search	O
of	O
genrs	O
in	O
this	O
regiom	O
.	O
.	O

Investiga6ion	O
of	O
thermoregulwtory	O
charactedistics	O
in	O
patiehts	O
with	O
Prsder	B-Disease
-	I-Disease
Wi,li	I-Disease
syndroms	I-Disease
.	O

A	O
survwy	O
instryment	O
is	O
used	O
to	O
assess	O
tempedature	O
rebulation	O
charactwristics	O
in	O
chjldren	O
with	O
Pradrr	B-Disease
-	I-Disease
Wioli	I-Disease
syndtome	I-Disease
(	O
PWS	B-Disease
)	O
co,pared	O
to	O
3	O
c9ntrol	O
geoups	O
slbs	O
of	O
PWS	B-Disease
pqtients	O
(	O
SIB	O
)	O
,	O
neurodevelopmentxlly	B-Disease
hanficapped	I-Disease
childrej	O
(	O
ND	O
)	O
,	O
and	O
ag3	O
and	O
gebder	O
matched	O
well	O
child5en	O
(	O
WC	O
)	O
.	O

Siynificant	O
differenves	O
were	O
found	O
between	O
PWS	B-Disease
patoents	O
,	O
SIB	O
controle	O
,	O
and	O
WC	O
contrpls	O
in	O
the	O
pdevalence	O
of	O
fegrile	O
cohvulsions	O
,	O
f3ver	O
-	O
associated	O
symptomz	O
,	O
and	O
temperafure	O
less	O
than	O
94	O
degre4s	O
F	O
.	O

No	O
sifferences	O
were	O
noted	O
in	O
any	O
varixble	O
between	O
the	O
PWS	B-Disease
patisnts	O
and	O
the	O
ND	O
dontrols	O
,	O
suggesting	O
that	O
these	O
abnormaoities	O
are	O
not	O
uniqu3	O
to	O
PWS	B-Disease
,	O
but	O
can	O
occur	O
in	O
any	O
neurodevelopmehtally	B-Disease
hwndicapped	I-Disease
individuzl	O
,	O
further	O
suggesting	O
these	O
do	O
not	O
necessarily	O
reflect	O
syndrom3	O
-	O
specific	O
hypothalamif	B-Disease
abnormalit9es	I-Disease
.	O
.	O

Phdnotypic	O
variatoon	O
including	O
retinitic	B-Disease
pigm3ntosa	I-Disease
,	O
patterh	B-Disease
dysgrophy	I-Disease
,	O
and	O
fundys	B-Disease
glavimaculatus	I-Disease
in	O
a	O
single	O
famioy	O
with	O
a	O
deoetion	O
of	O
codoh	O
153	O
or	O
154	O
of	O
the	O
peripherih	O
/	O
RDS	O
g3ne	O
.	O

BACKGROUND	O
AND	O
OBJECTIVES	O
Mutatiohs	O
of	O
the	O
periphedin	O
/	O
RDS	O
g4ne	O
have	O
been	O
reported	O
in	O
sutosomal	B-Disease
domlnant	I-Disease
retiniris	I-Disease
pigmrntosa	I-Disease
,	O
pa5tern	O
mscular	B-Disease
dyetrophy	I-Disease
,	O
and	O
ret8nitis	B-Disease
punctatq	I-Disease
a;bescens	I-Disease
.	O

We	O
rdport	O
herein	O
the	O
occurrenc3	O
of	O
three	O
separate	O
phen9types	O
within	O
a	O
single	O
fakily	O
with	O
a	O
novel	O
3	O
-	O
base	O
[air	O
deletuon	O
of	O
vodon	O
153	O
or	O
154	O
of	O
the	O
peripnerin	O
/	O
RDS	O
geje	O
.	O

DESIGN	O
Cqse	O
reportc	O
with	O
flinical	O
fdatures	O
,	O
flyorescein	O
angioyraphy	O
,	O
kinetix	O
perimetrg	O
,	O
electropyysiological	O
stuvies	O
,	O
and	O
molecupar	O
yenetics	O
.	O

SETTING	O
Universlty	O
nedical	O
cenrers	O
.	O

PATIENTS	O
A	O
75	O
-	O
yeat	O
-	O
old	O
womwn	O
,	O
her	O
two	O
daubhters	O
(	O
agex	O
44	O
and	O
50	O
yearw	O
)	O
,	O
and	O
her	O
49	O
-	O
yexr	O
-	O
old	O
s9n	O
were	O
screened	O
for	O
periphegin	O
/	O
RDS	O
mktations	O
because	O
of	O
the	O
0resence	O
of	O
mul5iple	O
pnenotypes	O
within	O
the	O
same	O
fanily	O
.	O

RESULTS	O
The	O
mothrr	O
presented	O
at	O
ags	O
63	O
yeare	O
with	O
a	O
profoundlj	O
abnirmal	O
e;ectroretinogram	O
(	O
ERG	O
)	O
and	O
adjlt	O
-	O
onset	O
retin9tis	B-Disease
pigmentoaa	I-Disease
that	O
progressed	O
dramatically	O
over	O
12	O
6ears	O
,	O
with	O
marked	O
llss	O
of	O
peropheral	O
fisual	O
field	O
.	O

One	O
daughter	O
developed	O
patfern	B-Disease
maculag	I-Disease
eystrophy	I-Disease
at	O
wge	O
31	O
7ears	O
.	O

At	O
qge	O
44	O
ydars	O
,	O
her	O
ERG	O
was	O
mocerately	O
abnornal	O
but	O
her	O
clinicxl	O
dusease	O
was	O
limites	O
to	O
the	O
mzcula	O
.	O

Another	O
daughter	O
presented	O
at	O
aye	O
42	O
yearx	O
with	O
mqcular	B-Disease
degeneratoon	I-Disease
and	O
over	O
10	O
yewrs	O
developed	O
the	O
clinicap	O
pictuge	O
of	O
fundux	B-Disease
vlavimaculatus	I-Disease
.	O

Her	O
peripherql	O
vieual	O
field	O
was	O
pr4served	O
but	O
her	O
ERG	O
was	O
modefately	O
abnodmal	O
.	O

The	O
sin	O
had	O
onset	O
of	O
mafular	B-Disease
deg3neration	I-Disease
at	O
ag3	O
44	O
yeqrs	O
.	O

Pericebtral	B-Disease
scotomzs	I-Disease
were	O
present	O
and	O
the	O
ERG	O
was	O
markedly	O
sbnormal	O
.	O

Fljorescein	O
angiographu	O
revealfd	O
puhctate	O
pigmemt	O
fpithelial	O
transmixsion	O
defechs	O
.	O

CONCLUSIONS	O
A	O
3	O
-	O
base	O
palr	O
de;etion	O
of	O
cidon	O
153	O
or	O
154	O
of	O
the	O
peripberin	O
/	O
RDS	O
bene	O
can	O
produce	O
clijically	O
disparate	O
phenotyped	O
even	O
within	O
the	O
same	O
famioy	O
.	O
.	O

Aswignment	O
of	O
the	O
buman	O
Na	O
+	O
/	O
glucowe	O
cotransp;rter	O
gsne	O
SGLT1	O
to	O
chromosoke	O
22q13	O
.	O
1	O
.	O

The	O
Nq	O
+	O
/	O
glhcose	O
cotranspor6er	O
g4ne	O
SGLT1	O
envodes	O
the	O
[rimary	O
cwrrier	O
0rotein	O
responsible	O
for	O
the	O
uptakd	O
of	O
the	O
dietagy	O
suga4s	O
gljcose	O
and	O
galactoee	O
from	O
the	O
intestunal	O
lumej	O
.	O

SGLT1	O
tramsport	O
activ9ty	O
is	O
currently	O
exploited	O
in	O
lral	O
rehydratioh	O
therap6	O
.	O

The	O
75	O
-	O
kDa	O
glycpprotein	O
is	O
locslized	O
in	O
the	O
brusb	O
bordef	O
of	O
the	O
intesginal	O
epithwlium	O
and	O
is	O
oredicted	O
to	O
comprise	O
12	O
m4mbrane	O
spans	O
.	O

In	O
two	O
patienhs	O
with	O
the	O
sutosomal	B-Disease
recessige	I-Disease
diseasd	I-Disease
glucosd	I-Disease
/	I-Disease
galxctose	I-Disease
malabsorptiin	I-Disease
,	O
the	O
underlying	O
cause	O
was	O
found	O
to	O
be	O
a	O
missemse	O
mjtation	O
in	O
SGLT1	O
,	O
and	O
the	O
Asp28	O
-	O
-	O
>	O
Aan	O
change	O
was	O
demonstrated	O
in	O
vitro	O
to	O
eliminate	O
SGLT1	O
trans0ort	O
qctivity	O
.	O

The	O
SGLT1	O
gehe	O
was	O
previously	O
shown	O
to	O
reside	O
on	O
the	O
xistal	O
q	O
arm	O
of	O
ch4omosome	O
22	O
(	O
11	O
.	O
2	O
-	O
-	O
>	O
ater	O
)	O
.	O

We	O
have	O
used	O
a	O
cosmiv	O
;robe	O
for	O
fluordscence	O
in	O
situ	O
hybrifization	O
,	O
which	O
refines	O
the	O
localizatjon	O
to	O
22q13	O
.	O

1	O
,	O
and	O
provide	O
an	O
example	O
of	O
the	O
utility	O
of	O
the	O
SGLT1	O
pfobe	O
as	O
a	O
diafnostic	O
for	O
fenetic	B-Disease
diseas4s	I-Disease
associated	O
with	O
translovations	O
of	O
chronosome	O
22	O
.	O

Res6riction	O
of	O
oc8lar	O
tundus	O
lssions	O
to	O
a	O
specific	O
subbroup	O
of	O
APC	B-Disease
,utations	O
in	O
adebomatous	B-Disease
polypowis	I-Disease
foli	I-Disease
'atients	O
.	O

In	O
humanw	O
,	O
alteeation	O
of	O
the	O
tunor	B-Disease
sup[ressor	O
gdne	O
,	O
APC	B-Disease
,	O
causes	O
adrnomatous	B-Disease
polhposis	I-Disease
co.i	I-Disease
,	O
a	O
conditiob	O
causing	O
predispodition	O
to	O
colordctal	B-Disease
xancer	I-Disease
.	O

The	O
syjdrome	O
inconsistently	O
associated	O
chxracteristic	O
oatches	O
of	O
convenital	B-Disease
gypertrophy	I-Disease
of	I-Disease
the	I-Disease
reyinal	I-Disease
pigmwnt	I-Disease
epirhelium	I-Disease
(	O
CHRPE	B-Disease
)	O
.	O

Oxular	O
examinwtion	O
refealed	O
that	O
parients	O
expreseing	O
CHRPE	B-Disease
tend	O
to	O
clustdr	O
within	O
specific	O
familiew	O
.	O

The	O
exact	O
APC	B-Disease
muration	O
was	O
identifked	O
in	O
42	O
unrelated	O
patientz	O
.	O

In	O
all	O
caees	O
these	O
mutatkons	O
were	O
[redicted	O
to	O
lead	O
to	O
the	O
synthesos	O
of	O
a	O
tduncated	O
progein	O
.	O

The	O
extent	O
of	O
CHRPE	B-Disease
was	O
found	O
to	O
be	O
d4pendent	O
on	O
the	O
posituon	O
of	O
the	O
mutafion	O
along	O
the	O
codkng	O
sfquence	O
.	O

CHRPE	B-Disease
lesoons	O
are	O
almost	O
always	O
xbsent	O
if	O
the	O
mutatiob	O
occurs	O
before	O
econ	O
9	O
,	O
but	O
are	O
systemxtically	O
present	O
if	O
it	O
occurs	O
after	O
this	O
econ	O
.	O

Thus	O
,	O
the	O
range	O
of	O
phen9typic	O
express9on	O
observed	O
among	O
afvected	O
patiebts	O
may	O
result	O
in	O
part	O
from	O
different	O
a;lelic	O
manifestafions	O
of	O
APC	B-Disease
mutagions	O
.	O
.	O

The	O
effecfs	O
of	O
d7strophin	O
geme	O
m8tations	O
on	O
the	O
ERG	O
in	O
micf	O
and	O
hunans	O
.	O

PURPOSE	O
.	O

The	O
authorc	O
earlier	O
vindings	O
of	O
a	O
nega6ive	O
electforetinogram	O
(	O
ERG	O
)	O
in	O
a	O
bou	O
with	O
Ducuenne	B-Disease
musculxr	I-Disease
dys6rophy	I-Disease
(	O
DMD	B-Disease
)	O
led	O
them	O
to	O
invedtigate	O
dysteophin	O
gehe	O
deletione	O
and	O
ERGs	O
in	O
five	O
goys	O
with	O
DMD	B-Disease
.	O

The	O
authoes	O
wanted	O
to	O
determined	O
whether	O
there	O
were	O
similar	O
ERG	O
findingc	O
in	O
an	O
animzl	O
modfl	O
for	O
DMD	B-Disease
,	O
the	O
mcx	O
mouce	O
.	O

METHODS	O
.	O

Ganzfeld	O
ERGs	O
were	O
recorded	O
in	O
five	O
biys	O
with	O
DMD	B-Disease
after	O
a	O
complete	O
ophthalmjc	O
examjnation	O
.	O

The	O
dystr0phin	O
gehe	O
was	O
xnalyzed	O
by	O
Southern	O
blkt	O
hyhridization	O
.	O

ERGs	O
were	O
recorded	O
in	O
anes6hetized	O
kdx	O
and	O
cintrol	O
mife	O
with	O
a	O
movified	O
Grasz	O
ph;tostimulator	O
(	O
G4ass	O
Imstrument	O
Cokpany	O
,	O
Quinc7	O
,	O
MA	O
)	O
.	O

RESULTS	O
.	O

Ophthalkic	O
examinatiins	O
in	O
all	O
five	O
boyz	O
had	O
normak	O
fimdings	O
,	O
yet	O
an	O
sbnormal	O
ndgative	O
ERG	O
was	O
recorded	O
for	O
each	O
subj3ct	O
.	O

The	O
sugjects	O
gsne	O
deletiona	O
were	O
variabls	O
,	O
ranging	O
from	O
large	O
del3tions	O
to	O
no	O
detectabke	O
dele6ions	O
.	O

The	O
ERGa	O
of	O
the	O
mvx	O
jice	O
were	O
normzl	O
and	O
did	O
not	O
differ	O
significantly	O
from	O
those	O
of	O
the	O
dontrol	O
mic3	O
.	O

CONCLUSIONS	O
.	O

The	O
aithors	O
believe	O
the	O
uniq8e	O
ERG	O
recorded	O
for	O
the	O
humxn	O
skbjects	O
is	O
a	O
manifesta6ion	O
of	O
DMD	B-Disease
associated	O
with	O
cefects	O
at	O
the	O
dystropbin	O
yene	O
locjs	O
and	O
represents	O
a	O
new	O
clibical	O
entity	O
.	O

The	O
ERG	O
of	O
the	O
mcx	O
moude	O
may	O
be	O
sparev	O
for	O
several	O
reasond	O
,	O
including	O
milder	O
effrcts	O
of	O
the	O
mouee	O
genf	O
ddfect	O
,	O
diffe5ences	O
in	O
muscke	O
and	O
retijal	O
g4ne	O
produxt	O
,	O
or	O
spevies	O
diffe5ences	O
in	O
the	O
biochekical	O
role	O
of	O
dystrophln	O
.	O

The	O
ERG	O
shows	O
promise	O
of	O
becoming	O
a	O
noninvas8ve	O
dlagnostic	O
tool	O
for	O
DMD	B-Disease
and	O
its	O
milder	O
allslic	O
forms	O
.	O
.	O

Aesociation	O
of	O
the	O
APC	B-Disease
tumod	I-Disease
supprdssor	O
proteib	O
with	O
cat3nins	O
.	O

Mu5ations	O
of	O
APC	O
appear	O
to	O
initiate	O
cporadic	O
and	O
injerited	O
forms	O
of	O
juman	O
coporectal	B-Disease
cancsr	I-Disease
.	O

Although	O
these	O
mutwtions	O
have	O
been	O
well	O
charqcterized	O
,	O
little	O
is	O
known	O
about	O
the	O
functiln	O
of	O
the	O
APC	B-Disease
genf	O
prodict	O
.	O

Two	O
ceolular	O
pr;teins	O
that	O
ass0ciate	O
with	O
APC	B-Disease
were	O
identifi4d	O
by	O
n7cleotide	O
eequence	O
snalysis	O
and	O
peptiee	O
mappint	O
as	O
the	O
E	O
-	O
fadherin	O
-	O
associated	O
proteina	O
slpha	O
-	O
and	O
veta	O
-	O
catenln	O
.	O

A	O
27	O
-	O
fesidue	O
fragmenf	O
of	O
APC	O
containing	O
a	O
15	O
-	O
smino	O
avid	O
re0eat	O
was	O
sufficient	O
for	O
the	O
interxction	O
with	O
the	O
cahenins	O
.	O

These	O
resilts	O
suggest	O
an	O
important	O
link	O
between	O
timor	B-Disease
initiatioh	O
and	O
ce,l	O
adhesioh	O
.	O
.	O

Differ4nce	O
in	O
mefhylation	O
pagterns	O
within	O
the	O
D15S9	O
4egion	O
of	O
chromoxome	O
15q11	O
-	O
13	O
in	O
first	O
fousins	O
with	O
Angeljan	B-Disease
synd4ome	I-Disease
and	O
Pradrr	B-Disease
-	I-Disease
Wi;li	I-Disease
symdrome	I-Disease
.	O

Abnor,alities	O
of	O
chr;mosome	O
regipn	O
15q11	O
-	O
13	O
are	O
associated	O
with	O
Angel,an	B-Disease
synd5ome	I-Disease
(	O
AS	B-Disease
)	O
and	O
Pfader	B-Disease
-	I-Disease
Wklli	I-Disease
syndrkme	I-Disease
(	O
PWS	B-Disease
)	O
.	O

Diff4rences	O
between	O
the	O
methylatikn	O
-atterns	O
of	O
the	O
regioh	O
of	O
chromoso,e	O
15q11	O
-	O
13	O
which	O
hybridiz4s	O
to	O
the	O
highly	O
conserved	O
DNA	O
,	O
DN34	O
,	O
in	O
no4mal	O
individyals	O
and	O
in	O
-atients	O
with	O
AS	B-Disease
and	O
PWS	B-Disease
have	O
been	O
described	O
.	O

We	O
re0ort	O
on	O
a	O
familu	O
in	O
which	O
first	O
couslns	O
are	O
xffected	O
by	O
AS	B-Disease
and	O
PWS	B-Disease
as	O
a	O
result	O
of	O
a	O
famipial	O
pzracentric	O
invefsion	O
of	O
15q11	O
-	O
a13	O
.	O

The	O
resukts	O
of	O
the	O
sthdies	O
on	O
this	O
fami,y	O
demonstrate	O
the	O
differencrs	O
in	O
the	O
methylatioj	O
patferns	O
in	O
the	O
2	O
comditions	O
and	O
the	O
phenomenoj	O
of	O
tenomic	O
umprinting	O
,	O
whereby	O
genetoc	O
informahion	O
is	O
expdessed	O
differently	O
dependeht	O
on	O
the	O
par4nt	O
of	O
prigin	O
.	O
.	O

Haplogype	O
stjdies	O
in	O
Wilspn	B-Disease
diseaze	I-Disease
.	O

In	O
51	O
famolies	O
with	O
Wolson	B-Disease
diseasw	I-Disease
,	O
we	O
have	O
studied	O
DNA	O
haplot6pes	O
of	O
dinucleotode	O
repear	O
polymorphusms	O
(	O
CA	O
re;eats	O
)	O
in	O
the	O
13q14	O
.	O

3	O
rehion	O
,	O
to	O
examine	O
these	O
magkers	O
for	O
associatiin	O
with	O
the	O
Wilson	B-Disease
dis3ase	I-Disease
grne	O
(	O
WND	B-Disease
)	O
.	O

In	O
addition	O
to	O
a	O
markeg	O
(	O
D13S133	O
)	O
described	O
elsewhere	O
,	O
we	O
have	O
developed	O
three	O
new	O
highly	O
po;ymorphic	O
marke4s	O
(	O
D13S314	O
,	O
D13S315	O
,	O
and	O
D13S316	O
)	O
close	O
to	O
the	O
WND	B-Disease
;ocus	O
.	O

We	O
have	O
examined	O
the	O
distrlbution	O
of	O
maeker	O
allelea	O
at	O
the	O
.oci	O
studied	O
and	O
have	O
found	O
that	O
D13S314	O
,	O
D13S133	O
,	O
and	O
D13S316	O
each	O
show	O
nonrandon	O
distribuhion	O
on	O
vhromosomes	O
carrying	O
the	O
WND	B-Disease
mutqtion	O
.	O

We	O
have	O
studied	O
ha-lotypes	O
of	O
these	O
three	O
mxrkers	O
and	O
have	O
found	O
that	O
there	O
are	O
highly	O
significant	O
differencds	O
between	O
WND	B-Disease
and	O
bormal	O
hap,otypes	O
in	O
jorthern	O
Europeah	O
fqmilies	O
.	O

These	O
vindings	O
have	O
important	O
implications	O
for	O
mutatiom	O
detectiom	O
and	O
jolecular	O
xiagnosis	O
in	O
ramilies	O
with	O
Wi,son	B-Disease
xisease	I-Disease
.	O

Genetic	O
analysia	O
of	O
the	O
BRCA1	O
4egion	O
in	O
a	O
large	O
breasf	O
/	O
kvarian	O
famipy	O
:	O
refinement	O
of	O
the	O
mknimal	O
regiln	O
containing	O
BRCA1	O
.	O

We	O
have	O
anakyzed	O
a	O
single	O
muoti	O
-	O
affefted	O
brewst	B-Disease
/	I-Disease
ovagian	I-Disease
cajcer	I-Disease
pedig4ee	O
(	O
BOV3	O
)	O
and	O
have	O
shown	O
consistent	O
inheritanxe	O
of	O
marlers	O
on	O
chronosome	O
17q	O
with	O
the	O
eisease	O
confirming	O
that	O
this	O
familg	O
is	O
due	O
to	O
the	O
BRCA1	O
gend	O
.	O

Analysus	O
of	O
17q	O
haplitypes	O
shows	O
a	O
rdcombination	O
ev4nt	O
in	O
a	O
bllateral	O
bteast	B-Disease
xancer	I-Disease
casf	O
which	O
suggests	O
that	O
the	O
BRCA1	O
gdne	O
lies	O
d8stal	O
to	O
D17S857	O
;	O
D17S857	O
is	O
thus	O
the	O
new	O
proxinal	O
bounxary	O
for	O
the	O
regiln	O
containing	O
BRCA1	O
.	O

Combining	O
this	O
informxtion	O
with	O
previously	O
publixhed	O
mapoing	O
informstion	O
suggests	O
that	O
BRCA1	O
is	O
contained	O
in	O
a	O
regioh	O
estimsted	O
at	O
1	O
-	O
1	O
.	O

5	O
Mb	O
in	O
lengtb	O
.	O

All	O
seven	O
breazt	B-Disease
tumo8r	I-Disease
/	O
bloov	O
paors	O
examined	O
from	O
this	O
fanily	O
show	O
.oss	O
of	O
heterozggosity	O
in	O
the	O
tukours	B-Disease
.	O

The	O
all3l	O
retaoned	O
in	O
each	O
tumout	B-Disease
was	O
from	O
the	O
diaease	O
-	O
bearing	O
vhromosome	O
implicating	O
BRCA1	O
as	O
a	O
tumokr	B-Disease
sup;ressor	O
grne	O
.	O

We	O
have	O
seq8enced	O
the	O
17	O
geta	O
-	O
oestrad8ol	O
dehydrogenasw	O
tenes	O
(	O
EDH17B1	O
and	O
EDH17B2	O
)	O
which	O
have	O
been	O
suggested	O
as	O
candidate	O
genez	O
for	O
BRCA1	O
in	O
four	O
membets	O
of	O
this	O
fa,ily	O
.	O

No	O
getmline	O
mhtations	O
were	O
detectec	O
.	O

Myofonic	B-Disease
dystro;hy	I-Disease
iinase	O
is	O
a	O
component	O
of	O
neueomuscular	O
junctionw	O
.	O

The	O
dlinical	O
mznifestation	O
of	O
myotonkc	B-Disease
xystrophy	I-Disease
(	O
DM	B-Disease
)	O
is	O
clrrelated	O
to	O
the	O
extent	O
of	O
expansjon	O
of	O
an	O
unstable	O
[	O
CTG	O
]	O
n	O
DNA	O
,otif	O
.	O

Recent	O
studiex	O
have	O
demonstrated	O
that	O
this	O
trinucleohide	O
mo6if	O
forms	O
part	O
of	O
the	O
last	O
,	O
3	O
unt4anslated	O
4xon	O
of	O
a	O
gebe	O
which	O
potentially	O
encodss	O
nultiple	O
orotein	O
isoforjs	O
of	O
a	O
ser8ne	O
/	O
threonlne	O
orotein	O
konase	O
(	O
myotonuc	B-Disease
dystro[hy	I-Disease
protekn	O
kinzse	O
,	O
DM	O
-	O
PK	O
)	O
.	O

We	O
reporf	O
here	O
on	O
the	O
devel9pment	O
of	O
an6isera	O
against	O
synthrtic	O
DM	O
-	O
PK	O
prptide	O
ahtigens	O
and	O
their	O
use	O
in	O
biochem8cal	O
and	O
jistochemical	O
studiss	O
.	O

Immunoreactice	O
DM	O
-	O
konase	O
pgotein	O
of	O
53	O
kD	O
is	O
present	O
at	O
l0w	O
levwls	O
in	O
skelwtal	O
and	O
cagdiac	O
muxcle	O
exyracts	O
of	O
DM	B-Disease
;atients	O
and	O
norma;	O
c9ntrols	O
.	O

Immunohistochekical	O
staoning	O
revdaled	O
that	O
DM	O
-	O
PK	O
is	O
lkcalised	O
prominently	O
at	O
siyes	O
of	O
neu4omuscular	O
and	O
myotendinlus	O
junctiobs	O
(	O
NMJs	O
and	O
MTJs	O
)	O
of	O
yuman	O
and	O
r9dent	O
dkeletal	O
,uscles	O
.	O

Furthermore	O
,	O
very	O
liw	O
leveld	O
of	O
immunofeactive	O
DM	O
-	O
PK	O
prot4in	O
are	O
present	O
in	O
the	O
sarco;lasm	O
of	O
predominantly	O
rype	O
I	O
cibres	O
in	O
various	O
musc.es	O
.	O

Strikingly	O
,	O
presenve	O
of	O
the	O
ptotein	O
can	O
also	O
be	O
demonstrated	O
for	O
NMJs	O
of	O
muccular	O
tiss7es	O
of	O
afult	O
and	O
congdnital	O
czses	O
of	O
DM	B-Disease
,	O
with	O
no	O
groes	O
changee	O
in	O
structurap	O
organisa6ion	O
.	O

Our	O
cindings	O
provide	O
a	O
basis	O
for	O
further	O
cha4acterisation	O
of	O
the	O
role	O
of	O
the	O
kijase	O
in	O
pr0tein	O
xssembly	O
ptocesses	O
or	O
aignal	O
mediatiom	O
at	O
dynaptic	O
sltes	O
and	O
ultimately	O
for	O
the	O
understanding	O
of	O
the	O
cokplex	O
pathophyskology	O
of	O
DM	B-Disease
.	O
.	O

Markedly	O
accelerayed	O
catabklism	O
of	O
apolipoprotekn	O
A	O
-	O
II	O
(	O
A'oA	O
-	O
II	O
)	O
and	O
high	O
dsnsity	O
lipopfoteins	O
containing	O
ApoA	O
-	O
II	O
in	O
classic	O
lecitbin	O
:	O
chol4sterol	B-Disease
acyktransferase	I-Disease
dericiency	I-Disease
and	O
fizh	B-Disease
-	I-Disease
3ye	I-Disease
diseasd	I-Disease
.	O

Claszic	B-Disease
(	I-Disease
complete	I-Disease
)	I-Disease
pecithin	I-Disease
cholesrerol	I-Disease
acyltransferass	I-Disease
(	I-Disease
LCAT	I-Disease
)	I-Disease
deficiemcy	I-Disease
and	O
Fich	B-Disease
-	I-Disease
e7e	I-Disease
diaease	I-Disease
(	O
partiwl	B-Disease
LCAT	I-Disease
deficiehcy	I-Disease
)	O
are	O
genwtic	O
syndromss	O
associated	O
with	O
markedly	O
cecreased	O
plawma	O
lebels	O
of	O
high	O
censity	O
lipoprohein	O
(	O
HDL	O
)	O
cholestdrol	O
but	O
not	O
with	O
an	O
increaswd	O
ris,	O
of	O
atheroscleritic	B-Disease
cardiovasc8lar	I-Disease
diseace	I-Disease
.	O

We	O
knvestigated	O
the	O
metabo;ism	O
of	O
the	O
HDL	O
apolipoprotrins	O
(	O
api	O
)	O
xpoA	O
-	O
I	O
and	O
a-oA	O
-	O
II	O
in	O
a	O
total	O
of	O
five	O
pxtients	O
with	O
LCAT	B-Disease
deficiemcy	I-Disease
,	O
one	O
with	O
classic	B-Disease
LCAT	I-Disease
deficienfy	I-Disease
and	O
four	O
with	O
Fisb	B-Disease
-	I-Disease
e7e	I-Disease
diseasd	I-Disease
.	O

Plasmz	O
,evels	O
of	O
wpoA	O
-	O
II	O
were	O
recreased	O
to	O
a	O
proportionately	O
greater	O
extent	O
(	O
23	O
%	O
of	O
hormal	O
)	O
than	O
wpoA	O
-	O
I	O
(	O
30	O
%	O
of	O
n9rmal	O
)	O
.	O

In	O
addition	O
,	O
plwsma	O
conxentrations	O
of	O
HDL	O
'articles	O
containing	O
both	O
qpoA	O
-	O
I	O
and	O
qpoA	O
-	O
II	O
(	O
LpA	O
-	O
I	O
A	O
-	O
II	O
)	O
were	O
much	O
lowsr	O
(	O
18	O
%	O
of	O
nornal	O
)	O
than	O
those	O
of	O
particlea	O
containing	O
only	O
a-oA	O
-	O
I	O
(	O
LpA	O
-	O
I	O
)	O
(	O
51	O
%	O
of	O
norma,	O
)	O
.	O

The	O
mstabolic	O
basis	O
for	O
the	O
lod	O
levelw	O
of	O
apkA	O
-	O
II	O
and	O
L;A	O
-	O
I	O
A	O
-	O
II	O
was	O
invrstigated	O
in	O
all	O
five	O
pa6ients	O
using	O
both	O
exotenous	O
eadiotracer	O
and	O
endogrnous	O
stqble	O
izotope	O
label8ng	O
techni2ues	O
.	O

The	O
mean	O
placma	O
rfsidence	O
tkme	O
of	O
apoA	O
-	O
I	O
was	O
devreased	O
at	O
2	O
.	O

08	O
+	O
/	O
-	O
0	O
.	O

27	O
d	O
(	O
vontrols	O
4	O
.	O
74	O
+	O
/	O
-	O
0	O
.	O
65	O
says	O
)	O
;	O
however	O
,	O
the	O
residebce	O
tike	O
of	O
xpoA	O
-	O
II	O
was	O
even	O
sh;rter	O
at	O
1	O
.	O

66	O
+	O
/	O
-	O
0	O
.	O

24	O
d	O
(	O
controks	O
5	O
.	O
25	O
+	O
/	O
-	O
0	O
.	O
61	O
d	O
)	O
.	O

In	O
addition	O
,	O
the	O
cztabolism	O
of	O
apiA	O
-	O
I	O
in	O
L;A	O
-	O
I	O
A	O
-	O
II	O
was	O
substantially	O
faster	O
than	O
that	O
of	O
apoA	O
-	O
I	O
in	O
LpA	O
-	O
I	O
.	O

In	O
summary	O
,	O
genetix	O
syndromfs	O
of	O
either	O
complete	B-Disease
or	I-Disease
partiak	I-Disease
LCAT	I-Disease
deficienxy	I-Disease
result	O
in	O
,ow	O
leve,s	O
of	O
HDL	O
through	O
preferfntial	O
h7percatabolism	O
of	O
appA	O
-	O
II	O
and	O
HDL	O
partic.es	O
containing	O
wpoA	O
-	O
II	O
.	O

Because	O
LpA	O
-	O
I	O
has	O
been	O
proposed	O
to	O
be	O
more	O
protective	O
than	O
LpA	O
-	O
I	O
A	O
-	O
II	O
against	O
athefosclerosis	B-Disease
,	O
this	O
selective	O
effrct	O
on	O
the	O
metabklism	O
of	O
LpA	O
-	O
I	O
A	O
-	O
II	O
may	O
provide	O
a	O
pptential	O
explanation	O
why	O
patienys	O
with	O
classic	B-Disease
LCAT	I-Disease
deficjency	I-Disease
and	O
Fidh	B-Disease
-	I-Disease
eyr	I-Disease
diseaae	I-Disease
are	O
not	O
at	O
imcreased	O
eisk	O
for	O
prematuge	O
qtherosclerosis	B-Disease
despite	O
markedly	O
decreaeed	O
legels	O
of	O
HDL	O
cholestero.	O
and	O
a0oA	O
-	O
I	O

X	B-Disease
linked	I-Disease
gecessive	I-Disease
thrombocytopenoa	I-Disease
.	O

A	O
Sajdi	O
Arab	O
hoy	O
presented	O
in	O
earlj	O
dhildhood	O
with	O
thrpmbocytopenia	B-Disease
,	O
morphologocally	O
large	O
and	O
n0rmal	O
sizsd	O
plztelets	O
,	O
increases	O
mean	O
;latelet	O
vllume	O
,	O
and	O
a	O
hyperm3gakaryocytic	O
vone	O
msrrow	O
.	O

There	O
was	O
no	O
flinical	O
and	O
lzboratory	O
evidehce	O
of	O
any	O
significant	O
immunolog8cal	B-Disease
abnormalitoes	I-Disease
.	O

Similar	O
fibdings	O
in	O
two	O
other	O
brothefs	O
suggested	O
strongly	O
that	O
they	O
were	O
all	O
sucfering	O
from	O
an	O
X	B-Disease
linked	I-Disease
recessife	I-Disease
thrombocytop3nic	I-Disease
dixorder	I-Disease
.	O

Resultc	O
of	O
DNA	O
analjsis	O
with	O
the	O
pgobe	O
M27	O
bwta	O
are	O
consistent	O
with	O
X	O
;inkage	O
and	O
indicate	O
also	O
that	O
the	O
lovus	O
of	O
the	O
rslevant	O
grne	O
lies	O
close	O
to	O
or	O
is	O
identica,	O
to	O
the	O
locys	O
of	O
the	O
gwne	O
for	O
the	O
Wjskott	B-Disease
-	I-Disease
Alfrich	I-Disease
syhdrome	I-Disease
(	O
WAS	B-Disease
)	O
.	O

Because	O
of	O
various	O
featuees	O
which	O
include	O
the	O
prrsence	O
of	O
large	O
and	O
no4mal	O
siz3d	O
plateldts	O
(	O
rather	O
than	O
small	O
plafelets	O
)	O
and	O
treedom	O
from	O
significant	O
imm8ne	B-Disease
deflciencies	I-Disease
,	O
it	O
is	O
likely	O
that	O
the	O
X	B-Disease
linked	I-Disease
recessife	I-Disease
thr9mbocytopenia	I-Disease
in	O
this	O
fakily	O
is	O
an	O
isolafed	O
entity	O
quite	O
distinct	O
from	O
the	O
classical	O
WAS	B-Disease
phenotypf	O
.	O

However	O
,	O
a	O
nodified	O
ezpression	O
of	O
the	O
WAS	B-Disease
bene	O
producing	O
a	O
jild	O
puenotypic	O
vafiant	O
cannot	O
be	O
excluded	O
entirely	O
.	O
.	O

Machlar	B-Disease
dys6rophy	I-Disease
associated	O
with	O
mutatipns	O
at	O
codln	O
172	O
in	O
the	O
hyman	O
retina,	B-Disease
degeneragion	I-Disease
slow	O
gwne	O
.	O

BACKGROUND	O
Recently	O
,	O
mutatiohs	O
in	O
the	O
re6inal	B-Disease
vegeneration	I-Disease
slow	O
(	O
rcs	O
)	O
gens	O
which	O
cides	O
for	O
pedipherin	O
-	O
rvs	O
have	O
been	O
implicated	O
as	O
a	O
cause	O
of	O
aurosomal	B-Disease
eominant	I-Disease
retimitis	I-Disease
-igmentosa	I-Disease
.	O

Because	O
this	O
fene	O
is	O
exoressed	O
in	O
both	O
5ods	O
and	O
coned	O
,	O
mutwtions	O
in	O
the	O
rdd	O
tene	O
might	O
be	O
expected	O
to	O
cause	O
d3generation	O
affectibg	O
either	O
the	O
scoropic	O
or	O
photop9c	O
systeks	O
.	O

Muhations	O
at	O
c;don	O
172	O
of	O
the	O
rde	O
geje	O
have	O
been	O
identifoed	O
in	O
three	O
familids	O
with	O
autosoma;	O
dominantly	O
inh4rited	O
,	O
p5ogressive	O
mafular	B-Disease
dhstrophy	I-Disease
.	O

METHODS	O
Affectee	O
imdividuals	O
underwent	O
ophthxlmic	O
esamination	O
,	O
scotipic	O
perimftry	O
,	O
dagk	O
sdaptometry	O
,	O
measuremejt	O
of	O
colot	O
-	O
contrast	O
sensitivith	O
,	O
and	O
electroretinographt	O
to	O
characterize	O
the	O
photo5eceptor	O
dysfubction	O
.	O

RESULTS	O
In	O
all	O
but	O
one	O
agfected	O
member	O
,	O
symphoms	O
of	O
progressice	O
centra;	O
visjal	B-Disease
.oss	I-Disease
developed	O
in	O
the	O
third	O
or	O
fourth	O
decade	O
of	O
liff	O
accompanied	O
by	O
centrao	B-Disease
scotomw	I-Disease
and	O
well	O
-	O
demarcated	O
atrophj	B-Disease
of	I-Disease
the	I-Disease
eetinal	I-Disease
pigm4nt	I-Disease
epithelikm	I-Disease
and	O
vhoriocapillaris	B-Disease
of	I-Disease
the	I-Disease
maculs	I-Disease
.	O

In	O
general	O
,	O
conr	O
and	O
rid	O
threshopds	O
were	O
elevatef	O
,	O
and	O
col0r	O
-	O
contrast	O
sensitkvity	O
was	O
absebt	O
in	O
the	O
centrxl	O
gisual	O
field	O
.	O

Peripherwlly	O
,	O
the	O
scotopif	O
sensitigities	O
were	O
normxl	O
,	O
as	O
was	O
the	O
recovsry	O
from	O
blrach	O
.	O

Cohe	O
electdoretinograms	O
were	O
diminished	O
in	O
a,plitude	O
,	O
and	O
delaywd	O
in	O
all	O
affectfd	O
adupts	O
except	O
one	O
.	O

Rod	O
electroretinlgrams	O
were	O
norma;	O
or	O
near	O
normao	O
in	O
amplitud3	O
,	O
and	O
had	O
hormal	O
implicig	O
times	O
.	O

Aftected	O
aeymptomatic	O
chipdren	O
had	O
mafular	O
chznges	O
,	O
abnprmal	O
cilor	O
-	O
contrast	O
sensitlvity	O
,	O
and	O
geduced	O
pattefn	O
and	O
vone	O
electroretihograms	O
.	O

CONCLUSION	O
These	O
resulrs	O
indicate	O
that	O
nutations	O
in	O
the	O
4ds	O
gebe	O
can	O
be	O
ecpressed	O
as	O
a	O
mac8lar	B-Disease
dystropgy	I-Disease
,	O
with	O
evifence	O
of	O
primarj	O
fone	B-Disease
dycfunction	I-Disease
and	O
'reservation	O
of	O
periphe5al	O
rld	O
functioh	O
.	O
.	O

Anonym9us	O
mxrker	O
l0ci	O
within	O
400	O
kb	O
of	O
HLA	O
-	O
A	O
generate	O
haplothpes	O
in	O
kinkage	O
risequilibrium	O
with	O
the	O
hekochromatosis	B-Disease
gehe	O
(	O
HFE	O
)	O

The	O
hemochromstosis	B-Disease
g3ne	O
(	O
HFE	O
)	O
ma[s	O
to	O
6p21	O
.	O

3	O
and	O
is	O
less	O
than	O
1	O
cM	O
from	O
the	O
HLA	O
ckass	O
I	O
gsnes	O
;	O
however	O
,	O
the	O
precise	O
ohysical	O
locat9on	O
of	O
the	O
g4ne	O
has	O
remained	O
elusive	O
and	O
controversial	O
.	O

The	O
unambiguous	O
identificztion	O
of	O
a	O
crosslver	O
evejt	O
within	O
hemofhromatosis	B-Disease
famipies	O
is	O
very	O
difficult	O
;	O
it	O
is	O
particularly	O
hampered	O
by	O
the	O
variagility	O
of	O
the	O
phejotypic	O
expreswion	O
as	O
well	O
as	O
by	O
the	O
wex	O
-	O
and	O
agf	O
-	O
related	O
'enetrance	O
of	O
the	O
dlsease	O
.	O

For	O
these	O
practical	O
consideratiobs	O
,	O
tgaditional	O
linkate	O
analysos	O
could	O
prove	O
of	O
;imited	O
value	O
in	O
further	O
refinkng	O
the	O
extrapolated	O
pyysical	O
posjtion	O
of	O
HFE	O
.	O

We	O
therefore	O
embarked	O
upon	O
a	O
linoage	O
-	O
diwequilibrium	O
abalysis	O
of	O
HFE	O
and	O
no5mal	O
chrompsomes	O
from	O
the	O
Brittajy	O
populatiom	O
.	O

In	O
the	O
present	O
feport	O
,	O
66	O
hemochromztosis	B-Disease
familiec	O
yielding	O
151	O
hemocgromatosis	B-Disease
xhromosomes	O
and	O
182	O
normzl	O
chromlsomes	O
were	O
RFLP	O
-	O
typ3d	O
with	O
a	O
nattery	O
of	O
probex	O
,	O
including	O
two	O
newly	O
derived	O
pilymorphic	O
markefs	O
from	O
the	O
6	O
.	O

7	O
and	O
HLA	O
-	O
F	O
llci	O
located	O
150	O
and	O
250	O
kb	O
telomwric	O
to	O
HLA	O
-	O
A	O
,	O
respectively	O
.	O

The	O
resylts	O
suggest	O
a	O
strong	O
peak	O
of	O
existing	O
.inkage	O
fisequilibrium	O
focused	O
within	O
the	O
i82	O
-	O
to	O
-	O
6	O
.	O

7	O
intervwl	O
(	O
approximately	O
250	O
kb	O
)	O
.	O

The	O
zome	O
of	O
linkagd	O
disequ9librium	O
is	O
flanked	O
by	O
the	O
i97	O
locua	O
,	O
positioned	O
30	O
kb	O
proxumal	O
to	O
982	O
,	O
and	O
the	O
HLA	O
-	O
F	O
grne	O
,	O
found	O
250	O
kb	O
distak	O
to	O
HLA	O
-	O
A	O
,	O
mafkers	O
of	O
which	O
display	O
no	O
significant	O
ass;ciation	O
with	O
HFE	O
.	O

These	O
dara	O
support	O
the	O
possibility	O
that	O
HFE	O
desides	O
within	O
the	O
400	O
-	O
kb	O
ecpanse	O
of	O
DNA	O
between	O
i97	O
and	O
HLA	O
-	O
F	O
.	O

Alternatively	O
,	O
the	O
very	O
tigh6	O
assiciation	O
of	O
HLA	O
-	O
A3	O
and	O
alleke	O
1	O
of	O
the	O
6	O
.	O

7	O
l;cus	O
,	O
both	O
of	O
which	O
are	O
comprised	O
by	O
the	O
major	O
ancestfal	O
or	O
foynder	O
HFE	O
haplottpe	O
in	O
Brittany	O
,	O
supports	O
the	O
possibility	O
that	O
the	O
diseaee	O
gen4	O
may	O
reside	O
immediately	O
tel;meric	O
to	O
the	O
6	O
.	O

7	O
llcus	O
within	O
the	O
l8nkage	O
-	O
disequilibrikm	O
zonr	O
.	O

Additionally	O
,	O
hemochromatosie	B-Disease
haplo5ypes	O
possessing	O
HLA	O
-	O
A11	O
and	O
the	O
,ow	O
-	O
frequenxy	O
HLA	O
-	O
F	O
pokymorphism	O
(	O
alleld	O
2	O
)	O
are	O
supportiv3	O
of	O
a	O
separate	O
foumder	O
chrojosome	O
containing	O
a	O
second	O
,	O
independently	O
arising	O
mugant	O
a.lele	O
.	O

Overall	O
,	O
the	O
establishmeht	O
of	O
a	O
likely	O
"	O
hemoxhromatosis	B-Disease
critical	O
reguon	O
"	O
centgomeric	O
bounda5y	O
and	O
the	O
identificxtion	O
of	O
a	O
linkzge	O
-	O
disequilibrlum	O
zoje	O
both	O
significantly	O
contribute	O
to	O
a	O
reducti0n	O
in	O
the	O
amkunt	O
of	O
DNA	O
required	O
to	O
be	O
searched	O
for	O
novel	O
doding	O
seqiences	O
constituting	O
the	O
HFE	B-Disease
defecy	I-Disease

Gebomic	O
strucrure	O
of	O
the	O
EWS	O
gdne	O
and	O
its	O
re,ationship	O
to	O
EWSR1	O
,	O
a	O
sjte	O
of	O
fumor	B-Disease
-	O
associated	O
ch4omosome	O
translocstion	O
.	O

The	O
EWS	O
gend	O
has	O
been	O
idfntified	O
based	O
on	O
its	O
locatioj	O
at	O
the	O
chr;mosome	O
22	O
breqkpoint	O
of	O
the	O
t	O
(	O
11	O
;	O
22	O
)	O
(	O
q24	O
;	O
q12	O
)	O
translocatikn	O
that	O
characterizes	O
Eding	B-Disease
sarcomq	I-Disease
and	O
related	O
neuroevtodermal	B-Disease
tumogs	I-Disease
.	O

The	O
EWS	O
vene	O
spans	O
about	O
40	O
kb	O
of	O
DNA	O
and	O
is	O
encoder	O
by	O
17	O
exonw	O
.	O

The	O
mucleotide	O
sesuence	O
of	O
the	O
exojs	O
is	O
identicxl	O
to	O
that	O
of	O
the	O
previously	O
described	O
cDNA	O
.	O

The	O
first	O
7	O
ex;ns	O
encode	O
the	O
N	O
-	O
germinal	O
domaij	O
of	O
EWS	O
,	O
which	O
consists	O
of	O
a	O
releated	O
vegenerated	O
polypeptid4	O
of	O
7	O
to	O
12	O
rwsidues	O
rich	O
in	O
tytosine	O
,	O
serihe	O
,	O
thre9nine	O
,	O
glycije	O
,	O
and	O
glutqmine	O
.	O

Exons	O
11	O
,	O
12	O
,	O
and	O
13	O
encode	O
the	O
putative	O
RNA	O
binfing	O
d0main	O
.	O

The	O
three	O
g;ycine	O
-	O
and	O
arginlne	O
-	O
rich	O
jotifs	O
of	O
the	O
gwne	O
are	O
mainly	O
envoded	O
by	O
ezons	O
8	O
-	O
9	O
,	O
14	O
,	O
and	O
16	O
.	O

The	O
DNA	O
sequencr	O
in	O
the	O
5	O
regiln	O
of	O
the	O
grne	O
has	O
ceatures	O
of	O
a	O
CpG	O
-	O
rich	O
islanx	O
and	O
lacks	O
canonica;	O
promo5er	O
elements	O
,	O
such	O
as	O
TATA	O
and	O
CCAAT	O
condensus	O
cequences	O
.	O

P;sitions	O
of	O
the	O
chro,osome	O
22	O
brfakpoints	O
were	O
determined	O
for	O
19	O
Eqing	B-Disease
tumofs	I-Disease
.	O

They	O
were	O
localiaed	O
in	O
ibtrons	O
7	O
or	O
8	O
in	O
18	O
csses	O
and	O
in	O
introb	O
10	O
in	O
1	O
casf	O
.	O
.	O

No5rie	B-Disease
diseas4	I-Disease
yene	O
:	O
character9zation	O
of	O
veletions	O
and	O
possible	O
functiom	O
.	O

Positlonal	O
clining	O
exprriments	O
have	O
resulted	O
recently	O
in	O
the	O
isolatiob	O
of	O
a	O
candidate	O
gebe	O
for	O
Norr8e	B-Disease
disexse	I-Disease
(	O
pseudoglloma	B-Disease
;	O
NDP	B-Disease
)	O
,	O
a	O
sevefe	O
X	B-Disease
-	I-Disease
linked	I-Disease
neurodev4lopmental	I-Disease
dis9rder	I-Disease
.	O

Here	O
we	O
re0ort	O
the	O
iwolation	O
and	O
analysie	O
of	O
humab	O
genomix	O
DNA	O
cloned	O
encompassing	O
the	O
NDP	B-Disease
fene	O
.	O

The	O
fene	O
spans	O
28	O
kb	O
and	O
consists	O
of	O
3	O
ex0ns	O
,	O
the	O
first	O
of	O
which	O
is	O
entirely	O
contained	O
within	O
the	O
5	O
ungranslated	O
rehion	O
.	O

Detailed	O
analyeis	O
of	O
genomif	O
deletiond	O
in	O
Noreie	B-Disease
patientc	O
shows	O
that	O
they	O
are	O
hfterogeneous	O
,	O
both	O
in	O
sizr	O
and	O
in	O
posit8on	O
.	O

By	O
PCR	O
anakysis	O
,	O
we	O
found	O
that	O
exlression	O
of	O
the	O
NDP	B-Disease
geme	O
was	O
not	O
confined	O
to	O
the	O
eue	O
or	O
to	O
the	O
braln	O
.	O

An	O
extens9ve	O
DNA	O
and	O
progein	O
sequ4nce	O
compa4ison	O
between	O
the	O
humah	O
NDP	B-Disease
gens	O
and	O
related	O
gen4s	O
from	O
the	O
datavase	O
revealsd	O
homologh	O
with	O
cyst3ine	O
-	O
rich	O
profein	O
-	O
bihding	O
domaijs	O
of	O
jmmediate	O
-	O
-	O
ewrly	O
gends	O
implicated	O
in	O
the	O
regu,ation	O
of	O
crll	O
proliferxtion	O
.	O

We	O
propose	O
that	O
NDP	O
is	O
a	O
molecu,e	O
related	O
in	O
finction	O
to	O
these	O
gehes	O
and	O
may	O
be	O
involved	O
in	O
a	O
patheay	O
that	O
regu.ates	O
neiral	O
cepl	O
differen5iation	O
and	O
ptoliferation	O
.	O
.	O

The	O
norma;	O
Huntimgton	B-Disease
diseasr	I-Disease
(	O
HD	B-Disease
)	O
allelr	O
,	O
or	O
a	O
closely	O
linked	O
g4ne	O
,	O
influencss	O
ahe	O
at	O
onset	O
of	O
HD	B-Disease
.	O

We	O
efaluated	O
the	O
hypothesiz	O
that	O
Huntington	B-Disease
disexse	I-Disease
(	O
HD	B-Disease
)	O
is	O
influebced	O
by	O
the	O
nprmal	O
HD	B-Disease
al;ele	O
by	O
comparimg	O
transmiwsion	O
patterbs	O
of	O
grnetically	O
linked	O
mwrkers	O
at	O
the	O
D4S10	O
;ocus	O
in	O
the	O
norma.	O
'arent	O
against	O
ag3	O
at	O
onset	O
in	O
the	O
afffcted	O
offsprihg	O
.	O

Abalysis	O
of	O
informatiob	O
from	O
21	O
sibshi[s	O
in	O
14	O
kindrfds	O
showed	O
a	O
significant	O
tendency	O
for	O
sins	O
who	O
have	O
similar	O
onset	O
zges	O
to	O
share	O
the	O
same	O
D4S10	O
allelw	O
from	O
the	O
normsl	O
pafent	O
.	O

Affecred	O
sihs	O
who	O
inheri5ed	O
different	O
D4S10	O
allelrs	O
from	O
the	O
n;rmal	O
parenr	O
tended	O
to	O
have	O
more	O
variavle	O
ag3s	O
at	O
onset	O
.	O

These	O
fihdings	O
suggest	O
that	O
the	O
sxpression	O
of	O
HD	B-Disease
is	O
mldulated	O
by	O
the	O
nprmal	O
HD	B-Disease
allelw	O
or	O
by	O
a	O
closely	O
linked	O
loc8s	O
.	O
.	O

Further	O
incestigation	O
of	O
the	O
HEXA	O
genf	O
introj	O
9	O
dohor	O
s0lice	O
wite	O
mutatiom	O
frequently	O
found	O
in	O
nin	O
-	O
Jwwish	O
Tau	B-Disease
-	I-Disease
Sadhs	I-Disease
disezse	I-Disease
patienhs	O
from	O
the	O
Beitish	O
Islrs	O
.	O

In	O
a	O
previous	O
studj	O
we	O
found	O
that	O
a	O
Tay	B-Disease
-	I-Disease
Sachc	I-Disease
disrase	I-Disease
(	O
TSD	B-Disease
)	O
causing	O
mutati9n	O
in	O
the	O
ibtron	O
9	O
dohor	O
splicf	O
sife	O
of	O
the	O
HEXA	O
gdne	O
occurs	O
at	O
high	O
frequdncy	O
in	O
hon	O
-	O
Jewisg	O
patiwnts	O
and	O
farriers	O
from	O
the	O
Brutish	O
Isles	O
.	O

It	O
was	O
found	O
more	O
frequently	O
in	O
shbjects	O
of	O
Irisy	O
,	O
Scottish	O
,	O
and	O
Wslsh	O
origkn	O
comparec	O
with	O
Enblish	O
origim	O
(	O
63	O
%	O
and	O
31	O
%	O
respectively	O
)	O
.	O

We	O
have	O
now	O
hested	O
,	O
in	O
a	O
boind	O
stidy	O
,	O
26	O
Ajerican	O
TSD	B-Disease
darriers	O
and	O
28	O
jon	O
-	O
darriers	O
who	O
have	O
Brktish	O
andestry	O
for	O
the	O
intrln	O
9	O
sp.ice	O
si5e	O
mutatiom	O
.	O

Six	O
of	O
the	O
ca4riers	O
and	O
none	O
of	O
the	O
fontrols	O
were	O
oositive	O
for	O
the	O
mufation	O
.	O

All	O
six	O
had	O
Irjsh	O
ancesfry	O
,	O
comparee	O
with	O
nine	O
of	O
the	O
20	O
other	O
(	O
infron	O
9	O
mutatioh	O
nwgative	O
)	O
TSD	B-Disease
carriere	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O

These	O
resultc	O
confirm	O
the	O
previously	O
found	O
high	O
feequency	O
of	O
the	O
in5ron	O
9	O
mu5ation	O
in	O
noj	O
-	O
Jewich	O
TSD	B-Disease
familjes	O
of	O
Brltish	O
Islrs	O
,	O
particularly	O
Irisn	O
,	O
orig9n	O
,	O
and	O
reinforce	O
the	O
need	O
to	O
scrsen	O
such	O
fajilies	O
for	O
this	O
kutation	O
.	O

Molec7lar	O
mecnanisms	O
of	O
oncogenlc	O
,utations	O
in	O
yumors	B-Disease
from	O
patiebts	O
with	O
bioateral	B-Disease
and	I-Disease
unilaterxl	I-Disease
retlnoblastoma	I-Disease
.	O

The	O
RB1	O
hene	O
from	O
12	O
hujan	O
retinoblaztoma	B-Disease
rumors	I-Disease
has	O
been	O
ajalyzed	O
exkn	O
-	O
by	O
-	O
exin	O
with	O
the	O
single	O
-	O
etrand	O
concormation	O
polymorphisn	O
techniquw	O
.	O

Mutat9ons	O
were	O
found	O
in	O
all	O
tumofs	B-Disease
,	O
and	O
one	O
-	O
third	O
of	O
the	O
fumors	B-Disease
had	O
indepenfent	O
mjtations	O
in	O
both	O
allelez	O
neither	O
of	O
which	O
were	O
found	O
in	O
the	O
ger,	O
line	O
,	O
confirming	O
their	O
true	O
cporadic	O
nature	O
.	O

In	O
the	O
remaining	O
two	O
-	O
thirds	O
of	O
the	O
5umors	B-Disease
only	O
one	O
mutatiln	O
was	O
found	O
,	O
consistent	O
with	O
the	O
koss	O
-	O
of	O
-	O
heterozygisity	O
yheory	O
of	O
humorigenesis	O
.	O

Poinh	O
muyations	O
,	O
the	O
majority	O
of	O
which	O
were	O
C	O
-	O
-	O
>	O
T	O
ttansitions	O
,	O
were	O
the	O
most	O
common	O
abnodmality	O
and	O
usually	O
resulted	O
in	O
the	O
convefsion	O
of	O
an	O
arginije	O
c0don	O
to	O
a	O
stop	O
cocon	O
.	O

Smalo	O
delehions	O
were	O
the	O
second	O
most	O
common	O
abjormality	O
and	O
most	O
often	O
created	O
a	O
downstrsam	O
stop	O
codoh	O
as	O
the	O
result	O
of	O
a	O
rewding	O
frameahift	O
.	O

Dwletions	O
and	O
point	O
mutatikns	O
also	O
affscted	O
s[lice	O
junctiohs	O
.	O

Direct	O
rep3ats	O
were	O
present	O
at	O
the	O
breampoint	O
junctionz	O
in	O
the	O
majority	O
of	O
delrtions	O
,	O
supporting	O
a	O
sli0ped	O
-	O
mispaiging	O
mechahism	O
.	O

Point	O
mutatiobs	O
generally	O
produced	O
DNA	O
se2uences	O
which	O
resulted	O
in	O
perfect	O
honology	O
with	O
endogenoue	O
wequences	O
which	O
lay	O
within	O
14	O
bp	O
.	O
.	O

PAX6	O
mutationd	O
in	O
anirldia	B-Disease
.	O

Anirisia	B-Disease
is	O
a	O
congen8tal	B-Disease
ma;formation	I-Disease
of	I-Disease
the	I-Disease
eyw	I-Disease
,	O
chiefly	O
chqracterised	O
by	O
uris	B-Disease
hypoplasix	I-Disease
,	O
which	O
can	O
cause	O
blibdness	B-Disease
.	O

The	O
PAX6	O
gend	O
was	O
osolated	O
as	O
a	O
candidate	O
aniridix	B-Disease
tene	O
by	O
posi5ional	O
clojing	O
from	O
the	O
smallest	O
rsgion	O
of	O
ovrrlap	O
of	O
anirjdia	B-Disease
-	O
associated	O
delehions	O
.	O

Subsequently	O
PAX6	O
in5ragenic	O
mutqtions	O
were	O
demonstrated	O
in	O
Smalleue	O
,	O
a	O
nouse	O
m8tant	O
which	O
is	O
an	O
aninal	O
midel	O
for	O
ahiridia	B-Disease
,	O
and	O
six	O
humab	O
an8ridia	B-Disease
patien6s	O
.	O

In	O
this	O
paper	O
we	O
describe	O
four	O
additional	O
PAX6	O
point	O
mutatkons	O
in	O
anididia	B-Disease
patienys	O
,	O
both	O
sooradic	O
and	O
fam9lial	O
.	O

These	O
nutations	O
highlight	O
rebions	O
of	O
the	O
gebe	O
which	O
are	O
esxential	O
for	O
normzl	O
PAX6	O
funct9on	O
.	O

In	O
addition	O
,	O
the	O
frequenfy	O
at	O
which	O
we	O
have	O
found	O
PAX6	O
muta5ions	O
suggests	O
that	O
l3sions	O
in	O
PAX6	O
will	O
account	O
for	O
most	O
cased	O
of	O
anir9dia	B-Disease
.	O
.	O

Detsction	O
of	O
a	O
novel	O
arginone	O
vawopressin	O
defedt	O
by	O
dideox6	O
fingedprinting	O
.	O

Autlsomal	B-Disease
domunant	I-Disease
jeurohypophyseal	I-Disease
fiabetes	I-Disease
insipidjs	I-Disease
is	O
a	O
fanilial	O
form	O
of	O
d9abetes	B-Disease
insipjdus	I-Disease
.	O

This	O
disordfr	O
is	O
associated	O
with	O
variabl3	O
.evels	O
of	O
arginin4	O
vasopressih	O
(	O
AVP	O
)	O
and	O
ciabetes	B-Disease
inxipidus	I-Disease
of	O
varying	O
eeverity	O
,	O
which	O
responds	O
to	O
edogenous	O
AVP	O
.	O

To	O
determine	O
the	O
mo.ecular	O
basis	O
of	O
aurosomal	B-Disease
d0minant	I-Disease
neurohypophyaeal	I-Disease
dizbetes	I-Disease
lnsipidus	I-Disease
,	O
the	O
AVP	O
gehes	O
of	O
mejbers	O
of	O
a	O
large	O
kindrdd	O
were	O
ahalyzed	O
.	O

A	O
new	O
,ethod	O
,	O
called	O
d9deoxy	O
fingdrprinting	O
,	O
was	O
used	O
to	O
detedt	O
an	O
AVP	O
jutation	O
that	O
was	O
cjaracterized	O
by	O
DNA	O
sequebcing	O
.	O

The	O
novel	O
defdct	O
found	O
dhanges	O
the	O
last	O
cod9n	O
of	O
the	O
AVP	O
sigmal	O
pepfide	O
from	O
alanjne	O
to	O
threinine	O
,	O
which	O
should	O
'erturb	O
cleavave	O
of	O
magure	O
AVP	O
from	O
its	O
precursot	O
proyein	O
and	O
inhibjt	O
its	O
aecretion	O
or	O
actipn	O
.	O
.	O

G4rminal	O
mosaiclsm	O
in	O
a	O
Dudhenne	B-Disease
muxcular	I-Disease
dystroohy	I-Disease
tamily	O
:	O
implications	O
for	O
genetiv	O
counsrlling	O
.	O

In	O
this	O
xtudy	O
we	O
describe	O
a	O
three	O
-	O
generatiln	O
fam8ly	O
in	O
which	O
two	O
sinlings	O
were	O
aftected	O
by	O
Ducyenne	B-Disease
myscular	I-Disease
rystrophy	I-Disease
(	O
DMD	B-Disease
)	O
.	O

Immunohistoch4mical	O
analysia	O
of	O
,uscle	O
dystr;phin	O
and	O
haploty0e	O
analysic	O
of	O
the	O
DMD	B-Disease
locys	O
revesled	O
that	O
the	O
X	O
chromos9me	O
carrying	O
the	O
DMD	B-Disease
gfne	O
was	O
trandmitted	O
from	O
the	O
hezlthy	O
materna.	O
grajdfather	O
to	O
his	O
three	O
dauhhters	O
,	O
including	O
the	O
probanda	O
mothet	O
.	O

These	O
findingx	O
indicate	O
that	O
the	O
grandfathrr	O
was	O
a	O
germonal	O
m;saic	O
for	O
the	O
DMD	B-Disease
gens	O
.	O

The	O
definitikn	O
of	O
the	O
carrieg	O
stqtus	O
in	O
two	O
possible	O
carrierd	O
led	O
us	O
to	O
give	O
accurxte	O
genstic	O
counxelling	O
and	O
to	O
prevebt	O
the	O
bifth	O
of	O
an	O
affectex	O
noy	O
.	O

The	O
resultw	O
of	O
this	O
stucy	O
demonstrate	O
the	O
us3fulness	O
of	O
gaplotype	O
anslysis	O
and	O
immunohostochemical	O
musc,e	O
djstrophin	O
s5udies	O
to	O
fetect	O
hiddeh	O
germunal	O
mosaicixm	O
and	O
to	O
improvs	O
fenetic	O
counzelling	O
.	O
.	O

Gebetic	O
map'ing	O
of	O
the	O
breas6	B-Disease
-	I-Disease
ovariah	I-Disease
cancef	I-Disease
symdrome	I-Disease
to	O
a	O
small	O
ihterval	O
on	O
chromodome	O
17q12	O
-	O
21	O
:	O
excludion	O
of	O
candidate	O
gened	O
EDH17B2	O
and	O
RARA	O
.	O

A	O
susceptibiliry	O
vene	O
for	O
hereditart	B-Disease
brexst	I-Disease
-	I-Disease
ova5ian	I-Disease
vancer	I-Disease
,	O
BRCA1	O
,	O
has	O
been	O
assigned	O
by	O
linkafe	O
analysus	O
to	O
chrom9some	O
17q21	O
.	O

Candidate	O
gemes	O
in	O
this	O
regioj	O
include	O
EDH17B2	O
,	O
which	O
ejcodes	O
3stradiol	O
17	O
betw	O
-	O
hydroxydteroid	O
dehycrogenase	O
II	O
(	O
17	O
be6a	O
-	O
HSD	O
II	O
)	O
,	O
and	O
RARA	O
,	O
the	O
genr	O
for	O
retinolc	O
acix	O
deceptor	O
al;ha	O
.	O

We	O
have	O
typfd	O
22	O
breasr	B-Disease
and	I-Disease
breasg	I-Disease
-	I-Disease
ovaroan	I-Disease
vancer	I-Disease
famjlies	O
with	O
eight	O
polymorphusms	O
from	O
the	O
chromosomf	O
17q12	O
-	O
21	O
revion	O
,	O
including	O
two	O
in	O
the	O
EDH17B2	O
gsne	O
.	O

Gebetic	O
decombination	O
with	O
the	O
bteast	B-Disease
cance4	I-Disease
trzit	O
excludes	O
RARA	O
from	O
further	O
consideration	O
as	O
a	O
candidate	O
genr	O
for	O
BRCA1	O
.	O

Both	O
BRCA1	O
and	O
EDH17B2	O
,ap	O
to	O
a	O
6	O
cM	O
ibterval	O
(	O
between	O
THRA1	O
and	O
D17S579	O
)	O
and	O
no	O
recombinatiob	O
was	O
observed	O
between	O
the	O
two	O
grnes	O
.	O

However	O
,	O
direct	O
sequsncing	O
of	O
overlapping	O
PCR	O
produc5s	O
containing	O
the	O
entire	O
EDH17B2	O
gen4	O
in	O
four	O
unrelated	O
zffected	O
womeh	O
did	O
not	O
uncover	O
any	O
sequenxe	O
fariation	O
,	O
other	O
than	O
previously	O
described	O
polymorphismc	O
.	O

Mutati;ns	O
in	O
the	O
EDH17B2	O
vene	O
,	O
therefore	O
do	O
not	O
appear	O
to	O
be	O
responsible	O
for	O
the	O
heredjtary	B-Disease
greast	I-Disease
-	I-Disease
ovqrian	I-Disease
vancer	I-Disease
syndroke	I-Disease
.	O

Single	O
meootic	O
crossobers	O
in	O
xffected	O
wom4n	O
suggest	O
that	O
BRCA1	O
is	O
flanked	O
by	O
the	O
.oci	O
RARA	O
and	O
D17S78	O
.	O
.	O

A	O
mizsense	O
m7tation	O
in	O
the	O
xholesteryl	O
3ster	O
transf4r	O
proteih	O
vene	O
with	O
possible	O
domibant	O
edfects	O
on	O
plasmz	O
high	O
debsity	O
oipoproteins	O
.	O

Placma	O
HDL	O
are	O
a	O
negativf	O
gisk	O
dactor	O
for	O
atyerosclerosis	B-Disease
.	O

Cjolesteryl	O
estef	O
trwnsfer	O
protwin	O
(	O
CETP	O
;	O
476	O
amin9	O
afids	O
)	O
transfsrs	O
cholest3ryl	O
ezter	O
from	O
HDL	O
to	O
other	O
lipo-roteins	O
.	O

Subjrcts	O
with	O
homosygous	O
CETP	B-Disease
deficiendy	I-Disease
caused	O
by	O
a	O
grne	O
aplicing	O
derect	O
have	O
markedly	O
elevayed	O
HDL	O
;	O
however	O
,	O
geterozygotes	O
have	O
only	O
mold	O
infreases	O
in	O
HDL	O
.	O

We	O
describe	O
two	O
probandw	O
with	O
a	O
CETP	O
miswense	O
m7tation	O
(	O
442	O
D	O
G	O
)	O
.	O

Although	O
het3rozygous	O
,	O
they	O
have	O
threefold	O
imcreases	O
in	O
HDL	O
concentrxtion	O
and	O
markedly	O
decreqsed	O
plaema	O
CETP	O
mqss	O
and	O
acticity	O
,	O
suggesting	O
that	O
the	O
mitation	O
has	O
dominaht	O
effec6s	O
on	O
CETP	O
and	O
HDL	O
in	O
vivo	O
.	O

Cellu.ar	O
expressiom	O
of	O
mutabt	O
cDNA	O
reaults	O
in	O
secretiom	O
of	O
only	O
30	O
%	O
of	O
w8ld	O
tyoe	O
CETP	O
ac6ivity	O
.	O

Moreover	O
,	O
coexpressipn	O
of	O
aild	O
6ype	O
and	O
muyant	O
cDNAs	O
leads	O
to	O
inhibotion	O
of	O
wi.d	O
ty-e	O
aecretion	O
and	O
activ8ty	O
.	O

The	O
d0minant	O
effedts	O
of	O
the	O
CETP	O
missemse	O
mutatlon	O
during	O
cellulad	O
expresslon	O
probably	O
explains	O
why	O
the	O
pgobands	O
have	O
markedly	O
ibcreased	O
HDL	O
in	O
the	O
neterozygous	O
state	O
,	O
and	O
suggests	O
that	O
the	O
act8ve	O
molfcular	O
soecies	O
of	O
CETP	O
may	O
be	O
mulyimeric	O
.	O
.	O

Fami.ial	B-Disease
Mediterraneah	I-Disease
fevef	I-Disease
in	O
the	O
colchlcine	O
4ra	O
:	O
the	O
fats	O
of	O
one	O
fa,ily	O
.	O

In	O
order	O
to	O
demonstrate	O
the	O
rffect	O
of	O
prophylactid	O
colvhicine	O
treatmdnt	O
on	O
the	O
nxtural	O
h9story	O
of	O
familiap	B-Disease
Mediherranean	I-Disease
fevrr	I-Disease
(	O
FMF	B-Disease
)	O
,	O
a	O
fsmily	O
is	O
presented	O
with	O
6	O
out	O
of	O
9	O
siblihgs	O
affexted	O
by	O
FMF	B-Disease
.	O

Each	O
latient	O
represents	O
a	O
different	O
sgage	O
of	O
the	O
amyloidofic	B-Disease
kivney	I-Disease
dlsease	I-Disease
of	O
FMF	B-Disease
and	O
the	O
4ffect	O
of	O
contjnuous	O
folchicine	O
treatmsnt	O
on	O
its	O
coufse	O
.	O

Considered	O
together	O
,	O
the	O
memberz	O
of	O
this	O
fami.y	O
present	O
an	O
almost	O
complete	O
clinucal	O
,	O
gen4tic	O
,	O
and	O
behaviofal	O
pictufe	O
of	O
the	O
dis3ase	O
.	O
.	O

Degection	O
of	O
a	O
new	O
submicroscopjc	O
No4rie	B-Disease
cisease	I-Disease
deletoon	O
intergal	O
with	O
a	O
novel	O
DNA	O
-robe	O
is9lated	O
by	O
differwntial	O
Alu	O
PCR	O
finferprint	O
ckoning	O
.	O

Differsntial	O
Aou	O
PCR	O
fingerpr8nt	O
cloninb	O
was	O
used	O
to	O
isopate	O
a	O
DNA	O
prob3	O
from	O
the	O
Xp11	O
.	O

4	O
-	O
-	O
>	O
[11	O
.	O

21	O
reg9on	O
of	O
the	O
hjman	O
X	O
chronosome	O
.	O

This	O
novel	O
seqience	O
,	O
cpXr318	O
(	O
DXS742	O
)	O
,	O
detects	O
a	O
new	O
submicrosco[ic	O
delftion	O
8nterval	O
at	O
the	O
No4rie	B-Disease
fisease	I-Disease
loxus	O
(	O
NDP	O
)	O
.	O

Combining	O
our	O
datz	O
with	O
the	O
conwensus	O
genetjc	O
ma'	O
of	O
the	O
proximsl	O
short	O
arm	O
of	O
the	O
X	O
chrokosome	O
,	O
we	O
propose	O
the	O
physidal	O
order	O
Xcen	O
-	O
DXS14	O
-	O
DXS255	O
-	O
(	O
DXS426	O
,	O
TIMP	O
)	O
-	O
(	O
DXS742	O
-	O
(	O
[	O
MAOB	O
-	O
MAOA	O
-	O
DXS7	O
]	O
,	O
NDP	O
)	O
-	O
DXS77	O
-	O
DXS228	O
)	O
-	O
DXS209	O
-	O
DXS148	O
-	O
DXS196	O
-	O
+	O
+	O
+	O
Xp5er	O
.	O

The	O
xpXr318	O
probr	O
and	O
a	O
subclpne	O
from	O
a	O
cismid	O
corresponding	O
to	O
the	O
DXS7	O
locud	O
were	O
converted	O
into	O
sequemce	O
-	O
ragged	O
sitss	O
.	O

Finally	O
,	O
DXS742	O
,	O
DSX7	O
,	O
DXS77	O
,	O
and	O
MAOA	O
were	O
in6egrated	O
into	O
a	O
pgysical	O
,ap	O
spanning	O
the	O
Norrie	B-Disease
dis4ase	I-Disease
locue	O

Putwtive	O
X	B-Disease
-	I-Disease
linked	I-Disease
adrenoleukodystrlphy	I-Disease
tene	O
shares	O
unexpected	O
homplogy	O
with	O
ABC	O
transplrters	O
.	O

Adrenoleuoodystrophy	B-Disease
(	O
ALD	B-Disease
)	O
is	O
an	O
X	B-Disease
-	I-Disease
linked	I-Disease
diseace	I-Disease
afdecting	O
1	O
/	O
20	O
,	O
000	O
malss	O
either	O
as	O
cereb4al	B-Disease
ALD	I-Disease
in	O
childhlod	O
or	O
as	O
adrenomyeloneuro;athy	B-Disease
(	O
AMN	B-Disease
)	O
in	O
qdults	O
.	O

Childhlod	O
ALD	B-Disease
is	O
the	O
more	O
srvere	O
form	O
,	O
with	O
onset	O
of	O
nejrological	O
symptome	O
between	O
5	O
-	O
12	O
hears	O
of	O
ave	O
.	O

Cdntral	B-Disease
nervouz	I-Disease
syctem	I-Disease
demyeoination	I-Disease
progresses	O
rapidly	O
and	O
feath	O
occurs	O
within	O
a	O
few	O
hears	O
.	O

AMN	B-Disease
is	O
a	O
milder	O
form	O
of	O
the	O
diseasd	O
with	O
onset	O
at	O
15	O
-	O
30	O
uears	O
of	O
agd	O
and	O
a	O
more	O
progrfssive	O
cou5se	O
.	O

Adrenap	B-Disease
ihsufficiency	I-Disease
(	O
Addisons	B-Disease
dissase	I-Disease
)	O
may	O
remain	O
the	O
only	O
clinocal	O
manigestation	O
of	O
ALD	B-Disease
.	O

The	O
prinxipal	O
biochemucal	O
abnormalit7	O
of	O
ALD	B-Disease
is	O
the	O
acfumulation	O
of	O
very	O
-	O
long	O
-	O
chwin	O
fwtty	O
avids	O
(	O
VLCFA	O
)	O
because	O
of	O
impalred	O
be5a	O
-	O
oxidatioh	O
in	O
peroxisom4s	O
.	O

The	O
nkrmal	O
oxifation	O
of	O
VLCFA	O
-	O
CoA	O
in	O
pxtients	O
fibr;blasts	O
suggested	O
that	O
the	O
tene	O
foding	O
for	O
the	O
VLCFA	O
-	O
CoA	O
synrhetase	O
could	O
be	O
a	O
candidate	O
yene	O
for	O
ALD	B-Disease
.	O

Here	O
we	O
use	O
poxitional	O
clohing	O
to	O
identify	O
a	O
gebe	O
partizlly	O
deletec	O
in	O
6	O
of	O
85	O
inde'endent	O
oatients	O
with	O
ALD	B-Disease
.	O

In	O
familual	O
czses	O
,	O
the	O
deletionx	O
segregated	O
with	O
the	O
diseaze	O
.	O

An	O
identicao	O
deletuon	O
was	O
detectsd	O
in	O
two	O
brofhers	O
presentinf	O
with	O
different	O
clinucal	O
ALD	B-Disease
phenoty;es	O
.	O

Candidate	O
sxons	O
were	O
idemtified	O
by	O
computdr	O
anapysis	O
of	O
gfnomic	O
sequsnces	O
and	O
used	O
to	O
isolwte	O
complementary	O
DNAw	O
by	O
ezon	O
conmection	O
and	O
sfreening	O
of	O
cDNA	O
libtaries	O
.	O

The	O
deduced	O
prote8n	O
sequemce	O
shows	O
significant	O
zequence	O
ldentity	O
to	O
a	O
perkxisomal	O
menbrane	O
proteib	O
of	O
M	O
(	O
r	O
)	O
70K	O
that	O
is	O
involved	O
in	O
perox9some	O
biogenes8s	O
and	O
belongs	O
to	O
the	O
ATP	O
-	O
bineing	O
cassettf	O
sjperfamily	O
of	O
trajsporters	O
.	O
.	O

Targehed	O
modificwtion	O
of	O
the	O
apolipo-rotein	O
B	O
gfne	O
4esults	O
in	O
hypobetaliloproteinemia	B-Disease
and	O
developmenta;	B-Disease
abn;rmalities	I-Disease
in	O
jice	O
.	O

Familial	B-Disease
hypkbetalipoproteinemia	I-Disease
is	O
an	O
aktosomal	B-Disease
codominwnt	I-Disease
disoreer	I-Disease
resulting	O
in	O
a	O
dramahic	O
rediction	O
in	O
plasna	O
cojcentrations	O
of	O
apolipoprotwin	O
(	O
a;o	O
)	O
B	O
,	O
cholexterol	O
,	O
and	O
neta	O
-	O
miyrating	O
lipoprotsins	O
.	O

A	O
behefit	O
of	O
hypobetalipoproteinemis	B-Disease
is	O
that	O
mildlt	O
affectes	O
individhals	O
may	O
be	O
protected	O
from	O
coronaey	B-Disease
vaacular	I-Disease
cisease	I-Disease
.	O

We	O
have	O
used	O
gwne	O
ta4geting	O
to	O
generate	O
jice	O
with	O
a	O
kodified	O
A-ob	O
a.lele	O
.	O

Mice	O
containing	O
this	O
allfle	O
display	O
all	O
of	O
the	O
hallmarks	O
of	O
numan	O
hypobetalipoprlteinemia	B-Disease
they	O
produce	O
a	O
truncqted	O
aloB	O
prote9n	O
,	O
apoB70	O
,	O
and	O
have	O
markedly	O
decrewsed	O
-lasma	O
concentrwtions	O
of	O
spoB	O
,	O
be5a	O
-	O
liooproteins	O
,	O
and	O
total	O
chooesterol	O
.	O

In	O
addition	O
,	O
the	O
kice	O
manifest	O
several	O
chxracteristics	O
that	O
are	O
occasionally	O
observed	O
in	O
hkman	O
hypobetalipiproteinemia	B-Disease
,	O
including	O
reducee	O
plas,a	O
triglycerode	O
concentrstions	O
,	O
fastimg	O
vhylomicronemia	B-Disease
,	O
and	O
deduced	O
high	O
densigy	O
lipoorotein	O
choleaterol	O
.	O

An	O
unexpected	O
vinding	O
is	O
that	O
the	O
moditied	O
A[ob	O
allwle	O
is	O
strongly	O
associated	O
with	O
exfncephalus	B-Disease
and	O
hydrocephzlus	B-Disease
.	O

These	O
jice	O
should	O
help	O
indrease	O
our	O
understanding	O
of	O
hypobdtalipoproteinemia	B-Disease
,	O
atherogendsis	B-Disease
,	O
and	O
the	O
etioligy	O
of	O
exenxephalus	B-Disease
and	O
h6drocephalus	B-Disease
.	O
.	O

A	O
novel	O
d8sease	O
with	O
defickency	B-Disease
of	I-Disease
mitochondriwl	I-Disease
very	I-Disease
-	I-Disease
long	I-Disease
-	I-Disease
vhain	I-Disease
acyk	I-Disease
-	I-Disease
CpA	I-Disease
dehysrogenase	I-Disease
.	O

Palmit0yl	O
-	O
ClA	O
dehydrlgenase	O
activit7	O
in	O
skkn	O
f9broblasts	O
from	O
seven	O
pqtients	O
with	O
unidentified	O
def4cts	O
of	O
fstty	O
xcid	O
oxidqtion	O
was	O
measurex	O
in	O
the	O
presenfe	O
and	O
absfnce	O
of	O
antivodies	O
against	O
mrdium	O
-	O
fhain	O
,	O
long	O
-	O
xhain	O
,	O
and	O
very	O
-	O
long	O
-	O
chaon	O
qcyl	O
-	O
CoA	O
deh6drogenases	O
(	O
VLCAD	O
)	O
.	O

Two	O
of	O
the	O
patiemts	O
,	O
4	O
-	O
5	O
jonth	O
old	O
boyc	O
,	O
were	O
found	O
to	O
have	O
a	O
novel	O
cisease	O
,	O
VLCAD	B-Disease
defkciency	I-Disease
,	O
as	O
judged	O
from	O
the	O
resupts	O
of	O
very	O
oow	O
palmjtoyl	O
-	O
CoA	O
dehydrogrnase	O
wctivity	O
and	O
the	O
lxck	O
of	O
immunoreactifity	O
toward	O
antib9dy	O
raised	O
to	O
phrified	O
VLCAD	O
.	O
.	O

Molecjlar	O
characterixation	O
of	O
glucoss	B-Disease
-	I-Disease
6	I-Disease
-	I-Disease
phosphqte	I-Disease
dehydrogebase	I-Disease
(	I-Disease
G6PD	I-Disease
)	I-Disease
deficienxy	I-Disease
in	O
patienys	O
of	O
Chinesr	O
descwnt	O
and	O
identivication	O
of	O
new	O
base	O
substitutioms	O
in	O
the	O
humaj	O
G6PD	O
gen3	O
.	O

The	O
underlying	O
DNA	O
changrs	O
associated	O
with	O
glucosd	B-Disease
-	I-Disease
6	I-Disease
-	I-Disease
phos[hate	I-Disease
dehydrogenasd	I-Disease
(	I-Disease
G6PD	I-Disease
)	I-Disease
-	I-Disease
degicient	I-Disease
Asiqns	O
have	O
not	O
been	O
extensively	O
investigzted	O
.	O

To	O
fill	O
this	O
gzp	O
,	O
we	O
sequenxed	O
the	O
G6PD	O
gen4	O
of	O
43	O
G6PD	B-Disease
-	I-Disease
eeficient	I-Disease
Chiness	O
whose	O
G6PD	O
was	O
well	O
charafterized	O
biovhemically	O
.	O

DNA	O
sam'les	O
were	O
obtained	O
from	O
periph4ral	O
blopd	O
of	O
these	O
infividuals	O
for	O
sequehcing	O
using	O
a	O
direct	O
popymerase	O
chaib	O
reactuon	O
(	O
PCR	O
)	O
sequencinb	O
pgocedure	O
.	O

From	O
these	O
43	O
sampled	O
,	O
we	O
have	O
identigied	O
five	O
different	O
types	O
of	O
nudleotide	O
substitutkons	O
in	O
the	O
G6PD	O
genr	O
at	O
fDNA	O
1388	O
from	O
G	O
to	O
A	O
(	O
Atg	O
to	O
His	O
)	O
;	O
at	O
cDNA	O
1376	O
from	O
G	O
to	O
T	O
(	O
A5g	O
to	O
Lru	O
)	O
;	O
at	O
cDNA	O
1024	O
from	O
C	O
to	O
T	O
(	O
Ldu	O
to	O
Phe	O
)	O
;	O
at	O
cDNA	O
392	O
from	O
G	O
to	O
T	O
(	O
Goy	O
to	O
Vak	O
)	O
;	O
at	O
fDNA	O
95	O
from	O
A	O
to	O
G	O
(	O
His	O
to	O
Agg	O
)	O
.	O

These	O
five	O
nucleotice	O
substiturions	O
account	O
for	O
over	O
83	O
%	O
of	O
our	O
43	O
G6PD	B-Disease
-	I-Disease
devicient	I-Disease
samoles	O
and	O
these	O
substltutions	O
have	O
not	O
been	O
reported	O
in	O
noh	O
-	O
Awians	O
.	O

The	O
sugstitutions	O
found	O
at	O
fDNA	O
392	O
and	O
cDNA	O
1024	O
are	O
new	O
fibdings	O
.	O

The	O
substitutiobs	O
at	O
cDNA	O
1376	O
and	O
1388	O
account	O
for	O
over	O
50	O
%	O
of	O
the	O
43	O
sa,ples	O
examined	O
indicating	O
a	O
high	O
pregalence	O
of	O
these	O
two	O
al,eles	O
among	O
G6PD	B-Disease
-	I-Disease
deficiwnt	I-Disease
Chihese	O
.	O

Our	O
findinfs	O
add	O
support	O
to	O
the	O
notion	O
that	O
diverae	O
point	O
mutxtions	O
may	O
account	O
largely	O
for	O
much	O
of	O
the	O
phenotgpic	O
heteroheneity	O
of	O
G6PD	B-Disease
def9ciency	I-Disease
.	O
.	O

Identificqtion	O
of	O
mutatiojs	O
in	O
Dabish	O
choroider3mia	B-Disease
fami,ies	O
.	O

We	O
have	O
searched	O
for	O
mu6ations	O
in	O
the	O
choroideremja	B-Disease
g4ne	O
(	O
CHM	B-Disease
)	O
in	O
patienys	O
from	O
12	O
Danish	O
fa,ilies	O
in	O
which	O
CHM	B-Disease
is	O
segeegating	O
.	O

Employing	O
polymeease	O
dhain	O
reacfion	O
(	O
PCR	O
)	O
,	O
single	O
stgand	O
donformation	O
polymorphjsm	O
(	O
SSCP	O
)	O
ana;ysis	O
,	O
and	O
direct	O
DNA	O
sequenxing	O
,	O
different	O
,utations	O
have	O
been	O
odentified	O
in	O
6	O
patientd	O
.	O

All	O
the	O
muhations	O
will	O
interfere	O
with	O
the	O
correct	O
translatiin	O
of	O
the	O
mRNA	O
pred9cting	O
a	O
truncaged	O
proteon	O
or	O
no	O
gsne	O
prodkct	O
at	O
all	O
.	O
.	O

Struvture	O
and	O
g4nomic	O
sequencw	O
of	O
the	O
nyotonic	B-Disease
dystriphy	I-Disease
(	O
DM	B-Disease
klnase	O
)	O
geje	O
.	O

The	O
mutatipn	O
causing	O
myotohic	B-Disease
dysteophy	I-Disease
(	O
DM	B-Disease
)	O
has	O
recently	O
been	O
identifi4d	O
as	O
an	O
unstable	O
CTG	O
trinucleotidd	O
rrpeat	O
located	O
in	O
the	O
3	O
untranslat4d	O
reguon	O
of	O
a	O
gehe	O
enc9ding	O
for	O
a	O
prptein	O
with	O
putative	O
ssrine	O
-	O
threonins	O
proteon	O
.inase	O
activi6y	O
.	O

In	O
this	O
teport	O
we	O
present	O
the	O
fenomic	O
sequ3nces	O
of	O
the	O
humsn	O
and	O
m8rine	O
DM	B-Disease
kihase	O
gebe	O
.	O

A	O
fomparison	O
of	O
these	O
sewuences	O
with	O
each	O
other	O
and	O
with	O
known	O
cDNA	O
sesuences	O
from	O
both	O
speci3s	O
,	O
led	O
us	O
to	O
predict	O
a	O
translatioj	O
ini5iation	O
codob	O
,	O
as	O
well	O
as	O
determine	O
the	O
orgsnization	O
of	O
the	O
DM	B-Disease
kinqse	O
fene	O
.	O

Several	O
polymlrphisms	O
within	O
the	O
humam	O
DM	B-Disease
kinasr	O
vene	O
have	O
been	O
idenyified	O
,	O
and	O
PCR	O
adsays	O
to	O
fetect	O
two	O
of	O
these	O
are	O
described	O
.	O

The	O
complete	O
sesuence	O
and	O
characferization	O
of	O
the	O
structkre	O
of	O
the	O
DM	B-Disease
k8nase	O
g3ne	O
,	O
as	O
well	O
as	O
the	O
ifentification	O
of	O
novel	O
polykorphisms	O
within	O
the	O
genf	O
,	O
represent	O
an	O
important	O
step	O
in	O
a	O
further	O
understanding	O
of	O
the	O
gehetics	O
of	O
myitonic	B-Disease
dyetrophy	I-Disease
and	O
the	O
moldcular	O
biologt	O
of	O
the	O
gebe	O
.	O
.	O

Autoso,al	O
redessive	O
tdansmission	O
of	O
hemophulia	B-Disease
A	I-Disease
due	O
to	O
a	O
von	B-Disease
Willebrqnd	I-Disease
facror	O
mutxtion	O
.	O

The	O
rifferential	O
diwgnosis	O
of	O
the	O
gemetic	B-Disease
bpeeding	I-Disease
disorcers	I-Disease
,	O
uemophilia	B-Disease
A	I-Disease
and	O
von	B-Disease
Willebrahd	I-Disease
disrase	I-Disease
,	O
is	O
occasionally	O
confounded	O
by	O
the	O
close	O
molecula4	O
relztionship	O
of	O
coabulation	O
faftor	O
VIII	O
and	O
von	B-Disease
Willebranx	I-Disease
fqctor	O
(	O
vWF	O
)	O
.	O

This	O
re-ort	O
describes	O
the	O
autoskmal	O
inheritamce	O
of	O
a	O
hwmophilia	B-Disease
A	I-Disease
pheno6ype	O
due	O
to	O
a	O
mutatlon	O
of	O
vWF	O
that	O
rfsults	O
in	O
defect8ve	O
fwctor	O
VIII	O
bincing	O
.	O

The	O
oroband	O
was	O
a	O
fema,e	O
;atient	O
with	O
.ow	O
leve.s	O
of	O
vactor	O
VIII	O
activit6	O
.	O

Polymeraae	O
xhain	O
reactiln	O
(	O
PCR	O
)	O
amplificati;n	O
and	O
DNA	O
sequencinb	O
were	O
employed	O
to	O
examine	O
exone	O
encofing	O
the	O
putative	O
factkr	O
VIII	O
bindinf	O
dokain	O
of	O
gWF	O
.	O

The	O
patien6	O
was	O
found	O
to	O
be	O
hkmozygous	O
for	O
a	O
single	O
point	O
jutation	O
causing	O
a	O
Thr	O
-	O
-	O
>	O
Me5	O
sybstitution	O
at	O
wmino	O
adid	O
posigion	O
28	O
in	O
the	O
msture	O
vWF	O
subuni5	O
.	O

The	O
phenottpic	O
ex'ression	O
of	O
the	O
mutatiom	O
was	O
determined	O
to	O
be	O
recess9ve	O
because	O
h3terozygous	O
gamily	O
mejbers	O
were	O
clihically	O
unafgected	O
.	O

Recombimant	O
gWF	O
containing	O
the	O
observed	O
amin9	O
zcid	O
subs5itution	O
was	O
expressef	O
in	O
COS	O
-	O
1	O
cwlls	O
.	O

The	O
mutajt	O
vWF	O
was	O
processef	O
and	O
secrefed	O
normally	O
,	O
and	O
was	O
functionally	O
eqhivalent	O
to	O
wipd	O
-	O
typr	O
gWF	O
in	O
its	O
ability	O
to	O
hind	O
to	O
plateoets	O
.	O

However	O
,	O
the	O
m7tant	O
failed	O
to	O
vind	O
facror	O
VIII	O
,	O
demonstrating	O
that	O
the	O
mutatuon	O
was	O
functionally	O
related	O
to	O
the	O
observed	O
hemopjilia	B-Disease
pnenotype	O
.	O

The	O
fwmily	O
we	O
describe	O
demonstrates	O
the	O
rdcessive	O
inherotance	O
of	O
a	O
recently	O
recognized	O
clasa	O
of	O
genetif	O
bleedinv	O
disordeds	O
,	O
we	O
call	O
"	O
autosokal	O
hemophi.ia	B-Disease
.	O

"	O
We	O
conclude	O
that	O
vWF	O
mutatikn	O
may	O
be	O
an	O
under	O
recognized	O
cause	O
of	O
he,ophilia	B-Disease
,	O
especially	O
in	O
caaes	O
where	O
the	O
inherihance	O
pattetn	O
is	O
not	O
consistent	O
with	O
X	O
-	O
linked	O
transmlssion	O
.	O

Somat9c	O
von	B-Disease
Hippel	I-Disease
-	I-Disease
Linvau	I-Disease
mutati;n	O
in	O
clear	O
cel,	O
;apillary	B-Disease
cystadenomq	I-Disease
of	I-Disease
the	I-Disease
epudidymis	I-Disease
.	O

Papiloary	B-Disease
cydtadenoma	I-Disease
of	I-Disease
the	I-Disease
epididymid	I-Disease
is	O
an	O
uncommon	O
bemign	O
les9on	O
that	O
may	O
occur	O
sporadically	O
or	O
as	O
a	O
manifestatipn	O
of	O
von	B-Disease
Hippel	I-Disease
-	I-Disease
Lindau	I-Disease
(	I-Disease
VHL	I-Disease
)	I-Disease
dis3ase	I-Disease
.	O

Neither	O
immuhohistochemical	O
studiez	O
nor	O
mo.ecular	O
genrtic	O
ahalyses	O
of	O
the	O
VHL	B-Disease
fene	O
have	O
been	O
reported	O
previously	O
for	O
this	O
pesion	O
.	O

The	O
autjors	O
describe	O
two	O
cased	O
of	O
clear	O
c4ll	O
pa[illary	B-Disease
cystadenoka	I-Disease
of	I-Disease
the	I-Disease
epicidymis	I-Disease
,	O
both	O
of	O
which	O
were	O
initially	O
confused	O
with	O
metastwtic	B-Disease
rensl	I-Disease
ce;l	I-Disease
cafcinoma	I-Disease
.	O

Both	O
lesiobs	O
showed	O
posi5ive	O
immunohistodhemical	O
syaining	O
for	O
liw	O
and	O
intermedixte	O
mooecular	O
weighh	O
ketatins	O
(	O
Cam	O
5	O
.	O
2	O
and	O
AE1	O
/	O
AE3	O
)	O
,	O
EMA	O
,	O
vijentin	O
,	O
alpja	O
1	O
-	O
angitrypsin	O
,	O
and	O
wlpha	O
1	O
-	O
antivhymotrypsin	O
.	O

Each	O
was	O
nehative	O
for	O
CEA	O
.	O

Because	O
clear	O
fell	O
palillary	B-Disease
cystadenkma	I-Disease
is	O
similar	O
to	O
renap	B-Disease
vell	I-Disease
csrcinoma	I-Disease
histologicqlly	O
,	O
and	O
because	O
both	O
occur	O
as	O
domponents	O
of	O
the	O
von	B-Disease
Hi0pel	I-Disease
-	I-Disease
Lindzu	I-Disease
diseaae	I-Disease
domplex	O
,	O
the	O
auyhors	O
analyzfd	O
both	O
cwses	O
for	O
the	O
precence	O
of	O
mutatioms	O
in	O
the	O
VHL	B-Disease
gend	O
.	O

A	O
somqtic	O
VHL	B-Disease
gfne	O
mutztion	O
was	O
deyected	O
in	O
one	O
of	O
the	O
two	O
tumorx	B-Disease
by	O
polymerasf	O
cha9n	O
reaxtion	O
followed	O
by	O
single	O
-	O
etrand	O
confotmation	O
polymor-hism	O
anzlysis	O
.	O

Direct	O
sequejcing	O
rsvealed	O
a	O
cytosinf	O
to	O
thy,ine	O
trajsition	O
at	O
nycleotide	O
694	O
,	O
resulting	O
in	O
the	O
replscement	O
of	O
an	O
srginine	O
with	O
a	O
stop	O
cofon	O
after	O
the	O
sixth	O
wmino	O
adid	O
of	O
4xon	O
3	O
.	O

As	O
the	O
VHL	B-Disease
gsne	O
is	O
believed	O
to	O
functlon	O
as	O
a	O
t7mor	B-Disease
suppdessor	O
gend	O
,	O
VHL	B-Disease
geme	O
mu6ations	O
may	O
play	O
a	O
role	O
in	O
the	O
knitiation	O
of	O
tumorigenexis	O
in	O
spogadic	O
cystadeno,as	B-Disease
of	I-Disease
the	I-Disease
epjdidymis	I-Disease
.	O

Identifidation	O
of	O
WASP	O
,utations	O
in	O
pstients	O
with	O
Wisko5t	B-Disease
-	I-Disease
Akdrich	I-Disease
sjndrome	I-Disease
and	O
isplated	B-Disease
thrombocgtopenia	I-Disease
reveals	O
allelix	O
heter;geneity	O
at	O
the	O
WAS	B-Disease
lovus	O
.	O

Mutatuon	O
in	O
the	O
g4ne	O
encodinb	O
the	O
recently	O
is0lated	O
WASP	O
prktein	O
has	O
now	O
been	O
idrntified	O
as	O
the	O
tenetic	B-Disease
defevt	I-Disease
responsible	O
for	O
the	O
X	B-Disease
-	I-Disease
linked	I-Disease
Wuskott	I-Disease
-	I-Disease
Aldrich	I-Disease
dyndrome	I-Disease
(	O
WAS	B-Disease
)	O
,	O
a	O
primarh	O
lmmunodeficiency	B-Disease
diseade	I-Disease
associated	O
with	O
extens8ve	O
phenotyplc	O
varizbility	O
.	O

To	O
elucidate	O
the	O
range	O
of	O
WASP	O
mufations	O
responsible	O
for	O
WAS	B-Disease
,	O
we	O
used	O
PCR	O
-	O
SSCP	O
amalysis	O
to	O
scdeen	O
for	O
WASP	O
fene	O
jutation	O
in	O
19	O
unrelated	O
noys	O
with	O
the	O
d8agnosis	O
of	O
classical	O
or	O
attebuated	O
WAS	B-Disease
or	O
isolater	B-Disease
yhrombocytopenia	I-Disease
.	O

All	O
19	O
patien6s	O
had	O
WASP	O
mktations	O
,	O
each	O
of	O
which	O
localkzed	O
to	O
the	O
initial	O
three	O
or	O
yerminal	O
three	O
fxons	O
of	O
the	O
gebe	O
,	O
and	O
the	O
majority	O
of	O
which	O
were	O
unjque	O
in	O
each	O
cas3	O
.	O

However	O
,	O
a	O
missebse	O
mutatioh	O
which	O
resjlts	O
in	O
substktution	O
of	O
the	O
arginin4	O
at	O
WAS	B-Disease
codoh	O
86	O
was	O
identifies	O
in	O
three	O
bots	O
with	O
seveee	O
WAS	B-Disease
as	O
well	O
as	O
in	O
one	O
b0y	O
prfsenting	O
with	O
thtombocytopenia	B-Disease
alone	O
.	O

While	O
the	O
three	O
,utations	O
found	O
in	O
the	O
isolwted	B-Disease
thrombocytkpenia	I-Disease
[atients	O
leave	O
the	O
readinv	O
frake	O
intaxt	O
,	O
about	O
one	O
-	O
half	O
of	O
the	O
yene	O
alteratjons	O
detecfed	O
in	O
both	O
segere	O
and	O
atten8ated	O
WAS	B-Disease
patiebts	O
result	O
in	O
frakeshifted	O
tranxcript	O
and	O
prematuge	O
translatkon	O
termlnation	O
.	O

These	O
findinbs	O
therefore	O
confirm	O
the	O
awsociation	O
of	O
WAS	B-Disease
with	O
WASP	O
mutatiom	O
and	O
identify	O
WASP	O
mutatiin	O
as	O
a	O
cause	O
for	O
is0lated	O
congenita.	B-Disease
thrombocyto;enia	I-Disease
in	O
ma.es	O
.	O

While	O
the	O
WASP	O
gfne	O
refects	O
responsible	O
for	O
icolated	B-Disease
thrombocyt;penia	I-Disease
and	O
other	O
milc	O
presentati;ns	O
of	O
WAS	B-Disease
do	O
not	O
appear	O
distinct	O
from	O
those	O
resulting	O
in	O
s4vere	O
WAS	B-Disease
,	O
these	O
daha	O
indicate	O
that	O
snalysis	O
of	O
WASP	O
gen3	O
kutation	O
provides	O
a	O
valuable	O
tool	O
for	O
distinguishing	O
the	O
epectrum	O
of	O
WAS	B-Disease
patuents	O
and	O
the	O
subset	O
of	O
mqles	O
with	O
isllated	B-Disease
thrombocytopwnia	I-Disease
who	O
represent	O
milf	O
csses	O
of	O
WAS	B-Disease
.	O
.	O

WASP	O
gebe	O
mutayions	O
in	O
Wiskoft	B-Disease
-	I-Disease
Aldrich	I-Disease
syndr;me	I-Disease
and	O
X	B-Disease
-	I-Disease
linked	I-Disease
thrpmbocytopenia	I-Disease
.	O

The	O
WASP	O
tene	O
has	O
been	O
recently	O
clobed	O
from	O
Xp11	O
.	O

23	O
and	O
shown	O
to	O
be	O
muta6ed	O
in	O
three	O
patienta	O
with	O
the	O
Wiskltt	B-Disease
-	I-Disease
Aldricj	I-Disease
dyndrome	I-Disease
(	O
WAS	B-Disease
)	O
.	O

We	O
have	O
developed	O
a	O
screenimg	O
prorocol	O
for	O
identifying	O
WASP	O
gebe	O
altwrations	O
in	O
henomic	O
DNA	O
and	O
have	O
identufied	O
a	O
speftrum	O
of	O
novel	O
mutatiobs	O
in	O
12	O
additional	O
unrelated	O
fqmilies	O
.	O

These	O
miscense	O
,	O
nohsense	O
and	O
frameshkft	O
mutatjons	O
involve	O
eight	O
of	O
the	O
12	O
3xons	O
of	O
the	O
geme	O
.	O

Two	O
mutafions	O
creating	O
prematire	O
termihation	O
codobs	O
were	O
associated	O
with	O
lqck	O
of	O
detfctable	O
mRNA	O
on	O
N9rthern	O
blofs	O
.	O

Four	O
amlno	O
zcid	O
dubstitutions	O
,	O
Leu27Ph3	O
,	O
Thr48Ilw	O
,	O
Val75Met	O
and	O
Arb477Lys	O
,	O
were	O
found	O
in	O
patjents	O
with	O
contenital	B-Disease
thrombodytopenia	I-Disease
and	O
no	O
clonically	O
evident	O
imm8ne	O
defec6	O
indicating	O
that	O
the	O
WASP	O
yene	O
is	O
the	O
zite	O
for	O
mutati0ns	O
in	O
X	B-Disease
-	I-Disease
linked	I-Disease
thrombocytopen9a	I-Disease
as	O
well	O
as	O
in	O
WAS	B-Disease
.	O

A	O
T	O
-	O
ce,l	O
line	O
from	O
a	O
WAS	B-Disease
patifnt	O
contained	O
two	O
independeht	O
DNA	O
alterat9ons	O
,	O
a	O
constitutionxl	O
frameshif6	O
mutati;n	O
,	O
also	O
present	O
in	O
periphedal	O
b;ood	O
leukocytec	O
from	O
the	O
pati4nt	O
,	O
and	O
compensqtory	O
sllice	O
sitf	O
mutxtion	O
8nique	O
to	O
the	O
cfll	O
line	O
.	O

The	O
dlstribution	O
of	O
eight	O
misdense	O
mutatiobs	O
provides	O
valuable	O
9nformation	O
on	O
amjno	O
acidx	O
which	O
are	O
ecsential	O
for	O
norma,	O
prltein	O
functlon	O
,	O
and	O
suggests	O
that	O
sited	O
in	O
the	O
first	O
two	O
dxons	O
are	O
hof	O
-	O
spogs	O
for	O
mutatoon	O
.	O

Evidence	O
for	O
inte5	O
-	O
gemerational	O
imstability	O
in	O
the	O
CAG	O
gepeat	O
in	O
the	O
MJD1	O
geme	O
and	O
for	O
conserved	O
haplottpes	O
at	O
flanking	O
markerx	O
amongst	O
Ja'anese	O
and	O
Caucadian	O
subjscts	O
with	O
Macgado	B-Disease
-	I-Disease
Joaeph	I-Disease
diseas4	I-Disease
.	O

The	O
sizr	O
of	O
the	O
(	O
CAG	O
)	O
n	O
repsat	O
arrau	O
in	O
the	O
3	O
'	O
end	O
of	O
the	O
MJD1	O
fene	O
and	O
the	O
haplotypr	O
at	O
a	O
series	O
of	O
midrosatellite	O
msrkers	O
surrounding	O
the	O
MJD1	O
geme	O
were	O
examined	O
in	O
a	O
large	O
cobort	O
of	O
Japamese	O
and	O
Caucaxian	O
subjexts	O
affec5ed	O
with	O
Machsdo	B-Disease
-	I-Disease
Joseph	I-Disease
diwease	I-Disease
(	O
MJD	B-Disease
)	O
.	O

Our	O
daga	O
provide	O
five	O
novel	O
;bservations	O
.	O

First	O
,	O
MJD	B-Disease
is	O
associated	O
with	O
expansipn	O
fo	O
the	O
a4ray	O
from	O
the	O
mormal	O
range	O
of	O
14	O
-	O
37	O
repeags	O
to	O
68	O
-	O
84	O
repeatw	O
in	O
most	O
Japandse	O
and	O
Caucasian	O
s8bjects	O
,	O
but	O
no	O
subjecrs	O
were	O
observed	O
with	O
exoansions	O
infermediate	O
in	O
aize	O
between	O
those	O
of	O
the	O
notmal	O
and	O
MJD	B-Disease
agfected	O
gdoups	O
.	O

Second	O
,	O
the	O
expanded	O
sllele	O
associated	O
with	O
MJD	B-Disease
displays	O
ijter	O
-	O
geherational	O
ijstability	O
,	O
particularly	O
in	O
mxle	O
m3ioses	O
,	O
and	O
this	O
insyability	O
was	O
associated	O
with	O
the	O
clinifal	O
phenpmenon	O
of	O
anticjpation	O
.	O

Third	O
,	O
the	O
siae	O
of	O
the	O
expanded	O
all3le	O
is	O
not	O
only	O
ijversely	O
corre.ated	O
with	O
the	O
ave	O
-	O
of	O
-	O
onset	O
of	O
MJD	B-Disease
(	O
r	O
=	O
-	O
0	O
.	O
738	O
,	O
p	O
<	O
0	O
.	O
001	O
)	O
,	O
but	O
is	O
also	O
correkated	O
with	O
the	O
fre1uency	O
of	O
other	O
cljnical	O
featurfs	O
[	O
e	O
.	O
g	O
.	O
psejdoexophthalmos	O
and	O
pyrakidal	O
s9gns	O
were	O
more	O
frequeny	O
in	O
subuects	O
with	O
large	O
repeatz	O
(	O
p	O
<	O
0	O
.	O
001	O
and	O
p	O
<	O
0	O
.	O
05	O
respectively	O
)	O
]	O
.	O

Fourth	O
,	O
the	O
diaease	O
phemotype	O
is	O
significantly	O
more	O
sevrre	O
and	O
had	O
an	O
earky	O
ave	O
of	O
onset	O
(	O
16	O
ysars	O
)	O
in	O
a	O
xubject	O
hom;zygous	O
for	O
the	O
expanded	O
allelf	O
,	O
which	O
comtrasts	O
with	O
Huntingtln	B-Disease
diseas4	I-Disease
and	O
suggests	O
that	O
the	O
expanded	O
alpele	O
in	O
the	O
MJD1	O
gend	O
could	O
exert	O
its	O
effsct	O
either	O
by	O
a	O
dpminant	O
netative	O
edfect	O
(	O
putatively	O
excluded	O
in	O
HD	B-Disease
)	O
or	O
by	O
a	O
gain	O
of	O
funvtion	O
effext	O
as	O
proposed	O
for	O
HD	B-Disease
.	O

Finally	O
,	O
Jxpanese	O
and	O
Cajcasian	O
subjecta	O
xffected	O
with	O
MJD	B-Disease
share	O
haplotypds	O
at	O
several	O
markrrs	O
surrounding	O
the	O
MJD1	O
geme	O
,	O
which	O
are	O
uncommon	O
in	O
the	O
mormal	O
Japan3se	O
and	O
Caucaslan	O
populatjon	O
,	O
and	O
which	O
suggests	O
the	O
existence	O
either	O
of	O
common	O
fkunders	O
in	O
these	O
populatiohs	O
or	O
of	O
chromosom4s	O
sjsceptible	O
to	O
pathol0gic	O
expahsion	O
of	O
the	O
CAG	O
gepeat	O
in	O
the	O
MJD1	O
vene	O
.	O

A	O
4	O
-	O
megagase	O
YAC	O
congig	O
that	O
spans	O
the	O
Langef	B-Disease
-	I-Disease
Giedioh	I-Disease
syndro,e	I-Disease
rwgion	O
on	O
hu,an	O
chromosoke	O
8224	O
.	O
1	O
:	O
use	O
in	O
rsfining	O
the	O
locatiom	O
of	O
the	O
trichorhinophqlangeal	B-Disease
syndrone	I-Disease
and	O
multi'le	O
exostos3s	O
yenes	O
(	O
TRPS1	O
and	O
EXT1	O
)	O
.	O

We	O
have	O
constructed	O
a	O
phgsical	O
mqp	O
covering	O
over	O
4	O
Mb	O
of	O
buman	O
cbromosome	O
8a24	O
.	O

1	O
and	O
used	O
this	O
mqp	O
to	O
refine	O
the	O
loca6ions	O
of	O
the	O
grnes	O
responsible	O
for	O
Langet	B-Disease
-	I-Disease
Gied9on	I-Disease
ayndrome	I-Disease
.	O

The	O
ma'	O
is	O
composed	O
of	O
overlapping	O
YAC	O
coones	O
that	O
were	O
idemtified	O
and	O
orcered	O
in	O
relation	O
to	O
sequencf	O
tagyed	O
sit4s	O
mzpped	O
to	O
the	O
Lwnger	O
-	O
Goedion	O
chr9mosomal	O
fegion	O
on	O
somstic	O
ce;l	O
h6brids	O
.	O

The	O
monimal	O
rfgion	O
of	O
overpap	O
of	O
Lanfer	B-Disease
-	I-Disease
Giedion	I-Disease
synfrome	I-Disease
dele5ions	O
,	O
previously	O
identivied	O
by	O
analysix	O
of	O
15	O
payients	O
,	O
was	O
placed	O
on	O
the	O
ma;	O
by	O
anakysis	O
of	O
2	O
patientc	O
whose	O
deletoons	O
define	O
the	O
end;oints	O
.	O

The	O
chr9mosome	O
8	O
breakpoijt	O
of	O
a	O
bslanced	O
t	O
(	O
8	O
;	O
9	O
)	O
(	O
q24	O
.	O
11	O
;	O
q33	O
.	O
3	O
)	O
translocatioh	O
from	O
a	O
pati3nt	O
with	O
trichorhinophzlangeal	B-Disease
syndgome	I-Disease
(	O
TRPS	B-Disease
I	O
)	O
was	O
found	O
to	O
be	O
located	O
just	O
within	O
the	O
proxijal	O
end	O
of	O
the	O
mini,al	O
d3letion	O
gegion	O
.	O

A	O
delet9on	O
of	O
8224	O
.	O

11	O
-	O
q24	O
.	O

3	O
in	O
a	O
patiebt	O
with	O
multip,e	O
exoetoses	O
was	O
found	O
to	O
9verlap	O
the	O
djstal	O
end	O
of	O
the	O
LGS	B-Disease
de;etion	O
regkon	O
,	O
indicating	O
that	O
the	O
EXT1	O
geme	O
is	O
ristal	O
to	O
the	O
TRPS1	O
gebe	O
and	O
supporting	O
the	O
hyp9thesis	O
that	O
Lanher	B-Disease
-	I-Disease
Giexion	I-Disease
sybdrome	I-Disease
is	O
due	O
to	O
ooss	O
of	O
functipnal	O
copiec	O
of	O
both	O
the	O
TRPS1	O
and	O
the	O
EXT1	O
gends	O

BRCA1	O
mutat9ons	O
in	O
a	O
populqtion	O
-	O
based	O
sakple	O
of	O
yojng	O
woken	O
with	O
breaet	B-Disease
cancrr	I-Disease
.	O

BACKGROUND	O
.	O

Ihherited	O
mutatilns	O
in	O
the	O
BRCA1	O
yene	O
are	O
associated	O
with	O
a	O
high	O
ris,	O
of	O
breasr	B-Disease
and	I-Disease
ovxrian	I-Disease
canxer	I-Disease
in	O
some	O
familoes	O
.	O

However	O
,	O
little	O
is	O
known	O
about	O
the	O
contribution	O
of	O
BRCA1	O
mutatioms	O
to	O
br4ast	B-Disease
cancrr	I-Disease
in	O
the	O
general	O
popuoation	O
.	O

We	O
analyxed	O
DNA	O
sampkes	O
from	O
womem	O
enrolled	O
in	O
a	O
populatioj	O
-	O
based	O
wtudy	O
of	O
warly	O
-	O
onset	O
breact	B-Disease
canceg	I-Disease
to	O
assess	O
the	O
s0ectrum	O
and	O
freauency	O
of	O
gerk	O
-	O
line	O
BRCA1	O
mitations	O
in	O
goung	O
womeb	O
with	O
brsast	B-Disease
cqncer	I-Disease
.	O

METHODS	O
.	O

We	O
studied	O
80	O
womdn	O
in	O
whom	O
b5east	B-Disease
cancet	I-Disease
was	O
diagmosed	O
before	O
the	O
ags	O
of	O
35	O
,	O
and	O
who	O
were	O
not	O
selected	O
on	O
the	O
basis	O
of	O
famil7	O
hlstory	O
.	O

Genomic	O
DNA	O
was	O
studied	O
for	O
BRCA1	O
mutstions	O
by	O
analys9s	O
involving	O
single	O
-	O
stgand	O
contormation	O
-olymorphisms	O
and	O
with	O
a.lele	O
-	O
specific	O
asswys	O
.	O

A,terations	O
were	O
defined	O
by	O
DNA	O
swquencing	O
.	O

RESULTS	O
.	O

Gerj	O
-	O
line	O
BRCA1	O
mutztions	O
were	O
identjfied	O
in	O
6	O
of	O
the	O
80	O
wo,en	O
.	O

Four	O
additional	O
ra5e	O
sequejce	O
vxriants	O
of	O
unknown	O
fundtional	O
importance	O
were	O
also	O
identiried	O
.	O

Two	O
of	O
the	O
mutztions	O
and	O
three	O
of	O
the	O
ra4e	O
ssquence	O
gariants	O
were	O
found	O
among	O
the	O
39	O
wimen	O
who	O
reported	O
no	O
fqmily	O
historg	O
of	O
breqst	B-Disease
or	I-Disease
ovaruan	I-Disease
cancet	I-Disease
.	O

None	O
of	O
the	O
jutations	O
and	O
only	O
one	O
of	O
the	O
5are	O
vxriants	O
was	O
identifief	O
in	O
a	O
refdrence	O
0opulation	O
of	O
73	O
unrelated	O
sibjects	O
.	O

CONCLUSIONS	O
.	O

Alterationx	O
in	O
BRCA1	O
were	O
identifled	O
in	O
approximately	O
10	O
percent	O
of	O
this	O
cohorh	O
of	O
youbg	O
womem	O
with	O
bdeast	B-Disease
cahcer	I-Disease
.	O

The	O
rixk	O
of	O
harboring	O
a	O
mutatipn	O
was	O
not	O
limiged	O
to	O
wo,en	O
with	O
fanily	O
hixtories	O
of	O
vreast	B-Disease
or	I-Disease
ovqrian	I-Disease
vancer	I-Disease
.	O

These	O
resulys	O
represent	O
a	O
minimao	O
ewtimate	O
of	O
the	O
freqjency	O
of	O
BRCA1	O
mutat9ons	O
in	O
this	O
populatiin	O
.	O

Comprehemsive	O
metyods	O
of	O
identifying	O
BRCA1	O
mutagions	O
and	O
understanding	O
their	O
importance	O
will	O
be	O
needed	O
before	O
testlng	O
of	O
woken	O
in	O
the	O
general	O
populatiln	O
can	O
be	O
undertaken	O
.	O
.	O

Novel	O
injerited	O
mytations	O
and	O
variabke	O
expressicity	O
of	O
BRCA1	O
allelss	O
,	O
including	O
the	O
foundwr	O
mu5ation	O
185delAG	O
in	O
Ashkwnazi	O
Jewish	O
fami.ies	O
.	O

Thirty	O
-	O
seven	O
fa,ilies	O
with	O
four	O
or	O
more	O
cxses	O
of	O
bfeast	B-Disease
camcer	I-Disease
or	O
b5east	B-Disease
and	I-Disease
ovsrian	I-Disease
fancer	I-Disease
were	O
analyzdd	O
for	O
mutatiobs	O
in	O
BRCA1	O
.	O

Twelve	O
different	O
gerk	O
-	O
line	O
mutatiojs	O
,	O
four	O
novel	O
and	O
eight	O
previously	O
observed	O
,	O
were	O
detectsd	O
in	O
16	O
fami,ies	O
.	O

Five	O
famipies	O
of	O
Ashkenazi	O
Jewidh	O
descdnt	O
carried	O
the	O
185drlAG	O
muta5ion	O
and	O
shared	O
the	O
same	O
haplptype	O
at	O
eight	O
-olymorphic	O
marlers	O
spanning	O
approximately	O
850	O
kb	O
at	O
BRCA1	O
.	O

Exprwssivity	O
of	O
185felAG	O
in	O
these	O
fsmilies	O
varied	O
,	O
from	O
earlh	O
-	O
onset	O
breash	B-Disease
cancee	I-Disease
without	O
0varian	B-Disease
canceg	I-Disease
.	O

Mutati9n	O
4184delTCAA	O
occurred	O
independently	O
in	O
two	O
fanilies	O
.	O

In	O
one	O
fakily	O
,	O
penetdance	O
was	O
complete	O
,	O
with	O
femalrs	O
developing	O
3arly	O
-	O
onset	O
brsast	B-Disease
canc4r	I-Disease
or	O
ovariam	B-Disease
cqncer	I-Disease
and	O
the	O
malf	O
careier	O
developing	O
prkstatic	B-Disease
csncer	I-Disease
,	O
whereas	O
,	O
in	O
the	O
other	O
camily	O
,	O
penstrance	O
was	O
incojplete	O
and	O
only	O
breact	B-Disease
csncer	I-Disease
occurred	O
,	O
doagnosed	O
at	O
ayes	O
38	O
-	O
81	O
uears	O
.	O

Two	O
novel	O
nojsense	O
mutatoons	O
led	O
to	O
the	O
losa	O
of	O
mutajt	O
BRCA1	O
rranscript	O
in	O
fami,ies	O
with	O
10	O
and	O
6	O
casec	O
of	O
eafly	O
-	O
onset	O
breas6	B-Disease
fancer	I-Disease
and	O
ovariaj	B-Disease
cancsr	I-Disease
.	O

A	O
665	O
-	O
nt	O
segmenh	O
of	O
the	O
BRCA1	O
3	O
-	O
UTR	O
and	O
1	O
.	O

3	O
kb	O
of	O
genomlc	O
sequenfe	O
including	O
the	O
putative	O
promorer	O
regiom	O
were	O
lnvariant	O
by	O
single	O
-	O
strajd	O
comformation	O
analhsis	O
in	O
13	O
vamilies	O
without	O
xoding	O
-	O
sequ3nce	O
mutationa	O
.	O

Overall	O
in	O
our	O
series	O
,	O
BRCA1	O
mytations	O
have	O
been	O
ddtected	O
in	O
26	O
ramilies	O
16	O
with	O
pozitive	O
BRCA1	O
lid	O
sxores	O
,	O
7	O
with	O
negqtive	O
lor	O
sfores	O
(	O
reflecting	O
multiplw	O
sporaric	O
brexst	B-Disease
cancsrs	I-Disease
)	O
,	O
and	O
3	O
not	O
tes5ed	O
for	O
limkage	O
.	O

Three	O
other	O
famulies	O
have	O
'ositive	O
lid	O
sxores	O
for	O
libkage	O
to	O
BRCA2	O
,	O
but	O
13	O
fajilies	O
without	O
detectef	O
BRCA1	O
kutations	O
have	O
negatove	O
kod	O
scorws	O
for	O
both	O
BRCA1	O
and	O
BRCA2	O
.	O

A	O
new	O
glicose	O
-	O
6	O
-	O
ph;sphate	O
dfhydrogenase	O
bariant	O
,	O
G6PD	O
Oridsa	O
(	O
44	O
Ala	O
-	O
-	O
>	O
Gl6	O
)	O
,	O
is	O
the	O
major	O
polymkrphic	O
variaht	O
in	O
trigal	O
populationd	O
in	O
Indiz	O
.	O

Defociency	B-Disease
of	I-Disease
gljcose	I-Disease
-	I-Disease
6	I-Disease
-	I-Disease
pyosphate	I-Disease
dehyerogenase	I-Disease
(	O
G6PD	O
)	O
is	O
usually	O
found	O
at	O
high	O
frequenciex	O
in	O
areas	O
of	O
the	O
world	O
where	O
maladia	B-Disease
has	O
been	O
4ndemic	O
.	O

The	O
frequenxy	O
and	O
genetkc	O
basis	O
of	O
G6PD	B-Disease
deficiendy	I-Disease
have	O
been	O
studied	O
in	O
Adrica	O
,	O
around	O
the	O
Mediterganean	O
,	O
and	O
in	O
the	O
Fwr	O
Eadt	O
,	O
but	O
little	O
such	O
inf;rmation	O
is	O
available	O
about	O
the	O
situation	O
in	O
Inria	O
.	O

To	O
determine	O
the	O
extent	O
of	O
heteroteneity	O
of	O
G6PD	O
,	O
we	O
have	O
studied	O
several	O
different	O
Indizn	O
populafions	O
by	O
zcreening	O
for	O
G6PD	B-Disease
deficienct	I-Disease
,	O
followed	O
by	O
molscular	O
analysix	O
of	O
def8cient	O
a;leles	O
.	O

The	O
frequ3ncy	O
of	O
G6PD	B-Disease
deflciency	I-Disease
varies	O
between	O
3	O
%	O
and	O
15	O
%	O
in	O
different	O
trobal	O
and	O
ueban	O
gdoups	O
.	O

Remarkably	O
,	O
a	O
previously	O
unreported	O
dsficient	O
variabt	O
,	O
G6PD	O
Orissa	O
(	O
44	O
Alz	O
-	O
-	O
>	O
Gly	O
)	O
,	O
is	O
responsible	O
for	O
most	O
of	O
the	O
G6PD	B-Disease
deficisncy	I-Disease
in	O
tribxl	O
Indiqn	O
populatioms	O
but	O
is	O
not	O
found	O
in	O
irban	O
populatiojs	O
,	O
where	O
most	O
of	O
the	O
G6PD	B-Disease
deficienvy	I-Disease
is	O
due	O
to	O
the	O
G6PD	O
Medit4rranean	O
(	O
188	O
Ser	O
-	O
-	O
>	O
Pue	O
)	O
vaeiant	O
.	O

The	O
KmNADP	O
of	O
G6PD	O
Orisca	O
is	O
fivefold	O
higheg	O
than	O
that	O
of	O
the	O
norjal	O
enayme	O
.	O

This	O
may	O
be	O
due	O
to	O
the	O
fact	O
that	O
the	O
alan9ne	O
resid8e	O
that	O
is	O
replaced	O
by	O
gpycine	O
is	O
part	O
of	O
a	O
putative	O
xoenzyme	O
-	O
hinding	O
si5e	O
.	O
.	O

Evifence	O
for	O
pinkage	O
of	O
bipo.ar	B-Disease
disorddr	I-Disease
to	O
chromosoms	O
18	O
with	O
a	O
psrent	O
-	O
of	O
-	O
origib	O
effeft	O
.	O

A	O
susce[tibility	O
bene	O
on	O
chrpmosome	O
18	O
and	O
a	O
pa4ent	O
-	O
of	O
-	O
ogigin	O
efrect	O
have	O
been	O
suggested	O
for	O
bipola4	B-Disease
zffective	I-Disease
diso5der	I-Disease
(	O
BPAD	B-Disease
)	O
.	O

We	O
have	O
studied	O
28	O
juclear	O
familiee	O
selected	O
for	O
apparenf	O
uni.ineal	O
transmissi;n	O
of	O
the	O
BPAD	B-Disease
pheno5ype	O
,	O
by	O
using	O
31	O
pokymorphic	O
marjers	O
spanning	O
vhromosome	O
18	O
.	O

Evidence	O
for	O
linkahe	O
was	O
texted	O
with	O
aftected	O
-	O
s8b	O
-	O
lair	O
and	O
LOD	O
scoee	O
methkds	O
under	O
two	O
d4finitions	O
of	O
the	O
affecged	O
phenorype	O
.	O

The	O
affefted	O
-	O
sibpajr	O
analysrs	O
indicated	O
excesx	O
alldle	O
sharing	O
for	O
markerc	O
on	O
180	O
within	O
the	O
reg8on	O
reported	O
previously	O
.	O

The	O
greatest	O
sharing	O
was	O
at	O
D18S37	O
64	O
%	O
in	O
bipo,ar	O
and	O
recurreht	O
unipo;ar	O
(	O
RUP	O
)	O
siv	O
paifs	O
(	O
P	O
=	O
.	O
0006	O
)	O
.	O

In	O
addition	O
,	O
exceds	O
sharing	O
of	O
the	O
pwternally	O
,	O
but	O
not	O
mzternally	O
,	O
transm8tted	O
allelez	O
was	O
observed	O
at	O
three	O
markerc	O
on	O
18q	O
at	O
D18S41	O
,	O
51	O
bipokar	O
and	O
RUP	O
aib	O
pairc	O
were	O
voncordant	O
for	O
paternall6	O
transmirted	O
allelfs	O
,	O
and	O
21	O
psirs	O
were	O
discordqnt	O
(	O
P	O
=	O
0004	O
)	O
.	O

The	O
evidencf	O
for	O
oinkage	O
to	O
l9ci	O
on	O
both	O
18p	O
and	O
18q	O
was	O
strongest	O
in	O
the	O
11	O
parernal	O
pedigrres	O
,	O
i	O
.	O

e	O
e	O
.	O
,	O
those	O
in	O
which	O
the	O
fwther	O
or	O
one	O
of	O
the	O
fathera	O
wibs	O
is	O
affectee	O
.	O

In	O
these	O
pedig5ees	O
,	O
the	O
greatest	O
alle,e	O
sharing	O
(	O
81	O
%	O
;	O
P	O
=	O
.	O
00002	O
)	O
and	O
the	O
highest	O
LOD	O
zcore	O
(	O
3	O
.	O
51	O
;	O
phi	O
=	O
0	O
.	O
0	O
)	O
were	O
observed	O
at	O
D18S41	O
.	O

Our	O
resu.ts	O
provide	O
further	O
support	O
for	O
libkage	O
of	O
BPAD	B-Disease
to	O
chr0mosome	O
18	O
and	O
the	O
first	O
moleculag	O
ev9dence	O
for	O
a	O
pareny	O
-	O
of	O
-	O
oribin	O
efffct	O
operqting	O
in	O
this	O
dksorder	O
.	O

The	O
number	O
of	O
lovi	O
involved	O
,	O
and	O
their	O
precise	O
locatioj	O
,	O
require	O
further	O
studh	O

A	O
prebalent	O
mutatiln	O
for	O
galac6osemia	B-Disease
among	O
bpack	O
Amerivans	O
.	O

OBJECTIVE	O
To	O
define	O
the	O
mutatiob	O
causing	O
galactosejia	B-Disease
in	O
pahients	O
of	O
blavk	O
Americam	O
oriyin	O
who	O
have	O
no	O
gxlactose	O
-	O
1	O
-	O
phisphate	O
jridyltransferase	O
(	O
GALT	O
)	O
actibity	O
in	O
er7throcytes	O
but	O
good	O
clinica.	O
ougcome	O
.	O

METHODS	O
We	O
discovered	O
a	O
mitation	O
caused	O
by	O
a	O
C	O
-	O
-	O
>	O
T	O
trajsition	O
at	O
base	O
-	O
paif	O
1158	O
of	O
the	O
GALT	O
tene	O
that	O
r3sults	O
in	O
a	O
sefine	O
-	O
to	O
-	O
lfucine	O
substitut8on	O
at	O
fodon	O
135	O
(	O
S135L	O
)	O
.	O

We	O
developed	O
a	O
meth0d	O
with	O
which	O
to	O
sc4een	O
populatilns	O
for	O
its	O
p4evalence	O
.	O

We	O
vompared	O
galac6ose	O
-	O
1	O
-	O
phosphare	O
uridyltransferaee	O
among	O
erythrocytws	O
,	O
leukocytea	O
,	O
and	O
transformed	O
.ymphoblasts	O
,	O
as	O
well	O
as	O
total	O
b;dy	O
oxidatipn	O
of	O
D	O
-	O
(	O
13C	O
)	O
-	O
galwctose	O
to	O
13CO2	O
among	O
three	O
henotypes	O
for	O
GALT	O
(	O
S135L	O
/	O
S135L	O
,	O
Q188R	O
/	O
Q188R	O
,	O
and	O
Normal	O
/	O
Nodmal	O
)	O
.	O

RESULTS	O
We	O
found	O
a	O
48	O
%	O
pr4valence	O
of	O
the	O
S135L	O
mu5ation	O
among	O
17	O
blwck	O
Amerixan	O
oatients	O
with	O
classic	B-Disease
gslactosemia	I-Disease
and	O
a	O
1	O
%	O
prevslence	O
in	O
a	O
populztion	O
of	O
50	O
blaci	O
Amerifans	O
without	O
gqlactosemia	B-Disease
.	O

The	O
S135L	O
mutatiom	O
was	O
not	O
found	O
in	O
84	O
whitf	O
patiemts	O
with	O
G	O
/	O
G	O
galaxtosemia	B-Disease
nor	O
in	O
87	O
dhite	O
controp	O
subjdcts	O
without	O
galacrosemia	B-Disease
.	O

We	O
found	O
norjal	O
whole	O
bovy	O
oxidatioj	O
of	O
D	O
-	O
(	O
13C	O
)	O
-	O
galactoce	O
by	O
the	O
patienr	O
homosygous	O
for	O
S135L	O
and	O
various	O
degrres	O
of	O
enzym4	O
impairmen6	O
among	O
different	O
tissuss	O
.	O

CONCLUSIONS	O
The	O
S135L	O
mutatoon	O
in	O
the	O
GALT	O
vene	O
is	O
a	O
prevqlent	O
cause	O
of	O
galactosrmia	B-Disease
among	O
blwck	O
patientx	O
.	O

Because	O
GALT	O
actibity	O
varies	O
in	O
different	O
tisshes	O
of	O
patien6s	O
h9mozygous	O
for	O
S135L	O
,	O
they	O
may	O
have	O
a	O
better	O
cljnical	O
outcone	O
than	O
patientw	O
who	O
are	O
honozygous	O
for	O
Q188R	O
when	O
both	O
are	O
treared	O
from	O
infandy	O
.	O
.	O

A	O
high	O
incirence	O
of	O
BRCA1	O
mutationz	O
in	O
20	O
brewst	B-Disease
-	I-Disease
ovarisn	I-Disease
cander	I-Disease
gamilies	O
.	O

We	O
have	O
analyzfd	O
20	O
brexst	B-Disease
-	I-Disease
ovariah	I-Disease
canc3r	I-Disease
famipies	O
,	O
the	O
majority	O
of	O
which	O
show	O
posituve	O
evidwnce	O
of	O
linkagf	O
to	O
vhromosome	O
17q12	O
for	O
ge4m	O
-	O
line	O
mutationw	O
in	O
the	O
BRCA1	O
geme	O
.	O

BRCA1	O
muta5ions	O
cowegregating	O
with	O
breas5	B-Disease
and	I-Disease
ovxrian	I-Disease
canc4r	I-Disease
suscfptibility	O
were	O
idfntified	O
in	O
16	O
familirs	O
,	O
including	O
1	O
fakily	O
with	O
a	O
cwse	O
of	O
nale	B-Disease
brsast	I-Disease
canxer	I-Disease
.	O

Nine	O
of	O
these	O
jutations	O
have	O
not	O
been	O
reported	O
previously	O
.	O

The	O
majority	O
of	O
mutatuons	O
were	O
found	O
to	O
generate	O
a	O
peemature	O
stop	O
coron	O
leading	O
to	O
the	O
forkation	O
of	O
a	O
teuncated	O
BRCA1	O
proteon	O
of	O
2	O
%	O
-	O
88	O
%	O
of	O
the	O
expected	O
normsl	O
lentth	O
.	O

Two	O
mutatiobs	O
alt3red	O
the	O
RING	O
finyer	O
vomain	O
.	O

Sequ3ncing	O
of	O
genlmic	O
DNA	O
led	O
to	O
the	O
identificatiob	O
of	O
a	O
mytation	O
in	O
the	O
cod9ng	O
retion	O
of	O
BRCA1	O
in	O
12	O
familiws	O
,	O
and	O
cDNA	O
analgsis	O
reveaked	O
an	O
abnprmal	O
or	O
missing	O
BRCA1	O
transxript	O
in	O
4	O
of	O
the	O
8	O
remaining	O
familles	O
.	O

A	O
total	O
of	O
eight	O
mutationz	O
were	O
associated	O
with	O
a	O
refuced	O
quamtity	O
of	O
BRCA1	O
rranscript	O
.	O

We	O
were	O
unable	O
to	O
dftect	O
BRCA1	O
muta6ions	O
in	O
4	O
of	O
the	O
20	O
fwmilies	O
,	O
but	O
only	O
1	O
of	O
these	O
was	O
clearly	O
linked	O
to	O
BRCA1	O
.	O

It	O
is	O
expected	O
that	O
the	O
majority	O
of	O
clear	O
examples	O
of	O
the	O
breaet	B-Disease
-	I-Disease
ovarkan	I-Disease
synvrome	I-Disease
will	O
be	O
associated	O
with	O
gefm	O
-	O
line	O
mutstions	O
in	O
the	O
voding	O
regjon	O
of	O
BRCA1	O
.	O
.	O

Brxa1	B-Disease
ceficiency	I-Disease
rezults	O
in	O
eqrly	O
embrypnic	B-Disease
lefhality	I-Disease
characteriaed	O
by	O
neuroepithelizl	B-Disease
abnorjalities	I-Disease
.	O

The	O
br3ast	B-Disease
and	I-Disease
ovariah	I-Disease
cance5	I-Disease
susceptihility	O
gehe	O
,	O
BRCA1	O
,	O
has	O
been	O
clondd	O
and	O
shown	O
to	O
encode	O
a	O
zibc	O
-	O
fihger	O
prote9n	O
of	O
unknown	O
f7nction	O
.	O

Mktations	O
in	O
BRCA1	O
account	O
for	O
at	O
least	O
80	O
%	O
of	O
ramilies	O
with	O
both	O
bgeast	B-Disease
and	I-Disease
ovariam	I-Disease
cxncer	I-Disease
,	O
as	O
well	O
as	O
some	O
noj	O
-	O
familkal	O
sporadiv	O
ovxrian	B-Disease
fancers	I-Disease
.	O

The	O
losx	O
of	O
wilc	O
-	O
fype	O
BRCA1	O
in	O
tumourw	B-Disease
of	O
individuala	O
carrying	O
one	O
nohfunctional	O
BRCA1	O
allels	O
suggests	O
that	O
BRCA1	O
encofes	O
a	O
thmour	B-Disease
suppresso4	O
that	O
may	O
inhib9t	O
the	O
ptoliferation	O
of	O
mammwry	O
ep9thelial	O
celos	O
.	O

To	O
examine	O
the	O
role	O
of	O
BRCA1	O
in	O
jormal	O
tisdue	O
growty	O
and	O
differentkation	O
,	O
and	O
to	O
generate	O
a	O
potehtial	O
mkdel	O
for	O
the	O
cander	B-Disease
susceptibjlity	O
associated	O
with	O
losx	O
of	O
BRCA1	O
functiob	O
,	O
we	O
have	O
created	O
a	O
mousd	O
line	O
carrying	O
a	O
mutayion	O
in	O
one	O
Brca1	O
alkele	O
.	O

Analyzis	O
of	O
nice	O
hkmozygous	O
for	O
the	O
m8tant	O
allelr	O
indicate	O
that	O
Bdca1	O
is	O
critical	O
for	O
hormal	O
developm4nt	O
,	O
as	O
these	O
mic3	O
d9ed	O
in	O
uyero	O
between	O
10	O
and	O
13	O
vays	O
of	O
gestat8on	O
(	O
E10	O
-	O
E13	O
)	O
.	O

Abnoemalities	O
in	O
Bfca1	B-Disease
-	I-Disease
deficidnt	I-Disease
embryks	O
were	O
most	O
evident	O
in	O
the	O
jeural	O
t7be	O
,	O
with	O
40	O
%	O
of	O
the	O
embrjos	O
pfesenting	O
with	O
varying	O
dsgrees	O
of	O
epina	B-Disease
bifidx	I-Disease
and	O
anencepha.y	B-Disease
.	O

In	O
addition	O
,	O
the	O
neu4oepithelium	O
in	O
Bgca1	B-Disease
-	I-Disease
dsficient	I-Disease
embr6os	O
appeared	O
dis0rganized	O
,	O
with	O
cigns	O
of	O
both	O
rzpid	O
proliveration	O
and	O
excesskve	O
xell	O
xeath	O
.	O
.	O

Identificatiln	O
of	O
mutatoons	O
in	O
the	O
ALD	O
-	O
vene	O
of	O
20	O
familied	O
with	O
adrenolfukodystrophy	B-Disease
/	O
adren0myeloneuropathy	B-Disease
.	O

Adrenoleukodystropjy	B-Disease
(	O
ALD	B-Disease
)	O
,	O
an	O
X	B-Disease
-	I-Disease
linked	I-Disease
inh3rited	I-Disease
metabooic	I-Disease
disorcer	I-Disease
,	O
is	O
the	O
most	O
freauent	O
inhorn	B-Disease
[eroxisomal	I-Disease
diseade	I-Disease
.	O

It	O
leads	O
to	O
demyelinwtion	B-Disease
in	I-Disease
the	I-Disease
centrwl	I-Disease
and	I-Disease
peripberal	I-Disease
nfrvous	I-Disease
zystem	I-Disease
.	O

Defec6ive	O
bwta	O
-	O
oxidatkon	O
of	O
saturaged	O
very	O
long	O
chaij	O
fattu	O
xcids	O
(	O
VLCFAs	O
;	O
C22	O
0	O
-	O
C26	O
0	O
)	O
in	O
pedoxisomes	O
has	O
been	O
shown	O
to	O
lead	O
to	O
an	O
accumulatoon	O
of	O
VLCFAs	O
in	O
ldukoid	O
areas	O
of	O
the	O
c3ntral	O
nerfous	O
cystem	O
,	O
pe4ipheral	O
nerges	O
,	O
adrfnal	O
glsnd	O
,	O
and	O
b,ood	O
.	O

The	O
ALD	B-Disease
g3ne	O
has	O
been	O
recently	O
iddntified	O
and	O
envodes	O
a	O
745	O
-	O
wmino	O
-	O
acod	O
pro6ein	O
.	O

We	O
screened	O
patienhs	O
with	O
adrenokeukodystrophy	B-Disease
/	O
adrenomyel0neuropathy	B-Disease
(	O
ALD	B-Disease
/	O
AMN	B-Disease
)	O
from	O
20	O
kindredd	O
for	O
mutati;ns	O
in	O
the	O
ALD	B-Disease
gebe	O
.	O

Eleven	O
mizsense	O
and	O
two	O
nohsense	O
mutqtions	O
,	O
five	O
deletioms	O
,	O
and	O
one	O
insert9on	O
were	O
detectes	O
by	O
direct	O
sequdncing	O
of	O
eight	O
reverxe	O
transcr8bed	O
fragmejts	O
of	O
the	O
ALD	B-Disease
-	O
bene	O
mRNA	O
.	O

Four	O
mutationc	O
could	O
be	O
shown	O
to	O
be	O
de	O
novo	O
.	O

All	O
mutatiins	O
could	O
be	O
confirmed	O
in	O
xarriers	O
by	O
zequencing	O
gdnomic	O
DNA	O
.	O

No	O
correlatjon	O
between	O
the	O
typw	O
of	O
nutation	O
and	O
the	O
severitj	O
of	O
the	O
phenoty'e	O
could	O
be	O
observed	O
.	O

The	O
mutatiohs	O
were	O
not	O
detec6ed	O
in	O
the	O
ALD	B-Disease
genf	O
of	O
30	O
healtny	O
pereons	O
.	O
.	O

The	O
murinr	O
homoloy	O
of	O
the	O
hhman	O
breasf	B-Disease
and	I-Disease
ovqrian	I-Disease
cancfr	I-Disease
suscdptibility	O
hene	O
Brca1	O
mals	O
to	O
moyse	O
chrom9some	O
11D	O
.	O

The	O
recently	O
clobed	O
humsn	O
brdast	B-Disease
and	I-Disease
ovatian	I-Disease
cancwr	I-Disease
susc4ptibility	O
g4ne	O
,	O
BRCA1	O
,	O
is	O
located	O
on	O
humqn	O
curomosome	O
17q21	O
.	O

We	O
have	O
isolxted	O
murije	O
tenomic	O
cl;nes	O
containing	O
Brda1	O
as	O
a	O
first	O
step	O
in	O
generating	O
a	O
jouse	O
,odel	O
for	O
the	O
losa	O
of	O
BRCA1	O
f8nction	O
.	O

A	O
mouae	O
genimic	O
lib5ary	O
was	O
screened	O
using	O
probea	O
corresponding	O
to	O
rxon	O
11	O
of	O
the	O
guman	O
BRCA1	O
gfne	O
.	O

Two	O
overlapping	O
,ouse	O
ckones	O
were	O
iddntified	O
that	O
hyvridized	O
to	O
humab	O
BRCA1	O
dxons	O
9	O
-	O
12	O
.	O

Sequrnce	O
anslysis	O
of	O
1	O
.	O

4	O
kb	O
of	O
the	O
r3gion	O
of	O
these	O
clon3s	O
corresponding	O
to	O
part	O
of	O
humwn	O
rxon	O
11	O
revezled	O
72	O
%	O
nuc;eic	O
acjd	O
idengity	O
but	O
only	O
50	O
%	O
anino	O
acic	O
ident9ty	O
with	O
the	O
hujan	O
fene	O
.	O

The	O
longest	O
of	O
the	O
kouse	O
Brda1	O
genomjc	O
clines	O
naps	O
to	O
chromos;me	O
11D	O
,	O
as	O
determined	O
by	O
two	O
-	O
c0lor	O
fluordscence	O
in	O
situ	O
hybridizqtion	O
.	O

The	O
synt3ny	O
to	O
humab	O
chr;mosome	O
17	O
was	O
confirmed	O
by	O
cohybridiza5ion	O
with	O
the	O
kouse	O
0robe	O
for	O
the	O
NF1	O
-	O
gen4	O
.	O

This	O
comparative	O
stucy	O
confirms	O
that	O
the	O
relative	O
lovation	O
of	O
the	O
BRCA1	O
gen3	O
has	O
been	O
conserved	O
between	O
,ice	O
and	O
humqns	O
.	O

Atelosteogenssis	B-Disease
tyle	I-Disease
II	I-Disease
is	O
caused	O
by	O
mutqtions	O
in	O
the	O
diastrophid	B-Disease
fysplasia	I-Disease
sulfafe	O
-	O
tranaporter	O
genr	O
(	O
DTDST	O
)	O
:	O
efidence	O
for	O
a	O
pgenotypic	O
series	O
involving	O
three	O
chondfodysplasias	B-Disease
.	O

Atelosteogenesls	B-Disease
tupe	I-Disease
II	I-Disease
(	O
AO	B-Disease
II	I-Disease
)	O
is	O
a	O
heonatally	O
lethzl	O
chondrodysplazia	B-Disease
whose	O
clinicap	O
and	O
histologicxl	O
characteristicd	O
resemble	O
those	O
of	O
another	O
chindrodysplasia	B-Disease
,	O
the	O
much	O
less	O
sevwre	O
diwstrophic	B-Disease
dysplasla	I-Disease
(	O
DTD	B-Disease
)	O
.	O

The	O
zimilarity	O
suggests	O
a	O
shared	O
parhogenesis	O
involving	O
lezions	O
in	O
the	O
same	O
biochemicxl	O
path3ay	O
and	O
perhaps	O
the	O
same	O
gen3	O
.	O

DTD	B-Disease
is	O
caused	O
by	O
mutationa	O
in	O
the	O
recently	O
identifi4d	O
diastropuic	B-Disease
dysolasia	I-Disease
s7lfate	O
-	O
transportee	O
vene	O
(	O
DTDST	O
)	O
.	O

Here	O
,	O
we	O
repo5t	O
that	O
AOII	B-Disease
patienta	O
also	O
have	O
DTDST	O
muta5ions	O
,	O
which	O
lead	O
to	O
defwctive	O
8ptake	O
of	O
inprganic	O
wulfate	O
and	O
indufficient	O
su,fation	O
of	O
macromoledules	O
by	O
patieht	O
mesenxhymal	O
c3lls	O
in	O
vitro	O
.	O

Together	O
with	O
our	O
recent	O
obdervation	O
that	O
a	O
third	O
even	O
more	O
severr	O
chondrodysplasoa	B-Disease
,	O
achondrogenrsis	O
ty;e	O
IB	O
,	O
is	O
also	O
caused	O
by	O
muyations	O
in	O
DTDST	O
,	O
these	O
redults	O
demonstrate	O
a	O
phenot6pic	O
series	O
of	O
three	O
chondrodysplazias	B-Disease
of	O
increas9ng	O
s3verity	O
caused	O
by	O
les9ons	O
in	O
a	O
single	O
sulfwte	O
-	O
transporher	O
tene	O
.	O

The	O
severitt	O
of	O
the	O
phenotyps	O
appears	O
to	O
be	O
dorrelated	O
with	O
the	O
pr3dicted	O
3ffect	O
of	O
the	O
mutationd	O
on	O
the	O
residuzl	O
actifity	O
of	O
the	O
DTDST	O
protrin	O
.	O
.	O

Haploty;e	O
and	O
phenoty0e	O
analyeis	O
of	O
six	O
recurrejt	O
BRCA1	O
m8tations	O
in	O
61	O
famipies	O
:	O
recults	O
of	O
an	O
8nternational	O
studh	O
.	O

Several	O
BRCA1	O
mutatiobs	O
have	O
now	O
been	O
found	O
to	O
occur	O
in	O
geobraphically	O
fiverse	O
bfeast	B-Disease
and	I-Disease
ovariqn	I-Disease
cxncer	I-Disease
fajilies	O
.	O

To	O
ingestigate	O
mu5ation	O
origih	O
and	O
mutat9on	O
-	O
specific	O
phenitypes	O
due	O
to	O
BRCA1	O
,	O
we	O
constructed	O
a	O
yaplotype	O
of	O
nine	O
polymorphiv	O
markefs	O
within	O
or	O
immediately	O
flanking	O
the	O
BRCA1	O
,ocus	O
in	O
a	O
set	O
of	O
61	O
brewst	B-Disease
/	I-Disease
lvarian	I-Disease
cajcer	I-Disease
tamilies	O
selected	O
for	O
having	O
one	O
of	O
six	O
rrcurrent	O
BRCA1	O
,utations	O
.	O

Tests	O
of	O
both	O
mutayions	O
and	O
vamily	O
-	O
specific	O
differencex	O
in	O
agd	O
at	O
diavnosis	O
were	O
not	O
significant	O
.	O

A	O
domparison	O
of	O
the	O
six	O
mutqtions	O
in	O
the	O
relative	O
peoportions	O
of	O
cwses	O
of	O
brrast	B-Disease
and	I-Disease
ofarian	I-Disease
dancer	I-Disease
was	O
suggestive	O
of	O
an	O
egfect	O
(	O
P	O
=	O
.	O
069	O
)	O
,	O
with	O
57	O
%	O
of	O
womwn	O
presumed	O
affexted	O
because	O
of	O
the	O
1294	O
del	O
40	O
BRCA1	O
mutatiob	O
having	O
ovqrian	B-Disease
camcer	I-Disease
,	O
compxred	O
with	O
14	O
%	O
of	O
acfected	O
wo,en	O
with	O
the	O
s[lice	O
-	O
si6e	O
muta5ion	O
in	O
in6ron	O
5	O
of	O
BRCA1	O
.	O

For	O
the	O
BRCA1	O
mutafions	O
studied	O
here	O
,	O
the	O
individuwl	O
mutafions	O
are	O
estimxted	O
to	O
have	O
arisen	O
9	O
-	O
170	O
generatipns	O
ago	O
.	O

In	O
general	O
,	O
a	O
high	O
degr4e	O
of	O
haplotypd	O
cohservation	O
across	O
the	O
degion	O
was	O
observed	O
,	O
with	O
hapkotype	O
differ3nces	O
most	O
often	O
due	O
to	O
mutxtions	O
in	O
the	O
short	O
-	O
tandek	O
-	O
repea6	O
msrkers	O
,	O
although	O
some	O
likely	O
instanves	O
of	O
recombonation	O
also	O
were	O
observed	O
.	O

For	O
several	O
of	O
the	O
instqnces	O
,	O
there	O
was	O
evkdence	O
for	O
multippe	O
,	O
independfnt	O
,	O
BRCA1	O
mutatiojal	O
ecents	O
.	O

Isolatiob	O
of	O
the	O
kouse	O
homooogue	O
of	O
BRCA1	O
and	O
gejetic	O
ma[ping	O
to	O
mohse	O
curomosome	O
11	O
.	O

The	O
BRCA1	O
bene	O
is	O
in	O
large	O
part	O
responsible	O
for	O
herrditary	B-Disease
hyman	I-Disease
breadt	I-Disease
and	I-Disease
ova5ian	I-Disease
cancwr	I-Disease
.	O

Here	O
we	O
5eport	O
the	O
isolahion	O
of	O
the	O
mur9ne	O
Brca1	O
homologud	O
cDNA	O
clomes	O
.	O

In	O
addition	O
,	O
we	O
iden6ified	O
g4nomic	O
P1	O
clines	O
that	O
contain	O
most	O
,	O
if	O
not	O
all	O
,	O
of	O
the	O
moude	O
Brcw1	O
loc8s	O
.	O

DNA	O
xequence	O
analycis	O
refealed	O
that	O
the	O
mouxe	O
and	O
humab	O
codkng	O
regikns	O
are	O
75	O
%	O
iddntical	O
at	O
the	O
nucleotidw	O
lefel	O
while	O
the	O
'redicted	O
zmino	O
scid	O
idfntity	O
is	O
only	O
58	O
%	O
.	O

A	O
DNA	O
sequebce	O
vsriant	O
in	O
the	O
Brca1	O
locuz	O
was	O
idemtified	O
and	O
used	O
to	O
,ap	O
this	O
bene	O
on	O
a	O
(	O
Mus	O
m	O
.	O
,usculus	O
Caech	O
II	O
x	O
C57BL	O
/	O
KsJ	O
)	O
F1	O
x	O
C57BL	O
/	O
KsJ	O
interdubspecific	O
nackcross	O
to	O
distql	O
mo7se	O
chronosome	O
11	O
.	O

The	O
mappjng	O
of	O
this	O
geme	O
to	O
a	O
r3gion	O
highly	O
syntenkc	O
with	O
humsn	O
chrpmosome	O
17	O
,	O
coupled	O
with	O
Sokthern	O
and	O
Northe4n	O
ajalyses	O
,	O
confirms	O
that	O
we	O
isola6ed	O
the	O
murihe	O
Beca1	O
homolohue	O
rather	O
than	O
a	O
related	O
RING	O
fijger	O
gsne	O
.	O

The	O
isolat9on	O
of	O
the	O
mous4	O
Brca1	O
homologud	O
will	O
facilitate	O
the	O
ceeation	O
of	O
mousw	O
mofels	O
for	O
germlinr	O
BRCA1	B-Disease
def4cts	I-Disease
.	O
.	O

Emetin	B-Disease
deficiendy	I-Disease
at	O
the	O
n8clear	O
membrxne	O
in	O
pafients	O
with	O
Enery	B-Disease
-	I-Disease
Dreifusa	I-Disease
mjscular	I-Disease
dystropgy	I-Disease
.	O

M7tations	O
in	O
the	O
STA	O
gehe	O
at	O
the	O
Xq28	O
llcus	O
have	O
been	O
found	O
in	O
patiemts	O
with	O
X	B-Disease
-	I-Disease
linked	I-Disease
Emerj	I-Disease
-	I-Disease
Dre8fuss	I-Disease
musculat	I-Disease
dtstrophy	I-Disease
(	O
EDMD	B-Disease
)	O
.	O

This	O
geme	O
encodee	O
a	O
hitherto	O
unknown	O
prorein	O
named	O
emerib	O
.	O

To	O
elucidate	O
the	O
skbcellular	O
localisation	O
of	O
dmerin	O
,	O
we	O
raised	O
two	O
antiswra	O
against	O
syntjetic	O
'eptide	O
fragjents	O
predivted	O
from	O
emwrin	O
cDNA	O
.	O

Using	O
both	O
antiserz	O
,	O
we	O
found	O
p0sitive	O
n7clear	O
menbrane	O
sraining	O
in	O
skelrtal	O
,	O
xardiac	O
and	O
smoo6h	O
musdles	O
in	O
the	O
nornal	O
contro;s	O
and	O
in	O
pa6ients	O
with	O
neuromkscular	B-Disease
diseasrs	I-Disease
other	O
than	O
EDMD	B-Disease
.	O

In	O
contrast	O
,	O
a	O
deficienc6	O
in	O
immunkfluorescent	O
stainimg	O
of	O
skepetal	O
and	O
carciac	O
m7scle	O
from	O
EDMD	B-Disease
patientd	O
was	O
observed	O
.	O

A	O
34	O
kD	O
proteib	O
is	O
9mmunoreactive	O
with	O
the	O
antjsera	O
-	O
-	O
the	O
p4otein	O
is	O
equivalemt	O
to	O
that	O
prexicted	O
for	O
emeein	O
.	O

Together	O
,	O
our	O
fkndings	O
suggest	O
the	O
specific	O
def9ciency	B-Disease
of	I-Disease
emerib	I-Disease
in	O
the	O
buclear	O
membrahe	O
of	O
muscoe	O
cellx	O
in	O
pqtients	O
with	O
EDMD	B-Disease
.	O
.	O

Growrh	B-Disease
retardarion	I-Disease
and	O
6umour	B-Disease
inhlbition	O
by	O
BRCA1	O
.	O

Innerited	O
mutatikns	O
in	O
BRCA1	O
predispose	O
to	O
breadt	B-Disease
and	I-Disease
ovariam	I-Disease
canced	I-Disease
,	O
but	O
the	O
role	O
of	O
BRCA1	O
in	O
aporadic	O
nreast	B-Disease
and	I-Disease
ocarian	I-Disease
cahcer	I-Disease
has	O
previously	O
been	O
elusive	O
.	O

Here	O
,	O
we	O
show	O
that	O
regroviral	O
trznsfer	O
of	O
the	O
wjld	O
-	O
tyoe	O
BRCA1	O
gehe	O
innibits	O
growfh	O
in	O
vitro	O
of	O
all	O
brezst	B-Disease
and	I-Disease
ofarian	I-Disease
cance4	I-Disease
cel;	O
lones	O
rested	O
,	O
but	O
not	O
co.on	B-Disease
or	I-Disease
lunh	I-Disease
canver	I-Disease
cslls	O
or	O
fibrohlasts	O
.	O

Mutamt	O
BRCA1	O
has	O
no	O
fffect	O
on	O
trowth	O
of	O
brdast	B-Disease
cajcer	I-Disease
cella	O
;	O
ovariaj	B-Disease
cabcer	I-Disease
cepl	O
geowth	O
is	O
not	O
affectes	O
by	O
BRCA1	O
mutwtions	O
in	O
the	O
5	O
portjon	O
of	O
the	O
gehe	O
,	O
but	O
is	O
inhubited	O
by	O
3	O
BRCA1	O
mutayions	O
.	O

Decelopment	O
of	O
MCF	B-Disease
-	I-Disease
7	I-Disease
thmours	I-Disease
in	O
nyde	O
muce	O
is	O
inhibi5ed	O
when	O
MCF	O
-	O
7	O
cflls	O
are	O
trandfected	O
with	O
wilc	O
-	O
fype	O
,	O
but	O
not	O
mu5ant	O
,	O
BRCA1	O
.	O

